PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Yahi, N; Aulas, A; Fantini, J				Yahi, Nouara; Aulas, Anais; Fantini, Jacques			How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's beta Amyloid Peptide (A beta(1-40))	PLOS ONE			English	Article							SPHINGOLIPID-BINDING DOMAIN; HELICOBACTER-PYLORI; PRECURSOR PROTEIN; LIPID MONOLAYERS; DISEASE; MEMBRANES; FIBRILLOGENESIS; CEREBROSIDE; FORM; GM1	Membrane lipids play a pivotal role in the pathogenesis of Alzheimer's disease, which is associated with conformational changes, oligomerization and/or aggregation of Alzheimer's beta-amyloid (A beta) peptides. Yet conflicting data have been reported on the respective effect of cholesterol and glycosphingolipids (GSLs) on the supramolecular assembly of A beta peptides. The aim of the present study was to unravel the molecular mechanisms by which cholesterol modulates the interaction between A beta(1-40) and chemically defined GSLs (GalCer, LacCer, GM1, GM3). Using the Langmuir monolayer technique, we show that A beta(1-40) selectively binds to GSLs containing a 2-OH group in the acyl chain of the ceramide backbone (HFA-GSLs). In contrast, A beta(1-40) did not interact with GSLs containing a nonhydroxylated fatty acid (NFA-GSLs). Cholesterol inhibited the interaction of A beta(1-40) with HFA-GSLs, through dilution of the GSL in the monolayer, but rendered the initially inactive NFA-GSLs competent for A beta(1-40) binding. Both crystallographic data and molecular dynamics simulations suggested that the active conformation of HFA-GSL involves a H-bond network that restricts the orientation of the sugar group of GSLs in a parallel orientation with respect to the membrane. This particular conformation is stabilized by the 2-OH group of the GSL. Correspondingly, the interaction of A beta(1-40) with HFA-GSLs is strongly inhibited by NaF, an efficient competitor of H-bond formation. For NFA-GSLs, this is the OH group of cholesterol that constrains the glycolipid to adopt the active L-shape conformation compatible with sugar-aromatic CH-pi stacking interactions involving residue Y10 of A beta(1-40). We conclude that cholesterol can either inhibit or facilitate membrane-A beta interactions through fine tuning of glycosphingolipid conformation. These data shed some light on the complex molecular interplay between cell surface GSLs, cholesterol and A beta peptides, and on the influence of this molecular ballet on A beta-membrane interactions.	[Yahi, Nouara; Aulas, Anais; Fantini, Jacques] Univ Aix Marseille 2, Univ Paul Cezanne Aix Marseille 3, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS UMR 6231,INRA USC 2027,Fac Sci St Jerome, Marseille, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Aix-Marseille Universite	Yahi, N (corresponding author), Univ Aix Marseille 2, Univ Paul Cezanne Aix Marseille 3, Ctr Rech Neurobiol & Neurophysiol Marseille, CNRS UMR 6231,INRA USC 2027,Fac Sci St Jerome, Marseille, France.	jacques.fantini@univ-cezanne.fr	Aulas, Anaïs/AAA-8813-2020	Aulas, Anais/0000-0003-4865-724X; Fantini, Jacques/0000-0001-8653-5521	Centre National de la Recherche Scienctifique (CNRS)	Centre National de la Recherche Scienctifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work has been entirely supported by institutional funds from the Centre National de la Recherche Scienctifique (CNRS) and the Universities of Aix-Marseille 2 and Aix-Marseille 3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Milh M, 2001, GLYCOCONJUGATE J, V18, P253, DOI 10.1023/A:1012460824913; Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; BARRIER L, 2008, NEUROBIOL A IN PRESS; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Fantini J, 2006, BIOCHEMISTRY-US, V45, P10957, DOI 10.1021/bi060762s; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Fantini J, 2009, BBA-BIOMEMBRANES, V1788, P2345, DOI 10.1016/j.bbamem.2009.08.016; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hammache D, 1998, J BIOL CHEM, V273, P7967, DOI 10.1074/jbc.273.14.7967; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris JR, 2008, MICRON, V39, P1192, DOI 10.1016/j.micron.2008.05.001; Harris JR, 2002, MICRON, V33, P609, DOI 10.1016/S0968-4328(02)00029-X; Hartmann T, 2007, J NEUROCHEM, V103, P159, DOI 10.1111/j.1471-4159.2007.04715.x; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Ikeda K, 2008, BIOCHEM BIOPH RES CO, V370, P525, DOI 10.1016/j.bbrc.2008.03.130; JOHNSTON DS, 1988, BIOCHIM BIOPHYS ACTA, V937, P10, DOI 10.1016/0005-2736(88)90222-2; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; KANNAGI R, 1983, CANCER RES, V43, P4997; Lahdo R, 2004, BIOCHEM J, V382, P987, DOI 10.1042/BJ20040777; Lingwood CA, 2010, CHEM PHYS LIPIDS, V163, P27, DOI 10.1016/j.chemphyslip.2009.09.001; Mahfoud R, 2002, J AGR FOOD CHEM, V50, P327, DOI 10.1021/jf010874k; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Maresca M, 2008, PHYS CHEM CHEM PHYS, V10, P2792, DOI 10.1039/b802594k; McLaurin J, 1998, J BIOL CHEM, V273, P4506, DOI 10.1074/jbc.273.8.4506; NISHIO M, 1995, TETRAHEDRON, V51, P8665, DOI 10.1016/0040-4020(94)01066-9; NYHOLM PG, 1990, CHEM PHYS LIPIDS, V52, P1, DOI 10.1016/0009-3084(90)90002-9; OBRIEN JS, 1964, J LIPID RES, V5, P339; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; PASCHER I, 1977, CHEM PHYS LIPIDS, V20, P175, DOI 10.1016/0009-3084(77)90033-0; QUIOCHO FA, 1986, ANNU REV BIOCHEM, V55, P287, DOI 10.1146/annurev.bi.55.070186.001443; SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOTTE JP, 1993, BIOCHEMISTRY-US, V32, P7886, DOI 10.1021/bi00082a008; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Thakur G, 2009, COLLOID SURFACE B, V74, P436, DOI 10.1016/j.colsurfb.2009.07.043; Valdes-Gonzalez T, 2001, PEPTIDES, V22, P1099, DOI 10.1016/S0196-9781(01)00432-6; van der Bijl P, 1996, BIOCHEM J, V317, P589, DOI 10.1042/bj3170589; Yanagisawa K, 2005, SUB CELL BIOCHEM, V38, P179; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881	48	81	83	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9079	10.1371/journal.pone.0009079	http://dx.doi.org/10.1371/journal.pone.0009079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140095	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400016
J	Hussenet, T; Dali, S; Exinger, J; Monga, B; Jost, B; Dembele, D; Martinet, N; Thibault, C; Huelsken, J; Brambilla, E; du Manoir, S				Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Martinet, Nadine; Thibault, Christelle; Huelsken, Joerg; Brambilla, Elisabeth; du Manoir, Stanislas			SOX2 Is an Oncogene Activated by Recurrent 3q26.3 Amplifications in Human Lung Squamous Cell Carcinomas	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION PROFILES; RESPIRATORY EPITHELIUM; CULLIN NEDDYLATION; GENOME BROWSER; BREAST-CANCER; SCCRO DCUN1D1; SOLID TUMORS; MODULE MAP; DIFFERENTIATION	Squamous cell carcinoma (SCC) of the lung is a frequent and aggressive cancer type. Gene amplifications, a known activating mechanism of oncogenes, target the 3q26-qter region as one of the most frequently gained/amplified genomic sites in SCC of various types. Here, we used array comparative genomic hybridization to delineate the consensus region of 3q26.3 amplifications in lung SCC. Recurrent amplifications occur in 20% of lung SCC (136 tumors in total) and map to a core region of 2 Mb (Megabases) that encompasses SOX2, a transcription factor gene. Intense SOX2 immunostaining is frequent in nuclei of lung SCC, indicating potential active transcriptional regulation by SOX2. Analyses of the transcriptome of lung SCC, SOX2-overexpressing lung epithelial cells and embryonic stem cells (ESCs) reveal that SOX2 contributes to activate ESC-like phenotypes and provide clues pertaining to the deregulated genes involved in the malignant phenotype. In cell culture experiments, overexpression of SOX2 stimulates cellular migration and anchorage-independent growth while SOX2 knockdown impairs cell growth. Finally, SOX2 over-expression in non-tumorigenic human lung bronchial epithelial cells is tumorigenic in immunocompromised mice. These results indicate that the SOX2 transcription factor, a major regulator of stem cell function, is also an oncogene and a driver gene for the recurrent 3q26.33 amplifications in lung SCC.	[Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; du Manoir, Stanislas] INSERM, U964, IGBMC, Dept Canc Biol, Illkirch Graffenstaden, France; [Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] INSERM, U964, IGBMC, Dept Biochip, Illkirch Graffenstaden, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] CNRS, UMR 7104, Illkirch Graffenstaden, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; Jost, Bernard; Dembele, Doulaye; Thibault, Christelle; du Manoir, Stanislas] Univ Strasbourg, Strasbourg, France; [Martinet, Nadine] Hop St Louis, INSERM, U728, Paris, France; [Hussenet, Thomas; Dali, Soraya; Exinger, Julien; Monga, Ben; du Manoir, Stanislas] Coll France, Chaire Genet, Illkirch Graffenstaden, France; [Huelsken, Joerg] EPFL SV ISREC CDTSO, Lausanne, Switzerland; [Brambilla, Elisabeth] INSERM, Inst Albert Bonniot, Dept Oncogenese & Biotechnol, U578, La Tronche, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France; Swiss Institute Experimental Cancer Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hussenet, T (corresponding author), INSERM, U964, IGBMC, Dept Canc Biol, Illkirch Graffenstaden, France.	hussenet@igbmc.fr; dumanoir@igbmc.fr	Brambilla, Elisabeth MP/L-8796-2013; Huelsken, Joerg/AAC-9581-2021; Dembélé, Doulaye/O-6513-2017; du manoir, stan p/O-8677-2017	Huelsken, Joerg/0000-0003-3105-9606; Dembélé, Doulaye/0000-0003-3879-6940; du manoir, stan p/0000-0002-2200-2651; Thibault-Carpentier, Christelle/0000-0003-1562-1451	Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Institut National du Cancer; Ligue Nationale Contre le Cancer; Association pour la Recherche sur le Cancer (ARC)	Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	Funding: This study was supported by funds from the Comitee Regional du Haut-Rhin de la Ligue Contre le Cancer, from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS) and the Institut National du Cancer (axe IV canceropole Grand-Est) as well as the Carte d'Identite des Tumeurs program (CIT) from the Ligue Nationale Contre le Cancer. Equipment necessary for array-CGH was funded by the Association pour la Recherche sur le Cancer (ARC). We are grateful to the Ligue Nationale Contre le Cancer for the "Allocation post-doctorale pour Jeune Chercheur Confirme'' attributed to Thomas Hussenet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beasley MB, 2005, SEMIN ROENTGENOL, V40, P90, DOI 10.1053/j.ro.2005.01.001; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Boelens MC, 2009, LUNG CANCER, V66, P372, DOI 10.1016/j.lungcan.2009.02.017; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Chi SM, 2006, CANCER LETT, V244, P53, DOI 10.1016/j.canlet.2005.11.036; Costa FF, 2005, GENE, V357, P83, DOI 10.1016/j.gene.2005.06.019; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Feng J, 2004, NEOPLASIA, V6, P623, DOI 10.1593/neo.04142; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gebhart E, 2000, INT J ONCOL, V16, P383; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HOGARTY MD, 2001, METABOLIC MOL BASES, P597; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; Hussenet T, 2006, CANCER GENET CYTOGEN, V169, P102, DOI 10.1016/j.cancergencyto.2006.03.009; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; KE Y, 1988, DIFFERENTIATION, V38, P60, DOI 10.1111/j.1432-0436.1988.tb00592.x; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lantuejoul S, 2005, CLIN CANCER RES, V11, P2074, DOI 10.1158/1078-0432.CCR-04-1376; Maeno K, 2006, ONCOGENE, V25, P271, DOI 10.1038/sj.onc.1209018; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Massion PP, 2002, CANCER RES, V62, P3636; Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moro-Sibilot D, 2008, EUR RESPIR J, V31, P854, DOI 10.1183/09031936.00058507; Muller D, 2006, BRIT J CANCER, V94, P1041, DOI 10.1038/sj.bjc.6603036; O-charoenrat P, 2008, CLIN CANCER RES, V14, P6780, DOI 10.1158/1078-0432.CCR-08-0719; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Park KS, 2006, AM J RESP CELL MOL, V34, P151, DOI 10.1165/rcmb.2005-0332OC; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Redon R, 2002, CANCER RES, V62, P6211; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sanada Y, 2006, PANCREAS, V32, P164, DOI 10.1097/01.mpa.0000202947.80117.a0; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Wilting SM, 2009, CANCER RES, V69, P647, DOI 10.1158/0008-5472.CAN-08-2478; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	67	226	234	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8960	10.1371/journal.pone.0008960	http://dx.doi.org/10.1371/journal.pone.0008960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126410	Green Published, gold, Green Submitted			2022-12-27	WOS:000274139100009
J	Sanz, AB; Sanchez-Nino, MD; Izquierdo, MC; Jakubowski, A; Justo, P; Blanco-Colio, LM; Ruiz-Ortega, M; Selgas, R; Egido, J; Ortiz, A				Sanz, Ana B.; Sanchez-Nino, Maria D.; Izquierdo, Maria C.; Jakubowski, Aniela; Justo, Pilar; Blanco-Colio, Luis M.; Ruiz-Ortega, Marta; Selgas, Rafael; Egido, Jesus; Ortiz, Alberto			TWEAK Activates the Non-Canonical NF kappa B Pathway in Murine Renal Tubular Cells: Modulation of CCL21	PLOS ONE			English	Article							EPITHELIAL-CELLS; NF-KAPPA-B2 P100; HUMAN KIDNEY; EXPRESSION; APOPTOSIS; INJURY; ALPHA; MICE; PROLIFERATION; INFLAMMATION	TWEAK is a member of the TNF superfamily of cytokines that contribute to kidney tubulointerstitial injury. It has previously been reported that TWEAK induces transient nuclear translocation of RelA and expression of RelA-dependent cytokines in renal tubular cells. Additionally, TWEAK induced long-lasting NF kappa B activation suggestive of engagement of the non-canonical NF kappa B pathway. We now explore TWEAK-induced activation of NF kappa B2 and RelB, as well as expression of CCL21, a T-cell chemotactic factor, in cultured murine tubular epithelial cells and in healthy kidneys in vivo. In cultured tubular cells, TWEAK and TNF alpha activated different DNA-binding NF kappa B complexes. TWEAK-induced sustained NF kappa B activation was associated with NF kappa B2 p100 processing to p52 via proteasome and nuclear translocation and DNA-binding of p52 and RelB. TWEAK, but not TNF alpha used as control), induced a delayed increase in CCL21a mRNA (3.5 +/- 1.22-fold over control) and CCL21 protein (2.5 +/- 0.8-fold over control), which was prevented by inhibition of the proteasome, or siRNA targeting of NIK or RelB, but not by RelA inhibition with parthenolide. A second NF kappa B2-dependent chemokine, CCL19, was upregulates by TWEAK, but not by TNF alpha. However, both cytokines promoted chemokine RANTES expression (3-fold mRNA at 24 h). In vivo, TWEAK induced nuclear NF kappa B2 and RelB translocation and CCL21a mRNA (1.5 +/- 0.3-fold over control) and CCL21 protein (1.6 +/- 0.5-fold over control) expression in normal kidney. Increased tubular nuclear RelB and tubular CCL21 expression in acute kidney injury were decreased by neutralization (2 +/- 0.9 vs 1.3 +/- 0.6-fold over healthy control) or deficiency of TWEAK (2 +/- 0.9 vs 0.8 +/- 0.6-fold over healthy control). Moreover, anti-TWEAK treatment prevented the recruitment of T cells to the kidney in this model (4.1 +/- 1.4 vs 1.8 +/- 1-fold over healthy control). Our results thus identify TWEAK as a regulator of non-canonical NF kappa B activation and CCL21 expression in tubular cells thus promoting lymphocyte recruitment to the kidney during acute injury.	[Sanchez-Nino, Maria D.; Izquierdo, Maria C.; Justo, Pilar; Blanco-Colio, Luis M.; Ruiz-Ortega, Marta; Egido, Jesus; Ortiz, Alberto] Univ Autonoma Madrid, Fdn Jimenez Diaz, Fdn Renal Inigo Alvarez de Toledo, Madrid, Spain; [Sanz, Ana B.; Selgas, Rafael] Hosp Univ La Paz, Serv Nefrol, Fdn Invest Biomed, Madrid, Spain; [Jakubowski, Aniela] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA USA	Autonomous University of Madrid; Hospital Universitario La Paz; Biogen	Sanz, AB (corresponding author), Hosp Univ La Paz, Serv Nefrol, Fdn Invest Biomed, Madrid, Spain.	aortiz@fjd.es	ortiz, alberto/Y-7582-2018; IZQUIERDO, M CONCEPCIÓN/A-8164-2013; Sanchez-Niño, Maria Dolores/B-7350-2019; Sanz, Ana Belen/C-9489-2013; Blanco-Colio, Luis M./Z-2390-2019; Ruiz-Ortega, Marta/D-3584-2012; Ortega, Marta Ruiz/AAN-2136-2020; ruiz-ortega, marta/D-3584-2012	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Sanz, Ana Belen/0000-0002-0255-5689; Ruiz-Ortega, Marta/0000-0002-1495-6535; Ortega, Marta Ruiz/0000-0002-1495-6535; ruiz-ortega, marta/0000-0002-1403-2690; IZQUIERDO, MARIA CONCEPCION/0000-0002-8690-0151; Blanco-Colio, Luis Miguel/0000-0002-1560-6609	FIS [CP04/00060, 06/0046]; EU [QLG1-CT-2002-01215]; Sociedad Espanola de Nefrologia; ISCIII-RETIC [REDinREN/RD06/0016]; Comunidad de Madrid [Madrid/FRACM/S-BIO0283/2006];  [SAF03/884];  [SAF2005-03378];  [SAF 2007-60896];  [PS09/00447]	FIS(Instituto de Salud Carlos III); EU(European Commission); Sociedad Espanola de Nefrologia; ISCIII-RETIC(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); ; ; ; 	Funding: Grant support: FIS CP04/00060, 06/0046, SAF03/884, SAF2005-03378, SAF 2007-60896, PS09/00447, EU QLG1-CT-2002-01215, Sociedad Espanola de Nefrologia, ISCIII-RETIC REDinREN/RD06/0016, Comunidad de Madrid/FRACM/S-BIO0283/2006. Salary support: FIS to PJ and to MCI and FIS and CAM to ABS, and to MDSN, Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 2002, J IMMUNOL, V168, P4301, DOI 10.4049/jimmunol.168.9.4301; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Boonstra JG, 1997, J AM SOC NEPHROL, V8, P1517; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Campbell S, 2004, FRONT BIOSCI-LANDMRK, V9, P2273, DOI 10.2741/1395; Carragher D, 2004, J IMMUNOL, V173, P2271, DOI 10.4049/jimmunol.173.4.2271; Chen SC, 2002, J IMMUNOL, V168, P1001, DOI 10.4049/jimmunol.168.3.1001; Chicheportiche Y, 2002, ARTHRITIS RES, V4, P126, DOI 10.1186/ar388; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Cuenca J, 2007, AM J PATHOL, V171, P820, DOI 10.2353/ajpath.2007.061076; de Haij S, 2004, KIDNEY INT, V65, P1577, DOI 10.1111/j.1523-1755.2004.00553.x; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dejardin E, 2006, BIOCHEM PHARMACOL, V72, P1161, DOI 10.1016/j.bcp.2006.08.007; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; GAO HX, 2009, CYTOKINE GROWTH F R, V20, P251; Harada N, 2002, BIOCHEM BIOPH RES CO, V299, P488, DOI 10.1016/S0006-291X(02)02670-0; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Justo P, 2006, KIDNEY INT, V70, P1750, DOI 10.1038/sj.ki.5001866; Justo P, 2003, KIDNEY INT, V64, pS52, DOI 10.1046/j.1523-1755.64.s86.10.x; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Lo JC, 2003, J CLIN INVEST, V112, P1495, DOI 10.1172/JCI200319188; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lorz C, 2000, J AM SOC NEPHROL, V11, P1266, DOI 10.1681/ASN.V1171266; Loverre A, 2004, J AM SOC NEPHROL, V15, P2675, DOI 10.1097/01.ASN.0000139932.00971.E4; Morrissey JJ, 1997, KIDNEY INT, V52, P926, DOI 10.1038/ki.1997.414; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Nemeth ZH, 2004, MOL PHARMACOL, V65, P342, DOI 10.1124/mol.65.2.342; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ortega A, 2006, J AM SOC NEPHROL, V17, P1594, DOI 10.1681/ASN.2005070690; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Remuzzi G, 1997, KIDNEY INT, V51, P2, DOI 10.1038/ki.1997.2; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; Sakai N, 2006, P NATL ACAD SCI USA, V103, P14098, DOI 10.1073/pnas.0511200103; Sanchez-Sanchez N, 2006, J IMMUNOL, V176, P5153, DOI 10.4049/jimmunol.176.9.5153; SANZ AB, 2009, J CELL MOL MED  0501; Sanz AB, 2008, J AM SOC NEPHROL, V19, P695, DOI 10.1681/ASN.2007050577; Starkey JM, 2006, DIABETES, V55, P1252, DOI 10.2337/db05-1554; Tran NL, 2005, J BIOL CHEM, V280, P3483, DOI 10.1074/jbc.M409906200; van Kooten C, 1999, EXP NEPHROL, V7, P429; Zhao Z, 2007, J IMMUNOL, V179, P7949, DOI 10.4049/jimmunol.179.11.7949	44	83	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8955	10.1371/journal.pone.0008955	http://dx.doi.org/10.1371/journal.pone.0008955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126461	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100006
J	Conteh, S; Chattopadhyay, R; Anderson, C; Hoffman, SL				Conteh, Solomon; Chattopadhyay, Rana; Anderson, Charles; Hoffman, Stephen L.			Plasmodium yoelii-Infected A. stephensi Inefficiently Transmit Malaria Compared to Intravenous Route	PLOS ONE			English	Article							SPOROZOITE SURFACE PROTEIN-2; ANOPHELES-STEPHENSI; MOSQUITO BITE; FALCIPARUM; BERGHEI; PROTECTION; SUSCEPTIBILITY; RADIATION; VACCINE; HUMANS	It was recently reported that when mosquitoes infected with P. berghei sporozoites feed on mice, they deposit approximately 100-300 sporozoites in the dermis. When we inoculate P. yoelii (Py) sporozoites intravenously (IV) into BALB/c mice, the 50% infectious dose (ID50) is often less than 3 sporozoites, indicating that essentially all Py sporozoites in salivary glands are infectious. Thus, it should only take the bite of one infected mosquito to infect 100% of mice. In human subjects, it takes the bite of at least 5 P. falciparum-infected mosquitoes to achieve 100% blood stage infection. Exposure to 1-2 infected mosquitoes only leads to blood stage infection in approximately 50% of subjects. If mosquitoes carrying Py sporozoites inoculate 100-300 sporozoites per bite, and 1 to 2 mosquito bites achieve 50% blood stage infection rates, then this would suggest that the majority of sporozoites inoculated by mosquitoes into the dermis are not responsible for a productive infection, or that a significant number of sporozoite-infected mosquitoes do not inoculate any sporozoites. The objective of this study was to determine if this is the case. We therefore studied the infectivity to mice of the bites of 1, 2, 4, or 5-8 Py-infected mosquitoes. The bite of one Py sporozoite-infected mosquito caused blood stage infection in 41.4% (12/29) of mice, two bites infected 66.7% (22/33), four bites infected 75% (18/24), and five to eight bites infected 100% (21/21). These findings demonstrate that inoculation of sporozoites by mosquito bite is much less efficient than IV inoculation of Py sporozoites by needle and syringe. Such data may have implications for determining the best route and dose of administration to humans of our attenuated P. falciparum sporozoite vaccine, the scientific basis of which is immunity by bites from irradiated infected mosquitoes, and suggest that the challenge is to develop a method of administration that approximates IV inoculation, not one that mimics mosquito bite.	[Conteh, Solomon; Chattopadhyay, Rana; Anderson, Charles; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA	Sanaria Inc.	Conteh, S (corresponding author), Sanaria Inc, Rockville, MD USA.	slhoffman@sanaria.com			Sanaria Inc	Sanaria Inc	All funds to support the project were provided by Sanaria Inc. The CEO of Sanaria is the senior author of the paper and had a significant role in study design, data analysis, and preparation of the manuscript.	Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; BEIER JC, 1992, J AM MOSQUITO CONTR, V8, P404; Chattopadhyay R, 2009, VACCINE, V27, P3675, DOI 10.1016/j.vaccine.2008.11.073; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; Engelmann S, 2006, MOL BIOCHEM PARASIT, V146, P30, DOI 10.1016/j.molbiopara.2005.10.015; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; KHAN ZM, 1991, INFECT IMMUN, V59, P2529, DOI 10.1128/IAI.59.8.2529-2534.1991; KHUSMITH S, 1991, SCIENCE, V252, P715, DOI 10.1126/science.1827210; KHUSMITH S, 1994, INFECT IMMUN, V62, P2979, DOI 10.1128/IAI.62.7.2979-2983.1994; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Matsuoka H, 2002, PARASITOL INT, V51, P17, DOI 10.1016/S1383-5769(01)00095-2; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; SCHELLER LF, 1994, INFECT IMMUN, V62, P4844, DOI 10.1128/IAI.62.11.4844-4847.1994; Sidjanski S, 1997, AM J TROP MED HYG, V57, P426, DOI 10.4269/ajtmh.1997.57.426; VANDERBERG JP, 1990, B WORLD HEALTH ORGAN, V68, P74; Vaughan JA, 1999, INFECT IMMUN, V67, P4285, DOI 10.1128/IAI.67.8.4285-4289.1999; Verhage DF, 2005, NETH J MED, V63, P52; WEISS WR, 1989, J IMMUNOL, V143, P4263; Yamauchi LM, 2007, CELL MICROBIOL, V9, P1215, DOI 10.1111/j.1462-5822.2006.00861.x	26	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8947	10.1371/journal.pone.0008947	http://dx.doi.org/10.1371/journal.pone.0008947			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126610	Green Published, Green Submitted, gold			2022-12-27	WOS:000274138000022
J	Hu, JF; Qi, Q; August, A				Hu, Jianfang; Qi, Qian; August, Avery			Itk Derived Signals Regulate the Expression of Th-POK and Controls the Development of CD4(+) T Cells	PLOS ONE			English	Article							TEC FAMILY KINASES; LINEAGE DIFFERENTIATION; TRANSCRIPTION FACTORS; CD8 LINEAGE; TCR SIGNALS; COMMITMENT; THPOK; MICE; REQUIREMENTS; DISTINCT	T cell development is critically dependent on both the environment and signals delivered by the T cell Receptor (TCR). The Tec family kinase Itk has been suggested to be an amplifier of signals emanating from the TCR and the loss of Itk partially affects most stages of thymopoiesis. Loss of Itk also differentially affects the development of conventional vs. non-conventional or innate memory phenotype T cells. Here, we examine whether these lineage choices are affected by a combination of TCR affinity and Itk by analyzing mice lacking Itk and carrying two TCR transgenes with differing affinities, OT-II and DO11.10. Our results show that developing thymocytes receive a gradient of signals, DO11.10 > OT-II > DO11.10/Itk(-/-) > OT-II/Itk(-/-). We also show that the development of CD4(+) T cells is controlled by TCR signaling via Itk, which regulates the expression of the transcription factor, Th-POK, an enforcement factor for CD4 commitment. This results in a reduction in CD4(+) T cell development, and an increase in the development of MHC class II restricted TCR transgenic CD8(+) T cells that resemble non-conventional or innate memory phenotype CD8 T cells. This alteration accompanies increased expression of Runx3 and its target genes Eomesodermin, Granzyme B and Perforin in Itk null OT-II CD4(+) thymocytes. All together, these data suggest that Itk plays an important role in CD4/CD8 commitment by regulating signal thresholds for the lineage commitment. Our data also suggest that the lower level of TCR signaling that occurs with a low affinity TCR in the absence of Itk can redirect some MHC class II restricted CD4(+) T cell to class II-restricted CD8(+) innate memory phenotype T cells.	[Hu, Jianfang; Qi, Qian; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Hu, Jianfang; Qi, Qian] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hu, JF (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA.	axa45@psu.edu	Qi, Qian/E-7454-2012		National Institutes of Health (NIH) [AI051626, AI065566]; Huck Institutes for Life Sciences; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051626, R01AI065566, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes for Life Sciences; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI051626 and AI065566 (NIH.gov) to AA. JH and QQ were Graduate Fellows of the Huck Institutes for Life Sciences. The Center for Molecular Immunology and Infectious Disease (supported in part under a grant from the Pennsylvania Department of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliahmad P, 2004, J EXP MED, V199, P1089, DOI 10.1084/jem.20040051; August A, 2002, INT J BIOCHEM CELL B, V34, P1184, DOI 10.1016/S1357-2725(02)00068-7; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg LJ, 2005, ANNU REV IMMUNOL, V23, P549, DOI 10.1146/annurev.immunol.22.012703.104743; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; GRATIOTDEANS J, 1994, P NATL ACAD SCI USA, V91, P10685, DOI 10.1073/pnas.91.22.10685; Hashimoto K, 1996, J EXP MED, V184, P931, DOI 10.1084/jem.184.3.931; Hayashi K, 2001, J IMMUNOL, V167, P4957, DOI 10.4049/jimmunol.167.9.4957; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Horai R, 2007, IMMUNITY, V27, P775, DOI 10.1016/j.immuni.2007.09.012; HU J, 2007, EUR J IMMUNOL; Hu JF, 2008, J IMMUNOL, V180, P6544, DOI 10.4049/jimmunol.180.10.6544; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; Keefe R, 1999, SCIENCE, V286, P1149, DOI 10.1126/science.286.5442.1149; Laky K, 2006, IMMUNOL REV, V209, P274, DOI 10.1111/j.0105-2896.2006.00358.x; Laky K, 2005, CURR OPIN IMMUNOL, V17, P116, DOI 10.1016/j.coi.2005.02.004; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Liu XL, 2004, NAT IMMUNOL, V5, P280, DOI 10.1038/ni1040; Lucas JA, 2002, J IMMUNOL, V168, P6142, DOI 10.4049/jimmunol.168.12.6142; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Lucas JA, 2007, J IMMUNOL, V179, P7561, DOI 10.4049/jimmunol.179.11.7561; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Nawijn MC, 2001, J IMMUNOL, V167, P715, DOI 10.4049/jimmunol.167.2.715; O Atherly L, 2006, IMMUNITY, V25, P79, DOI 10.1016/j.immuni.2006.05.012; Prince Amanda L, 2009, Immunol Rev, V228, P115, DOI 10.1111/j.1600-065X.2008.00746.x; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rothenberg EV, 2009, IMMUNOL CELL BIOL, V87, P109, DOI 10.1038/icb.2008.100; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Sharp LL, 1999, J IMMUNOL, V163, P6598; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8891	10.1371/journal.pone.0008891	http://dx.doi.org/10.1371/journal.pone.0008891			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126642	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500014
J	Tung, YCL; Ayuso, E; Shan, XY; Bosch, F; O'Rahilly, S; Coll, AP; Yeo, GSH				Tung, Yi-Chun Loraine; Ayuso, Eduard; Shan, Xiaoye; Bosch, Fatima; O'Rahilly, Stephen; Coll, Anthony P.; Yeo, Giles S. H.			Hypothalamic-Specific Manipulation of Fto, the Ortholog of the Human Obesity Gene FTO, Affects Food Intake in Rats	PLOS ONE			English	Article							BODY-MASS INDEX; ENERGY-INTAKE; CHILDREN; EXPENDITURE; VARIANT	Sequence variants in the first intron of FTO are strongly associated with human obesity and human carriers of the risk alleles show evidence for increased appetite and food intake. Mice globally lacking Fto display a complex phenotype characterised by both increased energy expenditure and increased food intake. The site of action of FTO on energy balance is unclear. Fasting reduces levels of Fto mRNA in the arcuate nucleus (ARC) of the hypothalamus, a site where Fto expression is particularly high. In this study, we have extended this nutritional link by demonstrating that consumption of a high fat diet (45%) results in a 2.5 fold increase in Arc Fto expression. We have further explored the role of hypothalamic Fto in the control of food intake by using stereotactic injections coupled with AAV technology to bi-directionally modulate Fto expression. An over expression of Fto protein by 2.5-fold in the ARC results in a 14% decrease in average daily food intake in the first week. In contrast, knocking down Arc Fto expression by 40% increases food intake by 16%. mRNA levels of Agrp, Pomc and Npy, ARC-expressed genes classically associated with the control of food intake, were not affected by the manipulation of Fto expression. However, over expression of Fto resulted in a 4-fold increase in the mRNA levels of Stat3, a signalling molecule critical for leptin receptor signalling, suggesting a possible candidate for the mediation of Fto's actions. These data provide further support for the notion that FTO itself can influence key components of energy balance, and is therefore a strong candidate for the mediation of the robust association between FTO intronic variants and adiposity. Importantly, this provide the first indication that selective alteration of FTO levels in the hypothalamus can influence food intake, a finding consistent with the reported effects of FTO alleles on appetite and food intake in man.	[Tung, Yi-Chun Loraine; Shan, Xiaoye; O'Rahilly, Stephen; Coll, Anthony P.; Yeo, Giles S. H.] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Addenbrookes Treatment Ctr,Inst Metab Sci, Cambridge CB2 2QQ, England; [Ayuso, Eduard; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Ctr Anim Biotechnol & Gene Therapy, E-08193 Barcelona, Spain; [Ayuso, Eduard; Bosch, Fatima] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Ayuso, Eduard; Bosch, Fatima] CIBER Diabet & Enfermedades Metab Asociadas, Barcelona, Spain	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Tung, YCL (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Addenbrookes Treatment Ctr,Inst Metab Sci, Cambridge CB2 2QQ, England.	so104@medschl.cam.ac.uk; gshy2@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; AYUSO LOPEZ, Eduardo/I-7686-2017	O'Rahilly, Stephen/0000-0003-2199-4449; BOSCH, FATIMA/0000-0002-7705-5515; Coll, Anthony Patrick/0000-0003-2594-7463; Yeo, Giles See How/0000-0001-8823-3615; Ayuso, Eduard/0000-0003-0811-2229	United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD); Wellcome Trust; European Union [LSHM-CT-2004-512013]; CLINIGENE; Ministerio de Ciencia e Innovacion [SAF2008-00962]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain;  [LSHB-CT-2006-018933]; MRC [G0600717] Funding Source: UKRI; Medical Research Council [G0600717] Funding Source: researchfish	United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union(European Commission); CLINIGENE(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the United Kingdom Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC-CORD), the Wellcome Trust, the European Union (FP6: EUGENE2, LSHM-CT-2004-512013 and CLINIGENE, LSHB-CT-2006-018933; FP7 EurOCHIP) and from Ministerio de Ciencia e Innovacion (SAF2008-00962), CIBER de Diabetes y Enfermedades Metabolicas Asociadas, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AYUSO E, GENE THER       1203; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; den Hoed M, 2009, AM J CLIN NUTR, V90, P1426, DOI 10.3945/ajcn.2009.28053; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; MEYRE D, 2009, DIABETES; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; SONESTEDT E, 2009, AM J CLIN NUTR; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; TANOFSKYKRAFF M, 2009, AM J CLIN NUTR; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Wright JF, 2005, MOL THER, V12, P171, DOI 10.1016/j.ymthe.2005.02.021	25	125	134	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8771	10.1371/journal.pone.0008771	http://dx.doi.org/10.1371/journal.pone.0008771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098739	Green Published, gold			2022-12-27	WOS:000273778900015
J	Costa, DP; Robinson, PW; Arnould, JPY; Harrison, AL; Simmons, SE; Hassrick, JL; Hoskins, AJ; Kirkman, SP; Oosthuizen, H; Villegas-Amtmann, S; Crocker, DE				Costa, Daniel P.; Robinson, Patrick W.; Arnould, John P. Y.; Harrison, Autumn-Lynn; Simmons, Samantha E.; Hassrick, Jason L.; Hoskins, Andrew J.; Kirkman, Stephen P.; Oosthuizen, Herman; Villegas-Amtmann, Stella; Crocker, Daniel E.			Accuracy of ARGOS Locations of Pinnipeds at-Sea Estimated Using Fastloc GPS	PLOS ONE			English	Article							TURTLES CARETTA-CARETTA; SATELLITE TELEMETRY; FORAGING ECOLOGY; ELEPHANT SEALS; HABITAT USE; TRACKING; MOVEMENT; BEHAVIOR	Background: ARGOS satellite telemetry is one of the most widely used methods to track the movements of free-ranging marine and terrestrial animals and is fundamental to studies of foraging ecology, migratory behavior and habitat-use. ARGOS location estimates do not include complete error estimations, and for many marine organisms, the most commonly acquired locations (Location Class 0, A, B, or Z) are provided with no declared error estimate. Methodology/Principal Findings: We compared the accuracy of ARGOS locations to those obtained using Fastloc GPS from the same electronic tags on five species of pinnipeds: 9 California sea lions (Zalophus californianus), 4 Galapagos sea lions (Zalophus wollebaeki), 6 Cape fur seals (Arctocephalus pusillus pusillus), 3 Australian fur seals (A. p. doriferus) and 5 northern elephant seals (Mirounga angustirostris). These species encompass a range of marine habitats (highly pelagic vs coastal), diving behaviors (mean dive durations 2-21 min) and range of latitudes (equator to temperate). A total of 7,318 ARGOS positions and 27,046 GPS positions were collected. Of these, 1,105 ARGOS positions were obtained within five minutes of a GPS position and were used for comparison. The 68(th) percentile ARGOS location errors as measured in this study were LC-3 0.49 km, LC-2 1.01 km, LC-1 1.20 km, LC-0 4.18 km, LC-A 6.19 km, LC-B 10.28 km. Conclusions/Significance: The ARGOS errors measured here are greater than those provided by ARGOS, but within the range of other studies. The error was non-normally distributed with each LC highly right-skewed. Locations of species that make short duration dives and spend extended periods on the surface (sea lions and fur seals) had less error than species like elephant seals that spend more time underwater and have shorter surface intervals. Supplemental data (S1) are provided allowing the creation of density distributions that can be used in a variety of filtering algorithms to improve the quality of ARGOS tracking data.	[Costa, Daniel P.; Robinson, Patrick W.; Harrison, Autumn-Lynn; Simmons, Samantha E.; Hassrick, Jason L.; Villegas-Amtmann, Stella] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Arnould, John P. Y.; Hoskins, Andrew J.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Oosthuizen, Herman] Dept Environm Affairs, Cape Town, South Africa; [Kirkman, Stephen P.] Univ Cape Town, Dept Zool, Anim Demog Unit, ZA-7700 Rondebosch, South Africa; [Crocker, Daniel E.] Sonoma State Univ, Dept Biol, Rohnert Pk, CA 94928 USA	University of California System; University of California Santa Cruz; Deakin University; Department of Environment, Forestry & Fisheries; University of Cape Town; California State University System; Sonoma State University	Costa, DP (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	costa@biology.ucsc.edu	Kirkman, Stephen/AAA-9139-2021; Hoskins, Andrew/T-2694-2019; Hassrick, Jason/AAE-4905-2020; Costa, Daniel/E-2616-2013	Kirkman, Stephen/0000-0001-5428-7375; Hoskins, Andrew/0000-0001-8907-6682; Simmons, Samantha/0000-0003-0326-6990; Costa, Daniel/0000-0002-0233-5782; Harrison, Autumn-Lynn/0000-0002-6213-1765	Marine Biology Trust; Friends of Long Marine Lab; Charles Darwin station; UCMEXUS; Center For Remote Sensing (UCSC); National Ocean Partnership Program [N00014-02-1-1012]; Office of Naval Research [N00014-00-1-0880, N00014-03-1-0651, N00014-08-1-1195]; National Science Foundation OPP [ANT-0523332, ANT-0440687-02]; International Association of Oil and Gas Producers [JIP2207-23]; Moore Foundation; Packard Foundation; Sloan Foundation; Australian Research Council	Marine Biology Trust; Friends of Long Marine Lab; Charles Darwin station; UCMEXUS; Center For Remote Sensing (UCSC); National Ocean Partnership Program; Office of Naval Research(Office of Naval Research); National Science Foundation OPP(National Science Foundation (NSF)); International Association of Oil and Gas Producers; Moore Foundation(Gordon and Betty Moore Foundation); Packard Foundation(The David & Lucile Packard Foundation); Sloan Foundation(Alfred P. Sloan Foundation); Australian Research Council(Australian Research Council)	Funding: This research was conducted as part of the Tagging of Pacific Predators (TOPP) program, and was supported in part by the Dr. Earl H. Myers and Ethel M. Myers Oceanographic, Marine Biology Trust, the Friends of Long Marine Lab, the Charles Darwin station, UCMEXUS, Center For Remote Sensing (UCSC), the National Ocean Partnership Program (N00014-02-1-1012), the Office of Naval Research (N00014-00-1-0880, N00014-03-1-0651 and N00014-08-1-1195), National Science Foundation OPP grants ANT-0523332 and ANT-0440687-02, International Association of Oil and Gas Producers contract JIP2207-23, the Moore, Packard, and Sloan Foundations and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnould JPY, 2007, AQUAT CONSERV, V17, pS53, DOI 10.1002/aqc.908; Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; Bekkby T, 2000, J SEA RES, V44, P267, DOI 10.1016/S1385-1101(00)00048-4; Bjorge A, 2002, MAR MAMMAL SCI, V18, P438, DOI 10.1111/j.1748-7692.2002.tb01047.x; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Burns JM, 2004, DEEP-SEA RES PT II, V51, P2279, DOI 10.1016/j.dsr2.2004.07.021; Burns JM, 2001, AM ZOOL, V41, P90, DOI 10.1668/0003-1569(2001)041[0090:HUBWSA]2.0.CO;2; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Eckert SA, 2002, J ZOOL, V257, P111, DOI 10.1017/S0952836902000705; Eckert SA, 2008, ECOL APPL, V18, P290, DOI 10.1890/06-2107.1; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Jonsen ID, 2006, J ANIM ECOL, V75, P1046, DOI 10.1111/j.1365-2656.2006.01129.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KEATING KA, 1991, J WILDLIFE MANAGE, V55, P160, DOI 10.2307/3809254; KUHN CE, 2006, MEASURING SEA FEEDIN; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; LEVANON N, 1985, IEEE T AERO ELEC SYS, V21, P783, DOI 10.1109/TAES.1985.310663; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MCCONNELL BJ, 1992, J ZOOL, V226, P271, DOI 10.1111/j.1469-7998.1992.tb03839.x; Millspaugh JJ., 2001, RADIO TRACKING ANIMA; Nicholls D. G., 2007, Notornis, V54, P137; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; RENAUD ML, 1994, B MAR SCI, V55, P1; Royer F, 2008, J EXP MAR BIOL ECOL, V359, P1, DOI 10.1016/j.jembe.2008.01.026; Shaffer SA, 2006, IEEE J OCEANIC ENG, V31, P82, DOI 10.1109/JOE.2006.872210; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; STEWART BS, 1989, MAR MAMMAL SCI, V5, P361, DOI 10.1111/j.1748-7692.1989.tb00348.x; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Turchin Peter, 1998; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616	45	178	180	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8677	10.1371/journal.pone.0008677	http://dx.doi.org/10.1371/journal.pone.0008677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090942	Green Submitted, gold, Green Published			2022-12-27	WOS:000273714900001
J	Adra, S; Sun, T; MacNeil, S; Holcombe, M; Smallwood, R				Adra, Salem; Sun, Tao; MacNeil, Sheila; Holcombe, Mike; Smallwood, Rod			Development of a Three Dimensional Multiscale Computational Model of the Human Epidermis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; BINDING-PROTEIN; GENE-EXPRESSION; CELL-MIGRATION; MECHANISMS; KERATINOCYTES; ACTIVATION; TGF-BETA-1	Transforming Growth Factor (TGF-beta 1) is a member of the TGF-beta superfamily ligand-receptor network. and plays a crucial role in tissue regeneration. The extensive in vitro and in vivo experimental literature describing its actions nevertheless describe an apparent paradox in that during re-epithelialisation it acts as proliferation inhibitor for keratinocytes. The majority of biological models focus on certain aspects of TGF-beta 1 behaviour and no one model provides a comprehensive story of this regulatory factor's action. Accordingly our aim was to develop a computational model to act as a complementary approach to improve our understanding of TGF-beta 1. In our previous study, an agent-based model of keratinocyte colony formation in 2D culture was developed. In this study this model was extensively developed into a three dimensional multiscale model of the human epidermis which is comprised of three interacting and integrated layers: (1) an agent-based model which captures the biological rules governing the cells in the human epidermis at the cellular level and includes the rules for injury induced emergent behaviours, (2) a COmplex PAthway SImulator (COPASI) model which simulates the expression and signalling of TGF-beta 1 at the sub-cellular level and (3) a mechanical layer embodied by a numerical physical solver responsible for resolving the forces exerted between cells at the multi-cellular level. The integrated model was initially validated by using it to grow a piece of virtual epidermis in 3D and comparing the in virtuo simulations of keratinocyte behaviour and of TGF-beta 1 signalling with the extensive research literature describing this key regulatory protein. This research reinforces the idea that computational modelling can be an effective additional tool to aid our understanding of complex systems. In the accompanying paper the model is used to explore hypotheses of the functions of TGF-beta 1 at the cellular and subcellular level on different keratinocyte populations during epidermal wound healing.	[Adra, Salem; Holcombe, Mike; Smallwood, Rod] Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England; [Sun, Tao] Univ Glasgow, Ctr Cell Engn, Glasgow, Lanark, Scotland; [MacNeil, Sheila] Univ Sheffield, Dept Mat Engn, Sheffield, S Yorkshire, England	University of Sheffield; University of Glasgow; University of Sheffield	Adra, S (corresponding author), Univ Sheffield, Dept Comp Sci, Sheffield S10 2TN, S Yorkshire, England.	s.adra@sheffield.ac.uk; r.smallwood@sheffield.ac.uk	Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632	Engineering and Physical Siences Research Council United Kingdom; University of Sheffield [GR/S62321/01]; University of York [GR/S62338/01]; Engineering and Physical Sciences Research Council [GR/S62321/01] Funding Source: researchfish	Engineering and Physical Siences Research Council United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); University of Sheffield; University of York(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work is part of the Epitheliome Project, which is funded by the Engineering and Physical Siences Research Council United Kingdom through two grants, one to the University of Sheffield (GR/S62321/01), and the other to the University of York (GR/S62338/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendt C, 2002, J CELL SCI, V115, P2189; Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Aukhil I, 2000, PERIODONTOL 2000, V22, P44, DOI 10.1034/j.1600-0757.2000.2220104.x; Baker CTH, 1998, J MATH BIOL, V37, P341, DOI 10.1007/s002850050133; Barcellos-Hoff MH, 1996, J MAMMARY GLAND BIOL, V1, P353, DOI 10.1007/BF02017391; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; COAKLEY S, 2007, THESIS U SHEFFIELD S; COFFEY RJ, 1988, MOL CELL BIOL, V8, P3088, DOI 10.1128/MCB.8.8.3088; DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; Eglen SJ, 2002, DEVELOPMENT, V129, P5399, DOI 10.1242/dev.00118; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fleischmajer R, 2000, MATRIX BIOL, V19, P637, DOI 10.1016/S0945-053X(00)00092-5; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; Frank S, 1996, J BIOL CHEM, V271, P10188, DOI 10.1074/jbc.271.17.10188; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; GAILIT J, 1994, J INVEST DERMATOL, V103, P221, DOI 10.1111/1523-1747.ep12393176; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Hakkinen L, 2004, AM J PATHOL, V164, P229, DOI 10.1016/S0002-9440(10)63113-6; HERTLE MD, 1992, J CLIN INVEST, V89, P1892, DOI 10.1172/JCI115794; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359; Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Kutz SM, 2001, J CELL SCI, V114, P3905; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzieri R, 2005, J CELL SCI, V118, P2177, DOI 10.1242/jcs.02352; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Morel D, 2001, ACTA BIOTHEOR, V49, P219, DOI 10.1023/A:1014201805222; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Munger JS, 1997, KIDNEY INT, V51, P1376, DOI 10.1038/ki.1997.188; Neurohr C, 2006, AM J RESP CELL MOL, V35, P252, DOI 10.1165/rcmb.2006-0013OC; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Olofsson A, 1995, J BIOL CHEM, V270, P31294, DOI 10.1074/jbc.270.52.31294; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Rashbass J, 1996, TRENDS CELL BIOL, V6, P280, DOI 10.1016/0962-8924(96)60028-2; SCHMID P, 1993, J PATHOL, V171, P191, DOI 10.1002/path.1711710307; SELLHEYER K, 1993, P NATL ACAD SCI USA, V90, P5237, DOI 10.1073/pnas.90.11.5237; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910; STREULI CH, 1993, J CELL BIOL, V120, P253, DOI 10.1083/jcb.120.1.253; Sun T, 2007, J R SOC INTERFACE, V4, P1077, DOI 10.1098/rsif.2007.0227; Vespa A, 2005, MOL BIOL CELL, V16, P4084, DOI 10.1091/mbc.e05-02-0087; Vilar JMG, 2006, PLOS COMPUT BIOL, V2, P36, DOI 10.1371/journal.pcbi.0020003; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Wang XJ, 1997, P NATL ACAD SCI USA, V94, P2386, DOI 10.1073/pnas.94.6.2386; Wawersik MJ, 2001, MOL BIOL CELL, V12, P3439, DOI 10.1091/mbc.12.11.3439; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Woolley K, 2000, BIOESSAYS, V22, P911; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yang LJ, 1999, AM J PATHOL, V154, P105, DOI 10.1016/S0002-9440(10)65256-X; Yang LJ, 2001, AM J PATHOL, V159, P2147, DOI 10.1016/S0002-9440(10)63066-0; YOUNG SJ, 2009, CELL PROLIFERAT, V42, P617; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	67	66	69	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8511	10.1371/journal.pone.0008511	http://dx.doi.org/10.1371/journal.pone.0008511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20076760	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600001
J	Mustafi, SB; Chakraborty, PK; Raha, S				Mustafi, Soumyajit Banerjee; Chakraborty, Prabir K.; Raha, Sanghamitra			Modulation of Akt and ERK1/2 Pathways by Resveratrol in Chronic Myelogenous Leukemia (CML) Cells Results in the Downregulation of Hsp70	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; CHRONIC MYELOID-LEUKEMIA; SERINE PHOSPHORYLATION; GENE-TRANSCRIPTION; CANCER; HEAT-SHOCK-PROTEIN-70; APOPTOSIS; PROTEINS; KINASE; ACTIVATION	Background: Resveratrol is known to downregulate the high endogenous level of Heat shock protein 70 (Hsp70) in Chronic Myelogenous Leukemia (CML) K562 cells and induce apoptosis. Since Heat Shock Factor 1 (HSF1) controls transcription of Hsp70, we wanted to probe the signaling pathways responsible for transcriptional activation of HSF1. Methodology/Principal Findings: Cells exposed to 40 mu M Resveratrol rapidly abolished serine473 phosphorylation of Akt and significantly reduced its kinase activity. Inactivation of Akt pathway by Resveratrol subsequently blocked serine9 phosphorylation of Gsk3 beta. Active non-phosphorylated Gsk3b rendered HSF1 transcriptionally inactive and reduced Hsp70 production. Blocking PI3K/Akt activity also demonstrated similar effects on Hsp70 comparable to Resveratrol. Inactivation of Gsk3b activity by inhibitors SB261763 or LiCl upregulated Hsp70. Resveratrol significantly modulated ERK1/2 activity as evident from hyper phosphorylation at T302/Y304 residues and simultaneous upregulation in kinase activity. Blocking ERK1/2 activation resulted in induction of Hsp70. Therefore, increase in ERK1/2 activity by Resveratrol provided another negative influence on Hsp70 levels through negative regulation of HSF1 activity. 17-allylamino-17-demethoxygeldanamycin (17AAG), a drug that inhibits Hsp90 chaperone and degrades its client protein Akt concomitantly elevated Hsp70 levels by promoting nuclear translocation of HSF1 from the cytosol. This effect is predominantly due to inhibition of both Akt and ERK1/2 activation by 17AAG. Simultaneously treating K562 with Resveratrol and 17AAG maintained phosho-ERK1/2 levels close to untreated controls demonstrating their opposite effects on ERK1/2 pathway. Resveratrol was found not to interfere with Bcr-Abl activation in K562 cells. Conclusion/Significance: Thus our study comprehensively illustrates that Resveratrol acts downstream of Bcr-Abl and inhibits Akt activity but stimulates ERK1/2 activity. This brings down the transcriptional activity of HSF1 and Hsp70 production in K562 cells. Additionally, Resveratrol can be used in combination with chemotherapeutic agents such as 17AAG, an Hsp90 inhibitor reported to induce Hsp70 and hence compromise its chemotherapeutic potential.	[Mustafi, Soumyajit Banerjee; Chakraborty, Prabir K.; Raha, Sanghamitra] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Mustafi, SB (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sanghamitra.raha@saha.ac.in			Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	The study was conducted with funds from the Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, EXP BIOL MED, V234, P825, DOI 10.3181/0902-MR-78; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Chakraborty PK, 2008, CANCER SCI, V99, P1109, DOI 10.1111/j.1349-7006.2008.00809.x; Chakraborty PK, 2008, PHARMACOL RES, V58, P281, DOI 10.1016/j.phrs.2008.08.007; Chu BY, 1996, J BIOL CHEM, V271, P30847, DOI 10.1074/jbc.271.48.30847; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cotto JJ, 1996, J BIOL CHEM, V271, P3355; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Frojdo S, 2007, BIOCHEM J, V406, P511, DOI 10.1042/BJ20070236; Guo F, 2005, CANCER RES, V65, P10536, DOI 10.1158/0008-5472.CAN-05-1799; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; He B, 1998, MOL CELL BIOL, V18, P6624, DOI 10.1128/MCB.18.11.6624; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Kantarjian HM, 2007, CLIN CANCER RES, V13, P1089, DOI 10.1158/1078-0432.CCR-06-2147; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mukherjee S, 2009, FREE RADICAL BIO MED, V46, P573, DOI 10.1016/j.freeradbiomed.2008.11.005; Nguyen TK, 2007, BLOOD, V109, P4006, DOI 10.1182/blood-2006-09-045039; Parmiani G, 2004, CLIN CANCER RES, V10, P8142, DOI 10.1158/1078-0432.CCR-04-1194; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Pocaly M, 2007, LEUKEMIA, V21, P93, DOI 10.1038/sj.leu.2404463; Puissant A, 2008, FASEB J, V22, P1894, DOI 10.1096/fj.07-101394; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Roccaro AM, 2008, CLIN CANCER RES, V14, P1849, DOI 10.1158/1078-0432.CCR-07-1750; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Sarkar FH, 2009, CELL SIGNAL, V21, P1541, DOI 10.1016/j.cellsig.2009.03.009; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Solit DB, 2003, CANCER RES, V63, P2139; Sreedhar AS, 2004, PHARMACOL THERAPEUT, V101, P227, DOI 10.1016/j.pharmthera.2003.11.004; Tao MH, 2005, BRIT J CANCER, V92, P2059, DOI 10.1038/sj.bjc.6602609; Wang XZ, 2003, MOL CELL BIOL, V23, P6013, DOI 10.1128/MCB.23.17.6013-6026.2003; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Zhang JD, 2006, BIOCHEM J, V397, P519, DOI 10.1042/BJ20050977	36	66	68	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8719	10.1371/journal.pone.0008719	http://dx.doi.org/10.1371/journal.pone.0008719			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090934	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600019
J	Holland, PJ; Hollis, T				Holland, Paul J.; Hollis, Thomas			Structural and Mutational Analysis of Escherichia coli AlkB Provides Insight into Substrate Specificity and DNA Damage Searching	PLOS ONE			English	Article							OXIDATIVE DEMETHYLATION; CRYSTAL-STRUCTURES; ALKYLATION DAMAGE; REPAIR; BACTERIAL; 3-METHYLTHYMINE; LESIONS; 1-METHYLGUANINE; PROTEIN; RNA	Background: In Escherichia coli, cytotoxic DNA methyl lesions on the N1 position of purines and N3 position of pyrimidines are primarily repaired by the 2-oxoglutarate (2-OG) iron(II) dependent dioxygenase, AlkB. AlkB repairs 1-methyladenine (1-meA) and 3-methylcytosine (3-meC) lesions, but it also repairs 1-methylguanine (1-meG) and 3-methylthymine (3-meT) at a much less efficient rate. How the AlkB enzyme is able to locate and identify methylated bases in ssDNA has remained an open question. Methodology/Principal Findings: We determined the crystal structures of the E. coli AlkB protein holoenzyme and the AlkB-ssDNA complex containing a 1-meG lesion. We coupled this to site-directed mutagenesis of amino acids in and around the active site, and tested the effects of these mutations on the ability of the protein to bind both damaged and undamaged DNA, as well as catalyze repair of a methylated substrate. Conclusions/Significance: A comparison of our substrate-bound AlkB-ssDNA complex with our unliganded holoenzyme reveals conformational changes of residues within the active site that are important for binding damaged bases. Site-directed mutagenesis of these residues reveals novel insight into their roles in DNA damage recognition and repair. Our data support a model that the AlkB protein utilizes at least two distinct conformations in searching and binding methylated bases within DNA: a "searching'' mode and "repair'' mode. Moreover, we are able to functionally separate these modes through mutagenesis of residues that affect one or the other binding state. Finally, our mutagenesis experiments show that amino acid D135 of AlkB participates in both substrate specificity and catalysis.	[Holland, Paul J.; Hollis, Thomas] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA	Wake Forest University; Wake Forest Baptist Medical Center	Holland, PJ (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA.	thollis@wfubmc.edu			American Cancer Society [RSG-04-187-01-GMC]	American Cancer Society(American Cancer Society)	American Cancer Society (to TH) grant # RSG-04-187-01-GMC (http://www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ARAVIND L, 2001, GENOME BIOL, V2, DOI DOI 10.1186/gb-2001-2-3-research0007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TJ, 2003, TRENDS BIOCHEM SCI, V28, P2, DOI 10.1016/S0968-0004(02)00010-5; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Delaney JC, 2005, NAT STRUCT MOL BIOL, V12, P855, DOI 10.1038/nsmb996; Delaney JC, 2004, P NATL ACAD SCI USA, V101, P14051, DOI 10.1073/pnas.0403489101; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P6260, DOI 10.1093/nar/gkh964; Falnes PO, 2004, NUCLEIC ACIDS RES, V32, P3456, DOI 10.1093/nar/gkh655; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; KATAOKA H, 1983, J BACTERIOL, V153, P1301, DOI 10.1128/JB.153.3.1301-1307.1983; Koivisto P, 2004, J BIOL CHEM, V279, P40470, DOI 10.1074/jbc.M407960200; Koivisto P, 2003, J BIOL CHEM, V278, P44348, DOI 10.1074/jbc.M307361200; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2005, ACTA CRYSTALLOGR D, V61, P465, DOI 10.1107/S0907444905001897; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ringvoll J, 2008, CANCER RES, V68, P4142, DOI 10.1158/0008-5472.CAN-08-0796; Sedgwick B, 2004, NAT REV MOL CELL BIO, V5, P148, DOI 10.1038/nrm1312; Sedgwick B, 2002, ONCOGENE, V21, P8886, DOI 10.1038/sj.onc.1205998; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sundheim O, 2006, EMBO J, V25, P3389, DOI 10.1038/sj.emboj.7601219; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; WESTBYE MP, 2008, J BIOL CHEM; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	32	49	50	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8680	10.1371/journal.pone.0008680	http://dx.doi.org/10.1371/journal.pone.0008680			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084272	gold, Green Submitted, Green Published			2022-12-27	WOS:000273554600031
J	Lee, JH; Jo, J; Hardikar, AA; Periwal, V; Rane, SG				Lee, Ji-Hyeon; Jo, Junghyo; Hardikar, Anandwardhan A.; Periwal, Vipul; Rane, Sushil G.			Cdk4 Regulates Recruitment of Quiescent beta-Cells and Ductal Epithelial Progenitors to Reconstitute beta-Cell Mass	PLOS ONE			English	Article							ISLET PRECURSOR CELLS; DIABETIC MOUSE MODEL; PANCREATIC B-CELL; STEM-CELLS; INSULIN-RESISTANCE; BONE-MARROW; REGENERATION; MICE; PROLIFERATION; ENDOCRINE	Insulin-producing pancreatic islet beta cells (beta-cells) are destroyed, severely depleted or functionally impaired in diabetes. Therefore, replacing functional beta-cell mass would advance clinical diabetes management. We have previously demonstrated the importance of Cdk4 in regulating beta-cell mass. Cdk4-deficient mice display beta-cell hypoplasia and develop diabetes, whereas beta-cell hyperplasia is observed in mice expressing an active Cdk4R24C kinase. While beta-cell replication appears to be the primary mechanism responsible for beta-cell mass increase, considerable evidence also supports a contribution from the pancreatic ductal epithelium in generation of new beta-cells. Further, while it is believed that majority of beta-cells are in a state of 'dormancy', it is unclear if and to what extent the quiescent cells can be coaxed to participate in the beta-cell regenerative response. Here, we address these queries using a model of partial pancreatectomy (PX) in Cdk4 mutant mice. To investigate the kinetics of the regeneration process precisely, we performed DNA analog-based lineage-tracing studies followed by mathematical modeling. Within a week after PX, we observed considerable proliferation of islet beta-cells and ductal epithelial cells. Interestingly, the mathematical model showed that recruitment of quiescent cells into the active cell cycle promotes beta-cell mass reconstitution in the Cdk4R24C pancreas. Moreover, within 24-48 hours post-PX, ductal epithelial cells expressing the transcription factor Pdx-1 dramatically increased. We also detected insulin-positive cells in the ductal epithelium along with a significant increase of islet-like cell clusters in the Cdk4R24C pancreas. We conclude that Cdk4 not only promotes beta-cell replication, but also facilitates the activation of beta-cell progenitors in the ductal epithelium. In addition, we show that Cdk4 controls beta-cell mass by recruiting quiescent cells to enter the cell cycle. Comparing the contribution of cell proliferation and islet-like clusters to the total increase in insulin-positive cells suggests a hitherto uncharacterized large non-proliferative contribution.	[Lee, Ji-Hyeon; Rane, Sushil G.] NIDDK, Regenerat Biol Sect, Diabet Branch, Natl Inst Hlth, Bethesda, MD 20892 USA; [Jo, Junghyo; Periwal, Vipul] NIDDK, Lab Biol Modeling, Natl Inst Hlth, Bethesda, MD USA; [Hardikar, Anandwardhan A.] Natl Ctr Cell Sci, Stem Cells & Diabet Sect, Pune, Maharashtra, India	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Lee, JH (corresponding author), NIDDK, Regenerat Biol Sect, Diabet Branch, Natl Inst Hlth, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Hardikar, Anandwardhan/ACF-7730-2022; Jo, Junghyo/D-4889-2011; Periwal, Vipul/I-1728-2012		National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055105, ZIADK075038] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health intramural program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Bonner-Weir S, 2002, J PATHOL, V197, P519, DOI 10.1002/path.1158; BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Georgia S, 2006, DIABETES, V55, P2950, DOI 10.2337/db06-0249; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gregory P., 2005, BAYESIAN LOGICAL DAT; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; HELLERSTROM C, 1984, DIABETOLOGIA, V26, P393; HELLERSTROM C, 1991, DIABETES, V40, P89, DOI 10.2337/diab.40.2.S89; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Joglekar MV, 2007, DEV BIOL, V311, P603, DOI 10.1016/j.ydbio.2007.09.008; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; Lipsett M, 2002, DIABETES, V51, P1834, DOI 10.2337/diabetes.51.6.1834; Liu YQ, 2000, AM J PHYSIOL-ENDOC M, V279, pE68, DOI 10.1152/ajpendo.2000.279.1.E68; Liu ZY, 2009, CELL, V138, P424, DOI 10.1016/j.cell.2009.07.022; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marzo N, 2008, J IMMUNOL, V180, P1189, DOI 10.4049/jimmunol.180.2.1189; Mettus RV, 2003, ONCOGENE, V22, P8413, DOI 10.1038/sj.onc.1206888; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nishio J, 2006, SCIENCE, V311, P1775, DOI 10.1126/science.1124004; Offield MF, 1996, DEVELOPMENT, V122, P983; Peshavaria M, 2006, DIABETES, V55, P3289, DOI 10.2337/db06-0017; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 2002, MOL CELL BIOL, V22, P644, DOI 10.1128/MCB.22.2.644-656.2002; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; SWENNE I, 1984, DIABETOLOGIA, V27, P464, DOI 10.1007/BF00273912; SWENNE I, 1983, DIABETES, V32, P14, DOI 10.2337/diabetes.32.1.14; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; Waguri M, 1997, DIABETES, V46, P1281, DOI 10.2337/diabetes.46.8.1281; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang XB, 2005, DIABETES, V54, P712, DOI 10.2337/diabetes.54.3.712; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	59	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8653	10.1371/journal.pone.0008653	http://dx.doi.org/10.1371/journal.pone.0008653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084282	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600012
J	Li, H; Greene, LH				Li, Hai; Greene, Lesley H.			Sequence and Structural Analysis of the Chitinase Insertion Domain Reveals Two Conserved Motifs Involved in Chitin-Binding	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINIDASE-H; EXPOSED AROMATIC RESIDUES; CRYSTAL-STRUCTURE; ENZYMATIC-PROPERTIES; FAMILY-18 CHITINASE; ANGSTROM RESOLUTION; AMINO-ACIDS; PROTEIN; MECHANISM; EVOLUTION	Background: Chitinases are prevalent in life and are found in species including archaea, bacteria, fungi, plants, and animals. They break down chitin, which is the second most abundant carbohydrate in nature after cellulose. Hence, they are important for maintaining a balance between carbon and nitrogen trapped as insoluble chitin in biomass. Chitinases are classified into two families, 18 and 19 glycoside hydrolases. In addition to a catalytic domain, which is a triosephosphate isomerase barrel, many family 18 chitinases contain another module, i.e., chitinase insertion domain. While numerous studies focus on the biological role of the catalytic domain in chitinase activity, the function of the chitinase insertion domain is not completely understood. Bioinformatics offers an important avenue in which to facilitate understanding the role of residues within the chitinase insertion domain in chitinase function. Results: Twenty-seven chitinase insertion domain sequences, which include four experimentally determined structures and span five kingdoms, were aligned and analyzed using a modified sequence entropy parameter. Thirty-two positions with conserved residues were identified. The role of these conserved residues was explored by conducting a structural analysis of a number of holo-enzymes. Hydrogen bonding and van der Waals calculations revealed a distinct subset of four conserved residues constituting two sequence motifs that interact with oligosaccharides. The other conserved residues may be key to the structure, folding, and stability of this domain. Conclusions: Sequence and structural studies of the chitinase insertion domains conducted within the framework of evolution identified four conserved residues which clearly interact with the substrates. Furthermore, evolutionary studies propose a link between the appearance of the chitinase insertion domain and the function of family 18 chitinases in the subfamily A.	[Li, Hai; Greene, Lesley H.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA	Old Dominion University	Li, H (corresponding author), Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA 23529 USA.	lgreene@odu.edu	LI, HAI/B-4052-2012; LI, HAI/G-3823-2012; Li, Hai/J-5419-2014		Old Dominion University Office of Research; Dominion Scholarship	Old Dominion University Office of Research; Dominion Scholarship	This work is supported by funding from the Old Dominion University Office of Research (to LHG) and Dominion Scholarship (to HL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson NN, 2003, BIOCHEM J, V376, P87, DOI 10.1042/bj20030273; Bortone K, 2002, J MOL BIOL, V320, P293, DOI 10.1016/S0022-2836(02)00444-8; Brameld KA, 1998, P NATL ACAD SCI USA, V95, P4276, DOI 10.1073/pnas.95.8.4276; BRANDEN C, 1998, INTRO PROTEIN STRUCT, P53; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cavada BS, 2006, FEBS J, V273, P3962, DOI 10.1111/j.1742-4658.2006.05400.x; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P255; Dahiya N, 2006, APPL MICROBIOL BIOT, V71, P773, DOI 10.1007/s00253-005-0183-7; Daimon T, 2005, INSECT BIOCHEM MOLEC, V35, P1112, DOI 10.1016/j.ibmb.2005.05.005; Duo-Chuan L, 2006, MYCOPATHOLOGIA, V161, P345, DOI 10.1007/s11046-006-0024-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferrandon S, 2003, BBA-GEN SUBJECTS, V1621, P31, DOI 10.1016/S0304-4165(03)00029-1; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Funkhouser JD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-96; Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200; Fusetti F, 2002, J BIOL CHEM, V277, P25537, DOI 10.1074/jbc.M201636200; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Greene LH, 2003, FEBS LETT, V553, P39, DOI 10.1016/S0014-5793(03)00925-6; Guda C, 2001, Pac Symp Biocomput, P275; HENNIG M, 1995, J MOL BIOL, V254, P237, DOI 10.1006/jmbi.1995.0614; Hoell IA, 2006, FEBS J, V273, P4889, DOI 10.1111/j.1742-4658.2006.05487.x; Hollis T, 2000, PROTEIN SCI, V9, P544, DOI 10.1110/ps.9.3.544; Horn SJ, 2006, FEBS J, V273, P491, DOI 10.1111/j.1742-4658.2005.05079.x; Hurtado-Guerrero R, 2007, CHEM BIOL, V14, P589, DOI 10.1016/j.chembiol.2007.03.015; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Katouno F, 2004, J BIOCHEM, V136, P163, DOI 10.1093/jb/mvh105; Kawase T, 2004, APPL ENVIRON MICROB, V70, P1135, DOI 10.1128/AEM.70.2.1135-1144.2004; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MELCHERS LS, 1994, PLANT J, V5, P469, DOI 10.1046/j.1365-313X.1994.5040469.x; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Nagano N, 2001, PROTEIN ENG, V14, P845, DOI 10.1093/protein/14.11.845; Nakamura T, 2007, ACTA CRYSTALLOGR F, V63, P7, DOI 10.1107/S1744309106051773; NOZAKI Y, 1971, J BIOL CHEM, V246, P2211; Palermo NY, 2008, INT J QUANTUM CHEM, V108, P814, DOI 10.1002/qua.21521; Papanikolau Y, 2001, BIOCHEMISTRY-US, V40, P11338, DOI 10.1021/bi010505h; Payan F, 2003, BIOCHEM J, V372, P399, DOI 10.1042/BJ20021802; PERRAKIS A, 1994, STRUCTURE, V2, P1169, DOI 10.1016/S0969-2126(94)00119-7; PESTSKO G, 2004, PROTEIN STRUCTURE FU, P33; Ramalho-Ortigao JM, 2003, INSECT BIOCHEM MOLEC, V33, P279, DOI 10.1016/S0965-1748(02)00209-6; Ranea JAG, 2006, J MOL EVOL, V63, P513, DOI 10.1007/s00239-005-0289-7; Rao FV, 2003, J BIOL CHEM, V278, P20110, DOI 10.1074/jbc.M300362200; Rao V, 1999, PROTEIN SCI, V8, P2338; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Renkema GH, 1998, EUR J BIOCHEM, V251, P504, DOI 10.1046/j.1432-1327.1998.2510504.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Schueler-Furman O, 2003, PROTEINS, V52, P225, DOI 10.1002/prot.10365; Sikorski P, 2006, BIOCHEMISTRY-US, V45, P9566, DOI 10.1021/bi060370l; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Srivastava DB, 2006, J STRUCT BIOL, V156, P505, DOI 10.1016/j.jsb.2006.05.008; Subramaniam V, 2001, J BIOL CHEM, V276, P21506, DOI 10.1074/jbc.M102292200; Suginta W, 2004, ARCH BIOCHEM BIOPHYS, V424, P171, DOI 10.1016/j.abb.2004.01.017; Sun YJ, 2001, J BIOL CHEM, V276, P17507, DOI 10.1074/jbc.M010416200; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Suzuki K, 1999, BIOCHEM J, V343, P587, DOI 10.1042/0264-6021:3430587; Taira T, 2002, BIOSCI BIOTECH BIOCH, V66, P970, DOI 10.1271/bbb.66.970; Todd AE, 1999, CURR OPIN CHEM BIOL, V3, P548, DOI 10.1016/S1367-5931(99)00007-1; Todd AE, 2001, J MOL BIOL, V307, P1113, DOI 10.1006/jmbi.2001.4513; Uchiyama T, 2001, J BIOL CHEM, V276, P41343, DOI 10.1074/jbc.M103610200; Vaaje-Kolstad G, 2004, J BIOL CHEM, V279, P3612, DOI 10.1074/jbc.M310057200; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; vanScheltinga ACT, 1996, J MOL BIOL, V262, P243, DOI 10.1006/jmbi.1996.0510; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Varela PF, 2002, J BIOL CHEM, V277, P13229, DOI 10.1074/jbc.M110502200; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Watanabe T, 2003, BIOCHEM J, V376, P237, DOI 10.1042/BJ20030419; Zees AC, 2009, BBA-PROTEINS PROTEOM, V1794, P23, DOI 10.1016/j.bbapap.2008.09.018	78	82	88	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8654	10.1371/journal.pone.0008654	http://dx.doi.org/10.1371/journal.pone.0008654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084296	gold, Green Submitted, Green Published			2022-12-27	WOS:000273554600013
J	Otkjaer, K; Holtmann, H; Kragstrup, TW; Paludan, SR; Johansen, C; Gaestel, M; Kragballe, K; Iversen, L				Otkjaer, Kristian; Holtmann, Helmut; Kragstrup, Tue Wenzel; Paludan, Soren Riis; Johansen, Claus; Gaestel, Matthias; Kragballe, Knud; Iversen, Lars			The p38 MAPK Regulates IL-24 Expression by Stabilization of the 3 ' UTR of IL-24 mRNA	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AU-RICH ELEMENT; DIFFERENTIATION-ASSOCIATED GENE-7; HUMAN-MELANOMA CELLS; MDA-7 EXPRESSION; PSORIATIC EPIDERMIS; MDA-7/IL-24; APOPTOSIS; IDENTIFICATION; RECEPTORS	Background: IL-24 (melanoma differentiation-associated gene-7 (mda-7)), a member of the IL-10 cytokine family, possesses the properties of a classical cytokine as well as tumor suppressor effects. The exact role of IL-24 in the immune system has not been defined but studies have indicated a role for IL-24 in inflammatory conditions such as psoriasis. The tumor suppressor effects of IL-24 include inhibition of angiogenesis, sensitization to chemotherapy, and p38 mitogen-activated protein kinase (MAPK)mediated apoptosis. Current knowledge on the regulation of IL-24 expression is sparse. Previous studies have suggested that mRNA stabilization is of major importance to IL-24 expression. Yet, the mechanisms responsible for the regulation of IL-24 mRNA stability remain unidentified. As p38 MAPK is known to regulate gene expression by interfering with mRNA degradation we examined the role of p38 MAPK in the regulation of IL-24 gene expression in cultured normal human keratinocytes. Methodology/Principal Findings: In the present study we show that anisomycin- and IL-1 beta-induced IL-24 expression is strongly dependent on p38 MAPK activation. Studies of IL-24 mRNA stability in anisomycin-treated keratinocytes reveal that the p38 MAPK inhibitor SB 202190 accelerates IL-24 mRNA decay suggesting p38 MAPK to regulate IL-24 expression by mRNA-stabilizing mechanisms. The insertion of the 3' untranslated region (UTR) of IL-24 mRNA in a tet-off reporter construct induces degradation of the reporter mRNA. The observed mRNA degradation is markedly reduced when a constitutively active mutant of MAPK kinase 6 (MKK6), which selectively activates p38 MAPK, is co-expressed. Conclusions/Significance: Taken together, we here report p38 MAPK as a regulator of IL-24 expression and determine interference with destabilization mediated by the 39 UTR of IL-24 mRNA as mode of action. As discussed in the present work these findings have important implications for our understanding of IL-24 as a tumor suppressor protein as well as an immune modulating cytokine.	[Otkjaer, Kristian] Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark; [Otkjaer, Kristian; Johansen, Claus; Kragballe, Knud; Iversen, Lars] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark; [Holtmann, Helmut; Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany; [Kragstrup, Tue Wenzel; Paludan, Soren Riis] Aarhus Univ, Inst Med Microbiol & Immunol, Aarhus, Denmark	Aarhus University; Aarhus University; Hannover Medical School; Aarhus University	Otkjaer, K (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, DK-8000 Aarhus, Denmark.	lars.iversen@ki.au.dk	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; Johansen, Claus/0000-0002-5665-5212; Johansen, Claus/0000-0003-0240-5127; Kragstrup, Tue Wenzel/0000-0002-6439-397X; Iversen, Lars/0000-0003-1816-4508	Novo Nordisk Foundation; Danish Cancer Society; Lundbeck Foundation; Danish Psoriasis Research Foundation; Aage Bang Foundation; Medical Research Council, Denmark; German Research Council [Ho 1116/4]; Deutsche Forschungsgemeinschaft	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Danish Psoriasis Research Foundation; Aage Bang Foundation; Medical Research Council, Denmark(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Research Council(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Novo Nordisk Foundation; the Danish Cancer Society; the Lundbeck Foundation; the Danish Psoriasis Research Foundation; the Aage Bang Foundation; the Medical Research Council, Denmark; and grant Ho 1116/4 of the German Research Council. The work of M. Gaestel was funded by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cunningham CC, 2005, MOL THER, V11, P149, DOI 10.1016/j.ymthe.2004.09.019; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Ekmekcioglu S, 2001, INT J CANCER, V94, P54, DOI 10.1002/ijc.1437; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Jiang HP, 1995, ONCOGENE, V11, P2477; Johansen C, 2006, J IMMUNOL, V176, P1431, DOI 10.4049/jimmunol.176.3.1431; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Kragstrup TW, 2008, CYTOKINE, V41, P16, DOI 10.1016/j.cyto.2007.10.004; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lebedeva IV, 2007, INT J ONCOL, V31, P985; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Madireddi MT, 2000, J CELL PHYSIOL, V185, P36, DOI 10.1002/1097-4652(200010)185:1<36::AID-JCP3>3.0.CO;2-V; Madireddi MT, 2000, ONCOGENE, V19, P1362, DOI 10.1038/sj.onc.1203424; Otkjaer K, 2005, BRIT J DERMATOL, V153, P911, DOI 10.1111/j.1365-2133.2005.06800.x; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Sainz-Perez A, 2006, LEUKEMIA, V20, P498, DOI 10.1038/sj.leu.2404073; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2008, P NATL ACAD SCI USA, V105, P9763, DOI 10.1073/pnas.0804089105; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Smalley KSM, 2002, MELANOMA RES, V12, P187, DOI 10.1097/00008390-200206000-00001; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Winzen R, 2004, MOL CELL BIOL, V24, P4835, DOI 10.1128/MCB.24.11.4835-4847.2004; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang R, 2000, J BIOL CHEM, V275, P24436, DOI 10.1074/jbc.M001958200	45	32	34	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8671	10.1371/journal.pone.0008671	http://dx.doi.org/10.1371/journal.pone.0008671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072629	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600023
J	Spigoni, G; Gedressi, C; Mallamaci, A				Spigoni, Giulia; Gedressi, Chiara; Mallamaci, Antonello			Regulation of Emx2 Expression by Antisense Transcripts in Murine Cortico-Cerebral Precursors	PLOS ONE			English	Article							GENE-EXPRESSION; NONCODING RNA; ENDOGENOUS SIRNAS; HOMEOBOX GENES; AREA IDENTITY; MOUSE-BRAIN; STEM-CELLS; ACTIVATION; CORTEX; DIFFERENTIATION	Background: Emx2 encodes for a transcription factor expressed in the embryonic intermediate mesoderm and central nervous system (CNS). It is implicated in several aspects of cerebral cortex development, including morphogenetic field specification, arealization, precursor proliferation and lamination. Four Emx2-associated antisense transcripts have been found in the urogenital system; one of them, Emx2OS, has been also detected in the adult brain. Until now, however, nothing is known about expression and function of Emx2OS in the developing CNS. Methodology/Principal Findings: By quantitative RT-PCR and in situ hybridization, we reconstructed the Emx2OS expression profile in the embryonic CNS, paying special attention to the developing cerebral cortex. Emx2OS was observed in a number of CNS structures expressing also Emx2. Within the cortex, Emx2OS was detectable in periventricular precursors, expressing the sense transcript, and peaked in newly born post-mitotic neurons not expressing such transcript. By integrating lentiviral gene delivery, RNAi, TetON technology, morpholino-mediated gene knock-down, drug-induced perturbation of gene expression, and quantitative RT-PCR, we addressed possible roles of Ex2 antisense RNA in Emx2 regulation, in primary CNS precursor cultures. We found that, in both cortical precursors and their neuronal progenies, Emx2 antisense RNA contributes to post-transcriptional down-regulation of its sense partner, possibly by a Dicer-promoted mechanism. The same RNA, when delivered to rhombo-spinal precursors, stimulates ectopic expression of Emx2, whereas Emx2 knock-out dramatically impairs Emx2OS transcription. This suggests that, within the developing CNS, a reciprocal Emx2/Emx2OS regulatory loop may normally sustain transcription at the Emx2 locus. Conclusions/Significance: This study shows that antisense transcripts may contribute to developmental regulation of a key transcription factor gene implicated in CNS patterning, possibly by complex and multilevel mechanisms. The activation of Emx2 by a short antisense transcript may be a prototype of a method for overexpressing single specific genes, without introducing additional copies of them into the genome.	[Spigoni, Giulia; Gedressi, Chiara; Mallamaci, Antonello] SISSA, ISAS, I-34014 Trieste, Italy	International School for Advanced Studies (SISSA)	Spigoni, G (corresponding author), SISSA, ISAS, I-34014 Trieste, Italy.	amallama@sissa.it	Mallamaci, Antonello/A-2975-2015	Mallamaci, Antonello/0000-0002-3621-1307	intramural SISSA	intramural SISSA	This work was entirely supported by intramural SISSA funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano G, 2005, HUM MOL GENET, V14, P913, DOI 10.1093/hmg/ddi084; Babajko S, 2009, CELLS TISSUES ORGANS, V189, P115, DOI 10.1159/000151748; Beiter T, 2009, CELL MOL LIFE SCI, V66, P94, DOI 10.1007/s00018-008-8381-y; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Berdal A, 2002, CONNECT TISSUE RES, V43, P148, DOI 10.1080/03008200290000970; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Blin-Wakkach C, 2001, P NATL ACAD SCI USA, V98, P7336, DOI 10.1073/pnas.131497098; Bouvier M, 2008, MOL CELL, V32, P827, DOI 10.1016/j.molcel.2008.10.027; Capowski EE, 2007, J NEUROSCI METH, V163, P338, DOI 10.1016/j.jneumeth.2007.02.022; Chen JJ, 2004, NUCLEIC ACIDS RES, V32, P4812, DOI 10.1093/nar/gkh818; Chen Z, 2008, MOL CANCER THER, V7, P698, DOI 10.1158/1535-7163.MCT-07-2312; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coudert AE, 2005, NUCLEIC ACIDS RES, V33, P5208, DOI 10.1093/nar/gki831; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Galli R, 2002, DEVELOPMENT, V129, P1633; Gangemi RMR, 2001, MECH DEVELOP, V109, P323, DOI 10.1016/S0925-4773(01)00546-9; Geng X, 2007, GENE EXPR PATTERNS, V7, P252, DOI 10.1016/j.modgep.2006.09.007; Gritti A, 1996, J NEUROSCI, V16, P1091; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Li YY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-18; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; Mao QQ, 2008, BIOCHEM BIOPH RES CO, V375, P566, DOI 10.1016/j.bbrc.2008.08.059; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Munroe SH, 2006, CELL MOL LIFE SCI, V63, P2102, DOI 10.1007/s00018-006-6070-2; Muzio L, 2005, CEREB CORTEX, V15, P2021, DOI 10.1093/cercor/bhi077; Muzio L, 2002, CEREB CORTEX, V12, P129, DOI 10.1093/cercor/12.2.129; Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892; Muzio L, 2005, J NEUROSCI, V25, P4435, DOI 10.1523/JNEUROSCI.4804-04.2005; Noonan FC, 2003, GENOMICS, V81, P58, DOI 10.1016/S0888-7543(02)00023-X; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Petit S, 2009, J CELL PHYSIOL, V220, P303, DOI 10.1002/jcp.21762; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Potenza N, 2009, CELL BIOL INT, V33, P734, DOI 10.1016/j.cellbi.2009.04.002; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rallu M, 2002, DEVELOPMENT, V129, P4963; *RIKEN GEN EXPL RE, SCIENCE, V309, P1564; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sessa L, 2007, RNA, V13, P223, DOI 10.1261/rna.266707; SHEN G, 2002, J PHYS CONDENS MATT, V14, P1; Shinozaki K, 2002, DEVELOPMENT, V129, P3479; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Theil T, 2002, DEVELOPMENT, V129, P3045; Theil T, 1999, DEVELOPMENT, V126, P3561; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yoshida M, 1997, DEVELOPMENT, V124, P101	71	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8658	10.1371/journal.pone.0008658	http://dx.doi.org/10.1371/journal.pone.0008658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066053	Green Published, gold, Green Submitted			2022-12-27	WOS:000273456300008
J	Chakrabarti, S; Panchenko, AR				Chakrabarti, Saikat; Panchenko, Anna R.			Structural and Functional Roles of Coevolved Sites in Proteins	PLOS ONE			English	Article							INFORMATION-THEORETIC ANALYSIS; AMINO-ACID SUBSTITUTIONS; MUTUAL INFORMATION; CORRELATED MUTATIONS; RESIDUES; COEVOLUTION; EVOLUTION; IDENTIFICATION; COVARIATION; ALIGNMENTS	Background: Understanding the residue covariations between multiple positions in protein families is very crucial and can be helpful for designing protein engineering experiments. These simultaneous changes or residue coevolution allow protein to maintain its overall structural-functional integrity while enabling it to acquire specific functional modifications. Despite the significant efforts in the field there is still controversy in terms of the preferable locations of coevolved residues on different regions of protein molecules, the strength of coevolutionary signal and role of coevolution in functional diversification. Methodology: In this paper we study the scale and nature of residue coevolution in maintaining the overall functionality and structural integrity of proteins. We employed a large scale study to investigate the structural and functional aspects of coevolved residues. We found that the networks representing the coevolutionary residue connections within our dataset are in general of 'small-world' type as they have clustering coefficient values higher than random networks and also show smaller mean shortest path lengths similar and/or lower than random and regular networks. We also found that altogether 11% of functionally important sites are coevolved with any other sites. Active sites are found more frequently to coevolve with any other sites (15%) compared to protein (11%) and ligand (9%) binding sites. Metal binding and active sites are also found to be more frequently coevolved with other metal binding and active sites, respectively. Analysis of the coupling between coevolutionary processes and the spatial distribution of coevolved sites reveals that a high fraction of coevolved sites are located close to each other. Moreover, similar to 80% of charge compensatory substitutions within coevolved sites are found at very close spatial proximity (< = 5 angstrom), pointing to the possible preservation of salt bridges in evolution. Conclusion: Our findings show that a noticeable fraction of functionally important sites undergo coevolution and also point towards compensatory substitutions as a probable coevolutionary mechanism within spatially proximal coevolved functional sites.	[Chakrabarti, Saikat; Panchenko, Anna R.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Chakrabarti, S (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	chakraba@ncbi.nlm.nih.gov; panch@ncbi.nlm.nih.gov			National Library of Medicine at National Institutes of Health/DHHS	National Library of Medicine at National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine at National Institutes of Health/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Bulka B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-329; Castoe TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002201; Chakrabarti S, 2007, PROTEIN SCI, V16, P4, DOI 10.1110/ps.062506407; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Chelvanayagam G, 1997, PROTEIN ENG, V10, P307, DOI 10.1093/protein/10.4.307; Choi SS, 2005, NAT GENET, V37, P1367, DOI 10.1038/ng1685; Daily MD, 2008, PROTEINS, V71, P455, DOI 10.1002/prot.21800; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Ferrer-Costa C, 2007, J MOL BIOL, V365, P249, DOI 10.1016/j.jmb.2006.09.053; Fitch W M, 1971, J Mol Evol, V1, P84, DOI 10.1007/BF01659396; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12; Govindarajan S, 2003, J MOL BIOL, V328, P1061, DOI 10.1016/S0022-2836(03)00357-7; Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937; JOHNSON DB, 1977, J ACM, V24, P1, DOI 10.1145/321992.321993; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kimura M., 1983, NEUTRAL THEORY MOL E; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Lee BC, 2008, PROTEINS, V72, P863, DOI 10.1002/prot.21972; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Moore GL, 2003, P NATL ACAD SCI USA, V100, P5091, DOI 10.1073/pnas.0831190100; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; Pritchard L, 2001, PROTEIN ENG, V14, P549, DOI 10.1093/protein/14.8.549; Saraf MC, 2003, PROTEIN ENG, V16, P1025, DOI 10.1093/protein/gzg129; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Voigt CA, 2001, J CELL BIOCHEM, V84, P58, DOI 10.1002/jcb.10066; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211	48	44	44	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8591	10.1371/journal.pone.0008591	http://dx.doi.org/10.1371/journal.pone.0008591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066038	gold, Green Submitted, Green Published			2022-12-27	WOS:000273338600014
J	Gehrau, RC; D'Astolfo, DS; Dumur, CI; Bocco, JL; Koritschoner, NP				Gehrau, Ricardo C.; D'Astolfo, Diego S.; Dumur, Catherine I.; Bocco, Jose L.; Koritschoner, Nicolas P.			Nuclear Expression of KLF6 Tumor Suppressor Factor Is Highly Associated with Overexpression of ERBB2 Oncoprotein in Ductal Breast Carcinomas	PLOS ONE			English	Article							TRANSCRIPTION FACTOR KLF6; PREDICTIVE MARKERS; GENE KLF6; IN-VIVO; CANCER; PROTEIN; ABSENCE; MUTATIONS; HETEROZYGOSITY; INACTIVATION	Background: Kruppel-like factor 6 (KLF6) is an evolutionarily conserved and ubiquitously expressed protein that belongs to the mammalian Sp1/KLF family of transcriptional regulators. Though KLF6 is a transcription factor and harbors a nuclear localization signal it is not systematically located in the nucleus but it was detected in the cytoplasm of several tissues and cell lines. Hence, it is still not fully settled whether the tumor suppressor function of KLF6 is directly associated with its ability to regulate target genes. Methodology/Principal Findings: In this study we analyzed KLF6 expression and sub-cellular distribution by immunohistochemistry in several normal and tumor tissues in a microarray format representing fifteen human organs. Results indicate that while both nuclear and cytoplasmic distribution of KLF6 is detected in normal breast tissues, breast carcinomas express KLF6 mainly detected in the cytoplasm. Expression of KLF6 was further analyzed in breast cancer tissues overexpressing ERBB2 oncoprotein, which is associated with poor disease prognosis and patient's survival. The analysis of 48 ductal carcinomas revealed a significant population expressing KLF6 predominantly in the nuclear compartment (X-2 p = 0.005; Fisher p = 0.003). Moreover, this expression pattern correlates directly with early stage and small ductal breast tumors and linked to metastatic events in lymph nodes. Conclusions/Significance: Data are consistent with a preferential localization of KLF6 in the nuclear compartment of early stage and small HER2-ERBB2 overexpressing ductal breast tumor cells, also presenting lymph node metastatic events. Thus, KLF6 tumor suppressor could represent a new molecular marker candidate for tumor prognosis and/or a potential target for therapy strategies.	[Gehrau, Ricardo C.; Bocco, Jose L.; Koritschoner, Nicolas P.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina; [D'Astolfo, Diego S.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC CONICET, RA-5000 Cordoba, Argentina; [Dumur, Catherine I.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Virginia Commonwealth University	Gehrau, RC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina.	jbocco@fcq.unc.edu.ar	Dumur, Catherine/AAH-9489-2020	Bocco, Jose Luis/0000-0002-9682-1270; Dumur, Catherine/0000-0003-3975-9332	Fundacion Antorchas; Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina; Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT) [PICT 15-20279, PICT 8321]; Third World Academy of Sciences (TWAS); Secretaria de Ciencia y Tecnologia; Universidad Nacional de Cordoba, Argentina	Fundacion Antorchas; Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT)(ANPCyTFONCyT); Third World Academy of Sciences (TWAS); Secretaria de Ciencia y Tecnologia(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad Nacional de Cordoba, Argentina	Fundacion Antorchas. - Beca Carrillo-onativia (Ministerio de Salud de la Nacion Argentina). - Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. - Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT: PICT 15-20279 to JLB; PICT 2000-2001 No 8321). - Third World Academy of Sciences (TWAS). - Secretaria de Ciencia y Tecnologia - Universidad Nacional de Cordoba, Argentina. D. S. D. and R. C. G. were supported by a CONICET and FONCyT fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Azim H, 2008, ONCOLOGY-BASEL, V74, P150, DOI 10.1159/000151362; Benson JR, 2003, LANCET ONCOL, V4, P56, DOI 10.1016/S1470-2045(03)00961-6; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Blanchon L, 2001, MECH DEVELOP, V105, P185, DOI 10.1016/S0925-4773(01)00391-4; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; Boyault S, 2005, HEPATOLOGY, V41, P681, DOI 10.1002/hep.20588; Bureau C, 2008, J GASTROEN HEPATOL, V23, P78, DOI 10.1111/j.1440-1746.2007.05234.x; Camacho-Vanegas O, 2007, INT J CANCER, V121, P1390, DOI 10.1002/ijc.22809; Chen C, 2002, ONCOGENE, V21, P6567, DOI 10.1038/sj.onc.1205817; Chen CS, 2005, ONCOGENE, V24, P3319, DOI 10.1038/sj.onc.1208497; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; D'Astolfo DS, 2008, CELL DEATH DIFFER, V15, P613, DOI 10.1038/sj.cdd.4402299; Faratian D, 2008, HISTOPATHOLOGY, V52, P91, DOI 10.1111/j.1365-2559.2007.02896.x; Foster KW, 2000, CANCER RES, V60, P6488; Gehrau RC, 2005, BBA-GENE STRUCT EXPR, V1730, P137, DOI 10.1016/j.bbaexp.2005.06.006; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Grizzle William E., 1998, V14, P143; Grizzle William E., 1998, V14, P161; Guo HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-110; Irvine T, 2007, EXPERT REV ANTICANC, V7, P135, DOI 10.1586/14737140.7.2.135; Ito G, 2004, CANCER RES, V64, P3838, DOI 10.1158/0008-5472.CAN-04-0185; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kohler B, 2004, INT J CANCER, V111, P644, DOI 10.1002/ijc.20302; Koivisto PA, 2004, INT J CANCER, V111, P642, DOI 10.1002/ijc.20301; Koritschoner NP, 1997, J BIOL CHEM, V272, P9573; Lievre A, 2005, ONCOGENE, V24, P7253, DOI 10.1038/sj.onc.1208867; LIU J, 2009, MOL CELL BIOCH; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Miyaki M, 2006, ONCOLOGY-BASEL, V71, P131, DOI 10.1159/000100523; Montanini L, 2004, INT J CANCER, V111, P640, DOI 10.1002/ijc.20303; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Narla G, 2008, J CLIN INVEST, V118, P2711, DOI 10.1172/JCI34780; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Payne SJL, 2008, HISTOPATHOLOGY, V52, P82, DOI 10.1111/j.1365-2559.2007.02897.x; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Sangodkar J, 2009, EUR J CANCER, V45, P666, DOI 10.1016/j.ejca.2008.11.009; Sirach E, 2007, CELL DEATH DIFFER, V14, P1202, DOI 10.1038/sj.cdd.4402114; Slavin D, 1999, BIOL REPROD, V61, P1586, DOI 10.1095/biolreprod61.6.1586; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Sun Ming, 2006, Zhonghua Nan Ke Xue, V12, P502; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; TAHARA E, 2009, CANC BIOL THER, V8; Tang P, 2007, CURR OPIN OBSTET GYN, V19, P63, DOI 10.1097/GCO.0b013e3280114a3a; Tong D, 2006, CLIN CANCER RES, V12, P2442, DOI 10.1158/1078-0432.CCR-05-0964; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wiechmann L, 2008, CANCER-AM CANCER SOC, V112, P2130, DOI 10.1002/cncr.23430; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Yea S, 2008, GASTROENTEROLOGY, V134, P1521, DOI 10.1053/j.gastro.2008.02.015	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8929	10.1371/journal.pone.0008929	http://dx.doi.org/10.1371/journal.pone.0008929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126619	gold, Green Published, Green Submitted			2022-12-27	WOS:000274138000008
J	Pethica, R; Barker, G; Kovacs, T; Gough, J				Pethica, Ralph; Barker, Gary; Kovacs, Tim; Gough, Julian			TreeVector: Scalable, Interactive, Phylogenetic Trees for the Web	PLOS ONE			English	Article							PROTEIN SEQUENCES; MANIPULATION; DISPLAY	Background: Phylogenetic trees are complex data forms that need to be graphically displayed to be human-readable. Traditional techniques of plotting phylogenetic trees focus on rendering a single static image, but increases in the production of biological data and large-scale analyses demand scalable, browsable, and interactive trees. Methodology/Principal Findings: We introduce TreeVector, a Scalable Vector Graphics-and Java-based method that allows trees to be integrated and viewed seamlessly in standard web browsers with no extra software required, and can be modified and linked using standard web technologies. There are now many bioinformatics servers and databases with a range of dynamic processes and updates to cope with the increasing volume of data. TreeVector is designed as a framework to integrate with these processes and produce user-customized phylogenies automatically. We also address the strengths of phylogenetic trees as part of a linked-in browsing process rather than an end graphic for print. Conclusions/Significance: TreeVector is fast and easy to use and is available to download precompiled, but is also open source. It can also be run from the web server listed below or the user's own web server. It has already been deployed on two recognized and widely used database Web sites.	[Pethica, Ralph; Kovacs, Tim; Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Barker, Gary] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Pethica, R (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.	pethica@cs.bris.ac.uk		Barker, Gary/0000-0002-9018-9526	Engineering and Physical Sciences Research Council Departmental Grant; Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish; BBSRC [BB/G022771/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council Departmental Grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Engineering and Physical Sciences Research Council Departmental Grant (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker G, 2003, BIOINFORMATICS, V19, P421, DOI 10.1093/bioinformatics/btf881; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fredslund J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-315; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; MADDISON WP, 1992, MCCLADE ANAL PHYLOGE; Makarenkov U, 2001, BIOINFORMATICS, V17, P664, DOI 10.1093/bioinformatics/17.7.664; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palidwor G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-79; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; [No title captured]	13	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8934	10.1371/journal.pone.0008934	http://dx.doi.org/10.1371/journal.pone.0008934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126613	gold, Green Published, Green Submitted			2022-12-27	WOS:000274138000012
J	Hyams, C; Tam, JCH; Brown, JS; Gordon, SB				Hyams, Catherine; Tam, Jerry C. H.; Brown, Jeremy S.; Gordon, Stephen B.			C3b/iC3b Deposition on Streptococcus pneumoniae Is Not Affected by HIV Infection	PLOS ONE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCOCCAL DISEASE; COMPLEMENT PATHWAY; MALAWIAN ADULTS; IMMUNITY; DEFICIENCY; RESPONSES; VACCINE; MICE	Streptococcus pneumoniae is a common cause of infection in both HIV positive patients and those with complement deficiencies. We hypothesised that HIV positive individuals might exhibit reduced opsonisation of pneumococcus with complement due to reduced levels of S. pneumoniae specific IgG. We discovered no difference in C3 deposition on S. pneumoniae between HIV positive or negative individuals, and furthermore C3 deposition remained unchanged as HIV progressed towards AIDS. We found no correlation between C3 deposition on S. pneumoniae and CD4 cell count in HIV infected individuals. Hence we have demonstrated no failure of complement immunity in HIV positive patients.	[Hyams, Catherine; Brown, Jeremy S.] UCL, Rayne Inst, Sch Med, Ctr Resp Res,Dept Med, London, England; [Tam, Jerry C. H.; Gordon, Stephen B.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; King's College London; University College London; UCL Medical School; Liverpool School of Tropical Medicine; University of Liverpool	Hyams, C (corresponding author), UCL, Rayne Inst, Sch Med, Ctr Resp Res,Dept Med, London, England.	sbgordon@liv.ac.uk	Hyams, Catherine/AAH-1721-2019; Tam, Jerry/P-1995-2014	Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361; Tam, Jerry/0000-0001-7991-1568; Gordon, Stephen/0000-0001-6576-1116	Astor Foundation; Glaxo Smith Kline; Wellcome Trust [061231]	Astor Foundation; Glaxo Smith Kline(GlaxoSmithKline); Wellcome Trust(Wellcome TrustEuropean Commission)	CH is supported by the Astor Foundation and Glaxo Smith Kline through the University College London MB PhD programme. SGB is supported by the Wellcome Trust ( grant 061231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1979, AM J MED, V67, P547, DOI 10.1016/0002-9343(79)90222-5; BERNSTEIN LJ, 1985, J PEDIATR-US, V107, P352, DOI 10.1016/S0022-3476(85)80505-9; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; CARSON PJ, 1995, J INFECT DIS, V172, P340, DOI 10.1093/infdis/172.2.340; Chang BG, 1999, AM J KIDNEY DIS, V33, P441, DOI 10.1016/S0272-6386(99)70180-0; CROSS AS, 1990, CURR TOP MICROBIOL, V150, P87; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; French N, 1998, AIDS, V12, P1683, DOI 10.1097/00002030-199813000-00017; Gilks CF, 1996, LANCET, V347, P718, DOI 10.1016/S0140-6736(96)90076-8; Gordon SB, 2003, J INFECT DIS, V188, P666, DOI 10.1086/377480; Gordon SB, 2002, AIDS, V16, P1409, DOI 10.1097/00002030-200207050-00013; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; LEVO Y, 1974, International Urology and Nephrology, V6, P233, DOI 10.1007/BF02089270; MAYERSIUTA R, 1988, MED MICROBIOL IMMUN, V177, P189, DOI 10.1007/BF00211218; Morrow M, 2008, AIDS RES HUM RETROV, V24, P621, DOI 10.1089/aid.2007.0186; MUSHER DM, 1990, INFECT IMMUN, V58, P3871, DOI 10.1128/IAI.58.12.3871-3876.1990; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Takahashi H, 2003, CLIN INFECT DIS, V37, P1534, DOI 10.1086/379511; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; WINKELSTEIN JA, 1968, NEW ENGL J MED, V279, P459, DOI 10.1056/NEJM196808292790904; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	22	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8902	10.1371/journal.pone.0008902	http://dx.doi.org/10.1371/journal.pone.0008902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126656	gold, Green Published, Green Accepted			2022-12-27	WOS:000273896500021
J	Kaczmarczyk, SJ; Sitaraman, K; Hill, T; Hartley, JL; Chatterjee, DK				Kaczmarczyk, Stanislaw J.; Sitaraman, Kalavathy; Hill, Thomas; Hartley, James L.; Chatterjee, Deb K.			Tus, an E. coli Protein, Contains Mammalian Nuclear Targeting and Exporting Signals	PLOS ONE			English	Article							ESCHERICHIA-COLI; TER COMPLEX; DNA-REPLICATION; SEQUENCE; TRANSLOCATION; TERMINATION; BINDING; DOMAIN; LOCALIZATION; RECOMBINASE	Shuttling of proteins between nucleus and cytoplasm in mammalian cells is facilitated by the presence of nuclear localization signals (NLS) and nuclear export signals (NES), respectively. However, we have found that Tus, an E. coli replication fork arresting protein, contains separate sequences that function efficiently as NLS and NES in mammalian cell lines, as judged by cellular location of GFP-fusion proteins. The NLS was localized to a short stretch of 9 amino acids in the carboxy-terminus of Tus protein. Alterations of any of these basic amino acids almost completely abolished the nuclear targeting. The NES comprises a cluster of leucine/hydrophobic residues located within 21 amino acids at the amino terminus of Tus. Finally, we have shown that purified GFP-Tus fusion protein or GFP-Tus NLS fusion protein, when added to the culture media, was internalized very efficiently into mammalian cells. Thus, Tus is perhaps the first reported bacterial protein to possess both NLS and NES, and has the capability to transduce protein into mammalian cells.	[Kaczmarczyk, Stanislaw J.; Sitaraman, Kalavathy; Hartley, James L.; Chatterjee, Deb K.] NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Hill, Thomas] Univ N Dakota, Sch Med & Hlth Sci, Dept Microbiol & Immunol, Grand Forks, ND 58201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of North Dakota Grand Forks	Kaczmarczyk, SJ (corresponding author), NCI, Prot Express Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA.	dchatterjee@mail.nih.gov			National Cancer Institute, National Institutes of Health [NO1-CO-12400]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. NO1-CO-12400. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alefantis T, 2003, J BIOL CHEM, V278, P21814, DOI 10.1074/jbc.M211576200; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Chatterjee DK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003265; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; DWORETZKY SI, 1988, J CELL BIOL, V106, P575, DOI 10.1083/jcb.106.3.575; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; GANGETEN S, 1997, NUCLEIC ACIDS RES, V25, P3326; GERACE L, 1995, CELL, V82, P341, DOI 10.1016/0092-8674(95)90420-4; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; GOTTLIEB PA, 1992, J BIOL CHEM, V267, P7434; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; KUEMPEL PL, 1973, MOL GEN GENET, V125, P1, DOI 10.1007/BF00292981; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Le YZ, 1999, NUCLEIC ACIDS RES, V27, P4703, DOI 10.1093/nar/27.24.4703; MASTERS M, 1971, NATURE-NEW BIOL, V232, P137, DOI 10.1038/newbio232137a0; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Murriel Christopher L, 2006, Expert Opin Drug Deliv, V3, P739, DOI 10.1517/17425247.3.6.739; NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3; Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Pelczar P, 2004, EMBO REP, V5, P632, DOI 10.1038/sj.embor.7400165; RICHARDSON WD, 1988, CELL, V52, P655, DOI 10.1016/0092-8674(88)90403-5; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2; Skokotas A, 1995, J BIOL CHEM, V270, P30941, DOI 10.1074/jbc.270.52.30941	33	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8889	10.1371/journal.pone.0008889	http://dx.doi.org/10.1371/journal.pone.0008889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126275	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500012
J	McConnell, JJ; Bragg, L; Shiboski, S; Grant, RM				McConnell, J. Jeff; Bragg, Larry; Shiboski, Stephen; Grant, Robert M.			Sexual Seroadaptation: Lessons for Prevention and Sex Research from a Cohort of HIV-Positive Men Who Have Sex with Men	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUAL BISEXUAL MEN; SAN-FRANCISCO; GAY MEN; SEROPOSITIVE GAY; SOCIAL NETWORKS; CONCURRENT PARTNERSHIPS; RISK BEHAVIOR; UNITED-STATES	Background: Surveillance data on sexually transmitted infections (STIs) and behavioral characteristics identified in studies of the risk of seroconversion are often used as to track sexual behaviors that spread HIV. However, such analyses can be confounded by "seroadaptation" - the restriction of unprotected anal intercourse (UAI), especially unprotected insertive UAI, to seroconcordant partnerships. Methods: We utilized sexual network methodology and repeated-measures statistics to test the hypothesis that seroadaptive strategies reduce the risk of HIV transmission despite numerous partnerships and frequent UAI. Principal Findings: In a prospective cohort study of HIV superinfection including 168 HIV-positive men who have sex with men (MSM), we found extensive seroadaptation. UAI was 15.5 times more likely to occur with a positive partner than a negative one (95% confidence interval [CI], 9.1-26.4). Receptive UAI was 4.3 times more likely in seroconcordant partnerships than with negative partners (95% CI, 2.8-6.6), but insertive UAI was 13.6 times more likely with positives (95% CI, 7.2-25.6). Our estimates suggest that seroadaptation reduced HIV transmissions by 98%. Conclusion: Potentially effective HIV prevention strategies, such as seroadaptation, have evolved in communities of MSM before they have been recognized in research or discussed in the public health forum. Thus, to be informative, studies of HIV risk must be designed to assess seroadaptive behaviors rather than be limited to individual characteristics, unprotected intercourse, and numbers of partners. STI surveillance is not an effective indicator of trends in HIV incidence where there are strong patterns of seroadaptation.	[McConnell, J. Jeff; Bragg, Larry; Grant, Robert M.] Gladstone Inst Virol & Immunol, San Francisco, CA USA; [Shiboski, Stephen] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Grant, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	McConnell, JJ (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA USA.	jmcconnell@gladstone.ucsf.edu		Grant, Robert/0000-0002-0851-7085	University of California San Francisco AIDS Research Institute Breakthrough Fund; University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR) [556232-29665]; Centers for Disease Control [U64/CCU917889-01]; University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA) [ID01-GI-115]; National Institutes of Health [R01 AI056988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056988] Funding Source: NIH RePORTER	University of California San Francisco AIDS Research Institute Breakthrough Fund; University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR); Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	University of California San Francisco AIDS Research Institute Breakthrough Fund, University of California San Francisco-Gladstone Centers for AIDS Research Developmental Award (CFAR) # 556232-29665, Centers for Disease Control grant # U64/CCU917889-01, University wide AIDS Research Program (UARP) Innovative Developmental Exploratory Award (IDEA) award # ID01-GI-115, National Institutes of Health R01 AI056988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P229; ANDERSON RM, 1989, ANN NY ACAD SCI, V569, P240, DOI 10.1111/j.1749-6632.1989.tb27374.x; ANDERSON RM, 1988, NATURE, V333, P514, DOI 10.1038/333514a0; [Anonymous], 1994, ADV SOCIAL NETWORK A; Bell DC, 1999, SOC NETWORKS, V21, P1, DOI 10.1016/S0378-8733(98)00010-0; BERNARD HR, 1990, SOC NETWORKS, V12, P179, DOI 10.1016/0378-8733(90)90005-T; Blower SMSS, 1997, AIDS BEHAV, V1, P273; BLYTHE SP, 1989, MATH BIOSCI, V96, P221, DOI 10.1016/0025-5564(89)90060-6; Bogard CJ, 1999, J HEALTH SOC BEHAV, V40, P46, DOI 10.2307/2676378; Catania JA, 2001, AM J PUBLIC HEALTH, V91, P907, DOI 10.2105/AJPH.91.6.907; Clatts MC, 2005, SEX TRANSM INFECT, V81, P373, DOI 10.1136/sti.2005.014894; Cox J, 2004, SEX TRANSM INFECT, V80, P518, DOI 10.1136/sti.2004.011288; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; DAWSON JM, 1994, AIDS, V8, P837, DOI 10.1097/00002030-199406000-00018; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; Elford J, 2006, CURR OPIN INFECT DIS, V19, P26, DOI 10.1097/01.qco.0000199018.50451.e1; Fischer C. S., 1982, DWELL FRIENDS PERSON; Fox KK, 2001, AM J PUBLIC HEALTH, V91, P959, DOI 10.2105/AJPH.91.6.959; Fox KK, 1998, SEX TRANSM DIS, V25, P386, DOI 10.1097/00007435-199808000-00011; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; GAGNON JH, 1989, DAEDALUS, V118, P47; GOEDERT JJ, 1984, LANCET, V2, P711; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; GRANT RM, 1987, J INFECT DIS, V156, P189, DOI 10.1093/infdis/156.1.189; GUPTA S, 1989, AIDS, V3, P807, DOI 10.1097/00002030-198912000-00005; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Hoff CC, 1997, J ACQ IMMUN DEF SYND, V14, P72, DOI 10.1097/00042560-199701010-00012; Katz MH, 2002, AM J PUBLIC HEALTH, V92, P388, DOI 10.2105/AJPH.92.3.388; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; KIPPAX S, 1993, AIDS, V7, P257, DOI 10.1097/00002030-199302000-00015; Kretzschmar M, 1996, MATH BIOSCI, V133, P165, DOI 10.1016/0025-5564(95)00093-3; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; LAUMANN EO, 1989, SCIENCE, V244, P1186, DOI 10.1126/science.2543079; Lemp GF, 1997, J ACQ IMMUN DEF SYND, V16, P182, DOI 10.1097/00042560-199711010-00007; LIEBOW E, 1995, SOC NETWORKS, V17, P257, DOI 10.1016/0378-8733(95)00266-Q; Mao LM, 2006, AIDS, V20, P1204, DOI 10.1097/01.aids.0000226964.17966.75; MARKS G, 1994, J ACQ IMMUN DEF SYND, V7, P866; MORRIS M, 1994, AM J EPIDEMIOL, V140, P217, DOI 10.1093/oxfordjournals.aje.a117241; MORRIS M, 1995, AIDS EDUC PREV, V7, P24; Morris M, 1997, AIDS, V11, pS209; MORRIS M, 1995, AIDS, V9, P507, DOI 10.1097/00002030-199509050-00014; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2000, AIDS, V14, P733, DOI 10.1097/00002030-200004140-00013; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Morris M, 1996, AIDS, V10, P1265, DOI 10.1097/00002030-199609000-00013; MORRIS M, 1994, ADV SOCIAL NETWORK A, P26; MOSS PM, 1998, THESIS RU US; NEEDLE RH, 1995, SOCIAL NETWORKS DRUG; Parsons JT, 2006, AIDS EDUC PREV, V18, P139, DOI 10.1521/aeap.2006.18.2.139; Parsons JT, 2005, AIDS, V19, pS87, DOI 10.1097/01.aids.0000167355.87041.63; Parsons JT, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000167348.15750.9a; Porco TC, 2004, AIDS, V18, P81, DOI 10.1097/00002030-200401020-00010; Rothenberg R B, 1995, NIDA Res Monogr, V151, P3; ROTHENBERG RB, 1995, SOC NETWORKS, V17, P273, DOI 10.1016/0378-8733(95)00267-R; Rothenberg RB, 1998, SEX TRANSM DIS, V25, P154, DOI 10.1097/00007435-199803000-00009; *SAN FRANC DEP PUB, 2001, 2001 SAN FRANC HIV P; Schwarcz S, 2001, AM J EPIDEMIOL, V153, P925, DOI 10.1093/aje/153.10.925; SERVICE SK, 1995, P ROY SOC B-BIOL SCI, V260, P237, DOI 10.1098/rspb.1995.0086; Shilts R., 1988, BAND PLAYED POLITICS, P588; Stall RD, 2000, AIDS, V14, pS101; Truong HHM, 2006, SEX TRANSM INFECT, V82, P461, DOI 10.1136/sti.2006.019950; Van de Ven P, 2002, AIDS CARE, V14, P471, DOI 10.1080/09540120208629666; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WINKELSTEIN W, 1987, AM J PUBLIC HEALTH, V77, P685, DOI 10.2105/AJPH.77.6.685; WINKELSTEIN W, 1988, AM J PUBLIC HEALTH, V78, P1472, DOI 10.2105/AJPH.78.11.1472; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P1470, DOI 10.1001/jama.1987.03390110046011; Xia Q, 2006, AIDS, V20, P2081, DOI 10.1097/01.aids.0000247566.57762.b2; 2007, SEROADAPTATION CHEZ	71	35	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8831	10.1371/journal.pone.0008831	http://dx.doi.org/10.1371/journal.pone.0008831			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546AJ	20098616	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100022
J	Edes, K; Cassidy, P; Shami, PJ; Moos, PJ				Edes, Kornelia; Cassidy, Pamela; Shami, Paul J.; Moos, Philip J.			JS-K, a Nitric Oxide Prodrug, Has Enhanced Cytotoxicity in Colon Cancer Cells with Knockdown of Thioredoxin Reductase 1	PLOS ONE			English	Article							DNA-BINDING ACTIVITY; MOTEXAFIN GADOLINIUM; IN-VIVO; LIPOIC ACID; ELECTROPHILIC PROSTAGLANDINS; ANTICANCER AGENTS; TUMOR-SUPPRESSOR; LEUKEMIA CELLS; SYSTEM; EXPRESSION	Background: The selenoenzyme thioredoxin reductase 1 has a complex role relating to cell growth. It is induced as a component of the cellular response to potentially mutagenic oxidants, but also appears to provide growth advantages to transformed cells by inhibiting apoptosis. In addition, selenocysteine-deficient or alkylated forms of thioredoxin reductase 1 have also demonstrated oxidative, pro-apoptotic activity. Therefore, a greater understanding of the role of thioredoxin reductase in redox initiated apoptotic processes is warranted. Methodology: The role of thioredoxin reductase 1 in RKO cells was evaluated by attenuating endogenous thioredoxin reductase 1 expression with siRNA and then either inducing a selenium-deficient thioredoxin reductase or treatment with distinct redox challenges including, hydrogen peroxide, an oxidized lipid, 4-hydroxy-2-nonenol, and a nitric oxide donating prodrug. Thioredoxin redox status, cellular viability, and effector caspase activity were measured. Conclusions/Significance: In cells with attenuated endogenous thioredoxin reductase 1, a stably integrated selenocysteine-deficient form of the enzyme was induced but did not alter either the thioredoxin redox status or the cellular growth kinetics. The oxidized lipid and the nitric oxide donor demonstrated enhanced cytotoxicity when thioredoxin reductase 1 was knocked-down; however, the effect was more pronounced with the nitric oxide prodrug. These results are consistent with the hypothesis that attenuation of the thioredoxin-system can promote apoptosis in a nitric oxide-dependent manner.	[Edes, Kornelia; Cassidy, Pamela] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Cassidy, Pamela] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Shami, Paul J.] Univ Utah, Dept Med Oncol, Salt Lake City, UT USA; [Moos, Philip J.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; [Cassidy, Pamela] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Edes, K (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	philip.moos@utah.edu		Moos, Philip/0000-0002-8223-442X	USPHS [CA115616];  [P30 CA042014]; NATIONAL CANCER INSTITUTE [R01CA115616, P30CA042014] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a USPHS Grant CA115616 (PJM). We also acknowledge the use of core facilities supported by P30 CA042014 awarded to the Huntsman Cancer Institute. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P73, DOI 10.3816/CGC.2008.n.011; Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Anestal K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001846; Arivarasu NA, 2007, LIFE SCI, V81, P393, DOI 10.1016/j.lfs.2007.06.001; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Biaglow JE, 2005, CANCER BIOL THER, V4, P6; BJORNSTEDT M, 1995, J BIOL CHEM, V270, P11761, DOI 10.1074/jbc.270.20.11761; Bleys J, 2008, ARCH INTERN MED, V168, P404, DOI 10.1001/archinternmed.2007.74; Bracht K, 2007, ANTI-CANCER DRUG, V18, P389, DOI 10.1097/CAD.0b013e3280140001; Cassidy PB, 2006, CARCINOGENESIS, V27, P2538, DOI 10.1093/carcin/bgl111; Fang JG, 2006, J AM CHEM SOC, V128, P1879, DOI 10.1021/ja057358l; Ford JM, 2007, INT J RADIAT ONCOL, V69, P831, DOI 10.1016/j.ijrobp.2007.04.017; Grogan TM, 2000, HUM PATHOL, V31, P475, DOI 10.1053/hp.2000.6546; Hashemy SI, 2006, J BIOL CHEM, V281, P10691, DOI 10.1074/jbc.M511373200; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Hu JD, 2001, ONCOGENE, V20, P4235, DOI 10.1038/sj.onc.1204585; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Kakolyris S, 2001, CLIN CANCER RES, V7, P3087; Kim KM, 2002, J BIOCHEM MOL BIOL, V35, P127; Kiziltepe T, 2007, BLOOD, V110, P709, DOI 10.1182/blood-2006-10-052845; Lamas S., 1998, Trends in Pharmacological Sciences, V19, P436, DOI 10.1016/S0165-6147(98)01265-6; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; May JM, 2007, CLIN BIOCHEM, V40, P1135, DOI 10.1016/j.clinbiochem.2007.06.009; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moos PJ, 2000, P NATL ACAD SCI USA, V97, P9215, DOI 10.1073/pnas.160241897; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Mullally JE, 2001, J BIOL CHEM, V276, P30366, DOI 10.1074/jbc.M102198200; Nilsson J, 2000, BLOOD, V95, P1420, DOI 10.1182/blood.V95.4.1420.004k12_1420_1426; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ravi D, 2004, CANCER CHEMOTH PHARM, V54, P449, DOI 10.1007/s00280-004-0833-y; Richards GM, 2007, EXPERT OPIN PHARMACO, V8, P351, DOI 10.1517/14656566.8.3.351; Rosenberg A, 2006, INT J RADIAT ONCOL, V64, P343, DOI 10.1016/j.ijrobp.2005.10.013; Rundlof AK, 2004, ANTIOXID REDOX SIGN, V6, P41, DOI 10.1089/152308604771978336; Saavedra JE, 2001, J ORG CHEM, V66, P3090, DOI 10.1021/jo0016529; Seemann S, 2005, ONCOGENE, V24, P3853, DOI 10.1038/sj.onc.1208549; Shami PJ, 2006, J MED CHEM, V49, P4356, DOI 10.1021/jm060022h; Shami PJ, 2003, MOL CANCER THER, V2, P409; Shao LE, 2001, CANCER RES, V61, P7333; Spyrou G, 1996, BIOCHEM BIOPH RES CO, V220, P42, DOI 10.1006/bbrc.1996.0353; SPYROU G, 1995, FEBS LETT, V368, P59, DOI 10.1016/0014-5793(95)00599-5; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sun Y, 2008, CANCER RES, V68, P8269, DOI 10.1158/0008-5472.CAN-08-2010; Udupi V, 2006, LEUKEMIA RES, V30, P1279, DOI 10.1016/j.leukres.2005.12.007; Wang XF, 2007, TOXICOL APPL PHARM, V218, P88, DOI 10.1016/j.taap.2006.10.029; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; William WN, 2007, J THORAC ONCOL, V2, P745, DOI 10.1097/JTO.0b013e31811f4719; Witte AB, 2005, FREE RADICAL BIO MED, V39, P696, DOI 10.1016/j.freeradbiomed.2005.04.025; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112	56	14	15	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8786	10.1371/journal.pone.0008786	http://dx.doi.org/10.1371/journal.pone.0008786			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098717	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779000015
J	Onken, B; Driscoll, M				Onken, Brian; Driscoll, Monica			Metformin Induces a Dietary Restriction-Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NEMATODE CAENORHABDITIS-ELEGANS; LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CYTOPLASMIC LOCALIZATION; SIGNALING PATHWAY; INDUCED LONGEVITY; SKELETAL-MUSCLE; MAMMARY-TUMORS; FAMILY-MEMBER	Metformin, a biguanide drug commonly used to treat type-2 diabetes, has been noted to extend healthspan of nondiabetic mice, but this outcome, and the molecular mechanisms that underlie it, have received relatively little experimental attention. To develop a genetic model for study of biguanide effects on healthspan, we investigated metformin impact on aging Caenorhabditis elegans. We found that metformin increases nematode healthspan, slowing lipofuscin accumulation, extending median lifespan, and prolonging youthful locomotory ability in a dose-dependent manner. Genetic data suggest that metformin acts through a mechanism similar to that operative in eating-impaired dietary restriction (DR) mutants, but independent of the insulin signaling pathway. Energy sensor AMPK and AMPK-activating kinase LKB1, which are activated in mammals by metformin treatment, are essential for health benefits in C. elegans, suggesting that metformin engages a metabolic loop conserved across phyla. We also show that the conserved oxidative stress-responsive transcription factor SKN-1/Nrf2 is essential for metformin healthspan benefits in C. elegans, a mechanistic requirement not previously described in mammals. skn-1, which functions in nematode sensory neurons to promote DR longevity benefits and in intestines for oxidative stress resistance lifespan benefits, must be expressed in both neurons and intestines for metformin-promoted healthspan extension, supporting that metformin improves healthy middle-life aging by activating both DR and antioxidant defense longevity pathways. In addition to defining molecular players operative in metformin healthspan benefits, our data suggest that metformin may be a plausible pharmacological intervention to promote healthy human aging.	[Onken, Brian; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Onken, B (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	driscoll@biology.rutgers.edu			National Institutes of Health [R01AG024882]; Ellison Medical Foundation; National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome [1-P50 AT002776-01]; New Jersey Commission on Cancer Research; Ellison Medical Foundation/American Federation of Aging Research; National Center for Complementary & Integrative Health [P50AT002776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; Ellison Medical Foundation/American Federation of Aging Research(Lawrence Ellison Foundation); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work was supported by National Institutes of Health funding R01AG024882, the Ellison Medical Foundation, and the National Institutes of Health Center for Dietary Supplements Research on Botanicals and Metabolic Syndrome, grant # 1-P50 AT002776-01. BO was supported by a grant from the New Jersey Commission on Cancer Research and by a Postdoctoral Fellowship in Aging Research from the Ellison Medical Foundation/American Federation of Aging Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Anedda A, 2008, J ENDOCRINOL, V199, P33, DOI 10.1677/JOE-08-0278; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Anisimov VN, 2005, B EXP BIOL MED+, V139, P721, DOI 10.1007/s10517-005-0389-9; Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007; Anisimov VN, 2003, EXP GERONTOL, V38, P1041, DOI 10.1016/S0531-5565(03)00169-4; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; Barzilai N, 2001, J NUTR, V131, p903S, DOI 10.1093/jn/131.3.903S; Beale EG, 2008, EXP BIOL MED, V233, P12, DOI 10.3181/0705-MR-117; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; BOLANOWSKI MA, 1981, MECH AGEING DEV, V15, P279, DOI 10.1016/0047-6374(81)90136-6; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; BRENNER S, 1974, GENETICS, V77, P71; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; DeFronzo RA, 2000, ANN INTERN MED, V133, P73, DOI 10.7326/0003-4819-133-1-200007040-00016; Dhahbi JM, 2005, PHYSIOL GENOMICS, V23, P343, DOI 10.1152/physiolgenomics.00069.2005; Dirkswager E., 2002, TEACHERS OWNERS KEY; DORMAN JB, 1995, GENETICS, V141, P1399; DUHON SA, 1995, J GERONTOL A-BIOL, V50, pB254, DOI 10.1093/gerona/50A.5.B254; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FRIEDMAN DB, 1988, GENETICS, V118, P75; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gami MS, 2006, AGING CELL, V5, P31, DOI 10.1111/j.1474-9726.2006.00188.x; Gerstbrein B, 2005, AGING CELL, V4, P127, DOI 10.1111/j.1474-9726.2005.00153.x; Glenn CF, 2004, J GERONTOL A-BIOL, V59, P1251, DOI 10.1093/gerona/59.12.1251; Greene AE, 2001, EPILEPSIA, V42, P1371, DOI 10.1046/j.1528-1157.2001.17601.x; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hayes JD, 2001, CANCER LETT, V174, P103, DOI 10.1016/S0304-3835(01)00695-4; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Holden-Dye Lindy, 2007, WormBook, P1, DOI 10.1895/wormbook.1.143.1; Houthoofd K, 2003, EXP GERONTOL, V38, P947, DOI 10.1016/S0531-5565(03)00161-X; Houthoofd K, 2002, EXP GERONTOL, V37, P1359, DOI 10.1016/S0531-5565(02)00172-9; Huang C, 2004, P NATL ACAD SCI USA, V101, P8084, DOI 10.1073/pnas.0400848101; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; HYUNG J, 2003, GENE DEV, V17, P1882; Ingram DK, 2006, AGING CELL, V5, P97, DOI 10.1111/j.1474-9726.2006.00202.x; Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lane MA, 2004, J GERONTOL A-BIOL, V59, P405; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lee HJ, 2008, J BIOL CHEM, V283, P14988, DOI 10.1074/jbc.M709115200; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Link CD, 2002, METHOD ENZYMOL, V353, P497; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Morck C, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-39; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; MORTON DG, 1992, GENETICS, V130, P771; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Rand JB, 1995, METHOD CELL BIOL, V48, P187; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Scarpello JHB, 2003, DIABETES METAB, V29, pS36; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Scott MP, 2002, J BIOL CHEM, V277, P28238, DOI 10.1074/jbc.M202783200; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Siegfried Z, 2003, PHYSIOL BEHAV, V79, P39, DOI 10.1016/S0031-9384(03)00103-3; Teale KFH, 1998, ANAESTHESIA, V53, P698, DOI 10.1046/j.1365-2044.1998.436-az0549.x; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; VOWELS JJ, 1992, GENETICS, V130, P105; Walker G, 2005, MECH AGEING DEV, V126, P929, DOI 10.1016/j.mad.2005.03.014; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	96	440	470	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8758	10.1371/journal.pone.0008758	http://dx.doi.org/10.1371/journal.pone.0008758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090912	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000016
J	Rosada, RS; Moreira, AP; Frantz, FG; Puri, RK; Rahman, A; Standiford, TJ; Zarate-Blades, CR; Silva, CL; Hogaboam, CM				Rosada, Rogerio S.; Moreira, Ana P.; Frantz, Fabiani G.; Puri, Raj K.; Rahman, Aquilur; Standiford, Theodore J.; Zarate-Blades, Carlos R.; Silva, Celio L.; Hogaboam, Cory M.			Therapeutic Efficacy of Cintredekin Besudotox (IL13-PE38QQR) in Murine Lung Fibrosis Is Unaffected by Immunity to Pseudomonas aeruginosa Exotoxin A	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; PARACOCCIDIOIDES-BRASILIENSIS CONIDIA; ALLERGIC AIRWAY DISEASE; RECEPTOR ALPHA-2 CHAIN; IL-13 RECEPTOR; INTERLEUKIN-13 RECEPTOR; CHIMERIC PROTEIN; CARCINOMA-CELLS; PERIBRONCHIAL FIBROSIS; SIGNAL-TRANSDUCTION	Background: We have previously explored a therapeutic strategy for specifically targeting the profibrotic activity of IL-13 during experimental pulmonary fibrosis using a fusion protein comprised of human IL-13 and a mutated form of Pseudomonas aeruginosa exotoxin A (IL13-PE) and observed that the intranasal delivery of IL13-PE reduced bleomycin-induced pulmonary fibrosis through its elimination of IL-13-responsive cells in the lung. The aim of the present study was to determine whether the presence of an immune response to P. aeruginosa and/or its exotoxin A (PE) would diminish the anti-fibrotic properties of IL13-PE. Methodology/Principal Findings: Fourteen days after P. aeruginosa infection, C57BL/6 mice were injected with bleomycin via the intratracheal route. Other groups of mice received 4 doses of saline or IL13-PE by either intranasal or intraperitoneal application, and were challenged i.t. with bleomycin 28 days later. At day 21 after bleomycin, all mice received either saline vehicle or IL13-PE by the intranasal route and histopatological analyses of whole lung samples were performed at day 28 after bleomycin. Intrapulmonary P. aeruginosa infection promoted a neutralizing IgG2A and IgA antibody response in BALF and serum. Surprisingly, histological analysis showed that a prior P. aeruginosa infection attenuated the development of bleomycin-induced pulmonary fibrosis, which was modestly further attenuated by the intranasal administration of IL13-PE. Although prior intranasal administration of IL13-PE failed to elicit an antibody response, the systemic administration of IL13-PE induced a strong neutralizing antibody response. However, the prior systemic sensitization of mice with IL13-PE did not inhibit the anti-fibrotic effect of IL13-PE in fibrotic mice. Conclusions: Thus, IL13-PE therapy in pulmonary fibrosis works regardless of the presence of a humoral immune response to Pseudomonas exotoxin A. Interestingly, a prior infection with P. aeruginosa markedly attenuated the pulmonary fibrotic response suggesting that the immune elicitation by this pathogen exerts anti-fibrotic effects.	[Rosada, Rogerio S.; Frantz, Fabiani G.; Zarate-Blades, Carlos R.; Silva, Celio L.] Univ Sao Paulo, Dept Bioquim & Imunol, Nucleo Pesquisa Tuberculose, Sao Paulo, Brazil; [Moreira, Ana P.; Hogaboam, Cory M.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Standiford, Theodore J.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Puri, Raj K.] US FDA, Tumor Vaccines & Biotechnol Branch, Div Cellular & Gene Therapies, Bethesda, MD 20014 USA; [Rahman, Aquilur] NeoPharm Inc, Lake Bluff, IL USA	Universidade de Sao Paulo; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Food & Drug Administration (FDA)	Rosada, RS (corresponding author), Univ Sao Paulo, Dept Bioquim & Imunol, Nucleo Pesquisa Tuberculose, Sao Paulo, Brazil.	hogaboam@umich.edu	Hogaboam, Cory M./AAI-1433-2021; Rosada, Rogerio/B-1396-2010; Silva, Celio/C-4639-2012; hogaboam, cory/M-3578-2014; Zárate-Bladés, Carlos R/C-9663-2015; Frantz, Fabiani Gai/B-9204-2016	Hogaboam, Cory M./0000-0003-3366-4850; Silva, Celio/0000-0002-0043-4568; Zárate-Bladés, Carlos R/0000-0002-7728-7869; Frantz, Fabiani Gai/0000-0001-6960-2438	National Institutes of Health (NIH); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); NeoPharm, Inc	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NeoPharm, Inc	Funding: These studies were supported by funding provided by the National Institutes of Health (NIH), the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), and NeoPharm, Inc. Neither the NIH nor the FAPESP had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Aquil Rahman is an employee of NeoPharm, Inc., and he was involved in the design of the experiments reported in this manuscript. Neither he nor NeoPharm, Inc. had any role in data collection and analysis, decision to publish, or preparation of the manuscript.	Belperio JA, 2002, AM J RESP CELL MOL, V27, P419, DOI 10.1165/rcmb.2002-0009OC; Blease K, 2001, J IMMUNOL, V167, P6583, DOI 10.4049/jimmunol.167.11.6583; Blease K, 2002, AM J PATHOL, V160, P481, DOI 10.1016/S0002-9440(10)64867-5; Debinski W, 1996, J BIOL CHEM, V271, P22428, DOI 10.1074/jbc.271.37.22428; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Doucet C, 1998, J CLIN INVEST, V101, P2129, DOI 10.1172/JCI741; Franco L, 1998, AM J TROP MED HYG, V58, P424, DOI 10.4269/ajtmh.1998.58.424; Gharaee-Kermani M, 2001, CYTOKINE, V15, P138, DOI 10.1006/cyto.2001.0903; Gonzalez A, 2008, MYCOPATHOLOGIA, V165, P313, DOI 10.1007/s11046-007-9072-1; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hogaboam CM, 2000, AM J PATHOL, V156, P723, DOI 10.1016/S0002-9440(10)64775-X; Jakubzick C, 2003, J IMMUNOL, V171, P2684, DOI 10.4049/jimmunol.171.5.2684; Jakubzick C, 2002, AM J PATHOL, V161, P1283, DOI 10.1016/S0002-9440(10)64405-7; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kawakami K, 2001, J EXP MED, V194, P1743, DOI 10.1084/jem.194.12.1743; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kawakami K, 2001, CANCER RES, V61, P6194; Keane MP, 1999, J IMMUNOL, V163, P5686; Keane MP, 1999, J IMMUNOL, V162, P5511; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; Kioi M, 2004, CLIN CANCER RES, V10, P6231, DOI 10.1158/1078-0432.CCR-04-0700; Lakatos HF, 2006, EXP LUNG RES, V32, P181, DOI 10.1080/01902140600817465; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Leland P, 2000, MOL MED, V6, P165, DOI 10.1007/BF03402112; Lukacs NW, 2001, CHEST, V120, p5S, DOI 10.1378/chest.120.1_suppl.S5; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Mueller-Ortiz SL, 2006, AM J PHYSIOL-LUNG C, V291, pL157, DOI 10.1152/ajplung.00358.2005; Murata T, 1998, INT IMMUNOL, V10, P1103, DOI 10.1093/intimm/10.8.1103; Murata T, 1997, BIOCHEM BIOPH RES CO, V238, P90, DOI 10.1006/bbrc.1997.7248; Obiri NI, 1997, J IMMUNOL, V158, P756; Ojielo CI, 2003, J IMMUNOL, V171, P4416, DOI 10.4049/jimmunol.171.8.4416; PRESTON MJ, 1991, INFECT IMMUN, V59, P1984, DOI 10.1128/IAI.59.6.1984-1990.1991; PURI RK, 1991, CANCER RES, V51, P3011; Puri RK, 1996, BLOOD, V87, P4333, DOI 10.1182/blood.V87.10.4333.bloodjournal87104333; SEMPOWSKI GD, 1994, J IMMUNOL, V152, P3606; Simonian PL, 2009, J IMMUNOL, V182, P657, DOI 10.4049/jimmunol.182.1.657; Toru H, 1998, J ALLERGY CLIN IMMUN, V102, P491, DOI 10.1016/S0091-6749(98)70140-X; WALLACE WAH, 1995, CLIN EXP IMMUNOL, V101, P436; Wallace WAH, 1999, J PATHOL, V187, P475, DOI 10.1002/(SICI)1096-9896(199903)187:4<475::AID-PATH268>3.0.CO;2-N; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	43	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8721	10.1371/journal.pone.0008721	http://dx.doi.org/10.1371/journal.pone.0008721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090941	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900003
J	Becker, S; Wandel, E; Wobus, M; Schneider, R; Amasheh, S; Sittig, D; Kerner, C; Naumann, R; Hamann, J; Aust, G				Becker, Susann; Wandel, Elke; Wobus, Manja; Schneider, Rick; Amasheh, Salah; Sittig, Doreen; Kerner, Christiane; Naumann, Ronald; Hamann, Joerg; Aust, Gabriela			Overexpression of CD97 in Intestinal Epithelial Cells of Transgenic Mice Attenuates Colitis by Strengthening Adherens Junctions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; BETA-CATENIN; TUMOR PROGRESSION; EXPRESSION; COMPLEX; CARCINOGENESIS; MIGRATION; CADHERINS; ADHESION	The adhesion G-protein-coupled receptor CD97 is present in normal colonic enterocytes but overexpressed in colorectal carcinoma. To investigate the function of CD97 in colorectal carcinogenesis, transgenic Tg(villin-CD97) mice overexpressing CD97 in enterocytes were generated and subjected to azoxymethane (AOM)/dextran sodium sulfate (DSS)-induced colitis-associated tumorigenesis. Unexpectedly, we found a CD97 cDNA copy number-dependent reduction of DSS-induced colitis in Tg compared to wild-type (WT) mice that was confirmed by applying a simple DSS protocol. Ultrastructural analysis revealed that overexpression of CD97 strengthened lateral cell-cell contacts between enterocytes, which, in contrast, were weakened in CD97 knockout (Ko) mice. Transepithelial resistance was not altered in Tg and Ko mice, indicating that tight junctions were not affected. In Tg murine and normal human colonic enterocytes as well as in colorectal cell lines CD97 was localized preferentially in E-cadherin-based adherens junctions. CD97 overexpression upregulated membrane-bound but not cytoplasmic or nuclear beta-catenin and reduced phospho-beta-catenin, labeled for degradation. This was associated with inactivation of glycogen synthase kinase-3 beta (GSK-3 beta) and activation of Akt. In summary, CD97 increases the structural integrity of enterocytic adherens junctions by increasing and stabilizing junctional b-catenin, thereby regulating intestinal epithelial strength and attenuating experimental colitis.	[Becker, Susann; Wandel, Elke; Wobus, Manja; Schneider, Rick; Sittig, Doreen; Kerner, Christiane; Aust, Gabriela] Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany; [Wandel, Elke] Univ Leipzig, Translat Ctr Regenerat Med, Leipzig, Germany; [Amasheh, Salah] Charite, Inst Clin Physiol, D-13353 Berlin, Germany; [Naumann, Ronald] MPI Mol Cell Biol & Genet, Transgen Core Facil, Dresden, Germany; [Hamann, Joerg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	Leipzig University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Amsterdam; Academic Medical Center Amsterdam	Becker, S (corresponding author), Univ Leipzig, Dept Surg, Res Labs, Leipzig, Germany.	gabriela.aust@medizin.uni-leipzig.de	Amasheh, Salah/AAG-4035-2021	Hamann, Jorg/0000-0002-9448-1727	Medical Faculty of the University of Leipzig; German Research Foundation (DFG); Netherlands Organization for Scientific Research (NWO)	Medical Faculty of the University of Leipzig; German Research Foundation (DFG)(German Research Foundation (DFG)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The work was supported by a grant from the Medical Faculty of the University of Leipzig (to S. B.) and grants from the German Research Foundation (DFG) and the Netherlands Organization for Scientific Research (NWO) (to G. A. and J.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Aust G, 1997, CANCER RES, V57, P1798; AUST G, 2007, CHIRURG FORUM, V36, P81; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; COOPER HS, 1993, LAB INVEST, V69, P238; EICHLER W, 1994, SCAND J IMMUNOL, V39, P111, DOI 10.1111/j.1365-3083.1994.tb03348.x; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Fitzpatrick LR, 2006, DIGEST DIS SCI, V51, P1269, DOI 10.1007/s10620-006-8047-2; Galle J, 2006, AM J PATHOL, V169, P1802, DOI 10.2353/ajpath.2006.060006; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; HORVAT B, 1990, HISTOCHEMISTRY, V93, P661, DOI 10.1007/BF00272210; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Kam Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004580; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; KREUSEL KM, 1991, AM J PHYSIOL, V261, pC574, DOI 10.1152/ajpcell.1991.261.4.C574; Kwakkenbos M.J., 2002, LEUCOCYTE TYPING, VVII, P381; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Pelech S, 2008, J PROTEOME RES, V7, P2860, DOI 10.1021/pr800082a; Pinto D, 1999, J BIOL CHEM, V274, P6476, DOI 10.1074/jbc.274.10.6476; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rivard N, 2009, FRONT BIOSCI-LANDMRK, V14, P510, DOI 10.2741/3259; Schulzke JD, 2005, BBA-BIOMEMBRANES, V1669, P34, DOI 10.1016/j.bbamem.2005.01.008; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zbar AP, 2004, J GASTROENTEROL, V39, P413, DOI 10.1007/s00535-004-1335-8; ZHANG L, 2004, HUM GEN M 2004 HGM 2	36	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8507	10.1371/journal.pone.0008507	http://dx.doi.org/10.1371/journal.pone.0008507			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084281	Green Published, gold			2022-12-27	WOS:000273554600004
J	Silvagno, F; De Vivo, E; Attanasio, A; Gallo, V; Mazzucco, G; Pescarmona, G				Silvagno, Francesca; De Vivo, Enrico; Attanasio, Angelo; Gallo, Valentina; Mazzucco, Gianna; Pescarmona, Gianpiero			Mitochondrial Localization of Vitamin D Receptor in Human Platelets and Differentiated Megakaryocytes	PLOS ONE			English	Article							LEUKEMIA-CELL LINE; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; EXPRESSION; IDENTIFICATION; INVOLVEMENT; ACTIVATION; MEMBRANE; PROTEINS	Background: Like other steroid hormones, vitamin D elicits both transcriptional events and rapid non genomic effects. Vitamin D receptor (VDR) localization and mechanisms of VDR-triggered non genomic responses are still controversial. Although anticoagulant effects of vitamin D have been reported and VDR signalling has been characterized in monocytes and vascular cells, nothing is known about VDR expression and functions in human platelets, anucleated fragments of megakaryocytes which are known targets of other steroids. Methodology/Principal Findings: In this study we characterized the expression and cellular localization of VDR in human platelets and in a megakaryocyte lineage. Human platelets and their TPA-differentiated precursors expressed a classical 50 kDa VDR protein, which increased with megakaryocytes maturation. By biochemical fractionation studies we demonstrated the presence of the receptor in the soluble and mitochondrial compartment of human platelets, and the observation was confirmed by immunoelectron microscopy analysis. Similar localization was found in mature megakaryocytes, where besides its classical nuclear localization the receptor was evident as soluble and mitochondria resident protein. Conclusions: The results reported here suggest that megakaryocytopoiesis and platelet activation, which are calcium-dependent events, might be modulated by a mitochondrial non genomic activity of VDR. These data open challenging future studies on VDR physiological role in platelets and more generally in mitochondria.	[Silvagno, Francesca; De Vivo, Enrico; Gallo, Valentina; Pescarmona, Gianpiero] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Silvagno, Francesca; Pescarmona, Gianpiero] S Giovanni Battista Hosp, CERMS, Turin, Italy; [Attanasio, Angelo; Mazzucco, Gianna] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Silvagno, F (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	francesca.silvagno@unito.it	Gallo, Valentina/E-1132-2011	Gallo, Valentina/0000-0002-1621-5829; PESCARMONA, GIAN PIERO/0000-0003-2143-8901	MIUR (Ministero dell'Istruzione Universita e Ricerca)	MIUR (Ministero dell'Istruzione Universita e Ricerca)(Ministry of Education, Universities and Research (MIUR))	Funding: This work was supported by MIUR (Ministero dell'Istruzione Universita e Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; BAATONT S, 1993, HEMATOL CELL THER, V10, P33; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; BORD S, 2001, J CELL BIOCHEM, V92, P219; Bouillon R, 2003, J CELL BIOCHEM, V88, P332, DOI 10.1002/jcb.10360; BRETONGORIUS J, 1986, SEMIN HEMATOL, V23, P43; BROEKMAN MJ, 1974, J CELL BIOL, V60, P507, DOI 10.1083/jcb.60.2.507; Casas F, 2003, FASEB J, V17, P426, DOI 10.1096/fj.02-0732com; Chambliss KL, 2000, CIRC RES, V87, pE44, DOI 10.1161/01.RES.87.11.e44; Chen JQ, 2004, AM J PHYSIOL-ENDOC M, V286, pE1011, DOI 10.1152/ajpendo.00508.2003; CONKERO JB, 2002, J BIOL CHEM, V277, P39665; DENDEKKER E, 2003, BIOCHIM BIOPHYS ACTA, V16, P85; DUSSO AS, 2005, AM J PHYSIOL-RENAL, V289, P3; GAVR, 2007, SCUAN REPROD MED, V25, P134; Hsieh JC, 2003, J BIOL CHEM, V278, P38665, DOI 10.1074/jbc.M304886200; Huhtakangas JA, 2004, MOL ENDOCRINOL, V18, P2660, DOI 10.1210/me.2004-0116; KAUSHANSKY K, 2003, BLOOD, V111, P931; KHET, 2000, BLOOD, V95, P2239; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; LAJDOVA I, 2003, EUR J PHARMACOL, V586, P11; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Leytin V, 2003, TRANSFUS APHER SCI, V28, P285, DOI 10.1016/S1473-0502(03)00048-X; Li YC, 2003, J CELL BIOCHEM, V88, P327, DOI 10.1002/jcb.10343; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Moraes LA, 2005, BLOOD, V106, P4167, DOI 10.1182/blood-2005-04-1723; MTOSKE G, 2000, EXP HEMATOL, V28, P111; NEMERE I, 1994, J BIOL CHEM, V269, P23750; NORM, 2006, ENDOCRINOLOGY, V147, P5542; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; O'Kelly J, 2002, J CLIN INVEST, V109, P1091, DOI 10.1172/JCI200212392; OGURA M, 1988, BLOOD, V72, P49; Ohsawa M, 2000, CIRCULATION, V102, P2867; PAMELA DK, 2004, J BIOL CHEM, V279, P16751; Pardo VG, 2008, BIOGERONTOLOGY, V9, P109, DOI 10.1007/s10522-007-9118-2; PILO R, 1981, THROMB HAEMOSTASIS, V46, P538; Psarra AMG, 2005, INT J BIOCHEM CELL B, V37, P2544, DOI 10.1016/j.biocel.2005.06.015; QUESADA JM, 1990, NEPHROL DIAL TRANSPL, V5, P1013, DOI 10.1093/ndt/5.12.1013; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Rebsamen MC, 2002, CIRC RES, V91, P17, DOI 10.1161/01.RES.0000025269.60668.0F; Reineri S, 2007, BBA-MOL CELL RES, V1773, P273, DOI 10.1016/j.bbamcr.2006.12.001; SATTAK T, 2003, LEUKOT ESSCUT FATTY, V69, P299; SELV, 1996, J INVEST DERMATOL, V1, P23; Silvagno F, 1996, J BIOL CHEM, V271, P11204, DOI 10.1074/jbc.271.19.11204; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song LN, 1996, J STEROID BIOCHEM, V57, P265, DOI 10.1016/0960-0760(95)00266-9; SONG LN, 1993, STEM CELLS, V11, P312, DOI 10.1002/stem.5530110409; TABI, 1924, LEUKEMIA RES, V3, P769; Zanello LP, 1996, BIOCHEM BIOPH RES CO, V225, P551, DOI 10.1006/bbrc.1996.1210	49	99	103	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8670	10.1371/journal.pone.0008670	http://dx.doi.org/10.1371/journal.pone.0008670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XC	20107497	gold, Green Published, Green Submitted			2022-12-27	WOS:000278099300001
J	Vrba, L; Jensen, TJ; Garbe, JC; Heimark, RL; Cress, AE; Dickinson, S; Stampfer, MR; Futscher, BW				Vrba, Lukas; Jensen, Taylor J.; Garbe, James C.; Heimark, Ronald L.; Cress, Anne E.; Dickinson, Sally; Stampfer, Martha R.; Futscher, Bernard W.			Role for DNA Methylation in the Regulation of miR-200c and miR-141 Expression in Normal and Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN PROSTATIC-CARCINOMA; BREAST-CANCER; HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; DOWN-REGULATION; CPG ISLANDS; E-CADHERIN; LINES; INVASION	Background: The microRNA-200 family participates in the maintenance of an epithelial phenotype and loss of its expression can result in epithelial to mesenchymal transition (EMT). Furthermore, the loss of expression of miR-200 family members is linked to an aggressive cancer phenotype. Regulation of the miR-200 family expression in normal and cancer cells is not fully understood. Methodology/Principal Findings: Epigenetic mechanisms participate in the control of miR-200c and miR-141 expression in both normal and cancer cells. A CpG island near the predicted mir-200c/mir-141 transcription start site shows a striking correlation between miR-200c and miR-141 expression and DNA methylation in both normal and cancer cells, as determined by MassARRAY technology. The CpG island is unmethylated in human miR-200/miR-141 expressing epithelial cells and in miR-200c/miR-141 positive tumor cells. The CpG island is heavily methylated in human miR-200c/miR-141 negative fibroblasts and miR-200c/miR-141 negative tumor cells. Mouse cells show a similar inverse correlation between DNA methylation and miR-200c expression. Enrichment of permissive histone modifications, H3 acetylation and H3K4 trimethylation, is seen in normal miR-200c/miR-141-positive epithelial cells, as determined by chromatin immunoprecipitation coupled to real-time PCR. In contrast, repressive H3K9 dimethylation marks are present in normal miR-200c/miR-141-negative fibroblasts and miR-200c/miR-141 negative cancer cells and the permissive histone modifications are absent. The epigenetic modifier drug, 5-aza-2'-deoxycytidine, reactivates miR-200c/miR-141 expression showing that epigenetic mechanisms play a functional role in their transcriptional control. Conclusions/Significance: We report that DNA methylation plays a role in the normal cell type-specific expression of miR-200c and miR-141 and this role appears evolutionarily conserved, since similar results were obtained in mouse. Aberrant DNA methylation of the miR-200c/141 CpG island is closely linked to their inappropriate silencing in cancer cells. Since the miR-200c cluster plays a significant role in EMT, our results suggest an important role for DNA methylation in the control of phenotypic conversions in normal cells.	[Vrba, Lukas; Jensen, Taylor J.; Heimark, Ronald L.; Cress, Anne E.; Dickinson, Sally; Stampfer, Martha R.; Futscher, Bernard W.] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Jensen, Taylor J.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Garbe, James C.; Stampfer, Martha R.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA USA; [Vrba, Lukas] ASCR, Ctr Biol, Vvi, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic	Arizona Center Cancer Care; University of Arizona; University of Arizona; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Vrba, L (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA.	bfutscher@azcc.arizona.edu	Cress, Anne/V-6527-2019; Vrba, Lukas/J-9268-2015	Cress, Anne/0000-0001-6194-0061; Vrba, Lukas/0000-0003-3042-6275	BIO5 interdisciplinary biotechnology center; NIH [U54 CA112970]; DOD [BCRP BC060444, DE-AC03-76SF00098];  [R01CA65662];  [P30ES06694];  [P30CA023074]; NATIONAL CANCER INSTITUTE [K07CA132956, U54CA112970, R01CA065662, P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	BIO5 interdisciplinary biotechnology center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Grants R01CA65662 to B. W. F supported this work. Center Grants P30ES06694 and P30CA023074, and the BIO5 interdisciplinary biotechnology center at the UA supported the Genomics Shared Service. J.C.G. and M. R. S. were supported by NIH U54 CA112970, DOD BCRP BC060444, and the Office of Energy Research, Office of Health and Biological Research, U. S. Department of Energy under Contract No. DE-AC03-76SF00098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta A, 1999, CARCINOGENESIS, V20, P2063, DOI 10.1093/carcin/20.11.2063; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Irizarry RA, 2009, MAMM GENOME; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jensen TJ, 2008, CARCINOGENESIS, V29, P1500, DOI 10.1093/carcin/bgn102; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; Oshiro MM, 2005, NEOPLASIA, V7, P799, DOI 10.1593/neo.05274; Oshiro MM, 2003, ONCOGENE, V22, P3624, DOI 10.1038/sj.onc.1206545; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Sharbati-Tehrani S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-34; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tran NL, 1999, AM J PATHOL, V155, P787, DOI 10.1016/S0002-9440(10)65177-2; VALERI N, 2009, MAMM GENOME; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763	46	235	258	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8697	10.1371/journal.pone.0008697	http://dx.doi.org/10.1371/journal.pone.0008697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084174	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600042
J	Wang, LG; Xi, YX; Yu, J; Dong, LP; Yen, LS; Li, W				Wang, Liguo; Xi, Yuanxin; Yu, Jun; Dong, Liping; Yen, Laising; Li, Wei			A Statistical Method for the Detection of Alternative Splicing Using RNA-Seq	PLOS ONE			English	Article							TRANSCRIPTOME	Deep sequencing of transcriptome (RNA-seq) provides unprecedented opportunity to interrogate plausible mRNA splicing patterns by mapping RNA-seq reads to exon junctions (thereafter junction reads). In most previous studies, exon junctions were detected by using the quantitative information of junction reads. The quantitative criterion (e. g. minimum of two junction reads), although is straightforward and widely used, usually results in high false positive and false negative rates, owning to the complexity of transcriptome. Here, we introduced a new metric, namely Minimal Match on Either Side of exon junction (MMES), to measure the quality of each junction read, and subsequently implemented an empirical statistical model to detect exon junctions. When applied to a large dataset (>200M reads) consisting of mouse brain, liver and muscle mRNA sequences, and using independent transcripts databases as positive control, our method was proved to be considerably more accurate than previous ones, especially for detecting junctions originated from low-abundance transcripts. Our results were also confirmed by real time RT-PCR assay. The MMES metric can be used either in this empirical statistical model or in other more sophisticated classifiers, such as logistic regression.	[Wang, Liguo; Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Wang, Liguo; Xi, Yuanxin; Dong, Liping; Yen, Laising; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dong, Liping; Yen, Laising] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Yu, Jun] Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Beijing Genomics Institute (BGI); Chinese Academy of Sciences	Wang, LG (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA.	WL1@bcm.edu	Li, Wei/A-8544-2009; 郑, 征/C-8514-2011	Li, Wei/0000-0001-9931-5990; Wang, Liguo/0000-0003-2072-4826	National Institutes of Health (NIH) Cancer Center [P30 CA125123]; Department of Defense [PC094421]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by National Institutes of Health (NIH) Cancer Center grant (P30 CA125123) and Department of Defense (PC094421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; CASTLE JC, 2008, NAT GENET; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Grasso C, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P29; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mortazavi A, 2008, NAT METHODS; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sharov AA, 2005, GENOME RES, V15, P748, DOI 10.1101/gr.3269805; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; SULTAN M, 2008, SCIENCE; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE	19	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8529	10.1371/journal.pone.0008529	http://dx.doi.org/10.1371/journal.pone.0008529			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072613	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200006
J	Untersmayr, E; Bises, G; Starkl, P; Bevins, CL; Scheiner, O; Boltz-Nitulescu, G; Wrba, F; Jensen-Jarolim, E				Untersmayr, Eva; Bises, Giovanna; Starkl, Philipp; Bevins, Charles L.; Scheiner, Otto; Boltz-Nitulescu, George; Wrba, Fritz; Jensen-Jarolim, Erika			The High Affinity IgE Receptor Fc epsilon RI Is Expressed by Human Intestinal Epithelial Cells	PLOS ONE			English	Article							TRANSEPITHELIAL ANTIGEN TRANSPORT; TRICHINELLA-SPIRALIS; BINDING-PROTEIN; COLORECTAL-CANCER; HUMAN EOSINOPHILS; CROHNS-DISEASE; MESSENGER-RNA; PANETH CELLS; HUMAN COLON; ALPHA	Background: IgE antibodies play a paramount role in the pathogenesis of various intestinal disorders. To gain insights in IgE-mediated pathophysiology of the gut, we investigated the expression of the high affinity IgE receptor Fc epsilon RI in human intestinal epithelium. Methodology/Principal Findings: Fc epsilon RI alpha-chain, as detected by immunohistochemistry, was positive in epithelial cells for eight of eleven (8/11) specimens from colon cancer patients and 5/11 patients with inflammation of the enteric mucosa. The Fc epsilon RI alpha positive epithelial cells co-expressed Fc epsilon RI gamma, whereas with one exception, none of the samples was positive for the beta-chain in the epithelial layer. The functionality of Fc epsilon RI was confirmed in situ by human IgE binding. In experiments with human intestinal tumor cell lines, subconfluent Caco-2/TC7 and HCT-8 cells were found to express the alpha- and gamma-chains of Fc epsilon RI and to bind IgE, whereas confluent cells were negative for gamma-chains. Conclusions/Significance: Our data provide the first evidence that the components of a functional Fc epsilon RI are in vitro expressed by the human intestinal epithelial cells depending on differentiation and, more importantly, in situ in epithelia of patients with colon cancer or gastrointestinal inflammations. Thus, a contribution of Fc epsilon RI either to immunosurveillance or pathophysiology of the intestinal epithelium is suggested.	[Untersmayr, Eva; Bises, Giovanna; Starkl, Philipp; Scheiner, Otto; Boltz-Nitulescu, George; Jensen-Jarolim, Erika] Med Univ Vienna, Dept Pathophysiol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Wrba, Fritz] Med Univ Vienna, Dept Pathol, Vienna, Austria	Medical University of Vienna; University of California System; University of California Davis; Medical University of Vienna	Untersmayr, E (corresponding author), Med Univ Vienna, Dept Pathophysiol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria.	eva.untersmayr@meduniwien.ac.at	Jensen-Jarolim, Erika/C-5120-2018; Untersmayr, Eva/GRY-4470-2022; Bevins, Charles L/P-4438-2015	Jensen-Jarolim, Erika/0000-0003-4019-5765; Bevins, Charles L/0000-0003-2725-2622; Untersmayr, Eva/0000-0002-1963-499X; Starkl, Philipp/0000-0001-7521-129X	OeNB Jubilaumsfond [11375]; Blanca Moser Fund [P21577-B11, APW0105FW, PA-18238-B13, SFB F 1808-B13]; Austrian Science funds FWF; Hochschuljubilaumsstiftung of the city of Vienna [H-02325/2007]; Austrian Science Fund (FWF) [P 21577] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738] Funding Source: NIH RePORTER	OeNB Jubilaumsfond; Blanca Moser Fund; Austrian Science funds FWF(Austrian Science Fund (FWF)); Hochschuljubilaumsstiftung of the city of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by OeNB Jubilaumsfond 11375 (http://www.oenb.at/de/ueber_die_oenb/foerderung/jubilaeumsfonds/jubilaeumsfonds.jsp), a Hans and Blanca Moser Fund project, P21577-B11, APW0105FW, PA-18238-B13 and SFB F 1808-B13 of the Austrian Science funds FWF (www.fwf.ac.at), and by the Hochschuljubilaumsstiftung of the city of Vienna H-02325/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Bevilacqua C, 2004, INT ARCH ALLERGY IMM, V135, P108, DOI 10.1159/000080653; Bises G, 2004, J HISTOCHEM CYTOCHEM, V52, P985, DOI 10.1369/jhc.4B6271.2004; Blumberg RS, 1999, IMMUNOL LETT, V69, P7, DOI 10.1016/S0165-2478(99)00093-0; BOLTZNITULESCU G, 1981, J EXP MED, V154, P374, DOI 10.1084/jem.154.2.374; Borkowski TA, 2001, J IMMUNOL, V167, P1290, DOI 10.4049/jimmunol.167.3.1290; Brandtzaeg P, 1996, ANN NY ACAD SCI, V778, P1, DOI 10.1111/j.1749-6632.1996.tb21110.x; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; CASTRONOVO V, 1992, JNCI-J NATL CANCER I, V84, P1161, DOI 10.1093/jnci/84.15.1161; CONRAD DH, 1990, ANNU REV IMMUNOL, V8, P623, DOI 10.1146/annurev.immunol.8.1.623; Cross HS, 2005, J STEROID BIOCHEM, V97, P121, DOI 10.1016/j.jsbmb.2005.06.005; DELAZZARI F, 1994, ITAL J GASTROENTEROL, V26, P7; DELESPESSE G, 1992, IMMUNOL REV, V125, P77, DOI 10.1111/j.1600-065X.1992.tb00626.x; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; GONZALEZMOLINA A, 1976, J IMMUNOL, V117, P1838; Gould HJ, 1999, EUR J IMMUNOL, V29, P3527, DOI 10.1002/(SICI)1521-4141(199911)29:11<3527::AID-IMMU3527>3.3.CO;2-X; GOUNNI AS, 1994, NATURE, V367, P183, DOI 10.1038/367183a0; GRANGETTE C, 1989, J IMMUNOL, V143, P3580; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; GSCHEIDLINGER R, 1998, THESIS U VIENNA; Gurish MF, 2004, J IMMUNOL, V172, P1139, DOI 10.4049/jimmunol.172.2.1139; HAKIMI J, 1990, J BIOL CHEM, V265, P22079; Hershberg RM, 1997, J CLIN INVEST, V100, P204, DOI 10.1172/JCI119514; Huber A, 1998, INT ARCH ALLERGY IMM, V115, P67, DOI 10.1159/000023832; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; JENSENJAROLIM E, 2008, ALLERGY; KAISERLIAN D, 1993, IMMUNOLOGY, V80, P90; Kalesnikoff J, 2001, IMMUNITY, V14, P801, DOI 10.1016/S1074-7613(01)00159-5; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; KUSTER H, 1992, J BIOL CHEM, V267, P12782; Lin SQ, 1996, CELL, V85, P985, DOI 10.1016/S0092-8674(00)81300-8; LIU FT, 1985, P NATL ACAD SCI USA, V82, P4100, DOI 10.1073/pnas.82.12.4100; Maurer D, 1996, J IMMUNOL, V157, P607; Maurer D, 1998, J IMMUNOL, V161, P2731; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; NegraoCorrea D, 1996, J IMMUNOL, V157, P4037; RAMASWAMY K, 1994, PARASITE IMMUNOL, V16, P435, DOI 10.1111/j.1365-3024.1994.tb00371.x; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Riemer AB, 2007, CANCER RES, V67, P3406, DOI 10.1158/0008-5472.CAN-06-3758; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; Seminario MC, 1999, J IMMUNOL, V162, P6893; Shen B, 2005, J CLIN PATHOL, V58, P687, DOI 10.1136/jcp.2004.022426; Stokes AJ, 2006, CELL SIGNAL, V18, P640, DOI 10.1016/j.cellsig.2005.06.003; VANSPREEUWEL JP, 1984, J CLIN PATHOL, V37, P601, DOI 10.1136/jcp.37.6.601; Wada Ryo, 2005, J Carcinog, V4, P5, DOI 10.1186/1477-3163-4-5; Wan T, 2002, NAT IMMUNOL, V3, P681, DOI 10.1038/ni811; Wehkamp J, 2006, CURR OPIN GASTROEN, V22, P644, DOI 10.1097/01.mog.0000245541.95408.86; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yu LCH, 2001, GASTROENTEROLOGY, V121, P370, DOI 10.1053/gast.2001.26470	52	28	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9023	10.1371/journal.pone.0009023	http://dx.doi.org/10.1371/journal.pone.0009023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126404	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200018
J	Braun, DA; Waldert, S; Aertsen, A; Wolpert, DM; Mehring, C				Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Wolpert, Daniel M.; Mehring, Carsten			Structure Learning in a Sensorimotor Association Task	PLOS ONE			English	Article							STIMULUS-RESPONSE THEORIES; EXTRADIMENSIONAL SHIFTS; NETWORK; MODELS	Learning is often understood as an organism's gradual acquisition of the association between a given sensory stimulus and the correct motor response. Mathematically, this corresponds to regressing a mapping between the set of observations and the set of actions. Recently, however, it has been shown both in cognitive and motor neuroscience that humans are not only able to learn particular stimulus-response mappings, but are also able to extract abstract structural invariants that facilitate generalization to novel tasks. Here we show how such structure learning can enhance facilitation in a sensorimotor association task performed by human subjects. Using regression and reinforcement learning models we show that the observed facilitation cannot be explained by these basic models of learning stimulus-response associations. We show, however, that the observed data can be explained by a hierarchical Bayesian model that performs structure learning. In line with previous results from cognitive tasks, this suggests that hierarchical Bayesian inference might provide a common framework to explain both the learning of specific stimulus-response associations and the learning of abstract structures that are shared by different task environments.	[Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Mehring, Carsten] Bernstein Ctr Computat Neurosci, Freiburg, Germany; [Braun, Daniel A.; Waldert, Stephan; Aertsen, Ad; Mehring, Carsten] Univ Freiburg, Fac Biol, Freiburg, Germany; [Braun, Daniel A.; Wolpert, Daniel M.] Univ Cambridge, Dept Engn, Cambridge CB2 1TN, England	University of Freiburg; University of Cambridge	Braun, DA (corresponding author), Bernstein Ctr Computat Neurosci, Freiburg, Germany.	dab54@cam.ac.uk	Mehring, Carsten/R-8986-2019; Braun, Daniel Alexander/B-7696-2015	Mehring, Carsten/0000-0001-8125-5205; Braun, Daniel Alexander/0000-0002-8637-6652; Wolpert, Daniel/0000-0003-2011-2790	German Federal Ministry of Education and Research [01GQ0420]; Bohringer-Ingelheim Fonds; SENSOPAC [IST-2005-028056]; Wellcome Trust	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bohringer-Ingelheim Fonds; SENSOPAC; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding: This study was supported in part by the German Federal Ministry of Education and Research (Grant 01GQ0420 to the Bernstein Center for Computational Neuroscience Freiburg), the Bohringer-Ingelheim Fonds, the European project SENSOPAC IST-2005-028056, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; BLACK AH, 1972, CLASSICAL CONDITION, V2, pR12; Braun DA, 2010, BEHAV BRAIN RES, V206, P157, DOI 10.1016/j.bbr.2009.08.031; Braun DA, 2009, J NEUROSCI, V29, P6472, DOI 10.1523/JNEUROSCI.3075-08.2009; Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Broomhead D. S., 1988, Complex Systems, V2, P321; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dayan P, 2001, THEORETICAL NEUROSCI, pxv; Garner JP, 2006, BEHAV BRAIN RES, V173, P53, DOI 10.1016/j.bbr.2006.06.002; GLUCK MA, 1988, J EXP PSYCHOL GEN, V117, P227, DOI 10.1037/0096-3445.117.3.227; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; HARLOW HF, 1949, PSYCHOL REV, V56, P51, DOI 10.1037/h0062474; Holland PC, 2008, LEARN BEHAV, V36, P227, DOI 10.3758/LB.36.3.227; KANDEL ER, 2000, PRINCIPLES NEURAL SC, pR41; KEMP C, 2009, COGNITIONP IN PRESS; Kemp C, 2008, P NATL ACAD SCI USA, V105, P10687, DOI 10.1073/pnas.0802631105; Kemp C, 2007, DEVELOPMENTAL SCI, V10, P307, DOI 10.1111/j.1467-7687.2007.00585.x; Kemp C, 2009, PSYCHOL REV, V116, P20, DOI 10.1037/a0014282; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Kohler W., 1925, MENTALITY APES; Kruschke JK, 2008, LEARN BEHAV, V36, P210, DOI 10.3758/LB.36.3.210; LUCAS CG, 2009, COGNITIONP IN PRESS; MACKINTO.NJ, 1969, PSYCHON SCI, V14, P5, DOI 10.3758/BF03336395; PAVLOV I. P., 1927; Perfors A., 2009, P 31 ANN C COGN SCI; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; REZNIKOVA ZI, 2007, ANIMAL INTELLIGENCE, pR14; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SKINNER B. F., 1938; SPENCE KW, 1950, PSYCHOL REV, V57, P159, DOI 10.1037/h0058250; Sutton R. S., 1998, REINFORCEMENT LEARNI, pXVIII; TENENBAUM JB, 2001, ADV NEURAL INFORM PR; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Trobalon JB, 2003, J EXP PSYCHOL ANIM B, V29, P143, DOI 10.1037/0097-7403.29.2.143; WIDROFF G, 1960, I RAD ENG W EL SHO 4; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	38	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8973	10.1371/journal.pone.0008973	http://dx.doi.org/10.1371/journal.pone.0008973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550PA	20126409	gold, Green Published			2022-12-27	WOS:000274139100021
J	Garavaglia, BS; Thomas, L; Gottig, N; Dunger, G; Garofalo, CG; Daurelio, LD; Ndimba, B; Orellano, EG; Gehring, C; Ottado, J				Garavaglia, Betiana S.; Thomas, Ludivine; Gottig, Natalia; Dunger, German; Garofalo, Cecilia G.; Daurelio, Lucas D.; Ndimba, Bongani; Orellano, Elena G.; Gehring, Chris; Ottado, Jorgelina			A Eukaryotic-Acquired Gene by a Biotrophic Phytopathogen Allows Prolonged Survival on the Host by Counteracting the Shut-Down of Plant Photosynthesis	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; XANTHOMONAS-AXONOPODIS; B RADIATION; PROTEIN; DEHYDROGENASE; CANKER; RESISTANCE; EXPRESSION; METABOLISM; EFFECTOR	Xanthomonas citri pv. citri, the bacteria responsible for citrus canker posses a biological active plant natriuretic peptide (PNP)-like protein, not present in any other bacteria. PNPs are a class of extracellular, systemically mobile peptides that elicit a number of plant responses important in homeostasis and growth. Previously, we showed that a Xanthomonas citri pv. citri mutant lacking the PNP-like protein XacPNP produced more necrotic lesions in citrus leaves than wild type infections and suggested a role for XacPNP in the regulation of host homeostasis. Here we have analyzed the proteome modifications observed in citrus leaves infected with the wild type and XacPNP deletion mutant bacteria. While both of them cause down-regulation of enzymes related to photosynthesis as well as chloroplastic ribosomal proteins, proteins related to defense responses are up-regulated. However, leaves infiltrated with the XacPNP deletion mutant show a more pronounced decrease in photosynthetic proteins while no reduction in defense related proteins as compared to the wild-type pathogen. This suggests that XacPNP serves the pathogen to maintain host photosynthetic efficiency during pathogenesis. The results from the proteomics analyses are consistent with our chlorophyll fluorescence data and transcript analyses of defense genes that show a more marked reduction in photosynthesis in the mutant but no difference in the induction of genes diagnostic for biotic-stress responses. We therefore conclude that XacPNP counteracts the shut-down of host photosynthesis during infection and in that way maintains the tissue in better conditions, suggesting that the pathogen has adapted a host gene to modify its natural host and render it a better reservoir for prolonged bacterial survival and thus for further colonization.	[Garavaglia, Betiana S.; Gottig, Natalia; Dunger, German; Garofalo, Cecilia G.; Daurelio, Lucas D.; Orellano, Elena G.; Ottado, Jorgelina] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina; [Garavaglia, Betiana S.] Univ Nacl Rosario, Consejo Invest, RA-2000 Rosario, Argentina; [Thomas, Ludivine; Ndimba, Bongani; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of the Western Cape; King Abdullah University of Science & Technology	Garavaglia, BS (corresponding author), Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Consejo Nacl Invest Cient & Tecn, Mol Biol Div,Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina.	ottado@ibr.gov.ar	Thomas, Ludivine/A-5062-2013; Dunger, German/AAT-6743-2021; Daurelio, Lucas/AAT-6969-2020	Thomas, Ludivine/0000-0003-0857-1775; Dunger, German/0000-0001-7307-6792; Gottig, Natalia/0000-0002-8730-8248; Daurelio, Lucas Damian/0000-0002-1156-2266; Gehring, Christoph/0000-0003-4355-4591	Argentine Federal Government (ANPCyT) [PICT2006-01073, PICT2006-00678]; South African National Research Foundation; King Abdullah University of Science and Technology (KAUST)	Argentine Federal Government (ANPCyT)(ANPCyT); South African National Research Foundation(National Research Foundation - South Africa); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This work was supported by grants from Argentine Federal Government (ANPCyT PICT2006-01073 to N.G. and PICT2006-00678 to J.O.), the South African National Research Foundation and King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baena-Gonzalez E, 2003, PLANT J, V35, P704, DOI 10.1046/j.1365-313X.2003.01842.x; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Brill EM, 1999, PLANT MOL BIOL, V41, P279, DOI 10.1023/A:1006381630494; Brosche M, 2003, PHYSIOL PLANTARUM, V117, P1, DOI 10.1034/j.1399-3054.2003.1170101.x; Casano LM, 2000, J BIOL CHEM, V275, P942, DOI 10.1074/jbc.275.2.942; Cernadas RA, 2008, MOL PLANT PATHOL, V9, P609, DOI 10.1111/J.1364-3703.2008.00486.X; De Gara L, 2003, PLANT PHYSIOL BIOCH, V41, P863, DOI 10.1016/S0981-9428(03)00135-9; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Dunger G, 2005, PLANT PATHOL, V54, P781, DOI 10.1111/j.1365-3059.2005.01284.x; Dunger G, 2007, ARCH MICROBIOL, V188, P127, DOI 10.1007/s00203-007-0227-8; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Gottig Natalia, 2009, Commun Integr Biol, V2, P89; Gottig N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004358; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Holley SR, 2003, PLANT PHYSIOL, V132, P1728, DOI 10.1104/pp.103.024414; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jansen MAK, 1998, TRENDS PLANT SCI, V3, P131, DOI 10.1016/S1360-1385(98)01215-1; Jelenska J, 2007, CURR BIOL, V17, P499, DOI 10.1016/j.cub.2007.02.028; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kunz BA, 2008, PLANT PHYSIOL, V148, P1021, DOI 10.1104/pp.108.125435; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Manning VA, 2009, MOL PLANT MICROBE IN, V22, P665, DOI 10.1094/MPMI-22-6-0665; Moiseyev GP, 1997, FEBS LETT, V407, P207, DOI 10.1016/S0014-5793(97)00337-2; Montesano M, 2003, PLANT MOL BIOL, V52, P177, DOI 10.1023/A:1023981631596; Nakajima S, 1998, NUCLEIC ACIDS RES, V26, P638, DOI 10.1093/nar/26.2.638; Nembaware V, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-10; Nielsen E, 2008, PLANT PHYSIOL, V147, P1516, DOI 10.1104/pp.108.121798; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; Ramagli LS, 1999, METH MOL B, V112, P99; Sheveleva EV, 1998, PLANT PHYSIOL, V117, P831, DOI 10.1104/pp.117.3.831; Somssich IE, 1996, P NATL ACAD SCI USA, V93, P14199, DOI 10.1073/pnas.93.24.14199; Speth EB, 2007, CURR OPIN PLANT BIOL, V10, P580, DOI 10.1016/j.pbi.2007.08.003; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Walters DR, 2006, TRENDS PLANT SCI, V11, P581, DOI 10.1016/j.tplants.2006.10.003; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	45	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8950	10.1371/journal.pone.0008950	http://dx.doi.org/10.1371/journal.pone.0008950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126632	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000025
J	Gonen-Gross, T; Goldman-Wohl, D; Huppertz, B; Lankry, D; Greenfield, C; Natanson-Yaron, S; Hamani, Y; Gilad, R; Yagel, S; Mandelboim, O				Gonen-Gross, Tsufit; Goldman-Wohl, Debra; Huppertz, Berthold; Lankry, Dikla; Greenfield, Caryn; Natanson-Yaron, Shira; Hamani, Yaron; Gilad, Ronit; Yagel, Simcha; Mandelboim, Ofer			Inhibitory NK Receptor Recognition of HLA-G: Regulation by Contact Residues and by Cell Specific Expression at the Fetal-Maternal Interface	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTOR; CLASS-I MOLECULES; CRYSTAL-STRUCTURE; HUMAN-REPRODUCTION; G PROTEIN; PREGNANCY; COMPLEX; SURFACE; ANTIGEN	The non-classical HLA-G protein is distinguished from the classical MHC class I molecules by its expression pattern, low polymorphism and its ability to form complexes on the cell surface. The special role of HLA-G in the maternal-fetal interface has been attributed to its ability to interact with specific receptors found on maternal immune cells. However this interaction is restricted to a limited number of receptors. In this study we elucidate the reason for this phenomenon by comparing the specific contact residues responsible for MHC-KIR interactions. This alignment revealed a marked difference between the HLA-G molecule and other MHC class I molecules. By mutating these residues to the equivalent classical MHC residues, the HLA-G molecule regained an ability of interacting with KIR inhibitory receptors found on NK cells derived either from peripheral blood or from the decidua. Functional NK killing assays further substantiated the binding results. Furthermore, double immunofluorescent staining of placental sections revealed that while the conformed form of HLA-G was expressed in all extravillous trophoblasts, the free heavy chain form of HLA-G was expressed in more distal cells of the column, the invasion front. Overall we suggest that HLA-G protein evolved to interact with only some of the NK inhibitory receptors thus allowing a control of inhibition, while permitting appropriate NK cell cytokine and growth factor production necessary for a viable maternal fetal interface.	[Gonen-Gross, Tsufit; Lankry, Dikla; Mandelboim, Ofer] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Goldman-Wohl, Debra; Greenfield, Caryn; Natanson-Yaron, Shira; Hamani, Yaron; Gilad, Ronit; Yagel, Simcha] Hadassah Univ Hosp, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; [Huppertz, Berthold] Med Univ Graz, Inst Cell Biol Histol & Embryol, Graz, Austria	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Medical University of Graz	Gonen-Gross, T (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel.	oferm@ekmd.huji.ac.il	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158; Mandelboim, Ofer/0000-0002-9354-1855	Israeli Cancer Research Foundation; Israeli Science Foundation; Israel Scientific Foundation (ISF) (Morasha); Rosenkratz Foundation; Israel-Croatia research; DKFZ-MOST; Association for International Cancer Research (AICR)	Israeli Cancer Research Foundation; Israeli Science Foundation(Israel Science Foundation); Israel Scientific Foundation (ISF) (Morasha)(Israel Science Foundation); Rosenkratz Foundation; Israel-Croatia research; DKFZ-MOST; Association for International Cancer Research (AICR)	This study was supported by grants from the Israeli Cancer Research Foundation, the Israeli Science Foundation, the Israel Scientific Foundation (ISF) (Morasha), the Rosenkratz Foundation, the Israel-Croatia research grant, the DKFZ-MOST and the Association for International Cancer Research (AICR) (all to O.M.). O.M. is a Crown professor of Molecular Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams EJ, 2001, IMMUNOGENETICS, V53, P200, DOI 10.1007/s002510100318; Allan DSJ, 2000, IMMUNOBIOLOGY, V202, P34, DOI 10.1016/S0171-2985(00)80050-9; APPS R, 2007, EUR J IMMUNOL; Arnaiz-Villena A, 2007, TISSUE ANTIGENS, V69, P156, DOI 10.1111/j.1399-0039.2006.763_8.x; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bellon T, 2002, J IMMUNOL, V168, P3351, DOI 10.4049/jimmunol.168.7.3351; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Boyson JE, 1996, J IMMUNOL, V157, P5428; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Favier B, 2007, TISSUE ANTIGENS, V69, P150, DOI 10.1111/j.1399-0039.2006.763_6.x; Gazit R, 2004, BLOOD, V103, P1965, DOI 10.1182/blood-2003-11-3796; Gomez-Lozano N, 2003, EUR J IMMUNOL, V33, P639, DOI 10.1002/eji.200323741; Gonen-Gross T, 2003, HUM IMMUNOL, V64, P1011, DOI 10.1016/j.humimm.2003.08.355; Gonen-Gross T, 2005, J IMMUNOL, V175, P4866, DOI 10.4049/jimmunol.175.8.4866; Gonen-Gross T, 2003, J IMMUNOL, V171, P1343, DOI 10.4049/jimmunol.171.3.1343; Gonen-Gross T, 2007, HUM IMMUNOL, V68, P227, DOI 10.1016/j.humimm.2006.10.013; Goodridge JP, 2003, J IMMUNOL, V171, P1768, DOI 10.4049/jimmunol.171.4.1768; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hanna J, 2003, BLOOD, V102, P1569, DOI 10.1182/blood-2003-02-0517; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Katz G, 2001, J IMMUNOL, V166, P7260, DOI 10.4049/jimmunol.166.12.7260; King A, 1996, AM J REPROD IMMUNOL, V35, P258; King A, 2000, PLACENTA, V21, P376, DOI 10.1053/plac.1999.0496; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Markel G, 2002, J CLIN INVEST, V110, P943, DOI 10.1172/JCI200215643; MCMASTER MT, 1995, J IMMUNOL, V154, P3771; Moesta AK, 2009, J IMMUNOL, V182, P3628, DOI 10.4049/jimmunol.0803401; Park B, 2001, IMMUNITY, V15, P213, DOI 10.1016/S1074-7613(01)00179-0; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Ponte M, 1999, P NATL ACAD SCI USA, V96, P5674, DOI 10.1073/pnas.96.10.5674; Rajagopalan S, 2006, PLOS BIOL, V4, P70, DOI 10.1371/journal.pbio.0040009; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rizzo R, 2007, HUM IMMUNOL, V68, P244, DOI 10.1016/j.humimm.2006.10.012; Sawicki MW, 2001, IMMUNOL REV, V181, P52, DOI 10.1034/j.1600-065X.2001.1810104.x; Shiroishi M, 2006, J BIOL CHEM, V281, P10439, DOI 10.1074/jbc.M512305200; STARKEY PM, 1988, IMMUNOLOGY, V65, P129; Tabiasco J, 2006, PLACENTA, V27, pS34, DOI 10.1016/j.placenta.2006.01.009; Vales-Gomez M, 1998, P NATL ACAD SCI USA, V95, P14326, DOI 10.1073/pnas.95.24.14326; van den Heuvel M, 2005, J REPROD IMMUNOL, V67, P21, DOI 10.1016/j.jri.2005.03.004; van der Meer A, 2007, MOL HUM REPROD, V13, P123, DOI 10.1093/molehr/gal100; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; Winter CC, 1998, J IMMUNOL, V161, P571	53	54	61	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8941	10.1371/journal.pone.0008941	http://dx.doi.org/10.1371/journal.pone.0008941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126612	Green Submitted, gold, Green Published			2022-12-27	WOS:000274138000018
J	Peifer, M; Weiss, J; Sos, ML; Koker, M; Heynck, S; Netzer, C; Fischer, S; Rode, H; Rauh, D; Rahnenfuhrer, J; Thomas, RK				Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Netzer, Christian; Fischer, Stefanie; Rode, Haridas; Rauh, Daniel; Rahnenfuehrer, Joerg; Thomas, Roman K.			Analysis of Compound Synergy in High-Throughput Cellular Screens by Population-Based Lifetime Modeling	PLOS ONE			English	Article							LUNG-CANCER; COMBINATION THERAPY; ACQUIRED-RESISTANCE; TYROSINE KINASE; GEFITINIB; EGFR; MUTATIONS; ERLOTINIB; INHIBITION; TUMORS	Despite the successful introduction of potent anti-cancer therapeutics, most of these drugs lead to only modest tumor-shrinkage or transient responses, followed by re-growth of tumors. Combining different compounds has resulted in enhanced tumor control and prolonged survival. However, methods querying the efficacy of such combinations have been hampered by limited scalability, analytical resolution, statistical feasibility, or a combination thereof. We have developed a theoretical framework modeling cellular viability as a stochastic lifetime process to determine synergistic compound combinations from high-throughput cellular screens. We apply our method to data derived from chemical perturbations of 65 cancer cell lines with two inhibitors. Our analysis revealed synergy for the combination of both compounds in subsets of cell lines. By contrast, in cell lines in which inhibition of one of both targets was sufficient to induce cell death, no synergy was detected, compatible with the topology of the oncogenically activated signaling network. In summary, we provide a tool for the measurement of synergy strength for combination perturbation experiments that might help define pathway topologies and direct clinical trials.	[Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Fischer, Stefanie; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany; [Peifer, Martin; Weiss, Jonathan; Sos, Martin L.; Koker, Mirjam; Heynck, Stefanie; Fischer, Stefanie; Thomas, Roman K.] Univ Cologne, Max Planck Soc, Fac Med, Cologne, Germany; [Netzer, Christian; Rahnenfuehrer, Joerg] Tech Univ Dortmund, Dept Stat, Dortmund, Germany; [Thomas, Roman K.] Univ Cologne, Dept Internal Med 1, Cologne, Germany; [Thomas, Roman K.] Univ Cologne, Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Rode, Haridas; Rauh, Daniel; Thomas, Roman K.] Max Planck Soc, Chem Genom Ctr, Dortmund, Germany	Max Planck Society; University of Cologne; Max Planck Society; University of Cologne; Dortmund University of Technology; University of Cologne; University of Cologne; Max Planck Society	Peifer, M (corresponding author), Univ Cologne, Max Planck Soc, Klaus Joachim Zulch Labs, Max Planck Inst Neurol Res, Cologne, Germany.	peifer@nf.mpg.de; nini@nf.mpg.de	Rauh, Daniel/G-1595-2013; Sos, Martin L/I-1852-2014	Peifer, Martin/0000-0002-5243-5503; Rahnenfuhrer, Jorg/0000-0002-8947-440X; Rauh, Daniel/0000-0002-1970-7642	Deutsche Krebshilfe [107954]; German Ministry of Science and Education (BMBF) [01GS08100]; Fritz-Thyssen Stiftung [10.08.2.175]; Deutsche Forschungsgemeinschaft [SFB832]	Deutsche Krebshilfe(Deutsche Krebshilfe); German Ministry of Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Fritz-Thyssen Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	1. Deutsche Krebshilfe (grant 107954) http://www.krebshilfe.de/ 2. German Ministry of Science and Education (BMBF) as part of the German National Genome Research Network (NGFNplus) program (grant 01GS08100) http://www.bmbf.de/en/ 3. Fritz-Thyssen Stiftung (grant 10.08.2.175) http://www.fritz-thyssen-stiftung.de/ 4. Deutsche Forschungsgemeinschaft through SFB832 http://www.dfg.de/en/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; BLISS CI, 1956, BACTERIOL REV, V20, P243, DOI 10.1128/MMBR.20.4.243-258.1956; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; CHOU TC, 1976, J THEOR BIOL, V59, P253, DOI 10.1016/0022-5193(76)90169-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Diehl V, 2004, LANCET ONCOL, V5, P19, DOI 10.1016/S1470-2045(03)01320-2; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P441; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Press W. H., 1992, ART SCI COMPUTING; REGALES L, 2009, J CLIN INVE IN PRESS; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; SOS ML, 2009, P NATL ACAD IN PRESS; SOS ML, 2009, INSIGHTS LTD A UNPUB; Uphoff Cord C, 2005, Methods Mol Biol, V290, P25	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8919	10.1371/journal.pone.0008919	http://dx.doi.org/10.1371/journal.pone.0008919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111714	Green Submitted, gold, Green Published			2022-12-27	WOS:000274114800021
J	Hewitt, FC; Samulski, RJ				Hewitt, F. Curtis; Samulski, R. Jude			Creating a Novel Origin of Replication through Modulating DNA-Protein Interfaces	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS AAV; ADENO-ASSOCIATED VIRUS; IN-VITRO; HELICASE ACTIVITY; TERMINAL REPEATS; NUCLEASE DOMAIN; REP PROTEIN; SEQUENCE; BINDING; NICKING	Background: While the molecular mechanisms of DNA-protein specificity at the origin of replication have been determined in many model organisms, these interactions remain unknown in the majority of higher eukaryotes and numerous vertebrate viruses. Similar to many viral origins of replication, adeno-associated virus (AAV) utilizes a cis-acting origin of replication and a virus specific Replication protein (Rep) to faithfully carry out self-priming replication. The mechanisms of AAV DNA replication are generally well understood. However, the molecular basis of specificity between the Rep protein and the viral origin of replication between different AAV serotypes remains uncharacterized. Methodology/Principal Findings: By generating a panel of chimeric and mutant origins between two AAV serotypes, we have mapped two independent DNA-Protein interfaces involved in replicative specificity. In vivo replication assays and structural modeling demonstrated that three residues in the AAV2 Rep active site are necessary to cleave its cognate origin. An analogous origin (AAV5) possesses a unique interaction between an extended Rep binding element and a 49 aa region of Rep containing two DNA binding interfaces. Conclusions/Significance: The elucidation of these structure-function relationships at the AAV origin led to the creation of a unique recombinant origin and compatible Rep protein with properties independent of either parent serotype. This novel origin may impact the safety and efficacy of AAV as a gene delivery tool. This work may also explain the unique ability of certain AAV serotypes to achieve site-directed integration into the human chromosome. Finally, this result impacts the study of conserved DNA viruses which employ rolling circle mechanisms of replication.	[Hewitt, F. Curtis; Samulski, R. Jude] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA; [Hewitt, F. Curtis; Samulski, R. Jude] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hewitt, FC (corresponding author), Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27515 USA.	rjs@med.unc.edu			National Institutes of Health [GM0529299, HL066973, HL051818, AI072176]; National Institute of Allergy and Infectious Diseases [AI007419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176, T32AI007419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants GM0529299, HL066973, HL051818, AI072176 awarded to Dr. Jude Samulski and National Institute of Allergy and Infectious Diseases grant AI007419 awarded to Curtis Hewitt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; Chiorini JA, 1999, J VIROL, V73, P4293, DOI 10.1128/JVI.73.5.4293-4298.1999; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; CHOMCZYNSKI P, 1992, ANAL BIOCHEM, V201, P134, DOI 10.1016/0003-2697(92)90185-A; DEISS V, 1990, VIROLOGY, V175, P247, DOI 10.1016/0042-6822(90)90205-6; Farkas SL, 2004, J GEN VIROL, V85, P555, DOI 10.1099/vir.0.19616-0; Grimm D, 2006, J VIROL, V80, P426, DOI 10.1128/JVI.80.1.426-439.2006; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; HERMONAT PL, 1997, FEBS LETT, V20, P180; Hewitt FC, 2009, J VIROL, V83, P3919, DOI 10.1128/JVI.02466-08; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; ILYINA TV, 1992, CELL, V84, P791; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Prasad KMR, 1995, VIROLOGY, V214, P360, DOI 10.1006/viro.1995.0045; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; SAMULSKI RJ, 1991, EMBO J, V10, P3941, DOI 10.1002/j.1460-2075.1991.tb04964.x; SAMULSKI RJ, 1983, CELL, V33, P135, DOI 10.1016/0092-8674(83)90342-2; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; VOS JC, 1993, GENE DEV, V7, P1244, DOI 10.1101/gad.7.7a.1244; Wu JW, 2001, ARCH BIOCHEM BIOPHYS, V389, P271, DOI 10.1006/abbi.2001.2348; Xiao X, 1997, J VIROL, V71, P941, DOI 10.1128/JVI.71.2.941-948.1997; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Young SM, 2000, J VIROL, V74, P3953, DOI 10.1128/JVI.74.9.3953-3966.2000; Young SM, 2000, METH MOL B, V133, P111; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	11	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8850	10.1371/journal.pone.0008850	http://dx.doi.org/10.1371/journal.pone.0008850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107513	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896100015
J	Giroud, S; Perret, M; Stein, P; Goudable, J; Aujard, F; Gilbert, C; Robin, JP; Le Maho, Y; Zahariev, A; Blanc, S; Momken, I				Giroud, Sylvain; Perret, Martine; Stein, Peter; Goudable, Joelle; Aujard, Fabienne; Gilbert, Caroline; Robin, Jean Patrice; Le Maho, Yvon; Zahariev, Alexandre; Blanc, Stephane; Momken, Iman			The Grey Mouse Lemur Uses Season-Dependent Fat or Protein Sparing Strategies to Face Chronic Food Restriction	PLOS ONE			English	Article							MICROCEBUS-MURINUS; GROUND-SQUIRRELS; METABOLIC-RATE; BODY-MASS; TORPOR; WATER; SUPPRESSION; PHOTOPERIOD; HIBERNATION; INHIBITION	During moderate calorie restriction (CR) the heterotherm Microcebus murinus is able to maintain a stable energy balance whatever the season, even if only wintering animals enter into torpor. To understand its energy saving strategies to respond to food shortages, we assessed protein and energy metabolisms associated with wintering torpor expression or summering torpor avoidance. We investigated body composition, whole body protein turnover, and daily energy expenditure (DEE), during a graded (40 and 80%) 35-day CR in short-days (winter; SD40 and SD80, respectively) and long-days (summer; LD40 and LD80, respectively) acclimated animals. LD40 animals showed no change in fat mass (FM) but a 12% fat free mass (FFM) reduction. Protein balance being positive after CR, the FFM loss was early and rapid. The 25% DEE reduction, in LD40 group was mainly explained by FFM changes. LD80 animals showed a steady body mass loss and were excluded from the CR trial at day 22, reaching a survival-threatened body mass. No data were available for this group. SD40 animals significantly decreased their FM level by 21%, but maintained FFM. Protein sparing was achieved through a 35 and 39% decrease in protein synthesis and catabolism (protein turnover), respectively, overall maintaining nitrogen balance. The 21% reduction in energy requirement was explained by the 30% nitrogen flux drop but also by torpor as DEE FFM-adjusted remained 13% lower compared to ad-libitum. SD80 animals were unable to maintain energy and nitrogen balances, losing both FM and FFM. Thus summering mouse lemurs equilibrate energy balance by a rapid loss of active metabolic mass without using torpor, whereas wintering animals spare protein and energy through increased torpor expression. Both strategies have direct fitness implication: 1) to maintain activities at a lower body size during the mating season and 2) to preserve an optimal wintering muscle mass and function.	[Giroud, Sylvain; Gilbert, Caroline; Robin, Jean Patrice; Le Maho, Yvon; Zahariev, Alexandre; Blanc, Stephane; Momken, Iman] Univ Strasbourg, UMR 7178, Dept Ecol Physiol Ethol, Inst Pluridisciplinaire Hubert Curien,CNRS, Strasbourg, France; [Giroud, Sylvain; Perret, Martine; Aujard, Fabienne] Museum Natl Hist Nat, CNRS, UMR 7179, Brunoy, France; [Stein, Peter] Univ Med & Dent New Jersey, Dept Surg, Stratford, NJ USA; [Goudable, Joelle] Hop Edouard Herriot, Inst Sci Pharmaceut & Biol, Fac Pharm, Lyon, France; [Gilbert, Caroline] Nancy Univ, Univ Henri Poincare, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Rutgers State University New Brunswick; Rutgers State University Medical Center; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lorraine	Giroud, S (corresponding author), Univ Strasbourg, UMR 7178, Dept Ecol Physiol Ethol, Inst Pluridisciplinaire Hubert Curien,CNRS, Strasbourg, France.	stephane.blanc@c-strasbourg.fr		Giroud, Sylvain/0000-0001-6621-7462; Gilbert, Caroline/0000-0002-9957-405X	MNRT; ANR AlimH	MNRT; ANR AlimH(French National Research Agency (ANR))	S. Giroud is supported by an MNRT fellowship. This work was supported by ANR AlimH (http://www.agence-nationale-recherche.fr), the FRM (http://www.frm.org) and the GIS Longevite (http://www.gis-longevite.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; BACHMAN GC, 1994, PHYSIOL ZOOL, V67, P756, DOI 10.1086/physzool.67.3.30163769; Blanc S, 2005, J MED PRIMATOL, V34, P130, DOI 10.1111/j.1600-0684.2005.00106.x; Bozinovic F, 2007, J COMP PHYSIOL B, V177, P393, DOI 10.1007/s00360-006-0137-0; CONCON JM, 1973, ANAL BIOCHEM, V53, P35, DOI 10.1016/0003-2697(73)90405-3; Coward WA, 1990, DOUBLY LABELLED WATE, P48; Crawford FIJ, 2007, PHYSIOL GENOMICS, V31, P521, DOI 10.1152/physiolgenomics.00131.2007; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; Evans MC, 2007, RESUSCITATION, V73, P296, DOI 10.1016/j.resuscitation.2006.08.029; Fietz J, 1998, FOLIA PRIMATOL, V69, P183, DOI 10.1159/000052712; Filaire E, 2002, INT J SPORTS MED, V23, P588, DOI 10.1055/s-2002-35531; French Alan R., 1992, P105; Frerichs KU, 1998, P NATL ACAD SCI USA, V95, P14511, DOI 10.1073/pnas.95.24.14511; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, AM J PHYSIOL-REG I, V284, pR811, DOI 10.1152/ajpregu.00525.2002; GIROUD S, 2008, AMERICAN J PHYSL REG, V294, P1958; Giroud S, 2009, AM J PHYSIOL-REG I, V297, pR950, DOI 10.1152/ajpregu.00214.2009; Grigg G, 2000, LIFE IN THE COLD, P5; HOWELL RR, 1961, J CLIN INVEST, V40, P2076, DOI 10.1172/JCI104433; KARMANN H, 1994, INT J OBESITY, V18, P351; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; LINDGARD K, 1992, J COMP PHYSIOL B, V162, P607, DOI 10.1007/BF00296641; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; MCBRIDE BW, 1990, J ANIM SCI, V68, P2997; MICHENER GR, 1992, OECOLOGIA, V89, P397, DOI 10.1007/BF00317418; Migliorini RH, 1997, AM J PHYSIOL-REG I, V272, pR656, DOI 10.1152/ajpregu.1997.272.2.R656; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MROSOVSKY N, 1985, INT J OBESITY, V9, P93; NELSON RA, 1978, KIDNEY INT, pS177; NELSON RA, 1980, FED PROC, V39, P2955; Orr AL, 2009, COMP BIOCHEM PHYS A, V153, P213, DOI 10.1016/j.cbpa.2009.02.016; Perret M, 1995, CREATURES OF THE DARK, P377; PERRET M, 1987, J CHEM ECOL, V13, P495, DOI 10.1007/BF01880095; Perret M, 1998, COMP BIOCHEM PHYS A, V119, P981, DOI 10.1016/S1095-6433(98)00015-4; PERRET M, 1998, P INT C CHRON PAR FR, P415; Petter-Rousseaux A, 1980, NOCTURNAL MALAGASY P; RACETTE SB, 1994, AM J PHYSIOL-ENDOC M, V267, pE585, DOI 10.1152/ajpendo.1994.267.4.E585; Radespiel U, 2000, AM J PRIMATOL, V51, P21, DOI 10.1002/(SICI)1098-2345(200005)51:1<21::AID-AJP3>3.0.CO;2-C; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; RUF T, 1992, PHYSIOL ZOOL, V65, P994, DOI 10.1086/physzool.65.5.30158554; Schmid J, 1999, J MAMMAL, V80, P749, DOI 10.2307/1383244; Schmid J, 2000, BASIC APPL ECOL, V1, P133, DOI 10.1078/1439-1791-00019; Schmid Jutta, 1996, P47; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 1997, DOUBLY LABELED WATER; van Breukelen F, 2004, AM J PHYSIOL-REG I, V287, pR349, DOI 10.1152/ajpregu.00728.2003; Van Breukelen F, 2001, AM J PHYSIOL-REG I, V281, pR1374, DOI 10.1152/ajpregu.2001.281.5.R1374; Velickovska V, 2005, J COMP PHYSIOL B, V175, P329, DOI 10.1007/s00360-005-0489-x; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; WATERLOW JC, 1978, AM J PHYSIOL, V235, pE165, DOI 10.1152/ajpendo.1978.235.2.E165; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Williams JB, 2001, J EXP BIOL, V204, P2301; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; Wunder Bruce A., 1996, P131; YOUNG JB, 1977, SCIENCE, V196, P1473, DOI 10.1126/science.867049	58	17	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8823	10.1371/journal.pone.0008823	http://dx.doi.org/10.1371/journal.pone.0008823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098678	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100015
J	Simpson, DC; Kabyemela, E; Muehlenbachs, A; Ogata, Y; Mutabingwa, TK; Duffy, PE; Fried, M				Simpson, David C.; Kabyemela, Edward; Muehlenbachs, Atis; Ogata, Yuko; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal			Plasma Levels of Apolipoprotein A1 in Malaria-Exposed Primigravidae Are Associated with Severe Anemia	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; SHOTGUN PROTEOMICS; FALCIPARUM-MALARIA; PROTEIN EXPRESSION; GENE-EXPRESSION; DATABASE SEARCH; HUMAN PLACENTA; BIRTH-WEIGHT; FACTOR-ALPHA; TNF-ALPHA	Background: Plasmodium falciparum placental malaria (PM) contributes to 10,000 maternal deaths due to severe anemia (SA) each year in Africa, primarily among primigravid women who are most susceptible. Increased levels of proinflammatory cytokines like TNF-alpha are associated with maternal anemia in first time mothers but not in other women. Here we aimed to identify additional changes in the plasma proteome associated with pregnancy malaria that may contribute to the development of malaria-related maternal anemia. Principal Findings: A semi-quantitative mass spectrometry approach was used to compare the relative abundance of plasma proteins in anemic versus non-anemic women with PM. Levels of 24 proteins differed significantly between anemic and non-anemic primigravidae, including several lipid metabolism proteins and molecular transport proteins involved in the acute phase response signaling network. These differences were not observed in multigravid women who enjoy specific immunity that protect them from PM. In a confirmatory study of a larger cohort of primigravid women, levels of the lipid metabolism protein Apolipoprotein (Apo)-AI were significantly lower in PM+ women with SA. Conclusions: Apo-AI levels are significantly lower in severely anemic primigravidae with PM, and ApoA1 levels positively correlate with hemoglobin levels in primigravid but not multigravid women. Apo-AI is known to have anti-inflammatory effects, and thus Apo-AI reductions may contribute to the inflammatory processes that result in SA.	[Simpson, David C.; Kabyemela, Edward; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal] Seattle Biomed Res Inst, MOMS Project, Seattle, WA 98109 USA; [Kabyemela, Edward; Mutabingwa, Theonest K.; Duffy, Patrick E.; Fried, Michal] Muheza Designated Dist Hosp, Muheza, Tanzania; [Mutabingwa, Theonest K.] Natl Inst Med Res, Dar Es Salaam, Tanzania; [Muehlenbachs, Atis; Duffy, Patrick E.; Fried, Michal] Univ Washington, Seattle, WA 98195 USA	Center for Infectious Disease Research; National Institute of Medical Research; University of Washington; University of Washington Seattle	Simpson, DC (corresponding author), Seattle Biomed Res Inst, MOMS Project, 4 Nickerson St, Seattle, WA 98109 USA.	michal.fried@sbri.org	Simpson, David/D-4677-2009	Simpson, David/0000-0002-1189-0833	US National Institutes of Health [AI52059, 1HD049641, R01HD058005]; Bill & Melinda Gates Foundation [3035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058005] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD049641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052059, ZIAAI001134] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the US National Institutes of Health (grants AI52059 to P. E. D and 1HD049641, R01HD058005 to M. F) and the Bill & Melinda Gates Foundation (grant 3035 to P. E. D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ C, 1986, CLIN CHEM, V32, P142; Beers A, 2006, BIOCHEMISTRY-US, V45, P2408, DOI 10.1021/bi0518040; Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Burger D, 2002, ARTHRITIS RES THER, V4, pS169, DOI 10.1186/ar558; Chenaud C, 2004, CRIT CARE MED, V32, P632, DOI 10.1097/01.CCM.0000114820.47460.0A; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CLARK IA, 1987, J IMMUNOL, V139, P3493; DJOUMESSI S, 1989, PATHOL BIOL, V37, P909; Duffy P. E., 2001, Malaria in pregnancy: deadly parasite, susceptible host, P1, DOI 10.4324/9780203302255_chapter_1; Faucher JF, 2002, PARASITOL RES, V88, P1040, DOI 10.1007/s00436-002-0712-6; FLEMING AF, 1989, T ROY SOC TROP MED H, V83, P441, DOI 10.1016/0035-9203(89)90241-1; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; GERSZTEN RE, 2008, AM J PHYSL LUNG CELL; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; Haas MJ, 2003, BBA-GEN SUBJECTS, V1623, P120, DOI 10.1016/j.bbagen.2003.08.004; Hyka N, 2001, BLOOD, V97, P2381, DOI 10.1182/blood.V97.8.2381; Kabyemela ER, 2008, INFECT IMMUN, V76, P1527, DOI 10.1128/IAI.00964-07; KABYEMELA ER, 2008, J INFECT DI IN PRESS; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim JS, 2008, ACTA TROP, V106, P39, DOI 10.1016/j.actatropica.2008.01.002; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Mooser V, 2000, ARTERIOSCL THROM VAS, V20, P1137, DOI 10.1161/01.ATV.20.4.1137; NILSSONEHLE I, 1990, J INTERN MED, V227, P151, DOI 10.1111/j.1365-2796.1990.tb00136.x; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Parola P, 2004, PARASITOL RES, V92, P464, DOI 10.1007/s00436-003-1012-5; ROBERTSON SA, 1994, CRIT REV IMMUNOL, V14, P239, DOI 10.1615/CritRevImmunol.v14.i3-4.30; Shulman CE, 2001, TROP MED INT HEALTH, V6, P770, DOI 10.1046/j.1365-3156.2001.00786.x; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273; Zucker JR, 1996, AM J TROP MED HYG, V55, P655, DOI 10.4269/ajtmh.1996.55.655	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8822	10.1371/journal.pone.0008822	http://dx.doi.org/10.1371/journal.pone.0008822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098675	gold, Green Submitted, Green Published			2022-12-27	WOS:000273779100014
J	Castro, JE; Varea, E; Marquez, C; Cordero, MI; Poirier, G; Sandi, C				Castro, Jorge E.; Varea, Emilio; Marquez, Cristina; Cordero, Maria Isabel; Poirier, Guillaume; Sandi, Carmen			Role of the Amygdala in Antidepressant Effects on Hippocampal Cell Proliferation and Survival and on Depression-like Behavior in the Rat	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MEDIAL PREFRONTAL CORTEX; BASOLATERAL AMYGDALA; DENTATE GYRUS; CHRONIC FLUOXETINE; ANIMAL-MODEL; ADULT NEUROGENESIS; UP-REGULATION; STRESS; MEMORY	The stimulation of adult hippocampal neurogenesis by antidepressants has been associated with multiple molecular pathways, but the potential influence exerted by other brain areas has received much less attention. The basolateral complex of the amygdala (BLA), a region involved in anxiety and a site of action of antidepressants, has been implicated in both basal and stress-induced changes in neural plasticity in the dentate gyrus. We investigated here whether the BLA modulates the effects of the SSRI antidepressant fluoxetine on hippocampal cell proliferation and survival in relation to a behavioral index of depression-like behavior (forced swim test). We used a lesion approach targeting the BLA along with a chronic treatment with fluoxetine, and monitored basal anxiety levels given the important role of this behavioral trait in the progress of depression. Chronic fluoxetine treatment had a positive effect on hippocampal cell survival only when the BLA was lesioned. Anxiety was related to hippocampal cell survival in opposite ways in sham-and BLA-lesioned animals (i.e., negatively in sham-and positively in BLA-lesioned animals). Both BLA lesions and low anxiety were critical factors to enable a negative relationship between cell proliferation and depression-like behavior. Therefore, our study highlights a role for the amygdala on fluoxetine-stimulated cell survival and on the establishment of a link between cell proliferation and depression-like behavior. It also reveals an important modulatory role for anxiety on cell proliferation involving both BLA-dependent and -independent mechanisms. Our findings underscore the amygdala as a potential target to modulate antidepressants' action in hippocampal neurogenesis and in their link to depression-like behaviors.	[Castro, Jorge E.; Varea, Emilio; Marquez, Cristina; Cordero, Maria Isabel; Poirier, Guillaume; Sandi, Carmen] Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Castro, JE (corresponding author), Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	carmen.sandi@epfl.ch	Cordero, Maria Isabel/A-2532-2013; Varea, Emilio/ABF-6367-2021; Cordero, Maria Isabel/AAF-2935-2019; Poirier, Guillaume/F-5256-2010	Cordero, Maria Isabel/0000-0003-0692-8064; Cordero, Maria Isabel/0000-0003-0692-8064; Sandi, Carmen/0000-0001-7713-8321; Poirier, Guillaume/0000-0001-6126-1755; Marquez, Cristina/0000-0003-1948-2727; Varea, Emilio/0000-0002-1996-2870	European Union [FP7-HEALTH-F2M-2007-201600]; Swiss National Science Foundation [310000-120791]	European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants from the European Union 7th Framework Programme (FP7-HEALTH-F2M-2007-201600; MemStick) and the Swiss National Science Foundation (310000-120791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Akirav I, 2001, EUR J NEUROSCI, V14, P719, DOI 10.1046/j.0953-816x.2001.01687.x; Akirav I, 1999, J NEUROSCI, V19, P10530; Anderson IM, 2007, NEUROREPORT, V18, P1351, DOI 10.1097/WNR.0b013e3282742115; Balu DT, 2009, NEUROPSYCHOPHARMACOL, V34, P1764, DOI 10.1038/npp.2008.234; Banasr M, 2004, NEUROPSYCHOPHARMACOL, V29, P450, DOI 10.1038/sj.npp.1300320; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bigos KL, 2008, NEUROPSYCHOPHARMACOL, V33, P3221, DOI 10.1038/npp.2008.52; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; CAMERON HA, 1995, J NEUROSCI, V15, P4687; Castren E, 2007, CURR OPIN PHARMACOL, V7, P18, DOI 10.1016/j.coph.2006.08.009; Cowen DS, 2008, BRAIN RES, V1228, P14, DOI 10.1016/j.brainres.2008.06.059; Czeh B, 2007, NEUROPSYCHOPHARMACOL, V32, P1490, DOI 10.1038/sj.npp.1301275; Dagyte G, 2009, NEUROSCIENCE, V162, P904, DOI 10.1016/j.neuroscience.2009.05.053; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Doremus TL, 2006, PHARMACOL BIOCHEM BE, V83, P570, DOI 10.1016/j.pbb.2006.03.019; Dranovsky A, 2006, BIOL PSYCHIAT, V59, P1136, DOI 10.1016/j.biopsych.2006.03.082; Drapier D, 2007, BEHAV BRAIN RES, V176, P202, DOI 10.1016/j.bbr.2006.10.002; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1999, BIOL PSYCHIAT, V46, P1181, DOI 10.1016/S0006-3223(99)00177-8; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; FAN X, 1996, ANN M AM ED RES ASS; FOURNIER NM, 2009, HIPPOCAMPUS; Fuss J, 2010, HIPPOCAMPUS, V20, P364, DOI 10.1002/hipo.20634; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Helfer V, 1996, NEUROSCIENCE, V73, P971, DOI 10.1016/0306-4522(96)00081-4; Herrero AI, 2006, NEUROBIOL LEARN MEM, V86, P150, DOI 10.1016/j.nlm.2006.02.001; HODES GE, 2009, NEUROSCIENCE; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Huang GJ, 2005, NEUROSCIENCE, V135, P803, DOI 10.1016/j.neuroscience.2005.05.056; IKEGAYA Y, 1994, BRAIN RES, V656, P157, DOI 10.1016/0006-8993(94)91377-3; Ikegaya Y, 1996, EUR J NEUROSCI, V8, P1833, DOI 10.1111/j.1460-9568.1996.tb01327.x; Joels M, 2006, TRENDS PHARMACOL SCI, V27, P244, DOI 10.1016/j.tips.2006.03.007; Kim JJ, 2001, J NEUROSCI, V21, P5222, DOI 10.1523/JNEUROSCI.21-14-05222.2001; Kim JJ, 2005, J NEUROSCI, V25, P1532, DOI 10.1523/JNEUROSCI.4623-04.2005; Kodamo M, 2004, BIOL PSYCHIAT, V56, P570, DOI 10.1016/j.biopsych.2004.07.008; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; Luksys G, 2009, NAT NEUROSCI, V12, P1180, DOI 10.1038/nn.2374; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Matsuzawa-Yanagida K, 2008, NEUROPSYCHOPHARMACOL, V33, P1952, DOI 10.1038/sj.npp.1301590; MCCORMICK CM, 2009, BEHAV BRAIN RES; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Muigg P, 2007, BIOL PSYCHIAT, V61, P782, DOI 10.1016/j.biopsych.2006.08.035; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nakao K, 2004, P NATL ACAD SCI USA, V101, P14270, DOI 10.1073/pnas.0405709101; Navailles S, 2008, J COMP NEUROL, V509, P372, DOI 10.1002/cne.21775; Parent JM, 1998, NEUROSCI LETT, V247, P9, DOI 10.1016/S0304-3940(98)00269-9; Poirier GL, 2008, J NEUROSCI, V28, P1034, DOI 10.1523/JNEUROSCI.4607-07.2008; Pollak DD, 2008, NEURON, V60, P149, DOI 10.1016/j.neuron.2008.07.041; Porsolt R. D., 2001, CURR PROTOC NEUROS A, V10A, DOI 10.1002/0471142301.ns0810as14; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; REVEST JM, 2009, MOL PSYCHIAT; Roche M, 2007, NEUROPSYCHOPHARMACOL, V32, P1312, DOI 10.1038/sj.npp.1301253; Roesler R, 2002, EUR J NEUROSCI, V15, P905, DOI 10.1046/j.1460-9568.2002.01924.x; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sairanen M, 2007, NEUROSCIENCE, V144, P368, DOI 10.1016/j.neuroscience.2006.08.069; Sandi C, 1997, PSYCHOPHARMACOLOGY, V133, P152, DOI 10.1007/s002130050385; Sandi C, 2008, EUR J NEUROSCI, V28, P1836, DOI 10.1111/j.1460-9568.2008.06451.x; Sandi Carmen, 2007, Neural Plasticity, V2007, DOI 10.1055/2007/78970; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schauwecker PE, 2006, BRAIN RES, V1120, P83, DOI 10.1016/j.brainres.2006.08.086; Schiller D, 2006, J PSYCHIATR RES, V40, P167, DOI 10.1016/j.jpsychires.2005.03.002; Scott BW, 1998, NEUROSCI LETT, V248, P73, DOI 10.1016/S0304-3940(98)00355-3; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shishkina GT, 2007, NEUROSCIENCE, V150, P404, DOI 10.1016/j.neuroscience.2007.09.017; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Smith PD, 2006, EUR J NEUROSCI, V24, P3195, DOI 10.1111/j.1460-9568.2006.05205.x; Smith PD, 2005, NEUROSCIENCE, V136, P405, DOI 10.1016/j.neuroscience.2005.07.055; Strauss CVA, 2003, PHYSIOL BEHAV, V78, P157, DOI 10.1016/S0031-9384(02)00960-5; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Wallace TL, 2004, BIOL PSYCHIAT, V56, P151, DOI 10.1016/j.biopsych.2004.04.010; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Woolley ML, 2006, BRAIN RES, V1078, P151, DOI 10.1016/j.brainres.2006.01.071; Wu XF, 2009, BIOL PSYCHIAT, V66, P5, DOI 10.1016/j.biopsych.2009.01.023; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Zoladz PR, 2009, DOSE-RESPONSE, V7, P132, DOI 10.2203/dose-response.08-015.Zoladz	96	54	56	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8618	10.1371/journal.pone.0008618	http://dx.doi.org/10.1371/journal.pone.0008618			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062812	Green Published, gold			2022-12-27	WOS:000273414200009
J	Grohmann, M; Hammer, P; Walther, M; Paulmann, N; Buttner, A; Eisenmenger, W; Baghai, TC; Schule, C; Rupprecht, R; Bader, M; Bondy, B; Zill, P; Priller, J; Walther, DJ				Grohmann, Maik; Hammer, Paul; Walther, Maria; Paulmann, Nils; Buettner, Andreas; Eisenmenger, Wolfgang; Baghai, Thomas C.; Schuele, Cornelius; Rupprecht, Rainer; Bader, Michael; Bondy, Brigitta; Zill, Peter; Priller, Josef; Walther, Diego J.			Alternative Splicing and Extensive RNA Editing of Human TPH2 Transcripts	PLOS ONE			English	Article							SEROTONIN 2C RECEPTOR; TRYPTOPHAN HYDROXYLASE-2 GENE; OF-FUNCTION MUTATION; PRE-MESSENGER-RNA; HUMAN TRYPTOPHAN-HYDROXYLASE-2 GENE; MEDIAN RAPHE NUCLEI; MAJOR DEPRESSION; HAPLOTYPE ANALYSIS; EXPRESSION; BRAIN	Brain serotonin (5-HT) neurotransmission plays a key role in the regulation of mood and has been implicated in a variety of neuropsychiatric conditions. Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the biosynthesis of 5-HT. Recently, we discovered a second TPH isoform (TPH2) in vertebrates, including man, which is predominantly expressed in brain, while the previously known TPH isoform (TPH1) is primarly a non-neuronal enzyme. Overwhelming evidence now points to TPH2 as a candidate gene for 5-HT-related psychiatric disorders. To assess the role of TPH2 gene variability in the etiology of psychiatric diseases we performed cDNA sequence analysis of TPH2 transcripts from human post mortem amygdala samples obtained from individuals with psychiatric disorders (drug abuse, schizophrenia, suicide) and controls. Here we show that TPH2 exists in two alternatively spliced variants in the coding region, denoted TPH2a and TPH2b. Moreover, we found evidence that the pre-mRNAs of both splice variants are dynamically RNA-edited in a mutually exclusive manner. Kinetic studies with cell lines expressing recombinant TPH2 variants revealed a higher activity of the novel TPH2B protein compared with the previously known TPH2A, whereas RNA editing was shown to inhibit the enzymatic activity of both TPH2 splice variants. Therefore, our results strongly suggest a complex fine-tuning of central nervous system 5-HT biosynthesis by TPH2 alternative splicing and RNA editing. Finally, we present molecular and large-scale linkage data evidencing that deregulated alternative splicing and RNA editing is involved in the etiology of psychiatric diseases, such as suicidal behaviour.	[Grohmann, Maik; Hammer, Paul; Walther, Maria; Paulmann, Nils; Walther, Diego J.] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Grohmann, Maik; Paulmann, Nils] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Grohmann, Maik; Priller, Josef] Charite, Neuropsychiat & Lab Mol Psychiat, D-13353 Berlin, Germany; [Buettner, Andreas; Eisenmenger, Wolfgang] Univ Munich, Inst Legal Med, Munich, Germany; [Bader, Michael] Max Delbruck Ctr Mol Med, Lab Mol Biol Peptide Hormones, Berlin, Germany; [Baghai, Thomas C.; Schuele, Cornelius; Rupprecht, Rainer; Bondy, Brigitta; Zill, Peter] Univ Munich, Dept Psychiat, D-8000 Munich, Germany	Max Planck Society; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Munich	Grohmann, M (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.	dwalther@molgen.mpg.de	Priller, Josef/ABW-3835-2022; Bader, Michael/K-2124-2013; Büttner, Andreas/I-5974-2014	Büttner, Andreas/0000-0002-6676-4957; Priller, Josef/0000-0001-7596-0979; Baghai, Thomas C/0000-0002-7873-4130; Bader, Michael/0000-0003-4780-4164	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding: The study was funded in part by grants of the Deutsche Forschungsgemeinschaft, the Bundesministerium fur Bildung und Forschung and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumaria N, 2008, CELL MOL NEUROBIOL, V28, P331, DOI 10.1007/s10571-007-9259-5; Bach-Mizrachi H, 2008, MOL PSYCHIATR, V13, P507, DOI 10.1038/sj.mp.4002143; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Barlati S, 2005, ACTA NEUROCHIR SUPPL, V93, P53; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bhalla T, 2004, NAT STRUCT MOL BIOL, V11, P950, DOI 10.1038/nsmb825; Bicalho MA, 2006, MOL PSYCHIATR, V11, P799, DOI 10.1038/sj.mp.4001861; Blanc V, 2003, J BIOL CHEM, V278, P1395, DOI 10.1074/jbc.R200024200; Bourara K, 2000, SCIENCE, V289, P1564, DOI 10.1126/science.289.5484.1564; Brown SM, 2005, MOL PSYCHIATR, V10, P884, DOI 10.1038/sj.mp.4001716; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Buznikov GA, 2005, NEUROCHEM RES, V30, P825, DOI 10.1007/s11064-005-6876-6; Canli T, 2005, J NEURAL TRANSM, V112, P1479, DOI 10.1007/s00702-005-0391-4; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; CATTANEO MG, 1993, CANCER RES, V53, P5566; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Cichon S, 2008, HUM MOL GENET, V17, P87, DOI 10.1093/hmg/ddm286; De Luca V, 2006, INT J NEUROPSYCHOPH, V9, P21, DOI 10.1017/S1461145705005572; De Luca V, 2005, PSYCHOPHARMACOLOGY, V183, P378, DOI 10.1007/s00213-005-0191-4; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Farrer T, 2002, NUCLEIC ACIDS RES, V30, P3360, DOI 10.1093/nar/gkf465; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Garriock HA, 2005, MOL PSYCHIATR, V10, P976, DOI 10.1038/sj.mp.4001712; Glatt C.E., 2005, NEURON, V45, P11; Glatt CE, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.019; Gurevich I, 2002, J NEUROSCI, V22, P10529; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Haghighi F, 2008, MOL PSYCHIATR, V13, P813, DOI 10.1038/sj.mp.4002127; Harvey M, 2004, MOL PSYCHIATR, V9, P980, DOI 10.1038/sj.mp.4001557; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Iwamoto K, 2003, NEUROSCI LETT, V346, P169, DOI 10.1016/S0304-3940(03)00608-6; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kulikov AV, 2005, GENES BRAIN BEHAV, V4, P482, DOI 10.1111/j.1601-183X.2005.00145.x; Lauder J M, 1981, Adv Exp Med Biol, V133, P477; Lesurtel M, 2006, SCIENCE, V312, P104, DOI 10.1126/science.1123842; Maas Stefan, 2006, RNA Biol, V3, P1; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; McKinney J, 2008, MOL PSYCHIATR, V13, P365, DOI 10.1038/sj.mp.4002152; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Meier JC, 2005, NAT NEUROSCI, V8, P736, DOI 10.1038/nn1467; Morecroft I, 2007, HYPERTENSION, V49, P232, DOI 10.1161/01.HYP.0000252210.58849.78; Navaratnam N, 2006, INT J HEMATOL, V83, P195, DOI 10.1532/IJH97.06032; Nishikura K, 2006, NAT REV MOL CELL BIO, V7, P919, DOI 10.1038/nrm2061; Niswender CM, 2001, NEUROPSYCHOPHARMACOL, V24, P478, DOI 10.1016/S0893-133X(00)00223-2; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Rosen JB, 2006, BIOL PSYCHOL, V73, P49, DOI 10.1016/j.biopsycho.2006.01.007; Sakowski SA, 2006, BRAIN RES, V1085, P11, DOI 10.1016/j.brainres.2006.02.047; Scheuch K, 2007, BIOL PSYCHIAT, V62, P1288, DOI 10.1016/j.biopsych.2007.01.015; Schonn JS, 2003, J NEUROCHEM, V84, P669, DOI 10.1046/j.1471-4159.2003.01561.x; SHARMA PM, 1994, GENE DEV, V8, P720, DOI 10.1101/gad.8.6.720; Sodhi MS, 2001, MOL PSYCHIATR, V6, P373, DOI 10.1038/sj.mp.4000920; Steele EJ, 2006, DNA REPAIR, V5, P1346, DOI 10.1016/j.dnarep.2006.06.002; Talarovicova Alzbeta, 2007, Endocr Regul, V41, P155; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Van den Bogaert A, 2005, NEURON, V48, P704, DOI 10.1016/j.neuron.2005.11.017; Walitza S, 2005, MOL PSYCHIATR, V10, P1126, DOI 10.1038/sj.mp.4001734; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Walther DJ, 2002, CANCER-AM CANCER SOC, V94, P3135, DOI 10.1002/cncr.10592; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Zhang XD, 2004, SCIENCE, V305, P217, DOI 10.1126/science.1097540; Zhang XD, 2005, NEURON, V45, P11, DOI 10.1016/j.neuron.2004.12.014; Zhou Z., 2005, NEURON, V48, P702; Zhou ZF, 2005, NEURON, V48, P702, DOI 10.1016/j.neuron.2005.11.018; Zill P, 2004, MOL PSYCHIATR, V9, P1030, DOI 10.1038/sj.mp.4001525; Zill P, 2004, BIOL PSYCHIAT, V56, P581, DOI 10.1016/j.biopsych.2004.07.015; Zill P, 2007, J PSYCHIATR RES, V41, P168, DOI 10.1016/j.jpsychires.2005.05.004	73	56	59	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8956	10.1371/journal.pone.0008956	http://dx.doi.org/10.1371/journal.pone.0008956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126463	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000274139100007
J	Priault, M; Hue, E; Marhuenda, F; Pilet, P; Oliver, L; Vallette, FM				Priault, Muriel; Hue, Erika; Marhuenda, Fanny; Pilet, Paul; Oliver, Lisa; Vallette, Francois M.			Differential Dependence on Beclin 1 for the Regulation of Pro-Survival Autophagy by Bcl-2 and Bcl-xL in HCT116 Colorectal Cancer Cells	PLOS ONE			English	Article							3-KINASE COMPLEX; APOPTOTIC DEATH; MECHANISMS; PROTEINS; DEPRIVATION; MACROAUTOPHAGY; NOMENCLATURE; PROGRESSION; INHIBITION; HOMOLOG	Autophagy is described to be involved in homeostasis, development and disease, both as a survival and a death process. Its involvement in cell death proceeds from interrelationships with the apoptotic pathway. We focused on survival autophagy and investigated its interplays with the apoptotic machinery. We found that while Mcl-1 remained ineffective, Bcl-2 and BclxL were required for starved cells to display a fully functional autophagic pathway as shown by proteolysis activity and detection of autophagic vesicles. Such pro-autophagic functions of Bcl-2 and Bcl-xL were independent of Bax. However they appeared to operate through non redundant mechanisms as Bcl-xL wielded a tighter control than Bcl-2 over the regulation of autophagy: unlike Bcl-2, Bcl-xL and Atg7 manipulation yielded identical phenotypes suggesting they could be components of the same signalling pathway; Bcl-xL subcellular localisation was modified upon starvation, and importantly Bcl-xL acted independently of Beclin 1. Still an intact BH3-binding site was required for Bcl-xL to stimulate a fully functional autophagic pathway. This study highlights that, in addition to their well-established anti-death function during apoptosis, Bcl-2 and Bcl-xL have a broader role in cell survival. Should Bcl-2 and Bcl-xL stand at the cross-roads between pro-survival and pro-death autophagy, this study introduces the new concept that the regulation of autophagy by Bcl-2 and Bcl-xL is adjusted according to its survival or death outcome.	[Priault, Muriel] CNRS, IBGC, UMR 5095, Bordeaux, France; [Priault, Muriel] Univ Bordeaux 2, F-33076 Bordeaux, France; [Hue, Erika; Marhuenda, Fanny; Oliver, Lisa; Vallette, Francois M.] INSERM, UMR 892, Nantes, France; [Hue, Erika; Marhuenda, Fanny; Oliver, Lisa; Vallette, Francois M.] Univ Nantes, Fac Med, Nantes, France; [Pilet, Paul] INSERM, UMR 791, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Priault, M (corresponding author), CNRS, IBGC, UMR 5095, Bordeaux, France.	muriel.priault@ibgc.cnrs.fr	Vallette, Francois/N-2361-2018; Oliver, Lisa J/L-3070-2015; Vallette, Francois M/K-9047-2015; Priault, Muriel/HHT-0658-2022; Paul, Pilet/A-3755-2015	Oliver, Lisa J/0000-0002-5588-7564; Vallette, Francois M/0000-0002-3296-8572; Priault, Muriel/0000-0001-8193-0389; Vallette, Francois/0000-0003-0802-0519; HUE, Erika/0000-0001-6930-3606	Institut National de la Santeet de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine; Agence Nationale pour la Recherche	Institut National de la Santeet de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by the Institut National de la Santeet de la Recherche Medicale (INSERM), the Centre National de la Recherche Scientifique (CNRS), Universitede Nantes, Universitede Bordeaux, the Conseil Regional d'Aquitaine (to UMR 5095), and the Agence Nationale pour la Recherche (project MABA to F. V.). M. P. was supported by a post-doctoral fellowship from INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Cardenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; DUNN WA, 1990, J CELL BIOL, V110, P1935, DOI 10.1083/jcb.110.6.1935; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Fengsrud M, 2000, BIOCHEM J, V352, P773, DOI 10.1042/0264-6021:3520773; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; LUO S, 2009, CELL DEATH DIFFER; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Niemann A, 2001, J HISTOCHEM CYTOCHEM, V49, P177, DOI 10.1177/002215540104900205; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Saeki K, 2000, CELL DEATH DIFFER, V7, P1263, DOI 10.1038/sj.cdd.4400759; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHWORER CM, 1979, P NATL ACAD SCI USA, V76, P3169, DOI 10.1073/pnas.76.7.3169; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735	43	40	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8755	10.1371/journal.pone.0008755	http://dx.doi.org/10.1371/journal.pone.0008755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090905	Green Submitted, gold, Green Published			2022-12-27	WOS:000273715000013
J	Coleman, SK; Cai, CL; Kalkkinen, N; Korpi, ER; Keinanen, K				Coleman, Sarah K.; Cai, Chunlin; Kalkkinen, Nisse; Korpi, Esa R.; Keinanen, Kari			Analysis of the Potential Role of GluA4 Carboxyl-Terminus in PDZ Interactions	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; SYNAPSE-ASSOCIATED PROTEIN-97; CALPAIN-MEDIATED PROTEOLYSIS; SURFACE EXPRESSION; POSTSYNAPTIC DENSITY; REGULATORY PROTEINS; HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; ACID RECEPTOR; GLUR1 SUBUNIT	Background: Specific delivery to synapses of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate (AMPA) receptors with long-tailed subunits is believed to be a key event in many forms of activity-dependent changes in synaptic strength. GluA1, the best characterized long-tailed AMPA receptor subunit, contains a C-terminal class I PDZ binding motif, which mediates its interaction with scaffold and trafficking proteins, including synapse-associated protein 97 (SAP97). In GluA4, another long-tailed subunit implicated in synaptic plasticity, the PDZ motif is blocked by a single proline residue. This feature is highly conserved in vertebrates, whereas the closest invertebrate homologs of GluA4 have a canonical class I PDZ binding motif. In this work, we have examined the role of GluA4 in PDZ interactions. Methodology/Principal Findings: Deletion of the carboxy-terminal proline residue of recombinant GluA4 conferred avid binding to SAP97 in cultured cells as shown by coimmunoprecipitation, whereas wild-type GluA4 did not associate with SAP97. Native GluA4 and SAP97 coimmunoprecipitated from mouse brain independently of the GluA1 subunit, supporting the possibility of in vivo PDZ interaction. To obtain evidence for or against the exposure of the PDZ motif by carboxyterminal processing of native GluA4 receptors, we generated an antibody reagent specific for proline-deleted GluA4 C-terminus. Immunoprecipitation and mass spectrometric analyses indicated that the carboxyl-terminus of native GluA4 AMPA receptors is intact and that the postulated single-residue cleavage does not occur to any significant extent. Conclusion/Significance: We conclude that native GluA4 receptors are not capable of canonical PDZ interactions and that their association with SAP97 is likely to be indirect.	[Coleman, Sarah K.; Cai, Chunlin; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, Helsinki, Finland; [Kalkkinen, Nisse] Univ Helsinki, Inst Biotechnol, Viikki Bioctr, Helsinki, Finland; [Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Coleman, SK (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem, Viikki Bioctr, Helsinki, Finland.	kari.keinanen@helsinki.fi	Keinanen, Kari/E-9122-2010; Kalkkinen, Nisse EJ/B-3923-2010	Coleman, Sarah/0000-0002-1066-8296; Korpi, Esa R./0000-0003-0683-4009	Academy of Finland [110900]; Finnish Graduate School of Neurosciences	Academy of Finland(Academy of Finland); Finnish Graduate School of Neurosciences	This study was supported by the Academy of Finland, Grant number 110900 (K.K.) and by the Finnish Graduate School of Neurosciences (C.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo IM, 2004, J NEUROCHEM, V91, P1322, DOI 10.1111/j.1471-4159.2004.02811.x; Bi XN, 1997, J NEUROCHEM, V68, P1484; Boehm J, 2006, LEARN MEMORY, V13, P562, DOI 10.1101/lm.253506; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Cai CL, 2006, J BIOL CHEM, V281, P4267, DOI 10.1074/jbc.M505886200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2003, J NEUROSCI, V23, P798; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; DeGiorgis JA, 2006, BRAIN CELL BIOL, V35, P239, DOI 10.1007/s11068-007-9017-0; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hirbec H, 2002, J BIOL CHEM, V277, P15221, DOI 10.1074/jbc.C200112200; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Jespersen LK, 2000, EUR J BIOCHEM, V267, P1382, DOI 10.1046/j.1432-1327.2000.01137.x; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Keifer J, 2003, EXP BRAIN RES, V151, P405, DOI 10.1007/s00221-003-1494-5; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li H, 2007, NEURON, V56, P1019, DOI 10.1016/j.neuron.2007.10.039; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mack V, 2001, SCIENCE, V292, P2501, DOI 10.1126/science.1059365; Meyer EL, 2002, J BIOL CHEM, V277, P10869, DOI 10.1074/jbc.M106744200; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nuriya M, 2005, J NEUROCHEM, V95, P544, DOI 10.1111/j.1471-4159.2005.03410.x; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Piccini A, 2002, J NEUROSCI, V22, P5387; QIN Y, GENES DEV, V19, P2000; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Stricker NL, 2003, NEUROPHARMACOLOGY, V45, P837, DOI 10.1016/S0028-3908(03)00275-2; Thomas GM, 2008, EMBO J, V27, P361, DOI 10.1038/sj.emboj.7601969; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Uchino S, 2006, J NEUROCHEM, V97, P1203, DOI 10.1111/j.1471-4159.2006.03831.x; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	49	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8715	10.1371/journal.pone.0008715	http://dx.doi.org/10.1371/journal.pone.0008715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090852	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714600016
J	Kovalovsky, D; Pezzano, M; Ortiz, BD; Sant'Angelo, DB				Kovalovsky, Damian; Pezzano, Mark; Ortiz, Benjamin D.; Sant'Angelo, Derek B.			A Novel TCR Transgenic Model Reveals That Negative Selection Involves an Immediate, Bim-Dependent Pathway and a Delayed, Bim-Independent Pathway	PLOS ONE			English	Article							T-CELL-RECEPTOR; IMMATURE CD4(+)CD8(+) THYMOCYTES; AUTOREACTIVE THYMOCYTES; CLONAL DELETION; IN-VIVO; EXPRESSION; APOPTOSIS; NUR77; MICE; MECHANISMS	A complete understanding of negative selection has been elusive due to the rapid apoptosis and clearance of thymocytes in vivo. We report a TCR transgenic model in which expression of the TCR during differentiation occurs only after V(D) J-like recombination. TCR expression from this transgene closely mimics expression of the endogenous TCR alpha locus allowing for development that is similar to wild type thymocytes. This model allowed us to characterize the phenotypic changes that occurred after TCR-mediated signaling in self-reactive thymocytes prior to their deletion in a highly physiological setting. Self-reactive thymocytes were identified as being immature, activated and CD4(lo)CD8(lo). These cells had upregulated markers of negative selection and were apoptotic. Elimination of Bim reduced the apoptosis of self-reactive thymocytes, but it did not rescue their differentiation and the cells remained at the immature CD4(lo)CD8(lo) stage of development. These cells upregulate Nur77 and do not contribute to the peripheral T cell repertoire in vivo. Remarkably, development past the CD4(lo)CD8(lo) stage was possible once the cells were removed from the negatively selecting thymic environment. In vitro development of these cells occurred despite their maintenance of high intracellular levels of Nur77. Therefore, in vivo, negatively selected Bim-deficient thymocytes are eliminated after prolonged developmental arrest via a Bim-independent pathway that is dependent on the thymic microenvironment. These data newly reveal a layering of immediate, Bim-dependent, and delayed Bim-independent pathways that both contribute to elimination of self-reactive thymocytes in vivo.	[Kovalovsky, Damian; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Pezzano, Mark] CUNY, Dept Biol, New York, NY 10021 USA; [Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY); Memorial Sloan Kettering Cancer Center; Cornell University	Kovalovsky, D (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org			NIH/NCI [U56 CA96299]; NIH/NIAID [1SC1AI081527]; NCRR [RCMI G12RR0360]; NIH-NCRR [RR003037]; NCI [P30-CA 08748];  [T32-CA-09149-32];  [UL1RR024996]; NATIONAL CANCER INSTITUTE [R01CA196299, T32CA009149, U56CA096299, P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081527, SC1AI104994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIH/NCI U56 CA96299 (M. P. and D. B. S); NIH/NIAID 1SC1AI081527; NCRR RCMI G12RR0360 (M. P.); T32-CA-09149-32 (D. K.), UL1RR024996 (B.D.O and D. B. S), NIH-NCRR grant RR003037 to Hunter College and NCI P30-CA 08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN S, 2008, PLOS BIOL, V191, pCD4; Aifantis I, 2006, J EXP MED, V203, P1543, DOI 10.1084/jem.20051711; Amsen D, 1999, P NATL ACAD SCI USA, V96, P622, DOI 10.1073/pnas.96.2.622; Baldwin TA, 2005, J EXP MED, V202, P111, DOI 10.1084/jem.20050359; Baldwin TA, 2007, J IMMUNOL, V179, P837, DOI 10.4049/jimmunol.179.2.837; Blank C, 2003, J IMMUNOL, V171, P4574, DOI 10.4049/jimmunol.171.9.4574; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; CALNAN BJ, 1995, IMMUNITY, V3, P273; Cunningham NR, 2006, J IMMUNOL, V177, P6660, DOI 10.4049/jimmunol.177.10.6660; Dashtsoodol N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003688; Egawa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001512; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gallo EM, 2007, NATURE, V450, P731, DOI 10.1038/nature06305; GODFREY DI, 1993, IMMUNOL TODAY, V14, P547, DOI 10.1016/0167-5699(93)90186-O; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; HUGO P, 1991, EUR J IMMUNOL, V21, P835, DOI 10.1002/eji.1830210346; KERSH GJ, 1995, J IMMUNOL, V154, P1057; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Lu BF, 2006, IMMUNOL RES, V36, P275, DOI 10.1385/IR:36:1:275; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Mathis D, 2007, NAT REV IMMUNOL, V7, P645, DOI 10.1038/nri2136; McCaughtry TM, 2008, J EXP MED, V205, P2575, DOI 10.1084/jem.20080866; PEARSE M, 1989, P NATL ACAD SCI USA, V86, P1614, DOI 10.1073/pnas.86.5.1614; PETRIE HT, 1995, J EXP MED, V182, P121, DOI 10.1084/jem.182.1.121; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sohn SJ, 2008, EMBO J, V27, P1896, DOI 10.1038/emboj.2008.114; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STRASSER A, 1994, P NATL ACAD SCI USA, V91, P1376, DOI 10.1073/pnas.91.4.1376; Strasser A, 2008, IMMUNOL CELL BIOL, V86, P57, DOI 10.1038/sj.icb.7100141; Thompson J, 2008, J EXP MED, V205, P1029, DOI 10.1084/jem.20080101; von Boehmer H, 2006, IMMUNOL REV, V209, P284, DOI 10.1111/j.0105-2896.2006.00346.x	43	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8675	10.1371/journal.pone.0008675	http://dx.doi.org/10.1371/journal.pone.0008675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072628	Green Published, gold			2022-12-27	WOS:000273554600027
J	Monteiro, S; Freitas, R; Rajasekhar, BT; Teixeira, AR; Ferreira, RB				Monteiro, Sara; Freitas, Regina; Rajasekhar, Baru T.; Teixeira, Artur R.; Ferreira, Ricardo B.			The Unique Biosynthetic Route from Lupinus beta-Conglutin Gene to Blad	PLOS ONE			English	Article							SEED STORAGE PROTEINS; UBIQUITIN-INTERACTING MOTIF; BEAN CANAVALIA-ENSIFORMIS; VIGNA-UNGUICULATA SEEDS; 3-DIMENSIONAL STRUCTURE; LEGUME SEEDS; GERMINATION; GLOBULINS; BINDING; MEMBERS	Background: During seed germination, beta-conglutin undergoes a major cycle of limited proteolysis in which many of its constituent subunits are processed into a 20 kDa polypeptide termed blad. Blad is the main component of a glycooligomer, accumulating exclusively in the cotyledons of Lupinus species, between days 4 and 12 after the onset of germination. Principal Findings: The sequence of the gene encoding b-conglutin precursor (1791 nucleotides) is reported. This gene, which shares 44 to 57% similarity and 20 to 37% identity with other vicilin-like protein genes, includes several features in common with these globulins, but also specific hallmarks. Most notable is the presence of an ubiquitin interacting motif (UIM), which possibly links the unique catabolic route of b-conglutin to the ubiquitin/proteasome proteolytic pathway. Significance: Blad forms through a unique route from and is a stable intermediary product of its precursor, b-conglutin, the major Lupinus seed storage protein. It is composed of 173 amino acid residues, is encoded by an intron-containing, internal fragment of the gene that codes for beta-conglutin precursor (nucleotides 394 to 913) and exhibits an isoelectric point of 9.6 and a molecular mass of 20,404.85 Da. Consistent with its role as a storage protein, blad contains an extremely high proportion of the nitrogen-rich amino acids.	[Monteiro, Sara; Freitas, Regina; Rajasekhar, Baru T.; Teixeira, Artur R.; Ferreira, Ricardo B.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Monteiro, Sara; Freitas, Regina; Ferreira, Ricardo B.] Univ Tecn Lisboa, Inst Super Agron, P-1100 Lisbon, Portugal	Universidade Nova de Lisboa; Universidade de Lisboa	Monteiro, S (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	smonteiro@isa.utl.pt	Ferreira, Ricardo M S Boavida/B-9502-2011	Freitas, Regina/0000-0001-8605-2925; Monteiro, Sara/0000-0002-7069-0591; Ferreira, Ricardo Boavida/0000-0002-5027-7564	Fundacao para a Ciencia e a Tecnologia [XXI/BTL/6250/95, XXI/BPD/16398/98, PRAXIS/BPD/5712/2001, PRAXIS/3/3.2/HORT/2140/95]; Agencia de Inovacao	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Agencia de Inovacao	This work was financially supported by the Fundacao para a Ciencia e a Tecnologia (Grants nos. PRAXIS XXI/BTL/6250/95, PRAXIS XXI/BPD/16398/98 and PRAXIS/BPD/5712/2001, and project no. PRAXIS/3/3.2/HORT/2140/95) and the Agencia de Inovacao, S.A. (under project RESOIDIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1985, EMBO J, V4, P1111, DOI 10.1002/j.1460-2075.1985.tb03747.x; Astwood JD, 2002, J ALLERGY CLIN IMMUN, V110, P26, DOI 10.1067/mai.2002.125690; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BLAGROVE R J, 1975, Australian Journal of Plant Physiology, V2, P13; BOYD SA, 1992, J MED CHEM, V35, P1735, DOI 10.1021/jm00088a007; CERLETTI P, 1983, PLANT FOOD HUM NUTR, V32, P145; CHLAN CA, 1986, PLANT MOL BIOL, V7, P475, DOI 10.1007/BF00020331; DECKERT JE, 1991, PLANT PHYSIOL BIOCH, V29, P269; Dunwell JM, 1998, BIOTECHNOL GENET ENG, V15, P1; DURANTI M, 1992, EUR J BIOCHEM, V206, P941, DOI 10.1111/j.1432-1033.1992.tb17004.x; Dure L 3rd, 1990, New Biol, V2, P487; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, INFERRING PHYLOGENIE; FERREIRA RB, 1995, AUST J PLANT PHYSIOL, V22, P373, DOI 10.1071/PP9950373; FERREIRA RB, 2003, RECENT DEV CURR TOPI, V4, P139; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Franco E, 1997, J AGR FOOD CHEM, V45, P3908, DOI 10.1021/jf9702813; Freitas RL, 2007, FOOD CHEM, V102, P323, DOI 10.1016/j.foodchem.2006.05.023; Frigerio L, 2000, PLANT PHYSIOL, V123, P1483, DOI 10.1104/pp.123.4.1483; Gallardo K, 2006, MEDICAGO TRUNCATULA; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GAYLER KR, 1984, BIOCHEM J, V221, P333, DOI 10.1042/bj2210333; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Gruis D, 2002, PLANT CELL, V14, P2863, DOI 10.1105/tpc.005009; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; KERMODE AR, 1995, PLANTA, V197, P501, DOI 10.1007/BF00196672; KO TP, 1993, PLANT PHYSIOL, V101, P729, DOI 10.1104/pp.101.3.729; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; Lilley GG, 1999, SEED PROTEINS, P315; MACEDO MLR, 1995, BRAZ J MED BIOL RES, V28, P183; MELO TS, 1994, PHYTOCHEMISTRY, V37, P641, DOI 10.1016/S0031-9422(00)90331-5; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Mosse J., 1983, CHEM BIOCH LEGUMES, P111; NG JD, 1993, PLANT PHYSIOL, V101, P713, DOI 10.1104/pp.101.3.713; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Ramos Paula Cristina Rodrigues Dos, 1997, Planta (Heidelberg), V203, P26; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Santos CN, 1997, J AGR FOOD CHEM, V45, P3821, DOI 10.1021/jf970075v; Shutov AD, 1995, J MOL EVOL, V41, P1057, DOI 10.1007/BF00173187; Shutov AD, 2003, J EXP BOT, V54, P1645, DOI 10.1093/jxb/erg165; SPENCER ME, 1992, PLANTA, V186, P567, DOI 10.1007/BF00198037; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461	47	20	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8542	10.1371/journal.pone.0008542	http://dx.doi.org/10.1371/journal.pone.0008542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066045	Green Published, gold			2022-12-27	WOS:000273338600006
J	Dhami, P; Bruce, AW; Jim, JH; Dillon, SC; Hall, A; Cooper, JL; Bonhoure, N; Chiang, K; Ellis, PD; Langford, C; Andrews, RM; Vetrie, D				Dhami, Pawandeep; Bruce, Alexander W.; Jim, Johanna H.; Dillon, Shane C.; Hall, Amanda; Cooper, Jonathan L.; Bonhoure, Nicolas; Chiang, Kelly; Ellis, Peter D.; Langford, Cordelia; Andrews, Robert M.; Vetrie, David			Genomic Approaches Uncover Increasing Complexities in the Regulatory Landscape at the Human SCL (TAL1) Locus	PLOS ONE			English	Article							STEM-CELL ENHANCER; TRANSCRIPTION FACTOR-BINDING; RNA-POLYMERASE-II; HEMATOPOIETIC PROGENITORS; HISTONE MODIFICATIONS; HYPERSENSITIVE SITES; CHROMATIN OCCUPANCY; NONCODING RNAS; PROTEIN CTCF; GENE	The SCL (TAL1) transcription factor is a critical regulator of haematopoiesis and its expression is tightly controlled by multiple cis-acting regulatory elements. To elaborate further the DNA elements which control its regulation, we used genomic tiling microarrays covering 256 kb of the human SCL locus to perform a concerted analysis of chromatin structure and binding of regulatory proteins in human haematopoietic cell lines. This approach allowed us to characterise further or redefine known human SCL regulatory elements and led to the identification of six novel elements with putative regulatory function both up and downstream of the SCL gene. They bind a number of haematopoietic transcription factors (GATA1, E2A LMO2, SCL, LDB1), CTCF or components of the transcriptional machinery and are associated with relevant histone modifications, accessible chromatin and low nucleosomal density. Functional characterisation shows that these novel elements are able to enhance or repress SCL promoter activity, have endogenous promoter function or enhancer-blocking insulator function. Our analysis opens up several areas for further investigation and adds new layers of complexity to our understanding of the regulation of SCL expression.	[Dhami, Pawandeep; Bruce, Alexander W.; Jim, Johanna H.; Dillon, Shane C.; Hall, Amanda; Cooper, Jonathan L.; Ellis, Peter D.; Langford, Cordelia; Andrews, Robert M.; Vetrie, David] Wellcome Trust Sanger Inst, Hinxton, England; [Bonhoure, Nicolas; Chiang, Kelly; Vetrie, David] Univ Glasgow, Sect Pathol & Gene Regulat, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland	Wellcome Trust Sanger Institute; University of Glasgow	Dhami, P (corresponding author), UCL, Inst Canc, London, England.	dlv1q@clinmed.gla.ac.uk	cheng, yong/I-4270-2012; Dillon, Shane/A-2280-2011; Bruce, Alexander W/H-4235-2014	Bruce, Alexander W/0000-0003-4297-4412; Vetrie, David/0000-0003-2075-4662; Andrews, Robert/0000-0002-3491-2361	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y., 1998, TFSEARCH SEARCHING T; Anguita E, 2001, P NATL ACAD SCI USA, V98, P12114, DOI 10.1073/pnas.201413098; APLAN PD, 1990, MOL CELL BIOL, V10, P6426, DOI 10.1128/MCB.10.12.6426; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Begley CG, 1999, BLOOD, V93, P2760; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Chung JH, 1997, P NATL ACAD SCI USA, V94, P575, DOI 10.1073/pnas.94.2.575; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Courtes C, 2000, J BIOL CHEM, V275, P949, DOI 10.1074/jbc.275.2.949; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; De Gobbi M, 2007, BLOOD, V110, P4503, DOI 10.1182/blood-2007-06-097964; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; Endoh M, 2002, EMBO J, V21, P6700, DOI 10.1093/emboj/cdf674; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; Fordham JL, 1999, LEUKEMIA, V13, P750, DOI 10.1038/sj.leu.2401420; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Gottgens B, 2004, MOL CELL BIOL, V24, P1870, DOI 10.1128/MCB.24.5.1870-1883.2004; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; Gottgens B, 2002, GENOME RES, V12, P749, DOI 10.1101/gr.45502; Gottgens B, 2000, NAT BIOTECHNOL, V18, P181, DOI 10.1038/72635; Gu XS, 2001, J BIOL CHEM, V276, P9421, DOI 10.1074/jbc.M010070200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Johnson KD, 2002, P NATL ACAD SCI USA, V99, P11760, DOI 10.1073/pnas.192285999; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; LARRICK JW, 1980, J IMMUNOL, V125, P6; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEROYVIARD K, 1994, BLOOD, V84, P3819, DOI 10.1182/blood.V84.11.3819.bloodjournal84113819; Lozzio B B, 1977, Int J Cancer, V19, P136, DOI 10.1002/ijc.2910190119; MARTIN P, 1982, SCIENCE, V216, P1233, DOI 10.1126/science.6177045; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; MORIKAWA S, 1978, INT J CANCER, V21, P166, DOI 10.1002/ijc.2910210207; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Ogilvy S, 2007, MOL CELL BIOL, V27, P7206, DOI 10.1128/MCB.00931-07; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Porcher C, 1996, CELL, V86, P47, DOI 10.1016/S0092-8674(00)80076-8; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Robb L, 1996, EMBO J, V15, P4123, DOI 10.1002/j.1460-2075.1996.tb00787.x; Robertson SM, 2000, DEVELOPMENT, V127, P2447; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Sanchez MJ, 2001, DEVELOPMENT, V128, P4815; SCHUG J, 1997, CBILT19971001V00 U P; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Sinclair AM, 1999, DEV BIOL, V209, P128, DOI 10.1006/dbio.1999.9236; Smith AM, 2008, GENOME RES, V18, P1422, DOI 10.1101/gr.077008.108; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; Xu ZX, 2007, GENE DEV, V21, P942, DOI 10.1101/gad.1528507; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	77	15	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9059	10.1371/journal.pone.0009059	http://dx.doi.org/10.1371/journal.pone.0009059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140202	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000274442400003
J	Kim, CX; Bailey, KR; Klee, GG; Ellington, AA; Liu, GH; Mosley, TH; Rehman, H; Kullo, IJ				Kim, Charles X.; Bailey, Kent R.; Klee, George G.; Ellington, Allison A.; Liu, Guanghui; Mosley, Thomas H., Jr.; Rehman, Hamid; Kullo, Iftikhar J.			Sex and Ethnic Differences in 47 Candidate Proteomic Markers of Cardiovascular Disease: The Mayo Clinic Proteomic Markers of Arteriosclerosis Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; IMMUNOLUMINOMETRIC ASSAY; AFRICAN-AMERICAN; RISK-FACTORS; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; NATRIURETIC PEPTIDES; PROGNOSTIC VALUE; QUALITY-CONTROL	Background: Cardiovascular disease (CVD) susceptibility differs between men and women and varies with ethnicity. This variability is not entirely explained by conventional CVD risk factors. We examined differences in circulating levels of 47 novel protein markers of CVD in 2561 men and women of African-American (AA) and non-Hispanic White (NHW) ethnicity, enrolled at geographically distinct sites. Methodology/Principal Findings: Participants (1,324 AAs, mean age 63.5 y, 71% women; 1,237 NHWs, mean age 58.9 y, 57% women) belonged to sibships ascertained on the basis of hypertension. Solid-phase immunoassays and immunoturbidometric, clot-based, chromogenic, and electrophoretic assays were used to measure the 47 protein markers in plasma or serum. Marker levels were log transformed and outliers were adjusted to within 4 SD. To identify markers independently associated with sex or ethnicity, we employed multivariable regression analyses that adjusted for conventional risk factors, prior history of CVD, medication use and lifestyle factors (physical activity, alcohol consumption and education). Generalized estimating equations were used to correct for intrafamilial correlations. After adjustment for the above covariates, female sex was associated with higher levels of 29 markers and lower levels of 6 markers. Female sex was independently associated with higher levels of several inflammatory markers as well as lipoproteins, adipokines, natriuretic peptides, vasoconstrictor peptides and markers of calcification and thrombosis. AA ethnicity was associated with higher levels of 19 markers and lower levels of 6 markers, including higher levels of several inflammatory makers, higher leptin and lower adiponectin levels, lower levels of vasodilator-natriuretic peptides, higher levels of vasoconstrictor-antidiuretic peptides and markers of calcification and thrombosis. Conclusions/Significance: Plasma levels of several novel protein markers of CVD differ significantly in the context of sex and ethnicity. These results have implications for individualized CVD risk assessment.	[Kim, Charles X.; Bailey, Kent R.; Klee, George G.; Ellington, Allison A.; Liu, Guanghui; Mosley, Thomas H., Jr.; Rehman, Hamid; Kullo, Iftikhar J.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Kim, CX (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	kullo.iftikhar@mayo.edu			National Institutes of Health [HL-81331, M01 RR00585]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000585] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL081331] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL-81331 and M01 RR00585 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert Michelle A, 2004, Rev Cardiovasc Med, V5 Suppl 3, pS22; [Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bakris G, 1997, J HYPERTENS, V15, P545, DOI 10.1097/00004872-199715050-00011; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brilakis ES, 2008, ATHEROSCLEROSIS, V199, P110, DOI 10.1016/j.atherosclerosis.2007.10.010; Brindle P, 2006, HEART, V92, P1752, DOI 10.1136/hrt.2006.087932; Cavusoglu E, 2007, AM J CARDIOL, V99, P1364, DOI 10.1016/j.amjcard.2006.12.060; Chang AY, 2007, J AM COLL CARDIOL, V49, P109, DOI 10.1016/j.jacc.2006.10.040; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Considine RV, 2008, OBESITY, V16, P428, DOI 10.1038/oby.2007.80; Davis CL, 2005, ETHNIC DIS, V15, P568; de Bold MLK, 1999, CARDIOVASC RES, V41, P524; Degawa-Yamauchi M, 2003, OBES RES, V11, P1384, DOI 10.1038/oby.2003.187; Ellington AA, 2009, CLIN CHEM, V55, P1092, DOI 10.1373/clinchem.2008.120717; Fan Amy Z, 2007, Atherosclerosis, V195, pe191, DOI 10.1016/j.atherosclerosis.2007.03.045; Fink E, 2000, OSTEOPOROSIS INT, V11, P295, DOI 10.1007/PL00004183; GERBES AL, 1994, J CLIN ENDOCR METAB, V78, P1307, DOI 10.1210/jc.78.6.1307; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Granger CB, 2004, CIRCULATION, V109, P1697, DOI 10.1161/01.CIR.0000121563.47232.2A; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Gundberg CM, 2002, BONE, V31, P703, DOI 10.1016/S8756-3282(02)00902-X; Ho RH, 2007, PHARMACOGENET GENOM, V17, P647, DOI 10.1097/FPC.0b013e3280ef698f; Hoffmann B, 2009, ENVIRON HEALTH PERSP, V117, P1302, DOI 10.1289/ehp.0800362; Ikonomidis I, 2008, ATHEROSCLEROSIS, V199, P3, DOI 10.1016/j.atherosclerosis.2008.02.019; JNEID H, 2008, CIRCULATION; Kaplan Robert C, 2008, J Stroke Cerebrovasc Dis, V17, P344, DOI 10.1016/j.jstrokecerebrovasdis.2008.04.006; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; Khawaja FJ, 2007, MAYO CLIN PROC, V82, P709; Klos KLE, 2005, ANN HUM GENET, V69, P157, DOI 10.1046/j.1529-8817.2004.00148.x; Knopp Robert H, 2005, Curr Atheroscler Rep, V7, P472, DOI 10.1007/s11883-005-0065-6; Laughlin GA, 2007, AM J EPIDEMIOL, V165, P164, DOI 10.1093/aje/kwk001; Leder BZ, 2007, J CLIN ENDOCR METAB, V92, P3453, DOI 10.1210/jc.2006-2695; Lee JH, 2003, J CLIN ENDOCR METAB, V88, P4848, DOI 10.1210/jc.2003-030519; LIEB W, 2008, DIABETES CARE; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Lukacs JL, 2006, MENOPAUSE, V13, P799, DOI 10.1097/01.gme.0000227023.89062.43; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; McTernan CL, 2002, LANCET, V359, P46, DOI 10.1016/S0140-6736(02)07281-1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Morgenthaler NG, 2005, CLIN CHEM, V51, P1823, DOI 10.1373/clinchem.2005.051110; Okosun IS, 2001, J HUM HYPERTENS, V15, P299, DOI 10.1038/sj.jhh.1001181; Omland T, 2008, J AM COLL CARDIOL, V51, P627, DOI 10.1016/j.jacc.2007.09.058; Palmas W, 2008, ETHNIC DIS, V18, P324; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Romero-Corral A, 2008, NAT CLIN PRACT CARD, V5, P418, DOI 10.1038/ncpcardio1218; Rothenbacher D, 2005, EUR HEART J, V26, P1640, DOI 10.1093/eurheartj/ehi340; Schellings MWM, 2004, CARDIOVASC RES, V64, P24, DOI 10.1016/j.cardiores.2004.06.006; Silswal N, 2005, BIOCHEM BIOPH RES CO, V334, P1092, DOI 10.1016/j.bbrc.2005.06.202; Sladek CD, 2008, FRONT NEUROENDOCRIN, V29, P114, DOI 10.1016/j.yfrne.2007.08.005; Sowers James R, 2008, Clin Cornerstone, V9, P32, DOI 10.1016/S1098-3597(08)60026-5; Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006; Stumvoll M, 2002, OBES RES, V10, P1197, DOI 10.1038/oby.2002.162; Sukhu K, 2003, CLIN LAB HAEMATOL, V25, P247, DOI 10.1046/j.1365-2257.2003.00523.x; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Vaidya D, 2008, METABOLISM, V57, P782, DOI 10.1016/j.metabol.2008.01.019; Verma S, 2003, CIRCULATION, V108, P736, DOI 10.1161/01.CIR.0000084503.91330.49; Wannamethee SG, 2007, DIABETES CARE, V30, P1200, DOI 10.2337/dc06-2416; WESTGARD JO, 1981, CLIN CHEM, V27, P493; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; 2002, HEART, V88, P222; 2002, HYPERTENSION, V39, P3	70	73	73	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9065	10.1371/journal.pone.0009065	http://dx.doi.org/10.1371/journal.pone.0009065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140090	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442400005
J	Lin, SL; Yan, LY; Zhang, XT; Yuan, J; Li, M; Qiao, J; Wang, ZY; Sun, QY				Lin, Sheng-Li; Yan, Li-Ying; Zhang, Xin-Tian; Yuan, Ju; Li, Mo; Qiao, Jie; Wang, Zhao-Yi; Sun, Qing-Yuan			ER-alpha 36, a Variant of ER-alpha, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; ACTIVATED PROTEIN-KINASE; ESTROGEN-RECEPTOR-ALPHA; SURGICAL ADJUVANT BREAST; GROWTH-FACTOR; ANTIESTROGEN RESISTANCE; MOLECULAR-MECHANISMS; C-MYC; EXPRESSION; ESTRADIOL	Background: Recently, a novel variant of ER-alpha, ER-alpha 36 was identified and cloned. ER-alpha 36 lacks intrinsic transcription activity and mainly mediates nongenomic estrogen signaling. Here, we studied the role of nongenomic estrogen signaling pathways mediated by ER-alpha 36 in tamoxifen resistance and agonist action. Methodology: The cellular localization of ER-alpha 36 was examined by immunofluorescence in MCF-7 cells and Hec1A cells. MCF-7 breast cancer cells, MCF-7 cells expressing recombinant ER-alpha 36 (MCF-7/ER36), Hec1A endometrial cancer cells and Hec1A cells with siRNA knockdown of ER-alpha 36 (Hec1A/RNAiER36) were treated with 17 beta-estradial (E2) and tamoxifen (TAM) in the absence and presence of kinase inhibitor U0126 and LY294002. We examined phosphorylation of signaling molecules and the expression of c-Myc by immunoblotting, and tumor cell growth by MTT assay. Conclusions: ER variant ER-alpha 36 enhances TAM agonist activity through activation of the membrane-initiated signaling pathways in endometrial cancer, and that ER-alpha 36 is involved in de novo and acquired TAM resistance in breast cancer.	[Lin, Sheng-Li; Yuan, Ju; Li, Mo; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Lin, Sheng-Li; Yuan, Ju; Li, Mo; Sun, Qing-Yuan] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Yan, Li-Ying; Qiao, Jie] Peking Univ Third Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing 100871, Peoples R China; [Zhang, Xin-Tian; Wang, Zhao-Yi] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Peking University; Creighton University	Lin, SL (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	jie.qiao@263.net; zywang@creighton.edu; sunqy@ioz.ac.cn			National Basic Research Program of China [2006CB504004, 2006CB944005]	National Basic Research Program of China(National Basic Research Program of China)	This study was supported by National Basic Research Program of China (2006CB504004, 2006CB944005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Clarke R, 2003, ONCOGENE, V22, P7316, DOI 10.1038/sj.onc.1206937; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; Cuzick J, 2003, LANCET, V361, P296, DOI 10.1016/S0140-6736(03)12342-2; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dufourny B, 1997, J BIOL CHEM, V272, P31163, DOI 10.1074/jbc.272.49.31163; Dutertre M, 2000, J PHARMACOL EXP THER, V295, P431; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; FISHER B, 1994, J NATL CANCER I, V86, P527, DOI 10.1093/jnci/86.7.527; FRIEDL A, 1989, CANCER RES, V49, P4758; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Gao J, 2005, INT J ONCOL, V26, P737; Glaros S, 2006, MOL ENDOCRINOL, V20, P996, DOI 10.1210/me.2005-0285; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; KHARBANDA S, 1995, NATURE, V376, P785, DOI 10.1038/376785a0; Levin ER, 2008, BREAST CANCER RES TR, V108, P351, DOI 10.1007/s10549-007-9618-4; Lewis JS, 2005, MUTAT RES-FUND MOL M, V591, P247, DOI 10.1016/j.mrfmmm.2005.02.028; LOVE RR, 1989, J CLIN ONCOL, V7, P803, DOI 10.1200/JCO.1989.7.6.803; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mueller H, 2000, INT J CANCER, V89, P384, DOI 10.1002/1097-0215(20000720)89:4<384::AID-IJC11>3.0.CO;2-R; NEVEN P, 1990, BRIT J OBSTET GYNAEC, V97, P551, DOI 10.1111/j.1471-0528.1990.tb02536.x; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; REDDEL RR, 1983, CANCER RES, V43, P4618; Rottmann S, 2005, P NATL ACAD SCI USA, V102, P15195, DOI 10.1073/pnas.0505114102; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sears R, 1999, MOL CELL, V3, P169, DOI 10.1016/S1097-2765(00)80308-1; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shibutani S, 2000, CARCINOGENESIS, V21, P1461, DOI 10.1093/carcin/21.8.1461; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sotgia F, 2006, CANCER RES, V66, P10647, DOI 10.1158/0008-5472.CAN-06-2805; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Tokunaga E, 2006, EUR J CANCER, V42, P629, DOI 10.1016/j.ejca.2005.11.025; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang ZY, 2006, P NATL ACAD SCI USA, V103, P9063, DOI 10.1073/pnas.0603339103; Wang ZY, 2005, BIOCHEM BIOPH RES CO, V336, P1023, DOI 10.1016/j.bbrc.2005.08.226; WATSON PH, 1991, CANCER RES, V51, P3996; Werf H. M. G. van der, 1995, Journal of the International Hemp Association, V2, P14; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; Yu J, 2004, AM J PHYSIOL-LUNG C, V286, pL694, DOI 10.1152/ajplung.00204.2003	47	101	120	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9013	10.1371/journal.pone.0009013	http://dx.doi.org/10.1371/journal.pone.0009013			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126312	Green Published, Green Submitted, gold			2022-12-27	WOS:000274207200011
J	Ortega, FJ; Moreno-Navarrete, JM; Pardo, G; Sabater, M; Hummel, M; Ferrer, A; Rodriguez-Hermosa, JI; Ruiz, B; Ricart, W; Peral, B; Fernandez-Real, JM				Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Hummel, Manuela; Ferrer, Anna; Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu; Ricart, Wifredo; Peral, Belen; Fernandez-Real, Jose M.			MiRNA Expression Profile of Human Subcutaneous Adipose and during Adipocyte Differentiation	PLOS ONE			English	Article							MICRORNA EXPRESSION; TISSUE CELLULARITY; CELL; ADIPOGENESIS; NUMBER; TUMORIGENESIS; GENES; IDENTIFICATION; CHILDREN; OBESITY	Background: Potential regulators of adipogenesis include microRNAs (miRNAs), small non-coding RNAs that have been recently shown related to adiposity and differentially expressed in fat depots. However, to date no study is available, to our knowledge, regarding miRNAs expression profile during human adipogenesis. Thereby, the aim of this study was to investigate whether miRNA pattern in human fat cells and subcutaneous adipose tissue is associated to obesity and co-morbidities and whether miRNA expression profile in adipocytes is linked to adipogenesis. Methodology/Principal Findings: We performed a global miRNA expression microarray of 723 human and 76 viral mature miRNAs in human adipocytes during differentiation and in subcutaneous fat samples from non-obese (n=6) and obese with (n=9) and without (n=13) Type-2 Diabetes Mellitus (DM-2) women. Changes in adipogenesis-related miRNAs were then validated by RT-PCR. Fifty of 799 miRNAs (6.2%) significantly differed between fat cells from lean and obese subjects. Seventy miRNAs (8.8%) were highly and significantly up or down-regulated in mature adipocytes as compared to pre-adipocytes. Otherwise, 17 of these 799 miRNAs (2.1%) were correlated with anthropometrical (BMI) and/or metabolic (fasting glucose and/or triglycerides) parameters. We identified 11 miRNAs (1.4%) significantly deregulated in subcutaneous fat from obese subjects with and without DM-2. Interestingly, most of these changes were associated with miRNAs also significantly deregulated during adipocyte differentiation. Conclusions/Significance: The remarkable inverse miRNA profile revealed for human pre-adipocytes and mature adipocytes hints at a closely crosstalk between miRNAs and adipogenesis. Such candidates may represent biomarkers and therapeutic targets for obesity and obesity-related complications.	[Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] CIBEROBN CB06 03 0010, Serv Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Ortega, Francisco J.; Moreno-Navarrete, Jose M.; Pardo, Gerard; Sabater, Monica; Ricart, Wifredo; Fernandez-Real, Jose M.] Inst Salud Carlos III, Girona, Spain; [Hummel, Manuela; Ferrer, Anna] UPF, Microarray Unit, CRG, Barcelona, Spain; [Peral, Belen] CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Peral, Belen] Univ Autonoma Madrid, Madrid, Spain; [Rodriguez-Hermosa, Jose I.; Ruiz, Bartomeu] Inst Invest Biomed Girona IdIBGi, Dept Surg, Girona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Ortega, FJ (corresponding author), CIBEROBN CB06 03 0010, Serv Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain.	jmfernandezreal.girona.ics@gencat.cat	Moreno-Navarrete, José María/H-9772-2015; Xie, Huangming/B-2260-2012; Moreno-Navarrete, José María/ABG-5548-2021; Sabater-Masdeu, Mònica/G-1168-2016; Duarte, Graziela Biude Silva/Q-7728-2016; Ortega, Francisco José J/F-3883-2016; Fernández-Real, Jose Manuel/AGH-3599-2022; Ferrer-Salvador, Anna/K-6001-2015; PERAL, BELEN/F-4562-2015	Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Sabater-Masdeu, Mònica/0000-0001-9636-0921; Ortega, Francisco José J/0000-0003-2111-769X; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Ferrer-Salvador, Anna/0000-0001-5507-0733; Ricart, Wifredo/0000-0002-3452-9098; PERAL, BELEN/0000-0003-4984-4020	Ministerio de Educacion y Ciencia (MEC) [SAF2008-02073]; Instituto de Salud Carlos III [CB06/03/0010]	Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by research grants from the Ministerio de Educacion y Ciencia (MEC) (SAF2008-02073), the Instituto de Salud Carlos III (CIBERObN, CB06/03/0010), and the Hospital Dr. Josep Trueta de Girona. The funders had no role in study design, data collection nor analysis, decision to publish, or preparation of the manuscript.	Avram MM, 2007, J AM ACAD DERMATOL, V56, P472, DOI 10.1016/j.jaad.2006.06.022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BROOK CGD, 1972, BMJ-BRIT MED J, V2, P25, DOI 10.1136/bmj.2.5804.25; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fajas L, 2003, ANN MED, V35, P79, DOI 10.1080/07853890310009999; GINSBERGFELLNER F, 1981, PEDIATR RES, V15, P1381, DOI 10.1203/00006450-198110000-00016; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Hauner H, 1988, Horm Metab Res Suppl, V19, P35; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Hernando E, 2007, CLIN TRANSL ONCOL, V9, P155, DOI 10.1007/s12094-007-0029-0; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Joglekar MV, 2009, GENE EXPR PATTERNS, V9, P109, DOI 10.1016/j.gep.2008.10.001; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Karp X, 2005, SCIENCE, V310, P1288, DOI 10.1126/science.1121566; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Obregon MJ, 2008, THYROID, V18, P185, DOI 10.1089/thy.2007.0254; Pasarica M, 2009, DIABETES CARE, V32, P900, DOI 10.2337/dc08-2240; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; RONCARI DAK, 1981, METABOLISM, V30, P425, DOI 10.1016/0026-0495(81)90174-8; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zhao JJ, 2009, CHILD NERV SYST, V25, P13, DOI 10.1007/s00381-008-0701-x	43	287	299	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9022	10.1371/journal.pone.0009022	http://dx.doi.org/10.1371/journal.pone.0009022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126310	gold, Green Published			2022-12-27	WOS:000274207200017
J	Pombert, JF; Keeling, PJ				Pombert, Jean-Francois; Keeling, Patrick J.			The Mitochondrial Genome of the Entomoparasitic Green Alga Helicosporidium	PLOS ONE			English	Article							GROUP-I INTRON; SEQUENCE; GENES; DNA; TREBOUXIOPHYCEAE; CHLOROPHYTA; SELECTION	Background: Helicosporidia are achlorophyllous, non-photosynthetic protists that are obligate parasites of invertebrates. Highly specialized, these pathogens feature an unusual cyst stage that dehisces inside the infected organism and releases a filamentous cell displaying surface projections, which will penetrate the host gut wall and eventually reproduce in the hemolymph. Long classified as incertae sedis or as relatives of other parasites such as Apicomplexa or Microsporidia, the Helicosporidia were surprisingly identified through molecular phylogeny as belonging to the Chlorophyta, a phylum of green algae. Most phylogenetic analyses involving Helicosporidia have placed them within the subgroup Trebouxiophyceae and further suggested a close affiliation between the Helicosporidia and the genus Prototheca. Prototheca species are also achlorophyllous and pathogenic, but they infect vertebrate hosts, inducing protothecosis in humans. The complete plastid genome of an Helicosporidium species was recently described and is a model of compaction and reduction. Here we describe the complete mitochondrial genome sequence of the same strain, Helicosporidium sp. ATCC 50920 isolated from the black fly Simulium jonesi. Methodology/Principal Findings: The circular mapping 49343 bp mitochondrial genome of Helicosporidium closely resembles that of the vertebrate parasite Prototheca wickerhamii. The two genomes share an almost identical gene complement and display a level of synteny that is higher than any other sequenced chlorophyte mitochondrial DNAs. Interestingly, the Helicosporidium mtDNA feature a trans-spliced group I intron, and a second group I intron that contains two open reading frames that appear to be degenerate maturase/endonuclease genes, both rare characteristics for this type of intron. Conclusions/Significance: The architecture, genome content, and phylogeny of the Helicosporidium mitochondrial genome are all congruent with its close relationship to Prototheca within the Trebouxiophyceae. The Helicosporidium mitochondrial genome does, however, contain a number of novel features, particularly relating to its introns.	[Pombert, Jean-Francois; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia	Pombert, JF (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	jpombert@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Pombert, Jean-Francois/0000-0002-3449-8375	Natural Sciences and Engineering Research Council (NSERC); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship; Canadian Institute for Advanced Research (CIFAR); Michael Smith Foundation for Health Research (MSFHR)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship(FQRNT); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	Funding: This work was supported by a Natural Sciences and Engineering Research Council (NSERC) operating grant to PJK. JFP is the recipient of the Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)/Genome Quebec Louis-Berlinguet Postdoctoral Fellowship. PJK is a Fellow of the Canadian Institute for Advanced Research (CIFAR), and a Senior Scholar of the Michael Smith Foundation for Health Research (MSFHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blaske-Lietze VU, 2006, J EUKARYOT MICROBIOL, V53, P165, DOI 10.1111/j.1550-7408.2006.00090.x; Blaske-Lietze VU, 2005, J INVERTEBR PATHOL, V90, P161, DOI 10.1016/j.jip.2005.09.002; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Boucias DG, 2001, J EUKARYOT MICROBIOL, V48, P460, DOI 10.1111/j.1550-7408.2001.tb00180.x; Burger G, 2009, TRENDS GENET, V25, P381, DOI 10.1016/j.tig.2009.07.003; BURKE JM, 1987, NUCLEIC ACIDS RES, V15, P7217, DOI 10.1093/nar/15.18.7217; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Conklin T, 2005, FLA ENTOMOL, V88, P431, DOI 10.1653/0015-4040(2005)88[431:IOTIOH]2.0.CO;2; de Koning AP, 2005, PROTIST, V156, P181, DOI 10.1016/j.protis.2005.02.005; de Koning AP, 2004, EUKARYOT CELL, V3, P1198, DOI 10.1128/EC.3.5.1198-1205.2004; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; Dotson PP, 2008, NUCLEIC ACIDS RES, V36, P5281, DOI 10.1093/nar/gkn507; Dotson PP, 2008, BIOCHEMISTRY-US, V47, P4780, DOI 10.1021/bi7020525; Einvik Christer, 2004, Methods Mol Biol, V252, P359; GORDON D, 2004, CURRENT PROTOCOLS BI; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Keilin D., 1921, Parasitology Cambridge, V13, P97, DOI 10.1017/S003118200001235X; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lass-Florl C, 2007, CLIN MICROBIOL REV, V20, P230, DOI 10.1128/CMR.00032-06; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Silva GH, 2006, J MOL BIOL, V361, P744, DOI 10.1016/j.jmb.2006.06.063; Tartar A, 2004, FEMS MICROBIOL LETT, V233, P153, DOI 10.1016/j.femsle.2004.02.006; Tartar A, 2003, INT J SYST EVOL MICR, V53, P1719, DOI 10.1099/ijs.0.02559-0; Tartar A, 2002, INT J SYST EVOL MICR, V52, P273, DOI 10.1099/00207713-52-1-273; Tesler G, 2002, BIOINFORMATICS, V18, P492, DOI 10.1093/bioinformatics/18.3.492; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210	37	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8954	10.1371/journal.pone.0008954	http://dx.doi.org/10.1371/journal.pone.0008954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126458	Green Published, gold, Green Submitted			2022-12-27	WOS:000274139100005
J	Stabentheiner, A; Kovac, H; Brodschneider, R				Stabentheiner, Anton; Kovac, Helmut; Brodschneider, Robert			Honeybee Colony Thermoregulation - Regulatory Mechanisms and Contribution of Individuals in Dependence on Age, Location and Thermal Stress	PLOS ONE			English	Article							APIS-MELLIFERA-CARNICA; FLIGHT MUSCLE DEVELOPMENT; DIVISION-OF-LABOR; OXYGEN-CONSUMPTION; CALORIMETRIC INVESTIGATIONS; AMBIENT-TEMPERATURE; RESTING HONEYBEES; BROOD-TEMPERATURE; PUPAL DEVELOPMENT; METABOLIC RATES	Honeybee larvae and pupae are extremely stenothermic, i.e. they strongly depend on accurate regulation of brood nest temperature for proper development (33-36 degrees C). Here we study the mechanisms of social thermoregulation of honeybee colonies under changing environmental temperatures concerning the contribution of individuals to colony temperature homeostasis. Beside migration activity within the nest, the main active process is "endothermy on demand" of adults. An increase of cold stress (cooling of the colony) increases the intensity of heat production with thoracic flight muscles and the number of endothermic individuals, especially in the brood nest. As endothermy means hard work for bees, this eases much burden of nestmates which can stay ectothermic. Concerning the active reaction to cold stress by endothermy, age polyethism is reduced to only two physiologically predetermined task divisions, 0 to similar to 2 days and older. Endothermic heat production is the job of bees older than about two days. They are all similarly engaged in active heat production both in intensity and frequency. Their active heat production has an important reinforcement effect on passive heat production of the many ectothermic bees and of the brood. Ectothermy is most frequent in young bees (<similar to 2 days) both outside and inside of brood nest cells. We suggest young bees visit warm brood nest cells not only to clean them but also to speed up flight muscle development for proper endothermy and foraging later in their life. Young bees inside brood nest cells mostly receive heat from the surrounding cell wall during cold stress, whereas older bees predominantly transfer heat from the thorax to the cell wall. Endothermic bees regulate brood comb temperature more accurately than local air temperature. They apply the heat as close to the brood as possible: workers heating cells from within have a higher probability of endothermy than those on the comb surface. The findings show that thermal homeostasis of honeybee colonies is achieved by a combination of active and passive processes. The differential individual endothermic and behavioral reactions sum up to an integrated action of the honeybee colony as a superorganism.	[Stabentheiner, Anton; Kovac, Helmut; Brodschneider, Robert] Karl Franzens Univ Graz, Inst Zool, Graz, Austria	University of Graz	Stabentheiner, A (corresponding author), Karl Franzens Univ Graz, Inst Zool, Graz, Austria.	anton.stabentheiner@uni-graz.at; he.kovac@uni-graz.at			Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF) [P13916, P16584]	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	Funding: Supported by the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (FWF, P13916, P16584). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile R, 2008, ZOOLOGY, V111, P433, DOI 10.1016/j.zool.2007.11.002; Becher MA, 2009, J COMP PHYSIOL A, V195, P673, DOI 10.1007/s00359-009-0442-7; BUDEL A, 1960, BIENE BIENENZUCHT; Bujok B, 2002, NATURWISSENSCHAFTEN, V89, P299, DOI 10.1007/s00114-002-0338-7; CAHILL K, 1976, COMP BIOCHEM PHYS A, V55, P355, DOI 10.1016/0300-9629(76)90060-8; Crailsheim K, 1999, ENTOMOL GEN, V24, P01; ESCH H, 1960, Z VERGL PHYSIOL, V43, P305, DOI 10.1007/BF00298066; FAHRENHOLZ L, 1992, J COMP PHYSIOL B, V162, P119, DOI 10.1007/BF00398337; Fehler M, 2007, NATURWISSENSCHAFTEN, V94, P675, DOI 10.1007/s00114-007-0240-4; GATES V, 1914, B USDA, V96, P1; Graham S, 2006, INSECT SOC, V53, P226, DOI 10.1007/s00040-005-0862-5; Groh C, 2004, P NATL ACAD SCI USA, V101, P4268, DOI 10.1073/pnas.0400773101; HARRISON JM, 1987, J EXP BIOL, V129, P53; Heinrich B., 1993, HOT BLOODED INSECTS; HERAN H, 1952, Z VERGL PHYSIOL, V34, P179; HEROLD RC, 1965, DEV BIOL, V12, P269, DOI 10.1016/0012-1606(65)90031-X; HEROLD RC, 1963, DEV BIOL, V8, P67, DOI 10.1016/0012-1606(63)90026-5; HERSCH MI, 1978, COMP BIOCHEM PHYS B, V61, P427, DOI 10.1016/0305-0491(78)90149-9; HESS W. R., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P465, DOI 10.1007/BF00340746; Himmer A, 1932, BIOL REV BIOL P CAMB, V7, P224; Johnson BR, 2002, BEHAV ECOL SOCIOBIOL, V51, P188, DOI 10.1007/s00265-001-0419-1; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Klein BA, 2008, J EXP BIOL, V211, P3028, DOI 10.1242/jeb.017426; Kleinhenz M, 2003, J EXP BIOL, V206, P4217, DOI 10.1242/jeb.00680; KOENIGER N, 1978, APIDOLOGIE, V9, P305, DOI 10.1051/apido:19780404; Kovac H, 2007, J INSECT PHYSIOL, V53, P1250, DOI 10.1016/j.jinsphys.2007.06.019; Kovac H, 2009, APIDOLOGIE, V40, P82, DOI 10.1051/apido/2008069; KRONENBERG F, 1982, J COMP PHYSIOL, V148, P65, DOI 10.1007/BF00688889; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; Mackasmiel LAM, 2000, J APICULT RES, V39, P125, DOI 10.1080/00218839.2000.11101032; Mandl M., 2004, P 1 EUR C AP EURBEE; MANDL M, 2005, THESIS K FRANZENS U, P227; MELAMPY R. M., 1939, PHYSIOL ZOOL, V12, P302; Moritz R.F.A., 1988, Biona Report, V6, P51; Moritz R.F.A., 1992, BEES SUPERORGANISMS; PAGE RE, 1991, ADV INSECT PHYSIOL, V23, P117, DOI 10.1016/S0065-2806(08)60093-4; Petz M, 2004, J COMP PHYSIOL B, V174, P511, DOI 10.1007/s00360-004-0439-z; RITTER W, 1982, APIDOLOGIE, V13, P169, DOI 10.1051/apido:19820205; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROTHE U, 1989, J COMP PHYSIOL B, V158, P739, DOI 10.1007/BF00693012; Sachs L., 1997, ANGEW STAT, P11, DOI [10.1007/978-3-662-05746-9_2, DOI 10.1007/978-3-662-05746-9_2, 10.1007/978-3-662-05746-9]; SAKAGAMI SF, 1956, Z VERGL PHYSIOL, V39, P21; Schmolz E, 2002, THERMOCHIM ACTA, V382, P221, DOI 10.1016/S0040-6031(01)00740-7; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1991, ETHOLOGY, V87, P284; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SEELEY TD, 1994, BEHAV ECOL SOCIOBIOL, V34, P51, DOI 10.1007/BF00175458; SEELEY TD, 1992, BEHAV ECOL SOCIOBIOL, V31, P375, DOI 10.1007/BF00170604; SIMPSON J, 1961, SCIENCE, V133, P1327, DOI 10.1126/science.133.3461.1327; SOUTHWICK EE, 1987, J INSECT PHYSIOL, V33, P623, DOI 10.1016/0022-1910(87)90130-2; SOUTHWICK EE, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P28; SOUTHWICK EE, 1985, J COMP PHYSIOL B, V156, P143, DOI 10.1007/BF00692937; Stabentheiner A, 1996, ETHOLOGY, V102, P360, DOI 10.1111/j.1439-0310.1996.tb01132.x; Stabentheiner A., 1987, Thermology, V2, P563; Stabentheiner A, 1995, J COMP PHYSIOL B, V165, P433, DOI 10.1007/BF00261297; STABENTHEINER A, 1991, NATURWISSENSCHAFTEN, V78, P471, DOI 10.1007/BF01134389; Stabentheiner A, 2003, J INSECT PHYSIOL, V49, P881, DOI 10.1016/S0022-1910(03)00148-3; Stabentheiner A, 2003, J EXP BIOL, V206, P353, DOI 10.1242/jeb.00082; Stabentheiner A, 2002, J EXP BIOL, V205, P2637; Stabentheiner A, 1999, ENTOMOL GEN, V24, P13; Stabentheiner A, 2001, J INSECT PHYSIOL, V47, P385, DOI 10.1016/S0022-1910(00)00132-3; STABENTHEINER A, 2002, APIDOLOGIE, V33, P499; Stabentheiner A, 2007, ETHOLOGY, V113, P995, DOI 10.1111/j.1439-0310.2007.01403.x; Starks PT, 2005, BEHAV ECOL, V16, P128, DOI 10.1093/beheco/arh124; Starks PT, 1999, NATURWISSENSCHAFTEN, V86, P438, DOI 10.1007/s001140050648; Tautz J, 2003, P NATL ACAD SCI USA, V100, P7343, DOI 10.1073/pnas.1232346100; Vollmann J., 2004, Mitteilungen der Deutschen Gesellschaft fur allgemeine und angewandte Entomologie, V14, P467; [No title captured]	71	143	149	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8967	10.1371/journal.pone.0008967	http://dx.doi.org/10.1371/journal.pone.0008967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126462	Green Published, Green Submitted, gold			2022-12-27	WOS:000274139100015
J	Fumagalli, M; Vergari, M; Pasqualetti, P; Marceglia, S; Mameli, F; Ferrucci, R; Mrakic-Sposta, S; Zago, S; Sartori, G; Pravettoni, G; Barbieri, S; Cappa, S; Priori, A				Fumagalli, Manuela; Vergari, Maurizio; Pasqualetti, Patrizio; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Sartori, Giuseppe; Pravettoni, Gabriella; Barbieri, Sergio; Cappa, Stefano; Priori, Alberto			Brain Switches Utilitarian Behavior: Does Gender Make the Difference?	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; HUMAN MOTOR CORTEX; SEX-DIFFERENCES; ELECTRICAL-STIMULATION; EXCITABILITY CHANGES; HEALTHY-INDIVIDUALS; MODULATION; DAMAGE	Decision often implies a utilitarian choice based on personal gain, even at the expense of damaging others. Despite the social implications of utilitarian behavior, its neurophysiological bases remain largely unknown. To assess how the human brain controls utilitarian behavior, we delivered transcranial direct current stimulation (tDCS) over the ventral prefrontal cortex (VPC) and over the occipital cortex (OC) in 78 healthy subjects. Utilitarian judgment was assessed with the moral judgment task before and after tDCS. At baseline, females provided fewer utilitarian answers than males for personal moral dilemmas (p = .007). In males, VPC-tDCS failed to induce changes and in both genders OC-tDCS left utilitarian judgments unchanged. In females, cathodal VPC-tDCS tended to decrease whereas anodal VPC-tDCS significantly increased utilitarian responses (p = .005). In males and females, reaction times for utilitarian responses significantly decreased after cathodal (p,. 001) but not after anodal (p = .735) VPC-tDCS. We conclude that ventral prefrontal tDCS interferes with utilitarian decisions, influencing the evaluation of the advantages and disadvantages of each option in both sexes, but does so more strongly in females. Whereas cathodal tDCS alters the time for utilitarian reasoning in both sexes, anodal stimulation interferes more incisively in women, modifying utilitarian reasoning and the possible consequent actions. The gender-related tDCS-induced changes suggest that the VPC differentially controls utilitarian reasoning in females and in males. The gender-specific functional organization of the brain areas involved in utilitarian behavior could be a correlate of the moral and social behavioral differences between the two sexes.	[Fumagalli, Manuela; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Priori, Alberto] Univ Milan, Dipartimento Sci Neurol, Milan, Italy; [Fumagalli, Manuela; Vergari, Maurizio; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Priori, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Ctr Clin Neuronanotecnol & Neurostimolaz, Milan, Italy; [Vergari, Maurizio; Barbieri, Sergio] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Neurofisiopatol Clin, Milan, Italy; [Fumagalli, Manuela; Marceglia, Sara; Mameli, Francesca; Ferrucci, Roberta; Mrakic-Sposta, Simona; Zago, Stefano; Priori, Alberto] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Unita Operat Neurol, Milan, Italy; [Pasqualetti, Patrizio] Osped San Giovanni Calibita Fatebenefratelli Isol, AFaR, Rome, Italy; [Sartori, Giuseppe] Univ Padua, Dipartimento Psicol Gen, Padua, Italy; [Pravettoni, Gabriella] Univ Milan, Dipartimento Sci Sociali & Polit, Milan, Italy; [Cappa, Stefano] Univ Vita Salute San Raffaele, Ctr Neurosci Cognit, Milan, Italy; [Cappa, Stefano] Ist Sci San Raffaele, Dipartimento Neurosci, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Padua; University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Fumagalli, M (corresponding author), Univ Milan, Dipartimento Sci Neurol, Milan, Italy.	alberto.priori@unimi.it	Pravettoni, Gabriella/AAC-3500-2022; Pravettoni, Gabriella/C-6915-2011; Pasqualetti, Patrizio/D-4496-2013; Sartori, Giuseppe/B-8140-2008; Priori, Alberto/K-9603-2016; Mrakic-Sposta, Simona/AAA-2991-2019; Ferrucci, Roberta/K-6081-2016; Cappa, Stefano/B-1874-2014; Marceglia, Sara/N-6999-2019; Pravettoni, Gabriella/E-6055-2012; Zago, Stefano/I-5838-2015; Zago, Stefano/AAW-8595-2021; Vergari, Maurizio/K-6513-2016	Pravettoni, Gabriella/0000-0002-4843-4663; Pasqualetti, Patrizio/0000-0001-5560-1979; Priori, Alberto/0000-0002-1549-3851; Mrakic-Sposta, Simona/0000-0001-7359-2690; Ferrucci, Roberta/0000-0001-5109-9483; Cappa, Stefano/0000-0003-1003-3925; Marceglia, Sara/0000-0002-0456-866X; Zago, Stefano/0000-0001-6578-4385; Zago, Stefano/0000-0001-6578-4385; Sartori, Giuseppe/0000-0002-6026-0133; Mameli, Francesca/0000-0003-4774-582X; Pravettoni, Gabriella/0000-0002-9135-2938; Vergari, Maurizio/0000-0002-5350-8014				Accornero N, 2007, EXP BRAIN RES, V178, P261, DOI 10.1007/s00221-006-0733-y; AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Australian Government National Health and Medical Research Council, 2007, AUSTR ASS PRESS 0426, P1; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bell EC, 2006, NEUROIMAGE, V30, P529, DOI 10.1016/j.neuroimage.2005.09.049; Boggio PS, 2008, NEUROSCI LETT, V447, P101, DOI 10.1016/j.neulet.2008.10.009; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Campbell A, 2008, BIOL PSYCHOL, V77, P1, DOI 10.1016/j.biopsycho.2007.09.001; CAMUS M, 2009, EUR J NEUROSCI; Cedzich C, 1998, NEUROSURGERY, V42, P527, DOI 10.1097/00006123-199803000-00018; Chaieb L, 2008, VISUAL NEUROSCI, V25, P77, DOI 10.1017/S0952523808080097; Chen XH, 2007, NEUROIMAGE, V36, P691, DOI 10.1016/j.neuroimage.2007.03.063; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; DAMASIO AR, 1994, DESCARTES ERROR; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Eisenberg N, 2005, NEBR SYM MOTIV, V51, P73; Fecteau S, 2007, J NEUROSCI, V27, P12500, DOI 10.1523/JNEUROSCI.3283-07.2007; Fecteau S, 2007, J NEUROSCI, V27, P6212, DOI 10.1523/JNEUROSCI.0314-07.2007; Ferrucci R, 2008, J COGNITIVE NEUROSCI, V20, P1687, DOI 10.1162/jocn.2008.20112; Ferrucci R, 2009, J AFFECT DISORDERS, V118, P215, DOI 10.1016/j.jad.2009.02.015; Fumagalli M, 2010, COGN PROCESS, V11, P219, DOI 10.1007/s10339-009-0335-2; Gilligan Carol., 1982, DIFFERENT VOICE; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; GREENFELD L, 1999, WOMEN OFFENDERS, P1; Hare RM, 1981, MORAL THINKING ITS L; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Holdefer RN, 2006, CLIN NEUROPHYSIOL, V117, P1388, DOI 10.1016/j.clinph.2006.02.020; HOLLIS V, 2003, PRISON POPULATION BR, P1; Jaffee S, 2000, PSYCHOL BULL, V126, P703, DOI 10.1037//0033-2909.126.5.703; Kaasinen V, 2001, AM J PSYCHIAT, V158, P308, DOI 10.1176/appi.ajp.158.2.308; KARIM AA, 2009, CEREB CORTEX; Kimura Doreen, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P67; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; KNOCH D, 2007, CEREB CORTEX; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koch K, 2007, NEUROPSYCHOLOGIA, V45, P2744, DOI 10.1016/j.neuropsychologia.2007.04.012; KOENIGS M, 2008, CLIN NEUROPHYSIOL; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Kuo MF, 2008, CEREB CORTEX, V18, P648, DOI 10.1093/cercor/bhm098; Kuo MF, 2006, NEUROREPORT, V17, P1703, DOI 10.1097/01.wnr.0000239955.68319.c2; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2009, CLIN NEUROPHYSIOL, V120, P1161, DOI 10.1016/j.clinph.2009.01.022; Miranda PC, 2006, CLIN NEUROPHYSIOL, V117, P1623, DOI 10.1016/j.clinph.2006.04.009; Moll J, 2007, TRENDS COGN SCI, V11, P319, DOI 10.1016/j.tics.2007.06.001; Moll J, 2006, P NATL ACAD SCI USA, V103, P15623, DOI 10.1073/pnas.0604475103; NATHAN SS, 1993, ELECTROEN CLIN NEURO, V86, P183, DOI 10.1016/0013-4694(93)90006-H; Nitsche MA, 2006, EUR J NEUROSCI, V23, P1651, DOI 10.1111/j.1460-9568.2006.04676.x; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Overman WH, 2004, NEUROPSYCHOLOGIA, V42, P1838, DOI 10.1016/j.neuropsychologia.2004.03.014; Pagonabarraga J, 2007, MOVEMENT DISORD, V22, P1430, DOI 10.1002/mds.21457; Paulus Walter, 2004, Suppl Clin Neurophysiol, V57, P708; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; RANGO M, 2008, MAGN RESON IN PRESS, V59; Riccardi P, 2006, AM J PSYCHIAT, V163, P1639, DOI 10.1176/appi.ajp.163.9.1639; Sabol WJ., 2007, PRISONERS 2007; SCHLAEPFER TE, 1995, PSYCHIAT RES-NEUROIM, V61, P129, DOI 10.1016/0925-4927(95)02634-A; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walsh V, 2003, BRADFORD BOOKS, P1; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	72	73	76	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8865	10.1371/journal.pone.0008865	http://dx.doi.org/10.1371/journal.pone.0008865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111608	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896300014
J	Sarig, R; Fuchs, O; Tencer, L; Panski, A; Nudel, U; Yaffe, D				Sarig, Rachel; Fuchs, Ora; Tencer, Lilach; Panski, Avi; Nudel, Uri; Yaffe, David			Cloned Myogenic Cells Can Transdifferentiate In Vivo into Neuron-Like Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; DIFFERENTIATION; TRANSPLANTATION; MARROW; PLURIPOTENCY; EXPRESSION; LINEAGES; PROMOTER; BRAIN	Background: The question of whether intact somatic cells committed to a specific differentiation fate, can be reprogrammed in vivo by exposing them to a different host microenvironment is a matter of controversy. Many reports on transdifferentiation could be explained by fusion with host cells or reflect intrinsic heterogeneity of the donor cell population. Methodology/Principal Findings: We have tested the capacity of cloned populations of mouse and human muscle progenitor cells, committed to the myogenic pathway, to transdifferentiate to neurons, following their inoculation into the developing brain of newborn mice. Both cell types migrated into various brain regions, and a fraction of them gained a neuronal morphology and expressed neuronal or glial markers. Likewise, inoculated cloned human myogenic cells expressed a human specific neurofilament protein. Brain injected donor cells that expressed a YFP transgene controlled by a neuronal specific promoter, were isolated by FACS. The isolated cells had a wild-type diploid DNA content. Conclusions: These and other results indicate a genuine transdifferentiation phenomenon induced by the host brain microenvironment and not by fusion with host cells. The results may potentially be relevant to the prospect of autologous cell therapy approach for CNS diseases.	[Sarig, Rachel; Fuchs, Ora; Tencer, Lilach; Nudel, Uri; Yaffe, David] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Panski, Avi] Kaplan Hosp, Dept Orthoped, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Kaplan Medical Center	Sarig, R (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	david.yaffe@weizmann.ac.il			Association Francaise Contre les Myopathies (AFM)	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	Supported by an Association Francaise Contre les Myopathies (AFM) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONI R, 2009, NEUROIMMUNOL, V215, P73; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; CARNEY RS, 2002, J NEUROSCI, V26, P11562; Comi AM, 2008, PEDIATR NEUROL, V38, P86, DOI 10.1016/j.pediatrneurol.2007.10.007; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; ERDO F, 2003, HOST DEPENDENT TUMOR; FENG G, 2000, NEURON, P141; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P8048, DOI 10.1073/pnas.1337135100; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; KONIGSBERG IR, 1963, SCIENCE, V140, P1273, DOI 10.1126/science.140.3573.1273; Krabbe C, 2005, APMIS, V113, P831, DOI 10.1111/j.1600-0463.2005.apm_3061.x; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Mignon L, 2005, J COMP NEUROL, V491, P96, DOI 10.1002/cne.20685; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 1999, J NEUROSCI, V19, P9986, DOI 10.1523/jneurosci.19-22-09986.1999; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; Sarig R, 2006, STEM CELLS, V24, P1769, DOI 10.1634/stemcells.2005-0547; Schultz SS, 2006, WOUND REPAIR REGEN, V14, P224, DOI 10.1111/j.1743-6109.2006.00114.x; Sigurjonsson OE, 2005, P NATL ACAD SCI USA, V102, P5227, DOI 10.1073/pnas.0501029102; Steffel J, 2003, STEM CELLS, V21, P181, DOI 10.1634/stemcells.21-2-181; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; Yaffe D, 1969, Curr Top Dev Biol, V4, P37, DOI 10.1016/S0070-2153(08)60480-9; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8814	10.1371/journal.pone.0008814	http://dx.doi.org/10.1371/journal.pone.0008814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098686	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100008
J	van Batenburg, MF; Li, HL; Polman, JA; Lachize, S; Datson, NA; Bussemaker, HJ; Meijer, OC				van Batenburg, Marinus F.; Li, Hualing; Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Bussemaker, Harmen J.; Meijer, Onno C.			Paired Hormone Response Elements Predict Caveolin-1 as a Glucocorticoid Target Gene	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DNA-BINDING; TRANSCRIPTIONAL SYNERGY; PLASMA-MEMBRANE; PROTEIN-BINDING; IN-VIVO; IDENTIFICATION; EXPRESSION; CELLS; SEQUENCE	Glucocorticoids act in part via glucocortocoid receptor binding to hormone response elements (HREs), but their direct target genes in vivo are still largely unknown. We developed the criterion that genomic occurrence of paired HREs at an inter-HRE distance less than 200 bp predicts hormone responsiveness, based on synergy of multiple HREs, and HRE information from known target genes. This criterion predicts a substantial number of novel responsive genes, when applied to genomic regions 10 kb upstream of genes. Multiple-tissue in situ hybridization showed that mRNA expression of 6 out of 10 selected genes was induced in a tissue-specific manner in mice treated with a single dose of corticosterone, with the spleen being the most responsive organ. Caveolin-1 was strongly responsive in several organs, and the HRE pair in its upstream region showed increased occupancy by glucocorticoid receptor in response to corticosterone. Our approach allowed for discovery of novel tissue specific glucocorticoid target genes, which may exemplify responses underlying the permissive actions of glucocorticoids.	[van Batenburg, Marinus F.] Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [van Batenburg, Marinus F.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Meijer, Onno C.] Leiden Amsterdam Ctr Drug Res, Div Med Pharmacol, Amsterdam, Netherlands; [Polman, J. Annelies; Lachize, Servane; Datson, Nicole A.; Meijer, Onno C.] Leiden Univ, Med Ctr, Amsterdam, Netherlands; [Li, Hualing] Nanjing Agr Univ, Life Sci Coll, Dept Biochem & Mol Biol, Nanjing, Peoples R China; [Li, Hualing] Yangzhou Univ, Coll Med, Dept Biochem & Mol Biol, Yangzhou, Peoples R China; [Bussemaker, Harmen J.] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; Columbia University; Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Nanjing Agricultural University; Yangzhou University; Columbia University	van Batenburg, MF (corresponding author), Univ Amsterdam, Acad Med Ctr, Bioinformat Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	o.meijer@lacdr.leidenuniv.nl	Datson, Nicole A./O-8797-2014; meijer, onno c/D-8070-2018	meijer, onno c/0000-0002-8394-6859; Datson, Nicole/0000-0003-2887-0238	Netherlands Organization for Scientific Research (NWO) [BMI-050.50.201, 050.71.404, 917.36.381]; Dutch Royal Academy of Arts and Sciences; NSFC of China [30370851, 30871461]; National Institutes of Health [R01HG003008, U54CA121852]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Royal Academy of Arts and Sciences; NSFC of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	M. F. v. B was supported by grants BMI-050.50.201 and 050.71.404 from the Netherlands Organization for Scientific Research (NWO). O. C. M. was supported by NWO VIDI grant 917.36.381, and the Dutch Royal Academy of Arts and Sciences. H. L was supported by grants 30370851, 30871461 from NSFC of China. H. J. B. was supported by National Institutes of Health grants R01HG003008 and U54CA121852. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Chandrasekhar S, 1999, AM J PHYSIOL-LUNG C, V276, pL319, DOI 10.1152/ajplung.1999.276.2.L319; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Datson NA, 2001, EUR J NEUROSCI, V14, P675, DOI 10.1046/j.0953-816x.2001.01685.x; DAYNES RA, 1990, J EXP MED, V171, P979, DOI 10.1084/jem.171.4.979; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; Gaudreault SB, 2004, NEUROBIOL AGING, V25, P753, DOI 10.1016/j.neurobiolaging.2003.07.004; Gershenzon NI, 2005, NUCLEIC ACIDS RES, V33, P2290, DOI 10.1093/nar/gki519; Geserick C, 2003, MOL ENDOCRINOL, V17, P1738, DOI 10.1210/me.2002-0379; Grenier J, 2004, MOL ENDOCRINOL, V18, P2866, DOI 10.1210/me.2004-0241; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; JEFFERIES WM, 1991, MED HYPOTHESES, V34, P198, DOI 10.1016/0306-9877(91)90212-H; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; Kel AE, 2001, J MOL BIOL, V309, P99, DOI 10.1006/jmbi.2001.4650; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Li L, 2003, P NATL ACAD SCI USA, V100, P4807, DOI 10.1073/PNAS.0831079100; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; LUND SD, 1991, MOL CELL BIOL, V11, P5426, DOI 10.1128/MCB.11.11.5426; Meijer OC, 2006, STRESS, V9, P61, DOI 10.1080/10253890600799669; Meijer OC, 2000, ENDOCRINOLOGY, V141, P2192, DOI 10.1210/en.141.6.2192; Meijer OC, 2005, ENDOCRINOLOGY, V146, P1438, DOI 10.1210/en.2004-0411; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; Razandi M, 2003, MOL CELL BIOL, V23, P1633, DOI 10.1128/MCB.23.5.1633-1646.2003; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; RHODES C, 1995, NUCLEIC ACIDS RES, V23, P2305, DOI 10.1093/nar/23.12.2305; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SALATINO M, 2006, ONCOGENE; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; SCHMID W, 1989, EMBO J, V8, P2257, DOI 10.1002/j.1460-2075.1989.tb08350.x; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; Tausk M., 1951, HORMON, V3, P1; Tonko M, 2001, FASEB J, V15, P693, DOI 10.1096/fj.00-0327com; VANDERLAAN S, 2008, J NEUROCHEM; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; WIEGERS GJ, 1994, ENDOCRINOLOGY, V135, P2351, DOI 10.1210/en.135.6.2351; Wu DQ, 2002, J BIOL CHEM, V277, P40449, DOI 10.1074/jbc.M206270200	48	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8839	10.1371/journal.pone.0008839	http://dx.doi.org/10.1371/journal.pone.0008839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098621	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100030
J	Hampton, M; Xu, WW; Kram, BW; Chambers, EM; Ehrnriter, JS; Gralewski, JH; Joyal, T; Carter, CJ				Hampton, Marshall; Xu, Wayne W.; Kram, Brian W.; Chambers, Emily M.; Ehrnriter, Jerad S.; Gralewski, Jonathan H.; Joyal, Teresa; Carter, Clay J.			Identification of Differential Gene Expression in Brassica rapa Nectaries through Expressed Sequence Tag Analysis	PLOS ONE			English	Article							ARABIDOPSIS; OLERACEA; ANATOMY	Background: Nectaries are the floral organs responsible for the synthesis and secretion of nectar. Despite their central roles in pollination biology, very little is understood about the molecular mechanisms underlying nectar production. This project was undertaken to identify genes potentially involved in mediating nectary form and function in Brassica rapa. Methodology and Principal Findings: Four cDNA libraries were created using RNA isolated from the median and lateral nectaries of B. rapa flowers, with one normalized and one non-normalized library being generated from each tissue. Approximately 3,000 clones from each library were randomly sequenced from the 5' end to generate a total of 11,101 high quality expressed sequence tags (ESTs). Sequence assembly of all ESTs together allowed the identification of 1,453 contigs and 4,403 singleton sequences, with the Basic Localized Alignment Search Tool ( BLAST) being used to identify 4,138 presumptive orthologs to Arabidopsis thaliana genes. Several genes differentially expressed between median and lateral nectaries were initially identified based upon the number of BLAST hits represented by independent ESTs, and later confirmed via reverse transcription polymerase chain reaction (RT PCR). RT PCR was also used to verify the expression patterns of eight putative orthologs to known Arabidopsis nectary-enriched genes. Conclusions/Significance: This work provided a snapshot of gene expression in actively secreting B. rapa nectaries, and also allowed the identification of differential gene expression between median and lateral nectaries. Moreover, 207 orthologs to known nectary-enriched genes from Arabidopsis were identified through this analysis. The results suggest that genes involved in nectar production are conserved amongst the Brassicaceae, and also supply clones and sequence information that can be used to probe nectary function in B. rapa.	[Hampton, Marshall] Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA; [Xu, Wayne W.] Univ Minnesota, Minnesota Supercomp Inst, Duluth, MN 55812 USA; [Kram, Brian W.; Chambers, Emily M.; Ehrnriter, Jerad S.; Gralewski, Jonathan H.; Joyal, Teresa; Carter, Clay J.] Univ Minnesota, Dept Biol, Duluth, MN 55812 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth	Hampton, M (corresponding author), Univ Minnesota, Dept Math & Stat, Duluth, MN 55812 USA.	cjcarter@d.umn.edu	xu, wayne/ABA-1961-2020	xu, wayne/0000-0003-0484-7340; Hampton, Marshall/0000-0002-9725-3316	United States Department of Agriculture [2006-35301-16887]; National Science Foundation [0820730]	United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the United States Department of Agriculture (www.csrees.usda.gov; 2006-35301-16887 to CJC) and the National Science Foundation (www.nsf.gov; 0820730 to CJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderle P, 2003, BIOTECHNIQUES, P36; BAKER H G, 1978, P57; Bernardello G., 2007, NECTARIES NECTAR, P129; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Carter C, 2006, NATURWISSENSCHAFTEN, V93, P72, DOI 10.1007/s00114-005-0062-1; Davis AR, 1998, PLANTA, V205, P305, DOI 10.1007/s004250050325; Davis AR, 1996, ANN BOT-LONDON, V77, P223, DOI 10.1006/anbo.1996.0026; DAVIS AR, 1986, CAN J BOT, V64, P2508, DOI 10.1139/b86-333; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; Fahn A., 1979, SECRETORY TISSUES PL; Kram BW, 2009, SEX PLANT REPROD, V22, P235, DOI 10.1007/s00497-009-0112-5; Kram BW, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-92; Mckim SM, 2008, DEVELOPMENT, V135, P1537, DOI 10.1242/dev.012807; Monaghan JR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-1; Mun JH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r111; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; Nicolson S.W., 2007, NECTARIES NECTAR; NIEUWHOF M, 1963, EUPHYTICA, V12, P17, DOI 10.1007/BF00022355; NIEUWHOF M, 1969, COLE CROPS; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; RUHLMANN JM, 2009, J EXP BOT; Simpson B.B., 1983, P142; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Soares Marcelo Bento, 2009, V533, P109, DOI 10.1007/978-1-60327-136-3_6; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; TAIR9 PROTEIN BLAST	27	22	24	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8782	10.1371/journal.pone.0008782	http://dx.doi.org/10.1371/journal.pone.0008782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098697	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000011
J	Sanchez, MS; Lloyd-Smith, JO; Getz, WM				Sanchez, Maria S.; Lloyd-Smith, James O.; Getz, Wayne M.			Monitoring Linked Epidemics: The Case of Tuberculosis and HIV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AFRICAN GOLD MINERS; INFECTION; IMPACT; PREVALENCE; STRAINS; EXAMPLE; MODELS; RISK; NEED	Background: The tight epidemiological coupling between HIV and its associated opportunistic infections leads to challenges and opportunities for disease surveillance. Methodology/Principal Findings: We review efforts of WHO and collaborating agencies to track and fight the TB/HIV coepidemic, and discuss modeling-via mathematical, statistical, and computational approaches-as a means to identify disease indicators designed to integrate data from linked diseases in order to characterize how co-epidemics change in time and space. We present RTB/HIV, an index comparing changes in TB incidence relative to HIV prevalence, and use it to identify those sub-Saharan African countries with outlier TB/HIV dynamics. RTB/HIV can also be used to predict epidemiological trends, investigate the coherency of reported trends, and cross-check the anticipated impact of public health interventions. Identifying the cause(s) responsible for anomalous RTB/HIV values can reveal information crucial to the management of public health. Conclusions/Significance: We frame our suggestions for integrating and analyzing co-epidemic data within the context of global disease monitoring. Used routinely, joint disease indicators such as RTB/HIV could greatly enhance the monitoring and evaluation of public health programs.	[Sanchez, Maria S.; Getz, Wayne M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Sanchez, MS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	mssanchezgm1@gmail.com	Lloyd-Smith, James/AAG-4463-2021; /K-4080-2012; Getz, Wayne/I-4521-2013	/0000-0001-7941-502X; Getz, Wayne/0000-0001-8784-9354	National Institutes of Health [R01 DA013510-05]; National Science Foundation [DEB-0090323]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (2000-2006 NIH/NIDA R01 DA013510-05) and National Science Foundation (DEB-0090323) to WMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; [Anonymous], GUID PREV TUB HLTH C; [Anonymous], 2009, TB HIV FACTS 2009; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Brooks JT, 2009, CLIN INFECT DIS, V48, P609, DOI 10.1086/596756; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Caribbean Epidemiology Centre, 2002, GUID UPGR HIV AIDS S; Chan K., 2000, SENSITIVITY ANAL; Cohen T, 2006, P NATL ACAD SCI USA, V103, P7042, DOI 10.1073/pnas.0600349103; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; ESCOMBE AR, 2009, 5036 WHO WC; GANDHI NR, 2009, AM J RESP CRIT  1015; Kettenring KM, 2006, BIOSCIENCE, V56, P59, DOI 10.1641/0006-3568(2006)056[0059:GPFSEM]2.0.CO;2; Lalloo Umesh G, 2008, Curr HIV/AIDS Rep, V5, P132, DOI 10.1007/s11904-008-0021-5; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lifson AR, 2008, HIV CLIN TRIALS, V9, P177, DOI 10.1310/hct0903-177; Lloyd-Smith JO, 2008, PARASITOLOGY, V135, P795, DOI 10.1017/S0031182008000292; Mansoer J, 2009, B WORLD HEALTH ORGAN, V87, P186, DOI 10.2471/BLT.08.051474; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; RIEDNER G, 1999, HIV AIDS SURVEILLANC; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Sanchez MS, 2008, AIDS, V22, P963, DOI 10.1097/QAD.0b013e3282f7cb4b; Sanchez MS, 2009, EPIDEMICS-NETH, V1, P14, DOI 10.1016/j.epidem.2008.08.001; Sanchez MS, 2006, EMERG INFECT DIS, V12, P191; Sanchez MS, 2005, B MATH BIOL, V67, P761, DOI 10.1016/j.bulm.2004.10.001; Sonnenberg P, 2005, J INFECT DIS, V191, P150, DOI 10.1086/426827; Suchindran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005561; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS, 2006, UNAIDS ANN REP 2006; *WHO, 2002, STRAT FRAM DECR BURD; *WHO, 2006, GLOB TUB CONTR SURV; WHO, 2005, TB HIV RES PRIOR RES; WHO, 2007, TUB CAR TB HIV COM; WHO, 2004, INT POL COLL TB HIV; *WHO, 2004, GUID MON EV COLL TB; WHO, 2007, IMPR DIAGN TREATM SM; WHO, 2009, WHOHTMTB2009411; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wilson DP, 2006, P NATL ACAD SCI USA, V103, P14228, DOI 10.1073/pnas.0509689103; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2003, GUID IMPL COLL TB HI; World Health Organization, 2004, GUID HIV SURV TUB PA; World Health Organization, 2007, NETW POL CHANG TB HI; World Health Organization, 2007, GLOB MDR TB XDR TB R; World Health Organization, 2006, WHO GLOB TB DAT	50	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8796	10.1371/journal.pone.0008796	http://dx.doi.org/10.1371/journal.pone.0008796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098716	Green Published, gold			2022-12-27	WOS:000273779000023
J	Bellone, M; Ceccon, M; Grioni, M; Jachetti, E; Calcinotto, A; Napolitano, A; Freschi, M; Casorati, G; Dellabona, P				Bellone, Matteo; Ceccon, Monica; Grioni, Matteo; Jachetti, Elena; Calcinotto, Arianna; Napolitano, Anna; Freschi, Massimo; Casorati, Giulia; Dellabona, Paolo			iNKT Cells Control Mouse Spontaneous Carcinoma Independently of Tumor-Specific Cytotoxic T Cells	PLOS ONE			English	Article							INVARIANT NKT CELLS; PROSTATE-CANCER; TRANSGENIC ADENOCARCINOMA; ALPHA-GALACTOSYLCERAMIDE; IMMUNE-RESPONSE; DENDRITIC CELLS; ANTITUMOR IMMUNITY; ANTIGEN; MICE; TOLERANCE	Background: CD1d-restricted invariant NKT (iNKT) cells are a subset of T lymphocytes endowed with innate effector functions that aid in the establishment of adaptive T and B cell immune responses. iNKT cells have been shown to play a spontaneous protective role against experimental tumors. Yet, the interplay between iNKT and tumor-specific T cells in cancer immune surveillance/editing has never been addressed. The transgenic adenocarcinoma of the mouse prostate (TRAMP) is a realistic model of spontaneous oncogenesis, in which the tumor-specific cytotoxic T cell (CTL) response undergoes full tolerance upon disease progression. Principal Findings: We report here that lack of iNKT cells in TRAMP mice resulted in the appearance of more precocious and aggressive tumors that significantly reduced animal survival. TRAMP mice bearing or lacking iNKT cells responded similarly to a tumor-specific vaccination and developed tolerance to a tumor-associated antigen at comparable rate. Conclusions: Hence, our data argue for a critical role of iNKT cells in the immune surveillance of carcinoma that is independent of tumor-specific CTL.	[Bellone, Matteo; Ceccon, Monica; Grioni, Matteo; Jachetti, Elena; Calcinotto, Arianna] Ist Sci San Raffaele, Cellular Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Napolitano, Anna; Casorati, Giulia; Dellabona, Paolo] Ist Sci San Raffaele, Expt Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy; [Freschi, Massimo] Ist Sci San Raffaele, Unita Operat Anat Patol, Milan, Italy; [Jachetti, Elena; Napolitano, Anna] Univ Vita Salute San Raffaele, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Bellone, M (corresponding author), Ist Sci San Raffaele, Cellular Immunol Unit, Div Immunol Transplantat & Infect Dis, Milan, Italy.	bellone.matteo@hsr.it; casorati.giulia@hsr.it; paolo.dellabona@hsr.it	Bellone, Matteo/B-6922-2013; Dellabona, Paolo/G-5416-2012; Matteo, Grioni/AAN-5912-2020; Jachetti, Elena/C-2145-2017; Casorati, Giulia/J-7141-2018	Bellone, Matteo/0000-0002-2586-2569; Dellabona, Paolo/0000-0002-1414-633X; Matteo, Grioni/0000-0002-9930-042X; Jachetti, Elena/0000-0001-6483-7350; Calcinotto, Arianna/0000-0003-1746-6424; Casorati, Giulia/0000-0002-5102-4112; Napolitano, Anna/0000-0001-8946-8002	Associazione Italiana per la Ricerca sul Cancro; Ministero del lavoro, della salute e delle politiche sociali; Fondazione CARIPLO; Association for International Cancer Research	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero del lavoro, della salute e delle politiche sociali(Ministry of Health, Italy); Fondazione CARIPLO(Fondazione Cariplo); Association for International Cancer Research	ssociazione Italiana per la Ricerca sul Cancro: www.airc.it Ministero del lavoro, della salute e delle politiche sociali:www.ministerosalute.it/ Fondazione CARIPLO: fondazionecariplo.it Association for International Cancer Research: www.aicr.org.uk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BERTILACCIO S, 2008, PROSTATE        0424; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Camporeale A, 2003, CANCER RES, V63, P3688; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chiaverotti T, 2008, AM J PATHOL, V172, P236, DOI 10.2353/ajpath.2008.070602; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; De Santo C, 2008, J CLIN INVEST, V118, P4036, DOI 10.1172/JCI36264; Degl'Innocenti E, 2005, EUR J IMMUNOL, V35, P66, DOI 10.1002/eji.200425531; Degl'Innocenti E, 2008, CANCER RES, V68, P292, DOI 10.1158/0008-5472.CAN-07-2429; DELLABONA P, 1994, J EXP MED, V180, P1171, DOI 10.1084/jem.180.3.1171; Dhodapkar KM, 2004, INT J CANCER, V109, P893, DOI 10.1002/ijc.20050; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Drake CG, 2005, CANCER CELL, V7, P239, DOI 10.1016/j.ccr.2005.01.027; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fedeli M, 2009, J IMMUNOL, V183, P2506, DOI 10.4049/jimmunol.0901361; Fiedler T, 2002, INT J CANCER, V98, P389, DOI 10.1002/ijc.10141; Foster BA, 1997, CANCER RES, V57, P3325; Fujii S, 2003, J EXP MED, V198, P267, DOI 10.1084/jem.20030324; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hayakawa Y, 2003, P NATL ACAD SCI USA, V100, P9464, DOI 10.1073/pnas.1630663100; Iezzi G, 2006, J IMMUNOL, V177, P2131, DOI 10.4049/jimmunol.177.4.2131; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Metelitsa LS, 2003, LEUKEMIA, V17, P1068, DOI 10.1038/sj.leu.2402943; Miller AM, 2007, CANCER IMMUNOL IMMUN, V56, P81, DOI 10.1007/s00262-005-0110-x; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; Mylin LM, 2000, J VIROL, V74, P6922, DOI 10.1128/JVI.74.15.6922-6934.2000; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Song LP, 2009, J CLIN INVEST, V119, P1524, DOI 10.1172/JCI37869; Swann J, 2004, IMMUNOL CELL BIOL, V82, P323, DOI 10.1111/j.1440-1711.2004.01254.x; SWANN JB, 2009, BLOOD           0220; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; TANAKA Y, 1988, J IMMUNOL, V140, P4348; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Terabe M, 2007, TRENDS IMMUNOL, V28, P491, DOI 10.1016/j.it.2007.05.008; Tonti E, 2009, BLOOD, V113, P370, DOI 10.1182/blood-2008-06-166249; Yanagisawa K, 2006, CANCER RES, V66, P11441, DOI 10.1158/0008-5472.CAN-06-0944; Zheng XC, 2002, J IMMUNOL, V169, P4761, DOI 10.4049/jimmunol.169.9.4761	52	54	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8646	10.1371/journal.pone.0008646	http://dx.doi.org/10.1371/journal.pone.0008646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072624	Green Submitted, Green Published, gold			2022-12-27	WOS:000273554600009
J	Diallo, A; Kane, N; Agharbaoui, Z; Badawi, M; Sarhan, F				Diallo, Amadou; Kane, Ndjido; Agharbaoui, Zahra; Badawi, Mohamed; Sarhan, Fathey			Heterologous Expression of Wheat VERNALIZATION 2 (TaVRN2) Gene in Arabidopsis Delays Flowering and Enhances Freezing Tolerance	PLOS ONE			English	Article							MADS BOX GENE; MAJOR DETERMINANT; LOW-TEMPERATURE; LOCUS; TIME; PHOTOPERIOD; REPRESSOR; WINTER; TRANSCRIPTION; CONSERVATION	The vernalization gene 2 (VRN2), is a major flowering repressor in temperate cereals that is regulated by low temperature and photoperiod. Here we show that the gene from Triticum aestivum (TaVRN2) is also regulated by salt, heat shock, dehydration, wounding and abscissic acid. Promoter analysis indicates that TaVRN2 regulatory region possesses all the specific responsive elements to these stresses. This suggests pleiotropic effects of TaVRN2 in wheat development and adaptability to the environment. To test if TaVRN2 can act as a flowering repressor in species different from the temperate cereals, the gene was ectopically expressed in the model plant Arabidopsis. Transgenic plants showed no alteration in morphology, but their flowering time was significantly delayed compared to controls plants, indicating that TaVRN2, although having no ortholog in Brassicaceae, can act as a flowering repressor in these species. To identify the possible mechanism by which TaVRN2 gene delays flowering in Arabidopsis, the expression level of several genes involved in flowering time regulation was determined. The analysis indicates that the late flowering of the 35S::TaVRN2 plants was associated with a complex pattern of expression of the major flowering control genes, FCA, FLC, FT, FVE and SOC1. This suggests that heterologous expression of TaVRN2 in Arabidopsis can delay flowering by modulating several floral inductive pathways. Furthermore, transgenic plants showed higher freezing tolerance, likely due to the accumulation of CBF2, CBF3 and the COR genes. Overall, our data suggests that TaVRN2 gene could modulate a common regulator of the two interacting pathways that regulate flowering time and the induction of cold tolerance. The results also demonstrate that TaVRN2 could be used to manipulate flowering time and improve cold tolerance in other species.	[Diallo, Amadou; Kane, Ndjido; Agharbaoui, Zahra; Badawi, Mohamed; Sarhan, Fathey] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	University of Quebec; University of Quebec Montreal	Diallo, A (corresponding author), Univ Quebec, Dept Sci Biol, CP 8888, Montreal, PQ H3C 3P8, Canada.	sarhan.fathey@uqam.ca	Kane, Ndjido Ardo/AAM-7656-2020	Kane, Ndjido Ardo/0000-0002-1879-019X	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a Natural Sciences and Engineering Research Council of Canada discovery grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H, 2007, PLANT CELL PHYSIOL, V48, P1192, DOI 10.1093/pcp/pcm089; Allaby RC, 1999, GENOME, V42, P296, DOI 10.1139/gen-42-2-296; Charron JBF, 2005, PLANT PHYSIOL, V139, P2017, DOI 10.1104/pp.105.070466; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Distelfeld A, 2009, PLANT PHYSIOL, V149, P245, DOI 10.1104/pp.108.129353; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Fowler DB, 2001, PLANT PHYSIOL, V127, P1676, DOI 10.1104/pp.010483; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Geraldo N, 2009, PLANT PHYSIOL, V150, P1611, DOI 10.1104/pp.109.137448; Hecht V, 2005, PLANT PHYSIOL, V137, P1420, DOI 10.1104/pp.104.057018; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Henderson IR, 2003, ANNU REV GENET, V37, P371, DOI 10.1146/annurev.genet.37.110801.142640; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Kane NA, 2005, PLANT PHYSIOL, V138, P2354, DOI 10.1104/pp.105.061762; Kane NA, 2007, PLANT J, V51, P670, DOI 10.1111/j.1365-313X.2007.03172.x; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KOORNNEEF M, 1994, PLANT J, V6, P911, DOI 10.1046/j.1365-313X.1994.6060911.x; Lee JH, 2005, PLANT MOL BIOL, V58, P823, DOI 10.1007/s11103-005-8105-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2003, P NATL ACAD SCI USA, V100, P10102, DOI 10.1073/pnas.1531467100; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; PUGSLEY AT, 1972, EUPHYTICA, V21, P547, DOI 10.1007/BF00039355; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Szucs P, 2007, MOL GENET GENOMICS, V277, P249, DOI 10.1007/s00438-006-0195-8; Tadege M, 2003, PLANT BIOTECHNOL J, V1, P361, DOI 10.1046/j.1467-7652.2003.00034.x; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	37	14	16	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8690	10.1371/journal.pone.0008690	http://dx.doi.org/10.1371/journal.pone.0008690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084169	Green Submitted, Green Published, gold			2022-12-27	WOS:000273554600038
J	Wallace, WHB; Kelsey, TW				Wallace, W. Hamish B.; Kelsey, Thomas W.			Human Ovarian Reserve from Conception to the Menopause	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ADULT MAMMALIAN OVARIES; GERMLINE STEM-CELLS; AGE; WOMEN; FOLLICLES; FAILURE; DECLINE; OOCYTE; NUMBER	The human ovary contains a fixed number of non-growing follicles (NGFs) established before birth that decline with increasing age culminating in the menopause at 50-51 years. The objective of this study is to model the age-related population of NGFs in the human ovary from conception to menopause. Data were taken from eight separate quantitative histological studies (n = 325) in which NGF populations at known ages from seven weeks post conception to 51 years ( median 32 years) were calculated. The data set was fitted to 20 peak function models, with the results ranked by obtained r(2) correlation coefficient. The highest ranked model was chosen. Our model matches the log-adjusted NGF population from conception to menopause to a five-parameter asymmetric double Gaussian cumulative (ADC) curve (r(2) = 0.81). When restricted to ages up to 25 years, the ADC curve has r(2) = 0.95. We estimate that for 95% of women by the age of 30 years only 12% of their maximum pre-birth NGF population is present and by the age of 40 years only 3% remains. Furthermore, we found that the rate of NGF recruitment towards maturation for most women increases from birth until approximately age 14 years then decreases towards the menopause. To our knowledge, this is the first model of ovarian reserve from conception to menopause. This model allows us to estimate the number of NGFs present in the ovary at any given age, suggests that 81% of the variance in NGF populations is due to age alone, and shows for the first time, to our knowledge, that the rate of NGF recruitment increases from birth to age 14 years then declines with age until menopause. An increased understanding of the dynamics of human ovarian reserve will provide a more scientific basis for fertility counselling for both healthy women and those who have survived gonadotoxic cancer treatments.	[Wallace, W. Hamish B.] Univ Edinburgh, Dept Reprod & Dev Sci, Div Child Life & Hlth, Edinburgh, Midlothian, Scotland; [Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews, Fife, Scotland	University of Edinburgh; University of St Andrews	Wallace, WHB (corresponding author), Univ Edinburgh, Dept Reprod & Dev Sci, Div Child Life & Hlth, Edinburgh, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; wallace, william, hamish/0000-0001-8080-5674	United Kingdom Engineering and Physical Sciences Research Council (EPSRC) [EP/CS23229/1, EP/H004092/1]; EPSRC [EP/H004092/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004092/1, EP/C523229/1] Funding Source: researchfish	United Kingdom Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TWK is supported by United Kingdom Engineering and Physical Sciences Research Council (EPSRC) grants EP/CS23229/1 and EP/H004092/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER TG, 1963, PROC R SOC SER B-BIO, V158, P417, DOI 10.1098/rspb.1963.0055; Bendsen E, 2006, HUM REPROD, V21, P30, DOI 10.1093/humrep/dei280; BLOCK E, 1953, ACTA ANAT, V17, P201; BLOCK E, 1952, ACTA ANAT, V14, P108; BRETHERICK KL, 2009, FERTILITY S IN PRESS; Brett S, 2009, REPROD BIOMED ONLINE, V18, P348, DOI 10.1016/S1472-6483(10)60092-2; Broekmans FJ, 2008, TRENDS ENDOCRIN MET, V19, P340, DOI 10.1016/j.tem.2008.08.002; Faddy MJ, 1996, HUM REPROD, V11, P1484; FADDY MJ, 1992, HUM REPROD, V7, P1342, DOI 10.1093/oxfordjournals.humrep.a137570; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; GOUGEON A, 1987, J REPROD FERTIL, V81, P433; Guibourdenche J, 2003, MOL CELL ENDOCRINOL, V211, P55, DOI 10.1016/j.mce.2003.09.011; Hansen KR, 2008, HUM REPROD, V23, P699, DOI 10.1093/humrep/dem408; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; JOSSO N, 1993, EARLY HUM DEV, V33, P91, DOI 10.1016/0378-3782(93)90204-8; Knauff EAH, 2009, J CLIN ENDOCR METAB, V94, P786, DOI 10.1210/jc.2008-1818; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; RICHARDSON SJ, 1987, J CLIN ENDOCR METAB, V65, P1231, DOI 10.1210/jcem-65-6-1231; Telfer EE, 2005, CELL, V122, P821, DOI 10.1016/j.cell.2005.09.004; Tilly JL, 2009, MOL HUM REPROD, V15, P393, DOI 10.1093/molehr/gap036; Wallace WH, 2004, HUM REPROD, V19, P1612, DOI 10.1093/humrep/deh285; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Wallace WHB, 2005, LANCET ONCOL, V6, P209, DOI 10.1016/S1470-2045(05)70092-9; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; YOUNIS JS, 2009, FERTILITY S IN PRESS; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	28	422	443	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8772	10.1371/journal.pone.0008772	http://dx.doi.org/10.1371/journal.pone.0008772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111701	gold, Green Published, Green Submitted			2022-12-27	WOS:000274114800003
J	Marinach-Patrice, C; Fekkar, A; Atanasova, R; Gomes, J; Djamdjian, L; Brossas, JY; Meyer, I; Buffet, P; Snounou, G; Datry, A; Hennequin, C; Golmard, JL; Mazier, D				Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Djamdjian, Laura; Brossas, Jean-Yves; Meyer, Isabelle; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Golmard, Jean-Louis; Mazier, Dominique			Rapid Species Diagnosis for Invasive Candidiasis Using Mass Spectrometry	PLOS ONE			English	Article							IDENTIFICATION; CANDIDEMIA; REVOLUTION; PATHOGENS	Background: Matrix-assisted laser desorption ionisation time of flight mass spectrometry (MALDI TOF-MS) allows the identification of most bacteria and an increasing number of fungi. The potential for the highest clinical benefit of such methods would be in severe acute infections that require prompt treatment adapted to the infecting species. Our objective was to determine whether yeasts could be identified directly from a positive blood culture, avoiding the 1-3 days subculture step currently required before any therapeutic adjustments can be made. Methodology/Principal Findings: Using human blood spiked with Candida albicans to simulate blood cultures, we optimized protocols to obtain MALDI TOF-MS fingerprints where signals from blood proteins are reduced. Simulated cultures elaborated using a set of 12 strains belonging to 6 different species were then tested. Quantifiable spectral differences in the 5000-7400 Da mass range allowed to discriminate between these species and to build a reference database. The validation of the method and the statistical approach to spectral analysis were conducted using individual simulated blood cultures of 36 additional strains (six for each species). Correct identification of the species of these strains was obtained. Conclusions/Significance: Direct MALDI TOF-MS analysis of aliquots from positive blood cultures allowed rapid and accurate identification of the main Candida species, thus obviating the need for sub-culturing on specific media. Subsequent to this proof-of-principle demonstration, the method can be extended to other clinically relevant yeast species, and applied to an adequate number of clinical samples in order to establish its potential to improve antimicrobial management of patients with fungemia.	[Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Brossas, Jean-Yves; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Mazier, Dominique] INSERM, U945, Paris, France; [Marinach-Patrice, Carine; Fekkar, Arnaud; Atanasova, Ralitsa; Gomes, Johanna; Brossas, Jean-Yves; Buffet, Pierre; Snounou, Georges; Datry, Annick; Hennequin, Christophe; Mazier, Dominique] Univ Paris 06, UMR S945, Paris, France; [Fekkar, Arnaud; Djamdjian, Laura; Meyer, Isabelle; Buffet, Pierre; Datry, Annick; Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Brossas, Jean-Yves] Grp Hosp Pitie Salpetriere, Ctr Invest Biomed, F-75634 Paris, France; [Snounou, Georges] Natl Univ Singapore, Fac Med, Dept Microbiol, Lab Mol & Cellular Parasitol, Singapore 117548, Singapore; [Hennequin, Christophe] Hop St Antoine, AP HP, Serv Parasitol Mycol, F-75571 Paris, France; [Golmard, Jean-Louis] Univ Paris 06, EA 3974, ER4, Modelisat Rech Clin, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; National University of Singapore; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Marinach-Patrice, C (corresponding author), INSERM, U945, Paris, France.	dominique.mazier@upmc.fr	Snounou, Georges/F-3352-2011; Fekkar, Arnaud/P-2803-2017; Buffet, Pierre A/O-6189-2017; Hennequin, Christophe/AAF-2755-2021	Snounou, Georges/0000-0002-6133-6398; Buffet, Pierre A/0000-0003-4010-929X; Hennequin, Christophe/0000-0002-4528-927X	INSERM; UPMC, France	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC, France	The study was supported by the INSERM and UPMC, France. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Fernandez J, 2009, DIAGN MICR INFEC DIS, V64, P402, DOI 10.1016/j.diagmicrobio.2009.04.002; Gherna M, 2009, J CLIN MICROBIOL, V47, P247, DOI 10.1128/JCM.01241-08; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Lau A, 2008, J CLIN MICROBIOL, V46, P3021, DOI 10.1128/JCM.00689-08; Marinach C, 2009, PROTEOMICS, V9, P4627, DOI 10.1002/pmic.200900152; MARINACHPATRICE C, 2009, CLIN MICROBIOL INFEC; MARKLEIN G, 2009, J CLIN MICROBIOL; Nassif X, 2009, CLIN INFECT DIS, V49, P552, DOI 10.1086/600886; Pappas PG, 2007, CLIN INFECT DIS, V45, P883, DOI 10.1086/520980; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Petersen Catherine E., 2009, V492, P367, DOI 10.1007/978-1-59745-493-3_22; Qian J, 2008, ANAL BIOANAL CHEM, V392, P439, DOI 10.1007/s00216-008-2288-1; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Tortorano AM, 2004, EUR J CLIN MICROBIOL, V23, P317, DOI 10.1007/s10096-004-1103-y	15	71	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8862	10.1371/journal.pone.0008862	http://dx.doi.org/10.1371/journal.pone.0008862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111603	Green Submitted, gold, Green Published			2022-12-27	WOS:000273896300012
J	Conway, JO; Sherwood, LJ; Collazo, MT; Garza, JA; Hayhurst, A				Conway, Jerry O.; Sherwood, Laura J.; Collazo, M. Thelma; Garza, John A.; Hayhurst, Andrew			Llama Single Domain Antibodies Specific for the 7 Botulinum Neurotoxin Serotypes as Heptaplex Immunoreagents	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; IMMUNOLOGICAL CHARACTERIZATION; IMMUNE-RESPONSE; BINDING DOMAIN; A NEUROTOXIN; TOXIN; FRAGMENTS; CHAIN; SEQUENCE; COMPLEX	Background: There are currently 7 known serotypes of botulinum neurotoxin (BoNT) classified upon non-cross reactivity of neutralizing immunoglobulins. Non-neutralizing immunoglobulins, however, can exhibit cross-reactivities between 2 or more serotypes, particularly mosaic forms, which can hamper the development of highly specific immunoassays, especially if based on polyclonal antisera. Here we employ facile recombinant antibody technology to subtractively select ligands to each of the 7 BoNT serotypes, resulting in populations with very high specificity for their intended serotype. Methods and Findings: A single llama was immunized with a cocktail of 7 BoNT toxoids to generate a phage display library of single domain antibodies (sdAb, VHH or nanobodies) which were selected on live toxins. Resulting sdAb were capable of detecting both toxin and toxin complex with the best combinations able to detect 100s-10s of pg per 50 mu L sample in a liquid bead array. The most sensitive sdAb were combined in a heptaplex assay to identify each of the BoNT serotypes in buffer and milk and to a lesser extent in carrot juice, orange juice and cola. Several anti-A(1) sdAb recognized A2 complex, showing that subtype cross-reactivity within a serotype was evident. Many of our sdAb could act as both captor and tracer for several toxin and toxin complexes suggesting sdAb can be used as architectural probes to indicate BoNT oligomerisation. Six of 14 anti-A clones exhibited inhibition of SNAP-25 cleavage in the neuro-2A assay indicating some sdAb had toxin neutralizing capabilities. Many sdAb were also shown to be refoldable after exposure to high temperatures in contrast to polyclonal antisera, as monitored by circular dichroism. Conclusions: Our panel of molecularly flexible antibodies should not only serve as a good starting point for ruggedizing assays and inhibitors, but enable the intricate architectures of BoNT toxins and complexes to be probed more extensively.	[Conway, Jerry O.; Sherwood, Laura J.; Collazo, M. Thelma; Garza, John A.; Hayhurst, Andrew] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA	Texas Biomedical Research Institute	Conway, JO (corresponding author), SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA.	ahayhurst@sfbr.org		Hayhurst, Andrew/0000-0003-4612-8707	Defense Threat Reduction Agency (DTRA) [HDTRA 1-07-C-0018]; National Institutes of Health (NIH) [C06 RR12087]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012087] Funding Source: NIH RePORTER	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Defense Threat Reduction Agency (DTRA) Medical Program (HDTRA 1-07-C-0018) and National Institutes of Health (NIH) construction grant C06 RR12087. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SFBR is a non-profit organization devoted to improving global human health through innovative biomedical research.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Amersdorfer P, 2002, VACCINE, V20, P1640, DOI 10.1016/S0264-410X(01)00482-0; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Bagramyan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002041; Baldwin MR, 2008, INFECT IMMUN, V76, P1314, DOI 10.1128/IAI.01025-07; Baldwin MR, 2005, INFECT IMMUN, V73, P6998, DOI 10.1128/IAI.73.10.6998-7005.2005; Binz T, 2009, J NEUROCHEM, V109, P1584, DOI 10.1111/j.1471-4159.2009.06093.x; Carter AT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-115; Chames Patrick, 2002, Methods Mol Biol, V178, P147; Chen F, 1998, INFECT IMMUN, V66, P2420, DOI 10.1128/IAI.66.6.2420-2425.1998; Chen F, 1997, INFECT IMMUN, V65, P1626, DOI 10.1128/IAI.65.5.1626-1630.1997; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Curran RM, 2009, VET IMMUNOL IMMUNOP, V130, P1, DOI 10.1016/j.vetimm.2008.11.018; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; Dertzbaugh MT, 1996, VACCINE, V14, P1538, DOI 10.1016/S0264-410X(96)00094-1; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; FRANZ DR, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P473; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; GIMENEZ DF, 1993, BOTULINUM AND TETANUS NEUROTOXINS, P421; Goldman ER, 2008, ANAL CHEM, V80, P8583, DOI 10.1021/ac8014774; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Goodnough MC, 2002, FEBS LETT, V513, P163, DOI 10.1016/S0014-5793(02)02268-8; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; HARMSEN MM, 2006, APPL MICROBIOL BIOT, P1; Hasegawa K, 2004, PROTEIN J, V23, P371, DOI 10.1023/B:JOPC.0000039551.42676.4c; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; HERRERO BA, 1967, EXP MOL PATHOL, V6, P84, DOI 10.1016/0014-4800(67)90007-X; Hines HB, 2008, APPL ENVIRON MICROB, V74, P653, DOI 10.1128/AEM.01690-07; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Jacobson MJ, 2008, APPL ENVIRON MICROB, V74, P2778, DOI 10.1128/AEM.02828-07; Jones RGA, 2008, J IMMUNOL METHODS, V337, P42, DOI 10.1016/j.jim.2008.05.009; Kalb SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005355; KASTELIC D, 2009, J IMMUNOL METHODS; Keller JE, 2008, CLIN VACCINE IMMUNOL, V15, P1374, DOI 10.1128/CVI.00117-08; Kiyatkin N, 1997, INFECT IMMUN, V65, P4586, DOI 10.1128/IAI.65.11.4586-4591.1997; Korotkov KV, 2009, STRUCTURE, V17, P255, DOI 10.1016/j.str.2008.11.011; KOZAKI S, 1991, INFECT IMMUN, V59, P457, DOI 10.1128/IAI.59.1.457-459.1991; Lacy DB, 1999, J MOL BIOL, V291, P1091, DOI 10.1006/jmbi.1999.2945; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; LAMANNA C, 1959, SCIENCE, V130, P763, DOI 10.1126/science.130.3378.763; LEDOUX DN, 1994, TOXICON, V32, P1095, DOI 10.1016/0041-0101(94)90393-X; Lee MS, 2008, HYBRIDOMA, V27, P18, DOI 10.1089/hyb.2007.0532; Marks James D, 2004, Anesthesiol Clin North Am, V22, P509, DOI 10.1016/j.atc.2004.05.010; Min D, 2004, P NATL ACAD SCI USA, V101, P14701, DOI 10.1073/pnas.0404107101; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; NEU HC, 1965, J BIOL CHEM, V240, P3685; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; OGUMA K, 1980, INFECT IMMUN, V30, P656; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pier CL, 2008, INFECT IMMUN, V76, P437, DOI 10.1128/IAI.00843-07; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; SAKAGUCHI G, 1982, PHARMACOL THERAPEUT, V19, P165, DOI 10.1016/0163-7258(82)90061-4; SCOTT AB, 1988, MOVEMENT DISORD, V3, P333, DOI 10.1002/mds.870030409; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; Sherwood LJ, 2007, J INFECT DIS, V196, pS213, DOI 10.1086/520586; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; SINGH BR, 1995, J PROTEIN CHEM, V14, P7, DOI 10.1007/BF01902839; SINGH BR, 1990, BIOPHYS CHEM, V38, P123, DOI 10.1016/0301-4622(90)80047-B; SINGH BR, 1989, TOXICON, V27, P403, DOI 10.1016/0041-0101(89)90202-X; Singh BR, 1996, TOXICON, V34, P267, DOI 10.1016/0041-0101(95)00113-1; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; SONNABEND OAR, 1985, LANCET, V1, P237; Stahl C, 2009, VACCINE, V27, P5661, DOI 10.1016/j.vaccine.2009.07.021; Tanha J, 2002, J IMMUNOL METHODS, V263, P97, DOI 10.1016/S0022-1759(02)00027-3; THOMPSON DE, 1993, FEMS MICROBIOL LETT, V108, P175, DOI 10.1111/j.1574-6968.1993.tb06095.x; TSUZUKI K, 1988, INFECT IMMUN, V56, P898, DOI 10.1128/IAI.56.4.898-902.1988; van der Linden R, 2000, J IMMUNOL METHODS, V240, P185, DOI 10.1016/S0022-1759(00)00188-5; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Webb RP, 2007, VACCINE, V25, P4273, DOI 10.1016/j.vaccine.2007.02.081; Webb RP, 2009, VACCINE, V27, P4490, DOI 10.1016/j.vaccine.2009.05.030; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Zhou HY, 2009, BIOORG MED CHEM LETT, V19, P662, DOI 10.1016/j.bmcl.2008.12.055	86	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8818	10.1371/journal.pone.0008818	http://dx.doi.org/10.1371/journal.pone.0008818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098614	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779100011
J	Denton, PW; Krisko, JF; Powell, DA; Mathias, M; Kwak, YT; Martinez-Torres, F; Zou, W; Payne, DA; Estes, JD; Garcia, JV				Denton, Paul W.; Krisko, John F.; Powell, Daniel A.; Mathias, Melissa; Kwak, Youn Tae; Martinez-Torres, Francisco; Zou, Wei; Payne, Deborah A.; Estes, Jacob D.; Garcia, J. Victor			Systemic Administration of Antiretrovirals Prior to Exposure Prevents Rectal and Intravenous HIV-1 Transmission in Humanized BLT Mice	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; VAGINAL SHIV CHALLENGE; PREEXPOSURE PROPHYLAXIS; REVERSE-TRANSCRIPTASE; SEXUAL TRANSMISSION; IMMUNE-RESPONSES; SIV INFECTION; MACAQUES; CHEMOPROPHYLAXIS; VACCINE	Successful antiretroviral pre-exposure prophylaxis (PrEP) for mucosal and intravenous HIV-1 transmission could reduce new infections among targeted high-risk populations including discordant couples, injection drug users, high-risk women and men who have sex with men. Targeted antiretroviral PrEP could be particularly effective at slowing the spread of HIV-1 if a single antiretroviral combination were found to be broadly protective across multiple routes of transmission. Therefore, we designed our in vivo preclinical study to systematically investigate whether rectal and intravenous HIV-1 transmission can be blocked by antiretrovirals administered systemically prior to HIV-1 exposure. We performed these studies using a highly relevant in vivo model of mucosal HIV-1 transmission, humanized Bone marrow/Liver/Thymus mice (BLT). BLT mice are susceptible to HIV-1 infection via three major physiological routes of viral transmission: vaginal, rectal and intravenous. Our results show that BLT mice given systemic antiretroviral PrEP are efficiently protected from HIV-1 infection regardless of the route of exposure. Specifically, systemic antiretroviral PrEP with emtricitabine and tenofovir disoproxil fumarate prevented both rectal (Chi square = 8.6, df = 1, p = 0.003) and intravenous (Chi square = 13, df = 1, p = 0.0003) HIV-1 transmission. Our results indicate that antiretroviral PrEP has the potential to be broadly effective at preventing new rectal or intravenous HIV transmissions in targeted high risk individuals. These in vivo preclinical findings provide strong experimental evidence supporting the potential clinical implementation of antiretroviral based pre-exposure prophylactic measures to prevent the spread of HIV/AIDS.	[Denton, Paul W.; Krisko, John F.; Powell, Daniel A.; Mathias, Melissa; Kwak, Youn Tae; Martinez-Torres, Francisco; Zou, Wei; Garcia, J. Victor] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Payne, Deborah A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Estes, Jacob D.] NCI, AIDS & Canc Virus Program, SAIC Frederick Inc, Frederick, MD 21701 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Denton, PW (corresponding author), Univ N Carolina, Ctr AIDS Res, Div Infect Dis, Chapel Hill, NC 27515 USA.	victor_garcia@med.unc.edu		Denton, Paul/0000-0003-2458-8147; Powell, Daniel/0000-0003-0503-3330	National Institutes of Health [AI073146, AI071940, 5T32AI005284, HHSN266200400088C]; Foundation for AIDS Research (amfAR) [107183-44-RFRL]; UT Southwestern Summer Medical Student Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073146, T32AI005284, R33AI071940, R21AI071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for AIDS Research (amfAR); UT Southwestern Summer Medical Student Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part with federal funds from National Institute of Allergy and Infectious Diseases, National Institutes of Health grants AI073146 and AI071940 (J. V. G.), 5T32AI005284 (J. F. K.), and the National Cancer Institute, National Institutes of Health, under contract HHSN266200400088C (J. E. D.). This work was supported in part by fellowship number 107183-44-RFRL from The Foundation for AIDS Research (amfAR) (P. W. D.). M. M. was supported by the UT Southwestern Summer Medical Student Research Program. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Derdelinckx I, 2006, PLOS MED, V3, P1999, DOI 10.1371/journal.pmed.0030454; Emau Peter, 2006, AIDS Res Ther, V3, P29, DOI 10.1186/1742-6405-3-29; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Ferrantelli F, 2007, VIROLOGY, V358, P69, DOI 10.1016/j.virol.2006.07.056; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; FRICK LW, 1994, ANTIMICROB AGENTS CH, V38, P2722, DOI 10.1128/AAC.38.12.2722; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Gay CL, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P107, DOI 10.1016/B978-0-12-374235-3.00005-4; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; GU ZX, 1994, ANTIMICROB AGENTS CH, V38, P275, DOI 10.1128/AAC.38.2.275; Gupta K, 2006, PLOS MED, V3, P181, DOI 10.1371/journal.pmed.0030079; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Johnson Victoria A, 2008, Top HIV Med, V16, P138; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landovitz Raphael J, 2007, Top HIV Med, V15, P99; Lederman MM, 2006, NAT REV IMMUNOL, V6, P371, DOI 10.1038/nri1848; Letvin NL, 2006, NAT REV IMMUNOL, V6, P930, DOI 10.1038/nri1959; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Mascolini Mark, 2009, J Int AIDS Soc, V12 Suppl 1, pS4, DOI 10.1186/1758-2652-12-S1-S4; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; McGowan I, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P85, DOI 10.1016/B978-0-12-374235-3.00004-2; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Misegades L, 2001, AIDS, V15, P534, DOI 10.1097/00002030-200103090-00017; Naesens L, 1998, ANTIMICROB AGENTS CH, V42, P1568, DOI 10.1128/AAC.42.7.1568; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Otten RA, 2000, J VIROL, V74, P9771, DOI 10.1128/JVI.74.20.9771-9775.2000; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Sekaly RP, 2008, J EXP MED, V205, P7, DOI 10.1084/jem.20072681; Stoddart CA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000655; Stone A, 2006, LANCET, V368, P431, DOI 10.1016/S0140-6736(06)69131-9; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Tsai CC, 2000, J MED PRIMATOL, V29, P248, DOI 10.1034/j.1600-0684.2000.290318.x; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; *US CDC, 2007, HIV AIDS SURV REP, V19; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Veazey RS, 2005, NATURE, V438, P99, DOI 10.1038/nature04055; Wainberg MA, 1999, ANTIVIR THER, V4, P87; Watkins DI, 2008, NAT MED, V14, P617, DOI 10.1038/nm.f.1759; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; White KL, 2002, ANTIMICROB AGENTS CH, V46, P3437, DOI 10.1128/AAC.46.11.3437-3446.2002; *WHO UNAIDS, 2008, 2008 REP GLOB AIDS E, P95; *WHO UNAIDS, 2006, 2006 REP GLOB AIDS E, P124; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027; Zeitlin L, 2001, SEX TRANSM DIS, V28, P417, DOI 10.1097/00007435-200107000-00010	56	118	121	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8829	10.1371/journal.pone.0008829	http://dx.doi.org/10.1371/journal.pone.0008829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098623	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100020
J	Barrias, ES; Reignault, LC; De Souza, W; Carvalho, TMU				Barrias, Emile S.; Reignault, Lissa C.; De Souza, Wanderley; Carvalho, Tecia M. U.			Dynasore, a Dynamin Inhibitor, Inhibits Trypanosoma cruzi Entry into Peritoneal Macrophages	PLOS ONE			English	Article							INVASION; PHAGOCYTOSIS; INFECTION; SUPERFAMILY; ACTIVATION; TRANSPORT; CELLS	Background: Trypanosoma cruzi is an intracellular parasite that, like some other intracellular pathogens, targets specific proteins of the host cell vesicular transport machinery, leading to a modulation of host cell processes that results in the generation of unique phagosomes. In mammalian cells, several molecules have been identified that selectively regulate the formation of endocytic transport vesicles and the fusion of such vesicles with appropriate acceptor membranes. Among these, the GTPase dynamin plays an important role in clathrin-mediated endocytosis, and it was recently found that dynamin can participate in a phagocytic process. Methodology/Principal Findings: We used a compound called dynasore that has the ability to block the GTPase activity of dynamin. Dynasore acts as a potent inhibitor of endocytic pathways by blocking coated vesicle formation within seconds of its addition. Here, we investigated whether dynamin is involved in the entry process of T. cruzi in phagocytic and non-phagocytic cells by using dynasore. In this aim, peritoneal macrophages and LLC-MK2 cells were treated with increasing concentrations of dynasore before interaction with trypomastigotes, amastigotes or epimastigotes. We observed that, in both cell lines, the parasite internalization was drastically diminished (by greater than 90% in LLC-MK2 cells and 70% in peritoneal macrophages) when we used 100 mu M dynasore. The T. cruzi adhesion index, however, was unaffected in either cell line. Analyzing these interactions by scanning electron microscopy and comparing peritoneal macrophages to LLC-MK2 cells revealed differences in the stage at which cell entry was blocked. In LLC-MK2 cells, this blockade is observed earlier than it is in peritoneal macrophages. In LLC-MK2 cells, the parasites were only associated with cellular microvilli, whereas in peritoneal macrophages, trypomastigotes were not completely engulfed by a host cell plasma membrane. Conclusions/Significance: Taken together our results demonstrate that dynamin is an essential molecule necessary for cell invasion and specifically parasitophorous vacuole formation by host cells during interaction with Trypanosoma cruzi.	[Barrias, Emile S.; Reignault, Lissa C.; De Souza, Wanderley; Carvalho, Tecia M. U.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Barrias, ES (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, CCS Bloco G, BR-21941 Rio De Janeiro, Brazil.	tecia@biof.ufrj.br		Reignault, Lissa Catherine/0000-0003-2553-9312	Conselho Nacional de Pesquisa (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Conselho Nacional de Pesquisa (CNPq), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazeed ME, 2005, J BIOL CHEM, V280, P4442, DOI 10.1074/jbc.M412553200; Abban CY, 2008, AM J THER, V15, P304, DOI 10.1097/MJT.0b013e3181754134; Alves Maria Julia M., 2008, V47, P58; ALVES MJM, 1986, MOL BIOCHEM PARASIT, V21, P75, DOI 10.1016/0166-6851(86)90081-2; Barrias ES, 2007, BIOCHEM BIOPH RES CO, V363, P828, DOI 10.1016/j.bbrc.2007.09.068; Calvet CM, 2003, J EUKARYOT MICROBIOL, V50, P97, DOI 10.1111/j.1550-7408.2003.tb00240.x; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; DOHERTY GJ, 2009, ANN REV BIO IN PRESS; Gold ES, 1999, J EXP MED, V190, P1849, DOI 10.1084/jem.190.12.1849; GOUT I, 1993, CELL, V75, P25, DOI 10.1016/0092-8674(93)90676-H; Huynh KK, 2008, CURR BIOL, V18, pR563, DOI 10.1016/j.cub.2008.05.032; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rittig MG, 1998, TRENDS MICROBIOL, V6, P384, DOI 10.1016/S0966-842X(98)01343-2; Rosestolato CTF, 2002, CELL STRUCT FUNCT, V27, P91, DOI 10.1247/csf.27.91; ROTH J, 1983, TECHNIQUES IMMUNOCYT, V2, P217; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Todorov AG, 2000, J BIOL CHEM, V275, P32182, DOI 10.1074/jbc.M909440199; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Vieira M, 2002, HISTOCHEM CELL BIOL, V118, P491, DOI 10.1007/s00418-002-0477-0; Wilkowsky SE, 2002, BIOCHEM BIOPH RES CO, V291, P516, DOI 10.1006/bbrc.2002.6474; Wilkowsky SE, 2001, EXP CELL RES, V264, P211, DOI 10.1006/excr.2000.5123	28	50	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e7764	10.1371/journal.pone.0007764	http://dx.doi.org/10.1371/journal.pone.0007764			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098746	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000001
J	Liu, BY; Soloviev, I; Chang, P; Lee, J; Huang, XD; Zhong, CL; Ferrara, N; Polakis, P; Sakanaka, C				Liu, Bob Y.; Soloviev, Irina; Chang, Peter; Lee, John; Huang, XiaoDong; Zhong, Cuiling; Ferrara, Napoleone; Polakis, Paul; Sakanaka, Chie			Stromal Cell-Derived Factor-1/CXCL12 Contributes to MMTV-Wnt1 Tumor Growth Involving Gr1(+)CD11b(+) Cells	PLOS ONE			English	Article							BETA-CATENIN; BREAST CARCINOMAS; MYELOID CELLS; WNT PATHWAY; ANGIOGENESIS; EXPRESSION; RECRUITMENT; RECEPTOR; IDENTIFICATION; MACROPHAGES	Background: Histological examinations of MMTV-Wnt1 tumors reveal drastic differences in the tumor vasculature when compared to MMTV-Her2 tumors. However, these differences have not been formally described, nor have any angiogenic factors been implicated to be involved in the Wnt1 tumors. Methodology/Principal Findings: Here, we show that MMTV-Wnt1 tumors were more vascularized than MMTV-Her2 tumors, and this correlated with significantly higher expression of a CXC chemokine, stromal cell-derived factor-1 (SDF1/CXCL12) but not with VEGFA. Isolation of various cell types from Wnt1 tumors revealed that SDF1 was produced by both tumor myoepithelial cells and stromal cells, whereas Her2 tumors lacked myoepithelial cells and contained significantly less stroma. The growth of Wnt1 tumors, but not Her2 tumors, was inhibited by a neutralizing antibody to SDF1, but not by neutralization of VEGFA. Anti-SDF1 treatment decreased the proportion of infiltrating Gr1(+) myeloid cells in the Wnt1 tumors, which correlated with a decrease in the percentage of endothelial cells. The involvement of Gr1(+) cells was evident from the retardation of Wnt1 tumor growth following in vivo depletion of these cells with an anti-Gr1-specific antibody. This degree of inhibition on Wnt1 tumor growth was comparable, but not additive, to the effect observed with anti-SDF1, indicative of overlapping mechanisms of inhibition. In contrast, Her2 tumors were not affected by the depletion of Gr1(+) cells. Conclusions/Significance: We demonstrated that SDF1 is important for Wnt1, but not for HER2, in inducing murine mammary tumor and the role of SDF1 in tumorigenesis involves Gr1(+) myeloid cells to facilitate growth and/or angiogenesis.	[Liu, Bob Y.; Soloviev, Irina; Chang, Peter; Lee, John; Zhong, Cuiling; Ferrara, Napoleone; Polakis, Paul; Sakanaka, Chie] Genentech Inc, Res Oncol, San Francisco, CA 94080 USA; [Huang, XiaoDong] Genentech Inc, Physiol Chem, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Liu, BY (corresponding author), Genentech Inc, Res Oncol, San Francisco, CA 94080 USA.	chies@gene.com			Genentech Inc	Genentech Inc(Roche HoldingGenentech)	This work was supported by Genentech Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn GO, 2008, CANCER CELL, V13, P193, DOI 10.1016/j.ccr.2007.11.032; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Easwaran V, 2003, CANCER RES, V63, P3145; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; FOX SB, 1994, BREAST CANCER RES TR, V29, P109, DOI 10.1007/BF00666186; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Imbert A, 2001, J CELL BIOL, V153, P555, DOI 10.1083/jcb.153.3.555; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kovacs A, 2003, J CLIN PATHOL, V56, P139, DOI 10.1136/jcp.56.2.139; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Michaelson JS, 2001, ONCOGENE, V20, P5093, DOI 10.1038/sj.onc.1204586; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3	38	22	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8611	10.1371/journal.pone.0008611	http://dx.doi.org/10.1371/journal.pone.0008611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20087418	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900003
J	Takesono, A; Heasman, SJ; Wojciak-Stothard, B; Garg, R; Ridley, AJ				Takesono, Aya; Heasman, Sarah J.; Wojciak-Stothard, Beata; Garg, Ritu; Ridley, Anne J.			Microtubules Regulate Migratory Polarity through Rho/ROCK Signaling in T Cells	PLOS ONE			English	Article							NEUTROPHIL POLARIZATION; ACTIN CYTOSKELETON; ALPHA-TUBULIN; RHO-GTPASES; IN-VIVO; CHEMOTAXIS; MOTILITY; LYMPHOCYTES; DYNAMICS; MYOSIN	Background: Migrating leukocytes normally have a polarized morphology with an actin-rich lamellipodium at the front and a uropod at the rear. Microtubules (MTs) are required for persistent migration and chemotaxis, but how they affect cell polarity is not known. Methodology/Principal Findings: Here we report that T cells treated with nocodazole to disrupt MTs are unable to form a stable uropod or lamellipodium, and instead often move by membrane blebbing with reduced migratory persistence. However, uropod-localized receptors and ezrin/radixin/moesin proteins still cluster in nocodazole-treated cells, indicating that MTs are required specifically for uropod stability. Nocodazole stimulates RhoA activity, and inhibition of the RhoA target ROCK allows nocodazole-treated cells to re-establish lamellipodia and uropods and persistent migratory polarity. ROCK inhibition decreases nocodazole-induced membrane blebbing and stabilizes MTs. The myosin inhibitor blebbistatin also stabilizes MTs, indicating that RhoA/ROCK act through myosin II to destabilize MTs. Conclusions/Significance: Our results indicate that RhoA/ROCK signaling normally contributes to migration by affecting both actomyosin contractility and MT stability. We propose that regulation of MT stability and RhoA/ROCK activity is a mechanism to alter T-cell migratory behavior from lamellipodium-based persistent migration to bleb-based migration with frequent turning.	[Takesono, Aya; Ridley, Anne J.] UCL, Dept Biochem & Mol Biol, London, England; [Takesono, Aya; Ridley, Anne J.] UCL, Ludwig Inst Canc Res, London, England; [Takesono, Aya] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Heasman, Sarah J.; Garg, Ritu; Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Wojciak-Stothard, Beata] Univ London Imperial Coll Sci Technol & Med, Dept Expt Med & Toxicol, London, England	University of London; University College London; Ludwig Institute for Cancer Research; University of London; University College London; University of Exeter; University of London; King's College London; Imperial College London	Takesono, A (corresponding author), UCL, Dept Biochem & Mol Biol, London, England.	anne.ridley@kcl.ac.uk		Ridley, Anne/0000-0001-8186-5708	Biotechnology and Biological Sciences Research Council (BBSRC) [31/C14420]; Leukaemia Research Fund United Kingdom [04021]; Cancer Research United Kingdom [C6620/A8833]; MRC [G0600806] Funding Source: UKRI; Medical Research Council [G0600806] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leukaemia Research Fund United Kingdom; Cancer Research United Kingdom(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant 31/C14420, Leukaemia Research Fund United Kingdom grant 04021 and Cancer Research United Kingdom grant C6620/A8833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; BORNENS M, 1989, J CELL BIOL, V109, P1071, DOI 10.1083/jcb.109.3.1071; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Burridge K, 2006, NAT CELL BIOL, V8, P781, DOI 10.1038/ncb0806-781; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chang YC, 2008, MOL BIOL CELL, V19, P2147, DOI 10.1091/mbc.E07-12-1269; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; DANOWSKI BA, 1989, J CELL SCI, V93, P255; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; del Pozo MA, 1998, CELL ADHES COMMUN, V6, P125, DOI 10.3109/15419069809004468; del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; GLASGOW JE, 1994, CELL MOTIL CYTOSKEL, V27, P88, DOI 10.1002/cm.970270110; Gomez-Mouton C, 2001, P NATL ACAD SCI USA, V98, P9642, DOI 10.1073/pnas.171160298; Grigoriev I, 2006, CELL MOTIL CYTOSKEL, V63, P29, DOI 10.1002/cm.20107; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Kanthou C, 2002, BLOOD, V99, P2060, DOI 10.1182/blood.V99.6.2060; KELLER HU, 1993, CELL MOTIL CYTOSKEL, V25, P10, DOI 10.1002/cm.970250103; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Ling L, 2004, J BIOL CHEM, V279, P32737, DOI 10.1074/jbc.M400601200; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Mseka T, 2007, J CELL SCI, V120, P4332, DOI 10.1242/jcs.017640; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Nijhara R, 2004, J IMMUNOL, V173, P4985, DOI 10.4049/jimmunol.173.8.4985; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Ratner S, 1997, J IMMUNOL, V159, P1063; Redd MJ, 2006, CELL MOTIL CYTOSKEL, V63, P415, DOI 10.1002/cm.20133; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sanchez-Madrid F, 1999, EMBO J, V18, P501, DOI 10.1093/emboj/18.3.501; Sanchez-Madrid F, 2009, NAT REV MOL CELL BIO, V10, P353, DOI 10.1038/nrm2680; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tan WF, 2006, J BIOL CHEM, V281, P39542, DOI 10.1074/jbc.M609062200; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; UEDA M, 1994, J CELL SCI, V107, P2071; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Vicente-Manzanares M, 2002, J IMMUNOL, V168, P400, DOI 10.4049/jimmunol.168.1.400; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2001, J CELL SCI, V114, P3795; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	72	126	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8774	10.1371/journal.pone.0008774	http://dx.doi.org/10.1371/journal.pone.0008774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098744	gold, Green Published, Green Submitted			2022-12-27	WOS:000273778900017
J	Singer, BB; Scheffrahn, I; Kammerer, R; Suttorp, N; Ergun, S; Slevogt, H				Singer, Bernhard B.; Scheffrahn, Inka; Kammerer, Robert; Suttorp, Norbert; Ergun, Suleyman; Slevogt, Hortense			Deregulation of the CEACAM Expression Pattern Causes Undifferentiated Cell Growth in Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN CEA; ADHESION MOLECULE CEACAM1; BILIARY GLYCOPROTEIN; EPITHELIAL-CELLS; C-CAM; PANCREATIC ADENOCARCINOMA; ELEVATED EXPRESSION; GENE-EXPRESSION; USPA1 PROTEIN; CANCER	CEACAM1, CEA/CEACAM5, and CEACAM6 are cell adhesion molecules (CAMs) of the carcinoembryonic antigen (CEA) family that have been shown to be deregulated in lung cancer and in up to 50% of all human cancers. However, little is known about the functional impact of these molecules on undifferentiated cell growth and tumor progression. Here we demonstrate that cell surface expression of CEACAM1 on confluent A549 human lung adenocarcinoma cells plays a critical role in differentiated, contact-inhibited cell growth. Interestingly, CEACAM1-L, but not CEACAM1-S, negatively regulates proliferation via its ITIM domain, while in proliferating cells no CEACAM expression is detectable. Furthermore, we show for the first time that CEACAM6 acts as an inducer of cellular proliferation in A549 cells, likely by interfering with the contact-inhibiting signal triggered by CEACAM1-4L, leading to undifferentiated anchorage-independent cell growth. We also found that A549 cells expressed significant amounts of non-membrane anchored variants of CEACAM5 and CEACAM6, representing a putative source for the increased CEACAM5/6 serum levels frequently found in lung cancer patients. Taken together, our data suggest that post-confluent contact inhibition is established and maintained by CEACAM1-4L, but disturbances of CEACAM1 signalling by CEACAM1-4S and other CEACAMs lead to undifferentiated cell growth and malignant transformation.	[Singer, Bernhard B.; Scheffrahn, Inka; Ergun, Suleyman] Univ Hosp Essen, Inst Anat, Essen, Germany; [Kammerer, Robert] Friedrich Loeffler Inst, Inst Immunol, Tubingen, Germany; [Suttorp, Norbert; Slevogt, Hortense] Charite, Dept Internal Med Infect Dis & Pulm Med, D-13353 Berlin, Germany	University of Duisburg Essen; Friedrich Loeffler Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Singer, BB (corresponding author), Univ Hosp Essen, Inst Anat, Essen, Germany.	BBSinger@gmx.de	Kammerer, Robert/AAQ-1338-2021; Singer, Bernhard B./AAP-9999-2020	Kammerer, Robert/0000-0003-3038-8205; Suttorp, Norbert/0000-0002-3958-1151	Deutsche Forschungsgesellschaf [SFB366, TPC1, DFG Er 276/4-4, SL 153/1-1]	Deutsche Forschungsgesellschaf	This work was supported by grants from the Deutsche Forschungsgesellschaft to BBS (SFB366, Zellulaere Signalerkennung und Umsetzung, TPC1), to SE (DFG Er 276/4-4), and to HS (SL 153/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger AM, 1998, AM J PATHOL, V152, P1401; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Brummer J, 1996, TISSUE ANTIGENS, V48, pMC306; Camacho-Leal P, 2008, ONCOGENE, V27, P1545, DOI 10.1038/sj.onc.1210789; Chen T, 2001, J LEUKOCYTE BIOL, V70, P335; CHEVINSKY AH, 1991, SEMIN SURG ONCOL, V7, P162, DOI 10.1002/ssu.2980070309; Croce M V, 1999, Pathol Oncol Res, V5, P197, DOI 10.1053/paor.1999.0212; Dango S, 2008, LUNG CANCER, V60, P426, DOI 10.1016/j.lungcan.2007.11.015; Duxbury MS, 2005, ANN SURG, V241, P491, DOI 10.1097/01.sla.0000154455.86404.e9; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; ENGER MD, 1986, AM J PHYSIOL, V250, pC256, DOI 10.1152/ajpcell.1986.250.2.C256; Fahlgren A, 2003, SCAND J IMMUNOL, V58, P628, DOI 10.1111/j.1365-3083.2003.01342.x; Gaur S, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-46; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; GRUNERT F, 1995, INT J CANCER, V63, P349, DOI 10.1002/ijc.2910630308; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Horst AK, 2004, HANDB EXP PHARM, V165, P283, DOI 10.1007/978-3-540-68170-0_10; HSIEH JT, 1995, CANCER RES, V55, P190; Huber M, 1999, J BIOL CHEM, V274, P335, DOI 10.1074/jbc.274.1.335; Ieta K, 2006, BRIT J CANCER, V95, P532, DOI 10.1038/sj.bjc.6603276; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Kleinerman DI, 1996, CANCER RES, V56, P3431; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Kunath T, 1995, ONCOGENE, V11, P2375; Laack E, 2002, J CLIN ONCOL, V20, P4279, DOI 10.1200/JCO.2002.08.067; Litkouhi B, 2008, GYNECOL ONCOL, V109, P234, DOI 10.1016/j.ygyno.2008.01.031; Luo WP, 1997, ONCOGENE, V14, P1697, DOI 10.1038/sj.onc.1200999; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; NEUMAIER M, 1993, P NATL ACAD SCI USA, V90, P10744, DOI 10.1073/pnas.90.22.10744; Obrink B, 1997, CURR OPIN CELL BIOL, V9, P616, DOI 10.1016/S0955-0674(97)80114-7; Obrink B, 2008, LUNG CANCER, V60, P309, DOI 10.1016/j.lungcan.2008.03.020; OHWADA A, 1994, AM J RESP CELL MOL, V11, P214, DOI 10.1165/ajrcmb.11.2.8049082; Opitz B, 2006, J BIOL CHEM, V281, P36173, DOI 10.1074/jbc.M604638200; Ordonez C, 2000, CANCER RES, V60, P3419; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Riethdorf S, 2008, INT J CANCER, V123, P1991, DOI 10.1002/ijc.23825; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; Scheffrahn I, 2005, EXP CELL RES, V307, P427, DOI 10.1016/j.yexcr.2005.03.030; Sienel W, 2003, CLIN CANCER RES, V9, P2260; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Singer BB, 2000, CANCER RES, V60, P1236; SINGER BB, 2005, CEACAM1 UCSD NATURE, DOI DOI 10.1038/MPA00359701; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Travis WD, 2006, J THORAC ONCOL, V1, pS13, DOI 10.1097/01243894-200611001-00004; Wang L, 2000, CLIN CANCER RES, V6, P2988; Watanabe N, 2002, AM J PHYSIOL-LUNG C, V283, pL726, DOI 10.1152/ajplung.00025.2002	52	64	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8747	10.1371/journal.pone.0008747	http://dx.doi.org/10.1371/journal.pone.0008747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090913	Green Submitted, Green Published, gold			2022-12-27	WOS:000273715000007
J	Canavese, M; Altruda, F; Silengo, L				Canavese, Miriam; Altruda, Fiorella; Silengo, Lorenzo			Therapeutic Efficacy and Immunological Response of CCL5 Antagonists in Models of Contact Skin Reaction	PLOS ONE			English	Article							CHEMOKINE SYSTEM; MET-RANTES; PSORIASIS; KERATINOCYTES; INTERFERENCE; DERMATITIS; RECEPTORS; DISEASE	Skin-infiltrating T-cells play a predominant role in allergic and inflammatory skin diseases such as atopic dermatitis, psoriasis and allergic contact dermatitis. These T-cells are attracted by several chemotactic factors including the chemokine CCL5/RANTES, a CC chemokine inducing both the migration and activation of specific leukocyte subsets. CCL5 has been found to be associated with various cell-mediated hypersensitive disorders such as psoriasis, atopic dermatitis and irritant contact dermatitis. We have used two antagonists, the first, Met-CCL5, a dual CCR1/CCR5 antagonist and the second, a variant in which GAG binding is abrogated, 44 AANA 47-CCL5, which acts as a dominant negative inhibitor of CCL5. The antagonists were tested in two models of contact skin reaction. The first, irritant contact dermatitis (ICD) is a pathological non-specific inflammatory skin condition arising from the release of pro-inflammatory cytokines by keratinocytes in response to haptens, usually chemicals. The second, contact hypersensitivity (CHS) is a T-cell dependent model, mimicking in part the T-cell-mediated skin diseases such as psoriasis. In both models, the CCL5 antagonists showed therapeutic efficacy by reducing swelling by 50% as well as the reduction of soluble mediators in homogenates derived from challenged ears. These results demonstrate that blocking the receptor or the ligand are both effective strategies to inhibit skin inflammation.	[Canavese, Miriam; Altruda, Fiorella; Silengo, Lorenzo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy	University of Turin	Canavese, M (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	miriamcanavese@yahoo.com			Merck Serono International	Merck Serono International	Funding: This work was supported by a Research Grant from Merck Serono International S. A. The funders supported study design, data collection and analysis, but they had no role in decision to publish and preparation of the manuscript.	Akahira-Azuma M, 2004, IMMUNOLOGY, V111, P306, DOI 10.1111/j.0019-2805.2004.01818.x; Asadullah K, 2002, TRENDS IMMUNOL, V23, P47, DOI 10.1016/S1471-4906(01)02119-6; Dahl M V, 1988, Adv Dermatol, V3, P261; Elsner J, 1999, INT ARCH ALLERGY IMM, V118, P462, DOI 10.1159/000024164; GILLITZER R, 1993, J INVEST DERMATOL, V101, P127, DOI 10.1111/1523-1747.ep12363613; Glass WG, 2004, J IMMUNOL, V172, P4018, DOI 10.4049/jimmunol.172.7.4018; Grabbe S, 1996, J CLIN INVEST, V98, P1158, DOI 10.1172/JCI118899; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; Johnson Z, 2005, TRENDS IMMUNOL, V26, P268, DOI 10.1016/j.it.2005.03.001; Kapuscinska Renata, 2004, Wiad Lek, V57, P599; Loffler H, 2000, HAUTARZT, V51, P203, DOI 10.1007/s001050051023; Matsui M, 2002, J NEUROIMMUNOL, V128, P16, DOI 10.1016/S0165-5728(02)00121-2; MCKAY IA, 1995, CLIN DERMATOL, V13, P105, DOI 10.1016/0738-081X(95)93817-8; NICKOLOFF BJ, 1994, AM J PATHOL, V144, P820; Nomura L, 2003, J ALLERGY CLIN IMMUN, V112, P1195, DOI 10.1016/j.jaci.2003.08.049; Pastore S, 2004, EUR J DERMATOL, V14, P203; Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478; Proudfoot AEI, 1996, J BIOL CHEM, V271, P2599, DOI 10.1074/jbc.271.5.2599; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Schon MP, 2001, NAT IMMUNOL, V2, P91, DOI 10.1038/84293; Teixeira MM, 1997, J CLIN INVEST, V100, P1657, DOI 10.1172/JCI119690	22	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8725	10.1371/journal.pone.0008725	http://dx.doi.org/10.1371/journal.pone.0008725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090949	Green Submitted, gold, Green Published			2022-12-27	WOS:000273714900006
J	Murray, RJ; Robinson, JO; White, JN; Hughes, F; Coombs, GW; Pearson, JC; Tan, HL; Chidlow, G; Williams, S; Christiansen, KJ; Smith, DW				Murray, Ronan J.; Robinson, James O.; White, Jodi N.; Hughes, Frank; Coombs, Geoffrey W.; Pearson, Julie C.; Tan, Hui-Leen; Chidlow, Glenys; Williams, Simon; Christiansen, Keryn J.; Smith, David W.			Community-Acquired Pneumonia Due to Pandemic A(H1N1)2009 Influenzavirus and Methicillin Resistant Staphylococcus aureus Co-Infection	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; BACTERIAL PNEUMONIA; H1N1 INFLUENZA; UNITED-STATES; ELECTROPHORESIS; CHILDREN; CRITERIA; STRAINS; ASSAY	Background: Bacterial pneumonia is a well described complication of influenza. In recent years, community-onset methicillin-resistant Staphylococcus aureus (cMRSA) infection has emerged as a contributor to morbidity and mortality in patients with influenza. Since the emergence and rapid dissemination of pandemic A(H1N1) 2009 influenzavirus in April 2009, initial descriptions of the clinical features of patients hospitalized with pneumonia have contained few details of patients with bacterial co-infection. Methodology/Principal Findings: Patients with community-acquired pneumonia (CAP) caused by co-infection with pandemic A(H1N1) 2009 influenzavirus and cMRSA were prospectively identified at two tertiary hospitals in one Australian city during July to September 2009, the period of intense influenza activity in our region. Detailed characterization of the cMRSA isolates was performed. 252 patients with pandemic A(H1N1) 2009 influenzavirus infection were admitted at the two sites during the period of study. Three cases of CAP due to pandemic A(H1N1) 2009/cMRSA co-infection were identified. The clinical features of these patients were typical of those with S. aureus co-infection or sequential infection following influenza. The 3 patients received appropriate empiric therapy for influenza, but inappropriate empiric therapy for cMRSA infection; all 3 survived. In addition, 2 fatal cases of CAP caused by pandemic A(H1N1) 2009/cMRSA co-infection were identified on postmortem examination. The cMRSA infections were caused by three different cMRSA clones, only one of which contained genes for Panton-Valentine Leukocidin (PVL). Conclusions/Significance: Clinicians managing patients with pandemic A(H1N1) 2009 influenzavirus infection should be alert to the possibility of co-infection or sequential infection with virulent, antimicrobial-resistant bacterial pathogens such as cMRSA. PVL toxin is not necessary for the development of cMRSA pneumonia in the setting of pandemic A(H1N1) 2009 influenzavirus co-infection.	[Murray, Ronan J.; Chidlow, Glenys; Williams, Simon; Smith, David W.] Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Microbiol & Infect Dis, Perth, WA, Australia; [Robinson, James O.; Coombs, Geoffrey W.; Pearson, Julie C.; Tan, Hui-Leen; Christiansen, Keryn J.] Royal Perth Hosp, PathW Lab Med WA, Dept Microbiol & Infect Dis, Perth, WA, Australia; [White, Jodi N.; Hughes, Frank] Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Forens Pathol, Perth, WA, Australia	University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Murray, RJ (corresponding author), Queen Elizabeth II Med Ctr, PathW Lab Med WA, Div Microbiol & Infect Dis, Perth, WA, Australia.	ronan.murray@health.wa.gov.au	Robinson, Owen/GNP-1638-2022	Smith, David/0000-0002-3107-5182; Williams, Simon/0000-0002-6276-4685; Coombs, Geoffrey/0000-0003-1635-6506	PathWest Laboratory Medicine WA; Health Department of Western Australia	PathWest Laboratory Medicine WA; Health Department of Western Australia	The study was funded by PathWest Laboratory Medicine WA and the Health Department of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	*AUSTR GOV DEP HLT, 2009, 24 AUSTR GOV DEP HLT; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Cheng VCC, 2009, J INFECTION, V59, P366, DOI 10.1016/j.jinf.2009.08.021; Chickering HT, 1919, J AMER MED ASSOC, V72, P617, DOI 10.1001/jama.1919.02610090001001; *CLIN LAB STAND I, 2009, M02A10 CLIN LAB STAN; Clinical and Laboratory Standards Institute, 2009, M100S18 CLIN LAB STA; Clinical and Laboratory Standards Institute, 2007, M7A7 CLIN LAB STAND; Costa AM, 2005, DIAGN MICR INFEC DIS, V51, P13, DOI 10.1016/j.diagmicrobio.2004.08.014; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Finlay JE, 1997, ANTIMICROB AGENTS CH, V41, P1137, DOI 10.1128/AAC.41.5.1137; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Gonzalez BE, 2005, CLIN INFECT DIS, V41, P583, DOI 10.1086/432475; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murata Y, 2007, J INFECT DIS, V195, P1029, DOI 10.1086/512160; *NAT HLTH MRC, 2003, DOES QUAL ASS HEALTH; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Reed C, 2009, PEDIATR INFECT DIS J, V28, P572, DOI 10.1097/INF.0b013e31819d8b71; ROBERTSON L, 1958, LANCET, V2, P233; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tenover FC, 2009, J ANTIMICROB CHEMOTH, V64, P441, DOI 10.1093/jac/dkp241; The National Health and Medical Research Council, 2007, NAT STAT ETH COND HU; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WEHRHAHN MC, 2010, EUR J CLIN IN PRESS; Whiley DM, 2005, DIAGN MICR INFEC DIS, V53, P335, DOI 10.1016/j.diagmicrobio.2005.08.002; Witte W, 2007, J ANTIMICROB CHEMOTH, V60, P1258, DOI 10.1093/jac/dkm384; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; [No title captured]	42	67	74	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8705	10.1371/journal.pone.0008705	http://dx.doi.org/10.1371/journal.pone.0008705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090931	gold, Green Published			2022-12-27	WOS:000273714600008
J	Wong, PP; Pickard, A; McCance, DJ				Wong, Ping-Pui; Pickard, Adam; McCance, Dennis J.			p300 Alters Keratinocyte Cell Growth and Differentiation through Regulation of p21(Waf1/CIP1)	PLOS ONE			English	Article							GENE-EXPRESSION; UP-REGULATION; DNA-BINDING; IN-VIVO; CYCLE; P53; TRANSCRIPTION; CDK; ACETYLATION; PROTEIN	Background: p300 functions as a transcriptional co-activator to regulate many cellular responses such as cell growth, transformation, development and differentiation. It has been shown to affect the transcriptional activity of p53 which regulates p21(Waf1/CIP1) expression, however, the role of p300 in differentiation remains unclear. Methodology and Principal Findings: Knockdown of p300 protein with short hairpin RNA (shRNA) molecules delays human neonatal foreskin keratinocyte (HFKs) differentiation. Moreover, depletion of p300 increases the proliferative capacity of HFKs, extends the life span of cells and allows differentiated HFKs to re-enter the cell cycle. Studies indicate that depletion of p300 down-regulates the acetylation and expression of p53, and chromatin immunoprecipitation (ChIP) analysis shows that induction of p21(Waf1/CIP1) in early differentiation is a result of p300 dependent activation of p53 and that depletion of p21(Waf1/CIP1) results in the delay of differentiation and a phenotype similar to p300 depletion. Conclusions: p300 has a direct role in the control of cell growth and differentiation in primary epithelial cells, and p21(Waf1/CIP1) is an important mediator of these p300 functions.	[Wong, Ping-Pui; Pickard, Adam; McCance, Dennis J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland	Queens University Belfast	Wong, PP (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	d.mccance@qub.ac.uk		Wong, Ping Pui/0000-0003-1592-4823; pickard, adam/0000-0001-9757-143X	Medical Research Council (MRC) [G0700754]; Medical Research Council [G0700754] Funding Source: researchfish; MRC [G0700754] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Medical Research Council (MRC) grant G0700754, URL:http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avantaggiati ML, 1997, CELL, V89, P1175, DOI 10.1016/S0092-8674(00)80304-9; Cheung WL, 2000, CURR OPIN CELL BIOL, V12, P326, DOI 10.1016/S0955-0674(00)00096-X; Devgan V, 2006, J BIOL CHEM, V281, P30463, DOI 10.1074/jbc.M604684200; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Howell MD, 2008, J INVEST DERMATOL, V128, P2248, DOI 10.1038/jid.2008.74; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kasten MM, 1998, CELL DEATH DIFFER, V5, P132, DOI 10.1038/sj.cdd.4400323; LI R, 1994, NATURE, V371, P534, DOI 10.1038/371534a0; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; LUO Y, 1995, NATURE, V375, P159, DOI 10.1038/375159a0; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; MISSERO C, 1995, P NATL ACAD SCI USA, V92, P5451, DOI 10.1073/pnas.92.12.5451; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Okuyama R, 2004, J INVEST DERM SYMP P, V9, P248, DOI 10.1111/j.1087-0024.2004.09308.x; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stiegler P, 1998, J CELL BIOCHEM, P30; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Westbrook TF, 2002, MOL CELL BIOL, V22, P7041, DOI 10.1128/MCB.22.20.7041-7052.2002; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Yugawa T, 2007, MOL CELL BIOL, V27, P3732, DOI 10.1128/MCB.02119-06; Zeng YX, 1997, NAT GENET, V15, P78, DOI 10.1038/ng0197-78; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	40	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8369	10.1371/journal.pone.0008369	http://dx.doi.org/10.1371/journal.pone.0008369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084294	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600002
J	Hemond, EM; Vollmer, SV				Hemond, Elizabeth M.; Vollmer, Steven V.			Genetic Diversity and Connectivity in the Threatened Staghorn Coral (Acropora cervicornis) in Florida	PLOS ONE			English	Article							CARIBBEAN CORAL; POPULATION-STRUCTURE; GENOTYPIC DIVERSITY; CLIMATE-CHANGE; REEF; FLOW; PHYLOGEOGRAPHY; REPRODUCTION; VARIABILITY; EXTINCTION	Over the past three decades, populations of the dominant shallow water Caribbean corals, Acropora cervicornis and A. palmata, have been devastated by white-band disease (WBD), resulting in the listing of both species as threatened under the U.S. Endangered Species Act. A key to conserving these threatened corals is understanding how their populations are genetically interconnected throughout the greater Caribbean. Genetic research has demonstrated that gene flow is regionally restricted across the Caribbean in both species. Yet, despite being an important site of coral reef research, little genetic data has been available for the Florida Acropora, especially for the staghorn coral, A. cervicornis. In this study, we present new mitochondrial DNA sequence data from 52 A. cervicornis individuals from 22 sites spread across the upper and lower Florida Keys, which suggest that Florida's A. cervicornis populations are highly genetically interconnected (F-ST=-0.081). Comparison between Florida and existing mtDNA data from six regional Caribbean populations indicates that Florida possesses high levels of standing genetic diversity (h = 0.824) relative to the rest of the greater Caribbean (h = 0.701 +/- 0.043). We find that the contemporary level of gene flow across the greater Caribbean, including Florida, is restricted (Phi(CT) = 0.117), but evidence from shared haplotypes suggests the Western Caribbean has historically been a source of genetic variation for Florida. Despite the current patchiness of A. cervicornis in Florida, the relatively high genetic diversity and connectivity within Florida suggest that this population may have sufficient genetic variation to be viable and resilient to environmental perturbation and disease. Limited genetic exchange across regional populations of the greater Caribbean, including Florida, indicates that conservation efforts for A. cervicornis should focus on maintaining and managing populations locally rather than relying on larval inputs from elsewhere.	[Hemond, Elizabeth M.; Vollmer, Steven V.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University	Hemond, EM (corresponding author), Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA.	hemond.e@husky.neu.edu			National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Florida Keys National Marine Sanctuary; National Science Foundation [OCE-0751666]; Northeastern University Excellence Fellowship	National Oceanic and Atmospheric Administration's Coral Reef Conservation Program; Florida Keys National Marine Sanctuary; National Science Foundation(National Science Foundation (NSF)); Northeastern University Excellence Fellowship	Fieldwork support was provided through the National Oceanic and Atmospheric Administration's Coral Reef Conservation Program and the Florida Keys National Marine Sanctuary. Research funding was also provided by National Science Foundation grant OCE-0751666 to S.V.V. and a Northeastern University Excellence Fellowship to E.M.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AROUSON RB, 2001, HYDROBIOLOGIA, V460, P25; Avise John C., 1994, pi; Ayre DJ, 2004, ECOL LETT, V7, P273, DOI 10.1111/j.1461-0248.2004.00585.x; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2005, MAR ECOL PROG SER, V288, P115, DOI 10.3354/meps288115; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Baums IB, 2006, LIMNOL OCEANOGR, V51, P1969, DOI 10.4319/lo.2006.51.5.1969; BENZIE JAH, 1995, MAR BIOL, V121, P731, DOI 10.1007/BF00349309; BOTSFORD L, 2009, CORAL REEFS; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; EXCOFFIER L, 1992, GENETICS, V131, P479; FU YX, 1993, GENETICS, V133, P693; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLENENT M, 2000, MOL ECOL, V9, P1657; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Grober-Dunsmore R, 2006, MAR ECOL PROG SER, V321, P123, DOI 10.3354/meps321123; Gutierrez-Rodriguez C, 2004, MOL ECOL, V13, P2211, DOI 10.1111/j.1365-294X.2004.02247.x; Gutierrez-Rodriguez C, 2009, MOL PHYLOGENET EVOL, V50, P1, DOI 10.1016/j.ympev.2008.09.019; Hard D. L, 1997, PRINCIPLES POPULATIO; HARE JA, 2007, CAN J FISH AQUAT SCI, V1234, P1217; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hedrick P, 2005, EVOLUTION, V59, P1596; HIGHSMITH RC, 1982, MAR ECOL PROG SER, V7, P207, DOI 10.3354/meps007207; Hogarth W.T., 2006, FED REGISTER, V71, P26852; LACSON JM, 1991, MAR BIOL, V110, P353, DOI 10.1007/BF01344354; LEE TN, 1992, CONT SHELF RES, V12, P971, DOI 10.1016/0278-4343(92)90055-O; Lessios HA, 2001, P ROY SOC B-BIOL SCI, V268, P2347, DOI 10.1098/rspb.2001.1806; Mackenzie JB, 2004, MOL ECOL, V13, P9, DOI 10.1046/j.1365-294X.2003.02019.x; MARUYAMA T, 1980, P NATL ACAD SCI-BIOL, V77, P6710, DOI 10.1073/pnas.77.11.6710; Miller MW, 2002, CORAL REEFS, V21, P179, DOI 10.1007/s00338-002-0228-7; MITTON JB, 1989, BIOL BULL-US, V177, P356, DOI 10.2307/1541595; MULLER S, 2008, POPULATION STATUS AE; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Murdoch TJT, 1999, CORAL REEFS, V18, P341, DOI 10.1007/s003380050210; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; PREEHT WE, 2004, FRONT ECOL ENVIRON, V2, P307; Purcell JFH, 2009, J FISH BIOL, V74, P403, DOI 10.1111/j.1095-8649.2008.02078.x; RAMOSOUSIUS SE, 2002, MOL BIOL EVOL, V19, P2002; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; ROZAS J, 2003, DNA POLYMORPHISM ANA, P2496; Schneider S., 2000, ARLEQUIN VERSION 20; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; SILBERMAN JD, 1994, MAR BIOL, V120, P601, DOI 10.1007/BF00350081; Sokal R.R., 2012, BIOMETRY; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; Van Oppen MJH, 2000, MOL ECOL, V9, P1363, DOI 10.1046/j.1365-294x.2000.01010.x; van Oppen MJH, 1999, MOL BIOL EVOL, V16, P1812, DOI 10.1093/oxfordjournals.molbev.a026094; Vargas-Angel B, 2002, CORAL REEFS, V21, P25, DOI 10.1007/s00338-001-0208-3; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIL E, 2004, CORAL RREF DIS WIDER, P35; Zubillaga AL, 2008, CORAL REEFS, V27, P63, DOI 10.1007/s00338-007-0291-1; 2005, FED REG, V70, P21359	65	33	33	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8652	10.1371/journal.pone.0008652	http://dx.doi.org/10.1371/journal.pone.0008652			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111583	gold, Green Submitted, Green Published			2022-12-27	WOS:000278099200003
J	Yamamoto, Y; Hino, H; Ueda, H				Yamamoto, Yuzo; Hino, Hiroshi; Ueda, Hiroshi			Olfactory Imprinting of Amino Acids in Lacustrine Sockeye Salmon	PLOS ONE			English	Article							PARR-SMOLT TRANSFORMATION; LONG-TERM POTENTIATION; COHO SALMON; RAINBOW-TROUT; ONCORHYNCHUS-KISUTCH; STREAM WATER; ODORANT RECEPTOR; PACIFIC SALMON; MASU SALMON; GENE	Juvenile salmon have an olfactory ability to imprint their natal stream odors, but neither the odor properties of natal stream water nor the imprinting timing and duration have been clarified as yet. Here we show, using electrophysiological and behavioral experiments, that one-year-old lacustrine sockeye salmon (Oncorhynchus nerka) can be imprinted around the stage of parr-smolt transformation (PST) by a single amino acid, 1 mu M L-proline (Pro), or L-glutamic acid (Glu). We also show by real-time PCR that changes occur in mRNA levels of the salmon olfactory imprinting-related gene (SOIG) around PST. The electro-olfactogram (EOG) responses of test fish exposed to Pro in March (before PST) and April-June (during PST) for 2 weeks were significantly (1.7-fold) greater than those of non-exposed control fish, but not those of test fish exposed in July (after PST). When Pro and control water were added to the water inlets of a two-choice test tank during the spawning season 2 years after the test water exposure, 80% of maturing and matured test fish exposed before and during PST showed a preference for Pro, whereas those exposed after PST did not. The EOG response of test fish exposed to Pro or Glu for 1 hour, 6 hours, 1 day, 7 days, or 14 days in May revealed that only the response after 14 days of exposure was significantly (1.8-fold) greater than the control. The expression levels of SOIG mRNA increased before and during PST, and decreased after PST. We conclude that one-year-old lacustrine sockeye salmon can be imprinted by a single amino acid before and during PST, and that imprinting requires exposure for at least 14 days.	[Yamamoto, Yuzo] Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Aquat Bioresources & Ecosyst, Field Sci Ctr No Biosphere, Sapporo, Hokkaido 060, Japan; Hokkaido Univ, Grad Sch Environm Earth Sci, Div Biosphere Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Yamamoto, Y (corresponding author), Hokkaido Univ, Grad Sch Environm Earth Sci, Lab Aquat Bioresources & Ecosyst, Field Sci Ctr No Biosphere, Sapporo, Hokkaido 060, Japan.	hueda@fsc.hokudai.ac.jp	Ueda, Hiroshi/G-4446-2010	Ueda, Hiroshi/0000-0002-4706-8665	Japanese Society for the Promotion of Science (JSPS) [17009156, 18208017]; Mitsubishi Foundation [35-4]; Mitsui Co. Ltd [08-A10]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mitsubishi Foundation; Mitsui Co. Ltd(Mitsui & Co., LTD.)	This study was supported by a Research Fellowship for Young Scientists to YY from the Japanese Society for the Promotion of Science (JSPS, 17009156), as well as partly by Grant-in-Aid for Scientific Research (A) (18208017) from JSPS, a natural science grant (35-4) from the Mitsubishi Foundation, and an environmental research grant (08-A10) from the Mitsui & Co. Ltd to HU. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BICKMORE WA, 1993, GENOMICS, V17, P129, DOI 10.1006/geno.1993.1293; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Chou JH, 2001, GENETICS, V157, P211; COOPER JC, 1976, J FISH RES BOARD CAN, V33, P703, DOI 10.1139/f76-087; COOPER JC, 1974, WISC ACAD SCI ARTS L, V62, P165; Dickhoff W.W., 1987, AM FISH SOC S, V1, P197; DICKHOFF WW, 1978, GEN COMP ENDOCR, V36, P229, DOI 10.1016/0016-6480(78)90027-8; Dittman AH, 1997, NEURON, V19, P381, DOI 10.1016/S0896-6273(00)80947-2; Dittman AH, 1996, CAN J FISH AQUAT SCI, V53, P434, DOI 10.1139/cjfas-53-2-434; Dittman AH, 1996, J EXP BIOL, V199, P83; Dukes JP, 2004, MOL ECOL, V13, P2851, DOI 10.1111/j.1365-294X.2004.02252.x; Ebbesson LOE, 2003, AQUACULTURE, V222, P59, DOI 10.1016/S0044-8486(03)00102-9; Ebbesson SOE, 1996, BRAIN RES, V742, P339, DOI 10.1016/S0006-8993(96)00993-6; Galloway H., 1994, THYROID INDUCED CHEM; Hasler A.D., 1983, OLFACTORY IMPRINTING; Hino H, 2007, AQUACULTURE, V273, P200, DOI 10.1016/j.aquaculture.2007.10.003; Jarrard HE, 1997, BRAIN BEHAV EVOLUT, V49, P249, DOI 10.1159/000112996; Kinoshita M, 2005, J COMP NEUROL, V484, P249, DOI 10.1002/cne.20473; Kudo H., 1994, Aquaculture and Fisheries Management, V25, P171; Lema SC, 2004, J EXP BIOL, V207, P3317, DOI 10.1242/jeb.01143; Matsuoka I, 1998, BBA-GENE STRUCT EXPR, V1395, P220, DOI 10.1016/S0167-4781(97)00164-4; MCKENZIE IFC, 1977, TRANSPLANT P, V9, P667; Morinishi F, 2007, COMP BIOCHEM PHYS B, V148, P329, DOI 10.1016/j.cbpb.2007.06.010; Nam RH, 2004, NEUROSCI LETT, V370, P248, DOI 10.1016/j.neulet.2004.08.037; NEVITT GA, 1994, P NATL ACAD SCI USA, V91, P4288, DOI 10.1073/pnas.91.10.4288; NORDENG H, 1971, NATURE, V233, P411, DOI 10.1038/233411a0; NORDENG H, 1977, OIKOS, V28, P155, DOI 10.2307/3543965; Quinn TP, 2005, BEHAV ECOLOGY PACIFI, P85; Ragno P, 2006, CELL MOL LIFE SCI, V63, P1028, DOI 10.1007/s00018-005-5428-1; Sato A, 1997, ZOOL SCI, V14, P1009, DOI 10.2108/zsj.14.1009; Satou M, 2006, J COMP PHYSIOL A, V192, P135, DOI 10.1007/s00359-005-0056-7; SCHOLZ AT, 1976, SCIENCE, V192, P1247, DOI 10.1126/science.1273590; Shimizu M, 1995, J FISH BIOL, V47, P1044, DOI 10.1111/j.1095-8649.1995.tb06028.x; Shoji T, 2000, CHEM SENSES, V25, P533, DOI 10.1093/chemse/25.5.533; Shoji T, 2003, FISH PHYSIOL BIOCHEM, V28, P249, DOI 10.1023/B:FISH.0000030544.64774.f6; SUH TT, 1994, J BIOL CHEM, V269, P25992; TILSON MB, 1995, ARTIFICIAL IMPRINTIN; Ueda H, 2007, AM FISH S S, V54, P5; Ueda K, 1985, NOAA TECH REP NMFS, V27, P97; WISBY WARREN J., 1954, JOUR FISH RES BD CANADA, V11, P472; Yamada H, 1997, GEN COMP ENDOCR, V106, P181, DOI 10.1006/gcen.1996.6861; Yamamoto Y, 2009, ZOOL SCI, V26, P778, DOI 10.2108/zsj.26.778	42	57	62	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8633	10.1371/journal.pone.0008633	http://dx.doi.org/10.1371/journal.pone.0008633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062811	Green Published, gold			2022-12-27	WOS:000273414200011
J	Tondeur, S; Pangault, C; Le Carrour, T; Lannay, Y; Benmahdi, R; Cubizolle, A; Assou, S; Pantesco, V; Klein, B; Hamamah, S; Schved, JF; Fest, T; De Vos, J				Tondeur, Sylvie; Pangault, Celine; Le Carrour, Tanguy; Lannay, Yoann; Benmahdi, Rima; Cubizolle, Aurelie; Assou, Said; Pantesco, Veronique; Klein, Bernard; Hamamah, Samir; Schved, Jean-Francois; Fest, Thierry; De Vos, John			Expression Map of the Human Exome in CD34+Cells and Blood Cells: Increased Alternative Splicing in Cell Motility and Immune Response Genes	PLOS ONE			English	Article							HUMAN GENOME; RNA; CANCER; TRANSCRIPTION; MICROARRAYS; ANNOTATION; PROMOTERS; VARIANTS; REVEALS; DISEASE	Background: Hematopoietic cells are endowed with very specific biological functions, including cell motility and immune response. These specific functions are dramatically altered during hematopoietic cell differentiation, whereby undifferentiated hematopoietic stem and progenitor cells (HSPC) residing in bone marrow differentiate into platelets, red blood cells and immune cells that exit into the blood stream and eventually move into lymphoid organs or inflamed tissues. The contribution of alternative splicing (AS) to these functions has long been minimized due to incomplete knowledge on AS events in hematopoietic cells. Principal Findings: Using Human Exon ST 1.0 microarrays, the entire exome expression profile of immature CD34+ HSPC and mature whole blood cells was mapped, compared to a collection of solid tissues and made freely available as an online exome expression atlas (Amazonia Exon! : http://amazonia.transcriptome.eu/exon.php). At a whole transcript level, HSPC strongly expressed EREG and the pluripotency marker DPPA4. Using a differential splicing index scheme (dsi), a list of 849 transcripts differentially expressed between hematopoietic cells and solid tissues was computed, that included NEDD9 and CD74. Some of these genes also underwent alternative splicing events during hematopoietic differentiation, such as INPP4B, PTPLA or COMMD6, with varied contribution of CD3+ T cells, CD19+ B cells, CD14+ or CD15+ myelomonocytic populations. Strikingly, these genes were significantly enriched for genes involved in cell motility, cell adhesion, response to wounding and immune processes. Conclusion: The relevance and the precision provided by this exon expression map highlights the contribution of alternative splicing to key feature of blood cells differentiation and function.	[Tondeur, Sylvie; Le Carrour, Tanguy; Assou, Said; Klein, Bernard; Hamamah, Samir; De Vos, John] CHU Montpellier, Hop St Eloi, Inst Res Biotherapy, Montpellier, France; [Tondeur, Sylvie; Le Carrour, Tanguy; Benmahdi, Rima; Cubizolle, Aurelie; Assou, Said; Pantesco, Veronique; Klein, Bernard; Hamamah, Samir; De Vos, John] INSERM, U847, Montpellier, France; [Tondeur, Sylvie; Klein, Bernard; Hamamah, Samir; Schved, Jean-Francois; De Vos, John] Univ Montpellier 1, UFR Med, Montpellier, France; [Pangault, Celine; Fest, Thierry] CHU Rennes, Hematol Lab, Rennes, France; [Pangault, Celine; Fest, Thierry] Univ Rennes 1, INSERM, U917, UFR Med, Rennes, France; [Lannay, Yoann; Hamamah, Samir] CHU Montpellier, Unite Biol Clin AMP DPI, Hop Arnaud Villeneuve, Montpellier, France; [Schved, Jean-Francois] CHU Montpellier, Hematol Lab, Hop St Eloi, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Tondeur, S (corresponding author), CHU Montpellier, Hop St Eloi, Inst Res Biotherapy, Montpellier, France.	john.devos@inserm.fr	De Vos, John/A-5703-2010; Pangault, Celine/C-3254-2017	De Vos, John/0000-0003-1880-4130; Pangault, Celine/0000-0003-3978-2209; Schved, Jean-Francois/0000-0003-0332-3254; fest, thierry/0000-0002-6437-4189; assou, said/0000-0001-6448-7995	Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS); Societe Francaise d'Hematologie (SFH)	Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS); Societe Francaise d'Hematologie (SFH)	This work was supported by Roche, the Groupe Ouest Est des Leucemies et Autres Maladies du Sang (GOELAMS) group and the Societe Francaise d'Hematologie (SFH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Bonafoux B, 2004, HAEMATOLOGICA, V89, P1434; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; de Bie P, 2006, BIOCHEM J, V398, P63, DOI 10.1042/BJ20051664; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; French PJ, 2007, CANCER RES, V67, P5635, DOI 10.1158/0008-5472.CAN-06-2869; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Gooding C, 2008, ADV EXP MED BIOL, V644, P27; Inamoto S, 2007, ONCOGENE, V26, P893, DOI 10.1038/sj.onc.1209848; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Maldonado-Saldivia J, 2007, STEM CELLS, V25, P19, DOI 10.1634/stemcells.2006-0269; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Pangoult C, 2007, M S-MED SCI, V23, P13, DOI 10.1051/medsci/2007231s13; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Revillion F, 2008, ANN ONCOL, V19, P73, DOI 10.1093/annonc/mdm431; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yates T, 2008, NUCLEIC ACIDS RES, V36, pD780, DOI 10.1093/nar/gkm779	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8990	10.1371/journal.pone.0008990	http://dx.doi.org/10.1371/journal.pone.0008990			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126548	Green Published, Green Submitted, gold			2022-12-27	WOS:000274209700016
J	Gilani, SR; Vuga, LJ; Lindell, KO; Gibson, KF; Xue, JM; Kaminski, N; Valentine, VG; Lindsay, EK; George, MP; Steele, C; Duncan, SR				Gilani, Syed R.; Vuga, Louis J.; Lindell, Kathleen O.; Gibson, Kevin F.; Xue, Jianmin; Kaminski, Naftali; Valentine, Vincent G.; Lindsay, Emily K.; George, M. Patricia; Steele, Chad; Duncan, Steven R.			CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; IDENTIFICATION; COSTIMULATION; PROLIFERATION; AUTOANTIGEN; LYMPHOCYTES; EXPANSIONS; SENESCENCE; EXPRESSION	Background: Although the etiology of idiopathic pulmonary fibrosis (IPF) remains perplexing, adaptive immune activation is evident among many afflicted patients. Repeated cycles of antigen-induced proliferation cause T-cells to lose surface expression of CD28, and we hypothesized this process might also occur in IPF. Methodology/Principal Findings: Peripheral blood CD4 T-cells from 89 IPF patients were analyzed by flow cytometry and cytokine multiplex assays, and correlated with clinical events. In comparison to autologous CD4(+) CD28(+) cells, the unusual CD4(+) CD28(null) lymphocytes seen in many IPF patients had discordant expressions of activation markers, more frequently produced cytotoxic mediators perforin (2.4 +/- 0.8% vs. 60.0 +/- 7.4%, p<0.0001) and granzyme B (4.5 +/- 2.8% vs. 74.9 +/- 6.5%, p<0.0001), produced greater amounts of many pro-inflammatory cytokines, and less frequently expressed the regulatory T-cell marker FoxP3 (12.9 +/- 1.1% vs. 3.3 +/- 0.6% p<0.0001). Infiltration of CD4(+) CD28(null) T-cells in IPF lungs was confirmed by confocal microscopy. Interval changes of CD28 expression among subjects who had replicate studies were correlated with conterminous changes of their forced vital capacities (r(s) = 0.49, p = 0.012). Most importantly, one-year freedom from major adverse clinical events (either death or lung transplantation) was 56 +/- 6% among 78 IPF patients with CD4(+) CD28(+)/CD4(total)>= 82%, compared to 9 +/- 9% among those with more extensive CD28 down-regulation (CD4(+) CD28(+)/CD4(total)<82%) (p = 0.0004). The odds ratio for major adverse events among those with the most extensive CD28 down-regulation was 13.0, with 95% confidence intervals 1.6-111.1. Conclusions/Significance: Marked down-regulation of CD28 on circulating CD4 T-cells, a result of repeated antigen-driven proliferations, is associated with poor outcomes in IPF patients. The CD4(+) CD28(null) cells of these patients have potentially enhanced pathogenic characteristics, including increased productions of cytotoxic mediators and pro-inflammatory cytokines. These findings show proliferative T-cell responses to antigen(s) resulting in CD28 down-regulation are associated with progression and manifestations of IPF, and suggest assays of circulating CD4 T-cells may identify patients at greatest risk for clinical deterioration.	[Gilani, Syed R.; Vuga, Louis J.; Lindell, Kathleen O.; Gibson, Kevin F.; Xue, Jianmin; Kaminski, Naftali; Lindsay, Emily K.; George, M. Patricia; Duncan, Steven R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Valentine, Vincent G.] Univ Texas Med Branch, Dept Med, Galveston, TX USA; [Steele, Chad] Univ Alabama, Dept Med, Birmingham, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston; University of Alabama System; University of Alabama Birmingham	Gilani, SR (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu	Lindell, Kathleen Oare/GQQ-6372-2022; Lindsay, Emily/AAF-7246-2021	Lindsay, Emily/0000-0002-5314-9517; Kaminski, Naftali/0000-0001-5917-4601; George, Marjorie Patricia/0000-0002-6534-1020	U.S. National Institutes of Health [1RO1HL073241, 1P50 HL084932, 5T32 HL007563]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073241, P50HL084932, T32HL007563] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This research was supported in part by U. S. National Institutes of Health grants 1RO1HL073241, 1P50 HL084932, and 5T32 HL007563. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Atamas SP, 2002, J IMMUNOL, V168, P1139, DOI 10.4049/jimmunol.168.3.1139; Barbas-Filho JV, 2001, J CLIN PATHOL, V54, P132, DOI 10.1136/jcp.54.2.132; Collard HR, 2004, AM J RESP CRIT CARE, V169, P1076; Colombatti A, 1998, CLIN IMMUNOL IMMUNOP, V89, P61, DOI 10.1006/clin.1998.4580; Conti P, 2003, IMMUNOL LETT, V86, P123, DOI 10.1016/S0165-2478(03)00002-6; Dobashi N, 2000, LUNG, V178, P171, DOI 10.1007/s004080000020; DUFFNER C, 2005, ARTERIOSCLER THROMB, V25, P1347; Duncan SR, 2002, AM J RESP CRIT CARE, V165, P1439, DOI 10.1164/rccm.2107009; Fasth AER, 2009, J IMMUNOL, V183, P4792, DOI 10.4049/jimmunol.0803688; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fontenot AP, 2003, J CLIN INVEST, V112, P776, DOI 10.1172/JCI200318317; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Hirokawa M, 2001, BONE MARROW TRANSPL, V27, P1095, DOI 10.1038/sj.bmt.1703045; Homolka J, 2003, RESPIRATION, V70, P262, DOI 10.1159/000072007; JENDRO MC, 1995, ARTHRITIS RHEUM, V38, P1242, DOI 10.1002/art.1780380912; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Kitani A, 2003, J EXP MED, V198, P1179, DOI 10.1084/jem.20030917; Komocsi A, 2002, AM J PATHOL, V160, P1717, DOI 10.1016/S0002-9440(10)61118-2; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; KRENSKY AM, 1990, NEW ENGL J MED, V322, P510, DOI 10.1056/NEJM199002223220805; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lambers C, 2009, CLIN EXP IMMUNOL, V155, P466, DOI 10.1111/j.1365-2249.2008.03835.x; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Magro CM, 2006, HUM IMMUNOL, V67, P284, DOI 10.1016/j.humimm.2006.02.026; Marchal-Somme J, 2006, J IMMUNOL, V176, P5735, DOI 10.4049/jimmunol.176.10.5735; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; Mason DP, 2007, ANN THORAC SURG, V84, P1121, DOI 10.1016/j.athoracsur.2007.04.096; Miyazaki H, 2004, J CLIN PATHOL, V57, P1292, DOI 10.1136/jcp.2003.015495; Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Pignatti P, 2006, AM J RESP CRIT CARE, V173, P310, DOI 10.1164/rccm.200502-244OC; Rosas IO, 2007, AM J RESP CRIT CARE, V176, P698, DOI 10.1164/rccm.200702-254OC; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Scheibenbogen C, 2000, J IMMUNOL METHODS, V244, P81, DOI 10.1016/S0022-1759(00)00257-X; Schirmer M, 1998, J IMMUNOL, V161, P1018; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shimizudani N, 2002, CLIN EXP IMMUNOL, V129, P140, DOI 10.1046/j.1365-2249.2002.01871.x; Studer SM, 2008, AM J RESP CRIT CARE, V178, P765, DOI 10.1164/rccm.200701-013OC; Tai XG, 2005, NAT IMMUNOL, V6, P152, DOI 10.1038/ni1160; Takahashi T, 2007, RESPIROLOGY, V12, P642, DOI 10.1111/j.1440-1843.2007.01140.x; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; WALLACE WAH, 1994, THORAX, V49, P1139, DOI 10.1136/thx.49.11.1139; WESTERMANN J, 1992, CLIN INVESTIGATOR, V70, P539; Zal B, 2004, CIRCULATION, V109, P1230, DOI 10.1161/01.CIR.0000118476.29352.2A; Zhu XH, 2009, J IMMUNOL, V182, P3270, DOI 10.4049/jimmunol.0802622	52	137	145	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8959	10.1371/journal.pone.0008959	http://dx.doi.org/10.1371/journal.pone.0008959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126467	Green Published, Green Accepted, gold			2022-12-27	WOS:000274139100008
J	Spurney, CF; Cha, HJ; Sali, A; Pandey, GS; Pistilli, E; Guerron, AD; Gordish-Dressman, H; Hoffman, EP; Nagaraju, K				Spurney, Christopher F.; Cha, Hee-Jae; Sali, Arpana; Pandey, Gouri S.; Pistilli, Emidio; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina			Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin beta-4 in the Dystrophin Deficient Mouse	PLOS ONE			English	Article							ACTIN-SEQUESTERING PEPTIDE; NF-KAPPA-B; MDX MOUSE; GENE-EXPRESSION; MUSCULAR-DYSTROPHY; REGENERATION; CARDIOMYOPATHY; EVOLUTION; DIAPHRAGM; BETA(4)	Thymosin beta-4 (T beta 4) is a ubiquitous protein with many properties relating to cell proliferation and differentiation that promotes wound healing and modulates inflammatory mediators. We studied the effects of chronic administration of T beta 4 on the skeletal and cardiac muscle of dystrophin deficient mdx mice, the mouse model of Duchenne muscular dystrophy. Female wild type (C57BL10/ScSnJ) and mdx mice, 8-10 weeks old, were treated with 150 mu g of T beta 4 twice a week for 6 months. To promote muscle pathology, mice were exercised for 30 minutes twice a week. Skeletal and cardiac muscle function were assessed via grip strength and high frequency echocardiography. Localization of T beta 4 and amount of fibrosis were quantified using immunohistochemistry and Gomori's tri-chrome staining, respectively. Mdx mice treated with T beta 4 showed a significant increase in skeletal muscle regenerating fibers compared to untreated mdx mice. T beta 4 stained exclusively in the regenerating fibers of mdx mice. Although untreated mdx mice had significantly decreased skeletal muscle strength compared to untreated wild type, there were no significant improvements in mdx mice after treatment. Systolic cardiac function, measured as percent shortening fraction, was decreased in untreated mdx mice compared to untreated wild type and there was no significant difference after treatment in mdx mice. Skeletal and cardiac muscle fibrosis were also significantly increased in untreated mdx mice compared to wild type, but there was no significant improvement in treated mdx mice. In exercised dystrophin deficient mice, chronic administration of T beta 4 increased the number of regenerating fibers in skeletal muscle and could have a potential role in treatment of skeletal muscle disease in Duchenne muscular dystrophy.	[Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA; [Cha, Hee-Jae] Kosin Univ, Coll Med, Dept Parasitol & Genet, Pusan, South Korea; [Sali, Arpana; Pandey, Gouri S.; Guerron, Alfredo D.; Gordish-Dressman, Heather; Hoffman, Eric P.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DE USA; [Pistilli, Emidio] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA	Children's National Health System; University of Pennsylvania	Spurney, CF (corresponding author), Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA.	knagaraju@cnmcresearch.org	Nagaraju, Kanneboyina/AAV-7684-2021; Cha, Hee-Jae/AFO-8772-2022; Nagaraju, Kanneboyina/ABA-6525-2021; Cruz, Alfredo Daniel Guerron/V-5188-2019	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award [K12HD001399-04, 1U54HD053177-01A1, R01-AR050478]; Department of Defense United States Army Medical Research Acquisition Activity [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001399] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Department of Defense United States Army Medical Research Acquisition Activity(United States Department of Defense); Foundation to Eradicate Duchenne, Inc.; Muscular Dystrophy Association(Muscular Dystrophy Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding: This work was supported by funding provided by the following: National Institutes of Health (NIH)/National Institute of Child Health and Human Development/Child Health Research Career Development Award K12HD001399-04 (PI: Spurney); Department of Defense United States Army Medical Research Acquisition Activity grant W81XWH-05-1-0616 (Mouse Drug Screening Core to K. Nagaraju and E. Hoffman), Foundation to Eradicate Duchenne, Inc. (www.duchennemd.org), Muscular Dystrophy Association (www.mda.org), Charley's Fund (K. Nagaraju)(www. charleysfund. com), NIH grant 1U54HD053177-01A1 (Wellstone Muscular Dystrophy Center to E. Hoffman and K. Nagaraju), and NIH grant R01-AR050478 (K. Nagaraju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Baudy AR, 2009, INT IMMUNOPHARMACOL, V9, P1209, DOI 10.1016/j.intimp.2009.07.001; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Cavasin MA, 2007, HYPERTENSION, V50, P130, DOI 10.1161/HYPERTENSIONAHA.106.084103; De Luca A, 2003, J PHARMACOL EXP THER, V304, P453, DOI 10.1124/jpet.102.041343; Hannappel E, 2003, VITAM HORM, V66, P257, DOI 10.1016/S0083-6729(03)01007-0; Hara Takahiko, 2005, Rinsho Shinkeigaku, V45, P880; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Malinda KM, 1999, J INVEST DERMATOL, V113, P364, DOI 10.1046/j.1523-1747.1999.00708.x; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Mora CA, 1997, INT J IMMUNOPHARMACO, V19, P1, DOI 10.1016/S0192-0561(97)00005-2; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; OATES KK, 1995, BIOL THERAPY CANC, P841; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Philp D, 2003, FASEB J, V17, P385, DOI 10.1096/fj.03-0244fje; Pokharel S, 2004, CIRCULATION, V110, P3129, DOI 10.1161/01.CIR.0000147180.87553.79; Porter JD, 2004, HUM MOL GENET, V13, P257, DOI 10.1093/hmg/ddh033; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Reti R, 2008, EUR J ORAL SCI, V116, P424, DOI 10.1111/j.1600-0722.2008.00569.x; Rouger K, 2002, AM J PHYSIOL-CELL PH, V283, pC773, DOI 10.1152/ajpcell.00112.2002; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; SAFER D, 1991, J BIOL CHEM, V266, P4029; SAFER D, 1990, P NATL ACAD SCI USA, V87, P2536, DOI 10.1073/pnas.87.7.2536; SANDERS MC, 1992, P NATL ACAD SCI USA, V89, P4678, DOI 10.1073/pnas.89.10.4678; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Sosne G, 2002, EXP EYE RES, V74, P293, DOI 10.1006/exer.2001.1125; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Sosne G, 2001, EXP EYE RES, V72, P605, DOI 10.1006/exer.2000.0985; Sosne G, 2007, EXP EYE RES, V84, P663, DOI 10.1016/j.exer.2006.12.004; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; TIETZ N, 1982, FUNDAMENTALS CLIN CH, P682; Tseng BS, 2002, J APPL PHYSIOL, V93, P537, DOI 10.1152/japplphysiol.00202.2002; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; WEBER A, 1992, BIOCHEMISTRY-US, V31, P6179, DOI 10.1021/bi00142a002; Zhang YQ, 2008, CANCER BIOL THER, V7, P419, DOI 10.4161/cbt.7.3.5415	40	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8976	10.1371/journal.pone.0008976	http://dx.doi.org/10.1371/journal.pone.0008976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126456	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100022
J	Clarke, ND; Bourque, G				Clarke, Neil D.; Bourque, Guillaume			Success in the DREAM3 Signaling Response Challenge Using Simple Weighted-Average Imputation: Lessons for Community-Wide Experiments in Systems Biology	PLOS ONE			English	Article							CASP7 PREDICTIONS; TARGETS	Our group produced the best predictions overall in the DREAM3 signaling response challenge, being tops by a substantial margin in the cytokine sub-challenge and nearly tied for best in the phosphoprotein sub-challenge. We achieved this success using a simple interpolation strategy. For each combination of a stimulus and inhibitor for which predictions were required, we had noted there were six other datasets using the same stimulus (but different inhibitor treatments) and six other datasets using the same inhibitor (but different stimuli). Therefore, for each treatment combination for which values were to be predicted, we calculated rank correlations for the data that were in common between the treatment combination and each of the 12 related combinations. The data from the 12 related combinations were then used to calculate missing values, weighting the contributions from each experiment based on the rank correlation coefficients. The success of this simple method suggests that the missing data were largely over-determined by similarities in the treatments. We offer some thoughts on the current state and future development of DREAM that are based on our success in this challenge, our success in the earlier DREAM2 transcription factor target challenge, and our experience as the data provider for the gene expression challenge in DREAM3.	[Clarke, Neil D.; Bourque, Guillaume] Genome Inst Singapore, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Clarke, ND (corresponding author), Genome Inst Singapore, Singapore, Singapore.	clarken@gis.a-star.edu.sg	Bourque, Guillaume/AFR-2927-2022; Clarke, Neil/D-9613-2014	Bourque, Guillaume/0000-0002-3933-9656; 	Agency for Science, Technology and Research (Singapore)	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR))	This work was funded by the Agency for Science, Technology and Research (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753; Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662; Vega VB, 2009, ANN NY ACAD SCI, V1158, P215, DOI 10.1111/j.1749-6632.2008.03759.x; 2009, PLOS ONE, P1	4	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8417	10.1371/journal.pone.0008417	http://dx.doi.org/10.1371/journal.pone.0008417			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126276	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500002
J	Gonzalez-Cabo, P; Ros, S; Palau, F				Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc			Flavin Adenine Dinucleotide Rescues the Phenotype of Frataxin Deficiency	PLOS ONE			English	Article							COMPLEX-I DEFICIENCY; PLACEBO-CONTROLLED TRIAL; FRIEDREICHS-ATAXIA; SACCHAROMYCES-CEREVISIAE; IDEBENONE TREATMENT; OXIDATIVE-PHOSPHORYLATION; DEHYDROGENASE DEFICIENCY; MITOCHONDRIAL IRON; RESPIRATORY-CHAIN; BETA-OXIDATION	Background: Friedreich ataxia is a neurodegenerative disease caused by the lack of frataxin, a mitochondrial protein. We previously demonstrated that frataxin interacts with complex II subunits of the electronic transport chain (ETC) and putative electronic transfer flavoproteins, suggesting that frataxin could participate in the oxidative phosphorylation. Methods and Findings: Here we have investigated the effect of riboflavin and its cofactors flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) in Saccharomyces cerevisiae and Caenorhabditis elegans models of frataxin deficiency. We used a S. cerevisiae strain deleted for the yfh1 gene obtained by homologous recombination and we assessed growth in fermentable and non-fermentable cultures supplemented with either riboflavin or its derivates. Experiments with C. elegans were performed in transient knock-down worms (frh-1[RNAi]) generated by microinjection of dsRNA frh-1 into the gonads of young worms. We observed that FAD rescues the phenotype of both defective organisms. We show that cell growth and enzymatic activities of the ETC complexes and ATP production of yfh1 Delta cells were improved by FAD supplementation. Moreover, FAD also improved lifespan and other physiological parameters in the C. elegans knock-down model for frataxin. Conclusions/Significance: We propose that rescue of frataxin deficiency by FAD supplementation could be explained by an improvement in mitochondrial respiration. We suggest that riboflavin may be useful in the treatment of Friedreich ataxia.	[Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc] CSIC, Inst Biomed, Lab Genet & Mol Med, Valencia, Spain; [Gonzalez-Cabo, Pilar; Ros, Sheila; Palau, Francesc] CIBERER, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gonzalez-Cabo, P (corresponding author), CSIC, Inst Biomed, Lab Genet & Mol Med, Valencia, Spain.	fpalau@ibv.csic.es	González-Cabo, Pilar/ABG-5080-2020; Gonzalez-Cabo, Pilar/H-1862-2015; Palau, Francesc/A-9391-2014	González-Cabo, Pilar/0000-0003-3131-6334; Gonzalez-Cabo, Pilar/0000-0003-3131-6334; Palau, Francesc/0000-0002-8635-5421	Spanish Ministry of Science and Innovation [SAF2006-01047, SAF2009-07063]; Generalitat Valenciana [Prometeo/2009/051]; Instituto de Salud Carlos III; Plan Nacional I+D+I	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Plan Nacional I+D+I	This work has been supported by the Spanish Ministry of Science and Innovation (grants SAF2006-01047 and SAF2009-07063) and the Generalitat Valenciana (grant Prometeo/2009/051). The CIBERER is funded by the Instituto de Salud Carlos III and the Plan Nacional I+D+I 2008-2011, and is an initiative of Ingenio 2010, Consolider Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTOZZI C, 1994, NEUROLOGY, V44, P2153, DOI 10.1212/WNL.44.11.2153; AVERY L, 1997, C ELEGANS, V2, P679, DOI [10.1101/087969532.33.679, DOI 10.1101/087969532.33.679]; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; BELL RB, 1990, NEUROLOGY, V40, P1779, DOI 10.1212/WNL.40.11.1779; BENTLAGE H, 1995, EUR J BIOCHEM, V227, P909, DOI 10.1111/j.1432-1033.1995.tb20218.x; BERNSEN PLJA, 1993, J NEUROL SCI, V118, P181, DOI 10.1016/0022-510X(93)90108-B; Boddaert N, 2007, BLOOD, V110, P401, DOI 10.1182/blood-2006-12-065433; BRENNER S, 1974, GENETICS, V77, P71; Bugiani M, 2006, BRAIN DEV-JPN, V28, P576, DOI 10.1016/j.braindev.2006.04.001; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Buyse G, 2003, NEUROLOGY, V60, P1679, DOI 10.1212/01.WNL.0000068549.52812.0F; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Castro M, 2000, HUM GENET, V106, P86, DOI 10.1007/s004399900201; Di Prospero NA, 2007, LANCET NEUROL, V6, P878, DOI 10.1016/S1474-4422(07)70220-X; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Eaton S, 2002, PROG LIPID RES, V41, P197, DOI 10.1016/S0163-7827(01)00024-8; Festenstein R, 2006, NAT CHEM BIOL, V2, P512, DOI 10.1038/nchembio1006-512; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2; Gold DR, 2001, SEMIN NEUROL, V21, P309, DOI 10.1055/s-2001-17948; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; Grant L, 2006, FEBS LETT, V580, P5399, DOI 10.1016/j.febslet.2006.09.006; GREGERSEN N, 1985, J INHERIT METAB DIS, V8, P65, DOI 10.1007/BF01800662; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; KMOCH S, 1995, J INHERIT METAB DIS, V18, P227, DOI 10.1007/BF00711774; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Mariotti C, 2003, NEUROLOGY, V60, P1676, DOI 10.1212/01.WNL.0000055872.50364.FC; Murphy MP, 2001, EXPERT OPIN BIOL TH, V1, P753, DOI 10.1517/14712598.1.5.753; Ogle RF, 1997, J PEDIATR-US, V130, P138, DOI 10.1016/S0022-3476(97)70323-8; PENN AMW, 1992, NEUROLOGY, V42, P2147, DOI 10.1212/WNL.42.11.2147; Pinard JM, 1999, ARCH PEDIATRIE, V6, P421, DOI 10.1016/S0929-693X(99)80224-3; Pineda M, 2008, EUR J PAEDIATR NEURO, V12, P470, DOI 10.1016/j.ejpn.2007.11.006; Priller J, 1997, ANN NEUROL, V42, P265, DOI 10.1002/ana.410420222; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Ramazzotti A, 2004, FEBS LETT, V557, P215, DOI 10.1016/S0014-5793(03)01498-4; Reihl P, 2005, J BIOL CHEM, V280, P39809, DOI 10.1074/jbc.M505002200; Richardson DR, 2001, BBA-MOL BASIS DIS, V1536, P133, DOI 10.1016/S0925-4439(01)00041-2; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schols L, 2001, NEUROSCI LETT, V306, P169, DOI 10.1016/S0304-3940(01)01892-4; SCHOLTE HR, 1995, BBA-MOL BASIS DIS, V1271, P75, DOI 10.1016/0925-4439(95)00013-T; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P331, DOI 10.1007/BF02435969; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Vergani L, 1999, BRAIN, V122, P2401, DOI 10.1093/brain/122.12.2401; Waldvogel D, 1999, ANN NEUROL, V46, P123, DOI 10.1002/1531-8249(199907)46:1<123::AID-ANA19>3.0.CO;2-H; YILMAZ K, 2008, EUR J PAEDIAT NEUROL; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i	55	32	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8872	10.1371/journal.pone.0008872	http://dx.doi.org/10.1371/journal.pone.0008872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111601	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300021
J	Wilson, SP; Law, JS; Mitchinson, B; Prescott, TJ; Bednar, JA				Wilson, Stuart P.; Law, Judith S.; Mitchinson, Ben; Prescott, Tony J.; Bednar, James A.			Modeling the Emergence of Whisker Direction Maps in Rat Barrel Cortex	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; THALAMOCORTICAL RESPONSE TRANSFORMATIONS; SOMATOSENSORY CORTEX; SELF-ORGANIZATION; RECEPTIVE-FIELDS; IN-VIVO; SPATIOTEMPORAL DYNAMICS; FEEDFORWARD INHIBITION; HORIZONTAL CONNECTIONS; THALAMIC BARRELOIDS	Based on measuring responses to rat whiskers as they are mechanically stimulated, one recent study suggests that barrel-related areas in layer 2/3 rat primary somatosensory cortex (S1) contain a pinwheel map of whisker motion directions. Because this map is reminiscent of topographic organization for visual direction in primary visual cortex (V1) of higher mammals, we asked whether the S1 pinwheels could be explained by an input-driven developmental process as is often suggested for V1. We developed a computational model to capture how whisker stimuli are conveyed to supragranular S1, and simulate lateral cortical interactions using an established self-organizing algorithm. Inputs to the model each represent the deflection of a subset of 25 whiskers as they are contacted by a moving stimulus object. The subset of deflected whiskers corresponds with the shape of the stimulus, and the deflection direction corresponds with the movement direction of the stimulus. If these two features of the inputs are correlated during the training of the model, a somatotopically aligned map of direction emerges for each whisker in S1. Predictions of the model that are immediately testable include (1) that somatotopic pinwheel maps of whisker direction exist in adult layer 2/3 barrel cortex for every large whisker on the rat's face, even peripheral whiskers; and (2) in the adult, neurons with similar directional tuning are interconnected by a network of horizontal connections, spanning distances of many whisker representations. We also propose specific experiments for testing the predictions of the model by manipulating patterns of whisker inputs experienced during early development. The results suggest that similar intracortical mechanisms guide the development of primate V1 and rat S1.	[Wilson, Stuart P.; Law, Judith S.; Bednar, James A.] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland; [Wilson, Stuart P.; Mitchinson, Ben; Prescott, Tony J.] Univ Sheffield, Act Touch Lab, Sheffield, S Yorkshire, England	University of Edinburgh; University of Sheffield	Wilson, SP (corresponding author), Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland.	S.P.Wilson@Sheffield.ac.uk	Prescott, Tony J/A-7574-2008	Prescott, Tony J/0000-0003-4927-5390; Wilson, Stuart/0000-0001-8125-5133	European Union [215910]; Engineering and Physical Sciences Research Council [EP/P504759/1]	European Union(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by European Union Framework 7 ICT Project 215910 (BIOTACT, www.biotact.org), and Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant EP/P504759/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima A, 2006, CEREB CORTEX, V16, P1202, DOI 10.1093/cercor/bhj061; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; Bale MR, 2009, J NEUROPHYSIOL, V102, P2771, DOI 10.1152/jn.00636.2009; Bednar JA, 2004, NEUROCOMPUTING, V58, P1129, DOI 10.1016/j.neucom.2004.01.177; Bednar JA, 2003, NEUROCOMPUTING, V52-4, P473, DOI 10.1016/SO925-2312(02)00735-X; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Bosking WH, 1997, J NEUROSCI, V17, P2112; Brecht M, 2002, J PHYSIOL-LONDON, V538, P495, DOI 10.1113/jphysiol.2001.012334; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; Bruno RM, 2009, J NEUROSCI, V29, P3172, DOI 10.1523/JNEUROSCI.5911-08.2009; Bruno RM, 2003, J NEUROSCI, V23, P9565; Bruno RM, 2002, J NEUROSCI, V22, P10966; Burger T, 2001, Z NATURFORSCH C, V56, P464; Derdikman D, 2003, J NEUROSCI, V23, P3100; Drew PJ, 2007, J NEUROPHYSIOL, V98, P1566, DOI 10.1152/jn.00056.2007; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2006, J PHYSIOL-LONDON, V575, P583, DOI 10.1113/jphysiol.2006.105106; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fox C, 2009, AUTON ROBOT, V26, P223, DOI 10.1007/s10514-009-9109-z; Fox K, 2005, NEURON, V48, P465, DOI 10.1016/j.neuron.2005.10.013; Furuta T, 2006, J NEUROSCI, V26, P10548, DOI 10.1523/JNEUROSCI.1746-06.2006; Ghazanfar AA, 1999, CEREB CORTEX, V9, P348, DOI 10.1093/cercor/9.4.348; Golomb D, 2006, J NEUROPHYSIOL, V95, P1735, DOI 10.1152/jn.00734.2005; Grant RA, 2009, J NEUROPHYSIOL, V101, P862, DOI 10.1152/jn.90783.2008; Hartings JA, 2000, J NEUROPHYSIOL, V83, P2791, DOI 10.1152/jn.2000.83.5.2791; Helmstaedter M, 2009, CEREB CORTEX, V19, P951, DOI 10.1093/cercor/bhn130; Higley MJ, 2007, J NEUROPHYSIOL, V97, P647, DOI 10.1152/jn.00777.2006; Jacob V, 2008, NEURON, V60, P1112, DOI 10.1016/j.neuron.2008.10.017; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kerr JND, 2007, J NEUROSCI, V27, P13316, DOI 10.1523/JNEUROSCI.2210-07.2007; Khatri V, 2007, CEREB CORTEX, V17, P599, DOI 10.1093/cercor/bhk006; Kida H, 2005, J NEUROPHYSIOL, V94, P2004, DOI 10.1152/jn.00113.2004; Krupa DJ, 2001, J NEUROSCI METH, V104, P199, DOI 10.1016/S0165-0270(00)00345-9; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Lavallee P, 2004, J NEUROSCI, V24, P6098, DOI 10.1523/JNEUROSCI.0973-04.2004; Lee SH, 2004, J NEUROPHYSIOL, V91, P223, DOI 10.1152/jn.00541.2003; Li L, 2007, J NEUROSCI, V27, P167, DOI 10.1523/JNEUROSCI.4165-06.2007; Li Y, 2006, NAT NEUROSCI, V9, P676, DOI 10.1038/nn1684; Martin KAC, 2002, CURR OPIN NEUROBIOL, V12, P418, DOI 10.1016/S0959-4388(02)00343-4; Miikkulainen R, 2005, COMPUTATIONAL MAPS V; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Mitchinson B, 2004, P ROY SOC B-BIOL SCI, V271, P2509, DOI 10.1098/rspb.2004.2882; Mitchinson B, 2008, BIOL CYBERN, V98, P185, DOI 10.1007/s00422-007-0208-7; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Neimark MA, 2003, J NEUROSCI, V23, P6499; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pinto DJ, 1996, J COMPUT NEUROSCI, V3, P247, DOI 10.1007/BF00161134; Polley DB, 2005, NEUROBIOL LEARN MEM, V83, P134, DOI 10.1016/j.nlm.2004.10.005; Puccini GD, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000137; Ren M, 2007, SCIENCE, V316, P758, DOI 10.1126/science.1135468; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; Sarid L, 2007, P NATL ACAD SCI USA, V104, P16353, DOI 10.1073/pnas.0707853104; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Shimegi S, 1999, J NEUROSCI, V19, P10164; Shoykhet M, 2008, J NEUROPHYSIOL, V99, P356, DOI 10.1152/jn.01063.2007; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; SIMONS DJ, 1989, J NEUROPHYSIOL, V61, P311, DOI 10.1152/jn.1989.61.2.311; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Sirosh J, 1997, NEURAL COMPUT, V9, P577, DOI 10.1162/neco.1997.9.3.577; Somers DC, 1998, CEREB CORTEX, V8, P204, DOI 10.1093/cercor/8.3.204; Stafford T, 2007, NEUROCOMPUTING, V70, P1932, DOI 10.1016/j.neucom.2006.10.134; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Swadlow HA, 2002, PHILOS T R SOC B, V357, P1717, DOI 10.1098/rstb.2002.1156; Swadlow HA, 2002, NAT NEUROSCI, V5, P403, DOI 10.1038/nn847; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; Temereanca S, 2004, NEURON, V41, P639, DOI 10.1016/S0896-6273(04)00046-7; Timofeeva E, 2003, J NEUROSCI, V23, P10717; Wallace H, 1999, SOMATOSENS MOT RES, V16, P122; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Wirth C, 2004, J NEUROPHYSIOL, V91, P1635, DOI 10.1152/jn.00950.2003	78	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8778	10.1371/journal.pone.0008778	http://dx.doi.org/10.1371/journal.pone.0008778			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107500	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000273896100003
J	Allgaier, M; Reddy, A; Park, JI; Ivanova, N; D'haeseleer, P; Lowry, S; Sapra, R; Hazen, TC; Simmons, BA; VanderGheynst, JS; Hugenholtz, P				Allgaier, Martin; Reddy, Amitha; Park, Joshua I.; Ivanova, Natalia; D'haeseleer, Patrik; Lowry, Steve; Sapra, Rajat; Hazen, Terry C.; Simmons, Blake A.; VanderGheynst, Jean S.; Hugenholtz, Philip			Targeted Discovery of Glycoside Hydrolases from a Switchgrass-Adapted Compost Community	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BOVINE RUMEN; BIOFUELS; BIOMASS; DEGRADATION; DECOMPOSITION; STRAW; METAGENOMICS; ENVIRONMENT; MICROBIOME	Development of cellulosic biofuels from non-food crops is currently an area of intense research interest. Tailoring depolymerizing enzymes to particular feedstocks and pretreatment conditions is one promising avenue of research in this area. Here we added a green-waste compost inoculum to switchgrass (Panicum virgatum) and simulated thermophilic composting in a bioreactor to select for a switchgrass-adapted community and to facilitate targeted discovery of glycoside hydrolases. Small-subunit (SSU) rRNA-based community profiles revealed that the microbial community changed dramatically between the initial and switchgrass-adapted compost (SAC) with some bacterial populations being enriched over 20-fold. We obtained 225 Mbp of 454-titanium pyrosequence data from the SAC community and conservatively identified 800 genes encoding glycoside hydrolase domains that were biased toward depolymerizing grass cell wall components. Of these, similar to 10% were putative cellulases mostly belonging to families GH5 and GH9. We synthesized two SAC GH9 genes with codon optimization for heterologous expression in Escherichia coli and observed activity for one on carboxymethyl cellulose. The active GH9 enzyme has a temperature optimum of 50 degrees C and pH range of 5.5 to 8 consistent with the composting conditions applied. We demonstrate that microbial communities adapt to switchgrass decomposition using simulated composting condition and that full-length genes can be identified from complex metagenomic sequence data, synthesized and expressed resulting in active enzyme.	[Allgaier, Martin; Reddy, Amitha; Park, Joshua I.; D'haeseleer, Patrik; Sapra, Rajat; Hazen, Terry C.; Simmons, Blake A.; VanderGheynst, Jean S.; Hugenholtz, Philip] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Reddy, Amitha; VanderGheynst, Jean S.] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Allgaier, Martin; Ivanova, Natalia; Lowry, Steve; Hugenholtz, Philip] Joint Genome Inst, Dept Energy DOE, Walnut Creek, CA USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Microbial Syst Biol Grp, Livermore, CA USA; [Hazen, Terry C.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Park, Joshua I.; Sapra, Rajat; Simmons, Blake A.] Sandia Natl Labs, Biomass Sci & Convers Technol Dept, Livermore, CA USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Sandia National Laboratories	Allgaier, M (corresponding author), Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA.	phugenholtz@lbl.gov	Hugenholtz, Philip/AAD-9138-2019; Simmons, Blake/N-6022-2016; Hazen, Terry C/C-1076-2012	Hugenholtz, Philip/0000-0001-5386-7925; Simmons, Blake/0000-0002-1332-1810; Hazen, Terry C/0000-0002-2536-9993; D'haeseleer, Patrik/0000-0003-0007-8150; Ivanova, Natalia/0000-0002-5802-9485	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the DOE Joint BioEnergy Institute (http://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U. S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; DESHPANDE MV, 1984, ANAL BIOCHEM, V138, P481, DOI 10.1016/0003-2697(84)90843-1; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EHRMAN T, 1996, 004 NREL CAT TASK LA; Eiland F, 2001, MICROBIAL ECOL, V41, P272, DOI 10.1007/s002480000071; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Gura T, 2009, CELL, V138, P9, DOI 10.1016/j.cell.2009.06.038; Heinzelman P, 2009, P NATL ACAD SCI USA, V106, P5610, DOI 10.1073/pnas.0901417106; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horwath WR, 1996, BIOL FERT SOILS, V21, P227, DOI 10.1007/BF00334896; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Kirby R, 2006, ADV APPL MICROBIOL, V58, P125, DOI 10.1016/S0065-2164(05)58004-3; KUNIN V, 2009, ENV MICROBIOL; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Margeot A, 2009, CURR OPIN BIOTECH, V20, P372, DOI 10.1016/j.copbio.2009.05.009; Marshall M. N., 2004, Resource recovery and reuse in organic solid waste management, P193; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; NAKASAKI K, 1985, APPL ENVIRON MICROB, V50, P1526, DOI 10.1128/AEM.50.6.1526-1530.1985; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Reddy AP, 2009, T ASABE, V52, P673, DOI 10.13031/2013.26806; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; RUIZ R, 1996, 002 NREL CAT TASK LA; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Ryckeboer J, 2003, J APPL MICROBIOL, V94, P127, DOI 10.1046/j.1365-2672.2003.01800.x; Simmons BA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-242; Takaku H, 2006, J BIOSCI BIOENG, V101, P42, DOI 10.1263/jbb.101.42; TEATHER RM, 1982, APPL ENVIRON MICROB, V43, P777, DOI 10.1128/AEM.43.4.777-780.1982; TEMPLETON D, 1995, 003 NREL CAT TASK LA; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; TWIDWELL EK, 1990, CROP SCI, V30, P1321, DOI 10.2135/cropsci1990.0011183X003000060033x; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WATANABE H, 2009, ANN REV ENTOMOL; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s; Yu H, 2007, BIODEGRADATION, V18, P793, DOI 10.1007/s10532-007-9108-8	44	129	132	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8812	10.1371/journal.pone.0008812	http://dx.doi.org/10.1371/journal.pone.0008812			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098679	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100006
J	Liu, MY; Rakowski, B; Gershburg, E; Weisend, CM; Lucas, O; Schmidt, EE; Halford, WP				Liu, Mingyu; Rakowski, Brandon; Gershburg, Edward; Weisend, Carla M.; Lucas, Olivier; Schmidt, Edward E.; Halford, William P.			ICP0 Antagonizes ICP4-Dependent Silencing of the Herpes Simplex Virus ICP0 Gene	PLOS ONE			English	Article							REGULATORY PROTEIN ICP0; GREEN FLUORESCENT PROTEIN; RNA-POLYMERASE-II; BINDING PROTEIN; LATENT INFECTION; DNA-BINDING; FUNCTIONAL INTERACTION; MONOCLONAL-ANTIBODIES; HISTONE DEACETYLASES; VIRAL TRANSCRIPTION	ICP0 is a regulatory protein that plays a critical role in the replication-latency balance of herpes simplex virus (HSV). Absence of ICP0 renders HSV prone to establish quiescent infections, and thus cellular repressor(s) are believed to silence HSV mRNA synthesis when ICP0 fails to accumulate. To date, an ICP0-antagonized repressor has not been identified that restricts HSV mRNA synthesis by more than 2-fold. We report the unexpected discovery that HSV's major transcriptional regulator, ICP4, meets the criteria of a bona fide ICP0-antagonized repressor of viral mRNA synthesis. Our study began when we noted a repressive activity that restricted ICP0 mRNA synthesis by up to 30-fold in the absence of ICP0. When ICP0 accumulated, the repressor only restricted ICP0 mRNA synthesis by 3-fold. ICP4 proved to be necessary and sufficient to repress ICP0 mRNA synthesis, and did so in an ICP4-binding-site-dependent manner. ICP4 co-immunoprecipitated with FLAG-tagged ICP0; thus, a physical interaction likely explains how ICP0 antagonizes ICP4's capacity to silence the ICP0 gene. These findings suggest that ICP0 mRNA synthesis is differentially regulated in HSV-infected cells by the virus-encoded repressor activity embedded in ICP4, and a virus-encoded antirepressor, ICP0. Bacteriophage lambda relies on a similar repression-antirepression regulatory scheme to "decide'' whether a given infection will be productive or silent. Therefore, our findings appear to add to the growing list of inexplicable similarities that point to a common evolutionary ancestry between the herpesviruses and tailed bacteriophage.	[Liu, Mingyu; Rakowski, Brandon; Gershburg, Edward; Halford, William P.] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA; [Weisend, Carla M.; Lucas, Olivier; Schmidt, Edward E.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA	Southern Illinois University System; Southern Illinois University; Montana State University System; Montana State University Bozeman	Liu, MY (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL USA.	halford@siumed.edu		Gershburg, Edward/0000-0003-3584-9947	Central Research Committee; Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health [R01 AI51414, R21 AI081072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081072, R01AI051414] Funding Source: NIH RePORTER	Central Research Committee; Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up funds and internal grants from the Central Research Committee and Excellence in Academic Medicine Committees of the Southern Illinois University School of Medicine, and by grants from the National Institutes of Health (R01 AI51414 and R21 AI081072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN M, 1984, J VIROL, V52, P108, DOI 10.1128/JVI.52.1.108-118.1984; Akhova O, 2005, J VIROL, V79, P14708, DOI 10.1128/JVI.79.23.14708-14718.2005; APRHYS CMJ, 1989, J VIROL, V63, P2798, DOI 10.1128/JVI.63.6.2798-2812.1989; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Balliet JW, 2007, VIROLOGY, V361, P372, DOI 10.1016/j.virol.2006.11.022; Boutell C, 2005, J VIROL, V79, P12342, DOI 10.1128/JVI.79.19.12342-12354.2005; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; CAI WH, 1993, J VIROL, V67, P7501, DOI 10.1128/JVI.67.12.7501-7512.1993; CAMPBELL A, 1994, ANNU REV MICROBIOL, V48, P193, DOI 10.1146/annurev.micro.48.1.193; Carrozza MJ, 1996, MOL CELL BIOL, V16, P3085; Chee AV, 2003, J VIROL, V77, P7101, DOI 10.1128/JVI.77.12.7101-7105.2003; Chelbi-Alix MK, 1999, ONCOGENE, V18, P935, DOI 10.1038/sj.onc.1202366; Cheng H, 2004, PROTEIN SCI, V13, P2260, DOI 10.1110/ps.04726004; Cliffe AR, 2008, J VIROL, V82, P12030, DOI 10.1128/JVI.01575-08; Danaher RJ, 2000, J NEUROVIROL, V6, P296, DOI 10.3109/13550280009030755; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELUCA NA, 1988, J VIROL, V62, P732, DOI 10.1128/JVI.62.3.732-743.1988; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; ELSHIEKH NA, 1991, J VIROL, V65, P6430, DOI 10.1128/JVI.65.12.6430-6437.1991; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; Everett RD, 2004, J VIROL, V78, P1763, DOI 10.1128/JVI.78.4.1763-1774.2004; EVERETT RD, 1993, VIROLOGY, V197, P751, DOI 10.1006/viro.1993.1651; Everett RD, 1998, EMBO J, V17, P7161, DOI 10.1093/emboj/17.24.7161; EVERETT RD, 1989, J GEN VIROL, V70, P1185, DOI 10.1099/0022-1317-70-5-1185; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 1999, EMBO J, V18, P1526, DOI 10.1093/emboj/18.6.1526; EVERETT RD, 1991, VIROLOGY, V180, P509, DOI 10.1016/0042-6822(91)90064-I; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Everett RD, 2007, J VIROL, V81, P10991, DOI 10.1128/JVI.00705-07; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; GELMAN IH, 1986, J MOL BIOL, V191, P395, DOI 10.1016/0022-2836(86)90135-X; Gu HD, 2007, P NATL ACAD SCI USA, V104, P17134, DOI 10.1073/pnas.0707266104; Gu HD, 2009, J VIROL, V83, P181, DOI 10.1128/JVI.01940-08; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Hancock MH, 2006, VIROLOGY, V352, P237, DOI 10.1016/j.virol.2006.04.021; HARRIS RA, 1989, J VIROL, V63, P3513, DOI 10.1128/JVI.63.8.3513-3515.1989; HONESS RW, 1974, J VIROL, V14, P8, DOI 10.1128/JVI.14.1.8-19.1974; JOHNSON AD, 1981, NATURE, V294, P217, DOI 10.1038/294217a0; Jordan Robert, 1997, Journal of Virology, V71, P6850; Kawaguchi Y, 1997, J VIROL, V71, P7328, DOI 10.1128/JVI.71.10.7328-7336.1997; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kuddus RH, 2007, J VIROL, V81, P9230, DOI 10.1128/JVI.01054-07; Kwun Hyun Jin, 2000, Molecular Cell Biology Research Communications, V3, P15, DOI 10.1006/mcbr.2000.0179; Lander GC, 2006, SCIENCE, V312, P1791, DOI 10.1126/science.1127981; Lee LY, 1998, J VIROL, V72, P4250, DOI 10.1128/JVI.72.5.4250-4264.1998; LeesMiller SP, 1996, J VIROL, V70, P7471, DOI 10.1128/JVI.70.11.7471-7477.1996; LILLYCROP KA, 1991, NEURON, V7, P381, DOI 10.1016/0896-6273(91)90290-G; Lin RT, 2004, J VIROL, V78, P1675, DOI 10.1128/JVI.78.4.1675-1684.2004; Little JW, 2005, P NATL ACAD SCI USA, V102, P5310, DOI 10.1073/pnas.0501645102; Lium EK, 1996, J VIROL, V70, P3488, DOI 10.1128/JVI.70.6.3488-3496.1996; Lomonte P, 2004, J VIROL, V78, P6744, DOI 10.1128/JVI.78.13.6744-6757.2004; Lomonte P, 2007, FEBS LETT, V581, P658, DOI 10.1016/j.febslet.2007.01.027; Lopez P, 2002, J VIROL, V76, P9355, DOI 10.1128/JVI.76.18.9355-9367.2002; MAUL GG, 1994, J GEN VIROL, V75, P1223, DOI 10.1099/0022-1317-75-6-1223; McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002; McMahon R, 2008, J VIROL, V82, P10218, DOI 10.1128/JVI.00859-08; MICHAEL N, 1993, P NATL ACAD SCI USA, V90, P2286, DOI 10.1073/pnas.90.6.2286; Minaker RL, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-85; MULLEN MA, 1995, J VIROL, V69, P476, DOI 10.1128/JVI.69.1.476-491.1995; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Poon APW, 2006, P NATL ACAD SCI USA, V103, P9993, DOI 10.1073/pnas.0604142103; Preston CM, 1998, J GEN VIROL, V79, P117, DOI 10.1099/0022-1317-79-1-117; Preston CM, 2000, J GEN VIROL, V81, P1; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; RESNICK J, 1989, J VIROL, V63, P2497, DOI 10.1128/JVI.63.6.2497-2503.1989; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; RICE SA, 1995, J VIROL, V69, P5550, DOI 10.1128/JVI.69.9.5550-5559.1995; Roizman B, 2005, CELL CYCLE, V4, P1019, DOI 10.4161/cc.4.8.1902; SACKS WR, 1987, J VIROL, V61, P829, DOI 10.1128/JVI.61.3.829-839.1987; Samaniego LA, 1998, J VIROL, V72, P3307, DOI 10.1128/JVI.72.4.3307-3320.1998; Sampath P, 2008, J VIROL, V82, P2339, DOI 10.1128/JVI.02459-07; SHEPARD AA, 1989, J VIROL, V63, P3714, DOI 10.1128/JVI.63.9.3714-3728.1989; SHOWALTER SD, 1981, INFECT IMMUN, V34, P684, DOI 10.1128/IAI.34.3.684-692.1981; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Soboleski MR, 2005, FASEB J, V19, P440, DOI 10.1096/fj.04-3180fje; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; STERN S, 1989, NATURE, V341, P624, DOI 10.1038/341624a0; Sun YH, 2000, J MOL BIOL, V297, P1195, DOI 10.1006/jmbi.2000.3620; TANG S, 2008, J VIROL; Terry-Allison T, 2007, J VIROL, V81, P12394, DOI 10.1128/JVI.01068-07; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; WU CL, 1990, NUCLEIC ACIDS RES, V18, P531, DOI 10.1093/nar/18.3.531; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Yang WC, 2002, J VIROL, V76, P12758, DOI 10.1128/JVI.76.24.12758-12774.2002; YAO F, 1994, J VIROL, V68, P8158, DOI 10.1128/JVI.68.12.8158-8168.1994; Zabierowski SE, 2008, J VIROL, V82, P3546, DOI 10.1128/JVI.02560-07	88	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8837	10.1371/journal.pone.0008837	http://dx.doi.org/10.1371/journal.pone.0008837			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098619	gold, Green Submitted, Green Published			2022-12-27	WOS:000273779100028
J	Carrasquillo, MM; Belbin, O; Zou, FG; Allen, M; Ertekin-Taner, N; Ansari, M; Wilcox, SL; Kashino, MR; Ma, L; Younkin, LH; Younkin, SG; Younkin, CS; Dincman, TA; Howard, ME; Howell, CC; Stanton, CM; Watson, CM; Crump, M; Vitart, V; Hayward, C; Hastie, ND; Rudan, I; Campbell, H; Polasek, O; Brown, K; Passmore, P; Craig, D; McGuinness, B; Todd, S; Kehoe, PG; Mann, DM; Smith, AD; Beaumont, H; Warden, D; Holmes, C; Heun, R; Kolsch, H; Kalsheker, N; Pankratz, VS; Dickson, DW; Graff-Radford, NR; Petersen, RC; Wright, AF; Younkin, SG; Morgan, K				Carrasquillo, Minerva M.; Belbin, Olivia; Zou, Fanggeng; Allen, Mariet; Ertekin-Taner, Nilufer; Ansari, Morad; Wilcox, Samantha L.; Kashino, Mariah R.; Ma, Li; Younkin, Linda H.; Younkin, Samuel G.; Younkin, Curtis S.; Dincman, Toros A.; Howard, Melissa E.; Howell, Chanley C.; Stanton, Chloe M.; Watson, Christopher M.; Crump, Michael; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas D.; Rudan, Igor; Campbell, Harry; Polasek, Ozren; Brown, Kristelle; Passmore, Peter; Craig, David; McGuinness, Bernadette; Todd, Stephen; Kehoe, Patrick G.; Mann, David M.; Smith, A. David; Beaumont, Helen; Warden, Donald; Holmes, Clive; Heun, Reinhard; Koelsch, Heike; Kalsheker, Noor; Pankratz, V. Shane; Dickson, Dennis W.; Graff-Radford, Neill R.; Petersen, Ronald C.; Wright, Alan F.; Younkin, Steven G.; Morgan, Kevin			Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, A beta, and Alzheimer's Disease	PLOS ONE			English	Article							BLOCK SPANNING IDE; APOLIPOPROTEIN-E; HAPLOTYPE BLOCK; IN-VIVO; EXTRACELLULAR LEVELS; WIDE ASSOCIATION; NO ASSOCIATION; ONSET; PROTEIN; RISK	Background: The insulin-degrading enzyme gene (IDE) is a strong functional and positional candidate for late onset Alzheimer's disease (LOAD). Methodology/Principal Findings: We examined conserved regions of IDE and its 10 kb flanks in 269 AD cases and 252 controls thereby identifying 17 putative functional polymorphisms. These variants formed eleven haplotypes that were tagged with ten variants. Four of these showed significant association with IDE transcript levels in samples from 194 LOAD cerebella. The strongest, rs6583817, which has not previously been reported, showed unequivocal association (p = 1.5 x 10(-8), fold-increase = 2.12,); the eleven haplotypes were also significantly associated with transcript levels (global p = 0.003). Using an in vitro dual luciferase reporter assay, we found that rs6583817 increases reporter gene expression in Be(2)-C (p = 0.006) and HepG2 (p = 0.02) cell lines. Furthermore, using data from a recent genome-wide association study of two Croatian isolated populations (n = 1,879), we identified a proxy for rs6583817 that associated significantly with decreased plasma A beta 40 levels (beta = 20.124, p = 0.011) and total measured plasma A beta levels (b = 20.130, p = 0.009). Finally, rs6583817 was associated with decreased risk of LOAD in 3,891 AD cases and 3,605 controls. (OR = 0.87, p = 0.03), and the eleven IDE haplotypes (global p = 0.02) also showed significant association. Conclusions: Thus, a previously unreported variant unequivocally associated with increased IDE expression was also associated with reduced plasma A beta 40 and decreased LOAD susceptibility. Genetic association between LOAD and IDE has been difficult to replicate. Our findings suggest that targeted testing of expression SNPs (eSNPs) strongly associated with altered transcript levels in autopsy brain samples may be a powerful way to identify genetic associations with LOAD that would otherwise be difficult to detect.	[Carrasquillo, Minerva M.; Belbin, Olivia; Zou, Fanggeng; Allen, Mariet; Ertekin-Taner, Nilufer; Wilcox, Samantha L.; Kashino, Mariah R.; Ma, Li; Younkin, Linda H.; Younkin, Samuel G.; Younkin, Curtis S.; Dincman, Toros A.; Howard, Melissa E.; Howell, Chanley C.; Stanton, Chloe M.; Watson, Christopher M.; Crump, Michael; Dickson, Dennis W.; Younkin, Steven G.] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA; [Allen, Mariet; Ansari, Morad; Vitart, Veronique; Hayward, Caroline; Hastie, Nicholas D.; Wright, Alan F.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Ertekin-Taner, Nilufer; Graff-Radford, Neill R.] Mayo Clin, Dept Neurol, Coll Med, Jacksonville, FL 32224 USA; [Rudan, Igor; Campbell, Harry; Polasek, Ozren] Univ Edinburgh, Sch Med, Dept Publ Hlth Sci, Edinburgh, Midlothian, Scotland; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor; Polasek, Ozren] Univ Hosp Sestre Milosrdnice, Ctr Clin Med Res, Zagreb, Croatia; [Brown, Kristelle; Kalsheker, Noor; Morgan, Kevin] Univ Nottingham, Inst Genet, Sch Mol Med Sci, Queens Med Ctr, Nottingham NG7 2RD, England; [Passmore, Peter; Craig, David; McGuinness, Bernadette; Todd, Stephen] Queens Univ Belfast, Sch Med & Dent, Div Psychiat & Neurosci, Belfast, Antrim, North Ireland; [Kehoe, Patrick G.] Univ Bristol, Frenchay Hosp, Dept Clin Sci N Bristol, Bristol, Avon, England; [Mann, David M.] Univ Manchester, Greater Manchester Neurosci Ctr, Manchester, Lancs, England; [Smith, A. David; Beaumont, Helen; Warden, Donald] Univ Dept Physiol Anat & Genet, Oxford Project Investigate Memory & Ageing OPTIMA, Oxford, England; [Holmes, Clive] Univ Southampton, Memory Assessment & Res Ctr, Southampton, Hants, England; [Heun, Reinhard] Univ Birmingham, Div Neurosci, Birmingham, W Midlands, England; [Koelsch, Heike] Univ Bonn, Dept Psychiat, D-5300 Bonn, Germany; [Pankratz, V. Shane] Mayo Clin & Mayo Fdn, Dept Biostat, Rochester, MN 55905 USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Petersen, Ronald C.] Mayo Clin, Coll Med, Mayo Alzheimer Dis Res Ctr, Rochester, MN USA	Mayo Clinic; University of Edinburgh; Mayo Clinic; University of Edinburgh; University of Split; University of Nottingham; Queens University Belfast; University of Bristol; University of Manchester; University of Oxford; University of Southampton; University of Birmingham; University of Bonn; Mayo Clinic; Mayo Clinic; Mayo Clinic	Carrasquillo, MM (corresponding author), Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA.	younkin.steven@mayo.edu	McGuinness, Bernadette/AAH-2755-2021; Campbell, Harry/E-2959-2010; Polasek, Ozren/B-6002-2011; Hayward, Caroline/M-8818-2016; Todd, Stephen/A-4299-2009; Smith, Anthony D./A-4233-2010; Rudan, Igor/I-1467-2012; Kehoe, Patrick/P-8760-2018	McGuinness, Bernadette/0000-0002-7028-5633; Campbell, Harry/0000-0002-6169-6262; Polasek, Ozren/0000-0002-5765-1862; Hayward, Caroline/0000-0002-9405-9550; Smith, Anthony D./0000-0002-1095-6722; Rudan, Igor/0000-0001-6993-6884; Dickson, Dennis W/0000-0001-7189-7917; Todd, Stephen/0000-0002-2312-9195; Dincman, Toros/0000-0002-4449-0510; Belbin, Olivia/0000-0002-9805-8408; Watson, Christopher Mark/0000-0003-2371-1844; Holmes, Clive/0000-0003-1999-6912; Belbin, Olivia/0000-0002-6109-6371; Morgan, Kevin/0000-0002-8217-2396; Kehoe, Patrick/0000-0002-7542-1139; Ansari, Morad/0000-0002-8905-5379	National Institutes of Health [R01 AG18023, KL2 RR024151]; National Institute on Aging [AG25711, AG17216, AG03949, U24 AG21886, F32 AG20903]; Mayo Alzheimer's Disease Research Center [P50 AG16574]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576]; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; Johnnie B. Byrd and Siragusa Foundation; Medical Research Council UK [108-1080315-0302]; European Commission [018947 LSHG-CT-2006-01947]; Alzheimer's Research Trust; Charles Wolfson Charitable Trust; Norman Collisson Foundation; Alzheimer's Research Trust and Merck and Co. Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG020903, P01AG003949, P50AG016574, R01AG032990, R01AG018023, U24AG021886, P01AG017216, P50AG025711] Funding Source: NIH RePORTER; MRC [MC_U127561128] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2008A-3, ART-NCG2008A-1, ART-BIG2009-1, ART-SB2010A-1, ART-NCG2006-1] Funding Source: researchfish; Medical Research Council [G0700704B, MC_U127561128] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Mayo Alzheimer's Disease Research Center; Mayo Alzheimer's Disease Patient Registry; Robert and Clarice Smith Postdoctoral Fellowship; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program; Palumbo Professorship in Alzheimer's Disease Research; Johnnie B. Byrd and Siragusa Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Alzheimer's Research Trust; Charles Wolfson Charitable Trust; Norman Collisson Foundation; Alzheimer's Research Trust and Merck and Co. Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institutes of Health [R01 AG18023 to N. R. G.-R. and S. G. Y., KL2 RR024151 to N. E.-T.]; National Institute on Aging [AG25711, AG17216, AG03949 to D. W. D., U24 AG21886 to N. C. R. A. D., F32 AG20903 to N. E.-T.]; Mayo Alzheimer's Disease Research Center [P50 AG16574 to R. C. P., D. W. D., N. R. G.-R. and S. G. Y.]; Mayo Alzheimer's Disease Patient Registry [U01 AG06576 to R. C. P.]; Robert and Clarice Smith Postdoctoral Fellowship to M. M. C.; Robert and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program to R. C. P., D. W. D., N. R. G.-R., S. G. Y.; the Palumbo Professorship in Alzheimer's Disease Research to S. G. Y.; the Johnnie B. Byrd and Siragusa Foundation grants to N. E.-T.; the Medical Research Council UK to H. C., A. F. W. and I. R.; the Ministry of Science, Education and Sports of the Republic of Croatia [108-1080315-0302] and from the European Commission FP6 STRP [018947 LSHG-CT-2006-01947] to I. R., and K. M. holds Network Centre, collaborative and project grants from the Alzheimer's Research Trust. Oxford Project to Investigate Memory and Ageing (OPTIMA) is supported by grants from the Charles Wolfson Charitable Trust, Norman Collisson Foundation, Alzheimer's Research Trust and Merck and Co. Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham R, 2001, HUM GENET, V109, P646, DOI 10.1007/s00439-001-0614-1; Ait-Ghezala G, 2002, NEUROSCI LETT, V325, P87, DOI 10.1016/S0304-3940(02)00243-4; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Bertram L, 2004, PHARMACOL RES, V50, P385, DOI 10.1016/j.phrs.2003.11.018; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bian L, 2004, NEUROLOGY, V63, P241, DOI 10.1212/01.WNL.0000129987.70037.DB; BJORK BF, 2006, NEUROBIOL AGING; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blomqvist MEL, 2005, NEUROBIOL AGING, V26, P795, DOI 10.1016/j.neurobiolaging.2004.07.011; Blomqvist MEL, 2004, NEUROGENETICS, V5, P115, DOI 10.1007/s10048-004-0173-4; Boussaha M, 2002, NEUROSCI LETT, V329, P121, DOI 10.1016/S0304-3940(02)00586-4; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Cellini E, 2005, ALZ DIS ASSOC DIS, V19, P246, DOI 10.1097/01.wad.0000189030.50826.86; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Edland SD, 2004, J MOL NEUROSCI, V23, P213, DOI 10.1385/JMN:23:3:213; Edland SD, 2003, NEUROSCI LETT, V345, P21, DOI 10.1016/S0304-3940(03)00488-9; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farris W, 2005, BIOCHEMISTRY-US, V44, P6513, DOI 10.1021/bi0476578; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Feuk L, 2005, AM J MED GENET B, V136B, P69, DOI 10.1002/ajmg.b.30172; Gatz M, 1997, J GERONTOL A-BIOL, V52, pM117, DOI 10.1093/gerona/52A.2.M117; HAROLD D, 2009, NAT GENET       0906; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LAMBERT JC, 2009, NAT GENET       0906; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; Mueller JC, 2007, NEUROBIOL AGING, V28, P727, DOI 10.1016/j.neurobiolaging.2006.03.009; Nowotny P, 2005, AM J MED GENET B, V136B, P62, DOI 10.1002/ajmg.b.30186; Ozturk A, 2006, NEUROSCI LETT, V406, P265, DOI 10.1016/j.neulet.2006.07.054; Prince JA, 2003, HUM MUTAT, V22, P363, DOI 10.1002/humu.10282; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu WQ, 2006, NEUROBIOL AGING, V27, P190, DOI 10.1016/j.neurobiolaging.2005.01.004; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sakai A, 2004, AM J MED GENET B, V125B, P87, DOI 10.1002/ajmg.b.20106; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Slager SL, 2001, HUM HERED, V52, P149, DOI 10.1159/000053370; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Zemunik T, 2009, CROAT MED J, V50, P23, DOI 10.3325/cmj.2009.50.23	52	42	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8764	10.1371/journal.pone.0008764	http://dx.doi.org/10.1371/journal.pone.0008764			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098734	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000273778900008
J	Zhang, SZ; Dai, HH; Wan, N; Moore, Y; Dai, ZH				Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua			Manipulating IL-2 Availability Amid Presentation of Donor MHC Antigens Suppresses Murine Alloimmune Responses by Inducing Regulatory T Cells	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LONG-TERM ACCEPTANCE; BONE-MARROW-CELLS; TRANSPLANTATION TOLERANCE; ALLOGRAFT SURVIVAL; HEART ALLOGRAFTS; ANTI-CD154 ANTIBODY; MONOCLONAL-ANTIBODY; BLOOD-TRANSFUSION; INTERFERON-GAMMA	Background: Major histocompatibility complex (MHC) antigens are important for alloimmune responses as well as immune tolerance. Previous studies have shown that presentation of donor MHC antigens by donor-specific transfusion prior to or upon transplantation promotes transplant tolerance induced by other agents. However, it is unclear whether presentation of donor MHC antigens by DNA vaccination induces long-term allograft survival. Methodology/Principal Findings: We investigated whether presentation of MHC class-II and/or class-I donor antigens by DNA vaccination suppresses alloimmune responses and promotes long-term allograft acceptance. We initially found that presentation of both MHC donor antigens by DNA vaccination itself prior to transplantation fails to significantly prolong islet allograft survival in otherwise untreated mice. However, islet allograft survival was significantly prolonged when MHC class-II DNA vaccination was accompanied with IL-2 administration (MHCII + IL-2) while MHC class-I DNA vaccination was followed by IL-2 and subsequent neutralizing anti-IL-2 treatments (MHCI + IL-2/anti-IL-2). Especially, this protocol promoted long-term allograft survival in the majority of recipients (57%) when combined with low doses of rapamycin post-transplantation. Importantly, MHCII + IL-2 induced FoxP3+ Treg cells in both spleens and grafts and suppressed graft-infiltrating CD4+ cell proliferation, whereas MHCI + IL-2/anti-IL-2 mainly inhibited graft-infiltrating CD8+ cell proliferation and donor-specific CTL activity. The combined protocol plus rapamycin treatment further reduced both CD4+ and CD8+ T cell proliferation as well as donor-specific CTL activity but spared FoxP3+ Treg cells. Depleting CD25+ Treg cells or adoptive transfer of pre-sensitized CD8+ T cells abolished this long-term allograft survival. Conclusions/Significance: Manipulating IL-2 availability during presentation of MHC class-II and class-I donor antigens by DNA vaccination pre-transplantation induces Treg cells, suppresses alloimmune responses and promotes long-term allograft survival.	[Zhang, Shuzi; Dai, Hehua; Wan, Ni; Moore, Yolonda; Dai, Zhenhua] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Zhang, SZ (corresponding author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Tyler, TX USA.	zhenhua.dai@uthct.edu			American Diabetes Association [ADA 1-06-RA-36]; Juvenile Diabetes Research Foundation International [JDRF 1-2008-583]	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This study was supported by research grants from American Diabetes Association (ADA 1-06-RA-36) and Juvenile Diabetes Research Foundation International (JDRF 1-2008-583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Chauhan SK, 2009, J IMMUNOL, V182, P148, DOI 10.4049/jimmunol.182.1.148; Chiang KC, 2009, J IMMUNOL, V182, P4282, DOI 10.4049/jimmunol.0800641; Dai ZH, 2004, J CLIN INVEST, V113, P310, DOI 10.1172/JCI200419727; Dai ZH, 1998, J IMMUNOL, V161, P1659; Dai ZH, 2000, J IMMUNOL, V165, P3031, DOI 10.4049/jimmunol.165.6.3031; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Graca L, 2002, J IMMUNOL, V168, P5558, DOI 10.4049/jimmunol.168.11.5558; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Itoh M, 1999, J IMMUNOL, V162, P5317; Iwakoshi NN, 2000, J IMMUNOL, V164, P512, DOI 10.4049/jimmunol.164.1.512; Jones TR, 2002, J IMMUNOL, V168, P1123, DOI 10.4049/jimmunol.168.3.1123; Kang HG, 2007, AM J TRANSPLANT, V7, P1907, DOI 10.1111/j.1600-6143.2007.01881.x; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; KNEITZ B, 1995, EUR J IMMUNOL, V25, P2572, DOI 10.1002/eji.1830250925; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LIN H, 1993, J EXP MED, V178, P1801, DOI 10.1084/jem.178.5.1801; Liu ZW, 2007, J IMMUNOL, V178, P4260, DOI 10.4049/jimmunol.178.7.4260; Margenthaler JA, 2003, TRANSPLANTATION, V75, P2119, DOI 10.1097/01.TP.0000069043.57679.85; Markees TG, 2004, TRANSPLANTATION, V78, P1601, DOI 10.1097/01.TP.0000140847.29917.65; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; MEDAWAR PB, 1963, TRANSPLANTATION, V1, P21, DOI 10.1097/00007890-196301010-00004; Murphy B, 1999, J CLIN INVEST, V103, P859, DOI 10.1172/JCI5734; Murphy B, 2003, J AM SOC NEPHROL, V14, P1053, DOI 10.1097/01.ASN.0000057541.69641.F8; Nakamura T, 2003, J IMMUNOL, V171, P1266, DOI 10.4049/jimmunol.171.3.1266; Nasr IW, 2005, J IMMUNOL, V174, P6161, DOI 10.4049/jimmunol.174.10.6161; PAINEAU J, 1991, J HEART LUNG TRANSPL, V10, P424; Peche H, 2004, TRANSPLANTATION, V77, P733, DOI 10.1097/01.TP.0000114613.70156.DB; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Ringers J, 2002, TRANSPLANTATION, V73, P862, DOI 10.1097/00007890-200203270-00006; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; SAYEGH MH, 1993, TRANSPLANTATION, V56, P461, DOI 10.1097/00007890-199308000-00040; Schenk S, 2005, J IMMUNOL, V174, P3741, DOI 10.4049/jimmunol.174.6.3741; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sonntag KC, 2001, J CLIN INVEST, V107, P65, DOI 10.1172/JCI11015; Sonoda KH, 2002, J IMMUNOL, V168, P2028, DOI 10.4049/jimmunol.168.4.2028; SOULILLOU JP, 1984, TRANSPLANTATION, V38, P63, DOI 10.1097/00007890-198407000-00015; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Umemura A, 2000, J IMMUNOL, V164, P4452, DOI 10.4049/jimmunol.164.9.4452; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Walsh PT, 2006, J CLIN INVEST, V116, P2521, DOI 10.1172/JCI28057; Wan N, 2008, J IMMUNOL, V180, P113, DOI 10.4049/jimmunol.180.1.113; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Wu K, 2008, TRANSPL P, V40, P3699, DOI 10.1016/j.transproceed.2008.06.084; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zang W, 2008, J IMMUNOL, V181, P7499, DOI 10.4049/jimmunol.181.11.7499; Zang WP, 2005, J AM SOC NEPHROL, V16, P3661, DOI 10.1681/ASN.2005050523; Zhai Y, 1999, CURR OPIN IMMUNOL, V11, P497, DOI 10.1016/S0952-7915(99)00007-2; Zhai YA, 2006, J IMMUNOL, V176, P5988, DOI 10.4049/jimmunol.176.10.5988	58	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8756	10.1371/journal.pone.0008756	http://dx.doi.org/10.1371/journal.pone.0008756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090908	Green Published, Green Submitted, gold			2022-12-27	WOS:000273715000014
J	Gregory, JA; Becker, EC; Jung, J; Tuwatananurak, I; Pogliano, K				Gregory, James A.; Becker, Eric C.; Jung, James; Tuwatananurak, Ida; Pogliano, Kit			Transposon Assisted Gene Insertion Technology (TAGIT): A Tool for Generating Fluorescent Fusion Proteins	PLOS ONE			English	Article							PHOTOACTIVATED LOCALIZATION MICROSCOPY; SITE-SPECIFIC RECOMBINATION; ESCHERICHIA-COLI K-12; BACILLUS-SUBTILIS; LAC REPRESSOR; POLAR LOCALIZATION; CELL-DIVISION; BACTERIA; GFP; ENGULFMENT	We constructed a transposon (transposon assisted gene insertion technology, or TAGIT) that allows the random insertion of gfp (or other genes) into chromosomal loci without disrupting operon structure or regulation. TAGIT is a modified Tn5 transposon that uses Kan(R) to select for insertions on the chromosome or plasmid, beta-galactosidase to identify in-frame gene fusions, and Cre recombinase to excise the kan and lacZ genes in vivo. The resulting gfp insertions maintain target gene reading frame (to the 59 and 39 of gfp) and are integrated at the native chromosomal locus, thereby maintaining native expression signals. Libraries can be screened to identify GFP insertions that maintain target protein function at native expression levels, allowing more trustworthy localization studies. We here use TAGIT to generate a library of GFP insertions in the Escherichia coli lactose repressor (LacI). We identified fully functional GFP insertions and partially functional insertions that bind DNA but fail to repress the lacZ operon. Several of these latter GFP insertions localize to lacO arrays integrated in the E. coli chromosome without producing the elongated cells frequently observed when functional LacI-GFP fusions are used in chromosome tagging experiments. TAGIT thereby faciliates the isolation of fully functional insertions of fluorescent proteins into target proteins expressed from the native chromosomal locus as well as potentially useful partially functional proteins.	[Gregory, James A.; Becker, Eric C.; Jung, James; Tuwatananurak, Ida; Pogliano, Kit] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Gregory, JA (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	kpogliano@ucsd.edu		Gregory, James/0000-0002-7733-3212; Pogliano, Kit/0000-0002-7868-3345	National Institutes of Health [GM 57045]; University of California at San Diego Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California at San Diego Academic Senate; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This research was supported by a grant from the National Institutes of Health ( GM 57045) and from the University of California at San Diego Academic Senate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; ABREMSKI K, 1986, J BIOL CHEM, V261, P391; ABREMSKI K, 1984, J BIOL CHEM, V259, P1509; Aung S, 2007, MOL MICROBIOL, V65, P1534, DOI 10.1111/j.1365-2958.2007.05887.x; AUSEBEL FM, 1992, CURRENT PROTOCOLS MO; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOENEMAN K, 2009, MOL MICROBIOL; Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dennis JJ, 1998, APPL ENVIRON MICROB, V64, P2710; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; EHRMANN M, 1990, P NATL ACAD SCI USA, V87, P7574, DOI 10.1073/pnas.87.19.7574; Goryshin IY, 1998, P NATL ACAD SCI USA, V95, P10716, DOI 10.1073/pnas.95.18.10716; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heintzmann R, 2007, METHOD CELL BIOL, V81, P561, DOI 10.1016/S0091-679X(06)81026-5; Ignatova Z, 2004, P NATL ACAD SCI USA, V101, P523, DOI 10.1073/pnas.0304533101; Kaltwasser M, 2002, APPL ENVIRON MICROB, V68, P2624, DOI 10.1128/AEM.68.5.2624-2628.2002; KARMAZYNCAMPELLI C, 1992, BIOCHIMIE, V74, P689, DOI 10.1016/0300-9084(92)90141-Z; KLEINA LG, 1990, J MOL BIOL, V212, P295, DOI 10.1016/0022-2836(90)90126-7; KOLTER R, 1978, CELL, V15, P1199, DOI 10.1016/0092-8674(78)90046-6; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Margolin W, 2000, METHODS, V20, P62, DOI 10.1006/meth.1999.0906; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Merkulov GV, 1998, GENE, V222, P213, DOI 10.1016/S0378-1119(98)00503-4; Miller J.H., 1972, EXPT MOL GENETICS; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Nelson BD, 1997, J BACTERIOL, V179, P3721, DOI 10.1128/jb.179.11.3721-3728.1997; Osawa M, 2005, MICROBIOL-SGM, V151, P4033, DOI 10.1099/mic.0.28219-0; Pinheiro LB, 2008, APPL MICROBIOL BIOT, V77, P1287, DOI 10.1007/s00253-007-1253-9; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Sharp MD, 2002, SCIENCE, V295, P137, DOI 10.1126/science.1066274; Sheridan DL, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-17; Sheridan DL, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-7; Shroff H, 2008, NAT METHODS, V5, P417, DOI [10.1038/nmeth.1202, 10.1038/NMETH.1202]; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Wang XD, 2008, BIOCHEM SOC T, V36, P749, DOI 10.1042/BST0360749; Wilson CJ, 2007, CELL MOL LIFE SCI, V64, P3, DOI 10.1007/s00018-006-6296-z; WU F, 1992, NUCLEIC ACIDS RES, V20, P811, DOI 10.1093/nar/20.4.811; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	53	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8731	10.1371/journal.pone.0008731	http://dx.doi.org/10.1371/journal.pone.0008731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090956	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900012
J	LeClair, EE; Topczewski, J				LeClair, Elizabeth E.; Topczewski, Jacek			Development and Regeneration of the Zebrafish Maxillary Barbel: A Novel Study System for Vertebrate Tissue Growth and Repair	PLOS ONE			English	Article							TASTE BUD DEVELOPMENT; CALRETININ IMMUNOREACTIVITY; TAIL REGENERATION; ADULT ZEBRAFISH; XENOPUS-LAEVIS; DANIO-RERIO; BROWN TROUT; FISH; CYPRINIDAE; PHYLOGENY	Background: Barbels are integumentary sense organs found in fishes, reptiles and amphibians. The zebrafish, Danio rerio, develops paired nasal and maxillary barbels approximately one month post fertilization. Small in diameter and optically clear, these adult appendages offer a window on the development, maintenance and function of multiple cell types including skin cells, neural-crest derived pigment cells, circulatory vessels, taste buds and sensory nerves. Importantly, barbels in other otophysan fishes (e. g., catfish) are known to regenerate; however, this capacity has not been tested in zebrafish. Methodology/Principal Findings: We describe the development of the maxillary barbel in a staged series of wild type and transgenic zebrafish using light microscopy, histology and immunohistochemistry. By imaging transgenic zebrafish containing fluorescently labeled endothelial cells (Tg(fli1a: EGFP)), we demonstrate that the barbel contains a long (similar to 2 3 mm) closed-end vessel that we interpret as a large lymphatic. The identity of this vessel was further supported by live imaging of the barbel circulation, extending recent descriptions of the lymphatic system in zebrafish. The maxillary barbel can be induced to regenerate by proximal amputation. After more than 750 experimental surgeries in which approximately 85% of the barbel's length was removed, we find that wound healing is complete within hours, followed by blastema formation (similar to 3 days), epithelial redifferentiation (3-5 days) and appendage elongation. Maximum regrowth occurs within 2 weeks of injury. Although superficially normal, the regenerates are shorter and thicker than the contralateral controls, have abnormally organized mesenchymal cells and extracellular matrix, and contain prominent connective tissue "stumps'' at the plane of section-a mode of regeneration more typical of mammalian scarring than other zebrafish appendages. Finally, we show that the maxillary barbel can regenerate after repeated injury and also in senescent fish (> 2 years old). Conclusions/Significance: Although the teleost barbel has no human analog, the cell types it contains are highly conserved. Thus "barbology'' may be a useful system for studying epithelial-mesenchymal interactions, angiogenesis and lymphangiogenesis, neural pathfinding, wound healing, scar formation and other key processes in vertebrate physiology.	[LeClair, Elizabeth E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Topczewski, Jacek] Northwestern Univ, Feinberg Sch Med, Dept Pediat, CMRC, Chicago, IL 60611 USA	DePaul University; Northwestern University; Feinberg School of Medicine	LeClair, EE (corresponding author), Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA.	eleclair@depaul.edu	Topczewski, Jacek/D-5895-2016	Topczewski, Jacek/0000-0001-6023-9556	DePaul University Research Council; NIH [R01(DE016678)]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016678] Funding Source: NIH RePORTER	DePaul University Research Council; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: This work was supported in part by a paid sabbatical leave to E. E. LeClair from the DePaul University Research Council and an NIH R01(DE016678) to J. Topczweski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens D, 1997, J ZOOL, V241, P117, DOI 10.1111/j.1469-7998.1997.tb05503.x; Alvarado AS, 2006, NAT REV GENET, V7, P873, DOI 10.1038/nrg1923; ARAI R, 2003, BULLETIN, V40, P1; Ausoni S, 2009, J CELL BIOL, V184, P357, DOI 10.1083/jcb.200810094; BARMAN RP, 1991, 137 ZOOL SURV IND; Becker CG, 2008, RESTOR NEUROL NEUROS, V26, P71; Becker CG, 2007, J NEUROSCI RES, V85, P2793, DOI 10.1002/jnr.21121; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Briolay J, 1998, MOL PHYLOGENET EVOL, V9, P100, DOI 10.1006/mpev.1997.0441; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brockes JP, 2001, J ANAT, V199, P3; Brown LA, 2000, MECH DEVELOP, V90, P237, DOI 10.1016/S0925-4773(99)00256-7; Bryant SV, 2002, INT J DEV BIOL, V46, P887; Castro A, 2006, J COMP NEUROL, V494, P792, DOI 10.1002/cne.20843; Castro A, 2006, J COMP NEUROL, V494, P435, DOI 10.1002/cne.20782; Castro A, 2003, J COMP NEUROL, V467, P254, DOI 10.1002/cne.10923; Castro A, 2008, J CHEM NEUROANAT, V35, P306, DOI 10.1016/j.jchemneu.2008.03.005; COLLINS MR, 1994, PROG FISH CULT, V56, P250, DOI 10.1577/1548-8640(1994)056<0250:EOSMFM>2.3.CO;2; Diaz-Regueira SM, 2005, BRAIN RES, V1031, P297, DOI 10.1016/j.brainres.2004.10.039; DIMMICK WW, 1988, COPEIA, P72; Dufourcq P, 2006, MOL CELL NEUROSCI, V33, P180, DOI 10.1016/j.mcn.2006.07.005; Eakin RR, 2006, POLAR BIOL, V30, P45, DOI 10.1007/s00300-006-0158-x; Fadaee B, 2006, J APPL ICHTHYOL, V22, P160, DOI 10.1111/j.1439-0426.2007.00945.x; Fox H, 1999, HYDROBIOLOGIA, V403, P153, DOI 10.1023/A:1003778125517; Germana A, 2007, BRAIN RES, V1162, P48, DOI 10.1016/j.brainres.2007.05.070; GHIOT F, 1984, Annales de la Societe Royale Zoologique de Belgique, V114, P261; GOSS RJ, 1955, AM J ANAT, V97, P59, DOI 10.1002/aja.1000970103; GOTO T, 1994, JPN J ICHTHYOL, V41, P167; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Harlow DE, 2007, DEV BIOL, V310, P317, DOI 10.1016/j.ydbio.2007.07.042; Hata S, 2007, DEV GROWTH DIFFER, V49, P163, DOI 10.1111/j.1440-169x.2007.00910.x; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Howe JC, 2002, FISH RES, V56, P1, DOI 10.1016/S0165-7836(01)00312-5; Humason G., 1967, ANIMAL TISSUE TECHNI; JOYCE EC, 1978, J MORPHOL, V158, P109, DOI 10.1002/jmor.1051580202; Kiyohara S, 2002, P ROY SOC B-BIOL SCI, V269, P1773, DOI 10.1098/rspb.2002.2086; Kotrschal K, 2000, PFLUG ARCH EUR J PHY, V439, pR178, DOI 10.1007/s004240000137; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LeClair E. E., 2009, J VIS EXP, DOI 1510.3791/1558; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Liu Q, 2004, DEV BRAIN RES, V150, P63, DOI 10.1016/j.devbrainres.2004.03.002; MCCORMICK MI, 1993, ENVIRON BIOL FISH, V37, P269, DOI 10.1007/BF00004634; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Nakatani Y, 2007, DEV GROWTH DIFFER, V49, P145, DOI 10.1111/j.1440-169x.2007.00917.x; Northcutt RG, 2005, J COMP NEUROL, V482, P1, DOI 10.1002/cne.20425; Ogawa K, 1997, CHEM SENSES, V22, P477, DOI 10.1093/chemse/22.4.477; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Raya A, 2004, CLONING STEM CELLS, V6, P345, DOI 10.1089/clo.2004.6.345; Saadatfar Z, 2007, J APPL ANIM RES, V32, P65, DOI 10.1080/09712119.2007.9706848; Sakata Y, 2001, FISHERIES SCI, V67, P1136, DOI 10.1046/j.1444-2906.2001.00371.x; SATO MITSUO, 1966, JAP J ICHTHYOL, V13, P169; SCHMIDT RE, 1983, J FRESHWATER ECOL, V2, P239, DOI 10.1080/02705060.1983.9664600; SHIBA Y, 1982, DEV GROWTH DIFFER, V24, P199; Tseng AS, 2008, J DENT RES, V87, P806, DOI 10.1177/154405910808700909; Webb AE, 2004, METH MOL B, V289, P137; WILSON SW, 1991, DEVELOPMENT, V112, P723; WINOKUR RM, 1982, J MORPHOL, V172, P59, DOI 10.1002/jmor.1051720106; Yoshii Y, 2005, DEV GROWTH DIFFER, V47, P563	60	54	54	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8737	10.1371/journal.pone.0008737	http://dx.doi.org/10.1371/journal.pone.0008737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090899	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900017
J	Tancevski, I; Demetz, E; Eller, P; Duwensee, K; Hoefer, J; Heim, C; Stanzl, U; Wehinger, A; Auer, K; Karer, R; Huber, J; Schgoer, W; Van Eck, M; Vanhoutte, J; Fievet, C; Stellaard, F; Rudling, M; Patsch, JR; Ritsch, A				Tancevski, Ivan; Demetz, Egon; Eller, Philipp; Duwensee, Kristina; Hoefer, Julia; Heim, Christiane; Stanzl, Ursula; Wehinger, Andreas; Auer, Kristina; Karer, Regina; Huber, Julia; Schgoer, Wilfried; Van Eck, Miranda; Vanhoutte, Jonathan; Fievet, Catherine; Stellaard, Frans; Rudling, Mats; Patsch, Josef R.; Ritsch, Andreas			The Liver-Selective Thyromimetic T-0681 Influences Reverse Cholesterol Transport and Atherosclerosis Development in Mice	PLOS ONE			English	Article							ESTER TRANSFER PROTEIN; RECEPTOR CLASS-B; DENSITY-LIPOPROTEIN RECEPTOR; IN-VIVO; LESION DEVELOPMENT; LDL CHOLESTEROL; SR-BI; OVEREXPRESSION; ABSORPTION; EXPRESSION	Background: Liver-selective thyromimetics have been reported to efficiently reduce plasma cholesterol through the hepatic induction of both, the low-density lipoprotein receptor (LDLr) and the high-density lipoprotein (HDL) receptor; the scavenger receptor class B type I (SR-BI). Here, we investigated the effect of the thyromimetic T-0681 on reverse cholesterol transport (RCT) and atherosclerosis, and studied the underlying mechanisms using different mouse models, including mice lacking LDLr, SR-BI, and apoE, as well as CETP transgenic mice. Methodology/Principal Findings: T-0681 treatment promoted bile acid production and biliary sterol secretion consistently in the majority of the studied mouse models, which was associated with a marked reduction of plasma cholesterol. Using an assay of macrophage RCT in mice, we found T-0681 to significantly increase fecal excretion of macrophage-derived neutral and acidic sterols. No positive effect on RCT was found in CETP transgenic mice, most likely due to the observed decrease in plasma CETP mass. Studies in SR-BI KO and LDLr KO mice suggested hepatic LDLr to be necessary for the action of T-0681 on lipid metabolism, as the compound did not have any influence on plasma cholesterol levels in mice lacking this receptor. Finally, prolonged treatment with T-0681 reduced the development of atherosclerosis by 60% in apoE KOs on Western type diet. In contrast, at an earlier time-point T-0681 slightly increased small fatty streak lesions, in part due to an impaired macrophage cholesterol efflux capacity, when compared to controls. Conclusions/Significance: The present results show that liver-selective thyromimetics can promote RCT and that such compounds may protect from atherosclerosis partly through induction of bile acid metabolism and biliary sterol secretion. On-going clinical trials will show whether selective thyromimetics do prevent atherosclerosis also in humans.	[Tancevski, Ivan; Demetz, Egon; Eller, Philipp; Duwensee, Kristina; Hoefer, Julia; Heim, Christiane; Stanzl, Ursula; Wehinger, Andreas; Auer, Kristina; Karer, Regina; Huber, Julia; Schgoer, Wilfried; Patsch, Josef R.; Ritsch, Andreas] Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria; [Van Eck, Miranda] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Gorlaeus Labs, Div Biopharmaceut, Leiden, Netherlands; [Stellaard, Frans] Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, NL-9713 AV Groningen, Netherlands; [Vanhoutte, Jonathan; Fievet, Catherine] Inst Pasteur, Dept Atherosclerose, F-59019 Lille, France; [Rudling, Mats] Karolinska Univ Hosp, Karolinska Inst, Ctr Endocrinol Metab & Diabet, Mol Nutr Unit,Dept Med, Stockholm, Sweden; [Rudling, Mats] Karolinska Univ Hosp, Karolinska Inst, Ctr Endocrinol Metab & Diabet, Mol Nutr Unit,Dept Biosci & Nutr, Stockholm, Sweden	Medical University of Innsbruck; Leiden University; Leiden University - Excl LUMC; University of Groningen; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tancevski, I (corresponding author), Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria.	ivan.tancevski@i-med.ac.at	Tancevski, Ivan/AID-5169-2022	Tancevski, Ivan/0000-0001-5116-8960; Demetz, Egon/0000-0002-5723-927X; Ritsch, Andreas/0000-0002-0417-5161; Hoefer, Julia/0000-0003-1138-3134; van Eck, Miranda/0000-0003-3936-3194	Hans und Blanca Moser Stiftung [61-1994/95]; Medizinische Forschungsforderung Innsbruck (MFI) [4316]; Jubilaumsfonds der Oesterreichischen Nationalbank (OENB) [12156]; Fonds zur Forderung der wissenschaftlichen Forschung (FWF) [P19999-B05]	Hans und Blanca Moser Stiftung; Medizinische Forschungsforderung Innsbruck (MFI); Jubilaumsfonds der Oesterreichischen Nationalbank (OENB); Fonds zur Forderung der wissenschaftlichen Forschung (FWF)(Austrian Science Fund (FWF))	Funding: This work was supported by the Hans und Blanca Moser Stiftung (No. 61-1994/95 to I. T.), by the Medizinische Forschungsforderung Innsbruck (MFI No. 4316 to I. T.), by the Jubilaumsfonds der Oesterreichischen Nationalbank (OENB, No. 12156 to I. T. and A. R.) and by the Fonds zur Forderung der wissenschaftlichen Forschung (FWF, P19999-B05 to A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; [Anonymous], 1972, JAMA, V220, P996; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berkenstam A, 2008, P NATL ACAD SCI USA, V105, P663, DOI 10.1073/pnas.0705286104; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Grover GJ, 2003, P NATL ACAD SCI USA, V100, P10067, DOI 10.1073/pnas.1633737100; Hayashi M, 2004, ARCH TOXICOL, V78, P460, DOI 10.1007/s00204-004-0561-4; Hennuyer N, 2005, ARTERIOSCL THROM VAS, V25, P1897, DOI 10.1161/01.ATV.0000175756.56818.ee; Hulten Lillemor Mattsson, 2005, Lipids Health Dis, V4, P6, DOI 10.1186/1476-511X-4-6; Johansson L, 2005, P NATL ACAD SCI USA, V102, P10297, DOI 10.1073/pnas.0504379102; Jones C, 2003, J BIOL CHEM, V278, P29024, DOI 10.1074/jbc.M304855200; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Kruit JK, 2006, WORLD J GASTROENTERO, V12, P6429, DOI 10.3748/wjg.v12.i40.6429; LUTJOHANN D, 1995, J LIPID RES, V36, P1763; MASHIGE F, 1976, CLIN CHIM ACTA, V70, P79, DOI 10.1016/0009-8981(76)90007-3; Mason RL, 1930, NEW ENGL J MED, V203, P1273, DOI 10.1056/NEJM193012252032601; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Moreno M, 2008, THYROID, V18, P239, DOI 10.1089/thy.2007.0248; Morkin E, 2004, J MOL CELL CARDIOL, V37, P1137, DOI 10.1016/j.yjmcc.2004.09.013; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Nijstad N, 2009, CIRCULATION, V120, pS443; Ritsch A, 2003, CURR OPIN LIPIDOL, V14, P173, DOI 10.1097/00041433-200304000-00009; RITSCH A, 1993, J LIPID RES, V34, P673; Singaraja RR, 2002, J CLIN INVEST, V110, P35, DOI 10.1172/JCI200215748; Spady DK, 1998, J BIOL CHEM, V273, P126, DOI 10.1074/jbc.273.1.126; Tancevski I, 2005, J MOL MED, V83, P927, DOI 10.1007/s00109-005-0695-8; Tancevski I, 2008, ENDOCRINOLOGY, V149, P3708, DOI 10.1210/en.2007-1387; Tancevski I, 2009, CURR OPIN INVEST DR, V10, P912; Tancevski I, 2009, J LIPID RES, V50, P938, DOI 10.1194/jlr.M800553-JLR200; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Van Eck M, 2004, AM J PATHOL, V165, P785, DOI 10.1016/S0002-9440(10)63341-X; Van Eck M, 2007, CIRC RES, V100, P678, DOI 10.1161/01.RES.0000260202.79927.4f; Wang X, 2006, CIRCULATION, V114, P146; Wu JE, 2004, J BIOL CHEM, V279, P22913, DOI 10.1074/jbc.M402838200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327; Zhang YZ, 2003, CIRCULATION, V108, P661, DOI 10.1161/01.CIR.0000086981.09834.E0	39	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8722	10.1371/journal.pone.0008722	http://dx.doi.org/10.1371/journal.pone.0008722			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090943	gold, Green Published			2022-12-27	WOS:000273714900004
J	Wang, SS; Gonzalez, P; Yu, K; Porras, C; Li, QZ; Safaeian, M; Rodriguez, AC; Sherman, ME; Bratti, C; Schiffman, M; Wacholder, S; Burk, RD; Herrero, R; Chanock, SJ; Hildesheim, A				Wang, Sophia S.; Gonzalez, Paula; Yu, Kai; Porras, Carolina; Li, Qizhai; Safaeian, Mahboobeh; Cecilia Rodriguez, Ana; Sherman, Mark E.; Bratti, Concepcion; Schiffman, Mark; Wacholder, Sholom; Burk, Robert D.; Herrero, Rolando; Chanock, Stephen J.; Hildesheim, Allan			Common Genetic Variants and Risk for HPV Persistence and Progression to Cervical Cancer	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; DNA-REPAIR GENES; COSTA-RICA; HEPARAN-SULFATE; NEOPLASIA; HOST	HPV infrequently persists and progresses to cervical cancer. We examined host genetic factors hypothesized to play a role in determining which subset of individuals infected with oncogenic human papillomavirus (HPV) have persistent infection and further develop cervical pre-cancer/cancer compared to the majority of infected individuals who will clear infection. We evaluated 7140 tag single nucleotide polymorphisms (SNPs) from 305 candidate genes hypothesized to be involved in DNA repair, viral infection and cell entry in 416 cervical intraepithelial neoplasia 3 (CIN3)/cancer cases, 356 HPV persistent women (median: 25 months), and 425 random controls (RC) from the 10,049 women Guanacaste Costa Rica Natural History study. We used logistic regression to compute odds ratios and p-trend for CIN3/cancer and HPV persistence in relation to SNP genotypes and haplotypes (adjusted for age). We obtained pathway and gene-level summary of associations by computing the adaptive combination of p-values. Genes/regions statistically significantly associated with CIN3/cancer included the viral infection and cell entry genes 29,59 oligoadenylate synthetase gene 3 (OAS3), sulfatase 1 (SULF1), and interferon gamma (IFNG); the DNA repair genes deoxyuridine triphosphate (DUT), dosage suppressor of mck 1 homolog (DMC1), and general transcription factor IIH, polypeptide 3 (GTF2H4); and the EVER1 and EVER2 genes (p<0.01). From each region, the single most significant SNPs associated with CIN3/cancer were OAS3 rs12302655, SULF1 rs4737999, IFNG rs11177074, DUT rs3784621, DMC1 rs5757133, GTF2H4 rs2894054, EVER1/EVER2 rs9893818 (p-trends <= 0.001). SNPs for OAS3, SULF1, DUT, and GTF2H4 were associated with HPV persistence whereas IFNG and EVER1/EVER2 SNPs were associated with progression to CIN3/cancer. We note that the associations observed were less than two-fold. We identified variations DNA repair and viral binding and cell entry genes associated with CIN3/cancer. Our results require replication but suggest that different genes may be responsible for modulating risk in the two critical transition steps important for cervical carcinogenesis: HPV persistence and disease progression.	[Wang, Sophia S.] City Hope Natl Med Ctr, Div Etiol, Duarte, CA 91010 USA; [Gonzalez, Paula; Porras, Carolina; Cecilia Rodriguez, Ana; Bratti, Concepcion; Herrero, Rolando] Fdn INCIENSA, San Jose, Costa Rica; [Wang, Sophia S.; Yu, Kai; Li, Qizhai; Safaeian, Mahboobeh; Sherman, Mark E.; Schiffman, Mark; Wacholder, Sholom; Hildesheim, Allan] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Li, Qizhai] Chinese Acad Sci, Acad Math & Syst Sci, Key Lab Syst & Control, Beijing, Peoples R China; [Burk, Robert D.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Chanock, Stephen J.] NCI, Core Genotyping Facil, Div Canc Epidemiol & Genet, Adv Technol Program,SAIC Frederick Inc, Frederick, MD 21701 USA	City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Wang, SS (corresponding author), City Hope Natl Med Ctr, Div Etiol, 1500 E Duarte Rd, Duarte, CA 91010 USA.	sowang@coh.org	Schiffman, Mark/B-9766-2015; Hildesheim, Allan/B-9760-2015	Hildesheim, Allan/0000-0003-0257-2363; WANG, SOPHIA/0000-0003-2597-9393	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP021081] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA078527, R01CA078527] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA-78527, CO-12400, CP-31061, R01 CA078527, N01CO12400, U01 CA078527, CP-21081] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brehin AC, 2009, VIROLOGY, V384, P216, DOI 10.1016/j.virol.2008.10.021; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Castle D, 2003, AM J BIOETHICS, V3, P28, DOI 10.1162/15265160360706499; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; Herrero R, 2005, J INFECT DIS, V191, P1796, DOI 10.1086/428850; Herrero R, 1997, Rev Panam Salud Publica, V1, P362, DOI 10.1590/S1020-49891997000500005; Hildesheim A, 2002, VIRUS RES, V89, P229, DOI 10.1016/S0168-1702(02)00191-0; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Orth G, 2008, CURR TOP MICROBIOL, V321, P59; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Taylor J, 2006, BIOSTATISTICS, V7, P167, DOI 10.1093/biostatistics/kxj009; Wang SS, 2009, J INFECT DIS, V199, P20, DOI 10.1086/595563; WANG SS, 2003, J NATL CANC I MONOGR, V31, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Wood RD, 2005, MUTAT RES-FUND MOL M, V577, P275, DOI 10.1016/j.mrfmmm.2005.03.007; Yu K, 2009, GENET EPIDEMIOL	20	84	86	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8667	10.1371/journal.pone.0008667	http://dx.doi.org/10.1371/journal.pone.0008667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084279	gold, Green Submitted, Green Published			2022-12-27	WOS:000273554600020
J	Liu, X; Zhao, YP				Liu, Xin; Zhao, Ya-Pu			Switch Region for Pathogenic Structural Change in Conformational Disease and Its Prediction	PLOS ONE			English	Article							VIRUS NUCLEOPROTEIN GENE; AMYLOID FIBRILS; INFLUENZA-VIRUS; PARKINSONS-DISEASE; SYNTHETIC PEPTIDES; ALPHA-SYNUCLEIN; PRION PROTEIN; IN-VITRO; MUTATIONS; VARIANT	Many diseases are believed to be related to abnormal protein folding. In the first step of such pathogenic structural changes, misfolding occurs in regions important for the stability of the native structure. This destabilizes the normal protein conformation, while exposing the previously hidden aggregation-prone regions, leading to subsequent errors in the folding pathway. Sites involved in this first stage can be deemed switch regions of the protein, and can represent perfect binding targets for drugs to block the abnormal folding pathway and prevent pathogenic conformational changes. In this study, a prediction algorithm for the switch regions responsible for the start of pathogenic structural changes is introduced. With an accuracy of 94%, this algorithm can successfully find short segments covering sites significant in triggering conformational diseases (CDs) and is the first that can predict switch regions for various CDs. To illustrate its effectiveness in dealing with urgent public health problems, the reason of the increased pathogenicity of H5N1 influenza virus is analyzed; the mechanisms of the pandemic swine-origin 2009 A(H1N1) influenza virus in overcoming species barriers and in infecting large number of potential patients are also suggested. It is shown that the algorithm is a potential tool useful in the study of the pathology of CDs because: (1) it can identify the origin of pathogenic structural conversion with high sensitivity and specificity, and (2) it provides an ideal target for clinical treatment.	[Liu, Xin; Zhao, Ya-Pu] Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Mechanics, CAS	Liu, X (corresponding author), Chinese Acad Sci, Inst Mech, State Key Lab Nonlinear Mech, Beijing 100080, Peoples R China.	liuxin@lnm.imech.ac.cn; yzhao@imech.ac.cn			National High-Tech R&D Program of China (863 Program) [2007AA021803]; National Basic Research Program of China (973 Program) [200703310500]; National Natural Science Foundation of China [10704077]	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was jointly supported by the National High-Tech R&D Program of China (863 Program, Grant No. 2007AA021803), National Basic Research Program of China (973 Program, Grant No. 200703310500), and National Natural Science Foundation of China, No. 10704077. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson M, 1996, SCAND J CLIN LAB INV, V56, P47; Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREOTTI G, DESIGNING A IN PRESS; Berkhoff EGM, 2005, J VIROL, V79, P11239, DOI 10.1128/JVI.79.17.11239-11246.2005; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Carrell RW, 1998, CURR OPIN STRUC BIOL, V8, P799, DOI 10.1016/S0959-440X(98)80101-2; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Collod-Beroud G, 1998, NUCLEIC ACIDS RES, V26, P229, DOI 10.1093/nar/26.1.229; DEBELLEROCHE J, 1995, J MED GENET, V32, P841, DOI 10.1136/jmg.32.11.841; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Frank PG, 2000, J LIPID RES, V41, P853; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hasegawa K, 2003, BIOCHEM BIOPH RES CO, V304, P101, DOI 10.1016/S0006-291X(03)00543-6; Haspel N, 2005, J MOL BIOL, V345, P1213, DOI 10.1016/j.jmb.2004.11.002; Henneke Marco, 2003, Hum Mutat, V22, P417, DOI 10.1002/humu.9187; Hiramatsu H, 2005, J AM CHEM SOC, V127, P7988, DOI 10.1021/ja050844o; Hiramatsu H, 2004, J AM CHEM SOC, V126, P3008, DOI 10.1021/ja0383017; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; JACOBSON DR, 1992, HUM GENET, V89, P353; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Johnson DJD, 2004, J BIOL CHEM, V279, P4913, DOI 10.1074/jbc.M311644200; Johnson RJK, 2005, J MOL BIOL, V352, P823, DOI 10.1016/j.jmb.2005.07.040; JUNG J, BIOCHEMISTRY, V48, P2597; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kazantzis A, 2002, EUR J BIOCHEM, V269, P780, DOI 10.1046/j.0014-2956.2001.02689.x; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Kuwata K, 2007, P NATL ACAD SCI USA, V104, P11921, DOI 10.1073/pnas.0702671104; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Liu X, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.051927; Liu XK, 2008, PROCEEDINGS OF THE 27TH CHINESE CONTROL CONFERENCE, VOL 2, P91, DOI 10.1109/CHICC.2008.4605378; Liu X, 2009, J THEOR BIOL, V261, P593, DOI 10.1016/j.jtbi.2009.08.028; Liu X, 2009, J THEOR BIOL, V258, P294, DOI 10.1016/j.jtbi.2009.02.009; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Reid AH, 2004, J VIROL, V78, P12462, DOI 10.1128/JVI.78.22.12462-12470.2004; SCHOLTISSEK C, 1993, ARCH VIROL, V131, P237, DOI 10.1007/BF01378629; Sebastiao MP, 1998, J BIOL CHEM, V273, P24715, DOI 10.1074/jbc.273.38.24715; SNYDER MH, 1987, J VIROL, V61, P2857, DOI 10.1128/JVI.61.9.2857-2863.1987; Soto C, 2001, FEBS LETT, V498, P204, DOI 10.1016/S0014-5793(01)02486-3; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Ventura S, 2004, P NATL ACAD SCI USA, V101, P7258, DOI 10.1073/pnas.0308249101; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	55	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8441	10.1371/journal.pone.0008441	http://dx.doi.org/10.1371/journal.pone.0008441			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111584	Green Published, gold, Green Submitted			2022-12-27	WOS:000278099200002
J	Sasco, AJ; Jaquet, A; Boidin, E; Ekouevi, DK; Thouillot, F; LeMabec, T; Forstin, MA; Renaudier, P; N'Dom, P; Malvy, D; Dabis, F				Sasco, Annie J.; Jaquet, Antoine; Boidin, Emilie; Ekouevi, Didier K.; Thouillot, Fabian; LeMabec, Thomas; Forstin, Marie-Anna; Renaudier, Philippe; N'Dom, Paul; Malvy, Denis; Dabis, Francois			The Challenge of AIDS-Related Malignancies in Sub-Saharan Africa	PLOS ONE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; NON-HODGKIN-LYMPHOMA; INVASIVE CERVICAL-CANCER; LIVER-RELATED MORTALITY; SWISS HIV COHORT; KAPOSIS-SARCOMA; LUNG-CANCER; HOMOSEXUAL-MEN	Background: With the lengthening of life expectancy among HIV-positive subjects related to the use of highly active antiretroviral treatments, an increased risk of cancer has been described in industrialized countries. The question is to determine what occurs now and will happen in the future in the low income countries and particularly in sub-Saharan Africa where more than two-thirds of all HIV-positive people live in the world. The objective of our paper is to review the link between HIV and cancer in sub-Saharan Africa, putting it in perspective with what is already known in Western countries. Methods and Findings: Studies for this review were identified from several bibliographical databases including Pubmed, Scopus, Cochrane, Pascal, Web of Science and using keywords "HIV, neoplasia, epidemiology and Africa'' and related MesH terms. A clear association was found between HIV infection and AIDS-classifying cancers. In case-referent studies, odds ratios (OR) were ranging from 21.9 (95% Confidence Interval (CI) 12.5-38.6) to 47.1 (31.9-69.8) for Kaposi sarcoma and from 5.0 (2.7-9.5) to 12.6 (2.2-54.4) for non Hodgkin lymphoma. The association was less strong for invasive cervical cancer with ORs ranging from 1.1 (0.7-1.2) to 1.6 (1.1-2.3), whereas ORs for squamous intraepithelial lesions were higher, from 4.4 (2.3-8.4) to 17.0 (2.2-134.1). For non AIDS-classifying cancers, squamous cell conjunctival carcinoma of the eye was associated with HIV in many case-referent studies with ORs from 2.6 (1.4-4.9) to 13.0 (4.5-39.4). A record-linkage study conducted in Uganda showed an association between Hodgkin lymphoma and HIV infection with a standardized incidence ratio of 5.7 (1.2-17) although OR in case-referent studies ranged from 1.4 (0.7-2.8) to 1.6 (1.0-2.7). Other cancer sites found positively associated with HIV include lung, liver, anus, penis, vulva, kidney, thyroid and uterus and a decreased risk of female breast cancer. These results so far based on a relatively small number of studies warrant further epidemiological investigations, taking into account other known risk factors for these tumors. Conclusion: Studies conducted in sub-Saharan Africa show that HIV infection is not only strongly associated with AIDS-classifying cancers but also provided some evidence of association for other neoplasia. African countries need now to implement well designed population-based studies in order to better describe the spectrum of AIDS-associated malignancies and the most effective strategies for their prevention, screening and treatment.	[Sasco, Annie J.; Jaquet, Antoine; Boidin, Emilie; Thouillot, Fabian; LeMabec, Thomas; Forstin, Marie-Anna] INSERM, U897, Bordeaux, France; [Sasco, Annie J.; Malvy, Denis; Dabis, Francois] Univ Victor Segalen Bordeaux 2, Bordeaux, France; [Jaquet, Antoine; Ekouevi, Didier K.; Dabis, Francois] Inst Publ Hlth, HIV Africa, INSERM, U897, Bordeaux, France; [Renaudier, Philippe] Hosp Civils Lyon, Hemovigilance Unit, Lyon, France; [N'Dom, Paul] Yaounde Gen Hosp, Dept Med Oncol, Yaounde, Cameroon; [Malvy, Denis] Hop St Andre, Trop Med Unit, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Lyon; CHU Bordeaux	Sasco, AJ (corresponding author), INSERM, U897, Bordeaux, France.	Annie.Sasco@isped.u-bordeaux2.fr	MALVY, Denis/T-7930-2019; DABIS, FRANCOIS/S-9298-2019; EKOUEVI, Didier K/E-7960-2014; Jaquet, Antoine/T-2794-2019	DABIS, FRANCOIS/0000-0002-1614-8857; Jaquet, Antoine/0000-0002-3426-9492	US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study has been provided by the US National Institutes of Health in the framework of the IeDEA Regional Centre for West Africa awarded to Pr Francois Dabis (National Cancer Institute, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Institute of Allergy and Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir H, 2001, ONCOL REP, V8, P659; Amir H, 2000, J NATL MED ASSOC, V92, P301; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1987, MMWR-MORBID MORTAL W, V36, p1S; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; ATEENYIAGABA C, 1995, LANCET, V345, P695, DOI 10.1016/S0140-6736(95)90870-6; BASSETT MT, 1995, INT J CANCER, V63, P29, DOI 10.1002/ijc.2910630107; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Biggar RJ, 2007, J NATL CANCER I, V99, P962, DOI 10.1093/jnci/djm010; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Blossom DB, 2007, J MED VIROL, V79, P758, DOI 10.1002/jmv.20817; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Bonnet F, 2006, REV MED INTERNE, V27, P227, DOI 10.1016/j.revmed.2005.10.003; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bower M, 2004, JAIDS-J ACQ IMM DEF, V37, P1563, DOI 10.1097/00126334-200412150-00004; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Bower M, 2003, AIDS, V17, P371, DOI 10.1097/00002030-200302140-00011; Burgi A, 2005, CANCER-AM CANCER SOC, V104, P1505, DOI 10.1002/cncr.21334; Busnach G, 2006, TRANSPLANT P, V38, P3533, DOI 10.1016/j.transproceed.2006.10.144; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chaturvedi AK, 2007, AIDS, V21, P207, DOI 10.1097/QAD.0b013e3280118fca; Chirenje ZM, 2005, BEST PRACT RES CL OB, V19, P269, DOI 10.1016/j.bpobgyn.2004.10.002; Chokunonga E, 1999, AIDS, V13, P2583, DOI 10.1097/00002030-199912240-00012; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Cook-Mozaffari P, 1998, BRIT J CANCER, V78, P1521, DOI 10.1038/bjc.1998.717; Dal Maso L, 2001, INT J CANCER, V93, P430, DOI 10.1002/1097-0215(20010801)93:3&lt;430::AID-IJC1344&gt;3.0.CO;2-K; Dal Maso L, 2001, EUR J CANCER, V37, P1188, DOI 10.1016/S0959-8049(01)00120-4; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; Dhir AA, 2008, CANCER CAUSE CONTROL, V19, P147, DOI 10.1007/s10552-007-9080-y; Didelot-Rousseau MN, 2006, BRIT J CANCER, V95, P355, DOI 10.1038/sj.bjc.6603252; DOLL DC, 1982, LANCET, V1, P1026; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Franceschi S, 1995, TUMORI, V81, P308, DOI 10.1177/030089169508100502; Franceschi S, 1998, BRIT J CANCER, V78, P966, DOI 10.1038/bjc.1998.610; Franceschi S, 2003, JAIDS-J ACQ IMM DEF, V34, P84, DOI 10.1097/00126334-200309010-00013; Frisch M, 2000, JNCI-J NATL CANCER I, V92, P1500, DOI 10.1093/jnci/92.18.1500; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gerard L, 2003, AIDS, V17, P81, DOI 10.1097/00002030-200301030-00011; Gichangi P, 2002, INT J GYNECOL OBSTET, V76, P55, DOI 10.1016/S0020-7292(01)00560-4; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Grulich AE, 1999, AIDS, V13, P839, DOI 10.1097/00002030-199905070-00014; Grulich AE, 2002, AIDS, V16, P1155, DOI 10.1097/00002030-200205240-00009; Guech-Ongey M, 2008, INT J CANCER, V122, P2590, DOI 10.1002/ijc.23384; Guth AA, 2003, J WOMEN HEALTH GEN-B, V12, P227, DOI 10.1089/154099903321667564; Hawes SE, 2003, J INFECT DIS, V188, P555, DOI 10.1086/376996; Hentrich M, 2006, ANN ONCOL, V17, P914, DOI 10.1093/annonc/mdl063; HESSOL NA, 1992, ANN INTERN MED, V117, P309, DOI 10.7326/0003-4819-117-4-309; HYMES KB, 1981, LANCET, V2, P598; *IARC WORK GROUP E, 1996, IARC MON EV CARC RIS, V67; *IARC WORK GROUP E, 2007, IARC MON EV CARC RIS, V90; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. World Health Organization, 1997, IARC MON EV CARC RIS, V70; Jaffe ES, 2001, WHO CLASSIFICATION T; Kaaya Ephata E, 2006, Afr Health Sci, V6, P69; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; KESTELYN P, 1990, LANCET, V336, P51, DOI 10.1016/0140-6736(90)91562-O; Kirk GD, 2004, HEPATOLOGY, V39, P211, DOI 10.1002/hep.20027; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; La Ruche G, 1998, CANCER-AM CANCER SOC, V82, P2401, DOI 10.1002/(SICI)1097-0142(19980615)82:12&lt;2401::AID-CNCR14&gt;3.3.CO;2-H; Langley CL, 1996, AIDS, V10, P413, DOI 10.1097/00002030-199604000-00010; Launay O, 2003, B CANCER, V90, P387; Leroy V, 1999, SEX TRANSM INFECT, V75, P103, DOI 10.1136/sti.75.2.103; Lessells RJ, 2008, LANCET, V371, P1504, DOI 10.1016/S0140-6736(08)60652-2; Levine A M, 1998, J Natl Cancer Inst Monogr, P37; LEVINE AM, 1993, JNCI-J NATL CANCER I, V85, P1382, DOI 10.1093/jnci/85.17.1382; LUCAS SB, 1994, INT J CANCER, V59, P20, DOI 10.1002/ijc.2910590106; LUO KH, 1995, AIDS, V9, P57, DOI 10.1097/00002030-199501000-00008; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Moodley JR, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-135; Moodley M, 2001, INT J GYNECOL CANCER, V11, P194, DOI 10.1046/j.1525-1438.2001.01022.x; Newton R, 2001, INT J CANCER, V92, P622, DOI 10.1002/1097-0215(20010601)92:5&lt;622::AID-IJC1256&gt;3.0.CO;2-K; NEWTON R, 1995, LANCET, V345, P1378, DOI 10.1016/S0140-6736(95)92583-X; Newton R, 2002, BRIT J CANCER, V87, P301, DOI 10.1038/sj.bjc.6600451; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Parkin DM, 2000, AIDS, V14, P2929, DOI 10.1097/00002030-200012220-00015; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; Parkin DM, 2003, IARC SCI PUBLICATION, V153; PARKIN DM, 2005, IARC NONSERIAL PUBLI; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; Powles T, 2003, INT J STD AIDS, V14, P647, DOI 10.1258/095646203322387875; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Sahasrabuddhe VV, 2007, BRIT J CANCER, V96, P1480, DOI 10.1038/sj.bjc.6603737; Schulz TF, 1996, LANCET, V348, P587, DOI 10.1016/S0140-6736(95)11033-X; Sekirime WK, 2007, GYNECOL OBSTET INVES, V63, P222, DOI 10.1159/000098197; Simonart T, 2006, CANCER LETT, V244, P1, DOI 10.1016/j.canlet.2006.02.005; Sinfield RL, 2007, PEDIATR BLOOD CANCER, V48, P515, DOI 10.1002/pbc.20917; Sitas F, 2000, INT J CANCER, V88, P489, DOI 10.1002/1097-0215(20001101)88:3&lt;489::AID-IJC25&gt;3.0.CO;2-Q; Stebbing J, 2004, J CLIN ONCOL, V22, P2177, DOI 10.1200/JCO.2004.11.097; Stein L, 2008, INT J CANCER, V122, P2260, DOI 10.1002/ijc.23391; Sun EC, 1997, CANCER EPIDEM BIOMAR, V6, P73; Temmerman M, 1999, INT J GYNECOL OBSTET, V65, P171, DOI 10.1016/S0020-7292(99)00043-0; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; *UNAIDS, 2007, AIDS EP UPD; VERNON SD, 1995, CLIN INFECT DIS, V21, pS121, DOI 10.1093/clinids/21.Supplement_1.S121; WABINGA HR, 1993, INT J CANCER, V54, P26, DOI 10.1002/ijc.2910540106; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Waddell KM, 1996, BRIT J OPHTHALMOL, V80, P503, DOI 10.1136/bjo.80.6.503; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; World Health Organization, 2002, CERVICAL CANC SCREEN; Yamada R, 2008, J MED VIROL, V80, P847, DOI 10.1002/jmv.21170; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904; 1985, MMWR MORB MORTAL WKL, V34, P373	108	56	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8621	10.1371/journal.pone.0008621	http://dx.doi.org/10.1371/journal.pone.0008621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066157	Green Submitted, gold, Green Published			2022-12-27	WOS:000273456300004
J	Ghosh, Z; Wilson, KD; Wu, Y; Hu, SJ; Quertermous, T; Wu, JC				Ghosh, Zhumur; Wilson, Kitchener D.; Wu, Yi; Hu, Shijun; Quertermous, Thomas; Wu, Joseph C.			Persistent Donor Cell Gene Expression among Human Induced Pluripotent Stem Cells Contributes to Differences with Human Embryonic Stem Cells	PLOS ONE			English	Article							ADIPOSE-TISSUE; HUMAN FIBROBLASTS; GENERATION; ADIPOCYTES; DERIVATION; REJECTION; PROFILES; THERAPY; DISPLAY; MEMORY	Human induced pluripotent stem cells (hiPSCs) generated by de-differentiation of adult somatic cells offer potential solutions for the ethical issues surrounding human embryonic stem cells (hESCs), as well as their immunologic rejection after cellular transplantation. However, although hiPSCs have been described as "embryonic stem cell-like'', these cells have a distinct gene expression pattern compared to hESCs, making incomplete reprogramming a potential pitfall. It is unclear to what degree the difference in tissue of origin may contribute to these gene expression differences. To answer these important questions, a careful transcriptional profiling analysis is necessary to investigate the exact reprogramming state of hiPSCs, as well as analysis of the impression, if any, of the tissue of origin on the resulting hiPSCs. In this study, we compare the gene profiles of hiPSCs derived from fetal fibroblasts, neonatal fibroblasts, adipose stem cells, and keratinocytes to their corresponding donor cells and hESCs. Our analysis elucidates the overall degree of reprogramming within each hiPSC line, as well as the "distance'' between each hiPSC line and its donor cell. We further identify genes that have a similar mode of regulation in hiPSCs and their corresponding donor cells compared to hESCs, allowing us to specify core sets of donor genes that continue to be expressed in each hiPSC line. We report that residual gene expression of the donor cell type contributes significantly to the differences among hiPSCs and hESCs, and adds to the incompleteness in reprogramming. Specifically, our analysis reveals that fetal fibroblast-derived hiPSCs are closer to hESCs, followed by adipose, neonatal fibroblast, and keratinocyte-derived hiPSCs.	[Ghosh, Zhumur; Wilson, Kitchener D.; Wu, Yi; Hu, Shijun; Quertermous, Thomas; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Ghosh, Zhumur; Wilson, Kitchener D.; Hu, Shijun; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA; [Wilson, Kitchener D.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Ghosh, Z (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	joewu@stanford.edu	Hu, Shijun/I-5818-2012; Wilson, Kitchener/A-7146-2016; Wu, Joseph/H-1067-2013	Ghosh, Zhumur/0000-0002-4877-7551; Wu, Joseph/0000-0002-6068-8041; Quertermous, Thomas/0000-0002-7645-9067; Hu, Shijun/0000-0002-0068-8429	Edward Mallinckrodt Foundation; NIH [R01AI085575, DP2OD004437]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL065585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085575] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	Edward Mallinckrodt Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank funding support from Edward Mallinckrodt Foundation, AHA Innovative Research Grant, NIH R01AI085575, and NIH DP2OD004437 (JCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang HH, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-11; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dahlman I, 2005, AM J CLIN NUTR, V81, P1275; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Gazel A, 2003, J INVEST DERMATOL, V121, P1459, DOI 10.1111/j.1523-1747.2003.12611.x; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Gosiewska A, 2001, WOUND REPAIR REGEN, V9, P213, DOI 10.1046/j.1524-475x.2001.00213.x; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; Mongan NP, 2006, MOL CARCINOGEN, V45, P887, DOI 10.1002/mc.20186; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Sipp D, 2009, CELL STEM CELL, V5, P360, DOI 10.1016/j.stem.2009.09.005; Sjoholm K, 2005, J CLIN ENDOCR METAB, V90, P2233, DOI 10.1210/jc.2004-1830; Stojkovic M, 2004, REPRODUCTION, V128, P259, DOI 10.1530/rep.1.00243; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; SUN NLM, 2010, CELL CYCLE IN PRESS; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Swijnenburg RJ, 2008, STEM CELLS DEV, V17, P1023, DOI 10.1089/scd.2008.0091; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Waddington C H, 1957, STRATEGY GENES DISCU; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yih LH, 2002, CARCINOGENESIS, V23, P867, DOI 10.1093/carcin/23.5.867; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	47	214	225	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8975	10.1371/journal.pone.0008975	http://dx.doi.org/10.1371/journal.pone.0008975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126639	Green Published, Green Submitted, gold			2022-12-27	WOS:000274209700007
J	Nunez-Iglesias, J; Liu, CC; Morgan, TE; Finch, CE; Zhou, XJ				Nunez-Iglesias, Juan; Liu, Chun-Chi; Morgan, Todd E.; Finch, Caleb E.; Zhou, Xianghong Jasmine			Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation	PLOS ONE			English	Article							MICRORNA; MICROARRAY; IDENTIFICATION; OLIGOMERS; NETWORKS; MIRBASE; TARGETS; GENES; BRAIN	Although microRNAs are being extensively studied for their involvement in cancer and development, little is known about their roles in Alzheimer's disease (AD). In this study, we used microarrays for the first joint profiling and analysis of miRNAs and mRNAs expression in brain cortex from AD and age-matched control subjects. These data provided the unique opportunity to study the relationship between miRNA and mRNA expression in normal and AD brains. Using a non-parametric analysis, we showed that the levels of many miRNAs can be either positively or negatively correlated with those of their target mRNAs. Comparative analysis with independent cancer datasets showed that such miRNA-mRNA expression correlations are not static, but rather context-dependent. Subsequently, we identified a large set of miRNA-mRNA associations that are changed in AD versus control, highlighting AD-specific changes in the miRNA regulatory system. Our results demonstrate a robust relationship between the levels of miRNAs and those of their targets in the brain. This has implications in the study of the molecular pathology of AD, as well as miRNA biology in general.	[Nunez-Iglesias, Juan; Liu, Chun-Chi; Zhou, Xianghong Jasmine] Univ So Calif, Los Angeles, CA 90089 USA; [Morgan, Todd E.; Finch, Caleb E.] Univ So Calif, Davis Sch Gerontol, Los Angeles, CA USA	University of Southern California; University of Southern California	Nunez-Iglesias, J (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	cefinch@usc.edu; xjzhou@usc.edu	Finch, Caleb/AAA-7250-2022	Nunez-Iglesias, Juan/0000-0002-7239-5828	National Institutes of Health [R01GM074163, P50HG002790, U54CA112952]; National Science Foundation [0515936, 0747475]; NATIONAL CANCER INSTITUTE [U54CA112952] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants [R01GM074163, P50HG002790, U54CA112952], and National Science Foundation grants [0515936, 0747475]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blalock EM, 2005, AGEING RES REV, V4, P481, DOI 10.1016/j.arr.2005.06.006; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lau P, 2008, J NEUROSCI, V28, P11720, DOI 10.1523/JNEUROSCI.1932-08.2008; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lonnstedt I, 2002, STAT SINICA, V12, P31; LU Y, 2007, NUCL ACIDS RES; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Maes OC, 2007, NEUROBIOL AGING, V28, P1795, DOI 10.1016/j.neurobiolaging.2006.08.004; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218	39	266	280	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8898	10.1371/journal.pone.0008898	http://dx.doi.org/10.1371/journal.pone.0008898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126538	Green Published, gold, Green Submitted			2022-12-27	WOS:000274209700001
J	Shah, S; Sanford, UR; Vargas, JC; Xu, HM; Groen, A; Paulusma, CC; Grenert, JP; Pawlikowska, L; Sen, S; Elferink, RPJO; Bull, LN				Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Groen, Annamiek; Paulusma, Coen C.; Grenert, James P.; Pawlikowska, Ludmila; Sen, Saunak; Elferink, Ronald P. J. Oude; Bull, Laura N.			Strain Background Modifies Phenotypes in the ATP8B1-Deficient Mouse	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY CHOLESTASIS; CANALICULAR MEMBRANE; BILE-SALTS; MICE; LIPOPROTEIN; DISEASE; PROTEIN; GENE; DEFICIENCY	Background: Mutations in ATP8B1 (FIC1) underlie cases of cholestatic disease, ranging from chronic and progressive (progressive familial intrahepatic cholestasis) to intermittent (benign recurrent intrahepatic cholestasis). The ATP8B1-deficient mouse serves as an animal model of human ATP8B1 deficiency. Methodology/Principal Findings: We investigated the effect of genetic background on phenotypes of ATP8B1-deficient and wild-type mice, using C57Bl/6 (B6), 129, and (B6-129) F1 strain backgrounds. B6 background resulted in greater abnormalities in ATP8B1-deficient mice than did 129 and/or F1 background. ATP8B1-deficient pups of B6 background gained less weight. In adult ATP8B1-deficient mice at baseline, those of B6 background had lower serum cholesterol levels, higher serum alkaline phosphatase levels, and larger livers. After challenge with cholate-supplemented diet, these mice exhibited higher serum alkaline phosphatase and bilirubin levels, greater weight loss and larger livers. ATP8B1-deficient phenotypes in mice of F1 and 129 backgrounds are usually similar, suggesting that susceptibility to manifestations of ATP8B1 deficiency may be recessive. We also detected differences in hepatobiliary phenotypes between wild-type mice of differing strains. Conclusions/Significance: Our results indicate that the ATP8B1-deficient mouse in a B6 background may be a better model of human ATP8B1 deficiency and highlight the importance of informed background strain selection for mouse models of liver disease.	[Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Grenert, James P.; Sen, Saunak; Bull, Laura N.] Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94143 USA; [Shah, Sohela; Sanford, Ukina R.; Vargas, Julie C.; Xu, Hongmei; Bull, Laura N.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Groen, Annamiek; Paulusma, Coen C.; Elferink, Ronald P. J. Oude] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Grenert, James P.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Pawlikowska, Ludmila; Bull, Laura N.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Sen, Saunak] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Shah, S (corresponding author), Univ Calif San Francisco, UCSF Liver Ctr, San Francisco, CA 94143 USA.	lbull@medsfgh.ucsf.edu	Shah, Sohela/B-3137-2013; xu, hong/GSD-8903-2022; Paulusma, Coen/AAR-7943-2021	Paulusma, Coen/0000-0001-7284-1974	U.S. National Institutes of Health [R01 DK50697, R01 GM078338, R01 DK072187]; NIH [P30 DK026743]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072187, R01DK050697, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078338] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the U.S. National Institutes of Health: R01 DK50697 to L. N. Bull, R01 GM078338 to S. Sen, and R01 DK072187 to S. Erickson, and the UCSF Liver Center (NIH P30 DK026743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Cai SY, 2009, GASTROENTEROLOGY, V136, P1060, DOI 10.1053/j.gastro.2008.10.025; Claudel T, 2002, J CLIN INVEST, V109, P961; CLAYTON RJ, 1969, AM J DIS CHILD, V117, P112, DOI 10.1001/archpedi.1969.02100030114014; COX DR, 2000, THEORY DESIGN EXPT; Elferink RPJO, 1998, J CLIN INVEST, V102, P1749, DOI 10.1172/JCI3597; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; GROEN AK, 1995, GASTROENTEROLOGY, V109, P1997, DOI 10.1016/0016-5085(95)90768-8; Groen A, 2008, GASTROENTEROLOGY, V134, P2091, DOI 10.1053/j.gastro.2008.02.097; Groen A, 2007, J HEPATOL, V47, P114, DOI 10.1016/j.jhep.2007.02.011; Groen A, 2006, MOL PHARMACEUT, V3, P756, DOI 10.1021/mp060009t; HAMILTON RL, 1971, SCIENCE, V172, P475, DOI 10.1126/science.172.3982.475; Kimmings N, 2001, SURGERY, V129, P282, DOI 10.1067/msy.2001.110855; Klomp LWJ, 2000, HEPATOLOGY, V32, P1337, DOI 10.1053/jhep.2000.20520; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; LINARELLI LG, 1972, J PEDIATR-US, V81, P484, DOI 10.1016/S0022-3476(72)80174-4; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nagasaka H, 2005, J PEDIATR-US, V146, P329, DOI 10.1016/j.jpeds.2004.10.047; Nagasaka H, 2004, J PEDIATR GASTR NUTR, V39, P404, DOI 10.1097/00005176-200410000-00018; Nagasaka H, 2007, J PEDIATR GASTR NUTR, V45, P96, DOI 10.1097/MPG.0b013e3180331df9; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Paulusma CC, 2006, HEPATOLOGY, V44, P195, DOI 10.1002/hep.21212; Paulusma CC, 2009, J BIOL CHEM, V284, P9947, DOI 10.1074/jbc.M808667200; Pawlikowska L, 2004, HUM MOL GENET, V13, P881, DOI 10.1093/hmg/ddh100; PAWLIKOWSKA L, J HEPAT IN PRESS; R Development Core Team, 2005, R LANG ENV STAT COMP; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; Ujhazy P, 2001, HEPATOLOGY, V34, P768, DOI 10.1053/jhep.2001.27663	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8984	10.1371/journal.pone.0008984	http://dx.doi.org/10.1371/journal.pone.0008984			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126555	gold, Green Published, Green Submitted			2022-12-27	WOS:000274209700012
J	Striegl, H; Andrade-Navarro, MA; Heinemann, U				Striegl, Harald; Andrade-Navarro, Miguel A.; Heinemann, Udo			Armadillo Motifs Involved in Vesicular Transport	PLOS ONE			English	Article							PROTEIN; P115; COMPLEX; CANCER	Armadillo (ARM) repeat proteins function in various cellular processes including vesicular transport and membrane tethering. They contain an imperfect repeating sequence motif that forms a conserved three-dimensional structure. Recently, structural and functional insight into tethering mediated by the ARM-repeat protein p115 has been provided. Here we describe the p115 ARM-motifs for reasons of clarity and nomenclature and show that both sequence and structure are highly conserved among ARM-repeat proteins. We argue that there is no need to invoke repeat types other than ARM repeats for a proper description of the structure of the p115 globular head region. Additionally, we propose to define a new subfamily of ARM-like proteins and show lack of evidence that the ARM motifs found in p115 are present in other long coiled-coil tethering factors of the golgin family.	[Striegl, Harald; Andrade-Navarro, Miguel A.; Heinemann, Udo] Max Delbruck Ctr Mol Med, Berlin, Germany; [Striegl, Harald; Heinemann, Udo] Free Univ Berlin, Inst Chem & Biochem, D-1000 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin	Striegl, H (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.	heinemann@mdc-berlin.de	Heinemann, Udo/S-3379-2016; Andrade, Miguel A/B-6565-2008; Heinemann, Udo/AAH-4766-2019	Heinemann, Udo/0000-0002-8191-3850; Andrade, Miguel A/0000-0001-6650-1711; Heinemann, Udo/0000-0002-8191-3850	Deutsche Forschungsgemeinschaft [740]; Helmholtz foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz foundation(Helmholtz Association)	work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) through SFB 740. M.A.A-N. acknowledges support from the Helmholtz foundation (www.helmholtz.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An Y, 2009, J MOL BIOL, V391, P26, DOI 10.1016/j.jmb.2009.04.062; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; CHAN EKL, 1998, ELECTRON J BIOTECHN, V1, P1; DeLano W. L., 2002, PYMOL MOL GRAPHICS S; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; HARTZFELD M, 1996, J CELL SCI, V109, P2767; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Huska MR, 2007, BIOINFORMATICS, V23, P3093, DOI 10.1093/bioinformatics/btm489; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; MCCREA PD, 1991, SCIENCE, V254, P1359, DOI 10.1126/science.1962194; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Palidwor GA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000304; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Ramirez IBR, 2009, SEMIN CELL DEV BIOL, V20, P770, DOI 10.1016/j.semcdb.2009.03.011; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Satoh A, 2008, TRAFFIC, V9, P1522, DOI 10.1111/j.1600-0854.2008.00783.x; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Striegl H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004656; Yamakawa H, 1996, J STRUCT BIOL, V116, P356, DOI 10.1006/jsbi.1996.0053	33	17	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8991	10.1371/journal.pone.0008991	http://dx.doi.org/10.1371/journal.pone.0008991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126549	Green Published, Green Accepted, gold			2022-12-27	WOS:000274209700017
J	Becirovic, E; Nakova, K; Hammelmann, V; Hennel, R; Biel, M; Michalakis, S				Becirovic, Elvir; Nakova, Kostadinka; Hammelmann, Verena; Hennel, Roman; Biel, Martin; Michalakis, Stylianos			The Retinitis Pigmentosa Mutation c.3444+1G > A in CNGB1 Results in Skipping of Exon 32	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; BETA-SUBUNIT	Retinitis pigmentosa (RP) is a severe hereditary eye disorder characterized by progressive degeneration of photoreceptors and subsequent loss of vision. Two of the RP associated mutations were found in the CNGB1 gene that encodes the B subunit of the rod cyclic nucleotide-gated channel (CNGB1a). One of them (c.3444+1G>A) is located at the donor site of exon 32 and has been proposed to result in a frameshift and truncation of the last 28 aa of the corresponding protein. However, this ambiguous conclusion was not verified by experimental data. Recently, another study reported that the last 28 aa of CNGB1a harbor a motif required for the proper targeting of this subunit to rod photoreceptor outer segments. This suggests that defective targeting is the major cause for the RP phenotype in affected patients. Here, we investigated the splicing of c.3444+1G>A by exon trapping experiments and could demonstrate that instead of the proposed truncation of the last 28 aa this mutation leads to replacement of the last 170 aa of CNGB1a by 68 unrelated amino acids. The 170 aa deletion covers the complete distal C-terminus including the last 10 aa of an important alpha (alpha C) helix within the ligand-binding domain of CNGB1a. When expressed in a heterologous expression system the corresponding mutant full-length CNGB1a subunit was more susceptible to proteosomal degradation compared to the wild-type counterpart. In conclusion, our experimental data do not support the hypothesis proposed by the original study on the c.3444+1G>A mutation. Based on this, we suggest that apart from the defective targeting other mechanisms may be responsible for the RP phenotype in affected individuals.	[Becirovic, Elvir] Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany; Univ Munich, Dept Pharm, Ctr Drug Res, Munich, Germany	University of Munich; University of Munich	Becirovic, E (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci CIPSM, Munich, Germany.	michalakis@lmu.de	Biel, Martin/G-1175-2014; Becirovic, Elvir/GWC-9928-2022; Michalakis, Stylianos/M-4677-2019; Michalakis, Stylianos/W-2094-2018; Becirovic, Elvir/ABE-6710-2020	Biel, Martin/0000-0002-9974-3052; Michalakis, Stylianos/0000-0001-5092-9238; Michalakis, Stylianos/0000-0001-5092-9238; Becirovic, Elvir/0000-0001-8801-0649	Deutsche Forschungsgemeinschaft [Mi1238/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: This work was supported by the Deutsche Forschungsgemeinschaft (Mi1238/1-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareil C, 2001, HUM GENET, V108, P328, DOI 10.1007/s004390100496; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Colville CA, 1996, J BIOL CHEM, V271, P32968, DOI 10.1074/jbc.271.51.32968; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; Kondo H, 2004, INVEST OPHTH VIS SCI, V45, P4433, DOI 10.1167/iovs.04-0544; Matulef K, 2002, NEURON, V36, P93, DOI 10.1016/S0896-6273(02)00878-4; Mazzolini M, 2002, BIOPHYS J, V83, P3283, DOI 10.1016/S0006-3495(02)75329-0; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Pages F, 2000, BIOPHYS J, V78, P1227, DOI 10.1016/S0006-3495(00)76680-X; TAKEYASU K, 1988, J BIOL CHEM, V263, P4347	10	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8969	10.1371/journal.pone.0008969	http://dx.doi.org/10.1371/journal.pone.0008969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126465	gold, Green Published, Green Submitted			2022-12-27	WOS:000274139100017
J	Boesch, C; Bole, C; Eckhardt, N; Boesch, H				Boesch, Christophe; Bole, Camille; Eckhardt, Nadin; Boesch, Hedwige			Altruism in Forest Chimpanzees: The Case of Adoption	PLOS ONE			English	Article							WILD CHIMPANZEES; KIN SELECTION; EVOLUTION; COMPETITION; PUNISHMENT; PATERNITY; BEHAVIOR; KINSHIP; HUMANS	In recent years, extended altruism towards unrelated group members has been proposed to be a unique characteristic of human societies. Support for this proposal seemingly came from experimental studies on captive chimpanzees that showed that individuals were limited in the ways they shared or cooperated with others. This dichotomy between humans and chimpanzees was proposed to indicate an important difference between the two species, and one study concluded that "chimpanzees are indifferent to the welfare of unrelated group members''. In strong contrast with these captive studies, consistent observations of potentially altruistic behaviors in different populations of wild chimpanzees have been reported in such different domains as food sharing, regular use of coalitions, cooperative hunting and border patrolling. This begs the question of what socio-ecological factors favor the evolution of altruism. Here we report 18 cases of adoption, a highly costly behavior, of orphaned youngsters by group members in Tai forest chimpanzees. Half of the adoptions were done by males and remarkably only one of these proved to be the father. Such adoptions by adults can last for years and thus imply extensive care towards the orphans. These observations reveal that, under the appropriate socio-ecologic conditions, chimpanzees do care for the welfare of other unrelated group members and that altruism is more extensive in wild populations than was suggested by captive studies.	[Boesch, Christophe; Eckhardt, Nadin; Boesch, Hedwige] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Bole, Camille; Eckhardt, Nadin] Ctr Suisse Rech Sci, Abidjan, Cote Ivoire	Max Planck Society	Boesch, C (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	boesch@eva.mpg.de			Swiss Science Foundation; Max Planck Society	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	For year-long faithful financial support, the authors are very grateful to the Swiss Science Foundation and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boesch C, 2006, AM J PHYS ANTHROPOL, V130, P103, DOI 10.1002/ajpa.20341; Boesch C, 2009, REAL CHIMPANZEE: SEX STRATEGIES IN THE FOREST, P1; Boesch C., 2008, AM J PRIMATOL, V70, P1; Boesch C, 2000, CHIMPANZEES TAI FORE; Boesch C, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P139, DOI 10.1007/3-540-28277-7_8; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Chapais B, 2001, BEHAV ECOL SOCIOBIOL, V49, P493, DOI 10.1007/s002650100335; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gomes CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005116; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kuehl HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002440; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Lehmann J, 2006, BEHAVIOUR, V143, P931, DOI 10.1163/156853906778623635; Lehmann L, 2008, TRENDS ECOL EVOL, V23, P664, DOI 10.1016/j.tree.2008.07.012; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Povinelli DJ, 2003, TRENDS COGN SCI, V7, P157, DOI 10.1016/S1364-6613(03)00053-6; RIEDMAN ML, 1982, Q REV BIOL, V57, P405, DOI 10.1086/412936; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Silk JB., 1987, CULTURAL ANTHR, V2, P39, DOI [10.1525/can.1987.2.1.02a00050, DOI 10.1525/CAN.1987.2.1.02A00050]; THIERRY B, 1986, INT J PRIMATOL, V7, P191, DOI 10.1007/BF02692318; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Vigilant L, 2001, P NATL ACAD SCI USA, V98, P12890, DOI 10.1073/pnas.231320498; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513	36	75	76	9	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8901	10.1371/journal.pone.0008901	http://dx.doi.org/10.1371/journal.pone.0008901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111704	gold, Green Published			2022-12-27	WOS:000274114800011
J	Funk, SM; Fa, JE				Funk, Stephan M.; Fa, John E.			Ecoregion Prioritization Suggests an Armoury Not a Silver Bullet for Conservation Planning	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; PRIORITY ECOREGIONS; SPECIES RICHNESS; AREAS; MAMMALS; LIFE; RARE	In the face of accelerating species extinctions, map-based prioritization systems are increasingly useful to decide where to pursue conservation action most effectively. However, a number of seemingly inconsistent schemes have emerged, mostly focussing on endemism. Here we use global vertebrate distributions in terrestrial ecoregions to evaluate how continuous and categorical ranking schemes target and accumulate endangered taxa within the IUCN Red List, Alliance for Zero Extinction (AZE), and EDGE of Existence programme. We employed total, endemic and threatened species richness and an estimator for richness-adjusted endemism as metrics in continuous prioritization, and WWF's Global200 and Conservation International's (CI) Hotspots in categorical prioritization. Our results demonstrate that all metrics target endangerment more efficiently than by chance, but each selects unique sets of top-ranking ecoregions, which overlap only partially, and include different sets of threatened species. Using the top 100 ecoregions as defined by continuous prioritization metrics, we develop an inclusive map for global vertebrate conservation that incorporates important areas for endemism, richness, and threat. Finally, we assess human footprint and protection levels within these areas to reveal that endemism sites are more impacted but have more protection, in contrast to high richness and threat ones. Given such contrasts, major efforts to protect global biodiversity must involve complementary conservation approaches in areas of unique species as well as those with highest diversity and threat.	[Funk, Stephan M.; Fa, John E.] Durrell Wildlife Conservat Trust, Trinity, NJ USA		Funk, SM (corresponding author), Durrell Wildlife Conservat Trust, Trinity, NJ USA.	jfa@durrell.org		FA, Julia Elizabeth/0000-0002-1572-9828	Institutional funding through Durrell Wildlife	Institutional funding through Durrell Wildlife	Institutional funding through Durrell Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonn A, 2002, ECOL LETT, V5, P733, DOI 10.1046/j.1461-0248.2002.00376.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cabeza M, 2008, J APPL ECOL, V45, P976, DOI 10.1111/j.1365-2664.2007.01364.x; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Fa JE, 2004, ORYX, V38, P91, DOI 10.1017/S0030605304000146; Fa John E., 2007, Endangered Species Research, V3, P31, DOI 10.3354/esr003031; Fjeldsa J, 2000, ENVIRON CONSERV, V27, P67, DOI 10.1017/S0376892900000084; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Jepson P, 2001, GLOBAL ECOL BIOGEOGR, V10, P225, DOI 10.1046/j.1466-822X.2001.00255.x; Kark S, 2009, P NATL ACAD SCI USA, V106, P15368, DOI 10.1073/pnas.0901001106; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lamoreux JF, 2007, CONSERV BIOL, V21, P269, DOI 10.1111/j.1523-1739.2006.00629.x; Lawler JJ, 2008, ANIM CONSERV, V11, P270, DOI 10.1111/j.1469-1795.2008.00176.x; Lee TM, 2008, P ROY SOC B-BIOL SCI, V275, P1261, DOI 10.1098/rspb.2007.1732; Loyola RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002120; Mace GM, 2000, NATURE, V405, P393, DOI 10.1038/35013247; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Margules CR, 2002, J BIOSCIENCES, V27, P309, DOI 10.1007/BF02704962; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McBride MF, 2007, CONSERV BIOL, V21, P1463, DOI 10.1111/j.1523-1739.2007.00832.x; McDonald RI, 2009, P NATL ACAD SCI USA, V106, P15101, DOI 10.1073/pnas.0908125106; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pearce D, 2007, ENVIRON RESOUR ECON, V37, P313, DOI 10.1007/s10640-007-9118-3; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Ulrich W, 2005, BIODIVERS CONSERV, V14, P1977, DOI 10.1007/s10531-004-2526-6; *UNESCO WORLD HER, 2007, GAL NIOK KOB NAT PAR; *US GEOL SURV, 2000, ESRI ARCVIEW EXT POI; *WWF, 2008, DAT DOWNL; 2006, IUCN; [No title captured]	43	29	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8923	10.1371/journal.pone.0008923	http://dx.doi.org/10.1371/journal.pone.0008923			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111722	Green Published, gold			2022-12-27	WOS:000274114800024
J	Jha, UM; Satyanarayana, S; Dewan, PK; Chadha, S; Wares, F; Sahu, S; Gupta, D; Chauhan, LS				Jha, Ugra Mohan; Satyanarayana, Srinath; Dewan, Puneet K.; Chadha, Sarabjit; Wares, Fraser; Sahu, Suvanand; Gupta, Devesh; Chauhan, L. S.			Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006	PLOS ONE			English	Article							SOUTH-INDIA; DOTS PROGRAM; BARRIERS	Setting: Under India's Revised National Tuberculosis Control Programme (RNTCP), >15% of previously-treated patients in the reported 2006 patient cohort defaulted from anti-tuberculosis treatment. Objective: To assess the timing, characteristics, and risk factors for default amongst re-treatment TB patients. Methodology: For this case-control study, in 90 randomly-selected programme units treatment records were abstracted from all 2006 defaulters from the RNTCP re-treatment regimen (cases), with one consecutively-selected non-defaulter per case. Patients who interrupted anti-tuberculosis treatment for >2 months were classified as defaulters. Results: 1,141 defaulters and 1,189 non-defaulters were included. The median duration of treatment prior to default was 81 days (25%-75% interquartile range 44-117 days) and documented retrieval efforts after treatment interruption were inadequate. Defaulters were more likely to have been male (adjusted odds ratio [aOR] 1.4, 95% confidence interval [CI] 1.2-1.7), have previously defaulted anti-tuberculosis treatment (aOR 1.3 95% CI 1.1-1.6], have previous treatment from non-RNTCP providers (AOR 1.3, 95% CI 1.0-1.6], or have public health facility-based treatment observation (aOR 1.3, 95% CI 1.1-1.6). Conclusions: Amongst the large number of re-treatment patients in India, default occurs early and often. Improved pretreatment counseling and community-based treatment provision may reduce default rates. Efforts to retrieve treatment interrupters prior to default require strengthening.	[Jha, Ugra Mohan; Gupta, Devesh; Chauhan, L. S.] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Satyanarayana, Srinath] The Union, Ctr Operat Res, Int Union TB & Lung Dis, New Delhi, India; [Dewan, Puneet K.; Chadha, Sarabjit; Wares, Fraser; Sahu, Suvanand] Off WHO Representat India, New Delhi, India	World Health Organization	Jha, UM (corresponding author), Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India.	srinaths@rntcp.org		Satyanarayana, Srinath/0000-0002-5420-2551				Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Bam TS, 2006, INT J TUBERC LUNG D, V10, P270; Chandrasekaran V, 2007, Indian J Tuberc, V54, P12; Chang KC, 2004, INT J TUBERC LUNG D, V8, P1492; Dandona R, 2004, NATL MED J INDIA, V17, P292; Dodor EA, 2004, INT J TUBERC LUNG D, V8, P1337; Dodor EA, 2005, T ROY SOC TROP MED H, V99, P827, DOI 10.1016/j.trstmh.2005.06.011; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Gopi PG, 2006, INDIAN J MED RES, V124, P71; Gopi P G, 2007, Indian J Tuberc, V54, P66; *GOV IND MIN HLTH, 2008, TB IND 2008 RNTCP ST; *GOV IND MIN HLTH, 2009, TB IND 2009 RNTCP ST; *GOV IND MIN HLTH, 2005, TECHN OP GUID TUB CO; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Jaggarajamma K, 2007, Indian J Tuberc, V54, P130; JAKUBOWIAK W, 2008, INT J INFECT DIS; Kolappan C, 2008, INT J TUBERC LUNG D, V12, P81; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; *MIN HLTH FAM WELF, 2002, MAN REV NAT TUB CONT; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Sisodia RS, 2006, INT J TUBERC LUNG D, V10, P1373; WHO, 2008, GLOBAL TUBERCULOSIS; WHO, 2009, WHOHTMTB2009411	23	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8873	10.1371/journal.pone.0008873	http://dx.doi.org/10.1371/journal.pone.0008873			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111727	gold, Green Published			2022-12-27	WOS:000273896300022
J	Han, Q; Ding, HZ; Robinson, H; Christensen, BM; Li, JY				Han, Qian; Ding, Haizhen; Robinson, Howard; Christensen, Bruce M.; Li, Jianyong			Crystal Structure and Substrate Specificity of Drosophila 3,4-Dihydroxyphenylalanine Decarboxylase	PLOS ONE			English	Article							DOPA-DECARBOXYLASE; HYPERSENSITIVE GENE; ACID DECARBOXYLASE; PARKINSONS-DISEASE; LOCOMOTOR-ACTIVITY; AMINO-ACIDS; MELANOGASTER; ENZYMES; MELANIZATION; INDUCTION	Background: 3,4-Dihydroxyphenylalanine decarboxylase (DDC), also known as aromatic L-amino acid decarboxylase, catalyzes the decarboxylation of a number of aromatic L-amino acids. Physiologically, DDC is responsible for the production of dopamine and serotonin through the decarboxylation of 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan, respectively. In insects, both dopamine and serotonin serve as classical neurotransmitters, neuromodulators, or neurohormones, and dopamine is also involved in insect cuticle formation, eggshell hardening, and immune responses. Principal Findings: In this study, we expressed a typical DDC enzyme from Drosophila melanogaster, critically analyzed its substrate specificity and biochemical properties, determined its crystal structure at 1.75 Angstrom resolution, and evaluated the roles residues T82 and H192 play in substrate binding and enzyme catalysis through site-directed mutagenesis of the enzyme. Our results establish that this DDC functions exclusively on the production of dopamine and serotonin, with no activity to tyrosine or tryptophan and catalyzes the formation of serotonin more efficiently than dopamine. Conclusions: The crystal structure of Drosophila DDC and the site-directed mutagenesis study of the enzyme demonstrate that T82 is involved in substrate binding and that H192 is used not only for substrate interaction, but for cofactor binding of drDDC as well. Through comparative analysis, the results also provide insight into the structure-function relationship of other insect DDC-like proteins.	[Han, Qian; Ding, Haizhen; Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Robinson, Howard] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Christensen, Bruce M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Wisconsin System; University of Wisconsin Madison	Han, Q (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	lij@vt.edu	Han, Qian/J-8696-2014; Han, Qian/AAS-2134-2020	Han, Qian/0000-0001-6245-5252; 	NIH [AI 19769]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R22AI019769, R37AI019769, R01AI019769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	NIH AI 19769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; Bertoldi M, 2000, BIOCHEM J, V352, P533, DOI 10.1042/0264-6021:3520533; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963; Chentsova NA, 2002, J COMP PHYSIOL B, V172, P643, DOI 10.1007/s00360-002-0293-9; CLARK WC, 1978, MOL GEN GENET, V162, P287, DOI 10.1007/BF00268854; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Davis MM, 2008, MOL CELL BIOL, V28, P4883, DOI 10.1128/MCB.02074-07; DeLano W.L., PYMOL MOL GRAPHICS S; Ferdig MT, 1996, INSECT MOL BIOL, V5, P119, DOI 10.1111/j.1365-2583.1996.tb00046.x; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hardie SL, 2007, DEV NEUROBIOL, V67, P1396, DOI 10.1002/dneu.20459; HIRSH J, 1986, MOL CELL BIOL, V6, P4548, DOI 10.1128/MCB.6.12.4548; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; Huang CY, 2005, INSECT MOL BIOL, V14, P237, DOI 10.1111/j.1365-2583.2004.00552.x; Jansonius JN, 1998, CURR OPIN STRUC BIOL, V8, P759, DOI 10.1016/S0959-440X(98)80096-1; Johnson BN, 2009, NEUROSCIENCE, V159, P1233, DOI 10.1016/j.neuroscience.2009.01.067; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kack H, 1999, J MOL BIOL, V291, P857, DOI 10.1006/jmbi.1999.2997; Kandel E.R., 2000, PRINCIPLES NEURAL SC, V4th; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI LS, 1994, J IMMUNOL, V152, P930; LIVINGSTONE MS, 1983, NATURE, V303, P67, DOI 10.1038/303067a0; Macey TA, 2005, J NEUROCHEM, V93, P128, DOI 10.1111/j.1471-4159.2004.02998.x; MARSH JL, 1986, GENETICS, V112, P249; McClung C, 1999, CURR BIOL, V9, P853, DOI 10.1016/S0960-9822(99)80389-3; MEHTA PK, 1993, EUR J BIOCHEM, V211, P373, DOI 10.1111/j.1432-1033.1993.tb19907.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAPPI AJ, 1992, COMP BIOCHEM PHYS B, V101, P453, DOI 10.1016/0305-0491(92)90027-O; Nassel DR, 1996, PROG NEUROBIOL, V48, P325, DOI 10.1016/0301-0082(95)00048-8; Neckameyer Wendi S., 2002, P141; Neff NH, 1995, PROG BRAIN RES, V106, P91; Osborne RH, 1996, PHARMACOL THERAPEUT, V69, P117, DOI 10.1016/0163-7258(95)02054-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paskewitz SM, 2008, COMP BIOCHEM PHYS B, V150, P403, DOI 10.1016/j.cbpb.2008.04.010; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Sideri M, 2008, IMMUNOLOGY, V123, P528, DOI 10.1111/j.1365-2567.2007.02722.x; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; SOURKES TL, 1966, PHARMACOL REV, V18, P53; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WANG DG, 1995, DEV BIOL, V168, P598, DOI 10.1006/dbio.1995.1105	45	42	42	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8826	10.1371/journal.pone.0008826	http://dx.doi.org/10.1371/journal.pone.0008826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098687	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100018
J	Mehta, S; Giovannucci, E; Mugusi, FM; Spiegelman, D; Aboud, S; Hertzmark, E; Msamanga, GI; Hunter, D; Fawzi, WW				Mehta, Saurabh; Giovannucci, Edward; Mugusi, Ferdinand M.; Spiegelman, Donna; Aboud, Said; Hertzmark, Ellen; Msamanga, Gernard I.; Hunter, David; Fawzi, Wafaie W.			Vitamin D Status of HIV-Infected Women and Its Association with HIV Disease Progression, Anemia, and Mortality	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; REGRESSION-MODELS; 1,25-DIHYDROXYVITAMIN-D3; DEFICIENCY; 25-HYDROXYVITAMIN-D; TUBERCULOSIS; EXPRESSION; INDUCTION; MONOCYTES; EXPOSURE	Background: Vitamin D has a potential role in slowing HIV disease progression and preventing mortality based on its extensive involvement in the immune system; however, this relationship has not been examined in large studies or in resource-limited settings. Methodology/Principal Findings: Vitamin D levels were assessed in 884 HIV-infected pregnant women at enrollment in a trial of multivitamin supplementation (not including vitamin D) in Tanzania. Women were followed up for a median of 69.5 months, and information on hemoglobin levels, HIV disease progression, and mortality was recorded. Proportional hazard models and generalized estimating equations were used to assess the relationship of these outcomes with vitamin D status. Conclusions/Significance: Low vitamin D status (serum 25-hydroxyvitamin D<32ng/mL) was significantly associated with progression to WHO HIV disease stage III or greater in multivariate models (incidence rate ratio [RR]: 1.25; 95% confidence intervals [CI]: 1.05, 1.50). No significant relationship was observed between vitamin D status and T-cell counts during follow-up. Women with low vitamin D status had 46% higher risk of developing severe anemia during follow-up, compared to women with adequate vitamin D levels (RR: 1.46; 95% CI: 1.09, 1.96). Women in the highest vitamin D quintile had a 42% lower risk of all-cause mortality, compared to the lowest quintile (RR: 0.58; 95% CI: 0.40, 0.84). Vitamin D status had a protective association with HIV disease progression, all-cause mortality, and development of anemia during follow-up in HIV-infected women. If confirmed in randomized trials, vitamin D supplementation could represent a simple and inexpensive method to prolonging the time to initiation of antiretroviral therapy in HIV-infected patients, particularly in resource-limited settings.	[Mehta, Saurabh; Giovannucci, Edward; Spiegelman, Donna; Hertzmark, Ellen; Hunter, David; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mehta, Saurabh; Giovannucci, Edward; Hunter, David; Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Giovannucci, Edward; Hunter, David] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Giovannucci, Edward; Hunter, David] Harvard Univ, Sch Med, Boston, MA USA; [Mugusi, Ferdinand M.] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Aboud, Said] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Msamanga, Gernard I.] Muhimbili Univ Hlth & Allied Sci, Dept Community Hlth, Dar Es Salaam, Tanzania; [Fawzi, Wafaie W.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Mehta, S (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	smehta@hsph.harvard.edu	Mehta, Saurabh/A-7874-2009; Mehta, Saurabh/L-8490-2017	Mehta, Saurabh/0000-0003-3788-0665	National Institute of Child Health and Human Development [NICHD R01 32257]; Fogarty International Center [NIH D43 TW00004]; Harvard School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032257] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Harvard School of Public Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study is supported by the National Institute of Child Health and Human Development (NICHD R01 32257), the Fogarty International Center (NIH D43 TW00004), and the Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; [Anonymous], 1985, THEORETICAL EPIDEMIO; BHALLA AK, 1983, J CLIN ENDOCR METAB, V57, P1308, DOI 10.1210/jcem-57-6-1308; Bodnar LM, 2007, J NUTR, V137, P447, DOI 10.1093/jn/137.2.447; Chaisson RE, 2008, NEW ENGL J MED, V358, P1089, DOI 10.1056/NEJMp0800809; CONNOR RI, 1991, BIOCHEM BIOPH RES CO, V176, P852, DOI 10.1016/S0006-291X(05)80264-5; COX DR, 1972, J R STAT SOC B, V34, P187; Dacie J.V., 1991, PRACTICAL HEMATOLOGY, pVIII +556; DELUCA HF, 1982, BIOCHEM SOC T, V10, P147, DOI 10.1042/bst0100147; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Fawzi WW, 1999, CONTROL CLIN TRIALS, V20, P75, DOI 10.1016/S0197-2456(98)00045-2; Fawzi WW, 2004, NEW ENGL J MED, V351, P23, DOI 10.1056/NEJMoa040541; Govindarajulu US, 2007, STAT MED, V26, P3735, DOI 10.1002/sim.2848; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; GRINDULIS H, 1986, ARCH DIS CHILD, V61, P843, DOI 10.1136/adc.61.9.843; HAUG C, 1994, J INFECT DIS, V169, P889, DOI 10.1093/infdis/169.4.889; HELDENBERG D, 1992, AM J CLIN NUTR, V56, P533, DOI 10.1093/ajcn/56.3.533; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; JAEGER P, 1994, J CLIN ENDOCR METAB, V79, P1701, DOI 10.1210/jc.79.6.1701; Kendrick J, 2008, NAT KIDN FDN SPRING; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; RIGBY WFC, 1990, BLOOD, V76, P189, DOI 10.1182/blood.V76.1.189.bloodjournal761189; SCHLESINGER M, 1989, IMMUNOL LETT, V22, P307, DOI 10.1016/0165-2478(89)90170-3; STRODER J, 1975, IMMUNITY VITAMIN D D, P675; Teichmann J, 2003, J INFECTION, V46, P221, DOI 10.1053/jinf.2002.1109; Urassa W, 1994, Clin Diagn Virol, V2, P1, DOI 10.1016/0928-0197(94)90030-2; Villamor E, 2006, NUTR REV, V64, P226, DOI 10.1111/j.1753-4887.2006.tb00205.x; YETGIN S, 1989, J PEDIATR-US, V114, P213, DOI 10.1016/S0022-3476(89)80785-1; 1993, AIDS, V7, P711	31	148	152	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8770	10.1371/journal.pone.0008770	http://dx.doi.org/10.1371/journal.pone.0008770			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098738	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900014
J	Panguluri, SK; Bhatnagar, S; Kumar, A; McCarthy, JJ; Srivastava, AK; Cooper, NG; Lundy, RF; Kumar, A				Panguluri, Siva K.; Bhatnagar, Shephali; Kumar, Akhilesh; McCarthy, John J.; Srivastava, Apurva K.; Cooper, Nigel G.; Lundy, Robert F.; Kumar, Ashok			Genomic Profiling of Messenger RNAs and MicroRNAs Reveals Potential Mechanisms of TWEAK-Induced Skeletal Muscle Wasting in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; MYOGENIC DIFFERENTIATION; MUSCULAR-DYSTROPHY; SARCOMERIC PROTEIN; CANCER CACHEXIA; WEAK INDUCER; CELL FATE; ACTIVATION; EXPRESSION	Background: Skeletal muscle wasting is a devastating complication of several physiological and pathophysiological conditions. Inflammatory cytokines play an important role in the loss of skeletal muscle mass in various chronic diseases. We have recently reported that proinflammatory cytokine TWEAK is a major muscle-wasting cytokine. Emerging evidence suggests that gene expression is regulated not only at transcriptional level but also at post-transcriptional level through the expression of specific non-coding microRNAs (miRs) which can affect the stability and/or translation of target mRNA. However, the role of miRs in skeletal muscle wasting is unknown. Methodology/Principal Findings: To understand the mechanism of action of TWEAK in skeletal muscle, we performed mRNA and miRs expression profile of control and TWEAK-treated myotubes. TWEAK increased the expression of a number of genes involved in inflammatory response and fibrosis and reduced the expression of few cytoskeletal gene (e. g. Myh4, Ankrd2, and TCap) and metabolic enzymes (e. g. Pgam2). Low density miR array demonstrated that TWEAK inhibits the expression of several miRs including muscle-specific miR-1-1, miR-1-2, miR-133a, miR-133b and miR-206. The expression of a few miRs including miR-146a and miR-455 was found to be significantly increased in response to TWEAK treatment. Ingenuity pathway analysis showed that several genes affected by TWEAK are known/putative targets of miRs. Our cDNA microarray data are consistent with miRs profiling. The levels of specific mRNAs and miRs were also found to be similarly regulated in atrophying skeletal muscle of transgenic mice (Tg) mice expressing TWEAK. Conclusions/Significance: Our results suggest that TWEAK affects the expression of several genes and microRNAs involved in inflammatory response, fibrosis, extracellular matrix remodeling, and proteolytic degradation which might be responsible for TWEAK-induced skeletal muscle loss.	[Panguluri, Siva K.; Bhatnagar, Shephali; Kumar, Akhilesh; Cooper, Nigel G.; Lundy, Robert F.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [McCarthy, John J.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Srivastava, Apurva K.] NCI, Lab Human Toxicol & Pharmacol, Appl & Dev Res Directorate SAIC Frederick, Frederick, MD 21701 USA	University of Louisville; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Panguluri, SK (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	ashok.kumar@louisville.edu	Panguluri, Siva Kumar/A-3084-2008	Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1 AG129623]; NCRR [P20RR16481]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant RO1 AG129623 to AK. Support from NCRR award P20RR16481 is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Dalla Libera L, 2004, CURR OPIN CLIN NUTR, V7, P435, DOI 10.1097/01.mco.0000134374.24181.5b; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; Kandarian SC, 2002, EXERC SPORT SCI REV, V30, P111, DOI 10.1097/00003677-200207000-00004; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuang W, 2009, BIOCHEM BIOPH RES CO, V378, P259, DOI 10.1016/j.bbrc.2008.11.041; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; KURIHARA Y, METHODS MOL BIOL, V592, P231; Kwon C, 2005, P NATL ACAD SCI USA, V102, P18986, DOI 10.1073/pnas.0509535102; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Li J, 2001, J BIOL CHEM, V276, P18579, DOI 10.1074/jbc.M100846200; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Markert CD, 2008, NEUROMUSCULAR DISORD, V18, P413, DOI 10.1016/j.nmd.2008.03.010; McCarthy JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC451, DOI 10.1152/ajpcell.00077.2007; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Meighan-Mantha RL, 1999, J BIOL CHEM, V274, P33166, DOI 10.1074/jbc.274.46.33166; Miller SM, 1998, MOL BIOL CELL, V9, p292A; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Rodrigues ADC, 2007, MICROSURG, V27, P664, DOI 10.1002/micr.20428; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Stevenson EJ, 2005, J APPL PHYSIOL, V98, P1396, DOI 10.1152/japplphysiol.01055.2004; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; TSAI LM, 2009, CLIN EXP PHARM PHYSL; Valle G, 1997, FEBS LETT, V415, P163, DOI 10.1016/S0014-5793(97)01108-3; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Ventadour S, 2006, CURR OPIN RHEUMATOL, V18, P631, DOI 10.1097/01.bor.0000245731.25383.de; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zhang N, 2009, J GLOB INF MANAG, V17, P49, DOI 10.4018/jgim.2009010103; Zhang RL, 2009, HUM MOL GENET, V18, P4130, DOI 10.1093/hmg/ddp362	77	62	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8760	10.1371/journal.pone.0008760	http://dx.doi.org/10.1371/journal.pone.0008760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098732	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900006
J	Guex, N; Migliavacca, E; Xenarios, I				Guex, Nicolas; Migliavacca, Eugenia; Xenarios, Ioannis			Multiple Imputations Applied to the DREAM3 Phosphoproteomics Challenge: A Winning Strategy	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; RECEPTOR; NETWORK	DREAM is an initiative that allows researchers to assess how well their methods or approaches can describe and predict networks of interacting molecules [1]. Each year, recently acquired datasets are released to predictors ahead of publication. Researchers typically have about three months to predict the masked data or network of interactions, using any predictive method. Predictions are assessed prior to an annual conference where the best predictions are unveiled and discussed. Here we present the strategy we used to make a winning prediction for the DREAM3 phosphoproteomics challenge. We used Amelia II, a multiple imputation software method developed by Gary King, James Honaker and Matthew Blackwell[2] in the context of social sciences to predict the 476 out of 4624 measurements that had been masked for the challenge. To chose the best possible multiple imputation parameters to apply for the challenge, we evaluated how transforming the data and varying the imputation parameters affected the ability to predict additionally masked data. We discuss the accuracy of our findings and show that multiple imputations applied to this dataset is a powerful method to accurately estimate the missing data. We postulate that multiple imputations methods might become an integral part of experimental design as a mean to achieve cost savings in experimental design or to increase the quantity of samples that could be handled for a given cost.	[Guex, Nicolas; Xenarios, Ioannis] Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Migliavacca, Eugenia] Swiss Inst Bioinformat, Bioinformat Core Facil, Lausanne, Switzerland	Swiss Institute of Bioinformatics; Swiss Institute of Bioinformatics	Guex, N (corresponding author), Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland.	nicolas.guex@isb-sib.ch	Xenarios, Ioannis/ABD-5045-2021	Xenarios, Ioannis/0000-0002-3413-6841; GUEX, Nicolas/0000-0001-6023-0519	European Commission [LSHG-CT-2005-518254]; Swiss Institute of Bioinformatics	European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss Institute of Bioinformatics	This work was supported in part by the Experimental Network for Functional INtegration (ENFIN; http://www.enfin.org), a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area "Life sciences, genomics and biotechnology for health'', contract number LSHG-CT-2005-518254. The research was funded in part by the Integrated Computational Genomics Resources of the Swiss Institute of Bioinformatics (http://www.isb-sib.ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXOPOULOS LG, 2009, COMP PATHWAY M UNPUB; de Brevern AG, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-114; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Gruenewald TL, 2006, P NATL ACAD SCI USA, V103, P14158, DOI 10.1073/pnas.0606215103; Kahlem P, 2007, ANN NY ACAD SCI, V1115, P23, DOI 10.1196/annals.1407.016; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lappe M, 2004, NAT BIOTECHNOL, V22, P98, DOI 10.1038/nbt921; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Moult J, 2005, PROTEINS, V61, P3, DOI 10.1002/prot.20716; Moult J, 2003, PROTEINS, V53, P334, DOI 10.1002/prot.10556; Moult J, 2001, PROTEINS, P2; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; MOULT J, 1997, PROTEINS, V1, P1; Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Team RDC, 2019, R LANG ENV STAT COMP; Teshima S, 2004, J HEPATOL, V40, P616, DOI 10.1016/j.jhep.2003.12.018	19	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8012	10.1371/journal.pone.0008012	http://dx.doi.org/10.1371/journal.pone.0008012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090915	Green Published, Green Submitted, gold			2022-12-27	WOS:000273715000001
J	Cisne, JL; Ziomkowski, RM; Schwager, SJ				Cisne, John L.; Ziomkowski, Robert M.; Schwager, Steven J.			Mathematical Philology: Entropy Information in Refining Classical Texts' Reconstruction, and Early Philologists' Anticipation of Information Theory	PLOS ONE			English	Article								Philologists reconstructing ancient texts from variously miscopied manuscripts anticipated information theorists by centuries in conceptualizing information in terms of probability. An example is the editorial principle difficilior lectio potior (DLP): in choosing between otherwise acceptable alternative wordings in different manuscripts, "the more difficult reading [is] preferable." As philologists at least as early as Erasmus observed (and as information theory's version of the second law of thermodynamics would predict), scribal errors tend to replace less frequent and hence entropically more information-rich wordings with more frequent ones. Without measurements, it has been unclear how effectively DLP has been used in the reconstruction of texts, and how effectively it could be used. We analyze a case history of acknowledged editorial excellence that mimics an experiment: the reconstruction of Lucretius's De Rerum Natura, beginning with Lachmann's landmark 1850 edition based on the two oldest manuscripts then known. Treating words as characters in a code, and taking the occurrence frequencies of words from a current, more broadly based edition, we calculate the difference in entropy information between Lachmann's 756 pairs of grammatically acceptable alternatives. His choices average 0.26+/-0.20 bits higher in entropy information (95% confidence interval, P = 0.005), as against the single bit that determines the outcome of a coin toss, and the average 2.16+/-0.10 bits (95%) of (predominantly meaningless) entropy information if the rarer word had always been chosen. As a channel width, 0.26+/-0.20 bits/word corresponds to a 0.790.79(-0.15)(+0.09) likelihood of the rarer word being the one accepted in the reference edition, which is consistent with the observed 547/756 = 0.72+/-0.03 (95%). Statistically informed application of DLP can recover substantial amounts of semantically meaningful entropy information from noise; hence the extension copiosior informatione lectio potior, "the reading richer in information [is] preferable." New applications of information theory promise continued refinement in the reconstruction of culturally fundamental texts.	[Cisne, John L.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA; [Ziomkowski, Robert M.] Ithaca Coll, Dept Modern Languages & Literatures, Ithaca, NY 14850 USA; [Schwager, Steven J.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA	Cornell University; Cornell University	Cisne, JL (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14850 USA.	john.cisne@cornell.edu						ALAND K, 1989, NEW TESTAMENT; Brillouin L., 1962, SCI INFORM THEORY; BUECHNER C, 1966, T LUCRETI CARI RERUM; Casson Lionel, 2001, LIB ANCIENT WORLD; Cisne JL, 2005, SCIENCE, V307, P1305, DOI 10.1126/science.1104718; CISNE JL, 2006, MEDIEVAL ACAD NEWS, P12; CISNE JL, 2005, SCIENCE, V308, pC1618; Contreni John, 1995, NEW CAMBRIDGE MEDIEV, V2, P709; DECLERCQ G, 2005, SCIENCE, V308, pB1618; ERNOUT A, 1966, LUCRECE NATURE; FELLER W, 1967, INTRO PROBABILITY IT, V1; Garcia Calvo A, 1997, T LUCRETI CARI RERUM; Glare P. G. W, 2012, OXFORD LATIN DICT, V2nd; Govaerts S., 1986, LUCRECE RERUM NATURA; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Greetham David C, 1992, TEXTUAL SCHOLARSHIP; JENNINGS M, 1977, STUD PHILOL, V74, P1; KULLBACK S, 1968, INFORM THEORY STAT; Lachmann Karl, 1850, TITI LUCRETI CARI RE; Lewis 36Charlton T., 1879, LATIN DICT; Maas Paul., 1958, TEXTUAL CRITICISM; MARTIN J, 1963, T LUCRETI CARI RERUM; Metzger Bruce M., 2005, TEXT NEW TESTAMENT I, V4th; Pierce J.R., 1980, INTRO INFORM THEORY; PLATNICK NI, 1977, SYST ZOOL, V26, P380, DOI 10.2307/2412794; Reynolds L. D., 1983, TEXTS TRANSMISSION S, P218; Reynolds L.D., 1991, SCRIBES SCHOLARS GUI; Rouse W.H.D., 1992, LUCRETIUS RERUM NATU; Salemans Ben J. P, 1996, STUDIES STEMMATOLOGY, P3; Searls DB, 2003, NATURE, V426, P391, DOI 10.1038/426391a; Shannon C. E., 1949, MATH THEORY COMMUNIC; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1951, BELL SYST TECH J, V30, P50, DOI 10.1002/j.1538-7305.1951.tb01366.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Snow C. P., 1998, 2 CULTURES; Timpanaro S., 2005, GENESIS LACHMANNS ME; Verdu S, 1998, IEEE T INFORM THEORY, V44, P2057, DOI 10.1109/18.720531; VonWaltershausen W. S., 1856, GAUSS MEMORIAL	38	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8661	10.1371/journal.pone.0008661	http://dx.doi.org/10.1371/journal.pone.0008661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	543EV	20084117	Green Submitted, Green Published, gold			2022-12-27	WOS:000273554600014
J	Lux, H; Flammann, H; Hafner, M; Lux, A				Lux, Heike; Flammann, Heiko; Hafner, Mathias; Lux, Andreas			Genetic and Molecular Analyses of PEG10 Reveal New Aspects of Genomic Organization, Transcription and Translation	PLOS ONE			English	Article							IMPRINTED GENE; HEPATOCELLULAR-CARCINOMA; MESSENGER-RNAS; TRANSPOSABLE ELEMENTS; FRAMESHIFT SIGNAL; MAMMALIAN GENOMES; START SITES; RETROTRANSPOSON; EXPRESSION; INITIATION	The paternally expressed gene PEG10 is a retrotransposon derived gene adapted through mammalian evolution located on human chromosome 7q21. PEG10 codes for at least two proteins, PEG10-RF1 and PEG10-RF1/2, by -1 frameshift translation. Overexpression or reinduced PEG10 expression was seen in malignancies, like hepatocellular carcinoma or B-cell acute and chronic lymphocytic leukemia. PEG10 was also shown to promote adipocyte differentiation. Experimental evidence suggests that the PEG10-RF1 protein is an inhibitor of apoptosis and mediates cell proliferation. Here we present new data on the genomic organization of PEG10 by identifying the major transcription start site, a new splice variant and report the cloning and analysis of 1.9 kb of the PEG10 promoter. Furthermore, we show for the first time that PEG10 translation is initiated at a non-AUG start codon upstream of the previously predicted AUG codon as well as at the AUG codon. The finding that PEG10 translation is initiated at different sides adds a new aspect to the already interesting feature of PEG10's 21 frameshift translation mechanism. It is now important to unravel the cellular functions of the PEG10 protein variants and how they are related to normal or pathological conditions. The generated promoter-reporter constructs can be used for future studies to investigate how PEG10 expression is regulated. In summary, our study provides new data on the genomic organization as well as expression and translation of PEG10, a prerequisite in order to study and understand the role of PEG10 in cancer, embryonic development and normal cell homeostasis.	[Lux, Heike; Flammann, Heiko; Hafner, Mathias; Lux, Andreas] Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany; [Hafner, Mathias; Lux, Andreas] Univ Heidelberg, Fac Med, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg	Lux, H (corresponding author), Mannheim Univ Appl Sci, Inst Mol & Cell Biol, Mannheim, Germany.	a.lux@hs-mannheim.de			MWK-Baden Wuerttemberg, Germany [2006.002-Hafner]; BMBF [Q5504.00]	MWK-Baden Wuerttemberg, Germany; BMBF(Federal Ministry of Education & Research (BMBF))	This research was supported by MWK-Baden Wuerttemberg, Germany, Grant No. 2006.002-Hafner to H. F. and M. H. and BMBF Grant No. Q5504.00 to M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cho K, 2008, SHOCK, V30, P105, DOI 10.1097/SHK.0b013e31816a363f; Clark MB, 2007, J BIOL CHEM, V282, P37359, DOI 10.1074/jbc.M705676200; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Farabaugh PJ, 1996, MICROBIOL REV, V60, P103, DOI 10.1128/MMBR.60.1.103-134.1996; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Hu CS, 2004, CELL MOL IMMUNOL, V1, P280; Ip WK, 2007, CANCER LETT, V250, P284, DOI 10.1016/j.canlet.2006.10.012; JIE X, 2007, ONCOGENE; KAINZ B, 2007, INT J CANC; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Manktelow E, 2005, NUCLEIC ACIDS RES, V33, P1553, DOI 10.1093/nar/gki299; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Okabe H, 2003, CANCER RES, V63, P3043; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; OSHEAGREENFIELD A, 1992, J BIOL CHEM, V267, P1391; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; Sun BW, 2006, HUM MOL GENET, V15, P65, DOI 10.1093/hmg/ddi427; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801; Wang CC, 2008, FEBS LETT, V582, P2793, DOI 10.1016/j.febslet.2008.07.009; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Wills NM, 2006, J BIOL CHEM, V281, P7082, DOI 10.1074/jbc.M511629200; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Zhang DY, 2004, HEPATOLOGY, V39, P954, DOI 10.1002/hep.20135; Zhang FW, 2007, J ANIM SCI, V85, P886, DOI 10.2527/jas.2006-278; Zhou QY, 2007, GENES GENET SYST, V82, P265, DOI 10.1266/ggs.82.265; 2004, NATURE, V431, P931	48	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8686	10.1371/journal.pone.0008686	http://dx.doi.org/10.1371/journal.pone.0008686			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084274	Green Submitted, gold, Green Published			2022-12-27	WOS:000273554600035
J	Chan, SH; Opitz, L; Higgins, L; O'Ioane, D; Xu, SY				Chan, Siu-hong; Opitz, Lars; Higgins, Lauren; O'Ioane, Diana; Xu, Shuang-yong			Cofactor Requirement of HpyAV Restriction Endonuclease	PLOS ONE			English	Article							YIG NUCLEASE SUPERFAMILY; MYCOIDES SUBSP MYCOIDES; DOUBLE-STRANDED DNA; N-H ENDONUCLEASES; II RESTRICTION; HELICOBACTER-PYLORI; HOMING ENDONUCLEASE; METAL-ION; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE	Background: Helicobacter pylori is the etiologic agent of common gastritis and a risk factor for gastric cancer. It is also one of the richest sources of Type II restriction-modification (R-M) systems in microorganisms. Principal/Findings: We have cloned, expressed and purified a new restriction endonuclease HpyAV from H. pylori strain 26695. We determined the HpyAV DNA recognition sequence and cleavage site as CCTTC 6/5. In addition, we found that HpyAV has a unique metal ion requirement: its cleavage activity is higher with transition metal ions than in Mg++. The special metal ion requirement of HpyAV can be attributed to the presence of a HNH catalytic site similar to ColE9 nuclease instead of the canonical PD-X-D/EXK catalytic site found in many other REases. Site-directed mutagenesis was carried out to verify the catalytic residues of HpyAV. Mutation of the conserved metal-binding Asn311 and His320 to alanine eliminated cleavage activity. HpyAV variant H295A displayed approximately 1% of wt activity. Conclusions/Significance: Some HNH-type endonucleases have unique metal ion cofactor requirement for optimal activities. Homology modeling and site-directed mutagenesis confirmed that HpyAV is a member of the HNH nuclease family. The identification of catalytic residues in HpyAV paved the way for further engineering of the metal binding site. A survey of sequenced microbial genomes uncovered 10 putative R-M systems that show high sequence similarity to the HpyAV system, suggesting lateral transfer of a prototypic HpyAV-like R-M system among these microorganisms.	[Chan, Siu-hong; Opitz, Lars; Higgins, Lauren; O'Ioane, Diana; Xu, Shuang-yong] New England Biolabs Inc, Res Dept, Ipswich, MA USA	New England Biolabs	Chan, SH (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA USA.	xus@neb.com		Chan, Siu-Hong/0000-0002-9554-7273	New England Biolabs, Inc	New England Biolabs, Inc	The project was funded by New England Biolabs, Inc. The funder had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allingham JS, 2002, J MOL BIOL, V319, P53, DOI 10.1016/S0022-2836(02)00297-8; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azarinskas A, 2006, J BIOTECHNOL, V123, P288, DOI 10.1016/j.jbiotec.2005.12.016; Baltrus DA, 2008, EVOLUTION, V62, P39, DOI 10.1111/j.1558-5646.2007.00271.x; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Bujnicki JM, 2001, TRENDS BIOCHEM SCI, V26, P9, DOI 10.1016/S0968-0004(00)01690-X; Caner V, 2007, WORLD J GASTROENTERO, V13, P2581, DOI 10.3748/wjg.v13.i18.2581; Chan SH, 2004, NUCLEIC ACIDS RES, V32, P6187, DOI 10.1093/nar/gkh958; Chandrashekaran S, 2004, J BIOL CHEM, V279, P49736, DOI 10.1074/jbc.M409483200; Cheng YS, 2002, J MOL BIOL, V324, P227, DOI 10.1016/S0022-2836(02)01092-6; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; CIRINO NM, 1995, BIOCHEMISTRY-US, V34, P9936, DOI 10.1021/bi00031a016; Cymerman IA, 2006, PROTEINS, V65, P867, DOI 10.1002/prot.21156; Derbyshire V, 1997, J MOL BIOL, V265, P494, DOI 10.1006/jmbi.1996.0754; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Eklund JL, 2007, NUCLEIC ACIDS RES, V35, P5839, DOI 10.1093/nar/gkm624; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; Galburt EA, 1999, NAT STRUCT BIOL, V6, P1096, DOI 10.1038/70027; Galburt EA, 2002, BIOCHEMISTRY-US, V41, P13851, DOI 10.1021/bi020467h; Gasiunas G, 2008, NUCLEIC ACIDS RES, V36, P938, DOI 10.1093/nar/gkm1090; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Harrington DJ, 2002, MICROBES INFECT, V4, P501, DOI 10.1016/S1286-4579(02)01565-4; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Horton J.R., 2004, RESTRICTION ENDONUCL, P316; HSU MT, 1978, BIOCHEMISTRY-US, V17, P131, DOI 10.1021/bi00594a019; Ibryashkina EM, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-48; Ibryashkina EM, 2009, J MOL BIOL, V387, P10, DOI 10.1016/j.jmb.2009.01.048; Israel DA, 2000, FEMS MICROBIOL LETT, V186, P275, DOI 10.1016/S0378-1097(00)00156-7; IZSVAK Z, 1989, BIOCHEM J, V258, P301, DOI 10.1042/bj2580301; Jakubauskas A, 2008, BIOCHEMISTRY-US, V47, P8546, DOI 10.1021/bi800660u; Jakubauskas A, 2007, J MOL BIOL, V370, P157, DOI 10.1016/j.jmb.2007.04.049; Kahng LS, 2001, J BACTERIOL, V183, P3065, DOI 10.1128/JB.183.10.3065-3075.2001; Kaminska KH, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-48; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kovall RA, 1999, CURR OPIN CHEM BIOL, V3, P578, DOI 10.1016/S1367-5931(99)00012-5; Kriukiene E, 2005, BBA-PROTEINS PROTEOM, V1751, P194, DOI 10.1016/j.bbapap.2005.06.006; Kriukiene E, 2006, FEBS LETT, V580, P6115, DOI 10.1016/j.febslet.2006.09.075; Ku WY, 2002, NUCLEIC ACIDS RES, V30, P1670, DOI 10.1093/nar/30.7.1670; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Mannino SJ, 1999, BIOCHEMISTRY-US, V38, P16178, DOI 10.1021/bi991452v; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; Miller MD, 1996, PROTEIN SCI, V5, P24; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; Morgan RD, 2008, NUCLEIC ACIDS RES, V36, P6558, DOI 10.1093/nar/gkn711; Morgan RD, 2009, NUCLEIC ACIDS RES, V37, P5208, DOI 10.1093/nar/gkp534; Nobusato A, 2000, GENE, V259, P89, DOI 10.1016/S0378-1119(00)00455-8; Nobusato Y, 2000, GENE, V259, P99, DOI 10.1016/S0378-1119(00)00456-X; Orlowski J, 2008, NUCLEIC ACIDS RES, V36, P3552, DOI 10.1093/nar/gkn175; Phillips ND, 2009, VET MICROBIOL, V134, P294, DOI 10.1016/j.vetmic.2008.08.006; Pilo P, 2007, VET J, V174, P513, DOI 10.1016/j.tvjl.2006.10.016; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Pingoud V, 2009, J MOL BIOL, V393, P140, DOI 10.1016/j.jmb.2009.08.011; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Pommer AJ, 1999, J BIOL CHEM, V274, P27153, DOI 10.1074/jbc.274.38.27153; Pommer AJ, 2001, J MOL BIOL, V314, P735, DOI 10.1006/jmbi.2001.5189; Pommer AJ, 1998, BIOCHEM J, V334, P387, DOI 10.1042/bj3340387; Roberts RJ, 2007, NUCLEIC ACIDS RES, V35, pD269, DOI 10.1093/nar/gkl891; SAMUELSON J, 2008, WO2008073746 WIPO; Saravanan M, 2004, NUCLEIC ACIDS RES, V32, P6129, DOI 10.1093/nar/gkh951; Saravanan M, 2007, NUCLEIC ACIDS RES, V35, P2777, DOI 10.1093/nar/gkm114; Shen BW, 2004, J MOL BIOL, V342, P43, DOI 10.1016/j.jmb.2004.07.032; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; Sokolowska M, 2009, NUCLEIC ACIDS RES, V37, P3799, DOI 10.1093/nar/gkp228; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; TAYLOR JD, 1989, BIOCHEMISTRY-US, V28, P6198, DOI 10.1021/bi00441a011; THIGPEN JE, 1983, J CLIN MICROBIOL, V18, P956, DOI 10.1128/JCM.18.4.956-960.1983; Truglio JJ, 2005, EMBO J, V24, P885, DOI 10.1038/sj.emboj.7600568; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Van Roey P, 2002, NAT STRUCT BIOL, V9, P806, DOI 10.1038/nsb853; VERMOTE CLM, 1992, BIOCHEMISTRY-US, V31, P6082, DOI 10.1021/bi00141a018; Viadiu H, 1998, NAT STRUCT BIOL, V5, P910, DOI 10.1038/2352; Walker DC, 2002, NUCLEIC ACIDS RES, V30, P3225, DOI 10.1093/nar/gkf420; Wei H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn182; Wittmayer PK, 1996, BIOCHEMISTRY-US, V35, P1076, DOI 10.1021/bi952363v; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3839, DOI 10.1093/nar/gkf504; Xu Q, 2000, P NATL ACAD SCI USA, V97, P9671, DOI 10.1073/pnas.97.17.9671; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Yang W, 2008, NAT STRUCT MOL BIOL, V15, P1228, DOI 10.1038/nsmb.1502; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	80	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9071	10.1371/journal.pone.0009071	http://dx.doi.org/10.1371/journal.pone.0009071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140205	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442400010
J	Gupta, PK; Liu, SH; Leppla, SH				Gupta, Pradeep K.; Liu, Shihui; Leppla, Stephen H.			Characterization of a Chinese Hamster Ovary Cell Mutant Having a Mutation in Elongation Factor-2	PLOS ONE			English	Article							PSEUDOMONAS EXOTOXIN-A; RECEPTOR-RELATED PROTEIN; ADP-RIBOSYLATING TOXINS; ANTHRAX LETHAL FACTOR; DIPHTHERIA-TOXIN; FACTOR-II; MAMMALIAN-CELLS; TRANSLATION ELONGATION-FACTOR-2; AMINO-ACID; DIPHTHAMIDE	Retroviral insertional mutagenesis provides an effective forward genetic method for identifying genes involved in essential cellular pathways. A Chinese hamster ovary cell line mutant resistant to several bacterial ADP-ribosylating was obtained by this approach. The toxins used catalyze ADP-ribosylation of eukaryotic elongation factor 2 (eEF-2), block protein synthesis, and cause cell death. Strikingly, in the CHO PR328 mutant cells, the eEF-2 substrate of these ADP-ribosylating toxins was found to be modified, but the cells remained viable. A systematic study of these cells revealed the presence of a structural mutation in one allele of the eEF-2 gene. This mutation, Gly717Arg, is close to His715, the residue that is modified to become diphthamide. This Arg substitution prevents diphthamide biosynthesis at His715, rendering the mutated eEF-2 non-responsive to ADP-ribosylating toxins, while having no apparent effect on protein synthesis. Thus, CHO PR328 cells are heterozygous, having wild type and mutant eEF-2 alleles, with the latter allowing the cells to survive even in the presence of ADP-ribosylating toxins. Here, we report the comprehensive characterization of these cells.	[Gupta, Pradeep K.; Liu, Shihui; Leppla, Stephen H.] NIAID, Lab Bacterial Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Gupta, PK (corresponding author), NIAID, Lab Bacterial Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov		Liu, Shihui/0000-0003-3444-1069	National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000929] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA N, 1993, J BIOL CHEM, V268, P3334; ARORA N, 1992, J BIOL CHEM, V267, P15542; BODLEY JW, 1984, METHOD ENZYMOL, V106, P378; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; FOLEY BT, 1995, J BIOL CHEM, V270, P23218, DOI 10.1074/jbc.270.39.23218; FOLEY BT, 1992, SOMAT CELL MOLEC GEN, V18, P227, DOI 10.1007/BF01233859; Gupta PK, 2008, CELL MICROBIOL, V10, P1687, DOI 10.1111/j.1462-5822.2008.01159.x; Gupta PK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003130; Hobson JP, 2006, NAT METHODS, V3, P259, DOI 10.1038/NMETH862; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; KOHNO K, 1987, J BIOL CHEM, V262, P12298; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; LEPPLA SH, 1976, INFECT IMMUN, V14, P1077, DOI 10.1128/IAI.14.4.1077-1086.1976; LEPPLA SH, 2006, COMPREHENSIVE SOURCE, P323; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Liu SH, 2003, MOL CELL, V12, P603, DOI 10.1016/j.molcel.2003.08.003; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; NAGLICH JG, 1992, CELL, V69, P1051, DOI 10.1016/0092-8674(92)90623-K; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; PERENTESIS JP, 1992, BIOFACTORS, V3, P173; Ramirez DM, 2002, J IND MICROBIOL BIOT, V28, P232, DOI 10.1038/sj/jim/700239; VANNESS BG, 1980, J BIOL CHEM, V255, P717; YAMAIZUMI M, 1978, CELL, V15, P245, DOI 10.1016/0092-8674(78)90099-5; Zhu PJ, 2009, BIOORGAN MED CHEM, V17, P5139, DOI 10.1016/j.bmc.2009.05.054	28	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9078	10.1371/journal.pone.0009078	http://dx.doi.org/10.1371/journal.pone.0009078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140093	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400015
J	Guo, XM; Ernst, NL; Carnes, J; Stuart, KD				Guo, Xuemin; Ernst, Nancy Lewis; Carnes, Jason; Stuart, Kenneth D.			The Zinc-Fingers of KREPA3 Are Essential for the Complete Editing of Mitochondrial mRNAs in Trypanosoma brucei	PLOS ONE			English	Article							BINDING PROTEIN; EDITOSOME INTEGRITY; GUIDE RNA; IN-VITRO; OB-FOLD; AFRICAN TRYPANOSOMES; CYTOCHROME-OXIDASE; B TRANSCRIPTS; DELETION; LEISHMANIA	Most mitochondrial mRNAs in trypanosomes undergo uridine insertion/deletion editing that is catalyzed by similar to 20S editosomes. The editosome component KREPA3 is essential for editosome structural integrity and its two zinc finger (ZF) motifs are essential for editing in vivo but not in vitro. KREPA3 function was further explored by examining the consequence of mutation of its N- and C-terminal ZFs (ZF1 and ZF2, respectively). Exclusively expressed myc-tagged KREPA3 with ZF2 mutation resulted in lower KREPA3 abundance and a relative increase in KREPA2 and KREL1 proteins. Detailed analysis of edited RNA products revealed the accumulation of partially edited mRNAs with less insertion editing compared to the partially edited mRNAs found in the cells with wild type KREPA3 expression. Mutation of ZF1 in TAP-tagged KREPA3 also resulted in accumulation of partially edited mRNAs that were shorter and only edited in the 39-terminal editing region. Mutation of both ZFs essentially eliminated partially edited mRNA. The mutations did not affect gRNA abundance. These data indicate that both ZFs are essential for the progression of editing and perhaps its accuracy, which suggests that KREPA3 plays roles in the editing process via its ZFs interaction with editosome proteins and/or RNA substrates.	[Guo, Xuemin; Ernst, Nancy Lewis; Carnes, Jason; Stuart, Kenneth D.] Seattle Biomed Res Inst, Seattle, WA 98109 USA	Center for Infectious Disease Research	Guo, XM (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	ken.stuart@sbri.org		Carnes, Jason/0000-0001-7302-1935	National Institutes of Health (NIH) [AI014012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014102] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant AI014012 to K. Stuart (http://www.nih.gov/). Research was conducted using equipment made possible by the Economic Development Administration - United States Department of Commerce (http://www.eda.gov/) and the M.J. Murdock Charitable Trust (http://www.murdock-trust.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JM, 1988, CELL, V55, P267, DOI 10.1016/0092-8674(88)90049-9; Agrawal V, 2003, CURR PROTEIN PEPT SC, V4, P195, DOI 10.2174/1389203033487207; Ammerman ML, 2008, RNA, V14, P1069, DOI 10.1261/rna.982908; Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Aphasizhev R, 2003, P NATL ACAD SCI USA, V100, P10617, DOI 10.1073/pnas.1833120100; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Babbarwal VK, 2007, RNA, V13, P737, DOI 10.1261/rna.327707; BENNE R, 1994, EUR J BIOCHEM, V221, P9, DOI 10.1111/j.1432-1033.1994.tb18710.x; BENNE R, 1992, MOL BIOL REP, V16, P217, DOI 10.1007/BF00419661; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BHAT GJ, 1990, CELL, V61, P885, DOI 10.1016/0092-8674(90)90199-O; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brecht M, 2005, MOL CELL, V17, P621, DOI 10.1016/j.molcel.2005.01.018; Carnes J, 2005, P NATL ACAD SCI USA, V102, P16614, DOI 10.1073/pnas.0506133102; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Clement SL, 2004, EUKARYOT CELL, V3, P862, DOI 10.1128/EC.3.4.862-869.2004; Cruz-Reyes J, 2002, MOL CELL BIOL, V22, P4652, DOI 10.1128/MCB.22.13.4652-4660.2002; DECKER CJ, 1990, CELL, V61, P1001, DOI 10.1016/0092-8674(90)90065-M; Domingo GJ, 2003, EUKARYOT CELL, V2, P569, DOI 10.1128/EC.2.3.569-577.2003; Ernst NL, 2009, RNA, V15, P947, DOI 10.1261/rna.1373009; Ernst NL, 2003, MOL CELL, V11, P1525, DOI 10.1016/S1097-2765(03)00185-0; FEAGIN JE, 1987, CELL, V49, P337, DOI 10.1016/0092-8674(87)90286-8; FEAGIN JE, 1988, P NATL ACAD SCI USA, V85, P539, DOI 10.1073/pnas.85.2.539; FEAGIN JE, 1988, CELL, V53, P413, DOI 10.1016/0092-8674(88)90161-4; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Fisk JC, 2009, MOL CELL BIOL, V29, P5214, DOI 10.1128/MCB.00520-09; Golden DE, 2005, RNA, V11, P29, DOI 10.1261/rna.7170705; Grams J, 2000, EMBO J, V19, P5525, DOI 10.1093/emboj/19.20.5525; Guo XM, 2008, MOL CELL BIOL, V28, P6939, DOI 10.1128/MCB.01115-08; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Kang XD, 2005, P NATL ACAD SCI USA, V102, P1017, DOI 10.1073/pnas.0409275102; Kang XD, 2006, P NATL ACAD SCI USA, V103, P13944, DOI 10.1073/pnas.0604476103; Koller J, 1997, J BIOL CHEM, V272, P3749, DOI 10.1074/jbc.272.6.3749; KOSLOWSKY DJ, 1990, CELL, V62, P901, DOI 10.1016/0092-8674(90)90265-G; Lambert L, 1999, NUCLEIC ACIDS RES, V27, P1429, DOI 10.1093/nar/27.6.1429; Law JA, 2008, RNA, V14, P1187, DOI 10.1261/rna.899508; Law JA, 2007, MOL CELL BIOL, V27, P777, DOI 10.1128/MCB.01460-06; Lukes J, 2005, CURR GENET, V48, P277, DOI 10.1007/s00294-005-0027-0; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Madison-Antenucci S, 2002, CELL, V108, P435, DOI 10.1016/S0092-8674(02)00653-0; Madison-Antenucci S, 2001, MOL CELL, V7, P879, DOI 10.1016/S1097-2765(01)00231-3; MASLOV DA, 1992, CELL, V70, P459, DOI 10.1016/0092-8674(92)90170-H; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; OCHSENREITER T, 2008, MOL CELL BIOL; Ochsenreiter T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001566; Ochsenreiter T, 2006, EMBO REP, V7, P1128, DOI 10.1038/sj.embor.7400817; Osato D, 2009, RNA, V15, P1338, DOI 10.1261/rna.1642809; Panigrahi AK, 2001, MOL CELL BIOL, V21, P6833, DOI 10.1128/MCB.21.20.6833-6840.2001; Panigrahi AK, 2006, RNA, V12, P1038, DOI 10.1261/rna.45506; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; READ LK, 1992, J BIOL CHEM, V267, P1123; Salavati R, 2006, RNA, V12, P819, DOI 10.1261/rna.2244106; Schnaufer A, 2003, MOL CELL, V12, P307, DOI 10.1016/S1097-2765(03)00286-7; Schnaufer A, 2001, SCIENCE, V291, P2159, DOI 10.1126/science.1058655; SCHNAUFER A, 2009, J BIOL CHEM; SHAW JM, 1988, CELL, V53, P401, DOI 10.1016/0092-8674(88)90160-2; Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704; Stuart K, 1997, MICROBIOL MOL BIOL R, V61, P105, DOI 10.1128/.61.1.105-120.1997; Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006; STURM NR, 1990, CELL, V61, P871, DOI 10.1016/0092-8674(90)90197-M; Tarun SZ, 2008, RNA, V14, P347, DOI 10.1261/rna.763308; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Trotter JR, 2005, MOL CELL, V20, P403, DOI 10.1016/j.molcel.2005.09.016; VANDERSPEK H, 1991, EMBO J, V10, P1217, DOI 10.1002/j.1460-2075.1991.tb08063.x; Vanhamme L, 1998, J BIOL CHEM, V273, P21825, DOI 10.1074/jbc.273.34.21825; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Wang BB, 2003, EUKARYOT CELL, V2, P578, DOI 10.1128/EC.2.3.578-587.2003; Worthey EA, 2003, NUCLEIC ACIDS RES, V31, P6392, DOI 10.1093/nar/gkg870	71	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8913	10.1371/journal.pone.0008913	http://dx.doi.org/10.1371/journal.pone.0008913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111718	Green Published, Green Submitted, gold			2022-12-27	WOS:000274114800016
J	Metzner, M; Schuh, W; Roth, E; Jack, HM; Wabl, M				Metzner, Mirjam; Schuh, Wolfgang; Roth, Edith; Jaeck, Hans-Martin; Wabl, Matthias			Two Forms of Activation-Induced Cytidine Deaminase Differing in Their Ability to Bind Agarose	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; DIVERSIFICATION ENZYME; EXPRESSION LEVELS; B-CELLS; AID; PHOSPHORYLATION	Background: Activation-induced cytidine deaminase ( AID) is a B-cell-specific DNA mutator that plays a key role in the formation of the secondary antibody repertoire in germinal center B cells. In the search for binding partners, protein coimmunoprecipitation assays are often performed, generally with agarose beads. Methodology/Principal Findings: We found that, regardless of whether cell lysates containing exogenous or endogenous AID were examined, one of two mouse AID forms bound to agarose alone. Conclusions/Significance: These binding characteristics may be due to the known post-translational modifications of AID; they may also need to be considered in coimmunoprecipitation experiments to avoid false-positive results.	[Metzner, Mirjam; Schuh, Wolfgang; Roth, Edith; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, Erlangen, Germany; [Metzner, Mirjam; Wabl, Matthias] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of Erlangen Nuremberg; University of California System; University of California San Francisco	Metzner, M (corresponding author), Univ Erlangen Nurnberg, Dept Internal Med 3, Nikolaus Fiebiger Ctr, Div Mol Immunol, Erlangen, Germany.	mirjam.metzner@ucsf.edu		Jack, Hans-Martin/0000-0002-6332-8463	National Institutes of Health [R01AI041570]; Deutsche Forschungsgemeinschaft [JA968/5, FOR832]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R01AI041570 to Matthias Wabl and by the Research Grant JA968/5 through FOR832 from the Deutsche Forschungsgemeinschaft to Hans-Martin Jack. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri S, 2004, IEEE T KNOWL DATA EN, V16, P992, DOI 10.1109/TKDE.2004.30; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Imai K, 2005, CLIN IMMUNOL, V115, P277, DOI 10.1016/j.clim.2005.02.003; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Krueger C, 2006, J GENE MED, V8, P1037, DOI 10.1002/jgm.932; Lorens JB, 2000, VIROLOGY, V272, P7, DOI 10.1006/viro.2000.0353; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pham P, 2008, J BIOL CHEM, V283, P17428, DOI 10.1074/jbc.M802121200; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takizawa M, 2008, J EXP MED, V205, P1949, DOI 10.1084/jem.20081007; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8883	10.1371/journal.pone.0008883	http://dx.doi.org/10.1371/journal.pone.0008883			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111710	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800008
J	le Feber, J; Stegenga, J; Rutten, WLC				le Feber, Joost; Stegenga, Jan; Rutten, Wim L. C.			The Effect of Slow Electrical Stimuli to Achieve Learning in Cultured Networks of Rat Cortical Neurons	PLOS ONE			English	Article							DYNAMICS; PLASTICITY; CALCIUM; BURSTS	Learning, or more generally, plasticity may be studied using cultured networks of rat cortical neurons on multi electrode arrays. Several protocols have been proposed to affect connectivity in such networks. One of these protocols, proposed by Shahaf and Marom, aimed to train the input-output relationship of a selected connection in a network using slow electrical stimuli. Although the results were quite promising, the experiments appeared difficult to repeat and the training protocol did not serve as a basis for wider investigation yet. Here, we repeated their protocol, and compared our 'learning curves' to the original results. Although in some experiments the protocol did not seem to work, we found that on average, the protocol showed a significantly improved stimulus response indeed. Furthermore, the protocol always induced functional connectivity changes that were much larger than changes that occurred after a comparable period of random or no stimulation. Finally, our data shows that stimulation at a fixed electrode induces functional connectivity changes of similar magnitude as stimulation through randomly varied sites; both larger than spontaneous connectivity fluctuations. We concluded that slow electrical stimulation always induced functional connectivity changes, although uncontrolled. The magnitude of change increased when we applied the adaptive (closed-loop) training protocol. We hypothesize that networks develop an equilibrium between connectivity and activity. Induced connectivity changes depend on the combination of applied stimulus and initial connectivity. Plain stimuli may drive networks to the nearest equilibrium that accommodates this input, whereas adaptive stimulation may direct the space for exploration and force networks to a new balance, at a larger distance from the initial state.	[le Feber, Joost; Stegenga, Jan; Rutten, Wim L. C.] Univ Twente, MIRA, Inst Biomed Engn, Dept Elect Engn Math & Comp Sci, NL-7500 AE Enschede, Netherlands	University of Twente	le Feber, J (corresponding author), Univ Twente, MIRA, Inst Biomed Engn, Dept Elect Engn Math & Comp Sci, POB 217, NL-7500 AE Enschede, Netherlands.	j.lefeber@utwente.nl			University of Twente	University of Twente	This work was funded by an internal grant (spearhead program) from the University of Twente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakkum DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002088; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Chiappalone M, 2008, EUR J NEUROSCI, V28, P221, DOI 10.1111/j.1460-9568.2008.06259.x; Eytan D, 2003, J NEUROSCI, V23, P9349; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N; Jimbo Y, 1998, IEEE T BIO-MED ENG, V45, P1297, DOI 10.1109/10.725326; JIMBO Y, 1993, IEEE T BIO-MED ENG, V40, P804, DOI 10.1109/10.238465; Jimbo Y, 2000, BIOL CYBERN, V83, P1, DOI 10.1007/PL00007970; Jimbo Y, 1999, BIOPHYS J, V76, P670, DOI 10.1016/S0006-3495(99)77234-6; le Feber J, 2007, J NEURAL ENG, V4, P54, DOI 10.1088/1741-2560/4/2/006; le Feber J, 2009, BIOPHYS J, V96, P3443, DOI 10.1016/j.bpj.2009.01.013; Li YL, 2007, BIOSENS BIOELECTRON, V22, P2976, DOI 10.1016/j.bios.2006.12.018; Marom S, 2002, Q REV BIOPHYS, V35, P63, DOI 10.1017/S0033583501003742; MELSSEN WJ, 1987, BIOL CYBERN, V57, P403, DOI 10.1007/BF00354985; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; ROMIJN HJ, 1984, NEUROSCI BIOBEHAV R, V8, P301, DOI 10.1016/0149-7634(84)90055-1; Ruaro ME, 2005, IEEE T BIO-MED ENG, V52, P371, DOI 10.1109/TBME.2004.842975; Shahaf G, 2001, J NEUROSCI, V21, P8782, DOI 10.1523/JNEUROSCI.21-22-08782.2001; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Stegenga J, 2008, IEEE T BIO-MED ENG, V55, P1382, DOI 10.1109/TBME.2007.913987; Stegenga J, 2009, IEEE T BIO-MED ENG, V56, P1220, DOI 10.1109/TBME.2008.2006856; Vajda I, 2008, BIOPHYS J, V94, P5028, DOI 10.1529/biophysj.107.112730; van Pelt J, 2004, IEEE T BIO-MED ENG, V51, P2051, DOI 10.1109/TBME.2004.827936; van Staveren GW, 2005, I IEEE EMBS C NEUR E, P328; Wagenaar DA, 2004, J NEUROSCI METH, V138, P27, DOI 10.1016/j.jneumeth.2004.03.005; Wagenaar DA, 2006, J NEGAT RESULTS BIOM, V5, DOI 10.1186/1477-5751-5-16; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	29	56	57	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8871	10.1371/journal.pone.0008871	http://dx.doi.org/10.1371/journal.pone.0008871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111726	Green Published, gold			2022-12-27	WOS:000273896300020
J	Yokoyama, M; Mori, H; Sato, H				Yokoyama, Masaru; Mori, Hiromi; Sato, Hironori			Allosteric Regulation of HIV-1 Reverse Transcriptase by ATP for Nucleotide Selection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-REPLICATION FIDELITY; T7 RNA-POLYMERASE; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; CRYSTAL-STRUCTURES; 3'-AZIDO-3'-DEOXYTHYMIDINE; TRANSLOCATION; INHIBITION; AZT	Background: Human immunodeficiency virus type 1 reverse transcriptase (HIV-1 RT) is a DNA polymerase that converts viral RNA genomes into proviral DNAs. How HIV-1 RT regulates nucleotide selectivity is a central issue for genetics and the nucleoside analog RT inhibitor (NRTI) resistance of HIV-1. Methodology/Principal Findings: Here we show that an ATP molecule at physiological concentrations acts as an allosteric regulator of HIV-1 RT to decrease the K-m value of the substrate, decrease the k(cat) value, and increase the K-i value of NRTIs for RT. Computer-assisted structural analyses and mutagenesis studies suggested the positions of the ATP molecule and NRTI-resistance mutations during a catalytic reaction, which immediately predict possible influences on nucleotide insertion into the catalytic site, the DNA polymerization, and the excision reaction. Conclusions/Significance: These data imply that the ATP molecule and NRTI mutations can modulate nucleotide selectivity by altering the fidelity of the geometric selection of nucleotides and the probability of an excision reaction.	[Yokoyama, Masaru; Mori, Hiromi; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan	National Institute of Infectious Diseases (NIID)	Yokoyama, M (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Musashimurayama, Tokyo, Japan.	yokoyama@nih.go.jp			Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Chen RX, 2005, J VIROL, V79, P12045, DOI 10.1128/JVI.79.18.12045-12057.2005; Das K, 2007, J MOL BIOL, V365, P77, DOI 10.1016/j.jmb.2006.08.097; FURMAN PA, 1986, P NATL ACAD SCI USA, V83, P8333, DOI 10.1073/pnas.83.21.8333; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Goto J, 2008, J CHEM INF MODEL, V48, P583, DOI 10.1021/ci700352q; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; KATI WM, 1992, J BIOL CHEM, V267, P25988; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Li Y, 1998, PROTEIN SCI, V7, P1116, DOI 10.1002/pro.5560070505; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PRESTON BD, 1988, SCIENCE, V242, P1168, DOI 10.1126/science.2460924; Ray AS, 2003, BIOCHEMISTRY-US, V42, P8831, DOI 10.1021/bi034435l; RITTINGER K, 1995, P NATL ACAD SCI USA, V92, P8046, DOI 10.1073/pnas.92.17.8046; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Sato H, 2001, J VIROL, V75, P5604, DOI 10.1128/JVI.75.12.5604-5613.2001; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; STARNES MC, 1989, J BIOL CHEM, V264, P7073; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Thompson AA, 2007, J MOL BIOL, V366, P1459, DOI 10.1016/j.jmb.2006.11.070; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; VRANG L, 1987, ANTIVIR RES, V7, P139, DOI 10.1016/0166-3542(87)90002-7; WILLEY RL, 1988, J VIROL, V62, P139, DOI 10.1128/JVI.62.1.139-147.1988; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	34	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8867	10.1371/journal.pone.0008867	http://dx.doi.org/10.1371/journal.pone.0008867			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111609	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300016
J	Cardinaud, S; Starck, SR; Chandra, P; Shastri, N				Cardinaud, Sylvain; Starck, Shelley R.; Chandra, Piyanka; Shastri, Nilabh			The Synthesis of Truncated Polypeptides for Immune Surveillance and Viral Evasion	PLOS ONE			English	Article							MHC CLASS-I; EPSTEIN-BARR-VIRUS; ANTIGEN-PROCESSING PATHWAY; DEFECTIVE RIBOSOMAL PRODUCTS; T-CELL RECOGNITION; NUCLEAR ANTIGEN-1; ENDOGENOUS PRESENTATION; PROTEIN-DEGRADATION; GENE-EXPRESSION; GENERATION	Background: Cytotoxic T cells detect intracellular pathogens by surveying peptide loaded MHC class I molecules (pMHC I) on the cell surface. Effective immune surveillance also requires infected cells to present pMHC I promptly before viral progeny can escape. Rapid pMHC I presentation apparently occurs because infected cells can synthesize and present peptides from antigenic precursors called defective ribosomal products (DRiPs). The molecular characteristics of DRiPs are not known. Methodology/Principal Findings: Here, using a novel method for detecting antigenic precursors and proteolytic intermediates, we tracked the synthesis and processing of Epstein-Barr Virus encoded nuclear antigen 1 (EBNA1). We find that ribosomes initiated translation appropriately, but rapidly produced DRiPs representing similar to 120 amino acid truncated EBNA1 polypeptides by premature termination. Moreover, specific sequences in EBNA1 mRNA strongly inhibited the generation of truncated DRiPs and pMHC I presentation. Significance: Our results reveal the first characterization of virus DRiPs as truncated translation products. Furthermore, production of EBNA1-derived DRiPs is down-regulated in cells, possibly limiting the antigenicity of EBNA1.	[Cardinaud, Sylvain; Starck, Shelley R.; Chandra, Piyanka; Shastri, Nilabh] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Cardinaud, S (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, 229 Stanley Hall, Berkeley, CA 94720 USA.	nshastri@berkeley.edu		CARDINAUD, Sylvain/0000-0002-2650-1108	National Institutes of Health [AI039548]; Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S. R. S. was supported in part by a National Institutes of Health training grant, a postdoctoral fellowship from the Cancer Research Institute and the NRSA fellowship from the National Institutes of Health. This research was supported by grant AI039548 from the National Institutes of Health to N. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apcher S, 2009, J VIROL, V83, P1289, DOI 10.1128/JVI.01369-08; Bennett NJ, 2005, PLOS BIOL, V3, P638, DOI 10.1371/journal.pbio.0030120; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Cristillo AD, 2001, J THEOR BIOL, V208, P475, DOI 10.1006/jtbi.2000.2233; Daskalogianni C, 2008, J BIOL CHEM, V283, P30090, DOI 10.1074/jbc.M803290200; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Gao JY, 2009, J VIROL, V83, P273, DOI 10.1128/JVI.01532-08; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goth S, 1996, J IMMUNOL, V157, P1894; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kloetzel PM, 2004, NAT IMMUNOL, V5, P661, DOI 10.1038/ni1090; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Kunisawa J, 2006, IMMUNITY, V24, P523, DOI 10.1016/j.immuni.2006.03.015; Lee SP, 2004, J EXP MED, V199, P1409, DOI 10.1084/jem.20040121; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; LEVITSKAYA J, 1995, NATURE, V375, P685, DOI 10.1038/375685a0; Moore PS, 2003, ANNU REV MICROBIOL, V57, P609, DOI 10.1146/annurev.micro.57.030502.090824; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Paz P, 1999, IMMUNITY, V11, P241, DOI 10.1016/S1074-7613(00)80099-0; Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Tellam J, 2004, J EXP MED, V199, P1421, DOI 10.1084/jem.20040191; Tellam J, 2008, P NATL ACAD SCI USA, V105, P9319, DOI 10.1073/pnas.0801968105; Tellam J, 2007, J EXP MED, V204, P525, DOI 10.1084/jem.20062508; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; Voo KS, 2004, J EXP MED, V199, P459, DOI 10.1084/jem.20031219; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yewdell JW, 1996, J IMMUNOL, V157, P1823; Yin Y, 2003, SCIENCE, V301, P1371, DOI 10.1126/science.1088902; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zaldumbide A, 2007, MOL IMMUNOL, V44, P1352, DOI 10.1016/j.molimm.2006.05.012	43	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8692	10.1371/journal.pone.0008692	http://dx.doi.org/10.1371/journal.pone.0008692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098683	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100002
J	Drgon, T; Zhang, PW; Johnson, C; Walther, D; Hess, J; Nino, M; Uhl, GR				Drgon, Tomas; Zhang, Ping-Wu; Johnson, Catherine; Walther, Donna; Hess, Judith; Nino, Michelle; Uhl, George R.			Genome Wide Association for Addiction: Replicated Results and Comparisons of Two Analytic Approaches	PLOS ONE			English	Article							SAMPLE-SIZE CALCULATIONS; CELL-ADHESION MOLECULES; MILD MENTAL IMPAIRMENT; NICOTINE DEPENDENCE; POOLED DNA; POLYSUBSTANCE ABUSERS; MACULAR DEGENERATION; SYNAPTIC PLASTICITY; VULNERABILITY LOCI; ALCOHOL DEPENDENCE	Background: Vulnerabilities to dependence on addictive substances are substantially heritable complex disorders whose underlying genetic architecture is likely to be polygenic, with modest contributions from variants in many individual genes. "Nontemplate" genome wide association (GWA) approaches can identity groups of chromosomal regions and genes that, taken together, are much more likely to contain allelic variants that alter vulnerability to substance dependence than expected by chance. Methodology/Principal Findings: We report pooled "nontemplate" genome-wide association studies of two independent samples of substance dependent vs control research volunteers (n = 1620), one European-American and the other African-American using 1 million SNP (single nucleotide polymorphism) Affymetrix genotyping arrays. We assess convergence between results from these two samples using two related methods that seek clustering of nominally-positive results and assess significance levels with Monte Carlo and permutation approaches. Both "converge then cluster" and "cluster then converge" analyses document convergence between the results obtained from these two independent datasets in ways that are virtually never found by chance. The genes identified in this fashion are also identified by individually-genotyped dbGAP data that compare allele frequencies in cocaine dependent vs control individuals. Conclusions/Significance: These overlapping results identify small chromosomal regions that are also identified by genome wide data from studies of other relevant samples to extents much greater than chance. These chromosomal regions contain more genes related to "cell adhesion" processes than expected by chance. They also contain a number of genes that encode potential targets for anti-addiction pharmacotherapeutics. "Nontemplate" GWA approaches that seek chromosomal regions in which nominally-positive associations are found in multiple independent samples are likely to complement classical, "template" GWA approaches in which "genome wide" levels of significance are sought for SNP data from single case vs control comparisons.	[Drgon, Tomas; Zhang, Ping-Wu; Johnson, Catherine; Walther, Donna; Hess, Judith; Nino, Michelle; Uhl, George R.] Natl Inst Drug Abuse, Mol Neurobiol Branch, Natl Inst Hlth Intramural Res Program, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Drgon, T (corresponding author), Natl Inst Drug Abuse, Mol Neurobiol Branch, Natl Inst Hlth Intramural Res Program, Baltimore, MD USA.	guhl@intra.nida.nih.gov			National Institutes of Health (NIH) [U01 HG004422, U01HG004438, HHSN268200782096C]; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004438, U01HG004422, U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U10AA008401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013423, ZIADA000401] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was fully supported by the National Institutes of Health (NIH) Intramural Research Program (National Institute on Drug Abuse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was supported financially by the NIH Intramural Research Program, National Institute on Drug Abuse, Department of Health and Human Services. Support for dbGAP data came from the NIH Genes, Environment and Health Initiative (GEI) (U01 HG004422)/Gene Environment Association Studies (GENEVA) which received assistance with phenotype harmonization, genotype cleaning, and study coordination from the GENEVA Coordinating Center (U01 HG004446), assistance with data cleaning from the National Center for Biotechnology Information, and assistance with collection of datasets and samples by the Collaborative Study on the Genetics of Alcoholism (COGA; U10 AA008401), the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392) and the Family Study of Cocaine Dependence (FSCD; R01 DA013423). Support for genotyping dbGAP samples at the Johns Hopkins University Center for Inherited Disease Research came through (U01HG004438), the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse and the NIH contract "High throughput genotyping for studying the genetic contributions to human disease" (HHSN268200782096C). dbGaP datasets were obtained at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id = phs000092.v1.p1 through dbGaP accession number phs000092.v1.p.	Amos C.I., 2008, NAT GENET; BARNES MR, 2005, HIGH DENSITY GENOME; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Beuten J, 2005, AM J HUM GENET, V76, P859, DOI 10.1086/429839; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Butcher LM, 2005, MOL PSYCHIATR, V10, P384, DOI 10.1038/sj.mp.4001589; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Gershon ES, 2008, MOL PSYCHIATR, V13, P1, DOI 10.1038/sj.mp.4002117; Gorroochurn P, 2007, GENET MED, V9, P325, DOI 10.1097/GIM.0b013e3180676d79; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hinds David A., 2004, Human Genomics, V1, P421; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Johnson C, 2006, AM J MED GENET B, V141B, P844, DOI 10.1002/ajmg.b.30346; Johnson C, 2009, AM J MED GENET B, V150B, P182, DOI 10.1002/ajmg.b.30900; Karkowski LM, 2000, AM J MED GENET, V96, P665, DOI 10.1002/1096-8628(20001009)96:5<665::AID-AJMG13>3.3.CO;2-F; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; Knight J, 2009, HUM HERED, V67, P219, DOI 10.1159/000194975; LACHMAN HM, 2007, HUM MOL GENET; Lambert JC, 2007, PSYCHONEUROENDOCRINO, V32, pS62, DOI 10.1016/j.psyneuen.2007.05.015; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Li CY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040002; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Liu QR, 2005, P NATL ACAD SCI USA, V102, P11864, DOI 10.1073/pnas.0500329102; Luczak SE, 2002, J STUD ALCOHOL, V63, P74; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; McElroy JP, 2008, CURR TOP MICROBIOL, V318, P45; Meaburn E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj027; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; Qiu SF, 2006, NEUROBIOL LEARN MEM, V85, P16, DOI 10.1016/j.nlm.2005.08.009; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; SCHUCKIT MA, 1982, J CLIN PSYCHIAT, V43, P415; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SKLAR P, 2008, WHOLE GENOME ASS STU; SMITH SS, 1992, ARCH GEN PSYCHIAT, V49, P723; Sullivan PF, 2007, BIOL PSYCHIAT, V61, P1121, DOI 10.1016/j.biopsych.2006.11.010; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; True WR, 1999, AM J MED GENET, V88, P391, DOI 10.1002/(SICI)1096-8628(19990820)88:4<391::AID-AJMG17>3.0.CO;2-L; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P683, DOI 10.1001/archpsyc.65.6.683; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Uhl GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-10; Uhl George R., 1995, P1793; Uhl GR, 2008, ANN NY ACAD SCI, V1141, P318, DOI 10.1196/annals.1441.018; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; Welzl H, 2003, NEWS PHYSIOL SCI, V18, P147, DOI 10.1152/nips.01422.2002; Ye BC, 2004, ANAL BIOCHEM, V333, P72, DOI 10.1016/j.ab.2004.05.016; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	58	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8832	10.1371/journal.pone.0008832	http://dx.doi.org/10.1371/journal.pone.0008832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098672	gold, Green Submitted, Green Published			2022-12-27	WOS:000273779100023
J	Kleemann, R; van Erk, M; Verschuren, L; van den Hoek, AM; Koek, M; Wielinga, PY; Jie, A; Pellis, L; Bobeldijk-Pastorova, I; Kelder, T; Toet, K; Wopereis, S; Cnubben, N; Evelo, C; van Ommen, B; Kooistra, T				Kleemann, Robert; van Erk, Marjan; Verschuren, Lars; van den Hoek, Anita M.; Koek, Maud; Wielinga, Peter Y.; Jie, Annie; Pellis, Linette; Bobeldijk-Pastorova, Ivana; Kelder, Thomas; Toet, Karin; Wopereis, Suzan; Cnubben, Nicole; Evelo, Chris; van Ommen, Ben; Kooistra, Teake			Time-Resolved and Tissue-Specific Systems Analysis of the Pathogenesis of Insulin Resistance	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MIGRATION INHIBITORY FACTOR; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION DATA; FATTY-ACIDS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; METABOLOMICS ANALYSIS; RECEPTOR ANTAGONIST; ABDOMINAL ANEURYSM	Background: The sequence of events leading to the development of insulin resistance (IR) as well as the underlying pathophysiological mechanisms are incompletely understood. As reductionist approaches have been largely unsuccessful in providing an understanding of the pathogenesis of IR, there is a need for an integrative, time-resolved approach to elucidate the development of the disease. Methodology/Principal Findings: Male ApoE3Leiden transgenic mice exhibiting a humanized lipid metabolism were fed a high-fat diet (HFD) for 0, 1, 6, 9, or 12 weeks. Development of IR was monitored in individual mice over time by performing glucose tolerance tests and measuring specific biomarkers in plasma, and hyperinsulinemic-euglycemic clamp analysis to assess IR in a tissue-specific manner. To elucidate the dynamics and tissue-specificity of metabolic and inflammatory processes key to IR development, a time-resolved systems analysis of gene expression and metabolite levels in liver, white adipose tissue (WAT), and muscle was performed. During HFD feeding, the mice became increasingly obese and showed a gradual increase in glucose intolerance. IR became first manifest in liver (week 6) and then in WAT (week 12), while skeletal muscle remained insulin-sensitive. Microarray analysis showed rapid upregulation of carbohydrate (only liver) and lipid metabolism genes (liver, WAT). Metabolomics revealed significant changes in the ratio of saturated to polyunsaturated fatty acids (liver, WAT, plasma) and in the concentrations of glucose, gluconeogenesis and Krebs cycle metabolites, and branched amino acids (liver). HFD evoked an early hepatic inflammatory response which then gradually declined to near baseline. By contrast, inflammation in WAT increased over time, reaching highest values in week 12. In skeletal muscle, carbohydrate metabolism, lipid metabolism, and inflammation was gradually suppressed with HFD. Conclusions/Significance: HFD-induced IR is a time- and tissue-dependent process that starts in liver and proceeds in WAT. IR development is paralleled by tissue-specific gene expression changes, metabolic adjustments, changes in lipid composition, and inflammatory responses in liver and WAT involving p65-NFkB and SOCS3. The alterations in skeletal muscle are largely opposite to those in liver and WAT.	[Kleemann, Robert; Verschuren, Lars; van den Hoek, Anita M.; Wielinga, Peter Y.; Jie, Annie; Toet, Karin; Kooistra, Teake] TNO, Leiden, Netherlands; [Kleemann, Robert; Verschuren, Lars] Leiden Univ, Med Ctr, Dept Vasc Surg, Leiden, Netherlands; [van Erk, Marjan; Koek, Maud; Pellis, Linette; Bobeldijk-Pastorova, Ivana; Wopereis, Suzan; Cnubben, Nicole; van Ommen, Ben] TNO, NL-3700 AJ Zeist, Netherlands; [Kleemann, Robert; Wielinga, Peter Y.; Toet, Karin] Top Inst Food & Nutr, Wageningen, Netherlands; [Kelder, Thomas; Evelo, Chris] Maastricht Univ, Dept Bioinformat, Maastricht, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Netherlands Organization Applied Science Research; Top Institute Food & Nutrition; Maastricht University	Kleemann, R (corresponding author), TNO, Leiden, Netherlands.	Robert.Kleemann@tno.nl	Evelo, Chris TA/D-2914-2009	Evelo, Chris TA/0000-0002-5301-3142	TNO; European Nutrigenomics Organisation (NuGO) [CT-2004-505944]; Top Institute Food and Nutrition	TNO; European Nutrigenomics Organisation (NuGO); Top Institute Food and Nutrition	This present study was mainly sponsored by the TNO research program Personalized Health (to R. K., M. v. E., L. V., N. C., A. J., I. B- P., M. K., L. P., B. v. O., and T. K.; animal work; transcriptomics; metabolomics). The authors gratefully acknowledge additional grant support from the European Nutrigenomics Organisation (NuGO, CT-2004-505944; Proof-of-Principle Study PPS1 to R. K., M. v. E., C. E., and T. K.) and from the Top Institute Food and Nutrition (SAA, fibrinogen, E-selectin, VCAM-1, vWF measurements; Top Institute Food and Nutrition work package A1004 to K. T., P. Y. W., and R. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobeldijk I, 2008, J CHROMATOGR B, V871, P306, DOI 10.1016/j.jchromb.2008.05.008; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlsen H, 2009, GENES NUTR, V4, P215, DOI 10.1007/s12263-009-0133-6; CHISHOLM KW, 1987, J NUTR SCI VITAMINOL, V33, P377, DOI 10.3177/jnsv.33.377; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; De Groot PJ, 2008, GENES NUTR, V3, P143, DOI 10.1007/s12263-008-0093-2; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Gervois P, 2004, J BIOL CHEM, V279, P16154, DOI 10.1074/jbc.M400346200; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Haslinger B, 2003, KIDNEY INT, V63, P2065, DOI 10.1046/j.1523-1755.2003.t01-2-00004.x; Herder C, 2008, DIABETOLOGIA, V51, P276, DOI 10.1007/s00125-007-0800-3; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kato K, 1999, BIOCHEM BIOPH RES CO, V258, P431, DOI 10.1006/bbrc.1999.0648; Kawaguchi T, 2008, INT J MOL MED, V22, P105; Kleemann R, 2003, BLOOD, V101, P545, DOI 10.1182/blood-2002-06-1762; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Koek MM, 2008, J CHROMATOGR A, V1186, P420, DOI 10.1016/j.chroma.2007.11.107; Kooistra T, 2006, ARTERIOSCL THROM VAS, V26, P2322, DOI 10.1161/01.ATV.0000238348.05028.14; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Montecucco F, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/767623; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; Pettinella C, 2007, J CHROMATOGR B, V850, P168, DOI 10.1016/j.jchromb.2006.11.023; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Rein D, 2006, J NUTR, V136, P2331, DOI 10.1093/jn/136.9.2331; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; SCHULTZ DR, 1990, SEMIN ARTHRITIS RHEU, V20, P129, DOI 10.1016/0049-0172(90)90055-K; Shi H, 2006, DIABETES, V55, P699, DOI 10.2337/diabetes.55.03.06.db05-0841; Singh U, 2004, CLIN SCI, V106, P421, DOI 10.1042/CS20030375; Somm E, 2006, DIABETOLOGIA, V49, P387, DOI 10.1007/s00125-005-0046-x; Steinberg GR, 2006, J CLIN ENDOCR METAB, V91, P3592, DOI 10.1210/jc.2006-0638; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Verschuren L, 2005, ARTERIOSCL THROM VAS, V25, P161, DOI 10.1161/01.ATV.0000148866.29829.19; Verschuren L, 2009, CIRC RES, V105, P99, DOI 10.1161/CIRCRESAHA.109.199166; Warensjo E, 2006, AM J CLIN NUTR, V84, P442; Wu Y, 2005, BRIT J PHARMACOL, V146, P234, DOI 10.1038/sj.bjp.0706306; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhou YT, 1999, P NATL ACAD SCI USA, V96, P2391, DOI 10.1073/pnas.96.5.2391; Zhou YE, 2009, METABOLISM, V58, P158, DOI 10.1016/j.metabol.2008.09.008	58	114	116	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8817	10.1371/journal.pone.0008817	http://dx.doi.org/10.1371/journal.pone.0008817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098690	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100010
J	Scolamacchia, F; Handel, IG; Fevre, EM; Morgan, KL; Tanya, VN; Bronsvoort, BMD				Scolamacchia, Francesca; Handel, Ian G.; Fevre, Eric M.; Morgan, Kenton L.; Tanya, Vincent N.; Bronsvoort, Barend M. de C.			Serological Patterns of Brucellosis, Leptospirosis and Q Fever in Bos indicus Cattle in Cameroon	PLOS ONE			English	Article							COXIELLA-BURNETII; RISK-FACTORS; BOVINE BRUCELLOSIS; CENTRAL-AFRICA; DAIRY-CATTLE; ANTIBODIES; PREVALENCE; INFECTION; LIVESTOCK; SEROPREVALENCE	Brucellosis, leptospirosis and Q fever are important infections of livestock causing a range of clinical conditions including abortions and reduced fertility. In addition, they are all important zoonotic infections infecting those who work with livestock and those who consume livestock related products such as milk, producing non-specific symptoms including fever, that are often misdiagnosed and that can lead to severe chronic disease. This study used banked sera from the Adamawa Region of Cameroon to investigate the seroprevalences and distributions of seropositive animals and herds. A classical statistical and a multi-level prevalence modelling approach were compared. The unbiased estimates were similar to 20% of herds were seropositive for Brucella spp. compared to similar to 95% for Leptospira spp. and similar to 68% for Q fever. The within-herd seroprevalences were similar to 16%, similar to 35% and similar to 39% respectively. There was statistical evidence of clustering of seropositive brucellosis and Q fever herds. The modelling approach has the major advantage that estimates of seroprevalence can be adjusted for the sensitivity and specificity of the diagnostic test used and the multi-level structure of the sampling. The study found a low seroprevalence of brucellosis in the Adamawa Region compared to a high proportion of leptospirosis and Q fever seropositive herds. This represents a high risk to the human population as well as potentially having a major impact on animal health and productivity in the region.	[Scolamacchia, Francesca; Handel, Ian G.; Bronsvoort, Barend M. de C.] Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin Bioctr, Roslin, Midlothian, Scotland; [Fevre, Eric M.] Univ Edinburgh, Inst Immunol & Infect Res, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Morgan, Kenton L.] Univ Liverpool, Dept Vet Clin Sci, Leahurst Vet Teaching Hosp, Wirral L64 7TE, Merseyside, England; [Tanya, Vincent N.] Minist Sci Res & Innovat, Yaounde, Cameroon	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Liverpool	Scolamacchia, F (corresponding author), Univ Edinburgh, Roslin Inst, Royal Dick Sch Vet Studies, Roslin Bioctr, Roslin, Midlothian, Scotland.	mark.bronsvoort@ed.ac.uk		Bronsvoort, Mark/0000-0002-3271-8485; Fevre, Eric/0000-0001-8931-4986	Wellcome Trust [053840, 085308]; DEFRA/SHEFC VTRI [VT101]; BBSRC [338BDD RA0762]	Wellcome Trust(Wellcome TrustEuropean Commission); DEFRA/SHEFC VTRI(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Dr Bronsvoort would like to thank the Wellcome Trust, grant no. 053840, for funding the original research project in Cameroon, DEFRA/SHEFC VTRI, grant no. VT101, for the MSc studentship for F. Scolamacchia and two summer studentships for B. Koterwas and F. Land who helped test the sera. Eric Fevre is funded by the Wellcome Trust grant no. 085308 and Ian Handel is funded by the BBSRC Programme Grant No. 338BDD RA0762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoel T, 2008, VET MICROBIOL, V130, P312, DOI 10.1016/j.vetmic.2008.01.009; Abdoel TH, 2007, DIAGN MICR INFEC DIS, V57, P123, DOI 10.1016/j.diagmicrobio.2006.08.017; Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Bertherat E, 1999, AM J TROP MED HYG, V60, P610, DOI 10.4269/ajtmh.1999.60.610; Bildfell RJ, 2000, J VET DIAGN INVEST, V12, P419, DOI 10.1177/104063870001200505; BORNAREL P, 1987, REV MED VET-TOULOUSE, V138, P55; Branscum AJ, 2004, PREV VET MED, V66, P101, DOI 10.1016/j.prevetmed.2004.09.009; Bronsvoort BMD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005221; Bronsvoort BMD, 2003, TROP ANIM HEALTH PRO, V35, P491, DOI 10.1023/A:1027302525301; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; CACCIAPUOTI B, 1982, T ROY SOC TROP MED H, V76, P178, DOI 10.1016/0035-9203(82)90270-X; CAROFF M, 1984, INFECT IMMUN, V46, P384, DOI 10.1128/IAI.46.2.384-388.1984; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; CUZICK J, 1990, J ROY STAT SOC B MET, V52, P73; DOMENECH J, 1980, REV ELEV MED VET PAY, V33, P277; DOMENECH J, 1982, REV ELEV MED VET PAY, V35, P15; ELLIS WA, 1986, VET REC, V118, P63, DOI 10.1136/vr.118.3.63; FERESU SB, 1992, VET REC, V130, P446, DOI 10.1136/vr.130.20.446; FERESU SB, 1987, TROP ANIM HEALTH PRO, V19, P209, DOI 10.1007/BF02242118; GHIROTTI M, 1991, VET RES COMMUN, V15, P25, DOI 10.1007/BF00497787; Greiner M, 2000, PREV VET MED, V45, P43, DOI 10.1016/S0167-5877(00)00116-1; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; GUMMOW B, 1987, ONDERSTEPOORT J VET, V54, P569; HANSON LE, 1982, J AM VET MED ASSOC, V181, P278; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; HUNTER P, 2004, INFECT DIS LIVESTOCK, V3, pCH136; Jordan D, 1998, PREV VET MED, V36, P187, DOI 10.1016/S0167-5877(98)00087-7; KELLY PJ, 1993, S AFR MED J, V83, P21; KELLY PJ, 2004, INFECT DIS LIVESTOCK, V1, pCH43; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Lohr S.L., 1999, SAMPLING DESIGN ANAL; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Muma JB, 2006, TROP ANIM HEALTH PRO, V38, P195, DOI 10.1007/s11250-006-4320-9; MYBURGH JG, 1989, ONDERSTEPOORT J VET, V56, P285; Nakoune E, 2004, ACTA TROP, V92, P147, DOI 10.1016/j.actatropica.2004.06.007; NIANG M, 1994, PREV VET MED, V18, P259, DOI 10.1016/0167-5877(94)90050-7; Nicoletti P, 2002, VET MICROBIOL, V90, P5, DOI 10.1016/S0378-1135(02)00209-2; Omer MK, 2000, EPIDEMIOL INFECT, V125, P447, DOI 10.1017/S0950268899004501; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Plummer M, 2009, RJAGS BAYESIAN GRAPH; Potts AD, 1995, ONDERSTEPOORT J VET, V62, P281; Rodolakis A, 2007, J DAIRY SCI, V90, P5352, DOI 10.3168/jds.2006-815; SAMARTINO LE, 1993, COMP IMMUNOL MICROB, V16, P95, DOI 10.1016/0147-9571(93)90001-L; SANKALE M, 1976, African Journal of Medicine and Medical Sciences, V5, P213; Schelling E, 2003, PREV VET MED, V61, P279, DOI 10.1016/j.prevetmed.2003.08.004; Schelling E, 2007, EMERG INFECT DIS, V13, P373, DOI 10.3201/eid1303.060391; Shey-Njila O., 2005, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V58, P139; Sofian M, 2008, INT J INFECT DIS, V12, P157, DOI 10.1016/j.ijid.2007.04.019; Stack JA, 1999, VET REC, V145, P735, DOI 10.1136/vr.145.25.735; STALEY GP, 1989, ONDERSTEPOORT J VET, V56, P205; Steinmann P, 2005, TROP MED INT HEALTH, V10, P612, DOI 10.1111/j.1365-3156.2005.01420.x; Swai ES, 2009, ZOONOSES PUBLIC HLTH, V56, P183, DOI 10.1111/j.1863-2378.2008.01175.x; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Weinhaupl I, 2000, TROP ANIM HEALTH PRO, V32, P147, DOI 10.1023/A:1005231514467; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Yan KT, 1999, VET MICROBIOL, V69, P173, DOI 10.1016/S0378-1135(99)00103-0	59	38	39	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8623	10.1371/journal.pone.0008623	http://dx.doi.org/10.1371/journal.pone.0008623			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098670	Green Published, gold			2022-12-27	WOS:000273779100001
J	Glattard, E; Welters, ID; Lavaux, T; Muller, AH; Laux, A; Zhang, D; Schmidt, AR; Delalande, F; Laventie, BJ; Dirrig-Grosch, S; Colin, DA; Van Dorsselaer, A; Aunis, D; Metz-Boutigue, MH; Schneider, F; Goumon, Y				Glattard, Elise; Welters, Ingeborg D.; Lavaux, Thomas; Muller, Arnaud H.; Laux, Alexis; Zhang, Dan; Schmidt, Alexander R.; Delalande, Francois; Laventie, Benoit-Joseph; Dirrig-Grosch, Sylvie; Colin, Didier A.; Van Dorsselaer, Alain; Aunis, Dominique; Metz-Boutigue, Marie-Helene; Schneider, Francis; Goumon, Yannick			Endogenous Morphine Levels Are Increased in Sepsis: A Partial Implication of Neutrophils	PLOS ONE			English	Article							MU-OPIOID-RECEPTOR; WHITE BLOOD-CELLS; PHOSPHATIDYLETHANOLAMINE-BINDING PROTEIN; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; OPIATE RECEPTOR; NITRIC-OXIDE; SPLICE VARIANTS; SEPTIC SHOCK; SYNTHESIZE MORPHINE; INDUCED SUPPRESSION	Background: Mammalian cells synthesize morphine and the respective biosynthetic pathway has been elucidated. Human neutrophils release this alkaloid into the media after exposure to morphine precursors. However, the exact role of endogenous morphine in inflammatory processes remains unclear. We postulate that morphine is released during infection and can be determined in the serum of patients with severe infection such as sepsis. Methodology: The presence and subcellular immunolocalization of endogenous morphine was investigated by ELISA, mass spectrometry analysis and laser confocal microscopy. Neutrophils were activated with Interleukin-8 (IL-8) or lipopolysaccharide (LPS). Morphine secretion was determined by a morphine-specific ELISA. m opioid receptor expression was assessed with flow cytometry. Serum morphine concentrations of septic patients were determined with a morphine-specific ELISA and morphine identity was confirmed in human neutrophils and serum of septic patients by mass spectrometry analysis. The effects of the concentration of morphine found in serum of septic patients on LPS-induced release of IL-8 by human neutrophils were tested. Principal Findings: We confirmed the presence of morphine in human neutrophil extracts and showed its colocalisation with lactoferrin within the secondary granules of neutrophils. Morphine secretion was quantified in the supernatant of activated human polymorphonuclear neutrophils in the presence and absence of Ca2+. LPS and IL-8 were able to induce a significant release of morphine only in presence of Ca2+. LPS treatment increased m opioid receptor expression on neutrophils. Low concentration of morphine (8 nM) significantly inhibited the release of IL-8 from neutrophils when coincubated with LPS. This effect was reversed by naloxone. Patients with sepsis, severe sepsis and septic shock had significant higher circulating morphine levels compared to patients with systemic inflammatory response syndrome and healthy controls. Mass spectrometry analysis showed that endogenous morphine from serum of patient with sepsis was identical to poppy-derived morphine. Conclusions: Our results indicate that morphine concentrations are increased significantly in the serum of patients with systemic infection and that morphine is, at least in part, secreted from neutrophils during sepsis. Morphine concentrations equivalent to those found in the serum of septic patients significantly inhibited LPS-induced IL-8 secretion in neutrophils.	[Glattard, Elise; Lavaux, Thomas; Muller, Arnaud H.; Laux, Alexis; Zhang, Dan; Delalande, Francois; Dirrig-Grosch, Sylvie; Aunis, Dominique; Metz-Boutigue, Marie-Helene; Goumon, Yannick] Univ Strasbourg, Physiopathol Syst Nerveux & Nocicept & Pain Dept, Inst Neurosci Cellulaires & Integrat, CNRS,INSERM,U575, Strasbourg, France; [Welters, Ingeborg D.] Univ Liverpool, Sch Clin Sci, Crit Care Res Unit, Liverpool L69 3BX, Merseyside, England; [Lavaux, Thomas; Schneider, Francis] Hop Univ, Serv Reanimat Med, Strasbourg, France; [Lavaux, Thomas; Schneider, Francis] Univ Strasbourg, Hop Hautepierre, Fac Med, Strasbourg, France; [Laventie, Benoit-Joseph; Colin, Didier A.] Univ Strasbourg, Inst Bacteriol, Lab Physiopathol Interact Hote Bacterie, EA3432, Strasbourg, France; [Welters, Ingeborg D.; Schmidt, Alexander R.] Univ Klinikum Giessen & Marburg, Abt Anaesthesiol Intens Med & Schmerztherapie, Giessen, Germany; [Van Dorsselaer, Alain] CNRS, UMR7178, ULP, Lab Spectrometrie Masse BioOrgan,IPHC DSA, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Liverpool; CHU Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University Hospital of Giessen & Marburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Glattard, E (corresponding author), Univ Strasbourg, Physiopathol Syst Nerveux & Nocicept & Pain Dept, Inst Neurosci Cellulaires & Integrat, CNRS,INSERM,U575, Strasbourg, France.	Ingeborg.D.Welters@chiru.med.uni-giessen.de	LAVENTIE, Benoît-Joseph/H-5260-2011; Dominique, Aunis/W-1419-2019	LAVENTIE, Benoît-Joseph/0000-0003-0205-0944; Delalande, Francois/0000-0003-3590-9874; , Elise/0000-0002-4501-9675; Laux-Biehlmann, Alexis/0000-0003-0508-3047; Goumon, Yannick/0000-0003-4336-3437; Welters, Ingeborg/0000-0002-3408-8798	Inserm; Universite de Strasbourg; Fondation de France; French Ministere de la Recherche et de l'Enseignement Superieur; Fondation Transplantation; Fondation pour la Recherche Medicale	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg; Fondation de France(Fondation de France); French Ministere de la Recherche et de l'Enseignement Superieur; Fondation Transplantation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This study was funded by Inserm, the Universite de Strasbourg, the Fondation de France (to Y.G.), the French Ministere de la Recherche et de l'Enseignement Superieur (Ph.D. fellowships to E.G., A.M. and A.L.), the Fondation Transplantation (to Y.G., D.Z., and D.A.) and the Fondation pour la Recherche Medicale (to Y.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge AJ, 2002, EUR J SURG, V168, P204, DOI 10.1080/11024150260102807; Atmanene C, 2009, MED SCI MONITOR, V15, pBR178; Beck M, 2002, PAIN, V98, P187, DOI 10.1016/S0304-3959(02)00044-1; Boettcher C, 2006, J IMMUNOL, V176, P5703, DOI 10.4049/jimmunol.176.10.5703; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Brix-Christensen V, 2000, ACTA ANAESTH SCAND, V44, P1204, DOI 10.1034/j.1399-6576.2000.441004.x; Brix-Christensen V, 1997, INT J CARDIOL, V62, P191, DOI 10.1016/S0167-5273(97)00229-5; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; BRYANT HU, 1991, ENDOCRINOLOGY, V128, P3253, DOI 10.1210/endo-128-6-3253; BUSSIERE JL, 1993, J PHARMACOL EXP THER, V264, P591; Cadet P, 2003, J IMMUNOL, V170, P5118, DOI 10.4049/jimmunol.170.10.5118; Cadet P, 2004, MED SCI MONITOR, V10, pBR351; Cadet P, 2004, MED SCI MONITOR, V10, pMS28; Cadet P, 2000, ENDOTHELIUM-J ENDOTH, V7, P185, DOI 10.3109/10623320009165316; Cadet P, 2007, J IMMUNOL, V179, P5839, DOI 10.4049/jimmunol.179.9.5839; CASSATELLA MA, 1992, J IMMUNOL, V148, P3216; Chang SLL, 2001, ADV EXP MED BIOL, V493, P187; Choi HS, 2006, BIOCHEM BIOPH RES CO, V343, P1132, DOI 10.1016/j.bbrc.2006.03.084; Doyle GA, 2007, GENE, V395, P98, DOI 10.1016/j.gene.2007.02.004; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fecho K, 2002, INFLAMMATION, V26, P259, DOI 10.1023/A:1021408500630; FECHO K, 1995, J PHARMACOL EXP THER, V272, P477; FINCKBARBANCON V, 1993, BIOCHIM BIOPHYS ACTA, V1182, P275, DOI 10.1016/0925-4439(93)90069-D; FLORES LR, 1995, J PHARMACOL EXP THER, V272, P1246; Gaveriaux-Ruff C, 1998, P NATL ACAD SCI USA, V95, P6326, DOI 10.1073/pnas.95.11.6326; Gein S V, 2009, Neurosci Behav Physiol, V39, P591, DOI 10.1007/s11055-009-9166-y; GINTZLER AR, 1978, SCIENCE, V199, P447, DOI 10.1126/science.339350; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Gomez-Flores R, 1999, J INTERF CYTOK RES, V19, P625, DOI 10.1089/107999099313767; Goumon Y, 2000, NEUROSCI LETT, V293, P135, DOI 10.1016/S0304-3940(00)01507-X; Goumon Y, 2000, MOL BRAIN RES, V77, P267, DOI 10.1016/S0169-328X(00)00056-5; Goumon Y, 2006, J BIOL CHEM, V281, P8082, DOI 10.1074/jbc.M502298200; Goumon Y, 2004, J BIOL CHEM, V279, P13054, DOI 10.1074/jbc.M308533200; Goumon Y, 2000, MOL BRAIN RES, V81, P177, DOI 10.1016/S0169-328X(00)00141-8; Goumon Y, 2009, AN REAL ACAD NAC F, V75, P389; Hedou G, 2000, J COMP NEUROL, V426, P549, DOI 10.1002/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y; Herzum I, 2008, CURR MED CHEM, V15, P581, DOI 10.2174/092986708783769704; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; KOIVURANTAVAARA P, 1987, INFECT IMMUN, V55, P2956, DOI 10.1128/IAI.55.12.2956-2961.1987; Lauriat S, 1998, SEMIN NEPHROL, V18, P498; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2004, EUR J BIOCHEM, V271, P303, DOI 10.1046/j.1432-1033.2003.03929.x; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; LOPKER A, 1980, BIOCHEM PHARMACOL, V29, P1361, DOI 10.1016/0006-2952(80)90431-1; Lotsch J, 2001, CLIN PHARMACOKINET, V40, P485; LOVSTAD RZ, 1996, CLIN INTENSIVE CARE, V7, P282; Magazine HI, 2000, J IMMUNOL, V165, P102, DOI 10.4049/jimmunol.165.1.102; Magazine HI, 1996, J IMMUNOL, V156, P4845; MAKMAN MH, 1995, J IMMUNOL, V154, P1323; Makman MH, 1998, ADV EXP MED BIOL, V437, P137; Matejec R, 2009, SHOCK, V31, P553, DOI 10.1097/SHK.0b013e318188dfb8; McCourt M, 2001, EUR J SURG ONCOL, V27, P396, DOI 10.1053/ejso.2001.1133; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; Molina PE, 2002, CLIN EXP PHARMACOL P, V29, P248, DOI 10.1046/j.1440-1681.2002.03638.x; MOLINA PE, 1995, BIOCHEM BIOPH RES CO, V207, P312, DOI 10.1006/bbrc.1995.1189; Muller A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001641; Neri C, 2008, J NEUROCHEM, V106, P2337, DOI 10.1111/j.1471-4159.2008.05572.x; Ocana MG, 2008, MOL IMMUNOL, V45, P2087, DOI 10.1016/j.molimm.2007.10.013; Olszyna DP, 2001, INFECT IMMUN, V69, P2736, DOI 10.1128/IAI.69.4.2736-2738.2001; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pan YX, 2005, MOL PHARMACOL, V68, P866, DOI 10.1124/mol.105.011858; Pasternak GW, 2007, J CLIN INVEST, V117, P3185, DOI 10.1172/JCI34035; Pellme S, 2006, J LEUKOCYTE BIOL, V79, P564, DOI 10.1189/jlb.0505248; PETERS WP, 1981, LANCET, V1, P529; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Rittner HL, 2007, BRAIN BEHAV IMMUN, V21, P1021, DOI 10.1016/j.bbi.2007.05.002; Roy S, 1999, J NEUROIMMUNOL, V95, P107, DOI 10.1016/S0165-5728(98)00265-3; Roy S, 1998, ADV EXP MED BIOL, V437, P21; ROZENFELD R, 2007, FASEB J; Sabroe I, 2004, BIOCHEM SOC T, V32, P468, DOI 10.1042/BST0320468; Stefano GB, 2000, TRENDS NEUROSCI, V23, P436, DOI 10.1016/S0166-2236(00)01611-8; Stefano GB, 2008, NEUROCHEM RES, V33, P1933, DOI 10.1007/s11064-008-9674-0; Stefano GB, 2007, INT J MOL MED, V20, P837; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; Suzuki S, 2000, BIOCHEM BIOPH RES CO, V279, P621, DOI 10.1006/bbrc.2000.4006; Tsiotou AG, 2005, MED SCI MONITOR, V11, pRA76; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; Vassou D, 2008, INT IMMUNOPHARMACOL, V8, P634, DOI 10.1016/j.intimp.2008.01.002; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Welters ID, 2007, EUR J ANAESTH, V24, P958, DOI 10.1017/S026502150700083X; Welters ID, 2000, ANESTHESIOLOGY, V92, P1677, DOI 10.1097/00000542-200006000-00027; Welters ID, 2003, CURR OPIN ANESTHESIO, V16, P509, DOI 10.1097/00001503-200310000-00011; Yokota T, 2000, CAN J ANAESTH, V47, P303, DOI 10.1007/BF03020942; Yoshida S, 2000, SURG ENDOSC-ULTRAS, V14, P137, DOI 10.1007/s004649900085; Zhu W, 2007, INT J IMMUNOPATH PH, V20, P229, DOI 10.1177/039463200702000203; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357; Zhu W, 2006, MED SCI MONITOR, V12, pBR350	91	54	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8791	10.1371/journal.pone.0008791	http://dx.doi.org/10.1371/journal.pone.0008791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098709	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000019
J	Fernandez-Marcos, PJ; Pantoja, C; Gonzalez-Rodriguez, A; Martin, N; Flores, JM; Valverde, AM; Hara, E; Serrano, M				Fernandez-Marcos, Pablo J.; Pantoja, Cristina; Gonzalez-Rodriguez, Agueda; Martin, Nicholas; Flores, Juana M.; Valverde, Angela M.; Hara, Eiji; Serrano, Manuel			Normal Proliferation and Tumorigenesis but Impaired Pancreatic Function in Mice Lacking the Cell Cycle Regulator Sei1	PLOS ONE			English	Article							MURINE FIBROBLASTS LACKING; CDK INHIBITORS; BETA-CELL; TRIP-BR; P27(KIP1); ACTIVATION; P34(SEI-1); FAMILY; GROWTH; CANCER	Sei1 is a positive regulator of proliferation that promotes the assembly of Cdk4-cyclin D complexes and enhances the transcriptional activity of E2f1. The potential oncogenic role of Sei1 is further suggested by its overexpression in various types of human cancers. To study the role of Sei1, we have generated a mouse line deficient for this gene. Sei1-null fibroblasts did not show abnormalities regarding proliferation or susceptibility to neoplastic transformation, nor did we observe defects on Cdk4 complexes or E2f activity. Sei1-null mice were viable, did not present overt pathologies, had a normal lifespan, and had a normal susceptibility to spontaneous and chemically-induced cancer. Pancreatic insulin-producing cells are known to be particularly sensitive to Cdk4-cyclin D and E2f activities, and we have observed that Sei1 is highly expressed in pancreatic islets compared to other tissues. Interestingly, Sei1-null mice present lower number of islets, decreased beta-cell area, impaired insulin secretion, and glucose intolerance. These defects were associated to nuclear accumulation of the cell-cycle inhibitors p21(Cip1) and p27(Kip1) in islet cells. We conclude that Sei1 plays an important role in pancreatic beta-cells, which supports a functional link between Sei1 and the core cell cycle regulators specifically in the context of the pancreas.	[Fernandez-Marcos, Pablo J.; Pantoja, Cristina; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] UAM, CSIC, Inst Biomed Alberto Sols, Madrid, Spain; [Gonzalez-Rodriguez, Agueda; Valverde, Angela M.] ISCIII, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Martin, Nicholas; Hara, Eiji] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; [Flores, Juana M.] Univ Complutense Madrid, Dept Anim Surg & Med, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Japanese Foundation for Cancer Research; Complutense University of Madrid	Fernandez-Marcos, PJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, Madrid, Spain.	mserrano@cnio.es	González-Rodróguez, Águeda/D-7651-2012; Serrano, Manuel/H-2634-2015; Fernandez, Pablo J/F-1840-2016	González-Rodróguez, Águeda/0000-0001-6559-0847; Serrano, Manuel/0000-0001-7177-9312; Fernandez, Pablo J/0000-0003-3515-4125; Gonzalez-Rodriguez, Agueda/0000-0003-2851-2318; Pantoja, Cristina/0000-0003-0180-5823	Centro Nacional de Investigaciones Oncologicas (CNIO); Spanish Ministry of Science; Regional Government of Madrid; European Union; European Research Council (ERC); "Marcelino Botin" Foundation [BFU2008- 02420]; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Centro Nacional de Investigaciones Oncologicas (CNIO); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); "Marcelino Botin" Foundation; Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM)	Work in the laboratory of M. S. is funded by the Centro Nacional de Investigaciones Oncologicas (CNIO) and by grants from the Spanish Ministry of Science (SAF and CONSOLIDER), the Regional Government of Madrid (GsSTEM), the European Union (PROTEOMAGE), the European Research Council (ERC), and the "Marcelino Botin'' Foundation. Work in the laboratory of A. M. V. was funded by the Ministry of Science (BFU2008- 02420) and by the Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Hong SW, 2009, CANCER RES, V69, P741, DOI 10.1158/0008-5472.CAN-08-1189; Hsu SIH, 2001, EMBO J, V20, P2273, DOI 10.1093/emboj/20.9.2273; Jones N C, 1990, Semin Cancer Biol, V1, P425; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lai IL, 2007, GENE, V388, P102, DOI 10.1016/j.gene.2006.10.008; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; Li JN, 2005, BIOCHEMISTRY-US, V44, P13246, DOI 10.1021/bi0504658; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; NEUMAN E, 1994, MOL CELL BIOL, V14, P6607, DOI 10.1128/MCB.14.10.6607; Olashaw N, 2004, CELL CYCLE, V3, P263; Pantoja C, 1999, ONCOGENE, V18, P4974, DOI 10.1038/sj.onc.1202880; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rachdi L, 2006, DIABETES, V55, P3520, DOI 10.2337/db06-0861; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Sugimoto M, 1999, GENE DEV, V13, P3027, DOI 10.1101/gad.13.22.3027; Sugimoto M, 2002, ONCOGENE, V21, P8067, DOI 10.1038/sj.onc.1206019; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Suzuki M, 1997, DIABETES, V46, P1440, DOI 10.2337/diabetes.46.9.1440; Tang DJ, 2005, CANCER RES, V65, P6504, DOI 10.1158/0008-5472.CAN-05-0351; Tang TCM, 2002, CANCER RES, V62, P7157; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; van Dekken H, 2001, AM J PATHOL, V158, P1961, DOI 10.1016/S0002-9440(10)64666-4; Zhong LW, 2007, J CLIN INVEST, V117, P2869, DOI 10.1172/JCI32198	32	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8744	10.1371/journal.pone.0008744	http://dx.doi.org/10.1371/journal.pone.0008744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090907	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000005
J	Lebesgue, D; Traub, M; De Butte-Smith, M; Chen, C; Zukin, RS; Kelly, MJ; Etgen, AM				Lebesgue, Diane; Traub, Michael; De Butte-Smith, Maxine; Chen, Christopher; Zukin, R. Suzanne; Kelly, Martin J.; Etgen, Anne M.			Acute Administration of Non-Classical Estrogen Receptor Agonists Attenuates Ischemia-Induced Hippocampal Neuron Loss in Middle-Aged Female Rats	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; GLOBAL-ISCHEMIA; G-PROTEIN; POSTMENOPAUSAL WOMEN; EXPERIMENTAL STROKE; MEMBRANE-RECEPTOR; BREAST-CANCER; CA1 NEURONS; CELL-DEATH; ESTRADIOL	Background: Pretreatment with 17 beta-estradiol (E2) is profoundly neuroprotective in young animals subjected to focal and global ischemia. However, whether E2 retains its neuroprotective efficacy in aging animals, especially when administered after brain insult, is largely unknown. Methodology/Principal Findings: We examined the neuroprotective effects of E2 and two agonists that bind to non-classical estrogen receptors, G1 and STX, when administered after ischemia in middle-aged rats after prolonged ovarian hormone withdrawal. Eight weeks after ovariectomy, middle-aged female rats underwent 10 minutes of global ischemia by four vessel occlusion. Immediately after reperfusion, animals received a single infusion of either E2 (2.25 mu g), G1 (50 mu g) or STX (50 mu g) into the lateral ventricle (ICV) or a single systemic injection of E2 (100 mu g/kg). Surviving pyramidal neurons in the hippocampal CA1 were quantified 1 week later. E2 and both agonists that target non-classical estrogen receptors (G1 and STX) administered ICV at the time of reperfusion provided significant levels of neuroprotection, with 55-60% of CA1 neurons surviving vs 15% survival in controls. A single systemic injection of a pharmacological dose of E2 also rescued approximately 50% of CA1 pyramidal neurons destined to die. To determine if E2 and G1 have similar mechanisms of action in hippocampal neurons, we compared the ability of E2 and G1 to modify CA1 pyramidal neuron responses to excitatory inputs from the Schaffer collaterals recorded in hippocampal slices derived from female rats not subjected to global ischemia. E2 and G1 (10 nM) significantly potentiated pyramidal neuron responses to excitatory inputs when applied to hippocampal slices. Conclusions/Significance: These findings suggest (1) that middle-aged female rats retain their responsiveness to E2 even after a long period of hormone withdrawal, (2) that non-classical estrogen receptors may mediate the neuroprotective actions of E2 when given after ischemia, and (3) that the neuroprotective efficacy of estrogens may be related to their modulation of synaptic activity in hippocampal slices.	[Lebesgue, Diane; De Butte-Smith, Maxine; Chen, Christopher; Zukin, R. Suzanne; Etgen, Anne M.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA; [Traub, Michael] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Kelly, Martin J.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Oregon Health & Science University	Lebesgue, D (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	anne.etgen@einstein.yu.edu			NIH [R37 MH41414, RO1 AG027702]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH041414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027702] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants R37 MH41414 and RO1 AG027702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAI F, 1993, BRAIN RES, V603, P87, DOI 10.1016/0006-8993(93)91302-9; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Alkayed NJ, 2000, STROKE, V31, P161, DOI 10.1161/01.STR.31.1.161; Barrera-Ocampo AA, 2008, REV NEUROLOGIA, V46, P32, DOI 10.33588/rn.4601.2007094; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Brown CM, 2009, SEMIN REPROD MED, V27, P240, DOI 10.1055/s-0029-1216277; Chen M, 2008, STROKE, V39, P3042, DOI 10.1161/STROKEAHA.108.521898; De Butte-Smith M, 2009, HORM BEHAV, V55, P442, DOI 10.1016/j.yhbeh.2008.11.011; DONCARLOS LL, 2009, PSYCHONEURO IN PRESS; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Farr TD, 2008, J NEUROENDOCRINOL, V20, P366, DOI 10.1111/j.1365-2826.2008.01648.x; Fugger HN, 2001, NEUROSCI LETT, V309, P207, DOI 10.1016/S0304-3940(01)02083-3; Gulinello M, 2006, HORM BEHAV, V49, P246, DOI 10.1016/j.yhbeh.2005.07.010; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Jordan VC, 2007, STEROIDS, V72, P7, DOI 10.1016/j.steroids.2006.10.009; Jover T, 2002, J NEUROSCI, V22, P2115, DOI 10.1523/JNEUROSCI.22-06-02115.2002; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kim MT, 2006, NEUROSCIENCE, V141, P391, DOI 10.1016/j.neuroscience.2006.03.075; Lebesgue D, 2009, STEROIDS, V74, P555, DOI 10.1016/j.steroids.2009.01.003; Liang HW, 2008, NEUROSCI LETT, V438, P116, DOI 10.1016/j.neulet.2008.04.058; Lin ZC, 2009, J CHIN SOC MECH ENG, V30, P1; Liu R, 2007, NEUROSCI LETT, V415, P237, DOI 10.1016/j.neulet.2007.01.074; Lobo RA, 2007, CLIMACTERIC, V10, P27, DOI 10.1080/13697130701550903; McCullough LD, 2001, STROKE, V32, P796, DOI 10.1161/01.STR.32.3.796; Otto C, 2009, BIOL REPROD, V80, P34, DOI 10.1095/biolreprod.108.071175; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Plahta WC, 2004, NEUROSCIENCE, V129, P187, DOI 10.1016/j.neuroscience.2004.07.037; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; Qiu J, 2003, J NEUROSCI, V23, P9529; Qiu J, 2008, STEROIDS, V73, P985, DOI 10.1016/j.steroids.2007.11.008; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Saleh TM, 2001, AM J PHYSIOL-REG I, V281, pR1531, DOI 10.1152/ajpregu.2001.281.5.R1531; SELVAMANI A, 2008, NEUROBIOL A IN PRESS; Simpkins JW, 2005, ANN NY ACAD SCI, V1052, P233, DOI 10.1196/annals.1347.019; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Strom JO, 2009, J CEREBR BLOOD F MET, V29, P1359, DOI 10.1038/jcbfm.2009.66; Suzuki S, 2007, P NATL ACAD SCI USA, V104, P6013, DOI 10.1073/pnas.0610394104; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tobias SC, 2006, CHEMMEDCHEM, V1, P565, DOI 10.1002/cmdc.200500098; Toung TJ, 2004, J CEREBR BLOOD F MET, V24, P1160, DOI 10.1097/01.WCB.0000135594.13576.D2; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Traub ML, 2009, J NEUROENDOCRINOL, V21, P1038, DOI 10.1111/j.1365-2826.2009.01927.x; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WONG M, 1992, J NEUROSCI, V12, P3217, DOI 10.1523/JNEUROSCI.12-08-03217.1992; Wren BG, 2009, MED J AUSTRALIA, V190, P321, DOI 10.5694/j.1326-5377.2009.tb02423.x; Yang SH, 2000, STROKE, V31, P745, DOI 10.1161/01.STR.31.3.745; Zhang HQ, 2009, BRAIN RES, V1247, P196, DOI 10.1016/j.brainres.2008.10.015; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhang YH, 2007, EXP NEUROL, V204, P819, DOI 10.1016/j.expneurol.2007.01.015	53	116	120	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8642	10.1371/journal.pone.0008642	http://dx.doi.org/10.1371/journal.pone.0008642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062809	Green Submitted, gold, Green Published			2022-12-27	WOS:000273414200019
J	Price, LB; Liu, CM; Johnson, KE; Aziz, M; Lau, MK; Bowers, J; Ravel, J; Keim, PS; Serwadda, D; Wawer, MJ; Gray, RH				Price, Lance B.; Liu, Cindy M.; Johnson, Kristine E.; Aziz, Maliha; Lau, Matthew K.; Bowers, Jolene; Ravel, Jacques; Keim, Paul S.; Serwadda, David; Wawer, Maria J.; Gray, Ronald H.			The Effects of Circumcision on the Penis Microbiome	PLOS ONE			English	Article							HIV-1 TARGET-CELLS; LANGERHANS-CELLS; PSEUDOMONAS-AERUGINOSA; INFECTION; TRANSMISSION; BACTERIA; MEN; SUSCEPTIBILITY; COMMUNITIES; PREVENTION	Background: Circumcision is associated with significant reductions in HIV, HSV-2 and HPV infections among men and significant reductions in bacterial vaginosis among their female partners. Methodology/Principal Findings: We assessed the penile (coronal sulci) microbiota in 12 HIV-negative Ugandan men before and after circumcision. Microbiota were characterized using sequence-tagged 16S rRNA gene pyrosequencing targeting the V3-V4 hypervariable regions. Taxonomic classification was performed using the RDP Naive Bayesian Classifier. Among the 42 unique bacterial families identified, Pseudomonadaceae and Oxalobactericeae were the most abundant irrespective of circumcision status. Circumcision was associated with a significant change in the overall microbiota (PerMANOVA p = 0.007) and with a significant decrease in putative anaerobic bacterial families (Wilcoxon Signed-Rank test p = 0.014). Specifically, two families-Clostridiales Family XI (p = 0.006) and Prevotellaceae (p = 0.006)-were uniquely abundant before circumcision. Within these families we identified a number of anaerobic genera previously associated with bacterial vaginosis including: Anaerococcus spp., Finegoldia spp., Peptoniphilus spp., and Prevotella spp. Conclusions/Significance: The anoxic microenvironment of the subpreputial space may support pro-inflammatory anaerobes that can activate Langerhans cells to present HIV to CD4 cells in draining lymph nodes. Thus, the reduction in putative anaerobic bacteria after circumcision may play a role in protection from HIV and other sexually transmitted diseases.	[Price, Lance B.; Liu, Cindy M.; Aziz, Maliha; Bowers, Jolene; Keim, Paul S.] Translat Genom Res Inst TGen, Flagstaff, AZ USA; [Liu, Cindy M.; Lau, Matthew K.; Keim, Paul S.] No Arizona Univ, Flagstaff, AZ 86011 USA; [Johnson, Kristine E.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Ravel, Jacques] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Serwadda, David] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Wawer, Maria J.; Gray, Ronald H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Translational Genomics Research Institute; Northern Arizona University; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; Makerere University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Price, LB (corresponding author), Translat Genom Res Inst TGen, Flagstaff, AZ USA.	lprice@tgen.org	Rohlf, F J/A-8710-2008; Ravel, Jacques/D-2530-2009; Liu, Cindy/ABF-7427-2020; Keim, Paul S/A-2269-2010	Ravel, Jacques/0000-0002-0851-2233	National Institutes of Allergy and Infectious Disease (NIAID) [UO1AI11171-01-02]; Division of AIDS; Translational Genomics Research Institute (TGen)	National Institutes of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Translational Genomics Research Institute (TGen)	This project was funded with a grant (UO1AI11171-01-02) from the National Institutes of Allergy and Infectious Disease (NIAID), Division of AIDS, National Institutes of Health and with funding from the Translational Genomics Research Institute (TGen). TGen is a 501(C)(3) non-profit research institute. TGen funds were provided as part of Dr. Price's institutional start-up package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2007, REPROD HEALTH MATTER, V15, P11; [Anonymous], 2007, LABDSV ORDINATION MU; Aroutcheva A, 2008, ANAEROBE, V14, P256, DOI 10.1016/j.anaerobe.2008.08.002; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Blanc DS, 2004, INTENS CARE MED, V30, P1964, DOI 10.1007/s00134-004-2389-z; Bostanci N, 2007, ORAL MICROBIOL IMMUN, V22, P52; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Chow E. D., 2007, ELLIPSE FUNCTIONS DR; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Crivaro V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-70; de Jong MAWP, 2009, J INTERN MED, V265, P18, DOI 10.1111/j.1365-2796.2008.02046.x; de Jong MAWP, 2008, J CLIN INVEST, V118, P3440, DOI 10.1172/JCI34721; de Witte L, 2008, TRENDS MOL MED, V14, P12, DOI 10.1016/j.molmed.2007.11.001; de Witte L, 2007, NAT MED, V13, P367, DOI 10.1038/nm1541; Donoval BA, 2006, AM J CLIN PATHOL, V125, P386, DOI 10.1309/JVHQVDJDYKM58EPH; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; FAITH DP, 1987, VEGETATIO, V69, P57, DOI 10.1007/BF00038687; Franco-Vidal V, 2007, OTOL NEUROTOL, V28, P771, DOI 10.1097/MAO.0b013e31805153bd; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Goslee SC, 2005, J TORREY BOT SOC, V132, P471, DOI 10.3159/1095-5674(2005)132[471:IOEHAV]2.0.CO;2; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Guggenheim M, 2009, BURNS, V35, P553, DOI 10.1016/j.burns.2008.09.004; Hazlett Linda D, 2007, Chem Immunol Allergy, V92, P185, DOI 10.1159/000099269; HOLMES C, 2009, AM J INFECT CONTROL; Kawamura T, 2005, J DERMATOL SCI, V40, P147, DOI 10.1016/j.jdermsci.2005.08.009; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Kim SJ, 2007, FEMS IMMUNOL MED MIC, V51, P407, DOI 10.1111/j.1574-695X.2007.00318.x; Kindt R., 2005, WORLD; LAU MK, 2009, DIVERSITYSAMPLER FUN; Mahiane SG, 2009, AIDS, V23, P377, DOI 10.1097/QAD.0b013e32831c5497; MAULDIN PD, 2009, ANTIMICROB AGENTS CH; McCoombe SG, 2006, AIDS, V20, P1491, DOI 10.1097/01.aids.0000237364.11123.98; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; MESTECKY J, 2009, J REPROD IMMUNOL; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Ogawa Y, 2009, BLOOD, V113, P5157, DOI 10.1182/blood-2008-10-185728; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Paiardini M, 2008, AIDS REV, V10, P36; Patterson BK, 2002, AM J PATHOL, V161, P867, DOI 10.1016/S0002-9440(10)64247-2; Peiser M, 2008, J LEUKOCYTE BIOL, V83, P1118, DOI 10.1189/jlb.0807567; PEIX A, 2009, INFECT GENET EVOL; Price LB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006462; R Core Team, 2020, R LANG ENV STAT COMP; Sanchez-Carrillo C, 2009, AM J INFECT CONTROL, V37, P150, DOI 10.1016/j.ajic.2008.04.259; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Song YL, 2007, J CLIN MICROBIOL, V45, P1746, DOI 10.1128/JCM.00213-07; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Trautmann M, 2008, AM J INFECT CONTROL, V36, P421, DOI 10.1016/j.ajic.2007.09.012; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	66	160	168	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8422	10.1371/journal.pone.0008422	http://dx.doi.org/10.1371/journal.pone.0008422			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066050	Green Published, Green Submitted, gold			2022-12-27	WOS:000273338600003
J	Guillemin, Y; Lopez, J; Gimenez, D; Fuertes, G; Valero, JG; Blum, L; Gonzalo, P; Salgado, J; Girard-Egrot, A; Aouacheria, A				Guillemin, Yannis; Lopez, Jonathan; Gimenez, Diana; Fuertes, Gustavo; Valero, Juan Garcia; Blum, Loic; Gonzalo, Philippe; Salgado, Jesus; Girard-Egrot, Agnes; Aouacheria, Abdel			Active Fragments from Pro- and Antiapoptotic BCL-2 Proteins Have Distinct Membrane Behavior Reflecting Their Functional Divergence	PLOS ONE			English	Article							BREWSTER-ANGLE MICROSCOPY; CYTOCHROME-C RELEASE; BAX-DERIVED PEPTIDE; MITOCHONDRIAL-MEMBRANE; LIPID-MEMBRANES; LANGMUIR-MONOLAYER; PORE FORMATION; X-L; ANTIMICROBIAL PEPTIDES; INDEPENDENT MECHANISMS	Background: The BCL-2 family of proteins includes pro-and antiapoptotic members acting by controlling the permeabilization of mitochondria. Although the association of these proteins with the outer mitochondrial membrane is crucial for their function, little is known about the characteristics of this interaction. Methodology/Principal Findings: Here, we followed a reductionist approach to clarify to what extent membrane-active regions of homologous BCL-2 family proteins contribute to their functional divergence. Using isolated mitochondria as well as model lipid Langmuir monolayers coupled with Brewster Angle Microscopy, we explored systematically and comparatively the membrane activity and membrane-peptide interactions of fragments derived from the central helical hairpin of BAX, BCL-xL and BID. The results show a connection between the differing abilities of the assayed peptide fragments to contact, insert, destabilize and porate membranes and the activity of their cognate proteins in programmed cell death. Conclusion/Significance: BCL-2 family-derived pore-forming helices thus represent structurally analogous, but functionally dissimilar membrane domains.	[Guillemin, Yannis; Lopez, Jonathan; Valero, Juan Garcia; Gonzalo, Philippe; Aouacheria, Abdel] Univ Lyon, IBCP, CNRS, UMR5086, Lyon, France; [Gimenez, Diana; Fuertes, Gustavo; Salgado, Jesus] Univ Valencia, ICMol, Valencia, Spain; [Blum, Loic; Girard-Egrot, Agnes] Univ Lyon, CNRS, ICBMS, UMR5246, Villeurbanne, France; [Salgado, Jesus] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); University of Valencia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; University of Valencia	Guillemin, Y (corresponding author), Univ Lyon, IBCP, CNRS, UMR5086, Lyon, France.	a.aouacheria@ibcp.fr	Salgado, Jesús/A-7759-2013; GONZALO, Philippe/P-1313-2019; GIRARD-EGROT, Agnès/AAP-5586-2020; Vives, Gustavo Fuertes/S-8618-2016	Salgado, Jesús/0000-0002-8537-1550; GONZALO, Philippe/0000-0002-9763-0150; GIRARD-EGROT, Agnès/0000-0003-2612-3124; Vives, Gustavo Fuertes/0000-0002-8564-8644; LOPEZ, Jonathan/0000-0003-3768-2378; Valero, Juan Garcia/0000-0003-3193-9099; Gimenez, Diana/0000-0003-2842-6989	La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Fondation d'Entreprise SILAB -Jean PAUFIQUE; Spanish MEC [BFU2007-67097]; EGIDE PHC PICASSO [17092SM]; MEC [HF2007-0090]; MRT; La Region Rhone-Alpes	La Ligue Contre le Cancer (Comites de la Drome et du Rhone); Fondation d'Entreprise SILAB -Jean PAUFIQUE; Spanish MEC(Spanish Government); EGIDE PHC PICASSO; MEC(European Commission); MRT; La Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by grants from La Ligue Contre le Cancer (Comites de la Drome et du Rhone), La Fondation d'Entreprise SILAB -Jean PAUFIQUE, the Spanish MEC (BFU2007-67097) and a collaborative French/Spanish project (EGIDE PHC PICASSO 17092SM; MEC, HF2007-0090). YG is a recipient of an MRT (Ministere de la Recherche des Sciences et Techniques) fellowship. JL is supported by Hospices Civils de Lyon. JGV is recipient of doctoral fellowship from La Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Aisenbrey C, 2007, EUR BIOPHYS J BIOPHY, V37, P71, DOI 10.1007/s00249-007-0165-z; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Capano M, 2002, BIOCHEM J, V367, P169, DOI 10.1042/BJ20020805; Cartron PF, 2003, J BIOL CHEM, V278, P11633, DOI 10.1074/jbc.M208955200; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Day CL, 2005, J BIOL CHEM, V280, P4738, DOI 10.1074/jbc.M411434200; de Mul MNG, 1998, LANGMUIR, V14, P2455, DOI 10.1021/la9713154; Denisov AY, 2003, J BIOL CHEM, V278, P21124, DOI 10.1074/jbc.M301798200; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Epand RF, 2002, BIOCHEM BIOPH RES CO, V298, P744, DOI 10.1016/S0006-291X(02)02544-5; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Franzin CM, 2004, MAGN RESON CHEM, V42, P172, DOI 10.1002/mrc.1322; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Garcia-Saez AJ, 2006, FEBS J, V273, P971, DOI 10.1111/j.1742-4658.2006.05123.x; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; GIORGI FD, 2002, FASEB J, V16, P607; Glomm WR, 2009, ANAL CHEM, V81, P3042, DOI 10.1021/ac8027257; Gong XM, 2004, J BIOL CHEM, V279, P28954, DOI 10.1074/jbc.M403490200; Grinberg M, 2002, J BIOL CHEM, V277, P12237, DOI 10.1074/jbc.M104893200; Hausmann G, 2000, J CELL BIOL, V149, P623, DOI 10.1083/jcb.149.3.623; Heimlich G, 2004, BIOCHEM J, V378, P247, DOI 10.1042/BJ20031152; HENDRICKSON HS, 1983, ARCH BIOCHEM BIOPHYS, V227, P242, DOI 10.1016/0003-9861(83)90367-3; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hinds MG, 2003, EMBO J, V22, P1497, DOI 10.1093/emboj/cdg144; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Ishitsuka Y, 2006, BBA-BIOMEMBRANES, V1758, P1450, DOI 10.1016/j.bbamem.2006.08.001; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; KERTESZ Z, 1995, BIOCHEM J, V310, P315, DOI 10.1042/bj3100315; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Kiss E, 2008, J COLLOID INTERF SCI, V325, P337, DOI 10.1016/j.jcis.2008.05.057; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Liang Y, 2002, MOL PHARMACOL, V61, P142, DOI 10.1124/mol.61.1.142; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MAGGIO B, 1994, BBA-BIOMEMBRANES, V1190, P137, DOI 10.1016/0005-2736(94)90043-4; Malhotra R, 1996, BIOCHEM J, V314, P297, DOI 10.1042/bj3140297; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Matsuyama S, 1998, J BIOL CHEM, V273, P30995, DOI 10.1074/jbc.273.47.30995; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Minn AJ, 1999, EMBO J, V18, P632, DOI 10.1093/emboj/18.3.632; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Nouraini S, 2000, MOL CELL BIOL, V20, P1604, DOI 10.1128/MCB.20.5.1604-1615.2000; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Roucou X, 2002, BIOCHEM J, V363, P547, DOI 10.1042/0264-6021:3630547; Schendel SL, 1997, P NATL ACAD SCI USA, V94, P5113, DOI 10.1073/pnas.94.10.5113; Schendel SL, 1998, CELL DEATH DIFFER, V5, P372, DOI 10.1038/sj.cdd.4400365; Schendel SL, 1999, J BIOL CHEM, V274, P21932, DOI 10.1074/jbc.274.31.21932; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Thuduppathy GR, 2006, J MOL BIOL, V359, P1045, DOI 10.1016/j.jmb.2006.03.052; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Van Mau N, 2005, J MEMBRANE BIOL, V207, P1, DOI 10.1007/s00232-005-0799-7; Vernoux N, 2007, J COLLOID INTERF SCI, V310, P436, DOI 10.1016/j.jcis.2007.01.093; Volinsky R, 2006, BBA-BIOMEMBRANES, V1758, P1393, DOI 10.1016/j.bbamem.2006.03.002; Vollhardt D, 1996, ADV COLLOID INTERFAC, V64, P143, DOI 10.1016/0001-8686(95)00285-5; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wieckowski MR, 2001, FEBS LETT, V505, P453, DOI 10.1016/S0014-5793(01)02858-7; Winsel K, 2003, EUR BIOPHYS J BIOPHY, V32, P544, DOI 10.1007/s00249-003-0290-2; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zemel A, 2004, BIOPHYS J, V86, P3607, DOI 10.1529/biophysj.103.033605; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200; Zong WX, 1999, GENE DEV, V13, P382, DOI 10.1101/gad.13.4.382	91	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9066	10.1371/journal.pone.0009066	http://dx.doi.org/10.1371/journal.pone.0009066			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140092	Green Submitted, gold, Green Published			2022-12-27	WOS:000274442400006
J	Jourdain, E; Gunnarsson, G; Wahlgren, J; Latorre-Margalef, N; Brojer, C; Sahlin, S; Svensson, L; Waldenstrom, J; Lundkvist, A; Olsen, B				Jourdain, Elsa; Gunnarsson, Gunnar; Wahlgren, John; Latorre-Margalef, Neus; Brojer, Caroline; Sahlin, Sofie; Svensson, Lovisa; Waldenstrom, Jonas; Lundkvist, Ake; Olsen, Bjorn			Influenza Virus in a Natural Host, the Mallard: Experimental Infection Data	PLOS ONE			English	Article							A VIRUS; ANAS-PLATYRHYNCHOS; FEBRILE RESPONSE; IMMUNE-RESPONSE; NORTHERN EUROPE; WILD BIRDS; HEART-RATE; DUCKS; H5N1; REPLICATION	Wild waterfowl, particularly dabbling ducks such as mallards (Anas platyrhynchos), are considered the main reservoir of low-pathogenic avian influenza viruses (LPAIVs). They carry viruses that may evolve and become highly pathogenic for poultry or zoonotic. Understanding the ecology of LPAIVs in these natural hosts is therefore essential. We assessed the clinical response, viral shedding and antibody production of juvenile mallards after intra-esophageal inoculation of two LPAIV subtypes previously isolated from wild congeners. Six ducks, equipped with data loggers that continually monitored body temperature, heart rate and activity, were successively inoculated with an H7N7 LPAI isolate (day 0), the same H7N7 isolate again (day 21) and an H5N2 LPAI isolate (day 35). After the first H7N7 inoculation, the ducks remained alert with no modification of heart rate or activity. However, body temperature transiently increased in four individuals, suggesting that LPAIV strains may have minor clinical effects on their natural hosts. The excretion patterns observed after both reinoculations differed strongly from those observed after the primary H7N7 inoculation, suggesting that not only homosubtypic but also heterosubtypic immunity exist. Our study suggests that LPAI infection has minor clinically measurable effects on mallards and that mallard ducks are able to mount immunological responses protective against heterologous infections. Because the transmission dynamics of LPAIVs in wild populations is greatly influenced by individual susceptibility and herd immunity, these findings are of high importance. Our study also shows the relevance of using telemetry to monitor disease in animals.	[Jourdain, Elsa; Gunnarsson, Gunnar; Latorre-Margalef, Neus; Svensson, Lovisa; Waldenstrom, Jonas; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Jourdain, Elsa] INRA, UR 346, F-63122 St Genes Champanelle, France; [Gunnarsson, Gunnar] Kristianstad Univ, Aquat Biol & Chem Grp, Kristianstad, Sweden; [Wahlgren, John; Sahlin, Sofie] Karolinska Inst, Microbiol & Tumor Biol Ctr MTC, Stockholm, Sweden; [Wahlgren, John; Sahlin, Sofie; Lundkvist, Ake] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Brojer, Caroline] Natl Vet Inst, S-75007 Uppsala, Sweden; [Brojer, Caroline] Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden	Linnaeus University; INRAE; Kristianstad University; Karolinska Institutet; Swedish Institute for Infectious Disease Control; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Uppsala University	Jourdain, E (corresponding author), Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	elsa.jourdain@clermont.inra.fr	Gunnarsson, Gunnar/G-8458-2014; Waldenström, Jonas/E-4460-2013	Gunnarsson, Gunnar/0000-0003-2345-3953; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X	Swedish Research Council; La Fondation pour La Recherche Medicale (FRM) [SPE20070709608]; Formas [2008-614]; Crafoordska Stiftelsen; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); La Fondation pour La Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Formas(Swedish Research Council Formas); Crafoordska Stiftelsen; Magnus Bergvalls Stiftelse	This study was funded by the Swedish Research Council for Spatial Planning and Agriculture (Formas, http://www.formas.se/) and the Swedish Research Council (VR, http://www.vr.se/). EJ had a grant from La Fondation pour La Recherche Medicale (FRM SPE20070709608, http://www.frm.org/) and GG from Formas (2008-614), Crafoordska Stiftelsen (http://www.crafoord.se/) and Magnus Bergvalls Stiftelse (http://www.magnbergvallsstiftelse.nu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHL AK, 1977, J WILDLIFE DIS, V13, P420, DOI 10.7589/0090-3558-13.4.420; Brojer C, 2009, J VET DIAGN INVEST, V21, P579, DOI 10.1177/104063870902100501; Caron A, 2009, INFECT GENET EVOL, V9, P298, DOI 10.1016/j.meegid.2008.12.001; COOLEY AJ, 1989, VET PATHOL, V26, P1, DOI 10.1177/030098588902600101; DALECY LG, 1975, J PHYSIOL-LONDON, V253, P223, DOI 10.1113/jphysiol.1975.sp011188; Davidson AJ, 2003, J BIOL RHYTHM, V18, P430, DOI 10.1177/0748730403256066; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Fallacara DM, 2001, AVIAN DIS, V45, P128, DOI 10.2307/1593019; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Foni E, 2005, MICROBIOLOGICA, V28, P31; Harms CA, 1997, CONDOR, V99, P231, DOI 10.2307/1370247; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; HOMME PJ, 1970, AVIAN DIS, V14, P285, DOI 10.2307/1588473; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Jansson DS, 2004, J MED MICROBIOL, V53, P293, DOI 10.1099/jmm.0.05488-0; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; KIDA H, 1980, INFECT IMMUN, V30, P547; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Laroucau K, 2009, VET MICROBIOL, V135, P82, DOI 10.1016/j.vetmic.2008.09.048; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; LAUDERT E, 1993, AVIAN DIS, V37, P845, DOI 10.2307/1592040; LAUDERT EA, 1993, J WILDLIFE DIS, V29, P523, DOI 10.7589/0090-3558-29.4.523; MA W, 2009, ZOONOSES PUBLIC HLTH, V3, P158; Machida N, 2001, J ZOO WILDLIFE MED, V32, P47, DOI 10.1638/1042-7260(2001)032[0047:EHRAHW]2.0.CO;2; Maloney SK, 1998, J COMP PHYSIOL B, V168, P177, DOI 10.1007/s003600050134; Munster VJ, 2009, J CLIN MICROBIOL, V47, P666, DOI 10.1128/JCM.01625-08; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PHILPOTT MS, 1989, J WILDLIFE DIS, V25, P507, DOI 10.7589/0090-3558-25.4.507; REED LJ, 1938, AM J HYG, V27; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Savory CJ, 1997, PHYSIOL BEHAV, V61, P963, DOI 10.1016/S0031-9384(97)00016-4; Seo SH, 2002, J VIROL, V76, P4886, DOI 10.1128/JVI.76.10.4886-4890.2002; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; SLEMONS RD, 1978, AVIAN DIS, V22, P367, DOI 10.2307/1589291; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; TOURE M, 1979, AVIAN DIS, V23, P335, DOI 10.2307/1589563; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; *VET LAB AG, 2008, PCR PROT DET AV INFL; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	46	109	112	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8935	10.1371/journal.pone.0008935	http://dx.doi.org/10.1371/journal.pone.0008935			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126617	gold, Green Submitted, Green Published			2022-12-27	WOS:000274138000013
J	Yang, ZS; Zhang, BA; Li, DP; Lv, M; Huang, CM; Shen, GX; Huang, B				Yang, Zhuoshun; Zhang, Biao; Li, Dapeng; Lv, Meng; Huang, Chunmei; Shen, Guan-Xin; Huang, Bo			Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model	PLOS ONE			English	Article							REGULATORY T-CELLS; HUMAN AIRWAY EPITHELIUM; IMMUNE-RESPONSES; BEARING HOST; CANCER; INFLAMMATION; INTERLEUKIN-17; MACROPHAGES; EXPRESSION; GROWTH	Tumor immunosuppression is commonly braided with chronic inflammation during tumor development. However, the relationship between immunosuppression and inflammation in tumor microenvironment is still unclear. We have demonstrated that mast cells are accumulated and exacerbate the inflammation and immunosuppression in tumor microenvironment via SCF/c-kit signaling pathway. Here, we further elucidate the underlying mechanism, which involves both myeloid-derived suppressor cells (MDSCs) and regulatory T (Treg) cells. Our data showed that mast cells mobilized the infiltration of MDSCs to tumor and induced the production of IL-17 by MDSCs; MDSCs-derived IL-17 indirectly attracted Treg cells, enhanced their suppressor function, and induced the IL-9 production by Treg cells; in turn, IL-9 strengthened the survival and protumor effect of mast cells in tumor microenvironment. Our findings disclose a closed loop among mast cells, MDSCs and Treg cells in tumor microenvironment, which provides a new insight into the paralleled developments of inflammation and immunosuppression in tumor microenvironment. Based on these findings, we propose that targeting tumor inflammation might be a potential strategy to reverse the immunosuppression of tumor microenvironment, thus facilitating cancer immunotherapy.	[Yang, Zhuoshun; Zhang, Biao; Li, Dapeng; Lv, Meng; Huang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China; [Huang, Chunmei; Shen, Guan-Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, ZS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	tjhuangbo@hotmail.com	Lv, Meng/I-5203-2014	Lv, Meng/0000-0001-6625-9523	Program for New Century Excellent Talents in University [NCET-08-0219]; National Natural Science Foundation of China [30871020]; Special Research Foundation [Z2009005]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Foundation	This work was supported by the Program for New Century Excellent Talents in University (NCET-08-0219) to BH, National Natural Science Foundation of China (30871020) to BH, Special Research Foundation for Universities affiliated with Ministry of Education of China to BH (Z2009005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bronte V, 2003, TRENDS IMMUNOL, V24, P302, DOI 10.1016/S1471-4906(03)00132-7; Cao YC, 2008, J IMMUNOL, V180, P7681, DOI 10.4049/jimmunol.180.11.7681; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Fossiez F, 1998, Int Rev Immunol, V16, P541, DOI 10.3109/08830189809043008; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang B, 2008, BLOOD, V112, P1269, DOI 10.1182/blood-2008-03-147033; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Jarnicki AG, 2006, J IMMUNOL, V177, P896, DOI 10.4049/jimmunol.177.2.896; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Kusmartsev S, 2004, J IMMUNOL, V172, P989, DOI 10.4049/jimmunol.172.2.989; Kusmartsev SA, 2000, J IMMUNOL, V165, P779, DOI 10.4049/jimmunol.165.2.779; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Nam JS, 2008, CANCER RES, V68, P3915, DOI 10.1158/0008-5472.CAN-08-0206; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmielau J, 2001, CANCER RES, V61, P4756; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Song CW, 2008, J IMMUNOL, V181, P6117, DOI 10.4049/jimmunol.181.9.6117; Sylvester J, 2004, CELL SIGNAL, V16, P469, DOI 10.1016/j.cellsig.2003.09.008; Tartour E, 1999, CANCER RES, V59, P3698; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xiao MJ, 2009, CANCER RES, V69, P2010, DOI 10.1158/0008-5472.CAN-08-3479; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	50	113	128	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8922	10.1371/journal.pone.0008922	http://dx.doi.org/10.1371/journal.pone.0008922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111717	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800023
J	Xiao, ZJ; Lv, CJ; Gao, C; Qin, JY; Ma, CQ; Liu, Z; Liu, PH; Li, LX; Xu, P				Xiao, Zijun; Lv, Chuanjuan; Gao, Chao; Qin, Jiayang; Ma, Cuiqing; Liu, Zhen; Liu, Peihai; Li, Lixiang; Xu, Ping			A Novel Whole-Cell Biocatalyst with NAD(+) Regeneration for Production of Chiral Chemicals	PLOS ONE			English	Article							NADH OXIDASE; COFACTOR REGENERATION; LACTOBACILLUS-BREVIS; ESCHERICHIA-COLI; REDUCTASE/2,3-BUTANEDIOL DEHYDROGENASE; GENE; 2,3-BUTANEDIOL; ACETOIN; CATALYST; SCALE	Background: The high costs of pyridine nucleotide cofactors have limited the applications of NAD(P)-dependent oxidoreductases on an industrial scale. Although NAD(P) H regeneration systems have been widely studied, NAD(P)(+) regeneration, which is required in reactions where the oxidized form of the cofactor is used, has been less well explored, particularly in whole-cell biocatalytic processes. Methodology/Principal Findings: Simultaneous overexpression of an NAD(+) dependent enzyme and an NAD(+) regenerating enzyme (H2O producing NADH oxidase from Lactobacillus brevis) in a whole-cell biocatalyst was studied for application in the NAD(+)-dependent oxidation system. The whole-cell biocatalyst with (2R,3R)-2,3-butanediol dehydrogenase as the catalyzing enzyme was used to produce (3R)-acetoin, (3S)-acetoin and (2S,3S)-2,3-butanediol. Conclusions/Significance: A recombinant strain, in which an NAD(+) regeneration enzyme was coexpressed, displayed significantly higher biocatalytic efficiency in terms of the production of chiral acetoin and (2S,3S)-2,3-butanediol. The application of this coexpression system to the production of other chiral chemicals could be extended by using different NAD(P)-dependent dehydrogenases that require NAD(P)(+) for catalysis.	[Xiao, Zijun; Lv, Chuanjuan; Gao, Chao; Qin, Jiayang; Ma, Cuiqing; Liu, Zhen; Liu, Peihai; Li, Lixiang; Xu, Ping] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Xu, Ping] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Shandong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xiao, ZJ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	macq@sdu.edu.cn; pingxu@sjtu.edu.cn		Gao, Chao/0000-0002-5205-0670; Ma, Cuiqing/0000-0002-7468-1027	National Natural Science Foundation of China [30770064, 30821005]; Chinese National Programs for High Technology Research and Development [2006AA02Z244]; National Basic Research Program of China [2007CB707803]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Programs for High Technology Research and Development(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This study was partly supported by the National Natural Science Foundation of China (30770064 and 30821005), Chinese National Programs for High Technology Research and Development (2006AA02Z244) and National Basic Research Program of China (2007CB707803). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranat I, 2002, NAT REV DRUG DISCOV, V1, P753, DOI 10.1038/nrd915; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; Endo T, 2001, ADV SYNTH CATAL, V343, P521, DOI 10.1002/1615-4169(200108)343:6/7<521::AID-ADSC521>3.0.CO;2-5; Findrik Z, 2007, J BIOSCI BIOENG, V104, P275, DOI 10.1263/jbb.104.275; Galkin A, 1997, APPL ENVIRON MICROB, V63, P4651, DOI 10.1128/AEM.63.12.4651-4656.1997; GARG SK, 1995, BIORESOURCE TECHNOL, V51, P103, DOI 10.1016/0960-8524(94)00136-O; Geueke B, 2003, ENZYME MICROB TECH, V32, P205, DOI 10.1016/S0141-0229(02)00290-9; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; HOHNBENTZ H, 1978, ARCH MICROBIOL, V116, P197, DOI 10.1007/BF00406037; Hosaka T, 2001, J BIOSCI BIOENG, V91, P539, DOI 10.1263/jbb.91.539; Hummel W, 2003, BIOTECHNOL LETT, V25, P51, DOI 10.1023/A:1021730131633; Hummel W, 1999, TRENDS BIOTECHNOL, V17, P487, DOI 10.1016/S0167-7799(98)01207-4; Ishige T, 2005, CURR OPIN CHEM BIOL, V9, P174, DOI 10.1016/j.cbpa.2005.02.001; KIM MJ, 1988, J AM CHEM SOC, V110, P2959, DOI 10.1021/ja00217a044; Nicholson WL, 2008, APPL ENVIRON MICROB, V74, P6832, DOI 10.1128/AEM.00881-08; Riebel BR, 2003, ADV SYNTH CATAL, V345, P707, DOI 10.1002/adsc.200303039; Saito S., 1992, US Patent, Patent No. 5164112; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237; Syu MJ, 2001, APPL MICROBIOL BIOT, V55, P10, DOI 10.1007/s002530000486; Ui S, 1998, LETT APPL MICROBIOL, V26, P275; van der Donk WA, 2003, CURR OPIN BIOTECH, V14, P421, DOI 10.1016/S0958-1669(03)00094-6; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; Xiao ZJ, 2007, APPL MICROBIOL BIOT, V74, P61, DOI 10.1007/s00253-006-0646-5; Yamada-Onodera K, 2002, ACTA BIOTECHNOL, V22, P355, DOI 10.1002/1521-3846(200207)22:3/4<355::AID-ABIO355>3.0.CO;2-6	26	120	125	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8860	10.1371/journal.pone.0008860	http://dx.doi.org/10.1371/journal.pone.0008860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126645	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500004
J	Frelet-Barrand, A; Boutigny, S; Moyet, L; Deniaud, A; Seigneurin-Berny, D; Salvi, D; Bernaudat, F; Richaud, P; Pebay-Peyroula, E; Joyard, J; Rolland, N				Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Deniaud, Aurelien; Seigneurin-Berny, Daphne; Salvi, Daniel; Bernaudat, Florent; Richaud, Pierre; Pebay-Peyroula, Eva; Joyard, Jacques; Rolland, Norbert			Lactococcus lactis, an Alternative System for Functional Expression of Peripheral and Intrinsic Arabidopsis Membrane Proteins	PLOS ONE			English	Article							CHLOROPLAST ENVELOPE MEMBRANES; HEAVY-METAL TRANSPORT; P-TYPE ATPASE; HETEROLOGOUS EXPRESSION; P-1B-TYPE ATPASE; SCALE PRODUCTION; BINDING DOMAIN; PURIFICATION; GENE; ATHMA4	Background: Despite their functional and biotechnological importance, the study of membrane proteins remains difficult due to their hydrophobicity and their low natural abundance in cells. Furthermore, into established heterologous systems, these proteins are frequently only produced at very low levels, toxic and mis- or unfolded. Lactococcus lactis, a Gram-positive lactic bacterium, has been traditionally used in food fermentations. This expression system is also widely used in biotechnology for large-scale production of heterologous proteins. Various expression vectors, based either on constitutive or inducible promoters, are available for this system. While previously used to produce bacterial and eukaryotic membrane proteins, the ability of this system to produce plant membrane proteins was until now not tested. Methodology/Principal Findings: The aim of this work was to test the expression, in Lactococcus lactis, of either peripheral or intrinsic Arabidopsis membrane proteins that could not be produced, or in too low amount, using more classical heterologous expression systems. In an effort to easily transfer genes from Gateway-based Arabidopsis cDNA libraries to the L. lactis expression vector pNZ8148, we first established a cloning strategy compatible with Gateway entry vectors. Interestingly, the six tested Arabidopsis membrane proteins could be produced, in Lactococcus lactis, at levels compatible with further biochemical analyses. We then successfully developed solubilization and purification processes for three of these proteins. Finally, we questioned the functionality of a peripheral and an intrinsic membrane protein, and demonstrated that both proteins were active when produced in this system. Conclusions/Significance: Altogether, these data suggest that Lactococcus lactis might be an attractive system for the efficient and functional production of difficult plant membrane proteins.	[Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] CNRS, UMR5168, Physiol Cellulaire Vegetale Lab, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] CEA, DSV, iRTSV, LPCV, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] INRA, Physiol Cellulaire Vegetale Lab, UMR1200, Grenoble, France; [Frelet-Barrand, Annie; Boutigny, Sylvain; Moyet, Lucas; Seigneurin-Berny, Daphne; Salvi, Daniel; Joyard, Jacques; Rolland, Norbert] Univ Grenoble 1, Physiol Cellulaire Vegetale Lab, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] CEA, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] CNRS, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Deniaud, Aurelien; Bernaudat, Florent; Pebay-Peyroula, Eva] Univ Grenoble 1, IBS Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Richaud, Pierre] CEA, DSV, iBEB, Lab Echanges Membranaires & Signalisat, St Paul Les Durance, France; [Richaud, Pierre] CNRS, UMR 6191, St Paul Les Durance, France; [Richaud, Pierre] Univ Aix Marseille, St Paul Les Durance, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CEA; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Frelet-Barrand, A (corresponding author), CNRS, UMR5168, Physiol Cellulaire Vegetale Lab, Grenoble, France.	daphne.berny@cea.fr	FRELET-BARRAND, Annie/AFX-2878-2022; frelet barrand, annie/E-5479-2015; ROLLAND, Norbert/B-4405-2012; Deniaud, Aurelien/L-5093-2019; Frelet-Barrand, Annie/S-1951-2017; SEIGNEURIN-BERNY, Daphne/C-8412-2017	FRELET-BARRAND, Annie/0000-0002-0849-9040; ROLLAND, Norbert/0000-0003-1959-6636; SEIGNEURIN-BERNY, Daphne/0000-0002-7436-9885	CEA (Commissariat a l'Energie Atomique); CNRS (Centre National de la Recherche Scientifique); AFM (Association Francaise contre les Myopathies); E.U.	CEA (Commissariat a l'Energie Atomique)(French Atomic Energy Commission); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); E.U.(European Commission)	This work has been supported by the CEA (Commissariat a l'Energie Atomique, funding of the CEA-PM project and Post-Doc fellowship to AFB), by the CNRS (Centre National de la Recherche Scientifique, PhD fellowship to SB and Post-Doc fellowship to AFB), by the AFM (Association Francaise contre les Myopathies) and E.U. Specific Targeted Research Project IMPS ( Innovative tools for Membrane Protein Structural proteomics) (AD and EPP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI P, 1993, BIOCHEM J, V292, P863, DOI 10.1042/bj2920863; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Batard Y, 2000, ARCH BIOCHEM BIOPHYS, V379, P161, DOI 10.1006/abbi.2000.1867; Block MA, 2007, PHOTOSYNTH RES, V92, P225, DOI 10.1007/s11120-007-9195-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chigri F, 2006, P NATL ACAD SCI USA, V103, P16051, DOI 10.1073/pnas.0607150103; Chua N. H, 1980, METHOD ENZYMOL, V69, P434; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Eren E, 2004, PLANT PHYSIOL, V136, P3712, DOI 10.1104/pp.104.046292; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Gasson MJ., 1994, GENETICS BIOTECHNOLO; Geertsma ER, 2007, NAT METHODS, V4, P705, DOI 10.1038/NMETH1073; Getz EB, 1999, ANAL BIOCHEM, V273, P73, DOI 10.1006/abio.1999.4203; Gravot A, 2004, FEBS LETT, V561, P22, DOI 10.1016/S0014-5793(04)00072-9; GRISSHAMMER R, 1995, Q REV BIOPHYS, V28, P315, DOI 10.1017/S0033583500003504; Hernandez I, 2007, APPL ENVIRON MICROB, V73, P1544, DOI 10.1128/AEM.01870-06; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; INGRAM LO, 1977, APPL ENVIRON MICROB, V33, P1233, DOI 10.1128/AEM.33.5.1233-1236.1977; JagerVottero P, 1997, P NATL ACAD SCI USA, V94, P1597, DOI 10.1073/pnas.94.4.1597; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; Jidenko M, 2006, PROTEIN EXPRES PURIF, V48, P32, DOI 10.1016/j.pep.2006.03.001; Junge F, 2008, CELL MOL LIFE SCI, V65, P1729, DOI 10.1007/s00018-008-8067-5; KAMPFENKEL K, 1995, FEBS LETT, V374, P351, DOI 10.1016/0014-5793(95)01143-3; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Kunji ERS, 2005, CURR OPIN BIOTECH, V16, P546, DOI 10.1016/j.copbio.2005.08.006; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; Lacapere JJ, 2007, TRENDS BIOCHEM SCI, V32, P259, DOI 10.1016/j.tibs.2007.04.001; Le Loir Y, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-2; le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Martinez-Cuesta MC, 2005, LETT APPL MICROBIOL, V40, P44, DOI 10.1111/j.1472-765X.2004.01621.x; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-16; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Miras S, 2002, J BIOL CHEM, V277, P47770, DOI 10.1074/jbc.M207477200; Miras S, 2007, J BIOL CHEM, V282, P29482, DOI 10.1074/jbc.M611112200; Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905; Morel M, 2009, PLANT PHYSIOL, V149, P894, DOI 10.1104/pp.108.130294; Morello E, 2008, J MOL MICROB BIOTECH, V14, P48, DOI 10.1159/000106082; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; Neuhaus HE, 1997, PLANT J, V11, P73, DOI 10.1046/j.1365-313X.1997.11010073.x; Nguyen HD, 2007, CURR MICROBIOL, V55, P89, DOI 10.1007/s00284-006-0419-5; Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39; Opekarova M, 2003, BBA-BIOMEMBRANES, V1610, P11, DOI 10.1016/S0005-2736(02)00708-3; Persson B, 2003, CHEM-BIOL INTERACT, V143, P271, DOI 10.1016/S0009-2797(02)00223-5; Rahman M, 2007, MOL MEMBR BIOL, V24, P407, DOI 10.1080/09687860701243998; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHLEIFER KH, 1985, SYST APPL MICROBIOL, V6, P183, DOI 10.1016/S0723-2020(85)80052-7; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; TERZAGHI BE, 1975, APPL MICROBIOL, V29, P807, DOI 10.1128/AEM.29.6.807-813.1975; Thuswaldner S, 2007, J BIOL CHEM, V282, P8848, DOI 10.1074/jbc.M609130200; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Tortech L, 2001, BBA-BIOMEMBRANES, V1514, P76, DOI 10.1016/S0005-2736(01)00370-4; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Trentmann O, 2008, J BIOL CHEM, V283, P36486, DOI 10.1074/jbc.M806903200; Ueda S, 2004, ANAL BIOCHEM, V332, P84, DOI 10.1016/j.ab.2004.04.035; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Vos W. M. de, 1994, Genetics and biotechnology of lactic acid bacteria., P52; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Wood BJB, 2003, GENETICS LACTIC ACID; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhou XX, 2006, BIOTECHNOL ADV, V24, P285, DOI 10.1016/j.biotechadv.2005.11.001	77	31	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8746	10.1371/journal.pone.0008746	http://dx.doi.org/10.1371/journal.pone.0008746			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098692	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779000007
J	Krasnova, IN; Justinova, Z; Ladenheim, B; Jayanthi, S; McCoy, MT; Barnes, C; Warner, JE; Goldberg, SR; Cadet, JL				Krasnova, Irina N.; Justinova, Zuzana; Ladenheim, Bruce; Jayanthi, Subramaniam; McCoy, Michael T.; Barnes, Chanel; Warner, John E.; Goldberg, Steven R.; Cadet, Jean Lud			Methamphetamine Self-Administration Is Associated with Persistent Biochemical Alterations in Striatal and Cortical Dopaminergic Terminals in the Rat	PLOS ONE			English	Article							BRAIN-SEROTONIN TRANSPORTER; INDUCED NEUROTOXICITY; INTRAVENOUS METHAMPHETAMINE; NEUROCHEMICAL CONSEQUENCES; TYROSINE-HYDROXYLASE; AMPHETAMINE ABUSE; OXIDATIVE STRESS; NULL MUTATION; USERS; IMPAIRMENT	Methamphetamine (meth) is an illicit psychostimulant that is abused throughout the world. Repeated passive injections of the drug given in a single day or over a few days cause significant and long-term depletion of dopamine and serotonin in the mammalian brain. Because meth self-administration may better mimic some aspects of human drug-taking behaviors, we examined to what extent this pattern of drug treatment might also result in damage to monoaminergic systems in the brain. Rats were allowed to intravenously self-administer meth (yoked control rats received vehicle) 15 hours per day for 8 days before being euthanized at either 24 hours or at 7 and 14 days after cessation of drug taking. Meth self-administration by the rats was associated with a progressive escalation of daily drug intake to 14 mg/kg per day. Animals that self-administered meth exhibited dose-dependent decreases in striatal dopamine levels during the period of observation. In addition, there were significant reductions in the levels of striatal dopamine transporter and tyrosine hydroxylase proteins. There were also significant decreases in the levels of dopamine, dopamine transporter, and tyrosine hydroxylase in the cortex. In contrast, meth self-administration caused only transient decreases in norepinephrine and serotonin levels in the two brain regions, with these values returning to normal at seven days after cessation of drug taking. Importantly, meth self-administration was associated with significant dose-dependent increases in glial fibrillary acidic protein in both striatum and cortex, with these changes being of greater magnitude in the striatum. These results suggest that meth self-administration by rats is associated with long-term biochemical changes that are reminiscent of those observed in post-mortem brain tissues of chronic meth abusers.	[Krasnova, Irina N.; Justinova, Zuzana; Ladenheim, Bruce; Jayanthi, Subramaniam; McCoy, Michael T.; Barnes, Chanel; Warner, John E.; Goldberg, Steven R.; Cadet, Jean Lud] NIDA, NIH, Baltimore, MD USA; [Justinova, Zuzana] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); University System of Maryland; University of Maryland Baltimore	Krasnova, IN (corresponding author), NIDA, NIH, Baltimore, MD USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020; Justinova, Zuzana/A-9109-2011	Justinova, Zuzana/0000-0001-5793-7484; Jayanthi, Subramaniam/0000-0002-5209-303X	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000003, ZIADA000001, ZIADA000174] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Albertson TE, 1999, WESTERN J MED, V170, P214; BARDSLEY ME, 1981, BIOCHEM PHARMACOL, V30, P1543, DOI 10.1016/0006-2952(81)90379-8; BITTNER SE, 1981, PHARMACOL BIOCHEM BE, V14, P481, DOI 10.1016/0091-3057(81)90306-3; BRAY GA, 1993, ANN INTERN MED, V119, P707, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00016; Cadet JL, 2007, NEUROTOX RES, V11, P183, DOI 10.1007/BF03033567; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cadet JL, 2009, NEUROTOX RES, V15, P252, DOI 10.1007/s12640-009-9026-0; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Chang L, 2007, ADDICTION, V102, P16, DOI 10.1111/j.1360-0443.2006.01782.x; CHERNER M, 2009, DRUG ALCOHOL DEPEND; Cho AK, 2002, J ADDICT DIS, V21, P21; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Davidson C, 2005, NEUROCHEM INT, V46, P189, DOI 10.1016/j.neuint.2004.11.004; Degenhardt L, 2008, DRUG ALCOHOL REV, V27, P243, DOI 10.1080/09595230801950572; Deng XL, 1999, J NEUROSCI, V19, P10107; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Fleckenstein AE, 2007, ANNU REV PHARMACOL, V47, P681, DOI 10.1146/annurev.pharmtox.47.120505.105140; Friedman SD, 1998, PHARMACOL BIOCHEM BE, V61, P35, DOI 10.1016/S0091-3057(98)00066-5; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Graham DL, 2008, J NEUROCHEM, V105, P1873, DOI 10.1111/j.1471-4159.2008.05269.x; Griffiths P, 2008, DRUG ALCOHOL REV, V27, P236, DOI 10.1080/09595230801932588; Hadlock GC, 2009, J PHARMACOL EXP THER, V329, P169, DOI 10.1124/jpet.108.145631; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hamill Cecily E, 2005, Clin Neurosurg, V52, P29; Homer BD, 2008, PSYCHOL BULL, V134, P301, DOI 10.1037/0033-2909.134.2.301; Johanson CE, 2006, PSYCHOPHARMACOLOGY, V185, P327, DOI 10.1007/s00213-006-0330-6; Johnson-Davis KL, 2003, EUR J PHARMACOL, V482, P151, DOI 10.1016/j.ejphar.2003.09.063; Kish S, 2009, PSYCHOPHARMACOLOGY, V202, P649, DOI 10.1007/s00213-008-1346-x; Kitamura O, 2006, PSYCHOPHARMACOLOGY, V186, P48, DOI 10.1007/s00213-006-0353-z; Kitamura O, 2007, INT J LEGAL MED, V121, P163, DOI 10.1007/s00414-006-0087-9; KRAMER JC, 1967, J AMER MED ASSOC, V201, P305, DOI 10.1001/jama.201.5.305; Krasnova IN, 2005, FASEB J, V19, P851, DOI 10.1096/fj.04-2881fje; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Krasnova IN, 2009, NEUROSCI RES, V65, P160, DOI 10.1016/j.neures.2009.06.007; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Ladenheim B, 2000, MOL PHARMACOL, V58, P1247, DOI 10.1124/mol.58.6.1247; Mandyam CD, 2007, J NEUROSCI, V27, P11442, DOI 10.1523/JNEUROSCI.2505-07.2007; Mandyam CD, 2008, BIOL PSYCHIAT, V64, P958, DOI 10.1016/j.biopsych.2008.04.010; Maxwell JC, 2008, DRUG ALCOHOL REV, V27, P229, DOI 10.1080/09595230801919460; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; Moszczynska A, 2004, BRAIN, V127, P363, DOI 10.1093/brain/awh046; Neale A, 2009, INT J EAT DISORDER, V42, P188, DOI 10.1002/eat.20587; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Ricca V, 2009, APPETITE, V52, P405, DOI 10.1016/j.appet.2008.11.013; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Scott JC, 2007, NEUROPSYCHOL REV, V17, P275, DOI 10.1007/s11065-007-9031-0; Segal DS, 2005, PSYCHOPHARMACOLOGY, V180, P501, DOI 10.1007/s00213-005-2188-4; Segal DS, 2003, NEUROPSYCHOPHARMACOL, V28, P1730, DOI 10.1038/sj.npp.1300247; Sekine Y, 2006, ARCH GEN PSYCHIAT, V63, P90, DOI 10.1001/archpsyc.63.1.90; Sekine Y, 2008, J NEUROSCI, V28, P5756, DOI 10.1523/JNEUROSCI.1179-08.2008; Shepard JD, 2006, PSYCHOPHARMACOLOGY, V185, P505, DOI 10.1007/s00213-006-0316-4; Sim T, 2002, J ADDICT DIS, V21, P75; Simon SL, 2000, AM J ADDICTION, V9, P222; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Stefanski R, 2002, EUR J PHARMACOL, V439, P59, DOI 10.1016/S0014-2999(02)01301-8; Stephans S, 1996, NEUROSCIENCE, V72, P593, DOI 10.1016/0306-4522(95)00587-0; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Thomas DM, 2008, J NEUROCHEM, V105, P605, DOI 10.1111/j.1471-4159.2007.05155.x; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Wee S, 2007, NEUROPSYCHOPHARMACOL, V32, P2238, DOI 10.1038/sj.npp.1301353; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Wilson JM, 1996, NAT MED, V2, P699, DOI 10.1038/nm0696-699; WOOLVERTON WL, 1989, BRAIN RES, V486, P73, DOI 10.1016/0006-8993(89)91279-1; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Zhu JPQ, 2005, BRAIN RES, V1049, P171, DOI 10.1016/j.brainres.2005.04.089	68	94	96	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8790	10.1371/journal.pone.0008790	http://dx.doi.org/10.1371/journal.pone.0008790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098750	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000018
J	Mitchell, IC; Brown, TS; Terada, LS; Amatruda, JF; Nwariaku, FE				Mitchell, Ian C.; Brown, Timothy S.; Terada, Lance S.; Amatruda, James F.; Nwariaku, Fiemu E.			Effect of Vascular Cadherin Knockdown on Zebrafish Vasculature during Development	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; VE-CADHERIN; MESENCHYMAL TRANSFORMATION; EMBRYOS; PHOSPHORYLATION; EXPRESSION; ADHESION; CELLS; GENE	Background: Vascular endothelial cadherin (VE-cad) is essential for endothelial barrier integrity and vascular sprouting. However, the role of this important protein in cardiovascular development is only recently becoming apparent. Methodology/Principal Findings: To characterize the role of VE-cadherin in cardiovascular development, we analyzed cardiovascular development in a zebrafish VE-cad knockdown model. Embryos deficient in VE-cad show profoundly impaired cardiac development despite having apparently normal peripheral vasculature. Initial formation of the heart proceeds normally in knockdown embryos, but subsequent looping morphogenesis is impaired. Consistent with these results, VE-cad knockdown embryos demonstrate impaired cardiac function and early circulatory arrest. Histologic examination of knockdown embryos shows persistent, abnormal separation of the endocardial and myocardial layers. Using transmission electron microscopy, we demonstrate that endocardial junctions form poorly in VE-cad knockdown embryos, with resulting leak across the endothelial layer and reduction in the density of the cardiac jelly. Conclusions: Our results demonstrate a significant role for VE-cadherin in cardiac development independent of its effects on the formation of the peripheral vasculature.	[Mitchell, Ian C.; Brown, Timothy S.; Nwariaku, Fiemu E.] Univ Texas SW Med Ctr Dallas, Dept Surg, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA; [Terada, Lance S.; Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Amatruda, James F.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mitchell, IC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Surg, Div Gastrointestinal & Endocrine Surg, Dallas, TX 75390 USA.	james.amatruda@UTSouthwestern.edu; fiemu.nwariaku@UTSouthwestern.edu		Terada, Lance/0000-0001-7441-9734; Brown, Timothy/0000-0002-5404-0433	National Institutes of Health [NIGMS GM067674-01]; Department of Surgery at the University of Texas Southwestern Medical Center; Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center; Lance Armstrong Foundation; Amon G. Carter Foundation; NATIONAL CANCER INSTITUTE [R01CA135731] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery at the University of Texas Southwestern Medical Center; Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center; Lance Armstrong Foundation; Amon G. Carter Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	FEN is supported by the National Institutes of Health (NIGMS GM067674-01), by the Malcom O Perry MD Professorship in Surgery and the Department of Surgery at the University of Texas Southwestern Medical Center. JFA is supported by the Horchow Family Endowed Scholarship in Pediatrics at UT Southwestern Medical Center and by grants from the Lance Armstrong Foundation and the Amon G. Carter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berdougo E, 2003, DEVELOPMENT, V130, P6121, DOI 10.1242/dev.00838; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Esser S, 1998, J CELL SCI, V111, P1853; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; Kim KH, 2007, DEV BIOL, V308, P494, DOI 10.1016/j.ydbio.2007.06.005; Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; MARKWALD RR, 1977, AM J ANAT, V148, P85, DOI 10.1002/aja.1001480108; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; POTTS JD, 1991, P NATL ACAD SCI USA, V88, P1516, DOI 10.1073/pnas.88.4.1516; THISSE C, 1993, DEVELOPMENT, V119, P1203; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Vincent PA, 2004, AM J PHYSIOL-CELL PH, V286, pC987, DOI 10.1152/ajpcell.00522.2003; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE	23	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8807	10.1371/journal.pone.0008807	http://dx.doi.org/10.1371/journal.pone.0008807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098718	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779000033
J	Sanchez-Guajardo, V; Febbraro, F; Kirik, D; Romero-Ramos, M				Sanchez-Guajardo, Vanesa; Febbraro, Fabia; Kirik, Deniz; Romero-Ramos, Marina			Microglia Acquire Distinct Activation Profiles Depending on the Degree of alpha-Synuclein Neuropathology in a rAAV Based Model of Parkinson's Disease	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; GROWTH-FACTOR-ALPHA; SUBSTANTIA-NIGRA; MOUSE MODEL; TARGETED OVEREXPRESSION; DOPAMINERGIC-NEURONS; CEREBROSPINAL-FLUID; OXIDATIVE STRESS; TRANSGENIC MICE; VIRAL VECTOR	Post-mortem analysis of brains from Parkinson's disease (PD) patients strongly supports microglia activation and adaptive immunity as factors contributing to disease progression. Such responses may be triggered by alpha-synuclein (alpha-syn), which is known to be the main constituent of the aggregated proteins found in Lewy bodies in the brains of PD patients. To investigate this we used a recombinant viral vector to express human alpha-syn in rat midbrain at levels that induced neuronal pathology either in the absence or the presence of dopaminergic cell death, thereby mimicking early or late stages of the disease. Microglia activation was assessed by stereological quantification of Mac1+ cells, as well as the expression patterns of CD68 and MCH II. In our study, when alpha-syn induced neuronal pathology but not cell death, a fast transient increase in microglia cell numbers resulted in the long-term induction of MHC II+ microglia, denoting antigen-presenting ability. On the other hand, when alpha-syn induced both neuronal pathology and cell death, there was a delayed increase in microglia cell numbers, which correlated with long-lasting CD68 expression and a morphology reminiscent of peripheral macrophages. In addition T-lymphocyte infiltration, as judged by the presence of CD4+ and CD8+ cells, showed distinct kinetics depending on the degree of neurodegeneration, and was significantly higher when cell death occurred. We have thus for the first time shown that the microglial response differs depending on whether alpha-syn expression results on cell death or not, suggesting that microglia may play different roles during disease progression. Furthermore, our data suggest that the microglial response is modulated by early events related to alpha-syn expression in substantia nigra and persists at the long term.	[Sanchez-Guajardo, Vanesa; Febbraro, Fabia; Romero-Ramos, Marina] Aarhus Univ, Dept Med Biochem, Cent Nervous Syst Dis Modeling Grp, Aarhus, Denmark; [Kirik, Deniz; Romero-Ramos, Marina] Lund Univ, Dept Expt Med Sci Brain Repair & Imaging Neural S, Lund, Sweden	Aarhus University; Lund University	Sanchez-Guajardo, V (corresponding author), Aarhus Univ, Dept Med Biochem, Cent Nervous Syst Dis Modeling Grp, Aarhus, Denmark.	mrr@biokemi.au.dk	Romero-Ramos, Marina/J-6834-2014; Febbraro, Fabia/AAO-9454-2020; Kirik, Deniz/E-5156-2011; Febbraro, Fabia/G-9097-2016	Romero-Ramos, Marina/0000-0003-0970-578X; Sanchez-Guajardo, Vanesa/0000-0002-3290-2047; Febbraro, Fabia/0000-0001-8336-2776	Swedish Research Council [K2007-61X-14552-05-3]; Lundbeck Foundation [R9-A1061, R17-A1564]; Danish Research Council [271-06-0261]; Danish Parkinson Foundation; Nordic Center of Excellence in Neurodegeneration	Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Parkinson Foundation; Nordic Center of Excellence in Neurodegeneration	This work was supported by grants from, The Swedish Research Council (K2007-61X-14552-05-3 to DK, www.vr.se), Lundbeck Foundation (R9-A1061 to MRR and R17-A1564 to VSG, www.lundbeckfonden.dk), the Danish Research Council (271-06-0261 to MRR, en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/medical-sciences), Danish Parkinson Foundation (to MRR, www.parkinson.dk), Nordic Center of Excellence in Neurodegeneration (to DK and MRR). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Austin SA, 2006, J NEUROSCI, V26, P10558, DOI 10.1523/JNEUROSCI.1799-06.2006; Baba Y, 2005, PARKINSONISM RELAT D, V11, P493, DOI 10.1016/j.parkreldis.2005.07.005; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; BOKA G, 1994, NEUROSCI LETT, V172, P151, DOI 10.1016/0304-3940(94)90684-X; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Brodacki B, 2008, NEUROSCI LETT, V441, P158, DOI 10.1016/j.neulet.2008.06.040; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Cabanas C, 1999, J BIOL REG HOMEOS AG, V13, P130; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; DEGUEURCE AM, 1986, ACTA PHYSIOL SCAND, V126, P313, DOI 10.1111/j.1748-1716.1986.tb07821.x; Eriksen JL, 2005, ARCH NEUROL-CHICAGO, V62, P353, DOI 10.1001/archneur.62.3.353; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Ferrer I, 2001, J NEURAL TRANSM, V108, P1383, DOI 10.1007/s007020100015; FUCHS J, 2007, NEUROLOGY; Gao HM, 2008, J NEUROSCI, V28, P7687, DOI 10.1523/JNEUROSCI.0143-07.2008; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Gomez-Isla T, 2003, NEUROBIOL AGING, V24, P245, DOI 10.1016/S0197-4580(02)00091-X; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Hartmann A, 2001, J NEUROSCI, V21, P2247, DOI 10.1523/JNEUROSCI.21-07-02247.2001; Hunot S, 1999, J NEUROSCI, V19, P3440; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jin JJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-2; Kim S, 2009, J NEUROCHEM, V109, P1483, DOI 10.1111/j.1471-4159.2009.06075.x; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kim YS, 2006, EXP MOL MED, V38, P333, DOI 10.1038/emm.2006.40; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; MCGEER PL, 1988, ANN NEUROL, V24, P574, DOI 10.1002/ana.410240415; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; MOGI M, 1994, NEUROSCI LETT, V180, P147, DOI 10.1016/0304-3940(94)90508-8; MOGI M, 1994, NEUROSCI LETT, V165, P208, DOI 10.1016/0304-3940(94)90746-3; Mogi M, 2000, J NEURAL TRANSM, V107, P335, DOI 10.1007/s007020050028; Mogi M, 1999, NEUROSCI LETT, V270, P45, DOI 10.1016/S0304-3940(99)00463-2; MOGI M, 1995, J NEURAL TRANSM-PARK, V9, P87, DOI 10.1007/BF02252965; Nagatsu T, 2007, J NEURAL TRANSM-SUPP, P113; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ouchi Y, 2005, ANN NEUROL, V57, P168, DOI 10.1002/ana.20338; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park JY, 2008, GLIA, V56, P1215, DOI 10.1002/glia.20691; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; REYNOLDS AD, 2008, J NEUROIMMUNE PHARM; REYNOLDS AD, 2007, J NEUROCHEM; Reynolds AD, 2009, J IMMUNOL, V182, P4137, DOI 10.4049/jimmunol.0803982; ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181; Rowe DB, 1998, J NEUROSCI RES, V53, P551, DOI 10.1002/(SICI)1097-4547(19980901)53:5<551::AID-JNR5>3.3.CO;2-T; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Shavali S, 2006, NEUROCHEM RES, V31, P85, DOI 10.1007/s11064-005-9233-x; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Su XM, 2009, NEUROTOX RES, V16, P238, DOI 10.1007/s12640-009-9053-x; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; van der Putten H, 2000, J NEUROSCI, V20, P6021, DOI 10.1523/JNEUROSCI.20-16-06021.2000; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Xu LF, 2001, HUM GENE THER, V12, P563, DOI 10.1089/104303401300042500; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	73	174	177	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8784	10.1371/journal.pone.0008784	http://dx.doi.org/10.1371/journal.pone.0008784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098715	Green Published, gold			2022-12-27	WOS:000273779000013
J	Taylor, PJ; Betts, GA; Maroulis, S; Gilissen, C; Pedersen, RL; Mowat, DR; Johnston, HM; Buckley, MF				Taylor, Peter J.; Betts, Grant A.; Maroulis, Sarah; Gilissen, Christian; Pedersen, Robyn L.; Mowat, David R.; Johnston, Heather M.; Buckley, Michael F.			Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy	PLOS ONE			English	Article							VERBAL WORKING-MEMORY; MENTAL-RETARDATION; INTELLECTUAL IMPAIRMENT; CARBOXY-TERMINUS; POINT MUTATIONS; DP71; DP140; INTELLIGENCE; DMD; ASSOCIATION	Background: A significant component of the variation in cognitive disability that is observed in Duchenne muscular dystrophy (DMD) is known to be under genetic regulation. In this study we report correlations between standardised measures of intelligence and mutational class, mutation size, mutation location and the involvement of dystrophin isoforms. Methods and Results: Sixty two male subjects were recruited as part of a study of the cognitive spectrum in boys with DMD conducted at the Sydney Children's Hospital (SCH). All 62 children received neuropsychological testing from a single clinical psychologist and had a defined dystrophin gene (DMD) mutation; including DMD gene deletions, duplications and DNA point mutations. Full Scale Intelligence Quotients (FSIQ) in unrelated subjects with the same mutation were found to be highly correlated (r = 0.83, p = 0.0008), in contrast to results in previous publications. In 58 cases (94%) it was possible to definitively assign a mutation as affecting one or more dystrophin isoforms. A strong association between the risk of cognitive disability and the involvement of groups of DMD isoforms was found. In particular, improvements in the correlation of FSIQ with mutation location were identified when a new classification system for mutations affecting the Dp140 isoform was implemented. Significance: These data represent one of the largest studies of FSIQ and mutational data in DMD patients and is among the first to report on a DMD cohort which has had both comprehensive mutational analysis and FSIQ testing through a single referral centre. The correlation between FSIQ results with the location of the dystrophin gene mutation suggests that the risk of cognitive deficit is a result of the cumulative loss of central nervous system (CNS) expressed dystrophin isoforms, and that correct classification of isoform involvement results in improved estimates of risk.	[Taylor, Peter J.; Maroulis, Sarah; Buckley, Michael F.] Prince Wales Hosp, Mol & Cytogenet Unit, Dept Haematol & Genet, Sydney, NSW, Australia; [Taylor, Peter J.; Betts, Grant A.; Pedersen, Robyn L.; Mowat, David R.; Johnston, Heather M.] Sydney Childrens Hosp, Sydney Neuromuscular Ctr, Sydney, NSW, Australia; [Gilissen, Christian; Buckley, Michael F.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Mowat, David R.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of Sydney; Radboud University Nijmegen; University of New South Wales Sydney	Taylor, PJ (corresponding author), Prince Wales Hosp, Mol & Cytogenet Unit, Dept Haematol & Genet, Sydney, NSW, Australia.	michael.buckley@sesiahs.health.nsw.gov.au	Gilissen, Christian/E-5246-2012	Gilissen, Christian/0000-0003-1693-9699; buckley, michael/0000-0002-8298-8758	Muscular Dystrophy Association of New South Wales; European Science Directorate	Muscular Dystrophy Association of New South Wales; European Science Directorate	Funding for genetic testing was generously provided by the Muscular Dystrophy Association of New South Wales (http://mdnsw.org.au/). MFB is a recipient of a Marie Curie Fellowship from the European Science Directorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Bardoni A, 2000, NEUROMUSCULAR DISORD, V10, P194, DOI 10.1016/S0960-8966(99)00108-X; Billard C, 1998, DEV MED CHILD NEUROL, V40, P12, DOI 10.1111/j.1469-8749.1998.tb15351.x; BILLARD C, 1992, NEUROMUSCULAR DISORD, V2, P371, DOI 10.1016/S0960-8966(06)80008-8; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; BRESOLIN N, 1994, NEUROMUSCULAR DISORD, V4, P359, DOI 10.1016/0960-8966(94)90072-8; BUSHBY KMD, 1993, J NEUROL, V240, P105, DOI 10.1007/BF00858726; BUSHBY KMD, 1995, DEV MED CHILD NEUROL, V37, P260; Ceccarini M, 1997, DEV BRAIN RES, V103, P77, DOI 10.1016/S0165-3806(97)00122-3; Cotton S, 2001, DEV MED CHILD NEUROL, V43, P497, DOI 10.1017/S0012162201000913; Cotton SM, 2005, DEV MED CHILD NEUROL, V47, P257, DOI 10.1017/S0012162205000496; DAOUD F, 2009, HUM MOL GENET; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; *DUCH BOUL GBA, 1973, NEUR CLASS, P60; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Felisari G, 2000, NEUROLOGY, V55, P559, DOI 10.1212/WNL.55.4.559; Florencia G, 2004, NEUROL RES, V26, P83, DOI 10.1179/016164104773026589; Greenwood J, 1996, J NEUROIMMUNOL, V71, P51, DOI 10.1016/S0165-5728(96)00130-0; Haenggi T, 2004, NEUROSCIENCE, V129, P403, DOI 10.1016/j.neuroscience.2004.06.079; Hinton VJ, 2007, DEV MED CHILD NEUROL, V49, P123, DOI 10.1111/j.1469-8749.2007.00123.x; Hinton VJ, 2001, J INT NEUROPSYCH SOC, V7, P45, DOI 10.1017/S1355617701711058; Hinton VJ, 2000, NEUROLOGY, V54, P2127, DOI 10.1212/WNL.54.11.2127; HODGSON SV, 1992, NEUROMUSCULAR DISORD, V2, P269, DOI 10.1016/0960-8966(92)90059-F; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; KARAGAN NJ, 1978, DEV MED CHILD NEUROL, V20, P435; KOCHLING S, 1995, HUM GENET, V95, P475; LEIBOWITZ D, 1981, DEV MED CHILD NEUROL, V23, P577; LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877; LIDOV HGW, 1995, HUM MOL GENET, V4, P329, DOI 10.1093/hmg/4.3.329; MARSH GG, 1974, ARCH DIS CHILD, V49, P118, DOI 10.1136/adc.49.2.118; Moizard MP, 1998, AM J MED GENET, V80, P32, DOI 10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y; Moizard MP, 2000, EUR J HUM GENET, V8, P552, DOI 10.1038/sj.ejhg.5200488; MORRIS GE, 1995, BIOCHEM BIOPH RES CO, V215, P361, DOI 10.1006/bbrc.1995.2474; MORROW R S, 1954, J Child Psychiatry, V3, P70; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NICHOLSON LVB, 1993, J MED GENET, V30, P737, DOI 10.1136/jmg.30.9.737; OGASAWARA A, 1989, AM J MENT RETARD, V93, P544; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; PROSSER EJ, 1969, ARCH DIS CHILD, V44, P221, DOI 10.1136/adc.44.234.221; RAPAPORT D, 1991, AM J MED GENET, V39, P437, DOI 10.1002/ajmg.1320390414; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; SMITH RA, 1990, DEV MED CHILD NEUROL, V32, P519; SOLLEE ND, 1985, J CLIN EXP NEUROPSYC, V7, P486, DOI 10.1080/01688638508401280; Taylor PJ, 2007, J MED GENET, V44, P368, DOI 10.1136/jmg.2006.047464; Tokarz SA, 1998, MOL GENET METAB, V65, P272, DOI 10.1006/mgme.1998.2763; TUFFERY S, 1995, HUM MUTAT, V6, P126, DOI 10.1002/humu.1380060205; Young HK, 2008, J CHILD NEUROL, V23, P155, DOI 10.1177/0883073807307975	47	111	113	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8803	10.1371/journal.pone.0008803	http://dx.doi.org/10.1371/journal.pone.0008803			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098710	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779000029
J	Welch, JJ				Welch, John J.			The "Island Rule" and Deep-Sea Gastropods: Re-Examining the Evidence	PLOS ONE			English	Article							REPAIRED SHELL DAMAGE; BODY-SIZE EVOLUTION; MAMMALS; PATTERNS; AREA; BIOGEOGRAPHY; DIVERSITY; PRIMATES	Background: One of the most intriguing patterns in mammalian biogeography is the "island rule'', which states that colonising species have a tendency to converge in body size, with larger species evolving decreased sizes and smaller species increased sizes. It has recently been suggested that an analogous pattern holds for the colonisation of the deep-sea benthos by marine Gastropoda. In particular, a pioneering study showed that gastropods from the Western Atlantic showed the same graded trend from dwarfism to gigantism that is evident in island endemic mammals. However, subsequent to the publication of the gastropod study, the standard tests of the island rule have been shown to yield false positives at a very high rate, leaving the result open to doubt. Methodology/Principal Findings: The evolution of gastropod body size in the deep sea is reexamined. Using an extended and updated data set, and improved statistical methods, it is shown that some results of the previous study may have been artifactual, but that its central conclusion is robust. It is further shown that the effect is not restricted to a single gastropod clade, that its strength increases markedly with depth, but that it applies even in the mesopelagic zone. Conclusions/Significance: The replication of the island rule in a distant taxonomic group and a partially analogous ecological situation could help to uncover the causes of the patterns observed-which are currently much disputed. The gastropod pattern is evident at intermediate depths, and so cannot be attributed to the unique features of abyssal ecology.	[Welch, John J.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Welch, JJ (corresponding author), Univ Montpellier 2, Pl Eugene Bataillon, Montpellier, France.	J.J.Welch10@gmail.com			BBSRC [DO17750]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Some preliminary work undertaken when JW was funded by BBSRC grant DO17750 awarded to Andrew Rambaut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouchet P, 2005, MALACOLOGIA, V47, P1; Bromham L, 2007, BIOL LETTERS, V3, P398, DOI 10.1098/rsbl.2007.0113; Clegg SM, 2002, P ROY SOC B-BIOL SCI, V269, P1359, DOI 10.1098/rspb.2002.2024; DAYTON PK, 1972, DEEP-SEA RES, V19, P199, DOI 10.1016/0011-7471(72)90031-9; De Souza Paulino J.S., 2002, Zootaxa, V49, P1; Duncan RP, 2004, GLOBAL ECOL BIOGEOGR, V13, P509, DOI 10.1111/j.1466-822X.2004.00132.x; FOSTER JB, 1964, NATURE, V202, P234, DOI 10.1038/202234a0; Gage J.D., 2005, P273, DOI 10.1002/9780470995129.ch7; Gage J. D., 1991, DEEP SEA BIOL NATURA; Guo H, 2007, MOL BIOL EVOL, V24, P352, DOI 10.1093/molbev/msl165; HEANEY LR, 1978, EVOLUTION, V32, P29, DOI 10.1111/j.1558-5646.1978.tb01096.x; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; LOMOLINO MV, 1984, AM NAT, V123, P468, DOI 10.1086/284217; LOMOLINO MV, 1985, AM NAT, V125, P310, DOI 10.1086/284343; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Marquet PA, 1998, EVOL ECOL, V12, P127, DOI 10.1023/A:1006567227154; MARTIN RD, 1989, FOLIA PRIMATOL, V53, P65, DOI 10.1159/000156409; McClain CR, 2005, MAR ECOL PROG SER, V297, P181, DOI 10.3354/meps297181; McClain CR, 2006, J BIOGEOGR, V33, P1578, DOI 10.1111/j.1365-2699.2006.01545.x; MCCOLLOM TM, 1999, OCEANOGRAPHIC RES PA, V47, P85; McNab BK, 2002, ECOL LETT, V5, P693, DOI 10.1046/j.1461-0248.2002.00365.x; Meiri S, 2005, ECOL LETT, V8, P1211, DOI 10.1111/j.1461-0248.2005.00825.x; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2007, GLOBAL ECOL BIOGEOGR, V16, P702, DOI 10.1111/j.1466-8238.2007.00327.x; Palkovacs EP, 2003, OIKOS, V103, P37, DOI 10.1034/j.1600-0706.2003.12502.x; Price TD, 2007, J BIOGEOGR, V34, P1998, DOI 10.1111/j.1365-2699.2007.01796.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Raia P, 2006, EVOLUTION, V60, P1731; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; REYMENT RA, 1983, OIKOS, V41, P299, DOI 10.2307/3544089; ROSENBERG G, 1993, AM MALACOL BULL, V10, P257; ROSENDAHL CO, 1909, MINNESOTA BOT STUDIE, V4, P1; Roth V.L., 1992, Oxford Surveys in Evolutionary Biology, V8, P259; Schmidt NM, 2003, CONSERV ECOL, V7; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; SMITH FA, 1992, FUNCT ECOL, V6, P265, DOI 10.2307/2389516; Sokal R.R., 2012, BIOMETRY; VALE FK, 1988, MALACOLOGIA, V28, P65; VALE FK, 1989, NAUTILUS, V103, P105; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; WALKER SE, 1994, PALAIOS, V9, P48, DOI 10.2307/3515078; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; WASSERSUG RJ, 1979, AM NAT, V114, P287, DOI 10.1086/283475; Welch JJ, 2009, P ROY SOC B-BIOL SCI, V276, P675, DOI 10.1098/rspb.2008.1180; WILLIAMS GC, NATURAL SELECTION DO	45	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8776	10.1371/journal.pone.0008776	http://dx.doi.org/10.1371/journal.pone.0008776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098740	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900019
J	Kumar, A; Greggio, E; Beilina, A; Kaganovich, A; Chan, D; Taymans, JM; Wolozin, B; Cookson, MR				Kumar, Azad; Greggio, Elisa; Beilina, Alexandra; Kaganovich, Alice; Chan, Diane; Taymans, Jean-Marc; Wolozin, Benjamin; Cookson, Mark R.			The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; MUTATIONS; GENE	Mutations in the gene encoding Leucine-rich repeat kinase 2 (LRRK2) are the most common cause of inherited Parkinson's disease (PD). LRRK2 is a multi-domain protein kinase containing a central catalytic core and a number of protein-protein interaction domains. An important step forward in the understanding of both the biology and the pathology of LRRK2 would be achieved by identification of its authentic physiological substrates. In the present study we examined phosphorylation of 4E-BP (eukaryotic initiation factor 4E (eIF4E)-binding protein), a recently proposed substrate for LRRKs. We found that LRRK2 is capable of phosphorylating 4E-BP in vitro. The PD related LRRK2-G2019S mutant was similar to 2 fold more active than wild type protein. However, LRRK2 autophosphorylation was stronger than 4E-BP phosphorylation under conditions of molar excess of 4E-BP to LRRK2. We also tested three other kinases (STK3, MAPK14/p38 alpha and DAPK2) and found that MAPK14/p38 alpha could efficiently phosphorylate 4E-BP at the same site as LRRK2 in vitro. Finally, we did not see changes in 4E-BP phosphorylation levels using inducible expression of LRRK2 in HEK cell lines. We also found that MAPK14/p38 alpha phosphorylates 4E-BP in transient overexpression experiments whereas LRRK2 did not. We suggest that increased 4EBP phosphorylation reported in some systems may be related to p38-mediated cell stress rather than direct LRRK2 activity. Overall, our results suggest that 4E-BP is a relatively poor direct substrate for LRRK2.	[Kumar, Azad; Greggio, Elisa; Beilina, Alexandra; Kaganovich, Alice; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Chan, Diane; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Chan, Diane; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Taymans, Jean-Marc] Katholieke Univ Leuven, Dept Mol & Cellular Med, Div Mol Med, Lab Neurobiol & Gene Therapy, Louvain, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Boston University; Boston University; KU Leuven	Kumar, A (corresponding author), NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	cookson@mail.nih.gov	Cookson, Mark/AAW-2516-2021; Greggio, Elisa/H-6119-2013; Kumar, Azad/AAD-2093-2020; Taymans, Jean-Marc/M-9175-2018	Cookson, Mark/0000-0002-1058-3831; Greggio, Elisa/0000-0002-8172-3598; Taymans, Jean-Marc/0000-0001-5503-5524; Chan, Diane/0000-0003-3765-190X	NIH, National Institute on Aging; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000948] Funding Source: NIH RePORTER	NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work was funded by the Intramural Research Program of the NIH, National Institute on Aging. J-MT is a postdoctoral researcher of the Flemish fund for scientific research (FWO, Flanders, Belgium) and a Fulbright research scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand VS, 2009, FEBS J, V276, P466, DOI 10.1111/j.1742-4658.2008.06789.x; Bonifati V, 2007, NEUROCHEM RES, V32, P1700, DOI 10.1007/s11064-007-9324-y; Di Fonzo A, 2005, LANCET, V365, P412; Diggle TA, 1996, BIOCHEM J, V316, P447, DOI 10.1042/bj3160447; Funayama M, 2005, ANN NEUROL, V57, P918, DOI 10.1002/ana.20484; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2007, J NEUROCHEM, V102, P93, DOI 10.1111/j.1471-4159.2007.04523.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Heesom KJ, 1999, FEBS LETT, V457, P489, DOI 10.1016/S0014-5793(99)01094-7; Iaccarino C, 2007, HUM MOL GENET, V16, P1319, DOI 10.1093/hmg/ddm080; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Luzon-Toro B, 2007, HUM MOL GENET, V16, P2031, DOI 10.1093/hmg/ddm151; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ross OA, 2005, BIOCHEM SOC T, V33, P586, DOI 10.1042/BST0330586; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Williams-Gray CH, 2006, J NEUROL NEUROSUR PS, V77, P665, DOI 10.1136/jnnp.2005.085019; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	30	76	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8730	10.1371/journal.pone.0008730	http://dx.doi.org/10.1371/journal.pone.0008730			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090955	gold, Green Published, Green Accepted			2022-12-27	WOS:000273714900011
J	Movassagh, M; Choy, MK; Goddard, M; Bennett, MR; Down, TA; Foo, RSY				Movassagh, Mehregan; Choy, Mun-Kit; Goddard, Martin; Bennett, Martin R.; Down, Thomas A.; Foo, Roger S. -Y.			Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure	PLOS ONE			English	Article							HISTONE DEACETYLASES; CARDIAC-HYPERTROPHY; GENE-EXPRESSION; CANCER; GENOME; METHYLOME; DISEASE; HYPERMETHYLATION; DEMETHYLATION; INFLAMMATION	Epigenetic mechanisms such as microRNA and histone modification are crucially responsible for dysregulated gene expression in heart failure. In contrast, the role of DNA methylation, another well-characterized epigenetic mark, is unknown. In order to examine whether human cardiomyopathy of different etiologies are connected by a unifying pattern of DNA methylation pattern, we undertook profiling with ischaemic and idiopathic end-stage cardiomyopathic left ventricular (LV) explants from patients who had undergone cardiac transplantation compared to normal control. We performed a preliminary analysis using methylated-DNA immunoprecipitation-chip (MeDIP-chip), validated differential methylation loci by bisulfite-(BS) PCR and high throughput sequencing, and identified 3 angiogenesis-related genetic loci that were differentially methylated. Using quantitative RT-PCR, we found that the expression of these genes differed significantly between CM hearts and normal control (p<0.01). Moreover, for each individual LV tissue, differential methylation showed a predicted correlation to differential expression of the corresponding gene. Thus, differential DNA methylation exists in human cardiomyopathy. In this series of heterogenous cardiomyopathic LV explants, differential DNA methylation was found in at least 3 angiogenesis-related genes. While in other systems, changes in DNA methylation at specific genomic loci usually precede changes in the expression of corresponding genes, our current findings in cardiomyopathy merit further investigation to determine whether DNA methylation changes play a causative role in the progression of heart failure.	[Movassagh, Mehregan; Choy, Mun-Kit; Bennett, Martin R.; Foo, Roger S. -Y.] Univ Cambridge, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Cambridge, England; [Goddard, Martin] Papworth Hosp, Dept Histopathol, Cambridge CB3 8RE, England; [Down, Thomas A.] Univ Cambridge, Canc Res UK Gurdon Inst, Cambridge, England	University of Cambridge; Papworth Hospital; Cancer Research UK; University of Cambridge	Movassagh, M (corresponding author), Univ Cambridge, Addenbrookes Ctr Clin Invest, Div Cardiovasc Med, Cambridge, England.	rsyf2@cam.ac.uk	Choy, Mun-Kit/C-2741-2014	Choy, Mun-Kit/0000-0003-3998-0774; Foo, Roger/0000-0002-8079-4618; Bennett, Martin/0000-0002-2565-1825	British Heart Foundations [FS/07/035, PG 06/101/21461, RG04/001]; NIHR Cambridge Biomedical Research Centre; British Heart Foundation [RG/08/009/25841] Funding Source: researchfish	British Heart Foundations; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was supported by British Heart Foundations grants FS/07/035 (to RS-YF), PG 06/101/21461 (to MRB and RS-YF) and RG04/001 (to MRB), and the NIHR Cambridge Biomedical Research Centre. Support was also received through Dr Steve Baker from Roche Ltd for 454 FLX sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson DL, 2000, J MOL CELL CARDIOL, V32, P1353, DOI 10.1006/jmcc.2000.1171; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Backdahl L, 2009, INT J BIOCHEM CELL B, V41, P176, DOI 10.1016/j.biocel.2008.08.023; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Dorn GW, 2008, CIRCULATION, V118, P216, DOI 10.1161/CIRCULATIONAHA.108.789933; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; ENVER T, 1988, GENE DEV, V2, P698, DOI 10.1101/gad.2.6.698; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Heidecker B, 2008, CIRCULATION, V118, P238, DOI 10.1161/CIRCULATIONAHA.107.756544; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Katari S, 2009, HUM MOL GENET, V18, P3769, DOI 10.1093/hmg/ddp319; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Peaston AE, 2006, MAMM GENOME, V17, P365, DOI 10.1007/s00335-005-0180-2; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Su ZJ, 2004, P NATL ACAD SCI USA, V101, P12212, DOI 10.1073/pnas.0404631101; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wolffe AP, 1999, P NATL ACAD SCI USA, V96, P5894, DOI 10.1073/pnas.96.11.5894; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	43	138	151	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8564	10.1371/journal.pone.0008564	http://dx.doi.org/10.1371/journal.pone.0008564			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084101	gold, Green Published, Green Submitted			2022-12-27	WOS:000273554600005
J	Mercer, F; Kozhaya, L; Unutmaz, D				Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya			Expression and Function of TNF and IL-1 Receptors on Human Regulatory T Cells	PLOS ONE			English	Article							X-LINKED INHERITANCE; INTERLEUKIN-1 RECEPTOR; IMMUNE DYSREGULATION; FOXP3; EXPANSION; CD4(+); POLYENDOCRINOPATHY; IDENTIFICATION; ENTEROPATHY; SUPPRESSION	Regulatory T cells (Tregs) suppress immune activation and are critical in preventing autoimmune diseases. While the ability of Tregs to inhibit proliferation of other T cells is well established, it is not yet clear whether Tregs also modulate inflammatory cytokines during an immune response. Here, we show that the expression of inflammatory cytokine receptors IL-1R1 and TNFR2 were higher on resting mature Tregs compared to naive or memory T cells. While upon activation through the T cell receptor (TCR), expression of IL-1R1 and TNFR2 were upregulated on all T cell subsets, IL-1R1 maintained significantly higher expression on activated Tregs as compared to other T cell subsets. The decoy receptor for IL-1 (IL-1R2) was not expressed by any of the resting T cells but was rapidly upregulated and preferentially expressed upon TCR-stimulation on Tregs. In addition, we found that Tregs also expressed high levels of mRNA for IL-1 antagonist, IL-1RA. TCR-stimulation of naive T cells in the presence of TGF beta, which induces FOXP3 expression, however did not result in upregulation of IL-1R1 or IL-1R2. In addition, ectopic expression of FOXP3 in non-Tregs, while causing significant upregulation of IL-1R1 and IL-1R2, did not achieve the levels seen in bona fide Tregs. We also determined that resting human Tregs expressing IL-1R1 did not have higher suppressive capacity compared to IL-1R1- Tregs, suggesting that IL-1R1 does not discriminate suppressive resting Tregs in healthy individuals. Functionally, activated human Tregs displayed a capacity to neutralize IL-1 beta, which suggests a physiological significance for the expression of IL-1 decoy receptor on Tregs. In conclusion, our findings that human Tregs preferentially express receptors for TNF and IL-1 suggest a potential function in sensing and dampening local inflammation.	[Mercer, Frances; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA	New York University; New York University	Mercer, F (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	Derya@mac.com			National Institutes of Health (NIH) [R01 AI065303, T32 AI00718026A2, T32 AI007647-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007647, R01AI065303] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grant R01 AI065303 to DU and NIH training grants T32 AI00718026A2 and T32 AI007647-10 to FM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoum A, 2007, HUM REPROD, V22, P1464, DOI 10.1093/humrep/dem021; Antons AK, 2008, J IMMUNOL, V180, P764, DOI 10.4049/jimmunol.180.2.764; AREND WP, 1994, J IMMUNOL, V153, P4766; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Belkaid Y, 2008, EUR J IMMUNOL, V38, P918, DOI 10.1002/eji.200738120; Bellehumeur C, 2005, HUM REPROD, V20, P1177, DOI 10.1093/humrep/deh749; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Brinster C, 2008, J LEUKOCYTE BIOL, V84, P480, DOI 10.1189/jlb.0208085; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; Deknuydt F, 2009, CLIN IMMUNOL, V131, P298, DOI 10.1016/j.clim.2008.12.008; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Herrmann-Lavoie C, 2007, ENDOCRINOLOGY, V148, P5377, DOI 10.1210/en.2007-0368; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hori S, 2008, EUR J IMMUNOL, V38, P928, DOI 10.1002/eji.200838147; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Lang D, 1998, J IMMUNOL, V161, P6871; Lim A, 2009, JAIDS-J ACQ IMM DEF, V51, P248, DOI 10.1097/QAI.0b013e3181a74fad; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Minigo G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000402; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Ochs HD, 2007, ADV EXP MED BIOL, V601, P27; Orlando S, 1997, J IMMUNOL, V158, P3861; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Powrie Fiona, 2003, Novartis Found Symp, V252, P92; Preas HL, 1996, BLOOD, V88, P2465; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Ware CF, 2008, CYTOKINE GROWTH F R, V19, P183, DOI 10.1016/j.cytogfr.2008.05.001; Watts TH, 2005, ANNU REV IMMUNOL, V23, P23, DOI 10.1146/annurev.immunol.23.021704.115839; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	45	53	55	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8639	10.1371/journal.pone.0008639	http://dx.doi.org/10.1371/journal.pone.0008639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066156	Green Submitted, Green Published, gold			2022-12-27	WOS:000273456300006
J	Byrne, K; Colgrave, ML; Vuocolo, T; Pearson, R; Bidwell, CA; Cockett, NE; Lynn, DJ; Fleming-Waddell, JN; Tellam, RL				Byrne, Keren; Colgrave, Michelle L.; Vuocolo, Tony; Pearson, Roger; Bidwell, Christopher A.; Cockett, Noelle E.; Lynn, David J.; Fleming-Waddell, Jolena N.; Tellam, Ross L.			The Imprinted Retrotransposon-Like Gene PEG11 (RTL1) Is Expressed as a Full-Length Protein in Skeletal Muscle from Callipyge Sheep	PLOS ONE			English	Article							POLAR OVERDOMINANCE; TRANS-INTERACTION; LOCUS; DLK1; HYPERTROPHY; GROWTH; PHENOTYPE; MAMMALS; GENOME; LAMBS	Members of the Ty3-Gypsy retrotransposon family are rare in mammalian genomes despite their abundance in invertebrates and some vertebrates. These elements contain a gag-pol-like structure characteristic of retroviruses but have lost their ability to retrotranspose into the mammalian genome and are thought to be inactive relics of ancient retrotransposition events. One of these retrotransposon-like elements, PEG11 (also called RTL1) is located at the distal end of ovine chromosome 18 within an imprinted gene cluster that is highly conserved in placental mammals. The region contains several conserved imprinted genes including BEGAIN, DLK1, DAT, GTL2 (MEG3), PEG11 (RTL1), PEG11as, MEG8, MIRG and DIO3. An intergenic point mutation between DLK1 and GTL2 causes muscle hypertrophy in callipyge sheep and is associated with large changes in expression of the genes linked in cis between DLK1 and MEG8. It has been suggested that over-expression of DLK1 is the effector of the callipyge phenotype; however, PEG11 gene expression is also strongly correlated with the emergence of the muscling phenotype as a function of genotype, muscle type and developmental stage. To date, there has been no direct evidence that PEG11 encodes a protein, especially as its anti-sense transcript (PEG11as) contains six miRNA that cause cleavage of the PEG11 transcript. Using immunological and mass spectrometry approaches we have directly identified the full-length PEG11 protein from postnatal nuclear preparations of callipyge skeletal muscle and conclude that its over-expression may be involved in inducing muscle hypertrophy. The developmental expression pattern of the PEG11 gene is consistent with the callipyge mutation causing recapitulation of the normal fetal-like gene expression program during postnatal development. Analysis of the PEG11 sequence indicates strong conservation of the regions encoding the antisense microRNA and in at least two cases these correspond with structural or functional domains of the protein suggesting co-evolution of the sense and antisense genes.	[Byrne, Keren; Colgrave, Michelle L.; Vuocolo, Tony; Pearson, Roger; Tellam, Ross L.] CSIRO Livestock Ind, St Lucia, Qld, Australia; [Bidwell, Christopher A.; Fleming-Waddell, Jolena N.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Cockett, Noelle E.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Lynn, David J.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Utah System of Higher Education; Utah State University; Simon Fraser University	Byrne, K (corresponding author), CSIRO Livestock Ind, St Lucia, Qld, Australia.	Ross.Tellam@csiro.au	Tellam, Ross/T-2423-2019; Tellam, Ross/H-2798-2013; Colgrave, Michelle/A-5710-2012; Byrne, Keren A/H-7552-2013; Vuocolo, Tony/H-7533-2013	Tellam, Ross/0000-0003-2353-1640; Colgrave, Michelle/0000-0001-8463-805X; Byrne, Keren A/0000-0003-4759-0645; Lynn, David/0000-0003-4664-1404; Vuocolo, Tony/0000-0002-5574-8126	SheepGenomics Australia	SheepGenomics Australia	The research was funded by SheepGenomics Australia (www.sheepgenomics.com), which is a joint initiative of Meat and Livestock Australia and Australian Wool Innovation Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Birchler JA, 2000, CURR OPIN GENET DEV, V10, P211, DOI 10.1016/S0959-437X(00)00065-4; Brandt J, 2005, CYTOGENET GENOME RES, V110, P307, DOI 10.1159/000084963; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Carpenter E, 1996, J ANIM SCI, V74, P388; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; COCKETT NE, 1994, P NATL ACAD SCI USA, V91, P3019, DOI 10.1073/pnas.91.8.3019; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; Druker R, 2004, J INHERIT METAB DIS, V27, P319, DOI 10.1023/B:BOLI.0000031096.81518.66; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Harlow E., 1988, ANTIBODIES LAB MANUA; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jackson SP, 1997, J ANIM SCI, V75, P14; Kawahara M, 2009, J BIOL CHEM, V284, P17751, DOI 10.1074/jbc.M109.000299; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lorenzen CL, 2000, J ANIM SCI, V78, P78; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Pask AJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r1; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smit M, 2003, GENETICS, V163, P453; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2003, COMP BIOCHEM PHYS B, V134, P315, DOI 10.1016/S1096-4959(02)00265-8; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; WHITE JD, 2007, DIFFERENTIATION; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youngson NA, 2005, J MOL EVOL, V61, P481, DOI 10.1007/s00239-004-0332-0	53	31	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8638	10.1371/journal.pone.0008638	http://dx.doi.org/10.1371/journal.pone.0008638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072617	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200016
J	Guillen-Ahlers, H; Suckow, MA; Castellino, FJ; Ploplis, VA				Guillen-Ahlers, Hector; Suckow, Mark A.; Castellino, Francis J.; Ploplis, Victoria A.			Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden	PLOS ONE			English	Article							FAS LIGAND EXPRESSION; COLON-CANCER; COLORECTAL-CANCER; MEDIATED APOPTOSIS; CELL-SURVIVAL; CD95 LIGAND; AKT; GENE; RESISTANCE; REJECTION	Background: Fas, a member of the tumor necrosis family, is responsible for initiating the apoptotic pathway when bound to its ligand, Fas-L. Defects in the Fas-mediated apoptotic pathway have been reported in colorectal cancer. Methodology/Principal Findings: In the present study, a variant of the Apc(Min/+) mouse, a model for the human condition, Familial Adenomatous Polyposis (FAP), was generated with an additional deficiency of Fas (Apc(Min/+)/Fas(lpr)) by crossbreeding Apc(Min/+) mice with Fas deficient (Fas(lpr)) mice. One of the main limitations of the Apc(Min/+) mouse model is that it only develops benign polyps. However, Apc(Min/+)/Fas(lpr) mice presented with a dramatic increase in tumor burden relative to Apc(Min/+) mice and invasive lesions at advanced ages. Proliferation and apoptosis markers revealed an increase in cellular proliferation, but negligible changes in apoptosis, while p53 increased at early ages. Fas-L was lower in Apc(Min/+)/Fas(lpr) mice relative to Apc(Min/+) cohorts, which resulted in enhanced inflammation. Conclusions/Significance: This study demonstrated that imposition of a Fas deletion in an Apc(Min/+) background results in a more aggressive phenotype of the Apc(Min/+) mouse model, with more rapid development of invasive intestinal tumors and a decrease in Fas-L levels.	[Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Guillen-Ahlers, Hector; Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Castellino, Francis J.; Ploplis, Victoria A.] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Suckow, Mark A.] Univ Notre Dame, Freimann Life Sci Ctr, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; University of Notre Dame	Guillen-Ahlers, H (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	vploplis@nd.edu	Suckow, Mark/C-2696-2014	Guillen Ahlers, Hector/0000-0001-6077-3425; Suckow, Mark/0000-0001-7317-697X	NIH (NHLBI) [HL 73750]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073750] Funding Source: NIH RePORTER	NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH (NHLBI) grant HL 73750 (FJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTOMARE DA, PERTURBATIONS AKT SI, V24, P7455; Arai H, 1997, P NATL ACAD SCI USA, V94, P13862, DOI 10.1073/pnas.94.25.13862; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BEDI A, 1995, CANCER RES, V55, P1811; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chappell DB, 1999, CANCER RES, V59, P59; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fingleton B, 2007, CANCER RES, V67, P4800, DOI 10.1158/0008-5472.CAN-06-4473; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Fuchs EJ, 1997, CANCER RES, V57, P2550; Green CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006713; Guillen-Ahlers H, 2008, CARCINOGENESIS, V29, P1421, DOI 10.1093/carcin/bgn123; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kang SM, 1998, TRANSPLANT P, V30, P538, DOI 10.1016/S0041-1345(97)01396-1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kita H, 2006, J GASTROENTEROL, V41, P1053, DOI 10.1007/s00535-006-1894-y; Lee SJ, 2000, J IMMUNOL, V164, P1277, DOI 10.4049/jimmunol.164.3.1277; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mahidhara RS, 2005, J SURG RES, V123, P302, DOI 10.1016/j.jss.2004.08.016; Mann B, 1999, BRIT J CANCER, V79, P1262, DOI 10.1038/sj.bjc.6690202; Matloff ET, 2004, CANCER J, V10, P280, DOI 10.1097/00130404-200409000-00002; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; O'Connell J, 1998, J PATHOL, V186, P240; O'Connell J, 2000, ANN NY ACAD SCI, V910, P178; O'Connor L, 2000, CANCER RES, V60, P1217; Pitti RM, 1998, NATURE, V396, P699, DOI 10.1038/25387; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Powell WC, 1999, CURR BIOL, V9, P1441, DOI 10.1016/S0960-9822(00)80113-X; Restifo NP, 2000, NAT MED, V6, P493, DOI 10.1038/74955; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Seino KI, 1997, NAT MED, V3, P165, DOI 10.1038/nm0297-165; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Thant AA, 2001, CLIN EXP METASTAS, V18, P423, DOI 10.1023/A:1010921730952; VAUX DL, 1995, NATURE, V377, P576, DOI 10.1038/377576a0; WOFSY D, 1981, J EXP MED, V154, P1671, DOI 10.1084/jem.154.5.1671; Yagita H, 1996, NATURE, V379, P682, DOI 10.1038/379682a0; Yao H, 2004, BRIT J CANCER, V91, P1718, DOI 10.1038/sj.bjc.6602136; Zhou BHP, 2002, SEMIN ONCOL, V29, P62, DOI 10.1053/sonc.2002.34057	48	24	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9070	10.1371/journal.pone.0009070	http://dx.doi.org/10.1371/journal.pone.0009070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140201	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400009
J	Sharma, A; Callahan, LM; Sul, JY; Kim, TK; Barrett, L; Kim, M; Powers, JM; Federoff, H; Eberwine, J				Sharma, Anup; Callahan, Linda M.; Sul, Jai-Yoon; Kim, Tae Kyung; Barrett, Lindy; Kim, Minsun; Powers, James M.; Federoff, Howard; Eberwine, James			A Neurotoxic Phosphoform of Elk-1 Associates with Inclusions from Multiple Neurodegenerative Diseases	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; COMPLEX FACTOR ELK-1; TRANSCRIPTION FACTOR; PARKINSONS-DISEASE; HUNTINGTON DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; ACTIVATION; DOMAIN; MECHANISM	Neurodegenerative diseases are characterized by a number of features including the formation of inclusions, early synaptic degeneration and the selective loss of neurons. Molecules serving as links between these shared features have yet to be identified. Identifying candidates within the diseased microenvironment will open up novel avenues for therapeutic intervention. The transcription factor Elk-1 resides within multiple brain areas both in nuclear and extranuclear neuronal compartments. Interestingly, its de novo expression within a single dendrite initiates neuronal death. Given this novel regionalized function, we assessed whether extranuclear Elk-1 and/or phospho-Elk-1 (pElk-1) protein might be associated with a spectrum of human neurodegenerative disease cases including Lewy body Disease (e. g. Parkinson's), Alzheimer's disease, and Huntington's Disease. We first determined the importance of Elk-1 post-translational modifications on its ability to initiate regionalized cell death. We next screened human cases from three major neurodegenerative diseases to look for remarkable levels of Elk-1 and/or pElk-1 protein as well as their association with inclusions characteristic of these diseases. We compared our findings to age-matched control cases. We find that the ability of Elk-1 to initiate regionalized neuronal death depends on a specific phosphosite, T417. Furthermore, we find that T417(+) Elk-1 uniquely associates with several types of inclusions present in cases of human Lewy body Disease, Alzheimer's disease, and Huntington's Disease. These results suggest a molecular link between the presence of inclusions and neuronal loss that is shared across a spectrum of neurodegenerative disease.	[Sharma, Anup; Eberwine, James] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Callahan, Linda M.; Powers, James M.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Sul, Jai-Yoon; Kim, Tae Kyung; Eberwine, James] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Barrett, Lindy] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Kim, Minsun] Wonkwang Univ, Sch Med, Dept Physiol, Iksan, South Korea; [Federoff, Howard] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; [Eberwine, James] Univ Penn, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Rochester; University of Pennsylvania; Memorial Sloan Kettering Cancer Center; Wonkwang University; Georgetown University; University of Pennsylvania	Sharma, A (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	eberwine@upenn.edu	Eberwine, James/B-2247-2010		National Institutes of Health (NIH); NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Baba M, 1998, AM J PATHOL, V152, P879; Barrett LE, 2006, P NATL ACAD SCI USA, V103, P5155, DOI 10.1073/pnas.0510477103; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Chai YL, 2001, ONCOGENE, V20, P1357, DOI 10.1038/sj.onc.1204256; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; GALLOWAY PG, 1992, AM J PATHOL, V140, P809; GILLE H, 1995, CURR BIOL, V5, P1191, DOI 10.1016/S0960-9822(95)00235-1; Greenamyre JT, 2007, NEW ENGL J MED, V356, P518, DOI 10.1056/NEJMcibr067022; Herndon ES, 2009, J NEUROPATH EXP NEUR, V68, P250, DOI 10.1097/NEN.0b013e318198d320; INCE PG, 2008, GREENFIELDS NEUROPAT, P897; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; LOWE J, 2008, GREENFIELDS NEUROPAT, P1041; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MIRANTI CK, 1995, MOL CELL BIOL, V15, P3672; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Wakabayashi K, 2007, NEUROPATHOLOGY, V27, P494, DOI 10.1111/j.1440-1789.2007.00803.x; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yang SH, 1999, EMBO J, V18, P5666, DOI 10.1093/emboj/18.20.5666; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	27	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9002	10.1371/journal.pone.0009002	http://dx.doi.org/10.1371/journal.pone.0009002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126313	Green Published, gold			2022-12-27	WOS:000274207200005
J	Mangla, K; Dill, DL; Horowitz, MA				Mangla, Karan; Dill, David L.; Horowitz, Mark A.			Timing Robustness in the Budding and Fission Yeast Cell Cycles	PLOS ONE			English	Article							NETWORK; TRANSCRIPTION; MODEL; GENE	Robustness of biological models has emerged as an important principle in systems biology. Many past analyses of Boolean models update all pending changes in signals simultaneously (i.e., synchronously), making it impossible to consider robustness to variations in timing that result from noise and different environmental conditions. We checked previously published mathematical models of the cell cycles of budding and fission yeast for robustness to timing variations by constructing Boolean models and analyzing them using model-checking software for the property of speed independence. Surprisingly, the models are nearly, but not totally, speed-independent. In some cases, examination of timing problems discovered in the analysis exposes apparent inaccuracies in the model. Biologically justified revisions to the model eliminate the timing problems. Furthermore, in silico random mutations in the regulatory interactions of a speed-independent Boolean model are shown to be unlikely to preserve speed independence, even in models that are otherwise functional, providing evidence for selection pressure to maintain timing robustness. Multiple cell cycle models exhibit strong robustness to timing variation, apparently due to evolutionary pressure. Thus, timing robustness can be a basis for generating testable hypotheses and can focus attention on aspects of a model that may need refinement.	[Mangla, Karan; Dill, David L.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Horowitz, Mark A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; Stanford University	Mangla, K (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	dill@cs.stanford.edu			King Abdullah University of Science and Technology (KAUST); Stanford University Department of Computer Science	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Stanford University Department of Computer Science	This research has been funded in part by a King Abdullah University of Science and Technology (KAUST) research grant under the KAUST-Stanford Academic Excellence Alliance program, and by a seed grant from the Stanford University Department of Computer Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Any opinions, findings, and conclusions or recommendations expressed in this paper are those of the authors and do not necessarily reflect the views of any of the funders.	ALUR R, 1994, THEORETICAL COMPUTER, V126, P235; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Cimatti, 2002, LECT NOTES COMPUTER, P359, DOI DOI 10.1007/3-540-45657-0_29; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Fages Francois, 2004, Journal of Biological Physics and Chemistry, V4, P64, DOI 10.4024/2040402.jbpc.04.02; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Fisher J, 2008, LECT N BIOINFORMAT, V5054, P17, DOI 10.1007/978-3-540-68413-8_2; Fisher J, 2007, PLOS COMPUT BIOL, V3, P862, DOI 10.1371/journal.pcbi.0030092; Garg A, 2008, BIOINFORMATICS, V24, P1917, DOI 10.1093/bioinformatics/btn336; Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; MAHER M, 1995, MOL CELL BIOL, V15, P3129; Novak B, 2001, CHAOS, V11, P277, DOI 10.1063/1.1345725; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pfleger CM, 2000, GENE DEV, V14, P655; Shen XL, 2008, P NATL ACAD SCI USA, V105, P11340, DOI 10.1073/pnas.0805258105; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Sveiczer Akos, 2004, Briefings in Functional Genomics & Proteomics, V2, P298, DOI 10.1093/bfgp/2.4.298; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8906	10.1371/journal.pone.0008906	http://dx.doi.org/10.1371/journal.pone.0008906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126540	gold, Green Submitted, Green Published			2022-12-27	WOS:000274209700002
J	Potter, WB; O'Riordan, KJ; Barnett, D; Osting, SMK; Wagoner, M; Burger, C; Roopra, A				Potter, Wyatt B.; O'Riordan, Kenneth J.; Barnett, David; Osting, Susan M. K.; Wagoner, Matthew; Burger, Corinna; Roopra, Avtar			Metabolic Regulation of Neuronal Plasticity by the Energy Sensor AMPK	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; TUBEROUS SCLEROSIS GENE; RAT HIPPOCAMPAL SLICES; SYNAPTIC PLASTICITY; MAMMALIAN TARGET; LATE-PHASE; SIGNALING PATHWAY; GLUCOSE-CONCENTRATION; RAPAMYCIN PATHWAY	Long Term Potentiation (LTP) is a leading candidate mechanism for learning and memory and is also thought to play a role in the progression of seizures to intractable epilepsy. Maintenance of LTP requires RNA transcription, protein translation and signaling through the mammalian Target of Rapamycin (mTOR) pathway. In peripheral tissue, the energy sensor AMP-activated Protein Kinase (AMPK) negatively regulates the mTOR cascade upon glycolytic inhibition and cellular energy stress. We recently demonstrated that the glycolytic inhibitor 2-deoxy-D-glucose (2DG) alters plasticity to retard epileptogenesis in the kindling model of epilepsy. Reduced kindling progression was associated with increased recruitment of the nuclear metabolic sensor CtBP to NRSF at the BDNF promoter. Given that energy metabolism controls mTOR through AMPK in peripheral tissue and the role of mTOR in LTP in neurons, we asked whether energy metabolism and AMPK control LTP. Using a combination of biochemical approaches and field-recordings in mouse hippocampal slices, we show that the master regulator of energy homeostasis, AMPK couples energy metabolism to LTP expression. Administration of the glycolytic inhibitor 2-deoxy-D-glucose (2DG) or the mitochondrial toxin and anti-Type II Diabetes drug, metformin, or AMP mimetic AICAR results in activation of AMPK, repression of the mTOR pathway and prevents maintenance of Late-Phase LTP (L-LTP). Inhibition of AMPK by either compound-C or the ATP mimetic ara-A rescues the suppression of L-LTP by energy stress. We also show that enhanced LTP via AMPK inhibition requires mTOR signaling. These results directly link energy metabolism to plasticity in the mammalian brain and demonstrate that AMPK is a modulator of LTP. Our work opens up the possibility of using modulators of energy metabolism to control neuronal plasticity in diseases and conditions of aberrant plasticity such as epilepsy.	[Potter, Wyatt B.; O'Riordan, Kenneth J.; Barnett, David; Osting, Susan M. K.; Wagoner, Matthew; Burger, Corinna; Roopra, Avtar] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Potter, WB (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	roopra@neurology.wisc.edu	O'Riordan, Kenneth J./H-6467-2019	O'Riordan, Kenneth J./0000-0003-0081-6010; Burger, Corinna/0000-0002-9432-0114	Department of Neurology, Graduate School and Medical School; University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE); Neuroscience Training Program; University of Wisconsin-Madison; Molecular and Cellular Pharmacology program, University of Wisconsin-Madison	Department of Neurology, Graduate School and Medical School; University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE); Neuroscience Training Program; University of Wisconsin-Madison; Molecular and Cellular Pharmacology program, University of Wisconsin-Madison	This work was supported by funds from the Department of Neurology, Graduate School and Medical School, University of Wisconsin-Madison and Citizens United for Research in Epilepsy (CURE) to A.R. and C.B., and Lilly's Fund to A.R. W.B.P. is supported by the Neuroscience Training Program, University of Wisconsin-Madison. M. P. W. is supported by the Molecular and Cellular Pharmacology program, University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JL, 2006, EXP BRAIN RES, V169, P126, DOI 10.1007/s00221-005-0314-5; Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; AZARI NP, 1991, PSYCHOPHARMACOLOGY, V105, P521, DOI 10.1007/BF02244373; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chinnadurai G, 2002, MOL CELL, V9, P213, DOI 10.1016/S1097-2765(02)00443-4; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Godfraind Jean-Marie, 2006, Critical Reviews in Neurobiology, V18, P37; GOLD PE, 1986, BEHAV NEURAL BIOL, V45, P342, DOI 10.1016/S0163-1047(86)80022-X; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Henin N, 1996, BBA-GEN SUBJECTS, V1290, P197, DOI 10.1016/0304-4165(96)00021-9; Horike N, 2008, J BIOL CHEM, V283, P33902, DOI 10.1074/jbc.M802537200; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamal A, 1999, BRAIN RES, V824, P238, DOI 10.1016/S0006-8993(99)01215-9; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Kopf SR, 1996, NEUROBIOL LEARN MEM, V65, P189, DOI 10.1006/nlme.1996.0020; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; McNay EC, 2001, NEUROBIOL LEARN MEM, V75, P325, DOI 10.1006/nlme.2000.3976; Meske V, 2008, J BIOL CHEM, V283, P100, DOI 10.1074/jbc.M704292200; NELLIST M, 1993, CELL, V75, P1305; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Roopra A, 2001, Mol Interv, V1, P219; Rubin LJ, 2005, J APPL PHYSIOL, V98, P296, DOI 10.1152/japplphysiol.00075.2004; Sadgrove MP, 2007, BRAIN RES, V1165, P30, DOI 10.1016/j.brainres.2007.06.052; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schroeder JP, 2003, EUR J NEUROSCI, V17, P1482, DOI 10.1046/j.1460-9568.2003.02578.x; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tekkok S, 1996, J NEUROPHYSIOL, V76, P2343, DOI 10.1152/jn.1996.76.4.2343; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; Tsokas P, 2007, J NEUROSCI, V27, P5885, DOI 10.1523/JNEUROSCI.4548-06.2007; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Vickers CA, 2005, J PHYSIOL-LONDON, V568, P803, DOI 10.1113/jphysiol.2005.092924; Xu YZ, 2001, BRAIN RES, V895, P250, DOI 10.1016/S0006-8993(01)02077-7; Zhao YT, 1997, CAN J PHYSIOL PHARM, V75, P368, DOI 10.1139/cjpp-75-5-368; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200	59	133	138	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8996	10.1371/journal.pone.0008996	http://dx.doi.org/10.1371/journal.pone.0008996			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126541	Green Published, Green Submitted, gold			2022-12-27	WOS:000274209700021
J	Nabe-Nielsen, J; Sibly, RM; Forchhammer, MC; Forbes, VE; Topping, CJ				Nabe-Nielsen, Jacob; Sibly, Richard M.; Forchhammer, Mads C.; Forbes, Valery E.; Topping, Christopher J.			The Effects of Landscape Modifications on the Long-Term Persistence of Animal Populations	PLOS ONE			English	Article							LIFE-HISTORY; METAPOPULATION DYNAMICS; HABITAT FRAGMENTATION; PATCH SIZE; PATTERN; CONNECTIVITY; MODEL; CORRIDORS; ABUNDANCE; LESSONS	Background: The effects of landscape modifications on the long-term persistence of wild animal populations is of crucial importance to wildlife managers and conservation biologists, but obtaining experimental evidence using real landscapes is usually impossible. To circumvent this problem we used individual-based models (IBMs) of interacting animals in experimental modifications of a real Danish landscape. The models incorporate as much as possible of the behaviour and ecology of four species with contrasting life-history characteristics: skylark (Alauda arvensis), vole (Microtus agrestis), a ground beetle (Bembidion lampros) and a linyphiid spider (Erigone atra). This allows us to quantify the population implications of experimental modifications of landscape configuration and composition. Methodology/Principal Findings: Starting with a real agricultural landscape, we progressively reduced landscape complexity by (i) homogenizing habitat patch shapes, (ii) randomizing the locations of the patches, and (iii) randomizing the size of the patches. The first two steps increased landscape fragmentation. We assessed the effects of these manipulations on the long-term persistence of animal populations by measuring equilibrium population sizes and time to recovery after disturbance. Patch rearrangement and the presence of corridors had a large effect on the population dynamics of species whose local success depends on the surrounding terrain. Landscape modifications that reduced population sizes increased recovery times in the short-dispersing species, making small populations vulnerable to increasing disturbance. The species that were most strongly affected by large disturbances fluctuated little in population sizes in years when no perturbations took place. Significance: Traditional approaches to the management and conservation of populations use either classical methods of population analysis, which fail to adequately account for the spatial configurations of landscapes, or landscape ecology, which accounts for landscape structure but has difficulty predicting the dynamics of populations living in them. Here we show how realistic and replicable individual-based models can bridge the gap between non-spatial population theory and non-dynamic landscape ecology. A major strength of the approach is its ability to identify population vulnerabilities not detected by standard population viability analyses.	[Nabe-Nielsen, Jacob; Forchhammer, Mads C.] Univ Aarhus, Natl Environm Res Inst, Dept Arctic Environm, Roskilde, Denmark; [Nabe-Nielsen, Jacob; Sibly, Richard M.; Forchhammer, Mads C.; Forbes, Valery E.; Topping, Christopher J.] Roskilde Univ, Dept Environm Social & Spatial Change, CIPE, Roskilde, Denmark; [Sibly, Richard M.] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 2AJ, Berks, England; [Topping, Christopher J.] Univ Aarhus, Natl Environm Res Inst, Dept Wildlife Ecol & Biodivers, Ronde, Denmark	Aarhus University; Roskilde University; University of Reading; Aarhus University	Nabe-Nielsen, J (corresponding author), Univ Aarhus, Natl Environm Res Inst, Dept Arctic Environm, Roskilde, Denmark.	nabe@dmu.dk	Forchhammer, Mads/I-7474-2013; Forbes, Valery E/K-6763-2012; marcos, filipa/G-7133-2011; Topping, Christopher J/A-9167-2009; Nabe-Nielsen, Jacob/A-5891-2010; Forbes, Valery/P-9360-2019	Topping, Christopher J/0000-0003-0874-7603; Nabe-Nielsen, Jacob/0000-0002-0716-9525; Forbes, Valery/0000-0001-9819-9385; Sibly, Richard/0000-0001-6828-3543	Centre for Integrated Population Ecology (CIPE); Danish Natural Sciences Research Council	Centre for Integrated Population Ecology (CIPE); Danish Natural Sciences Research Council(Danish Natural Science Research Council)	The research was financed by The Centre for Integrated Population Ecology (CIPE). CIPE is an international centre of excellence supported by the Danish Natural Sciences Research Council (http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/scientific-research-councils/natural-sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Bender DJ, 2005, ECOLOGY, V86, P1023, DOI 10.1890/03-0769; Bilde T, 2004, ECOSCIENCE, V11, P64, DOI 10.1080/11956860.2004.11682810; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Caswell, 2000, MATRIX POPULATION MO; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Costanza R, 2002, ECOL MONOGR, V72, P203, DOI 10.1890/0012-9615(2002)072[0203:IEEMOT]2.0.CO;2; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; DeAngelis DL, 2005, ANNU REV ECOL EVOL S, V36, P147, DOI 10.1146/annurev.ecolsys.36.102003.152644; Duncan RP, 2007, ECOLOGY, V88, P324, DOI 10.1890/0012-9658(2007)88[324:TTMTOE]2.0.CO;2; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Ewers RM, 2007, CONSERV BIOL, V21, P926, DOI 10.1111/j.1523-1739.2007.00720.x; Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2; Fahrig L, 2005, ECOSYSTEM FUNCTION IN HETEROGENEOUS LANDSCAPES, P95, DOI 10.1007/0-387-24091-8_6; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falcy MR, 2007, CONSERV BIOL, V21, P1341, DOI 10.1111/j.1523-1739.2007.00766.x; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Flather CH, 2002, AM NAT, V159, P40, DOI 10.1086/324120; Fujiwara M, 2007, ECOLOGY, V88, P2345, DOI 10.1890/06-1405.1; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; HANSKI I, 1991, BIOL J LINN SOC, V42, P17, DOI 10.1111/j.1095-8312.1991.tb00549.x; Hiebeler D, 2000, ECOLOGY, V81, P1629, DOI 10.1890/0012-9658(2000)081[1629:POFLWS]2.0.CO;2; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; KAREIVA P, 1990, PHILOS T R SOC B, V330, P175, DOI 10.1098/rstb.1990.0191; King AW, 2002, ECOL MODEL, V147, P23, DOI 10.1016/S0304-3800(01)00400-8; Lande R, 2006, AM NAT, V168, P76, DOI 10.1086/504851; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2003, ECOL LETT, V6, P41, DOI 10.1046/j.1461-0248.2003.00391.x; MAY RM, 1975, J THEOR BIOL, V51, P511, DOI 10.1016/0022-5193(75)90078-8; Mccoy ED, 2007, ECOLOGY, V88, P1401, DOI 10.1890/06-1188; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McIntire EJB, 2007, J APPL ECOL, V44, P725, DOI 10.1111/j.1365-2664.2007.01326.x; MOLLER AP, 1989, OIKOS, V56, P240, DOI 10.2307/3565342; Pinheiro JC, 2004, MIXED EFFECTS MODELS; R Core Team, 2018, R LANG ENV STAT COMP; Ritchie LE, 2009, FOREST ECOL MANAG, V257, P1920, DOI 10.1016/j.foreco.2009.01.028; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Sibly RM, 2007, ECOL LETT, V10, P970, DOI 10.1111/j.1461-0248.2007.01092.x; Sibly Richard M., 2009, BMC Ecology, V9, P18, DOI 10.1186/1472-6785-9-18; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Thorbek P, 2005, BIOCONTROL, V50, P1, DOI 10.1007/s10526-004-1114-8; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Topping CJ, 1999, J ARACHNOL, V27, P378; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Turner MG, 2005, ANNU REV ECOL EVOL S, V36, P319, DOI 10.1146/annurev.ecolsys.36.102003.152614; Vos CC, 2001, AM NAT, V157, P24, DOI 10.1086/317004; Wiegand T, 2005, CONSERV BIOL, V19, P108, DOI 10.1111/j.1523-1739.2005.00208.x; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811	58	29	29	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8932	10.1371/journal.pone.0008932	http://dx.doi.org/10.1371/journal.pone.0008932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126614	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000274138000010
J	Hutson, CL; Abel, JA; Carroll, DS; Olson, VA; Braden, ZH; Hughes, CM; Dillon, M; Hopkins, C; Karem, KL; Damon, IK; Osorio, JE				Hutson, Christina L.; Abel, Jason A.; Carroll, Darin S.; Olson, Victoria A.; Braden, Zachary H.; Hughes, Christine M.; Dillon, Michael; Hopkins, Consuelo; Karem, Kevin L.; Damon, Inger K.; Osorio, Jorge E.			Comparison of West African and Congo Basin Monkeypox Viruses in BALB/c and C57BL/6 Mice	PLOS ONE			English	Article							EXPERIMENTAL-INFECTION; SQUIRRELS	Although monkeypox virus (MPXV) studies in wild rodents and non-human primates have generated important knowledge regarding MPXV pathogenesis and inferences about disease transmission, it might be easier to dissect the importance of virulence factors and correlates of protection to MPXV in an inbred mouse model. Herein, we compared the two clades of MPXV via two routes of infection in the BALB/c and C57BL/6 inbred mice strains. Our studies show that similar to previous animal studies, the Congo Basin strain of MPXV was more virulent than West African MPXV in both mouse strains as evidenced by clinical signs. Although animals did not develop lesions as seen in human MPX infections, localized signs were apparent with the foot pad route of inoculation, primarily in the form of edema at the site of inoculation; while the Congo Basin intranasal route of infection led to generalized symptoms, primarily weight loss. We have determined that future studies with MPXV and laboratory mice would be very beneficial in understanding the pathogenesis of MPXV, in particular if used in in vivo imaging studies. Although this mouse model may not suffice as a model of human MPX disease, with an appropriate inbred mouse model, we can unravel many unknown aspects of MPX pathogenesis, including virulence factors, disease progression in rodent hosts, and viral shedding from infected animals. In addition, such a model can be utilized to test antivirals and the next generation of orthopoxvirus vaccines for their ability to alter the course of disease.	[Hutson, Christina L.; Abel, Jason A.; Carroll, Darin S.; Olson, Victoria A.; Braden, Zachary H.; Hughes, Christine M.; Dillon, Michael; Hopkins, Consuelo; Karem, Kevin L.; Damon, Inger K.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Osorio, Jorge E.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	Centers for Disease Control & Prevention - USA; University of Wisconsin System; University of Wisconsin Madison	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	zuu6@cdc.gov			NIH [1-U54-AI-057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge membership within and support from the Region V 'Great Lakes' RCE (NIH award 1-U54-AI-057153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Meyer H, 2002, J CLIN MICROBIOL, V40, P2919, DOI 10.1128/JCM.40.8.2919-2921.2002; Osorio JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006592; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; Schultz DA, 2009, VIROLOGY, V383, P86, DOI 10.1016/j.virol.2008.09.025; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; SHCHELUKHINA EM, 1975, VOP VIRUSOL+, P703; Tesh RB, 2004, EMERG INFECT DIS, V10, P1563, DOI 10.3201/eid1009.040310; VONMAGNUS P, 1959, POX LIKE DIS CYNOMOL, P156; Xiao SY, 2005, EMERG INFECT DIS, V11, P539, DOI 10.3201/eid1104.040907; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	20	26	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8912	10.1371/journal.pone.0008912	http://dx.doi.org/10.1371/journal.pone.0008912			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111702	Green Published, gold			2022-12-27	WOS:000274114800015
J	MacKellar, J; Cushman, SW; Periwal, V				MacKellar, Jennifer; Cushman, Samuel W.; Periwal, Vipul			Waves of Adipose Tissue Growth in the Genetically Obese Zucker Fatty Rat	PLOS ONE			English	Article							CELL-SIZE; ADIPOCYTE SIZE; INSULIN-RESISTANCE; CELLULARITY; HYPERPHAGIA; DEPOTS	Background: In mammals, calories ingested in excess of those used are stored primarily as fat in adipose tissue; consistent ingestion of excess calories requires an enlargement of the adipose tissue mass. Thus, a dysfunction in adipose tissue growth may be a key factor in insulin resistance due to imbalanced fat storage and disrupted insulin action. Adipose tissue growth requires the recruitment and then the development of adipose precursor cells, but little is known about these processes in vivo. Methodology: In this study, adipose cell-size probability distributions were measured in two Zucker fa/fa rats over a period of 151 and 163 days, from four weeks of age, using micro-biopsies to obtain subcutaneous (inguinal) fat tissue from the animals. These longitudinal probability distributions were analyzed to assess the probability of periodic phenomena. Conclusions: Adipose tissue growth in this strain of rat exhibits a striking temporal periodicity of approximately 55 days. A simple model is proposed for the periodicity, with PPAR signaling driven by a deficit in lipid uptake capacity leading to the periodic recruitment of new adipocytes. This model predicts that the observed period will be diet-dependent.	[MacKellar, Jennifer; Cushman, Samuel W.] NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA; [Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	MacKellar, J (corresponding author), NIDDK, Diabet Branch, NIH, Bethesda, MD 20892 USA.	vipulp@mail.nih.gov	Periwal, Vipul/I-1728-2012	MacKellar, Jennifer/0000-0003-0162-7430	National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013035, ZIADK075014] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Diabetes Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Andersson CX, 2008, DIABETES-METAB RES, V24, P595, DOI 10.1002/dmrr.889; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Drolet R, 2008, INT J OBESITY, V32, P283, DOI 10.1038/sj.ijo.0803708; Farkas K, 1996, LIPIDS, V31, P313, DOI 10.1007/BF02529878; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Gregory P., 2005, BAYESIAN LOGICAL DAT; Hausman DB, 2004, EXP BIOL MED, V229, P512, DOI 10.1177/153537020422900609; Hausman DB, 2003, OBES RES, V11, P674, DOI 10.1038/oby.2003.96; HIRSCH J, 1968, J LIPID RES, V9, P110; HIRSCH J, 1970, FED PROC, V29, P1516; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; JOHNSON PR, 1971, J LIPID RES, V12, P706; KAPLAN ML, 1980, METABOLISM, V29, P333, DOI 10.1016/0026-0495(80)90006-2; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Marques BG, 1998, AM J PHYSIOL-REG I, V275, pR1898, DOI 10.1152/ajpregu.1998.275.6.R1898; Marti A, 2008, P NUTR SOC, V67, P1, DOI 10.1017/S002966510800596X; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; REYNE Y, 1985, J LIPID RES, V26, P1036; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; SMITH U, 1971, J LIPID RES, V12, P65; SMITH U, 1971, ANAT REC, V169, P97, DOI 10.1002/ar.1091690109; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tierney L., 1990, LISP STAT OBJECT ORI; VASSELLI JR, 1985, BRAIN RES BULL, V14, P633, DOI 10.1016/0361-9230(85)90113-3; VASSELLI JR, 1992, AM J PHYSIOL, V262, pR33, DOI 10.1152/ajpregu.1992.262.1.R33	28	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8197	10.1371/journal.pone.0008197	http://dx.doi.org/10.1371/journal.pone.0008197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107501	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896100001
J	Akkers, RC; van Heeringen, SJ; Manak, JR; Green, RD; Stunnenberg, HG; Veenstra, GJC				Akkers, Robert C.; van Heeringen, Simon J.; Manak, J. Robert; Green, Roland D.; Stunnenberg, Hendrik G.; Veenstra, Gert Jan C.			ChIP-Chip Designs to Interrogate the Genome of Xenopus Embryos for Transcription Factor Binding and Epigenetic Regulation	PLOS ONE			English	Article							GENE-REGULATION; STEM-CELLS; HISTONE MODIFICATIONS; CHROMATIN STATE; HIGH-RESOLUTION; MAPS; TBP; METHYLATIONS; ROLES; DNA	Background: Chromatin immunoprecipitation combined with genome tile path microarrays or deep sequencing can be used to study genome-wide epigenetic profiles and the transcription factor binding repertoire. Although well studied in a variety of cell lines, these genome-wide profiles have so far been little explored in vertebrate embryos. Principal Findings: Here we report on two genome tile path ChIP-chip designs for interrogating the Xenopus tropicalis genome. In particular, a whole-genome microarray design was used to identify active promoters by close proximity to histone H3 lysine 4 trimethylation. A second microarray design features these experimentally derived promoter regions in addition to currently annotated 5' ends of genes. These regions truly represent promoters as shown by binding of TBP, a key transcription initiation factor. Conclusions: A whole-genome and a promoter tile path microarray design was developed. Both designs can be used to study epigenetic phenomena and transcription factor binding in developing Xenopus embryos.	[Akkers, Robert C.; van Heeringen, Simon J.; Stunnenberg, Hendrik G.; Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NL-6525 ED Nijmegen, Netherlands; [Manak, J. Robert; Green, Roland D.] Roche Nimblegen Inc, Madison, WI USA; [Manak, J. Robert] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	Radboud University Nijmegen; Roche Holding; University of Iowa	Akkers, RC (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NL-6525 ED Nijmegen, Netherlands.	g.veenstra@ncmls.ru.nl	Veenstra, Gert Jan C./D-4963-2012; van Heeringen, Simon/Q-8530-2017; Stunnenberg, Hendrik G./D-6875-2012	Veenstra, Gert Jan C./0000-0002-7787-4940; van Heeringen, Simon/0000-0002-0411-3219; Stunnenberg, Hendrik G./0000-0002-0066-1576; Manak, John/0000-0002-6562-7694	United States National Institutes of Health [5 R01 HD054356]; Netherlands Organization of Scientific Research [864.03.002]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054356] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the United States National Institutes of Health (grant 5 R01 HD054356, www.nih.gov) and the Netherlands Organization of Scientific Research (NWO-ALW VIDI grant 864.03.002, www.nwo.nl) to GJCV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Jacobi UG, 2007, EMBO J, V26, P3900, DOI 10.1038/sj.emboj.7601822; Jallow Z, 2004, P NATL ACAD SCI USA, V101, P13525, DOI 10.1073/pnas.0405536101; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roh Tae-Young, 2008, V387, P95; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Veenstra GJC, 2000, SCIENCE, V290, P2312, DOI 10.1126/science.290.5500.2312; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wardle FC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r71; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8820	10.1371/journal.pone.0008820	http://dx.doi.org/10.1371/journal.pone.0008820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098671	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100012
J	Zhou, Y; Hancock, JF; Lichtenberger, LM				Zhou, Yong; Hancock, John F.; Lichtenberger, Lenard M.			The Nonsteroidal Anti-Inflammatory Drug Indomethacin Induces Heterogeneity in Lipid Membranes: Potential Implication for Its Diverse Biological Action	PLOS ONE			English	Article							PLASMA-MEMBRANE; DOMAIN FORMATION; H-RAS; RAFTS; ACTIVATION; MECHANISMS; PROTEINS; PHASES; AGENTS; NSAIDS	Background: The nonsteroidal anti-inflammatory drug (NSAID), indomethacin (Indo), has a large number of divergent biological effects, the molecular mechanism(s) for which have yet to be fully elucidated. Interestingly, Indo is highly amphiphilic and associates strongly with lipid membranes, which influence localization, structure and function of membrane-associating proteins and actively regulate cell signaling events. Thus, it is possible that Indo regulates diverse cell functions by altering micro-environments within the membrane. Here we explored the effect of Indo on the nature of the segregated domains in a mixed model membrane composed of dipalmitoyl phosphatidyl-choline (di16:0 PC, or DPPC) and dioleoyl phosphatidyl-choline (di18:1 PC or DOPC) and cholesterol that mimics biomembranes. Methodology/Principal Findings: Using a series of fluorescent probes in a fluorescence resonance energy transfer (FRET) study, we found that Indo induced separation between gel domains and fluid domains in the mixed model membrane, possibly by enhancing the formation of gel-phase domains. This effect originated from the ability of Indo to specifically target the ordered domains in the mixed membrane. These findings were further confirmed by measuring the ability of Indo to affect the fluidity-dependent fluorescence quenching and the level of detergent resistance of membranes. Conclusion/Significance: Because the tested lipids are the main lipid constituents in cell membranes, the observed formation of gel phase domains induced by Indo potentially occurs in biomembranes. This marked Indo-induced change in phase behavior potentially alters membrane protein functions, which contribute to the wide variety of biological activities of Indo and other NSAIDs.	[Zhou, Yong; Hancock, John F.; Lichtenberger, Lenard M.] Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston	Zhou, Y (corresponding author), Univ Texas Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX USA.	Lenard.M.Lichtenberger@uth.tmc.edu		Hancock, John/0000-0003-0542-4710; Zhou, Yong/0000-0002-0214-8151	Digestive Disease Center, Texas Medical Center, Houston, Texas [T32 - DK07664, DK56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007664, P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066717] Funding Source: NIH RePORTER	Digestive Disease Center, Texas Medical Center, Houston, Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by National Institutes of Health (NIH) grant T32 - DK07664 and Public Health Service (PHS) grant DK56338 from the Digestive Disease Center, Texas Medical Center, Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 2006, TOHOKU J EXPT MED, V135, P205; Aouad SM, 2004, J IMMUNOL, V172, P2316, DOI 10.4049/jimmunol.172.4.2316; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Chan TA, 1998, P NATL ACAD SCI USA, V95, P681, DOI 10.1073/pnas.95.2.681; Gennis R. B., 1989, BIOMEMBRANES MOL STR, DOI [10.1007/978-1-4757-2065-5, DOI 10.1007/978-1-4757-2065-5]; Gerli R, 1998, BLOOD, V92, P2389, DOI 10.1182/blood.V92.7.2389.2389_2389_2398; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Keller S, 2005, J AM CHEM SOC, V127, P11469, DOI 10.1021/ja052764q; LASONDER E, 1990, J COLLOID INTERF SCI, V139, P469, DOI 10.1016/0021-9797(90)90119-9; Leidy G, 2001, BIOPHYS J, V80, P1819, DOI 10.1016/S0006-3495(01)76152-8; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lichtenberger LM, 2006, J PHARM PHARMACOL, V58, P1421, DOI 10.1211/jpp.58.10.0001; LICHTENBERGER LM, 1995, NAT MED, V1, P154, DOI 10.1038/nm0295-154; Lucio M, 2008, LANGMUIR, V24, P4132, DOI 10.1021/la703584s; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Silva LC, 2007, BIOPHYS J, V92, P502, DOI 10.1529/biophysj.106.091876; Silvius JR, 2003, BIOPHYS J, V85, P1034, DOI 10.1016/S0006-3495(03)74542-1; SKLAR LA, 1979, BIOCHEMISTRY-US, V18, P1707, DOI 10.1021/bi00576a012; Soh JW, 2003, PROG EXP TUMOR RES, V37, P261; SPINK CH, 1990, BIOCHIM BIOPHYS ACTA, V1023, P25, DOI 10.1016/0005-2736(90)90005-9; STADLER P, 1991, DIGEST DIS SCI, V36, P594, DOI 10.1007/BF01297025; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; Zhou Y, 2005, BIOPHYS J, V89, P1789, DOI 10.1529/biophysj.104.054510	26	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8811	10.1371/journal.pone.0008811	http://dx.doi.org/10.1371/journal.pone.0008811			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098676	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100005
J	Forsberg, EC; Passegue, E; Prohaska, SS; Wagers, AJ; Koeva, M; Stuart, JM; Weissman, IL				Forsberg, E. Camilla; Passegue, Emmanuelle; Prohaska, Susan S.; Wagers, Amy J.; Koeva, Martina; Stuart, Joshua M.; Weissman, Irving L.			Molecular Signatures of Quiescent, Mobilized and Leukemia-Initiating Hematopoietic Stem Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; MYELOPROLIFERATIVE DISORDER; PROGENITOR CELLS; SELF-RENEWAL; NF-Y; MARROW; DIFFERENTIATION; RECEPTOR; PBX1	Hematopoietic stem cells (HSC) are rare, multipotent cells capable of generating all specialized cells of the blood system. Appropriate regulation of HSC quiescence is thought to be crucial to maintain their lifelong function; however, the molecular pathways controlling stem cell quiescence remain poorly characterized. Likewise, the molecular events driving leukemogenesis remain elusive. In this study, we compare the gene expression profiles of steady-state bone marrow HSC to non-self-renewing multipotent progenitors; to HSC treated with mobilizing drugs that expand the HSC pool and induce egress from the marrow; and to leukemic HSC in a mouse model of chronic myelogenous leukemia. By intersecting the resulting lists of differentially regulated genes we identify a subset of molecules that are downregulated in all three circumstances, and thus may be particularly important for the maintenance and function of normal, quiescent HSC. These results identify potential key regulators of HSC and give insights into the clinically important processes of HSC mobilization for transplantation and leukemic development from cancer stem cells.	[Forsberg, E. Camilla; Koeva, Martina; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA; [Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Prohaska, Susan S.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Prohaska, Susan S.; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wagers, Amy J.] Harvard Univ, Harvard Stem Cell Inst, Joslin Diabet Ctr, Cambridge, MA 02138 USA; [Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Stanford University; Stanford University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu		Passegue, Emmanuelle/0000-0002-3516-297X; Stuart, Joshua/0000-0002-2171-565X	California Institute for Regenerative Medicine; American Society of Hematology (ASH); Burroughs Wellcome Fund; National Institutes of Health (NIH) [1RO1HL092471-01, 1RO1HL088582-01, R01CA086017, R01HL058770, R01CA086065, P01DK053074]; California Institute for Regenerative Medicine (CIRM); Department of Biomolecular Engineering, University of California Santa Cruz; National Science Foundation's Division of Biological Infrastructure [DBI-0543197]; Alfred P. Sloan Foundation; NATIONAL CANCER INSTITUTE [R01CA086017, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770, R01HL092471, R01HL088582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK053074] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); American Society of Hematology (ASH); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Department of Biomolecular Engineering, University of California Santa Cruz; National Science Foundation's Division of Biological Infrastructure(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a New Faculty Award from the California Institute for Regenerative Medicine (ECF); by an American Society of Hematology (ASH) Scholar Award (EP), by grants from the Burroughs Wellcome Fund (AJW) and the National Institutes of Health (NIH) (1RO1HL092471-01 (EP) and 1RO1HL088582-01 (AJW)); a predoctoral fellowship from the California Institute for Regenerative Medicine (CIRM) stem cell training program at the Institute for Biology of Stem Cells, Department of Biomolecular Engineering, University of California Santa Cruz (MK); the National Science Foundation's Division of Biological Infrastructure DBI-0543197 (JMS) and by a fellowship from the Alfred P. Sloan Foundation (JMS); and by NIH grants R01CA086017, R01HL058770, R01CA086065, and P01DK053074 (ILW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2003, BLOOD, V101, P383, DOI 10.1182/blood-2002-06-1780; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Antonchuk J, 2001, EXP HEMATOL, V29, P1125, DOI 10.1016/S0301-472X(01)00681-6; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Choo A, 2006, CURR GENE THER, V6, P543, DOI 10.2174/156652306778520683; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dick JE, 2005, INT J HEMATOL, V82, P389, DOI 10.1532/IJH97.05144; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gitler AD, 2004, PEDIATR RES, V55, P581, DOI 10.1203/01.PDR.0000113462.98851.2E; Guzman Monica L, 2004, Cancer Control, V11, P97; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jordan CT, 2007, BEST PRACT RES CL HA, V20, P13, DOI 10.1016/j.beha.2006.10.005; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Masuoka HC, 2002, BLOOD, V99, P736, DOI 10.1182/blood.V99.3.736; Mikkola H, 2009, BLOOD, V113, P2871, DOI 10.1182/blood-2009-01-199794; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; NEBEN S, 1993, BLOOD, V81, P1960; Ng SYM, 2007, CURR OPIN IMMUNOL, V19, P116, DOI 10.1016/j.coi.2007.02.014; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Papayannopoulou T, 2003, CURR OPIN HEMATOL, V10, P214, DOI 10.1097/00062752-200305000-00004; Passegue E, 2001, CELL, V104, P21, DOI 10.1016/S0092-8674(01)00188-X; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pina C, 2008, CELL STEM CELL, V2, P264, DOI 10.1016/j.stem.2008.01.013; Praetor A, 2009, BLOOD, V113, P1919, DOI 10.1182/blood-2008-06-159574; Preisler HD, 2001, AM J HEMATOL, V68, P23, DOI 10.1002/ajh.1144; Quentmeier H, 2005, LEUKEMIA, V19, P1488, DOI 10.1038/sj.leu.2403820; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; SANTAGUIDA M, 2009, CANC CELL IN PRESS; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Sato T, 2008, CANCER SCI, V99, P1407, DOI 10.1111/j.1349-7006.2008.00842.x; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Sugano Y, 2008, BLOOD, V111, P1167, DOI 10.1182/blood-2007-03-081554; Svensson E, 2007, DNA CELL BIOL, V26, P589, DOI 10.1089/dna.2007.0586; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Testa U, 2004, LEUKEMIA, V18, P1864, DOI 10.1038/sj.leu.2403472; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida K, 1997, CYTOGENET CELL GENET, V78, P209, DOI 10.1159/000134658; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zhu J, 2005, P NATL ACAD SCI USA, V102, P11728, DOI 10.1073/pnas.0503405102; Zhu J, 2003, BLOOD, V102, P2420, DOI 10.1182/blood-2003-01-0251	83	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8785	10.1371/journal.pone.0008785	http://dx.doi.org/10.1371/journal.pone.0008785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098702	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779000014
J	Lamba, DA; McUsic, A; Hirata, RK; Wang, PR; Russell, D; Reh, TA				Lamba, Deepak A.; McUsic, Andrew; Hirata, Roli K.; Wang, Pei-Rong; Russell, David; Reh, Thomas A.			Generation, Purification and Transplantation of Photoreceptors Derived from Human Induced Pluripotent Stem Cells	PLOS ONE			English	Article							RETINOID-BINDING PROTEIN; FIBROBLASTS; DIFFERENTIATION; INDUCTION; MOUSE	Background: Inherited and acquired retinal degenerations are frequent causes of visual impairment and photoreceptor cell replacement therapy may restore visual function to these individuals. To provide a source of new retinal neurons for cell based therapies, we developed methods to derive retinal progenitors from human ES cells. Methodology/Physical Findings: In this report we have used a similar method to direct induced pluripotent stem cells (iPS) from human fibroblasts to a retinal progenitor fate, competent to generate photoreceptors. We also found we could purify the photoreceptors derived from the iPS cells using fluorescence activated cell sorting (FACS) after labeling photoreceptors with FACS purified iPSC derived photoreceptors, they were able to integrate into a normal mouse retina and express photoreceptor markers. Conclusions: This report provides evidence that enriched populations of human photoreceptors can be derived from iPS cells.	[Lamba, Deepak A.; McUsic, Andrew; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Hirata, Roli K.; Wang, Pei-Rong; Russell, David] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Russell, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Lamba, Deepak A.; McUsic, Andrew; Russell, David; Reh, Thomas A.] Univ Washington, Inst Stem Cells & Regenerat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Lamba, DA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@u.washington.edu			Foundation Fighting Blindness [TA-CBT-0608-0464-UWA-EW, TACBT-0507-0377-UWA]; National Institute of General Medical Sciences (NIGMS) [5P01GM081619]; National Institutes of Health (NIH); National Science Foundation (NSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	Foundation Fighting Blindness(European Commission); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a gift from an anonymous donor and support from the Foundation Fighting Blindness (TA-CBT-0608-0464-UWA-EW and TACBT-0507-0377-UWA) and National Institute of General Medical Sciences (NIGMS) 5P01GM081619 to T. A. R, National Institutes of Health (NIH) funds to D.W.R and a National Science Foundation (NSF) Fellowship to A.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; EISENFELD AJ, 1985, INVEST OPHTH VIS SCI, V26, P775; Gharwan H, 2007, MOL THER, V15, P1827, DOI 10.1038/sj.mt.6300244; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YOKOYAMA T, 1992, EXP EYE RES, V55, P225, DOI 10.1016/0014-4835(92)90186-V; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	288	313	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8763	10.1371/journal.pone.0008763	http://dx.doi.org/10.1371/journal.pone.0008763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098701	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779000009
J	Bass, MS; Finer, M; Jenkins, CN; Kreft, H; Cisneros-Heredia, DF; McCracken, SF; Pitman, NCA; English, PH; Swing, K; Villa, G; Di Fiore, A; Voigt, CC; Kunz, TH				Bass, Margot S.; Finer, Matt; Jenkins, Clinton N.; Kreft, Holger; Cisneros-Heredia, Diego F.; McCracken, Shawn F.; Pitman, Nigel C. A.; English, Peter H.; Swing, Kelly; Villa, Gorky; Di Fiore, Anthony; Voigt, Christian C.; Kunz, Thomas H.			Global Conservation Significance of Ecuador's Yasuni National Park	PLOS ONE			English	Article							BIRD COMMUNITY STRUCTURE; NEOTROPICAL RAIN-FOREST; TREE ALPHA-DIVERSITY; SPECIES RICHNESS; CLIMATE-CHANGE; AMAZONIAN FOREST; BATRACHOCHYTRIUM-DENDROBATIDIS; BIODIVERSITY HOTSPOTS; WESTERN AMAZON; LAND-USE	Background: The threats facing Ecuador's Yasuni National Park are emblematic of those confronting the greater western Amazon, one of the world's last high-biodiversity wilderness areas. Notably, the country's second largest untapped oil reserves-called "ITT''-lie beneath an intact, remote section of the park. The conservation significance of Yasuni may weigh heavily in upcoming state-level and international decisions, including whether to develop the oil or invest in alternatives. Methodology/Principal Findings: We conducted the first comprehensive synthesis of biodiversity data for Yasuni. Mapping amphibian, bird, mammal, and plant distributions, we found eastern Ecuador and northern Peru to be the only regions in South America where species richness centers for all four taxonomic groups overlap. This quadruple richness center has only one viable strict protected area (IUCN levels I-IV): Yasuni. The park covers just 14% of the quadruple richness center's area, whereas active or proposed oil concessions cover 79%. Using field inventory data, we compared Yasuni's local (alpha) and landscape (gamma) diversity to other sites, in the western Amazon and globally. These analyses further suggest that Yasuni is among the most biodiverse places on Earth, with apparent world richness records for amphibians, reptiles, bats, and trees. Yasuni also protects a considerable number of threatened species and regional endemics. Conclusions/Significance: Yasuni has outstanding global conservation significance due to its extraordinary biodiversity and potential to sustain this biodiversity in the long term because of its 1) large size and wilderness character, 2) intact large-vertebrate assemblage, 3) IUCN level-II protection status in a region lacking other strict protected areas, and 4) likelihood of maintaining wet, rainforest conditions while anticipated climate change-induced drought intensifies in the eastern Amazon. However, further oil development in Yasuni jeopardizes its conservation values. These findings form the scientific basis for policy recommendations, including stopping any new oil activities and road construction in Yasuni and creating areas off-limits to large-scale development in adjacent northern Peru.	[Bass, Margot S.; Villa, Gorky] Finding Species, Takoma Pk, MD USA; [Finer, Matt] Save Amer Forests, Washington, DC USA; [Jenkins, Clinton N.; Pitman, Nigel C. A.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Jenkins, Clinton N.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Kreft, Holger] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Cisneros-Heredia, Diego F.] Kings Coll London, Dept Geog, London WC2R 2LS, England; [Cisneros-Heredia, Diego F.; Swing, Kelly] Univ San Francisco Quito, Coll Biol & Environm Sci, Quito, Ecuador; [McCracken, Shawn F.] Texas State Univ, Dept Biol, San Marcos, TX USA; [McCracken, Shawn F.] TADPOLE Org, San Marcos, TX USA; [English, Peter H.] Univ Texas Austin, Sch Biol Sci, Austin, TX 78712 USA; [Di Fiore, Anthony] NYU, Dept Anthropol, New York, NY 10003 USA; [Voigt, Christian C.] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	Duke University; University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego; University of London; King's College London; Texas State University System; Texas State University San Marcos; University of Texas System; University of Texas Austin; New York University; Leibniz Institut fur Zoo und Wildtierforschung; Boston University	Bass, MS (corresponding author), Finding Species, Takoma Pk, MD USA.	matt@saveamericasforests.org	Cisneros-Heredia, Diego F./D-1744-2011; Kreft, Holger/A-4736-2008; McCracken, Shawn/G-9524-2012; Kreft, Holger/AAY-7573-2020; Jenkins, Clinton/D-6134-2011; Pitman, Nigel C A/A-7681-2008	Cisneros-Heredia, Diego F./0000-0002-6132-2738; Kreft, Holger/0000-0003-4471-8236; Kreft, Holger/0000-0003-4471-8236; Jenkins, Clinton/0000-0003-2198-0637; Pitman, Nigel C A/0000-0002-9211-2880; McCracken, Shawn/0000-0001-6455-537X	Blue Moon Fund; Conservation, Food & Health Foundation; Forrest and Frances Lattner Foundation; US National Science Foundation [DBI-0434875]; Texas State University-Department of Biology; TADPOLE; US National Science Foundation; L.S.B. Leakey Foundation; Wenner-Gren Foundation for Anthropological Research; Primate Conservation, Inc.	Blue Moon Fund; Conservation, Food & Health Foundation; Forrest and Frances Lattner Foundation; US National Science Foundation(National Science Foundation (NSF)); Texas State University-Department of Biology; TADPOLE; US National Science Foundation(National Science Foundation (NSF)); L.S.B. Leakey Foundation; Wenner-Gren Foundation for Anthropological Research; Primate Conservation, Inc.	The Blue Moon Fund, the Conservation, Food & Health Foundation, and the Forrest and Frances Lattner Foundation funded MF. The US National Science Foundation (Graduate Research Fellowship Program), Texas State University-Department of Biology, and TADPOLE funded SM. The US National Science Foundation, the L.S.B. Leakey Foundation, the Wenner-Gren Foundation for Anthropological Research, and Primate Conservation, Inc. funded AD. Establishment of the Tiputini Biodiversity Station supported by the US National Science Foundation-DBI-0434875 (Thomas H. Kunz, PI, with Laura M. MacLatchy, Christopher J. Schneider, and C. Kelly Swing, Co-PIs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre LF, 2002, J MAMMAL, V83, P775, DOI 10.1644/1545-1542(2002)083<0775:SOANSB>2.0.CO;2; AGUIRRE M, 2007, QUIEN IMPORTAN ESAS; *AIDESEP, 2005, EST TECN DEL TERR FA; ALBACETE C, 2004, RAPID EVALUATION GRA; ALONSO JA, IMPORTANCIA ZONA RES; Alvarez MD, 2002, CONSERV BIOL, V16, P1086, DOI 10.1046/j.1523-1739.2002.00537.x; ANDERSON RP, 2003, INT C EC TRANSP ICOE, P597; *AZ STAT U IUCN CO, 2008, AN MANN 2008 IUCN RE; AZEVEDORAMOS C, 2004, IUCN 2008; BALSLEV H, 1988, TAXON, V37, P567, DOI 10.2307/1221100; BARRIGA R, 2001, CONSERVACION DESARRO, P139; Barthlott W, 2005, NOVA ACT LC, V92, P61; Bilsborrow Richard E., 2004, Acta Amaz., V34, P635, DOI 10.1590/S0044-59672004000400015; *BIRDLIFE INT, 2008, HARP HARP; *BIRDLIFE INT, 2008, MORPH GUIAN; Blake JG, 2007, CONDOR, V109, P237, DOI 10.1650/0010-5422(2007)109[237:NFBCAC]2.0.CO;2; Blake JG, 2009, BIOTROPICA, V41, P85, DOI 10.1111/j.1744-7429.2008.00445.x; Boitani L, 2008, PLOS BIOL, V6, P436, DOI 10.1371/journal.pbio.0060066; BOUBLI JP, 2008, IUCN 2008; BOYLA K, 2005, BIRDLIFE CONSERVATIO, V14; BROMLEY RJ, 1972, TIJDSCHR ECON SOC GE, V63, P278, DOI 10.1111/j.1467-9663.1972.tb01179.x; Bunyavejchewin S, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P482; Burgess N., 2004, Terrestrial ecoregions of Africa and Madagascar: a conservation assessment; Burnham RJ, 2004, FOREST ECOL MANAG, V190, P43, DOI 10.1016/j.foreco.2003.10.005; Burnham RJ, 2002, J TROP ECOL, V18, P845, DOI 10.1017/S0266467402002559; CAMPOS YF, 1998, PLAN MAESTRO PROTECC; CASO A, 2008, IUCN 2008; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; CHERNOFF B, 1999, B BIOL ASSESSMENT, V15, P39; *CHIC FIELD MUS, 2009, TROP PLANT GUID INCL; Chuyong GB, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P506; CISNEROSHEREDIA DF, 2009, PAPEIS AVUL IN PRESS; CISNEROSHEREDIA DF, 2006, THESIS U SAN FRANCIS; Co LL, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P574; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Condit R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P79; *CTFS SMITHS TROP, PLOT INF SUMM; *CTFS SMITHS TROP, YAS FOR DYN PLOT SPE; CUELLAR E, 2008, IUCN 2008; Da Silva JMC, 2005, CONSERV BIOL, V19, P689, DOI 10.1111/j.1523-1739.2005.00705.x; DASILVA NJ, 1995, CONSERV BIOL, V9, P873, DOI 10.1046/j.1523-1739.1995.09040873.x; DELATORRE S, 2008, IUCN 2008; DEOLIVEIRA T, 2008, IUCN 2008; Dew JL, 2003, AM J PHYS ANTHROPOL, P89; DIFIORE A, 2001, CONSERVACION DESAROL, P165; DIXON J R, 1975, Milwaukee Public Museum Contributions in Biology and Geology, V4, P1; Doan TM, 2002, BIOTROPICA, V34, P101, DOI 10.1111/j.1744-7429.2002.tb00246.x; Dudley N., 2008, GUIDELINES APPL PROT, DOI [10.2305/IUCN.CH.2008.PAPS.2.en, DOI 10.2305/IUCN.CH.2008.PAPS.2.EN]; DUELLMAN WE, 1988, ANN MO BOT GARD, V75, P79, DOI 10.2307/2399467; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; DUELLMAN WE, 1991, OCCAS PAP MUS NAT HI, V143, P1; DUPLAIX N, 2008, IUCN 2008; Elias T.S., 1980, COMPLETE TREES N AM; ENGLISH PH, 1998, THESIS U TEXAS AUSTI; *ENTR INC, 2006, PROYECT DES PROD BLO; Erwin Terry L., 2005, Proceedings of the California Academy of Sciences, V56, P72; EVANS AV, 2007, NATL WILDLIFE FEDERA; Finer M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034005; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; FONSECA R, 2004, MUSEUM TEXAS TU OCCA, V242, P1; Foster R.B., 1994, TAMBOPATA CANDAMO RE; Frank N., 1995, A complete guide to scientific and common names of reptiles and amphibians of the world.; FRANZEN M, 2005, THESIS U CALIFORNIA; Franzen M, 2006, ENVIRON CONSERV, V33, P36, DOI 10.1017/S0376892906002712; Galacatos K, 2004, ENVIRON BIOL FISH, V71, P33, DOI 10.1023/B:EBFI.0000043156.69324.94; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; *GOOGL INC, 2009, AR CALC US GOOGL EAR; Greenberg JA, 2005, REMOTE SENS ENVIRON, V96, P202, DOI 10.1016/j.rse.2005.02.010; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; GUAYASAMIN AO, 2001, CONSERVACION DESARRO, P29; Gunatilleke CVS, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P599; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Haffer J, 1997, BIODIVERS CONSERV, V6, P451, DOI 10.1023/A:1018320925954; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Herrmann HW, 2005, REV SUISSE ZOOL, V112, P1045, DOI 10.5962/bhl.part.80336; HUTTON WC, 1995, SOC PETROLEUM ENG, P441, DOI DOI 10.2118/30684-MS; *INT DEV BANK, 2006, 23 IIRSA INT DEV BAN; *ITIS, 2009, INT TAX INF SYST ONL; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; *IUCN CONS INT NAT, 2008, AN AMPH 2008 IUCN RE; *IUCN RED LIST THR, IUCN 2009; JARAMILLO J, 2002, ESTUDIO FLORA FAUNA; JOCHNICK C, 1995, MULTINATIONAL MONITO, V16; JORGENSON JP, 2001, CONSERVACION DESARRO, P194; JORGENSON PM, 1999, CATALOGUE VASCULAR P; Kanzaki M, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P474; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Killeen T. J., 2007, ADV APPL BIODIVERSIT, V7; Killeen TJ, 2008, PHILOS T R SOC B, V363, P1881, DOI 10.1098/rstb.2007.0018; Killeen TJ, 2007, J BIOGEOGR, V34, P1357, DOI 10.1111/j.1365-2699.2006.01682.x; KOENIG K, 2007, MULTINATL MONIT, V4, P10; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kreft H, 2004, J BIOGEOGR, V31, P1463, DOI 10.1111/j.1365-2699.2004.01083.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kress WJ, 1998, BIODIVERS CONSERV, V7, P1577, DOI 10.1023/A:1008889803319; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Larrea Carlos, 2009, YASUNI ITT INITIATIV; Lee HS, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P527; Leigh EG, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P451; LEITE MRP, 2008, IUCN 2008; Link A, 2006, J TROP ECOL, V22, P235, DOI 10.1017/S0266467405003081; LU F, 1999, THESIS U N CAROLINA; Lum SKY, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P464; Lynch John D., 2005, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V29, P581; MAHER JL, 2009, MONGABAY; Makana JR, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P492; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Malkmus Rudolf, 2002, P1; Manokaran N, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P585; MARINHO JS, 1998, BAT BIOL CONSERVATIO, P342; MARMONTEL M, 2008, IUCN 2008; MARSH L, 2008, IUCN 2008; Marsh Laura K., 2004, Neotropical Primates, V12, P75; *MAX EC INC, 1992, PLAN MAN AMB AG 1992; McCracken Shawn, 2009, Herpetological Review, V40, P190; McCracken Shawn F., 2008, Herpetological Review, V39, P170; Miles L, 2004, GLOBAL ECOL BIOGEOGR, V13, P553, DOI 10.1111/j.1466-822X.2004.00105.x; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; MYERS N, 1993, ENVIRON CONSERV, V20, P9, DOI 10.1017/S0376892900037176; Myers N, 2003, BIOSCIENCE, V53, P916; Nabe-Nielsen J, 2001, J TROP ECOL, V17, P1, DOI 10.1017/S0266467401001018; *NAT CONS, 2006, PARKS PER LA PAYA NA; NAVEDA A, 2008, IUCN 2008; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; *NY BOT GARD, 2009, CV STARR VIRT HERB; O'Rourke D, 2003, ANNU REV ENV RESOUR, V28, P587, DOI 10.1146/annurev.energy.28.050302.105617; Olson DD., 1998, FRESHWATER BIODIVERS; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; PAYAN E, 2008, IUCN 2008; PEARSON DL, 1977, CONDOR, V79, P232, DOI 10.2307/1367167; PERES CA, 1995, CONSERV BIOL, V9, P34, DOI 10.1046/j.1523-1739.1995.09010034.x; Peres CA, 2005, CONSERV BIOL, V19, P728, DOI 10.1111/j.1523-1739.2005.00691.x; PERES CA, 1993, J TROP ECOL, V9, P259, DOI 10.1017/S026646740000729X; Peres CA, 1997, J TROP ECOL, V13, P381, DOI 10.1017/S0266467400010580; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; *PETR, 2007, DIAGN SOC CULT AMB L, V43; Pichon FJ, 1997, ECON DEV CULT CHANGE, V45, P707, DOI 10.1086/452305; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 2002, ECOLOGY, V83, P3210, DOI 10.1890/0012-9658(2002)083[3210:ACOTSD]2.0.CO;2; PITMAN NCA, 2000, THESIS DUKE U DURHAM; Pitman NCA, 2008, BIOTROPICA, V40, P525, DOI 10.1111/j.1744-7429.2008.00424.x; PUERTAS P, 1993, BIODIVERS CONSERV, V2, P586, DOI 10.1007/BF00051959; READ M, 1996, REPTILES AMPHIBIANS; REMSEN JV, 1983, BIOTROPICA, V15, P223, DOI 10.2307/2387833; Revenga C., 1998, WATERSHEDS WORLD ECO; Revenga C., 2003, WATERSHEDS WORLD CD; Rex K, 2008, BIOL J LINN SOC, V94, P617, DOI 10.1111/j.1095-8312.2008.01014.x; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Ridgely R. S., 2003, DIGITAL DISTRIBUTION; Ridgely RS, 2001, BIRDS ECUADOR; RIVADENEIRA J, 2007, BIRD SPECIES NAPO WI; RIVERA C, 2003, LIM PER RES 6 C LAT; Robinson WD, 2000, ECOL MONOGR, V70, P209, DOI 10.1890/0012-9615(2000)070[0209:FBCSIC]2.0.CO;2; Rodrigues MT, 2005, CONSERV BIOL, V19, P659, DOI 10.1111/j.1523-1739.2005.00690.x; RODRIGUEZ LO, 1994, U KANSAS NATURAL HIS, V22, P1; Romoleroux K., 1997, ESTUDIOS DIVERSIDAD, P189; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; RON SR, 2001, ANFIBIOS PARQUE NACL; ROSENFELD AB, 2001, FOOTPRINTS JUNGLE, P55; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; SCHULMAN L, 2003, LYONIA, V5, P91; Sierra R, 2000, APPL GEOGR, V20, P1, DOI 10.1016/S0143-6228(99)00014-4; SIERRA R, 2004, SPATIAL ANAL ECOLOGI; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; SOUTHGATE D, 1991, WORLD DEV, V19, P1145, DOI 10.1016/0305-750X(91)90063-N; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; STEVENSON P, 2008, IUCN 2008; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Sukumar R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P551; Sun IF, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P564; Taco M.P., 2001, CONSERVACION DESARRO, P48; TAVARES V, 2008, IUCN 2008; Ter Steege H, 2003, BIODIVERS CONSERV, V12, P2255, DOI 10.1023/A:1024593414624; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; TERBORGH J, 1990, ECOL MONOGR, V60, P213, DOI 10.2307/1943045; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; THIOLLAY JM, 1989, CONSERV BIOL, V3, P128, DOI 10.1111/j.1523-1739.1989.tb00065.x; THIOLLAY JM, 1994, J TROP ECOL, V10, P449, DOI 10.1017/S0266467400008154; Thompson J, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P540; TIMM RM, 1994, LA SELVA ECOLOGY NAT, P394; Tirira D., 2007, EDICIONES MURCIE LAG, V6, P576; Tuomisto H, 2003, ECOL APPL, V13, P352, DOI 10.1890/1051-0761(2003)013[0352:LFPWSH]2.0.CO;2; Tuomisto H, 2002, BIOTROPICA, V34, P516, DOI 10.1111/j.1744-7429.2002.tb00571.x; *U AARH, 2009, AAU HERB DAT; *UN FAO, 2005, STAT WORLDS FOR; *UN FAO, 2007, STAT WORLDS FOR; *UNESCO, 2009, BIOSPH RES INF EC YA; *US EIA, 2009, COUNTR AN BRIEFS EC; *US GEOL SURV NAT, 2009, FIND SPEC SPEC COLL; UTRERAS BV, 2001, LIBRO ROJO MAMIFEROS, V1, P61; UTRERAS BV, 2001, CONSERVACION DESARRO, P145; UTRERAS BV, 2002, TREBON IUCN OTTER A, V19, P365; Val A.L., 1995, FISHES AMAZON THEIR; Vale MM, 2008, CONSERV BIOL, V22, P1006, DOI 10.1111/j.1523-1739.2008.00939.x; Valencia R, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P609; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; Valencia R., 2000, LIBRO ROJO PLANTAS E; Vallejo MI, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P517; Vigle Gregory O., 2008, Breviora, V514, P1, DOI 10.3099/0006-9698-514.1.1; VILLAVERDE X, 2005, PARQUE NACL RESERVA; Vina A, 2004, AMBIO, V33, P118, DOI 10.1639/0044-7447(2004)033[0118:SCDAOD]2.0.CO;2; Voss RS, 1996, B AM MUS NAT HIST, P3; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; *WILDL CONS SOC, 2006, WILDL CONS SOC B, V1, P1; Wilkie KTR, 2007, NATURWISSENSCHAFTEN, V94, P725, DOI 10.1007/s00114-007-0250-2; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104; Wilson D.E., 2005, MAMMAL SPECIES WORLD, V1; Woodward CL, 2007, TAXON, V56, P157, DOI 10.2307/25065746; WUNDER S, 2003, OIL WEALTH FATE FORE; WUNDER S, 1997, 976 CTR DEV RES WORK; *WWF, 2001, WILDWORLD EC PROF WW; Young B.E., 2004, DISAPPEARING JEWELS; Zapata Rios G., 2006, Lyonia, V10, P47; 2004, TECHNICAL ADVISORY R	221	249	274	6	200	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8767	10.1371/journal.pone.0008767	http://dx.doi.org/10.1371/journal.pone.0008767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098736	Green Published, gold			2022-12-27	WOS:000273778900011
J	Genung, MA; Lessard, JP; Brown, CB; Bunn, WA; Cregger, MA; Reynolds, WN; Felker-Quinn, E; Stevenson, ML; Hartley, AS; Crutsinger, GM; Schweitzer, JA; Bailey, JK				Genung, Mark A.; Lessard, Jean-Philippe; Brown, Claire B.; Bunn, Windy A.; Cregger, Melissa A.; Reynolds, Wm Nicholas; Felker-Quinn, Emmi; Stevenson, Mary L.; Hartley, Amanda S.; Crutsinger, Gregory M.; Schweitzer, Jennifer A.; Bailey, Joseph K.			Non-Additive Effects of Genotypic Diversity Increase Floral Abundance and Abundance of Floral Visitors	PLOS ONE			English	Article							SOLIDAGO-ALTISSIMA; POLLINATOR COMMUNITIES; ECOSYSTEM GENETICS; GOLDENROD SOLIDAGO; PLANT GENOTYPE; SEED-SET; SELECTION; FITNESS; TRAITS; BEES	Background: In the emerging field of community and ecosystem genetics, genetic variation and diversity in dominant plant species have been shown to play fundamental roles in maintaining biodiversity and ecosystem function. However, the importance of intraspecific genetic variation and diversity to floral abundance and pollinator visitation has received little attention. Methodology/Principal Findings: Using an experimental common garden that manipulated genotypic diversity (the number of distinct genotypes per plot) of Solidago altissima, we document that genotypic diversity of a dominant plant can indirectly influence flower visitor abundance. Across two years, we found that 1) plant genotype explained 45% and 92% of the variation in flower visitor abundance in 2007 and 2008, respectively; and 2) plant genotypic diversity had a positive and non-additive effect on floral abundance and the abundance of flower visitors, as plots established with multiple genotypes produced 25% more flowers and received 45% more flower visits than would be expected under an additive model. Conclusions/Significance: These results provide evidence that declines in genotypic diversity may be an important but little considered factor for understanding plant-pollinator dynamics, with implications for the global decline in pollinators due to reduced plant diversity in both agricultural and natural ecosystems.	[Genung, Mark A.; Lessard, Jean-Philippe; Brown, Claire B.; Bunn, Windy A.; Cregger, Melissa A.; Reynolds, Wm Nicholas; Felker-Quinn, Emmi; Stevenson, Mary L.; Hartley, Amanda S.; Crutsinger, Gregory M.; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Genung, MA (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mgenung@utk.edu	Genung, Mark/K-5897-2012; Cregger, Melissa/D-7142-2018	Cregger, Melissa/0000-0001-8329-366X; Genung, Mark/0000-0002-9383-667X	Environmental Protection Agency (EPA) STAR; National Science Foundation (NSF); Department of Ecology and Evolutionary Biology at the University of Tennessee	Environmental Protection Agency (EPA) STAR(United States Environmental Protection Agency); National Science Foundation (NSF)(National Science Foundation (NSF)); Department of Ecology and Evolutionary Biology at the University of Tennessee	G. Crutsinger was funded by an Environmental Protection Agency (EPA) STAR fellowship and a National Science Foundation (NSF) Graduate Research Fellowship. Special thanks to Chris Boake and the Department of Ecology and Evolutionary Biology at the University of Tennessee for class support and funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson WG, 2005, PLANT ECOL, V177, P43, DOI 10.1007/s11258-005-2069-2; BAILEY JK, 2009, PHILOS T A IN PRESS; BARBOUR RC, 2009, ECOLOGY IN PRESS; Becker WA, 1985, MANUAL QUANTITATIVE, P190; Booth RE, 2003, J ECOL, V91, P721, DOI 10.1046/j.1365-2745.2003.00804.x; CALLAWAY RM, 1995, BOT REV, V61, P304; Committee on the Status of Pollinators in North America, 2007, STAT POLL N AM; Craig TP, 2007, EVOLUTION, V61, P1137, DOI 10.1111/j.1558-5646.2007.00099.x; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Crutsinger GM, 2008, OIKOS, V117, P255, DOI 10.1111/j.2007.0030-1299.16276.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Feldman TS, 2004, OIKOS, V105, P197, DOI 10.1111/j.0030-1299.2004.12845.x; Frankie GW, 2005, J KANSAS ENTOMOL SOC, V78, P227, DOI 10.2317/0407.08.1; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; GROSS RS, 1983, ECOL MONOGR, V53, P95, DOI 10.2307/1942589; Haddad NM, 2000, OECOLOGIA, V124, P73, DOI 10.1007/s004420050026; Halverson K, 2008, OECOLOGIA, V154, P755, DOI 10.1007/s00442-007-0863-3; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; HOLTSFORD TP, 1992, EVOLUTION, V46, P216, DOI 10.1111/j.1558-5646.1992.tb01996.x; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Irwin RE, 2005, AM NAT, V165, P225, DOI 10.1086/426714; Johnson MTJ, 2007, TRENDS ECOL EVOL, V22, P250, DOI 10.1016/j.tree.2007.01.014; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kevan PG, 2001, CONSERV ECOL, V5; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Lazaro A, 2009, OIKOS, V118, P691, DOI 10.1111/j.1600-0706.2008.17168.x; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; MADDOX GD, 1989, AM J BOT, V76, P318, DOI 10.2307/2444674; MADDOX GD, 1990, ECOLOGY, V71, P2115, DOI 10.2307/1938625; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Madritch MD, 2002, ECOLOGY, V83, P2084, DOI 10.1890/0012-9658(2002)083[2084:PDIEFI]2.0.CO;2; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; Schweitzer JA, 2005, ECOLOGY, V86, P2834, DOI 10.1890/04-1955; Schweitzer JA, 2002, AM J BOT, V89, P981, DOI 10.3732/ajb.89.6.981; Schweitzer JA, 2008, ECOLOGY, V89, P773, DOI 10.1890/07-0337.1; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stinchcombe JR, 2002, AM NAT, V160, P511, DOI 10.1086/342069; TEPEDINO VJ, 1982, OIKOS, V3, P384; THOMPSON JN, 1988, ANNU REV ECOL SYST, V19, P65, DOI 10.1146/annurev.es.19.110188.000433; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; WEIS AE, 1986, AM NAT, V127, P681, DOI 10.1086/284513; WEIS AE, 1990, EVOLUTION, V44, P820, DOI 10.1111/j.1558-5646.1990.tb03807.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Wimp GM, 2005, EVOLUTION, V59, P61, DOI 10.1111/j.0014-3820.2005.tb00894.x	53	48	52	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8711	10.1371/journal.pone.0008711	http://dx.doi.org/10.1371/journal.pone.0008711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090850	Green Published, gold			2022-12-27	WOS:000273714600014
J	Rynda, A; Maddaloni, M; Ochoa-Reparaz, J; Callis, G; Pascual, DW				Rynda, Agnieszka; Maddaloni, Massimo; Ochoa-Reparaz, Javier; Callis, Gayle; Pascual, David W.			IL-28 Supplants Requirement for T-reg Cells in Protein sigma 1-Mediated Protection against Murine Experimental Autoimmune Encephalomyelitis (EAE)	PLOS ONE			English	Article							TOXIN B-SUBUNIT; MYELIN BASIC-PROTEIN; ORAL TOLERANCE; CUTTING EDGE; TGF-BETA; ANTIBODY-RESPONSES; INDUCTION; IL-10; SUPPRESSION; MECHANISMS	Conventional methods to induce tolerance in humans have met with limited success. Hence, efforts to redirect tolerogen uptake using reovirus adhesin, protein sigma 1 (p sigma 1), may circumvent these shortcomings based upon the recent finding that when reovirus ps1 is engineered to deliver chicken ovalbumin (OVA) mucosally, tolerance is obtained, even with a single dose. To test whether single-dose tolerance can be induced to treat EAE, proteolipid protein (PLP130-151) was genetically fused to OVA to p sigma 1 (PLP: OVA-p sigma 1) and shown to significantly ameliorate EAE, suppressing proinflammatory cytokines by IL-10(+) forkhead box P3 (FoxP3)(+) CD25(+)CD4(+) T-reg and IL-4(+)CD25(-)CD4(+) Th2 cells. IL-10R or IL-4 neutralization reversed protection to EAE conferred by PLP:OVA-p sigma 1, and adoptive transfer of Ag-specific Treg or Th2 cells restored protection against EAE in recipients. Upon assessment of each relative participant, functional inactivation of CD25 impaired PLP: OVA-p sigma 1's protective capacity, triggering TGF-beta-mediated inflammation; however, concomitant inactivation of TGF-beta and CD25 reestablished PLP:OVA-p sigma 1-mediated protection by IL-28-producing FoxP3(+)CD25(-)CD4(+)T cells. Thus, p sigma 1-based therapy can resolve EAE independently of or dependently upon CD25 and assigns IL-28 as an alternative therapy for autoimmunity.	[Rynda, Agnieszka; Maddaloni, Massimo; Ochoa-Reparaz, Javier; Callis, Gayle; Pascual, David W.] Montana State Univ, Bozeman, MT 59717 USA; [Rynda, Agnieszka; Ochoa-Reparaz, Javier] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA	Montana State University System; Montana State University Bozeman; Dartmouth College	Rynda, A (corresponding author), Montana State Univ, Bozeman, MT 59717 USA.	dpascual@montana.edu	Pascual, David/AAC-2248-2022	Ochoa-Reparaz, Javier/0000-0001-9610-3175	National Institutes of Health (NIH) [1R01 AI-078938]; Montana Agricultural Station; United States Department of Agriculture Formula Funds; NIH/National Center for Research Resources; Centers of Biomedical Excellence [P20 RR-020185]; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078938] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana Agricultural Station; United States Department of Agriculture Formula Funds; NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Centers of Biomedical Excellence; M.J. Murdock Charitable Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institutes of Health (NIH) grant 1R01 AI-078938 and, in part, by Montana Agricultural Station and United States Department of Agriculture Formula Funds. The VMB flow cytometry facility was, in part, supported by NIH/National Center for Research Resources, Centers of Biomedical Excellence P20 RR-020185, and an equipment grant from the M.J. Murdock Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ank N, 2009, BIOFACTORS, V35, P82, DOI 10.1002/biof.19; Aspord C, 2002, CLIN EXP IMMUNOL, V130, P204, DOI 10.1046/j.1365-2249.2002.01988.x; BERGQUIST C, 1995, INFECT IMMUN, V63, P2021, DOI 10.1128/IAI.63.5.2021-2025.1995; Bergquist C, 1997, INFECT IMMUN, V65, P2676, DOI 10.1128/IAI.65.7.2676-2684.1997; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Faria AMC, 2003, J AUTOIMMUN, V20, P135, DOI 10.1016/S0896-8411(02)00112-9; Faria AMC, 1999, ADV IMMUNOL, V73, P153, DOI 10.1016/S0065-2776(08)60787-7; Faria AMC, 2006, CLIN DEV IMMUNOL, V13, P143, DOI 10.1080/17402520600876804; Fujihashi K, 2001, P NATL ACAD SCI USA, V98, P3310, DOI 10.1073/pnas.061412598; Fukaura H, 1996, J CLIN INVEST, V98, P70, DOI 10.1172/JCI118779; Gonnella PA, 2004, J AUTOIMMUN, V23, P193, DOI 10.1016/j.jaut.2004.08.001; Gonnet Florence, 2003, Proteome Sci, V1, P2, DOI 10.1186/1477-5956-1-2; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Herrero C, 2003, J IMMUNOL, V171, P5034, DOI 10.4049/jimmunol.171.10.5034; Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526; Jun SM, 2005, J IMMUNOL, V175, P6733, DOI 10.4049/jimmunol.175.10.6733; Kato H, 2001, J IMMUNOL, V166, P3114, DOI 10.4049/jimmunol.166.5.3114; Kim WU, 2002, ARTHRITIS RHEUM-US, V46, P1109, DOI 10.1002/art.10198; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Lycke N, 2004, ANN NY ACAD SCI, V1029, P193, DOI 10.1196/annals.1309.036; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Masuda K, 2002, MICROBIOL IMMUNOL, V46, P55, DOI 10.1111/j.1348-0421.2002.tb02677.x; Mennechet FJD, 2006, BLOOD, V107, P4417, DOI 10.1182/blood-2005-10-4129; Min B, 1998, J EXP MED, V188, P2007, DOI 10.1084/jem.188.11.2007; Miyamoto K, 2005, J IMMUNOL, V175, P7341, DOI 10.4049/jimmunol.175.11.7341; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; O'Hehir RE, 2007, CURR MED CHEM, V14, P2235, DOI 10.2174/092986707781696609; Ochoa-Reparaz J, 2008, J IMMUNOL, V181, P954, DOI 10.4049/jimmunol.181.2.954; Ochoa-Reparaz J, 2007, J IMMUNOL, V178, P1791, DOI 10.4049/jimmunol.178.3.1791; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Passalacqua G, 2004, ANN ALLERG ASTHMA IM, V93, P3, DOI 10.1016/S1081-1206(10)61440-8; Pillemer BBL, 2009, J IMMUNOL, V183, P155, DOI 10.4049/jimmunol.0803733; Rynda A, 2008, J IMMUNOL, V180, P5187, DOI 10.4049/jimmunol.180.8.5187; SCADDING GK, 1986, CLIN ALLERGY, V16, P483, DOI 10.1111/j.1365-2222.1986.tb01983.x; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Sharif MN, 2004, J IMMUNOL, V172, P6476, DOI 10.4049/jimmunol.172.10.6476; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Stohlman SA, 1999, J IMMUNOL, V163, P6338; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Sun JB, 1996, P NATL ACAD SCI USA, V93, P7196, DOI 10.1073/pnas.93.14.7196; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; TURNER DL, 1992, VIROLOGY, V186, P219, DOI 10.1016/0042-6822(92)90076-2; Uze G, 2007, BIOCHIMIE, V89, P729, DOI 10.1016/j.biochi.2007.01.008; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Weiner HL, 2004, ANN NY ACAD SCI, V1029, P211, DOI 10.1196/annals.1309.053; Weiner HL, 1997, IMMUNOL TODAY, V18, P335, DOI 10.1016/S0167-5699(97)01053-0; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176; Yokoyama Y, 2002, INT J PEDIATR OTORHI, V63, P235, DOI 10.1016/S0165-5876(02)00021-6; Yuki Y, 2001, BIOTECHNOL BIOENG, V74, P62, DOI 10.1002/bit.1095; Zheng SG, 2008, J IMMUNOL, V180, P7112, DOI 10.4049/jimmunol.180.11.7112	56	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8720	10.1371/journal.pone.0008720	http://dx.doi.org/10.1371/journal.pone.0008720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090936	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600020
J	Park, Y; Moore, C; Bader, JS				Park, Yongjin; Moore, Cristopher; Bader, Joel S.			Dynamic Networks from Hierarchical Bayesian Graph Clustering	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; CELL-CYCLE; ARABIDOPSIS; MODELS; GENE; EXPRESSION	Biological networks change dynamically as protein components are synthesized and degraded. Understanding the time-dependence and, in a multicellular organism, tissue-dependence of a network leads to insight beyond a view that collapses time-varying interactions into a single static map. Conventional algorithms are limited to analyzing evolving networks by reducing them to a series of unrelated snapshots. Here we introduce an approach that groups proteins according to shared interaction patterns through a dynamical hierarchical stochastic block model. Protein membership in a block is permitted to evolve as interaction patterns shift over time and space, representing the spatial organization of cell types in a multicellular organism. The spatiotemporal evolution of the protein components are inferred from transcript profiles, using Arabidopsis root development (5 tissues, 3 temporal stages) as an example. The new model requires essentially no parameter tuning, out-performs existing snapshot-based methods, identifies protein modules recruited to specific cell types and developmental stages, and could have broad application to social networks and other similar dynamic systems.	[Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Park, Yongjin; Bader, Joel S.] Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD USA; [Moore, Cristopher] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA; [Moore, Cristopher] Univ New Mexico, Dept Phys, Albuquerque, NM 87131 USA; [Moore, Cristopher] Santa Fe Inst, Santa Fe, NM 87501 USA	Johns Hopkins University; Johns Hopkins University; University of New Mexico; University of New Mexico; The Santa Fe Institute	Park, Y (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	joel.bader@jhu.edu	Bader, Joel/A-1818-2009	Bader, Joel/0000-0002-6020-4625; Moore, Cristopher/0000-0002-2062-1942	National Science Foundation; National Institutes of Heatlth	National Science Foundation(National Science Foundation (NSF)); National Institutes of Heatlth(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JSB acknowledges funding from the National Science Foundation and the National Institutes of Heatlth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi EM, 2008, J MACH LEARN RES, V9, P1981; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Beal MJ, 2006, BAYESIAN ANAL, V1, P793, DOI 10.1214/06-BA126; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; CLAUSET A, 2006, WORKSH STAT NETW AN, P4503; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fu W., 2009, ICML 09 P 26 ANN INT; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hofman JM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258701; Jordan MI, 1999, MACH LEARN, V37, P183, DOI 10.1023/A:1007665907178; KUHNER MK, 1995, GENETICS, V140, P1421; Lago C, 2004, GENE, V342, P231, DOI 10.1016/j.gene.2004.08.023; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Newman MEJ, 2007, P NATL ACAD SCI USA, V104, P9564, DOI 10.1073/pnas.0610537104; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamada Y, 2007, PLANT CELL PHYSIOL, V48, P134, DOI 10.1093/pcp/pcl048; ZHANG H, 2007, P 22 AAAI C ART INT	23	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8118	10.1371/journal.pone.0008118	http://dx.doi.org/10.1371/journal.pone.0008118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20084108	Green Published, gold, Green Submitted			2022-12-27	WOS:000273456300001
J	Jahnke, VE; Sabido, O; Defour, A; Castells, J; Lefai, E; Roussel, D; Freyssenet, D				Jahnke, Vanessa E.; Sabido, Odile; Defour, Aurelia; Castells, Josiane; Lefai, Etienne; Roussel, Damien; Freyssenet, Damien			Evidence for Mitochondrial Respiratory Deficiency in Rat Rhabdomyosarcoma Cells	PLOS ONE			English	Article							SKELETAL-MUSCLE; ALVEOLAR RHABDOMYOSARCOMA; MYOBLAST DIFFERENTIATION; GENE-EXPRESSION; CARDIOLIPIN; BIOGENESIS; PAX3; DNA; REGENERATION; STIMULATION	Background: Mitochondria can sense signals linked to variations in energy demand to regulate nuclear gene expression. This retrograde signaling pathway is presumed to be involved in the regulation of myoblast proliferation and differentiation. Rhabdomyosarcoma cells are characterized by their failure to both irreversibly exit the cell cycle and complete myogenic differentiation. However, it is currently unknown whether mitochondria are involved in the failure of rhabdomyosarcoma cells to differentiate. Methodology/Principal Findings: Mitochondrial biogenesis and metabolism were studied in rat L6E9 myoblasts and R1H rhabdomyosacoma cells during the cell cycle and after 36 hours of differentiation. Using a combination of flow cytometry, polarographic and molecular analyses, we evidenced a marked decrease in the cardiolipin content of R1H cells cultured in growth and differentiation media, together with a significant increase in the content of mitochondrial biogenesis factors and mitochondrial respiratory chain proteins. Altogether, these data indicate that the mitochondrial inner membrane composition and the overall process of mitochondrial biogenesis are markedly altered in R1H cells. Importantly, the dysregulation of protein-to-cardiolipin ratio was associated with major deficiencies in both basal and maximal mitochondrial respiration rates. This deficiency in mitochondrial respiration probably contributes to the inability of R1H cells to decrease mitochondrial H2O2 level at the onset of differentiation. Conclusion/Significance: A defect in the regulation of mitochondrial biogenesis and mitochondrial metabolism may thus be an epigenetic mechanism that may contribute to the tumoral behavior of R1H cells. Our data underline the importance of mitochondria in the regulation of myogenic differentiation.	[Jahnke, Vanessa E.; Sabido, Odile; Defour, Aurelia; Castells, Josiane; Freyssenet, Damien] Univ St Etienne, Univ Lyon, Lab Physiol Exercice, EA4338, St Etienne, France; [Sabido, Odile] Univ St Etienne, Univ Lyon, Ctr Commun Cytometrie Flux, St Etienne, France; [Lefai, Etienne] Univ Lyon 1, INSERM, Regulat Metab Nutr & Diabet U870, F-69622 Villeurbanne, France; [Roussel, Damien] Univ Lyon 1, CNRS, Lab Physiol Integrat Cellulaire & Mol, U5123, F-69622 Villeurbanne, France	Universite Jean Monnet; Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Jahnke, VE (corresponding author), Univ St Etienne, Univ Lyon, Lab Physiol Exercice, EA4338, St Etienne, France.	damien.freyssenet@univ-st-etienne.fr	Lefai, Etienne/L-7961-2019; Lefai, Etienne/E-9615-2019	Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; defour, aurelia/0000-0002-9114-0054; Roussel, Damien/0000-0002-8865-5428	Ligue Contre le Cancer Comite de la Loire; Ligue Contre le Cancer	Ligue Contre le Cancer Comite de la Loire; Ligue Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by the Ligue Contre le Cancer Comite de la Loire (grant to D. Freyssenet). V. E. Jahnke was supported by an Allocation Doctorale de Recherche from the Ligue Contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barani AE, 2003, EXP CELL RES, V283, P196, DOI 10.1016/S0014-4827(02)00030-7; BARENDSEN GW, 1969, EUR J CANCER, V5, P373, DOI 10.1016/0014-2964(69)90051-6; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Brubacher JL, 2001, J IMMUNOL METHODS, V251, P81, DOI 10.1016/S0022-1759(01)00308-8; Cavalli LR, 1997, CELL GROWTH DIFFER, V8, P1189; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Desquiret V, 2006, BBA-BIOENERGETICS, V1757, P21, DOI 10.1016/j.bbabio.2005.11.005; DIAS P, 1992, CANCER RES, V52, P6431; Duguez S, 2004, EXP CELL RES, V299, P27, DOI 10.1016/j.yexcr.2004.05.017; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Epstein JA, 1996, P NATL ACAD SCI USA, V93, P4213, DOI 10.1073/pnas.93.9.4213; FLEISCHER S, 1967, J LIPID RES, V8, P170; Freyssenet D, 1996, ARCH PHYSIOL BIOCHEM, V104, P129, DOI 10.1076/apab.104.2.129.12878; Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; Grandemange S, 2005, CANCER RES, V65, P4282, DOI 10.1158/0008-5472.CAN-04-3652; HEDDI A, 1993, J BIOL CHEM, V268, P12156; Jahnke VE, 2009, AM J PHYSIOL-CELL PH, V296, pC1185, DOI 10.1152/ajpcell.00377.2008; Kuhnt T, 2007, NEUROCHEM RES, V32, P973, DOI 10.1007/s11064-006-9254-0; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Lugli E, 2005, CYTOM PART A, V68A, P28, DOI 10.1002/cyto.a.20188; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Petrosillo G, 2009, FREE RADICAL BIO MED, V46, P88, DOI 10.1016/j.freeradbiomed.2008.09.031; REINHOLD H. S., 1965, EUR J CANCER, V1, P67, DOI 10.1016/0014-2964(65)90081-2; REMELS AH, 2009, MOL CELL ENDOCR 1003; Rochard P, 2000, J BIOL CHEM, V275, P2733, DOI 10.1074/jbc.275.4.2733; Seyer P, 2006, J CELL PHYSIOL, V207, P75, DOI 10.1002/jcp.20539; SHAPIRO DN, 1993, CANCER RES, V53, P5108; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; TONIN PN, 1991, CANCER RES, V51, P5100; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	41	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8637	10.1371/journal.pone.0008637	http://dx.doi.org/10.1371/journal.pone.0008637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072609	gold, Green Published, Green Submitted			2022-12-27	WOS:000273414200015
J	Chen, XW; Hackett, CA; Niks, RE; Hedley, PE; Booth, C; Druka, A; Marcel, TC; Vels, A; Bayer, M; Milne, I; Morris, J; Ramsay, L; Marshall, D; Cardle, L; Waugh, R				Chen, Xinwei; Hackett, Christine A.; Niks, Rients E.; Hedley, Peter E.; Booth, Clare; Druka, Arnis; Marcel, Thierry C.; Vels, Anton; Bayer, Micha; Milne, Iain; Morris, Jenny; Ramsay, Luke; Marshall, David; Cardle, Linda; Waugh, Robbie			An eQTL Analysis of Partial Resistance to Puccinia hordei in Barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; DENSITY CONSENSUS MAP; FALSE DISCOVERY RATE; GENE-EXPRESSION; POWDERY MILDEW; LEAF RUST; FLOWERING-TIME; STEM RUST; BASAL DEFENSE; ARABIDOPSIS	Background: Genetic resistance to barley leaf rust caused by Puccinia hordei involves both R genes and quantitative trait loci. The R genes provide higher but less durable resistance than the quantitative trait loci. Consequently, exploring quantitative or partial resistance has become a favorable alternative for controlling disease. Four quantitative trait loci for partial resistance to leaf rust have been identified in the doubled haploid Steptoe (St)/Morex (Mx) mapping population. Further investigations are required to study the molecular mechanisms underpinning partial resistance and ultimately identify the causal genes. Methodology/Principal Findings: We explored partial resistance to barley leaf rust using a genetical genomics approach. We recorded RNA transcript abundance corresponding to each probe on a 15K Agilent custom barley microarray in seedlings from St and Mx and 144 doubled haploid lines of the St/Mx population. A total of 1154 and 1037 genes were, respectively, identified as being P. hordei-responsive among the St and Mx and differentially expressed between P. hordei-infected St and Mx. Normalized ratios from 72 distant-pair hybridisations were used to map the genetic determinants of variation in transcript abundance by expression quantitative trait locus (eQTL) mapping generating 15685 eQTL from 9557 genes. Correlation analysis identified 128 genes that were correlated with resistance, of which 89 had eQTL co-locating with the phenotypic quantitative trait loci (pQTL). Transcript abundance in the parents and conservation of synteny with rice allowed us to prioritise six genes as candidates for Rphq11, the pQTL of largest effect, and highlight one, a phospholipid hydroperoxide glutathione peroxidase (HvPHGPx) for detailed analysis. Conclusions/Significance: The eQTL approach yielded information that led to the identification of strong candidate genes underlying pQTL for resistance to leaf rust in barley and on the general pathogen response pathway. The dataset will facilitate a systems appraisal of this host-pathogen interaction and, potentially, for other traits measured in this population.	[Chen, Xinwei; Hedley, Peter E.; Booth, Clare; Druka, Arnis; Bayer, Micha; Milne, Iain; Morris, Jenny; Ramsay, Luke; Marshall, David; Cardle, Linda; Waugh, Robbie] Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland; [Niks, Rients E.; Marcel, Thierry C.; Vels, Anton] Wageningen Univ, Grad Sch Expt Plant Sci, Lab Plant Breeding, Wageningen, Netherlands	James Hutton Institute; Wageningen University & Research	Chen, XW (corresponding author), Scottish Crop Res Inst, Genet Programme, Dundee DD2 5DA, Scotland.	xinwei.chen@scri.ac.uk; Robbie.Waugh@scri.ac.uk	Druka, Arnis/E-9701-2011; Hackett, Christine/F-1196-2011; Milne, Iain/A-3614-2010; Hedley, Peter/F-1149-2011; chen, xinwei/L-2582-2013; Niks, Rients/Y-4720-2019; Marcel, Thierry/ABI-2242-2020; Bayer, Micha/F-2255-2013	Hedley, Peter/0000-0003-0866-324X; Niks, Rients/0000-0002-3912-3775; Marcel, Thierry/0000-0002-7452-4013; Bayer, Micha/0000-0003-0041-3115; Marshall, David/0000-0001-9309-2570; Milne, Linda/0000-0002-1798-8022; Milne, Iain/0000-0002-4126-0859; Chen, Xinwei/0000-0003-1507-2253	European Union [513959]; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	European Union(European Commission); Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Funding for this experiment was provided by the European Union Bioexploit Grant No. 513959 (FOOD) to RW and RN (www. bioexploit. net) and by Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) Programme 1, Work Package 1 (http://www.programme1.net/programmes.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arfaoui A, 2007, PLANT PHYSIOL BIOCH, V45, P470, DOI 10.1016/j.plaphy.2007.04.004; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger S, 2004, PHYSIOL PLANTARUM, V122, P419, DOI 10.1111/j.1399-3054.2004.00433.x; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Caldo RA, 2004, PLANT CELL, V16, P2514, DOI 10.1105/tpc.104.023382; Caldo RA, 2006, MOL PLANT MICROBE IN, V19, P939, DOI 10.1094/MPMI-19-0939; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Collinge DB, 2008, EUR J PLANT PATHOL, V121, P257, DOI 10.1007/s10658-008-9271-8; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Domingo C, 2009, MOL PLANT MICROBE IN, V22, P201, DOI 10.1094/MPMI-22-2-0201; Druka A, 2008, THEOR APPL GENET, V117, P261, DOI 10.1007/s00122-008-0771-x; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Field B, 2006, NEW PHYTOL, V172, P193, DOI 10.1111/j.1469-8137.2006.01863.x; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Fu JY, 2006, GENETICS, V172, P1993, DOI 10.1534/genetics.105.047001; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Hansen BG, 2008, TRENDS PLANT SCI, V13, P72, DOI 10.1016/j.tplants.2007.11.008; Holub EB, 2004, TRENDS PLANT SCI, V9, P211, DOI 10.1016/j.tplants.2004.03.002; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Jukanti AK, 2008, NEW PHYTOL, V177, P333, DOI 10.1111/j.1469-8137.2007.02270.x; Keurentjes JJB, 2007, P NATL ACAD SCI USA, V104, P1708, DOI 10.1073/pnas.0610429104; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Kroymann J, 2003, P NATL ACAD SCI USA, V100, P14587, DOI 10.1073/pnas.1734046100; Kunzel G, 2000, GENETICS, V154, P397; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LAURENCE J, 2008, J EXPT BOT, V59, P4219; LI Y, 2006, PLOS GENETICS, V2; Luo ZW, 2007, GENETICS, V176, P789, DOI 10.1534/genetics.106.067843; Mammadov JA, 2003, CROP SCI, V43, P388, DOI 10.2135/cropsci2003.0388; Marcel TC, 2007, THEOR APPL GENET, V114, P487, DOI 10.1007/s00122-006-0448-2; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; Niks RE, 2000, AGRONOMIE, V20, P769, DOI 10.1051/agro:2000174; NIKS RE, 1986, PHYSIOL MOL PLANT P, V28, P309, DOI 10.1016/S0048-4059(86)80073-X; Panstruga R, 2002, MOL PLANT PATHOL, V3, P495, DOI 10.1046/j.1364-3703.2002.00145.x; Parrott DL, 2007, NEW PHYTOL, V176, P56, DOI 10.1111/j.1469-8137.2007.02158.x; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Potokina E, 2008, PLANT J, V56, P287, DOI 10.1111/j.1365-313X.2008.03601.x; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Qi X, 1998, THEOR APPL GENET, V96, P1205, DOI 10.1007/s001220050858; ROHRINGER R, 1977, PHYTOPATHOLOGY, V67, P808, DOI 10.1094/Phyto-67-808; Rostoks N, 2005, MOL GENET GENOMICS, V274, P515, DOI 10.1007/s00438-005-0046-z; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Weerasena JS, 2004, THEOR APPL GENET, V108, P712, DOI 10.1007/s00122-003-1470-2; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhang L, 2006, THEOR APPL GENET, V113, P847, DOI 10.1007/s00122-006-0342-y; Zhang L, 2008, FUNCT INTEGR GENOMIC, V8, P187, DOI 10.1007/s10142-007-0069-0; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	70	58	59	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8598	10.1371/journal.pone.0008598	http://dx.doi.org/10.1371/journal.pone.0008598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066049	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600017
J	Festa, RA; McAllister, F; Pearce, MJ; Mintseris, J; Burns, KE; Gygi, SP; Darwin, KH				Festa, Richard A.; McAllister, Fiona; Pearce, Michael J.; Mintseris, Julian; Burns, Kristin E.; Gygi, Steven P.; Darwin, K. Heran			Prokayrotic Ubiquitin-Like Protein (Pup) Proteome of Mycobacterium tuberculosis	PLOS ONE			English	Article							PROTEASOME; GENE; PHOP; EXPRESSION; VIRULENCE; SYSTEM; STRAIN; GROWTH; PURIFICATION; PERSISTENCE	Prokaryotic ubiquitin-like protein (Pup) in Mycobacterium tuberculosis (Mtb) is the first known post-translational small protein modifier in prokaryotes, and targets several proteins for degradation by a bacterial proteasome in a manner akin to ubiquitin (Ub) mediated proteolysis in eukaryotes. To determine the extent of pupylation in Mtb, we used tandem affinity purification to identify its "pupylome''. Mass spectrometry identified 55 out of 604 purified proteins with confirmed pupylation sites. Forty-four proteins, including those with and without identified pupylation sites, were tested as substrates of proteolysis in Mtb. Under steady state conditions, the majority of the test proteins did not accumulate in degradation mutants, suggesting not all targets of pupylation are necessarily substrates of the proteasome under steady state conditions. Four proteins implicated in Mtb pathogenesis, Icl (isocitrate lyase), Ino1 (inositol-1-phosphate synthase), MtrA (Mtb response regulator A) and PhoP (phosphate response regulator P), showed altered levels in degradation defective Mtb. Icl, Ino1 and MtrA accumulated in Mtb degradation mutants, suggesting these proteins are targeted to the proteasome. Unexpectedly, PhoP was present in wild type Mtb but undetectable in the degradation mutants. Taken together, these data demonstrate that pupylation regulates numerous proteins in Mtb and may not always lead to degradation.	[Festa, Richard A.; Pearce, Michael J.; Burns, Kristin E.; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [McAllister, Fiona; Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	New York University; Harvard University; Harvard Medical School	Festa, RA (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	steven_gygi@hms.harvard.edu; heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	National Institutes of Health (NIH) [GM67945, HG3456, HG3616, AI065437, HL092774]; Center for AIDS Research Pilot Project [A1027742-17, 5T32AI07189-25]; Jan T. Vilcek Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003616, R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI007189, R56AI065437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research Pilot Project; Jan T. Vilcek Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM67945, HG3456, and HG3616 awarded to S. P. G., and AI065437, HL092774 and a Center for AIDS Research Pilot Project grant (A1027742-17) awarded to K.H.D. M.J.P. received support from 5T32AI07189-25 and R. A. F. was the recipient of a Jan T. Vilcek Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; CHONG SR, 1994, BIOTECHNIQUES, V17, P686; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Darwin KH, 2009, NAT REV MICROBIOL, V7, P485, DOI 10.1038/nrmicro2148; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Denison C, 2005, CURR OPIN CHEM BIOL, V9, P69, DOI 10.1016/j.cbpa.2004.10.010; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gonzalo-Asensio J, 2008, J BACTERIOL, V190, P7068, DOI 10.1128/JB.00712-08; Groisman EA, 1997, NAT MED, V3, P1190, DOI 10.1038/nm1197-1190; Hatfull GF, 2000, MOL GENETICS MYCOBAC; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; HOUGH R, 1986, J BIOL CHEM, V261, P2391; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lamichhane G, 2006, J INFECT DIS, V194, P1233, DOI 10.1086/508288; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; LIAO S, 2009, BIOCH J IN PRESS; Martin C, 2006, VACCINE, V24, P3408, DOI 10.1016/j.vaccine.2006.03.017; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Movahedzadeh F, 2004, MOL MICROBIOL, V51, P1003, DOI 10.1046/j.1365-2958.2003.03900.x; Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252; NATHAN C, 2003, TUBERCULOSIS; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Perez E, 2001, MOL MICROBIOL, V41, P179, DOI 10.1046/j.1365-2958.2001.02500.x; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rosas-Acosta G, 2005, MOL CELL PROTEOMICS, V4, P56, DOI 10.1074/mcp.M400149-MCP200; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaeffer ML, 2001, J BIOL CHEM, V276, P47029, DOI 10.1074/jbc.M108903200; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; STRIEBEL F, 2009, NAT STRUCT MOL BIOL; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Walters SB, 2006, MOL MICROBIOL, V60, P312, DOI 10.1111/j.1365-2958.2006.05102.x; Yu AYH, 2007, FEBS LETT, V581, P3749, DOI 10.1016/j.febslet.2007.04.076; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000	53	111	217	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8589	10.1371/journal.pone.0008589	http://dx.doi.org/10.1371/journal.pone.0008589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066036	Green Submitted, gold, Green Published			2022-12-27	WOS:000273338600012
J	Pendergast, JS; Friday, RC; Yamazaki, S				Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin			Distinct Functions of Period2 and Period3 in the Mouse Circadian System Revealed by In Vitro Analysis	PLOS ONE			English	Article							GENE-EXPRESSION; BEHAVIORAL RHYTHMS; CLOCK; OSCILLATIONS; COMPONENTS; HOMOLOGS; MUTATION; CULTURE; MPER3; MICE	The mammalian circadian system, which is composed of a master pacemaker in the suprachiasmatic nuclei (SCN) as well as other oscillators in the brain and peripheral tissues, controls daily rhythms of behavior and physiology. Lesions of the SCN abolish circadian rhythms of locomotor activity and transplants of fetal SCN tissue restore rhythmic behavior with the periodicity of the donor's genotype, suggesting that the SCN determines the period of the circadian behavioral rhythm. According to the model of timekeeping in the SCN, the Period (Per) genes are important elements of the transcriptional/translational feedback loops that generate the endogenous circadian rhythm. Previous studies have investigated the functions of the Per genes by examining locomotor activity in mice lacking functional PERIOD proteins. Variable behavioral phenotypes were observed depending on the line and genetic background of the mice. In the current study we assessed both wheel-running activity and Per1-promoter-driven luciferase expression (Per1-luc) in cultured SCN, pituitary, and lung explants from Per2(-/-) and Per3(-/-) mice congenic with the C57BL/6J strain. We found that the Per2(-/-) phenotype is enhanced in vitro compared to in vivo, such that the period of Per1-luc expression in Per2(-/-) SCN explants is 1.5 hours shorter than in Per2(+/+) SCN, while the free-running period of wheel-running activity is only 11 minutes shorter in Per2(-/-) compared to Per2(+/+) mice. In contrast, circadian rhythms in SCN explants from Per3(-/-) mice do not differ from Per3(+/+) mice. Instead, the period and phase of Per1-luc expression are significantly altered in Per3(-/-) pituitary and lung explants compared to Per3(+/+) mice. Taken together these data suggest that the function of each Per gene may differ between tissues. Per2 appears to be important for period determination in the SCN, while Per3 participates in timekeeping in the pituitary and lung.	[Pendergast, Julie S.; Friday, Rio C.; Yamazaki, Shin] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Pendergast, JS (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	shin.yamazaki@vanderbilt.edu		Yamazaki, Shin/0000-0002-6691-1531	National Institutes of Health [NS051278]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051278] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a National Institutes of Health grant (NS051278 to S. Y.). R. C. F. was supported by the Vanderbilt Undergraduate Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Andrews R V, 1971, Gegenbaurs Morphol Jahrb, V117, P89; ANDREWS RV, 1964, COMP BIOCHEM PHYSIOL, V11, P393, DOI 10.1016/0010-406X(64)90006-4; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; HARDELAND R, 1973, INT J BIOCHEM, V4, P581, DOI 10.1016/0020-711X(73)90037-2; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LANGNER R, 1972, Z NATURFORSCH PT B, VB 27, P1117; LEHMAN MN, 1987, J NEUROSCI, V7, P1626; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Pendergast JS, 2009, J NEUROSCI, V29, P14681, DOI 10.1523/JNEUROSCI.3261-09.2009; POSSIDENTE B, 1988, BEHAV GENET, V18, P109, DOI 10.1007/BF01067080; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RUSAK B, 1979, PHYSIOL REV, V59, P449, DOI 10.1152/physrev.1979.59.3.449; SAWAKI Y, 1984, Neuroscience Research, V1, P67, DOI 10.1016/0168-0102(84)90031-2; Schibler Ueli, 2007, Dialogues Clin Neurosci, V9, P257; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Sujino M, 2003, CURR BIOL, V13, P664, DOI 10.1016/S0960-9822(03)00222-7; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takahashi J. S., 2001, CIRCADIAN CLOCKS; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	44	53	53	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 1	2010	5	1							e8552	10.1371/journal.pone.0008552	http://dx.doi.org/10.1371/journal.pone.0008552			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	539AG	20072700	gold, Green Published, Green Submitted			2022-12-27	WOS:000273225000015
J	Larsen, AP; Olesen, SP				Larsen, Anders Peter; Olesen, Soren-Peter			Differential Expression of hERG1 Channel Isoforms Reproduces Properties of Native I-Kr and Modulates Cardiac Action Potential Characteristics	PLOS ONE			English	Article							RECTIFIER K+ CURRENT; LONG-QT SYNDROME; VENTRICULAR MYOCYTES; GUINEA-PIG; ELECTRICAL RESTITUTION; POTASSIUM CHANNEL; M CELLS; CANINE; REPOLARIZATION; DURATION	Background: The repolarizing cardiac rapid delayed rectifier current, I-Kr, is composed of ERG1 channels. It has been suggested that two isoforms of the ERG1 protein, ERG1a and ERG1b, both contribute to I-Kr. Marked heterogeneity in the kinetic properties of native I-Kr has been described. We hypothesized that the heterogeneity of native I-Kr can be reproduced by differential expression of ERG1a and ERG1b isoforms. Furthermore, the functional consequences of differential expression of ERG1 isoforms were explored as a potential mechanism underlying native heterogeneity of action potential duration (APD) and restitution. Methodology/Principal Findings: The results show that the heterogeneity of native I-Kr can be reproduced in heterologous expression systems by differential expression of ERG1a and ERG1b isoforms. Characterization of the macroscopic kinetics of ERG1 currents demonstrated that these were dependent on the relative abundance of ERG1a and ERG1b. Furthermore, we used a computational model of the ventricular cardiomyocyte to show that both APD and the slope of the restitution curve may be modulated by varying the relative abundance of ERG1a and ERG1b. As the relative abundance of ERG1b was increased, APD was gradually shortened and the slope of the restitution curve was decreased. Conclusions/Significance: Our results show that differential expression of ERG1 isoforms may explain regional heterogeneity of I-Kr kinetics. The data demonstrate that subunit dependent changes in channel kinetics are important for the functional properties of ERG1 currents and hence I-Kr. Importantly, our results suggest that regional differences in the relative abundance of ERG1 isoforms may represent a potential mechanism underlying the heterogeneity of both APD and APD restitution observed in mammalian hearts.	[Larsen, Anders Peter; Olesen, Soren-Peter] Univ Copenhagen, Dept Biomed Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Larsen, AP (corresponding author), Univ Copenhagen, Dept Biomed Sci, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, Copenhagen, Denmark.	spo@mfi.ku.dk	Olesen, Søren P/H-4206-2011; Olesen, Søren-Peter/B-9621-2012	Olesen, Søren P/0000-0002-4381-5192; 	Danish National Research Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by the Danish National Research Foundation (http://www.dg.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balati B, 1998, ACTA PHYSIOL SCAND, V164, P181; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Bryant SM, 1998, CARDIOVASC RES, V40, P322, DOI 10.1016/S0008-6363(98)00133-3; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Fink M, 2008, PROG BIOPHYS MOL BIO, V96, P357, DOI 10.1016/j.pbiomolbio.2007.07.011; Garny A, 2009, PHILOS T R SOC A, V367, P1885, DOI 10.1098/rsta.2008.0289; Gintant GA, 2000, AM J PHYSIOL-HEART C, V278, pH806, DOI 10.1152/ajpheart.2000.278.3.H806; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Karma A, 1994, CHAOS, V4, P461, DOI 10.1063/1.166024; Kirchberger NM, 2006, J PHYSIOL-LONDON, V571, P27, DOI 10.1113/jphysiol.2005.101667; Larsen AP, 2008, PFLUG ARCH EUR J PHY, V456, P1137, DOI 10.1007/s00424-008-0476-7; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; LeesMiller JP, 1997, CIRC RES, V81, P719; LIU DW, 1995, CIRC RES, V76, P351, DOI 10.1161/01.RES.76.3.351; London B, 1997, CIRC RES, V81, P870; Luo XB, 2008, AM J PHYSIOL-HEART C, V294, pH1371, DOI 10.1152/ajpheart.01026.2007; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Riccio ML, 1999, CIRC RES, V84, P955; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Szabo G, 2005, PFLUG ARCH EUR J PHY, V450, P307, DOI 10.1007/s00424-005-1445-z; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2001, J MOL CELL CARDIOL, V33, P835, DOI 10.1006/jmcc.2000.1317; Viswanathan PC, 1999, CIRCULATION, V99, P2466, DOI 10.1161/01.CIR.99.18.2466; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Weiss JN, 1999, CIRCULATION, V99, P2819, DOI 10.1161/01.CIR.99.21.2819; Yan GX, 1998, CIRCULATION, V98, P1921, DOI 10.1161/01.CIR.98.18.1921; Yue AM, 2005, J AM COLL CARDIOL, V46, P1067, DOI 10.1016/j.jacc.2005.05.074; ZENG JL, 1995, CIRC RES, V77, P140, DOI 10.1161/01.RES.77.1.140	32	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9021	10.1371/journal.pone.0009021	http://dx.doi.org/10.1371/journal.pone.0009021			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126398	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200016
J	Shindo, A; Hara, Y; Yamamoto, TS; Ohkura, M; Nakai, J; Ueno, N				Shindo, Asako; Hara, Yusuke; Yamamoto, Takamasa S.; Ohkura, Masamichi; Nakai, Junichi; Ueno, Naoto			Tissue-Tissue Interaction-Triggered Calcium Elevation Is Required for Cell Polarization during Xenopus Gastrulation	PLOS ONE			English	Article							MECHANICAL-STRESS; EPITHELIAL-CELLS; ATP; COMMUNICATION; POLARITY; RECEPTOR; RELEASE; PATHWAY; INTERCALATION; ORGANIZATION	The establishment of cell polarity is crucial for embryonic cells to acquire their proper morphologies and functions, because cell alignment and intracellular events are coordinated in tissues during embryogenesis according to the cell polarity. Although much is known about the molecules involved in cell polarization, the direct trigger of the process remains largely obscure. We previously demonstrated that the tissue boundary between the chordamesoderm and lateral mesoderm of Xenopus laevis is important for chordamesodermal cell polarity. Here, we examined the intracellular calcium dynamics during boundary formation between two different tissues. In a combination culture of nodal-induced chordamesodermal explants and a heterogeneous tissue, such as ectoderm or lateral mesoderm, the chordamesodermal cells near the boundary frequently displayed intracellular calcium elevation; this frequency was significantly less when homogeneous explants were used. Inhibition of the intracellular calcium elevation blocked cell polarization in the chordamesodermal explants. We also observed frequent calcium waves near the boundary of the dorsal marginal zone ( DMZ) dissected from an early gastrula-stage embryo. Optical sectioning revealed that where heterogeneous explants touched, the chordamesodermal surface formed a wedge with the narrow end tucked under the heterogeneous explant. No such configuration was seen between homogeneous explants. When physical force was exerted against a chordamesodermal explant with a glass needle at an angle similar to that created in the explant, or migrating chordamesodermal cells crawled beneath a silicone block, intracellular calcium elevation was frequent and cell polarization was induced. Finally, we demonstrated that a purinergic receptor, which is implicated in mechano-sensing, is required for such frequent calcium elevation in chordamesoderm and for cell polarization. This study raises the possibility that tissue-tissue interaction generates mechanical forces through cell-cell contact that initiates coordinated cell polarization through a transient increase in intracellular calcium.	[Shindo, Asako; Hara, Yusuke; Yamamoto, Takamasa S.; Ueno, Naoto] Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Japan; [Ohkura, Masamichi; Nakai, Junichi] Saitama Univ, Brain Sci Inst, Saitama 3388570, Japan; [Hara, Yusuke; Ueno, Naoto] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Aichi, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Saitama University; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Shindo, A (corresponding author), Natl Inst Basic Biol, Dept Dev Biol, Okazaki, Japan.	ueno@nibb.ac.jp	Hara, Yusuke/B-7916-2010; Nakai, Junichi/GQZ-6415-2022; Hara, Yusuke/AAQ-1000-2021; Ohkura, Masamichi/J-6976-2012	Hara, Yusuke/0000-0002-2005-7704; Hara, Yusuke/0000-0002-2005-7704; Ueno, Naoto/0000-0002-8375-2317; Shindo, Asako/0000-0002-3314-7151; Ohkura, Masamichi/0000-0002-3659-7780	Ministry of Education, Culture, Sport, Science and Technology, Japan; Human Frontier Science Program; Grants-in-Aid for Scientific Research [21500379] Funding Source: KAKEN	Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by a grant from the Ministry of Education, Culture, Sport, Science and Technology, Japan to N.U. and M.O. and Human Frontier Science Program to J.N.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Communi D, 1997, J BIOL CHEM, V272, P31969, DOI 10.1074/jbc.272.51.31969; Devader C, 2007, FEBS LETT, V581, P5332, DOI 10.1016/j.febslet.2007.10.024; Dzamba BJ, 2009, DEV CELL, V16, P421, DOI 10.1016/j.devcel.2009.01.008; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Formigli L, 2007, J CELL PHYSIOL, V211, P296, DOI 10.1002/jcp.20936; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Homolya L, 2000, J CELL BIOL, V150, P1349, DOI 10.1083/jcb.150.6.1349; KELLER R, 1989, J EXP ZOOL, V251, P134, DOI 10.1002/jez.1402510204; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Millward-Sadler SJ, 2004, BIORHEOLOGY, V41, P567; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ninomiya H, 2008, NAT CELL BIOL, V10, P61, DOI 10.1038/ncb1669; Pedersen S, 1999, BBA-BIOMEMBRANES, V1416, P271, DOI 10.1016/S0005-2736(98)00228-4; Reinhart-King CA, 2008, BIOPHYS J, V95, P6044, DOI 10.1529/biophysj.107.127662; SANDERSON MJ, 1990, CELL REGUL, V1, P585, DOI 10.1091/mbc.1.8.585; Sauer H, 2000, AM J PHYSIOL-CELL PH, V279, pC295, DOI 10.1152/ajpcell.2000.279.2.C295; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shindo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001600; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Strong CF, 2000, DEV BIOL, V222, P405, DOI 10.1006/dbio.2000.9710; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, CURR BIOL, V11, P652, DOI 10.1016/S0960-9822(01)00201-9; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; WIRTZ HRW, 1990, SCIENCE, V250, P1266, DOI 10.1126/science.2173861; Yamamoto TS, 2001, DEVELOPMENT, V128, P2769; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211	33	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8897	10.1371/journal.pone.0008897	http://dx.doi.org/10.1371/journal.pone.0008897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126393	Green Submitted, Green Published, gold			2022-12-27	WOS:000274207200001
J	Burkepile, DE; Hay, ME				Burkepile, Deron E.; Hay, Mark E.			Impact of Herbivore Identity on Algal Succession and Coral Growth on a Caribbean Reef	PLOS ONE			English	Article							PARROTFISH SCARUS-VETULA; FUNCTIONAL REDUNDANCY; ECOSYSTEM FUNCTION; GRAZING INTENSITY; PHASE-SHIFTS; HABITAT USE; COMMUNITY; COMPETITION; MACROALGAE; DIVERSITY	Background: Herbivory is an important top-down force on coral reefs that regulates macroalgal abundance, mediates competitive interactions between macroalgae and corals, and provides resilience following disturbances such as hurricanes and coral bleaching. However, reductions in herbivore diversity and abundance via disease or over-fishing may harm corals directly and may indirectly increase coral susceptibility to other disturbances. Methodology and Principal Findings: In two experiments over two years, we enclosed equivalent densities and masses of either single-species or mixed-species of herbivorous fishes in replicate, 4 m 2 cages at a depth of 17 m on a reef in the Florida Keys, USA to evaluate the effects of herbivore identity and species richness on colonization and development of macroalgal communities and the cascading effects of algae on coral growth. In Year 1, we used the redband parrotfish (Sparisoma aurofrenatum) and the ocean surgeonfish (Acanthurus bahianus); in Year 2, we used the redband parrotfish and the princess parrotfish (Scarus taeniopterus). On new substrates, rapid grazing by ocean surgeonfish and princess parrotfish kept communities in an early successional stage dominated by short, filamentous algae and crustose coralline algae that did not suppress coral growth. In contrast, feeding by redband parrotfish allowed an accumulation of tall filaments and later successional macroalgae that suppressed coral growth. These patterns contrast with patterns from established communities not undergoing primary succession; on established substrates redband parrotfish significantly reduced upright macroalgal cover while ocean surgeonfish and princess parrotfish allowed significant increases in late successional macroalgae. Significance: This study further highlights the importance of biodiversity in affecting ecosystem function in that different species of herbivorous fishes had very different impacts on reef communities depending on the developmental stage of the community. The species-specific effects of herbivorous fishes suggest that a species-rich herbivore fauna can be critical in providing the resilience that reefs need for recovery from common disturbances such as coral bleaching and storm damage.	[Burkepile, Deron E.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Burkepile, Deron E.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, N Miami, FL USA	University System of Georgia; Georgia Institute of Technology; State University System of Florida; Florida International University	Burkepile, DE (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	deron.burkepile@fiu.edu	Burkepile, Deron/F-2368-2013; Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Undersea Research Center [SEGM-2003-19A]; National Science Foundation Integrative Graduate Education and Research Traineeship; National Science Foundation; Teasley Endowment to Georgia Tech.	National Undersea Research Center; National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Teasley Endowment to Georgia Tech.	Funding: Support was provided by National Undersea Research Center Project # SEGM-2003-19A to M. E. H., National Science Foundation Integrative Graduate Education and Research Traineeship and National Science Foundation Graduate Fellowship to D. E. B., and the Teasley Endowment to Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; BRUGGEMANN JH, 1994, MAR ECOL PROG SER, V112, P51, DOI 10.3354/meps112051; Bruggemann JH, 1996, MAR ECOL PROG SER, V134, P59, DOI 10.3354/meps134059; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2007, OECOLOGIA, V154, P167, DOI 10.1007/s00442-007-0801-4; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; CARPENTER RC, 1988, P NATL ACAD SCI USA, V85, P511, DOI 10.1073/pnas.85.2.511; CARPENTER RC, 1986, ECOL MONOGR, V56, P345, DOI 10.2307/1942551; CARPENTER RC, 1985, LIMNOL OCEANOGR, V30, P784, DOI 10.4319/lo.1985.30.4.0784; Duffy JE, 2002, OIKOS, V99, P201, DOI 10.1034/j.1600-0706.2002.990201.x; Duffy JE, 2003, ECOL LETT, V6, P637; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; HAY ME, 1981, AQUAT BOT, V11, P97, DOI 10.1016/0304-3770(81)90051-6; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Horn M.H., 1989, Oceanography and Marine Biology an Annual Review, V27, P167; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jompa J, 2002, J EXP MAR BIOL ECOL, V271, P25, DOI 10.1016/S0022-0981(02)00040-0; Kuffner IB, 2006, MAR ECOL PROG SER, V323, P107, DOI 10.3354/meps323107; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LEWIS SM, 1985, J EXP MAR BIOL ECOL, V87, P215, DOI 10.1016/0022-0981(85)90206-0; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; LEWIS SM, 1985, OECOLOGIA, V65, P370, DOI 10.1007/BF00378911; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; MARKS KW, 2007, AGRRA SUMMARY PRODUC; McAfee ST, 1996, MAR BIOL, V125, P427; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V218, P77, DOI 10.1016/S0022-0981(97)00069-5; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Menge BA, 1997, AM NAT, V149, P801, DOI 10.1086/286025; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Miller MW, 1998, OECOLOGIA, V113, P231, DOI 10.1007/s004420050373; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; MORRISON D, 1988, ECOLOGY, V69, P1367, DOI 10.2307/1941634; Mumby PJ, 2008, TRENDS ECOL EVOL, V23, P555, DOI 10.1016/j.tree.2008.06.011; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; River GF, 2001, J EXP MAR BIOL ECOL, V261, P159, DOI 10.1016/S0022-0981(01)00266-0; Rotjan RD, 2008, MAR ECOL PROG SER, V367, P73, DOI 10.3354/meps07531; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stachowicz JJ, 2008, ECOLOGY, V89, P3008, DOI 10.1890/07-1873.1; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Williams ID, 2001, MAR ECOL PROG SER, V222, P187, DOI 10.3354/meps222187; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	59	120	129	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8963	10.1371/journal.pone.0008963	http://dx.doi.org/10.1371/journal.pone.0008963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126450	Green Submitted, gold, Green Published			2022-12-27	WOS:000274139100011
J	Aitken, S; Robert, MC; Alexander, RD; Goryanin, I; Bertrand, E; Beggs, JD				Aitken, Stuart; Robert, Marie-Cecile; Alexander, Ross D.; Goryanin, Igor; Bertrand, Edouard; Beggs, Jean D.			Processivity and Coupling in Messenger RNA Transcription	PLOS ONE			English	Article							POLYMERASE-II; GENE-EXPRESSION; PROTEIN EXPRESSION; REAL-TIME; NOISE; DYNAMICS; MOLECULE; FLUCTUATIONS; REVEALS; BIOLOGY	Background: The complexity of messenger RNA processing is now being uncovered by experimental techniques that are capable of detecting individual copies of mRNA in cells, and by quantitative real-time observations that reveal the kinetics. This processing is commonly modelled by permitting mRNA to be transcribed only when the promoter is in the on state. In this simple on/off model, the many processes involved in active transcription are represented by a single reaction. These processes include elongation, which has a minimum time for completion and processing that is not captured in the model. Methodology: In this paper, we explore the impact on the mRNA distribution of representing the elongation process in more detail. Consideration of the mechanisms of elongation leads to two alternative models of the coupling between the elongating polymerase and the state of the promoter: Processivity allows polymerases to complete elongation irrespective of the promoter state, whereas coupling requires the promoter to be active to produce a full-length transcript. We demonstrate that these alternatives have a significant impact on the predicted distributions. Models are simulated by the Gillespie algorithm, and the third and fourth moments of the resulting distribution are computed in order to characterise the length of the tail, and sharpness of the peak. By this methodology, we show that the moments provide a concise summary of the distribution, showing statistically-significant differences across much of the feasible parameter range. Conclusions: We conclude that processivity is not fully consistent with the on/off model unless the probability of successfully completing elongation is low-as has been observed. The results also suggest that some form of coupling between the promoter and a rate-limiting step in transcription may explain the cell's inability to maintain high mRNA levels at low noise-a prediction of the on/off model that has no supporting evidence.	[Aitken, Stuart; Alexander, Ross D.; Goryanin, Igor; Beggs, Jean D.] Univ Edinburgh, Ctr Syst Biol, Edinburgh, Midlothian, Scotland; [Robert, Marie-Cecile; Bertrand, Edouard] CNRS, Inst Genet Mol Montpellier, UMR5535, Montpellier, France; [Alexander, Ross D.; Beggs, Jean D.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Edinburgh	Aitken, S (corresponding author), Univ Edinburgh, Ctr Syst Biol, Edinburgh, Midlothian, Scotland.	s.aitken@ed.ac.uk	Beggs, Jean/H-4861-2011; , jbeggs/N-9551-2019; Goryanin, Igor/AAB-1400-2022; Goryanin, Igor/J-1913-2015	Beggs, Jean/0000-0002-8179-6519; Goryanin, Igor/0000-0002-8293-774X; bertrand, edouard/0000-0002-9642-7994	Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council [BB/D019621/1]; European Union [518280]; eDIKT; BBSRC [BB/D019621/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union(European Commission); eDIKT; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology (CISB) funded by the Biotechnology and Biological Sciences Research Council and by the Engineering and Physical Sciences Research Council, reference BB/D019621/1. This work was also supported by the European Union funded RiboSys project no. 518280. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF). The ECDF is partially supported by the eDIKT initiative (http://www.edikt.org.uk).	Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boireau S, 2007, J CELL BIOL, V179, P291, DOI 10.1083/jcb.200706018; Buchan JR, 2007, BIOL CELL, V99, P475, DOI 10.1042/BC20070037; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Darzacq X, 2007, NAT STRUCT MOL BIOL, V14, P796, DOI 10.1038/nsmb1280; Dobrzynski M, 2009, P NATL ACAD SCI USA, V106, P2583, DOI 10.1073/pnas.0803507106; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hastie T., 2003, ELEMENTS STAT LEARNI; Komili S, 2008, NAT REV GENET, V9, P38, DOI 10.1038/nrg2223; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Romano MC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198104; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; Voliotis M, 2008, BIOPHYS J, V94, P334, DOI 10.1529/biophysj.107.105767; Voliotis M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258101; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	33	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8845	10.1371/journal.pone.0008845	http://dx.doi.org/10.1371/journal.pone.0008845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126621	gold, Green Published, Green Submitted			2022-12-27	WOS:000274138000001
J	Frykman, S; Hur, JY; Franberg, J; Aoki, M; Winblad, B; Nahalkova, J; Behbahani, H; Tjernberg, LO				Frykman, Susanne; Hur, Ji-Yeun; Franberg, Jenny; Aoki, Mikio; Winblad, Bengt; Nahalkova, Jarmila; Behbahani, Homira; Tjernberg, Lars O.			Synaptic and Endosomal Localization of Active gamma-Secretase in Rat Brain	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; INSULIN-DEGRADING ENZYME; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; GOLGI NETWORK; LIPID RAFTS; PRESENILIN-1; ASSOCIATION; NICASTRIN; PEPTIDES	Background: A key player in the development of Alzheimer's disease (AD) is the gamma-secretase complex consisting of at least four components: presenilin, nicastrin, Aph-1 and Pen-2. gamma-Secretase is crucial for the generation of the neurotoxic amyloid beta-peptide (A beta) but also takes part in the processing of many other substrates. In cell lines, active gamma-secretase has been found to localize primarily to the Golgi apparatus, endosomes and plasma membranes. However, no thorough studies have been performed to show the subcellular localization of the active gamma-secretase in the affected organ of AD, namely the brain. Principal Findings: We show by subcellular fractionation of rat brain that high gamma-secretase activity, as assessed by production of A beta 40, is present in an endosome-and plasma membrane-enriched fraction of an iodixanol gradient. We also prepared crude synaptic vesicles as well as synaptic membranes and both fractions showed high A beta 40 production and contained high amounts of the gamma-secretase components. Further purification of the synaptic vesicles verified the presence of the gamma-secretase components in these compartments. The localization of an active gamma-secretase in synapses and endosomes was confirmed in rat brain sections and neuronal cultures by using a biotinylated gamma-secretase inhibitor together with confocal microscopy. Significance: The information about the subcellular localization of gamma-secretase in brain is important for the understanding of the molecular mechanisms of AD. Furthermore, the identified fractions can be used as sources for highly active gamma-secretase.	[Frykman, Susanne; Hur, Ji-Yeun; Aoki, Mikio; Winblad, Bengt; Nahalkova, Jarmila; Behbahani, Homira; Tjernberg, Lars O.] Karolinska Inst, Dainippon Sumitomo Pharma Alzheimer Ctr KASPAC, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden; [Franberg, Jenny] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Care Sci & Soc NVS, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Frykman, S (corresponding author), Karolinska Inst, Dainippon Sumitomo Pharma Alzheimer Ctr KASPAC, Dept Neurobiol Care Sci & Soc NVS, Huddinge, Sweden.	susanne.frykman@ki.se	Nahálková, Jarmila/E-9931-2016	Nahálková, Jarmila/0000-0001-9918-6105; Hur, Ji Yeun/0000-0002-9895-3090	Dainippon Sumitomo Pharma (DSP); Foundation for Alzheimer's Disease and Dementia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039287, R01NS038752] Funding Source: NIH RePORTER	Dainippon Sumitomo Pharma (DSP); Foundation for Alzheimer's Disease and Dementia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was supported by Dainippon Sumitomo Pharma (DSP) and DSP had a role in reading the manuscript and decision to publish. Apart from that DSP had no role in study design, data collection and analysis and have no financial interest in the manuscript. JF was supported by The Foundation for Alzheimer's Disease and Dementia and this funder had no role in study design, data colection and analysis, decision to publish or preparation of the manuscript.	Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Behbahani H, 2005, J NEUROSCI RES, V82, P432, DOI 10.1002/jnr.20634; Beher D, 1999, J NEUROCHEM, V72, P1564, DOI 10.1046/j.1471-4159.1999.721564.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Chun J, 2004, J ORG CHEM, V69, P7344, DOI 10.1021/jo0486948; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; Edbauer D, 2002, J BIOL CHEM, V277, P13389, DOI 10.1074/jbc.M111571200; Efthimiopoulos S, 1998, J NEUROCHEM, V71, P2365; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Franberg J, 2007, BIOCHEMISTRY-US, V46, P7647, DOI 10.1021/bi0621258; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; KOO EH, 1994, J BIOL CHEM, V269, P17386; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; Lah JJ, 1997, J NEUROSCI, V17, P1971; MCCARTHY JV, 2009, CELL MOL LIFE SCI; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Ribaut-Barassin C, 2003, NEUROSCIENCE, V120, P405, DOI 10.1016/S0306-4522(03)00332-4; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Siman R, 2003, J NEUROCHEM, V84, P1143, DOI 10.1046/j.1471-4159.2003.01616.x; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Teranishi Y., 2009, J CELL MOL MED; Torp R, 2003, NEUROSCIENCE, V120, P291, DOI 10.1016/S0306-4522(03)00320-8; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082	38	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8948	10.1371/journal.pone.0008948	http://dx.doi.org/10.1371/journal.pone.0008948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126630	Green Published, Green Submitted, gold			2022-12-27	WOS:000274138000023
J	Steptoe, A; Hamer, M; O'Donnell, K; Venuraju, S; Marmot, MG; Lahiri, A				Steptoe, Andrew; Hamer, Mark; O'Donnell, Katie; Venuraju, Shreenidhi; Marmot, Michael G.; Lahiri, Avijit			Socioeconomic Status and Subclinical Coronary Disease in the Whitehall II Epidemiological Study	PLOS ONE			English	Article							ARTERY RISK DEVELOPMENT; INTIMA-MEDIA THICKNESS; HEART-DISEASE; CARDIOVASCULAR-DISEASE; YOUNG-ADULTS; PSYCHOSOCIAL FACTORS; SOCIAL INEQUALITIES; CALCIFICATION; ATHEROSCLEROSIS; PROGRESSION	Background: There are pronounced socioeconomic disparities in coronary heart disease, but the extent to which these primarily reflect gradients in underlying coronary artery disease severity or in the clinical manifestation of advanced disease is uncertain. We measured the relationship between socioeconomic status (SES) as indexed by grade of employment and coronary artery calcification (CAC) in the Whitehall II epidemiological cohort, and tested the contribution of lifestyle, biological and psychosocial factors in accounting for this association. Methods and Findings: CAC was assessed in 528 asymptomatic men and women aged 53-76 years, stratified into higher, intermediate and lower by grade of employment groups. Lifestyle (smoking, body mass index, alcohol consumption, physical activity), biological (blood pressure, lipids, fasting glucose, inflammatory markers) and psychosocial factors (work stress, financial strain, social support, depression, hostility, optimism) were also measured. Detectable CAC was present in 293 participants (55.5%). The presence of calcification was related to lifestyle and biological risk factors, but not to grade of employment. But among individuals with detectable calcification, the severity of CAC was inversely associated with grade of employment (p = 0.010), and this relationship remained after controlling for demographic, lifestyle, biological and psychosocial factors. Compared with the higher grade group, there was a mean increase in log Agatston scores of 0.783 (95% C. I. 0.265-1.302, p = 0.003) in the intermediate and 0.941 (C. I. 0.226-1.657, p = 0.010) in the lower grade of employment groups, after adjustment for demographic, lifestyle, biological and psychosocial factors. Conclusions: Low grade of employment did not predict the presence of calcification in this cohort, but was related to the severity of CAC. These findings suggest that lower SES may be particularly relevant at advanced stages of subclinical coronary artery disease, when calcification has developed.	[Steptoe, Andrew; Hamer, Mark; O'Donnell, Katie; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Venuraju, Shreenidhi; Lahiri, Avijit] Wellington Hosp, Cardiac Imaging & Res Ctr, London, England	University of London; University College London; Wellington Hospital	Steptoe, A (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	a.steptoe@ucl.ac.uk	Hamer, Mark/C-1602-2008; Marmot, M G/Y-3920-2019; Hamer, Mark/AAJ-6814-2021; Steptoe, Andrew/Y-2440-2019	Hamer, Mark/0000-0002-8726-7992; Marmot, M G/0000-0002-2431-6419; Hamer, Mark/0000-0002-8726-7992; Steptoe, Andrew/0000-0001-7808-4943	British Heart Foundation [RG/05/006]; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G19/35, G0100222, G0902037] Funding Source: researchfish; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the British Heart Foundation (RG/05/006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand DV, 2007, J AM COLL CARDIOL, V50, P2218, DOI 10.1016/j.jacc.2007.08.032; Bild DE, 2001, ARTERIOSCL THROM VAS, V21, P852, DOI 10.1161/01.ATV.21.5.852; Brydon L, 2004, BRAIN BEHAV IMMUN, V18, P281, DOI 10.1016/j.bbi.2003.09.011; Chandola T, 2008, EUR HEART J, V29, P640, DOI 10.1093/eurheartj/ehm584; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; Cohen Sheldon, 1997, JAMA (Journal of the American Medical Association), V277, P1940, DOI 10.1001/jama.277.24.1940; Colhoun HM, 2000, BMJ-BRIT MED J, V321, P1262, DOI 10.1136/bmj.321.7271.1262; Dragano N, 2007, EUR J CARDIOV PREV R, V14, P568, DOI 10.1097/HJR.0b013e32804955c4; Everson-Rose SA, 2005, ANNU REV PUBL HEALTH, V26, P469, DOI 10.1146/annurev.publhealth.26.021304.144542; Gibson PH, 2009, HEART, V95, P793, DOI 10.1136/hrt.2008.149849; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Kivimaki M, 2005, ARTERIOSCL THROM VAS, V25, P2197, DOI 10.1161/01.ATV.0000183729.91449.6e; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Kop WJ, 2005, PSYCHOSOM MED, V67, P343, DOI 10.1097/01.psy.0000161201.45643.8d; LYNCH J, 1995, CIRCULATION, V92, P1786, DOI 10.1161/01.CIR.92.7.1786; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Marmot MG, 2008, DIABETOLOGIA, V51, P1980, DOI 10.1007/s00125-008-1144-3; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1986, LANCET, V2, P274; Mittleman MA, 1997, ARCH INTERN MED, V157, P769, DOI 10.1001/archinte.157.7.769; Moser DK, 2006, CIRCULATION, V114, P168, DOI 10.1161/CIRCULATIONAHA.106.176040; O'Malley PG, 2000, NEW ENGL J MED, V343, P1298, DOI 10.1056/NEJM200011023431803; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ranjit N, 2006, ARTERIOSCL THROM VAS, V26, P411, DOI 10.1161/01.ATV.0000198245.16342.3d; Roux AVD, 2006, ANN INTERN MED, V144, P822, DOI 10.7326/0003-4819-144-11-200606060-00008; Roux AVD, 2005, CIRCULATION, V112, P1557, DOI 10.1161/CIRCULATIONAHA.104.530147; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; STANSFELD S, 1992, SOC SCI MED, V35, P1027, DOI 10.1016/0277-9536(92)90242-I; Steptoe A, 2002, EUR HEART J, V23, P1757, DOI 10.1053/euhj.2001.3233; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793	32	31	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8874	10.1371/journal.pone.0008874	http://dx.doi.org/10.1371/journal.pone.0008874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	547NM	20111604	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896300023
J	Pust, S; Dyve, AB; Torgersen, ML; van Deurs, B; Sandvig, K				Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; van Deurs, Bo; Sandvig, Kirsten			Interplay between Toxin Transport and Flotillin Localization	PLOS ONE			English	Article							SHIGA TOXIN; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; MEMBRANE MICRODOMAINS; PLASMA-MEMBRANE; GOLGI TRANSPORT; REGGIE/FLOTILLIN PROTEINS; TYROSINE SULFATION; RAFT ASSOCIATION; CHOLERA-TOXIN	The flotillin proteins are localized in lipid domains at the plasma membrane as well as in intracellular compartments. In the present study, we examined the importance of flotillin-1 and flotillin-2 for the uptake and transport of the bacterial Shiga toxin (Stx) and the plant toxin ricin and we investigated whether toxin binding and uptake were associated with flotillin relocalization. We observed a toxin-induced redistribution of the flotillins, which seemed to be regulated in a p38-dependent manner. Our experiments provide no evidence for a changed endocytic uptake of Stx or ricin in cells silenced for flotillin-1 or -2. However, the Golgi-dependent sulfation of both toxins was significantly reduced in flotillin knockdown cells. Interestingly, when the transport of ricin to the ER was investigated, we obtained an increased mannosylation of ricin in flotillin-1 and flotillin-2 knockdown cells. The toxicity of both toxins was twofold increased in flotillin-depleted cells. Since BFA (Brefeldin A) inhibits the toxicity even in flotillin knockdown cells, the retrograde toxin transport is apparently still Golgi-dependent. Thus, flotillin proteins regulate and facilitate the retrograde transport of Stx and ricin.	[Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; Sandvig, Kirsten] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Pust, Sascha; Dyve, Anne Berit; Torgersen, Maria L.; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [van Deurs, Bo] Univ Copenhagen, Panum Inst, Struct Cell Biol Unit, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark	University of Oslo; University of Oslo; University of Copenhagen	Pust, S (corresponding author), Univ Oslo, Ctr Canc Biomed, Oslo, Norway.	ksandvig@radium.uio.no	Torgersen, Maria Lyngaas L/F-3492-2017; Torgersen, Maria Lyngaas/O-6240-2019; Pust, Sascha/M-3201-2013	Torgersen, Maria Lyngaas L/0000-0003-2616-7194; Torgersen, Maria Lyngaas/0000-0003-2616-7194; Pust, Sascha/0000-0002-0178-2206	Norwegian Cancer Society; Norwegian Research Council for Science and Humanities; Helse Sor-Ost	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council for Science and Humanities; Helse Sor-Ost	This work was supported by The Norwegian Cancer Society, The Norwegian Research Council for Science and Humanities, and Helse Sor-Ost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri MA, 1996, ARCH BIOCHEM BIOPHYS, V326, P64, DOI 10.1006/abbi.1996.0047; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Fernow I, 2007, EUR J CELL BIOL, V86, P345, DOI 10.1016/j.ejcb.2007.03.004; Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078; Gkantiragas I, 2001, MOL BIOL CELL, V12, P1819, DOI 10.1091/mbc.12.6.1819; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; GRIFFITHS GD, 1987, J PATHOL, V151, P221, DOI 10.1002/path.1711510310; Grimmer S, 2000, MOL BIOL CELL, V11, P4205, DOI 10.1091/mbc.11.12.4205; Grimmer S, 2006, TRAFFIC, V7, P1243, DOI 10.1111/j.1600-0854.2006.00456.x; HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051; IWANAGA T, 2009, PROG LIPID RES; Jackson CL, 2009, J CELL SCI, V122, P443, DOI 10.1242/jcs.032581; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kato N, 2006, J IMMUNOL, V177, P147, DOI 10.4049/jimmunol.177.1.147; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; LEITINGER B, 1994, J BIOL CHEM, V269, P8115; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Lingwood CA, 1999, BBA-MOL BASIS DIS, V1455, P375, DOI 10.1016/S0925-4439(99)00062-9; Liu J, 2005, J BIOL CHEM, V280, P16125, DOI 10.1074/jbc.M500940200; Llorente A, 2003, J BIOL CHEM, V278, P35850, DOI 10.1074/jbc.M303425200; McCormick PJ, 2008, TRAFFIC, V9, P1984, DOI 10.1111/j.1600-0854.2008.00814.x; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Planey SL, 2009, MOL MEMBR BIOL, V26, P14, DOI 10.1080/09687680802646703; Raa H, 2009, TRAFFIC, V10, P868, DOI 10.1111/j.1600-0854.2009.00919.x; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; SANDVIG K, 1979, EXP CELL RES, V121, P15, DOI 10.1016/0014-4827(79)90439-7; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schulte T, 1997, DEVELOPMENT, V124, P577; SKANLAND SS, 2009, CELL MICROBIOL; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Walchli S, 2009, CELL SIGNAL, V21, P1161, DOI 10.1016/j.cellsig.2009.03.005; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Ying M, 2003, TRAFFIC, V4, P772, DOI 10.1034/j.1600-0854.2003.00134.x	55	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8844	10.1371/journal.pone.0008844	http://dx.doi.org/10.1371/journal.pone.0008844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107503	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896100010
J	Cooper, EA; Whittall, JB; Hodges, SA; Nordborg, M				Cooper, Elizabeth A.; Whittall, Justen B.; Hodges, Scott A.; Nordborg, Magnus			Genetic Variation at Nuclear Loci Fails to Distinguish Two Morphologically Distinct Species of Aquilegia	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DROSOPHILA-PSEUDOOBSCURA; HAPLOTYPE RECONSTRUCTION; LINKAGE DISEQUILIBRIUM; HELIANTHUS-ANNUUS; ANNUAL SUNFLOWERS; POPULATION SIZES; SPECIATION; FLOW; HYBRIDIZATION	Aquilegia formosa and pubescens are two closely related species belonging to the columbine genus. Despite their morphological and ecological differences, previous studies have revealed a large degree of intercompatibility, as well as little sequence divergence between these two taxa [1,2]. We compared the inter- and intraspecific patterns of variation for 9 nuclear loci, and found that the two species were practically indistinguishable at the level of DNA sequence polymorphism, indicating either very recent speciation or continued gene flow. As a comparison, we also analyzed variation at two loci across 30 other Aquilegia taxa; this revealed slightly more differentiation among taxa, which seemed best explained by geographic distance. By contrast, we found no evidence for isolation by distance on a more local geographic scale. We conclude that the extremely low levels of genetic differentiation between A. formosa and A. pubescens at neutral loci will facilitate future genome-wide scans for speciation genes.	[Cooper, Elizabeth A.] Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA; [Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Hodges, Scott A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Nordborg, Magnus] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria	University of Southern California; Santa Clara University; University of California System; University of California Santa Barbara; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Cooper, EA (corresponding author), Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA.	eacooper@usc.edu		Hodges, Scott/0000-0002-0401-6072; Cooper, Elizabeth/0000-0002-2688-7418; Nordborg, Magnus/0000-0001-7178-9748	NSF [EF-0412727]	NSF(National Science Foundation (NSF))	This work was supported by an NSF grant: EF-0412727. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; CHASE VC, 1975, EVOLUTION, V29, P474, DOI [10.2307/2407260, 10.1111/j.1558-5646.1975.tb00837.x]; Clarke B, 1996, PHILOS T R SOC B, V351, P773, DOI 10.1098/rstb.1996.0072; Coyne J.A., 2004, SPECIATION; Crow KD, 2007, BIOL J LINN SOC, V91, P135, DOI 10.1111/j.1095-8312.2007.00786.x; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fulton M, 1999, P ROY SOC B-BIOL SCI, V266, P2247, DOI 10.1098/rspb.1999.0915; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GRANT VERNE, 1952, ALISO, V2, P341; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P5129, DOI 10.1073/pnas.91.11.5129; Hodges SA, 2004, NEW PHYTOL, V161, P113, DOI 10.1046/j.1469-8137.2003.00950.x; HODGES SA, 1994, P NATL ACAD SCI USA, V91, P2493, DOI 10.1073/pnas.91.7.2493; HUDSON RR, 1992, GENETICS, V132, P583; JUKES T H, 1969, P21; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kolkman JM, 2007, GENETICS, V177, P457, DOI 10.1534/genetics.107.074054; Lawton-Rauh A, 2007, MOL ECOL, V16, P3995, DOI 10.1111/j.1365-294X.2007.03445.x; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; MANTEL N, 1967, CANCER RES, V27, P209; Munz Philip A., 1946, GENTES HERBARUM, V7, P1; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; PRAZMO W., 1965, ACTA SOC BOT POL, V34, P667; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Rosenberg N.A, 2002, DISTRUCT PROGRAM GRA; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Scotti-Saintagne C, 2004, GENETICS, V168, P1615, DOI 10.1534/genetics.104.026849; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strasburg JL, 2008, EVOLUTION, V62, P1936, DOI 10.1111/j.1558-5646.2008.00415.x; TAJIMA F, 1983, GENETICS, V105, P437; TAYLOR RJ, 1967, BRITTONIA, V19, P374, DOI 10.2307/2805535; TEAM RDC, 2007, R LANGUAGE ENV STAT; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Wang RL, 1997, GENETICS, V147, P1091; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WEIR BS, 1986, AM J HUM GENET, V38, P776; Whittall JB, 2006, MOL PHYLOGENET EVOL, V39, P124, DOI 10.1016/j.ympev.2005.10.010; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang JY, 2005, MOL ECOL NOTES, V5, P317, DOI 10.1111/j.1471-8286.2005.00913.x; Yatabe Y, 2007, GENETICS, V175, P1883, DOI 10.1534/genetics.106.064469; Zhu YL, 2003, GENETICS, V163, P1123	55	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8655	10.1371/journal.pone.0008655	http://dx.doi.org/10.1371/journal.pone.0008655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098727	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900005
J	Tan, PT; Heiny, AT; Miotto, O; Salmon, J; Marques, ETA; Lemonnier, F; August, JT				Tan, Paul ThiamJoo; Heiny, A. T.; Miotto, Olivo; Salmon, Jerome; Marques, Ernesto T. A., Jr.; Lemonnier, Francois; August, J. Thomas			Conservation and Diversity of Influenza A H1N1 HLA-Restricted T Cell Epitope Candidates for Epitope-Based Vaccines	PLOS ONE			English	Article							DOUBLE-KNOCKOUT MICE; CLASS-I SUPERTYPES; TRANSGENIC MICE; MEDIATED PROTECTION; LETHAL INFLUENZA; VIRUS INFECTION; CTL EPITOPES; HIGH-AVIDITY; LYMPHOCYTE; PEPTIDE	Background: The immune-related evolution of influenza viruses is exceedingly complex and current vaccines against influenza must be reformulated for each influenza season because of the high degree of antigenic drift among circulating influenza strains. Delay in vaccine production is a serious problem in responding to a pandemic situation, such as that of the current H1N1 strain. Immune escape is generally attributed to reduced antibody recognition of the viral hemagglutinin and neuraminidase proteins whose rate of mutation is much greater than that of the internal non-structural proteins. As a possible alternative, vaccines directed at T cell epitope domains of internal influenza proteins, that are less susceptible to antigenic variation, have been investigated. Methodology/Principal Findings: HLA transgenic mouse strains expressing HLA class I A*0201, A*2402, and B*0702, and class II DRB1*1501, DRB1*0301 and DRB1*0401 were immunized with 196 influenza H1N1 peptides that contained residues of highly conserved proteome sequences of the human H1N1, H3N2, H1N2, H5N1, and avian influenza A strains. Fifty-four (54) peptides that elicited 63 HLA-restricted peptide-specific T cell epitope responses were identified by IFN-gamma ELISpot assay. The 54 peptides were compared to the 2007-2009 human H1N1 sequences for selection of sequences in the design of a new candidate H1N1 vaccine, specifically targeted to highly-conserved HLA-restricted T cell epitopes. Conclusions/Significance: Seventeen (17) T cell epitopes in PB1, PB2, and M1 were selected as vaccine targets based on sequence conservation over the past 30 years, high functional avidity, non-identity to human peptides, clustered localization, and promiscuity to multiple HLA alleles. These candidate vaccine antigen sequences may be applicable to any avian or human influenza A virus.	[Tan, Paul ThiamJoo; Salmon, Jerome; August, J. Thomas] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Heiny, A. T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Miotto, Olivo] Univ Oxford, Ctr Genom & Global Hlth, Oxford, England; [Miotto, Olivo] Mahidol Univ, Fac Trop Med, Mahidol Oxford Res Unit, Bangkok, Thailand; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Marques, Ernesto T. A., Jr.] LaVITE, FIOCRUZ Dept Virol, Ctr Pesquisa Aggeu Magalhaes, Recife, PE, Brazil; [Lemonnier, Francois] Inst Pasteur, Unite Immunite Cellulaire Antivirale, Paris, France	Johns Hopkins University; National University of Singapore; University of Oxford; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fundacao Oswaldo Cruz; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tan, PT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	ptan4@jhmi.edu	Marques, Ernesto T. A/L-4967-2013; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013; Miotto, Olivo/AAE-7124-2019	Marques, Ernesto T. A/0000-0003-3826-9358; Marques, Ernesto/0000-0003-3826-9358; Miotto, Olivo/0000-0001-8060-6771; Francois, Lemonnier/0000-0002-6741-2742	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA [5 U19 AI56541, HHSN2662-00400085C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056541] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part with Federal Funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, USA under Grant No. 5 U19 AI56541 and Contract No. HHSN2662-00400085C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlexanderMiller MA, 1996, P NATL ACAD SCI USA, V93, P4102, DOI 10.1073/pnas.93.9.4102; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; Berkhoff EGM, 2006, VACCINE, V24, P6594, DOI 10.1016/j.vaccine.2006.05.051; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; BIDDISON WE, 2001, CURR PROTOC IMMUNOL; Brown DM, 2006, J IMMUNOL, V177, P2888, DOI 10.4049/jimmunol.177.5.2888; Carson RT, 1999, J IMMUNOL, V162, P1; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Doytchinova IA, 2005, J IMMUNOL, V174, P7085, DOI 10.4049/jimmunol.174.11.7085; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein SL, 1998, J IMMUNOL, V160, P322; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; FUGGER L, 1994, P NATL ACAD SCI USA, V91, P6151, DOI 10.1073/pnas.91.13.6151; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Gonzalez S, 1996, NUCLEIC ACIDS RES, V24, P4456, DOI 10.1093/nar/24.22.4456; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; Lalvani A, 1997, J IMMUNOL METHODS, V210, P65, DOI 10.1016/S0022-1759(97)00177-4; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Li X, 2006, CLIN EXP RHEUMATOL, V24, P148; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S18; Mirshahidi S, 2004, J IMMUNOL, V172, P5346, DOI 10.4049/jimmunol.172.9.5346; Mozdzanowska K, 2005, J VIROL, V79, P5943, DOI 10.1128/JVI.79.10.5943-5951.2005; Niedermann G, 2002, CURR TOP MICROBIOL, V268, P91; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Powell TJ, 2007, J IMMUNOL, V178, P1030, DOI 10.4049/jimmunol.178.2.1030; Richards KA, 2009, J VIROL, V83, P6566, DOI 10.1128/JVI.00302-09; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Sedlik C, 2000, J VIROL, V74, P5769, DOI 10.1128/JVI.74.13.5769-5775.2000; Sette A, 1999, IMMUNOGENETICS, V50, P201, DOI 10.1007/s002510050594; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Strutt TM, 2009, J CLIN IMMUNOL, V29, P145, DOI 10.1007/s10875-008-9266-4; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tobery TW, 2001, J IMMUNOL METHODS, V254, P59, DOI 10.1016/S0022-1759(01)00397-0; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tsitoura DC, 1996, J IMMUNOL, V156, P2801; Vandenbark AA, 2003, J IMMUNOL, V171, P127, DOI 10.4049/jimmunol.171.1.127	50	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8754	10.1371/journal.pone.0008754	http://dx.doi.org/10.1371/journal.pone.0008754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090904	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000273715000012
J	Fedele, G; Spensieri, F; Palazzo, R; Nasso, M; Cheung, GYC; Coote, JG; Ausiello, CM				Fedele, Giorgio; Spensieri, Fabiana; Palazzo, Raffaella; Nasso, Maria; Cheung, Gordon Yiu Chong; Coote, John Graham; Ausiello, Clara Maria			Bordetella pertussis Commits Human Dendritic Cells to Promote a Th1/Th17 Response through the Activity of Adenylate Cyclase Toxin and MAPK-Pathways	PLOS ONE			English	Article							IL-17-PRODUCING T-CELLS; IMMUNE-RESPONSE; MOLECULAR PATHOGENESIS; DEPENDENT PATHWAY; INFECTION; ACTIVATION; INDUCTION; INNATE; IL-12; INFLAMMATION	The complex pathology of B. pertussis infection is due to multiple virulence factors having disparate effects on different cell types. We focused our investigation on the ability of B. pertussis to modulate host immunity, in particular on the role played by adenylate cyclase toxin (CyaA), an important virulence factor of B. pertussis. As a tool, we used human monocyte derived dendritic cells (MDDC), an ex vivo model useful for the evaluation of the regulatory potential of DC on T cell immune responses. The work compared MDDC functions after encounter with wild-type B. pertussis (BpWT) or a mutant lacking CyaA (BpCyaA(-)), or the BpCyaA(-) strain supplemented with either the fully functional CyaA or a derivative, CyaA*, lacking adenylate cyclase activity. As a first step, MDDC maturation, cytokine production, and modulation of T helper cell polarization were evaluated. As a second step, engagement of Toll-like receptors (TLR) 2 and TLR4 by B. pertussis and the signaling events connected to this were analyzed. These approaches allowed us to demonstrate that CyaA expressed by B. pertussis strongly interferes with DC functions, by reducing the expression of phenotypic markers and immunomodulatory cytokines, and blocking IL-12p70 production. B. pertussis-treated MDDC promoted a mixed Th1/Th17 polarization, and the activity of CyaA altered the Th1/Th17 balance, enhancing Th17 and limiting Th1 expansion. We also demonstrated that Th1 effectors are induced by B. pertussis-MDDC in the absence of IL-12p70 through an ERK1/2 dependent mechanism, and that p38 MAPK is essential for MDDC-driven Th17 expansion. The data suggest that CyaA mediates an escape strategy for the bacterium, since it reduces Th1 immunity and increases Th17 responses thought to be responsible, when the response is exacerbated, for enhanced lung inflammation and injury.	[Fedele, Giorgio; Spensieri, Fabiana; Palazzo, Raffaella; Nasso, Maria; Ausiello, Clara Maria] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Cheung, Gordon Yiu Chong; Coote, John Graham] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Biomed & Life Sci, Div Infect & Immun, Glasgow, Lanark, Scotland	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); University of Glasgow	Fedele, G (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	clara.ausiello@iss.it	FEDELE, GIORGIO/M-4357-2015; fedele, giorgio/N-4681-2015; Cheung, Yiu Chong/K-3565-2012; Ausiello, Clara/G-3232-2011; PALAZZO, RAFFAELLA/M-4364-2015	FEDELE, GIORGIO/0000-0003-0017-6711; 	Istituto Superiore di Sanita (ISS) Italy-USA [28C6]; Italian Ministry of Health Ricerca Finalizzata [8ABF/1, 8AGF]; Commission of the European Communities; ChildINNOVAC [201502]	Istituto Superiore di Sanita (ISS) Italy-USA; Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Commission of the European Communities(European Commission); ChildINNOVAC	Funding: This work was supported by grants from Istituto Superiore di Sanita (ISS) Italy-USA scientific cooperation agreement (# 28C6); Italian Ministry of Health Ricerca Finalizzata (8ABF/1, 8AGF); and from the Commission of the European Communities, contract # 201502 ChildINNOVAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author has any financial, personal, or professional interests that could be construed to have influenced the paper.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Ausiello CM, 2000, J INFECT DIS, V181, P1989, DOI 10.1086/315509; Bagley KC, 2002, J LEUKOCYTE BIOL, V72, P962; Bassinet L, 2000, INFECT IMMUN, V68, P1934, DOI 10.1128/IAI.68.4.1934-1941.2000; BOUHSS A, 1993, J BIOL CHEM, V268, P1690; Boyd AP, 2005, J IMMUNOL, V175, P730, DOI 10.4049/jimmunol.175.2.730; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Cheung GYC, 2006, INFECT IMMUN, V74, P6797, DOI 10.1128/IAI.01104-06; Fedele G, 2005, INFECT IMMUN, V73, P1590, DOI 10.1128/IAI.73.3.1590-1597.2005; Fedele G, 2004, EUR J IMMUNOL, V34, P1342, DOI 10.1002/eji.200324728; Fedele G, 2008, J IMMUNOL, V181, P208, DOI 10.4049/jimmunol.181.1.208; Fedele G, 2007, MICROBES INFECT, V9, P855, DOI 10.1016/j.micinf.2007.03.002; Frasca L, 2006, BLOOD, V107, P2392, DOI 10.1182/blood-2005-07-2913; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; Hewlett EL, 2005, NEW ENGL J MED, V352, P1215, DOI 10.1056/NEJMcp041025; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; Hickey FB, 2008, J LEUKOCYTE BIOL, V84, P234, DOI 10.1189/jlb.0208113; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; KHELEF N, 1992, MICROB PATHOGENESIS, V12, P227, DOI 10.1016/0882-4010(92)90057-U; KHELEF N, 1994, INFECT IMMUN, V62, P2893, DOI 10.1128/IAI.62.7.2893-2900.1994; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F; Locht C, 2001, CURR OPIN MICROBIOL, V4, P82, DOI 10.1016/S1369-5274(00)00169-7; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mascart F, 2003, J IMMUNOL, V170, P1504, DOI 10.4049/jimmunol.170.3.1504; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Nasso M, 2009, J IMMUNOL, V183, P1892, DOI 10.4049/jimmunol.0901071; Nembrini C, 2009, J ALLERGY CLIN IMMUN, V123, P986, DOI 10.1016/j.jaci.2009.03.033; Rescigno M, 2002, TRENDS MICROBIOL, V10, P425, DOI 10.1016/S0966-842X(02)02425-3; Ross PJ, 2004, INFECT IMMUN, V72, P1568, DOI 10.1128/IAI.72.3.1568-1579.2004; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Siciliano NA, 2006, J IMMUNOL, V177, P7131, DOI 10.4049/jimmunol.177.10.7131; Spensieri F, 2006, INFECT IMMUN, V74, P2831, DOI 10.1128/IAI.74.5.2831-2838.2006; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Vojtova J, 2006, CURR OPIN MICROBIOL, V9, P69, DOI 10.1016/j.mib.2005.12.011; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Westrop GD, 1996, GENE, V180, P91, DOI 10.1016/S0378-1119(96)00412-X; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497	48	61	63	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8734	10.1371/journal.pone.0008734	http://dx.doi.org/10.1371/journal.pone.0008734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090944	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900014
J	Reichmann, WM; Losina, E; Seage, GR; Arbelaez, C; Safren, SA; Katz, JN; Hetland, A; Walensky, RP				Reichmann, William M.; Losina, Elena; Seage, George R., III; Arbelaez, Christian; Safren, Steven A.; Katz, Jeffrey N.; Hetland, Adam; Walensky, Rochelle P.			Does Modality of Survey Administration Impact Data Quality: Audio Computer Assisted Self Interview (ACASI) Versus Self-Administered Pen and Paper?	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; EMERGENCY SEVERITY INDEX; RANDOMIZED-TRIAL; RISK BEHAVIORS; DRUG-USERS; HIV RISK; IMPLEMENTATION; MODE; BIAS	Background: In the context of a randomized controlled trial (RCT) on HIV testing in the emergency department (ED) setting, we evaluated preferences for survey modality and data quality arising from each modality. Methods: Enrolled participants were offered the choice of answering a survey via audio computer assisted self-interview (ACASI) or pen and paper self-administered questionnaire (SAQ). We evaluated factors influencing choice of survey modality. We defined unusable data for a particular survey domain as answering fewer than 75% of the questions in the domain. We then compared ACASI and SAQ with respect to unusable data for domains that address sensitive topics. Results: Of 758 enrolled ED patients, 218 (29%) chose ACASI, 343 chose SAQ (45%) and 197 (26%) opted not to complete either. Results of the log-binomial regression indicated that older (RR = 1.08 per decade) and less educated participants (RR = 1.25) were more likely to choose SAQ over ACASI. ACASI yielded substantially less unusable data than SAQ. Conclusions: In the ED setting there may be a tradeoff between increased participation with SAQ versus better data quality with ACASI. Future studies of novel approaches to maximize the use of ACASI in the ED setting are needed.	[Reichmann, William M.; Losina, Elena; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Reichmann, William M.; Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Walensky, Rochelle P.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Seage, George R., III; Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Arbelaez, Christian; Hetland, Adam] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Safren, Steven A.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Walensky, Rochelle P.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Reichmann, WM (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.	wreichmann@partners.org		Losina, ELENA/0000-0002-3424-0892; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Mental Health [R01 MH073445, R01 MH65869]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869, R01MH073445] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding: This work was supported by the National Institute of Mental Health [R01 MH073445, R01 MH65869]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbor T. F., 2001, ALCOHOL USE DISORDER; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Carey MP, 2002, AIDS EDUC PREV, V14, P172, DOI 10.1521/aeap.14.2.172.23902; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Des Jarlais DC, 1999, LANCET, V353, P1657, DOI 10.1016/S0140-6736(98)07026-3; Eitel DR, 2003, ACAD EMERG MED, V10, P1070, DOI 10.1197/S1069-6563(03)00350-6; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Gribble JN, 1999, J SEX RES, V36, P16, DOI 10.1080/00224499909551963; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI 10.1111/j.1553-2712.2007.tb02335.x; Jones R, 2003, WESTERN J NURS RES, V25, P349, DOI 10.1177/0193945902250423; Kurth AE, 2004, SEX TRANSM DIS, V31, P719, DOI 10.1097/01.olq.0000145855.36181.13; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Macalino GE, 2002, AIDS EDUC PREV, V14, P367, DOI 10.1521/aeap.14.6.367.24075; Mehta SD, 2007, ACAD EMERG MED, V14, P250, DOI [10.1197/j.aem.2006.10.106, 10.1111/j.1553-2712.2007.tb01782.x]; Morrison-Beedy D, 2006, AIDS BEHAV, V10, P541, DOI 10.1007/s10461-006-9081-y; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rickert VI, 2009, J ADOLESCENT HEALTH, V45, P163, DOI 10.1016/j.jadohealth.2008.12.012; Rogers SM, 2005, SEX TRANSM INFECT, V81, P501, DOI 10.1136/sti.2004.014266; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Simoes AA, 2006, J SUBST ABUSE TREAT, V30, P237, DOI 10.1016/j.jsat.2005.12.002; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tourangeau R, 1996, PUBLIC OPIN QUART, V60, P275, DOI 10.1086/297751; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; U. S. Department of Health and Human Services, 2004, CES D SCAL; WALENSKY RPA, 2009, 1039 CROI; Webb PM, 1999, J ADOLESCENT HEALTH, V24, P383, DOI 10.1016/S1054-139X(99)00005-1; Wuerz RC, 2001, ACAD EMERG MED, V8, P170, DOI 10.1111/j.1553-2712.2001.tb01283.x; Wuerz RC, 2000, ACAD EMERG MED, V7, P236, DOI 10.1111/j.1553-2712.2000.tb01066.x	29	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8728	10.1371/journal.pone.0008728	http://dx.doi.org/10.1371/journal.pone.0008728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545EI	20090953	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900009
J	Krebs, RM; Woldorff, MG; Tempelmann, C; Bodammer, N; Noesselt, T; Boehler, CN; Scheich, H; Hopf, JM; Duzel, E; Heinze, HJ; Schoenfeld, MA				Krebs, Ruth M.; Woldorff, Marty G.; Tempelmann, Claus; Bodammer, Nils; Noesselt, Toemme; Boehler, Carsten N.; Scheich, Henning; Hopf, Jens-Max; Duzel, Emrah; Heinze, Hans-Jochen; Schoenfeld, Mircea A.			High-Field fMRI Reveals Brain Activation Patterns Underlying Saccade Execution in the Human Superior Colliculus	PLOS ONE			English	Article							EVENT-RELATED FMRI; POSTERIOR PARIETAL CORTEX; FRONTAL EYE FIELD; PREPARATION SIGNALS; NEURONAL RESPONSES; LATERAL GENICULATE; FUNCTIONAL-ANATOMY; OCULOMOTOR SYSTEM; SPATIAL ATTENTION; COVERT SHIFTS	Background: The superior colliculus (SC) has been shown to play a crucial role in the initiation and coordination of eye-and head-movements. The knowledge about the function of this structure is mainly based on single-unit recordings in animals with relatively few neuroimaging studies investigating eye-movement related brain activity in humans. Methodology/Principal Findings: The present study employed high-field (7 Tesla) functional magnetic resonance imaging (fMRI) to investigate SC responses during endogenously cued saccades in humans. In response to centrally presented instructional cues, subjects either performed saccades away from (centrifugal) or towards (centripetal) the center of straight gaze or maintained fixation at the center position. Compared to central fixation, the execution of saccades elicited hemodynamic activity within a network of cortical and subcortical areas that included the SC, lateral geniculate nucleus (LGN), occipital cortex, striatum, and the pulvinar. Conclusions/Significance: Activity in the SC was enhanced contralateral to the direction of the saccade (i.e., greater activity in the right as compared to left SC during leftward saccades and vice versa) during both centrifugal and centripetal saccades, thereby demonstrating that the contralateral predominance for saccade execution that has been shown to exist in animals is also present in the human SC. In addition, centrifugal saccades elicited greater activity in the SC than did centripetal saccades, while also being accompanied by an enhanced deactivation within the prefrontal default-mode network. This pattern of brain activity might reflect the reduced processing effort required to move the eyes toward as compared to away from the center of straight gaze, a position that might serve as a spatial baseline in which the retinotopic and craniotopic reference frames are aligned.	[Krebs, Ruth M.; Tempelmann, Claus; Bodammer, Nils; Noesselt, Toemme; Hopf, Jens-Max; Duzel, Emrah; Heinze, Hans-Jochen; Schoenfeld, Mircea A.] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Boehler, Carsten N.; Scheich, Henning; Hopf, Jens-Max; Heinze, Hans-Jochen; Schoenfeld, Mircea A.] Leibniz Inst Neurobiol, Magdeburg, Germany; [Krebs, Ruth M.; Woldorff, Marty G.; Boehler, Carsten N.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA; [Woldorff, Marty G.] Duke Univ, Dept Psychiat, Durham, NC USA; [Schoenfeld, Mircea A.] Kliniken Schmieder, Allensbach, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Duke University; Duke University	Krebs, RM (corresponding author), Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany.	ruth.krebs@duke.edu	Schoenfeld, Mircea Ariel/G-2096-2013; Duzel, Emrah/A-1794-2010; Schoenfeld, Ariel/O-7513-2019; Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Schoenfeld, Ariel/0000-0001-9003-4092; Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Tempelmann, Claus/0000-0001-8570-4960; Woldorff, Marty/0000-0002-2683-4551; Noesselt, Toemme/0000-0002-9611-9713; Duzel, Emrah/0000-0002-0139-5388	Deutsche Forschungsgemeinschaft (DFG) [Scho 1217/1-1, SFB 779 A1]; National Institutes of Health [NIMH R01-MH060415, NINDS P01-NS41328]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG Scho 1217/1-1 and SFB 779 A1) awarded to M. A. S, and from the National Institutes of Health (NIMH R01-MH060415 and NINDS P01-NS41328 Proj. 1) to M. G. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; Boehnke SE, 2008, CURR OPIN NEUROBIOL, V18, P544, DOI 10.1016/j.conb.2008.11.004; Brett M, 2002, NEUROIMAGE, V16; BRIDGEMAN B, 1975, VISION RES, V15, P719, DOI 10.1016/0042-6989(75)90290-4; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; Campos M, 2006, J NEUROPHYSIOL, V95, P505, DOI 10.1152/jn.00639.2005; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 2007, J NEUROSCI, V27, P5053, DOI 10.1523/JNEUROSCI.4212-06.2007; DuBois RM, 2000, NEUROIMAGE, V12, P63, DOI 10.1006/nimg.2000.0590; EVDOKIMIDIS I, 1991, ELECTROEN CLIN NEURO, V79, P503, DOI 10.1016/0013-4694(91)90169-5; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; Field CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003928; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fuller JH, 1996, EXP BRAIN RES, V109, P457; Gagnon D, 2002, BRAIN, V125, P123, DOI 10.1093/brain/awf005; Gitelman DR, 2002, NEUROIMAGE, V15, P970, DOI 10.1006/nimg.2001.1006; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; Heide W, 2001, EUR J NEUROSCI, V13, P1177, DOI 10.1046/j.0953-816x.2001.01472.x; Himmelbach M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-66; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Kalesnykas RP, 1996, VISION RES, V36, P3195, DOI 10.1016/0042-6989(96)00029-6; Kanowski M, 2007, J NEUROSCI METH, V160, P10, DOI 10.1016/j.jneumeth.2006.08.001; Kardamakis AA, 2009, J NEUROSCI, V29, P7723, DOI 10.1523/JNEUROSCI.5518-08.2009; Kastner S, 2007, J NEUROPHYSIOL, V97, P3494, DOI 10.1152/jn.00010.2007; Konen CS, 2008, J NEUROSCI, V28, P8361, DOI 10.1523/JNEUROSCI.1930-08.2008; Konen CS, 2004, NEUROIMAGE, V22, P304, DOI 10.1016/j.neuroimage.2003.12.039; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Marino RA, 2008, J NEUROPHYSIOL, V100, P2564, DOI 10.1152/jn.90688.2008; Mort DJ, 2003, NEUROIMAGE, V18, P231, DOI 10.1016/S1053-8119(02)00028-9; Moschovakis AK, 2001, NAT NEUROSCI, V4, P1026, DOI 10.1038/nn727; Moschovakis AK, 1996, BRAIN RES BULL, V40, P337, DOI 10.1016/0361-9230(96)00124-4; Moschovakis AK, 1996, CURR OPIN NEUROBIOL, V6, P811, DOI 10.1016/S0959-4388(96)80032-8; Munoz DP, 2000, CAN J PHYSIOL PHARM, V78, P934, DOI 10.1139/cjpp-78-11-934; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; Pare M, 1996, J NEUROPHYSIOL, V76, P3666, DOI 10.1152/jn.1996.76.6.3666; Perry RJ, 2000, BRAIN, V123, P2273, DOI 10.1093/brain/123.11.2273; Petit L, 2003, J NEUROPHYSIOL, V89, P2516, DOI 10.1152/jn.00988.2002; Populin LC, 2004, J NEUROPHYSIOL, V92, P2151, DOI 10.1152/jn.00453.2004; Raemaekers M, 2005, NEUROREPORT, V16, P1043, DOI 10.1097/00001756-200507130-00003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rieger JW, 2008, BRAIN RES, V1233, P89, DOI 10.1016/j.brainres.2008.07.108; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Schiller PH, 2001, PROG BRAIN RES, V134, P127; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; Schmitz B, 2004, HUM BRAIN MAPP, V23, P40, DOI 10.1002/hbm.20046; Schneider KA, 2005, J NEUROPHYSIOL, V94, P2491, DOI 10.1152/jn.00288.2005; Schneider KA, 2009, J NEUROSCI, V29, P1784, DOI 10.1523/JNEUROSCI.4452-08.2009; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1381, DOI 10.1152/jn.00738.2003; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673, DOI 10.1152/jn.2001.85.4.1673; Sommer MA, 2008, ANNU REV NEUROSCI, V31, P317, DOI 10.1146/annurev.neuro.31.060407.125627; Sparks D, 2000, VISION RES, V40, P2763, DOI 10.1016/S0042-6989(00)00133-4; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; STRASCHILL M, 1977, EXP BRAIN RES, V27, P131; STRYKER MP, 1975, EXP BRAIN RES, V23, P103; Sylvester R, 2005, CURR BIOL, V15, P37, DOI 10.1016/j.cub.2004.12.061; Sylvester R, 2007, J NEUROPHYSIOL, V97, P1495, DOI 10.1152/jn.00835.2006; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; Wall MB, 2009, NEUROIMAGE, V47, P1620, DOI 10.1016/j.neuroimage.2009.05.094; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; WURTZ RH, 1972, INVEST OPHTH VISUAL, V11, P441; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201; Zaitsev M, 2004, MAGNET RESON MED, V52, P1156, DOI 10.1002/mrm.20261	76	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8691	10.1371/journal.pone.0008691	http://dx.doi.org/10.1371/journal.pone.0008691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084170	Green Published, gold			2022-12-27	WOS:000273554600039
J	Todaka, N; Inoue, T; Saita, K; Ohkuma, M; Nalepa, CA; Lenz, M; Kudo, T; Moriya, S				Todaka, Nemuri; Inoue, Tetsushi; Saita, Kanako; Ohkuma, Moriya; Nalepa, Christine A.; Lenz, Michael; Kudo, Toshiaki; Moriya, Shigeharu			Phylogenetic Analysis of Cellulolytic Enzyme Genes from Representative Lineages of Termites and a Related Cockroach	PLOS ONE			English	Article							ACTIVE-SITE; PSEUDOTRICHONYMPHA-GRASSII; CELLOBIOHYDROLASE-I; MOLECULAR-CLONING; SYMBIOTIC PROTIST; CRYSTAL-STRUCTURE; CATALYTIC CORE; CELLULASE; COPTOTERMES; LIGNOCELLULOSE	The relationship between xylophagous termites and the protists resident in their hindguts is a textbook example of symbiosis. The essential steps of lignocellulose degradation handled by these protists allow the host termites to thrive on a wood diet. There has never been a comprehensive analysis of lignocellulose degradation by protists, however, as it has proven difficult to establish these symbionts in pure culture. The trends in lignocellulose degradation during the evolution of the host lineage are also largely unknown. To clarify these points without any cultivation technique, we performed meta-expressed sequence tag (EST) analysis of cDNA libraries originating from symbiotic protistan communities in four termite species and a wood-feeding cockroach. Our results reveal the establishment of a degradation system with multiple enzymes at the ancestral stage of termite-protistan symbiosis, especially GHF5 and 7. According to our phylogenetic analyses, the enzymes comprising the protistan lignocellulose degradation system are coded not only by genes innate to the protists, but also genes acquired by the protists via lateral transfer from bacteria. This gives us a fresh perspective from which to understand the evolutionary dynamics of symbiosis.	[Todaka, Nemuri; Inoue, Tetsushi; Saita, Kanako; Kudo, Toshiaki; Moriya, Shigeharu] Yokohama City Univ, Grad Sch, Lab Environm Mol Biol, Kanagawa, Japan; [Ohkuma, Moriya] RIKEN Tsukuba Inst, Bio Resource Ctr, Wako, Saitama, Japan; [Nalepa, Christine A.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Lenz, Michael] CSIRO Entomol, Canberra, ACT, Australia; [Moriya, Shigeharu] RIKEN Adv Sci Inst, Biosphere Oriented Biol Res Unit, Kanagawa, Japan	Yokohama City University; RIKEN; University of North Carolina; North Carolina State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); RIKEN	Todaka, N (corresponding author), Toyota Cent Res & Dev Labs Inc, Sustainable Mat Div, 41-1 Aza Yokomichi, Nagakute, Aichi 48011, Japan.	smoriya@riken.jp	Ohkuma, Moriya/A-8100-2011; Moriya, Shigeharu/AGY-8351-2022; Moriya, Shigeharu/F-4604-2014; Moriya, Shigeharu/H-1656-2011	Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874	New Energy and Industrial Technology Development Organization (NEDO); Ministry of Education, Science, Sports and Culture [16770182]; Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN)	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN)	This research was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) program for the development of elemental technology for bioenergy conversion; by a Grant-in-Aid for Scientific Research (# 16770182, 2004) from the Ministry of Education, Science, Sports and Culture and the Bio Recycle Project (JST), Eco-molecular research program (RIKEN), and Bio-architect research program (RIKEN); and by the Program for the Promotion of Basic Research Activity for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; BREZNAK JA, 1994, ANNU REV ENTOMOL, V39, P453, DOI 10.1146/annurev.en.39.010194.002321; DAVIES GJ, 1993, NATURE, V365, P362, DOI 10.1038/365362a0; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Girard C, 1999, INSECT BIOCHEM MOLEC, V29, P1129, DOI 10.1016/S0965-1748(99)00104-6; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Inoue T, 2005, GENE, V349, P67, DOI 10.1016/j.gene.2004.11.048; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lee SJ, 2004, COMP BIOCHEM PHYS B, V139, P107, DOI 10.1016/j.cbpc.2004.06.015; Li L, 2003, EUKARYOT CELL, V2, P1091, DOI 10.1128/EC.2.5.1091-1098.2003; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; Lo N, 2000, CURR BIOL, V10, P801, DOI 10.1016/S0960-9822(00)00561-3; MARUYAMA K, 1994, GENE, V138, P171; Nakashima K, 2002, CELL MOL LIFE SCI, V59, P1554, DOI 10.1007/s00018-002-8528-1; OBRIEN DA, 1985, APPL ENVIRON MICROB, V49, P614; OBRIEN DA, 1985, APPL ENVIRON MICROB, V49, P622; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Ohkuma M, 2008, TRENDS MICROBIOL, V16, P345, DOI 10.1016/j.tim.2008.04.004; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Slomovic S, 2006, CRIT REV PLANT SCI, V25, P65, DOI 10.1080/07352680500391337; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SUGIMOTO A, MJA TERMITES EVOLUTI, P409; Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x; TULL D, 1991, J BIOL CHEM, V266, P15621; WAKARCHUK WW, 1994, PROTEIN SCI, V3, P467; WANG QP, 1993, J BIOL CHEM, V268, P14096; Watanabe H, 2002, CELL MOL LIFE SCI, V59, P1983, DOI 10.1007/PL00012520; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; YAMIN MA, 1978, J PROTOZOOL, V25, P535, DOI 10.1111/j.1550-7408.1978.tb04181.x; YAMIN MA, 1981, SCIENCE, V211, P58, DOI 10.1126/science.211.4477.58	36	54	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8636	10.1371/journal.pone.0008636	http://dx.doi.org/10.1371/journal.pone.0008636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072608	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414200014
J	Murholm, M; Dixen, K; Qvortrup, K; Hansen, LHL; Amri, EZ; Madsen, L; Barbatelli, G; Quistorff, B; Hansen, JB				Murholm, Maria; Dixen, Karen; Qvortrup, Klaus; Hansen, Lillian H. L.; Amri, Ez-Zoubir; Madsen, Lise; Barbatelli, Giorgio; Quistorff, Bjorn; Hansen, Jacob B.			Dynamic Regulation of Genes Involved in Mitochondrial DNA Replication and Transcription during Mouse Brown Fat Cell Differentiation and Recruitment	PLOS ONE			English	Article							ADIPOSE-TISSUE; RECEPTOR-ALPHA; RETINOBLASTOMA PROTEIN; INDUCIBLE COACTIVATOR; COREPRESSOR RIP140; RNA-POLYMERASE; WHITE FAT; FACTOR-A; BIOGENESIS; EXPRESSION	Background: Brown adipocytes are specialised in dissipating energy through adaptive thermogenesis, whereas white adipocytes are specialised in energy storage. These essentially opposite functions are possible for two reasons relating to mitochondria, namely expression of uncoupling protein 1 (UCP1) and a remarkably higher mitochondrial abundance in brown adipocytes. Methodology/Principal Findings: Here we report a comprehensive characterisation of gene expression linked to mitochondrial DNA replication, transcription and function during white and brown fat cell differentiation in vitro as well as in white and brown fat, brown adipose tissue fractions and in selected adipose tissues during cold exposure. We find a massive induction of the majority of such genes during brown adipocyte differentiation and recruitment, e. g. of the mitochondrial transcription factors A (Tfam) and B2 (Tfb2m), whereas only a subset of the same genes were induced during white adipose conversion. In addition, PR domain containing 16 (PRDM16) was found to be expressed at substantially higher levels in brown compared to white pre-adipocytes and adipocytes. We demonstrate that forced expression of Tfam but not Tfb2m in brown adipocyte precursor cells promotes mitochondrial DNA replication, and that silencing of PRDM16 expression during brown fat cell differentiation blunts mitochondrial biogenesis and expression of brown fat cell markers. Conclusions/Significance: Using both in vitro and in vivo model systems of white and brown fat cell differentiation, we report a detailed characterisation of gene expression linked to mitochondrial biogenesis and function. We find significant differences in differentiating white and brown adipocytes, which might explain the notable increase in mitochondrial content observed during brown adipose conversion. In addition, our data support a key role of PRDM16 in triggering brown adipocyte differentiation, including mitochondrial biogenesis and expression of UCP1.	[Murholm, Maria; Dixen, Karen; Qvortrup, Klaus; Hansen, Lillian H. L.; Quistorff, Bjorn; Hansen, Jacob B.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Amri, Ez-Zoubir] Univ Nice Sophia Antipolis, CNRS, IBDC, UMR 6543, Nice, France; [Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Barbatelli, Giorgio] Univ Ancona, Sch Med, Dept Mol Pathol & Innovat Therapies, Ancona, Italy	University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Copenhagen; Marche Polytechnic University	Murholm, M (corresponding author), Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark.	jbhansen@sund.ku.dk	Madsen, Lise/C-6246-2012; Hansen, Jacob B/F-3775-2010	Madsen, Lise/0000-0003-4468-1947; Hansen, Jacob B/0000-0001-5249-2586; amri, Ez-Zoubir/0000-0001-8426-5396; Qvortrup, Klaus/0000-0001-8811-0260	Danish Medical Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Aase & Ejnar Danielsen Foundation; Augustinus Foundation; Beckett Foundation; Grosserer Ernst Fischers Mindelegat; Novo Scholarship Program	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Aase & Ejnar Danielsen Foundation; Augustinus Foundation; Beckett Foundation; Grosserer Ernst Fischers Mindelegat; Novo Scholarship Program	This work was supported by grants to J.B.H. from the Danish Medical Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the Aase & Ejnar Danielsen Foundation, the Augustinus Foundation, the Beckett Foundation and Grosserer Ernst Fischers Mindelegat. M. M. was supported by the Novo Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2000, METH MOL B, V155, P213; Chen Y, 2005, BIOCHEM BIOPH RES CO, V337, P1112, DOI 10.1016/j.bbrc.2005.09.164; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GOGLIA F, 1992, AM J PHYSIOL, V262, pC1018, DOI 10.1152/ajpcell.1992.262.4.C1018; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2006, BIOCHEM J, V398, P153, DOI 10.1042/BJ20060402; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Murano I., 2005, ADIPOCYTES, V1, P121; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; REHNMARK S, 1989, EXP CELL RES, V180, P574, DOI 10.1016/0014-4827(89)90086-4; RODBELL M, 1964, J BIOL CHEM, V239, P375; Rong JX, 2007, DIABETES, V56, P1751, DOI 10.2337/db06-1135; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Vega RB, 1997, J BIOL CHEM, V272, P31693, DOI 10.1074/jbc.272.50.31693; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang XJ, 2005, MOL CELL ENDOCRINOL, V238, P1, DOI 10.1016/j.mce.2005.04.009; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	66	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 24	2009	4	12							e8458	10.1371/journal.pone.0008458	http://dx.doi.org/10.1371/journal.pone.0008458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	537HN	20107496	Green Published, gold, Green Submitted			2022-12-27	WOS:000273104000019
J	Waldenstrom, J; Axelsson-Olsson, D; Olsen, B; Hasselquist, D; Griekspoor, P; Jansson, L; Teneberg, S; Svensson, L; Ellstrom, P				Waldenstrom, Jonas; Axelsson-Olsson, Diana; Olsen, Bjorn; Hasselquist, Dennis; Griekspoor, Petra; Jansson, Lena; Teneberg, Susann; Svensson, Lovisa; Ellstrom, Patrik			Campylobacter jejuni Colonization in Wild Birds: Results from an Infection Experiment	PLOS ONE			English	Article							GENETIC DIVERSITY; SUBSP JEJUNI; PREVALENCE; RESISTANCE; GENOTYPES; RESERVOIR; CHICKENS; ANIMALS; POULTRY	Campylobacter jejuni is a common cause of bacterial gastroenteritis in most parts of the world. The bacterium has a broad host range and has been isolated from many animals and environments. To investigate shedding patterns and putative effects on an avian host, we developed a colonization model in which a wild bird species, the European Robin Erithacus rubecula, was inoculated orally with C. jejuni from either a human patient or from another wild bird species, the Song Thrush Turdus philomelos. These two isolates were genetically distinct from each other and provoked very different host responses. The Song Thrush isolate colonized all challenged birds and colonization lasted 6.8 days on average. Birds infected with this isolate also showed a transient but significant decrease in body mass. The human isolate did not colonize the birds and could be detected only in the feces of the birds shortly after inoculation. European Robins infected with the wild bird isolate generated a specific antibody response to C. jejuni membrane proteins from the avian isolate, which also was cross-reactive to membrane proteins of the human isolate. In contrast, European Robins infected with the human isolate did not mount a significant response to bacterial membrane proteins from either of the two isolates. The difference in colonization ability could indicate host adaptations.	[Waldenstrom, Jonas; Axelsson-Olsson, Diana; Olsen, Bjorn; Griekspoor, Petra; Svensson, Lovisa; Ellstrom, Patrik] Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Waldenstrom, Jonas; Hasselquist, Dennis] Lund Univ, Dept Anim Ecol, S-22362 Lund, Sweden; [Olsen, Bjorn] Uppsala Univ, Dept Infect Dis, Uppsala, Sweden; [Jansson, Lena; Teneberg, Susann] Univ Gothenburg, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Ellstrom, Patrik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Ellstrom, Patrik] Univ Uppsala Hosp, Uppsala, Sweden	Linnaeus University; Lund University; Uppsala University; University of Gothenburg; Uppsala University; Uppsala University; Uppsala University Hospital	Waldenstrom, J (corresponding author), Linnaeus Univ, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden.	jonas.waldenstrom@lnu.se	Hasselquist, Dennis/M-5223-2014; Waldenström, Jonas/E-4460-2013	Hasselquist, Dennis/0000-0002-0056-6616; Waldenström, Jonas/0000-0002-1152-4235; Olsen, Bjorn/0000-0002-4646-691X; Axelsson Olsson, Diana/0000-0003-4474-8531	Swedish Research Council; Swedish Research Council for Environment; Agricultural Science and Spatial Planning (FORMAS) [2008-10]; Carl Tryggers Stiftelse; Swedish Medical Research Council [12628]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment(Swedish Research Council Formas); Agricultural Science and Spatial Planning (FORMAS)(Swedish Research Council Formas); Carl Tryggers Stiftelse; Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	Funding for this project came from the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Science and Spatial Planning (FORMAS, grant no. 2008-10), Carl Tryggers Stiftelse, and the Swedish Medical Research Council (grant no. 12628). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BLASER MJ, 1983, INFECT IMMUN, V42, P276, DOI 10.1128/IAI.42.1.276-284.1983; Broman T, 2004, J APPL MICROBIOL, V96, P834, DOI 10.1111/j.1365-2672.2004.02232.x; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Broman T, 2000, APPL ENVIRON MICROB, V66, P449, DOI 10.1128/AEM.66.1.449-452.2000; CABRITA J, 1992, J APPL BACTERIOL, V73, P279, DOI 10.1111/j.1365-2672.1992.tb04978.x; Cawthraw SA, 1996, EPIDEMIOL INFECT, V117, P213, DOI 10.1017/S0950268800001333; Colles FM, 2008, APPL ENVIRON MICROB, V74, P3583, DOI 10.1128/AEM.02491-07; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Colles FM, 2008, ENVIRON MICROBIOL, V10, P2042, DOI 10.1111/j.1462-2920.2008.01623.x; Dingle KE, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P43; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; FRIEDMAN CR, 2000, CAMPYLOBACTER, V121, P138; Friis LM, 2005, J MICROBIOL METH, V61, P145, DOI 10.1016/j.mimet.2004.12.003; Grindstaff JL, 2006, P ROY SOC B-BIOL SCI, V273, P2551, DOI 10.1098/rspb.2006.3608; Hald B, 2004, EMERG INFECT DIS, V10, P1490, DOI 10.3201/eid1008.040129; HASSELQUIST D, 1985, RINGING MIGRATION, V6, P66; Hickey TE, 1999, INFECT IMMUN, V67, P88, DOI 10.1128/IAI.67.1.88-93.1999; Ilmonen P, 2000, P ROY SOC B-BIOL SCI, V267, P665, DOI 10.1098/rspb.2000.1053; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones K, 2001, J APPL MICROBIOL, V90, p68S, DOI 10.1046/j.1365-2672.2001.01355.x; KAPPERUD G, 1983, APPL ENVIRON MICROB, V45, P375, DOI 10.1128/AEM.45.2.375-380.1983; Kinana AD, 2006, APPL ENVIRON MICROB, V72, P3309, DOI 10.1128/AEM.72.5.3309-3313.2006; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; McCarthy ND, 2007, EMERG INFECT DIS, V13, P267, DOI 10.3201/eid1302.060620; Miller WG, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P101; Newell D. G., 2001, Society for Applied Microbiology Symposium Series, p57S; OELSCHLAEGER TA, 1993, P NATL ACAD SCI USA, V90, P6884, DOI 10.1073/pnas.90.14.6884; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; ROSEF O, 1983, APPL ENVIRON MICROB, V45, P381, DOI 10.1128/AEM.45.2.381-383.1983; STERN NJ, 1990, AVIAN DIS, V34, P602, DOI 10.2307/1591251; Strother KO, 2005, J MED ENTOMOL, V42, P42, DOI 10.1603/0022-2585(2005)042[0042:RCOLMC]2.0.CO;2; Waldenstrom J, 2002, APPL ENVIRON MICROB, V68, P5911, DOI 10.1128/AEM.68.12.5911-5917.2002; WHELAN CD, 1988, EPIDEMIOL INFECT, V101, P259, DOI 10.1017/S0950268800054170	37	36	38	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9082	10.1371/journal.pone.0009082	http://dx.doi.org/10.1371/journal.pone.0009082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140204	gold, Green Submitted, Green Published			2022-12-27	WOS:000274442400018
J	Leahy, SC; Kelly, WJ; Altermann, E; Ronimus, RS; Yeoman, CJ; Pacheco, DM; Li, D; Kong, ZH; McTavish, S; Sang, C; Lambie, SC; Janssen, PH; Dey, D; Attwood, GT				Leahy, Sinead C.; Kelly, William J.; Altermann, Eric; Ronimus, Ron S.; Yeoman, Carl J.; Pacheco, Diana M.; Li, Dong; Kong, Zhanhao; McTavish, Sharla; Sang, Carrie; Lambie, Suzanne C.; Janssen, Peter H.; Dey, Debjit; Attwood, Graeme T.			The Genome Sequence of the Rumen Methanogen Methanobrevibacter ruminantium Reveals New Possibilities for Controlling Ruminant Methane Emissions	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE; METHANOBACTERIUM-RUMINANTIUM; KYOTO ENCYCLOPEDIA; FATTY-ACIDS; DATABASE; GENES; ARCHAEA; IDENTIFICATION; PREDICTION; PROTEINS	Background: Methane (CH4) is a potent greenhouse gas (GHG), having a global warming potential 21 times that of carbon dioxide (CO2). Methane emissions from agriculture represent around 40% of the emissions produced by human-related activities, the single largest source being enteric fermentation, mainly in ruminant livestock. Technologies to reduce these emissions are lacking. Ruminant methane is formed by the action of methanogenic archaea typified by Methanobrevibacter ruminantium, which is present in ruminants fed a wide variety of diets worldwide. To gain more insight into the lifestyle of a rumen methanogen, and to identify genes and proteins that can be targeted to reduce methane production, we have sequenced the 2.93 Mb genome of M. ruminantium M1, the first rumen methanogen genome to be completed. Methodology/Principal Findings: The M1 genome was sequenced, annotated and subjected to comparative genomic and metabolic pathway analyses. Conserved and methanogen-specific gene sets suitable as targets for vaccine development or chemogenomic-based inhibition of rumen methanogens were identified. The feasibility of using a synthetic peptide-directed vaccinology approach to target epitopes of methanogen surface proteins was demonstrated. A prophage genome was described and its lytic enzyme, endoisopeptidase PeiR, was shown to lyse M1 cells in pure culture. A predicted stimulation of M1 growth by alcohols was demonstrated and microarray analyses indicated up-regulation of methanogenesis genes during co-culture with a hydrogen (H-2) producing rumen bacterium. We also report the discovery of non-ribosomal peptide synthetases in M. ruminantium M1, the first reported in archaeal species. Conclusions/Significance: The M1 genome sequence provides new insights into the lifestyle and cellular processes of this important rumen methanogen. It also defines vaccine and chemogenomic targets for broad inhibition of rumen methanogens and represents a significant contribution to worldwide efforts to mitigate ruminant methane emissions and reduce production of anthropogenic greenhouse gases.	[Leahy, Sinead C.; Kelly, William J.; Altermann, Eric; Ronimus, Ron S.; Yeoman, Carl J.; Pacheco, Diana M.; Li, Dong; Kong, Zhanhao; McTavish, Sharla; Sang, Carrie; Lambie, Suzanne C.; Janssen, Peter H.; Dey, Debjit; Attwood, Graeme T.] AgResearch Ltd, Grasslands Res Ctr, Food & Text Grp, Rumen Microbial Genom Food Metab & Microbiol Sect, Palmerston North, New Zealand	AgResearch - New Zealand	Leahy, SC (corresponding author), AgResearch Ltd, Grasslands Res Ctr, Food & Text Grp, Rumen Microbial Genom Food Metab & Microbiol Sect, Palmerston North, New Zealand.	graeme.attwood@agresearch.co.nz	Chen, Tianren/AAS-6018-2021; Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Janssen, Peter/0000-0002-1022-3502; Attwood, Graeme Trevor/0000-0002-6443-8760; Leahy, Sinead/0000-0002-5461-6738; McTavish, Sharla/0000-0002-8794-4981; Sang, Carrie/0000-0003-4368-1558; Ronimus, Ron/0000-0001-8669-5840; Altermann, Eric/0000-0003-1376-1549	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Foundation for Research, Science and Technology (FRST) [METH0201, METH0701]	Pastoral Greenhouse Gas Research Consortium (PGgRc); New Zealand Foundation for Research, Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology)	Authors acknowledge the financial support of the Pastoral Greenhouse Gas Research Consortium (PGgRc), an industry led partnership co-funded by the New Zealand Foundation for Research, Science and Technology (FRST), http://www.pggrc.co.nz/ (Grant No.s METH0201 A genomics approach to identify targets for methanogen inhibition; METH0201 Reducing ruminant methane emission: a consortium approach; METH0701 Pastoral Greenhouse Gas Research Consortium). All authors are current or past employees of AgResearch Limited (www.agresearch.co.nz), a New Zealand Crown Research Institute. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Authors required PGgRc approval to publish.	Abken HJ, 1998, J BACTERIOL, V180, P2027, DOI 10.1128/JB.180.8.2027-2032.1998; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; ALTERMANN E, 2009, PHAGE PHI MRU POLYNU; Altermann Eric, 2003, OMICS A Journal of Integrative Biology, V7, P161, DOI 10.1089/153623103322246557; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amoutzias GD, 2008, FUTURE MICROBIOL, V3, P361, DOI 10.2217/17460913.3.3.361; Asanuma N, 2005, CURR MICROBIOL, V51, P91, DOI 10.1007/s00284-005-4477-x; Attwood GT, 2008, AUST J EXP AGR, V48, P83, DOI 10.1071/EA07269; BALCH WE, 1979, MICROBIOL REV, V43, P260, DOI 10.1128/MMBR.43.2.260-296.1979; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berk H, 1997, ARCH MICROBIOL, V168, P396, DOI 10.1007/s002030050514; Bhavsar AP, 2006, MOL MICROBIOL, V60, P1077, DOI 10.1111/j.1365-2958.2006.05169.x; Boekhorst J, 2005, J BACTERIOL, V187, P4928, DOI 10.1128/JB.187.14.4928-4934.2005; BRYANT MP, 1971, ADV CHEM SER, P23; Bryant MP, 1965, PHYSL DIGESTION RUMI; Caron PR, 2001, CURR OPIN CHEM BIOL, V5, P464, DOI 10.1016/S1367-5931(00)00229-5; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; GOLDBERG SM, P NATL ACAD SCI US, V103, P11240; Graham DE, 2002, J BIOL CHEM, V277, P13421, DOI 10.1074/jbc.M201011200; GRAHAM LL, 1994, J BACTERIOL, V176, P1413, DOI 10.1128/jb.176.5.1413-1421.1994; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; JARRELL KF, 1992, CAN J MICROBIOL, V38, P65, DOI 10.1139/m92-010; Jensen LJ, 1999, RES MICROBIOL, V150, P773, DOI 10.1016/S0923-2508(99)00116-3; JOBLIN KN, 1990, APPL ENVIRON MICROB, V56, P2287, DOI 10.1128/AEM.56.8.2287-2295.1990; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; KANDLER O, 1978, ARCH MICROBIOL, V118, P141, DOI 10.1007/BF00415722; Kandler O, 1998, CELL MOL LIFE SCI, V54, P305, DOI 10.1007/s000180050156; KANDLER O, BACTERIA, V8, P413; Klieve AV, 1999, AUST J AGR RES, V50, P1315, DOI 10.1071/AR99006; KONIG H, 1994, SYST APPL MICROBIOL, V16, P510; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Leslie M, 2008, AUST J EXP AGR, V48, P1, DOI 10.1071/EA07306; Lienard T, 1996, EUR J BIOCHEM, V239, P857, DOI 10.1111/j.1432-1033.1996.0857u.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MAKAROVA KS, 2007, BIOL DIRECT, V27, P2; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; McAllister TA, 2008, AUST J EXP AGR, V48, P7, DOI 10.1071/EA07218; MCINERNEY MJ, 1979, ARCH MICROBIOL, V122, P129, DOI 10.1007/BF00411351; MILLER TL, 2001, BERGEYS MANUAL SYSTE, V1, P218; *MIN ENV, 2007, NZ GREENH GAS INV 19; Moon CD, 2008, INT J SYST EVOL MICR, V58, P2041, DOI 10.1099/ijs.0.65845-0; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Reymond N, 2004, BIOINFORMATICS, V20, P271, DOI 10.1093/bioinformatics/btg401; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROBINSON IM, 1969, J BACTERIOL, V97, P1220, DOI 10.1128/JB.97.3.1220-1226.1969; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; SCHEEHLE EA, 2006, ENERGY J, V3, P33; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Smith DR, 1997, J BACTERIOL, V179, P7135, DOI 10.1128/jb.179.22.7135-7155.1997; SMITH PH, 1958, J BACTERIOL, V75, P713, DOI 10.1128/JB.75.6.713-718.1958; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Staden R, 2000, Methods Mol Biol, V132, P115; *STAT NZ, 2008, GLOB NZ INT TRAD INV; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Tokura M, 1999, J GEN APPL MICROBIOL, V45, P43, DOI 10.2323/jgam.45.43; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; *UN, 1997, UNEPIUC9910; USA-Department of Agriculture, 2008, RIS FOOD PRIC INT FO; Vivona S, 2008, TRENDS BIOTECHNOL, V26, P190, DOI 10.1016/j.tibtech.2007.12.006; Volfovsky N., 2001, GENOME BIOL, V2, DOI [DOI 10.1186/GB-2001-2-8-RESEARCH0027, 10.1186/gb-2001-2-8-research0027]; WEDLOCK DN, 2009, NZ VET J IN PRESS; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804; Yurist-Doutsch S, 2008, MOL MICROBIOL, V68, P1079, DOI 10.1111/j.1365-2958.2008.06224.x; ZEIKUS JG, 1975, CAN J MICROBIOL, V21, P121, DOI 10.1139/m75-019	91	196	223	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8926	10.1371/journal.pone.0008926	http://dx.doi.org/10.1371/journal.pone.0008926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126622	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000005
J	Cainarca, S; Fenu, S; Ferri, C; Nucci, C; Arioli, P; Menegon, A; Piemonti, L; Lohmer, S; Wrabetz, L; Corazza, S				Cainarca, Silvia; Fenu, Simone; Ferri, Cinzia; Nucci, Cinzia; Arioli, Patrizia; Menegon, Andrea; Piemonti, Lorenzo; Lohmer, Stefan; Wrabetz, Lawrence; Corazza, Sabrina			A Photoprotein in Mouse Embryonic Stem Cells Measures Ca2+ Mobilization in Cells and in Animals	PLOS ONE			English	Article							GREEN-FLUORESCENT PROTEIN; DIFFERENTIATION; EXPRESSION; AEQUORIN; PROLIFERATION; PHIALIDIN; INDICATOR; SEQUENCE	Exogenous expression of pharmacological targets in transformed cell lines has been the traditional platform for high throughput screening of small molecules. However, exogenous expression in these cells is limited by aberrant dosage, or its toxicity, the potential lack of interaction partners, and alterations to physiology due to transformation itself. Instead, primary cells or cells differentiated from precursors are more physiological, but less amenable to exogenous expression of reporter systems. To overcome this challenge, we stably expressed c-Photina, a Ca2+- sensitive photoprotein, driven by a ubiquitous promoter in a mouse embryonic stem (mES) cell line. The same embryonic stem cell line was also used to generate a transgenic mouse that expresses c-Photina in most tissues. We show here that these cells and mice provide an efficient source of primary cells, cells differentiated from mES cells, including cardiomyocytes, neurons, astrocytes, macrophages, endothelial cells, pancreatic islet cells, stably and robustly expressing c-Photina, and may be exploited for miniaturized high throughput screening. Moreover, we provide evidence that the transgenic mice may be suitable for ex-vivo bioimaging studies in both cells and tissues.	[Cainarca, Silvia; Fenu, Simone; Nucci, Cinzia; Arioli, Patrizia; Lohmer, Stefan; Corazza, Sabrina] Axxam SpA, Milan, Italy; [Ferri, Cinzia; Wrabetz, Lawrence] DIBIT, San Raffaele Sci Inst, Div Genet & Cell Biol, Milan, Italy; [Menegon, Andrea] Ist Sci San Raffaele, ALEMBIC, I-20132 Milan, Italy; [Piemonti, Lorenzo] Ist Sci San Raffaele, San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Cainarca, S (corresponding author), Axxam SpA, Milan, Italy.	silvia.cainarca.sc@axxam.com	Piemonti, Lorenzo/P-7605-2017; Ferri, Cinzia/ABG-8426-2020; menegon, andrea/AAN-3736-2020	Piemonti, Lorenzo/0000-0002-2172-2198; Ferri, Cinzia/0000-0003-1800-4993; menegon, andrea/0000-0002-2396-756X; Cainarca, Silvia/0000-0002-4590-4420	Regione Lombardia (Italy); Telethon (Italy); National Institutes of Health; Axxam SpA	Regione Lombardia (Italy)(Regione Lombardia); Telethon (Italy)(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Axxam SpA	This work was supported in part by a Metadistretti grant from Regione Lombardia (Italy) to Axxam and LW, and grants from Telethon (Italy) and the National Institutes of Health to LW. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was also supported by Axxam SpA, which paid for the employment of 6 (SC, SF, CN, PA, SL, SC) out of 10 authors.	Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Bhaumik S, 2002, P NATL ACAD SCI USA, V99, P377, DOI 10.1073/pnas.012611099; BLOEMERS SM, 1993, BIOCHEM BIOPH RES CO, V191, P118, DOI 10.1006/bbrc.1993.1192; Boheler KR, 2003, METHOD ENZYMOL, V365, P228; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bovolenta S, 2007, J BIOMOL SCREEN, V12, P694, DOI 10.1177/1087057107301497; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; CAMPBELL AK, 1981, BIOLUMINESCENCE CHEM, P601; Chiesa A, 2001, BIOCHEM J, V355, P1, DOI 10.1042/0264-6021:3550001; DAVIES JQ, 2005, METH MOL BIOL BASIC, P91; DeGiorgi F, 1996, GENE, V173, P113, DOI 10.1016/0378-1119(95)00687-7; Fedirko N, 2006, J NEUROPHYSIOL, V96, P919, DOI 10.1152/jn.00258.2006; Fico A, 2008, STEM CELLS DEV, V17, P573, DOI 10.1089/scd.2007.0130; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Heo JS, 2006, STEM CELLS, V24, P2637, DOI 10.1634/stemcells.2005-0588; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; Johnson F.H., 1978, Methods in Enzymology, V57, P271; Kendall JM, 1998, TRENDS BIOTECHNOL, V16, P216, DOI 10.1016/S0167-7799(98)01184-6; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LEE K, 2008, NEUROSCI B, V24, P195; LEVINE LD, 1982, COMP BIOCHEM PHYS B, V72, P77, DOI 10.1016/0305-0491(82)90013-X; MATTHEAKIS LC, 2000, DRUG DISCOV TODAY S, V1, P18; McNeish J, 2004, NAT REV DRUG DISCOV, V3, P70, DOI 10.1038/nrd1281; Melzi R, 2008, CELL TRANSPLANT, V17, P1361, DOI 10.3727/096368908787648146; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x; Odorico JS, 2001, STEM CELLS, V19, P193, DOI 10.1634/stemcells.19-3-193; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RINK TJ, 1990, FEBS LETT, V268, P381, DOI 10.1016/0014-5793(90)81290-5; Rizzuto R, 1999, CELL CALCIUM, V26, P193, DOI 10.1054/ceca.1999.0076; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; Rogers KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000974; Romoser VA, 1997, J BIOL CHEM, V272, P13270, DOI 10.1074/jbc.272.20.13270; Sambrook J., 2001, MOL CLONING LAB MANU; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SHIMOMURA O, 1985, BIOCHEM J, V228, P745, DOI 10.1042/bj2280745; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stewart MH, 2008, J MOL MED, V86, P875, DOI 10.1007/s00109-008-0356-9; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5; Yanagida E, 2004, CELL CALCIUM, V36, P135, DOI 10.1016/j.ceca.2004.01.022	44	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8882	10.1371/journal.pone.0008882	http://dx.doi.org/10.1371/journal.pone.0008882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111708	Green Submitted, gold, Green Published			2022-12-27	WOS:000274114800007
J	Ashktorab, H; Schaffer, AA; Daremipouran, M; Smoot, DT; Lee, E; Brim, H				Ashktorab, Hassan; Schaeffer, Alejandro A.; Daremipouran, Mohammad; Smoot, Duane T.; Lee, Edward; Brim, Hassan			Distinct Genetic Alterations in Colorectal Cancer	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; HUMAN BREAST; CHROMOSOMAL INSTABILITY; MLL3 MUTATIONS; CARCINOMA; ABNORMALITIES; EXPRESSION; SEQUENCES; ADENOMAS; PROFILES	Background: Colon cancer (CRC) development often includes chromosomal instability (CIN) leading to amplifications and deletions of large DNA segments. Epidemiological, clinical, and cytogenetic studies showed that there are considerable differences between CRC tumors from African Americans (AAs) and Caucasian patients. In this study, we determined genomic copy number aberrations in sporadic CRC tumors from AAs, in order to investigate possible explanations for the observed disparities. Methodology/Principal Findings: We applied genome-wide array comparative genome hybridization (aCGH) using a 105k chip to identify copy number aberrations in samples from 15 AAs. In addition, we did a population comparative analysis with aCGH data in Caucasians as well as with a widely publicized list of colon cancer genes (CAN genes). There was an average of 20 aberrations per patient with more amplifications than deletions. Analysis of DNA copy number of frequently altered chromosomes revealed that deletions occurred primarily in chromosomes 4, 8 and 18. Chromosomal duplications occurred in more than 50% of cases on chromosomes 7, 8, 13, 20 and X. The CIN profile showed some differences when compared to Caucasian alterations. Conclusions/Significance: Chromosome X amplification in male patients and chromosomes 4, 8 and 18 deletions were prominent aberrations in AAs. Some CAN genes were altered at high frequencies in AAs with EXOC4, EPHB6, GNAS, MLL3 and TBX22 as the most frequently deleted genes and HAPLN1, ADAM29, SMAD2 and SMAD4 as the most frequently amplified genes. The observed CIN may play a distinctive role in CRC in AAs.	[Ashktorab, Hassan] Howard Univ, Dept Med, Coll Med, Washington, DC 20059 USA; [Ashktorab, Hassan] Howard Univ, Ctr Canc, Coll Med, Washington, DC 20059 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA; [Daremipouran, Mohammad; Smoot, Duane T.; Lee, Edward; Brim, Hassan] Howard Univ, Coll Med, Dept Pathol, Washington, DC USA	Howard University; Howard University; National Institutes of Health (NIH) - USA; Howard University	Ashktorab, H (corresponding author), Howard Univ, Dept Med, Coll Med, Washington, DC 20059 USA.	hashktorab@howard.edu	Ashktorab, hassan/AAJ-2908-2020; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012		National Institutes of Health [CA102681]; NIH; NLM; Howard University; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Howard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by PHS grant from the National Institutes of Health CA102681, the Intramural Research Program of the NIH, NLM and GCRC award from Howard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ahn CH, 2007, APMIS, V115, P859, DOI 10.1111/j.1600-0463.2007.apm_696.x; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; BARDI G, 1995, GENE CHROMOSOME CANC, V12, P97, DOI 10.1002/gcc.2870120204; BOMME L, 1994, GENE CHROMOSOME CANC, V10, P190, DOI 10.1002/gcc.2870100307; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; CLARKE DC, 2009, MOL CELL BIOL; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fox BP, 2009, ONCOGENE, V28, P1706, DOI 10.1038/onc.2009.18; Georgiades IB, 1999, ONCOGENE, V18, P7933, DOI 10.1038/sj.onc.1203368; Goel A, 2003, CANCER RES, V63, P1608; He QJ, 2003, CANCER GENET CYTOGEN, V144, P112, DOI 10.1016/S0165-4608(02)00959-7; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; James MR, 2001, ENDOCRINOLOGY, V142, P1497, DOI 10.1210/en.142.4.1497; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Laramie JM, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-46; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Lehnerdt GF, 2008, LARYNGOSCOPE, V118, P2172, DOI 10.1097/MLG.0b013e318185793ds; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Markowitz S, 2000, J CLIN ONCOL, V18, p75S; Martinez-Gimeno M, 2003, INVEST OPHTH VIS SCI, V44, P2171, DOI 10.1167/iovs.02-0871; MULERIS M, 1995, GENE CHROMOSOME CANC, V14, P223, DOI 10.1002/gcc.2870140312; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sakurai-Yageta M, 2008, J CELL BIOL, V181, P985, DOI 10.1083/jcb.200709076; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Shin SK, 2007, GASTROENTEROLOGY, V133, P1849, DOI 10.1053/j.gastro.2007.08.074; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Unotoro J, 2006, J INT MED RES, V34, P397, DOI 10.1177/147323000603400409; Vakoc CR, 2009, CANCER GENET CYTOGEN, V189, P140, DOI 10.1016/j.cancergencyto.2008.10.014; Vik-Mo EO, 2003, NEUROSCIENCE, V119, P73, DOI 10.1016/S0306-4522(03)00065-4; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weizman N, 2003, J BIOL CHEM, V278, P6741, DOI 10.1074/jbc.M211168200; Wirrig EE, 2007, DEV BIOL, V310, P291, DOI 10.1016/j.ydbio.2007.07.041; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	45	87	89	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8879	10.1371/journal.pone.0008879	http://dx.doi.org/10.1371/journal.pone.0008879			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126641	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500008
J	Meier, S; Ruzvidzo, O; Morse, M; Donaldson, L; Kwezi, L; Gehring, C				Meier, Stuart; Ruzvidzo, Oziniel; Morse, Monique; Donaldson, Lara; Kwezi, Lusisizwe; Gehring, Chris			The Arabidopsis Wall Associated Kinase-Like 10 Gene Encodes a Functional Guanylyl Cyclase and Is Co-Expressed with Pathogen Defense Related Genes	PLOS ONE			English	Article							WALL-ASSOCIATED KINASES; CELL-WALL; SALICYLIC-ACID; NITRIC-OXIDE; PROTEIN-KINASE; DISEASE RESISTANCE; RECEPTOR KINASE; TRIGGERED IMMUNITY; CHITIN ELICITOR; INNATE IMMUNITY	Background: Second messengers have a key role in linking environmental stimuli to physiological responses. One such messenger, guanosine 39,59-cyclic monophosphate (cGMP), has long been known to be an essential signaling molecule in many different physiological processes in higher plants, including biotic stress responses. To date, however, the guanylyl cyclase (GC) enzymes that catalyze the formation of cGMP from GTP have largely remained elusive in higher plants. Principal Findings: We have identified an Arabidopsis receptor type wall associated kinase-like molecule (AtWAKL10) as a candidate GC and provide experimental evidence to show that the intracellular domain of AtWAKL10431-700 can generate cGMP in vitro. Further, we also demonstrate that the molecule has kinase activity indicating that AtWAKL10 is a twin-domain catalytic protein. A co-expression and stimulus-specific expression analysis revealed that AtWAKL10 is consistently co-expressed with well characterized pathogen defense related genes and along with these genes is induced early and sharply in response to a range of pathogens and their elicitors. Conclusions: We demonstrate that AtWAKL10 is a twin-domain, kinase-GC signaling molecule that may function in biotic stress responses that are critically dependent on the second messenger cGMP.	[Meier, Stuart; Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Ruzvidzo, Oziniel; Morse, Monique; Donaldson, Lara; Kwezi, Lusisizwe; Gehring, Chris] Univ Western Cape, Dept Biotechnol, ZA-7535 Bellville, South Africa	King Abdullah University of Science & Technology; University of the Western Cape	Meier, S (corresponding author), King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia.	christoph.gehring@KAUST.edu.sa		Donaldson, Lara/0000-0001-5727-3155; Gehring, Christoph/0000-0003-4355-4591	South African National Research Foundation	South African National Research Foundation(National Research Foundation - South Africa)	The project was supported by a grant from the South African National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Boon EM, 2005, NAT CHEM BIOL, V1, P53, DOI 10.1038/nchembio704; BOWLER C, 1994, GENE DEV, V8, P2188, DOI 10.1101/gad.8.18.2188; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Clarke A, 2000, PLANT J, V24, P667, DOI 10.1046/j.1365-313x.2000.00911.x; Craigon DJ, 2004, NUCLEIC ACIDS RES, V32, pD575, DOI 10.1093/nar/gkh133; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Decreux A, 2005, PLANT CELL PHYSIOL, V46, P268, DOI 10.1093/pcp/pci026; Decreux A, 2006, PHYTOCHEMISTRY, V67, P1068, DOI 10.1016/j.phytochem.2006.03.009; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Donaldson L, 2004, FEBS LETT, V569, P317, DOI 10.1016/j.febslet.2004.06.016; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Fellbrich G, 2002, PLANT J, V32, P375, DOI 10.1046/j.1365-313X.2002.01454.x; Felle HH, 2004, MOL PLANT MICROBE IN, V17, P118, DOI 10.1094/MPMI.2004.17.1.118; Ferrari S, 2007, PLANT PHYSIOL, V144, P367, DOI 10.1104/pp.107.095596; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; He ZH, 1996, J BIOL CHEM, V271, P19789, DOI 10.1074/jbc.271.33.19789; He ZH, 1998, PLANT J, V14, P55, DOI 10.1046/j.1365-313X.1998.00092.x; He ZH, 1999, PLANT MOL BIOL, V39, P1189, DOI 10.1023/A:1006197318246; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hoefle C, 2008, CELL MICROBIOL, V10, P2400, DOI 10.1111/j.1462-5822.2008.01238.x; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; Huckelhoven R, 2007, ANNU REV PHYTOPATHOL, V45, P101, DOI 10.1146/annurev.phyto.45.062806.094325; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kankainen M, 2004, NUCLEIC ACIDS RES, V32, pW222, DOI 10.1093/nar/gkh463; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; KING EO, 1954, J LAB CLIN MED, V44, P301; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kohorn BD, 2001, CURR OPIN CELL BIOL, V13, P529, DOI 10.1016/S0955-0674(00)00247-7; KOSHIBA T, 1995, J MOL BIOL, V253, P396, DOI 10.1006/jmbi.1995.0562; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Kwezi L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000449; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Lecourieux D, 2002, PLANT CELL, V14, P2627, DOI 10.1105/tpc.005579; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Ludidi N, 2003, J BIOL CHEM, V278, P6490, DOI 10.1074/jbc.M210983200; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Manfield IW, 2006, NUCLEIC ACIDS RES, V34, pW504, DOI 10.1093/nar/gkl204; Meier Stuart, 2008, Biotechnology Journal, V3, P1375, DOI 10.1002/biot.200800142; Meier S, 2009, PLANT SIGNAL BEHAV, V4, P307, DOI 10.4161/psb.4.4.8066; Meier S, 2007, PLANT SIGNAL BEHAV, V2, P536, DOI 10.4161/psb.2.6.4788; Meier S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-24; Michel K, 2006, PLANT MOL BIOL, V62, P561, DOI 10.1007/s11103-006-9045-7; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Murray SL, 2002, MOL PLANT MICROBE IN, V15, P557, DOI 10.1094/MPMI.2002.15.6.557; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Newton RP, 2004, PHYTOCHEMISTRY, V65, P2423, DOI 10.1016/j.phytochem.2004.07.026; Nishiuchi T, 2002, PLANT MOL BIOL, V49, P473, DOI 10.1023/A:1015553232309; Nuhse TS, 2003, J BIOL CHEM, V278, P45248, DOI 10.1074/jbc.M307443200; O'Connor TR, 2005, BIOINFORMATICS, V21, P4411, DOI 10.1093/bioinformatics/bti714; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Parker A, 2001, J BIOL CHEM, V276, P5547, DOI 10.1074/jbc.M008463200; Pasqualini S, 2009, NEW PHYTOL, V181, P860, DOI 10.1111/j.1469-8137.2008.02711.x; Penson SP, 1996, PLANT CELL, V8, P2325, DOI 10.1105/tpc.8.12.2325; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Peumans WJ, 2003, BIOCHEM J, V376, P717, DOI 10.1042/BJ20031069; Pharmawati M, 2001, PLANT PHYSIOL BIOCH, V39, P385, DOI 10.1016/S0981-9428(01)01252-9; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schaap P, 2005, FRONT BIOSCI-LANDMRK, V10, P1485, DOI 10.2741/1633; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Schuhegger R, 2007, J PLANT PHYSIOL, V164, P636, DOI 10.1016/j.jplph.2006.04.012; Schuhegger R, 2006, PLANT PHYSIOL, V141, P1248, DOI 10.1104/pp.106.082024; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; SHRIDHAR S, 2009, NUCL ACIDS RES; Shults MD, 2003, J AM CHEM SOC, V125, P14248, DOI 10.1021/ja0380502; Shults MD, 2006, ANAL BIOCHEM, V352, P198, DOI 10.1016/j.ab.2006.03.003; Sweetlove LJ, 2005, NEW PHYTOL, V168, P9, DOI 10.1111/j.1469-8137.2005.01513.x; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; THORPE DS, 1990, J BIOL CHEM, V265, P14717; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; Tsutsui T, 2006, BIOSCI BIOTECH BIOCH, V70, P2042, DOI 10.1271/bbb.50700; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Verica JA, 2003, PLANT PHYSIOL, V133, P1732, DOI 10.1104/pp.103.028530; Verica JA, 2002, PLANT PHYSIOL, V129, P455, DOI 10.1104/pp.011028; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; Wagner TA, 2001, PLANT CELL, V13, P303, DOI 10.1105/tpc.13.2.303; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2005, CURR OPIN PLANT BIOL, V8, P353, DOI 10.1016/j.pbi.2005.05.004	104	92	97	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8904	10.1371/journal.pone.0008904	http://dx.doi.org/10.1371/journal.pone.0008904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126659	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500023
J	Zohar, A; Dekel, N; Rubinsky, B; Parnas, H				Zohar, Assaf; Dekel, Noa; Rubinsky, Boris; Parnas, Hanna			New Mechanism for Voltage Induced Charge Movement Revealed in GPCRs - Theory and Experiments	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SHAKER K+ CHANNELS; GATING-CURRENTS; POTASSIUM CHANNELS; XENOPUS-OOCYTES; IONIC LOCK; ACTIVATION; INACTIVATION; RHODOPSIN; RELEASE	Depolarization induced charge movement associated currents, analogous to gating currents in channels, were recently demonstrated in G-protein coupled receptors (GPCRs), and were found to affect the receptor's Agonist binding Affinity, hence denoted AA-currents. Here we study, employing a combined theoretical-experimental approach, the properties of the AA-currents using the m2-muscarinic receptor (m2R) as a case study. We found that the AA-currents are characterized by a "bump'', a distinct rise followed by a slow decline, which appears both in the On and the Off responses. The cumulative features implied a directional behavior of the AA-currents. This forced us to abandon the classical chemical reaction type of models and develop instead a model that includes anisotropic processes, thus producing directionality. This model fitted well the experimental data. Our main findings are that the AA-currents include two components. One is extremely fast, similar to 0.2ms, at all voltages. The other is slow, 2-3ms at all voltages. Surprisingly, the slow component includes a process which strongly depends on voltage and can be as fast as 0.3ms at + 40mV. The reason that it does not affect the overall time constant of the slow component is that it carries very little charge. The two fast processes are suitable candidates to link between charge movement and agonist binding affinity under physiological conditions.	[Zohar, Assaf; Dekel, Noa; Parnas, Hanna] Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel; [Rubinsky, Boris] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Ctr Bioengn, Serv Humanity & Soc, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Zohar, A (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Jerusalem, Israel.	hannap@savion.huji.ac.il	Rubinsky, Boris/B-4439-2010	Rubinsky, Boris/0000-0002-2794-1543	Hebrew University of Jerusalem, Israel	Hebrew University of Jerusalem, Israel	This work was not supported by any grant. The experiments were performed and supported by the resources of the Hebrew University of Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Ballesteros J, 1998, J BIOL CHEM, V273, P10445, DOI 10.1074/jbc.273.17.10445; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; BEZANILLA F, 1982, ABNORMAL NERVES MUSC, P62; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; DURELL SR, 1992, BIOPHYS J, V62, P238, DOI 10.1016/S0006-3495(92)81809-X; Friedman MH, 1986, PRINCIPLES MODELS BI, P74; KOWDLEY GC, 1994, J GEN PHYSIOL, V103, P217, DOI 10.1085/jgp.103.2.217; Kupchik YM, 2008, P NATL ACAD SCI USA, V105, P4435, DOI 10.1073/pnas.0708540105; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; LU L, 1990, BIOPHYS J, V57, P1117, DOI 10.1016/S0006-3495(90)82632-1; Ohana L, 2006, J BIOL CHEM, V281, P24204, DOI 10.1074/jbc.M513447200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parnas H, 2005, J NEUROPHYSIOL, V93, P3257, DOI 10.1152/jn.01131.2004; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Sigg D, 2003, BIOPHYS J, V84, P3703, DOI 10.1016/S0006-3495(03)75099-1; SPIRES S, 1989, J GEN PHYSIOL, V93, P263, DOI 10.1085/jgp.93.2.263; Stefani E, 1998, METHOD ENZYMOL, V293, P300; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Weber WM, 1999, BBA-BIOMEMBRANES, V1421, P213, DOI 10.1016/S0005-2736(99)00135-2; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8752	10.1371/journal.pone.0008752	http://dx.doi.org/10.1371/journal.pone.0008752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107506	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896100002
J	Nakamura, K; Sasajima, J; Mizukami, Y; Sugiyama, Y; Yamazaki, M; Fujii, R; Kawamoto, T; Koizumi, K; Sato, K; Fujiya, M; Sasaki, K; Tanno, S; Okumura, T; Shimizu, N; Kawabe, J; Karasaki, H; Kono, T; Ii, M; Bardeesy, N; Chung, DC; Kohgo, Y				Nakamura, Kazumasa; Sasajima, Junpei; Mizukami, Yusuke; Sugiyama, Yoshiaki; Yamazaki, Madoka; Fujii, Rie; Kawamoto, Toru; Koizumi, Kazuya; Sato, Kazuya; Fujiya, Mikihiro; Sasaki, Katsunori; Tanno, Satoshi; Okumura, Toshikatsu; Shimizu, Norihiko; Kawabe, Jun-ichi; Karasaki, Hidenori; Kono, Toru; Ii, Masaaki; Bardeesy, Nabeel; Chung, Daniel C.; Kohgo, Yutaka			Hedgehog Promotes Neovascularization in Pancreatic Cancers by Regulating Ang-1 and IGF-1 Expression in Bone-Marrow Derived Pro-Angiogenic Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MESENCHYMAL STEM-CELLS; SONIC HEDGEHOG; BRANCHING MORPHOGENESIS; GENE-THERAPY; FACTOR-I; GROWTH; TUMOR; DIFFERENTIATION; LUNG	Background: The hedgehog (Hh) pathway has been implicated in the pathogenesis of cancer including pancreatic ductal adenocarcinoma (PDAC). Recent studies have suggested that the oncogenic function of Hh in PDAC involves signaling in the stromal cells rather than cell autonomous effects on the tumor cells. However, the origin and nature of the stromal cell type(s) that are responsive to Hh signaling remained unknown. Since Hh signaling plays a crucial role during embryonic and postnatal vasculogenesis, we speculated that Hh ligand may act on tumor vasculature specifically focusing on bone marrow (BM)-derived cells. Methodology/Principal Findings: Cyclopamine was utilized to inhibit the Hh pathway in human PDAC cell lines and their xenografts. BM transplants, co-culture systems of tumor cells and BM-derived pro-angiogenic cells (BMPCs) were employed to assess the role of tumor-derived Hh in regulating the BM compartment and the contribution of BM-derived cells to angiogenesis in PDAC. Cyclopamine administration attenuated Hh signaling in the stroma rather than in the cancer cells as reflected by decreased expression of full length Gli2 protein and Gli1 mRNA specifically in the compartment. Cyclopamine inhibited the growth of PDAC xenografts in association with regression of the tumor vasculature and reduced homing of BM-derived cells to the tumor. Host-derived Ang-1 and IGF-1 mRNA levels were downregulated by cyclopamine in the tumor xenografts. In vitro co-culture and matrigel plug assays demonstrated that PDAC cell-derived Shh induced Ang-1 and IGF-1 production in BMPCs, resulting in their enhanced migration and capillary morphogenesis activity. Conclusions/Significance: We identified the BMPCs as alternative stromal targets of Hh-ligand in PDAC suggesting that the tumor vasculature is an attractive therapeutic target of Hh blockade. Our data is consistent with the emerging concept that BM-derived cells make important contributions to epithelial tumorigenesis.	[Nakamura, Kazumasa; Sasajima, Junpei; Mizukami, Yusuke; Sugiyama, Yoshiaki; Yamazaki, Madoka; Fujii, Rie; Kawamoto, Toru; Koizumi, Kazuya; Sato, Kazuya; Fujiya, Mikihiro; Sasaki, Katsunori; Tanno, Satoshi; Kohgo, Yutaka] Asahikawa Med Coll, Div Gastroenterol & Hematol Oncol, Dept Med, Asahikawa, Hokkaido 078, Japan; [Tanno, Satoshi; Okumura, Toshikatsu] Asahikawa Med Coll, Dept Gen Med, Asahikawa, Hokkaido 078, Japan; [Shimizu, Norihiko] Asahikawa Med Coll, Dept Anim Facil, Asahikawa, Hokkaido 078, Japan; [Kawabe, Jun-ichi] Asahikawa Med Coll, Dept Cardiovasc Regenerat & Innovat, Asahikawa, Hokkaido 078, Japan; [Karasaki, Hidenori; Kono, Toru] Asahikawa Med Coll, Div Gastroenterol & Gen Surg, Dept Surg, Asahikawa, Hokkaido 078, Japan; [Ii, Masaaki] Inst Biomed Res & Innovat, Grp Vasc Regenerat Res, Kobe, Hyogo, Japan; [Bardeesy, Nabeel; Chung, Daniel C.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Bardeesy, Nabeel; Chung, Daniel C.] Harvard Univ, Sch Med, Boston, MA USA; [Chung, Daniel C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Asahikawa Medical College; Institute for Biomedical Research & Innovation (IBRI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Nakamura, K (corresponding author), Asahikawa Med Coll, Div Gastroenterol & Hematol Oncol, Dept Med, Asahikawa, Hokkaido 078, Japan.	mizu@asahikawa-med.ac.jp	Kohgo, Yutaka/AAN-4863-2020; Mizukami, Yusuke/AAU-1767-2021; Mizukami, Yusuke/AAB-1777-2019	Mizukami, Yusuke/0000-0002-1068-7024; Okumura, Toshikatsu/0000-0003-1810-007X	New Energy and Industrial Technology Development Organization of Japan [07A05010a]; NATIONAL CANCER INSTITUTE [R01CA133557] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22590754] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant to Y. M. from the New Energy and Industrial Technology Development Organization of Japan (07A05010a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Conejo-Garcia JR, 2005, BLOOD, V105, P679, DOI 10.1182/blood-2004-05-1906; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Elia D, 2007, BBA-MOL CELL RES, V1773, P1438, DOI 10.1016/j.bbamcr.2007.06.006; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Fontaine C, 2008, STEM CELLS, V26, P1037, DOI 10.1634/stemcells.2007-0974; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guimaraes AR, 2008, PANCREAS, V37, P440, DOI 10.1097/MPA.0b013e31817c5113; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Ijichi H, 2001, BIOCHEM BIOPH RES CO, V289, P350, DOI 10.1006/bbrc.2001.5988; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kawahira H, 2005, DEV BIOL, V280, P111, DOI 10.1016/j.ydbio.2005.01.008; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kopp HG, 2006, CURR OPIN HEMATOL, V13, P175, DOI 10.1097/01.moh.0000219664.26528.da; Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313; Lee SW, 2007, INT J MOL MED, V19, P445; Lin N, 2008, BIOCHEM BIOPH RES CO, V372, P260, DOI 10.1016/j.bbrc.2008.05.029; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Matsuno S, 2004, PANCREAS, V28, P219, DOI 10.1097/00006676-200404000-00002; McCarty MF, 2007, J CLIN INVEST, V117, P2114, DOI 10.1172/JCI31334; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Morton JP, 2007, P NATL ACAD SCI USA, V104, P5103, DOI 10.1073/pnas.0701158104; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Ohuchida K, 2006, J PATHOL, V210, P42, DOI 10.1002/path.2019; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; ROBERTS DJ, 1995, DEVELOPMENT, V121, P3163; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Saif MW, 2007, J PANCREAS, V8, P365; Schuller U, 2007, MOL CELL BIOL, V27, P8259, DOI 10.1128/MCB.00707-07; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thum T, 2007, CIRC RES, V100, P434, DOI 10.1161/01.RES.0000257912.78915.af; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; van Tuyl M, 2007, DEV BIOL, V303, P514, DOI 10.1016/j.ydbio.2006.11.029; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamazaki M, 2008, CANCER SCI, V99, P1131, DOI 10.1111/j.1349-7006.2008.00795.x; YANG SH, 2008, NAT GENET; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhu GF, 1999, DEV BIOL, V215, P118, DOI 10.1006/dbio.1999.9431	60	59	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8824	10.1371/journal.pone.0008824	http://dx.doi.org/10.1371/journal.pone.0008824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098680	Green Submitted, gold, Green Published			2022-12-27	WOS:000273779100016
J	Poduslo, JF; Gilles, EJ; Ramakrishnan, M; Howell, KG; Wengenack, TM; Curran, GL; Kandimalla, KK				Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.			HH Domain of Alzheimer's Disease A beta Provides Structural Basis for Neuronal Binding in PC12 and Mouse Cortical/Hippocampal Neurons	PLOS ONE			English	Article							AMYLOID-BETA; IN-VIVO; PEPTIDE; BRAIN; PLAQUES; PROTEIN; NEUROTOXICITY; ACCUMULATION; AGGREGATION; ENDOCYTOSIS	A key question in understanding AD is whether extracellular A beta deposition of parenchymal amyloid plaques or intraneuronal A beta accumulation initiates the AD process. Amyloid precursor protein (APP) is endocytosed from the cell surface into endosomes where it is cleaved to produce soluble A beta which is then released into the brain interstitial fluid. Intraneuronal A beta accumulation is hypothesized to predominate from the neuronal uptake of this soluble extracellular A beta rather than from ER/Golgi processing of APP. We demonstrate that substitution of the two adjacent histidine residues of A beta 40 results in a significant decrease in its binding with PC12 cells and mouse cortical/hippocampal neurons. These substitutions also result in a dramatic enhancement of both thioflavin-T positive fibril formation and binding to preformed A beta fibrils while maintaining its plaque-binding ability in AD transgenic mice. Hence, alteration of the histidine domain of A beta prevented neuronal binding and drove A beta to enhanced fibril formation and subsequent amyloid plaque deposition - a potential mechanism for removing toxic species of A beta. Substitution or even masking of these A beta histidine residues might provide a new therapeutic direction for minimizing neuronal uptake and subsequent neuronal degeneration and maximizing targeting to amyloid plaques.	[Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurol, Rochester, MN 55905 USA; [Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurobiol, Rochester, MN USA; [Poduslo, Joseph F.; Gilles, Emily J.; Ramakrishnan, Muthu; Howell, Kyle G.; Wengenack, Thomas M.; Curran, Geoffry L.; Kandimalla, Karunya K.] Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Biochem Mol Biol, Rochester, MN USA; [Kandimalla, Karunya K.] Florida A&M Univ, Dept Pharm & Pharmacol, Tallahassee, FL USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; State University System of Florida; Florida A&M University	Poduslo, JF (corresponding author), Mayo Clin, Coll Med, Mol Neurobiol Lab, Dept Neurol, Rochester, MN 55905 USA.	poduslo.joseph@mayo.edu			Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER	Mayo Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding from the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnham KJ, 2008, P NATL ACAD SCI USA, V105, P6813, DOI 10.1073/pnas.0800712105; Bi X, 2002, NEUROSCIENCE, V112, P827, DOI 10.1016/S0306-4522(02)00132-X; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; CICCOTOSTO GD, 2009, NEUROBIOL A IN PRESS; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COLLINGRIDGE GL, 1995, J NEUROSCI METH, V59, P5, DOI 10.1016/0165-0270(94)00187-L; D'Andrea MR, 2001, HISTOPATHOLOGY, V38, P120, DOI 10.1046/j.1365-2559.2001.01082.x; Diaz JC, 2006, BIOL RES, V39, P447, DOI 10.4067/S0716-97602006000300007; Echeverria V, 2002, MOL NEUROBIOL, V26, P299, DOI 10.1385/MN:26:2-3:299; FRASER PE, 1992, BIOCHEMISTRY-US, V31, P10716, DOI 10.1021/bi00159a011; Fukuda M, 2004, J BIOCHEM, V136, P245, DOI 10.1093/jb/mvh116; Fung J, 2004, J NEUROCHEM, V91, P1398, DOI 10.1111/j.1471-4159.2004.02828.x; Giulian D, 1998, J BIOL CHEM, V273, P29719, DOI 10.1074/jbc.273.45.29719; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Gredell JA, 2004, BRIT J ANAESTH, V93, P810, DOI 10.1093/bja/aeh272; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Kandimalla KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004627; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; LaFerla FM, 1997, J CLIN INVEST, V100, P310, DOI 10.1172/JCI119536; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lee G, 2002, PEPTIDES, V23, P1249, DOI 10.1016/S0196-9781(02)00060-8; Liu ST, 1999, BIOCHEMISTRY-US, V38, P9373, DOI 10.1021/bi990205o; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mochizuki A, 2000, LANCET, V355, P42, DOI 10.1016/S0140-6736(99)04937-5; Morris AM, 2008, BIOCHEMISTRY-US, V47, P2413, DOI 10.1021/bi701899y; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nagele RG, 2002, NEUROSCIENCE, V110, P199, DOI 10.1016/S0306-4522(01)00460-2; Poduslo JF, 2004, BIOCHEMISTRY-US, V43, P6064, DOI 10.1021/bi0359574; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; SHIVERS BD, 1988, EMBO J, V7, P1365, DOI 10.1002/j.1460-2075.1988.tb02952.x; Simakova O, 2007, J NEUROSCI, V27, P13719, DOI 10.1523/JNEUROSCI.3006-07.2007; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Tickler AK, 2005, J BIOL CHEM, V280, P13355, DOI 10.1074/jbc.M414178200; Tseng Bertrand P., 2004, Current Alzheimer Research, V1, P231, DOI 10.2174/1567205043332045; Wengenack TM, 2000, NAT BIOTECHNOL, V18, P868, DOI 10.1038/78482; Winkler K, 1999, J LIPID RES, V40, P447; Wirths O, 2004, J NEUROCHEM, V91, P513, DOI 10.1111/j.1471-4159.2004.02737.x; Xu HX, 1996, P NATL ACAD SCI USA, V93, P4081, DOI 10.1073/pnas.93.9.4081; Yang DS, 2000, EUR J BIOCHEM, V267, P6692, DOI 10.1046/j.1432-1327.2000.01767.x	46	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8813	10.1371/journal.pone.0008813	http://dx.doi.org/10.1371/journal.pone.0008813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098681	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100007
J	Rai, M; Soragni, E; Chou, CJ; Barnes, G; Jones, S; Rusche, JR; Gottesfeld, JM; Pandolfo, M				Rai, Myriam; Soragni, Elisabetta; Chou, C. James; Barnes, Glenn; Jones, Steve; Rusche, James R.; Gottesfeld, Joel M.; Pandolfo, Massimo			Two New Pimelic Diphenylamide HDAC Inhibitors Induce Sustained Frataxin Upregulation in Cells from Friedreich's Ataxia Patients and in a Mouse Model	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; EPIGENETIC CHANGES; GENE; VORINOSTAT; INTRON-1; REPEATS; SLOW; DNA	Background: Friedreich's ataxia (FRDA), the most common recessive ataxia in Caucasians, is due to severely reduced levels of frataxin, a highly conserved protein, that result from a large GAA triplet repeat expansion within the first intron of the frataxin gene (FXN). Typical marks of heterochromatin are found near the expanded GAA repeat in FRDA patient cells and mouse models. Histone deacetylase inhibitors (HDACIs) with a pimelic diphenylamide structure and HDAC3 specificity can decondense the chromatin structure at the FXN gene and restore frataxin levels in cells from FRDA patients and in a GAA repeat based FRDA mouse model, KIKI, providing an appealing approach for FRDA therapeutics. Methodology/Principal Findings: In an effort to further improve the pharmacological profile of pimelic diphenylamide HDACIs as potential therapeutics for FRDA, we synthesized additional compounds with this basic structure and screened them for HDAC3 specificity. We characterized two of these compounds, 136 and 109, in FRDA patients' peripheral blood lymphocytes and in the KIKI mouse model. We tested their ability to upregulate frataxin at a range of concentrations in order to determine a minimal effective dose. We then determined in both systems the duration of effect of these drugs on frataxin mRNA and protein, and on total and local histone acetylation. The effects of these compounds exceeded the time of direct exposure in both systems. Conclusions/Significance: Our results support the pre-clinical development of a therapeutic approach based on pimelic diphenylamide HDACIs for FRDA and provide information for the design of future human trials of these drugs, suggesting an intermittent administration of the drug.	[Rai, Myriam; Pandolfo, Massimo] Free Univ Brussels, Hop Erasme, Lab Neurol Expt, B-1070 Brussels, Belgium; [Soragni, Elisabetta; Chou, C. James; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Barnes, Glenn; Jones, Steve; Rusche, James R.] Repligen Corp, Waltham, MA USA	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Scripps Research Institute	Rai, M (corresponding author), Free Univ Brussels, Hop Erasme, Lab Neurol Expt, 808 Route Lennik, B-1070 Brussels, Belgium.	massimo.pandolfo@ulb.ac.be	Chou, C. James/I-6563-2012; Pandolfo, Massimo/B-2853-2010	Gottesfeld, Joel/0000-0002-4643-5777	GoFar; Fondazione CRT (Italy); Kyle Bryant translational research award; Association Francaise Ataxie de Friedreich (AFAF); Fonds de la Recherche Scientifique - FNRS; Fonds Erasme; Friedreich's Ataxia Research Alliance (FARA); National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS); Repligen Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	GoFar; Fondazione CRT (Italy); Kyle Bryant translational research award; Association Francaise Ataxie de Friedreich (AFAF); Fonds de la Recherche Scientifique - FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Erasme; Friedreich's Ataxia Research Alliance (FARA); National Ataxia Foundation (NAF); National Institutes of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Repligen Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from GoFar and the Fondazione CRT (Italy), from the Kyle Bryant translational research award, the Association Francaise Ataxie de Friedreich (AFAF), the Fonds de la Recherche Scientifique - FNRS and the Fonds Erasme - Jean Van Damme to MP; from the Kyle Bryant translational research award to JRR; from the Friedreich's Ataxia Research Alliance (FARA), the National Ataxia Foundation (NAF), the National Institutes of Neurological Disorders and Stroke (NINDS) to JMG. Repligen Corporation partly funded the work described in this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chou CJ, 2008, J BIOL CHEM, V283, P35402, DOI 10.1074/jbc.M807045200; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Kawamata N, 2007, BLOOD, V110, P2667, DOI 10.1182/blood-2005-11-026344; Langley B, 2005, CNS NEUROL DISORD-DR, V4, P41, DOI 10.2174/1568007053005091; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Pandolfo M, 2009, J NEUROL, V256, P1, DOI 10.1007/s00415-009-1001-4; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	19	106	112	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8825	10.1371/journal.pone.0008825	http://dx.doi.org/10.1371/journal.pone.0008825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098685	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100017
J	Shen, YY; Liu, J; Irwin, DM; Zhang, YP				Shen, Yong-Yi; Liu, Jie; Irwin, David M.; Zhang, Ya-Ping			Parallel and Convergent Evolution of the Dim-Light Vision Gene RH1 in Bats (Order: Chiroptera)	PLOS ONE			English	Article							VISUAL PIGMENTS; COLOR-VISION; PHYLOGENETIC ANALYSIS; TRICHROMATIC VISION; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; EATING BATS; BRANCH-SITE; ECHOLOCATION; MAMMALS	Rhodopsin, encoded by the gene Rhodopsin (RH1), is extremely sensitive to light, and is responsible for dim-light vision. Bats are nocturnal mammals that inhabit poor light environments. Megabats (Old-World fruit bats) generally have well-developed eyes, while microbats (insectivorous bats) have developed echolocation and in general their eyes were degraded, however, dramatic differences in the eyes, and their reliance on vision, exist in this group. In this study, we examined the rod opsin gene (RH1), and compared its evolution to that of two cone opsin genes (SWS1 and M/LWS). While phylogenetic reconstruction with the cone opsin genes SWS1 and M/LWS generated a species tree in accord with expectations, the RH1 gene tree united Pteropodidae (Old-World fruit bats) and Yangochiroptera, with very high bootstrap values, suggesting the possibility of convergent evolution. The hypothesis of convergent evolution was further supported when nonsynonymous sites or amino acid sequences were used to construct phylogenies. Reconstructed RH1 sequences at internal nodes of the bat species phylogeny showed that: (1) Old-World fruit bats share an amino acid change (S270G) with the tomb bat; (2) Miniopterus share two amino acid changes (V104I, M183L) with Rhinolophoidea; (3) the amino acid replacement I123V occurred independently on four branches, and the replacements L99M, L266V and I286V occurred each on two branches. The multiple parallel amino acid replacements that occurred in the evolution of bat RH1 suggest the possibility of multiple convergences of their ecological specialization (i.e., various photic environments) during adaptation for the nocturnal lifestyle, and suggest that further attention is needed on the study of the ecology and behavior of bats.	[Shen, Yong-Yi; Liu, Jie; Zhang, Ya-Ping] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China; [Shen, Yong-Yi; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Peoples R China; [Shen, Yong-Yi; Liu, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5S 1A1, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming Inst Zool, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022	Irwin, David/0000-0001-6131-4933	National Basic Research Program of China [2007CB411600]; National Natural Science Foundation of China [30621092]; Bureau of Science and Technology of Yunnan Province	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province	This work was supported by the National Basic Research Program of China (973 Program, 2007CB411600), National Natural Science Foundation of China (30621092), and Bureau of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KK, 1998, BEHAV PROCESS, V44, P59, DOI 10.1016/S0376-6357(98)00028-X; Calderone JB, 1999, VISUAL NEUROSCI, V16, P53, DOI 10.1017/S0952523899161029; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; Fure Alison, 2006, London Naturalist, V85, P93; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; Heffner RS, 2001, J ACOUST SOC AM, V109, P412, DOI 10.1121/1.1329620; Huelsenbeck J. P., 2001, MRBAYES BAYESIAN INF, P754; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Jacobs GH, 2009, PHILOS T R SOC B, V364, P2957, DOI 10.1098/rstb.2009.0039; JACOBS GH, 1992, J COMP PHYSIOL A, V171, P351; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Kim TJ, 2008, MOL CELLS, V26, P373; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; LI WH, 1985, MOL BIOL EVOL, V2, P150; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Peichl L, 2000, INVEST OPHTH VIS SCI, V41, pS494; Phillips CJ, 2000, THEORETICAL CONSIDER; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Sanchez F, 2006, J CHEM ECOL, V32, P1289, DOI 10.1007/s10886-006-9085-0; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schnitzler HU, 1998, ECHOLOCATING BATS SE; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Surridge AK, 2003, TRENDS ECOL EVOL, V18, P198, DOI 10.1016/S0169-5347(03)00012-0; SWOFFORD DL, PAUP PHYLOGENETIC AN; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YAU KW, 1994, INVEST OPHTH VIS SCI, V35, P9; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	37	25	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8838	10.1371/journal.pone.0008838	http://dx.doi.org/10.1371/journal.pone.0008838			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098620	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100029
J	Williams, CM; Kramer, EM				Williams, Christopher M.; Kramer, Eric M.			The Advantages of a Tapered Whisker	PLOS ONE			English	Article							ACTIVE TOUCH; MYSTACIAL VIBRISSAE; RADIAL DISTANCE; SENSORY SYSTEM; RAT; CONTACT; RESONANCE; BEHAVIOR; FEATURES; HAIR	The role of facial vibrissae (whiskers) in the behavior of terrestrial mammals is principally as a supplement or substitute for short-distance vision. Each whisker in the array functions as a mechanical transducer, conveying forces applied along the shaft to mechanoreceptors in the follicle at the whisker base. Subsequent processing of mechanoreceptor output in the trigeminal nucleus and somatosensory cortex allows high accuracy discriminations of object distance, direction, and surface texture. The whiskers of terrestrial mammals are tapered and approximately circular in cross section. We characterize the taper of whiskers in nine mammal species, measure the mechanical deflection of isolated felid whiskers, and discuss the mechanics of a single whisker under static and oscillatory deflections. We argue that a tapered whisker provides some advantages for tactile perception (as compared to a hypothetical untapered whisker), and that this may explain why the taper has been preserved during the evolution of terrestrial mammals.	[Williams, Christopher M.; Kramer, Eric M.] Bard Coll Simons Rock, Dept Phys, Great Barrington, MA USA		Williams, CM (corresponding author), Bard Coll Simons Rock, Dept Phys, Great Barrington, MA USA.	ekramer@simons-rock.edu	Kramer, Eric M/B-9752-2008	Kramer, Eric/0000-0002-1424-2356	Bard College at Simon's Rock	Bard College at Simon's Rock	Bard College at Simon's Rock (www.simons-rock.edu) provided a summer research fellowship to CMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL AS, 1987, J MAMMAL, V68, P848, DOI 10.2307/1381563; AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; Andermann ML, 2008, BRAIN RES, V1235, P74, DOI 10.1016/j.brainres.2008.06.054; Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Andermann ML, 2004, NEURON, V42, P451, DOI 10.1016/S0896-6273(04)00198-9; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; BARBER DJ, 1989, INTRO PROPERTIES CON; Barnes TG, 2001, J APPL MECH-T ASME, V68, P948, DOI 10.1115/1.1406955; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CAUNA N, 1954, ANAT RECORD, V119, P449, DOI 10.1002/ar.1091190405; Chernova OF, 2006, BIOL BULL+, V33, P43, DOI 10.1134/S1062359006010067; Conway H.D., 1964, J APPL MECH-T ASME, V31, P329; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; GOTTSCHALDT KM, 1973, J PHYSIOL-LONDON, V235, P287, DOI 10.1113/jphysiol.1973.sp010388; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Hausman LA, 1920, AM NAT, V54, P496, DOI 10.1086/279782; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; IBRAHIM L, 1975, J EMBRYOL EXP MORPH, V33, P831; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Kaneko M, 1998, IEEE T ROBOTIC AUTOM, V14, P278, DOI 10.1109/70.681246; KERNAN MJ, 2007, EUROPEAN J PHYSL, V454, P703; Kim D, 2007, ROBOT AUTON SYST, V55, P229, DOI 10.1016/j.robot.2006.08.001; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Krupa DJ, 2001, J NEUROSCI, V21, P5752, DOI 10.1523/JNEUROSCI.21-15-05752.2001; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Maeno T, 1998, JSME INT J C-MECH SY, V41, P94, DOI 10.1299/jsmec.41.94; MCIVER SB, 1975, ANNU REV ENTOMOL, V20, P381, DOI 10.1146/annurev.en.20.010175.002121; Mitchinson B, 2007, P R SOC B, V274, P1035, DOI 10.1098/rspb.2006.0347; Neimark MA, 2003, J NEUROSCI, V23, P6499; Pearson MJ, 2007, ADAPT BEHAV, V15, P223, DOI 10.1177/1059712307082089; Perrin WF, 2008, ENCY MARINE MAMMALS, V2nd; POCOCK RI, 1914, P ZOOL SOC LOND, V84, P889; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Ritt JT, 2008, NEURON, V57, P599, DOI 10.1016/j.neuron.2007.12.024; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; SOKOLOV VE, 1987, MAMMALIA, V51, P125, DOI 10.1515/mamm.1987.51.1.125; Solomon JH, 2006, NATURE, V443, P525, DOI 10.1038/443525a; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Vetterling W.T., 1989, NUMERICAL RECIPES; Von Heimendahl M, 2007, PLOS BIOL, V5, P2696, DOI 10.1371/journal.pbio.0050305; Yanli B, 1998, J FORESTRY RES, V9, P273	48	56	56	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8806	10.1371/journal.pone.0008806	http://dx.doi.org/10.1371/journal.pone.0008806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098714	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779000032
J	Lloyd, KG; Albert, DB; Biddle, JF; Chanton, JP; Pizarro, O; Teske, A				Lloyd, Karen G.; Albert, Daniel B.; Biddle, Jennifer F.; Chanton, Jeffrey P.; Pizarro, Oscar; Teske, Andreas			Spatial Structure and Activity of Sedimentary Microbial Communities Underlying a Beggiatoa spp. Mat in a Gulf of Mexico Hydrocarbon Seep	PLOS ONE			English	Article							COENZYME-M REDUCTASE; METHANE-OXIDIZING ARCHAEA; SULFATE-REDUCING BACTERIA; MARINE SUBSURFACE SEDIMENTS; GAS HYDRATE DEPOSIT; ANAEROBIC OXIDATION; DEEP-SEA; CONTINENTAL-SLOPE; RIBOSOMAL-RNA; COLD SEEPS	Background: Subsurface fluids from deep-sea hydrocarbon seeps undergo methane-and sulfur-cycling microbial transformations near the sediment surface. Hydrocarbon seep habitats are naturally patchy, with a mosaic of active seep sediments and non-seep sediments. Microbial community shifts and changing activity patterns on small spatial scales from seep to non-seep sediment remain to be examined in a comprehensive habitat study. Methodology/Principal Findings: We conducted a transect of biogeochemical measurements and gene expression related to methane-and sulfur-cycling at different sediment depths across a broad Beggiatoa spp. mat at Mississippi Canyon 118 (MC118) in the Gulf of Mexico. High process rates within the mat (similar to 400 cm and similar to 10 cm from the mat's edge) contrasted with sharply diminished activity at similar to 50 cm outside the mat, as shown by sulfate and methane concentration profiles, radiotracer rates of sulfate reduction and methane oxidation, and stable carbon isotopes. Likewise, 16S ribosomal rRNA, dsrAB (dissimilatory sulfite reductase) and mcrA (methyl coenzyme M reductase) mRNA transcripts of sulfate-reducing bacteria (Desulfobacteraceae and Desulfobulbaceae) and methane-cycling archaea (ANME-1 and ANME-2) were prevalent at the sediment surface under the mat and at its edge. Outside the mat at the surface, 16S rRNA sequences indicated mostly aerobes commonly found in seawater. The seep-related communities persisted at 12-20 cm depth inside and outside the mat. 16S rRNA transcripts and V6-tags reveal that bacterial and archaeal diversity underneath the mat are similar to each other, in contrast to oxic or microoxic habitats that have higher bacterial diversity. Conclusions/Significance: The visual patchiness of microbial mats reflects sharp discontinuities in microbial community structure and activity over sub-meter spatial scales; these discontinuities have to be taken into account in geochemical and microbiological inventories of seep environments. In contrast, 12-20 cm deep in the sediments microbial communities performing methane-cycling and sulfate reduction persist at lower metabolic rates regardless of mat cover, and may increase activity rapidly when subsurface flow changes.	[Lloyd, Karen G.; Albert, Daniel B.; Biddle, Jennifer F.; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Chanton, Jeffrey P.] Florida State Univ, Dept Oceanog, Tallahassee, FL 32306 USA; [Pizarro, Oscar] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia	University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida State University; University of Sydney	Lloyd, KG (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	karen.lloyd@biology.au.dk	Teske, Andreas/AAQ-9577-2021; Biddle, Jennifer F/F-8323-2010; Lloyd, Karen/A-4165-2011	Biddle, Jennifer F/0000-0002-4344-8724; Pizarro, Oscar/0000-0001-6612-2738; Lloyd, Karen/0000-0003-0914-6375	National Aeronautics and Space Administration (NASA) Astrobiology Institutes [NCC 21054, NCC 2-1275]; Environmental Protection Agency (EPA) [91671401-0]; University of Mississippi Gulf of Mexico Hydrate Research Consortium; Department of Energy; United States Minerals Management Services; Keck Foundation	National Aeronautics and Space Administration (NASA) Astrobiology Institutes(National Aeronautics & Space Administration (NASA)); Environmental Protection Agency (EPA)(United States Environmental Protection Agency); University of Mississippi Gulf of Mexico Hydrate Research Consortium; Department of Energy(United States Department of Energy (DOE)); United States Minerals Management Services; Keck Foundation(W.M. Keck Foundation)	Funding: This study was supported by the National Aeronautics and Space Administration (NASA) Astrobiology Institutes "Environmental genomes'' (NCC 21054) and "Subsurface Biospheres'' (NCC 2-1275) (A. T) and an Environmental Protection Agency (EPA) STAR fellowship # 91671401-0 (K. G. L.) and through a grant from the University of Mississippi Gulf of Mexico Hydrate Research Consortium and Department of Energy. This portion of the Gulf of Mexico Gas Hydrate Research Consortium cruise was funded by United States Minerals Management Services. Tagged sequencing was supported by the W. M. Keck Foundation through the International Census of Marine Microbes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller JY, 2008, FEMS MICROBIOL ECOL, V65, P74, DOI 10.1111/j.1574-6941.2008.00498.x; Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990; Amend JP, 2005, PALAEOGEOGR PALAEOCL, V219, P131, DOI 10.1016/j.palaeo.2004.10.018; Arvidson RS, 2004, MAR CHEM, V87, P97, DOI 10.1016/j.marchem.2003.11.004; Barry JP, 1997, LIMNOL OCEANOGR, V42, P318, DOI 10.4319/lo.1997.42.2.0318; Bent SJ, 2008, ISME J, V2, P689, DOI 10.1038/ismej.2008.44; BERDALET E, 1993, MAR BIOL, V117, P163, DOI 10.1007/BF00346439; Berner R.A., 1980, EARLY DIAGENESIS THE; Biddle JF, 2006, P NATL ACAD SCI USA, V103, P3846, DOI 10.1073/pnas.0600035103; Blum SAE, 1997, SYST APPL MICROBIOL, V20, P513, DOI 10.1016/S0723-2020(97)80021-5; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; CARUSO S, 2007, INTEGRATED GEOLOGICA; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chin KJ, 2008, MICROB ECOL, V55, P489, DOI 10.1007/s00248-007-9294-2; Colwell RK, 2013, ESTIMATES STAT ESTIM; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; Dell'Anno A, 1998, APPL ENVIRON MICROB, V64, P3238; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dhillon A, 2003, APPL ENVIRON MICROB, V69, P2765, DOI 10.1128/AEM.69.5.2765-2772.2003; DURBIN A, 2009, MICROBIAL DIVERSITY; Edlund A, 2008, ENVIRON MICROBIOL, V10, P2051, DOI 10.1111/j.1462-2920.2008.01624.x; Evguenieva-Hackenberg E, 2009, PROG MOL BIOL TRANSL, V85, P275, DOI 10.1016/S0079-6603(08)00807-6; Felske A, 1996, APPL ENVIRON MICROB, V62, P4162, DOI 10.1128/AEM.62.11.4162-4167.1996; Friedrich MW, 2005, METHOD ENZYMOL, V397, P428, DOI 10.1016/S0076-6879(05)97026-2; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Harrison BK, 2009, APPL ENVIRON MICROB, V75, P1487, DOI 10.1128/AEM.01812-08; HENNIGAN AN, 1994, MOL MICROBIOL, V11, P655, DOI 10.1111/j.1365-2958.1994.tb00344.x; Hill TM, 2006, P NATL ACAD SCI USA, V103, P13570, DOI 10.1073/pnas.0601304103; Hoefs J., 1987, STABLE ISOTOPE GEOCH, V3rd; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Inagaki F, 2004, APPL ENVIRON MICROB, V70, P7445, DOI 10.1128/AEM.70.12.7445-7455.2004; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kaneko R, 2007, MAR BIOTECHNOL, V9, P429, DOI 10.1007/s10126-007-9003-7; KARL DM, 1981, APPL ENVIRON MICROB, V42, P802, DOI 10.1128/AEM.42.5.802-810.1981; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kendall MM, 2007, APPL ENVIRON MICROB, V73, P407, DOI 10.1128/AEM.01154-06; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Lapham LL, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001944; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Lloyd KG, 2006, APPL ENVIRON MICROB, V72, P7218, DOI 10.1128/AEM.00886-06; LUTKEN CB, 2006, OFFSHORE TECHNOLOGY; MacDonald IR, 2005, EARTH PLANET SC LETT, V233, P45, DOI 10.1016/j.epsl.2005.02.002; MacDonald IR, 2003, MAR GEOL, V198, P133, DOI 10.1016/S0025-3227(03)00098-7; MacGregor BJ, 1997, APPL ENVIRON MICROB, V63, P1178, DOI 10.1128/AEM.63.3.1178-1181.1997; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Massana R, 2000, APPL ENVIRON MICROB, V66, P1777, DOI 10.1128/AEM.66.5.1777-1787.2000; Mills HJ, 2005, APPL ENVIRON MICROB, V71, P3235, DOI 10.1128/AEM.71.6.3235-3247.2005; Mills HJ, 2004, APPL ENVIRON MICROB, V70, P5447, DOI 10.1128/AEM.70.9.5447-5458.2004; Nercessian O, 2003, ENVIRON MICROBIOL, V5, P492, DOI 10.1046/j.1462-2920.2003.00437.x; Neretin LN, 2003, ENVIRON MICROBIOL, V5, P660, DOI 10.1046/j.1462-2920.2003.00452.x; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Orcutt B, 2005, GEOCHIM COSMOCHIM AC, V69, P4267, DOI 10.1016/j.gca.2005.04.012; Orcutt BN, 2004, CHEM GEOL, V205, P239, DOI 10.1016/j.chemgeo.2003.12.020; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Peng C, 2007, J ENVIRON SCI-CHINA, V19, P1326, DOI 10.1016/S1001-0742(07)60216-2; Pizarro O, 2003, IEEE J OCEANIC ENG, V28, P651, DOI 10.1109/JOE.2003.819154; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Raskin L, 1996, APPL ENVIRON MICROB, V62, P3847, DOI 10.1128/AEM.62.10.3847-3857.1996; Rice AL, 2001, ANAL CHEM, V73, P4104, DOI 10.1021/ac0155106; Roberts HH, 1997, ECON GEOL BULL SOC, V92, P863, DOI 10.2113/gsecongeo.92.7-8.863; Rother M, 2005, J BACTERIOL, V187, P5552, DOI 10.1128/JB.187.16.5552-5559.2005; Sassen R, 2003, ORG GEOCHEM, V34, P1455, DOI 10.1016/S0146-6380(03)00135-9; Sassen R, 2004, CHEM GEOL, V205, P195, DOI 10.1016/j.chemgeo.2003.12.032; SASSEN R, 2006, MISSISSIPPI CANYON 1; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Solomon EA, 2008, EARTH PLANET SC LETT, V270, P95, DOI 10.1016/j.epsl.2008.03.024; Solomon EA, 2009, NAT GEOSCI, V2, P561, DOI 10.1038/NGEO574; Sorensen KB, 2006, APPL ENVIRON MICROB, V72, P4596, DOI 10.1128/AEM.00562-06; SPRINGER E, 1995, INT J SYST BACTERIOL, V45, P554, DOI 10.1099/00207713-45-3-554; SRIVASTAVA AK, 1990, ANNU REV MICROBIOL, V44, P105, DOI 10.1146/annurev.mi.44.100190.000541; STAHL DA, 1988, APPL ENVIRON MICROB, V54, P1079, DOI 10.1128/AEM.54.5.1079-1084.1988; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Takai K, 1999, GENETICS, V152, P1285; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; Teske A, 2008, ISME J, V2, P3, DOI 10.1038/ismej.2007.90; Thomsen TR, 2001, APPL ENVIRON MICROB, V67, P1646, DOI 10.1128/AEM.67.4.1646-1656.2001; Ussler W, 2008, EARTH PLANET SC LETT, V266, P271, DOI 10.1016/j.epsl.2007.10.056; Valentine DL, 2007, NAT REV MICROBIOL, V5, P316, DOI 10.1038/nrmicro1619; Wagner M, 2005, METHOD ENZYMOL, V397, P469, DOI 10.1016/S0076-6879(05)97029-8; Wagner M, 1998, J BACTERIOL, V180, P2975, DOI 10.1128/JB.180.11.2975-2982.1998; WALLACE PJ, 2000, P OCEAN DRILLING PRO, V164; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	95	93	97	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8738	10.1371/journal.pone.0008738	http://dx.doi.org/10.1371/journal.pone.0008738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090951	gold, Green Published			2022-12-27	WOS:000273714900018
J	Daigneault, M; Preston, JA; Marriott, HM; Whyte, MKB; Dockrell, DH				Daigneault, Marc; Preston, Julie A.; Marriott, Helen M.; Whyte, Moira K. B.; Dockrell, David H.			The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HUMAN ALVEOLAR MACROPHAGES; MONONUCLEAR PHAGOCYTES; BLOOD MONOCYTES; NITRIC-OXIDE; FACTOR-ALPHA; STREPTOCOCCUS-PNEUMONIAE; BRONCHOALVEOLAR LAVAGE; VITRO DIFFERENTIATION; DENDRITIC CELLS	Differentiated macrophages are the resident tissue phagocytes and sentinel cells of the innate immune response. The phenotype of mature tissue macrophages represents the composite of environmental and differentiation-dependent imprinting. Phorbol-12-myristate-13-acetate (PMA) and 1,25-dihydroxyvitamin D3 (VD3) are stimuli commonly used to induce macrophage differentiation in monocytic cell lines but the extent of differentiation in comparison to primary tissue macrophages is unclear. We have compared the phenotype of the promonocytic THP-1 cell line after various protocols of differentiation utilising VD3 and PMA in comparison to primary human monocytes or monocyte-derived macrophages (MDM). Both stimuli induced changes in cell morphology indicative of differentiation but neither showed differentiation comparable to MDM. In contrast, PMA treatment followed by 5 days resting in culture without PMA (PMAr) increased cytoplasmic to nuclear ratio, increased mitochondrial and lysosomal numbers and altered differentiation-dependent cell surface markers in a pattern similar to MDM. Moreover, PMAr cells showed relative resistance to apoptotic stimuli and maintained levels of the differentiation-dependent anti-apoptotic protein Mcl-1 similar to MDM. PMAr cells retained a high phagocytic capacity for latex beads, and expressed a cytokine profile that resembled MDM in response to TLR ligands, in particular with marked TLR2 responses. Moreover, both MDM and PMAr retained marked plasticity to stimulus-directed polarization. These findings suggest a modified PMA differentiation protocol can enhance macrophage differentiation of THP-1 cells and identify increased numbers of mitochondria and lysosomes, resistance to apoptosis and the potency of TLR2 responses as important discriminators of the level of macrophage differentiation for transformed cells.	[Daigneault, Marc; Preston, Julie A.; Marriott, Helen M.; Whyte, Moira K. B.; Dockrell, David H.] Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England	University of Sheffield	Daigneault, M (corresponding author), Univ Sheffield, Sch Med, Dept Infect & Immun, Sheffield, S Yorkshire, England.	d.h.dockrell@sheffield.ac.uk	Whyte, Moira/E-6210-2010	Marriott, Helen/0000-0003-1070-0054; Dockrell, David/0000-0002-2718-4861; Preston, Julie/0000-0001-5289-3160	Wellcome Trust [076945]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust (www.Wellcome.ac.uk) Senior Clinical Fellowship to DHD, 076945. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINTON DF, 1980, MACROPHAGE, P1; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; BLUSSEVANOUDALBLAS A, 1979, J EXP MED, V149, P1504, DOI 10.1084/jem.149.6.1504; BURCHETT SK, 1988, J IMMUNOL, V140, P3473; COHN ZA, 1965, J EXP MED, V121, P153, DOI 10.1084/jem.121.1.153; COHN ZA, 1966, J EXP MED, V123, P757, DOI 10.1084/jem.123.4.757; COLLINS SJ, 1987, BLOOD, V70, P1233; DEMACOUILLARDPO.G, 1998, CYTOMETRY, V33, P333; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Dockrell DH, 2001, J INFECT DIS, V184, P713, DOI 10.1086/323084; FLEIT HB, 1991, J LEUKOCYTE BIOL, V49, P556, DOI 10.1002/jlb.49.6.556; Gantner F, 1997, BRIT J PHARMACOL, V121, P221, DOI 10.1038/sj.bjp.0701124; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; GESSANI S, 1993, J IMMUNOL, V151, P3758; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon SB, 2000, INFECT IMMUN, V68, P2286, DOI 10.1128/IAI.68.4.2286-2293.2000; Gordon S, 2007, EUR J IMMUNOL, V37, pS9, DOI 10.1002/eji.200737638; Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810; Henning LN, 2008, J IMMUNOL, V180, P7847, DOI 10.4049/jimmunol.180.12.7847; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; KRADIN RL, 1986, J LEUKOCYTE BIOL, V40, P407, DOI 10.1002/jlb.40.4.407; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; LEPEZUNIGA JL, 1990, LYMPHOKINE RES, V9, P309; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANGAN DF, 1991, J IMMUNOL, V146, P1541; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marriott HM, 2005, J CLIN INVEST, V115, P359, DOI 10.1172/JCI200521766; Marriott HM, 2004, FASEB J, V18, P1126, DOI 10.1096/fj.03-1450fje; McCullough KC, 1999, IMMUNOLOGY, V98, P203, DOI 10.1046/j.1365-2567.1999.00867.x; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MUNN DH, 1995, J EXP MED, V181, P127, DOI 10.1084/jem.181.1.127; MURAO S, 1983, CANCER RES, V43, P4989; Murphy J, 2008, AM J RESP CELL MOL, V38, P380, DOI 10.1165/rcmb.2007-0224RC; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; NETEA MG, 2008, BLOOD; NICHOLS BA, 1971, J CELL BIOL, V50, P498, DOI 10.1083/jcb.50.2.498; OLSSON I, 1983, CANCER RES, V43, P5862; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Pham TNQ, 2003, NITRIC OXIDE-BIOL CH, V9, P123, DOI 10.1016/j.niox.2003.09.006; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; ROVERA G, 1979, SCIENCE, V204, P868, DOI 10.1126/science.286421; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; SOKOL RJ, 1987, J ANAT, V151, P27; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; STEINBACH F, 1994, J IMMUNOL METHODS, V174, P109, DOI 10.1016/0022-1759(94)90015-9; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Surewicz K, 2004, CELL IMMUNOL, V228, P34, DOI 10.1016/j.cellimm.2004.03.007; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; VANHAARST JMW, 1994, AM J RESP CELL MOL, V11, P344, DOI 10.1165/ajrcmb.11.3.8086170; WEWERS MD, 1984, J CLIN INVEST, V74, P2208, DOI 10.1172/JCI111647	57	733	758	12	257	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8668	10.1371/journal.pone.0008668	http://dx.doi.org/10.1371/journal.pone.0008668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084270	Green Published, gold			2022-12-27	WOS:000273554600021
J	Myles, S; Chia, JM; Hurwitz, B; Simon, C; Zhong, GY; Buckler, E; Ware, D				Myles, Sean; Chia, Jer-Ming; Hurwitz, Bonnie; Simon, Charles; Zhong, Gan Yuan; Buckler, Edward; Ware, Doreen			Rapid Genomic Characterization of the Genus Vitis	PLOS ONE			English	Article							REDUCED REPRESENTATION; SNP DISCOVERY; GENETIC-STRUCTURE; VINIFERA L.; WIDE ASSOCIATION; CHALLENGES; LIBRARIES; SUCCESS; TRAITS; MAIZE	Next-generation sequencing technologies promise to dramatically accelerate the use of genetic information for crop improvement by facilitating the genetic mapping of agriculturally important phenotypes. The first step in optimizing the design of genetic mapping studies involves large-scale polymorphism discovery and a subsequent genome-wide assessment of the population structure and pattern of linkage disequilibrium (LD) in the species of interest. In the present study, we provide such an assessment for the grapevine (genus Vitis), the world's most economically important fruit crop. Reduced representation libraries (RRLs) from 17 grape DNA samples (10 cultivated V. vinifera and 7 wild Vitis species) were sequenced with sequencing-by-synthesis technology. We developed heuristic approaches for SNP calling, identified hundreds of thousands of SNPs and validated a subset of these SNPs on a 9K genotyping array. We demonstrate that the 9K SNP array provides sufficient resolution to distinguish among V. vinifera cultivars, between V. vinifera and wild Vitis species, and even among diverse wild Vitis species. We show that there is substantial sharing of polymorphism between V. vinifera and wild Vitis species and find that genetic relationships among V. vinifera cultivars agree well with their proposed geographic origins using principal components analysis (PCA). Levels of LD in the domesticated grapevine are low even at short ranges, but LD persists above background levels to 3 kb. While genotyping arrays are useful for assessing population structure and the decay of LD across large numbers of samples, we suggest that whole-genome sequencing will become the genotyping method of choice for genome-wide genetic mapping studies in high-diversity plant species. This study demonstrates that we can move quickly towards genome-wide studies of crop species using next-generation sequencing. Our study sets the stage for future work in other high diversity crop species, and provides a significant enhancement to current genetic resources available to the grapevine genetic community.	[Myles, Sean; Buckler, Edward] Cornell Univ, Inst Genom Divers, Ithaca, NY 14850 USA; [Chia, Jer-Ming; Hurwitz, Bonnie; Ware, Doreen] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Simon, Charles; Zhong, Gan Yuan] Cornell Univ, New York State Agr Expt Stn, Geneva, NY 14456 USA; [Simon, Charles; Zhong, Gan Yuan; Buckler, Edward; Ware, Doreen] ARS, USDA, Ithaca, NY USA	Cornell University; Cold Spring Harbor Laboratory; Cornell University; United States Department of Agriculture (USDA)	Myles, S (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14850 USA.	esb33@cornell.edu; ware@cshl.edu	Buckler, Edward/L-7651-2019; Chia, Jer-Ming/C-9992-2012; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Myles, Sean/0000-0001-9754-5987	United States Department of Agriculture [1907-21000-030-00D]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This work is funded by the United States Department of Agriculture (CRIS#: 1907-21000-030-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Aradhya MK, 2003, GENET RES, V81, P179, DOI 10.1017/S0016672303006177; Barbazuk WB, 2007, PLANT J, V51, P910, DOI 10.1111/j.1365-313X.2007.03193.x; Barbazuk WB, 2005, BIOESSAYS, V27, P839, DOI 10.1002/bies.20262; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Brockman W, 2008, GENOME RES, V18, P763, DOI 10.1101/gr.070227.107; Clark AG, 2005, GENOME RES, V15, P1463, DOI 10.1101/gr.4244005; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Emberton J, 2005, GENOME RES, V15, P1441, DOI 10.1101/gr.3362105; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GORE MA, 2009, PLANT J IN PRESS; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; LANDER E S, 1988, Genomics, V2, P231; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malhis N, 2009, BIOINFORMATICS, V25, P6, DOI 10.1093/bioinformatics/btn565; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Muir William M, 2008, P NATL ACAD SCI; MYLES S, PLANT CELL IN PRESS; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Olmo H., 1995, EVOLUTION CROP PLANT, V1, P485; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; R Core Team, 2018, R LANG ENV STAT COMP; Salmaso M, 2004, MOL BREEDING, V14, P385, DOI 10.1007/s11032-004-0261-z; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Warnes G., 2008, GENETICS POPULATION; Wiedmann RT, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-81; ZOHARY D, 1997, ORIGINS ANCIENT HIST, P23	34	159	163	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8219	10.1371/journal.pone.0008219	http://dx.doi.org/10.1371/journal.pone.0008219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084295	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000273554600001
J	Nakano, MM; Lin, A; Zuber, CS; Newberry, KJ; Brennan, RG; Zuber, P				Nakano, Michiko M.; Lin, Ann; Zuber, Cole S.; Newberry, Kate J.; Brennan, Richard G.; Zuber, Peter			Promoter Recognition by a Complex of Spx and the C-Terminal Domain of the RNA Polymerase alpha Subunit	PLOS ONE			English	Article							GLOBAL TRANSCRIPTIONAL CONTROL; SIGNAL-TRANSDUCTION SYSTEM; BACILLUS-SUBTILIS; DISULFIDE STRESS; COMPETENCE DEVELOPMENT; STAPHYLOCOCCUS-AUREUS; SIGMA-70 SUBUNIT; OXIDATIVE STRESS; GENE-EXPRESSION; P-3 PROMOTER	Background: Spx, an ArsC (arsenate reductase) family member, is a global transcriptional regulator of the microbial stress response and is highly conserved amongst Gram-positive bacteria. Bacillus subtilis Spx protein exerts positive and negative control of transcription through its interaction with the C-terminal domain of the RNA polymerase (RNAP) alpha subunit (alpha CTD). Spx activates trxA (thioredoxin) and trxB (thioredoxin reductase) in response to thiol stress, and bears an N-terminal C10XXC13 redox disulfide center that is oxidized in active Spx. Methodology/Principal Findings: The structure of mutant Spx(C10S) showed a change in the conformation of helix alpha 4. Amino acid substitutions R60E and K62E within and adjacent to helix alpha 4 conferred defects in Spx-activated transcription but not Spx-dependent repression. Electrophoretic mobility-shift assays showed alpha CTD interaction with trxB promoter DNA, but addition of Spx generated a supershifted complex that was disrupted in the presence of reductant (DTT). Interaction of alpha CTD/Spx complex with promoter DNA required the cis-acting elements -45AGCA-42 and -34AGCG-31 of the trxB promoter. The Spx(G52R) mutant, defective in alpha CTD binding, did not interact with the alpha CTD-trxB complex. Spx R60E not only failed to complex with alpha CTD-trxB, but also disrupted alpha CTD-trxB DNA interaction. Conclusions/Significance: The results show that Spx and alpha CTD form a complex that recognizes the promoter DNA of an Spx-controlled gene. A conformational change during oxidation of Spx to the disulfide form likely alters the structure of Spx alpha helix alpha 4, which contains residues that function in transcriptional activation and alpha CTD/Spx-promoter interaction. The results suggest that one of these residues, R60 of the alpha 4 region of oxidized Spx, functions in alpha CTD/Spx-promoter contact but not in alpha CTD interaction.	[Nakano, Michiko M.; Lin, Ann; Zuber, Cole S.; Zuber, Peter] Oregon Hlth & Sci Univ, Sch Med, Dept Sci & Engn, Beaverton, OR USA; [Newberry, Kate J.; Brennan, Richard G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX USA	Oregon Health & Science University; University of Texas System; UTMD Anderson Cancer Center	Nakano, MM (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Sci & Engn, Beaverton, OR USA.	pzuber@ebs.ogi.edu		Brennan, Richard/0000-0001-7647-485X; Zuber, Peter/0000-0003-1757-7837; Nakano, Michiko/0000-0002-0635-8535	Welch Foundation [G-0040]; National Institutes of Health [GM045898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045898] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by grants G-0040 from the Welch Foundation (to RGB) and GM045898 from the National Institutes of Health (to PZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANNER CDB, 1983, J MOL BIOL, V168, P351, DOI 10.1016/S0022-2836(83)80023-0; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Bergman NH, 2007, APPL ENVIRON MICROB, V73, P846, DOI 10.1128/AEM.01686-06; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chatterjee SS, 2006, INFECT IMMUN, V74, P1323, DOI 10.1128/IAI.74.2.1323-1338.2006; DAHL MK, 1994, GENE, V145, P151, DOI 10.1016/0378-1119(94)90341-7; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Garg SK, 2009, J BACTERIOL, V191, P1268, DOI 10.1128/JB.01289-08; Geng H, 2007, METHOD ENZYMOL, V422, P448, DOI 10.1016/S0076-6879(06)22023-8; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood C.R., 1990, MOL BIOL METHODS BAC; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hochgrafe F, 2008, J BACTERIOL, V190, P4997, DOI 10.1128/JB.01846-07; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajfasz JK, 2009, J BACTERIOL, V191, P2060, DOI 10.1128/JB.01609-08; Lamour V, 2009, J STRUCT BIOL, V168, P352, DOI 10.1016/j.jsb.2009.07.001; Larsson JT, 2007, MOL MICROBIOL, V66, P669, DOI 10.1111/j.1365-2958.2007.05949.x; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leelakriangsak M, 2007, J BACTERIOL, V189, P1727, DOI 10.1128/JB.01519-06; Leelakriangsak M, 2007, J BACTERIOL, V189, P1736, DOI 10.1128/JB.01520-06; Leslie AGW, 1992, RECENT CHANGES MOSFL; Liu JJ, 1999, MOL MICROBIOL, V33, P415, DOI 10.1046/j.1365-2958.1999.01489.x; Liu JJ, 2000, MOL MICROBIOL, V37, P885, DOI 10.1046/j.1365-2958.2000.02053.x; Miller J.H., 1972, EXPT MOL GENETICS; Moch C, 2000, J BACTERIOL, V182, P4384, DOI 10.1128/JB.182.16.4384-4393.2000; Nakano MM, 2006, J BACTERIOL, V188, P5878, DOI 10.1128/JB.00486-06; Nakano MM, 2000, MOL MICROBIOL, V37, P869, DOI 10.1046/j.1365-2958.2000.02052.x; NAKANO MM, 1991, J BACTERIOL, V173, P5487, DOI 10.1128/jb.173.17.5487-5493.1991; Nakano MM, 2001, MOL MICROBIOL, V42, P383, DOI 10.1046/j.1365-2958.2001.02639.x; Nakano S, 2005, MOL MICROBIOL, V55, P498, DOI 10.1111/j.1365-2958.2004.04395.x; Nakano S, 2003, P NATL ACAD SCI USA, V100, P13603, DOI 10.1073/pnas.2235180100; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Pamp SJ, 2006, J BACTERIOL, V188, P4861, DOI 10.1128/JB.00194-06; Qi Y, 1998, MOL MICROBIOL, V28, P1187, DOI 10.1046/j.1365-2958.1998.00882.x; Reyes DY, 2008, MOL MICROBIOL, V69, P765, DOI 10.1111/j.1365-2958.2008.06330.x; ROGGIANI M, 1993, J BACTERIOL, V175, P3182, DOI 10.1128/JB.175.10.3182-3187.1993; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Tam LT, 2006, PROTEOMICS, V6, P4565, DOI 10.1002/pmic.200600100; Turlan C, 2009, MOL MICROBIOL, V73, P492, DOI 10.1111/j.1365-2958.2009.06789.x; Zenno S, 1998, BIOSCI BIOTECH BIOCH, V62, P1978, DOI 10.1271/bbb.62.1978; Zhang Y, 2007, J BACTERIOL, V189, P7669, DOI 10.1128/JB.00745-07; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06; Zuber P, 2004, J BACTERIOL, V186, P1911, DOI 10.1128/JB.186.7.1911-1918.2004	49	41	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8664	10.1371/journal.pone.0008664	http://dx.doi.org/10.1371/journal.pone.0008664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084284	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600017
J	Oliveira, AF; Ruas, LP; Cardoso, SA; Soares, SG; Roque-Barreira, MC				Oliveira, Aline F.; Ruas, Luciana P.; Cardoso, Silvia A.; Soares, Sandro G.; Roque-Barreira, Maria-Cristina			Vaccination of Mice with Salmonella Expressing VapA: Mucosal and Systemic Th1 Responses Provide Protection against Rhodococcus equi Infection	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CD8(+) T-LYMPHOCYTES; PROTEIN-A; PULMONARY CLEARANCE; HYPERIMMUNE PLASMA; ORAL IMMUNIZATION; IMMUNE-RESPONSES; INTERFERON-GAMMA; ADULT HORSES; VIRULENCE	Conventional vaccines to prevent the pneumonia caused by Rhodococcus equi have not been successful. We have recently demonstrated that immunization with Salmonella enterica Typhimurium expressing the VapA antigen protects mice against R. equi infection. We now report that oral vaccination of mice with this recombinant strain results in high and persistent fecal levels of antigen-specific IgA, and specific proliferation of the spleen cells of immunized mice in response to the in vitro stimulation with R. equi antigen. After in vitro stimulation, spleen cells of immunized mice produce high levels of Th1 cytokines and show a prominent mRNA expression of the Th1 transcription factor T-bet, in detriment of the Th2 transcription factor GATA-3. Following R. equi challenge, a high H2O2, NO, IL-12, and IFN-gamma content is detected in the organs of immunized mice. On the other hand, TNF-alpha and IL-4 levels are markedly lower in the organs of vaccinated mice, compared with the non-vaccinated ones. The IL-10 content and the mRNA transcription level of TGF-beta are also higher in the organs of immunized mice. A greater incidence of CD4(+) and CD8(+) T cells and B lymphocytes is verified in vaccinated mice. However, there is no difference between vaccinated and non-vaccinated mice in terms of the frequency of CD4(+)CD25(+)Foxp3(+) T cells. Finally, we show that the vaccination confers a long-term protection against R. equi infection. Altogether, these data indicate that the oral vaccination of mice with S. enterica Typhimurium expressing VapA induces specific and long-lasting humoral and cellular responses against the pathogen, which are appropriately regulated and allow tissue integrity after challenge.	[Oliveira, Aline F.; Ruas, Luciana P.; Cardoso, Silvia A.; Soares, Sandro G.; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil	Universidade de Sao Paulo	Oliveira, AF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Soares, Sandro/O-7114-2016; de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; Ruas, Luciana/A-4259-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; Gomes Soares, Sandro/AGA-3968-2022; Cardoso, Silvia Almeida/I-8351-2015; Soares, Sandro/B-3601-2008	Soares, Sandro/0000-0001-7205-2510; Ruas, Luciana/0000-0002-1028-7872; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Gomes Soares, Sandro/0000-0001-7205-2510; Cardoso, Silvia Almeida/0000-0001-6586-6591; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). A.F.O. received a scholarship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzakouk M, 2002, BRIT J BIOMED SCI, V59, P173, DOI 10.1080/09674845.2002.11783656; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Cong H, 2005, PARASITE IMMUNOL, V27, P29, DOI 10.1111/j.1365-3024.2005.00738.x; Criscione LG, 2002, CURR OPIN RHEUMATOL, V14, P204, DOI 10.1097/00002281-200205000-00002; CURTISS R, 1987, INFECT IMMUN, V55, P3035, DOI 10.1128/IAI.55.12.3035-3043.1987; Darrah PA, 2000, INFECT IMMUN, V68, P3587, DOI 10.1128/IAI.68.6.3587-3593.2000; Dietrich G, 2001, VACCINE, V19, P2506, DOI 10.1016/S0264-410X(00)00480-1; DONG C, 2000, SCI STKE, V49, P1; Donisi A, 1996, AIDS, V10, P359, DOI 10.1097/00002030-199604000-00002; Du AF, 2005, INT J PARASITOL, V35, P777, DOI 10.1016/j.ijpara.2005.03.005; Giguere S, 1999, INFECT IMMUN, V67, P3548; Giguere S, 1997, VET MICROBIOL, V56, P313, DOI 10.1016/S0378-1135(97)00099-0; Giguere S, 2002, J AM VET MED ASSOC, V220, P59, DOI 10.2460/javma.2002.220.59; Hines SA, 2003, CLIN DIAGN LAB IMMUN, V10, P208, DOI 10.1128/CDLI.10.2.208-215.2003; Hines SA, 1997, VET MICROBIOL, V56, P177, DOI 10.1016/S0378-1135(97)00086-2; HOCHADEL JF, 1977, J INFECT DIS, V135, P813, DOI 10.1093/infdis/135.5.813; Hondalus MK, 1997, VET MICROBIOL, V56, P257, DOI 10.1016/S0378-1135(97)00094-1; Hooper-McGrevy KE, 2001, AM J VET RES, V62, P1307, DOI 10.2460/ajvr.2001.62.1307; HURLEY JR, 1995, AUST VET J, V72, P418, DOI 10.1111/j.1751-0813.1995.tb06192.x; Jain S, 2003, MOL MICROBIOL, V50, P115, DOI 10.1046/j.1365-2958.2003.03689.x; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; KANALY ST, 1993, INFECT IMMUN, V61, P4929, DOI 10.1128/IAI.61.11.4929-4932.1993; KANALY ST, 1995, INFECT IMMUN, V63, P3037, DOI 10.1128/IAI.63.8.3037-3041.1995; Kanaly ST, 1996, INFECT IMMUN, V64, P1126, DOI 10.1128/IAI.64.4.1126-1132.1996; Kasuga-Aoki H, 1999, IMMUNOLOGY, V96, P122, DOI 10.1046/j.1365-2567.1999.00657.x; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; MADIGAN JE, 1991, J REPROD FERTIL, P571; Magnusson H., 1923, ARCH WISS PRAKTI TIE, V50, P22; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; MASTROENI P, 1992, MICROB PATHOGENESIS, V13, P477, DOI 10.1016/0882-4010(92)90014-F; Meijer WG, 2004, VET RES, V35, P383, DOI 10.1051/vetres:2004024; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Muscatello G, 2007, EQUINE VET J, V39, P470, DOI 10.2746/042516407X209217; NORDMANN P, 1992, INFECT IMMUN, V60, P2748, DOI 10.1128/IAI.60.7.2748-2752.1992; Oliveira AF, 2007, MICROBES INFECT, V9, P382, DOI 10.1016/j.micinf.2006.12.019; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Patton KM, 2004, INFECT IMMUN, V72, P7073, DOI 10.1128/IAI.72.12.7073-7083.2004; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; Prescott JF, 1997, VET MICROBIOL, V56, P213, DOI 10.1016/S0378-1135(97)00090-4; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Shiau AL, 2005, VACCINE, V23, P5563, DOI 10.1016/j.vaccine.2005.07.004; TAKAI S, 1992, INFECT IMMUN, V60, P2995, DOI 10.1128/IAI.60.7.2995-2997.1992; Takai S, 2000, INFECT IMMUN, V68, P6840, DOI 10.1128/IAI.68.12.6840-6847.2000; Wyszynska A, 2004, VACCINE, V22, P1379, DOI 10.1016/j.vaccine.2003.11.001; YAGER JA, 1991, VET MICROBIOL, V28, P363, DOI 10.1016/0378-1135(91)90071-M; Yang XH, 2007, J IMMUNOL, V178, P1059, DOI 10.4049/jimmunol.178.2.1059	49	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8644	10.1371/journal.pone.0008644	http://dx.doi.org/10.1371/journal.pone.0008644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072623	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600008
J	Mumby, PJ; Harborne, AR				Mumby, Peter J.; Harborne, Alastair R.			Marine Reserves Enhance the Recovery of Corals on Caribbean Reefs	PLOS ONE			English	Article							CLIMATE-CHANGE; CONSERVATION; RESILIENCE; COMPETITION; FISHERY; GROWTH; SIZE; POPULATIONS; MACROALGAE; HERBIVORY	The fisheries and biodiversity benefits of marine reserves are widely recognised but there is mounting interest in exploiting the importance of herbivorous fishes as a tool to help ecosystems recover from climate change impacts. This approach might be particularly suitable for coral reefs, which are acutely threatened by climate change, yet the trophic cascades generated by reserves are strong enough that they might theoretically enhance the rate of coral recovery after disturbance. However, evidence for reserves facilitating coral recovery has been lacking. Here we investigate whether reductions in macroalgal cover, caused by recovery of herbivorous parrotfishes within a reserve, have resulted in a faster rate of coral recovery than in areas subject to fishing. Surveys of ten sites inside and outside a Bahamian marine reserve over a 2.5-year period demonstrated that increases in coral cover, including adjustments for the initial size-distribution of corals, were significantly higher at reserve sites than those in non-reserve sites. Furthermore, macroalgal cover was significantly negatively correlated with the change in total coral cover over time. Recovery rates of individual species were generally consistent with small-scale manipulations on coral-macroalgal interactions, but also revealed differences that demonstrate the difficulties of translating experiments across spatial scales. Size-frequency data indicated that species which were particularly affected by high abundances of macroalgae outside the reserve had a population bottleneck restricting the supply of smaller corals to larger size classes. Importantly, because coral cover increased from a heavily degraded state, and recovery from such states has not previously been described, similar or better outcomes should be expected for many reefs in the region. Reducing herbivore exploitation as part of an ecosystem-based management strategy for coral reefs appears to be justified.	[Mumby, Peter J.; Harborne, Alastair R.] Univ Exeter, Marine Spatial Ecol Lab, Sch BioSci, Hatherly Lab, Exeter, Devon, England	University of Exeter	Mumby, PJ (corresponding author), Univ Exeter, Marine Spatial Ecol Lab, Sch BioSci, Hatherly Lab, Exeter, Devon, England.	P.J.Mumby@ex.ac.uk	Harborne, Alastair R/F-6155-2013; Mumby, Peter/F-9914-2010	Harborne, Alastair R/0000-0002-6818-8615; Mumby, Peter/0000-0002-6297-9053	Khalid bin Sultan Living Oceans Foundation; National Science Foundation; Environmental Protection Agency; Natural Environment Research Council; National Oceanic and Atmospheric Administration; Natural Environment Research Council [NE/F015704/1, NE/E00606X/1] Funding Source: researchfish; NERC [NE/E00606X/1, NE/F015704/1] Funding Source: UKRI	Khalid bin Sultan Living Oceans Foundation; National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this study was provided by the Khalid bin Sultan Living Oceans Foundation (http://www.livingoceansfoundation.org/); the National Science Foundation (NSF-http://www.nsf.gov/); the Environmental Protection Agency (EPA-http://www.epa.gov/); the Natural Environment Research Council (NERC http://www.nerc.ac.uk/); the Undersea Research Program of the National Oceanic and Atmospheric Administration (NURP-http://www.nurp.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Aronson RB, 2006, CORAL REEFS, V25, P441, DOI 10.1007/s00338-006-0122-9; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Box SJ, 2007, MAR ECOL PROG SER, V342, P139, DOI 10.3354/meps342139; Chiappone M, 2000, B MAR SCI, V66, P691; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Foster NL, 2008, MAR ECOL PROG SER, V367, P143, DOI 10.3354/meps07594; Halpern BS, 2003, ECOL APPL, V13, pS117; Harborne AR, 2008, J APPL ECOL, V45, P1010, DOI 10.1111/j.1365-2664.2008.01490.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kramer PA., 2003, ATOLL RES BULL, V496, P77, DOI DOI 10.5479/SI.00775630.496-5.76; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Meesters EH, 2001, MAR ECOL PROG SER, V209, P43, DOI 10.3354/meps209043; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Mosqueira I, 2000, ANIM CONSERV, V3, P321, DOI 10.1017/S1367943000001049; Mumby PJ, 2008, CONSERV BIOL, V22, P941, DOI 10.1111/j.1523-1739.2008.00933.x; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Nugues MM, 2006, MAR ECOL PROG SER, V315, P75, DOI 10.3354/meps315075; Ray C, 1958, REPORT EXUMA C UNPUB; Sale PF, 2005, TRENDS ECOL EVOL, V20, P74, DOI 10.1016/j.tree.2004.11.007; Sary Z, 1997, MAR ECOL PROG SER, V154, P107, DOI 10.3354/meps154107; Skirving W, 2006, RE S D I PR, V9, P11, DOI 10.1007/1-4020-3968-9_2; SMITH SR, 2008, CONTINUING DECLINE M; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; VANMOORSEL GWNM, 1988, MAR ECOL PROG SER, V50, P127, DOI 10.3354/meps050127; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wilkinson C, 2008, STATUS CARIBBEAN COR	39	211	216	2	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8657	10.1371/journal.pone.0008657	http://dx.doi.org/10.1371/journal.pone.0008657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20066158	Green Published, gold			2022-12-27	WOS:000273456300007
J	Babai, N; Kanevsky, N; Dascal, N; Rozanski, GJ; Singh, DP; Fatma, N; Thoreson, WB				Babai, Norbert; Kanevsky, Nataly; Dascal, Nathan; Rozanski, George J.; Singh, Dhirendra P.; Fatma, Nigar; Thoreson, Wallace B.			Anion-Sensitive Regions of L-Type CaV1.2 Calcium Channels Expressed in HEK293 Cells	PLOS ONE			English	Article							CA2+ CHANNEL; OPEN PROBABILITY; BETA-SUBUNITS; SYNAPTIC-TRANSMISSION; INSULIN-SECRETION; LYOTROPIC ANIONS; CA(V)1.2 CHANNEL; PATCH-CLAMP; CHLORIDE; MODULATION	L-type calcium currents (I-Ca) are influenced by changes in extracellular chloride, but sites of anion effects have not been identified. Our experiments showed that CaV1.2 currents expressed in HEK293 cells are strongly inhibited by replacing extracellular chloride with gluconate or perchlorate. Variance-mean analysis of I-Ca and cell-attached patch single channel recordings indicate that gluconate-induced inhibition is due to intracellular anion effects on Ca2+ channel open probability, not conductance. Inhibition of CaV1.2 currents produced by replacing chloride with gluconate was reduced from similar to 75%-80% to similar to 50% by omitting beta subunits but unaffected by omitting alpha(2)delta subunits. Similarly, gluconate inhibition was reduced to similar to 50% by deleting an alpha 1 subunit N-terminal region of 15 residues critical for beta subunit interactions regulating open probability. Omitting beta subunits with this mutant alpha 1 subunit did not further diminish inhibition. Gluconate inhibition was unchanged with expression of different beta subunits. Truncating the C terminus at AA1665 reduced gluconate inhibition from similar to 75%-80% to similar to 50% whereas truncating it at AA1700 had no effect. Neutralizing arginines at AA1696 and 1697 by replacement with glutamines reduced gluconate inhibition to similar to 60% indicating these residues are particularly important for anion effects. Expressing CaV1.2 channels that lacked both N and C termini reduced gluconate inhibition to similar to 25% consistent with additive interactions between the two tail regions. Our results suggest that modest changes in intracellular anion concentration can produce significant effects on CaV1.2 currents mediated by changes in channel open probability involving beta subunit interactions with the N terminus and a short C terminal region.	[Babai, Norbert; Singh, Dhirendra P.; Fatma, Nigar; Thoreson, Wallace B.] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA; [Rozanski, George J.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE USA; [Kanevsky, Nataly; Dascal, Nathan] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Babai, N (corresponding author), Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA.	wbthores@unmc.edu	Dascal, Nathan/O-3915-2015; Thoreson, Wallace B./F-6172-2010; Babai, Norbert/T-2952-2019	Dascal, Nathan/0000-0002-5397-4146; Thoreson, Wallace B./0000-0001-7104-042X; 	NIH [EY-10542, HL-66446]; Binational Science Foundation [2005340]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R29EY010542, R55EY010542, R01EY010542] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066446] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Binational Science Foundation(US-Israel Binational Science Foundation); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by NIH (EY-10542, HL-66446), the Binational Science Foundation (#2005340), and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekar LK, 1999, J NEUROPHYSIOL, V82, P248, DOI 10.1152/jn.1999.82.1.248; Bekar LK, 2002, GLIA, V39, P207, DOI 10.1002/glia.10096; Bell DC, 2001, J NEUROPHYSIOL, V85, P816, DOI 10.1152/jn.2001.85.2.816; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Best L, 2005, J PHYSIOL-LONDON, V568, P137, DOI 10.1113/jphysiol.2005.093740; Best L, 1996, PFLUG ARCH EUR J PHY, V431, P363, DOI 10.1007/BF02207273; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chi CN, 2006, J BIOL CHEM, V281, P36811, DOI 10.1074/jbc.M607883200; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; Collins KD, 1997, BIOPHYS J, V72, P65, DOI 10.1016/S0006-3495(97)78647-8; DANI JA, 1983, J GEN PHYSIOL, V81, P255, DOI 10.1085/jgp.81.2.255; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; DELAY M, 1990, J PHYSIOL-LONDON, V425, P449, DOI 10.1113/jphysiol.1990.sp018113; DJAMGOZ MBA, 1987, VISION RES, V27, P1481, DOI 10.1016/0042-6989(87)90157-X; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Doughty JM, 1998, J PHYSIOL-LONDON, V507, P433, DOI 10.1111/j.1469-7793.1998.433bt.x; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Drews G, 1998, BBA-BIOMEMBRANES, V1370, P8, DOI 10.1016/S0005-2736(97)00240-X; FOX AP, 1987, J PHYSIOL-LONDON, V394, P173, DOI 10.1113/jphysiol.1987.sp016865; FRY CH, 1993, CARDIOVASC RES, V27, P856, DOI 10.1093/cvr/27.5.856; GALLANT EM, 1993, AM J PHYSIOL, V264, pC559, DOI 10.1152/ajpcell.1993.264.3.C559; Garcia L, 1997, AM J PHYSIOL-CELL PH, V272, pC1178, DOI 10.1152/ajpcell.1997.272.4.C1178; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Herzig S, 2007, FASEB J, V21, P1527, DOI 10.1096/fj.06-7377com; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P3597; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Kanevsky N, 2006, J GEN PHYSIOL, V128, P15, DOI 10.1085/jgp.200609485; Kobayashi T, 2007, J PHARMACOL SCI, V103, P347, DOI 10.1254/jphs.CR0070012; Kurokawa J, 2007, BIOL PHARM BULL, V30, P2231, DOI 10.1248/bpb.30.2231; Larsson-Nyren G, 2001, PFLUG ARCH EUR J PHY, V441, P587, DOI 10.1007/s004240000426; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; MA J, 1993, J GEN PHYSIOL, V102, P423, DOI 10.1085/jgp.102.3.423; MCDONALD TF, 1994, PHYSIOL REV, V74, P365, DOI 10.1152/physrev.1994.74.2.365; McGee AW, 2004, NEURON, V42, P89, DOI 10.1016/S0896-6273(04)00149-7; MCLAUGHLIN S, 1975, BIOCHIM BIOPHYS ACTA, V394, P304, DOI 10.1016/0005-2736(75)90267-9; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Numoto N, 2008, BIOCHEMISTRY-US, V47, P11231, DOI 10.1021/bi8012609; ODELL TJ, 1991, J PHYSIOL-LONDON, V436, P739, DOI 10.1113/jphysiol.1991.sp018577; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; PERUTZ MF, 1993, J MOL BIOL, V233, P536, DOI 10.1006/jmbi.1993.1530; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Rabl K, 2003, VISUAL NEUROSCI, V20, P557, DOI 10.1017/S0952523803205095; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Rozanski GJ, 2002, AM J PHYSIOL-HEART C, V282, pH2346, DOI 10.1152/ajpheart.00894.2001; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; SALA S, 1990, BIOPHYS J, V58, P567, DOI 10.1016/S0006-3495(90)82400-0; SCATCHARD G, 1957, J AM CHEM SOC, V79, P12, DOI 10.1021/ja01558a003; Sheader EA, 2001, MOL CELL ENDOCRINOL, V181, P179, DOI 10.1016/S0303-7207(01)00509-3; SLESINGER PA, 1991, J PHYSIOL-LONDON, V439, P301, DOI 10.1113/jphysiol.1991.sp018668; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Takahashi SX, 2004, P NATL ACAD SCI USA, V101, P7193, DOI 10.1073/pnas.0306665101; Thoreson WB, 2000, VISUAL NEUROSCI, V17, P197, DOI 10.1017/S0952523800172025; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; Thoreson WB, 2003, J NEUROPHYSIOL, V90, P1747, DOI 10.1152/jn.00932.2002; Thoreson WB, 2000, BBA-BIOMEMBRANES, V1464, P142, DOI 10.1016/S0005-2736(99)00257-6; Thoreson WB, 1996, J GEN PHYSIOL, V107, P631, DOI 10.1085/jgp.107.5.631; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Zhou SS, 2002, J APPL PHYSIOL, V93, P1660, DOI 10.1152/japplphysiol.00220.2002; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	67	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8602	10.1371/journal.pone.0008602	http://dx.doi.org/10.1371/journal.pone.0008602			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066046	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600020
J	Tan, YHC; Krishnaswamy, S; Nandi, S; Kanteti, R; Vora, S; Onel, K; Hasina, R; Lo, FY; El-Hashani, E; Cervantes, G; Robinson, M; Kales, SC; Lipkowitz, S; Karrison, T; Sattler, M; Vokes, EE; Wang, YC; Salgia, R				Tan, Yi-Hung Carol; Krishnaswamy, Soundararajan; Nandi, Suvobroto; Kanteti, Rajani; Vora, Sapana; Onel, Kenan; Hasina, Rifat; Lo, Fang-Yi; El-Hashani, Essam; Cervantes, Gustavo; Robinson, Matthew; Kales, Stephen C.; Lipkowitz, Stanley; Karrison, Theodore; Sattler, Martin; Vokes, Everett E.; Wang, Yi-Ching; Salgia, Ravi			CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACQUIRED UNIPARENTAL DISOMY; C-CBL; UBIQUITIN LIGASE; BINDING-SITE; OF-FUNCTION; PROTEIN; DOMAIN; AMPLIFICATION; PHOSPHORYLATION	Background: Non-small cell lung cancer (NSCLC) is a heterogeneous group of disorders with a number of genetic and proteomic alterations. c-CBL is an E3 ubiquitin ligase and adaptor molecule important in normal homeostasis and cancer. We determined the genetic variations of c-CBL, relationship to receptor tyrosine kinases (EGFR and MET), and functionality in NSCLC. Methods and Findings: Using archival formalin-fixed paraffin embedded (FFPE) extracted genomic DNA, we show that c-CBL mutations occur in somatic fashion for lung cancers. c-CBL mutations were not mutually exclusive of MET or EGFR mutations; however they were independent of p53 and KRAS mutations. In normal/tumor pairwise analysis, there was significant loss of heterozygosity (LOH) for the c-CBL locus (22%, n = 8/37) and none of these samples revealed any mutation in the remaining copy of c-CBL. The c-CBL LOH also positively correlated with EGFR and MET mutations observed in the same samples. Using select c-CBL somatic mutations such as S80N/H94Y, Q249E and W802* (obtained from Caucasian, Taiwanese and African-American samples, respectively) transfected in NSCLC cell lines, there was increased cell viability and cell motility. Conclusions: Taking the overall mutation rate of c-CBL to be a combination as somatic missense mutation and LOH, it is clear that c-CBL is highly mutated in lung cancers and may play an essential role in lung tumorigenesis and metastasis.	[Tan, Yi-Hung Carol; Lo, Fang-Yi] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Krishnaswamy, Soundararajan; Nandi, Suvobroto; Kanteti, Rajani; Hasina, Rifat; El-Hashani, Essam; Cervantes, Gustavo; Robinson, Matthew; Vokes, Everett E.; Salgia, Ravi] Univ Chicago, Pritzker Sch Med, Med Ctr, Canc Res Ctr,Dept Med, Chicago, IL 60637 USA; [Vora, Sapana; Onel, Kenan] Univ Chicago, Pritzker Sch Med, Med Ctr, Canc Res Ctr,Dept Pediat, Chicago, IL 60637 USA; [Kales, Stephen C.; Lipkowitz, Stanley] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, Natl Inst Hlth, Bethesda, MD 20892 USA; [Karrison, Theodore] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Sattler, Martin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sattler, Martin] Harvard Univ, Sch Med, Boston, MA USA; [Wang, Yi-Ching] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan	National Taiwan Normal University; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; National Cheng Kung University	Tan, YHC (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	rsalgia@medicine.bsd.uchicago.edu	Wang, Yi-Ching/J-8702-2019; Vokes, Everett/Q-2146-2019	Wang, Yi-Ching/0000-0002-7694-2067; Tan, Yi-Hung Carol/0000-0001-7541-007X	National Institutes of Health (NIH)/National Cancer Institute (NCI) [5RO1CA125541-03, 3RO1CA125541-03S109, 5RO1CA129501-02, 3RO1CA129501-02S109, 1R21CA140003-01]; MARF; V-Foundation; National Science Council, Taiwan [NSC96-2628-B-006-048-MY3]; NATIONAL CANCER INSTITUTE [R01CA125541, ZIABC010977, R01CA134660, R01CA129501, R21CA140003] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MARF; V-Foundation; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: Supported by National Institutes of Health (NIH)/National Cancer Institute (NCI) Grants: 5RO1CA125541-03, 3RO1CA125541-03S109, 5RO1CA129501-02, 3RO1CA129501-02S109, 1R21CA140003-01, MARF, V-Foundation, Cancer Research Foundation and American Respiratory Health Association of America (RS) and grant NSC96-2628-B-006-048-MY3 from the National Science Council, Taiwan. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funding agenices had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidoye O, 2007, REV RECENT CLIN TRIA, V2, P143, DOI 10.2174/157488707780599357; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Caligiuri MA, 2007, BLOOD, V110, P1022, DOI 10.1182/blood-2006-12-061176; Clague MJ, 2001, J CELL SCI, V114, P3075; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Higgins RSD, 2003, ANN THORAC SURG, V76, pS1363, DOI 10.1016/S0003-4975(03)01208-6; Hirsch DS, 2006, CANCER RES, V66, P3523, DOI 10.1158/0008-5472.CAN-05-1547; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kozlov G, 2007, J BIOL CHEM, V282, P27547, DOI 10.1074/jbc.M703333200; Krishnaswamy S, 2009, CLIN CANCER RES, V15, P5714, DOI 10.1158/1078-0432.CCR-09-0070; LANGDON WY, 1989, J VIROL, V63, P5420, DOI 10.1128/JVI.63.12.5420-5424.1989; Lill NL, 2000, J BIOL CHEM, V275, P367, DOI 10.1074/jbc.275.1.367; MEISNER H, 1995, J BIOL CHEM, V270, P25332, DOI 10.1074/jbc.270.43.25332; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Nau MM, 2003, GENE, V308, P103, DOI 10.1016/S0378-1119(03)00471-2; Onozato R, 2009, J THORAC ONCOL, V4, P5, DOI 10.1097/JTO.0b013e3181913e0e; Peschard P, 2001, MOL CELL, V8, P995, DOI 10.1016/S1097-2765(01)00378-1; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Shtiegman K, 2007, ONCOGENE, V26, P6968, DOI 10.1038/sj.onc.1210503; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; TAN YH, 2009, BIOFORMOSA, V44, P1; Thien CBF, 1997, ONCOGENE, V14, P2239, DOI 10.1038/sj.onc.1201193; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Wang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001447; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	40	84	87	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8972	10.1371/journal.pone.0008972	http://dx.doi.org/10.1371/journal.pone.0008972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126411	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100020
J	Simon, JC; Dickinson, MH				Simon, Jasper C.; Dickinson, Michael H.			A New Chamber for Studying the Behavior of Drosophila	PLOS ONE			English	Article							COURTSHIP; MELANOGASTER; AGGRESSION; CIRCUIT; FLY	Methods available for quickly and objectively quantifying the behavioral phenotypes of the fruit fly, Drosophila melanogaster, lag behind in sophistication the tools developed for manipulating their genotypes. We have developed a simple, easy-to-replicate, general-purpose experimental chamber for studying the ground-based behaviors of fruit flies. The major innovative feature of our design is that it restricts flies to a shallow volume of space, forcing all behavioral interactions to take place within a monolayer of individuals. The design lessens the frequency that flies occlude or obscure each other, limits the variability in their appearance, and promotes a greater number of flies to move throughout the center of the chamber, thereby increasing the frequency of their interactions. The new chamber design improves the quality of data collected by digital video and was conceived and designed to complement automated machine vision methodologies for studying behavior. Novel and improved methodologies for better quantifying the complex behavioral phenotypes of Drosophila will facilitate studies related to human disease and fundamental questions of behavioral neuroscience.	[Simon, Jasper C.; Dickinson, Michael H.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Simon, JC (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	jasper@caltech.edu		Simon, Jasper/0000-0003-3022-258X	United States National Institutes of Health [320 R01 DA022777]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022777] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this research was provided by United States National Institutes of Health grant 320 R01 DA022777 (to MHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; GOTZ KG, 1973, J COMP PHYSIOL, V85, P235, DOI 10.1007/BF00694232; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; HOTTA Y, 1976, P NATL ACAD SCI USA, V73, P4154, DOI 10.1073/pnas.73.11.4154; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Katsov AY, 2008, NEURON, V59, P322, DOI 10.1016/j.neuron.2008.05.022; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; O'Dell KMC, 2003, BEHAV PROCESS, V64, P211, DOI 10.1016/S0376-6357(03)00136-0; Ramazani RB, 2007, J NEUROSCI METH, V162, P171, DOI 10.1016/j.jneumeth.2007.01.005; Straw AD, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-5; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192	22	67	68	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8793	10.1371/journal.pone.0008793	http://dx.doi.org/10.1371/journal.pone.0008793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111707	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000274114800004
J	Ugo, V; Tondeur, S; Menot, ML; Bonnin, N; Le Gac, G; Tonetti, C; Mas, VMD; Lecucq, L; Kiladjian, JJ; Chomienne, C; Dosquet, C; Parquet, N; Darnige, L; Porneuf, M; Escoffre-Barbe, M; Giraudier, S; Delabesse, E; Cassinat, B				Ugo, Valerie; Tondeur, Sylvie; Menot, Marie-Laurence; Bonnin, Nadine; Le Gac, Gerald; Tonetti, Carole; Mas, Veronique Mansat-De; Lecucq, Lydie; Kiladjian, Jean-Jacques; Chomienne, Christine; Dosquet, Christine; Parquet, Nathalie; Darnige, Luc; Porneuf, Marc; Escoffre-Barbe, Martine; Giraudier, Stephane; Delabesse, Eric; Cassinat, Bruno		French Intergrp Myeloproliferative	Interlaboratory Development and Validation of a HRM Method Applied to the Detection of JAK2 Exon 12 Mutations in Polycythemia Vera Patients	PLOS ONE			English	Article							RESOLUTION MELTING ANALYSIS; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE-DISORDERS; DIAGNOSTIC-TOOL; DIFFERENTIATION; IDENTIFICATION; MYELOFIBROSIS; NEOPLASMS; VARIANTS; TUMORS	Background: Myeloproliferative disorders are characterized by clonal expansion of normal mature blood cells. Acquired mutations giving rise to constitutive activation of the JAK2 tyrosine kinase has been shown to be present in the majority of patients. Since the demonstration that the V617F mutation in the exon 14 of the JAK2 gene is present in about 90% of patients with Polycythemia Vera (PV), the detection of this mutation has become a key tool for the diagnosis of these patients. More recently, additional mutations in the exon 12 of the JAK2 gene have been described in 5 to 10% of the patients with erythrocytosis. According to the updated WHO criteria the presence of these mutations should be looked for in PV patients with no JAK2 V617F mutation. Reliable and accurate methods dedicated to the detection of these highly variable mutations are therefore necessary. Methods/Findings: For these reasons we have defined the conditions of a High Resolution DNA Melting curve analysis (HRM) method able to detect JAK2 exon 12 mutations. After having validated that the method was able to detect mutated patients, we have verified that it gave reproducible results in repeated experiments, on DNA extracted from either total blood or purified granulocytes. This HRM assay was further validated using 8 samples bearing different mutant sequences in 4 different laboratories, on 3 different instruments. Conclusion: The assay we have developed is thus a valid method, adapted to routine detection of JAK2 exon 12 mutations with highly reproducible results.	[Ugo, Valerie; Lecucq, Lydie] CHU Brest, Hematol Lab, F-29285 Brest, France; [Tondeur, Sylvie] Hop St Eloi, CHU Montpellier, Hematol Lab, Montpellier, France; [Menot, Marie-Laurence; Bonnin, Nadine; Chomienne, Christine; Cassinat, Bruno] Hop St Louis, AP HP, Unite Biol Cellulaire, Paris, France; [Ugo, Valerie; Le Gac, Gerald] INSERM, U613, Brest, France; [Tonetti, Carole; Giraudier, Stephane] Hop Henri Mondor, AP HP, Hematol Lab, F-94010 Creteil, France; [Mas, Veronique Mansat-De; Delabesse, Eric] Hop Purpan, CHU Toulouse, Hematol Lab, Toulouse, France; [Kiladjian, Jean-Jacques] Hop Avicenne, AP HP, Dept Hematol, F-93009 Bobigny, France; [Dosquet, Christine; Parquet, Nathalie] Hop St Louis, AP HP, Unite Therapie Cellulaire, Paris, France; [Darnige, Luc] Hop Europeen Georges Pompidou, AP HP, Hematol Lab, Paris, France; [Porneuf, Marc] CH Le Foll, Serv Hematol, St Brieuc, France; [Escoffre-Barbe, Martine] Hop Pontchaillou, CHU Rennes, Serv Hematol, Rennes, France; [Kiladjian, Jean-Jacques; Chomienne, Christine; Parquet, Nathalie; Cassinat, Bruno] Hop St Louis, PV Nord Grp, Paris, France	CHU Brest; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Ugo, V (corresponding author), CHU Brest, Hematol Lab, F-29285 Brest, France.	bruno.cassinat@sls.aphp.fr	darnige, luc/J-2538-2019; DELABESSE, Eric/I-5221-2016; Darnige, Luc/AAO-6452-2021; CASSINAT, BRUNO/N-2752-2017; Le Gac, Gérald/AFQ-1679-2022; De Mas, Véronique/P-2414-2014; Kiladjian, Jean-Jacques/K-5345-2019	DELABESSE, Eric/0000-0002-0928-0753; Darnige, Luc/0000-0003-3210-2821; CASSINAT, BRUNO/0000-0002-6514-3905; CHOMIENNE, Christine/0000-0001-5513-5752; Ugo, Valerie/0000-0002-4678-2138; LE GAC, Gerald/0000-0003-3236-7280; Kiladjian, Jean-Jacques/0000-0002-8121-438X	Institut National du Cancer	Institut National du Cancer(Institut National du Cancer (INCA) France)	The authors want to thank the Institut National du Cancer funding Plateforme de genetique moleculaire des cancers du CHU de Brest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cheng JC, 2006, CLIN CHEM, V52, P1997, DOI 10.1373/clinchem.2006.069286; Delhommeau F, 2007, BLOOD, V109, P71, DOI 10.1182/blood-2006-03-007146; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Holden JA, 2007, AM J CLIN PATHOL, V128, P230, DOI 10.1309/7TEH56K6WWXENNQY; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2008, HAEMATOL-HEMATOL J, V93, P1560, DOI 10.3324/haematol.12883; Kiladjian JJ, 2008, BLOOD, V111, P4922, DOI 10.1182/blood-2007-11-125328; Kouroupi E, 2008, BRIT J HAEMATOL, V142, P676, DOI 10.1111/j.1365-2141.2008.07223.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lasho TL, 2008, LEUKEMIA, V22, P1790, DOI 10.1038/leu.2008.56; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li S, 2008, BLOOD, V111, P3863, DOI 10.1182/blood-2007-09-111971; Lin JH, 2008, J CLIN MICROBIOL, V46, P1090, DOI 10.1128/JCM.02015-07; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Pietra D, 2008, BLOOD, V111, P1686, DOI 10.1182/blood-2007-07-101576; Rapado I, 2009, J MOL DIAGN, V11, P155, DOI 10.2353/jmoldx.2009.080110; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Seipp MT, 2008, CLIN CHEM, V54, P108, DOI 10.1373/clinchem.2007.097121; Steensma DP, 2005, BLOOD, V106, P1207, DOI 10.1182/blood-2005-03-1183; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955	24	27	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8893	10.1371/journal.pone.0008893	http://dx.doi.org/10.1371/journal.pone.0008893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126644	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896500016
J	Hassan, SW; Doody, KM; Hardy, S; Uetani, N; Cournoyer, D; Tremblay, ML				Hassan, Syed-Wajahat; Doody, Karen M.; Hardy, Serge; Uetani, Noriko; Cournoyer, Denis; Tremblay, Michel L.			Increased Susceptibility to Dextran Sulfate Sodium Induced Colitis in the T Cell Protein Tyrosine Phosphatase Heterozygous Mouse	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MICE; FAMILY; ASSOCIATION; REGULATOR; BLOCKADE; PATHWAY; MODEL; GENE	T cell protein tyrosine phosphatase (TC-PTP / PTPN2) is an enzyme that is essential for the proper functioning of the immune system and that participates in the control of cell proliferation, and inflammation. We previously observed that TC-PTP-/- mice display various immunodeficiencies, hypersensitivity to LPS and die within three weeks of birth due to anemia and widespread inflammation. A recent analysis of the Wellcome Trust Case Control Consortium (WTCC) genome wide scan data, reported in 2007, indicated a potential role for TC-PTP in inflammatory bowel disease (IBD). To further investigate the potential role of TC-PTP in IBD, we studied heterozygous TC-PTP mutant mice challenged with dextran sulfate sodium (DSS) in their drinking water. In comparison to control animals, we observed significant changes in the colon mucosa of DSS-treated TC-PTP+/- mice, in the ratio of colon to body weight, as well as an up-regulation of mRNA transcripts for IL-6, IL-23, 1L-12 beta, IFN-gamma, TNF-alpha. Moreover, up-regulation of serum IL-6 levels in DSS- treated TC-PTP+/- mice confirms that mice with a single copy of the TC-PTP gene display increased susceptibility to systemic inflammation due to bowel epithelial erosion resulting from DSS challenge. Our findings support the lack of modulation of Janus kinases 1 and 3 (Jak1, Jak3), and the downstream signal transducer and activator of transcription 1,3 and 5 (Stat1, Stat3, Stat 5) by PTPN2 in the development of IBD like condition. Pathological and molecular analysis reveal that the deficiency of TC-PTP results in pro-inflammatory condition in the bowel of heterozygous TC-PTP+/- mice. These novel findings in TC-PTP hemi-deficiency support the hypothesis that TC-PTP is an important regulator of inflammatory cytokine signaling and that it may be implicated in the pathophysiology of IBD.	[Hassan, Syed-Wajahat; Doody, Karen M.; Hardy, Serge; Uetani, Noriko; Cournoyer, Denis; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada; [Hassan, Syed-Wajahat; Cournoyer, Denis; Tremblay, Michel L.] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ, Canada; [Doody, Karen M.; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cournoyer, Denis] McGill Univ, Dept Oncol, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University	Hassan, SW (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada.	michel.tremblay@mcgill.ca			Canadian Cancer Society [NCIC 015200]	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work has been supported by the Canadian Cancer Society (NCIC#015200) grant to MLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya R, 2000, J ALLERGY CLIN IMMUN, V105, pS29, DOI 10.1016/S0091-6749(00)90514-1; Balding J, 2004, MEDIAT INFLAMM, V13, P181, DOI 10.1080/09511920410001713529; BARRETT JC, 2008, NAT GENET; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; COOL DE, 1989, P NATL ACAD SCI USA, V86, P5257, DOI 10.1073/pnas.86.14.5257; Doody KM, 2009, IMMUNOL REV, V228, P325, DOI 10.1111/j.1600-065X.2008.00743.x; FISHER SA, 2008, NAT GENET; Fitzpatrick LR, 2000, DIGEST DIS SCI, V45, P2327, DOI 10.1023/A:1005630723111; FRANKE A, 2008, NAT GENET; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Glinsky GV, 2008, CELL CYCLE, V7, P2570, DOI 10.4161/cc.7.16.6524; Gu F, 2003, MOL CELL BIOL, V23, P3753, DOI 10.1128/MCB.23.11.3753-3762.2003; Heinonen KM, 2006, P NATL ACAD SCI USA, V103, P2776, DOI 10.1073/pnas.0508563103; Heinonen KM, 2004, BLOOD, V103, P3457, DOI 10.1182/blood-2003-09-3153; IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Malago JJ, 2008, J ZHEJIANG UNIV-SC B, V9, P341, DOI 10.1631/jzus.B0720198; Masubuchi Y, 2004, DRUG METAB DISPOS, V32, P437, DOI 10.1124/dmd.32.4.437; McCaffery DM, 1999, GUT, V45, P864, DOI 10.1136/gut.45.6.864; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Nielsen OH, 2003, SCAND J GASTROENTERO, V38, P180, DOI 10.1080/00365520310000672; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roviezzo F, 2006, FASEB J, V20, P340, DOI 10.1096/fj.05-4647fje; SAKAGUCHI AY, 1992, GENOMICS, V12, P151, DOI 10.1016/0888-7543(92)90418-R; Sasaki S, 2002, EUR J IMMUNOL, V32, P3197, DOI 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	32	34	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8868	10.1371/journal.pone.0008868	http://dx.doi.org/10.1371/journal.pone.0008868			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111595	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896300017
J	Mohtashemi, M; Kawamura, LM				Mohtashemi, Mojdeh; Kawamura, L. Masae			Empirical Evidence for Synchrony in the Evolution of TB Cases and HIV plus Contacts among the San Francisco Homeless	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; SPATIAL HIERARCHIES; RISK-FACTORS; PREVALENCE; INFECTION; AFRICA; ADULTS; TRENDS; IMPACT; WAVES	The re-emergence of tuberculosis (TB) in the mid-1980s in many parts of the world, including the United States, is often attributed to the emergence and rapid spread of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). Although it is well established that TB transmission is particularly amplified in populations with high HIV prevalence, the epidemiology of interaction between TB and HIV is not well understood. This is partly due to the scarcity of HIV-related data, a consequence of the voluntary nature of HIV status reporting and testing, and partly due to current practices of screening high risk populations through separate surveillance programs for HIV and TB. The San Francisco Department of Public Health, TB Control Program, has been conducting active surveillance among the San Francisco high-risk populations since the early 1990s. We present extensive TB surveillance data on HIV and TB infection among the San Francisco homeless to investigate the association between the TB cases and their HIV+ contacts. We applied wavelet coherence and phase analyses to the TB surveillance data from January 1993 through December 2005, to establish and quantify statistical association and synchrony in the highly non-stationary and ostensibly non-periodic waves of TB cases and their HIV+ contacts in San Francisco. When stratified by homelessness, we found that the evolution of TB cases and their HIV+ contacts is highly coherent over time and locked in phase at a specific periodic scale among the San Francisco homeless, but no significant association was observed for the non-homeless. This study confirms the hypothesis that the dynamics of HIV and TB are significantly intertwined and that HIV is likely a key factor in the sustenance of TB transmission among the San Francisco homeless. The findings of this study underscore the importance of contact tracing in detection of HIV+ individuals that may otherwise remain undetected, and thus highlights the ever-increasing need for HIV-related data and an integrative approach to monitoring high-risk populations with respect to HIV and TB transmission.	[Mohtashemi, Mojdeh] Mitre Corp, Mclean, VA USA; [Mohtashemi, Mojdeh] MIT, Comp Sci & Ai Lab, Cambridge, MA USA; [Kawamura, L. Masae] San Francisco Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	MITRE Corporation; Massachusetts Institute of Technology (MIT); San Francisco Department of Public Health	Mohtashemi, M (corresponding author), Mitre Corp, Mclean, VA USA.	mojdeh@mit.edu			MITRE Corporation; San Francisco Department of Public Health	MITRE Corporation; San Francisco Department of Public Health	M. M. was fully supported by an internal grant from the MITRE Corporation. L. M. K. was supported by the San Francisco Department of Public Health. The study sponsors did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; BERMEJO A, 1992, AIDS, V6, P1203, DOI 10.1097/00002030-199210000-00022; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chatfield J. R, 1989, ANAL TIME SERIES INT; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Daubechies I, 1992, LECT WAVELETS; de Magny GC, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-20; DeRiemer K, 2007, AM J RESP CRIT CARE, V176, P936, DOI 10.1164/rccm.200603-440OC; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; *I MED EM INF, 1992, MICR THREATS HLTH US; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2006, AIDS, V20, P1787, DOI 10.1097/01.aids.0000242831.27990.da; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Marks S., 2007, Morbidity and Mortality Weekly Report, V56, P1103; Nason GP, 1999, PHILOS T R SOC A, V357, P2511, DOI 10.1098/rsta.1999.0445; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; *SAN FRANC DEP PUB, 2003, SAN FRANC DEP PUBL H; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Williams B, 2007, AM J RESP CRIT CARE, V175, P6, DOI 10.1164/rccm.200609-1376ED; Wood R, 2007, AM J RESP CRIT CARE, V175, P87, DOI 10.1164/rccm.200606-759OC; World Health Organization, 2004, WORLD HLTH REP 2004; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yang L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001399; Zetola NM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002591; ZOLOPA AR, 1994, JAMA-J AM MED ASSOC, V272, P455, DOI 10.1001/jama.272.6.455	33	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8851	10.1371/journal.pone.0008851	http://dx.doi.org/10.1371/journal.pone.0008851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107514	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896100016
J	Roy, PH; Tetu, SG; Larouche, A; Elbourne, L; Tremblay, S; Ren, QH; Dodson, R; Harkins, D; Shay, R; Watkins, K; Mahamoud, Y; Paulsen, IT				Roy, Paul H.; Tetu, Sasha G.; Larouche, Andre; Elbourne, Liam; Tremblay, Simon; Ren, Qinghu; Dodson, Robert; Harkins, Derek; Shay, Ryan; Watkins, Kisha; Mahamoud, Yasmin; Paulsen, Ian T.			Complete Genome Sequence of the Multiresistant Taxonomic Outlier Pseudomonas aeruginosa PA7	PLOS ONE			English	Article							BETA-LACTAMASE; IV PILINS; D-ARAF; VIRULENCE; RESISTANCE; GENES; IDENTIFICATION; EVOLUTION; REVEALS; STRAIN	Pseudomonas aeruginosa PA7 is a non-respiratory human isolate from Argentina that is multiresistant to antibiotics. We first sequenced gyrA, gyrB, parC, parE, ampC, ampR, and several housekeeping genes and found that PA7 is a taxonomic outlier. We report here the complete sequence of the 6,588,339 bp genome, which has only about 95% overall identity to other strains. PA7 has multiple novel genomic islands and a total of 51 occupied regions of genomic plasticity. These islands include antibiotic resistance genes, parts of transposons, prophages, and a pKLC102-related island. Several PA7 genes not present in PAO1 or PA14 are putative orthologues of other Pseudomonas spp. and Ralstonia spp. genes. PA7 appears to be closely related to the known taxonomic outlier DSM1128 (ATCC9027). PA7 lacks several virulence factors, notably the entire TTSS region corresponding to PA1690-PA1725 of PAO1. It has neither exoS nor exoU and lacks toxA, exoT, and exoY. PA7 is serotype O12 and pyoverdin type II. Preliminary proteomic studies indicate numerous differences with PAO1, some of which are probably a consequence of a frameshift mutation in the mvfR quorum sensing regulatory gene.	[Roy, Paul H.; Larouche, Andre; Tremblay, Simon] Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada; [Roy, Paul H.; Larouche, Andre; Tremblay, Simon] Univ Laval, Ctr Rech Infectiol, Quebec City, PQ, Canada; [Tetu, Sasha G.; Elbourne, Liam; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Ren, Qinghu; Dodson, Robert; Harkins, Derek; Shay, Ryan; Watkins, Kisha; Mahamoud, Yasmin; Paulsen, Ian T.] J Craig Venter Inst, Rockville, MD USA	Laval University; Laval University; Macquarie University; J. Craig Venter Institute	Roy, PH (corresponding author), Univ Laval, Dept Biochim & Microbiol, Quebec City, PQ, Canada.	ipaulsen@science.mq.edu.au	Paulsen, Ian T/K-3832-2012; Tetu, Sasha/C-8760-2013; Elbourne, Liam/G-6150-2011	Paulsen, Ian T/0000-0001-9015-9418; Elbourne, Liam/0000-0002-9784-0959; Tetu, Sasha/0000-0002-8943-3499	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services [N01-AI-30071]; Canadian Institutes for Health Research (CIHR) [MT-13564]; Strategic Training Initiative in Heath Reasearch (STIHR) [STP-59324]; New South Wales Office of Science and Medical Research	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Strategic Training Initiative in Heath Reasearch (STIHR); New South Wales Office of Science and Medical Research	This work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Department of Health and Human Services, under NIAID contract N01-AI-30071, and the Canadian Institutes for Health Research (CIHR) grant MT-13564 to PHR. ST was a recipient of a fellowship from the Strategic Training Initiative in Heath Reasearch (STIHR) training grant STP-59324. ITP is supported by a Life Science Research Award, provided by the New South Wales Office of Science and Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; BODILIS J, 2009, ENV MICROBIOL; Crespo MP, 2004, J CLIN MICROBIOL, V42, P5094, DOI 10.1128/JCM.42.11.5094-5101.2004; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Dotsch A, 2009, ANTIMICROB AGENTS CH, V53, P2522, DOI 10.1128/AAC.00035-09; Dong YH, 2005, MOL MICROBIOL, V58, P552, DOI 10.1111/j.1365-2958.2005.04851.x; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hanau-Bercot B, 2002, MOL MICROBIOL, V44, P119, DOI 10.1046/j.1365-2958.2002.02843.x; HUANG HJ, 1992, FEMS MICROBIOL LETT, V97, P267, DOI 10.1111/j.1574-6968.1992.tb05474.x; Jalal S, 1998, MICROB DRUG RESIST, V4, P257, DOI 10.1089/mdr.1998.4.257; Joardar V, 2005, J BACTERIOL, V187, P6488, DOI 10.1128/JB.187.18.6488-6498.2005; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Kiewitz C, 2000, J BACTERIOL, V182, P3125, DOI 10.1128/JB.182.11.3125-3135.2000; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; MARTIN C, 1990, NATURE, V345, P739, DOI 10.1038/345739a0; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; Mifsud AJ, 1997, J HOSP INFECT, V36, P105, DOI 10.1016/S0195-6701(97)90116-X; Mikkelsen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006018; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Moore RA, 1999, ANTIMICROB AGENTS CH, V43, P465, DOI 10.1128/AAC.43.3.465; Paulsen IT, 2002, P NATL ACAD SCI USA, V99, P13148, DOI 10.1073/pnas.192319099; Ramisse F, 2000, FEMS IMMUNOL MED MIC, V28, P241, DOI 10.1016/S0928-8244(00)00162-0; RATHER PN, 1992, J BACTERIOL, V174, P3196, DOI 10.1128/jb.174.10.3196-3203.1992; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Salunkhe P, 2005, J BACTERIOL, V187, P4908, DOI 10.1128/JB.187.14.4908-4920.2005; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; Smith EE, 2005, J BACTERIOL, V187, P2138, DOI 10.1128/JB.187.6.2138-2147.2005; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Talarmin A, 1996, EUR J CLIN MICROBIOL, V15, P459, DOI 10.1007/BF01691312; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winstanley C, 2009, GENOME RES, V19, P12, DOI 10.1101/gr.086082.108; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Wuerdemann D, 2007, FEMS MICROBIOL LETT, V275, P244, DOI 10.1111/j.1574-6968.2007.00891.x; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951	43	174	182	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8842	10.1371/journal.pone.0008842	http://dx.doi.org/10.1371/journal.pone.0008842			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107499	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896100008
J	Lorier, AR; Funk, GD; Greer, JJ				Lorier, Amanda R.; Funk, Gregory D.; Greer, John J.			Opiate-Induced Suppression of Rat Hypoglossal Motoneuron Activity and Its Reversal by Ampakine Therapy	PLOS ONE			English	Article							PRE-BOTZINGER COMPLEX; MU-OPIOID RECEPTORS; IN-VITRO; RESPIRATORY DEPRESSION; ALLOSTERIC MODULATORS; SLEEP-APNEA; NEURONS; CURRENTS; MUSCLE; RHYTHM	Background: Hypoglossal (XII) motoneurons innervate tongue muscles and are vital for maintaining upper-airway patency during inspiration. Depression of XII nerve activity by opioid analgesics is a significant clinical problem, but underlying mechanisms are poorly understood. Currently there are no suitable pharmacological approaches to counter opiate-induced suppression of XII nerve activity while maintaining analgesia. Ampakines accentuate alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA) receptor responses. The AMPA family of glutamate receptors mediate excitatory transmission to XII motoneurons. Therefore the objectives were to determine whether the depressant actions of mu-opioid receptor activation on inspiratory activity includes a direct inhibitory action at the inspiratory premotoneuron to XII motoneuron synapse, and to identify underlying mechanism(s). We then examined whether ampakines counteract opioid-induced depression of XII motoneuron activity. Methodology/Principal Findings: A medullary slice preparation from neonatal rat that produces inspiratory-related output in vitro was used. Measurements of inspiratory burst amplitude and frequency were made from XII nerve roots. Whole-cell patch recordings from XII motoneurons were used to measure membrane currents and synaptic events. Application of the m-opioid receptor agonist, DAMGO, to the XII nucleus depressed the output of inspiratory XII motoneurons via presynaptic inhibition of excitatory glutamatergic transmission. Ampakines (CX614 and CX717) alleviated DAMGO-induced depression of XII MN activity through postsynaptic actions on XII motoneurons. Conclusions/Significance: The inspiratory-depressant actions of opioid analgesics include presynaptic inhibition of XII motoneuron output. Ampakines counteract mu-opioid receptor-mediated depression of XII motoneuron inspiratory activity. These results suggest that ampakines may be beneficial in countering opiate-induced suppression of XII motoneuron activity and resultant impairment of airway patency.	[Lorier, Amanda R.; Funk, Gregory D.; Greer, John J.] Univ Alberta, Div Neurosci, Edmonton, AB T6G 2S2, Canada	University of Alberta	Lorier, AR (corresponding author), Univ Alberta, Div Neurosci, Edmonton, AB T6G 2S2, Canada.	john.greer@ualberta.ca		Funk, Gregory/0000-0001-5848-0631	Canadian Institutes for Health Research; Cortex Pharmaceuticals; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research (AHFMR)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Cortex Pharmaceuticals; Alberta Science and Research Authority; Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	Research was supported by the Canadian Institutes for Health Research (Ottawa, Ontario, Canada), Cortex Pharmaceuticals (Irvine, California), and the Alberta Science and Research Authority (Edmonton, Alberta, Canada). ARL received a postdoctoral fellowship from the Alberta Heritage Foundation for Medical Research (AHFMR). JJG and GDF are scientists of the AHFMR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2005, J APPL PHYSIOL, V98, P1297, DOI 10.1152/japplphysiol.00977.2004; Arai A, 1996, J PHARMACOL EXP THER, V278, P627; Arai AC, 2007, CURR DRUG TARGETS, V8, P583, DOI 10.2174/138945007780618490; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Arai AC, 2002, J PHARMACOL EXP THER, V303, P1075, DOI 10.1124/jpet.102.040360; BARTLETT D, 1986, RESP PHYSIOL, V64, P289, DOI 10.1016/0034-5687(86)90122-2; Bellingham MC, 1996, J NEUROPHYSIOL, V76, P3758, DOI 10.1152/jn.1996.76.6.3758; Bellingham MC, 2000, CLIN EXP PHARMACOL P, V27, P132, DOI 10.1046/j.1440-1681.2000.03192.x; Boushra NN, 1996, CAN J ANAESTH, V43, P599, DOI 10.1007/BF03011774; Brown KA, 2006, ANESTHESIOLOGY, V105, P665, DOI 10.1097/00000542-200610000-00009; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; Ding YQ, 1996, J COMP NEUROL, V367, P375; Doraiswamy PM, 2006, EXPERT OPIN PHARMACO, V7, P1, DOI 10.1517/14656566.7.1.1; Funk GD, 1995, CURR OPIN NEUROBIOL, V5, P778, DOI 10.1016/0959-4388(95)80106-5; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; FUNK GD, 1995, J NEUROSCI, V15, P4046; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Hajiha M, 2009, J PHYSIOL-LONDON, V587, P2677, DOI 10.1113/jphysiol.2009.171678; Horner RL, 2007, AM J RESP CRIT CARE, V175, P426, DOI 10.1164/rccm.200701-043UP; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kivell BM, 2004, DEV BRAIN RES, V148, P185, DOI 10.1016/j.devbrainres.2003.12.002; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Lalley PM, 2003, AM J PHYSIOL-REG I, V285, pR1287, DOI 10.1152/ajpregu.00199.2003; Lape R, 2000, J NEUROPHYSIOL, V83, P2987, DOI 10.1152/jn.2000.83.5.2987; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; LENAL FC, 2007, SOC NEUR ABSTR, V597; Liu X, 2005, J PHYSIOL-LONDON, V565, P965, DOI 10.1113/jphysiol.2005.084657; Lorier AR, 2007, J NEUROSCI, V27, P993, DOI 10.1523/JNEUROSCI.3948-06.2007; Lynch G, 2006, CURR OPIN PHARMACOL, V6, P82, DOI 10.1016/j.coph.2005.09.005; Lynch G, 2004, CURR OPIN PHARMACOL, V4, P4, DOI 10.1016/j.coph.2003.09.009; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Moos Daniel D, 2006, J Perianesth Nurs, V21, P103, DOI 10.1016/j.jopan.2006.02.001; MOOS DD, 2006, J PERIANESTH NURS, V21, P116; Ostermeier AM, 1997, ANESTH ANALG, V85, P452, DOI 10.1097/00000539-199708000-00037; Pagliardini S, 2005, J NEUROSCI, V25, P2591, DOI 10.1523/JNEUROSCI.4930-04.2005; Porrino LJ, 2005, PLOS BIOL, V3, P1639, DOI 10.1371/journal.pbio.0030299; Ren J, 2008, ADV EXP MED BIOL, V605, P149; Ren J, 2006, AM J RESP CRIT CARE, V174, P1384, DOI 10.1164/rccm.200606-778OC; Ren J, 2009, ANESTHESIOLOGY, V110, P1364, DOI 10.1097/ALN.0b013e31819faa2a; Richardson KA, 2005, BRAIN RES, V1032, P23, DOI 10.1016/j.brainres.2004.10.045; SCHROEDER JE, 1991, NEURON, V6, P13, DOI 10.1016/0896-6273(91)90117-I; Skulsky EM, 2007, SLEEP, V30, P566, DOI 10.1093/sleep/30.5.566; STAUBLI U, 1994, P NATL ACAD SCI USA, V91, P777, DOI 10.1073/pnas.91.2.777; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Swarm RA, 2001, CURR PROB SURG, V38, P845, DOI 10.1067/msg.2001.118495; Waters KA, 2002, J APPL PHYSIOL, V92, P1987, DOI 10.1152/japplphysiol.00619.2001; Wesensten NJ, 2007, AVIAT SPACE ENVIR MD, V78, P937, DOI 10.3357/ASEM.2055.2007; WILLIAMS JT, 1988, J NEUROSCI, V8, P4299	48	44	45	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8766	10.1371/journal.pone.0008766	http://dx.doi.org/10.1371/journal.pone.0008766			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098731	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900010
J	Niehuis, O; Gibson, JD; Rosenberg, MS; Pannebakker, BA; Koevoets, T; Judson, AK; Desjardins, CA; Kennedy, K; Duggan, D; Beukeboom, LW; van de Zande, L; Shuker, DM; Werren, JH; Gadau, J				Niehuis, Oliver; Gibson, Joshua D.; Rosenberg, Michael S.; Pannebakker, Bart A.; Koevoets, Tosca; Judson, Andrea K.; Desjardins, Christopher A.; Kennedy, Kathleen; Duggan, David; Beukeboom, Leo W.; van de Zande, Louis; Shuker, David M.; Werren, John H.; Gadau, Juergen			Recombination and Its Impact on the Genome of the Haplodiploid Parasitoid Wasp Nasonia	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; SHOWING SEGREGATION DISTORTION; MAXIMUM-LIKELIHOOD MODELS; X-CHROMOSOME CENTROMERE; BIASED GENE CONVERSION; NATURAL-SELECTION; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; MEIOTIC RECOMBINATION; CROSSING-OVER	Homologous meiotic recombination occurs in most sexually reproducing organisms, yet its evolutionary advantages are elusive. Previous research explored recombination in the honeybee, a eusocial hymenopteran with an exceptionally high genome-wide recombination rate. A comparable study in a non-social member of the Hymenoptera that would disentangle the impact of sociality from Hymenoptera-specific features such as haplodiploidy on the evolution of the high genome-wide recombination rate in social Hymenoptera is missing. Utilizing single-nucleotide polymorphisms (SNPs) between two Nasonia parasitoid wasp genomes, we developed a SNP genotyping microarray to infer a high-density linkage map for Nasonia. The map comprises 1,255 markers with an average distance of 0.3 cM. The mapped markers enabled us to arrange 265 scaffolds of the Nasonia genome assembly 1.0 on the linkage map, representing 63.6% of the assembled N. vitripennis genome. We estimated a genome-wide recombination rate of 1.4-1.5 cM/Mb for Nasonia, which is less than one tenth of the rate reported for the honeybee. The local recombination rate in Nasonia is positively correlated with the distance to the center of the linkage groups, GC content, and the proportion of simple repeats. In contrast to the honeybee genome, gene density in the parasitoid wasp genome is positively associated with the recombination rate; regions of low recombination are characterized by fewer genes with larger introns and by a greater distance between genes. Finally, we found that genes in regions of the genome with a low recombination frequency tend to have a higher ratio of non-synonymous to synonymous substitutions, likely due to the accumulation of slightly deleterious non-synonymous substitutions. These findings are consistent with the hypothesis that recombination reduces interference between linked sites and thereby facilitates adaptive evolution and the purging of deleterious mutations. Our results imply that the genomes of haplodiploid and of diploid higher eukaryotes do not differ systematically in their recombination rates and associated parameters.	[Niehuis, Oliver; Gibson, Joshua D.; Rosenberg, Michael S.; Judson, Andrea K.; Gadau, Juergen] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Rosenberg, Michael S.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Funct Genom, Tempe, AZ USA; [Pannebakker, Bart A.; Shuker, David M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Pannebakker, Bart A.; Koevoets, Tosca; Beukeboom, Leo W.; van de Zande, Louis] Univ Groningen, Ctr Ecol & Evolutionary Studies, Haren, Netherlands; [Desjardins, Christopher A.; Werren, John H.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Kennedy, Kathleen; Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Shuker, David M.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Edinburgh; University of Groningen; University of Rochester; Translational Genomics Research Institute; University of St Andrews	Niehuis, O (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	oliver.niehuis@gmail.com	Pannebakker, Bart A./D-3823-2012; Shuker, David M/E-8827-2013; Rosenberg, Michael S/A-4621-2008; Beukeboom, L.W./D-1808-2012; Pannebakker, Bart/D-1479-2010	Pannebakker, Bart A./0000-0001-8503-3896; Rosenberg, Michael S/0000-0001-7882-2467; Desjardins, Christopher/0000-0002-3160-4734; van de Zande, Louis/0000-0001-5687-3220; Gibson, Joshua/0000-0002-0193-2307; Werren, John/0000-0001-9353-2070	Alexander von Humboldt Foundation; Netherlands Organization for Scientific Research NWO/ALW [863.08.008, 816.01.004, 833.02.003]; Natural Environment Research Council [NE/C51932X/1, NE/D009979/1]; National Institutes of Health [NIH 5R01GM070026, NIH 1R21 RR024199-01]; NERC [NE/D009979/1, NE/D009979/2] Funding Source: UKRI; Natural Environment Research Council [NE/D009979/2] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070026, R24GM084917] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Netherlands Organization for Scientific Research NWO/ALW(Netherlands Organization for Scientific Research (NWO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ON acknowledges the Alexander von Humboldt Foundation for a Feodor Lynen Research Fellowship for Postdoctoral Researchers. BAP, TK, and LWB acknowledge the Netherlands Organization for Scientific Research NWO/ALW (grants 863.08.008, 816.01.004, and 833.02.003). BAP and DMS were supported by the Natural Environment Research Council (NE/C51932X/1 and NE/D009979/1). Computational work by CAD was supported by a grant from the National Institutes of Health to JHW (NIH 5R01GM070026). This research was enabled by a grant to JG from the National Institutes of Health (NIH 1R21 RR024199-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antolin MF, 1996, GENETICS, V143, P1727; Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bagshaw AT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-49; BAKER BS, 1976, ANNU REV GENET, V10, P53, DOI 10.1146/annurev.ge.10.120176.000413; BARTON NH, 1995, GENETICS, V140, P821; Beadle GW, 1932, P NATL ACAD SCI USA, V18, P160, DOI 10.1073/pnas.18.2.160; Betancourt AJ, 2002, P NATL ACAD SCI USA, V99, P13616, DOI 10.1073/pnas.212277199; Beukeboom LW, 2007, SCIENCE, V315, P206, DOI 10.1126/science.1133388; Beye M, 2006, GENOME RES, V16, P1339, DOI 10.1101/gr.5680406; Birdsell JA, 2002, MOL BIOL EVOL, V19, P1181, DOI 10.1093/oxfordjournals.molbev.a004176; Bordenstein SR, 1998, GENETICS, V148, P1833; Borrmann L, 2003, ONCOGENE, V22, P756, DOI 10.1038/sj.onc.1206073; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Carvalho AB, 1999, NATURE, V401, P344, DOI 10.1038/43827; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Choo KHA, 1998, GENOME RES, V8, P81, DOI 10.1101/gr.8.2.81; Colombo PC, 1997, HEREDITY, V79, P214, DOI 10.1038/sj.hdy.6881930; Comeron JM, 2000, GENETICS, V156, P1175; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Curi RA, 2005, ANIM GENET, V36, P58, DOI 10.1111/j.1365-2052.2004.01226.x; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; Drapeau MD, 1999, EVOL ECOL RES, V1, P223; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; EPPLEN JT, 2005, ENCY LIFE SCI ELS; FELSENSTEIN J, 1974, GENETICS, V78, P737; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Gadau J, 1999, GENETICS, V153, P1731; Gadau J, 2000, NATURWISSENSCHAFTEN, V87, P87, DOI 10.1007/s001140050016; Gadau Juergen, 2008, V1, P27, DOI 10.1007/978-3-540-73833-6_3; Galtier N, 2001, GENETICS, V159, P907; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; Gendrel CG, 2000, GENE DEV, V14, P1261; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GIBSON JD, 2010, HEREDITY IN PRESS; Gokhman Vladimir E., 2000, Beitraege zur Entomologie, V50, P193; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Haldane JBS, 1919, J GENET, V8, P299; Hammock EAD, 2004, MOL BIOL EVOL, V21, P1057, DOI 10.1093/molbev/msh104; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; HAWLEY RS, 1993, TRENDS GENET, V9, P310; Hey J, 2002, GENETICS, V160, P595; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Holloway AK, 2000, GENETICS, V154, P205; HUNT GJ, 1995, GENETICS, V139, P1371; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; Kirkpatrick DT, 1999, MOL CELL BIOL, V19, P7661; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; KLIMAN RM, 1993, MOL BIOL EVOL, V10, P1239; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; KOROL AB, 1989, GENETIKA+, V25, P2225; Kulathinal RJ, 2008, P NATL ACAD SCI USA, V105, P10051, DOI 10.1073/pnas.0801848105; LAMBIE EJ, 1986, GENETICS, V114, P769; Laurent V, 1998, GENETICS, V150, P275; Leonard JE, 2006, ANIM BEHAV, V71, P641, DOI 10.1016/j.anbehav.2005.07.010; Li W. H, 1997, MOL EVOLUTION; Liu B.-H., 1998, STAT GENOMICS LINKAG; LORIEUX M, 1995, THEOR APPL GENET, V90, P81, DOI 10.1007/BF00220999; LORIEUX M, 1995, THEOR APPL GENET, V90, P73, DOI 10.1007/BF00220998; MAHTANI MM, 1990, GENOMICS, V7, P607, DOI 10.1016/0888-7543(90)90206-A; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Majewski J, 2000, GENOME RES, V10, P1108, DOI 10.1101/gr.10.8.1108; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Mather K, 1939, GENETICS, V24, P413; Mester D, 2003, GENETICS, V165, P2269; Mester DI, 2004, COMPUT BIOL CHEM, V28, P281, DOI 10.1016/j.compbiolchem.2004.08.003; Mester DI, 2003, THEOR APPL GENET, V107, P1102, DOI 10.1007/s00122-003-1305-1; Michod R. E., 1988, THE EVOLUTION OF SEX; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Niehuis O, 2007, J ECON ENTOMOL, V100, P1033, DOI 10.1603/0022-0493(2007)100[1033:SSPASS]2.0.CO;2; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Otto SP, 1997, GENETICS, V147, P879; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Pal C, 2001, MOL BIOL EVOL, V18, P2323, DOI 10.1093/oxfordjournals.molbev.a003779; PECK JR, 1994, GENETICS, V137, P597; Peng J, 2000, GENOME RES, V10, P1509, DOI 10.1101/gr.150300; PIETSCH C, 2005, THESIS U WURZBURG WU; Prachumwat A, 2004, GENETICS, V166, P1585, DOI 10.1534/genetics.166.3.1585; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROSENBERG MS, 2008, PASSAGE PATTERN ANAL; Round EK, 1997, GENOME RES, V7, P1045, DOI 10.1101/gr.7.11.1045; Rutten KB, 2004, CYTOGENET GENOME RES, V105, P126, DOI 10.1159/000078019; SCHULTES NP, 1991, MOL CELL BIOL, V11, P322, DOI 10.1128/MCB.11.1.322; Sirvio A, 2006, J EVOLUTION BIOL, V19, P1475, DOI 10.1111/j.1420-9101.2006.01131.x; Smith KN, 1998, CURR OPIN GENET DEV, V8, P200, DOI 10.1016/S0959-437X(98)80142-1; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Sturtevant A. H., 1915, Zs indukt Abstamm Berlin, V13, DOI 10.1007/BF01792906; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; THURIAUX P, 1977, NATURE, V268, P460, DOI 10.1038/268460a0; THURSTON MI, 2005, MSATFINDER DETECTION; TRECO D, 1986, MOL CELL BIOL, V6, P3934, DOI 10.1128/MCB.6.11.3934; True JR, 1996, GENETICS, V142, P507; Uhlemann AC, 2004, J INFECT DIS, V189, P2227, DOI 10.1086/421242; Velthuis BJ, 2005, ANIM BEHAV, V69, P1107, DOI 10.1016/j.anbehav.2004.06.032; Wang Y, 2006, GENETICS, V172, P2529, DOI 10.1534/genetics.106.055772; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Weston RF, 1999, J EVOLUTION BIOL, V12, P586, DOI 10.1046/j.1420-9101.1999.00048.x; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; YAMAMOTO M, 1978, CHROMOSOMA, V66, P71, DOI 10.1007/BF00285817; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	106	50	50	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8597	10.1371/journal.pone.0008597	http://dx.doi.org/10.1371/journal.pone.0008597			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20087411	Green Published, gold, Green Submitted			2022-12-27	WOS:000273778900001
J	Okuda, H; Kuwahara, R; Matsuzaki, S; Miyata, S; Kumamoto, N; Hattori, T; Shimizu, S; Yamada, K; Kawamoto, K; Hashimoto, R; Takeda, M; Katayama, T; Tohyama, M				Okuda, Hiroaki; Kuwahara, Ryusuke; Matsuzaki, Shinsuke; Miyata, Shingo; Kumamoto, Natsuko; Hattori, Tsuyoshi; Shimizu, Shoko; Yamada, Kohei; Kawamoto, Keisuke; Hashimoto, Ryota; Takeda, Masatoshi; Katayama, Taiichi; Tohyama, Masaya			Dysbindin Regulates the Transcriptional Level of Myristoylated Alanine-Rich Protein Kinase C Substrate via the Interaction with NF-YB in Mice Brain	PLOS ONE			English	Article							HIGH-RISK HAPLOTYPE; SUSCEPTIBILITY GENE; DTNBP1 GENE; NEUROTRANSMITTER RELEASE; CHRONIC-SCHIZOPHRENIA; ANTIPSYCHOTIC-DRUGS; SYNAPTIC PLASTICITY; NEURITE OUTGROWTH; DOWN-REGULATION; FINGER PROTEIN	Background: An accumulating body of evidence suggests that Dtnbp1 (Dysbindin) is a key susceptibility gene for schizophrenia. Using the yeast-two-hybrid screening system, we examined the candidate proteins interacting with Dysbindin and revealed one of these candidates to be the transcription factor NF-YB. Methods: We employed an immunoprecipitation (IP) assay to demonstrate the Dysbindin-NF-YB interaction. DNA chips were used to screen for altered expression of genes in cells in which Dysbindin or NF-YB was down regulated, while Chromatin IP and Reporter assays were used to confirm the involvement of these genes in transcription of Myristoylated alanine-rich protein kinase C substrate (MARCKS). The sdy mutant mice with a deletion in Dysbindin, which exhibit behavioral abnormalities, and wild-type DBA2J mice were used to investigate MARCKS expression. Results: We revealed an interaction between Dysbindin and NF-YB. DNA chips showed that MARCKS expression was increased in both Dysbindin knockdown cells and NF-YB knockdown cells, and Chromatin IP revealed interaction of these proteins at the MARCKS promoter region. Reporter assay results suggested functional involvement of the interaction between Dysbindin and NF-YB in MARCKS transcription levels, via the CCAAT motif which is a NF-YB binding sequence. MARCKS expression was increased in sdy mutant mice when compared to wild-type mice. Conclusions: These findings suggest that abnormal expression of MARCKS via dysfunction of Dysbindin might cause impairment of neural transmission and abnormal synaptogenesis. Our results should provide new insights into the mechanisms of neuronal development and the pathogenesis of schizophrenia.	[Okuda, Hiroaki; Kuwahara, Ryusuke; Matsuzaki, Shinsuke; Miyata, Shingo; Kumamoto, Natsuko; Hattori, Tsuyoshi; Shimizu, Shoko; Yamada, Kohei; Kawamoto, Keisuke; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan; [Okuda, Hiroaki] Nara Med Univ, Fac Med, Dept Anat 2, Nara, Japan; [Matsuzaki, Shinsuke; Miyata, Shingo; Hattori, Tsuyoshi; Hashimoto, Ryota; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Osaka, Japan; [Hashimoto, Ryota; Takeda, Masatoshi] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan	Osaka University; Nara Medical University; Osaka University; Kanazawa University; Osaka University; Hamamatsu University School of Medicine; Osaka University	Okuda, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Osaka, Japan.	s-matsuzaki@anat2.med.osaka-u.ac.jp	Hashimoto, Ryota/P-8572-2014; Kuwahara, Ryusuke/J-5024-2015; Okuda, Hiroaki/S-4959-2019; Hashimoto, Ryota/AAE-3200-2019; Okuda, Hiroaki/E-9418-2018	Hashimoto, Ryota/0000-0002-5941-4238; Kuwahara, Ryusuke/0000-0002-7041-0828; Okuda, Hiroaki/0000-0002-6252-9634; Hashimoto, Ryota/0000-0002-5941-4238; Okuda, Hiroaki/0000-0002-6252-9634	Osaka Medical Research Foundation; Twenty- First Century Center of Excellence (COE) program; Global COE program	Osaka Medical Research Foundation; Twenty- First Century Center of Excellence (COE) program; Global COE program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Osaka Medical Research Foundation For Incurable Diseases (Shinsuke Matsuzaki) and the Twenty- First Century Center of Excellence (COE) program and the Global COE program (Hiroaki Okuda, Ryusuke Kuwahara, Shinsuke Matsuzaki, Shingo Miyata, Natsuko Kumamoto, Tsuyoshi Hattori, Shoko Shimizu, Kohei Yamada, Taiichi Katayama and Masaya Tohyama). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Bilder RM, 2002, BIOL PSYCHIAT, V52, P701, DOI 10.1016/S0006-3223(02)01416-6; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Chen XN, 2004, AM J MED GENET B, V129B, P23, DOI 10.1002/ajmg.b.30078; Chiba S, 2006, J NEURAL TRANSM, V113, P1337, DOI 10.1007/s00702-005-0414-1; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Corvin A, 2008, NEUROSCI LETT, V431, P146, DOI 10.1016/j.neulet.2007.11.031; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Donati G, 2006, NUCLEIC ACIDS RES, V34, P3116, DOI 10.1093/nar/gkl304; Donohoe G, 2007, NEUROPSYCHOLOGIA, V45, P454, DOI 10.1016/j.neuropsychologia.2006.06.016; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Funke B, 2004, AM J HUM GENET, V75, P891, DOI 10.1086/425279; Garver DL, 2006, CURR DRUG TARGETS, V7, P1205, DOI 10.2174/138945006778226543; GORNICK MC, 2005, J AUTISM DEV DISORD, V10, P1; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Kirov G, 2004, BIOL PSYCHIAT, V55, P971, DOI 10.1016/j.biopsych.2004.01.025; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lewis DA, 2006, NAT MED, V12, P1016, DOI 10.1038/nm1478; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; LUCIANO M, 2008, GENES BRAIN BEHAV; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Maity SN, 1998, TRENDS BIOCHEM SCI, V23, P174, DOI 10.1016/S0968-0004(98)01201-8; Manji HK, 1999, BIOL PSYCHIAT, V46, P1328, DOI 10.1016/S0006-3223(99)00235-8; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Millar JK, 2001, MOL PSYCHIATR, V6, P173, DOI 10.1038/sj.mp.4000784; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Morris DW, 2004, AM J MED GENET B, V125B, P50, DOI 10.1002/ajmg.b.20109; Mouri A, 2007, NEUROCHEM INT, V51, P173, DOI 10.1016/j.neuint.2007.06.019; Murotani T, 2007, NEUROSCI LETT, V421, P47, DOI 10.1016/j.neulet.2007.05.019; Nian H, 2007, ARCH BIOCHEM BIOPHYS, V465, P157, DOI 10.1016/j.abb.2007.05.013; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Park YS, 2006, J NEUROSCI, V26, P8999, DOI 10.1523/JNEUROSCI.2828-06.2006; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; Sillitoe RV, 2003, J NEUROSCI, V23, P6576; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Sokolov BP, 2000, BIOL PSYCHIAT, V48, P184, DOI 10.1016/S0006-3223(00)00875-1; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; STRAUB RE, 1995, NAT GENET, V11, P287, DOI 10.1038/ng1195-287; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Tang JX, 2003, MOL PSYCHIATR, V8, P717, DOI 10.1038/sj.mp.4001287; Trifaro JM, 2000, BIOCHIMIE, V82, P339, DOI 10.1016/S0300-9084(00)00193-0; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van den Oord EJCG, 2003, MOL PSYCHIATR, V8, P499, DOI 10.1038/sj.mp.4001263; WANG SB, 1995, NAT GENET, V10, P41, DOI 10.1038/ng0595-41; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2004, BIOL PSYCHIAT, V55, P192, DOI 10.1016/j.biopsych.2003.11.002; Williams NM, 2004, ARCH GEN PSYCHIAT, V61, P336, DOI 10.1001/archpsyc.61.4.336; Zinkstok JR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-19	64	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8773	10.1371/journal.pone.0008773	http://dx.doi.org/10.1371/journal.pone.0008773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098743	Green Published, gold, Green Submitted			2022-12-27	WOS:000273778900016
J	Woo, J; Chan, R; Leung, J; Wong, M				Woo, Jean; Chan, Ruth; Leung, Jason; Wong, Moses			Relative Contributions of Geographic, Socioeconomic, and Lifestyle Factors to Quality of Life, Frailty, and Mortality in Elderly	PLOS ONE			English	Article							PHYSICAL-ACTIVITY SCALE; FOOD-FREQUENCY QUESTIONNAIRE; CHINESE POPULATION; SOCIAL-STATUS; DIET QUALITY; HEALTH DISADVANTAGE; AIR-POLLUTION; HONG-KONG; INDEX; VALIDITY	Background: To date, few studies address disparities in older populations specifically using frailty as one of the health outcomes and examining the relative contributions of individual and environmental factors to health outcomes. Methodology/Principal Findings: Using a data set from a health survey of 4,000 people aged 65 years and over living in all regions of Hong Kong, we examined regional variations in self-rated health, frailty, and four-year mortality, and analyzed the relative contributions of lifestyle, socioeconomic status, and geographical location of residence to these outcomes using path analysis. We hypothesize that lifestyle, socioeconomic status, and regional characteristics directly and indirectly through interactions contribute to self-rated physical and psychological health, frailty, and four-year mortality. District variations directly affect self-rated physical health, and also exert an effect through socioeconomic position as well as lifestyle factors. Socioeconomic position in turn directly affects self-rated physical health, as well as indirectly through lifestyle factors. A similar pattern of interaction is observed for self-rated mental health, frailty, and mortality, although there are differences in different lifestyle factors and district associations. Lifestyle factors also directly affect physical and mental components of health, frailty, and mortality. The magnitude of direct district effect is comparable to those of lifestyle and socioeconomic position. Conclusions/Significance: We conclude that district variations in health outcomes exist in the Hong Kong elderly population, and these variations result directly from district factors, and are also indirectly mediated through socioeconomic position as well as lifestyle. Provision and accessibility to health services are unlikely to play a significant role. Future studies on these district factors would be important in reducing health disparities in the older population.	[Woo, Jean; Chan, Ruth; Wong, Moses] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Woo, Jean; Chan, Ruth] Chinese Univ Hong Kong, Sch Publ Hlth, Ctr Nutr Studies, Hong Kong, Hong Kong, Peoples R China; [Leung, Jason] Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Woo, J (corresponding author), Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China.	jeanwoowong@cuhk.edu.hk	Woo, Jean/K-2625-2014; Chan, Ruth/K-4995-2014	Woo, Jean/0000-0001-7593-3081; Chan, Ruth/0000-0002-5725-4066				Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; APPLEBY J, 2007, HLTH SERVICE J, V117, P23; Ashworth M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2030; Avendano M, 2009, AM J PUBLIC HEALTH, V99, P540, DOI 10.2105/AJPH.2008.139469; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Barker DJP, 1998, MOTHERS BABIES HLTH; BERNSTEIN EF, 1982, SURG CLIN N AM, V62, P473; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Census and Statistics Department, 2006, HONG KONG 2006 POP B; Chan TF, 2003, DEMENT GERIATR COGN, V15, P10, DOI 10.1159/000066672; Curtis S, 2004, SOC SCI MED, V58, P57, DOI 10.1016/S0277-9536(03)00149-7; Dinger MK, 2004, J SPORT MED PHYS FIT, V44, P186; Dunn JR, 2006, SOC SCI MED, V62, P1465, DOI 10.1016/j.socscimed.2005.07.038; Elstad JI, 2005, EUR J PUBLIC HEALTH, V15, P51, DOI 10.1093/eurpub/cki114; Goggins WB, 2005, J GERONTOL A-BIOL, V60, P1046, DOI 10.1093/gerona/60.8.1046; Grundy E, 2000, SOC SCI MED, V51, P1061, DOI 10.1016/S0277-9536(00)00023-X; Grundy E, 2003, SOC SCI MED, V56, P935, DOI 10.1016/S0277-9536(02)00093-X; Hagiwara A, 2008, GERIATR GERONTOL INT, V8, P143, DOI 10.1111/j.1447-0594.2008.00463.x; Huff N, 1999, J PUBLIC HEALTH MED, V21, P81, DOI 10.1093/pubmed/21.1.81; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kim S, 2003, J NUTR, V133, P3476, DOI 10.1093/jn/133.11.3476; Ko FWS, 2007, THORAX, V62, P780, DOI 10.1136/thx.2006.076166; Krewski D, 2007, J TOXICOL ENV HEAL A, V70, P275, DOI 10.1080/15287390600884859; Kuh D, 2006, AM J EPIDEMIOL, V164, P110, DOI 10.1093/aje/kwj193; Lahelma E, 2002, SOC SCI MED, V54, P727, DOI 10.1016/S0277-9536(01)00105-8; Lam CLK, 2005, QUAL LIFE RES, V14, P539, DOI 10.1007/s11136-004-0704-3; Lee H.-c.B., 1993, CLIN GERONTOLOGIST, V14, P37; Markle-Reid M, 2003, J ADV NURS, V44, P58, DOI 10.1046/j.1365-2648.2003.02767.x; Marmot M, 2001, BMJ-BRIT MED J, V322, P1233, DOI 10.1136/bmj.322.7296.1233; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; Mitchell R, 2008, LANCET, V372, P1655, DOI 10.1016/S0140-6736(08)61689-X; Mitnitski A B, 2001, ScientificWorldJournal, V1, P323; Mitnitski Arnold B, 2002, BMC Geriatr, V2, P1; Newby PK, 2003, AM J CLIN NUTR, V78, P941, DOI 10.1093/ajcn/78.5.941; Paul A. A., 1978, COMPOSITION FOODS; ROCKWOOD K, 1994, CAN MED ASSOC J, V150, P489; SIEGRIST J, 2006, SOCIAL INEQUALITIES; Singh-Manoux A, 2005, PSYCHOSOM MED, V67, P855, DOI 10.1097/01.psy.0000188434.52941.a0; Smith KB, 2008, AUST J RURAL HEALTH, V16, P56, DOI 10.1111/j.1440-1584.2008.00953.x; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stookey JD, 2000, EUR J CLIN NUTR, V54, P811, DOI 10.1038/sj.ejcn.1601098; Sun RJ, 2008, AM J EPIDEMIOL, V168, P1311, DOI 10.1093/aje/kwn260; van Lenthe FJ, 2006, SOCIAL INEQUALITIES, P167, DOI DOI 10.1093/ACPR0F:0S0/9780; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Weisz D, 2008, EUR J PUBLIC HEALTH, V18, P166, DOI 10.1093/eurpub/ckm084; Woo J, 2008, WOMEN HEALTH, V48, P209, DOI 10.1080/03630240802313563; Woo J, 2008, EUR J CLIN NUTR, V62, P480, DOI 10.1038/sj.ejcn.1602702; Woo J, 2006, DISABIL REHABIL, V28, P515, DOI 10.1080/09638280500215867; Woo J, 2005, GERONTOLOGY, V51, P402, DOI 10.1159/000088705; Woo J, 1997, NUTR RES, V17, P1633, DOI 10.1016/S0271-5317(97)00170-X; Woo J, 2009, LANCET, V373, P299, DOI 10.1016/S0140-6736(09)60094-5; YANG Y, 2002, CHINA FOOD COMPOSITO; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	54	67	70	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8775	10.1371/journal.pone.0008775	http://dx.doi.org/10.1371/journal.pone.0008775			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546AH	20098745	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900018
J	Cheli, Y; Williams, SA; Ballotti, R; Nugent, DJ; Kunicki, TJ				Cheli, Yann; Williams, Shirley A.; Ballotti, Robert; Nugent, Diane J.; Kunicki, Thomas J.			Enhanced Binding of Poly(ADP-ribose)polymerase-1 and Ku80/70 to the ITGA2 Promoter via an Extended Cytosine-Adenosine Repeat	PLOS ONE			English	Article							INTEGRIN ALPHA(2) GENE; DNA-BINDING; COLLAGEN RECEPTOR; KU AUTOANTIGEN; EXPRESSION; POLYMERASE; TRANSCRIPTION; ASSOCIATION; SEQUENCE; POLYMORPHISMS	Background: We have identified a cytosine-adenosine (CA) repeat length polymorphism in the 5'-regulatory region of the human integrin alpha 2 gene ITGA2 that begins at -605. Our objective was to establish the contribution of this polymorphism to the regulation of integrin alpha 2 beta 1 expression, which is known to vary several-fold among normal individuals, and to investigate the underlying mechanism(s). Methodology/Principal Findings: In combination with the SNP C-52T, previously identified by us as a binding site for the transcription factor Sp1, four ITGA2 haplotypes can be distinguished, in the order in which they enhance ITGA2 transcription: (CA)(12)/-52C>(CA)(11)/-52C>(CA)(11)/-52T>(CA)(10)/-52T. By DNA affinity chromatography and chromatin immunoprecipitation (ChIP) assays, we show that poly (ADP-ribose) polymerase-1 (PARP-1) and Ku80/70 bind specifically and with enhanced affinity to the longer (CA)(12) repeat alleles. Conclusions/Significance: The increased binding of PARP-1 and Ku80/70, known components of transcription co-activator complexes, to the longer (CA)(12) alleles of ITGA2 coincides with enhanced alpha 2 beta 1 expression. The most likely explanation for these findings is that PARP-1 and Ku80/70 contribute to the transcriptional regulation of ITGA2. These observations provide new insight into the mechanisms(s) underlying haplotype-dependent variability in integrin alpha 2 beta 1 expression in human platelets and other cells.	[Cheli, Yann; Kunicki, Thomas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Cheli, Yann; Ballotti, Robert] Univ Nice, Inst Natl Sante & Rech Med, U895, Nice, France; [Williams, Shirley A.; Nugent, Diane J.] Childrens Hosp Orange Cty, Div Hematol, Orange, CA 92668 USA	Scripps Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Childrens Hospital of Orange County	Cheli, Y (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	tomk@scripps.edu	Cheli, Yann/O-5783-2016; BALLOTTI, Robert/F-8825-2013	Cheli, Yann/0000-0001-9839-4332; BALLOTTI, Robert/0000-0002-7322-4908	National Heart, Lung and Blood Institute [HL075821, HL086904]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075821, R01HL086904] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This study was supported by grants HL075821 and HL086904 from the National Heart, Lung and Blood Institute awarded to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheli Y, 2007, BBA-GENE STRUCT EXPR, V1769, P546, DOI 10.1016/j.bbaexp.2007.06.004; Cheli Y, 2006, BLOOD, V107, P4391, DOI 10.1182/blood-2005-12-4822; COLLER BS, 1989, BLOOD, V74, P182; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; DEMURCIA G, 1994, TRENDS BIOCHEM SCI, V19, P172, DOI 10.1016/0968-0004(94)90280-1; Di Paola J, 2005, J THROMB HAEMOST, V3, P1511, DOI 10.1111/j.1538-7836.2005.01273.x; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; Furihata K, 2002, ARTERIOSCL THROM VAS, V22, P1733, DOI 10.1161/01.ATV.0000034493.76465.FF; Giffin W, 1997, J BIOL CHEM, V272, P5647, DOI 10.1074/jbc.272.9.5647; Grote J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-48; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Jacquelin B, 2001, J BIOL CHEM, V276, P23518, DOI 10.1074/jbc.M102019200; Jacquelin B, 2001, BLOOD, V97, P1721, DOI 10.1182/blood.V97.6.1721; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KALB R, 1994, THROMB HAEMOSTASIS, V71, P651; Kannan P, 1999, NUCLEIC ACIDS RES, V27, P866, DOI 10.1093/nar/27.3.866; Kelavkar UP, 2000, GENES IMMUN, V1, P237, DOI 10.1038/sj.gene.6363665; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Kritzik M, 1998, BLOOD, V92, P2382, DOI 10.1182/blood.V92.7.2382; Kunicki TJ, 2009, J THROMB HAEMOST, V7, P2116, DOI 10.1111/j.1538-7836.2009.03610.x; Kunicki TJ, 1997, BLOOD, V89, P1939, DOI 10.1182/blood.V89.6.1939; Kunicki TJ, 2004, BLOOD, V104, P2359, DOI 10.1182/blood-2004-01-0349; Le Rhun Y, 1998, BIOCHEM BIOPH RES CO, V245, P1; Meisterernst M, 1997, P NATL ACAD SCI USA, V94, P2261, DOI 10.1073/pnas.94.6.2261; PIDARD D, 1983, J BIOL CHEM, V258, P2582; PISCHEL KD, 1987, J IMMUNOL, V138, P226; Reiner AP, 2003, THROMB HAEMOSTASIS, V89, P142; Reiner AP, 2000, STROKE, V31, P1628, DOI 10.1161/01.STR.31.7.1628; Rose JL, 2005, MOL PHARMACOL, V68, P439, DOI 10.1124/mol.104.010876; Santoso S, 1999, BLOOD, V93, P2449, DOI 10.1182/blood.V93.8.2449.408k34_2449_2453; Schild-Poulter C, 2003, DNA CELL BIOL, V22, P65, DOI 10.1089/104454903321515887; Simbulan-Rosenthal CM, 2000, P NATL ACAD SCI USA, V97, P11274, DOI 10.1073/pnas.200285797; SYDOR WJ, 2003, J THROMBOSIS HAEM S1, V1; Torrance H, 1998, J BIOL CHEM, V273, P20810, DOI 10.1074/jbc.273.33.20810; Ullrich O, 2001, NAT CELL BIOL, V3, P1035, DOI 10.1038/ncb1201-1035; ZUTTER MM, 1994, J BIOL CHEM, V269, P463	36	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8743	10.1371/journal.pone.0008743	http://dx.doi.org/10.1371/journal.pone.0008743			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090957	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900023
J	Giel, JL; Sorg, JA; Sonenshein, AL; Zhu, J				Giel, Jennifer L.; Sorg, Joseph A.; Sonenshein, Abraham L.; Zhu, Jun			Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficile	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; ANION-EXCHANGE RESINS; ANTIBIOTIC-TREATMENT; ESCHERICHIA-COLI; GNOTOBIOTIC MICE; TOXIN PRODUCTION; CYTO-TOXIN; DISEASE; ACIDS; INFECTION	Clostridium difficile, a spore-forming bacterium, causes antibiotic-associated diarrhea. In order to produce toxins and cause disease, C. difficile spores must germinate and grow out as vegetative cells in the host. Although a few compounds capable of germinating C. difficile spores in vitro have been identified, the in vivo signal(s) to which the spores respond were not previously known. Examination of intestinal and cecal extracts from untreated and antibiotic-treated mice revealed that extracts from the antibiotic-treated mice can stimulate colony formation from spores to greater levels. Treatment of these extracts with cholestyramine, a bile salt binding resin, severely decreased the ability of the extracts to stimulate colony formation from spores. This result, along with the facts that the germination factor is small, heat-stable, and water-soluble, support the idea that bile salts stimulate germination of C. difficile spores in vivo. All extracts able to stimulate high level of colony formation from spores had a higher proportion of primary to secondary bile salts than extracts that could not. In addition, cecal flora from antibiotic-treated mice was less able to modify the germinant taurocholate relative to flora from untreated mice, indicating that the population of bile salt modifying bacteria differed between the two groups. Taken together, these data suggest that an in vivo-produced compound, likely bile salts, stimulates colony formation from C. difficile spores and that levels of this compound are influenced by the commensal gastrointestinal flora.	[Sorg, Joseph A.; Sonenshein, Abraham L.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Giel, Jennifer L.; Zhu, Jun] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	Tufts University; University of Pennsylvania	Giel, JL (corresponding author), UBC Envis Grp, Philadelphia, PA USA.	junzhu@mail.med.upenn.edu	Zhu, Jun/A-1324-2007	Sorg, Joseph/0000-0001-7822-2656	National Institutes of Health [R01AI072479, N01 AI60050]; National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS) [K12 GM074869]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050, R01AI072479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was supported by National Institutes of Health grant R01AI072479 to J. Z. A. L. S. acknowledges funding from the National Institutes of Health contract N01 AI60050 (S. Tzipori, principal investigator). J. A. S. acknowledges support through National Institutes of Health Federal Training in Education and Critical Research Skills (TEACRS) fellowship K12 GM074869. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; ARIANO RE, 1990, CAN MED ASSOC J, V142, P1049; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Blossom DB, 2007, CLIN INFECT DIS, V45, P222, DOI 10.1086/518874; Chen XH, 2008, GASTROENTEROLOGY, V135, P1984, DOI 10.1053/j.gastro.2008.09.002; CORTHIER G, 1985, APPL ENVIRON MICROB, V49, P250, DOI 10.1128/AEM.49.1.250-252.1985; EDENHARDER R, 1984, J STEROID BIOCHEM, V21, P413, DOI 10.1016/0022-4731(84)90304-2; EYSSEN HJ, 1976, EUR J BIOCHEM, V66, P507, DOI 10.1111/j.1432-1033.1976.tb10576.x; FEKETY R, 1979, AM J CLIN NUTR, V32, P244, DOI 10.1093/ajcn/32.1.244; Giel JL, 2006, MOL MICROBIOL, V60, P1058, DOI 10.1111/j.1365-2958.2006.05160.x; Hashimoto S, 1996, LIPIDS, V31, P601, DOI 10.1007/BF02523830; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Jarvis WR, 2009, AM J INFECT CONTROL, V37, P263, DOI 10.1016/j.ajic.2009.01.001; Keel MK, 2006, VET PATHOL, V43, P225, DOI 10.1354/vp.43-3-225; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Liacouras CA, 1996, J CLIN GASTROENTEROL, V22, P186, DOI 10.1097/00004836-199604000-00007; MACDONALD IA, 1980, J LIPID RES, V21, P381; Merrigan M, 2003, ANAEROBE, V9, P91, DOI 10.1016/S1075-9964(03)00063-5; Monaghan T, 2009, POSTGRAD MED J, V85, P152, DOI 10.1136/gut.2007.128157; Murphy C, 2006, AGE AGEING, V35, P85, DOI 10.1093/ageing/afi212; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nerandzic MM, 2009, ANTIMICROB AGENTS CH, V53, P4133, DOI 10.1128/AAC.00252-09; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; ONDERDONK AB, 1980, INFECT IMMUN, V28, P277, DOI 10.1128/IAI.28.1.277-282.1980; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POWELL RC, 1962, AM J CLIN NUTR, V11, P156, DOI 10.1093/ajcn/11.2.156; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Razavi B, 2007, INFECTION, V35, P300, DOI 10.1007/s15010-007-6113-0; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; SAMUEL P, 1973, CIRC RES, V33, P393, DOI 10.1161/01.RES.33.4.393; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Sorg JA, 2009, J BACTERIOL, V191, P1115, DOI 10.1128/JB.01260-08; Stiefel U, 2008, J ANTIMICROB CHEMOTH, V62, P1105, DOI 10.1093/jac/dkn298; TAYLOR NS, 1980, J INFECT DIS, V141, P92, DOI 10.1093/infdis/141.1.92; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; WADOLKOWSKI EA, 1988, INFECT IMMUN, V56, P1030, DOI 10.1128/IAI.56.5.1030-1035.1988; WILSON KH, 1982, J CLIN MICROBIOL, V15, P443, DOI 10.1128/JCM.15.3.443-446.1982; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983	44	131	136	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8740	10.1371/journal.pone.0008740	http://dx.doi.org/10.1371/journal.pone.0008740			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090901	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900020
J	Garcia-Ayllon, MS; Riba-Llena, I; Serra-Basante, C; Alom, J; Boopathy, R; Saez-Valero, J				Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Alom, Jordi; Boopathy, Rathnam; Saez-Valero, Javier			Altered Levels of Acetylcholinesterase in Alzheimer Plasma	PLOS ONE			English	Article							MOLECULAR ISOFORM DISTRIBUTION; BLOOD-BRAIN-BARRIER; CEREBROSPINAL-FLUID; SENILE DEMENTIA; HUMAN BUTYRYLCHOLINESTERASE; CHOLINESTERASE ACTIVITY; MONOCLONAL-ANTIBODIES; VYSYA COMMUNITY; SELECTIVE LOSS; DISEASE	Background: Many studies have been conducted in an extensive effort to identify alterations in blood cholinesterase levels as a consequence of disease, including the analysis of acetylcholinesterase (AChE) in plasma. Conventional assays using selective cholinesterase inhibitors have not been particularly successful as excess amounts of butyrylcholinesterase (BuChE) pose a major problem. Principal Findings: Here we have estimated the levels of AChE activity in human plasma by first immunoprecipitating BuChE and measuring AChE activity in the immunodepleted plasma. Human plasma AChE activity levels were similar to 20 nmol/min/mL, about 160 times lower than BuChE. The majority of AChE species are the light G(1)+G(2) forms and not G(4) tetramers. The levels and pattern of the molecular forms are similar to that observed in individuals with silent BuChE. We have also compared plasma AChE with the enzyme pattern obtained from human liver, red blood cells, cerebrospinal fluid (CSF) and brain, by sedimentation analysis, Western blotting and lectin-binding analysis. Finally, a selective increase of AChE activity was detected in plasma from Alzheimer's disease (AD) patients compared to age and gender-matched controls. This increase correlates with an increase in the G(1)+G(2) forms, the subset of AChE species which are increased in Alzheimer's brain. Western blot analysis demonstrated that a 78 kDa immunoreactive AChE protein band was also increased in Alzheimer's plasma, attributed in part to AChE-T subunits common in brain and CSF. Conclusion: Plasma AChE might have potential as an indicator of disease progress and prognosis in AD and warrants further investigation.	[Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain; [Garcia-Ayllon, Maria-Salud; Riba-Llena, Iolanda; Serra-Basante, Carol; Alom, Jordi; Saez-Valero, Javier] Ctr Invest Biomed Res Enfermedades Neurodegenerat, Madrid, Spain; [Riba-Llena, Iolanda; Alom, Jordi] Hosp Gen Univ Elche, Serv Neurol, Alicante, Spain; [Boopathy, Rathnam] Bharathiar Univ, Dept Biotechnol, Coimbatore, Tamil Nadu, India	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Bharathiar University	Garcia-Ayllon, MS (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alacant, Spain.	j.saez@umh.es	Sáez, Javier/K-5756-2014; GARCIA-AYLLON, MARIA-SALUD/M-4387-2019	Sáez, Javier/0000-0001-7480-320X; , Iolanda/0000-0002-7276-0979; Garcia-Ayllon, Maria-Salud/0000-0001-5140-9752	CIEN Foundation; Fondo de Investigaciones Sanitarias [PI06/0181]; CIBERNED; Instituto de Salud Carlos III from Spain	CIEN Foundation; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); CIBERNED(Instituto de Salud Carlos III); Instituto de Salud Carlos III from Spain(Instituto de Salud Carlos III)	This work was supported by grants from CIEN Foundation (http://www.fundacioncien.es/), Fondo de Investigaciones Sanitarias (PI06/0181), and CIBERNED, Instituto de Salud Carlos III from Spain (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEYARD ME, 1983, LANCET, V2, P452; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1987, J NEUROCHEM, V48, P1845, DOI 10.1111/j.1471-4159.1987.tb05746.x; ATACK JR, 1985, J NEUROL SCI, V70, P1, DOI 10.1016/0022-510X(85)90182-0; ATACK JR, 1988, ANN NEUROL, V23, P161, DOI 10.1002/ana.410230209; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; Boschetti N, 1996, CLIN CHEM, V42, P19; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; BRIMIJOIN S, 1988, J NEUROCHEM, V51, P1227, DOI 10.1111/j.1471-4159.1988.tb03091.x; Carvalho FA, 2005, FEBS J, V272, P5584, DOI 10.1111/j.1742-4658.2005.04953.x; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Darreh-Shori T, 2004, J NEUROCHEM, V88, P1102, DOI 10.1046/j.1471-4159.2003.02230.x; Darreh-Shori T, 2002, NEUROLOGY, V59, P563, DOI 10.1212/WNL.59.4.563; DAVIES P, 1976, LANCET, V2, P1403; Flores-Flores C, 1997, NEUROSCI LETT, V239, P101, DOI 10.1016/S0304-3940(97)00902-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Ayllon MS, 2008, BRAIN, V131, P2946, DOI 10.1093/brain/awn209; Garcia-Ayllon MS, 2007, J NEUROCHEM, V101, P1701, DOI 10.1111/j.1471-4159.2007.04461.x; Garcia-Ayllon MS, 1999, NEUROSCI LETT, V265, P211, DOI 10.1016/S0304-3940(99)00252-9; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; Garcia-Ayllon MS, 2001, NEUROSCIENCE, V107, P199, DOI 10.1016/S0306-4522(01)00355-4; Grisaru D, 1999, EUR J BIOCHEM, V264, P672, DOI 10.1046/j.1432-1327.1999.00693.x; HODGSON AJ, 1983, J NEUROCHEM, V41, P654, DOI 10.1111/j.1471-4159.1983.tb04791.x; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Jaganathan L, 1998, INDIAN J BIOCHEM BIO, V35, P142; Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x; LADU BN, 1991, CELL MOL NEUROBIOL, V11, P79, DOI 10.1007/BF00712801; Li B, 2000, J NEUROCHEM, V75, P1320, DOI 10.1046/j.1471-4159.2000.751320.x; Li B, 2005, BIOCHEM PHARMACOL, V70, P1673, DOI 10.1016/j.bcp.2005.09.002; LIAO J, 1994, J NEUROCHEM, V63, P1446; MADER M, 1991, EUR J CLIN CHEM CLIN, V29, P51; Manoharan I, 2007, J NEURAL TRANSM, V114, P939, DOI 10.1007/s00702-007-0631-x; Manoharan I, 2007, CLIN CHIM ACTA, V378, P128, DOI 10.1016/j.cca.2006.11.005; Manoharan I, 2006, PHARMACOGENET GENOM, V16, P461; MARQUIS JK, 1985, BIOL PSYCHIAT, V20, P605, DOI 10.1016/0006-3223(85)90095-2; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MEFLAH K, 1984, BIOCHIMIE, V66, P59, DOI 10.1016/0300-9084(84)90192-5; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; MESULAM MM, 1987, ANN NEUROL, V22, P223, DOI 10.1002/ana.410220206; MINTZ KP, 1985, J NEUROCHEM, V45, P284, DOI 10.1111/j.1471-4159.1985.tb05505.x; MOORADIAN AD, 1988, NEUROBIOL AGING, V9, P31, DOI 10.1016/S0197-4580(88)80013-7; PERRY EK, 1977, LANCET, V1, P189; PERRY RH, 1982, LANCET, V1, P174; RAKONCZAY Z, 1985, BIOCHIM BIOPHYS ACTA, V832, P127, DOI 10.1016/0167-4838(85)90323-1; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Santos SCR, 2007, J BIOL CHEM, V282, P25597, DOI 10.1074/jbc.M700569200; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saez-Valero J, 2005, NEUROSCI LETT, V383, P93, DOI 10.1016/j.neulet.2005.03.045; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; Saez-Valero J, 2002, NEUROSCI LETT, V325, P199, DOI 10.1016/S0304-3940(02)00282-3; Saez-Valero J, 2000, ACTA NEUROL SCAND, V102, P49, DOI 10.1034/j.1600-0404.2000.00307.x; Sberna G, 1998, J NEUROCHEM, V71, P723; Silveyra MX, 2008, MOL CELL BIOL, V28, P2908, DOI 10.1128/MCB.02065-07; SIRVIO J, 1989, J NEURAL TRANSM, V75, P119, DOI 10.1007/BF01677425; SORENSEN K, 1986, CLIN CHIM ACTA, V158, P1, DOI 10.1016/0009-8981(86)90109-9; STCLAIR DM, 1986, J NEUROL SCI, V73, P169, DOI 10.1016/0022-510X(86)90128-0; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; STIEGER S, 1987, J NEUROCHEM, V49, P460, DOI 10.1111/j.1471-4159.1987.tb02887.x; SZILAGYI AK, 1987, EUR ARCH PSY CLIN N, V236, P309, DOI 10.1007/BF00380958; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; TSIM KWK, 1988, EMBO J, V7, P2451, DOI 10.1002/j.1460-2075.1988.tb03091.x; ULRICH J, 1990, ACTA NEUROPATHOL, V80, P624, DOI 10.1007/BF00307630; YAMAMOTO Y, 1990, ANN CLIN BIOCHEM, V27, P321, DOI 10.1177/000456329002700407	64	77	78	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8701	10.1371/journal.pone.0008701	http://dx.doi.org/10.1371/journal.pone.0008701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090844	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600004
J	Mosha, JF; Conteh, L; Tediosi, F; Gesase, S; Bruce, J; Chandramohan, D; Gosling, R				Mosha, Jacklin F.; Conteh, Lesong; Tediosi, Fabrizio; Gesase, Samwel; Bruce, Jane; Chandramohan, Daniel; Gosling, Roly			Cost Implications of Improving Malaria Diagnosis: Findings from North-Eastern Tanzania	PLOS ONE			English	Article							COMBINATION THERAPY; AFRICAN CHILDREN; FEBRILE ILLNESS; CASE-MANAGEMENT; ECONOMIC COSTS; TESTS; KENYA; AREA; ERA; OVERDIAGNOSIS	Background: Over diagnosis of malaria contributes to improper treatment, wastage of drugs and resistance to the few available drugs. This paper attempts to estimate the rates of over diagnosis of malaria among children attending dispensaries in rural Tanzania and examines the potential cost implications of improving the quality of diagnosis. Methodology/Principal Findings: The magnitude of over diagnosis of malaria was estimated by comparing the proportion of outpatient attendees of all ages clinically diagnosed as malaria to the proportion of attendees having a positive malaria rapid diagnostic test over a two month period. Pattern of causes of illness observed in a <2 year old cohort of children over one year was compared to the pattern of causes of illness in <5 year old children recorded in the routine health care system during the same period. Drug and diagnostic costs were modelled using local and international prices. Over diagnosis of malaria by the routine outpatient care system compared to RDT confirmed cases of malaria was highest among <5 year old children in the low transmission site (RR 17.9, 95% CI 5.8-55.3) followed by the >= 5 year age group in the lower transmission site (RR 14.0.95% CI 8.2-24.2). In the low transmission site the proportion of morbidity attributable to malaria was substantially lower in <2 year old cohort compared to children seen at routine care system. (0.08% vs 28.2%; p<0.001). A higher proportion of children were diagnosed with ARI in the <2 year old cohort compared to children seen at the routine care system (42% vs 26%; p<0.001). Using a RDT reduced overall drug and diagnostic costs by 10% in the high transmission site and by 15% in the low transmission site compared to total diagnostic and drug costs of treatment based on clinical judgment in routine health care system. Implications: The introduction of RDTs is likely to lead to financial savings. However, improving diagnosis to one disease may lead to over diagnosis of another illness. Quality improvement is complex but introducing RDTs for the diagnosis of malaria is a good start.	[Mosha, Jacklin F.] Natl Inst Med Res, Mwanza, Tanzania; [Conteh, Lesong; Bruce, Jane; Chandramohan, Daniel; Gosling, Roly] London Sch Hyg & Trop Med, London WC1, England; [Conteh, Lesong; Tediosi, Fabrizio] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Tediosi, Fabrizio] Univ Bocconi, Milan, Italy; [Gesase, Samwel] Natl Inst Med Res, Tanga, Tanzania	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; University of Basel; Swiss Tropical & Public Health Institute; Bocconi University	Mosha, JF (corresponding author), Natl Inst Med Res, Mwanza, Tanzania.	jfmosha@yahoo.com	Tediosi, Fabrizio/AAD-4805-2022; Conteh, Lesong/ABE-9550-2020; Tediosi, Fabrizio/ABC-7880-2020	Tediosi, Fabrizio/0000-0001-8671-9400; Conteh, Lesong/0000-0002-0719-3672; Mosha, Jacklin/0000-0001-7940-8903	Bill and Melinda Gates Foundation [28579]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The Bill and Melinda Gates Foundation funded this work. Grant no. 28579. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-Elgayoum SME, 2009, DIAGN MICR INFEC DIS, V64, P20, DOI 10.1016/j.diagmicrobio.2009.01.029; Abeku TA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-202; [Anonymous], 2007, LANCET, V370, P1459; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Chanda Pascalina, 2009, Cost Eff Resour Alloc, V7, P5, DOI 10.1186/1478-7547-7-5; Chandler CIR, 2008, TROP MED INT HEALTH, V13, P1131, DOI 10.1111/j.1365-3156.2008.02118.x; Chandler CIR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-53; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; Chuma JM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-76; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; De Savigny D, 2004, AM J TROP MED HYG, V71, P224, DOI 10.4269/ajtmh.2004.71.224; Drakeley C, 2009, T ROY SOC TROP MED H, V103, P333, DOI 10.1016/j.trstmh.2008.10.003; Gosling RD, 2009, TROP MED INT HEALTH, V14, P1003, DOI 10.1111/j.1365-3156.2009.02303.x; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; *MED STOR DEP, 2007, PRIC CAT ESS MED HOS; Mwanziva C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-232; Ndyomugyenyi R, 2007, T ROY SOC TROP MED H, V101, P209, DOI 10.1016/j.trstmh.2006.06.004; NJUNWA KJ, 1991, ACTA TROP, V49, P87, DOI 10.1016/0001-706X(91)90056-P; Okiro EA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-151; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Rolland E, 2006, TROP MED INT HEALTH, V11, P398, DOI 10.1111/j.1365-3156.2006.01580.x; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Uzochukwu BSC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-265; Zikusooka CM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-176; Zurovac D, 2008, AM J TROP MED HYG, V78, P884, DOI 10.4269/ajtmh.2008.78.884; 2007, INT DRUG PRICE INDIC	35	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8707	10.1371/journal.pone.0008707	http://dx.doi.org/10.1371/journal.pone.0008707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090933	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000273714600010
J	Landrum, ML; Fieberg, AM; Chun, HM; Crum-Cianflone, NF; Marconi, VC; Weintrob, AC; Ganesan, A; Barthel, RV; Wortmann, G; Agan, BK				Landrum, Michael L.; Fieberg, Ann M.; Chun, Helen M.; Crum-Cianflone, Nancy F.; Marconi, Vincent C.; Weintrob, Amy C.; Ganesan, Anuradha; Barthel, Robert V.; Wortmann, Glenn; Agan, Brian K.			The Effect of Human Immunodeficiency Virus on Hepatitis B Virus Serologic Status in Co-Infected Adults	PLOS ONE			English	Article							T-CELL RESPONSES; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; HIV-INFECTION; HBV; SEROCONVERSION; RECOMMENDATIONS; COMPLICATIONS; MANAGEMENT; MORTALITY	Background: Factors associated with serologic hepatitis B virus (HBV) outcomes in HIV-infected individuals remain incompletely understood, yet such knowledge may lead to improvements in the prevention and treatment of chronic HBV infection. Methods and Findings: HBV-HIV co-infected cohort participants were retrospectively analyzed. HBV serologic outcomes were classified as chronic, resolved, and isolated-HBcAb. Chronic HBV (CHBV) was defined as the presence of HBsAg on two or more occasions at least six months apart. Risk factors for HBV serologic outcome were assessed using logistic regression. Of 2037 participants with HBV infection, 281 (14%) had CHBV. Overall the proportions of HBV infections classified as CHBV were 11%, 16%, and 19% for CD4 cell count strata of >= 500, 200-499, and,200, respectively (p<0.0001). Risk of CHBV was increased for those with HBV infection occurring after HIV diagnosis (OR 2.62; 95% CI 1.78-3.85). This included the subset with CD4 count >= 500 cells/mu L where 21% of those with HBV after HIV diagnosis had CHBV compared with 9% for all other cases of HBV infection in this stratum (p = 0.0004). Prior receipt of HAART was associated with improved HBV serologic outcome overall (p = 0.012), and specifically among those with HBV after HIV (p = 0.002). In those with HBV after HIV, HAART was associated with reduced risk of CHBV overall (OR 0.18; 95% CI 0.04-0.79); including reduced risk in the subsets with CD4 >= 350 cells/mu L (p<0.001) and CD4 >= 500 cells/mu L (p = 0.01) where no cases of CHBV were seen in those with a recent history of HAART use. Conclusions: Clinical indicators of immunologic status in HIV-infected individuals, such as CD4 cell count, are associated with HBV serologic outcome. These data suggest that immunologic preservation through the increased use of HAART to improve functional anti-HBV immunity, whether by improved access to care or earlier initiation of therapy, would likely improve HBV infection outcomes in HIV-infected individuals.	[Landrum, Michael L.; Fieberg, Ann M.; Weintrob, Amy C.; Ganesan, Anuradha; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA; [Landrum, Michael L.; Crum-Cianflone, Nancy F.; Marconi, Vincent C.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Fieberg, Ann M.] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Chun, Helen M.] USN, Hlth Res Ctr, Dept Def HIV AIDS Prevent Program, San Diego, CA USA; [Crum-Cianflone, Nancy F.] USN, Med Ctr, Infect Dis Clin, San Diego, CA USA; [Weintrob, Amy C.; Wortmann, Glenn] Walter Reed Army Med Ctr, Infect Dis Serv, Washington, DC 20307 USA; [Ganesan, Anuradha] Natl Naval Med Ctr, Div Infect Dis, Bethesda, MD USA; [Barthel, Robert V.] USN, Med Ctr, Div Infect Dis, Portsmouth, VA USA	Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); United States Department of Defense; United States Navy; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy	Landrum, ML (corresponding author), Uniformed Serv Univ Hlth Sci, Infect Dis Clin Res Program, Bethesda, MD 20814 USA.	mlandrum@idcrp.org	Marconi, Vincent/AFK-5812-2022; Marconi, Vincent/N-3210-2014; Marconi, Vincent/GRJ-4553-2022	Marconi, Vincent/0000-0001-8409-4689; Marconi, Vincent/0000-0001-8409-4689; Agan, Brian/0000-0002-5114-1669	IDCRP [G187YS-RV198]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER	IDCRP; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work (IDCRP# G187YS-RV198) was provided by the Infectious Disease Clinical Research Program (IDCRP, www. idcrp. org), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072. The IDCRP reviewed the study design, collected the data, and provided salary support to investigators (M. L. L. A. M. F., N. F. C., A. C. W., A. G., and B. K. A.). The analyses, conclusions and decision to submit the manuscript are the independent work and decision of the authors. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BODSWORTH NJ, 1991, J INFECT DIS, V163, P1138, DOI 10.1093/infdis/163.5.1138; Brodine SK, 2003, AIDS, V17, P2521, DOI 10.1097/00002030-200311210-00016; Carr A, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(05)62892-9; Centers for Disease Control and Prevention, 1992, MMWR, V41; Chun HM, 2007, INFECT DIS CLIN PRAC, V15, P38, DOI 10.1097/01.idc.0000246152.78893.40; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hoff J, 2001, CLIN INFECT DIS, V32, P963, DOI 10.1086/319368; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; LANDRUM ML, 2009, AIDS, V23, DOI DOI 10.1097/QAD.1090-B1013E32832CD32899E; Lascar RM, 2003, J INFECT DIS, V188, P1815, DOI 10.1086/379896; Lascar RM, 2005, J INFECT DIS, V191, P1169, DOI 10.1086/428502; Miailhes P, 2007, CLIN INFECT DIS, V45, P624, DOI 10.1086/520752; Nunez M, 2006, AIDS RES HUM RETROV, V22, P842, DOI 10.1089/aid.2006.22.842; *PAN ANT GUID AD A, 2008, GUID US ANT AG HIV 1; Piroth L, 2000, J ACQ IMMUN DEF SYND, V23, P356; Piroth L, 2002, J HEPATOL, V36, P681, DOI 10.1016/S0168-8278(02)00019-3; Piroth L, 2007, AIDS, V21, P1323, DOI 10.1097/QAD.0b013e32810c8bcf; Puoti M, 2006, J HEPATOL, V44, pS65, DOI 10.1016/j.jhep.2005.11.015; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Rouphael NG, 2007, AIDS, V21, P771, DOI 10.1097/QAD.0b013e3280ad47f5; Sheng WH, 2007, CLIN INFECT DIS, V45, P1221, DOI 10.1086/522173; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Tedaldi E, 2008, CLIN INFECT DIS, V47, P1468, DOI 10.1086/593102; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Velasco M, 1999, NEW ENGL J MED, V340, P1765, DOI 10.1056/NEJM199906033402215; Vierling John M, 2007, Clin Liver Dis, V11, P727, DOI 10.1016/j.cld.2007.08.001; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Weintrob AC, 2008, JAIDS-J ACQ IMM DEF, V49, P40, DOI 10.1097/QAI.0b013e31817bec05	33	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8687	10.1371/journal.pone.0008687	http://dx.doi.org/10.1371/journal.pone.0008687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084275	Green Submitted, Green Published, gold			2022-12-27	WOS:000273554600036
J	Wanner, KW; Nichols, AS; Allen, JE; Bunger, PL; Garczynski, SF; Linn, CE; Robertson, HM; Luetje, CW				Wanner, Kevin W.; Nichols, Andrew S.; Allen, Jean E.; Bunger, Peggy L.; Garczynski, Stephen F.; Linn, Charles E., Jr.; Robertson, Hugh M.; Luetje, Charles W.			Sex Pheromone Receptor Specificity in the European Corn Borer Moth, Ostrinia nubilalis	PLOS ONE			English	Article							DROSOPHILA ODORANT RECEPTORS; NEURON RESPONSIVENESS; OLFACTORY RECEPTORS; SPP. LEPIDOPTERA; EVOLUTION; RESPONSES; GENES; FURNACALIS; EXPRESSION; COMPONENTS	Background: The European corn borer (ECB), Ostrinia nubilalis (Hubner), exists as two separate sex pheromone races. ECB(Z) females produce a 97:3 blend of Z11- and E11-tetradecenyl acetate whereas ECB(E) females produce an opposite 1:99 ratio of the Z and E isomers. Males of each race respond specifically to their conspecific female's blend. A closely related species, the Asian corn borer (ACB), O. furnacalis, uses a 3:2 blend of Z12- and E12-tetradecenyl acetate, and is believed to have evolved from an ECB-like ancestor. To further knowledge of the molecular mechanisms of pheromone detection and its evolution among closely related species we identified and characterized sex pheromone receptors from ECB(Z). Methodology: Homology-dependent (degenerate PCR primers designed to conserved amino acid motifs) and homology-independent (pyrophosphate sequencing of antennal cDNA) approaches were used to identify candidate sex pheromone transcripts. Expression in male and female antennae was assayed by quantitative real-time PCR. Two-electrode voltage clamp electrophysiology was used to functionally characterize candidate receptors expressed in Xenopus oocytes. Conclusion: We characterized five sex pheromone receptors, OnOrs1 and 3-6. Their transcripts were 14-100 times more abundant in male compared to female antennae. OnOr6 was highly selective for Z11-tetradecenyl acetate (EC50 = 0.86 +/- 0.27 mu M) and was at least three orders of magnitude less responsive to E11-tetradecenyl acetate. Surprisingly, OnOr1, 3 and 5 responded to all four pheromones tested (Z11- and E11-tetradecenyl acetate, and Z12- and E12-tetradecenyl acetate) and to Z9-tetradecenyl acetate, a behavioral antagonist. OnOr1 was selective for E12-tetradecenyl acetate based on an efficacy that was at least 5-fold greater compared to the other four components. This combination of specifically-and broadly-responsive pheromone receptors corresponds to published results of sensory neuron activity in vivo. Receptors broadly-responsive to a class of pheromone components may provide a mechanism for variation in the male moth response that enables population level shifts in pheromone blend use.	[Wanner, Kevin W.; Allen, Jean E.; Bunger, Peggy L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Nichols, Andrew S.; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Garczynski, Stephen F.] ARS, Yakima Agr Res Lab, USDA, Wapato, WA USA; [Linn, Charles E., Jr.] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Barton Lab, Geneva, NY 14456 USA; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	Montana State University System; Montana State University Bozeman; University of Miami; United States Department of Agriculture (USDA); Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Wanner, KW (corresponding author), Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA.	kwanner@montana.edu			Montana State University; United States Department of Agriculture (USDA) [2007-35604-17756, 2008-35302-18815]; National Institutes of Health (NIH) [DC008119]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091, R01DC008119] Funding Source: NIH RePORTER	Montana State University; United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	K. W. W. gratefully acknowledges the support of Montana State University. This work was funded in part by United States Department of Agriculture (USDA) grants 2007-35604-17756 and 2008-35302-18815 to H. M. R. and National Institutes of Health (NIH) grant DC008119 to C. W. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; BRINDLEY TA, 1975, ANNU REV ENTOMOL, V20, P221, DOI 10.1146/annurev.en.20.010175.001253; Carde RT, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P283, DOI 10.1017/CBO9780511542664.009; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; Domingue MJ, 2008, J INSECT PHYSIOL, V54, P1261, DOI 10.1016/j.jinsphys.2008.06.001; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P488, DOI 10.1016/j.jinsphys.2007.01.009; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Grimaldi David, 2005, pi; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HANSSON BS, 1995, J INSECT PHYSIOL, V41, P171, DOI 10.1016/0022-1910(94)00086-V; HANSSON BS, 1994, TISSUE CELL, V26, P503, DOI 10.1016/0040-8166(94)90003-5; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Karpati Z, 2008, J EXP BIOL, V211, P2841, DOI 10.1242/jeb.017319; KLUN JA, 1980, LIFE SCI, V27, P1603, DOI 10.1016/0024-3205(80)90570-6; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2005, EUR J NEUROSCI, V21, P2167, DOI 10.1111/j.1460-9568.2005.04058.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2002, J EXP BIOL, V205, P989; Linn CE, 2007, J CHEM ECOL, V33, P909, DOI 10.1007/s10886-007-9268-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOFSTEDT C, 1993, PHILOS T R SOC B, V340, P167, DOI 10.1098/rstb.1993.0055; LOFSTEDT C, 1989, GENETICS, V123, P553; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2009, INT J BIOL SCI, V5, P319; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Pelozuelo L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000555; Phelan PL, 1997, INSECT PHEROMONE RESEARCH, P563; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2003, P NATL ACAD SCI USA, V100, P9179, DOI 10.1073/pnas.1233767100a; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; ROELOFS WL, 1985, J CHEM ECOL, V11, P829, DOI 10.1007/BF01012071; Rozen S, 2000, Methods Mol Biol, V132, P365; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; SCHNEIDER D, 1992, NATURWISSENSCHAFTEN, V79, P241, DOI 10.1007/BF01175388; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; VANDERPERS JNC, 1978, J INSECT PHYSIOL, V24, P337, DOI 10.1016/0022-1910(78)90033-1; Wanner KW, 2008, INSECT MOL BIOL, V17, P621, DOI 10.1111/j.1365-2583.2008.00836.x; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; WANNER KW, 2009, MOL BIOL GENETICS LE, P153; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104	50	110	123	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8685	10.1371/journal.pone.0008685	http://dx.doi.org/10.1371/journal.pone.0008685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084285	Green Submitted, gold, Green Published			2022-12-27	WOS:000273554600034
J	Sahasrabuddhe, VV; Bhosale, RA; Joshi, SN; Kavatkar, AN; Nagwanshi, CA; Kelkar, RS; Jenkins, CA; Shepherd, BE; Sahay, S; Risbud, AR; Vermund, SH; Mehendale, SM				Sahasrabuddhe, Vikrant V.; Bhosale, Ramesh A.; Joshi, Smita N.; Kavatkar, Anita N.; Nagwanshi, Chandraprabha A.; Kelkar, Rohini S.; Jenkins, Cathy A.; Shepherd, Bryan E.; Sahay, Seema; Risbud, Arun R.; Vermund, Sten H.; Mehendale, Sanjay M.			Prevalence and Predictors of Colposcopic-Histopathologically Confirmed Cervical Intraepithelial Neoplasia in HIV-Infected Women in India	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; ANTIRETROVIRAL THERAPY; REGRESSION-MODELS; HPV; LESIONS; REPRODUCIBILITY; PREVENTION; GUIDELINES; MANAGEMENT	Background: Prevalence estimates of cervical intraepithelial neoplasia (CIN) among HIV-infected women in India have been based on cervical cytology, which may have underestimated true disease burden. We sought to better establish prevalence estimates and evaluate risk factors of CIN among HIV-infected women in Pune, India using colposcopy and histopathology as diagnostic tools. Methodology: Previously unscreened, non-pregnant HIV-infected women underwent cervical cancer screening evaluation including standardized diagnostic colposcopy by a gynecologist. Histopathologic confirmation was conducted among consenting women with clinical suspicion of CIN. The prevalence of CIN was evaluated by a composite diagnosis based on colposcopy and histopathology results. Multivariable ordinal logistic regression analysis was conducted to determine independent predictors of increasing severity of CIN. Results: The median age of the n = 303 enrolled HIV-infected women was 30 years (interquartile range, 27-34). A majority of the participants were widowed or separated (187/303, 61.7%), more than one-third (114/302, 37.7%) were not educated beyond primary school, and nearly two-thirds (196/301, 64.7%) had a family per capita income of <1,000 Indian Rupees (similar to US$22) per month. Cervical high-risk HPV-DNA was detected in 41.7% (124/297) of participants. The composite colposcopic-histopathologic diagnoses revealed no evidence of CIN in 220 out of 303 (72.6%) women, CIN1 in 33/303 (10.9%), CIN2 in 31/303 (10.2%), CIN3 in 18/303 (5.9%) and 1 (0.3%) woman was diagnosed with ICC. Thus, over a quarter of the participants [83/303: 27.7% (95% CI: 22.7-33.1)] had >= CIN1 lesions and a sixth [50/303: 16.5% (95% CI: 12.2-21.9)] had evidence of advanced (>= CIN2) neoplastic disease. The independent predictors of increasing severity of CIN as revealed by a proportional odds model using multivariable ordinal logistic regression included (i) currently receiving antiretroviral therapy [adjusted odds ratios (aOR): 2.24 (1.17, 4.26), p = 0.01] and (ii) presence of cervical high-risk HPV-DNA [aOR: 1.93 (1.13, 3.28), p = 0.02]. Conclusions: HIV-infected women in Pune, India have a substantial burden of cervical precancerous lesions, which may progress to invasive cervical cancer unless appropriately detected and treated. Increased attention should focus on recognizing and addressing this entirely preventable cancer among HIV-infected women, especially in the context of increasing longevity due to antiretroviral therapy.	[Sahasrabuddhe, Vikrant V.; Vermund, Sten H.] Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA; [Bhosale, Ramesh A.] Byramjee Jeejeebhoy Med Coll, Dept Obstet & Gynecol, Pune, Maharashtra, India; [Joshi, Smita N.; Mehendale, Sanjay M.] Natl AIDS Res Inst, Dept Epidemiol, Pune, Maharashtra, India; [Kavatkar, Anita N.; Nagwanshi, Chandraprabha A.] Byramjee Jeejeebhoy Med Coll, Dept Pathol, Pune, Maharashtra, India; [Kelkar, Rohini S.] Tata Mem Hosp, Dept Microbiol, Mumbai, Maharashtra, India; [Jenkins, Cathy A.; Shepherd, Bryan E.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Sahay, Seema] Natl AIDS Res Inst, Dept Social & Behav Sci, Pune, Maharashtra, India; [Risbud, Arun R.] Natl AIDS Res Inst, Dept Microbiol, Pune, Maharashtra, India	Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Tata Memorial Centre (TMC); Tata Memorial Hospital; Vanderbilt University; Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI); Indian Council of Medical Research (ICMR); ICMR - National AIDS Research Institute (NARI)	Sahasrabuddhe, VV (corresponding author), Vanderbilt Univ, Inst Global Hlth, Nashville, TN 37203 USA.	vikrant.sahasrabuddhe@vanderbilt.edu	Joshi, Smita/S-2716-2019; Vermund, Sten/AAD-3592-2020	Vermund, Sten/0000-0001-7289-8698; Sahay, Seema/0000-0001-6064-827X	National Institutes of Health (NIH), National Cancer Institute [R21CA113465]; National Institutes of Health (NIH), Fogarty International Center [D43TW001035]; National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [P30AI54999]; Indian Council of Medical Research (ICMR); FOGARTY INTERNATIONAL CENTER [D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA113465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI054999] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the following grants from the National Institutes of Health (NIH): R21CA113465 (from the National Cancer Institute), D43TW001035 (from the Fogarty International Center) and P30AI54999 (from the National Institute of Allergy and Infectious Diseases). Additional support was received from intramural resources of the Indian Council of Medical Research (ICMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG BG, 1989, AM J EPIDEMIOL, V129, P191, DOI 10.1093/oxfordjournals.aje.a115109; Ballagh S, 2004, JAIDS-J ACQ IMM DEF, V37, pS152, DOI 10.1097/00126334-200410013-00003; Denny L, 2008, OBSTET GYNECOL, V111, P1380, DOI 10.1097/AOG.0b013e3181743327; Dexeus S, 2002, EUR J GYNAECOL ONCOL, V23, P269; Dhir AA, 2008, CURR OPIN ONCOL, V20, P517, DOI 10.1097/CCO.0b013e32830a4c87; Franceschi S, 2007, CLIN INFECT DIS, V45, P510, DOI 10.1086/520022; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Gakidou E, 2008, PLOS MED, V5, P863, DOI 10.1371/journal.pmed.0050132; GHATE M, 2008, INT J INFECT DIS; Gravitt PE, 2008, VACCINE, V26, pK42, DOI 10.1016/j.vaccine.2008.05.002; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Harrell FE, 2001, REGRESSION MODELING; Hawes SE, 2006, J NATL CANCER I, V98, P100, DOI 10.1093/jnci/djj010; Heard I, 2004, ANTIVIR THER, V9, P13; Jeronimo J, 2006, AM J OBSTET GYNECOL, V195, P349, DOI 10.1016/j.ajog.2006.01.091; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; JOSHI J, 1993, CYTOPATHOLOGY, V4, P63, DOI 10.1111/j.1365-2303.1993.tb00076.x; Joshi S, 2001, INDIAN J MED RES, V113, P161; Joshi SN, 2005, J MED VIROL, V76, P470, DOI 10.1002/jmv.20385; Kosinski AS, 2003, BIOMETRICS, V59, P163, DOI 10.1111/1541-0420.00019; Massad L S, 2001, J Low Genit Tract Dis, V5, P212; Massad LS, 2005, OBSTET GYNECOL, V106, P525, DOI 10.1097/01.AOG.0000172429.45130.1f; McCluggage WG, 1998, BRIT J OBSTET GYNAEC, V105, P206, DOI 10.1111/j.1471-0528.1998.tb10054.x; McCluggage WG, 1996, J CLIN PATHOL, V49, P833, DOI 10.1136/jcp.49.10.833; Minkoff H, 2001, AIDS, V15, P2157, DOI 10.1097/00002030-200111090-00011; Mwanahamuntu M.H., 2008, B WHO, V86; Mwanahamuntu MH, 2009, NEW ENGL J MED, V361, P305; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Over M, 2006, SEX TRANSM DIS, V33, pS145, DOI 10.1097/01.olq.0000238457.93426.0d; Palefsky Joel M, 2003, J Natl Cancer Inst Monogr, P41; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patro B K, 2007, Indian J Public Health, V51, P216; Peedicayil A, 2009, J LOW GENIT TRACT DI, V13, P159, DOI 10.1097/LGT.0b013e31818fb40d; Pretorius RG, 2007, INT J CANCER, V121, P2218, DOI 10.1002/ijc.22991; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Richart R M, 1973, Pathol Annu, V8, P301; Sankaranarayanan R, 2005, INT J GYNECOL OBSTET, V89, pS4, DOI 10.1016/j.ijgo.2005.01.009; Sankaranarayanan R, 2008, VACCINE, V26, pM43, DOI 10.1016/j.vaccine.2008.05.005; Sellors J. W., 2003, COLPOSCOPY TREATMENT; STIGMA, 2019, GUID MAN SEX TRANSM; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Terry G, 2001, J MED VIROL, V65, P155, DOI 10.1002/jmv.2015; *UNAIDS, 2007, 2007 AIDS EP UPD JOI; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	47	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8634	10.1371/journal.pone.0008634	http://dx.doi.org/10.1371/journal.pone.0008634			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072610	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200012
J	Gluschnaider, U; Hidas, G; Cojocaru, G; Yutkin, V; Ben-Neriah, Y; Pikarsky, E				Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli			beta-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; ANDROGEN-INDEPENDENT GROWTH; NF-KAPPA-B; BOX PROTEIN BETA-TRCP1; LNCAP CELLS; DEGRADATION; CATENIN; TUMORIGENESIS; PROGRESSION; IDENTIFICATION	Background: Prostate cancer is a common and heterogeneous disease, where androgen receptor (AR) signaling plays a pivotal role in development and progression. The initial treatment for advanced prostate cancer is suppression of androgen signaling. Later on, essentially all patients develop an androgen independent stage which does not respond to anti hormonal treatment. Thus, alternative strategies targeting novel molecular mechanisms are required. beta-TrCP is an E3 ligase that targets various substrates essential for many aspects of tumorigenesis. Methodology/Principal Findings: Here we show that beta-TrCP depletion suppresses prostate cancer and identify a relevant growth control mechanism. shRNA targeted against beta-TrCP reduced prostate cancer cell growth and cooperated with androgen ablation in vitro and in vivo. We found that beta-TrCP inhibition leads to upregulation of the aryl hydrocarbon receptor (AhR) mediating the therapeutic effect. This phenomenon could be ligand independent, as the AhR ligand 2,3,7,8-Tetrachlorodibenzo- p-Dioxin (TCDD) did not alter prostate cancer cell growth. We detected high AhR expression and activation in basal cells and atrophic epithelial cells of human cancer bearing prostates. AhR expression and activation is also significantly higher in tumor cells compared to benign glandular epithelium. Conclusions/Significance: Together these observations suggest that AhR activation may be a cancer counteracting mechanism in the prostate. We maintain that combining b-TrCP inhibition with androgen ablation could benefit advanced prostate cancer patients.	[Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel; [Gluschnaider, Udi; Hidas, Guy; Cojocaru, Gady; Yutkin, Vladimir; Ben-Neriah, Yinon; Pikarsky, Eli] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol, IL-91010 Jerusalem, Israel; [Hidas, Guy; Yutkin, Vladimir] Hadassah Hebrew Univ, Med Ctr, Dept Urol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center	Gluschnaider, U (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel.	peli@hadassah.org.il		pikarsky, eli/0000-0003-4186-7105	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Prostate Cancer Foundation - Israel	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Prostate Cancer Foundation - Israel	This work was supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, Prostate Cancer Foundation - Israel and the Prostate Cancer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2001, SEMIN ONCOL, V28, P613, DOI 10.1053/sonc.2001.28609; Barouki R, 2007, FEBS LETT, V581, P3608, DOI 10.1016/j.febslet.2007.03.046; Belaidouni N, 2005, ONCOGENE, V24, P2271, DOI 10.1038/sj.onc.1208418; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Cai Y, 2009, CANCER RES, V69, P819, DOI 10.1158/0008-5472.CAN-08-2537; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Chesire DR, 2002, ONCOGENE, V21, P2679, DOI 10.1038/sj.onc.1205352; COFFEY DS, 1981, UROLOGY, V17, P17; Deutsch E, 2004, LANCET ONCOL, V5, P303, DOI 10.1016/S1470-2045(04)01468-8; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gao S, 2005, MOL ENDOCRINOL, V19, P1792, DOI 10.1210/me.2004-0445; Gerstein AV, 2002, GENE CHROMOSOME CANC, V34, P9, DOI 10.1002/gcc.10037; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kizu R, 2003, ARCH TOXICOL, V77, P335, DOI 10.1007/s00204-003-0454-y; Kudo Y, 2004, MOL CELL BIOL, V24, P8184, DOI 10.1128/MCB.24.18.8184-8194.2004; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liang CY, 2006, CELL SIGNAL, V18, P1309, DOI 10.1016/j.cellsig.2005.10.011; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Morrow D, 2004, J STEROID BIOCHEM, V88, P27, DOI 10.1016/j.jsbmb.2003.10.005; Nadiminty N, 2008, PROSTATE, V68, P1725, DOI 10.1002/pros.20839; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Pearson HB, 2009, CANCER RES, V69, P94, DOI 10.1158/0008-5472.CAN-08-2895; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Ray D, 2006, J BIOL CHEM, V281, P23060, DOI 10.1074/jbc.M604311200; Rowland JG, 2007, PROTEOMICS, V7, P47, DOI 10.1002/pmic.200600697; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Setlur SR, 2005, ADV ANAT PATHOL, V12, P265, DOI 10.1097/01.pap.0000184179.50672.f7; Soldatenkov VA, 1999, CANCER RES, V59, P5085; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Tang WG, 2005, CANCER RES, V65, P1904, DOI 10.1158/0008-5472.CAN-04-2597; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159; Zhang XP, 2009, INT J CANCER, V124, P1980, DOI 10.1002/ijc.24139; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	49	33	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9060	10.1371/journal.pone.0009060	http://dx.doi.org/10.1371/journal.pone.0009060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140206	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400004
J	Ali, MS; Hammonds, J; Ding, LM; Spearman, P				Ali, Mohammed S.; Hammonds, Jason; Ding, Lingmei; Spearman, Paul			CAML Does Not Modulate Tetherin-Mediated Restriction of HIV-1 Particle Release	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VPU PROTEIN; CYCLOPHILIN LIGAND; MOLECULAR-CLONING; INHIBITS HIV-1; CELL-SURFACE; DEGRADATION; CD4; MECHANISM; DOMAIN	Background: Tetherin/BST-2 is a recently-identified potent restriction factor in human cells that restricts HIV particle release following particle formation and budding at the plasma membrane. Vpu counteracts tetherin's restriction of particle release in a manner that has not yet been fully defined. We recently identified calcium-modulating cyclophilin ligand (CAML) as a Vpu-interacting protein that also restricts particle release. We hypothesized that CAML may act to enhance tetherin-mediated restriction of particle release and thereby explain how two distinct factors could be responsible for Vpu-responsive restriction. Methodology/Principal Findings: Endogenous levels of tetherin in human cells correlated well with their restriction pattern and responsiveness to Vpu, while levels of cellular CAML protein did not. Tetherin but not CAML was inducible by interferon in a wide variety of human cells. Stable depletion of human CAML in restrictive HeLa cells had no effect on cell surface levels of tetherin, and failed to relieve tetherin-mediated restriction. Stable depletion of tetherin from HeLa cells, in contrast, rendered HeLa cells permissive and Vpu-unresponsive. Tetherin but not CAML expression in permissive human cells rendered them restrictive and Vpu responsive. Depletion of CAML had no influence on cell surface levels of tetherin. Conclusions/Significance: We conclude that tetherin restricts particle release and does not require CAML for this effect. Furthermore, these results do not support a major role for CAML in restricting HIV particle release in human cells.	[Ali, Mohammed S.; Hammonds, Jason; Ding, Lingmei; Spearman, Paul] Emory Univ & Childrens Healthcare Atlanta, Dept Pediat, Atlanta, GA USA	Children's Healthcare of Atlanta (CHOA); Emory University	Ali, MS (corresponding author), William Beaumont Army Med Ctr, Dept Clin Invest, El Paso, TX 79920 USA.	Paul.spearman@emory.edu	Hammonds, Jason/AAC-5330-2019	Hammonds, Jason/0000-0002-1649-9008	National Institutes of Health (NIH) [R01 AI58828]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058828] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) R01 AI58828. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	ARRIGO SJ, 1991, GENE DEV, V5, P808, DOI 10.1101/gad.5.5.808; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bego MG, 2009, J VIROL, V83, P13032, DOI 10.1128/JVI.01786-09; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Holloway MP, 1996, J BIOL CHEM, V271, P8549, DOI 10.1074/jbc.271.15.8549; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; SCHUBERT U, 1994, J VIROL, V68, P2260, DOI 10.1128/JVI.68.4.2260-2271.1994; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Schwartz MD, 1996, VIROLOGY, V224, P302, DOI 10.1006/viro.1996.0532; SCHWARTZ S, 1990, J VIROL, V64, P5448, DOI 10.1128/JVI.64.11.5448-5456.1990; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Yuan X, 2008, MOL CELL NEUROSCI, V38, P277, DOI 10.1016/j.mcn.2008.03.002	31	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9005	10.1371/journal.pone.0009005	http://dx.doi.org/10.1371/journal.pone.0009005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126395	Green Published, Green Submitted, gold			2022-12-27	WOS:000274207200006
J	Koup, RA; Roederer, M; Lamoreaux, L; Fischer, J; Novik, L; Nason, MC; Larkin, BD; Enama, ME; Ledgerwood, JE; Bailer, RT; Mascola, JR; Nabel, GJ; Graham, BS				Koup, Richard A.; Roederer, Mario; Lamoreaux, Laurie; Fischer, Jennifer; Novik, Laura; Nason, Martha C.; Larkin, Brenda D.; Enama, Mary E.; Ledgerwood, Julie E.; Bailer, Robert T.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.		VRC 009 Study Team; VRC 010 Study Team	Priming Immunization with DNA Augments Immunogenicity of Recombinant Adenoviral Vectors for Both HIV-1 Specific Antibody and T-Cell Responses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LONG-TERM NONPROGRESSORS; VACCINE-INDUCED IMMUNITY; NEUTRALIZING ANTIBODY; CANDIDATE VACCINE; GLYCOPROTEIN-120 VACCINE; PREVENTIVE VACCINE; EFFECTOR FUNCTIONS; PHASE-1 SAFETY; NAIVE ADULTS	Background: Induction of HIV-1-specific T-cell responses relevant to diverse subtypes is a major goal of HIV vaccine development. Prime-boost regimens using heterologous gene-based vaccine vectors have induced potent, polyfunctional T cell responses in preclinical studies. Methods: The first opportunity to evaluate the immunogenicity of DNA priming followed by recombinant adenovirus serotype 5 (rAd5) boosting was as open-label rollover trials in subjects who had been enrolled in prior studies of HIV-1 specific DNA vaccines. All subjects underwent apheresis before and after rAd5 boosting to characterize in depth the T cell and antibody response induced by the heterologous DNA/rAd5 prime-boost combination. Results: rAd5 boosting was well-tolerated with no serious adverse events. Compared to DNA or rAd5 vaccine alone, sequential DNA/rAd5 administration induced 7-fold higher magnitude Env-biased HIV-1-specific CD8(+)T-cell responses and 100-fold greater antibody titers measured by ELISA. There was no significant neutralizing antibody activity against primary isolates. Vaccine-elicited CD4(+) and CD8(+)T-cells expressed multiple functions and were predominantly long-term (CD127(+)) central or effector memory T cells and that persisted in blood for >6 months. Epitopes mapped in Gag and Env demonstrated partial cross-clade recognition. Conclusion: Heterologous prime-boost using vector-based gene delivery of vaccine antigens is a potent immunization strategy for inducing both antibody and T-cell responses.	[Koup, Richard A.; Roederer, Mario; Lamoreaux, Laurie; Fischer, Jennifer; Novik, Laura; Larkin, Brenda D.; Enama, Mary E.; Ledgerwood, Julie E.; Bailer, Robert T.; Mascola, John R.; Nabel, Gary J.; Graham, Barney S.; VRC 009 Study Team; VRC 010 Study Team] NIAID, Vaccine Res Ctr, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koup, RA (corresponding author), NIAID, Vaccine Res Ctr, Div Clin Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@nih.gov	Mascola, John/AAI-7193-2021; Roederer, Mario/G-1887-2011; Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853	National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005011, ZIAAI005021, ZIAAI005073, ZIAAI005035] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for the conduct of this clinical trial was provided by the National Institute of Allergy and Infectious Diseases (NIAID) intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Asmuth DM, 2010, J INFECT DIS, V201, P132, DOI 10.1086/648591; Barouch DH, 2003, J VIROL, V77, P7367, DOI 10.1128/JVI.77.13.7367-7375.2003; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Butman BT, 2006, DEV BIOLOGICALS, V123, P225; BUTMAN BT, 2006, DEV BIOL BASEL, V123, P265; Casazza JP, 2006, J EXP MED, V203, P2865, DOI 10.1084/jem.20052246; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; COONEY EL, 1993, P NATL ACAD SCI USA, V90, P1882, DOI 10.1073/pnas.90.5.1882; Cox KS, 2008, J VIROL, V82, P8161, DOI 10.1128/JVI.00620-08; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Dunachie SJ, 2006, INFECT IMMUN, V74, P5933, DOI 10.1128/IAI.00590-06; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; GIRARD M, 1991, P NATL ACAD SCI USA, V88, P542, DOI 10.1073/pnas.88.2.542; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Graham BS, 2005, J INFECT DIS, V191, P647, DOI 10.1086/428406; GRAHAM BS, 1993, J INFECT DIS, V167, P533, DOI 10.1093/infdis/167.3.533; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; HU SL, 1992, SCIENCE, V255, P456, DOI 10.1126/science.1531159; Irvine KR, 1997, J NATL CANCER I, V89, P1595, DOI 10.1093/jnci/89.21.1595; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Johnston MI, 2008, NEW ENGL J MED, V359, P888, DOI 10.1056/NEJMp0806162; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KORBER BTM, 2007, THEORETICAL BIOL BIO; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; LEONG KH, 1995, VACCINES, V95, P327; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Letvin NL, 1997, P NATL ACAD SCI USA, V94, P9378, DOI 10.1073/pnas.94.17.9378; Li FS, 2006, VACCINE, V24, P6893, DOI 10.1016/j.vaccine.2006.06.009; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Malhotra U, 2007, J VIROL, V81, P5225, DOI 10.1128/JVI.02564-06; Malhotra U, 2007, VACCINE, V25, P381, DOI 10.1016/j.vaccine.2006.07.045; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Moodie Z, 2006, J IMMUNOL METHODS, V315, P121, DOI 10.1016/j.jim.2006.07.015; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Ramsay AJ, 1997, IMMUNOL CELL BIOL, V75, P382, DOI 10.1038/icb.1997.60; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Roederer M, 2003, J IMMUNOL METHODS, V274, P221, DOI 10.1016/S0022-1759(02)00423-4; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Yang Otto O., 2009, V485, P407, DOI 10.1007/978-1-59745-170-3_27	66	114	127	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9015	10.1371/journal.pone.0009015	http://dx.doi.org/10.1371/journal.pone.0009015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126394	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200012
J	Lavasani, S; Dzhambazov, B; Nouri, M; Fak, F; Buske, S; Molin, G; Thorlacius, H; Alenfall, J; Jeppsson, B; Westrom, B				Lavasani, Shahram; Dzhambazov, Balik; Nouri, Mehrnaz; Fak, Frida; Buske, Sophia; Molin, Goran; Thorlacius, Henrik; Alenfall, Jan; Jeppsson, Bengt; Westrom, Bjorn			A Novel Probiotic Mixture Exerts a Therapeutic Effect on Experimental Autoimmune Encephalomyelitis Mediated by IL-10 Producing Regulatory T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LACTOBACILLUS-CASEI; NATURAL RECOVERY; SUPPRESSION; MECHANISMS; DISEASE; INTERLEUKIN-10; INFLAMMATION; PROTECTION; TOLERANCE	Background: Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system (CNS). One potential therapeutic strategy for MS is to induce regulatory cells that mediate immunological tolerance. Probiotics, including lactobacilli, are known to induce immunomodulatory activity with promising effects in inflammatory diseases. We tested the potential of various strains of lactobacilli for suppression of experimental autoimmune encephalomyelitis (EAE), an animal model of MS. Methodology/Principal Findings: The preventive effects of five daily-administered strains of lactobacilli were investigated in mice developing EAE. After a primary screening, three Lactobacillus strains, L. paracasei DSM 13434, L. plantarum DSM 15312 and DSM 15313 that reduced inflammation in CNS and autoreactive T cell responses were chosen. L. paracasei and L. plantarum DSM 15312 induced CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) in mesenteric lymph nodes (MLNs) and enhanced production of serum TGF-beta 1, while L. plantarum DSM 15313 increased serum IL-27 levels. Further screening of the chosen strains showed that each monostrain probiotic failed to be therapeutic in diseased mice, while a mixture of the three lactobacilli strains suppressed the progression and reversed the clinical and histological signs of EAE. The suppressive activity correlated with attenuation of pro-inflammatory Th1 and Th17 cytokines followed by IL-10 induction in MLNs, spleen and blood. Additional adoptive transfer studies demonstrated that IL-10 producing CD4(+)CD25(+) Tregs are involved in the suppressive effect induced by the lactobacilli mixture. Conclusions/Significance: Our data provide evidence showing that the therapeutic effect of the chosen mixture of probiotic lactobacilli was associated with induction of transferable tolerogenic Tregs in MLNs, but also in the periphery and the CNS, mediated through an IL-10-dependent mechanism. Our findings indicate a therapeutic potential of oral administration of a combination of probiotics and provide a more complete understanding of the host-commensal interactions that contribute to beneficial effects in autoimmune diseases.	[Lavasani, Shahram; Fak, Frida; Buske, Sophia; Westrom, Bjorn] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Dzhambazov, Balik] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Lavasani, Shahram; Nouri, Mehrnaz; Thorlacius, Henrik; Jeppsson, Bengt] Lund Univ, Surg Res Unit, Clin Res Ctr, Dept Clin Sci, Malmo, Sweden; [Molin, Goran] Lund Univ, Ctr Chem, Dept Food Technol Engn & Nutr, Lund, Sweden; [Alenfall, Jan] Probi AB, Lund, Sweden	Lund University; Lund University; Lund University; Lund University	Lavasani, S (corresponding author), Lund Univ, Dept Cell & Organism Biol, Lund, Sweden.	Shahram.Lavasani@med.lu.se	Dzhambazov, Balik/H-1220-2015; Weström, Björn R/N-2232-2016	Dzhambazov, Balik/0000-0001-8052-5840; Weström, Björn R/0000-0001-9296-2845; Lavasani, Shahram/0000-0003-4922-9351	Royal Physiographic Society (Lund, Sweden); Knut och Alice Wallenbergs Stiftelse (Sweden)	Royal Physiographic Society (Lund, Sweden); Knut och Alice Wallenbergs Stiftelse (Sweden)(Knut & Alice Wallenberg Foundation)	This project was partially financed by grants from the Royal Physiographic Society (Lund, Sweden) and resources provided by Knut och Alice Wallenbergs Stiftelse (Sweden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 1996, APPL ENVIRON MICROB, V62, P2244, DOI 10.1128/AEM.62.7.2244-2251.1996; Ahrne S, 1998, J APPL MICROBIOL, V85, P88; Alvarez S, 2001, J FOOD PROTECT, V64, P1768, DOI 10.4315/0362-028X-64.11.1768; Astier AL, 2006, J CLIN INVEST, V116, P3252, DOI 10.1172/JCI29251; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Boirivant M, 2007, CURR OPIN GASTROEN, V23, P679, DOI 10.1097/MOG.0b013e3282f0cffc; Boyle RJ, 2006, CLIN EXP ALLERGY, V36, P568, DOI 10.1111/j.1365-2222.2006.02472.x; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Di Giacinto C, 2005, J IMMUNOL, V174, P3237, DOI 10.4049/jimmunol.174.6.3237; Durkin HG, 2001, IMMUNOL REV, V182, P33, DOI 10.1034/j.1600-065X.2001.1820103.x; El Behi M, 2005, IMMUNOL LETT, V96, P11, DOI 10.1016/j.imlet.2004.07.017; Erickson KL, 2000, J NUTR, V130, p403S, DOI 10.1093/jn/130.2.403S; Fasano A, 2005, NAT CLIN PRACT GASTR, V2, P416, DOI 10.1038/ncpgasthep0259; Gionchetti P, 2000, GASTROENTEROLOGY, V119, P305, DOI 10.1053/gast.2000.9370; Gionchetti P, 2001, CURR OPIN GASTROEN, V17, P331, DOI 10.1097/00001574-200107000-00006; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hart AL, 2004, GUT, V53, P1602, DOI 10.1136/gut.2003.037325; Hemmer B, 2006, NAT CLIN PRACT NEURO, V2, P201, DOI 10.1038/ncpneuro0154; Isolauri E, 2001, AM J CLIN NUTR, V73, p444S, DOI 10.1093/ajcn/73.2.444s; ISOLAURI E, 1991, PEDIATRICS, V88, P90; Isolauri E, 2002, CURR OPIN ALLERGY CL, V2, P263, DOI 10.1097/00130832-200206000-00018; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; JOHNS LD, 1991, J IMMUNOL, V147, P1792; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; KHOURY SJ, 1992, J EXP MED, V176, P1355, DOI 10.1084/jem.176.5.1355; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Maassen CBM, 2008, VACCINE, V26, P2056, DOI 10.1016/j.vaccine.2008.02.035; Madsen KL, 2001, CAN J GASTROENTEROL, V15, P817, DOI 10.1155/2001/690741; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; MOLIN G, 1993, J APPL BACTERIOL, V74, P314, DOI 10.1111/j.1365-2672.1993.tb03031.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; POWRIE F, 1993, EUR J IMMUNOL, V23, P3043, DOI 10.1002/eji.1830231147; Reid G, 2003, CLIN MICROBIOL REV, V16, P658, DOI 10.1128/CMR.16.4.658-672.2003; Runstrom A, 2006, J NEUROIMMUNOL, V173, P69, DOI 10.1016/j.jneuroim.2005.11.023; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Schwartz RH, 2005, NAT IMMUNOL, V6, P327, DOI 10.1038/ni1184; So JS, 2008, MOL IMMUNOL, V45, P2690, DOI 10.1016/j.molimm.2007.12.010; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Steinman L, 1999, NEURON, V24, P511, DOI 10.1016/S0896-6273(00)81107-1; Timmerman HM, 2007, CLIN NUTR, V26, P450, DOI 10.1016/j.clnu.2007.04.008; Timmerman HM, 2004, INT J FOOD MICROBIOL, V96, P219, DOI 10.1016/j.ijfoodmicro.2004.05.012; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zou LP, 2002, NEUROPHARMACOLOGY, V42, P731, DOI 10.1016/S0028-3908(02)00015-1	60	295	307	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9009	10.1371/journal.pone.0009009	http://dx.doi.org/10.1371/journal.pone.0009009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126401	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200008
J	Csibi, A; Cornille, K; Leibovitch, MP; Poupon, A; Tintignac, LA; Sanchez, AMJ; Leibovitch, SA				Csibi, Alfredo; Cornille, Karen; Leibovitch, Marie-Pierre; Poupon, Anne; Tintignac, Lionel A.; Sanchez, Anthony M. J.; Leibovitch, Serge A.			The Translation Regulatory Subunit eIF3f Controls the Kinase-Dependent mTOR Signaling Required for Muscle Differentiation and Hypertrophy in Mouse	PLOS ONE			English	Article							INITIATION-FACTOR 3F; MAMMALIAN TARGET; BINDING PARTNER; S6 KINASE; SKELETAL; ATROPHY; TOR; RAPTOR; GROWTH; PHOSPHORYLATION	The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size.	[Csibi, Alfredo; Cornille, Karen; Leibovitch, Marie-Pierre; Tintignac, Lionel A.; Leibovitch, Serge A.] SupAgro INRA, Differenciat Cellulaire & Croissance UMR866, Lab Genom Fonct & Myogenese, Montpellier, France; [Poupon, Anne] INRA, UMR Physiol Reprod & Comportements, F-37380 Nouzilly, France; [Sanchez, Anthony M. J.] SupAgro INRA, Differenciat Cellulaire & Croissance UMR866, Equipe Remodelage Musculaire & Signalisat, Montpellier, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE; INRAE; Institut Agro; Montpellier SupAgro	Csibi, A (corresponding author), Univ Montpellier Sud France, Montpellier, France.	leibovs@supagro.inra.fr	Sanchez, Anthony MJ/N-8092-2019	Sanchez, Anthony MJ/0000-0003-3054-6349; Poupon, Anne/0000-0003-0617-0935; Tintignac, Lionel/0000-0001-5902-1138	Association Francaise contre les Myopathies (AFM); Institut Nationale de la Recherche Agronomique (INRA); Institut National de la Sante et de la Recherche Medicale (INSERM)	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Institut Nationale de la Recherche Agronomique (INRA); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by grants from the Association Francaise contre les Myopathies (AFM), the department of Phyiologie Animale et Systeme d'Elevage (PHASE) from Institut Nationale de la Recherche Agronomique (INRA) and the Institut National de la Sante et de la Recherche Medicale (INSERM). Mrs A. Csibi is a graduate of an AFM and INRA fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Csibi A, 2008, CELL CYCLE, V7, P1698, DOI 10.4161/cc.7.12.6090; Csibi A, 2009, J BIOL CHEM, V284, P4413, DOI 10.1074/jbc.M807641200; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; GOLDSPINK DF, 1983, BIOCHEM J, V210, P89, DOI 10.1042/bj2100089; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lagirand-Cantaloube J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004973; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Miyamoto S, 2005, J BIOL CHEM, V280, P28251, DOI 10.1074/jbc.M414129200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, J BIOL CHEM, V280, P32009, DOI 10.1074/jbc.M506120200; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Richardson CJ, 2004, SEMIN CELL DEV BIOL, V15, P147, DOI 10.1016/j.semcdb.2003.12.023; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sanches M, 2007, J MOL BIOL, V370, P846, DOI 10.1016/j.jmb.2007.04.084; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shi JQ, 2009, FEBS LETT, V583, P971, DOI 10.1016/j.febslet.2009.02.028; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Valente ST, 2009, P NATL ACAD SCI USA, V106, P4071, DOI 10.1073/pnas.0900557106; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200; Yoon MS, 2008, J CELL SCI, V121, P282, DOI 10.1242/jcs.022566; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308	54	73	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8994	10.1371/journal.pone.0008994	http://dx.doi.org/10.1371/journal.pone.0008994			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126553	gold, Green Submitted, Green Published			2022-12-27	WOS:000274209700020
J	Bishop, SC; Woolliams, JA				Bishop, Stephen C.; Woolliams, John A.			On the Genetic Interpretation of Disease Data	PLOS ONE			English	Article							ATLANTIC SALMON; RESISTANCE; SUSCEPTIBILITY; TUBERCULOSIS; PARAMETERS; CATTLE; RISK	Background: The understanding of host genetic variation in disease resistance increasingly requires the use of field data to obtain sufficient numbers of phenotypes. We introduce concepts necessary for a genetic interpretation of field disease data, for diseases caused by microparasites such as bacteria or viruses. Our focus is on variance component estimation and we introduce epidemiological concepts to quantitative genetics. Methodology/Principal Findings: We have derived simple deterministic formulae to predict the impacts of incomplete exposure to infection, or imperfect diagnostic test sensitivity and specificity on heritabilities for disease resistance. We show that these factors all reduce the estimable heritabilities. The impacts of incomplete exposure depend on disease prevalence but are relatively linear with the exposure probability. For prevalences less than 0.5, imperfect diagnostic test sensitivity results in a small underestimation of heritability, whereas imperfect specificity leads to a much greater underestimation, with the impact increasing as prevalence declines. These impacts are reversed for prevalences greater than 0.5. Incomplete data recording in which infected or diseased individuals are not observed, e. g. data recording for too short a period, has impacts analogous to imperfect sensitivity. Conclusions/Significance: These results help to explain the often low disease resistance heritabilities observed under field conditions. They also demonstrate that incomplete exposure to infection, or suboptimal diagnoses, are not fatal flaws for demonstrating host genetic differences in resistance, they merely reduce the power of datasets. Lastly, they provide a tool for inferring the true extent of genetic variation in disease resistance given knowledge of the disease biology.	[Bishop, Stephen C.] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Bishop, SC (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	Stephen.Bishop@roslin.ed.ac.uk	Bishop, Stephen/C-8487-2013		Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/D/05191133] Funding Source: researchfish; BBSRC [BBS/E/D/05191133] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors were funded by the Biotechnology and Biological Sciences Research Council (BBSRC), via The Roslin Institute's Institute Strategic Programme Grant (ISPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; BISHOP SC, 2005, ENCY ANIMAL SCI, P288; Clapperton M, 2008, ANIMAL, V2, P1575, DOI 10.1017/S1751731108002929; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; DETILLEUX JC, 1994, J DAIRY SCI, V77, P2640, DOI 10.3168/jds.S0022-0302(94)77205-2; Gianola D, 2006, GENETICS, V173, P2247, DOI 10.1534/genetics.105.054197; Guy DR, 2009, AQUACULTURE, V290, P229, DOI 10.1016/j.aquaculture.2009.02.015; Henryon M, 2006, ANIM SCI, V82, P597, DOI 10.1079/ASC200671; Henryon M, 2003, LIVEST PROD SCI, V83, P121, DOI 10.1016/S0301-6226(03)00053-8; Henryon M, 2001, ANIM SCI, V73, P375, DOI 10.1017/S1357729800058343; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Kjoglum S, 2008, AQUAC RES, V39, P498, DOI 10.1111/j.1365-2109.2008.01904.x; Lynch M., 1998, GENETICS ANAL QUANTI; NOORDHUIZEN JPT, 1997, APPL QUANTITATIVE ME; ROBERTSON A, 1949, GENETICS, V34, P395; Rupp R, 2003, VET RES, V34, P671, DOI 10.1051/vetres:2003020; Segal S, 2003, TRENDS MICROBIOL, V11, P445, DOI 10.1016/S0966-842X(03)00207-5; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Trammell RA, 2008, EXPERT REV MOL DIAGN, V8, P515, DOI 10.1586/14737159.8.4.515	21	79	84	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8940	10.1371/journal.pone.0008940	http://dx.doi.org/10.1371/journal.pone.0008940			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126627	Green Submitted, Green Published, gold			2022-12-27	WOS:000274138000017
J	Caruso, F; Darnowski, JW; Opazo, C; Goldberg, A; Kishore, N; Agoston, ES; Rossi, M				Caruso, Francesco; Darnowski, James W.; Opazo, Cristian; Goldberg, Alexander; Kishore, Nina; Agoston, Elin S.; Rossi, Miriam			Taurolidine Antiadhesive Properties on Interaction with E. coli; Its Transformation in Biological Environment and Interaction with Bacteria Cell Wall	PLOS ONE			English	Article							FORMALDEHYDE-INDUCED MODIFICATIONS; ESCHERICHIA-COLI; IN-VITRO; ADHESION; IDENTIFICATION; PERITONEAL; MOLECULES; MODEL; APPROXIMATION; CONSERVATION	The taurine amino-acid derivative, taurolidine, bis-(1,1-dioxoperhydro-1,2,4-thiabiazinyl-4)methane, shows broad antibacterial action against gram-positive and gram-negative bacteria, mycobacteria and some clinically relevant fungi. It inhibits, in vitro, the adherence of Escherichia coli and Staphylococcus aureus to human epithelial and fibroblast cells. Taurolidine is unstable in aqueous solution and breaks down into derivatives which are thought to be responsible for the biological activity. To understand the taurolidine antibacterial mechanism of action, we provide the experimental single crystal X-ray diffraction results together with theoretical methods to characterize the hydrolysis/decomposition reactions of taurolidine. The crystal structure features two independent molecules linked through intermolecular H-bonds with one of them somewhat positively charged. Taurolidine in a biological environment exists in equilibrium with taurultam derivatives and this is described theoretically as a 2-step process without an energy barrier: formation of cationic taurolidine followed by a nucleophilic attack of O(hydroxyl) on the exocyclic C(methylene). A concerted mechanism describes the further hydrolysis of the taurolidine derivative methylol-taurultam. The interaction of methylol-taurultam with the diaminopimelic NH2 group in the E. coli bacteria cell wall (peptidoglycan) has a negative Delta G value (-38.2 kcal/mol) but a high energy barrier (45.8 kcal/mol) suggesting no reactivity. On the contrary, taurolidine docking into E. coli fimbriae protein, responsible for bacteria adhesion to the bladder epithelium, shows it has higher affinity than mannose (the natural substrate), whereas methyloltaurultam and taurultam are less tightly bound. Since taurolidine is readily available because it is administered in high doses after peritonitis surgery, it may successfully compete with mannose explaining its effectiveness against bacterial infections at laparoscopic lesions.	[Caruso, Francesco] CNR, Ist Chim Biomol, Rome, Italy; [Darnowski, James W.] Rhode Isl Hosp, Dept Med, Div Hematol Oncol, Providence, RI 02903 USA; [Darnowski, James W.] Brown Univ, Providence, RI 02912 USA; [Opazo, Cristian] Vassar Coll, Acad Comp Serv, Poughkeepsie, NY 12601 USA; [Goldberg, Alexander] Accelrys Inc, San Diego, CA USA; [Kishore, Nina; Agoston, Elin S.; Rossi, Miriam] Vassar Coll, Dept Chem, Poughkeepsie, NY 12601 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica Biomolecolare (ICB-CNR); Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Vassar College; BIOVIA; Vassar College	Caruso, F (corresponding author), CNR, Ist Chim Biomol, Rome, Italy.	caruso@vassar.edu; rossi@vassar.edu		Kishore, Nina/0000-0002-8283-6201; Rossi, Miriam/0000-0001-9609-474X	Camille and Henri Dreyfus Foundation; Vassar College; Consiglio Nazionale delle Ricereche	Camille and Henri Dreyfus Foundation; Vassar College; Consiglio Nazionale delle Ricereche	This work was supported by the Camille and Henri Dreyfus Foundation Special Grant for Chemical Sciences, and the institutions where authors are employed, specifically Vassar College (Committee on Research) and Consiglio Nazionale delle Ricereche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM SN, 1987, J BACTERIOL, V169, P5530, DOI 10.1128/jb.169.12.5530-5536.1987; ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; ABRAHAM SN, 1992, J BACTERIOL, V174, P5145, DOI 10.1128/JB.174.15.5145-5148.1992; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bobrich E, 2007, J SURG RES, V137, P75, DOI 10.1016/j.jss.2006.07.013; Braumann C, 2003, CLIN EXP METASTAS, V20, P387, DOI 10.1023/A:1025402919341; Braumann C, 2007, J SURG RES, V143, P372, DOI 10.1016/j.jss.2007.01.041; Braumann Chris, 2006, World J Surg Oncol, V4, P34, DOI 10.1186/1477-7819-4-34; BROWN SJ, 1985, J FINANC ECON, V14, P3, DOI 10.1016/0304-405X(85)90042-X; BROWNE MK, 1985, NEW CONCEPT ANTIMICR, P51; Calabresi P, 2001, CANCER RES, V61, P6816; CAMALLI M, 1994, J APPL CRYSTALLOGR, V27, P861; Da Costa ML, 2001, J SURG RES, V101, P111, DOI 10.1006/jsre.2001.6250; Darnowski JW, 2004, CANCER CHEMOTH PHARM, V54, P249, DOI 10.1007/s00280-004-0806-1; DARNOWSKI JW, 2 PATIENTS TRE UNPUB; Delley B, 1996, J PHYS CHEM-US, V100, P6107, DOI 10.1021/jp952713n; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Delley B, 2000, J CHEM PHYS, V113, P7756, DOI 10.1063/1.1316015; DUPONT L, 1995, ACTA CRYSTALLOGR C, V51, P2412, DOI 10.1107/S0108270195008006; GARDINER KR, 1994, HEPATO-GASTROENTEROL, V41, P554; GIDLEY MJ, 1981, FEBS LETT, V127, P225, DOI 10.1016/0014-5793(81)80211-6; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; GORMAN SP, 1987, LETT APPL MICROBIOL, V4, P103, DOI 10.1111/j.1472-765X.1987.tb01593.x; HAGBERG L, 1981, INFECT IMMUN, V31, P564, DOI 10.1128/IAI.31.2.564-570.1981; Hung CS, 2002, MOL MICROBIOL, V44, P903, DOI 10.1046/j.1365-2958.2002.02915.x; Jacobi CA, 1997, AM J SURG, V174, P359, DOI 10.1016/S0002-9610(97)00099-8; KEITH BR, 1986, INFECT IMMUN, V53, P693, DOI 10.1128/IAI.53.3.693-696.1986; KILLEAN RCG, 1971, ACTA CRYSTALL B-STRU, VB 27, P1707, DOI 10.1107/S0567740871004680; Koldehoff A, 2004, INT J ANTIMICROB AG, V24, P491, DOI 10.1016/j.ijantimicag.2004.06.006; KROGFELT KA, 1990, INFECT IMMUN, V58, P1995, DOI 10.1128/IAI.58.6.1995-1998.1990; LOWE G, 1988, J AM CHEM SOC, V110, P8512, DOI 10.1021/ja00233a030; MAIN P, 1978, SYSTEM COMPUTER PROG; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Metz B, 2006, BIOCONJUGATE CHEM, V17, P815, DOI 10.1021/bc050340f; MOSER G, 1978, SCHWEIZ RUNDSCH MED, V67, P425; NICI L, 2000, CLIN CANCER RES, V10, P7655; Oguz H, 2004, CURR EYE RES, V28, P225, DOI 10.1076/ceyr.28.4.225.27833; OROURKE N, 1993, LANCET, V342, P368, DOI 10.1016/0140-6736(93)91511-J; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; PFIRRMANN R, 1999, Patent No. 9934805; Shrayer DP, 2003, ANTI-CANCER DRUG, V14, P295, DOI 10.1097/00001813-200304000-00007; Stendel R, 2004, ANTICANCER RES, V24, P1143; Stendel R, 2002, ANTICANCER RES, V22, P809; Tarhan OR, 2008, J SURG RES, V144, P151, DOI 10.1016/j.jss.2007.09.006; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; TRAUB WH, 1993, CHEMOTHERAPY, V39, P322, DOI 10.1159/000239144; Vandemaele FJ, 2004, VET MICROBIOL, V101, P147, DOI 10.1016/j.vetmic.2004.03.013; Wenger FA, 2002, CLIN EXP METASTAS, V19, P169, DOI 10.1023/A:1014579718391; WOLD AE, 1988, INFECT IMMUN, V56, P2531, DOI 10.1128/IAI.56.10.2531-2537.1988; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306	50	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8927	10.1371/journal.pone.0008927	http://dx.doi.org/10.1371/journal.pone.0008927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126631	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000006
J	Leja, J; Nilsson, B; Yu, D; Gustafson, E; Akerstrom, G; Oberg, K; Giandomenico, V; Essand, M				Leja, Justyna; Nilsson, Berith; Yu, Di; Gustafson, Elisabet; Akerstrom, Goran; Oberg, Kjell; Giandomenico, Valeria; Essand, Magnus			Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability	PLOS ONE			English	Article							CHROMOGRANIN-A; TRANSGENE EXPRESSION; ENDOGENOUS MICRORNA	Background: We have previously developed an oncolytic serotype 5 adenovirus (Ad5) with chromogranin-A (CgA) promoter-controlled E1A expression, Ad[CgA-E1A], with the intention to treat neuroendocrine tumors, including carcinoids. Since carcinoids tend to metastasize to the liver it is important to fully repress viral replication in hepatocytes to avoid adenovirus-related liver toxicity. Herein, we explore miRNA-based regulation of E1A expression as a complementary mechanism to promoter-based transcriptional control. Methodology/Principal Findings: Ad[CgA-E1A-miR122], where E1A expression is further controlled by six tandem repeats of the target sequence for the liver-specific miR122, was constructed and compared to Ad[CgA-E1A]. We observed E1A suppression and replication arrest of the miR122-detargeted adenovirus in normal hepatocytes, while the two viruses killed carcinoid cells to the same degree. Repeated intravenous injections of Ad[CgA-E1A] induced liver toxicity in mice while Ad[CgA-E1A-miR122] injections did not. Furthermore, a miR122-detargeted adenovirus with the wild-type E1A promoter showed reduced replication in hepatic cells compared to wild-type Ad5 but not to the same extent as the miR122-detargeted adenovirus with the neuroendocrine-selective CgA promoter. Conclusions/Significance: A combination of transcriptional ( promoter) and post-transcriptional (miRNA target) regulation to control virus replication may allow for the use of higher doses of adenovirus for efficient tumors treatment without liver toxicity.	[Leja, Justyna; Nilsson, Berith; Yu, Di; Essand, Magnus] Uppsala Univ, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden; [Gustafson, Elisabet] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Akerstrom, Goran] Univ Uppsala Hosp, Dept Surg Sci, Uppsala, Sweden; [Oberg, Kjell; Giandomenico, Valeria] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Leja, J (corresponding author), Uppsala Univ, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.	magnus.essand@klinimm.uu.se	Oberg, Kjell/AAG-7118-2019	Yu, Di/0000-0002-8636-0351	Swedish Cancer Society [CAN 2007/885]; Swedish Children Cancer Foundation [PROJ08/006]; Gunnar Nilsson's Cancer Foundation [E50/08]; Swedish Research Council [K2008-68X-15270-04-3]; European Community [LSHB-CT-2004-512087]	Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Gunnar Nilsson's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); European Community(European Commission)	This work was supported by funding from the Swedish Cancer Society (CAN 2007/885), the Swedish Children Cancer Foundation (PROJ08/006), Gunnar Nilsson's Cancer Foundation (E50/08), the Swedish Research Council (K2008-68X-15270-04-3) and the European Community on behalf of GIANT (Grant LSHB-CT-2004-512087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bajetta E, 1999, CANCER, V86, P858, DOI 10.1002/(SICI)1097-0142(19990901)86:5<858::AID-CNCR23>3.0.CO;2-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Brown BD, 2006, NAT MED, V12, P585, DOI 10.1038/nm1398; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Cawood R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000440; Cheng WS, 2004, MOL THER, V10, P355, DOI 10.1016/j.ymthe.2004.05.022; Danielsson A, 2008, CANCER GENE THER, V15, P203, DOI 10.1038/sj.cgt.7701117; Essand M, 2005, J MOL ENDOCRINOL, V35, P489, DOI 10.1677/jme.1.01875; Feldman SA, 2003, ENDOCR PATHOL, V14, P3, DOI 10.1385/EP:14:1:3; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; HITT MM, 1990, VIROLOGY, V179, P667, DOI 10.1016/0042-6822(90)90134-D; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; PRAGE L, 1970, VIROLOGY, V42, P341, DOI 10.1016/0042-6822(70)90278-3; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Suzuki T, 2008, MOL THER, V16, P1719, DOI 10.1038/mt.2008.159; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141; Ylosmaki E, 2008, J VIROL, V82, P11009, DOI 10.1128/JVI.01608-08	23	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8916	10.1371/journal.pone.0008916	http://dx.doi.org/10.1371/journal.pone.0008916			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111709	Green Published, gold			2022-12-27	WOS:000274114800019
J	Chapel, L; Castello, X; Bernard, C; Deffuant, G; Eguiluz, VM; Martin, S; Miguel, MS				Chapel, Laetitia; Castello, Xavier; Bernard, Claire; Deffuant, Guillaume; Eguiluz, Victor M.; Martin, Sophie; Miguel, Maxi San			Viability and Resilience of Languages in Competition	PLOS ONE			English	Article							BILINGUALISM; EVOLUTION; DYNAMICS; DEATH; MODEL	We study the viability and resilience of languages, using a simple dynamical model of two languages in competition. Assuming that public action can modify the prestige of a language in order to avoid language extinction, we analyze two cases: (i) the prestige can only take two values, (ii) it can take any value but its change at each time step is bounded. In both cases, we determine the viability kernel, that is, the set of states for which there exists an action policy maintaining the coexistence of the two languages, and we define such policies. We also study the resilience of the languages and identify configurations from where the system can return to the viability kernel (finite resilience), or where one of the languages is lead to disappear (zero resilience). Within our current framework, the maintenance of a bilingual society is shown to be possible by introducing the prestige of a language as a control variable.	[Chapel, Laetitia; Bernard, Claire; Deffuant, Guillaume] Irstea, Lab Ingn Syst Complexes, Aubiere, France; [Castello, Xavier; Eguiluz, Victor M.; Martin, Sophie; Miguel, Maxi San] CSIC UIB, IFISC, Palma de Mallorca, Spain	INRAE; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Barcelona	Chapel, L (corresponding author), Irstea, Lab Ingn Syst Complexes, Aubiere, France.	guillaume.deffuant@cemagref.fr	Eguíluz, Víctor M./B-9655-2008; San Miguel, Maxi/G-3224-2015	Eguíluz, Víctor M./0000-0003-1133-1289; San Miguel, Maxi/0000-0001-6237-425X	PATtern RESilience (FP6 NEST) [043268]; FISICOS (Spain) [FIS2007-60327]; Govern de les Illes Balears (Spain)	PATtern RESilience (FP6 NEST); FISICOS (Spain); Govern de les Illes Balears (Spain)	This work has been supported by European contract PATtern RESilience (FP6 NEST no 043268) and project FISICOS [FIS2007-60327] (Spain). X. CastellA3 also acknowledges financial support from a PhD fellowship of the Govern de les Illes Balears (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2003, NATURE, V424, P900, DOI 10.1038/424900a; Annila Arto, J NON-EQUIL THERMODY, V35, DOI [10.1515/jnetdy.2010.019, DOI 10.1515/JNETDY.2010.019]; Aubin J.P., 1991, VIABILITY THEORY; Castellano C, 2003, EUROPHYS LETT, V63, P153, DOI 10.1209/epl/i2003-00490-0; Castello X, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/66006; Castello X, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/308; CHAPEL L, 2007, P INT C ENV SYST TEC, P204; Crystal D., 2000, LANGUAGE DEATH; de Bot K., 2002, INT J SOCIOL LANG, V153, P1, DOI [DOI 10.1515/IJSL.2002.003, 10.1515/ijsl.2002.003]; de Oliveira VM, 2006, PHYSICA A, V361, P361, DOI 10.1016/j.physa.2005.06.069; Deffuant G, 2007, IEEE T AUTOMAT CONTR, V52, P933, DOI 10.1109/TAC.2007.895881; HOLLEY RA, 1976, ANN PROBAB, V4, P195, DOI 10.1214/aop/1176996130; Labov W., 1972, SOCIOLINGUISTIC PATT; Ludwig D., 1997, CONSERV ECOL, V1, P1; Martin S, 2004, ECOL SOC, V9; Minett JW, 2008, LINGUA, V118, P19, DOI 10.1016/j.lingua.2007.04.001; Mira J, 2005, EUROPHYS LETT, V69, P1031, DOI 10.1209/epl/i2004-10438-4; Nettle D, 1999, LINGUA, V108, P95, DOI 10.1016/S0024-3841(98)00046-1; Nowak MA, 2001, SCIENCE, V291, P114, DOI 10.1126/science.291.5501.114; O'Driscoll J., 2001, MULTILINGUA, V20, P245, DOI DOI 10.1515/MULT.2001.002; Patriarca M, 2004, PHYSICA A, V338, P296, DOI 10.1016/j.physa.2004.02.056; Patriarca M, 2009, PHYSICA A, V388, P174, DOI 10.1016/j.physa.2008.09.034; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pinasco JP, 2006, PHYSICA A, V361, P355, DOI 10.1016/j.physa.2005.06.068; Schulze C, 2008, COMMUN COMPUT PHYS, V3, P271; Schulze C, 2006, COMPUT SCI ENG, V8, P60, DOI 10.1109/MCSE.2006.47; Schulze C, 2005, INT J MOD PHYS C, V16, P781, DOI 10.1142/S0129183105007479; Stauffer D, 2007, PHYSICA A, V374, P835, DOI 10.1016/j.physa.2006.07.036; Suchecki K, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036132; Toivonen R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016109; Vazquez F, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063011; Wang WSY, 2005, TRENDS ECOL EVOL, V20, P263, DOI 10.1016/j.tree.2005.03.001; Weinreich Uriel, 1953, LANGUAGES CONTACT; Wurm S. A, 2001, ATLAS WORLDS LANGUAG	34	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8681	10.1371/journal.pone.0008681	http://dx.doi.org/10.1371/journal.pone.0008681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126655	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500003
J	Chaudhuri, RR; Sebaihia, M; Hobman, JL; Webber, MA; Leyton, DL; Goldberg, MD; Cunningham, AF; Scott-Tucker, A; Ferguson, PR; Thomas, CM; Frankel, G; Tang, CM; Dudley, EG; Roberts, IS; Rasko, DA; Pallen, MJ; Parkhill, J; Nataro, JP; Thomson, NR; Henderson, IR				Chaudhuri, Roy R.; Sebaihia, Mohammed; Hobman, Jon L.; Webber, Mark A.; Leyton, Denisse L.; Goldberg, Martin D.; Cunningham, Adam F.; Scott-Tucker, Anthony; Ferguson, Paul R.; Thomas, Christopher M.; Frankel, Gad; Tang, Christoph M.; Dudley, Edward G.; Roberts, Ian S.; Rasko, David A.; Pallen, Mark J.; Parkhill, Julian; Nataro, James P.; Thomson, Nicholas R.; Henderson, Ian R.			Complete Genome Sequence and Comparative Metabolic Profiling of the Prototypical Enteroaggregative Escherichia coli Strain 042	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ENTERICA SEROVAR TYPHIMURIUM; OUTER-MEMBRANE PERMEABILITY; INTESTINAL EPITHELIAL-CELLS; HEAT-STABLE ENTEROTOXIN-1; PLASMID-ENCODED TOXIN; L-SORBOSE UTILIZATION; V PROTEIN SECRETION; GENE-CLUSTER; SHIGELLA-FLEXNERI	Background: Escherichia coli can experience a multifaceted life, in some cases acting as a commensal while in other cases causing intestinal and/or extraintestinal disease. Several studies suggest enteroaggregative E. coli are the predominant cause of E. coli-mediated diarrhea in the developed world and are second only to Campylobacter sp. as a cause of bacterial-mediated diarrhea. Furthermore, enteroaggregative E. coli are a predominant cause of persistent diarrhea in the developing world where infection has been associated with malnourishment and growth retardation. Methods: In this study we determined the complete genomic sequence of E. coli 042, the prototypical member of the enteroaggregative E. coli, which has been shown to cause disease in volunteer studies. We performed genomic and phylogenetic comparisons with other E. coli strains revealing previously uncharacterised virulence factors including a variety of secreted proteins and a capsular polysaccharide biosynthetic locus. In addition, by using Biolog (TM) Phenotype Microarrays we have provided a full metabolic profiling of E. coli 042 and the non-pathogenic lab strain E. coli K-12. We have highlighted the genetic basis for many of the metabolic differences between E. coli 042 and E. coli K-12. Conclusion: This study provides a genetic context for the vast amount of experimental and epidemiological data published thus far and provides a template for future diagnostic and intervention strategies.	[Chaudhuri, Roy R.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sebaihia, Mohammed; Parkhill, Julian; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Cambridge, England; [Hobman, Jon L.] Univ Nottingham, Sch Biosci, Loughborough, England; [Webber, Mark A.; Leyton, Denisse L.; Cunningham, Adam F.; Scott-Tucker, Anthony; Ferguson, Paul R.; Pallen, Mark J.; Henderson, Ian R.] Univ Birmingham, Sch Immun & Infect, Birmingham, W Midlands, England; [Goldberg, Martin D.; Thomas, Christopher M.] Univ Birmingham, Sch Life & Environm Sci, Birmingham, W Midlands, England; [Frankel, Gad; Tang, Christoph M.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England; [Dudley, Edward G.] Penn State Univ, Coll Agr Sci, University Pk, PA 16802 USA; [Roberts, Ian S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Rasko, David A.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Nataro, James P.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA	University of Cambridge; Wellcome Trust Sanger Institute; University of Nottingham; University of Birmingham; University of Birmingham; Imperial College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Manchester; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Chaudhuri, RR (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	i.r.henderson@bham.ac.uk	Parkhill, Julian/G-4703-2011; Pallen, Mark J./E-7619-2011; Henderson, Ian/AAD-5369-2019; Leyton, Denisse L/A-6915-2015; Chaudhuri, Roy/E-3774-2014; Webber, Mark/B-4257-2009; Sebaihia, Mohammed/AAF-6589-2019; Thomas, Christopher M/J-8258-2017; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Leyton, Denisse L/0000-0003-4808-9289; Chaudhuri, Roy/0000-0001-5037-2695; Sebaihia, Mohammed/0000-0002-3324-3346; Thomas, Christopher M/0000-0002-2810-0455; Hobman, Jon/0000-0003-0998-9444; Pallen, Mark/0000-0003-1807-3657; Cunningham, Adam/0000-0003-0248-964X; Henderson, Ian/0000-0002-9954-4977; Webber, Mark/0000-0001-9169-7592; Thomson, Nicholas/0000-0002-4432-8505; David, Rasko/0000-0002-7337-7154	Wellcome Trust; United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C510075/1, BB/E01044X/1]; MRC [G0801209] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C510075/1] Funding Source: researchfish; Medical Research Council [G0801209, G9818340B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (www.wellcome.ac.uk) and by the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) (www.bbsrc.ac.uk) grants BB/C510075/1 to IRH, MP, CWP and BB/E01044X/1 to CWP, JH and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerley BJ, 2002, P NATL ACAD SCI USA, V99, P966, DOI 10.1073/pnas.012602299; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Bodelon G, 2009, J BACTERIOL, V191, P5169, DOI 10.1128/JB.00458-09; Brinkkotter A, 2000, MOL MICROBIOL, V37, P125, DOI 10.1046/j.1365-2958.2000.01969.x; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chaudhuri RR, 2008, NUCLEIC ACIDS RES, V36, pD543, DOI 10.1093/nar/gkm928; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Christensen M, 2003, J BACTERIOL, V185, P6042, DOI 10.1128/JB.185.20.6042-6050.2003; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; de Luna MD, 2008, FEMS MICROBIOL LETT, V284, P237, DOI 10.1111/j.1574-6968.2008.01207.x; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Desvaux M, 2004, CURR ISSUES MOL BIOL, V6, P111; DEY S, 1995, J BACTERIOL, V177, P385, DOI 10.1128/jb.177.2.385-389.1995; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Eslava C, 1998, INFECT IMMUN, V66, P3155, DOI 10.1128/IAI.66.7.3155-3163.1998; Fujiyama R, 2008, CURR MICROBIOL, V56, P474, DOI 10.1007/s00284-008-9115-y; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Goldman SR, 2008, J BACTERIOL, V190, P3526, DOI 10.1128/JB.00151-08; Grosse C, 2006, MOL MICROBIOL, V62, P120, DOI 10.1111/j.1365-2958.2006.05326.x; HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Harrington SM, 2009, INFECT IMMUN, V77, P2465, DOI 10.1128/IAI.01494-08; Hasona A, 2004, J BACTERIOL, V186, P7593, DOI 10.1128/JB.186.22.7593-7600.2004; Henderson IR, 1999, INFECT IMMUN, V67, P5338, DOI 10.1128/IAI.67.10.5338-5344.1999; Henderson IR, 2000, TRENDS MICROBIOL, V8, P352, DOI 10.1016/S0966-842X(00)01814-X; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Hobman JL, 2007, MOL MICROBIOL, V64, P881, DOI 10.1111/j.1365-2958.2007.05710.x; Hu J, 2005, WORLD J GASTROENTERO, V11, P5816, DOI 10.3748/wjg.v11.i37.5816; Huang DB, 2006, CLIN INFECT DIS, V43, P556, DOI 10.1086/505869; Hubbard BK, 1998, BIOCHEMISTRY-US, V37, P14369, DOI 10.1021/bi981124f; Humphries A, 2005, INFECT IMMUN, V73, P5329, DOI 10.1128/IAI.73.9.5329-5338.2005; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Jouve M, 1997, INFECT IMMUN, V65, P4082, DOI 10.1128/IAI.65.10.4082-4089.1997; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kim CH, 1997, J BACTERIOL, V179, P7631, DOI 10.1128/jb.179.24.7631-7637.1997; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KROENKER R, 2008, QUANTREG QUANTILE RE; Lehmacher A, 2007, INT J MED MICROBIOL, V297, P245, DOI 10.1016/j.ijmm.2007.01.007; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lithgow JK, 2007, MOL MICROBIOL, V66, P685, DOI 10.1111/j.1365-2958.2007.05950.x; Menard LP, 2004, PROTEIN EXPRES PURIF, V33, P223, DOI 10.1016/j.pep.2003.09.008; Arancibia EM, 2009, J ANTIMICROB CHEMOTH, V64, P343, DOI 10.1093/jac/dkp178; Monterrubio R, 2000, J BACTERIOL, V182, P2672, DOI 10.1128/JB.182.9.2672-2674.2000; Moritz RL, 2006, J CLIN MICROBIOL, V44, P4038, DOI 10.1128/JCM.01172-06; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nataro JP, 2006, CLIN INFECT DIS, V43, P402, DOI 10.1086/505867; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Pallen M. J., 2007, V3, P30, DOI 10.1159/000107602; Pallen MJ, 2003, PROTEIN SCI, V12, P1804, DOI 10.1110/ps.0371103; Parham NJ, 2004, FEMS MICROBIOL LETT, V230, P73, DOI 10.1016/S0378-1097(03)00862-0; PARSOT C, 1991, P NATL ACAD SCI USA, V88, P1641, DOI 10.1073/pnas.88.5.1641; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poulsen TS, 1999, J BACTERIOL, V181, P7126, DOI 10.1128/JB.181.22.7126-7130.1999; Pugsley AP, 1997, FOLIA MICROBIOL, V42, P184, DOI 10.1007/BF02818976; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Ray WK, 2004, MOL MICROBIOL, V51, P813, DOI 10.1046/j.1365-2958.2003.03868.x; Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004; Ren CP, 2005, J BACTERIOL, V187, P1430, DOI 10.1128/JB.187.4.1430-1440.2005; Rodriguez E, 1999, ANTIMICROB AGENTS CH, V43, P2176, DOI 10.1128/AAC.43.9.2176; Sang WK, 1997, EMERG INFECT DIS, V3, P373, DOI 10.3201/eid0303.970317; SAVARINO SJ, 1993, P NATL ACAD SCI USA, V90, P3093, DOI 10.1073/pnas.90.7.3093; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Sheikh J, 2006, MOL MICROBIOL, V61, P338, DOI 10.1111/j.1365-2958.2006.05234.x; SMITH AN, 1990, MOL MICROBIOL, V4, P1863, DOI 10.1111/j.1365-2958.1990.tb02035.x; Stegmeier JF, 2007, BIOL CHEM, V388, P37, DOI 10.1515/BC.2007.004; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Steiner TS, 1998, J INFECT DIS, V177, P88, DOI 10.1086/513809; Tauschek M, 2002, P NATL ACAD SCI USA, V99, P7066, DOI 10.1073/pnas.092152899; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thanassi DG, 1997, J BACTERIOL, V179, P2512, DOI 10.1128/jb.179.8.2512-2518.1997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Vila J, 1999, ANTIMICROB AGENTS CH, V43, P3022, DOI 10.1128/AAC.43.12.3022; Vila J, 2001, J MED MICROBIOL, V50, P996, DOI 10.1099/0022-1317-50-11-996; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; von Rhein C, 2008, FEMS MICROBIOL LETT, V287, P143, DOI 10.1111/j.1574-6968.2008.01290.x; von Rhein C, 2006, INFECT IMMUN, V74, P6505, DOI 10.1128/IAI.00779-06; Wanke CA, 1998, J INFECT DIS, V178, P185, DOI 10.1086/515595; Webber MA, 2008, J ANTIMICROB CHEMOTH, V62, P83, DOI 10.1093/jac/dkn137; Wells TJ, 2007, FEMS MICROBIOL LETT, V274, P163, DOI 10.1111/j.1574-6968.2007.00833.x; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wilson A, 2001, EUR J EPIDEMIOL, V17, P1125, DOI 10.1023/A:1021224915322; WOODWARD MJ, 1982, J GEN MICROBIOL, V128, P1969; YAMAMOTO T, 1992, J INFECT DIS, V165, P744, DOI 10.1093/infdis/165.4.744; Yang J, 2007, J BACTERIOL, V189, P142, DOI 10.1128/JB.01115-06; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao YF, 2006, INFECT IMMUN, V74, P2196, DOI 10.1128/IAI.74.4.2196-2206.2006; Yen MR, 2002, BBA-BIOMEMBRANES, V1562, P6, DOI 10.1016/S0005-2736(02)00359-0; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003	114	132	145	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8801	10.1371/journal.pone.0008801	http://dx.doi.org/10.1371/journal.pone.0008801			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098708	Green Published, gold			2022-12-27	WOS:000273779000028
J	Penteriani, V; Delgado, MD; Campioni, L; Lourenco, R				Penteriani, Vincenzo; Delgado, Maria del Mar; Campioni, Letizia; Lourenco, Rui			Moonlight Makes Owls More Chatty	PLOS ONE			English	Article							PREDATION RISK; LUNAR CYCLES; BUBO-BUBO; BEHAVIOR; BADGE; BRIGHTNESS; AVOIDANCE; DENSITY; PREY; MOON	Background: Lunar cycles seem to affect many of the rhythms, temporal patterns and behaviors of living things on Earth. Ambient light is known to affect visual communication in animals, with the conspicuousness of visual signals being largely determined by the light available for reflection by the sender. Although most previous studies in this context have focused on diurnal light, moonlight should not be neglected from the perspective of visual communication among nocturnal species. We recently discovered that eagle owls Bubo bubo communicate with conspecifics using a patch of white throat plumage that is repeatedly exposed during each call and is only visible during vocal displays. Methodology/Principal Findings: Here we provide evidence that this species uses moonlight to increase the conspicuousness of this visual signal during call displays. We found that call displays are directly influenced by the amount of moonlight, with silent nights being more frequent during periods with no-moonlight than moonlight. Furthermore, high numbers of calling bouts were more frequent at moonlight. Finally, call posts were located on higher positions on moonlit nights. Conclusions/Significance: Our results support the idea that moon phase affects the visual signaling behavior of this species, and provide a starting point for examination of this method of communication by nocturnal species.	[Penteriani, Vincenzo; Delgado, Maria del Mar; Campioni, Letizia; Lourenco, Rui] CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain; [Penteriani, Vincenzo] Univ Helsinki, Zool Museum, Finnish Museum Nat Hist, Helsinki, Finland; [Delgado, Maria del Mar] Univ Helsinki, Dept Biol & Environm Sci, Lab Ecol & Evolutionary Dynam, Helsinki, Finland; [Lourenco, Rui] Univ Evora, Inst Mediterranean Agr Sci ICAM, Evora, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Helsinki; University of Helsinki; University of Evora	Penteriani, V (corresponding author), CSIC, Estac Biol Donana, Dept Conservat Biol, E-41080 Seville, Spain.	penteriani@ebd.csic.es	Lourenço, Rui/AAB-6030-2020; campioni, letizia/AAZ-2888-2020; Lourenço, Rui/B-7148-2012	Lourenço, Rui/0000-0001-7694-0478; campioni, letizia/0000-0002-6319-6931; Lourenço, Rui/0000-0001-7694-0478; Delgado, Maria del Mar/0000-0002-3009-738X	Spanish Ministry of Science and Innovation [CGL2008-02871/BOS]; Spanish Secretaria General de Universidades, Ministry of Education	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Secretaria General de Universidades, Ministry of Education	The work was funded by a research project of the Spanish Ministry of Science and Innovation (CGL2008-02871/BOS); V.P. was granted by the Spanish Secretaria General de Universidades, Ministry of Education (Salvador de Madariaga Program). The authors manipulated and marked owls under Junta de Andalucia Consejeria de Medio Ambiente permits No. SCFFS-AFR/GGG RS-260/02 and SCFFS-AFR/CMM RS-1904/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Delgado MM, 2007, J ZOOL, V271, P3, DOI 10.1111/j.1469-7998.2006.00205.x; Di Bitetti MS, 2006, J ZOOL, V270, P153, DOI 10.1111/j.1469-7998.2006.00102.x; Dixon DR, 2006, ACTA ETHOL, V9, P59, DOI 10.1007/s10211-006-0016-4; Foster RG, 2008, CURR BIOL, V18, pR784, DOI 10.1016/j.cub.2008.07.003; Gainzarain JA, 2000, BIRD STUDY, V47, P225, DOI 10.1080/00063650009461177; GANEY JL, 1990, CONDOR, V92, P485, DOI 10.2307/1368245; Gannon MR, 1997, BIOTROPICA, V29, P525, DOI 10.1111/j.1744-7429.1997.tb00048.x; James D, 2000, CR ACAD SCI III-VIE, V323, P215, DOI 10.1016/S0764-4469(00)00121-9; Sabato MAL, 2006, BEHAV PROCESS, V73, P228, DOI 10.1016/j.beproc.2006.05.012; Martin G., 1990, BIRDS NIGHT; Mougeot F, 2000, J AVIAN BIOL, V31, P376, DOI 10.1034/j.1600-048X.2000.310314.x; Naylor E, 2001, EARTH MOON PLANETS, V85-6, P291, DOI 10.1023/A:1017088504226; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Penteriani V, 2008, J AVIAN BIOL, V39, P215, DOI 10.1111/j.0908-8857.2008.04280.x; Penteriani V, 2007, BEHAV ECOL, V18, P143, DOI 10.1093/beheco/arl060; Penteriani V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004960; Rahman MS, 2001, COMP BIOCHEM PHYS B, V129, P367, DOI 10.1016/S1096-4959(01)00323-2; Rosenthal GG, 2007, ANNU REV ECOL EVOL S, V38, P155, DOI 10.1146/annurev.ecolsys.38.091206.095745; Takemura A, 2004, FISH FISH, V5, P317, DOI 10.1111/j.1467-2679.2004.00164.x; Thery M., 2006, BIRD COLORATION, V1, P148; TRILLMICH F, 1981, OECOLOGIA, V48, P85, DOI 10.1007/BF00346992; Yamamoto T, 2008, ANIM BEHAV, V76, P1647, DOI 10.1016/j.anbehav.2008.07.019	24	52	55	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8696	10.1371/journal.pone.0008696	http://dx.doi.org/10.1371/journal.pone.0008696			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098700	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779000005
J	Sipe, JC; Scott, TM; Murray, S; Harismendy, O; Simon, GM; Cravatt, BF; Waalen, J				Sipe, Jack C.; Scott, T. Michael; Murray, Sarah; Harismendy, Olivier; Simon, Gabriel M.; Cravatt, Benjamin F.; Waalen, Jill			Biomarkers of Endocannabinoid System Activation in Severe Obesity	PLOS ONE			English	Article							ACID-AMIDE-HYDROLASE; BINGE-EATING DISORDER; MISSENSE POLYMORPHISM; CANNABINOID RECEPTOR; ANANDAMIDE; DERIVATIVES; FAAH; BIOCHEMISTRY; LIGANDS; CB1	Background: Obesity is a worldwide epidemic, and severe obesity is a risk factor for many diseases, including diabetes, heart disease, stroke, and some cancers. Endocannabinoid system (ECS) signaling in the brain and peripheral tissues is activated in obesity and plays a role in the regulation of body weight. The main research question here was whether quantitative measurement of plasma endocannabinoids, anandamide, and related N-acylethanolamines (NAEs), combined with genotyping for mutations in fatty acid amide hydrolase ( FAAH) would identify circulating biomarkers of ECS activation in severe obesity. Methodology/Principal Findings: Plasma samples were obtained from 96 severely obese subjects with body mass index (BMI) of >= 40 kg/m(2), and 48 normal weight subjects with BMI of <= 26 kg/m(2). Triple-quadrupole mass spectroscopy methods were used to measure plasma ECS analogs. Subjects were genotyped for human FAAH gene mutations. The principal analysis focused on the FAAH 385 C -> A (P129T) mutation by comparing plasma ECS metabolite levels in the FAAH 385 minor A allele carriers versus wild-type C/C carriers in both groups. The main finding was significantly elevated mean plasma levels of anandamide (15.1 +/- 1.4 pmol/ml) and related NAEs in study subjects that carried the FAAH 385 A mutant alleles versus normal subjects (13.3 +/- 1.0 pmol/ml) with wild-type FAAH genotype (p = 0.04), and significance was maintained after controlling for BMI. Conclusions/Significance: Significantly increased levels of the endocannabinoid anandamide and related NAEs were found in carriers of the FAAH 385 A mutant alleles compared with wild-type FAAH controls. This evidence supports endocannabinoid system activation due to the effect of FAAH 385 mutant A genotype on plasma AEA and related NAE analogs. This is the first study to document that FAAH 385 A mutant alleles have a direct effect on elevated plasma levels of anandamide and related NAEs in humans. These biomarkers may indicate risk for severe obesity and may suggest novel ECS obesity treatment strategies.	[Sipe, Jack C.; Scott, T. Michael; Harismendy, Olivier; Waalen, Jill] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Simon, Gabriel M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Murray, Sarah; Harismendy, Olivier] Scripps Res Inst, Scripps Genom Med Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Sipe, JC (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jcsipe@scripps.edu	Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888	National Institutes of Health [DA023448]; Center for AIDS Research [3 P30 AI036214-13S1]; Sanofi-Aventis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; Sanofi-Aventis(Sanofi-Aventis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by National Institutes of Health grant #DA023448 and in part by Center for AIDS Research core grant 3 P30 AI036214-13S1, as well as a research grant and supply of subject samples from Sanofi-Aventis to JCS and BFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellocchio L, 2008, J NEUROENDOCRINOL, V20, P850, DOI 10.1111/j.1365-2826.2008.01728.x; CHIANG K, 2004, HUM MOL GENET, V13, P1; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; de Fonseca FR, 2005, ALCOHOL ALCOHOLISM, V40, P2, DOI 10.1093/alcalc/agh110; DEVANE WA, 1994, P NATL ACAD SCI USA, V91, P6698, DOI 10.1073/pnas.91.14.6698; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 1998, NEUROBIOL DIS, V5, P386, DOI 10.1006/nbdi.1998.0214; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; Di Marzo V, 1999, CURR MED CHEM, V6, P721; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Engel Michael S., 2008, Nova Supplementa Entomologica, V20, P1; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Engeli Stefan, 2006, Clin Cornerstone, V8 Suppl 4, pS24, DOI 10.1016/S1098-3597(06)80041-4; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Gonthier MP, 2007, OBESITY, V15, P837, DOI 10.1038/oby.2007.581; Jensen DP, 2007, J MOL MED, V85, P445, DOI 10.1007/s00109-006-0139-0; Jesudason D, 2008, CURR OPIN LIPIDOL, V19, P344, DOI 10.1097/MOL.0b013e328304b62b; Kaufmann I, 2008, PSYCHONEUROENDOCRINO, V33, P676, DOI 10.1016/j.psyneuen.2008.02.009; Kirkham TC, 2005, BEHAV PHARMACOL, V16, P297, DOI 10.1097/00008877-200509000-00004; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Martin BR, 1999, LIFE SCI, V65, P573, DOI 10.1016/S0024-3205(99)00281-7; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Mechoulam R, 1999, FORSCH KOMPLEMENTMED, V6, P16, DOI 10.1159/000057151; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Monteleone P, 2008, PSYCHONEUROENDOCRINO, V33, P546, DOI 10.1016/j.psyneuen.2008.01.004; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Palandra J, 2009, J CHROMATOGR B, V877, P2052, DOI 10.1016/j.jchromb.2009.05.043; Papazoglou D, 2008, HORM METAB RES, V40, P907, DOI 10.1055/s-0028-1087169; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Sipe JC, 2005, INT J OBESITY, V29, P755, DOI 10.1038/sj.ijo.0802954; Walker JM, 2002, CHEM PHYS LIPIDS, V121, P159, DOI 10.1016/S0009-3084(02)00152-4	34	92	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8792	10.1371/journal.pone.0008792	http://dx.doi.org/10.1371/journal.pone.0008792			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098695	gold, Green Submitted, Green Published			2022-12-27	WOS:000273779000020
J	Sjodin, P; Bataillon, T; Schierup, MH				Sjodin, Per; Bataillon, Thomas; Schierup, Mikkel H.			Insertion and Deletion Processes in Recent Human History	PLOS ONE			English	Article							HUMAN GENOME; RECOMBINATION RATES; MAMMALIAN GENOMES; EVOLUTION; SEQUENCES; ARABIDOPSIS; DIVERGENCE; MECHANISMS; EXPANSION; MAJORITY	Background: Although insertions and deletions (indels) account for a sizable portion of genetic changes within and among species, they have received little attention because they are difficult to type, are alignment dependent and their underlying mutational process is poorly understood. A fundamental question in this respect is whether insertions and deletions are governed by similar or different processes and, if so, what these differences are. Methodology/Principal Findings: We use published resequencing data from Seattle SNPs and NIEHS human polymorphism databases to construct a genomewide data set of short polymorphic insertions and deletions in the human genome (n = 6228). We contrast these patterns of polymorphism with insertions and deletions fixed in the same regions since the divergence of human and chimpanzee (n = 10546). The macaque genome is used to resolve all indels into insertions and deletions. We find that the ratio of deletions to insertions is greater within humans than between human and chimpanzee. Deletions segregate at lower frequency in humans, providing evidence for deletions being under stronger purifying selection than insertions. The insertion and deletion rates correlate with several genomic features and we find evidence that both insertions and deletions are associated with point mutations. Finally, we find no evidence for a direct effect of the local recombination rate on the insertion and deletion rate. Conclusions/Significance: Our data strongly suggest that deletions are more deleterious than insertions but that insertions and deletions are otherwise generally governed by the same genomic factors.	[Sjodin, Per; Bataillon, Thomas; Schierup, Mikkel H.] Bioinformat Res Ctr, Aarhus, Denmark	Aarhus University	Sjodin, P (corresponding author), Bioinformat Res Ctr, CF Mollers Alle, Aarhus, Denmark.	persj@cs.au.dk	Bataillon, Thomas/AAJ-7652-2020; Schierup, Mikkel H/F-1675-2010; Schierup, Mikkel Heide/AAM-4997-2020; Bataillon, Thomas/AAK-1822-2020	Bataillon, Thomas/0000-0002-4730-2538; Schierup, Mikkel H/0000-0002-5028-1790; Schierup, Mikkel Heide/0000-0002-5028-1790; 	Carl Trygger's Foundation [CTS 06: 417]; Danish Council for Natural Science [95092886]; Danish Council for Technology and Production [LSHC-CT-2005-018827]	Carl Trygger's Foundation; Danish Council for Natural Science; Danish Council for Technology and Production	PS was supported by a post doctoral grant (grant number CTS 06: 417, URL http://www.carltryggersstiftelse.se/) from Carl Trygger's Foundation. TB was supported by a Steno Fellowship (grant number 95092886, URL http://en.fi.dk/councils-commissions/the-danish-council-for-independent-research/) from the Danish Council for Natural Science (FNU). MHS was supported by a grant (grant number LSHC-CT-2005-018827, URL http://en.fi.dk/councils-commissions/the danish council-for-independent-research/) from the Danish Council for Technology and Production. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Ball EV, 2005, HUM MUTAT, V26, P205, DOI 10.1002/humu.20212; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Britten RJ, 2003, P NATL ACAD SCI USA, V100, P4661, DOI 10.1073/pnas.0330964100; Chen WL, 1999, GENETICS, V151, P1299; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Duval A, 2002, CANCER RES, V62, P2447; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Galtier N, 2001, GENETICS, V159, P907; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000330; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kvikstad EM, 2007, PLOS COMPUT BIOL, V3, P1772, DOI 10.1371/journal.pcbi.0030176; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Lynch M, 2007, ORIGINS GENOME ARCHI; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Messer PW, 2007, MOL BIOL EVOL, V24, P1190, DOI 10.1093/molbev/msm035; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Opperman R, 2004, GENETICS, V168, P2207, DOI 10.1534/genetics.104.032896; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; R Development Core Team, 2007, R LANG ENV STAT COMP; Tanay A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r37; Taylor MS, 2006, PLOS GENET, V2, P627, DOI 10.1371/journal.pgen.0020030; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	31	23	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8650	10.1371/journal.pone.0008650	http://dx.doi.org/10.1371/journal.pone.0008650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098729	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900004
J	Amano, M; Tsumura, Y; Taki, K; Harada, H; Mori, K; Nishioka, T; Kato, K; Suzuki, T; Nishioka, Y; Iwamatsu, A; Kaibuchi, K				Amano, Mutsuki; Tsumura, Yuta; Taki, Kentaro; Harada, Hidenori; Mori, Kazutaka; Nishioka, Tomoki; Kato, Katsuhiro; Suzuki, Takeshi; Nishioka, Yosuke; Iwamatsu, Akihiro; Kaibuchi, Kozo			A Proteomic Approach for Comprehensively Screening Substrates of Protein Kinases Such as Rho-Kinase	PLOS ONE			English	Article							MIGRATING NEURONS; PHOSPHORYLATION; PHOSPHATASE; IDENTIFICATION; SPECIFICITY; AFFINITY; BALANCE; TAU	Background: Protein kinases are major components of signal transduction pathways in multiple cellular processes. Kinases directly interact with and phosphorylate downstream substrates, thus modulating their functions. Despite the importance of identifying substrates in order to more fully understand the signaling network of respective kinases, efficient methods to search for substrates remain poorly explored. Methodology/Principal Findings: We combined mass spectrometry and affinity column chromatography of the catalytic domain of protein kinases to screen potential substrates. Using the active catalytic fragment of Rho-kinase/ROCK/ROK as the model bait, we obtained about 300 interacting proteins from the rat brain cytosol fraction, which included the proteins previously reported as Rho-kinase substrates. Several novel interacting proteins, including doublecortin, were phosphorylated by Rho-kinase both in vitro and in vivo. Conclusions/Significance: This method would enable identification of novel specific substrates for kinases such as Rho-kinase with high sensitivity.	[Amano, Mutsuki; Tsumura, Yuta; Taki, Kentaro; Harada, Hidenori; Mori, Kazutaka; Nishioka, Tomoki; Kato, Katsuhiro; Suzuki, Takeshi; Nishioka, Yosuke; Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan; [Mori, Kazutaka; Kato, Katsuhiro] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4648601, Japan; [Iwamatsu, Akihiro] Prot Res Network Inc, Yokohama, Kanagawa, Japan; [Kaibuchi, Kozo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST)	Amano, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4648601, Japan.	kaibuchi@med.nagoya-u.ac.jp	Kato, Katsuhiro/AAV-8356-2020; Amano, Mutsuki/M-4820-2014; Nishioka, Tomoki/M-4976-2014	Amano, Mutsuki/0000-0002-0662-1524; 	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [20058012, 17024024, 20227006, 20590308]; Japan Science and Technology Agency, CREST [26-J-Jc08]	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This research was supported in part by Grant-in-Aid for Scientific Research on Priority Areas (20058012, 17024024) and Grant-in-Aid for Scientific Research (S) (20227006) and (C) (20590308) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT). This research was also supported in part by Japan Science and Technology Agency, CREST (26-J-Jc08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Biondi RM, 2003, BIOCHEM J, V372, P1, DOI 10.1042/BJ20021641; Futer O, 2006, BIOCHEMISTRY-US, V45, P7913, DOI 10.1021/bi052468q; HIKITA T, 2009, J NEUROCHEM; Inada H, 1999, J BIOL CHEM, V274, P34932, DOI 10.1074/jbc.274.49.34932; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kawauchi T, 2008, DEV NEUROSCI-BASEL, V30, P36, DOI 10.1159/000109850; Machida M, 2007, FEBS J, V274, P1576, DOI 10.1111/j.1742-4658.2007.05705.x; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Schaar BT, 2004, NEURON, V41, P203, DOI 10.1016/S0896-6273(03)00843-2; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Taniguchi T, 2001, J BIOL CHEM, V276, P10025, DOI 10.1074/jbc.M007427200; Tedford NC, 2009, PROTEOMICS, V9, P1469, DOI 10.1002/pmic.200800468; Trauger JW, 2002, BIOCHEMISTRY-US, V41, P8948, DOI 10.1021/bi0258243; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203	20	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8704	10.1371/journal.pone.0008704	http://dx.doi.org/10.1371/journal.pone.0008704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090853	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600007
J	Sanokawa-Akakura, R; Cao, WH; Allan, K; Patel, K; Ganesh, A; Heiman, G; Burke, R; Kemp, FW; Bogden, JD; Camakaris, J; Birge, RB; Konsolaki, M				Sanokawa-Akakura, Reiko; Cao, Weihuan; Allan, Kirsten; Patel, Khyati; Ganesh, Anupama; Heiman, Gary; Burke, Richard; Kemp, Francis W.; Bogden, John D.; Camakaris, James; Birge, Raymond B.; Konsolaki, Mary			Control of Alzheimer's Amyloid Beta Toxicity by the High Molecular Weight Immunophilin FKBP52 and Copper Homeostasis in Drosophila	PLOS ONE			English	Article							A-BETA; PROTEIN; EXPRESSION; MODEL; MELANOGASTER; MECHANISMS; DISEASE; BRAIN; PHOSPHORYLATION; PIGMENTATION	FK506 binding proteins (FKBPs), also called immunophilins, are prolyl-isomerases (PPIases) that participate in a wide variety of cellular functions including hormone signaling and protein folding. Recent studies indicate that proteins that contain PPIase activity can also alter the processing of Alzheimer's Amyloid Precursor Protein (APP). Originally identified in hematopoietic cells, FKBP52 is much more abundantly expressed in neurons, including the hippocampus, frontal cortex, and basal ganglia. Given the fact that the high molecular weight immunophilin FKBP52 is highly expressed in CNS regions susceptible to Alzheimer's, we investigated its role in A beta toxicity. Towards this goal, we generated A beta transgenic Drosophila that harbor gain of function or loss of function mutations of FKBP52. FKBP52 overexpression reduced the toxicity of A beta and increased lifespan in A beta flies, whereas loss of function of FKBP52 exacerbated these A beta phenotypes. Interestingly, the A beta pathology was enhanced by mutations in the copper transporters Atox1, which interacts with FKBP52, and Ctr1A and was suppressed in FKBP52 mutant flies raised on a copper chelator diet. Using mammalian cultures, we show that FKBP52 (-/-) cells have increased intracellular copper and higher levels of A beta. This effect is reversed by reconstitution of FKBP52. Finally, we also found that FKBP52 formed stable complexes with APP through its FK506 interacting domain. Taken together, these studies identify a novel role for FKBP52 in modulating toxicity of A beta peptides.	[Cao, Weihuan; Patel, Khyati; Ganesh, Anupama; Heiman, Gary; Konsolaki, Mary] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Sanokawa-Akakura, Reiko; Birge, Raymond B.] Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA; [Allan, Kirsten; Burke, Richard] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Kemp, Francis W.; Bogden, John D.] Univ Med & Dent New Jersey, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA; [Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic, Australia	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Monash University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Melbourne	Konsolaki, M (corresponding author), Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA.	konsolaki@biology.rutgers.edu	Heiman, Gary A/K-2366-2018; BOGDEN, JOHN D./ABG-6718-2020	Heiman, Gary A/0000-0001-5859-0259; Burke, Richard/0000-0003-0086-0767	Johnson & Johnson Focused; National Institutes of Health (NIH) [AG027198]; National Health and Medical Research Council (NHMRC); NATIONAL INSTITUTE ON AGING [R21AG027198] Funding Source: NIH RePORTER	Johnson & Johnson Focused; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Johnson & Johnson Focused Giving grants to RBB and MK, as well as National Institutes of Health (NIH) AG027198 to RBB and National Health and Medical Research Council (NHMRC) project grant to RB and JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brecht S, 2003, NEUROSCIENCE, V120, P1037, DOI 10.1016/S0306-4522(03)00404-4; Breiman A, 2002, TRANSGENIC RES, V11, P321, DOI 10.1023/A:1016331814412; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Davies P, 2008, BIOCHEM SOC T, V36, P1299, DOI 10.1042/BST0361299; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Gaburjakova M, 2001, J BIOL CHEM, V276, P16931, DOI 10.1074/jbc.M100856200; Goel M, 2001, J BIOL CHEM, V276, P38762, DOI 10.1074/jbc.M104125200; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kemp FW, 2007, ENVIRON HEALTH PERSP, V115, P630, DOI 10.1289/ehp.9389; Kitazawa M, 2009, J NEUROCHEM, V108, P1550, DOI 10.1111/j.1471-4159.2009.05901.x; Kong GKW, 2007, ACTA CRYSTALLOGR F, V63, P819, DOI 10.1107/S1744309107041139; Li F, 2004, J NEUROSCI RES, V76, P383, DOI 10.1002/jnr.20067; Liu FL, 2006, BIOCHEM BIOPH RES CO, V350, P472, DOI 10.1016/j.bbrc.2006.09.073; LYONS WE, 1994, P NATL ACAD SCI USA, V91, P3191, DOI 10.1073/pnas.91.8.3191; LYONS WE, 1995, J NEUROSCI, V15, P2985; Norgate M, 2006, MOL BIOL CELL, V17, P475, DOI 10.1091/mbc.E05-06-0492; Norgate M, 2007, BIOMETALS, V20, P683, DOI 10.1007/s10534-006-9075-2; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Puig S, 2002, CURR OPIN CHEM BIOL, V6, P171, DOI 10.1016/S1367-5931(02)00298-3; Rival T, 2009, EUR J NEUROSCI, V29, P1335, DOI 10.1111/j.1460-9568.2009.06701.x; Sanokawa-Akakura R, 2004, J BIOL CHEM, V279, P27845, DOI 10.1074/jbc.C400118200; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; SMITH DF, 1993, J BIOL CHEM, V268, P18356; STEINER JP, 1992, NATURE, V358, P584, DOI 10.1038/358584a0; TAI PKK, 1986, BIOCHEMISTRY-US, V25, P5269, DOI 10.1021/bi00366a043; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; van der Burg JW, 2009, AIAA J, V47, P60, DOI 10.2514/1.34300; VELDHUIS NA, 2009, INT J BIOCH CEL 0701; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Willnow TE, 2006, MOL INTERV, V6, P137, DOI 10.1124/mi.6.3.4; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Zaffran S, 2000, GENE, V246, P103, DOI 10.1016/S0378-1119(00)00058-5; Zhou H, 2003, J BIOL CHEM, V278, P48210, DOI 10.1074/jbc.M309820200	43	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8626	10.1371/journal.pone.0008626	http://dx.doi.org/10.1371/journal.pone.0008626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084280	Green Published, gold			2022-12-27	WOS:000273554600007
J	Leergaard, TB; White, NS; de Crespigny, A; Bolstad, I; D'Arceuil, H; Bjaalie, JG; Dale, AM				Leergaard, Trygve B.; White, Nathan S.; de Crespigny, Alex; Bolstad, Ingeborg; D'Arceuil, Helen; Bjaalie, Jan G.; Dale, Anders M.			Quantitative Histological Validation of Diffusion MRI Fiber Orientation Distributions in the Rat Brain	PLOS ONE			English	Article							AXON DIAMETER DISTRIBUTION; SPHERICAL DECONVOLUTION; TENSOR MRI; SUPERIOR COLLICULUS; ANGULAR RESOLUTION; OPTIC TRACTS; WEIGHTED MRI; TRACTOGRAPHY; NMR; RECONSTRUCTION	Diffusion MRI (dMRI) is widely used to measure microstructural features of brain white matter, but commonly used dMRI measures have limited capacity to resolve the orientation structure of complex fiber architectures. While several promising new approaches have been proposed, direct quantitative validation of these methods against relevant histological architectures remains missing. In this study, we quantitatively compare neuronal fiber orientation distributions (FODs) derived from ex vivo dMRI data against histological measurements of rat brain myeloarchitecture using manual recordings of individual myelin stained fiber orientations. We show that accurate FOD estimates can be obtained from dMRI data, even in regions with complex architectures of crossing fibers with an intrinsic orientation error of approximately 5-6 degrees in these regions. The reported findings have implications for both clinical and research studies based on dMRI FOD measures, and provide an important biological benchmark for improved FOD reconstruction and fiber tracking methods.	[Leergaard, Trygve B.; Bolstad, Ingeborg; Bjaalie, Jan G.] Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway; [White, Nathan S.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA 92103 USA; [de Crespigny, Alex; D'Arceuil, Helen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, AA Martinos Ctr Biomed Imaging, Boston, MA USA; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA	University of Oslo; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Diego; University of California System; University of California San Diego	Leergaard, TB (corresponding author), Univ Oslo, Inst Basic Med Sci, Ctr Mol Biol & Neurosci, Oslo, Norway.	amdale@ucsd.edu	Dale, Anders M/A-5180-2010; Bjaalie, Jan G. G./AAW-6445-2021	Bjaalie, Jan G. G./0000-0001-7899-906X; Leergaard, Trygve B./0000-0001-5965-8470; Bolstad, Ingeborg/0000-0001-7316-6309	Research Council of Norway; NIH [R01-EB00790, U24-RR021382]; Martinos Center for Biomedical imaging; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Martinos Center for Biomedical imaging; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This project was funded by grants from The Research Council of Norway (to TBL and JGB), the NIH (R01-EB00790, U24-RR021382 to AMD), The Martinos Center for Biomedical imaging, and The American Heart Association (to AdC and HD'A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS FJ, 1988, J COMP NEUROL, V274, P357, DOI 10.1002/cne.902740306; Alexander DC, 2005, LECT NOTES COMPUT SC, V3565, P76; Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Anderson AW, 2005, MAGN RESON MED, V54, P1194, DOI 10.1002/mrm.20667; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; CALLAGHAN PT, 1991, NATURE, V351, P467, DOI 10.1038/351467a0; Campbell JSW, 2005, NEUROIMAGE, V27, P725, DOI 10.1016/j.neuroimage.2005.05.014; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; CORY DG, 1990, MAGNET RESON MED, V14, P435, DOI 10.1002/mrm.1910140303; D'Arceuil H, 2007, NEUROIMAGE, V36, P64, DOI 10.1016/j.neuroimage.2007.02.039; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; EDWARDS MA, 1986, J COMP NEUROL, V248, P395, DOI 10.1002/cne.902480308; HEIMER LENNART, 1967, BRAIN RES, V5, P171, DOI 10.1016/0006-8993(67)90085-6; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Holmes AA, 2000, MAGNET RESON MED, V44, P157, DOI 10.1002/1522-2594(200007)44:1<157::AID-MRM22>3.0.CO;2-F; HSU EW, 1995, MAGNET RESON MED, V34, P194, DOI 10.1002/mrm.1910340210; Hsu EW, 1998, AM J PHYSIOL-HEART C, V274, pH1627, DOI 10.1152/ajpheart.1998.274.5.H1627; Jian B, 2007, IEEE T MED IMAGING, V26, P1464, DOI 10.1109/TMI.2007.907552; Johansen-Berg H, 2006, CURR OPIN NEUROL, V19, P379, DOI 10.1097/01.wco.0000236618.82086.01; Canales-Rodriguez EJ, 2008, MAGN RESON MED, V60, P616, DOI 10.1002/mrm.21673; Kaden E, 2007, NEUROIMAGE, V37, P474, DOI 10.1016/j.neuroimage.2007.05.012; Kaufman JA, 2005, ANAT REC PART A, V287A, P1026, DOI 10.1002/ar.a.20264; Le Bihan D, 2006, J MAGN RESON IMAGING, V24, P478, DOI 10.1002/jmri.20683; LEBIHAN D, 1986, RADIOLOGY, V161, P401, DOI 10.1148/radiology.161.2.3763909; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lin CP, 2001, NEUROIMAGE, V14, P1035, DOI 10.1006/nimg.2001.0882; Melie-Garcia L, 2008, NEUROIMAGE, V42, P750, DOI 10.1016/j.neuroimage.2008.04.242; MERBOLDT KD, 1991, MAGNET RESON MED, V19, P233, DOI 10.1002/mrm.1910190208; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; MOSELEY ME, 1990, AM J NEURORADIOL, V11, P423; Perrin M, 2005, PHILOS T R SOC B, V360, P881, DOI 10.1098/rstb.2005.1650; Sargon MF, 2003, ANAT HISTOL EMBRYOL, V32, P141, DOI 10.1046/j.1439-0264.2003.00446.x; Scollan DF, 1998, AM J PHYSIOL-HEART C, V275, pH2308, DOI 10.1152/ajpheart.1998.275.6.H2308; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; TAYLOR DG, 1985, PHYS MED BIOL, V30, P345, DOI 10.1088/0031-9155/30/4/009; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch D S, 2002, THESIS MIT; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1; White NS, 2009, HUM BRAIN MAPP, V30, P3696, DOI 10.1002/hbm.20799; WISE SP, 1976, J COMP NEUROL, V168, P313, DOI 10.1002/cne.901680302; Woelcke M, 1942, J PSYCHOL NEUROL, V51, P199; Zhan W, 2006, J MAGN RESON, V183, P193, DOI 10.1016/j.jmr.2006.08.005	55	140	143	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8595	10.1371/journal.pone.0008595	http://dx.doi.org/10.1371/journal.pone.0008595			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062822	Green Published, gold, Green Submitted			2022-12-27	WOS:000273414100005
J	Lightowler, JVJ; Cooke, GS; Mutevedzi, P; Lessells, RJ; Newell, ML; Dedicoat, M				Lightowler, Josephine V. J.; Cooke, Graham S.; Mutevedzi, Portia; Lessells, Richard J.; Newell, Marie-Louise; Dedicoat, Martin			Treatment of Cryptococcal Meningitis in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AIDS-ASSOCIATED CRYPTOCOCCOSIS; ACTIVE ANTIRETROVIRAL THERAPY; COHORT; UGANDA; FLUCONAZOLE; INFECTIONS; MORTALITY; DISEASE; BURDEN	Background: Cryptococcal meningitis (CM) remains a leading cause of death for HIV-infected individuals in sub-Saharan Africa. Improved treatment strategies are needed if individuals are to benefit from the increasing availability of antiretroviral therapy. We investigated the factors associated with mortality in routine care in KwaZulu-Natal, South Africa. Methodology/Principal Findings: A prospective year long, single-center, consecutive case series of individuals diagnosed with cryptococcal meningitis 190 patients were diagnosed with culture positive cryptococcal meningitis, of whom 186 were included in the study. 52/186 (28.0%) patients died within 14 days of diagnosis and 60/186 (32.3%) had died by day 28. In multivariable cox regression analysis, focal neurology (aHR 11 95%C.I. 3.08-39.3, P < 0.001), diastolic blood pressure <60 mmHg (aHR 2.37 95%C.I. 1.11-5.04, P = 0.025), concurrent treatment for tuberculosis (aHR 2.11 95%C.I. 1.02-4.35, P = 0.044) and use of fluconazole monotherapy (aHR 3.69 95%C.I. 1.74-7.85, P < 0.001) were associated with increased mortality at 14 and 28 days. Conclusions: Even in a setting where amphotericin B is available, mortality from cryptococcal meningitis in this setting is high, particularly in the immediate period after diagnosis. This highlights the still unmet need not only for earlier diagnosis of HIV and timely access to treatment of opportunistic infections, but for better treatment strategies of cryptococcal meningitis.	[Lightowler, Josephine V. J.; Dedicoat, Martin] Ngwelezane Hosp, Empangeni, Kwazulu Natal, South Africa; [Lightowler, Josephine V. J.] John Radcliffe Hosp, Oxford OX3 9DU, England; [Cooke, Graham S.; Mutevedzi, Portia; Lessells, Richard J.; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Cooke, Graham S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London, England; [Newell, Marie-Louise] UCL Inst Child Hlth, London, England; [Dedicoat, Martin] Univ Limpopo, Limpopo, South Africa	University of Oxford; University of Kwazulu Natal; Imperial College London; University of London; University College London; University of Limpopo	Lightowler, JVJ (corresponding author), Ngwelezane Hosp, Empangeni, Kwazulu Natal, South Africa.	gcooke@africacentre.ac.za	Dedicoat, Martin/AFC-7815-2022; Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Cooke, Graham/0000-0001-6475-5056; Lessells, Richard/0000-0003-0926-710X; Dedicoat, Martin/0000-0001-9833-4882	Wellcome Trust [GR085957]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded in part by Wellcome Trust grant (GR085957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Antinori S, 2009, HIV MED, V10, P6, DOI 10.1111/j.1468-1293.2008.00645.x; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bisson GP, 2008, JAIDS-J ACQ IMM DEF, V49, P227, DOI 10.1097/QAI.0b013e318183181e; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Corbett EL, 2002, CLIN INFECT DIS, V34, P1251, DOI 10.1086/339540; Dickson SJ, 2007, THORAX, V62, P964, DOI 10.1136/thx.2006.072256; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; MAKADZANGE A, 2009, EARLY VS DELAYED ART; MCCARTHY K, 2007, S AFR J HIV MED, P25; Okongo M, 1998, INT J EPIDEMIOL, V27, P698, DOI 10.1093/ije/27.4.698; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; UNAIDS, 2008, REP GLOB AIDS EP; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	23	20	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 7	2010	5	1							e8630	10.1371/journal.pone.0008630	http://dx.doi.org/10.1371/journal.pone.0008630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KN	20062814	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000273414100014
J	Senderovich, Y; Izhaki, I; Halpern, M				Senderovich, Yigal; Izhaki, Ido; Halpern, Malka			Fish as Reservoirs and Vectors of Vibrio cholerae	PLOS ONE			English	Article							CHIRONOMID EGG MASSES; III SECRETION SYSTEM; NON-O1; CHITIN; POPULATION; STRAINS; WATER	Vibrio cholerae, the etiologic agent of cholera, is autochthonous to various aquatic environments, but despite intensive efforts its ecology remains an enigma. Recently, it was suggested that copepods and chironomids, both considered as natural reservoirs of V. cholerae, are dispersed by migratory waterbirds, thus possibly distributing the bacteria between water bodies within and between continents. Although fish have been implicated in the scientific literature with cholera cases, as far as we know, no study actually surveyed the presence of the bacteria in the fish. Here we show for the first time that fish of various species and habitats contain V. cholerae in their digestive tract. Fish (n = 110) were randomly sampled from freshwater and marine habitats in Israel. Ten different fish species sampled from freshwater habitats (lake, rivers and fish ponds), and one marine species, were found to carry V. cholerae. The fish intestine of Sarotherodon galilaeus harboured ca. 56x10(3) V. cholerae cfu per 1 gr intestine content-high rates compared with known V. cholerae cfu numbers in the bacteria's natural reservoirs. Our results, combined with evidence from the literature, suggest that fish are reservoirs of V. cholerae. As fish carrying the bacteria swim from one location to another (some fish species move from rivers to lakes or sea and vice versa), they serve as vectors on a small scale. Nevertheless, fish are consumed by waterbirds, which disseminate the bacteria on a global scale. Moreover, V. cholerae isolates had the ability to degrade chitin, indicating a commensal relationship between V. cholerae and fish. Better understanding of V. cholerae ecology can help reduce the times that human beings come into contact with this pathogen and thus minimize the health risk this poses.	[Senderovich, Yigal; Izhaki, Ido; Halpern, Malka] Univ Haifa, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel; [Halpern, Malka] Univ Haifa, Dept Biol Educ, Fac Sci & Sci Educ, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Senderovich, Y (corresponding author), Univ Haifa, Dept Evolutionary & Environm Biol, Fac Sci & Sci Educ, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Halpern, Malka/AAH-1498-2019; Izhaki, Ido/D-5586-2011; Izhaki, Ido/I-9712-2019	Halpern, Malka/0000-0002-3407-2198; Izhaki, Ido/0000-0002-4525-4683; Izhaki, Ido/0000-0002-4525-4683	University of Haifa, Israel	University of Haifa, Israel	This study was supported by the Research Authority, University of Haifa, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta CJ, 2001, EMERG INFECT DIS, V7, P583; BOOTH LV, 1990, J INFECTION, V20, P55, DOI 10.1016/S0163-4453(90)92346-M; Broza M, 2001, NATURE, V412, P40, DOI 10.1038/35083691; CARVAJAL GH, 1988, J GEN APPL MICROBIOL, V44, P27; Chatterjee S, 2009, J CLIN MICROBIOL, V47, P1087, DOI 10.1128/JCM.02026-08; Cheasty T, 1999, LANCET, V354, P89, DOI 10.1016/S0140-6736(99)00151-8; Colwell R, 2001, HYDROBIOLOGIA, V460, P141, DOI 10.1023/A:1013111016642; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; Debellis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005074; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; FINCH MJ, 1987, AM J TROP MED HYG, V36, P393, DOI 10.4269/ajtmh.1987.36.393; Forssman B, 2007, MED J AUSTRALIA, V187, P345, DOI 10.5694/j.1326-5377.2007.tb01278.x; Halpern M, 2006, FEMS MICROBIOL ECOL, V55, P98, DOI 10.1111/j.1574-6941.2005.00020.x; Halpern M, 2004, MICROB ECOL, V47, P341, DOI 10.1007/s00248-003-2007-6; Halpern M, 2003, APPL ENVIRON MICROB, V69, P4200, DOI 10.1128/AEM.69.7.4200-4204.2003; Halpern M, 2007, MICROB ECOL, V53, P285, DOI 10.1007/s00248-006-9094-0; Halpern M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000173; HSU SC, 1975, APPL MICROBIOL, V29, P422, DOI 10.1128/AEM.29.3.422-426.1975; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; KAMAL AM, 1971, J EGYPT PUBLIC HLTH, V46, P125; KIIYUKIA C, 1992, APPL ENVIRON MICROB, V58, P3078, DOI 10.1128/AEM.58.9.3078-3082.1992; Lewin S. M., 1996, P228; Maggi P, 1997, EUR J EPIDEMIOL, V13, P95, DOI 10.1023/A:1007329700125; MCINTYRE RC, 1979, LANCET, V10, P311; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Mukhopadhyay AK, 1996, J CLIN MICROBIOL, V34, P2537, DOI 10.1128/JCM.34.10.2537-2543.1996; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; PANDIT CG, 1951, INDIAN J MED SCI, V15, P343; Plesnik V., 2006, Epidemiologie Mikrobiologie Imunologie, V55, P30; Pruzzo C, 2008, ENVIRON MICROBIOL, V10, P1400, DOI 10.1111/j.1462-2920.2007.01559.x; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Schurmann D, 2002, EUR J CLIN MICROBIOL, V21, P827, DOI 10.1007/s10096-002-0832-z; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005	35	103	104	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8607	10.1371/journal.pone.0008607	http://dx.doi.org/10.1371/journal.pone.0008607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066040	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600025
J	Kalua, K; Chirwa, T; Kalilani, L; Abbenyi, S; Mukaka, M; Bailey, R				Kalua, Khumbo; Chirwa, Tobias; Kalilani, Linda; Abbenyi, Sam; Mukaka, Mavuto; Bailey, Robin			Prevalence and Risk Factors for Trachoma in Central and Southern Malawi	PLOS ONE			English	Article							ACTIVE TRACHOMA; BLINDNESS; TANZANIA; GAMBIA; TRIAL; NTD	Background: Trachoma, one of the neglected tropical diseases is suspected to be endemic in Malawi. Objectives: To determine the prevalence of trachoma and associated risk factors in central and southern Malawi. Methodology/Principal Findings: A population based survey conducted in randomly selected clusters in Chikwawa district (population 438,895), southern Malawi and Mchinji district (population 456,558), central Malawi. Children aged 1-9 years and adults aged 15 and above were assessed for clinical signs of trachoma. In total, 1010 households in Chikwawa and 1016 households in Mchinji districts were enumerated within 108 clusters (54 clusters in each district). A total of 6,792 persons were examined for ocular signs of trachoma. The prevalence of trachomatous inflammation, follicular (TF) among children aged 1-9 years was 13.6% (CI 11.6-15.6) in Chikwawa and 21.7% (CI 19.5-23.9) in Mchinji districts respectively. The prevalence of trachoma trichiasis (TT) in women and men aged 15 years and above was 0.6% (CI 0.2-0.9) in Chikwawa and 0.3% (CI 0.04-0.6) in Mchinji respectively. The presence of a dirty face was significantly associated with trachoma follicular (TF) in both Chikwawa and Mchinji districts (P<0.001). Conclusion/Significance: Prevalence rates of trachoma follicles (TF) in Central and Southern Malawi exceeds the WHO guidelines for the intervention with mass antibiotic distribution (TF>10%), and warrants the trachoma SAFE control strategy to be undertaken in Chikwawa and Mchinji districts.	[Kalua, Khumbo] Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi; [Chirwa, Tobias] Univ Malawi, Chancellor Coll, Dept Math & Stat, Zomba, Malawi; [Kalilani, Linda] Univ Malawi, Coll Med, Res Support Ctr, Blantyre, Malawi; [Abbenyi, Sam] ITI, New York, NY USA; [Mukaka, Mavuto] MLWT, Coll Med, Blantyre, Malawi; [Kalua, Khumbo; Bailey, Robin] London Sch Hyg & Trop Med, London WC1, England	University of Malawi; University of Malawi; University of Malawi; University of Malawi; University of London; London School of Hygiene & Tropical Medicine	Kalua, K (corresponding author), Univ Malawi, Coll Med, Dept Ophthalmol, Blantyre, Malawi.	khumbokalua@yahoo.com	Chirwa, Tobias/AAI-9087-2021; Kalua, Khumbo k/D-8449-2019	Kalua, Khumbo k/0000-0001-9284-9009	National Prevention of Blindness Committee; Ministry of Health, Malawi by Sight Savers International (SSI)	National Prevention of Blindness Committee; Ministry of Health, Malawi by Sight Savers International (SSI)	The study was funded through National Prevention of Blindness Committee, Ministry of Health, Malawi by Sight Savers International (SSI), a UK based charity organisation which has been supporting eye care activities in Malawi for the last 30 years. SSI Malawi country office staff helped in providing logistics for the survey (printing questionnaires and assisting with transportation) but did not take part in manuscript writing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggaley RF, 2006, TROP MED INT HEALTH, V11, P220, DOI 10.1111/j.1365-3156.2005.01553.x; Bailey R, 2007, BRIT J OPHTHALMOL, V91, P271, DOI 10.1136/bjo.2006.105270; Bowman RJC, 2001, OPHTHALMOLOGY, V108, P2219, DOI 10.1016/S0161-6420(01)00645-5; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Courtright P, 2003, BRIT J OPHTHALMOL, V87, P1079, DOI 10.1136/bjo.87.9.1079; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Emerson PM, 2004, LANCET, V363, P1093, DOI 10.1016/S0140-6736(04)15891-1; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; MABEY DCW, 1987, LANCET, V2, P452; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; Ngondi J, 2007, AM J TROP MED HYG, V77, P126, DOI 10.4269/ajtmh.2007.77.126; Polack S, 2005, B WORLD HEALTH ORGAN, V83, P913; Reddy M, 2007, JAMA-J AM MED ASSOC, V298, P1911, DOI 10.1001/jama.298.16.1911; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; TIELSCH JM, 1988, AM J TROP MED HYG, V38, P393, DOI 10.4269/ajtmh.1988.38.393; West SK, 1996, AM J EPIDEMIOL, V143, P73, DOI 10.1093/oxfordjournals.aje.a008659; WHO, 2006, TRACH CONTR GUID PRO; WHO simplified trachoma grading system, 2004, COMMUNITY EYE HLTH, V17, P68	22	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9067	10.1371/journal.pone.0009067	http://dx.doi.org/10.1371/journal.pone.0009067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140094	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000274442400007
J	Cachaco, AS; Carvalho, T; Santos, AC; Igreja, C; Fragoso, R; Osorio, C; Ferreira, M; Serpa, J; Correia, S; Pinto-do-O, P; Dias, S				Cachaco, Ana Sofia; Carvalho, Tania; Santos, Ana Cristina; Igreja, Catia; Fragoso, Rita; Osorio, Catarina; Ferreira, Manuela; Serpa, Jacinta; Correia, Sofia; Pinto-do-O, Perpetua; Dias, Sergio			TNF-alpha Regulates the Effects of Irradiation in the Mouse Bone Marrow Microenvironment	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYELODYSPLASTIC SYNDROMES; FACTOR RECEPTOR; IN-VITRO; SIGNALING PATHWAYS; MYELOID-LEUKEMIA; PROGENITOR CELLS; APLASTIC-ANEMIA; FANCONI-ANEMIA; FUSION PROTEIN	Background: Secondary bone marrow (BM) myelodysplastic syndromes (MDS) are increasingly common, as a result of radio or chemotherapy administered to a majority of cancer patients. Patients with secondary MDS have increased BM cell apoptosis, which results in BM dysfunction (cytopenias), and an increased risk of developing fatal acute leukemias. In the present study we asked whether TNF-alpha, known to regulate cell apoptosis, could modulate the onset of secondary MDS. Principal Findings: We show that TNF-alpha is induced by irradiation and regulates BM cells apoptosis in vitro and in vivo. In contrast to irradiated wild type (WT) mice, TNF-alpha deficient (TNF-alpha KO) mice or WT mice treated with a TNF-alpha-neutralizing antibody were partially protected from the apoptotic effects of irradiation. Next we established a 3-cycle irradiation protocol, in which mice were sub-lethally irradiated once monthly over a 3 month period. In this model, irradiated WT mice presented loss of microsatellite markers on BM cells, low white blood cell (WBC) counts, reduced megakaryocyte (MK) and platelet levels (thrombocytopenia) and macrocytic anemia, phenoypes that suggest the irradiation protocol resulted in BM dysfunction with clinical features of MDS. In contrast, TNF-alpha KO mice were protected from the irradiation effects: BM cell apoptosis following irradiation was significantly reduced, concomitant with sustained BM MK numbers and absence of other cytopenias. Moreover, irradiated WT mice with long term (>= 5 months) BM dysfunction had increased BM angiogenesis, MMPs and VEGF and NFkB p65, suggestive of disease progression. Conclusion: Taken together, our data shows that TNF-alpha induction following irradiation modulates BM cell apoptosis and is a crucial event in BM dysfunction, secondary MDS onset and progression.	[Cachaco, Ana Sofia; Carvalho, Tania; Igreja, Catia; Fragoso, Rita; Osorio, Catarina; Ferreira, Manuela; Serpa, Jacinta; Dias, Sergio] Inst Portugues Oncol Francisco Gentil, CIPM, Angiogenesis Lab, Lisbon, Portugal; [Santos, Ana Cristina] Univ Lisbon, Fac Med, Dept Anat Patol, P-1699 Lisbon, Portugal; [Dias, Sergio] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Correia, Sofia; Pinto-do-O, Perpetua] Univ Porto, INEB, Div Biomat, P-4100 Oporto, Portugal	Portuguese Institute of Oncology; Universidade de Lisboa; Instituto Gulbenkian de Ciencia; Universidade do Porto	Cachaco, AS (corresponding author), Inst Portugues Oncol Francisco Gentil, CIPM, Angiogenesis Lab, Lisbon, Portugal.	sergidias@ipolisboa.min-saude.pt	Igreja, Catia/I-8902-2018; Serpa, Jacinta/AAD-1861-2020; Fragoso, Rita/ABH-3528-2020; Pinto-do-Ó, Perpetua/ABD-7205-2020; Igreja, Catia/J-3674-2017; Serpa, Jacinta/A-4772-2013; Dias, Sergio/L-1250-2014; Ferreira, Manuela/I-7904-2018; Fragoso, Rita/O-7164-2019; Serpa, Jacinta/GLV-1532-2022; Carvalho, Tânia/GNM-6203-2022; Pinto-do-Ó, Perpetua/K-3742-2012; Osorio, Catarina/G-1700-2017; Ferreira, Manuela/AAF-5299-2020; Carvalho, Tânia/X-2873-2019	Serpa, Jacinta/0000-0002-1548-5907; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Dias, Sergio/0000-0002-7603-4616; Ferreira, Manuela/0000-0001-9498-8061; Fragoso, Rita/0000-0002-9206-1964; Pinto-do-Ó, Perpetua/0000-0002-6477-6030; Ferreira, Manuela/0000-0001-9498-8061; Carvalho, Tânia/0000-0002-5283-5013; Ferreira, Manuela/0000-0002-0075-2400; Cachaco, Ana/0000-0002-4080-018X; Osorio, Catarina/0000-0002-5228-0599; Igreja, Catia/0000-0003-3563-1788; Correia, Sofia/0000-0002-9361-1999; Correia, Sofia/0000-0003-2222-6396	Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul; Portuguese Science Foundation Fellowships	Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul; Portuguese Science Foundation Fellowships	This work was supported by Associacao Portuguesa Contra a Leucemia and Liga Portuguesa Contra o Cancro, Nucleo Regional Sul. During the realization of this Project, Ana Sofia Cachaco, Tania Carvalho, Catia Igreja, Rita Fragoso, Catarina Osorio, Jacinta Serpa were recipients of Portuguese Science Foundation Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Boula A, 2006, CLIN CANCER RES, V12, P3099, DOI 10.1158/1078-0432.CCR-06-0254; Daigle JL, 2001, CANCER RES, V61, P8859; De Roos AJ, 2007, CANCER CAUSE CONTROL, V18, P1199, DOI 10.1007/s10552-007-9060-2; Deeg HJ, 2002, LEUKEMIA, V16, P162, DOI 10.1038/sj.leu.2402356; Drutskaya MS, 2005, EXP HEMATOL, V33, P1348, DOI 10.1016/j.exphem.2005.08.001; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Dy LC, 1999, J BIOL CHEM, V274, P26917, DOI 10.1074/jbc.274.38.26917; Hagemann T, 2004, CARCINOGENESIS, V25, P1543, DOI 10.1093/carcin/bgh146; Hara T, 2004, EUR J HAEMATOL, V73, P10, DOI 10.1111/j.1600-0609.2004.00259.x; HARANGHERA N, 1992, LEUKEMIA, V6, P689; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Kerbauy DB, 2007, EXP HEMATOL, V35, P1739, DOI 10.1016/j.exphem.2007.09.007; Kuruvilla J, 2003, EUR J HAEMATOL, V71, P396, DOI 10.1034/j.1600-0609.2003.00115.x; Kuruvilla J, 2004, EUR J HAEMATOL, V72, P306; Lejeune F J, 2006, Bull Cancer, V93, pE90; Leone G, 2007, HAEMATOLOGICA, V92, P1389, DOI 10.3324/haematol.11034; Lv L, 2007, LEUKEMIA RES, V31, P1479, DOI 10.1016/j.leukres.2007.01.014; Maciejewski JP, 2002, BRIT J HAEMATOL, V117, P1002; Maciejewski JP, 2002, BRIT J HAEMATOL, V117, P119, DOI 10.1046/j.1365-2141.2002.03381.x; Malcovati Luca, 2008, Cancer Control, V15 Suppl, P4; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Muller K, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2007.01.017; Natoli G, 1998, J BIOL CHEM, V273, P31262, DOI 10.1074/jbc.273.47.31262; Padmanabhan A, 2008, LEUKEMIA RES, V32, P1820, DOI 10.1016/j.leukres.2008.03.032; Priestley GV, 2006, BLOOD, V107, P2959, DOI 10.1182/blood-2005-07-2670; Raza A, 2000, BLOOD, V95, P1580, DOI 10.1182/blood.V95.5.1580.005k45_1580_1587; Rebel VI, 1999, J EXP MED, V190, P1493, DOI 10.1084/jem.190.10.1493; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Reza S, 1998, J INTERF CYTOK RES, V18, P871, DOI 10.1089/jir.1998.18.871; ROSSELLI F, 1994, BLOOD, V83, P1216; Rube CE, 2002, RADIOTHER ONCOL, V64, P177, DOI 10.1016/S0167-8140(02)00077-4; SATO H, 1993, ONCOGENE, V8, P395; Scott KA, 2004, ONCOGENE, V23, P6954, DOI 10.1038/sj.onc.1207915; SEED TM, 1981, SCAN ELECTRON MICROS, P61; TOLLE DV, 1979, VET PATHOL, V16, P243, DOI 10.1177/030098587901600210; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2007, CELL, V129, P1097, DOI 10.1016/j.cell.2007.05.014; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; Yang WL, 2004, CANCER RES, V64, P1534, DOI 10.1158/0008-5472.CAN-03-2928; Zhang M, 2008, CLIN CANCER RES, V14, P1868, DOI 10.1158/1078-0432.CCR-07-1894; ZHANG Y, 1995, BLOOD, V86, P2930	44	29	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8980	10.1371/journal.pone.0008980	http://dx.doi.org/10.1371/journal.pone.0008980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126546	Green Submitted, Green Published, gold			2022-12-27	WOS:000274209700009
J	Little, MP; Heidenreich, WF; Li, GQ				Little, Mark P.; Heidenreich, Wolfgang F.; Li, Guangquan			Parameter Identifiability and Redundancy: Theoretical Considerations	PLOS ONE			English	Article							COLON-CANCER; GLOBAL IDENTIFIABILITY; CARCINOGENESIS; MODEL; INSTABILITY; SUFFICIENT	Background: Models for complex biological systems may involve a large number of parameters. It may well be that some of these parameters cannot be derived from observed data via regression techniques. Such parameters are said to be unidentifiable, the remaining parameters being identifiable. Closely related to this idea is that of redundancy, that a set of parameters can be expressed in terms of some smaller set. Before data is analysed it is critical to determine which model parameters are identifiable or redundant to avoid ill-defined and poorly convergent regression. Methodology/Principal Findings: In this paper we outline general considerations on parameter identifiability, and introduce the notion of weak local identifiability and gradient weak local identifiability. These are based on local properties of the likelihood, in particular the rank of the Hessian matrix. We relate these to the notions of parameter identifiability and redundancy previously introduced by Rothenberg (Econometrica 39 (1971) 577-591) and Catchpole and Morgan (Biometrika 84 (1997) 187-196). Within the widely used exponential family, parameter irredundancy, local identifiability, gradient weak local identifiability and weak local identifiability are shown to be largely equivalent. We consider applications to a recently developed class of cancer models of Little and Wright ( Math Biosciences 183 (2003) 111-134) and Little et al. (J Theoret Biol 254 (2008) 229-238) that generalize a large number of other recently used quasi-biological cancer models. Conclusions/Significance: We have shown that the previously developed concepts of parameter local identifiability and redundancy are closely related to the apparently weaker properties of weak local identifiability and gradient weak local identifiability-within the widely used exponential family these concepts largely coincide.	[Little, Mark P.; Li, Guangquan] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London, England; [Heidenreich, Wolfgang F.] German Res Ctr Environm Hlth, Inst Strahlenschutz, Helmholtz Zentrum Munchen, Neuherberg, Germany	Imperial College London; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, St Marys Campus, London, England.	mark.little@imperial.ac.uk	Li, Guangquan/AAW-6920-2021	Li, Guangquan/0000-0002-8736-5349; Little, Mark/0000-0003-0980-7567	European Commission [FI6R-CT-2003-508842, FP6-036465]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was funded partially by the European Commission under contracts FI6R-CT-2003-508842 (RISC-RAD) and FP6-036465 (NOTE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Bellu G, 2007, COMPUT METH PROG BIO, V88, P52, DOI 10.1016/j.cmpb.2007.07.002; Catchpole EA, 2002, J APPL STAT, V29, P625, DOI 10.1080/02664760120108601; Catchpole EA, 1997, BIOMETRIKA, V84, P187, DOI 10.1093/biomet/84.1.187; DICKSON LE, 1926, MODERN ALGEBRAIC THE; GIMENEZ O, 2004, ANIMAL BIODIVERSITY, P1; Heidenreich WF, 1996, RADIAT ENVIRON BIOPH, V35, P127, DOI 10.1007/s004110050020; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Little MP, 2008, J THEOR BIOL, V255, P268, DOI 10.1016/j.jtbi.2008.09.001; Little MP, 2008, J THEOR BIOL, V254, P229, DOI 10.1016/j.jtbi.2008.05.027; Little MP, 2007, CARCINOGENESIS, V28, P479, DOI 10.1093/carcin/bgl173; Little MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008520; Little MP, 2003, MATH BIOSCI, V183, P111, DOI 10.1016/S0025-5564(03)00040-3; Little MP, 1995, BIOMETRICS, V51, P1278, DOI 10.2307/2533259; McCullagh P, 1989, GEN LINEAR MODELS; MOOLGAVKAR SH, 1979, MATH BIOSCI, V47, P55, DOI 10.1016/0025-5564(79)90005-1; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; PAULINO CDM, 1994, J ITAL STAT SOC, V1, P125; PICCI G, 1977, SIAM J APPL MATH, V33, P383, DOI 10.1137/0133025; ROTHENBERG TJ, 1971, ECONOMETRICA, V39, P577, DOI 10.2307/1913267; Rudin W., 1976, PRINCIPLES MATH ANAL, V3; Silvey S.D., 1975, REPRINTING MONOGRAPH; Viallefont A, 1998, BIOMETRICAL J, V40, P313, DOI 10.1002/(SICI)1521-4036(199807)40:3<313::AID-BIMJ313>3.0.CO;2-2	25	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8915	10.1371/journal.pone.0008915	http://dx.doi.org/10.1371/journal.pone.0008915			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111720	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000274114800018
J	Yang, HY; Bogner, M; Stierhof, YD; Ludewig, U				Yang, Huaiyu; Bogner, Martin; Stierhof, York-Dieter; Ludewig, Uwe			H+-Independent Glutamine Transport in Plant Root Tips	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; EXPRESSION; CELLS; NANOSENSORS; NITROGEN; GLUCOSE; EFFLUX; FAMILY; COATS; SEEDS	Background: Glutamine is one of the primary amino acids in nitrogen assimilation and often the most abundant amino acid in plant roots. To monitor this important metabolite, a novel genetically encoded fluorescent FRET-reporter was constructed and expressed in Arabidopsis thaliana. As a candidate for the glutamine fluxes, the root tip localized, putative amino acid transporter CAT8 was analyzed and heterologously expressed in yeast and oocytes. Principal Findings: Rapid and reversible in vivo fluorescence changes were observed in reporter-expressing root tips upon exposure and removal of glutamine. FRET changes were detected at acid and neutral pH and in the presence of a protonophore, suggesting that part of the glutamine fluxes were independent of the pH. The putative amino acid transporter CAT8 transported glutamine, had a half maximal activity at similar to 100 mu M and the transport was independent of external pH. CAT8 localized not only to the plasma membrane, but additionally to the tonoplast, when tagged with GFP. Ultrastructural analysis confirmed this dual localization and additionally identified CAT8 in membranes of autophagosomes. Loss-of function of CAT8 did not affect growth in various conditions, but over-expressor plants had increased sensitivity to a structural substrate analog, the glutamine synthetase inhibitor L-methionine sulfoximine. Conclusions: The combined data suggest that proton-independent glutamine facilitators exist in root tips.	[Yang, Huaiyu; Ludewig, Uwe] Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany; [Yang, Huaiyu; Bogner, Martin; Stierhof, York-Dieter] Univ Tubingen, Ctr Mol Biol Plants ZMBP, Tubingen, Germany	Technical University of Darmstadt; Eberhard Karls University of Tubingen	Yang, HY (corresponding author), Tech Univ Darmstadt, Inst Bot, Darmstadt, Germany.	ludewig@bio.tu-darmstadt.de		Yang, Huaiyu/0000-0001-8258-8511	German Science Foundation (DFG)	German Science Foundation (DFG)(German Research Foundation (DFG))	German Science Foundation (DFG), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bogner M, 2007, J FLUORESC, V17, P350, DOI 10.1007/s10895-007-0192-2; BOLLARD EG, 1966, PLANT SOIL, V25, P153, DOI 10.1007/BF01347815; Carter C, 2004, PLANT CELL, V16, P3285, DOI 10.1105/tpc.104.027078; Chaudhuri B, 2008, PLANT J, V56, P948, DOI 10.1111/j.1365-313X.2008.03652.x; Curi R, 2007, FRONT BIOSCI-LANDMRK, V12, P344, DOI 10.2741/2068; De D. N., 2000, PLANT CELL VACUOLES; deJong A, 1997, PLANT PHYSIOL, V114, P731, DOI 10.1104/pp.114.2.731; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dundar E, 2009, PLANTA, V229, P1047, DOI 10.1007/s00425-009-0892-8; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Forsum O, 2008, NEW PHYTOL, V179, P1058, DOI 10.1111/j.1469-8137.2008.02546.x; FROMMER WB, 1993, P NATL ACAD SCI USA, V90, P5944, DOI 10.1073/pnas.90.13.5944; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hammes UZ, 2006, PLANT J, V48, P414, DOI 10.1111/j.1365-313X.2006.02880.x; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Jaquinod M, 2007, MOL CELL PROTEOMICS, V6, P394, DOI 10.1074/mcp.M600250-MCP200; Laube B, 2004, NEUROPHARMACOLOGY, V47, P994, DOI 10.1016/j.neuropharm.2004.07.041; Lee YH, 2007, PLANT J, V50, P305, DOI 10.1111/j.1365-313X.2007.03045.x; Lesuffleur F, 2007, PLANT SOIL, V294, P235, DOI 10.1007/s11104-007-9249-x; LI ZC, 1990, PLANT PHYSIOL, V94, P268, DOI 10.1104/pp.94.1.268; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lohaus G, 1997, J EXP BOT, V48, P1779, DOI 10.1093/jexbot/48.315.1779; Offler CE, 2003, ANNU REV PLANT BIOL, V54, P431, DOI 10.1146/annurev.arplant.54.031902.134812; Okumoto S, 2008, NEW PHYTOL, V180, P271, DOI 10.1111/j.1469-8137.2008.02611.x; Pilot G, 2004, PLANT CELL, V16, P1827, DOI 10.1105/tpc.021642; RONZIO RA, 1968, P NATL ACAD SCI USA, V59, P164, DOI 10.1073/pnas.59.1.164; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Svennerstam H, 2008, NEW PHYTOL, V180, P620, DOI 10.1111/j.1469-8137.2008.02589.x; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; von der Fecht-Bartenbach J, 2007, PLANT J, V50, P466, DOI 10.1111/j.1365-313X.2007.03061.x; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Zhou YC, 2007, PLANT J, V49, P750, DOI 10.1111/j.1365-313X.2006.03000.x	34	58	60	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8917	10.1371/journal.pone.0008917	http://dx.doi.org/10.1371/journal.pone.0008917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111724	Green Submitted, gold, Green Published			2022-12-27	WOS:000274114800020
J	Sanchez-Calderon, H; Rodriguez-de la Rosa, L; Milo, M; Pichel, JG; Holley, M; Varela-Nieto, I				Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Milo, Marta; Pichel, Jose G.; Holley, Matthew; Varela-Nieto, Isabel			RNA Microarray Analysis in Prenatal Mouse Cochlea Reveals Novel IGF-I Target Genes: Implication of MEF2 and FOXM1 Transcription Factors	PLOS ONE			English	Article							GROWTH-FACTOR-I; INNER HAIR-CELLS; EXPRESSION PATTERNS; SIGNALING PATHWAYS; AUDITORY-SYSTEM; SPIRAL GANGLION; HEARING-LOSS; INSULIN; MICE; DIFFERENTIATION	Background: Insulin-like growth factor-I (IGF-I) provides pivotal cell survival and differentiation signals during inner ear development throughout evolution. Homozygous mutations of human IGF1 cause syndromic sensorineural deafness, decreased intrauterine and postnatal growth rates, and mental retardation. In the mouse, deficits in IGF-I result in profound hearing loss associated with reduced survival, differentiation and maturation of auditory neurons. Nevertheless, little is known about the molecular basis of IGF-I activity in hearing and deafness. Methodology/Principal Findings: A combination of quantitative RT-PCR, subcellular fractionation and Western blotting, along with in situ hybridization studies show IGF-I and its high affinity receptor to be strongly expressed in the embryonic and postnatal mouse cochlea. The expression of both proteins decreases after birth and in the cochlea of E18.5 embryonic Igf1(-/-) null mice, the balance of the main IGF related signalling pathways is altered, with lower activation of Akt and ERK1/2 and stronger activation of p38 kinase. By comparing the Igf1(-/-) and Igf1(+/+) transcriptomes in E18.5 mouse cochleae using RNA microchips and validating their results, we demonstrate the up-regulation of the FoxM1 transcription factor and the misexpression of the neural progenitor transcription factors Six6 and Mash1 associated with the loss of IGF-I. Parallel, in silico promoter analysis of the genes modulated in conjunction with the loss of IGF-I revealed the possible involvement of MEF2 in cochlear development. E18.5 Igf1(+/+) mouse auditory ganglion neurons showed intense MEF2A and MEF2D nuclear staining and MEF2A was also evident in the organ of Corti. At P15, MEF2A and MEF2D expression were shown in neurons and sensory cells. In the absence of IGF-I, nuclear levels of MEF2 were diminished, indicating less transcriptional MEF2 activity. By contrast, there was an increase in the nuclear accumulation of FoxM1 and a corresponding decrease in the nuclear cyclin-dependent kinase inhibitor p27(Kip1). Conclusions/Significance: We have defined the spatiotemporal expression of elements involved in IGF signalling during inner ear development and reveal novel regulatory mechanisms that are modulated by IGF-I in promoting sensory cell and neural survival and differentiation. These data will help us to understand the molecular bases of human sensorineural deafness associated to deficits in IGF-I.	[Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Sanchez-Calderon, Hortensia; Rodriguez-de la Rosa, Lourdes; Varela-Nieto, Isabel] Inst Salud Carlos III, CIBERER, U761, Madrid, Spain; [Milo, Marta; Holley, Matthew] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Pichel, Jose G.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Ctr Invest Canc, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; University of Sheffield; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Sanchez-Calderon, H (corresponding author), CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain.	hsanchez@iib.uam.es	Pichel, Jose G/AAF-2255-2019; de la Rosa, Lourdes Rodríguez/K-3037-2017; Varela-Nieto, Isabel/G-5289-2015	Pichel, Jose G/0000-0001-8580-0952; de la Rosa, Lourdes Rodríguez/0000-0002-7518-6036; Varela-Nieto, Isabel/0000-0003-3077-0500; Holley, Matthew/0000-0001-9547-1953	Royal Society; DIGNA Biotech; Ministerio de Ciencia e Innovacion [BFU2005-00084, SAF2008-00470]; Fundacion Mutua Madrilena; Consejo Superior de Investigaciones Cientifica; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)	Royal Society(Royal Society of London); DIGNA Biotech; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Consejo Superior de Investigaciones Cientifica; Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER)	This work was partially supported by the Royal Society, DIGNA Biotech, Ministerio de Ciencia e Innovacion (BFU2005-00084, SAF2008-00470) and the Fundacion Mutua Madrilena. Hortensia Sanchez Calderon and Lourdes Rodriguez-de la Rosa hold contracts from Consejo Superior de Investigaciones Cientificas-FSE I3 programme and Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson CL, 2002, J COMP NEUROL, V447, P331, DOI 10.1002/cne.10244; Adesanya OO, 1999, P NATL ACAD SCI USA, V96, P3287, DOI 10.1073/pnas.96.6.3287; Al-Semari A, 2007, AM J MED GENET A, V143A, P149, DOI 10.1002/ajmg.a.31497; Bergeron AL, 2005, JARO-J ASSOC RES OTO, V6, P401, DOI 10.1007/s10162-005-0018-3; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bonapace G, 2003, J MED GENET, V40, P913, DOI 10.1136/jmg.40.12.913; Butts BD, 2003, HORM METAB RES, V35, P763; Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7; Camarero G, 2002, HEARING RES, V170, P2, DOI 10.1016/S0378-5955(02)00447-1; Camarero G, 2001, J NEUROSCI, V21, P7630, DOI 10.1523/JNEUROSCI.21-19-07630.2001; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Castro DS, 2006, DEV CELL, V11, P831, DOI 10.1016/j.devcel.2006.10.006; Cediel R, 2006, EUR J NEUROSCI, V23, P587, DOI 10.1111/j.1460-9568.2005.04584.x; Cho YS, 2002, JARO, V3, P54, DOI 10.1007/s101620010042; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Fritzsch B, 2006, BRAIN RES, V1091, P151, DOI 10.1016/j.brainres.2006.02.078; Gallardo ME, 1999, GENOMICS, V61, P82, DOI 10.1006/geno.1999.5916; Gao WQ, 1999, J NEUROBIOL, V39, P142, DOI 10.1002/(SICI)1097-4695(199904)39:1<142::AID-NEU11>3.0.CO;2-H; Gong TWL, 2006, JARO-J ASSOC RES OTO, V7, P317, DOI 10.1007/s10162-006-0046-7; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jacques BE, 2007, DEVELOPMENT, V134, P3021, DOI 10.1242/dev.02874; Karsten SL, 2003, DEV BIOL, V261, P165, DOI 10.1016/S0012-1606(03)00274-4; Knipper M, 1998, DEVELOPMENT, V125, P3709; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; LeRoith D, 2008, ENDOCRINOLOGY, V149, P5951, DOI 10.1210/en.2008-1190; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Liberman MC, 2006, JARO-J ASSOC RES OTO, V7, P211, DOI 10.1007/s10162-006-0035-x; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LIU Q, 2008, INVEST OPHTHALMOL VI; Liu XJ, 2005, BIOINFORMATICS, V21, P3637, DOI 10.1093/bioinformatics/bti583; Liu XJ, 2006, BIOINFORMATICS, V22, P2107, DOI 10.1093/bioinformatics/btl361; Lopez-Rios J, 1999, MECH DEVELOP, V83, P155, DOI 10.1016/S0925-4773(99)00017-9; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005; Nakada Y, 2004, DEVELOPMENT, V131, P1319, DOI 10.1242/dev.01008; Otaegi G, 2006, J CELL SCI, V119, P2739, DOI 10.1242/jcs.03012; Parker M, 2007, J BIOETHIC INQ, V4, P29, DOI 10.1007/s11673-007-9036-7; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pazyra-Murphy MF, 2009, J NEUROSCI, V29, P6700, DOI 10.1523/JNEUROSCI.0233-09.2009; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; ROBERTS CT, 1999, IGF SYSTEM MOL BIOL; Ruberte J, 2004, J CLIN INVEST, V113, P1149, DOI 10.1172/JCI200419478; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Sanchez-Calderon H, 2004, GENE EXPR PATTERNS, V4, P659, DOI 10.1016/j.modgep.2004.04.008; Sanchez-Calderon H, 2007, INT J DEV BIOL, V51, P557, DOI 10.1387/ijdb.072373hs; Sanchez-Calderon H, 2007, GENE EXPR PATTERNS, V7, P30, DOI 10.1016/j.modgep.2006.05.003; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teijido O, 2007, NEUROBIOL DIS, V26, P532, DOI 10.1016/j.nbd.2007.01.016; Torres-Aleman I, 2008, ENDOCRINOLOGY, V149, P5952, DOI 10.1210/en.2008-0905; Walenkamp MJE, 2005, J CLIN ENDOCR METAB, V90, P2855, DOI 10.1210/jc.2004-1254; WANG XD, 2005, J ORGAN DYSFUNCT, V1, P2; Werner Haim, 2008, Archives of Physiology and Biochemistry, V114, P17, DOI [10.1080/13813450801900694, 10.1080/13813450801900694 ]; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zhang Q, 2003, Anesth Prog, V50, P53; Zhao FJ, 1999, J CEREAL SCI, V30, P19, DOI 10.1006/jcrs.1998.0244; Zheng WM, 2003, DEVELOPMENT, V130, P3989, DOI 10.1242/dev.00628	71	69	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8699	10.1371/journal.pone.0008699	http://dx.doi.org/10.1371/journal.pone.0008699			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111592	Green Published, Green Accepted, gold			2022-12-27	WOS:000273896300004
J	Pathi, SP; Kowalczewski, C; Tadipatri, R; Fischbach, C				Pathi, Siddharth P.; Kowalczewski, Christine; Tadipatri, Ramya; Fischbach, Claudia			A Novel 3-D Mineralized Tumor Model to Study Breast Cancer Bone Metastasis	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR; OSTEOBLAST ADHESION; CELL-PROLIFERATION; SIGNALING PATHWAY; RAW264.7 CELLS; IN-VIVO; EXPRESSION; HYDROXYAPATITE; OSTEOPONTIN	Background: Metastatic bone disease is a frequent cause of morbidity in patients with advanced breast cancer, but the role of the bone mineral hydroxyapatite (HA) in this process remains unclear. We have developed a novel mineralized 3-D tumor model and have employed this culture system to systematically investigate the pro-metastatic role of HA under physiologically relevant conditions in vitro. Methodology/Principal Findings: MDA-MB231 breast cancer cells were cultured within non-mineralized or mineralized polymeric scaffolds fabricated by a gas foaming-particulate leaching technique. Tumor cell adhesion, proliferation, and secretion of pro-osteoclastic interleukin-8 (IL-8) was increased in mineralized tumor models as compared to non-mineralized tumor models, and IL-8 secretion was more pronounced for bone-specific MDA-MB231 subpopulations relative to lung-specific breast cancer cells. These differences were pathologically significant as conditioned media collected from mineralized tumor models promoted osteoclastogenesis in an IL-8 dependent manner. Finally, drug testing and signaling studies with transforming growth factor beta (TGF beta) confirmed the clinical relevance of our culture system and revealed that breast cancer cell behavior is broadly affected by HA. Conclusions/Significance: Our results indicate that HA promotes features associated with the neoplastic and metastatic growth of breast carcinoma cells in bone and that IL-8 may play an important role in this process. The developed mineralized tumor models may help to reveal the underlying cellular and molecular mechanisms that may ultimately enable more efficacious therapy of patients with advanced breast cancer.	[Pathi, Siddharth P.; Kowalczewski, Christine; Tadipatri, Ramya; Fischbach, Claudia] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University	Pathi, SP (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cf99@cornell.edu	Fischbach, Claudia/C-8550-2009	Fischbach, Claudia/0000-0002-9368-0150	National Science Foundation (NSF); Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York [AR046121]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a National Science Foundation (NSF) graduate research fellowship (SPP) (nsfgrfp.org) and funding by the Musculoskeletal Repair and Regeneration Core Center at the Hospital for Special Surgery in New York (Grant AR046121) (http://www.hss.edu/repair-regeneration-center.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2; Bachelder RE, 2001, CANCER RES, V61, P5736; Bancroft CC, 2002, INT J CANCER, V99, P538, DOI 10.1002/ijc.10398; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Bendre MS, 2003, BONE, V33, P28, DOI 10.1016/S8756-3282(03)00086-3; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BOSKEY AL, 1993, BONE MINER, V22, P147, DOI 10.1016/S0169-6009(08)80225-5; Boskey AL, 2002, CALCIFIED TISSUE INT, V71, P145, DOI 10.1007/s00223-001-1121-z; Boyan B. D., 2003, European Cells & Materials, V6, P22; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Chirgwin JM, 2000, CRIT REV EUKAR GENE, V10, P159; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Fischbach C, 2009, P NATL ACAD SCI USA, V106, P399, DOI 10.1073/pnas.0808932106; Fong YC, 2008, J BONE MINER RES, V23, P961, DOI 10.1359/JBMR.080206; Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Guise TA, 2003, CLIN ORTHOP RELAT R, pS32, DOI 10.1097/01.blo.0000093055.96273.69; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Hartley JW, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-1; Hiraga T, 2001, CANCER RES, V61, P4418; Iafisco M, 2008, LANGMUIR, V24, P4924, DOI 10.1021/la703381h; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Khalili P, 2006, MOL CANCER THER, V5, P2271, DOI 10.1158/1535-7163.MCT-06-0100; Kim SS, 2006, BIOMATERIALS, V27, P1399, DOI 10.1016/j.biomaterials.2005.08.016; Kindle L, 2006, J BONE MINER RES, V21, P193, DOI 10.1359/JBMR.051027; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Kostic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006361; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Mailland M, 1997, ENDOCRINOLOGY, V138, P3601, DOI 10.1210/en.138.9.3601; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mitsuyama H, 2004, J BONE MINER RES, V19, P671, DOI 10.1359/JBMR.0301256; Mizukami Y, 2005, NAT MED, V11, P992, DOI 10.1038/nm1294; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Mundy GR, 1997, CANCER-AM CANCER SOC, V80, P1546, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1546::AID-CNCR4>3.3.CO;2-R; Nagano M, 1996, BIOMATERIALS, V17, P1771, DOI 10.1016/0142-9612(95)00357-6; Nakagawa N, 1998, BIOCHEM BIOPH RES CO, V253, P395, DOI 10.1006/bbrc.1998.9788; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pezzatini S, 2007, BONE, V41, P523, DOI 10.1016/j.bone.2007.06.016; Polek TC, 2003, J BIOL CHEM, V278, P32317, DOI 10.1074/jbc.M302518200; Rao H, 2009, BONE, V44, pS141, DOI 10.1016/j.bone.2009.01.447; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Singhal H, 1997, CLIN CANCER RES, V3, P605; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Tanaka Y, 2007, CLIN CANCER RES, V13, P816, DOI 10.1158/1078-0432.CCR-06-2258; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Youngs SJ, 1997, INT J CANCER, V71, P257, DOI 10.1002/(SICI)1097-0215(19970410)71:2<257::AID-IJC22>3.0.CO;2-D	61	67	69	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8849	10.1371/journal.pone.0008849	http://dx.doi.org/10.1371/journal.pone.0008849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107512	Green Submitted, gold, Green Published			2022-12-27	WOS:000273896100014
J	Carr, RW; Sittl, R; Fleckenstein, J; Grafe, P				Carr, Richard W.; Sittl, Ruth; Fleckenstein, Johannes; Grafe, Peter			GABA Increases Electrical Excitability in a Subset of Human Unmyelinated Peripheral Axons	PLOS ONE			English	Article							ROOT GANGLION NEURONS; GAMMA-AMINOBUTYRIC-ACID; PRIMARY AFFERENT NEURONS; HUMAN SKIN; C-FIBERS; CHLORIDE REGULATION; SENSORY NEURONS; NERVOUS-SYSTEM; RECEPTORS; RAT	Background: A proportion of small diameter primary sensory neurones innervating human skin are chemosensitive. They respond in a receptor dependent manner to chemical mediators of inflammation as well as naturally occurring algogens, thermogens and pruritogens. The neurotransmitter GABA is interesting in this respect because in animal models of neuropathic pain GABA pre-synaptically regulates nociceptive input to the spinal cord. However, the effect of GABA on human peripheral unmyelinated axons has not been established. Methodology/Principal Findings: Electrical stimulation was used to assess the effect of GABA on the electrical excitability of unmyelinated axons in isolated fascicles of human sural nerve. GABA (0.1-100 mu M) increased electrical excitability in a subset (ca. 40%) of C-fibres in human sural nerve fascicles suggesting that axonal GABA sensitivity is selectively restricted to a sub-population of human unmyelinated axons. The effects of GABA were mediated by GABA(A) receptors, being mimicked by bath application of the GABA(A) agonist muscimol (0.1-30 mu M) while the GABA(B) agonist baclofen (10-30 mu M) was without effect. Increases in excitability produced by GABA (10-30 mu M) were blocked by the GABA(A) antagonists gabazine (10-20 mu M), bicuculline (10-20 mu M) and picrotoxin (10-20 mu M). Conclusions/Significance: Functional GABA(A) receptors are present on a subset of unmyelinated primary afferents in humans and their activation depolarizes these axons, an effect likely due to an elevated intra-axonal chloride concentration. GABA(A) receptor modulation may therefore regulate segmental and peripheral components of nociception.	[Carr, Richard W.; Sittl, Ruth; Grafe, Peter] Univ Munich, Inst Physiol, D-8000 Munich, Germany; [Fleckenstein, Johannes] Univ Munich, Dept Anaesthesiol, D-8000 Munich, Germany	University of Munich; University of Munich	Carr, RW (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	Richard.Carr@med.uni-muenchen.de	Carr, Richard/GSD-4859-2022; Fleckenstein, Johannes/AAL-1315-2021; Carr, Richard/AAE-9188-2020	Carr, Richard/0000-0001-8617-9133; Fleckenstein, Johannes/0000-0003-3442-0380	Deutsche Forschungsgemeinschaft [GR 801/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (GR 801/3-1). The funding body had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BALLANYI K, 1985, J PHYSIOL-LONDON, V365, P41, DOI 10.1113/jphysiol.1985.sp015758; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; BOWERY NG, 1976, BRIT J PHARMACOL, V57, P73, DOI 10.1111/j.1476-5381.1976.tb07658.x; BOWERY NG, 1979, J PHYSIOL-LONDON, V293, P51, DOI 10.1113/jphysiol.1979.sp012878; BROWN DA, 1979, TRENDS NEUROSCI, V2, P271, DOI 10.1016/0166-2236(79)90107-3; BROWN DA, 1979, J PHYSIOL-PARIS, V75, P667; BROWN DA, 1978, BRAIN RES, V156, P187, DOI 10.1016/0006-8993(78)90098-7; Campero M, 2004, ACTA PHYSIOL SCAND, V182, P305, DOI 10.1111/j.1365-201X.2004.01357.x; Carlton SM, 1999, NEUROSCIENCE, V93, P713, DOI 10.1016/S0306-4522(99)00101-3; CHOI DW, 1981, J NEUROPHYSIOL, V45, P632, DOI 10.1152/jn.1981.45.4.632; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; DESARMENIEN M, 1984, EXP BRAIN RES, V54, P521; DESCHENES M, 1976, BRAIN RES, V118, P494, DOI 10.1016/0006-8993(76)90319-X; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Freysoldt A, 2009, BRIT J PHARMACOL, V158, P797, DOI 10.1111/j.1476-5381.2009.00347.x; Funk K, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-32; GALLAGHER JP, 1978, J PHYSIOL-LONDON, V275, P263, DOI 10.1113/jphysiol.1978.sp012189; Ito K, 2007, BBA-GEN SUBJECTS, V1770, P291, DOI 10.1016/j.bbagen.2006.09.017; JORUM E, 1989, J PHYSIOL-LONDON, V416, P291, DOI 10.1113/jphysiol.1989.sp017761; Kocsis Jeffery D., 1995, P281; Lang PM, 2006, J NEUROPHYSIOL, V96, P2963, DOI 10.1152/jn.00716.2006; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Maddox FN, 2004, DEV BRAIN RES, V149, P143, DOI 10.1016/j.devbrainres.2004.01.001; Magnaghi V, 2006, J MOL NEUROSCI, V28, P89, DOI 10.1385/JMN:28:1:89; Magnaghi V, 2004, EUR J NEUROSCI, V19, P2641, DOI 10.1111/j.0953-816X.2004.03368.x; Mayer C, 1999, PAIN, V81, P317, DOI 10.1016/S0304-3959(99)00015-9; Moalem-Taylor G, 2007, MUSCLE NERVE, V36, P172, DOI 10.1002/mus.20793; MORITA K, 1993, J NEUROPHYSIOL, V70, P1874, DOI 10.1152/jn.1993.70.5.1874; MORRIS ME, 1983, BRAIN RES, V278, P117, DOI 10.1016/0006-8993(83)90230-5; Munro G, 2009, TRENDS PHARMACOL SCI, V30, P453, DOI 10.1016/j.tips.2009.06.004; Murinson BB, 2005, J COMP NEUROL, V484, P392, DOI 10.1002/cne.20506; OCHOA J, 1969, ACTA NEUROPATHOL, V13, P197, DOI 10.1007/BF00690642; Pawson L, 2009, J NEUROSCI, V29, P2695, DOI 10.1523/JNEUROSCI.5974-08.2009; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; RANG HP, 1968, J PHYSIOL-LONDON, V196, P183, DOI 10.1113/jphysiol.1968.sp008502; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Semyanov A, 2004, TRENDS NEUROSCI, V27, P262, DOI 10.1016/j.tins.2004.03.005; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; Soleng AF, 2003, J PHYSIOL-LONDON, V552, P459, DOI 10.1113/jphysiol.2003.048058; Sung KW, 2000, J NEUROSCI, V20, P7531; Trigo FF, 2008, EUR J NEUROSCI, V28, P841, DOI 10.1111/j.1460-9568.2008.06404.x; Valeyev AY, 1996, J NEUROPHYSIOL, V76, P3555, DOI 10.1152/jn.1996.76.5.3555; Valeyev AY, 1999, J NEUROPHYSIOL, V82, P1; Verdier D, 2003, J NEUROSCI, V23, P2002; WALLIS DI, 1982, NEUROPHARMACOLOGY, V21, P31, DOI 10.1016/0028-3908(82)90207-6; Weidner C, 1999, J NEUROSCI, V19, P10184; Zeilhofer HU, 2009, TRENDS PHARMACOL SCI, V30, P397, DOI 10.1016/j.tips.2009.05.007	50	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8780	10.1371/journal.pone.0008780	http://dx.doi.org/10.1371/journal.pone.0008780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098693	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779000010
J	Qiang, M; Denny, A; Chen, JG; Ticku, MK; Yan, B; Henderson, G				Qiang, Mei; Denny, Ashley; Chen, Jiguo; Ticku, Maharaj K.; Yan, Bo; Henderson, George			The Site Specific Demethylation in the 5 '-Regulatory Area of NMDA Receptor 2B Subunit Gene Associated with CIE-Induced Up-Regulation of Transcription	PLOS ONE			English	Article							CHRONIC ETHANOL TREATMENT; MESSENGER-RNA EXPRESSION; D-ASPARTATE RECEPTORS; DNA METHYLATION; CORTICAL-NEURONS; EPIGENETIC MECHANISMS; MEMORY FORMATION; NERVOUS-SYSTEM; GABAERGIC INTERNEURONS; ALCOHOL-WITHDRAWAL	Background: The NMDA receptor represents a particularly important site of ethanol action in the CNS. We recently reported that NMDA receptor 2B (NR2B) gene expression was persistently up-regulated following chronic intermittent ethanol (CIE) treatment. Increasing evidence that epigenetic mechanisms are involved in dynamic and long-lasting regulation of gene expression in multiple neuroadaptive processes prompted us to investigate the role of DNA methylation in mediating CIE-induced up-regulation of NR2B gene transcription. To dissect the changes of DNA methylation in the NR2B gene, we have screened a large number of CpG sites within its 5'-regulatory area following CIE treatment. Methods: Primary cortical cultured neurons were subjected to ethanol treatment in a CIE paradigm. Bisulfite conversion followed by pyrosequencing was used for quantitative measurement and analysis of CpG methylation status within the 5'-regulatory area of the NR2B gene; chromatin immunoprecipitation (ChIP) assay was used to examine DNA levels associated with methylation and transcription factor binding. Electrophoretic mobility shift assay (EMSA) and in vitro DNA methylation assays were performed to determine the direct impact of DNA methylation on the interaction between DNA and transcription factor and promoter activity. Results: Analysis of individual CpG methylation sites within the NR2B 5'-regulatory area revealed three regions with clusters of site-specific CpG demethylation following CIE treatment and withdrawal. This was confirmed by ChIP showing similar decreases of methylated DNA in the same regions. The CIE-induced demethylation is characterized by being located near certain transcription factor binding sequences, AP-1 and CRE, and occurred during treatment as well as after ethanol withdrawal. Furthermore, the increase in vitro of methylated DNA decreased transcription factor binding activity and promoter activity. An additional ChIP assay indicated that the CIE-induced DNA demethylation is accompanied by increased occupation by transcription factors. Conclusions: These results suggest an important role of DNA demethylation in mediating CIE-induced NR2B gene up-regulation, thus implicating a novel molecular site of alcohol action.	[Qiang, Mei; Denny, Ashley; Ticku, Maharaj K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Yan, Bo] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA; [Chen, Jiguo] Mississippi State Univ, Dept Biol Sci, Mississippi State, MS 39762 USA; [Henderson, George] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Dept Pharmacol & Neurosci, Lubbock, TX 79430 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Mississippi State University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Qiang, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA.	qiang@uthscsa.edu		Chen, Jack/0000-0001-7528-4835	National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism [RO1 AA017362]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017362] Funding Source: NIH RePORTER	National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by funding provided by National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov) RO1 AA017362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Cagetti E, 2003, MOL PHARMACOL, V63, P53, DOI 10.1124/mol.63.1.53; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; CREUSOT F, 1982, J BIOL CHEM, V257, P2041; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; FOLLESA P, 1995, MOL BRAIN RES, V29, P99, DOI 10.1016/0169-328X(94)00235-7; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Inano K, 2000, J BIOCHEM-TOKYO, V128, P315, DOI 10.1093/oxfordjournals.jbchem.a022755; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; Jiang Y, 2008, J NEUROSCI, V28, P11753, DOI 10.1523/JNEUROSCI.3797-08.2008; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; KOKKA N, 1993, ALCOHOL CLIN EXP RES, V17, P525, DOI 10.1111/j.1530-0277.1993.tb00793.x; Krystal JH, 2003, PHARMACOL THERAPEUT, V99, P79, DOI 10.1016/S0163-7258(03)00054-8; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mattson MP, 2003, AGEING RES REV, V2, P329, DOI 10.1016/S1568-1637(03)00013-8; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Nagy J, 2004, NEUROCHEM INT, V44, P17, DOI 10.1016/S0197-0186(03)00100-1; Nagy J, 2002, NEUROCHEM INT, V40, P585, DOI 10.1016/S0197-0186(01)00131-0; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Narita M, 2000, EUR J PHARMACOL, V401, P191, DOI 10.1016/S0014-2999(00)00428-3; Nelson ED, 2008, J NEUROSCI, V28, P395, DOI 10.1523/JNEUROSCI.3796-07.2008; Nelson TE, 2005, BRAIN RES, V1048, P69, DOI 10.1016/j.brainres.2005.04.041; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Ng HH, 1999, CURR OPIN GENET DEV, V9, P158, DOI 10.1016/S0959-437X(99)80024-0; NIEUWENHUYS R, 1994, ANAT EMBRYOL, V190, P307; Noh JS, 2005, P NATL ACAD SCI USA, V102, P1749, DOI 10.1073/pnas.0409648102; Ogata J, 2006, J PHARMACOL EXP THER, V318, P434, DOI 10.1124/jpet.106.101691; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; PASCALE RM, 1991, ANTICANCER RES, V11, P1617; Qiang M, 2005, J NEUROCHEM, V95, P1332, DOI 10.1111/j.1471-4159.2005.03464.x; Qiang M, 2005, MOL PHARMACOL, V67, P2115, DOI 10.1124/mol.104.010751; QIANG M, 2007, MOL PHARM; Ramchandani S, 1999, P NATL ACAD SCI USA, V96, P6107, DOI 10.1073/pnas.96.11.6107; Rani CSS, 2006, ALCOHOL, V38, P89, DOI 10.1016/j.alcohol.2006.05.002; Rani CSS, 2005, MOL PHARMACOL, V67, P2126, DOI 10.1124/mol.104.007872; Ravindran CRM, 2004, MOL BRAIN RES, V121, P19, DOI 10.1016/j.molbrainres.2003.10.025; ROBERTSON KD, 1995, MOL CELL BIOL, V15, P6150; RON D, 2005, SCI STKE, pRE14; Ronald KM, 2001, J BIOL CHEM, V276, P44729, DOI 10.1074/jbc.M102800200; Roth TL, 2009, CURR OPIN NEUROBIOL, V19, P336, DOI 10.1016/j.conb.2009.05.011; Ruzicka WB, 2007, MOL PSYCHIATR, V12, P385, DOI 10.1038/sj.mp.4001954; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Satta R, 2008, P NATL ACAD SCI USA, V105, P16356, DOI 10.1073/pnas.0808699105; Shi HD, 2003, CANCER RES, V63, P2164; Szyf M, 2005, BIOCHEMISTRY-MOSCOW+, V70, P533, DOI 10.1007/s10541-005-0147-7; Szyf M, 2004, BIOCHEM PHARMACOL, V68, P1187, DOI 10.1016/j.bcp.2004.04.030; Tremolizzo L, 2002, P NATL ACAD SCI USA, V99, P17095, DOI 10.1073/pnas.262658999; TREVISAN L, 1994, J NEUROCHEM, V62, P1635; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Veldic M, 2007, SCHIZOPHR RES, V91, P51, DOI 10.1016/j.schres.2006.11.029; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wu H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.264pe17; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07	76	43	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8798	10.1371/journal.pone.0008798	http://dx.doi.org/10.1371/journal.pone.0008798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098704	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000025
J	Gonzalo, V; Lozano, JJ; Munoz, J; Balaguer, F; Pellise, M; de Miguel, CR; Andreu, M; Jover, R; Llor, X; Giraldez, MD; Ocana, T; Serradesanferm, A; Alonso-Espinaco, V; Jimeno, M; Cuatrecasas, M; Sendino, O; Castellvi-Bel, S; Castells, A				Gonzalo, Victoria; Jose Lozano, Juan; Munoz, Jenifer; Balaguer, Francesc; Pellise, Maria; Rodriguez de Miguel, Cristina; Andreu, Montserrat; Jover, Rodrigo; Llor, Xavier; Dolores Giraldez, M.; Ocana, Teresa; Serradesanferm, Anna; Alonso-Espinaco, Virginia; Jimeno, Mireya; Cuatrecasas, Miriam; Sendino, Oriol; Castellvi-Bel, Sergi; Castells, Antoni		Spanish Gastroenterological Assoc	Aberrant Gene Promoter Methylation Associated with Sporadic Multiple Colorectal Cancer	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; REVISED BETHESDA GUIDELINES; K-RAS MUTATIONS; DNA METHYLATION; ULCERATIVE-COLITIS; COLON; RASSF1A; MULTICENTER; IDENTIFICATION; SURVEILLANCE	Background: Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in multiplicity. To assess the effect of methylation in tumor multiplicity in sporadic CRC, hypermethylation of key tumor suppressor genes was evaluated in patients with both multiple and solitary tumors, as a proof-of-concept of an underlying epigenetic defect. Methodology/Principal Findings: We examined a total of 47 synchronous/metachronous primary CRC from 41 patients, and 41 gender, age (5-year intervals) and tumor location-paired patients with solitary tumors. Exclusion criteria were polyposis syndromes, Lynch syndrome and inflammatory bowel disease. DNA methylation at the promoter region of the MGMT, CDKN2A, SFRP1, TMEFF2, HS3ST2 (3OST2), RASSF1A and GATA4 genes was evaluated by quantitative methylation specific PCR in both tumor and corresponding normal appearing colorectal mucosa samples. Overall, patients with multiple lesions exhibited a higher degree of methylation in tumor samples than those with solitary tumors regarding all evaluated genes. After adjusting for age and gender, binomial logistic regression analysis identified methylation of MGMT2 (OR, 1.48; 95% CI, 1.10 to 1.97; p = 0.008) and RASSF1A (OR, 2.04; 95% CI, 1.01 to 4.13; p = 0.047) as variables independently associated with tumor multiplicity, being the risk related to methylation of any of these two genes 4.57 (95% CI, 1.53 to 13.61; p = 0.006). Moreover, in six patients in whom both tumors were available, we found a correlation in the methylation levels of MGMT2 (r = 0.64, p = 0.17), SFRP1 (r = 0.83, 0.06), HPP1 (r = 0.64, p = 0.17), 3OST2 (r = 0.83, p = 0.06) and GATA4 (r = 0.6, p = 0.24). Methylation in normal appearing colorectal mucosa from patients with multiple and solitary CRC showed no relevant difference in any evaluated gene. Conclusions: These results provide a proof-of-concept that gene promoter methylation is associated with tumor multiplicity. This underlying epigenetic defect may have noteworthy implications in the prevention of patients with sporadic CRC.	[Gonzalo, Victoria; Munoz, Jenifer; Balaguer, Francesc; Pellise, Maria; Rodriguez de Miguel, Cristina; Dolores Giraldez, M.; Ocana, Teresa; Alonso-Espinaco, Virginia; Sendino, Oriol; Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, Dept Gastroenterol, Inst Malalties Digest & Metab,IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain; [Jose Lozano, Juan] Ctr Invest Biomed Red Area Temat Enfermedades Hep, Barcelona, Catalonia, Spain; [Andreu, Montserrat] Hosp del Mar, Dept Gastroenterol, Barcelona, Catalonia, Spain; [Jover, Rodrigo] Gen Hosp Univ Alicante, Dept Gastroenterol, E-03080 Alicante, Spain; [Llor, Xavier] Univ Illinois, Sect Digest Dis & Nutr, Chicago, IL USA; [Serradesanferm, Anna] Univ Barcelona, Prevent Med & Epidemiol Unit, IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain; [Jimeno, Mireya; Cuatrecasas, Miriam] Univ Barcelona, Dept Pathol,IDIBAPS, Inst Malalties Digest & Metab,Ctr Diagnost Biomed, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; General University Hospital of Alicante; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gonzalo, V (corresponding author), Univ Barcelona, Dept Gastroenterol, Inst Malalties Digest & Metab,IDIBAPS, Hosp Clin,Ctr Invest Biomed Red Area Temat Enferm, Barcelona, Catalonia, Spain.	castells@clinic.ub.es	Bujanda, Luis/AAB-2485-2021; BALAGUER, FRANCESC/G-2389-2016; Dolz Abadía, Carlos/I-1757-2017; Cuatrecasas, Miriam/C-9156-2019; Giraldez, Maria D/E-7395-2018; Castells, Antoni/ABC-1002-2021; Balaguer, Francesc/GPX-7801-2022; Felis, Carmen Pinol/C-6397-2011; Andreu, Montserrat/D-9911-2015; CUBIELLA, JOAQUIN/G-7692-2017; Padillo-Ruiz, Javier/AAF-9792-2021; Jover, Rodrigo/ABC-3258-2021; Pellise, Maria/ABC-3246-2021; Carballo, Fernando/M-4668-2016	Bujanda, Luis/0000-0002-4353-9968; Cuatrecasas, Miriam/0000-0003-3063-0110; Giraldez, Maria D/0000-0001-6829-7603; Castells, Antoni/0000-0001-8431-2033; Felis, Carmen Pinol/0000-0003-0626-1298; Andreu, Montserrat/0000-0003-4286-1098; CUBIELLA, JOAQUIN/0000-0002-9994-4831; Padillo-Ruiz, Javier/0000-0002-1220-0822; Jover, Rodrigo/0000-0003-3742-3413; Alenda, Cristina/0000-0002-0560-1759; Bessa Caserras, Xavier/0000-0003-4680-1228; Castellvi-Bel, Sergi/0000-0003-1217-5097; ESTEVE, MARIA/0000-0001-7716-0027; Fernandez-Banares, Fernando/0000-0002-1489-504X; Sanchez Hernandez, Eloy/0000-0003-2493-8303; Sendino, Oriol/0000-0002-2235-6927; Pinol, Virginia/0000-0003-3669-6989; Pellise, Maria/0000-0001-9739-4998; Balaguer, Francesc/0000-0002-0206-0539; Rodriguez de Miguel, Cristina/0000-0002-5576-0854; Carballo, Fernando/0000-0003-1152-1517; Lozano, Juan Jose/0000-0001-7613-3908	Ministerio de Ciencia e Innovacion [SAF 07-64873]; Fondo de Investigacio n Sanitaria [PI061384, PI080024]; Asociacio n Espanola Contra el Cancer; Fundacion Investigacio n Medica Mutua Madrilena [PI040296]; Fundacio n Olga Torres [PI040212]; Olympus Medical Systems-Europe; Instituto de Salud Carlos III [PI016017]; Fundacion Alfonso Martin Escudero; Fondo de Investigacion Sanitaria [CP 03-0070]; Instituto de Salud Carlos III	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo de Investigacio n Sanitaria(Instituto de Salud Carlos III); Asociacio n Espanola Contra el Cancer; Fundacion Investigacio n Medica Mutua Madrilena; Fundacio n Olga Torres; Olympus Medical Systems-Europe; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Alfonso Martin Escudero; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (SAF 07-64873), Fondo de Investigacio n Sanitaria (PI061384 and PI080024), Asociacio n Espanola Contra el Cancer (Fundacion Cientifi ca and Junta de Barcelona), Fundacion Investigacio n Medica Mutua Madrilena (PI040296), Fundacio n Olga Torres (PI040212), and Accionen Cancer (Instituto de Salud Carlos III). Victoria Gonzalo was supported by a grant from the Hospital Clinic, Cristina Rodriguez by a grant from Olympus Medical Systems-Europe, Mireya Jimeno by a grant from the Instituto de Salud Carlos III (PI016017), Francesc Balaguer by a grant from Fundacion Alfonso Martin Escudero, and Sergi Castellvi-Bel by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070). Centro de Investigacio n Biome dica en Red en el A rea tema tica de Enfermedades Hepa ticas y Digestivas (CIBERehd) is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; [Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; Balaguer F, 2008, GASTROENTEROLOGY, V134, P39, DOI 10.1053/j.gastro.2007.10.042; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Belshaw NJ, 2008, BRIT J CANCER, V99, P136, DOI 10.1038/sj.bjc.6604432; Burt R, 2005, GASTROENTEROLOGY, V128, P1696, DOI 10.1053/j.gastro.2005.03.036; Caldwell GM, 2006, BRIT J CANCER, V94, P922, DOI 10.1038/sj.bjc.6602967; Eads CA, 1999, CANCER RES, V59, P2302; Eads CA, 2000, CANCER RES, V60, P5021; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Esteller M, 2000, CANCER RES, V60, P2368; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Greenspan EJ, 2006, CARCINOGENESIS, V27, P1316, DOI 10.1093/carcin/bgi373; Guan RJ, 1999, GASTROENTEROLOGY, V116, P1063, DOI 10.1016/S0016-5085(99)70009-0; Gupta RB, 2007, GASTROENTEROLOGY, V133, P1099, DOI 10.1053/j.gastro.2007.08.001; Huang EH, 2008, TRENDS MOL MED, V14, P503, DOI 10.1016/j.molmed.2008.09.005; Itzkowitz SH, 2005, INFLAMM BOWEL DIS, V11, P314, DOI 10.1097/01.MIB.0000160811.76729.d5; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kawakami K, 2006, BRIT J CANCER, V94, P593, DOI 10.1038/sj.bjc.6602940; Konishi K, 2009, CANCER PREV RES, V2, P814, DOI 10.1158/1940-6207.CAPR-09-0054; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llor X, 2005, CLIN CANCER RES, V11, P7304, DOI 10.1158/1078-0432.CCR-05-0965; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Nagasaka T, 2008, INT J CANCER, V122, P2429, DOI 10.1002/ijc.23398; Nosho K, 2007, CARCINOGENESIS, V28, P1364, DOI 10.1093/carcin/bgl246; Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Ogino S, 2007, GUT, V56, P1564, DOI 10.1136/gut.2007.119750; Ogino S, 2006, MODERN PATHOL, V19, P1083, DOI 10.1038/modpathol.3800618; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Oliveira C, 2005, ONCOGENE, V24, P7630, DOI 10.1038/sj.onc.1208906; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Pinol V, 2004, EUR J GASTROEN HEPAT, V16, P39, DOI 10.1097/00042737-200401000-00007; Rodriguez-Moranta F, 2006, J CLIN ONCOL, V24, P386, DOI 10.1200/JCO.2005.02.0826; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Sakamoto N, 2004, ONCOGENE, V23, P8900, DOI 10.1038/sj.onc.1207993; Sato F, 2002, CANCER RES, V62, P6820; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Takahashi T, 2006, INT J CANCER, V118, P924, DOI 10.1002/ijc.21453; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van Engeland M, 2002, ONCOGENE, V21, P3792, DOI 10.1038/sj.onc.1205466; Wagner KJ, 2002, ONCOGENE, V21, P7277, DOI 10.1038/sj.onc.1205922; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Xicola RM, 2007, JNCI-J NATL CANCER I, V99, P244, DOI 10.1093/jnci/djk033; Xiong ZG, 2001, CANCER EPIDEM BIOMAR, V10, P799; Young J, 2001, P NATL ACAD SCI USA, V98, P265, DOI 10.1073/pnas.011415298	51	51	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8777	10.1371/journal.pone.0008777	http://dx.doi.org/10.1371/journal.pone.0008777			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098741	Green Published, gold, Green Submitted			2022-12-27	WOS:000273778900020
J	Notari, S; Moleres, FJ; Hunter, SB; Belay, ED; Schonberger, LB; Cali, I; Parchi, P; Shieh, WJ; Brown, P; Zaki, S; Zou, WQ; Gambetti, P				Notari, Silvio; Moleres, Francisco J.; Hunter, Stephen B.; Belay, Ermias D.; Schonberger, Lawrence B.; Cali, Ignazio; Parchi, Piero; Shieh, Wun-Ju; Brown, Paul; Zaki, Sherif; Zou, Wen-Quan; Gambetti, Pierluigi			Multiorgan Detection and Characterization of Protease-Resistant Prion Protein in a Case of Variant CJD Examined in the United States	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY PRIONS; CLINICAL-FEATURES; TRUNCATED FORMS; URINE; TRANSMISSION; ACCUMULATION; PRPSC; BSE; LOCALIZATION	Background: Variant Creutzfeldt-Jakob disease (vCJD) is a prion disease thought to be acquired by the consumption of prion-contaminated beef products. To date, over 200 cases have been identified around the world, but mainly in the United Kingdom. Three cases have been identified in the United States; however, these subjects were likely exposed to prion infection elsewhere. Here we report on the first of these subjects. Methodology/Principal Findings: Neuropathological and genetic examinations were carried out using standard procedures. We assessed the presence and characteristics of protease-resistant prion protein (PrP(res)) in brain and 23 other organs and tissues using immunoblots performed directly on total homogenate or following sodium phosphotungstate precipitation to increase PrP(res) detectability. The brain showed a lack of typical spongiform degeneration and had large plaques, likely stemming from the extensive neuronal loss caused by the long duration (32 months) of the disease. The PrP(res) found in the brain had the typical characteristics of the PrP(res) present in vCJD. In addition to the brain and other organs known to be prion positive in vCJD, such as the lymphoreticular system, pituitary and adrenal glands, and gastrointestinal tract, PrP(res) was also detected for the first time in the dura mater, liver, pancreas, kidney, ovary, uterus, and skin. Conclusions/Significance: Our results indicate that the number of organs affected in vCJD is greater than previously realized and further underscore the risk of iatrogenic transmission in vCJD.	[Notari, Silvio; Moleres, Francisco J.; Cali, Ignazio; Zou, Wen-Quan; Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Hunter, Stephen B.] Emory Univ Hosp, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Belay, Ermias D.; Schonberger, Lawrence B.; Shieh, Wun-Ju; Zaki, Sherif] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA USA; [Parchi, Piero] Univ Bologna, Dipartimento Sci Neurol, I-40126 Bologna, Italy; [Brown, Paul] SEPIA, iMETI, DSV, CEA, Paris, France	Case Western Reserve University; Emory University; Centers for Disease Control & Prevention - USA; University of Bologna; CEA; UDICE-French Research Universities; Universite Paris Saclay	Notari, S (corresponding author), Case Western Reserve Univ, Inst Pathol, 2085 Adelbert Rd, Cleveland, OH 44106 USA.	pxg13@case.edu	Zou, Wenquan/ABF-2875-2020; cali, ignazio/AAS-1127-2020; Parchi, Piero/L-9833-2015; Zou, Wenquan/GWQ-3489-2022; Belay, Ermias/A-8829-2013	cali, ignazio/0000-0001-5770-3848; Parchi, Piero/0000-0002-9444-9524; Belay, Ermias/0000-0002-9837-0960	National Institutes of Health [AG14359]; Centers for Disease Control and Prevention ( [CCU515004]; Charles S. Britton Fund; NIH [R01 NS062787]; Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention ((United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Charles S. Britton Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institutes of Health grant AG14359, Centers for Disease Control and Prevention (CCU515004), and the Charles S. Britton Fund to PG; grant NIH R01 NS062787 and the Creutzfeldt-Jakob Disease Foundation to WQZ, as for cost of supplies and salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrievskaia O, 2008, J VET DIAGN INVEST, V20, P141, DOI 10.1177/104063870802000201; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Belay ED, 2005, EMERG INFECT DIS, V11, P1351, DOI 10.3201/eid1109.050371; BIGNAMI A, 1970, BRAIN, V93, P89, DOI 10.1093/brain/93.1.89; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Cali I, 2009, BRAIN IN PRESS; Castilla J, 2005, J VIROL, V79, P8665, DOI 10.1128/JVI.79.13.8665-8668.2005; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Head MW, 2003, INVEST OPHTH VIS SCI, V44, P342, DOI 10.1167/iovs.01-1273; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Ironside JW, 2004, CURR TOP MICROBIOL, V284, P133; Kariv-Inbal Z, 2006, NEURODEGENER DIS, V3, P123, DOI 10.1159/000094770; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Lasmezas CI, 1996, NATURE, V381, P743, DOI 10.1038/381743a0; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl A, P3; MURRAY K, 2009, J NEUROL NE IN PRESS; Narang HK, 2005, EXP BIOL MED, V230, P343, DOI 10.1177/153537020523000508; *NAT CJD SURV UN, 2007, CREUTZF JAK DIS SURV; Noguchi-Shinohara M, 2007, NEUROLOGY, V69, P360, DOI 10.1212/01.wnl.0000266624.63387.4a; Notari S, 2008, J BIOL CHEM, V283, P30557, DOI 10.1074/jbc.M801877200; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 1997, NATURE, V386, P232, DOI 10.1038/386232a0; PARCHI P, 2009, ACTA NERUOP IN PRESS; Pastore M, 2005, AM J PATHOL, V167, P1729, DOI 10.1016/S0002-9440(10)61254-0; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2007, J GEN VIROL, V88, P1068, DOI 10.1099/vir.0.81913-0; Piccardo P, 2007, P NATL ACAD SCI USA, V104, P4712, DOI 10.1073/pnas.0609241104; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Siso S, 2008, J PATHOL, V215, P126, DOI 10.1002/path.2336; Spencer MD, 2002, BRIT MED J, V324, P1479, DOI 10.1136/bmj.324.7352.1479; Thomzig A, 2007, PLOS PATHOG, V3, P659, DOI 10.1371/journal.ppat.0030066; Valleron AJ, 2001, SCIENCE, V294, P1726, DOI 10.1126/science.1066838; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Will RG, 2003, BRIT MED BULL, V66, P255, DOI 10.1093/bmb/66.1.255; Will RG, 2000, ANN NEUROL, V47, P575; Will RG, 2004, CURR TOP MICROBIOL, V284, P121; WILL RG, 1996, LANCET, V347, P925; Xiao XZ, 2009, AM J PATHOL, V174, P1602, DOI 10.2353/ajpath.2009.081045; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003; Zou WQ, 2003, J BIOL CHEM, V278, P40429, DOI 10.1074/jbc.M308550200	54	44	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8765	10.1371/journal.pone.0008765	http://dx.doi.org/10.1371/journal.pone.0008765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098730	Green Submitted, gold, Green Published			2022-12-27	WOS:000273778900009
J	Grossman, EJ; Lee, DD; Tao, J; Wilson, RA; Park, SY; Bell, GI; Chong, AS				Grossman, Eric J.; Lee, David D.; Tao, Jing; Wilson, Raphael A.; Park, Soo-Young; Bell, Graeme I.; Chong, Anita S.			Glycemic Control Promotes Pancreatic Beta-Cell Regeneration in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							MASS; REVERSAL; APOPTOSIS; RECOVERY; GROWTH; RATS	Background: Pancreatic beta-cells proliferate following administration of the beta-cell toxin streptozotocin. Defining the conditions that promote beta-cell proliferation could benefit patients with diabetes. We have investigated the effect of insulin treatment on pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice, and, in addition, report on a new approach to quantify beta-cell regeneration in vivo. Methodology/Principal Findings: Streptozotocin-induced diabetic were treated with either syngeneic islets transplanted under the kidney capsule or subcutaneous insulin implants. After either 60 or 120 days of insulin treatment, the islet transplant or insulin implant were removed and blood glucose levels monitored for 30 days. The results showed that both islet transplants and insulin implants restored normoglycemia in the 60 and 120 day treated animals. However, only the 120-day islet and insulin implant groups maintained euglycemia (<200 mg/dl) following discontinuation of insulin treatment. The beta-cell was significantly increased in all the 120 day insulin-treated groups (insulin implant, 0.69 +/- 0.23 mg; and islet transplant, 0.91 +/- 0.23 mg) compared non-diabetic control mice (1.54 +/- 0.25 mg). We also show that we can use bioluminescent imaging to monitor beta-cell regeneration in living MIP-luc transgenic mice. Conclusions/Significance: The results show that insulin treatment can promote beta-cell regeneration. Moreover, the extent of restoration of beta-cell function and mass depend on the length of treatment period and overall level of glycemic control with better control being associated with improved recovery. Finally, real-time bioluminescent imaging can be used to monitor beta-cell recovery in living MIP-luc transgenic mice.	[Grossman, Eric J.; Lee, David D.; Tao, Jing; Wilson, Raphael A.; Chong, Anita S.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Park, Soo-Young; Bell, Graeme I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lee, David D.] Rush Presbyterian St Lukes Med Ctr, Dept Gen Surg, Chicago, IL USA	University of Chicago; University of Chicago; Rush University	Grossman, EJ (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	eric.grossman@uchospitals.edu	Lee, David/ABH-1406-2021; Lee, David/ABA-4123-2021	Lee, David/0000-0002-2086-0150; Wilson, Raphael/0000-0003-3325-6734	National Institute of Diabetes and Digestive And Kidney Diseases [R21DK073529, P60DK020595]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R21DK073529] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive And Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported in part by awards R21DK073529 and P60DK020595 (University of Chicago Diabetes Research and Training Center) from the National Institute of Diabetes and Digestive And Kidney Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Diabetes And Digestive and Kidney Diseases or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Chong AS, 2006, SCIENCE, V311, P1774, DOI 10.1126/science.1123510; Donath MY, 2008, ENDOCR REV, V29, P334, DOI 10.1210/er.2007-0033; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Guo ZG, 1997, TRANSPLANTATION, V63, P711, DOI 10.1097/00007890-199703150-00017; Guz Y, 2001, ENDOCRINOLOGY, V142, P4956, DOI 10.1210/en.142.11.4956; Karges B, 2004, DIABETES CARE, V27, P1207, DOI 10.2337/diacare.27.5.1207; Kodama S, 2003, SCIENCE, V302, P1223, DOI 10.1126/science.1088949; LOHR M, 1987, DIABETOLOGIA, V30, P757; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; NAKANISHI K, 1993, METABOLISM, V42, P196, DOI 10.1016/0026-0495(93)90035-M; Park SY, 2009, HORM METAB RES, V41, P1, DOI 10.1055/s-0028-1087209; Park SY, 2005, GENESIS, V43, P80, DOI 10.1002/gene.20157; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Ryu S, 2001, J CLIN INVEST, V108, P63, DOI 10.1172/JCI200112335; Smith SJ, 2006, MOL IMAGING, V5, P65, DOI 10.2310/7290.2006.00007; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; VIROSTKO J, 2009, MOL IMAGING BIOL; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yin DP, 2006, DIABETES, V55, P3256, DOI 10.2337/db05-1275; Zhao HL, 2006, DIABETOLOGIA, V49, P2801, DOI 10.1007/s00125-006-0411-4	27	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8749	10.1371/journal.pone.0008749	http://dx.doi.org/10.1371/journal.pone.0008749			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090914	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000008
J	Cudaback, E; Marrs, W; Moeller, T; Stella, N				Cudaback, Eiron; Marrs, William; Moeller, Thomas; Stella, Nephi			The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas	PLOS ONE			English	Article							REGULATED KINASE ACTIVATION; CANNABINOID RECEPTOR; GLIOMA-CELLS; HUNTINGTONS-DISEASE; PROTEIN-KINASES; CANCER; BRAIN; ENDOCANNABINOIDS; IDENTIFICATION; PATHWAY	Background: Cannabinoids represent unique compounds for treating tumors, including astrocytomas. Whether CB1 and CB2 receptors mediate this therapeutic effect is unclear. Principal Findings: We generated astrocytoma subclones that express set levels of CB1 and CB2, and found that cannabinoids induce apoptosis only in cells expressing low levels of receptors that couple to ERK1/2. In contrast, cannabinoids do not induce apoptosis in cells expressing high levels of receptors because these now also couple to the prosurvival signal AKT. Remarkably, cannabinoids applied at high concentration induce apoptosis in all subclones independently of CB1, CB2 and AKT, but still through a mechanism involving ERK1/2. Significance: The high expression level of CB1 and CB2 receptors commonly found in malignant astrocytomas precludes the use of cannabinoids as therapeutics, unless AKT is concomitantly inhibited, or cannabinoids are applied at concentrations that bypass CB1 and CB2 receptors, yet still activate ERK1/2.	[Cudaback, Eiron; Marrs, William; Stella, Nephi] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Marrs, William] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; [Moeller, Thomas] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Stella, Nephi] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cudaback, E (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nstella@u.washington.edu			National Institutes of Health (NIH); National Institute on Drug Abuse (NIDA) [R01 DA014486]; University of Washington Royalty Research; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014486] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of Washington Royalty Research(University of Washington); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by research grants from the National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) (grant number R01 DA014486; http://www.nida.nih.gov/index.html) and the University of Washington Royalty Research (http://www.washington.edu/research/main.php?page=rrf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, SCI MARIJUANA; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Chen K, 2003, NEURON, V39, P599, DOI 10.1016/S0896-6273(03)00499-9; Cudaback E, 2007, MOL NEUROBIOL, V36, P36, DOI 10.1007/s12035-007-0016-z; Derkinderen P, 2001, J NEUROCHEM, V77, P957, DOI 10.1046/j.1471-4159.2001.00333.x; Ellert-Miklaszewska A, 2005, CELL SIGNAL, V17, P25, DOI 10.1016/j.cellsig.2004.05.011; Galve-Roperh I, 2002, MOL PHARMACOL, V62, P1385, DOI 10.1124/mol.62.6.1385; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Galve-Roperh I, 2008, CURR PHARM DESIGN, V14, P2279, DOI 10.2174/138161208785740117; GLASS M, 1993, NEUROSCIENCE, V56, P523, DOI 10.1016/0306-4522(93)90352-G; GOMEZ DP, 2000, BIOCHEM J, V347, P369; Gonsiorek W, 2006, J BIOL CHEM, V281, P28143, DOI 10.1074/jbc.M602364200; Guzman M, 2005, HANDB EXP PHARMACOL, V168, P627; Guzman M, 2006, BRIT J CANCER, V95, P197, DOI 10.1038/sj.bjc.6603236; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Held-Feindt J, 2006, J NEUROCHEM, V98, P886, DOI 10.1111/j.1471-4159.2006.03911.x; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; KUMANISHI T, 1967, JPN J EXP MED, V37, P461; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; Massi P, 2006, CELL MOL LIFE SCI, V63, P2057, DOI 10.1007/s00018-006-6156-x; McCaw EA, 2004, EUR J BIOCHEM, V271, P4909, DOI 10.1111/j.1432-1033.2004.04460.x; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Nickl K, 2008, NEUROSCI LETT, V447, P68, DOI 10.1016/j.neulet.2008.09.078; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Pei Y, 2008, CHEM BIOL, V15, P1207, DOI 10.1016/j.chembiol.2008.10.011; Petitet F, 1996, NEUROREPORT, V7, P789, DOI 10.1097/00001756-199602290-00026; Picone RP, 2005, MOL PHARMACOL, V68, P1623, DOI 10.1124/mol.105.014407; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Sanchez C, 2001, CANCER RES, V61, P5784; Sanchez C, 1998, FEBS LETT, V436, P6, DOI 10.1016/S0014-5793(98)01085-0; Sarfaraz S, 2008, CANCER RES, V68, P339, DOI 10.1158/0008-5472.CAN-07-2785; Shoemaker JL, 2005, J PHARMACOL EXP THER, V315, P828, DOI 10.1124/jpet.105.089474; Thimmaiah KN, 2005, J BIOL CHEM, V280, P31924, DOI 10.1074/jbc.M507057200; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wallace MJ, 2003, J PHARMACOL EXP THER, V307, P129, DOI 10.1124/jpet.103.051920; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Widmer M, 2008, J NEUROSCI RES, V86, P3212, DOI 10.1002/jnr.21757	41	67	72	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8702	10.1371/journal.pone.0008702	http://dx.doi.org/10.1371/journal.pone.0008702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090845	gold, Green Submitted, Green Published			2022-12-27	WOS:000273714600005
J	Fuentes-Calvo, I; Blazquez-Medela, AM; Santos, E; Lopez-Novoa, JM; Martinez-Salgado, C				Fuentes-Calvo, Isabel; Blazquez-Medela, Ana M.; Santos, Eugenio; Lopez-Novoa, Jose M.; Martinez-Salgado, Carlos			Analysis of K-Ras Nuclear Expression in Fibroblasts and Mesangial Cells	PLOS ONE			English	Article							N-RAS; H-RAS; PROTEINS; MOUSE; TARGETS; GROWTH; FAMILY; GENE; LINE	Background: Ras GTPases are considered cytoplasmic proteins that must be localized to cell membranes for activation, and there are few evidences of the presence of any Ras isoform in nuclei of eukaryotic cells. Methodology/Principal Findings: Using conventional antibodies and inmunocytochemistry, differential centrifugation and western blot, we have observed the putative presence of K-Ras isoform in the nuclei of fibroblasts and mesangial cells. In order to avoid cross-reactions with other Ras isoforms, and using antibodies against K-Ras (R-3400, H3845-M01, sc-30) or pan-Ras (05-516, OP40) in cells that only expressed the K-Ras isoform (fibroblasts obtained from H-ras(-/-), N-ras(-/-) mice) we also detected some nuclear positive expression. To further probe the identity of nuclear K-Ras, we have generated K-Ras knockout (K-ras(-/-)) embrionary fibroblasts by mating of K-ras(+/-) heterozygote mice. Using specific antibodies, only H- and N-Ras isoforms were observed in the cytoplasm of K-ras(-/-) fibroblasts. However, both K-Ras4A and K-Ras4B positive signals were detected by immunocytochemistry and Western blot with two commercial antibodies (sc-522 and sc-521 against each isoforms, respectively) in both cytoplasm and nuclei from K-ras(-/-) fibroblasts. Conclusions/Significance: We show that the presence of K-Ras4B in fibroblast nuclei, already described by other authors, is probably due to a cross-reaction of the antibody with an undetermined nucleolar protein. Although this study also shows the possible nuclear expression of K-Ras isoform in fibroblasts or in mesangial cells, it also reveals the importance of being cautious in these studies about distribution of protein isoforms due to some important limitations imposed by the unspecificity of the antibodies or contaminations in cellular preparations.	[Fuentes-Calvo, Isabel; Blazquez-Medela, Ana M.; Lopez-Novoa, Jose M.; Martinez-Salgado, Carlos] Univ Salamanca, Inst Reina Sofia Invest Nefrol, Unidad Fisiopatol Renal & Cardiovasc, E-37008 Salamanca, Spain; [Santos, Eugenio] Univ Salamanca, CSIC, Ctr Invest Canc IBMCC, E-37008 Salamanca, Spain; [Martinez-Salgado, Carlos] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain	University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca	Fuentes-Calvo, I (corresponding author), Univ Salamanca, Inst Reina Sofia Invest Nefrol, Unidad Fisiopatol Renal & Cardiovasc, E-37008 Salamanca, Spain.	carloms@usal.es	IBSAL, Secretaría/H-3719-2011; Lopez-Novoa, Jose M/A-3672-2008; Fuentes-Calvo, Isabel/A-6900-2016; Blázquez-Medela, Ana/K-3142-2014; Blázquez-Medela, Ana/ABC-1517-2021; Martinez-Salgado, Carlos/E-7299-2012	Fuentes-Calvo, Isabel/0000-0003-1406-346X; Blázquez-Medela, Ana/0000-0003-3829-6997; Lopez-Novoa, Jose M./0000-0002-6211-7269; Martinez-Salgado, Carlos/0000-0003-4641-6717	Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo) [CP03/00094, PI041817, PI021570, C03/10]; Comision Interministerial de Ciencia y Tecnologi-a [BFU-2004-00285/BFI, SAF2003-04177]; Junta de Castilla y Leon [SA001/C05, SA029A05, GRS 167/A/07, GR100]	Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo)(Instituto de Salud Carlos III); Comision Interministerial de Ciencia y Tecnologi-a(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by grants from Instituto de Salud Carlos III (Ministerio de Sanidad y Consumo, CP03/00094, PI041817, PI021570 and C03/10), Comision Interministerial de Ciencia y Tecnologi-a (BFU-2004-00285/BFI;SAF2003-04177), and Junta de Castilla y Leon (SA001/C05; SA029A05; GRS 167/A/07 and excellence group GR100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banas B, 1999, J AM SOC NEPHROL, V10, P2314; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Birchenall-Roberts MC, 2006, BIOCHEM BIOPH RES CO, V348, P540, DOI 10.1016/j.bbrc.2006.07.094; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Dhanasekaran N, 1998, ONCOGENE, V17, P1447, DOI 10.1038/sj.onc.1202251; DYER RB, 1995, BIOTECHNIQUES, V19, P192; Elam C, 2005, CANCER RES, V65, P3117, DOI 10.1158/0008-5472.CAN-04-0749; Ellis CA, 2000, CELL SIGNAL, V12, P425, DOI 10.1016/S0898-6568(00)00084-X; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Martinez-Salgado C, 2006, EXP CELL RES, V312, P2093, DOI 10.1016/j.yexcr.2006.03.008; Mitra RS, 2003, ONCOGENE, V22, P6243, DOI 10.1038/sj.onc.1206534; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; PUDDINGTON L, 1985, J BIOL CHEM, V260, P5641; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Wurzer G, 2001, J CELL BIOCHEM, P1	21	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8703	10.1371/journal.pone.0008703	http://dx.doi.org/10.1371/journal.pone.0008703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090846	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714600006
J	Cusimano, M; Marshall, S; Rinner, C; Jiang, DP; Chipman, M				Cusimano, Michael; Marshall, Sean; Rinner, Claus; Jiang, Depeng; Chipman, Mary			Patterns of Urban Violent Injury: A Spatio-Temporal Analysis	PLOS ONE			English	Article							CRIME; MULTILEVEL; COLLISIONS; EMERGENCY; MORTALITY	Objectives: Injury related to violent acts is a problem in every society. Although some authors have examined the geography of violent crime, few have focused on the spatio-temporal patterns of violent injury and none have used an ambulance dataset to explore the spatial characteristics of injury. The purpose of this study was to describe the combined spatial and temporal characteristics of violent injury in a large urban centre. Methodology/Principal Findings: Using a geomatics framework and geographic information systems software, we studied 4,587 ambulance dispatches and 10,693 emergency room admissions for violent injury occurrences among adults (aged 1864) in Toronto, Canada, during 2002 and 2004, using population-based datasets. We created kernel density and choropleth maps for 24-hour periods and four-hour daily time periods and compared location of ambulance dispatches and patient residences with local land use and socioeconomic characteristics. We used multivariate regressions to control for confounding factors. We found the locations of violent injury and the residence locations of those injured were both closely related to each other and clearly clustered in certain parts of the city characterised by high numbers of bars, social housing units, and homeless shelters, as well as lower household incomes. The night and early morning showed a distinctive peak in injuries and a shift in the location of injuries to a "nightlife" district. The locational pattern of patient residences remained unchanged during those times. Conclusions/Significance: Our results demonstrate that there is a distinctive spatio-temporal pattern in violent injury reflected in the ambulance data. People injured in this urban centre more commonly live in areas of social deprivation. During the day, locations of injury and locations of residences are similar. However, later at night, the injury location of highest density shifts to a "nightlife" district, whereas the residence locations of those most at risk of injury do not change.	[Cusimano, Michael; Marshall, Sean] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Cusimano, Michael] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Cusimano, Michael; Chipman, Mary] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; [Rinner, Claus] Ryerson Univ, Dept Geog, Toronto, ON, Canada; [Jiang, Depeng] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Toronto Metropolitan University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Cusimano, M (corresponding author), St Michaels Hosp, Injury Prevent Res Off, 30 Bond St, Toronto, ON M5B 1W8, Canada.	injuryprevention@smh.toronto.on.ca	Cusimano, Michael/GWR-1025-2022; Rinner, Christoph/AAL-4672-2020; Cusimano, Michael/X-4059-2019	Rinner, Christoph/0000-0002-3847-5664; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research (CIHR) [ATF 66678]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant (ATF 66678) from the Canadian Institutes of Health Research (CIHR). Parts of this material are based on data and information provided by the Canadian Institute for Health Information. However, the analyses, conclusions, opinions and statements expressed herein are those of the authors, and not necessarily those of the Canadian Institute for Health Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backe SN, 2008, SCAND J PUBLIC HEALT, V36, P250, DOI 10.1177/1403494807086973; *CIT TOR, TOR NEIGHB PROF; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Cusimano MD, 2007, INJURY PREV, V13, P51, DOI 10.1136/ip.2006.012468; Faelker T, 2000, Inj Prev, V6, P203, DOI 10.1136/ip.6.3.203; Graham K, 2006, ADDICTION, V101, P1569, DOI 10.1111/j.1360-0443.2006.01608.x; Gruenewald PJ, 2006, ADDICTION, V101, P666, DOI 10.1111/j.1360-0443.2006.01405.x; HOPE T, 1985, 86 HOM OFF; Kim SW, 2005, BRIT J CRIMINOL, V45, P81, DOI 10.1093/bjc/azh082; LaScala EA, 2000, ACCIDENT ANAL PREV, V32, P651, DOI 10.1016/S0001-4575(99)00100-1; Loukaitou-Sideris A, 2007, J PLAN EDUC RES, V26, P338, DOI 10.1177/0739456X06297008; Nelson AL, 2001, APPL GEOGR, V21, P249, DOI 10.1016/S0143-6228(01)00008-X; Runyan CW, 2005, AM J PREV MED, V28, P73, DOI 10.1016/j.amepre.2004.09.010; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Scott G, 2007, J URBAN HEALTH, V84, P292, DOI 10.1007/s11524-007-9157-7; Seow E, 2001, EMERG MED J, V18, P297, DOI 10.1136/emj.18.4.297; SHEPHERD JP, 1990, INJURY, V21, P139, DOI 10.1016/0020-1383(90)90081-5; SHERMAN LW, 1989, CRIMINOLOGY, V27, P27, DOI 10.1111/j.1745-9125.1989.tb00862.x; Warburton AL, 2006, EMERG MED J, V23, P12, DOI 10.1136/emj.2004.023028; Wikstrom P.-O.H., 1991, URBAN CRIME CRIMINAL	20	59	59	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8669	10.1371/journal.pone.0008669	http://dx.doi.org/10.1371/journal.pone.0008669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	543EV	20084271	gold, Green Published			2022-12-27	WOS:000273554600022
J	Melzer, D; Rice, NE; Lewis, C; Henley, WE; Galloway, TS				Melzer, David; Rice, Neil E.; Lewis, Ceri; Henley, William E.; Galloway, Tamara S.			Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ENDOCRINE DISRUPTORS; ENDOTHELIAL-CELLS; RECEPTOR-GAMMA; HUMAN EXPOSURE; US POPULATION; HUMAN HEALTH; ATHEROSCLEROSIS; PLASMA; RAT	Background: Bisphenol A (BPA) is a high production volume chemical widely used in food and drinks packaging. Associations have previously been reported between urinary BPA concentrations and heart disease, diabetes and liver enzymes in adult participants of the National Health and Nutrition Examination Survey (NHANES) 2003/04. We aimed to estimate associations between urinary BPA concentrations and health measures in NHANES 2005/06 and in data pooled across collection years. Methodology and Findings: A cross-sectional analysis of NHANES: subjects were n = 1455 (2003/04) and n = 1493 (2005/06) adults aged 18-74 years, representative of the general adult population of the United States. Regression models were adjusted for age, sex, race/ethnicity, education, income, smoking, BMI, waist circumference, and urinary creatinine concentration. Main outcomes were reported diagnoses of heart attack, coronary heart disease, angina and diabetes and serum liver enzyme levels. Urinary BPA concentrations in 2005/06 (geometric mean 1.79 ng/ml, 95% CI: 1.64 to 1.96) were lower than in 2003/04 (2.49 ng/ml, CI: 2.20 to 2.83, difference p-value = 0.00002). Higher BPA concentrations were associated with coronary heart disease in 2005/06 (OR per z-score increase in BPA = 1.33, 95% CI: 1.01 to 1.75, p = 0.043) and in pooled data (OR = 1.42, CI: 1.17 to 1.72, p = 0.001). Associations with diabetes did not reach significance in 2005/06, but pooled estimates remained significant (OR = 1.24, CI: 1.10 to 1.40, p = 0.001). There was no overall association with gamma glutamyl transferase concentrations, but pooled associations with alkaline phosphatase and lactate dehydrogenase remained significant. Conclusions: Higher BPA exposure, reflected in higher urinary concentrations of BPA, is consistently associated with reported heart disease in the general adult population of the USA. Studies to clarify the mechanisms of these associations are urgently needed.	[Melzer, David; Rice, Neil E.] Univ Exeter, Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England; [Lewis, Ceri; Galloway, Tamara S.] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England	University of Exeter; University of Exeter; University of Plymouth	Melzer, D (corresponding author), Univ Exeter, Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England.	david.melzer@pms.ac.uk	Galloway, Tamara/C-1662-2009	Lewis, Ceri/0000-0002-3564-2906; Melzer, David/0000-0002-0170-3838	Peninsula Medical School	Peninsula Medical School	This work was funded internally by the Peninsula Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Bisphenol A, 2003, EUR CHEM NEWS, p14e20; BOMBICK DW, 1984, BIOCHEM BIOPH RES CO, V118, P548, DOI 10.1016/0006-291X(84)91337-8; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Centers for Disease Control and Prevention (CDC), 2004, NAT HLTH NUTR EX SUR; Drobna Z, 2002, FASEB J, V16, P67, DOI 10.1096/fj.02-0287fje; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Eto K, 2001, EUR J PHARMACOL, V423, P1, DOI 10.1016/S0014-2999(01)01047-0; Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hennig B, 2002, INT J HYG ENVIR HEAL, V205, P95, DOI 10.1078/1438-4639-00134; Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Lee HJ, 2003, TOXICOL SCI, V75, P40, DOI 10.1093/toxsci/kfg150; LOVATI MR, 1984, TOXICOL APPL PHARM, V75, P91, DOI 10.1016/0041-008X(84)90079-6; Mahadik Sujata R., 2008, Metabolic Syndrome and Related Disorders, V6, P121, DOI 10.1089/met.2007.0034; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Melzer D, 2008, EPIDEMIOLOGY, V19, pS379; Melzer D, 2009, JAMA-J AM MED ASSOC, V301, P721; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Nemmar A, 2003, CIRCULATION, V107, P1202, DOI 10.1161/01.CIR.0000053568.13058.67; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Simeonova PP, 2004, TOXICOL APPL PHARM, V198, P444, DOI 10.1016/j.taap.2003.10.018; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; STEGEMAN JJ, 1995, MOL PHARMACOL, V47, P296; Suwa T, 2002, J AM COLL CARDIOL, V39, P935, DOI 10.1016/S0735-1097(02)01715-1; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; UNION E, 2003, EU RISK ASSESSMENT R; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Wang CH, 2002, CIRCULATION, V105, P1804, DOI 10.1161/01.CIR.0000015862.64816.B2; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Wood SN, 2006, AUST NZ J STAT, V48, P445, DOI 10.1111/j.1467-842X.2006.00450.x; Wozniak AL, 2005, ENVIRON HEALTH PERSP, V113, P431, DOI 10.1289/ehp.7505; Wright HM, 2000, J BIOL CHEM, V275, P1873, DOI 10.1074/jbc.275.3.1873; Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014	54	390	407	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8673	10.1371/journal.pone.0008673	http://dx.doi.org/10.1371/journal.pone.0008673			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084273	Green Published, gold			2022-12-27	WOS:000273554600025
J	Rouvinen, J; Janis, J; Laukkanen, ML; Jylha, S; Niemi, M; Paivinen, T; Makinen-Kiljunen, S; Haahtela, T; Soderlund, H; Takkinen, K				Rouvinen, Juha; Janis, Janne; Laukkanen, Marja-Leena; Jylha, Sirpa; Niemi, Merja; Paivinen, Tero; Makinen-Kiljunen, Soili; Haahtela, Tari; Soderlund, Hans; Takkinen, Kristiina			Transient Dimers of Allergens	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; BET V 1; CRYSTAL-STRUCTURE; CROSS-REACTIVITY; MAJOR ALLERGEN; MACROMOLECULAR ASSEMBLIES; PROTEIN INTERACTIONS; MASS-SPECTROMETRY; X-RAY; IGE	Background: Allergen-mediated cross-linking of IgE antibodies bound to the Fc epsilon RI receptors on the mast cell surface is the key feature of the type I allergy. If an allergen is a homodimer, its allergenicity is enhanced because it would only need one type of antibody, instead of two, for cross-linking. Methodology/Principal Findings: An analysis of 55 crystal structures of allergens showed that 80% of them exist in symmetric dimers or oligomers in crystals. The majority are transient dimers that are formed at high protein concentrations that are reached in cells by colocalization. Native mass spectrometric analysis showed that native allergens do indeed form transient dimers in solution, while hypoallergenic variants of them exist almost solely in the monomeric form. We created a monomeric Bos d 5 allergen and show that it has a reduced capability to induce histamine release. Conclusions/Significance: The results suggest that dimerization would be a very common and essential feature for allergens. Thus, the preparation of purely monomeric variants of allergens could open up novel possibilities for specific immunotherapy.	[Rouvinen, Juha; Janis, Janne; Niemi, Merja; Paivinen, Tero] Univ Eastern Finland, Dept Chem, Joensuu, Finland; [Laukkanen, Marja-Leena; Jylha, Sirpa; Soderlund, Hans; Takkinen, Kristiina] VTT Tech Res Ctr Finland, Espoo, Finland; [Makinen-Kiljunen, Soili; Haahtela, Tari] Univ Helsinki, Dept Allergy, Cent Hosp, Helsinki, Finland	University of Eastern Finland; VTT Technical Research Center Finland; University of Helsinki; Helsinki University Central Hospital	Rouvinen, J (corresponding author), Univ Eastern Finland, Dept Chem, Joensuu, Finland.	juha.rouvinen@uef.fi	Jänis, Janne/B-7326-2014	Rouvinen, Juha/0000-0003-1843-5718	Sigrid Juselius Foundation; National Graduate School in Informational and Structural Biology; Frontier Funding of VTT-Technical Research Centre of Finland,; Helsinki University Central Hospital [TYH7111]	Sigrid Juselius Foundation(Sigrid Juselius Foundation); National Graduate School in Informational and Structural Biology; Frontier Funding of VTT-Technical Research Centre of Finland,; Helsinki University Central Hospital	Funding was provided by the Sigrid Juselius Foundation, the National Graduate School in Informational and Structural Biology, the Frontier Funding of VTT-Technical Research Centre of Finland, and a grant (TYH7111) from the special government subsidy for health sciences research from the Helsinki University Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellinghausen I, 2008, CLIN EXP ALLERGY, V38, P539, DOI 10.1111/j.1365-2222.2007.02910.x; Blundell TL, 1996, P NATL ACAD SCI USA, V93, P14243, DOI 10.1073/pnas.93.25.14243; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Derewenda U, 2002, J MOL BIOL, V318, P189, DOI 10.1016/S0022-2836(02)00027-X; Fedorov AA, 1997, STRUCTURE, V5, P33, DOI 10.1016/S0969-2126(97)00164-0; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Gottschalk M, 2003, J PHYS CHEM B, V107, P7914, DOI 10.1021/jp034527k; Gould HJ, 2008, NAT REV IMMUNOL, V8, P205, DOI 10.1038/nri2273; Gustchina A, 2005, J MOL BIOL, V348, P433, DOI 10.1016/j.jmb.2005.02.062; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; HOUSLEY ZM, 2003, J MOL BIOL, V325, P123; Janis J, 2008, J MASS SPECTROM, V43, P1376, DOI 10.1002/jms.1413; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Kurup VP, 2003, PEPTIDES, V24, P179, DOI 10.1016/S0196-9781(03)00024-X; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Mari A, 2006, CELL IMMUNOL, V244, P97, DOI 10.1016/j.cellimm.2007.02.012; Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6; Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pasquato N, 2006, J MOL BIOL, V356, P684, DOI 10.1016/j.jmb.2005.11.063; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rajashankar K, 2002, ACTA CRYSTALLOGR D, V58, P1175, DOI 10.1107/S0907444902007254; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Sakurai K, 2002, J BIOL CHEM, V277, P25735, DOI 10.1074/jbc.M203659200; Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; TERWILLIGER TC, 1982, BIOPHYS J, V37, P353, DOI 10.1016/S0006-3495(82)84683-3; Thomas K, 2008, FOOD CHEM TOXICOL, V46, P3219, DOI 10.1016/j.fct.2008.06.078; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje; Wagner S, 2008, J ALLERGY CLIN IMMUN, V121, P246, DOI 10.1016/j.jaci.2007.08.006; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080	36	50	50	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9037	10.1371/journal.pone.0009037	http://dx.doi.org/10.1371/journal.pone.0009037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140203	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400001
J	Alkhuder, K; Meibom, KL; Dubail, I; Dupuis, M; Charbit, A				Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain			Identification of trkH, Encoding a Potassium Uptake Protein Required for Francisella tularensis Systemic Dissemination in Mice	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; PATHOGENICITY ISLAND; SCHU S4; NOVICIDA; TRANSCRIPTION; REPLICATION; TULAREMIA; BACTERIA; MUTANTS; GROWTH	Francisella tularensis is a highly infectious bacterium causing the zoonotic disease tularaemia. During its infectious cycle, F. tularensis is not only exposed to the intracellular environment of macrophages but also resides transiently in extracellular compartments, in particular during its systemic dissemination. The screening of a bank of F. tularensis LVS transposon insertion mutants on chemically defined medium (CDM) led us to identify a gene, designated trkH, encoding a homolog of the potassium uptake permease TrkH. Inactivation of trkH impaired bacterial growth in CDM. Normal growth of the mutant was only restored when CDM was supplemented with potassium at high concentration. Strikingly, although not required for intracellular survival in cell culture models, TrkH appeared to be essential for bacterial virulence in the mouse. In vivo kinetics of bacterial dissemination revealed a severe defect of multiplication of the trkH mutant in the blood of infected animals. The trkH mutant also showed impaired growth in blood ex vivo. Genome sequence analyses suggest that the Trk system constitutes the unique functional active potassium transporter in both tularensis and holarctica subspecies. Hence, the impaired survival of the trkH mutant in vivo is likely to be due to its inability to survive in the low potassium environment (1-5 mM range) of the blood. This work unravels thus the importance of potassium acquisition in the extracellular phase of the F. tularensis infectious cycle. More generally, potassium could constitute an important mineral nutrient involved in other diseases linked to systemic dissemination of bacterial pathogens.	[Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain] Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France; [Alkhuder, Khaled; Meibom, Karin L.; Dubail, Iharilalao; Dupuis, Marion; Charbit, Alain] INSERM, U1002, Unite Pathogenie Infect Syst, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Alkhuder, K (corresponding author), Univ Paris 05, Fac Med Necker Enfants Malad, Paris, France.	alain.charbit@inserm.fr		charbit, alain/0000-0001-5243-4861; Alkhuder, Khaled/0000-0002-4992-586X; Meibom, Karin/0000-0002-2612-6424	INSERM; CNRS; University Rene Descartes Paris	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Rene Descartes Paris	Funding: This study was funded by INSERM, CNRS and University Rene Descartes Paris V. K. A. was supported in part by a fellowship from the Syrian government and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhuder K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000284; ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Balaji B, 2005, APPL ENVIRON MICROB, V71, P8273, DOI 10.1128/AEM.71.12.8273-8283.2005; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Bar-Haim E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000211; Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; BERRY MN, 1989, CLIN CHEM, V35, P817; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; Broteke A, 2008, INFECT IMMUN, V76, P3473, DOI 10.1128/IAI.00430-08; Buchan BW, 2009, INFECT IMMUN, V77, P2517, DOI 10.1128/IAI.00229-09; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chen YC, 2004, INFECT IMMUN, V72, P629, DOI 10.1128/IAI.72.2.629-636.2004; Dominguez-Ferreras A, 2009, J BACTERIOL, V191, P2133, DOI 10.1128/JB.01567-08; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; FRYMIER JS, J BACTERIOL, V179, P3061; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Johnson HA, 2009, J BACTERIOL, V191, P2276, DOI 10.1128/JB.01367-08; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; KEM DC, 1983, POTASIUM BIOL SIGNIF, P25; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Lombardo MJ, 2007, P NATL ACAD SCI USA, V104, P18229, DOI 10.1073/pnas.0705636104; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; Martinac B, 2008, PHYSIOL REV, V88, P1449, DOI 10.1152/physrev.00005.2008; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Mohapatra NP, 2007, INFECT IMMUN, V75, P3305, DOI 10.1128/IAI.00351-07; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Stingl K, 2007, EMBO J, V26, P232, DOI 10.1038/sj.emboj.7601471; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Weiss DS, 2007, ANN NY ACAD SCI, V1105, P219, DOI 10.1196/annals.1409.005; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Youn JH, 2009, ANNU REV PHYSIOL, V71, P381, DOI 10.1146/annurev.physiol.010908.163241; Yu JJ, 2008, EUR J CLIN MICROBIOL, V27, P323, DOI 10.1007/s10096-007-0434-x	52	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8966	10.1371/journal.pone.0008966	http://dx.doi.org/10.1371/journal.pone.0008966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126460	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100014
J	Dong, JJ; Mury, SP; Drahos, KE; Moscovitch, M; Zia, RKP; Finkielstein, CV				Dong, JiaJia; Mury, Sean P.; Drahos, Karen E.; Moscovitch, Marko; Zia, Royce K. P.; Finkielstein, Carla V.			Shorter Exposures to Harder X-Rays Trigger Early Apoptotic Events in Xenopus laevis Embryos	PLOS ONE			English	Article							STRAND BREAK REPAIR; PROGRAMMED CELL-DEATH; MAJOR DEVELOPMENTAL TRANSITION; DNA-DAMAGE; SMALL-INTESTINE; IONIZING-RADIATION; HOMOLOGOUS RECOMBINATION; MIDBLASTULA TRANSITION; STRESS-RESPONSE; IN-SITU	Background: A long-standing conventional view of radiation-induced apoptosis is that increased exposure results in augmented apoptosis in a biological system, with a threshold below which radiation doses do not cause any significant increase in cell death. The consequences of this belief impact the extent to which malignant diseases and non-malignant conditions are therapeutically treated and how radiation is used in combination with other therapies. Our research challenges the current dogma of dose-dependent induction of apoptosis and establishes a new parallel paradigm to the photoelectric effect in biological systems. Methodology/Principal Findings: We explored how the energy of individual X-ray photons and exposure time, both factors that determine the total dose, influence the occurrence of cell death in early Xenopus embryo. Three different experimental scenarios were analyzed and morphological and biochemical hallmarks of apoptosis were evaluated. Initially, we examined cell death events in embryos exposed to increasing incident energies when the exposure time was preset. Then, we evaluated the embryo's response when the exposure time was augmented while the energy value remained constant. Lastly, we studied the incidence of apoptosis in embryos exposed to an equal total dose of radiation that resulted from increasing the incoming energy while lowering the exposure time. Conclusions/Significance: Overall, our data establish that the energy of the incident photon is a major contributor to the outcome of the biological system. In particular, for embryos exposed under identical conditions and delivered the same absorbed dose of radiation, the response is significantly increased when shorter bursts of more energetic photons are used. These results suggest that biological organisms display properties similar to the photoelectric effect in physical systems and provide new insights into how radiation-mediated apoptosis should be understood and utilized for therapeutic purposes.	[Mury, Sean P.; Drahos, Karen E.; Finkielstein, Carla V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Integrated Cellular Responses Lab, Blacksburg, VA 24061 USA; [Dong, JiaJia; Zia, Royce K. P.] Virginia Polytech Inst & State Univ, Dept Phys, Blacksburg, VA 24061 USA; [Moscovitch, Marko] Georgetown Univ, Med Ctr, Dept Radiat Med, Washington, DC 20007 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Georgetown University	Dong, JJ (corresponding author), Hamline Univ, Dept Phys, St Paul, MN 55104 USA.	finkielc@vt.edu	Dong, JiaJia/E-3154-2012	Dong, JiaJia/0000-0001-9908-2699; Zia, R K P/0000-0002-0489-2937; finkielstein, carla/0000-0002-8417-4643	American Heart Association [0665363U]; Institute for Critical Technology and Applied Science [ICTAS117432]; Susan G. Komen Foundation [BCTR0706931]; Division of Material Research of the National Science Foundation [DMR-0705152]	American Heart Association(American Heart Association); Institute for Critical Technology and Applied Science; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Division of Material Research of the National Science Foundation	Funding: This work was supported by the American Heart Association (0665363U, http://www.americanheart.org/), Institute for Critical Technology and Applied Science (ICTAS117432), and the Susan G. Komen Foundation (BCTR0706931, http://ww5.komen.org/) to C. V. F., and the Division of Material Research of the National Science Foundation (DMR-0705152, http://www.nsf.gov/index.jsp) to R. K. P. Z. K. E. D is a Sigma Xi Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JA, 1997, MOL BIOL CELL, V8, P1195, DOI 10.1091/mbc.8.7.1195; Badie C, 1997, CANCER RES, V57, P4600; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Finkielstein CV, 2002, J BIOL CHEM, V277, P38476, DOI 10.1074/jbc.M206184200; Finkielstein CV, 2001, P NATL ACAD SCI USA, V98, P1006, DOI 10.1073/pnas.98.3.1006; FREDERICK DL, 1994, J EXP ZOOL, V270, P410, DOI 10.1002/jez.1402700411; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Guerci AM, 2004, CYTOGENET GENOME RES, V104, P173, DOI 10.1159/000077484; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P611, DOI 10.1080/09553008214551591; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hensey C, 1998, DEV BIOL, V203, P36, DOI 10.1006/dbio.1998.9028; IMOH H, 1986, CELL DIFFER DEV, V19, P35, DOI 10.1016/0045-6039(86)90023-0; Kegel P, 2007, DNA REPAIR, V6, P1692, DOI 10.1016/j.dnarep.2007.05.013; Kellerer AM, 2002, RADIAT RES, V158, P13, DOI 10.1667/0033-7587(2002)158[0013:ESATRO]2.0.CO;2; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Liu SZ, 1996, MUTAT RES-FUND MOL M, V358, P185, DOI 10.1016/S0027-5107(96)00119-4; Lobrich M, 2005, DNA REPAIR, V4, P749, DOI 10.1016/j.dnarep.2004.12.008; Lobrich M, 1995, P NATL ACAD SCI USA, V92, P12050, DOI 10.1073/pnas.92.26.12050; MacPhail SH, 2003, INT J RADIAT BIOL, V79, P351, DOI 10.1080/0955300032000093128; Mladenov E, 2009, RADIAT RES, V171, P397, DOI 10.1667/RR1487.1; Moscovitch M, 2006, RADIAT PROT DOSIM, V119, P248, DOI 10.1093/rpd/nci692; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; Nieuwkoop P. D., 1975, NORMAL TABLE XENOPUS; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Nikjoo H, 2001, RADIAT RES, V156, P577, DOI 10.1667/0033-7587(2001)156[0577:CAFDTS]2.0.CO;2; Nussenzweig A, 2007, CELL CYCLE, V6, P2339, DOI 10.4161/cc.6.19.4995; Patel T, 1998, SEMIN LIVER DIS, V18, P105, DOI 10.1055/s-2007-1007147; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pena LA, 2000, CANCER RES, V60, P321; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Prise KM, 1998, INT J RADIAT BIOL, V74, P173, DOI 10.1080/095530098141564; Rainaldi G, 2003, ANTICANCER RES, V23, P2505; REMPEL RE, 1995, J BIOL CHEM, V270, P6843, DOI 10.1074/jbc.270.12.6843; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rief N, 2002, J BIOL CHEM, V277, P20572, DOI 10.1074/jbc.M200265200; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2001, CANCER RES, V61, P3886; Rudin CM, 1997, ANNU REV MED, V48, P267; Sanders EJ, 1997, ANAT EMBRYOL, V195, P147, DOI 10.1007/s004290050033; Sible JC, 1997, DEV BIOL, V189, P335, DOI 10.1006/dbio.1997.8683; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Stack JH, 1997, DEVELOPMENT, V124, P3185; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Ueno S, 2007, MUTAT RES-GEN TOX EN, V634, P135, DOI 10.1016/j.mrgentox.2007.06.011; Wang GC, 1999, MUTAT RES-DNA REPAIR, V433, P147, DOI 10.1016/S0921-8777(99)00007-5; Wroble BN, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-119; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451	58	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8970	10.1371/journal.pone.0008970	http://dx.doi.org/10.1371/journal.pone.0008970			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126466	Green Published, gold			2022-12-27	WOS:000274139100018
J	Gilli, F; Lindberg, RLP; Valentino, P; Marnetto, F; Malucchi, S; Sala, A; Capobianco, M; di Sapio, A; Sperli, F; Kappos, L; Calogero, RA; Bertolotto, A				Gilli, Francesca; Lindberg, Raija L. P.; Valentino, Paola; Marnetto, Fabiana; Malucchi, Simona; Sala, Arianna; Capobianco, Marco; di Sapio, Alessia; Sperli, Francesca; Kappos, Ludwig; Calogero, Raffaele A.; Bertolotto, Antonio			Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis	PLOS ONE			English	Article							BREAST-CANCER CELLS; REGULATORY T-CELLS; OLIGONUCLEOTIDE ARRAYS; HORMONE ESTRIOL; RECEPTOR; DISEASE; HYBRIDIZATION; NORMALIZATION; PROFILES; RELAPSE	Background: Pregnancy is associated with reduced activity of multiple sclerosis (MS). However, the biological mechanisms underlying this pregnancy-related decrease in disease activity are poorly understood. Methodology: We conducted a genome-wide transcription analysis in peripheral blood mononuclear cells (PBMCs) from 12 women (7 MS patients and 5 healthy controls) followed during their pregnancy. Samples were obtained before, during (i.e. at the third, sixth, and ninth month of gestation) and after pregnancy. A validation of the expression profiles has been conducted by using the same samples and an independent group of 25 MS patients and 11 healthy controls. Finally, considering the total group of 32 MS patients, we compared expression profiles of patients relapsing during pregnancy (n = 6) with those of relapse-free patients (n = 26). Principal Findings: Results showed an altered expression of 347 transcripts in non-pregnant MS patients with respect to non-pregnant healthy controls. Complementary changes in expression, occurring during pregnancy, reverted the previous imbalance particularly for seven inflammation-related transcripts, i.e. SOCS2, TNFAIP3, NR4A2, CXCR4, POLR2J, FAM49B, and STAG3L1. Longitudinal analysis showed that the overall deregulation of gene expression reverted to "normal" already within the third month of gestation, while in the post-partum gene expressions rebounded to pre-pregnancy levels. Six (18.7%) of the 32 MS patients had a relapse during pregnancy, mostly in the first trimester. The latter showed delayed expression profiles when compared to relapse-free patients: in these patients expression imbalance was reverted later in the pregnancy, i.e. at sixth month. Conclusions: Specific changes in expression during pregnancy were associated with a decrease in disease activity assessed by occurrence of relapses during pregnancy. Findings might help in understanding the pathogenesis of MS and may provide basis for the development of novel therapeutic strategies.	[Gilli, Francesca; Valentino, Paola; Marnetto, Fabiana; Malucchi, Simona; Sala, Arianna; Capobianco, Marco; di Sapio, Alessia; Sperli, Francesca; Bertolotto, Antonio] Azienda Osped Univ San Luigi Gonzaga, Reg Ctr Multiple Sclerosis CReSM & Clin Neurobiol, Orbassano, Italy; [Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Lindberg, Raija L. P.; Kappos, Ludwig] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Calogero, Raffaele A.] Azienda Osped Univ San Luigi Gonzaga, Genom & Bioinformat Unit, Dept Clin & Biol Sci, Orbassano, Italy	Azienda Ospedaliero-Universitaria San Luigi Gonzaga; University of Basel; University of Basel; Azienda Ospedaliero-Universitaria San Luigi Gonzaga	Gilli, F (corresponding author), Azienda Osped Univ San Luigi Gonzaga, Reg Ctr Multiple Sclerosis CReSM & Clin Neurobiol, Orbassano, Italy.	francesca.gilli@fastwebnet.it	Calogero, Raffaele/K-9428-2019; Valentino, Paola/K-6758-2016; sperli, francesca/AAC-2055-2022; Sala, Arianna/AAB-9966-2022; Capobianco, Marco/AAC-2215-2022; Bertolotto, Antonio/K-8346-2015; Gilli, Francesca/H-4428-2019; VALENTINO, Paola/AAA-4243-2019	Calogero, Raffaele/0000-0002-2848-628X; Valentino, Paola/0000-0003-3819-9409; Sala, Arianna/0000-0001-8940-368X; Capobianco, Marco/0000-0003-2501-2932; Bertolotto, Antonio/0000-0002-7052-1907; VALENTINO, Paola/0000-0001-7863-9195; Gilli, Francesca/0000-0002-2306-458X; Di Sapio, Alessia/0000-0002-5575-7567	Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM [2004/R/9]; Swiss Multiple Sclerosis Society; Regional Health Service of Piedmont	Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM; Swiss Multiple Sclerosis Society; Regional Health Service of Piedmont	Funding: Financial support was obtained from the Italian Multiple Sclerosis Society (Fondazione Italiana Sclerosi Multipla, FISM, grant number 2004/R/9), the Swiss Multiple Sclerosis Society, and the Regional Health Service of Piedmont. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shammri S, 2004, J NEUROL SCI, V222, P21, DOI 10.1016/j.jns.2004.03.027; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; de Saizieu A, 1998, NAT BIOTECHNOL, V16, P45, DOI 10.1038/nbt0198-45; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irony-Tur-Sinai M, 2006, EXP NEUROL, V198, P136, DOI 10.1016/j.expneurol.2005.11.012; Kira J, 1996, ANN NEUROL, V40, P569; Koklanaris N, 2006, AM J OBSTET GYNECOL, V194, P687, DOI 10.1016/j.ajog.2006.01.067; KORNLUBETZKI I, 1984, ANN NEUROL, V16, P229, DOI 10.1002/ana.410160211; Kumar A, 2004, PLACENTA, V25, P347, DOI 10.1016/j.placenta.2003.10.003; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lopez C, 2006, MULT SCLER J, V12, P421, DOI 10.1191/1352458506ms1287oa; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Parmigiani G, 2004, CLIN CANCER RES, V10, P2922, DOI 10.1158/1078-0432.CCR-03-0490; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Romagnani S, 2006, CLIN EXP ALLERGY, V36, P1357, DOI 10.1111/j.1365-2222.2006.02606.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sanchez-Ramon S, 2005, IMMUNOL LETT, V96, P195, DOI 10.1016/j.imlet.2004.09.004; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Shuster EA, 2008, CURR TOP MICROBIOL, V318, P267; Sicotte NL, 2002, ANN NEUROL, V52, P421, DOI 10.1002/ana.10301; Soldan SS, 2003, J IMMUNOL, V171, P6267, DOI 10.4049/jimmunol.171.11.6267; Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Stromnes IM, 2008, NAT MED, V14, P337, DOI 10.1038/nm1715; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tsao JT, 2008, CLIN EXP MED, V8, P179, DOI 10.1007/s10238-008-0006-0; Vendrell JA, 2007, ONCOGENE, V26, P4656, DOI 10.1038/sj.onc.1210269; VONHEYDEBRECK A, 2004, BIOCONDUCTOR PROJECT; VOSKUHL R, 2003, MULTIPLE SCLEROSIS T, V32, P53; Vukusic S, 2004, BRAIN, V127, P1353, DOI 10.1093/brain/awh152; Zou LH, 2004, CANCER RES, V64, P8451, DOI 10.1158/0008-5472.CAN-04-1987	45	62	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8962	10.1371/journal.pone.0008962	http://dx.doi.org/10.1371/journal.pone.0008962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126412	gold, Green Published, Green Submitted			2022-12-27	WOS:000274139100010
J	Naeger, DM; Martin, JN; Sinclair, E; Hunt, PW; Bangsberg, DR; Hecht, F; Hsue, P; McCune, JM; Deeks, SG				Naeger, David M.; Martin, Jeffrey N.; Sinclair, Elizabeth; Hunt, Peter W.; Bangsberg, David R.; Hecht, Frederick; Hsue, Priscilla; McCune, Joseph M.; Deeks, Steven G.			Cytomegalovirus-Specific T Cells Persist at Very High Levels during Long-Term Antiretroviral Treatment of HIV Disease	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LYMPHOCYTE SUBPOPULATIONS; HIGH-FREQUENCIES; AIDS PATIENTS; RNA LEVELS; INFECTION; CD4(+); IMMUNE; LOAD; IMMUNOSENESCENCE	Background: In healthy, HIV seronegative, CMV seropositive adults, a large proportion of T cells are CMV-specific. High-level CMV-specific T cell responses are associated with accelerated immunologic aging ("immunosenesence") in the elderly population. The impact of untreated and treated HIV infection on the frequency of these cells remains undefined. Methodology/Principal Findings: We measured the proportion of CD4+ and CD8+ T cells responding to CMV pp65 and IE proteins was measured using flow cytometry in 685 unique HIV seronegative and seropositive individuals. The proportion of CMV-specific CD8+ T cells was consistently higher in the HIV-seropositive subjects compared to the HIV-seronegative subjects. This HIV effect was observed even in patients who lacked measurable immunodeficiency. Among the HIV-seropositive subjects, CMV-specific CD8+ T cell responses were proportionately lower during recent infection, higher during chronic untreated infection and higher still during long-term antiretroviral treated infection. The CD8+ T cell response to just two CMV proteins (pp65 and IE) was approximately 6% during long-term therapy, which was over twice that seen in HIV-seronegative persons. CMV-specific CD4+ T cell responses followed the same trends, but the magnitude of the effect was smaller. Conclusions/Significance: Long-term successfully treated HIV infected patients have remarkably high levels of CMV-specific effector cells. These levels are similar to that observed in the elderly, but occur at much younger ages. Future studies should focus on defining the potential role of the CMV-specific inflammatory response in non-AIDS morbidity and mortality, including immunosenescence.	[Naeger, David M.; Martin, Jeffrey N.; Sinclair, Elizabeth; Hunt, Peter W.; Hecht, Frederick; Hsue, Priscilla; McCune, Joseph M.; Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Harvard Initiat Global Hlth, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital	Naeger, DM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	sdeeks@php.ucsf.edu	Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870; Hecht, Frederick/0000-0002-5782-1171; Naeger, David/0000-0002-1884-280X	National Institutes of Health [AI41531, AI052745, AI069994, DPI OD00329]; University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research [P30 MH59037]; UCSF Clinical and Translational Research Institute Clinical Research Center [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; Doris Duke Charitable Foundation; American Foundation for AIDS Research [106710-40-RGRL]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI069994, U01AI041531, R01AI052745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037, P30MH062246, R01MH054907] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000329] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research; UCSF Clinical and Translational Research Institute Clinical Research Center; Center for AIDS Prevention Studies; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); American Foundation for AIDS Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This research was supported by a grants from the National Institutes of Health (AI41531, AI052745, AI069994)), University of California San Francisco-Gladstone Institute of Virology & Immunology Center for AIDS Research, P30 MH59037; the UCSF Clinical and Translational Research Institute Clinical Research Center (UL1 RR024131); the Center for AIDS Prevention Studies (P30 MH62246); The Doris Duke Charitable Foundation and the American Foundation for AIDS Research (106710-40-RGRL). JMM is a recipient of the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research and the NIH Director's Pioneer Award Program, part of the NIH Roadmap for Medical Research, through grant number DPI OD00329. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J GERONTOL A-BIOL, V63, P610, DOI 10.1093/gerona/63.6.610; Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Bowen EF, 1996, AIDS, V10, P1515, DOI 10.1097/00002030-199611000-00009; Casazza JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000646; Corey L, 2007, NEW ENGL J MED, V356, P854, DOI 10.1056/NEJMe068302; Davidson R, 1993, ESTIMATION INFERENCE; Deayton JR, 2004, LANCET, V363, P2116, DOI 10.1016/S0140-6736(04)16500-8; Deeks SG, 2004, J INFECT DIS, V189, P312, DOI 10.1086/380098; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; DETELS R, 1994, J INFECT DIS, V169, P766, DOI 10.1093/infdis/169.4.766; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Effros RB, 2004, MECH AGEING DEV, V125, P103, DOI 10.1016/j.mad.2003.11.003; Emery VC, 1999, J INFECT DIS, V180, P695, DOI 10.1086/314936; Franceschi C, 1999, EXP GERONTOL, V34, P911, DOI 10.1016/S0531-5565(99)00068-6; Gress RE, 2009, J CLIN INVEST, V119, P2884, DOI 10.1172/JCI40855; Griffiths PP, 2006, J CLIN VIROL, V35, P489, DOI 10.1016/j.jcv.2005.10.016; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hsue PY, 2006, AIDS, V20, P2275, DOI 10.1097/QAD.0b013e3280108704; Jabs DA, 2005, OPHTHALMOLOGY, V112, P771, DOI 10.1016/j.ophtha.2004.10.049; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kern F, 2002, J INFECT DIS, V185, P1709, DOI 10.1086/340637; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Koch S, 2007, ANN NY ACAD SCI, V1114, P23, DOI 10.1196/annals.1396.043; Komanduri KV, 1998, NAT MED, V4, P953, DOI 10.1038/nm0898-953; Kovacs A, 1999, NEW ENGL J MED, V341, P77, DOI 10.1056/NEJM199907083410203; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Maecker HT, 2001, J IMMUNOL METHODS, V255, P27, DOI 10.1016/S0022-1759(01)00416-1; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Nikolich-Zugich J, 2008, NAT REV IMMUNOL, V8, P512, DOI 10.1038/nri2318; Olsson J, 2000, MECH AGEING DEV, V121, P187; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Posnett DN, 1999, INT IMMUNOL, V11, P229, DOI 10.1093/intimm/11.2.229; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Qin OY, 2003, J CLIN IMMUNOL, V23, P247, DOI 10.1023/A:1024580531705; Sabin CA, 2000, J INFECT DIS, V181, P1800, DOI 10.1086/315476; Sacre K, 2005, J EXP MED, V201, P1999, DOI 10.1084/jem.20042408; Sauce D, 2009, J CLIN INVEST, V119, P3070, DOI 10.1172/JCI39269; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Spaulding C, 1999, EXP GERONTOL, V34, P633, DOI 10.1016/S0531-5565(99)00033-9; Spector SA, 1998, J CLIN INVEST, V101, P497, DOI 10.1172/JCI1101; Stone SF, 2005, AIDS, V19, P555, DOI 10.1097/01.aids.0000163931.68907.7e; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Targonski PV, 2007, VACCINE, V25, P3066, DOI 10.1016/j.vaccine.2007.01.025; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Valantine HA, 1999, CIRCULATION, V100, P61, DOI 10.1161/01.CIR.100.1.61; Vasto Sonya, 2007, Immun Ageing, V4, P2, DOI 10.1186/1742-4933-4-2; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Wikby A, 2002, EXP GERONTOL, V37, P445, DOI 10.1016/S0531-5565(01)00212-1	58	145	148	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8886	10.1371/journal.pone.0008886	http://dx.doi.org/10.1371/journal.pone.0008886			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126452	Green Submitted, gold, Green Published			2022-12-27	WOS:000274139100003
J	Benoit, M; Thuny, F; Le Priol, Y; Lepidi, H; Bastonero, S; Casalta, JP; Collart, F; Capo, C; Raoult, D; Mege, JL				Benoit, Marie; Thuny, Franck; Le Priol, Yannick; Lepidi, Hubert; Bastonero, Sonia; Casalta, Jean-Paul; Collart, Frederic; Capo, Christian; Raoult, Didier; Mege, Jean-Louis			The Transcriptional Programme of Human Heart Valves Reveals the Natural History of Infective Endocarditis	PLOS ONE			English	Article							VALVULAR LESIONS; CARDIAC VALVES; MESSENGER-RNA; T-CELLS; EXPRESSION; MONOCYTES; ACTIVATION; DIAGNOSIS; LEUKOCYTES; APOPTOSIS	Infective endocarditis (IE) is an infectious disease that is mainly caused by Staphylococcus aureus and Streptococcus sp. It usually leads to valvular destruction and vegetation formation. Its pathophysiology is badly understood and likely involves immune and coagulation systems with close interactions with the microorganism. Our objective was to evaluate host response by comparing transcriptional profiles of cardiac valves from IE patients with controls. Hierarchical clustering revealed a signature of IE consisting of 146 genes. Among the 89 up-regulated genes, we identified two genes strongly associated with IE: metalloproteinase 12 (MMP-12) and aquaporin-9, a member of the aquaglyceroporin membrane channel family. The up-regulation of MMP-12 gene is strengthened by the down-modulation of the gene encoding its inhibitor TIMP3. In addition, MMP-12 was expressed in macrophages infiltrating EI valves. We also found that aquaporin-9 was expressed in endothelial cells lining neo-vessel lumen, suggesting that aquaporin-9 might be associated with neovascularization of infected valves leading to tissue oedema secondary to the inflammatory process. The Gene Ontology annotation and the resulting functional classification showed that most up-regulated genes account for recruitment of inflammatory cells in vegetations, angiogenesis and remodelling of endocardium tissue. A network analysis confirmed the involvement of molecules related to the remodelling of endocardium tissue and angiogenesis in IE. It also evidenced the role of caspases, especially that of caspase-9 and intrinsic apoptotic pathway in IE. Based on this study we propose a scenario for the natural history of IE in humans. Some parameters identified in this work could become tools for measuring the disease activity and should be tested as biomarkers for diagnosis or prognosis assessment in future studies.	[Benoit, Marie; Lepidi, Hubert; Bastonero, Sonia; Casalta, Jean-Paul; Capo, Christian; Raoult, Didier; Mege, Jean-Louis] Univ Mediterranee, CNRS,Fac Med, UMR 6236, Unite Rech Malad Infect Transmissibles & Emergent, Marseille, France; [Thuny, Franck] Hop Enfants La Timone, Serv Cardiol, Marseille, France; [Le Priol, Yannick] Inst Trop Med, Serv Sante Armees, Marseille, France; [Collart, Frederic] Hop Enfants La Timone, Serv Chirurg Cardiaque, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Benoit, M (corresponding author), Univ Mediterranee, CNRS,Fac Med, UMR 6236, Unite Rech Malad Infect Transmissibles & Emergent, Marseille, France.	jean-louis.mege@univmed.fr	MEGE, JEAN-LOUIS/O-6063-2016; Thuny, Franck/GSD-2668-2022; RAOULT, Didier/A-8434-2008; Thuny, Franck/ABC-7157-2020; Thuny, Franck/ABB-2408-2021	Thuny, Franck/0000-0002-8727-7154; RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Le Priol, Yannick/0000-0002-5176-0857	Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille	Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Centre National de la Recherche Scientifique et Assistance Publique - Hopitaux de Marseille. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Bancsi MJLMF, 1998, INFECT IMMUN, V66, P448, DOI 10.1128/IAI.66.2.448-450.1998; Bastonero S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005357; Benoit M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000066; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Butler TL, 2006, AM J PHYSIOL-HEART C, V291, pH705, DOI 10.1152/ajpheart.00090.2006; Carrell TWG, 2002, CIRCULATION, V105, P477, DOI 10.1161/hc0402.102621; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Chorianopoulos E, 2009, CELL TISSUE RES, V335, P153, DOI 10.1007/s00441-008-0687-4; Fournier PE, 1998, J CLIN MICROBIOL, V36, P1823, DOI 10.1128/JCM.36.7.1823-1834.1998; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Greub G, 2005, AM J MED, V118, P230, DOI 10.1016/j.amjmed.2004.12.014; Houpikian P, 2005, MEDICINE, V84, P162, DOI 10.1097/01.md.0000165658.82869.17; Kellen MR, 2003, AM J PHYSIOL-HEART C, V285, pH1303, DOI 10.1152/ajpheart.00933.2001; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Kruse E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-206; Lepidi H, 2006, CLIN INFECT DIS, V42, P590, DOI 10.1086/500135; Lepidi H, 2000, AM J CLIN PATHOL, V114, P880, DOI 10.1309/R0KQ-823A-BTC7-MUUJ; Lepidi H, 2004, J INFECT DIS, V190, P935, DOI 10.1086/422845; MAHIMKAR R, 2009, CARDIOVASC IN PRESS; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Mylonakis E, 2001, NEW ENGL J MED, V345, P1318, DOI 10.1056/NEJMra010082; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Rodriguez A, 2006, FEBS LETT, V580, P4771, DOI 10.1016/j.febslet.2006.07.080; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Rouzet F, 2008, CIRCULATION, V117, P781, DOI 10.1161/CIRCULATIONAHA.107.718114; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Soini Y, 2001, J PATHOL, V194, P225, DOI 10.1002/path.850; Sumby P, 2008, INFECT IMMUN, V76, P978, DOI 10.1128/IAI.01354-07; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Veltrop MHAM, 2000, INFECT IMMUN, V68, P4818, DOI 10.1128/IAI.68.8.4818-4821.2000; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095; Woller G, 2008, J LEUKOCYTE BIOL, V83, P936, DOI 10.1189/jlb.0907592; Yamauchi R, 2004, ARTERIOSCL THROM VAS, V24, P282, DOI 10.1161/01.ATV.0000114565.42679.c6; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yoshioka M, 2006, NAT MED, V12, P1151, DOI 10.1038/nm1476; Zeng LF, 2009, P NATL ACAD SCI USA, V106, P8326, DOI 10.1073/pnas.0903197106	42	31	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8939	10.1371/journal.pone.0008939	http://dx.doi.org/10.1371/journal.pone.0008939			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126625	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000016
J	Obermuller, S; Calegari, F; King, A; Lindqvist, A; Lundquist, I; Salehi, A; Francolini, M; Rosa, P; Rorsman, P; Huttner, WB; Barg, S				Obermuller, Stefanie; Calegari, Federico; King, Angus; Lindqvist, Anders; Lundquist, Ingmar; Salehi, Albert; Francolini, Maura; Rosa, Patrizia; Rorsman, Patrik; Huttner, Wieland B.; Barg, Sebastian			Defective Secretion of Islet Hormones in Chromogranin-B Deficient Mice	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; INSULIN GRANULE EXOCYTOSIS; DENSE-CORE GRANULES; SECRETOGRANIN FAMILY; ENDOCRINE PANCREAS; TARGETED ABLATION; ON/OFF SWITCH; BIOGENESIS; PATHWAY; PROINSULIN	Granins are major constituents of dense-core secretory granules in neuroendocrine cells, but their function is still a matter of debate. Work in cell lines has suggested that the most abundant and ubiquitously expressed granins, chromogranin A and B (CgA and CgB), are involved in granulogenesis and protein sorting. Here we report the generation and characterization of mice lacking chromogranin B (CgB-ko), which were viable and fertile. Unlike neuroendocrine tissues, pancreatic islets of these animals lacked compensatory changes in other granins and were therefore analyzed in detail. Stimulated secretion of insulin, glucagon and somatostatin was reduced in CgB-ko islets, in parallel with somewhat impaired glucose clearance and reduced insulin release, but normal insulin sensitivity in vivo. CgB-ko islets lacked specifically the rapid initial phase of stimulated secretion, had elevated basal insulin release, and stored and released twice as much proinsulin as wildtype (wt) islets. Stimulated release of glucagon and somatostatin was reduced as well. Surprisingly, biogenesis, morphology and function of insulin granules were normal, and no differences were found with regard to beta-cell stimulus-secretion coupling. We conclude that CgB is not required for normal insulin granule biogenesis or maintenance in vivo, but is essential for adequate secretion of islet hormones. Consequentially CgB-ko animals display some, but not all, hallmarks of human type-2 diabetes. However, the molecular mechanisms underlying this defect remain to be determined.	[Obermuller, Stefanie; Lindqvist, Anders; Lundquist, Ingmar; Salehi, Albert; Barg, Sebastian] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Calegari, Federico; Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Calegari, Federico; Francolini, Maura; Rosa, Patrizia] Univ Milan, Dept Med Pharmacol, Inst Neurosci, CNR, Milan, Italy; [King, Angus; Huttner, Wieland B.] Univ Heidelberg, Dept Neurobiol, D-6900 Heidelberg, Germany; [Rorsman, Patrik] Univ Oxford, Churchill Hosp, OCDEM, Oxford, England; [Barg, Sebastian] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Lund University; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); University of Milan; Ruprecht Karls University Heidelberg; University of Oxford; Uppsala University	Obermuller, S (corresponding author), Lund Univ, Dept Clin Sci, Malmo, Sweden.	huttner@mpi-cbg.de; sebastian.barg@mcb.uu.se	Calegari, Federico/A-2422-2009; Salehi, Albert/F-7768-2018; Rorsman, Patrik/A-4331-2016; Barg, Sebastian/F-9523-2010; Huttner, Wieland B./P-4080-2018; Calegari, Federico/N-7827-2019	Salehi, Albert/0000-0001-6120-3539; Rorsman, Patrik/0000-0001-7578-0767; Barg, Sebastian/0000-0003-4661-5724; calegari, federico/0000-0002-3703-2802; FRANCOLINI, MAURA/0000-0002-3126-1575; Rosa, Patrizia/0000-0002-2590-6955	Swedish Science Council; European Foundation for the Study of Diabetes; European Molecular Biology Organization (EMBO); Knut and Alice Wallenberg Foundation; Zetterlings stiftelse; Goran Gustafsson stiftelse; Deutsche Forschungsgemeinschaft (DFG); Fonds der Chemischen Industrie	Swedish Science Council; European Foundation for the Study of Diabetes; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Zetterlings stiftelse; Goran Gustafsson stiftelse; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	S.O. was a fellow of the Diabetes Programme at Lund University (DPLU), S. B. was supported by the Swedish Science Council (Vetenskapsradet), the European Foundation for the Study of Diabetes, and long-term fellowships from European Molecular Biology Organization (EMBO), the Knut and Alice Wallenberg Foundation, Zetterlings stiftelse, and Goran Gustafsson stiftelse. W. B. H. was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Fonds der Chemischen Industrie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARDAL S, 1993, J NEUROENDOCRINOL, V5, P405, DOI 10.1111/j.1365-2826.1993.tb00501.x; Barg S, 2000, DIABETES, V49, P1500, DOI 10.2337/diabetes.49.9.1500; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Borgonovo B, 2006, CURR OPIN CELL BIOL, V18, P365, DOI 10.1016/j.ceb.2006.06.010; Borjesson A, 2007, J ENDOCRINOL, V192, P381, DOI 10.1677/joe.1.06676; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Gayen JR, 2009, J BIOL CHEM, V284, P28498, DOI 10.1074/jbc.M109.020636; GERDES HH, 1989, J BIOL CHEM, V264, P12009; Hauge-Evans AC, 2009, DIABETES, V58, P403, DOI 10.2337/db08-0792; HEDING LG, 1966, LABELLED PROTEINS TR, P345; HELLE KB, 1990, ACTA PHYSIOL SCAND, V138, P565, DOI 10.1111/j.1748-1716.1990.tb08885.x; Helle KB, 2004, BIOL REV, V79, P769, DOI 10.1017/S146479310400644X; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; HUTTNER WB, 1991, TRENDS BIOCHEM SCI, V16, P27, DOI 10.1016/0968-0004(91)90012-K; IACANGELO AL, 1995, REGUL PEPTIDES, V58, P65, DOI 10.1016/0167-0115(95)00069-N; Iijima Y, 2004, BIOL PSYCHIAT, V56, P10, DOI 10.1016/j.biopsych.2004.03.012; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Karlsson E, 2000, REGUL PEPTIDES, V87, P33, DOI 10.1016/S0167-0115(99)00105-6; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; KING A, 1996, THESIS U HEIDELBERG; Kromer A, 1998, J CELL BIOL, V140, P1331, DOI 10.1083/jcb.140.6.1331; Lukinius A, 2003, PANCREAS, V27, P38, DOI 10.1097/00006676-200307000-00006; Ma L, 2004, P NATL ACAD SCI USA, V101, P9266, DOI 10.1073/pnas.0403201101; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Michael DJ, 2006, DIABETES, V55, P600, DOI 10.2337/diabetes.55.03.06.db05-1054; Molinete M, 2000, SEMIN CELL DEV BIOL, V11, P243, DOI 10.1006/scdb.2000.0173; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; Natori S, 1996, P NATL ACAD SCI USA, V93, P4431, DOI 10.1073/pnas.93.9.4431; Obermuller S, 2005, J CELL SCI, V118, P4271, DOI 10.1242/jcs.02549; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; ORCI L, 1971, J CELL BIOL, V50, P565, DOI 10.1083/jcb.50.3.565; Portela-Gomes GM, 2008, REGUL PEPTIDES, V151, P19, DOI 10.1016/j.regpep.2008.07.005; RERUP C, 1966, ACTA ENDOCRINOL-COP, V52, P357, DOI 10.1530/acta.0.0520357; RHODES CJ, 1987, J CELL BIOL, V105, P145, DOI 10.1083/jcb.105.1.145; ROSA P, 1985, J CELL BIOL, V101, P1999, DOI 10.1083/jcb.101.5.1999; ROSA P, 1994, J ENDOCRINOL INVEST, V17, P207, DOI 10.1007/BF03347721; Takahashi N, 2002, SCIENCE, V297, P1349, DOI 10.1126/science.1073806; TATEMOTO K, 1986, NATURE, V324, P476, DOI 10.1038/324476a0; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Westphal CH, 1999, CELL, V96, P689, DOI 10.1016/S0092-8674(00)80579-6; WINKLER H, 1992, NEUROSCIENCE, V49, P497, DOI 10.1016/0306-4522(92)90222-N; Zhang KX, 2009, CIRC-CARDIOVASC GENE, V2, P46, DOI 10.1161/CIRCGENETICS.108.785659; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10299, DOI 10.1073/pnas.162352799	55	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8936	10.1371/journal.pone.0008936	http://dx.doi.org/10.1371/journal.pone.0008936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126668	Green Published, gold			2022-12-27	WOS:000274138000014
J	Equils, O; Nambiar, P; Hobel, CJ; Smith, R; Simmons, CF; Vali, S				Equils, Ozlem; Nambiar, Priya; Hobel, Calvin J.; Smith, Roger; Simmons, Charles F.; Vali, Shireen			A Computer Simulation of Progesterone and Cox2 Inhibitor Treatment for Preterm Labor	PLOS ONE			English	Article							FACTOR-KAPPA-B; HUMAN MYOMETRIUM; RECEPTOR-A; HUMAN PARTURITION; PROTEIN-KINASE; EXPRESSION; CYCLOOXYGENASE-2; BINDING; CELLS; PROSTAGLANDINS	Background: Sufficient information from in vitro and in vivo studies has become available to permit computer modeling of the processes that occur in the myometrium during labor. This development allows the in silico investigation of pathological mechanisms and the trialing of potential treatments. Methods/Results: Based on the human literature, we developed a computer model of the immune-endocrine environment of the myometrial cell. The interactions between molecules are represented by differential equations. The model is designed to simulate the estrogen and progesterone receptor changes during pregnancy and particularly the changes in the progesterone receptor (PR) isoforms A and B that are thought to mediate functional progesterone withdrawal in the human at labor. Parturition is represented by an increase in the PRA to PRB ratio to levels seen in women in labor. Infection is shown by inducing inflammation in the system by increasing phospho-IkB kinase concentration (IKK) levels; which lead to increased NF-kappa B activation, causing an increase in the PRA/PRB ratio. We examined the effects of progesterone or cyclooxygenase 2 (Cox2) inhibitor treatments on the PRA/PRB ratio in silico. The model predicted that high doses of progesterone and Cox2 inhibition would be effective in preventing an NF-kappa B-induced PRA/PRB ratio increase to the levels found during labor. Conclusions: Our data illustrate the use of dynamic biological computer simulations to test the effectiveness of therapeutic interventions. This may allow the early rejection of ineffective therapies prior to expensive field trials.	[Equils, Ozlem; Simmons, Charles F.] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr,Burns & Allen Res Inst, Dept Pediat,Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90095 USA; [Equils, Ozlem; Simmons, Charles F.] Pfizer Inc, Div Med, New York, NY USA; [Nambiar, Priya; Vali, Shireen] Cellworks Grp Inc, Saratoga, CA USA; [Smith, Roger] John Hunter Hosp, Hunter Med Res Inst, Mothers & Babies Res Ctr, Endocrine Unit, Newcastle, NSW, Australia	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Pfizer; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle	Equils, O (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr,Burns & Allen Res Inst, Dept Pediat,Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90095 USA.	ozlem.equils@cshs.org		Smith, Roger/0000-0003-4720-0280				Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Bartlett SR, 1999, J PHYSIOL-LONDON, V520, P399, DOI 10.1111/j.1469-7793.1999.00399.x; BERNARD A, 1988, ACTA PHYSIOL HUNG, V71, P507; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Chapman NR, 2004, J CLIN ENDOCR METAB, V89, P5683, DOI 10.1210/jc.2004-0873; Conneely OM, 2000, STEROIDS, V65, P571, DOI 10.1016/S0039-128X(00)00115-X; Erkinheimo TL, 2000, J CLIN ENDOCR METAB, V85, P3468, DOI 10.1210/jc.85.9.3468; Facchinetti F, 2008, AM J PERINAT, V25, P503, DOI 10.1055/s-0028-1085071; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; Giangrande PH, 2000, MOL CELL BIOL, V20, P3102, DOI 10.1128/MCB.20.9.3102-3115.2000; Gierse JK, 2005, J PHARMACOL EXP THER, V312, P1206, DOI 10.1124/jpet.104.076877; Groom KM, 2005, BJOG-INT J OBSTET GY, V112, P725, DOI 10.1111/j.1471-0528.2005.00539.x; Henderson D, 2001, AM J OBSTET GYNECOL, V185, P579, DOI 10.1067/mob.2001.116753; Hirsch E, 2006, AM J OBSTET GYNECOL, V194, P1334, DOI 10.1016/j.ajog.2005.11.004; Kalkhoven E, 1996, J BIOL CHEM, V271, P6217, DOI 10.1074/jbc.271.11.6217; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; Khan AH, 2008, FRONT BIOSCI-LANDMRK, V13, P5794; Lindstrom TM, 2005, REPRODUCTION, V130, P569, DOI 10.1530/rep.1.00197; Madsen G, 2004, J CLIN ENDOCR METAB, V89, P1010, DOI 10.1210/jc.2003-031037; Mesiano S, 2002, J CLIN ENDOCR METAB, V87, P2924, DOI 10.1210/jc.87.6.2924; Mesiano S, 2001, FRONT HORM RES, V27, P86; NORTON ME, 1993, NEW ENGL J MED, V329, P1602, DOI 10.1056/NEJM199311253292202; Olson DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1329, DOI 10.2741/2151; Ouellet M, 2001, P NATL ACAD SCI USA, V98, P14583, DOI 10.1073/pnas.251543298; Pieber D, 2001, EUR J PHARMACOL, V427, P7, DOI 10.1016/S0014-2999(01)01189-X; Pieber D, 2001, MOL HUM REPROD, V7, P875, DOI 10.1093/molehr/7.9.875; Raichur A, 2006, NEUROSCIENCE, V142, P859, DOI 10.1016/j.neuroscience.2006.06.052; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Russell RB, 2007, PEDIATRICS, V120, pE1, DOI 10.1542/peds.2006-2386; Sawdy R J, 2004, J Obstet Gynaecol, V24, P226; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; SPEROFF L, 1989, CLIN GYNECOLOGIC END, P317; Sung MH, 2004, MOL PHARMACOL, V66, P70, DOI 10.1124/mol.66.1.70; Thornton JG, 2007, NEW ENGL J MED, V357, P499, DOI 10.1056/NEJMe078097; TUNG L, 1993, MOL ENDOCRINOL, V7, P1256, DOI 10.1210/me.7.10.1256; van der Burg B, 1996, MOL HUM REPROD, V2, P433, DOI 10.1093/molehr/2.6.433; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; Wang H, 2003, BIOL REPROD, V69, P1957, DOI 10.1095/biolreprod.103.019620; Weiss G, 2000, J CLIN ENDOCR METAB, V85, P4421, DOI 10.1210/jc.85.12.4421; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356	41	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8502	10.1371/journal.pone.0008502	http://dx.doi.org/10.1371/journal.pone.0008502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111699	Green Submitted, Green Published, gold			2022-12-27	WOS:000274114800001
J	Einstein, F; Thompson, RF; Bhagat, TD; Fazzari, MJ; Verma, A; Barzilai, N; Greally, JM				Einstein, Francine; Thompson, Reid F.; Bhagat, Tushar D.; Fazzari, Melissa J.; Verma, Amit; Barzilai, Nir; Greally, John M.			Cytosine Methylation Dysregulation in Neonates Following Intrauterine Growth Restriction	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; DEVELOPMENTAL ORIGINS; DIABETES-MELLITUS; PRENATAL EXPOSURE; MASS-SPECTROMETRY; DNA METHYLATION; PREGNANT RATS; BIRTH-WEIGHT; LEADS	Background: Perturbations of the intrauterine environment can affect fetal development during critical periods of plasticity, and can increase susceptibility to a number of age-related diseases (e. g., type 2 diabetes mellitus; T2DM), manifesting as late as decades later. We hypothesized that this biological memory is mediated by permanent alterations of the epigenome in stem cell populations, and focused our studies specifically on DNA methylation in CD34+ hematopoietic stem and progenitor cells from cord blood from neonates with intrauterine growth restriction (IUGR) and control subjects. Methods and Findings: Our epigenomic assays utilized a two-stage design involving genome-wide discovery followed by quantitative, single-locus validation. We found that changes in cytosine methylation occur in response to IUGR of moderate degree and involving a restricted number of loci. We also identify specific loci that are targeted for dysregulation of DNA methylation, in particular the hepatocyte nuclear factor 4 alpha (HNF4A) gene, a well-known diabetes candidate gene not previously associated with growth restriction in utero, and other loci encoding HNF4A-interacting proteins. Conclusions: Our results give insights into the potential contribution of epigenomic dysregulation in mediating the long-term consequences of IUGR, and demonstrate the value of this approach to studies of the fetal origin of adult disease.	[Einstein, Francine] Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Thompson, Reid F.; Greally, John M.] Albert Einstein Coll Med, Dept Genet Computat Genet, Bronx, NY 10467 USA; [Bhagat, Tushar D.; Verma, Amit] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA; [Fazzari, Melissa J.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Barzilai, Nir; Greally, John M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Barzilai, Nir; Greally, John M.] Albert Einstein Coll Med, Ctr Epigen, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Einstein, F (corresponding author), Albert Einstein Coll Med, Dept Obstet Gynecol & Womens Hlth, Bronx, NY 10467 USA.	nir.barzilai@einstein.yu.edu; john.greally@einstein.yu.edu	Greally, John/AAF-9540-2019	Greally, John/0000-0001-6069-7960; Thompson, Reid/0000-0003-3661-5296; Fazzari, Melissa/0000-0002-5674-3589	American Association of Obstetricians & Gynecologists Foundation; National Institutes of Health [HG004401, HD044078, AG21654, AG18381]; Albert Einstein Diabetes Research and Training Center [DK 20541]; NIA; National Institutes of Health (NIH) MSTP [GM007288]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044078] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018381, R37AG018381, P01AG021654] Funding Source: NIH RePORTER	American Association of Obstetricians & Gynecologists Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Diabetes Research and Training Center; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH) MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding: This work is supported by a research training scholarship from American Association of Obstetricians & Gynecologists Foundation with the Society for Maternal-Fetal Medicine to F. E., grants from the National Institutes of Health to J.M.G. (HG004401, HD044078) and N.B. (AG21654 and AG18381) and by the Core laboratories of the Albert Einstein Diabetes Research and Training Center (DK 20541). R. F. T. was supported by a NIA T32 training grant, and by National Institutes of Health (NIH) MSTP Training Grant GM007288. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Baserga M, 2007, AM J PHYSIOL-REG I, V292, pR1943, DOI 10.1152/ajpregu.00558.2006; Bertram CE, 2001, BRIT MED BULL, V60, P103, DOI 10.1093/bmb/60.1.103; Boloker J, 2002, DIABETES, V51, P1499, DOI 10.2337/diabetes.51.5.1499; Couri CEB, 2009, JAMA-J AM MED ASSOC, V301, P1573, DOI 10.1001/jama.2009.470; DAHRI S, 1991, DIABETES, V40, P115, DOI 10.2337/diab.40.2.S115; Dennison EM, 2001, PAEDIATR PERINAT EP, V15, P211, DOI 10.1046/j.1365-3016.2001.00350.x; DUNCAN SA, 1994, P NATL ACAD SCI USA, V91, P7598, DOI 10.1073/pnas.91.16.7598; Egeland GM, 2000, BMJ-BRIT MED J, V321, P546, DOI 10.1136/bmj.321.7260.546; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gangenahalli GU, 2006, STEM CELLS DEV, V15, P305, DOI 10.1089/scd.2006.15.305; Glass JL, 2007, NUCLEIC ACIDS RES, V35, P6798, DOI 10.1093/nar/gkm489; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hombach-Klonisch S, 2008, J MOL MED, V86, P1301, DOI 10.1007/s00109-008-0383-6; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; MAGEE TR, 2008, AM J OBSTET GYNECOL, V271, pE271; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Navas TA, 2006, BLOOD, V108, P4170, DOI 10.1182/blood-2006-05-023093; Nyirenda MJ, 2006, DIABETOLOGIA, V49, P1412, DOI 10.1007/s00125-006-0188-5; ODA M, 2009, NUCL ACIDS RES; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ozanne SE, 1996, AM J PHYSIOL-ENDOC M, V271, pE1128, DOI 10.1152/ajpendo.1996.271.6.E1128; Ozanne SE, 2005, MECH AGEING DEV, V126, P852, DOI 10.1016/j.mad.2005.03.005; Ozanne SE, 2003, J ENDOCRINOL, V177, P235, DOI 10.1677/joe.0.1770235; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Pranke P, 2001, ACTA HAEMATOL-BASEL, V105, P71, DOI 10.1159/000046537; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rhee J, 2006, J BIOL CHEM, V281, P14683, DOI 10.1074/jbc.M512636200; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; Sekaric P, 2007, ONCOGENE, V26, P6261, DOI 10.1038/sj.onc.1210462; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Stoffers DA, 2003, DIABETES, V52, P734, DOI 10.2337/diabetes.52.3.734; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Vuguin P, 2004, DIABETES, V53, P2617, DOI 10.2337/diabetes.53.10.2617; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	60	107	115	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8887	10.1371/journal.pone.0008887	http://dx.doi.org/10.1371/journal.pone.0008887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126273	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500010
J	Zhang, Q; Chakravarty, S; Ghersi, D; Zeng, L; Plotnikov, AN; Sanchez, R; Zhou, MM				Zhang, Qiang; Chakravarty, Suvobrata; Ghersi, Dario; Zeng, Lei; Plotnikov, Alexander N.; Sanchez, Roberto; Zhou, Ming-Ming			Biochemical Profiling of Histone Binding Selectivity of the Yeast Bromodomain Family	PLOS ONE			English	Article							STRUCTURAL BASIS; LYSINE 9; CHROMATIN; RECOGNITION; ACETYLATION; COMPLEX; H3; ATPASE; FORMS; PCAF	Background: It has been shown that molecular interactions between site-specific chemical modifications such as acetylation and methylation on DNA-packing histones and conserved structural modules present in transcriptional proteins are closely associated with chromatin structural changes and gene activation. Unlike methyl-lysine that can interact with different protein modules including chromodomains, Tudor and MBT domains, as well as PHD fingers, acetyl-lysine (Kac) is known thus far to be recognized only by bromodomains. While histone lysine acetylation plays a crucial role in regulation of chromatin-mediated gene transcription, a high degree of sequence variation of the acetyl-lysine binding site in the bromodomains has limited our understanding of histone binding selectivity of the bromodomain family. Here, we report a systematic family-wide analysis of 14 yeast bromodomains binding to 32 lysine-acetylated peptides derived from known major acetylation sites in four core histones that are conserved in eukaryotes. Methodology: The histone binding selectivity of purified recombinant yeast bromodomains was assessed by using the native core histones in an overlay assay, as well as N-terminally biotinylated lysine-acetylated histone peptides spotted on streptavidin-coated nitrocellulose membrane in a dot blot assay. NMR binding analysis further validated the interactions between histones and selected bromodomain. Structural models of all yeast bromodomains were built using comparative modeling to provide insights into the molecular basis of their histone binding selectivity. Conclusions: Our study reveals that while not all members of the bromodomain family are privileged to interact with acetylated-lysine, identifiable sequence features from those that bind histone emerge. These include an asparagine residue at the C-terminus of the third helix in the 4-helix bundle, negatively charged residues around the ZA loop, and preponderance of aromatic amino acid residues in the binding pocket. Further, while bromodomains exhibit selectivity for different sites in histones, individual interactions are of modest affinity. Finally, electrostatic interactions appear to be a primary determining factor that guides productive association between a bromodomain and a lysine-acetylated histone.	[Zhang, Qiang; Chakravarty, Suvobrata; Ghersi, Dario; Zeng, Lei; Plotnikov, Alexander N.; Sanchez, Roberto; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Icahn School of Medicine at Mount Sinai	Zhang, Q (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA.	Ming-Ming.Zhou@mssm.edu	Ghersi, Dario/H-4468-2019; Ghersi, Dario/E-5875-2010		National Science Foundation [MCB0517352]; National Institutes of Health [HG004508, CA87658]; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by grants from the National Science Foundation (MCB0517352 to M.-M.Z. and R. S.) and the National Institutes of Health (HG004508 and CA87658 to M.-M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Du J, 1998, GENETICS, V150, P987; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Manning ET, 2001, MOL CELL BIOL, V21, P3876, DOI 10.1128/MCB.21.12.3876-3887.2001; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muchardt C, 1999, SEMIN CELL DEV BIOL, V10, P189, DOI 10.1006/scdb.1999.0300; Muchardt C, 1998, EMBO J, V17, P223, DOI 10.1093/emboj/17.1.223; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Syntichaki P, 2000, NATURE, V404, P414, DOI 10.1038/35006136; Travers A, 1999, CURR BIOL, V9, pR23, DOI 10.1016/S0960-9822(99)80037-2; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Yan KS, 2002, FEBS LETT, V513, P67, DOI 10.1016/S0014-5793(01)03305-1; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	39	29	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8903	10.1371/journal.pone.0008903	http://dx.doi.org/10.1371/journal.pone.0008903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126658	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896500022
J	Gamboa, D; Ho, MF; Bendezu, J; Torres, K; Chiodini, PL; Barnwell, JW; Incardona, S; Perkins, M; Bell, D; McCarthy, J; Cheng, Q				Gamboa, Dionicia; Ho, Mei-Fong; Bendezu, Jorge; Torres, Katherine; Chiodini, Peter L.; Barnwell, John W.; Incardona, Sandra; Perkins, Mark; Bell, David; McCarthy, James; Cheng, Qin			A Large Proportion of P. falciparum Isolates in the Amazon Region of Peru Lack pfhrp2 and pfhrp3: Implications for Malaria Rapid Diagnostic Tests	PLOS ONE			English	Article							HISTIDINE-RICH PROTEIN-2; PLASMODIUM-FALCIPARUM; EXPERT MICROSCOPY; PARASITES; PERFORMANCE; INFECTION; COMMUNITY; ACCURACY; DEVICES; ANTIGEN	Background: Malaria rapid diagnostic tests (RDTs) offer significant potential to improve the diagnosis of malaria, and are playing an increasing role in malaria case management, control and elimination. Peru, along with other South American countries, is moving to introduce malaria RDTs as components of malaria control programmes supported by the Global Fund for AIDS, TB and malaria. The selection of the most suitable malaria RDTs is critical to the success of the programmes. Methods: Eight of nine microscopy positive P. falciparum samples collected in Iquitos, Peru tested negative or weak positive using HRP2-detecting RDTs. These samples were tested for the presence of pfhrp2 and pfhrp3 and their flanking genes by PCR, as well as the presence of HRP proteins by ELISA. To investigate for geographic extent of HRP-deleted parasites and their temporal occurrence a retrospective study was undertaken on 148 microscopy positive P. falciparum samples collected in different areas of the Amazon region of Peru. Findings: Eight of the nine isolates lacked the pfhrp2 and/or pfhrp3 genes and one or both flanking genes, and the absence of HRP was confirmed by ELISA. The retrospective study showed that 61 (41%) and 103 (70%) of the 148 samples lacked the pfhrp2 or pfhrp3 genes respectively, with 32 (21.6%) samples lacking both hrp genes. Conclusions: This is the first documentation of P. falciparum field isolates lacking pfhrp2 and/or pfhrp3. The high frequency and wide distribution of different parasites lacking pfhrp2 and/or pfhrp3 in widely dispersed areas in the Peruvian Amazon implies that malaria RDTs targeting HRP2 will fail to detect a high proportion of P. falciparum in malaria-endemic areas of Peru and should not be used. RDTs detecting parasite LDH or aldolase and quality microscopy should be use for malaria diagnosis in this region. There is an urgent need for investigation of the abundance and geographic distribution of these parasites in Peru and neighbouring countries.	[Gamboa, Dionicia; Bendezu, Jorge; Torres, Katherine] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Fac Ciencias, Dept Bioquim Biol Mol & Farmacol, Lima, Peru; [Ho, Mei-Fong; McCarthy, James; Cheng, Qin] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Chiodini, Peter L.] Hosp Trop Dis, London NW1 0PE, England; [Barnwell, John W.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Incardona, Sandra; Perkins, Mark; Bell, David] FIND, Geneva, Switzerland; [Bell, David] WHO, Reg Off Western Pacific, Manila, Philippines; [McCarthy, James] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Ho, Mei-Fong; Cheng, Qin] Australian Army Malaria Inst, Brisbane, Qld, Australia	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; QIMR Berghofer Medical Research Institute; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; WHO Western Pacific Regional Office; World Health Organization; University of Queensland; QIMR Berghofer Medical Research Institute	Gamboa, D (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.	qin.cheng@defence.gov.au	Gamboa, Dionicia/CAF-2097-2022; McCarthy, James S/C-1681-2009; Bendezu, Jorge/L-6597-2019; Cheng, Qin/AAO-2198-2020	Gamboa, Dionicia/0000-0002-1420-7729; Bendezu, Jorge/0000-0001-7102-3144; Cheng, Qin/0000-0001-7776-4437; Torres, Katherine/0000-0003-0414-7547; Chiodini, Peter/0000-0003-0317-7090; Incardona, Sandra/0000-0003-4994-1736; McCarthy, James/0000-0001-6596-9718	AusAID; World Health Organisation (WHO)-Western Pacific Regional Office; WHO/TDR; Foundation for Innovative New Diagnostics (FIND); Directorate General for Development Cooperation (DGCD) of the Belgian Government [95501]; NIH/NIAID [RO1 AI067727-03]; UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme; NHMRC, Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067727] Funding Source: NIH RePORTER	AusAID(Australian Aid (AusAID)); World Health Organisation (WHO)-Western Pacific Regional Office(World Health Organization); WHO/TDR(World Health Organization); Foundation for Innovative New Diagnostics (FIND); Directorate General for Development Cooperation (DGCD) of the Belgian Government; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme; NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is partially funded by the AusAID, the World Health Organisation (WHO)-Western Pacific Regional Office, WHO/TDR and Foundation for Innovative New Diagnostics (FIND). The retrospective sample collection was financed by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 02, 2003-2007), project 95501. DG is supported by DGCD and NIH/NIAID (RO1 AI067727-03). PLC is supported by the UCL Hospitals Comprehensive Biomedical Research Centre Infection Theme and JMC is supported by the NHMRC, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, with the exception of WHO and FIND facilitating the sample collection and approving the publication of the findings.	[Anonymous], 2005, Rev. perú. med. exp. salud publica, V22, P241; [Anonymous], 2008, WORLD MAL REP 2008; ARROSPIDE N, 2001, REV PERU MED EXP SAL, V19, P76; Arróspide V Nancy, 2004, Rev. perú. med. exp. salud publica, V21, P76; Arrospide V Nancy, 2006, Rev. perú. med. exp. salud publica, V23, P81; Baker J, 2005, J INFECT DIS, V192, P870, DOI 10.1086/432010; BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Bechem NN, 1999, T ROY SOC TROP MED H, V93, P46, DOI 10.1016/S0035-9203(99)90175-X; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; Bellia PL, 2006, IEEE SECUR PRIV, V4, P20, DOI 10.1109/MSP.2006.80; BENDEZU J, 2008, EVALUACION CAMPO PRU; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Durand V Salomón, 2005, Rev. perú. med. exp. salud publica, V22, P47; Forney JR, 2003, J CLIN MICROBIOL, V41, P2358, DOI 10.1128/JCM.41.6.2358-2366.2003; Forney JR, 2001, J CLIN MICROBIOL, V39, P2884, DOI 10.1128/JCM.39.8.2884-2890.2001; Gaye O, 1998, PARASITE, V5, P189, DOI 10.1051/parasite/1998052189; Harvey SA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-160; HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269; Huong NM, 2002, TROP MED INT HEALTH, V7, P304, DOI 10.1046/j.1365-3156.2002.00869.x; Iqbal J, 2002, J CLIN MICROBIOL, V40, P4675, DOI 10.1128/JCM.40.12.4675-4678.2002; Jiang HY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-398; KEMP DJ, 1987, P NATL ACAD SCI USA, V84, P7672, DOI 10.1073/pnas.84.21.7672; Lee N, 2006, J CLIN MICROBIOL, V44, P2773, DOI 10.1128/JCM.02557-05; Llanos-Zavalaga Fernando, 2002, Rev. perú. med. exp. salud publica, V19, P39; Padley D, 2003, ANN TROP MED PARASIT, V97, P131, DOI 10.1179/000349803125002977; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Ranford-Cartwright LC, 1997, T ROY SOC TROP MED H, V91, P719, DOI 10.1016/S0035-9203(97)90539-3; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Rubio JM, 1999, AM J TROP MED HYG, V60, P183, DOI 10.4269/ajtmh.1999.60.183; Rubio JM, 2001, J CLIN MICROBIOL, V39, P2736, DOI 10.1128/JCM.39.7.2736-2737.2001; Singh N, 2000, ANN TROP MED PARASIT, V94, P421, DOI 10.1080/00034983.2000.11813560; Tarazona Alonso Soto, 2004, Braz J Infect Dis, V8, P151, DOI 10.1590/S1413-86702004000200005; Stow NW, 1999, T ROY SOC TROP MED H, V93, P519, DOI 10.1016/S0035-9203(99)90359-0; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Veron V, 2006, AM J TROP MED HYG, V74, P941, DOI 10.4269/ajtmh.2006.74.941; WELLEMS TE, 1986, P NATL ACAD SCI USA, V83, P6065, DOI 10.1073/pnas.83.16.6065; WELLEMS TE, 1988, REV BRAS GENET, V11, P813; *WHO REG OFF W PAC, 2008, METH MAN LAB QUAL CO; Wongsrichanalai C, 1999, ACTA TROP, V73, P263, DOI 10.1016/S0001-706X(99)00040-6; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; 2009, B EPIDEMIOLOGICO 200	42	289	297	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8091	10.1371/journal.pone.0008091	http://dx.doi.org/10.1371/journal.pone.0008091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111602	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896300001
J	Liu, SH; Ma, JF; Wang, W; Zhang, MX; Xin, QT; Peng, SM; Li, RX; Zhu, HZ				Liu, Shaohui; Ma, Jinfang; Wang, Wei; Zhang, Maoxiang; Xin, Qingting; Peng, Siman; Li, Rongxiu; Zhu, Huanzhang			Mutational Analysis of Highly Conserved Residues in the Phage PhiC31 Integrase Reveals Key Amino Acids Necessary for the DNA Recombination	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; NONVIRAL GENETIC CORRECTION; GAMMA-DELTA-RESOLVASE; C-TERMINAL DOMAIN; PHI-C31 INTEGRASE; GENOMIC INTEGRATION; CLOSTRIDIUM-PERFRINGENS; CENTRAL DINUCLEOTIDE; BXB1 INTEGRATION; SYNAPSIS	Background: Amino acid sequence alignment of phage phiC31 integrase with the serine recombinases family revealed highly conserved regions outside the catalytic domain. Until now, no system mutational or biochemical studies have been carried out to assess the roles of these conserved residues in the recombinaton of phiC31 integrase. Methodology/Principal Findings: To determine the functional roles of these conserved residues, a series of conserved residues were targeted by site-directed mutagenesis. Out of the 17 mutants, 11 mutants showed impaired or no recombination ability, as analyzed by recombination assay both in vivo and in vitro. Results of DNA binding activity assays showed that mutants (R18A, I141A, L143A, E153A, I432A and V571A) exhibited a great decrease in DNA binding affinity, and mutants (G182A/F183A, C374A, C376A/G377A, Y393A and V566A) had completely lost their ability to bind to the specific target DNA attB as compared with wild-type protein. Further analysis of mutants (R18A, I141A, L143A and E153A) synapse and cleavage showed that these mutants were blocked in recombination at the stage of strand cleavage. Conclusions/Significance: This data reveals that some of the highly conserved residues both in the N-terminus and C-terminus region of phiC31 integrase, play vital roles in the substrate binding and cleavage. The cysteine-rich motif and the C-tail val-rich region of phiC31 integrase may represent the major DNA binding domains of phiC31 integrase.	[Liu, Shaohui; Ma, Jinfang; Wang, Wei; Zhang, Maoxiang; Xin, Qingting; Peng, Siman; Zhu, Huanzhang] Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Li, Rongxiu] Shanghai Jiao Tong Univ, MOE Key Lab Microbial Metab, Shanghai 200030, Peoples R China; [Li, Rongxiu] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, SH (corresponding author), Fudan Univ, Inst Genet, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.	Hzzhu@fudan.edu.cn	Zhang, Maoxiang/G-1079-2015; Rong Xiu, Li/C-9683-2010	Zhang, Maoxiang/0000-0003-2790-0431; Rong Xiu, Li/0000-0002-7491-0854; wang, Wei/0000-0002-0600-7276	National Natural Science Funding of China [30671190, 3071120569]; National Grand Program on Key Infectious Disease [2008ZX10001-006]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); National Grand Program on Key Infectious Disease	This work is supported by National Natural Science Funding of China (No. 30671190 No. 3071120569), and National Grand Program on Key Infectious Disease (2008ZX10001-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2006, MOL MICROBIOL, V60, P591, DOI 10.1111/j.1365-2958.2006.05120.x; Adams V, 2004, MOL MICROBIOL, V53, P1195, DOI 10.1111/j.1365-2958.2004.04198.x; Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen JZ, 2006, NUCLEIC ACIDS RES, V34, P6298, DOI 10.1093/nar/gkl890; Crellin PK, 1997, J BACTERIOL, V179, P5148, DOI 10.1128/jb.179.16.5148-5156.1997; Fish MP, 2007, NAT PROTOC, V2, P2325, DOI 10.1038/nprot.2007.328; Ghosh P, 2005, J MOL BIOL, V349, P331, DOI 10.1016/j.jmb.2005.03.043; Ghosh P, 2003, MOL CELL, V12, P1101, DOI 10.1016/S1097-2765(03)00444-1; Grainge I, 2002, J MOL BIOL, V320, P515, DOI 10.1016/S0022-2836(02)00517-X; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Gupta M, 2007, NUCLEIC ACIDS RES, V35, P3407, DOI 10.1093/nar/gkm206; Haren L, 2000, J MOL BIOL, V296, P757, DOI 10.1006/jmbi.1999.3485; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Kamtekar S, 2006, P NATL ACAD SCI USA, V103, P10642, DOI 10.1073/pnas.0604062103; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Li WK, 2005, SCIENCE, V309, P1210, DOI 10.1126/science.1112064; Lucet IS, 2005, J BIOL CHEM, V280, P2503, DOI 10.1074/jbc.M409702200; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McEwan AR, 2009, NUCLEIC ACIDS RES, V37, P4764, DOI 10.1093/nar/gkp485; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ortiz-Urda S, 2003, HUM GENE THER, V14, P923, DOI 10.1089/104303403765701204; Rowley PA, 2008, J BACTERIOL, V190, P6918, DOI 10.1128/JB.00612-08; Rowley PA, 2008, NUCLEIC ACIDS RES, V36, P3879, DOI 10.1093/nar/gkn269; Sclimenti CR, 2001, NUCLEIC ACIDS RES, V29, P5044, DOI 10.1093/nar/29.24.5044; Smith MCA, 2004, NUCLEIC ACIDS RES, V32, P2607, DOI 10.1093/nar/gkh538; Smith MCA, 2004, MOL MICROBIOL, V51, P1719, DOI 10.1111/j.1365-2958.2003.03942.x; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; STARK WM, 1991, EMBO J, V10, P3541, DOI 10.1002/j.1460-2075.1991.tb04918.x; Thomason LC, 2001, MOL GENET GENOMICS, V265, P1031, DOI 10.1007/s004380100498; Thorpe HM, 2000, MOL MICROBIOL, V38, P232, DOI 10.1046/j.1365-2958.2000.02142.x; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Tiana G, 2004, P NATL ACAD SCI USA, V101, P2846, DOI 10.1073/pnas.0306638101; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verkhivker GM, 2006, BIOINFORMATICS, V22, P1846, DOI 10.1093/bioinformatics/btl199; Wang HM, 2000, J BACTERIOL, V182, P6577, DOI 10.1128/JB.182.23.6577-6583.2000	48	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8863	10.1371/journal.pone.0008863	http://dx.doi.org/10.1371/journal.pone.0008863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111606	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300013
J	Keller, MJ; Mesquita, PMM; Torres, NM; Cho, S; Shust, G; Madan, RP; Cohen, HW; Petrie, J; Ford, T; Soto-Torres, L; Profy, AT; Herold, BC				Keller, Marla J.; Mesquita, Pedro M. M.; Torres, N. Merna; Cho, Sylvia; Shust, Gail; Madan, Rebecca P.; Cohen, Hillel W.; Petrie, Julie; Ford, Tara; Soto-Torres, Lydia; Profy, Albert T.; Herold, Betsy C.			Postcoital Bioavailability and Antiviral Activity of 0.5% PRO 2000 Gel: Implications for Future Microbicide Clinical Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; HIV-INFECTION; CELLULOSE SULFATE; TOPICAL MICROBICIDES; SEMINAL PLASMA; VAGINAL GEL; HERPES; TRANSMISSION; CELL	Background: The pharmacokinetics and pharmacodynamics of vaginal microbicides are typically assessed among sexually abstinent women. However, the physical act of sex may modulate gel distribution, and preclinical studies demonstrate seminal plasma interferes with the antiviral activity of several microbicides. This study compared the biological activity and concentration of PRO 2000 in cervicovaginal lavage (CVL) collected in the absence or following coitus. Methods: CVL samples were collected from ten heterosexual couples at baseline, after sex, after a single dose of 0.5% PRO 2000 gel and sex, and after gel application without sex. The impact of CVL on HIV-1 infection of TZM-bl cells and HSV-2 infection of CaSki cells was monitored by luciferase and plaque assay, respectively. PRO 2000 concentrations were measured by fluorescence. Results: CVL collected after PRO 2000 application significantly inhibited HIV-1 and HSV-2 (p = 0.01). However, the antiviral activity was reduced following sex and no significant protective effect was observed in postcoital CVL obtained in the presence compared to the absence of PRO 2000 for HIV (p = 0.45) or HSV-2 (p = 0.56). Less PRO 2000 was recovered in postcoital CVL, which, in conjunction with interference by seminal plasma, may have contributed to lower antiviral activity. Conclusions: Postcoital responses to PRO 2000 differ from precoital measures and the results obtained may provide insights into the clinical trial findings in which there was no significant protection against HIV-1 or HSV-2. Postcoital studies should be incorporated into clinical studies before embarking on large-scale efficacy trials.	[Keller, Marla J.; Petrie, Julie; Ford, Tara] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Keller, Marla J.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Mesquita, Pedro M. M.; Torres, N. Merna; Cho, Sylvia; Shust, Gail; Madan, Rebecca P.; Herold, Betsy C.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10467 USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Herold, Betsy C.] Albert Einstein Coll Med, Dept & Microbiol & Immunol, Bronx, NY 10467 USA; [Soto-Torres, Lydia] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Profy, Albert T.] Endo Pharmaceut, Chadds Ford, PA USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Endo Pharmaceuticals Inc.	Keller, MJ (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	betsy.herold@einstein.yu.edu		Mesquita, Pedro/0000-0002-6591-4896; Herold, Betsy/0000-0001-9974-0786; Cohen, Hillel/0000-0002-4524-0898	National Institutes of Health [AI077549, AI065309, UL1RR025750]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077549, R01AI065309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI077549, AI065309 and UL1RR025750). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Indevus Pharmaceuticals (now Endo) provided PRO 2000 gel and is the employer of one of the co-authors, Al Profy. Their involvement does not alter our adherence to all the PLoS ONE policies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheshenko N, 2004, ANTIMICROB AGENTS CH, V48, P2025, DOI 10.1128/AAC.48.6.2025-2036.2004; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Herold BC, 1997, ANTIMICROB AGENTS CH, V41, P2776, DOI 10.1128/AAC.41.12.2776; Huskens D, 2009, ANTIVIR RES, V84, P38, DOI 10.1016/j.antiviral.2009.07.013; John M, 2005, J INFECT DIS, V192, P1731, DOI 10.1086/497168; Karim SA, 2009, 16 C RETR OPP INF MO; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; Keller MJ, 2006, J INFECT DIS, V193, P27, DOI 10.1086/498533; Lackman-Smith C, 2008, ANTIMICROB AGENTS CH, V52, P1768, DOI 10.1128/AAC.01328-07; Mesquita PMM, 2008, J VIROL, V82, P6576, DOI 10.1128/JVI.00335-08; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Microbicides Development Programme, 2009, HIV PREV GEL PRO 200; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Neurath AR, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-150; Patel S, 2007, J INFECT DIS, V196, P1394, DOI 10.1086/522606; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; SHUST G, 2009, AM J REPROD IMM 1215; Tao W, 2008, AIDS RES HUM RETROV, V24, P925, DOI 10.1089/aid.2008.0043; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; ZHU TF, 1993, SCIENCE, V261, P1179, DOI 10.1126/science.8356453	23	59	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8781	10.1371/journal.pone.0008781	http://dx.doi.org/10.1371/journal.pone.0008781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107502	gold, Green Submitted, Green Published			2022-12-27	WOS:000273896100004
J	Mishchenko, Y				Mishchenko, Yuriy			On Optical Detection of Densely Labeled Synapses in Neuropil and Mapping Connectivity with Combinatorially Multiplexed Fluorescent Synaptic Markers	PLOS ONE			English	Article							SEMIAUTOMATED RECONSTRUCTION; CIRCUIT RECONSTRUCTION; POSTSYNAPTIC DENSITY; ELECTRON-MICROSCOPY; DENDRITIC SPINES; ULTRASTRUCTURE; VOLUME	We propose a new method for mapping neural connectivity optically, by utilizing Cre/Lox system Brainbow to tag synapses of different neurons with random mixtures of different fluorophores, such as GFP, YFP, etc., and then detecting patterns of fluorophores at different synapses using light microscopy (LM). Such patterns will immediately report the pre- and postsynaptic cells at each synaptic connection, without tracing neural projections from individual synapses to corresponding cell bodies. We simulate fluorescence from a population of densely labeled synapses in a block of hippocampal neuropil, completely reconstructed from electron microscopy data, and show that high-end LM is able to detect such patterns with over 95% accuracy. We conclude, therefore, that with the described approach neural connectivity in macroscopically large neural circuits can be mapped with great accuracy, in scalable manner, using fast optical tools, and straightforward image processing. Relying on an electron microscopy dataset, we also derive and explicitly enumerate the conditions that should be met to allow synaptic connectivity studies with high-resolution optical tools.	[Mishchenko, Yuriy] Columbia Univ, Dept Stat, New York, NY 10027 USA; [Mishchenko, Yuriy] Columbia Univ, Ctr Theoret Neurosci, New York, NY USA	Columbia University; Columbia University	Mishchenko, Y (corresponding author), Columbia Univ, Dept Stat, New York, NY 10027 USA.	yuriy.mishchenko@gmail.com			Columbia University	Columbia University	The author has no support or funding to report. The study was not specifically financially supported by Columbia University. Nonetheless, the study was performed while the author was an employee at Columbia University.	Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOHLAND J, 2009, PROPOSAL COORDINATED; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Broome BM, 2006, NEURON, V51, P467, DOI 10.1016/j.neuron.2006.07.018; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Dunn NA, 2004, J COMPUT NEUROSCI, V17, P137, DOI 10.1023/B:JCNS.0000037679.42570.d5; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fiala JC, 2003, J COMP NEUROL, V465, P90, DOI 10.1002/cne.10825; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; GUSTAFSSON MGL, 2005, NONLINEAR STRUCTURED, P13081; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HELMSTAEDTER M, 2009, CURRENT OPINIONS NEU; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jones LM, 2007, P NATL ACAD SCI USA, V104, P18772, DOI 10.1073/pnas.0705546104; JURRUS E, 2006, AXON TRACKING SERIAL; Kubitscheck U, 2000, BIOPHYS J, V78, P2170, DOI 10.1016/S0006-3495(00)76764-6; LICHTMAN JW, 2008, NATURE REV NEUROSCIE; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lu J, 2009, PLOS BIOL, V7, P996, DOI 10.1371/journal.pbio.1000108; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005655; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; MISHCHENKO Y, 2009, STRATEGIES IDENTIFYI; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Smith SJ, 2007, CURR OPIN NEUROBIOL, V17, P601, DOI 10.1016/j.conb.2007.11.004; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; SVOBODA K, COMMUNICATION; Wang S, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P1; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	40	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8853	10.1371/journal.pone.0008853	http://dx.doi.org/10.1371/journal.pone.0008853			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107507	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896100017
J	Karbassi, F; Quiros, V; Pancholi, V; Kornblatt, MJ				Karbassi, Farhad; Quiros, Veronica; Pancholi, Vijay; Kornblatt, Mary J.			Dissociation of the Octameric Enolase from S. Pyogenes - One Interface Stabilizes Another	PLOS ONE			English	Article							MITOCHONDRIAL CREATINE-KINASE; STREPTOCOCCAL SURFACE ENOLASE; TRYPANOSOMA-BRUCEI ENOLASE; YEAST ENOLASE; CRYSTAL-STRUCTURE; ALPHA-ENOLASE; PLASMINOGEN-BINDING; ACTIVE MONOMERS; FORMIMINOTRANSFERASE-CYCLODEAMINASE; CELL-SURFACE	Most enolases are homodimers. There are a few that are octamers, with the eight subunits arranged as a tetramer of dimers. These dimers have the same basic fold and same subunit interactions as are found in the dimeric enolases. The dissociation of the octameric enolase from S. pyogenes was examined, using NaClO4, a weak chaotrope, to perturb the quaternary structure. Dissociation was monitored by sedimentation velocity. NaClO4 dissociated the octamer into inactive monomers. There was no indication that dissociation of the octamer into monomers proceeded via formation of significant amounts of dimer or any other intermediate species. Two mutations at the dimer-dimer interface, F137L and E363G, were introduced in order to destabilize the octameric structure. The double mutant was more easily dissociated than was the wild type. Dissociation could also be produced by other salts, including tetramethylammonium chloride (TMACl) or by increasing pH. In all cases, no significant amounts of dimers or other intermediates were formed. Weakening one interface in this protein weakened the other interface as well. Although enolases from most organisms are dimers, the dimeric form of the S. pyogenes enzyme appears to be unstable.	[Karbassi, Farhad; Quiros, Veronica; Kornblatt, Mary J.] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H3G 1M8, Canada; [Pancholi, Vijay] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA	Concordia University - Canada; Ohio State University	Kornblatt, MJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.	judithk@alcor.concordia.ca	Pancholi, Vijay/E-3810-2011		Natural Sciences and Engineering Research Council of Canada [RGPIN 451-02]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada (www.nserc.crsng.gc.ca), grant RGPIN 451-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrell J, 2009, BIOCHEMISTRY-US, V48, P3915, DOI 10.1021/bi900075d; Bergmann S, 2001, MOL MICROBIOL, V40, P1273, DOI 10.1046/j.1365-2958.2001.02448.x; BREWER JM, 1995, PHYS ASPECTS PROTEIN, P57; Brown CK, 1998, J PROTEIN CHEM, V17, P855, DOI 10.1023/A:1020790604887; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Chai GQ, 2004, J MOL BIOL, V341, P1015, DOI 10.1016/j.jmb.2004.05.068; Cork AJ, 2009, J BIOL CHEM, V284, P17129, DOI 10.1074/jbc.M109.004317; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; DUQUERROY S, 1995, BIOCHEMISTRY-US, V34, P12513, DOI 10.1021/bi00039a005; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; FINDLAY WA, 1987, BIOCHEMISTRY-US, V26, P1948, DOI 10.1021/bi00381a024; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; Giotto MTD, 2003, J MOL BIOL, V331, P653, DOI 10.1016/S0022-2836(03)00752-6; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; GROSS M, 1993, BIOCHEMISTRY-US, V32, P13933, DOI 10.1021/bi00213a024; HOLLEMAN WH, 1973, BIOCHIM BIOPHYS ACTA, V327, P176, DOI 10.1016/0005-2744(73)90115-0; KERESZTESNAGY S, 1971, BIOCHEMISTRY-US, V10, P2506, DOI 10.1021/bi00789a013; KORNBLATT MJ, 1990, ARCH BIOCHEM BIOPHYS, V277, P301, DOI 10.1016/0003-9861(90)90583-K; Kornblatt MJ, 1998, EUR J BIOCHEM, V251, P775, DOI 10.1046/j.1432-1327.1998.2510775.x; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Mao YX, 2004, EMBO J, V23, P2963, DOI 10.1038/sj.emboj.7600327; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Navarro MVDS, 2007, FEBS J, V274, P5077, DOI 10.1111/j.1742-4658.2007.06027.x; Pace C. N., 1997, PROTEIN STRUCTURE PR, P253; Pal-Bhowmick I, 2007, FEBS J, V274, P1932, DOI 10.1111/j.1742-4658.2007.05738.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pandey AK, 2009, MOL GENET GENOMICS, V281, P135, DOI 10.1007/s00438-008-0397-3; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHURIG H, 1995, PROTEIN SCI, V4, P228; Sims PA, 2005, J MOL CATAL B-ENZYM, V32, P77, DOI 10.1016/j.molcatb.2004.10.002; STEC B, 1990, J MOL BIOL, V211, P235, DOI 10.1016/0022-2836(90)90023-F; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; VERONESE FM, 1984, INT J PEPT PROT RES, V24, P557; WHITE MF, 1993, BIOCHEM J, V295, P743, DOI 10.1042/bj2950743; Zhao SP, 2008, FEBS J, V275, P97, DOI 10.1111/j.1742-4658.2007.06177.x	36	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8810	10.1371/journal.pone.0008810	http://dx.doi.org/10.1371/journal.pone.0008810			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098674	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100004
J	Corti, D; Langedijk, JPM; Hinz, A; Seaman, MS; Vanzetta, F; Fernandez-Rodriguez, BM; Silacci, C; Pinna, D; Jarrossay, D; Balla-Jhagjhoorsingh, S; Willems, B; Zekveld, MJ; Dreja, H; O'Sullivan, E; Pade, C; Orkin, C; Jeffs, SA; Montefiori, DC; Davis, D; Weissenhorn, W; McKnight, A; Heeney, JL; Sallusto, F; Sattentau, QJ; Weiss, RA; Lanzavecchia, A				Corti, Davide; Langedijk, Johannes P. M.; Hinz, Andreas; Seaman, Michael S.; Vanzetta, Fabrizia; Fernandez-Rodriguez, Blanca M.; Silacci, Chiara; Pinna, Debora; Jarrossay, David; Balla-Jhagjhoorsingh, Sunita; Willems, Betty; Zekveld, Maria J.; Dreja, Hanna; O'Sullivan, Eithne; Pade, Corinna; Orkin, Chloe; Jeffs, Simon A.; Montefiori, David C.; Davis, David; Weissenhorn, Winfried; McKnight, Aine; Heeney, Jonathan L.; Sallusto, Federica; Sattentau, Quentin J.; Weiss, Robin A.; Lanzavecchia, Antonio			Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL REGION; TYPE-1 INFECTION; SUBTYPE-B; ENVELOPE GLYCOPROTEIN; HIV-1 NEUTRALIZATION; PASSIVE TRANSFER; BINDING-SITE; ENV CLONES; IN-VITRO	Background: The isolation of human monoclonal antibodies (mAbs) that neutralize a broad spectrum of primary HIV-1 isolates and the characterization of the human neutralizing antibody B cell response to HIV-1 infection are important goals that are central to the design of an effective antibody-based vaccine. Methods and Findings: We immortalized IgG(+) memory B cells from individuals infected with diverse clades of HIV-1 and selected on the basis of plasma neutralization profiles that were cross-clade and relatively potent. Culture supernatants were screened using various recombinant forms of the envelope glycoproteins (Env) in multiple parallel assays. We isolated 58 mAbs that were mapped to different Env surfaces, most of which showed neutralizing activity. One mAb in particular (HJ16) specific for a novel epitope proximal to the CD4 binding site on gp120 selectively neutralized a multi-clade panel of Tier-2 HIV-1 pseudoviruses, and demonstrated reactivity that was comparable in breadth, but distinct in neutralization specificity, to that of the other CD4 binding site-specific neutralizing mAb b12. A second mAb (HGN194) bound a conserved epitope in the V3 crown and neutralized all Tier-1 and a proportion of Tier-2 pseudoviruses tested, irrespective of clade. A third mAb (HK20) with broad neutralizing activity, particularly as a Fab fragment, recognized a highly conserved epitope in the HR-1 region of gp41, but showed striking assay-dependent selectivity in its activity. Conclusions: This study reveals that by using appropriate screening methods, a large proportion of memory B cells can be isolated that produce mAbs with HIV-1 neutralizing activity. Three of these mAbs show unusual breadth of neutralization and therefore add to the current panel of HIV-1 neutralizing antibodies with potential for passive protection and template-based vaccine design.	[Corti, Davide; Vanzetta, Fabrizia; Fernandez-Rodriguez, Blanca M.; Silacci, Chiara; Pinna, Debora; Jarrossay, David; Sallusto, Federica; Lanzavecchia, Antonio] Biomed Res Inst, Bellinzona, Switzerland; [Langedijk, Johannes P. M.; Zekveld, Maria J.] Pepscan Therapeut BV, Lelystad, Netherlands; [Hinz, Andreas; Weissenhorn, Winfried] UJF, EMBL, CNRS, Unit Virus Host Cell Interact,UMI 3265, Grenoble, France; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Balla-Jhagjhoorsingh, Sunita; Willems, Betty] Inst Trop Med, B-2000 Antwerp, Belgium; [Dreja, Hanna; O'Sullivan, Eithne; Pade, Corinna; McKnight, Aine] Queen Mary Univ, London, England; [Orkin, Chloe] Barts & London NHS Trust, London, England; [Jeffs, Simon A.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, Wright Fleming Inst, Fac Med, London, England; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Davis, David] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Sattentau, Quentin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Weiss, Robin A.] UCL, Div Infect & Immun, London, England	Universita della Svizzera Italiana; Pepscan Therapeutics B.V.; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Harvard University; Beth Israel Deaconess Medical Center; Institute of Tropical Medicine (ITM); University of London; Queen Mary University London; Barts Health NHS Trust; Imperial College London; Duke University; University of Cambridge; University of Oxford; University of London; University College London	Corti, D (corresponding author), Biomed Res Inst, Bellinzona, Switzerland.	R.Weiss@ucl.ac.uk; Lanzavecchia@irb.unisi.ch		Pade, Corinna/0000-0003-0626-2346; Zatta, Fabrizia/0000-0003-4945-8058; McKnight, Aine/0000-0002-8113-817X; Heeney, Jonathan/0000-0003-2702-1621	Bill and Melinda Gates Foundation; Medical Research Council [G0000635, G117/547] Funding Source: researchfish; MRC [G0000635, G117/547] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was conducted as part of the Collaboration for AIDS Vaccine Discovery funded by the Bill and Melinda Gates Foundation. QJS is a Jenner Vaccine Institute Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2000, MOL CELL BIOCHEM, V206, P1, DOI 10.1023/A:1007007626813; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Brandt SM, 2002, J BIOL CHEM, V277, P17291, DOI 10.1074/jbc.M108232200; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; CONLEY AJ, 1994, J VIROL, V68, P6994, DOI 10.1128/JVI.68.11.6994-7000.1994; Davis D, 2006, J MED VIROL, V78, P864, DOI 10.1002/jmv.20635; Fenyo EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004505; Ferrantelli F, 2004, J INFECT DIS, V189, P2167, DOI 10.1086/420833; Gorny MK, 2006, J VIROL, V80, P6865, DOI 10.1128/JVI.02202-05; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Jeffs SA, 2004, VACCINE, V22, P1032, DOI 10.1016/j.vaccine.2003.08.042; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kunert R, 1998, AIDS RES HUM RETROV, V14, P1115, DOI 10.1089/aid.1998.14.1115; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Langedijk JPM, 1997, J VIROL, V71, P4055, DOI 10.1128/JVI.71.5.4055-4061.1997; Larcher C, 1990, FEMS Microbiol Immunol, V2, P103; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; MADDON PJ, 1988, CELL, V54, P865, DOI 10.1016/S0092-8674(88)91241-X; MANN AM, 2009, AIDS; Manrique A, 2007, J VIROL, V81, P8793, DOI 10.1128/JVI.00598-07; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; MONTEFIORI D, 2004, CURRENT PROTOCOLS IM; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Reeves JD, 2002, P NATL ACAD SCI USA, V99, P16249, DOI 10.1073/pnas.252469399; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Robertson MJ, 2000, CELL IMMUNOL, V199, P8, DOI 10.1006/cimm.1999.1601; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Stewart KD, 2007, J COMPUT AID MOL DES, V21, P121, DOI 10.1007/s10822-007-9107-1; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2009, SCIENCE; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wu XL, 2008, VIROLOGY, V380, P285, DOI 10.1016/j.virol.2008.07.007; Zhang MY, 2004, J VIROL, V78, P9233, DOI 10.1128/JVI.78.17.9233-9242.2004; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	71	360	383	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8805	10.1371/journal.pone.0008805	http://dx.doi.org/10.1371/journal.pone.0008805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098712	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000031
J	Ott, PA; Hamilton, A; Jones, A; Haas, N; Shore, T; Liddell, S; Christos, PJ; Doyle, LA; Millward, M; Muggia, FM; Pavlick, AC				Ott, Patrick A.; Hamilton, Anne; Jones, Amanda; Haas, Naomi; Shore, Tsiporah; Liddell, Sandra; Christos, Paul J.; Doyle, L. Austin; Millward, Michael; Muggia, Franco M.; Pavlick, Anna C.			A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma	PLOS ONE			English	Article							ADVANCED MALIGNANT-MELANOMA; COOPERATIVE-ONCOLOGY-GROUP; DOCETAXEL TAXOTERE; PROSTATE-CANCER; CLINICAL-TRIALS; SOLID TUMORS; CHEMOTHERAPY; ANTHRACYCLINE; PACLITAXEL; TAXANE	Background: Ixabepilone (BMS-247550), an epothilone B analog, is a microtubule stabilizing agent which has shown activity in several different tumor types and preclinical models in melanoma. In an open label, one-arm, multi-center phase II trial the efficacy and toxicity of this epothilone was investigated in two different cohorts: chemotherapy-naive ( previously untreated) and previously treated patients with metastatic melanoma. Methodology/Principal Findings: Eligible patients had histologically-confirmed stage IV melanoma, with an ECOG performance status of 0 to 2. Ixabepilone was administered at a dose of 20 mg/m(2) on days 1, 8, and 15 during each 28-day cycle. The primary endpoint was response rate (RR); secondary endpoints were time to progression (TTP) and toxicity. Twenty-four patients were enrolled and 23 were evaluable for response. Initial serum lactate dehydrogenase (LDH) levels were elevated in 6/11 (55%) of the previously treated and in 5/13 (38%) of the previously untreated patients. No complete or partial responses were seen in either cohort. One patient in the previously treated group developed neutropenia and fatal septic shock. Seventeen patients (8 in the previously untreated group and 9 in the previously treated group) progressed after 2 cycles, whereas six patients (3 in each group) had stable disease after 2-6 cycles. Median TTP was 1.74 months in the previously untreated group (95% CI = 1.51 months, upper limit not estimated) and 1.54 months in the previously treated group (95% CI = 1.15 months, 2.72 months). Grade 3 and/or 4 toxicities occurred in 5/11 (45%) of previously untreated and in 5/13 (38%) of previously treated patients and included neutropenia, peripheral neuropathy, fatigue, diarrhea, and dyspnea. Conclusions/Significance: Ixabepilone has no meaningful activity in either chemotherapy-naive (previously untreated) or previously treated patients with metastatic melanoma. Further investigation with ixabepilone as single agent in the treatment of melanoma is not warranted.	[Ott, Patrick A.; Jones, Amanda; Muggia, Franco M.; Pavlick, Anna C.] NYU, Inst Canc, Dept Med Oncol, New York, NY 10012 USA; [Hamilton, Anne; Liddell, Sandra] Royal Prince Alfred Hosp, Sydney Canc Ctr, Sydney, NSW, Australia; [Hamilton, Anne] Sydney Melanoma Unit, Sydney, NSW, Australia; [Hamilton, Anne] Univ Sydney, Sydney, NSW 2006, Australia; [Haas, Naomi] Univ Penn, Abramson Canc Ctr, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Shore, Tsiporah] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY USA; [Shore, Tsiporah] New York Presbyterian Hosp, New York, NY USA; [Christos, Paul J.] Weill Cornell Med Coll, Div Biostat & Epidemiol, New York, NY USA; [Doyle, L. Austin] NCI, Invest Drug Branch, Bethesda, MD 20892 USA; [Millward, Michael] Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia; [Millward, Michael] Univ Western Australia, Perth, WA 6009, Australia	New York University; University of Sydney; Melanoma Institute Australia; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Cornell University; NewYork-Presbyterian Hospital; Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Western Australia	Ott, PA (corresponding author), NYU, Inst Canc, Dept Med Oncol, New York, NY 10012 USA.	anna.pavlick@nyumc.org	Shore, Tsiporah/K-3819-2019; Millward, Michael/H-5456-2014	Shore, Tsiporah/0000-0001-6033-0747; Muggia, Franco/0000-0003-0703-9146	United States Department of Health and Human Service [N01-CM-62204]; United States National Institutes of Health [1U01 CA76642]; NATIONAL CANCER INSTITUTE [U01CA076642] Funding Source: NIH RePORTER	United States Department of Health and Human Service; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the United States Department of Health and Human Service contract N01-CM-62204 (P.I. Joseph A. Sparano, MD) and United States National Institutes of Health grant 1U01 CA76642 (P.I. Franco Muggia, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMDAL S, 1994, EUR J CANCER, V30A, P1061, DOI 10.1016/0959-8049(94)90456-1; Ajani JA, 2006, INVEST NEW DRUG, V24, P441, DOI 10.1007/s10637-006-7304-8; Altmann KH, 2000, BBA-REV CANCER, V1470, pM79, DOI 10.1016/S0304-419X(00)00009-3; Awada A, 2009, CANCER CHEMOTH PHARM, V63, P417, DOI 10.1007/s00280-008-0751-5; Azzabi A, 2005, BRIT J CANCER, V92, P1006, DOI 10.1038/sj.bjc.6602438; Baselga J, 2009, J CLIN ONCOL, V27, P526, DOI 10.1200/JCO.2007.14.2646; Bedikian AY, 2004, MELANOMA RES, V14, P63, DOI 10.1097/01.cmr.0000114661.02608.7e; BEDIKIAN AY, 1995, J CLIN ONCOL, V13, P2895, DOI 10.1200/JCO.1995.13.12.2895; Burtness BA, 2008, ANN ONCOL, V19, P977, DOI 10.1093/annonc/mdm591; Chou TC, 2008, P NATL ACAD SCI USA, V105, P13157, DOI 10.1073/pnas.0804773105; Dreicer R, 2007, CANCER-AM CANCER SOC, V110, P759, DOI 10.1002/cncr.22839; EINZIG AI, 1991, INVEST NEW DRUG, V9, P59; Einzig AI, 1996, MED ONCOL, V13, P111, DOI 10.1007/BF02993861; Eng C, 2004, ANN ONCOL, V15, P928, DOI 10.1093/annonc/mdh236; ENSIGN LG, 1994, STAT MED, V13, P1727, DOI 10.1002/sim.4780131704; Ferretti S, 2005, CLIN CANCER RES, V11, P7773, DOI 10.1158/1078-0432.CCR-05-1165; Galsky MD, 2005, J CLIN ONCOL, V23, P1439, DOI 10.1200/JCO.2005.09.042; Goel S, 2008, ANN ONCOL, V19, P2048, DOI 10.1093/annonc/mdn420; Gogas H, 2004, MELANOMA RES, V14, P415, DOI 10.1097/00008390-200410000-00013; HOFFMANN J, 2008, NEURO ONCOL; Hussain M, 2005, J CLIN ONCOL, V23, P8724, DOI 10.1200/JCO.2005.02.4448; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; LEGHA SS, 1990, CANCER, V65, P2478, DOI 10.1002/1097-0142(19900601)65:11<2478::AID-CNCR2820651114>3.0.CO;2-S; Perez EA, 2007, J CLIN ONCOL, V25, P3407, DOI 10.1200/JCO.2006.09.3849; Posadas EM, 2007, CANCER BIOL THER, V6, P490, DOI 10.4161/cbt.6.4.3831; Roche H, 2007, J CLIN ONCOL, V25, P3415, DOI 10.1200/JCO.2006.09.7535; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Thomas ES, 2007, J CLIN ONCOL, V25, P5210, DOI 10.1200/JCO.2007.12.6557; Vansteenkiste J, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.09.7097	29	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8714	10.1371/journal.pone.0008714	http://dx.doi.org/10.1371/journal.pone.0008714			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098694	gold, Green Submitted, Green Published			2022-12-27	WOS:000273779000006
J	Pan-Montojo, F; Anichtchik, O; Dening, Y; Knels, L; Pursche, S; Jung, R; Jackson, S; Gille, G; Spillantini, MG; Reichmann, H; Funk, RHW				Pan-Montojo, Francisco; Anichtchik, Oleg; Dening, Yanina; Knels, Lilla; Pursche, Stefan; Jung, Roland; Jackson, Sandra; Gille, Gabriele; Spillantini, Maria Grazia; Reichmann, Heinz; Funk, Richard H. W.			Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; SUBSTANTIA-NIGRA; NEURONS; EXPOSURE; MODEL; GENE; NEURODEGENERATION; NEUROPATHOLOGY; DYSFUNCTION; MECHANISMS	In patients with Parkinson's disease (PD), the associated pathology follows a characteristic pattern involving inter alia the enteric nervous system (ENS), the dorsal motor nucleus of the vagus (DMV), the intermediolateral nucleus of the spinal cord and the substantia nigra, providing the basis for the neuropathological staging of the disease. Here we report that intragastrically administered rotenone, a commonly used pesticide that inhibits Complex I of the mitochondrial respiratory chain, is able to reproduce PD pathological staging as found in patients. Our results show that low doses of chronically and intragastrically administered rotenone induce alpha-synuclein accumulation in all the above-mentioned nervous system structures of wild-type mice. Moreover, we also observed inflammation and alpha-synuclein phosphorylation in the ENS and DMV. HPLC analysis showed no rotenone levels in the systemic blood or the central nervous system (detection limit [rotenone]<20 nM) and mitochondrial Complex I measurements showed no systemic Complex I inhibition after 1.5 months of treatment. These alterations are sequential, appearing only in synaptically connected nervous structures, treatment time-dependent and accompanied by inflammatory signs and motor dysfunctions. These results strongly suggest that the local effect of pesticides on the ENS might be sufficient to induce PD-like progression and to reproduce the neuroanatomical and neurochemical features of PD staging. It provides new insight into how environmental factors could trigger PD and suggests a transsynaptic mechanism by which PD might spread throughout the central nervous system.	[Pan-Montojo, Francisco; Dening, Yanina; Knels, Lilla; Funk, Richard H. W.] Tech Univ Dresden, Inst Anat, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Pan-Montojo, Francisco; Jackson, Sandra; Gille, Gabriele; Reichmann, Heinz] Tech Univ Dresden, Dept Neurol, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Anichtchik, Oleg; Spillantini, Maria Grazia] Univ Cambridge, Ctr Brain Repair, Cambridge, England; [Pursche, Stefan] Tech Univ Dresden, Dept Internal Med 1, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Jung, Roland] Tech Univ Dresden, Expt Ctr, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany; [Pan-Montojo, Francisco] Int Max Planck Res Sch, Max Planck Inst Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Cambridge; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Max Planck Society	Pan-Montojo, F (corresponding author), Tech Univ Dresden, Inst Anat, Med Fac Carl Gustav Carus, D-8027 Dresden, Germany.	pan-montojo@mpi-cbg.de; richard.funk@tu-dresden.de	Anichtchik, Oleg/AAJ-3783-2021; Anichtchik, Oleg/G-3671-2014	Anichtchik, Oleg/0000-0003-0772-7475	Pedro Barrie de la Maza Foundation; UK Parkinson's Disease Society; Parkinson&quot;s UK [G-0701] Funding Source: researchfish	Pedro Barrie de la Maza Foundation; UK Parkinson's Disease Society(Parkinson's UK); Parkinson&quot;s UK(Parkinson&apos;s UK)	F. P.-M. is the recipient of a grant from the Pedro Barrie de la Maza Foundation. O.A. and M. G. S. are recipients of a grant from the UK Parkinson's Disease Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Adler CH, 2005, NEUROLOGY, V64, pS12, DOI 10.1212/WNL.64.12_suppl_3.S12; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BIRCHMACHIN MA, 1993, STUDY SKELETAL MUSCL, P58; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Braak H, 2006, NEUROSCI LETT, V396, P67, DOI 10.1016/j.neulet.2005.11.012; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Buzas B, 2004, NEUROLOGY, V62, P2156, DOI 10.1212/01.WNL.0000130384.56476.75; Chaudhuri KR, 2008, EUR J NEUROL, V15, P2, DOI 10.1111/j.1468-1331.2008.02212.x; CROSSMAN AR, 1989, COMP BIOCHEM PHYS A, V93, P141, DOI 10.1016/0300-9629(89)90201-6; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Drolet RE, 2009, NEUROBIOL DIS, V36, P96, DOI 10.1016/j.nbd.2009.06.017; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Goetz C G, 1986, Mov Disord, V1, P45, DOI 10.1002/mds.870010106; Goldstein DS, 2006, CLIN AUTON RES, V16, P46, DOI 10.1007/s10286-006-0317-8; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Greenamyre JT, 2003, PARKINSONISM RELAT D, V9, pS59, DOI 10.1016/S1353-8020(03)00023-3; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hawkes CH, 1999, QJM-MON J ASSOC PHYS, V92, P473, DOI 10.1093/qjmed/92.8.473; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; Huang J, 2006, BIOMATERIALS, V27, P937, DOI 10.1016/j.biomaterials.2005.07.005; Inden M, 2007, J NEUROCHEM, V101, P1491, DOI 10.1111/j.1471-4159.2006.04440.x; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Kadar A, 2009, J NEUROSCI METH, V184, P115, DOI 10.1016/j.jneumeth.2009.07.010; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lang AE, 2004, ANN NEUROL, V55, P761, DOI 10.1002/ana.20102; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Liu J, 2009, J NEUROSCI, V29, P1480, DOI 10.1523/JNEUROSCI.6202-08.2009; McGeer PL, 2008, EXP NEUROL, V212, P235, DOI 10.1016/j.expneurol.2008.04.008; McGeer PL, 2004, PARKINSONISM RELAT D, V10, pS3, DOI 10.1016/j.parkreldis.2004.01.005; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Monville C, 2006, J NEUROSCI METH, V158, P219, DOI 10.1016/j.jneumeth.2006.06.001; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pfeiffer RF, 2003, LANCET NEUROL, V2, P107, DOI 10.1016/S1474-4422(03)00307-7; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Porta EA, 2002, ANN NY ACAD SCI, V959, P57, DOI 10.1111/j.1749-6632.2002.tb02083.x; Richter F, 2007, J NEUROSCI RES, V85, P681, DOI 10.1002/jnr.21159; Rojo AI, 2007, EXP NEUROL, V208, P120, DOI 10.1016/j.expneurol.2007.07.022; Ross GW, 2006, MOVEMENT DISORD, V21, P2062, DOI 10.1002/mds.21076; Schapira A, 2004, LANCET NEUROL, V3, P362, DOI 10.1016/S1474-4422(04)00769-0; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; WAKABAYASHI K, 1990, ACTA NEUROPATHOL, V79, P581, DOI 10.1007/BF00294234; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	60	344	351	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8762	10.1371/journal.pone.0008762	http://dx.doi.org/10.1371/journal.pone.0008762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098733	Green Published, Green Submitted, gold			2022-12-27	WOS:000273778900007
J	Riedel, M; Goldbaum, O; Schwarz, L; Schmitt, S; Richter-Landsberg, C				Riedel, Michael; Goldbaum, Olaf; Schwarz, Lisa; Schmitt, Sebastian; Richter-Landsberg, Christiane			17-AAG Induces Cytoplasmic alpha-Synuclein Aggregate Clearance by Induction of Autophagy	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; RAT-BRAIN OLIGODENDROCYTES; MULTIPLE SYSTEM ATROPHY; HEAT-SHOCK RESPONSE; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATION; PROTEOLYTIC STRESS; FIBRIL FORMATION; NEURONAL CELLS; PROTEASOME	Background: The accumulation and aggregation of alpha-synuclein in nerve cells and glia are characteristic features of a number of neurodegenerative diseases termed synucleinopathies. alpha-Synuclein is a highly soluble protein which in a nucleation dependent process is capable of self-aggregation. The causes underlying aggregate formation are not yet understood, impairment of the proteolytic degradation systems might be involved. Methodology/Principal Findings: In the present study the possible aggregate clearing effects of the geldanamycin analogue 17-AAG (17-(Allylamino)-17-demethoxygeldanamycin) was investigated. Towards this, an oligodendroglial cell line (OLN-93 cells), stably expressing human alpha-synuclein (A53T mutation) was used. In these cells small punctate aggregates, not staining with thioflavine S, representing prefibrillary aggregates, occur characteristically. Our data demonstrate that 17-AAG attenuated the formation of alpha-synuclein aggregates by stimulating macroautophagy. By blocking the lysosomal compartment with NH4Cl the aggregate clearing effects of 17-AAG were abolished and alpha-synuclein deposits were enlarged. Analysis of LC3-II immunoreactivity, which is an indicator of autophagosome formation, further revealed that 17-AAG led to the recruitment of LC3-II and to the formation of LC3 positive puncta. This effect was also observed in cultured oligodendrocytes derived from the brains of newborn rats. Inhibition of macroautophagy by 3-methyladenine prevented 17-AAG induced occurrence of LC3 positive puncta as well as the removal of alpha-synuclein aggregates in OLN-A53T cells. Conclusions: Our data demonstrate for the first time that 17-AAG not only causes the upregulation of heat shock proteins, but also is an effective inducer of the autophagic pathway by which alpha-synuclein can be removed. Hence geldanamycin derivatives may provide a means to modulate autophagy in neural cells, thereby ameliorating pathogenic aggregate formation and protecting the cells during disease and aging.	[Riedel, Michael; Goldbaum, Olaf; Schwarz, Lisa; Schmitt, Sebastian; Richter-Landsberg, Christiane] Carl von Ossietzky Univ Oldenburg, Dept Biol, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Riedel, M (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol, D-2900 Oldenburg, Germany.	Christiane.Richter.Landsberg@Uni-Oldenburg.de			Deutsche Forschungsgemeinschaft, Germany; Tonjes-Vagt Stiftung (Bremen, Germany)	Deutsche Forschungsgemeinschaft, Germany(German Research Foundation (DFG)); Tonjes-Vagt Stiftung (Bremen, Germany)	This work was supported by the Deutsche Forschungsgemeinschaft, Germany, and the Tonjes-Vagt Stiftung (Bremen, Germany). These funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2005, J BIOL CHEM, V280, P2873, DOI 10.1074/jbc.M412106200; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bandhyopadhyay U, 2007, EXP GERONTOL, V42, P120, DOI 10.1016/j.exger.2006.05.019; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; BORENFREUND E, 1985, TOXICOL LETT, V24, P119, DOI 10.1016/0378-4274(85)90046-3; Burn DJ, 2001, J CLIN PATHOL-MOL PA, V54, P419; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dedmon MM, 2005, J BIOL CHEM, V280, P14733, DOI 10.1074/jbc.m413024200; Dickson DW, 1999, BRAIN PATHOL, V9, P721; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Goedert M, 2001, CURR OPIN GENET DEV, V11, P343, DOI 10.1016/S0959-437X(00)00200-8; Goldbaum O, 2004, J NEUROSCI, V24, P5748, DOI 10.1523/JNEUROSCI.1307-04.2004; Goldbaum O, 2003, J NEUROSCI, V23, P8872; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kumar B, 2004, CANCER LETT, V204, P53, DOI 10.1016/j.canlet.2003.09.017; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lantos PL, 1998, J NEUROPATH EXP NEUR, V57, P1099, DOI 10.1097/00005072-199812000-00001; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Lu AG, 2002, J NEUROCHEM, V81, P355, DOI 10.1046/j.1471-4159.2002.00835.x; McLean PJ, 2004, BIOCHEM BIOPH RES CO, V321, P665, DOI 10.1016/j.bbrc.2004.07.021; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Neckers L, 2003, NATURE, V425, P357, DOI 10.1038/425357a; NEUHOFF V, 1979, H-S Z PHYSIOL CHEM, V360, P1657, DOI 10.1515/bchm2.1979.360.2.1657; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Richter-Landsberg C, 2000, J NEUROSCI RES, V62, P9, DOI 10.1002/1097-4547(20001001)62:1<9::AID-JNR2>3.0.CO;2-U; Richter-Landsberg C, 2003, CELL MOL LIFE SCI, V60, P337, DOI 10.1007/s000180300028; RichterLandsberg C, 1996, J NEUROSCI RES, V45, P161, DOI 10.1002/(SICI)1097-4547(19960715)45:2<161::AID-JNR8>3.0.CO;2-8; Riedel M, 2009, J MOL NEUROSCI, V39, P226, DOI 10.1007/s12031-009-9190-y; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Sittler A, 2001, HUM MOL GENET, V10, P1307, DOI 10.1093/hmg/10.12.1307; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Uryu K, 2006, AM J PATHOL, V168, P947, DOI 10.2353/ajpath.2006.050770; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	56	70	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8753	10.1371/journal.pone.0008753	http://dx.doi.org/10.1371/journal.pone.0008753			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090920	Green Submitted, gold, Green Published			2022-12-27	WOS:000273715000011
J	Benard, C; Cultrone, A; Michel, C; Rosales, C; Segain, JP; Lahaye, M; Galmiche, JP; Cherbut, C; Blottiere, HM				Benard, Claudine; Cultrone, Antonietta; Michel, Catherine; Rosales, Carlos; Segain, Jean-Pierre; Lahaye, Marc; Galmiche, Jean-Paul; Cherbut, Christine; Blottiere, Herve M.			Degraded Carrageenan Causing Colitis in Rats Induces TNF Secretion and ICAM-1 Upregulation in Monocytes through NF-kappa B Activation	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; MOLECULAR-WEIGHT-DISTRIBUTION; NUCLEAR FACTOR ACTIVATION; TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; GUINEA-PIGS; INTERLEUKIN-8 PRODUCTION; GASTROINTESTINAL-TRACT; ADHESION MOLECULES	Carrageenan (CGN) is a high molecular weight sulphated polysaccharide derived from red seaweeds. In rodents, its degraded forms (dCGN) can induce intestinal inflammation associated with macrophage recruitment and activation. The aim of this study was: 1) to analyze the size-dependent effects of dCGN on colon inflammation in vivo, and 2) to correlate these effects with monocyte/macrophage proliferation, cytokine production and expression of various cell surface antigens including ICAM-1 adhesion molecule. Peripheral blood monocytes (PBM) and THP-1 monocytic cells were cultured in the presence of either 10 or 40 kDa, dCGN. The 40 kDa, but not the 10 kDa dCGN, induced colitis in in vivo. Degraded CGN inhibited THP-1 cell proliferation in vitro, arresting the cells in G1 phase. In addition, dCGN increased ICAM-1 expression in both PBM and THP-1 cells with a major effect seen after 40 kDa dCGN exposure. Also, dCGN stimulated monocyte aggregation in vitro that was prevented by incubation with anti-ICAM-1 antibody. Finally, dCGN stimulated TNF-alpha expression and secretion by both PBM and THP-1 cells. All these effects were linked to NF-kappa B activation. These data strongly suggest that the degraded forms of CGN have a pronounced effect on monocytes, characteristic of an inflammatory phenotype.	[Benard, Claudine; Michel, Catherine; Segain, Jean-Pierre; Cherbut, Christine] Univ Nantes, INRA, UMR PHAN 1280, CHU Hotel Dieu, Nantes, France; [Cultrone, Antonietta; Blottiere, Herve M.] INRA, UEPSD UR910, Jouy En Josas, France; [Galmiche, Jean-Paul] CHU Hotel Dieu, INSERM, U913, Nantes, France; [Lahaye, Marc] INRA, BIA, F-44026 Nantes, France; [Rosales, Carlos] Univ Nacl Autonoma Mexico, Dept Immunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico	INRAE; Nantes Universite; CHU de Nantes; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; INRAE; Universidad Nacional Autonoma de Mexico	Benard, C (corresponding author), Univ Nantes, INRA, UMR PHAN 1280, CHU Hotel Dieu, Nantes, France.	Herve.Blottiere@jouy.inra.fr	MICHEL, Catherine D/Q-2879-2018; ROSALES, CARLOS/AAA-5206-2019; BLOTTIERE, Hervé M/C-6120-2011; LAHAYE, Marc/C-6324-2009; Lahaye, Marc/C-6324-2009	MICHEL, Catherine D/0000-0001-7695-1038; ROSALES, CARLOS/0000-0003-2568-5723; BLOTTIERE, Hervé M/0000-0002-8390-0607; LAHAYE, Marc/0000-0001-8380-0334; Lahaye, Marc/0000-0002-7752-4158	INRA; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [48573-M]	INRA; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by INRA and in part by grant 48573-M from Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico (to CR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; ANEGON I, 1993, J LEUKOCYTE BIOL, V53, P390, DOI 10.1002/jlb.53.4.390; Axelsson LG, 1996, INFLAMM RES, V45, P181, DOI 10.1007/BF02285159; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Barbier M, 1998, GUT, V43, P783, DOI 10.1136/gut.43.6.783; Basile JR, 2003, MOL CANCER RES, V1, P262; Bhattacharyya S, 2008, BBA-GEN SUBJECTS, V1780, P973, DOI 10.1016/j.bbagen.2008.03.019; Bhattacharyya S, 2008, J BIOL CHEM, V283, P10550, DOI 10.1074/jbc.M708833200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Borthakur A, 2007, AM J PHYSIOL-GASTR L, V292, pG829, DOI 10.1152/ajpgi.00380.2006; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; EKSTROM LG, 1983, CARBOHYD RES, V116, P89, DOI 10.1016/S0008-6215(00)90956-X; EKSTROM LG, 1985, CARBOHYD RES, V135, P283, DOI 10.1016/S0008-6215(00)90779-1; ELSON CO, 1995, GASTROENTEROLOGY, V109, P1344, DOI 10.1016/0016-5085(95)90599-5; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Feng Jun-Ming, 2003, Hepatobiliary Pancreat Dis Int, V2, P265; Fiocchi C, 1997, AM J PHYSIOL-GASTR L, V273, pG769, DOI 10.1152/ajpgi.1997.273.4.G769; Garcia-Garcia E, 2007, J IMMUNOL METHODS, V320, P104, DOI 10.1016/j.jim.2006.12.006; Garcia-Garcia E, 2009, J IMMUNOL, V182, P4547, DOI 10.4049/jimmunol.0801468; GRIMM MC, 1995, J GASTROEN HEPATOL, V10, P387, DOI 10.1111/j.1440-1746.1995.tb01589.x; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Jobin C, 2000, AM J PHYSIOL-CELL PH, V278, pC451, DOI 10.1152/ajpcell.2000.278.3.C451; KITANO A, 1986, CANCER RES, V46, P1374; KITSUKAWA Y, 1992, GASTROENTEROLOGY, V102, P1859, DOI 10.1016/0016-5085(92)90306-J; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; LING KY, 1988, GASTROENTEROLOGY, V95, P1487, DOI 10.1016/S0016-5085(88)80067-2; Liu ZX, 1996, SCAND J GASTROENTERO, V31, P706, DOI 10.3109/00365529609009154; Liu ZX, 1997, SCAND J GASTROENTERO, V32, P1241, DOI 10.3109/00365529709028154; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; MARCUS AJ, 1989, J PHARM PHARMACOL, V41, P423, DOI 10.1111/j.2042-7158.1989.tb06493.x; MARCUS R, 1971, LANCET, V2, P765; Michel C, 1996, J APPL BACTERIOL, V80, P349, DOI 10.1111/j.1365-2672.1996.tb03230.x; MISHRA L, 1993, GASTROENTEROLOGY, V104, P772, DOI 10.1016/0016-5085(93)91012-7; MIURA M, 1987, J CLIN LAB IMMUNOL, V24, P167; Nemeth ZH, 2002, AM J PATHOL, V161, P987, DOI 10.1016/S0002-9440(10)64259-9; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Perkins ND, 2006, CELL DEATH DIFFER, V13, P759, DOI 10.1038/sj.cdd.4401838; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; Rochet V, 1997, REPROD NUTR DEV, V37, P221, DOI 10.1051/rnd:19970210; Rosales C, 1996, CANCER RES, V56, P2302; RUGVEIT J, 1997, GASTROENTEROLOGY, V112, P1493; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Stanley N., 1987, PRODUCTION UTILIZATI, V288, P116; Stanley N.F., 1990, FOOD GELS, P79; Tobacman JK, 2001, ENVIRON HEALTH PERSP, V109, P983, DOI 10.2307/3454951; VANDERWAAIJ D, 1974, GASTROENTEROLOGY, V67, P460; VIEBKE C, 1995, CARBOHYD POLYM, V27, P145, DOI 10.1016/0144-8617(95)00017-2; Weiner ML, 2007, FOOD CHEM TOXICOL, V45, P98, DOI 10.1016/j.fct.2006.07.033	51	44	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8666	10.1371/journal.pone.0008666	http://dx.doi.org/10.1371/journal.pone.0008666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072622	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600019
J	Hellmann, JK; Munter, S; Wink, M; Frischknecht, F				Hellmann, Janina K.; Muenter, Sylvia; Wink, Michael; Frischknecht, Friedrich			Synergistic and Additive Effects of Epigallocatechin Gallate and Digitonin on Plasmodium Sporozoite Survival and Motility	PLOS ONE			English	Article							GREEN TEA POLYPHENOL; SAPONINS	Background: Most medicinal plants contain a mixture of bioactive compounds, including chemicals that interact with intracellular targets and others that can act as adjuvants to facilitate absorption of polar agents across cellular membranes. However, little is known about synergistic effects between such potential drug candidates and adjuvants. To probe for such effects, we tested the green tea compound epigallocatechin gallate (EGCG) and the membrane permeabilising digitonin on Plasmodium sporozoite motility and viability. Methodology/Principal Findings: Green fluorescent P. berghei sporozoites were imaged using a recently developed visual screening methodology. Motility and viability parameters were automatically analyzed and IC50 values were calculated, and the synergism of drug and adjuvant was assessed by the fractional inhibitory concentration index. Validating our visual screening procedure, we showed that sporozoite motility and liver cell infection is inhibited by EGCG at nontoxic concentrations. Digitonin synergistically increases the cytotoxicity of EGCG on sporozoite survival, but shows an additive effect on sporozoite motility. Conclusions/Significance: We proved the feasibility of performing highly reliable visual screens for compounds against Plasmodium sporozoites. We thereby could show an advantage of administering mixtures of plant metabolites on inhibition of cell motility and survival. Although the effective concentration of both drugs is too high for use in malaria prophylaxis, the demonstration of a synergistic effect between two plant compounds could lead to new avenues in drug discovery.	[Hellmann, Janina K.; Muenter, Sylvia] Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany; [Wink, Michael; Frischknecht, Friedrich] Heidelberg Univ, Dept Biol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Hellmann, JK (corresponding author), Heidelberg Univ, Sch Med, Dept Infect Dis, Heidelberg, Germany.	wink@uni-hd.de; freddy.frischknecht@med.uni-heidelberg.de	Wink, Michael/E-3803-2012	Wink, Michael/0000-0002-7875-4510; Frischknecht, Friedrich/0000-0002-8332-6668	German Federal Ministry for Education and Research; Cluster of Excellence CellNetworks; Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology; Medical School at the University of Heidelberg	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Cluster of Excellence CellNetworks; Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology; Medical School at the University of Heidelberg	The work was funded by grants from the German Federal Ministry for Education and Research (BMBF, BioFuture, and NGFN) to FF. Support from the Cluster of Excellence CellNetworks, the Hartmut Hoffmann-Berling International Graduate School for Molecular and Cellular Biology, and the Medical School at the University of Heidelberg is gratefully acknowledged. Part of this work constituted the master thesis of JKH within the Molecular Biotechnology Program of Heidelberg University. FF is a member of the European Network of Excellence BioMalPar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, PLANTA MED, V75, P216, DOI 10.1055/s-0028-1088378; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Benelli R, 2002, BIOL CHEM, V383, P101, DOI 10.1515/BC.2002.010; Buttemeyer R, 2003, TRANSPL P, V35, P3116, DOI 10.1016/j.transproceed.2003.10.055; Chow HHS, 2003, CLIN CANCER RES, V9, P3312; Dormeyer M, 2006, ANTIMICROB AGENTS CH, V50, P724, DOI 10.1128/AAC.50.2.724-730.2006; Fuchs H, 2009, CURR DRUG TARGETS, V10, P140, DOI 10.2174/138945009787354584; Gupta J., 2008, IJP - International Journal of Pharmacology, V4, P314; HALL MJ, 1983, J ANTIMICROB CHEMOTH, V11, P427, DOI 10.1093/jac/11.5.427; Harborne J. B., 1990, CIBA F SYMP, V154, P126; HEGGE S, 2009, BIOTECHNOLOGY J; Hostettmann K., 1995, SAPONINS, DOI 10.1017/CBO9780511565113; Kensil CR, 1996, CRIT REV THER DRUG, V13, P1; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Orhan G, 2005, J CLIN MICROBIOL, V43, P140, DOI 10.1128/JCM.43.1.140-143.2005; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Rao A V, 2000, Drug Metabol Drug Interact, V17, P211; Sannella AR, 2007, BIOCHEM BIOPH RES CO, V353, P177, DOI 10.1016/j.bbrc.2006.12.005; Schafer Holger, 2009, Biotechnology Journal, V4, P1684, DOI 10.1002/biot.200900229; Sharma SK, 2007, J MED CHEM, V50, P765, DOI 10.1021/jm061154d; Silvie O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000086; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; Tobi SE, 2002, INT J CANCER, V102, P439, DOI 10.1002/ijc.10730; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; Van WykB E, 2004, MED PLANTS WORLD ILL, P480; WATERMAN PG, 1992, CIBA F SYMP, V171, P255; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; WINK M, 2007, MED PLANT BIOTECHNOL, P97; Wink M, 2008, CURR DRUG METAB, V9, P996, DOI 10.2174/138920008786927794; Yoda Yoshiyuki, 2004, Journal of Infection and Chemotherapy, V10, P55, DOI 10.1007/s10156-003-0284-0	34	37	40	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8682	10.1371/journal.pone.0008682	http://dx.doi.org/10.1371/journal.pone.0008682			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072627	gold, Green Published, Green Submitted			2022-12-27	WOS:000273554600032
J	Liu, FX; Xu, WY; Wei, Q; Zhang, ZH; Xing, Z; Tan, LB; Di, C; Yao, DX; Wang, CC; Tan, YJ; Yan, H; Ling, Y; Sun, CQ; Xue, YB; Su, Z				Liu, Fengxia; Xu, Wenying; Wei, Qiang; Zhang, Zhenghai; Xing, Zhuo; Tan, Lubin; Di, Chao; Yao, Dongxia; Wang, Chunchao; Tan, Yuanjun; Yan, Hong; Ling, Yi; Sun, Chuanqing; Xue, Yongbiao; Su, Zhen			Gene Expression Profiles Deciphering Rice Phenotypic Variation between Nipponbare (Japonica) and 93-11 (Indica) during Oxidative Stress	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CINNAMOYL-COA REDUCTASE; ARABIDOPSIS-THALIANA; LIGNIN BIOSYNTHESIS; DRAFT SEQUENCE; GENOME; PLANTS; POLYMORPHISMS; INDUCTION; IDENTIFICATION	Rice is a very important food staple that feeds more than half the world's population. Two major Asian cultivated rice (Oryza sativa L.) subspecies, japonica and indica, show significant phenotypic variation in their stress responses. However, the molecular mechanisms underlying this phenotypic variation are still largely unknown. A common link among different stresses is that they produce an oxidative burst and result in an increase of reactive oxygen species (ROS). In this study, methyl viologen (MV) as a ROS agent was applied to investigate the rice oxidative stress response. We observed that 93-11 (indica) seedlings exhibited leaf senescence with severe lesions under MV treatment compared to Nipponbare (japonica). Whole-genome microarray experiments were conducted, and 1,062 probe sets were identified with gene expression level polymorphisms between the two rice cultivars in addition to differential expression under MV treatment, which were assigned as Core Intersectional Probesets (CIPs). These CIPs were analyzed by gene ontology (GO) and highlighted with enrichment GO terms related to toxin and oxidative stress responses as well as other responses. These GO term-enriched genes of the CIPs include glutathine S-transferases (GSTs), P450, plant defense genes, and secondary metabolism related genes such as chalcone synthase (CHS). Further insertion/deletion (InDel) and regulatory element analyses for these identified CIPs suggested that there may be some eQTL hotspots related to oxidative stress in the rice genome, such as GST genes encoded on chromosome 10. In addition, we identified a group of marker genes individuating the japonica and indica subspecies. In summary, we developed a new strategy combining biological experiments and data mining to study the possible molecular mechanism of phenotypic variation during oxidative stress between Nipponbare and 93-11. This study will aid in the analysis of the molecular basis of quantitative traits.	[Liu, Fengxia; Wei, Qiang; Zhang, Zhenghai; Di, Chao; Yao, Dongxia; Wang, Chunchao; Tan, Yuanjun; Yan, Hong; Ling, Yi; Sun, Chuanqing; Su, Zhen] China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China; [Xu, Wenying; Xing, Zhuo; Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Mol & Dev Biol Lab, Beijing, Peoples R China; [Xu, Wenying; Xing, Zhuo; Xue, Yongbiao] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Tan, Lubin; Sun, Chuanqing] China Agr Univ, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [Tan, Lubin; Sun, Chuanqing] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; China Agricultural University; China Agricultural University	Liu, FX (corresponding author), China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China.	ybxue@genetics.ac.cn; zhensu@cau.edu.cn	Tan, Lubin/H-9270-2017; Di, Chao/G-1130-2015; xing, zhuo/L-7165-2016	Tan, Lubin/0000-0003-3775-7720; xing, zhuo/0000-0002-4635-6630	Ministry of Science and Technology of China [30570139, 2006CB100105, 2005CB120804]; China Agriculture University	Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Agriculture University	This work was supported by grants from the Ministry of Science and Technology of China (30570139, 2006CB100105, and 2005CB120804) and the China Agriculture University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Chen WQJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r32; Cheng KS, 1985, RICE GENET NEWSL, V2, P46; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Debnam PM, 2004, PLANT J, V38, P49, DOI 10.1111/j.1365-313X.2004.02017.x; Drost DR, 2009, PLANT J, V58, P1054, DOI 10.1111/j.1365-313X.2009.03828.x; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Feltus FA, 2004, GENOME RES, V14, P1812, DOI 10.1101/gr.2479404; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gojobori T, 2007, GENOME RES, V17, P175, DOI 10.1101/gr.5509507; GuetaDahan Y, 1997, PLANTA, V203, P460, DOI 10.1007/s004250050215; Han B, 2003, CURR OPIN PLANT BIOL, V6, P134, DOI 10.1016/S1369-5266(03)00004-9; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Kandel S, 2005, J BIOL CHEM, V280, P35881, DOI 10.1074/jbc.M500918200; KATO SHIGEMOTO, 1928, BULT SCI FAK TERK KJUSU IMP UNIV, V3, P132; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kong L, 2005, GENOME, V48, P29, DOI 10.1139/G04-097; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laloi C, 2007, P NATL ACAD SCI USA, V104, P672, DOI 10.1073/pnas.0609063103; Li L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000294; Lim CE, 2008, MOL CELLS, V25, P368; Liu XH, 2007, PLANT MOL BIOL, V65, P403, DOI 10.1007/s11103-007-9174-7; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; MITRICK AJ, 2007, FUNCT INTEGR GENOMIC, V7, P135; Moons A, 2005, VITAM HORM, V72, P155, DOI 10.1016/S0083-6729(05)72005-7; Morgante M, 2006, CURR OPIN BIOTECH, V17, P168, DOI 10.1016/j.copbio.2006.03.001; MORISHIMA H, 1981, JPN J BREED, V31, P402; Neuefeind T, 1997, BIOL CHEM, V378, P199; Pan QL, 2000, J MOL EVOL, V50, P203, DOI 10.1007/s002399910023; Paolocci F, 2005, J EXP BOT, V56, P1093, DOI 10.1093/jxb/eri101; Plantegenet S, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.79; Ray SD, 2004, BIOFACTORS, V21, P223, DOI 10.1002/biof.552210144; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Rogers O.S., 1998, PLANT MOL BIOL MAN A, VA6, P1; Santosa IE, 2007, PLANTA, V226, P193, DOI 10.1007/s00425-006-0457-z; Scarpeci TE, 2008, PLANT MOL BIOL, V66, P361, DOI 10.1007/s11103-007-9274-4; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Shin JH, 2009, MOL CELLS, V27, P67, DOI 10.1007/s10059-009-0006-2; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tang T, 2006, PLOS GENET, V2, P1824, DOI 10.1371/journal.pgen.0020199; TSANG EWT, 1991, PLANT CELL, V3, P783, DOI 10.1105/tpc.3.8.783; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wadenback J, 2008, TRANSGENIC RES, V17, P379, DOI 10.1007/s11248-007-9113-z; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Werner T, 2008, CURR OPIN BIOTECH, V19, P50, DOI 10.1016/j.copbio.2007.11.005; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000032; Zhang X, 2007, CURR OPIN PLANT BIOL, V10, P142, DOI 10.1016/j.pbi.2007.02.002; Zhao MG, 2007, J PLANT PHYSIOL, V164, P737, DOI 10.1016/j.jplph.2006.03.002; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	60	50	53	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8632	10.1371/journal.pone.0008632	http://dx.doi.org/10.1371/journal.pone.0008632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072620	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200004
J	Uhde, CW; Vives, J; Jaeger, I; Li, M				Uhde, Christopher W.; Vives, Joaquim; Jaeger, Ines; Li, Meng			Rmst Is a Novel Marker for the Mouse Ventral Mesencephalic Floor Plate and the Anterior Dorsal Midline Cells	PLOS ONE			English	Article							MIDBRAIN DOPAMINERGIC-NEURONS; SUBSTANTIA-NIGRA; GENE-EXPRESSION; NERVOUS-SYSTEM; IDENTIFICATION; SPECIFICATION	The availability of specific markers expressed in different regions of the developing nervous system provides a useful tool to illuminate their development, regulation and function. We have identified by expression profiling a putative non-coding RNA, Rmst, that exhibits prominent expression in the midbrain floor plate region, the isthmus and the roof plate of the anterior neural tube. At the developmental stage when the ventral dopaminergic neuron territory is being established, Rmst expression appears to be restricted to the presumptive dopaminergic neurons of the ventral tegmental area that lies close to the ventral midline. Thus this study presents Rmst as a novel marker for the developing dopaminergic neurons in the mesencephalic floor plate as well as a marker for the dorsal midline cells of the anterior neural tube and the isthmic organizer.	[Uhde, Christopher W.; Vives, Joaquim; Jaeger, Ines; Li, Meng] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England	Imperial College London	Uhde, CW (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London, England.	meng.li2@imperial.ac.uk	Li, Meng/I-6941-2013; Vives, Joaquim/J-6303-2019	Vives, Joaquim/0000-0001-9719-5235	UK Medical Research Council; UK Parkinsons Disease Society; European Commission; Medical Research Council [G117/560, MC_U120085817] Funding Source: researchfish; MRC [G117/560, MC_U120085817] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Parkinsons Disease Society(Parkinson's UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the UK Medical Research Council, the UK Parkinsons Disease Society and the frame work six programme of the European Commission (Eurostemcell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Bouchard M, 2005, DEVELOPMENT, V132, P2633, DOI 10.1242/dev.01833; Chan AS, 2002, ONCOGENE, V21, P3029, DOI 10.1038/sj.onc.1205460; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dunston JA, 2005, EUR J HUM GENET, V13, P330, DOI 10.1038/sj.ejhg.5201332; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Failli V, 2002, MECH DEVELOP, V118, P225, DOI 10.1016/S0925-4773(02)00254-X; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Klafke R, 2008, PHARMACOPSYCHIATRY, V41, pS44, DOI 10.1055/s-2008-1080902; Li JYH, 2001, DEVELOPMENT, V128, P4979; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Rock JR, 2007, GENE EXPR PATTERNS, V8, P19, DOI 10.1016/j.modgep.2007.08.004; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	20	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8641	10.1371/journal.pone.0008641	http://dx.doi.org/10.1371/journal.pone.0008641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062813	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414200018
J	Yu, YL; Lee, P; Ke, YH; Zhang, YK; Yu, Q; Lee, J; Li, MZ; Song, JL; Chen, JG; Dai, JH; Do Couto, FJR; An, ZQ; Zhu, WM; Yu, GL				Yu, Yanlan; Lee, Pierre; Ke, Yaohuang; Zhang, Yongke; Yu, Qiu; Lee, Jonathan; Li, Mingzhen; Song, Jialiang; Chen, Jungang; Dai, Jihong; Do Couto, Fernando Jose Rebelo; An, Zhiqiang; Zhu, Weimin; Yu, Guo-Liang			A Humanized Anti-VEGF Rabbit Monoclonal Antibody Inhibits Angiogenesis and Blocks Tumor Growth in Xenograft Models	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; METASTATIC BREAST-CANCER; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; RECEPTOR-BINDING; PHAGE DISPLAY; KINASE DOMAIN; MOUSE; BEVACIZUMAB; AFFINITY	Rabbit antibodies have been widely used in research and diagnostics due to their high antigen specificity and affinity. Though these properties are also highly desirable for therapeutic applications, rabbit antibodies have remained untapped for human disease therapy. To evaluate the therapeutic potential of rabbit monoclonal antibodies (RabMAbs), we generated a panel of neutralizing RabMAbs against human vascular endothelial growth factor-A (VEGF). These neutralizing RabMAbs are specific to VEGF and do not cross-react to other members of the VEGF protein family. Guided by sequence and lineage analysis of a panel of neutralizing RabMAbs, we humanized the lead candidate by substituting non-critical residues with human residues within both the frameworks and the CDR regions. We showed that the humanized RabMAb retained its parental biological properties and showed potent inhibition of the growth of H460 lung carcinoma and A673 rhabdomyosarcoma xenografts in mice. These studies provide proof of principle for the feasibility of developing humanized RabMAbs as therapeutics.	[Yu, Yanlan] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China; [Lee, Pierre; Ke, Yaohuang; Zhang, Yongke; Yu, Qiu; Lee, Jonathan; Do Couto, Fernando Jose Rebelo; An, Zhiqiang; Zhu, Weimin; Yu, Guo-Liang] Epitomics Inc, Burlingame, CA USA; [Li, Mingzhen; Song, Jialiang; Chen, Jungang; Dai, Jihong] Hangzhou Yikang Biotech Inc, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yu, YL (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Urol, Hangzhou 310003, Zhejiang, Peoples R China.	zhiqiang.an@uth.tmc.edu		An, Zhiqiang/0000-0001-9309-2335				Aguayo A, 1999, BLOOD, V94, P3717, DOI 10.1182/blood.V94.11.3717.423k09_3717_3721; AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; BYSTRYN JC, 1982, HYBRIDOMA, V1, P465, DOI 10.1089/hyb.1.1982.1.465; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; COUTO FJR, 2005, Patent No. 016950; COUTO FJRD, 2004, Patent No. 7462697; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Gerber HP, 2000, CANCER RES, V60, P6253; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; HEIDMANN O, 1984, NATURE, V311, P74, DOI 10.1038/311074a0; High K, 2005, ANAL BIOCHEM, V347, P159, DOI 10.1016/j.ab.2005.09.007; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Huang XM, 1998, BIOCHEM BIOPH RES CO, V252, P643, DOI 10.1006/bbrc.1998.9717; Huang ZD, 2006, APPL IMMUNOHISTO M M, V14, P229, DOI 10.1097/01.pai.0000157906.38495.31; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kabat EA, 1991, SEQUENCES PROTEINS I; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CMY, 2007, NAT PROTOC, V2, P3001, DOI 10.1038/nprot.2007.448; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Lu D, 2003, J BIOL CHEM, V278, P43496, DOI 10.1074/jbc.M307742200; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; Muller YA, 1997, P NATL ACAD SCI USA, V94, P7192, DOI 10.1073/pnas.94.14.7192; Muller YA, 1998, STRUCTURE, V6, P1153, DOI 10.1016/S0969-2126(98)00116-6; Oldham RK, 2008, J CLIN ONCOL, V26, P1774, DOI 10.1200/JCO.2007.15.7438; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; Pytela R., 2008, United States patent, Patent No. [7, 429-487, 7429487, USP7429487]; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; ROGUSKA MA, 1994, P NATL ACAD SCI USA, V91, P969, DOI 10.1073/pnas.91.3.969; Rossi S, 2005, AM J CLIN PATHOL, V124, P295, DOI 10.1309/NR8HN08GDPVEMU08; Seo Y, 2000, CANCER, V88, P2239, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V; SHAMBLOTT MJ, 1989, EMBO J, V8, P3733, DOI 10.1002/j.1460-2075.1989.tb08549.x; Sitnikova T, 1998, MOL BIOL EVOL, V15, P617, DOI 10.1093/oxfordjournals.molbev.a025965; SPIEKERPOLET H, 1995, P NATL ACAD SCI USA, V92, P9348, DOI 10.1073/pnas.92.20.9348; Sugihara T, 1998, J BIOL CHEM, V273, P3033, DOI 10.1074/jbc.273.5.3033; Tao GZ, 2006, EXP CELL RES, V312, P411, DOI 10.1016/j.yexcr.2005.11.010; Velders MP, 1998, BRIT J CANCER, V78, P478, DOI 10.1038/bjc.1998.518; WEIDNER N, 1992, JNCI-J NATL CANCER I, V84, P1875, DOI 10.1093/jnci/84.24.1875; WELLER A, 1987, DEVELOPMENT, V100, P351; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; ZHU W, 2009, THERAPEUTIC MONOCLON, P889; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039; Zhu Z, 2003, LEUKEMIA, V17, P604, DOI 10.1038/sj.leu.2402831	56	47	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9072	10.1371/journal.pone.0009072	http://dx.doi.org/10.1371/journal.pone.0009072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140208	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400011
J	Antic, D; Stubbs, JL; Suyama, K; Kintner, C; Scott, MP; Axelrod, JD				Antic, Dragana; Stubbs, Jennifer L.; Suyama, Kaye; Kintner, Chris; Scott, Matthew P.; Axelrod, Jeffrey D.			Planar Cell Polarity Enables Posterior Localization of Nodal Cilia and Left-Right Axis Determination during Mouse and Xenopus Embryogenesis	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; NEURAL-TUBE CLOSURE; INNER-EAR; POLARIZATION; ZEBRAFISH; NEURULATION; MECHANISMS; EXTENSION; DIVISION; MAMMALS	Left-right asymmetry in vertebrates is initiated in an early embryonic structure called the ventral node in human and mouse, and the gastrocoel roof plate (GRP) in the frog. Within these structures, each epithelial cell bears a single motile cilium, and the concerted beating of these cilia produces a leftward fluid flow that is required to initiate left-right asymmetric gene expression. The leftward fluid flow is thought to result from the posterior tilt of the cilia, which protrude from near the posterior portion of each cell's apical surface. The cells, therefore, display a morphological planar polarization. Planar cell polarity (PCP) is manifested as the coordinated, polarized orientation of cells within epithelial sheets, or as directional cell migration and intercalation during convergent extension. A set of evolutionarily conserved proteins regulates PCP. Here, we provide evidence that vertebrate PCP proteins regulate planar polarity in the mouse ventral node and in the Xenopus gastrocoel roof plate. Asymmetric anterior localization of VANGL1 and PRICKLE2 (PK2) in mouse ventral node cells indicates that these cells are planar polarized by a conserved molecular mechanism. A weakly penetrant Vangl1 mutant phenotype suggests that compromised Vangl1 function may be associated with left-right laterality defects. Stronger functional evidence comes from the Xenopus GRP, where we show that perturbation of VANGL2 protein function disrupts the posterior localization of motile cilia that is required for leftward fluid flow, and causes aberrant expression of the left side-specific gene Nodal. The observation of anterior-posterior PCP in the mouse and in Xenopus embryonic organizers reflects a strong evolutionary conservation of this mechanism that is important for body plan determination.	[Antic, Dragana; Axelrod, Jeffrey D.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Antic, Dragana; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Stubbs, Jennifer L.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Salk Institute	Antic, D (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	mscott@stanford.edu; jaxelrod@stanford.edu			Howard Hughes Medical Institute [R01 GM059823, RO1 GM076507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823, R01GM076507] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM059823 (J. D. A.), by RO1 GM076507 (C. K.) and by the Howard Hughes Medical Institute. M. P. S. is an Investigator of the H. H. M. I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Basu B, 2008, CURR TOP DEV BIOL, V85, P151, DOI 10.1016/S0070-2153(08)00806-5; Blum M, 2009, DEV DYNAM, V238, P1215, DOI 10.1002/dvdy.21855; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Crompton LA, 2007, DEV DYNAM, V236, P3137, DOI 10.1002/dvdy.21338; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HASHIMOTO M, NAT CELL BI IN PRESS; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Jiang D, 2005, CURR BIOL, V15, P79; Kaufman M.H., 1992, ATLAS MOUSE DEV; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Marshall WF, 2008, CURR OPIN CELL BIOL, V20, P48, DOI 10.1016/j.ceb.2007.11.009; Mitchell B, 2009, CURR BIOL, V19, P924, DOI 10.1016/j.cub.2009.04.018; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schweickert A, 2007, CURR BIOL, V17, P60, DOI 10.1016/j.cub.2006.10.067; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sive HL, 1998, EARLY DEV XENOPUS LA; Strutt H, 2009, SEMIN CELL DEV BIOL, V20, P957, DOI 10.1016/j.semcdb.2009.03.006; Stubbs JL, 2006, DEVELOPMENT, V133, P2507, DOI 10.1242/dev.02417; Stubbs JL, 2008, NAT GENET, V40, P1454, DOI 10.1038/ng.267; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Vick P, 2009, DEV BIOL, V331, P281, DOI 10.1016/j.ydbio.2009.05.547; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Yin C, 2008, J CELL BIOL, V180, P221, DOI 10.1083/jcb.200704150; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	41	123	127	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8999	10.1371/journal.pone.0008999	http://dx.doi.org/10.1371/journal.pone.0008999			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126399	Green Submitted, Green Published, gold			2022-12-27	WOS:000274207200003
J	Batters, C; Zhu, HN; Sale, JE				Batters, Christopher; Zhu, Hannah; Sale, Julian E.			Visualisation of PCNA Monoubiquitination In Vivo by Single Pass Spectral Imaging FRET Microscopy	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; RESONANCE ENERGY-TRANSFER; DNA-DAMAGE TOLERANCE; CROSS-LINK REPAIR; UBIQUITIN CONJUGATION; TRANSLESION SYNTHESIS; FLUORESCENT PROTEINS; GENOMIC INSTABILITY; LIVING CELLS; HUMAN SHPRH	Monoubiquitination of the DNA sliding clamp, PCNA, plays a central role in the control of damage bypass during replication. By combining a widely-spaced FRET donor/acceptor pair (CFP and mRFP) with spectral imaging, we have developed a simple method for the visualisation of PCNA monoubiquitination in both fixed and live cells with a single imaging pass. We validate the method with genetic controls in the avian cell line DT40 and use it to examine the intracellular dynamics of PCNA ubiquitination following subnuclear UV irradiation. This general approach is likely to be of utility for live imaging of post-translational modifications of a wide range of substrates in vivo.	[Zhu, Hannah] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Batters, C (corresponding author), Univ Munich, Inst Physiol, Pettenkoferstr 12, D-8000 Munich, Germany.	jes@mrc-lmb.cam.ac.uk		Sale, Julian/0000-0002-5031-3780	Association for International Cancer Research [05-160, 08-0017]; Medical Research Council [U.1051.03.012.00001.01]; Medical Research Council [MC_U105178808] Funding Source: researchfish; MRC [MC_U105178808] Funding Source: UKRI	Association for International Cancer Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Association for International Cancer Research (www.aicr.org.uk) Project grants 05-160 and 08-0017. Medical Research Council U.1051.03.012.00001.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Blastyak A, 2007, MOL CELL, V28, P167, DOI 10.1016/j.molcel.2007.07.030; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen Y, 2007, J MICROSC-OXFORD, V228, P139, DOI 10.1111/j.1365-2818.2007.01838.x; Dinant C, 2008, J MICROSC-OXFORD, V231, P97, DOI 10.1111/j.1365-2818.2008.02020.x; Edmunds CE, 2008, MOL CELL, V30, P519, DOI 10.1016/j.molcel.2008.03.024; Essers J, 2005, MOL CELL BIOL, V25, P9350, DOI 10.1128/MCB.25.21.9350-9359.2005; FRAMPTON J, 2006, MOL BIOL CELL; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gillespie David A F, 2006, Subcell Biochem, V40, P359; Haracska L, 2004, MOL CELL BIOL, V24, P4267, DOI 10.1128/MCB.24.10.4267-4274.2004; Hiraoka Y, 2002, CELL STRUCT FUNCT, V27, P367, DOI 10.1247/csf.27.367; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Katsumi S, 2001, J INVEST DERMATOL, V117, P1156, DOI 10.1046/j.0022-202x.2001.01540.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Megias D, 2009, MICROSC RES TECHNIQ, V72, P1, DOI 10.1002/jemt.20633; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motegi A, 2006, J CELL BIOL, V175, P703, DOI 10.1083/jcb.200606145; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Rasband W., 2006, IMAGEJ; Ross AL, 2005, NUCLEIC ACIDS RES, V33, P1280, DOI 10.1093/nar/gki279; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Unk I, 2006, P NATL ACAD SCI USA, V103, P18107, DOI 10.1073/pnas.0608595103; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Zhang SF, 2008, CELL CYCLE, V7, P3399, DOI 10.4161/cc.7.21.6949	39	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9008	10.1371/journal.pone.0009008	http://dx.doi.org/10.1371/journal.pone.0009008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126408	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200007
J	Mangone, M; Myers, MP; Herr, W				Mangone, Marco; Myers, Michael P.; Herr, Winship			Role of the HCF-1 Basic Region in Sustaining Cell Proliferation	PLOS ONE			English	Article							MAMMALIAN-CELLS; VP16; PROTEIN; FAMILY; CYTOKINESIS; ASSOCIATION; SEPARATE; POLYPEPTIDES; PROGRESSION; ACTIVATION	Background: The human herpes simplex virus-associated host cell factor 1 (HCF-1) is a conserved human transcriptional coregulator that links positive and negative histone modifying activities with sequence-specific DNA-binding transcription factors. It is synthesized as a 2035 amino acid precursor that is cleaved to generate an amino- (HCF-1(N)) terminal subunit, which promotes G1-to-S phase progression, and a carboxy- (HCF-1(C)) terminal subunit, which controls multiple aspects of cell division during M phase. The HCF-1(N) subunit contains a Kelch domain that tethers HCF-1 to sequence-specific DNA-binding transcription factors, and a poorly characterized so called "Basic'' region (owing to a high ratio of basic vs. acidic amino acids) that is required for cell proliferation and has been shown to associate with the Sin3 histone deacetylase (HDAC) component. Here we studied the role of the Basic region in cell proliferation and G1-to-S phase transition assays. Methodology/Principal Findings: Surprisingly, much like the transcriptional activation domains of sequence-specific DNA-binding transcription factors, there is no unique sequence within the Basic region required for promoting cell proliferation or G1-to-S phase transition. Indeed, the ability to promote these activities is size dependent such that the shorter the Basic region segment the less activity observed. We find, however, that the Basic region requirements for promoting cell proliferation in a temperature-sensitive tsBN67 cell assay are more stringent than for G1-to-S phase progression in an HCF-1 siRNA-depletion HeLa-cell assay. Thus, either half of the Basic region alone can support G1-to-S phase progression but not cell proliferation effectively in these assays. Nevertheless, the Basic region displays considerable structural plasticity because each half is able to promote cell proliferation when duplicated in tandem. Consistent with a potential role in promoting cell-cycle progression, the Sin3a HDAC component can associate independently with either half of the Basic region fused to the HCF-1 Kelch domain. Conclusions/Significance: While conserved, the HCF-1 Basic region displays striking structural flexibility for controlling cell proliferation.	[Mangone, Marco; Myers, Michael P.; Herr, Winship] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mangone, M (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	winship.herr@unil.ch	Herr, Winship/E-6491-2012; Mangone, Marco/H-2462-2016	Herr, Winship/0000-0002-3606-4546; Mangone, Marco/0000-0001-7551-8793	National Institutes of Health (NIH); Swiss National Science Foundation; University of Lausanne	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Lausanne	These studies were supported by the National Institutes of Health (NIH), the Swiss National Science Foundation, Oncosuisse, and the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Gunther M, 2000, MOL CELL BIOCHEM, V210, P131, DOI 10.1023/A:1007177623283; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Knez J, 2006, MOL CELL BIOCHEM, V288, P79, DOI 10.1007/s11010-006-9122-x; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lee S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001213; Mahajan SS, 2000, MOL CELL BIOL, V20, P919, DOI 10.1128/MCB.20.3.919-928.2000; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; NISHIMOTO T, 1980, SOMAT CELL GENET, V6, P465, DOI 10.1007/BF01539150; Reilly PT, 2002, EXP CELL RES, V277, P119, DOI 10.1006/excr.2002.5551; Reilly PT, 2002, MOL CELL BIOL, V22, P6767, DOI 10.1128/MCB.22.19.6767-6778.2002; TYAGI S, 2009, EMBO J IN PRESS; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Vogel JL, 2000, EMBO J, V19, P683, DOI 10.1093/emboj/19.4.683; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	23	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9020	10.1371/journal.pone.0009020	http://dx.doi.org/10.1371/journal.pone.0009020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126307	Green Published, gold, Green Accepted			2022-12-27	WOS:000274207200015
J	Perez-Costas, E; Gandy, JC; Melendez-Ferro, M; Roberts, RC; Bijur, GN				Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.			Light and Electron Microscopy Study of Glycogen Synthase Kinase-3 beta in the Mouse Brain	PLOS ONE			English	Article							PROTEIN-KINASE-I; DIFFERENTIAL REGULATION; ALZHEIMERS-DISEASE; TAU; PHOSPHORYLATION; LOCALIZATION; EXPRESSION; INHIBITION; GSK-3-BETA; ACTIVATION	Glycogen synthase kinase-3 beta (GSK3 beta) is highly abundant in the brain. Various biochemical analyses have indicated that GSK3 beta is localized to different intracellular compartments within brain cells. However, ultrastructural visualization of this kinase in various brain regions and in different brain cell types has not been reported. The goal of the present study was to examine GSK3 beta distribution and subcellular localization in the brain using immunohistochemistry combined with light and electron microscopy. Initial examination by light microscopy revealed that GSK3 beta is expressed in brain neurons and their dendrites throughout all the rostrocaudal extent of the adult mouse brain, and abundant GSK3 beta staining was found in the cortex, hippocampus, basal ganglia, the cerebellum, and some brainstem nuclei. Examination by transmission electron microscopy revealed highly specific subcellular localization of GSK3 beta in neurons and astrocytes. At the subcellular level, GSK3 beta was present in the rough endoplasmic reticulum, free ribosomes, and mitochondria of neurons and astrocytes. In addition GSK3 beta was also present in dendrites and dendritic spines, with some postsynaptic densities clearly labeled for GSK3 beta. Phosphorylation at serine-9 of GSK3 beta (pSer9GSK3 beta) reduces kinase activity. pSer9GSK3 beta labeling was present in all brain regions, but the pattern of staining was clearly different, with an abundance of labeling in microglia cells in all regions analyzed and much less neuronal staining in the subcortical regions. At the subcellular level pSer9GSK3 beta labeling was located in the endoplasmic reticulum, free ribosomes and in some of the nuclei. Overall, in normal brains constitutively active GSK3 beta is predominantly present in neurons while pSer9GSK3 beta is more evident in resting microglia cells. This visual assessment of GSK3 beta localization within the subcellular structures of various brain cells may help in understanding the diverse role of GSK3 beta signaling in the brain.	[Perez-Costas, Emma; Gandy, Johanna C.; Melendez-Ferro, Miguel; Roberts, Rosalinda C.; Bijur, Gautam N.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Perez-Costas, E (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	gautam@uab.edu		PEREZ-COSTAS, EMMA/0000-0002-9050-9593; Pasek, Johanna/0000-0003-1300-6164	National Institutes of Health (NIH) [NS044853, MH66123, MH60744]; University of Alabama at Birmingham Neuroscience Core [NS47466]; Cellular and Molecular Biology Program [GM008111]; Civitan International Research Center Emerging Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066123, R01MH060744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, R01NS044853] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Neuroscience Core; Cellular and Molecular Biology Program; Civitan International Research Center Emerging Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants NS044853 to GNB, MH66123 and MH60744 to RCR, and the University of Alabama at Birmingham Neuroscience Core grant NS47466. JCG is supported by the Cellular and Molecular Biology Program training grant GM008111 and the Civitan International Research Center Emerging Scholars Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohamad H, 2005, BIOL PSYCHIAT, V57, P533, DOI 10.1016/j.biopsych.2004.11.036; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Bijur GN, 2003, NEUROREPORT, V14, P2415, DOI 10.1097/00001756-200312190-00025; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002804; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Sarno P, 2006, NEUROBIOL AGING, V27, P413, DOI 10.1016/j.neurobiolaging.2005.03.003; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Elyaman W, 2002, EUR J NEUROSCI, V15, P651, DOI 10.1046/j.1460-9568.2002.01899.x; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ferrer I, 2002, ACTA NEUROPATHOL, V104, P583, DOI 10.1007/s00401-002-002-0587-8; GOODE N, 1992, J BIOL CHEM, V267, P16878; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; HEMMINGS BA, 1981, EUR J BIOCHEM, V119, P443, DOI 10.1111/j.1432-1033.1981.tb05628.x; Hernandez F, 2008, FEBS LETT, V582, P3848, DOI 10.1016/j.febslet.2008.10.026; Hooper C, 2007, EUR J NEUROSCI, V25, P81, DOI 10.1111/j.1460-9568.2006.05245.x; HOSHI M, 1995, J BIOCHEM-TOKYO, V118, P683, DOI 10.1093/oxfordjournals.jbchem.a124965; Hoshi M, 1996, P NATL ACAD SCI USA, V93, P2719, DOI 10.1073/pnas.93.7.2719; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Jope RS, 1999, MOL PSYCHIATR, V4, P117, DOI 10.1038/sj.mp.4000494; Kim H, 2007, J COMPUT-MEDIAT COMM, V12, P1183, DOI 10.1111/j.1083-6101.2007.00369.x; King TD, 2008, NEUROTOX RES, V14, P367, DOI 10.1007/BF03033861; King TD, 2001, BRAIN RES, V919, P106, DOI 10.1016/S0006-8993(01)03005-0; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2000, AM J PSYCHIAT, V157, P831, DOI 10.1176/appi.ajp.157.5.831; Lee SJ, 2006, NEUROSCI LETT, V409, P134, DOI 10.1016/j.neulet.2006.09.026; Leroy K, 2002, ACTA NEUROPATHOL, V103, P91; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Pandey GN, 2009, NEUROCHEM RES, V34, P274, DOI 10.1007/s11064-008-9770-1; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Pei JJ, 1997, J NEUROPATH EXP NEUR, V56, P70, DOI 10.1097/00005072-199701000-00007; Peineau S, 2008, BRIT J PHARMACOL, V153, pS428, DOI 10.1038/bjp.2008.2; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Petit-Paitel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005491; Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213; Rowe MK, 2007, NEUROSCI BIOBEHAV R, V31, P920, DOI 10.1016/j.neubiorev.2007.03.002; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; Shiurba RA, 1996, BRAIN RES, V737, P119, DOI 10.1016/0006-8993(96)00717-2; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Yuskaitis CJ, 2009, CELL SIGNAL, V21, P264, DOI 10.1016/j.cellsig.2008.10.014; Zhu LQ, 2007, J NEUROSCI, V27, P12211, DOI 10.1523/JNEUROSCI.3321-07.2007	56	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8911	10.1371/journal.pone.0008911	http://dx.doi.org/10.1371/journal.pone.0008911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111716	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800014
J	Zilhao, J; Davis, SJM; Duarte, C; Soares, AMM; Steier, P; Wild, E				Zilhao, Joao; Davis, Simon J. M.; Duarte, Cidalia; Soares, Antonio M. M.; Steier, Peter; Wild, Eva			Pego do Diabo (Loures, Portugal): Dating the Emergence of Anatomical Modernity in Westernmost Eurasia	PLOS ONE			English	Article							UPPER PALEOLITHIC TRANSITION; MODERN HUMAN ORIGINS; OXFORD AMS-SYSTEM; MODERN HUMANS; NEANDERTHAL EXTINCTION; RADIOCARBON-DATES; IBERIA; BONE; INTERSTRATIFICATION; AURIGNACIAN	Background: Neandertals and the Middle Paleolithic persisted in the Iberian Peninsula south of the Ebro drainage system for several millennia beyond their assimilation/replacement elsewhere in Europe. As only modern humans are associated with the later stages of the Aurignacian, the duration of this persistence pattern can be assessed via the dating of diagnostic occurrences of such stages. Methodology/Principal Findings: Using AMS radiocarbon and advanced pretreatment techniques, we dated a set of stratigraphically associated faunal samples from an Aurignacian III-IV context excavated at the Portuguese cave site of Pego do Diabo. Our results establish a secure terminus ante quem of ca.34,500 calendar years ago for the assimilation/replacement process in westernmost Eurasia. Combined with the chronology of the regional Late Mousterian and with less precise dating evidence for the Aurignacian II, they place the denouement of that process in the 37th millennium before present. Conclusions/Significance: These findings have implications for the understanding of the emergence of anatomical modernity in the Old World as a whole, support explanations of the archaic features of the Lagar Velho child's anatomy that invoke evolutionarily significant Neandertal/modern admixture at the time of contact, and counter suggestions that Neandertals could have survived in southwest Iberia until as late as the Last Glacial Maximum.	[Zilhao, Joao] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England; [Davis, Simon J. M.; Duarte, Cidalia] Inst Gestao Patrimonio Arquitecton & Arqueol, Lisbon, Portugal; [Soares, Antonio M. M.] Inst Tecnol & Nucl, Lisbon, Portugal; [Steier, Peter; Wild, Eva] Univ Vienna, Fac Phys, VERA Lab, Vienna, Austria	University of Bristol; Universidade de Lisboa; University of Vienna	Zilhao, J (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	Joao.Zilhao@bristol.ac.uk	Soares, António/K-1456-2013; Soares, António/AAD-5492-2019; Steier, Peter/AAZ-6043-2020; Zilhão, João/L-5670-2014	Soares, António/0000-0001-7112-0649; Soares, António/0000-0001-7112-0649; Zilhão, João/0000-0001-5937-3061; davis, simon/0000-0002-3124-1638	Instituto Portugues de Arqueologia [20062009]; University of Bristol Arts Faculty Research Fund	Instituto Portugues de Arqueologia; University of Bristol Arts Faculty Research Fund	The research was funded by the Instituto Portugues de Arqueologia (http://www.ipa.min-cultura.pt/), research project PALEOALMONDA III ( 20062009), and the University of Bristol Arts Faculty Research Fund (http://www.bristol.ac.uk/arts/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA F, 2006, MEDITERRANEAN BASIN, P119; ANGELUCCI DE, 2002, PORTRAIT ARTIST CHIL, P58; Angelucci DE, 2009, GEOARCHAEOLOGY, V24, P277, DOI 10.1002/gea.20267; Aubry T., 2001, REV PORT ARQUEOL, V4, P19; AUBRY T, 2008, SPACE TIME WHICH DIA, P9; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; BARROSO C, 2003, PLEISTOCENO SUPERIOR, P469; Belfer-Cohen A., 2003, MORE MEETS EYE STUDI, P1; Bicho N., 2005, PROMONTORIA, V3, P173; Boaretto E, 2002, J QUATERNARY SCI, V17, P633, DOI 10.1002/jqs.702; Bon F., 2002, ALAUDA, P29; Bon F., 2002, AURIGNACIEN GROTTE R, P115; BORDES JG, 2006, DEFINITION AURIGNACI, P147; BREUIL H, 1942, COMUNICACOES SERVICO, V23, P1; Bricker H.M., 1995, PALEOLITHIQUE SUPERI; Bronk Ramsey C, 2000, ARCHAEOMETRY, V42, P459; BRONKRAMSEY C, 1997, NUCL INSTR METHODS P, V123, P539; Cardoso J. L., 1993, CAMARA MUNICIPAL OEI, P567; Chiotti L., 1999, IND LITHIQUES NIVEAU; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; Connet N., 2002, THESIS U LILLE 1; Currat M, 2004, PLOS BIOL, V2, P2264, DOI 10.1371/journal.pbio.0020421; d'Errico F, 2003, QUATERNARY SCI REV, V22, P769, DOI 10.1016/S0277-3791(03)00009-X; Davis S., 2002, REV PORTUGUESA ARQUE, V5, P29; Davis SJM, 2007, COUR FOR SEKENBG, V259, P213; DAVIS SJM, 1992, 1992 HBMC AM LAB; Delporte H, 1991, B SOC PREHISTORIQUE, V88, P243; Delson E, 2006, NATURE, V443, DOI 10.1038/nature05207; Demars P.-Y., 1989, TYPES OUTILS LITHIQU; Duarte C, 1999, P NATL ACAD SCI USA, V96, P7604, DOI 10.1073/pnas.96.13.7604; Eswaran V, 2005, J HUM EVOL, V49, P1, DOI 10.1016/j.jhevol.2005.02.006; Finlayson C, 2008, QUATERN INT, V181, P64, DOI 10.1016/j.quaint.2007.11.016; Finlayson C, 2006, NATURE, V443, P850, DOI 10.1038/nature05195; *GEPP, 1979, INFORM ARQUEOLOGICA, V1, P22; GOWLETT JAJ, 1986, ARCHAEOMETRY, V28, P206, DOI 10.1111/j.1475-4754.1986.tb00389.x; HARPSOE C, 1987, ARQUEOLOGIA, V15, P140; Hawks J, 2007, P NATL ACAD SCI USA, V104, P20753, DOI 10.1073/pnas.0707650104; Higham TFG, 2006, RADIOCARBON, V48, P179, DOI 10.1017/S0033822200066388; Higham T, 2009, QUATERNARY SCI REV, V28, P1257, DOI 10.1016/j.quascirev.2008.12.018; Iturbe G., 1993, RECERQUES MUSEU DALC, V2, P23; Jimenez-Espejo FJ, 2007, QUATERNARY SCI REV, V26, P836, DOI 10.1016/j.quascirev.2006.12.013; Joris O., 2003, TRABAJOS PREHIST, V60, P15, DOI DOI 10.3989/TP.2003.V60.I2.79; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lucas G., 1997, PALEO, V9, P191; Marks A.E., 2000, 3 C ARQ PEN ACT PAL, V2, P341; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; Mellars P, 2007, P NATL ACAD SCI USA, V104, P3657, DOI 10.1073/pnas.0608053104; Neugebauer-Maresch C., 1999, PALEOLITHIQUE AUTRIC; NEUGEBAUERMARES.C, 1996, PALEOLITHIC MIDDLE D, P67; Neves MJ., 2006, TRABALHOS ARQUEOLOGI, P95; PARIS C, 2005, THESIS U PARIS 1 PAN; Perpere M., 2002, AURIGNACIEN GROTTE R, P143; PESESSE D, 2008, THESIS U PROVENCE; Pettitt P.B., 2000, NEANDERTHALS EDGE, P155; PETTITT PB, 2002, PORTRAIT ARTIST CHIL, P132; Ramsey CB, 2004, RADIOCARBON, V46, P155, DOI 10.1017/S0033822200039473; Rougier H, 2007, P NATL ACAD SCI USA, V104, P1165, DOI 10.1073/pnas.0610538104; Scheuer L., 2004, DEV JUVENILE OSTEOLO; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SOARES AMM, 1989, EFEITO RESERVATORIO; Soficaru A, 2007, CURR ANTHROPOL, V48, P611, DOI 10.1086/519915; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Sonneville-Bordes D., 1956, BULL SOC PREHIST FR, V53, P547; Straus LG, 2000, ANTIQUITY, V74, P553; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; TABORIN Y, 2002, AURIGNACIEN GROTTE R, P251; Teyssandier N., 2007, ROUTE OUEST DEBUTS A; Teyssandier N, 2008, WORLD ARCHAEOL, V40, P493, DOI 10.1080/00438240802452676; Thorne A. G., 2003, SCI AM, V13, P46; Trinkaus E, 2005, ANNU REV ANTHROPOL, V34, P207, DOI 10.1146/annurev.anthro.34.030905.154913; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; TRINKAUS E, 2002, PORTRAIT ARTIST CHIL, P497; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Valente Maria Joao, 2004, Revue de Paleobiologie, V23, P611; VALENTE MJ, 2000, THESIS U LISBON; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Vaquero Rodriguez M., 2006, PYRENAE, V37, P107; VEGA LG, 2005, NEANDERTALES CANTABR, P541; Walker MJ, 2008, P NATL ACAD SCI USA, V105, P20631, DOI 10.1073/pnas.0811213106; WALKER MJ, 2006, ACT 14 C UISPP SECT, P167; WALKER MJ, 2004, SETTELEMENT DYNAMICS, P461; WATSON JPN, 1979, J ARCHAEOL SCI, V6, P127, DOI 10.1016/0305-4403(79)90058-X; Weninger B, 2007, CALPAL 2007 COLOGNE; Weninger B, 2008, J HUM EVOL, V55, P772, DOI 10.1016/j.jhevol.2008.08.017; White R., 2002, AURIGNACIEN GROTTE R, P257; Wild EM, 2005, NATURE, V435, P332, DOI 10.1038/nature03585; Zilhao J, 1999, J WORLD PREHIST, V13, P1, DOI 10.1023/A:1022348410845; Zilhao J., 2006, TRABALHOS ARQUEOLOGI, P53; ZILHAO J, 2002, PORTRAIT ARTIST CHIL, P542; ZILHAO J, 2006, BEFORE FARMING, P95; ZILHAO J, 1996, ACT 1 C NEOL PEN IB, V2, P659; Zilhao J., 2008, PALEOANTHROPOLOGY, P1; Zilhao J., 2003, PALEO, V15, P69; Zilhao J., 1993, ORIGEN HOMBRE MODERN, P127; Zilhao J., 1997, PALEOLITICO SUPERIOR; Zilhao J., 2006, PYRENAE, V37, P7, DOI DOI 10.1039/C4CC09587A; ZILHAO J, 2010, P NATL ACAD IN PRESS; Zilhao J., 2002, PORTRAIT ARTIST CHIL, P29; Zilhao J, 2006, MISCELANEA HOMENAJE, VI, P372; Zilhao J., 2006, P PREHIST SOC, V72, P1; Zilhao J, 2007, J ARCHAEOL RES, V15, P1, DOI 10.1007/s10814-006-9008-1; Zilhao J, 2006, EVOL ANTHROPOL, V15, P183, DOI 10.1002/evan.20110; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103; Zilhao Joao, 2000, P111; Zilhao Joao, 2007, RETHINKING HUMAN REV, P249	107	69	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8880	10.1371/journal.pone.0008880	http://dx.doi.org/10.1371/journal.pone.0008880			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550FX	20111705	gold, Green Submitted, Green Published			2022-12-27	WOS:000274114800006
J	Huang, Y; Pastor, WA; Shen, YH; Tahiliani, M; Liu, DR; Rao, A				Huang, Yun; Pastor, William A.; Shen, Yinghua; Tahiliani, Mamta; Liu, David R.; Rao, Anjana			The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; TET2 MUTATIONS; CYTOSINE METHYLATION; MAMMALIAN DEVELOPMENT; MLL RECOMBINOME; EUKARYOTIC DNA; THYMINE GLYCOL; CPG SEQUENCES; CANCER	Background: We recently showed that enzymes of the TET family convert 5-mC to 5-hydroxymethylcytosine (5-hmC) in DNA. 5-hmC is present at high levels in embryonic stem cells and Purkinje neurons. The methylation status of cytosines is typically assessed by reaction with sodium bisulfite followed by PCR amplification. Reaction with sodium bisulfite promotes cytosine deamination, whereas 5-methylcytosine (5-mC) reacts poorly with bisulfite and is resistant to deamination. Since 5-hmC reacts with bisulfite to yield cytosine 5-methylenesulfonate (CMS), we asked how DNA containing 5-hmC behaves in bisulfite sequencing. Methodology/Principal Findings: We used synthetic oligonucleotides with different distributions of cytosine as templates for generation of DNAs containing C, 5-mC and 5-hmC. The resulting DNAs were subjected in parallel to bisulfite treatment, followed by exposure to conditions promoting cytosine deamination. The extent of conversion of 5-hmC to CMS was estimated to be 99.7%. Sequencing of PCR products showed that neither 5-mC nor 5-hmC undergo C-to-T transitions after bisulfite treatment, confirming that these two modified cytosine species are indistinguishable by the bisulfite technique. DNA in which CMS constituted a large fraction of all bases (28/201) was much less efficiently amplified than DNA in which those bases were 5-mC or uracil (the latter produced by cytosine deamination). Using a series of primer extension experiments, we traced the inefficient amplification of CMS-containing DNA to stalling of Taq polymerase at sites of CMS modification, especially when two CMS bases were either adjacent to one another or separated by 1-2 nucleotides. Conclusions: We have confirmed that the widely used bisulfite sequencing technique does not distinguish between 5-mC and 5-hmC. Moreover, we show that CMS, the product of bisulfite conversion of 5-hmC, tends to stall DNA polymerases during PCR, suggesting that densely hydroxymethylated regions of DNA may be underrepresented in quantitative methylation analyses.	[Huang, Yun; Pastor, William A.; Tahiliani, Mamta; Rao, Anjana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Huang, Yun; Pastor, William A.; Tahiliani, Mamta; Rao, Anjana] Immune Dis Inst, Boston, MA USA; [Shen, Yinghua; Liu, David R.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Shen, Yinghua; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard University; Howard Hughes Medical Institute	Huang, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@idi.harvard.edu	Liu, David R./HCH-3132-2022	Huang, Yun/0000-0001-5950-9168	National Institutes of Health (NIH) [R01 AI044432, RC1 DA028422]; Juvenile Diabetes Research Foundation; Howard Hughes Medical Institute; NIH/National Institute of General Medical Sciences (NIGMS) [R01 GM065865]; National Science Foundation and Department of Defense; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation and Department of Defense; GlaxoSmithKline-Immune Disease Institute Alliance; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01 AI044432 and RC1 DA028422 and a Scholar Award from the Juvenile Diabetes Research Foundation to A. R., Howard Hughes Medical Institute and NIH/National Institute of General Medical Sciences (NIGMS) (R01 GM065865) funding to D. R. L., and National Science Foundation and Department of Defense graduate fellowships to W. A. P. Y.H. is the recipient of a fellowship from the GlaxoSmithKline-Immune Disease Institute Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller P, 2007, P NATL ACAD SCI USA, V104, P814, DOI 10.1073/pnas.0606648104; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Burmeister T, 2009, BLOOD, V113, P4011, DOI 10.1182/blood-2008-10-183483; CLARK JM, 1986, NUCLEIC ACIDS RES, V14, P737, DOI 10.1093/nar/14.2.737; Clark SJ, 2006, NAT PROTOC, V1, P2353, DOI 10.1038/nprot.2006.324; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; GRUENBAUM Y, 1981, FEBS LETT, V124, P67, DOI 10.1016/0014-5793(81)80055-5; HAYATSU H, 1979, BIOCHEMISTRY-US, V18, P632, DOI 10.1021/bi00571a013; HAYATSU H, 1970, BIOCHEMISTRY-US, V9, P2858, DOI 10.1021/bi00816a016; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jankowska AM, 2009, BLOOD, V113, P6403, DOI 10.1182/blood-2009-02-205690; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Levine RL, 2009, NEW ENGL J MED, V360, P2355, DOI 10.1056/NEJMe0902257; LISTER R, 2009, NATURE; Lister R, 2009, GENOME RES, V19, P959, DOI 10.1101/gr.083451.108; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Mullighan CG, 2009, NAT GENET, V41, P766, DOI 10.1038/ng0709-766; Ono R, 2002, CANCER RES, V62, P4075; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rein T, 1998, NUCLEIC ACIDS RES, V26, P2255, DOI 10.1093/nar/26.10.2255; Smith LT, 2007, TRENDS GENET, V23, P449, DOI 10.1016/j.tig.2007.07.005; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tefferi A, 2009, LEUKEMIA, V23, P900, DOI 10.1038/leu.2009.37; Tetzner R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl955; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Zilberman D, 2007, DEVELOPMENT, V134, P3959, DOI 10.1242/dev.001131	45	516	539	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8888	10.1371/journal.pone.0008888	http://dx.doi.org/10.1371/journal.pone.0008888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126651	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896500011
J	Yip, KY; Alexander, RP; Yan, KK; Gerstein, M				Yip, Kevin Y.; Alexander, Roger P.; Yan, Koon-Kiu; Gerstein, Mark			Improved Reconstruction of In Silico Gene Regulatory Networks by Integrating Knockout and Perturbation Data	PLOS ONE			English	Article								We performed computational reconstruction of the in silico gene regulatory networks in the DREAM3 Challenges. Our task was to learn the networks from two types of data, namely gene expression profiles in deletion strains (the 'deletion data') and time series trajectories of gene expression after some initial perturbation (the 'perturbation data'). In the course of developing the prediction method, we observed that the two types of data contained different and complementary information about the underlying network. In particular, deletion data allow for the detection of direct regulatory activities with strong responses upon the deletion of the regulator while perturbation data provide richer information for the identification of weaker and more complex types of regulation. We applied different techniques to learn the regulation from the two types of data. For deletion data, we learned a noise model to distinguish real signals from random fluctuations using an iterative method. For perturbation data, we used differential equations to model the change of expression levels of a gene along the trajectories due to the regulation of other genes. We tried different models, and combined their predictions. The final predictions were obtained by merging the results from the two types of data. A comparison with the actual regulatory networks suggests that our approach is effective for networks with a range of different sizes. The success of the approach demonstrates the importance of integrating heterogeneous data in network reconstruction.	[Yip, Kevin Y.; Gerstein, Mark] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Alexander, Roger P.; Yan, Koon-Kiu; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA	Yale University; Yale University; Yale University	Yip, KY (corresponding author), Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA.	mark.gerstein@yale.edu	Yan, Koon-Kiu/A-5940-2009; Alexander, Roger/A-8643-2008; Yip, Kevin/AAT-4771-2020	Alexander, Roger/0000-0002-2967-7395; Yip, Kevin/0000-0001-5516-9944	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bonneau R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r36; Boyd S., 2004, CONVEX OPTIMIZATION; Chapelle O., 2006, IEEE T NEURAL NETWOR, V20, P542; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Dahlquist G, 2003, NUMERICAL METHODS; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Markowetz F, 2007, BIOINFORMATICS, V23, pI305, DOI 10.1093/bioinformatics/btm178; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Vaske CJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000274; Vu TT, 2007, NUCLEIC ACIDS RES, V35, P279, DOI 10.1093/nar/gkl1001; Wagner A, 2004, J COMPUT BIOL, V11, P53, DOI 10.1089/106652704773416885; Yeang CH, 2004, J COMPUT BIOL, V11, P243, DOI 10.1089/1066527041410382; DREAM3 CHALLENGES; DREAM DIALOGUE REVER	23	71	78	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8121	10.1371/journal.pone.0008121	http://dx.doi.org/10.1371/journal.pone.0008121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126643	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500001
J	Heiner, M; Sriram, K				Heiner, Monika; Sriram, K.			Structural Analysis to Determine the Core of Hypoxia Response Network	PLOS ONE			English	Article							PETRI NETS; OXYGEN; BIOLOGY; SYSTEMS; ROBUSTNESS; EXPRESSION; PROTEIN; MODEL	The advent of sophisticated molecular biology techniques allows to deduce the structure of complex biological networks. However, networks tend to be huge and impose computational challenges on traditional mathematical analysis due to their high dimension and lack of reliable kinetic data. To overcome this problem, complex biological networks are decomposed into modules that are assumed to capture essential aspects of the full network's dynamics. The question that begs for an answer is how to identify the core that is representative of a network's dynamics, its function and robustness. One of the powerful methods to probe into the structure of a network is Petri net analysis. Petri nets support network visualization and execution. They are also equipped with sound mathematical and formal reasoning based on which a network can be decomposed into modules. The structural analysis provides insight into the robustness and facilitates the identification of fragile nodes. The application of these techniques to a previously proposed hypoxia control network reveals three functional modules responsible for degrading the hypoxia-inducible factor (HIF). Interestingly, the structural analysis identifies superfluous network parts and suggests that the reversibility of the reactions are not important for the essential functionality. The core network is determined to be the union of the three reduced individual modules. The structural analysis results are confirmed by numerical integration of the differential equations induced by the individual modules as well as their composition. The structural analysis leads also to a coarse network structure highlighting the structural principles inherent in the three functional modules. Importantly, our analysis identifies the fragile node in this robust network without which the switch-like behavior is shown to be completely absent.	[Heiner, Monika] Brandenburg Tech Univ Cottbus, Dept Comp Sci, Cottbus, Germany; [Sriram, K.] INRIA Rocquencourt, Projet Contraintes, Le Chesnay, France	Brandenburg University of Technology Cottbus	Heiner, M (corresponding author), Brandenburg Tech Univ Cottbus, Dept Comp Sci, Cottbus, Germany.	monika.heiner@tu-cottbus.de	Heiner, Monika/AAG-1022-2019	Heiner, Monika/0000-0003-1815-1205				Bause F, 1999, STOCHASTIC PETRI NET; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bonzanni N, 2009, BIOINFORMATICS, V25, P2049, DOI 10.1093/bioinformatics/btp355; Breitling R, 2008, BRIEF BIOINFORM, V9, P404, DOI 10.1093/bib/bbn026; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; CHEN L, 2009, BMC SYSTEMS BIOL, V3, P42; David R., 2005, DISCRETE CONTINUOUS; Dayan F, 2009, J THEOR BIOL, V259, P304, DOI 10.1016/j.jtbi.2009.03.009; Felix MA, 2008, HEREDITY, V100, P132, DOI 10.1038/sj.hdy.6800915; GILBERT D, 2008, P 2 IFIP C BIOL INSP, P163; Gilbert D, 2006, LECT NOTES COMPUT SC, V4024, P181; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heiner M, 2004, LECT NOTES COMPUT SC, V3099, P216; HEINER M, 2008, P PNTAP 2008 ASS SIM; HEINER M, 2010, SYMBOLIC SY IN PRESS; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Heiner M, 2008, LECT NOTES COMPUT SC, V5016, P215; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; LAUTENBACH K, 1973, 82 GMD; Los M, 1996, LAB INVEST, V75, P231; Marwan W, 2011, NAT COMPUT, V10, P639, DOI 10.1007/s11047-009-9152-x; Matsuda S, 2006, ELECTRON COMM JPN 1, V89, P11, DOI 10.1002/ecja.20240; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; NAGASAKI M, 2009, FDN SYSTEMS BIOL USI; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Qutub AA, 2006, J CELL SCI, V119, P3467, DOI 10.1242/jcs.03087; Saugstad OD, 2006, J PERINATOL, V26, pS46, DOI 10.1038/sj.jp.7211475; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Vaupel P, 2004, SEMIN RADIAT ONCOL, V14, P198, DOI 10.1016/j.semradonc.2004.04.008; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; 2008, TOOL ANAL PLACE TRAN	38	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8600	10.1371/journal.pone.0008600	http://dx.doi.org/10.1371/journal.pone.0008600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098728	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900002
J	Poulsen, M; Currie, CR				Poulsen, Michael; Currie, Cameron R.			Symbiont Interactions in a Tripartite Mutualism: Exploring the Presence and Impact of Antagonism between Two Fungus-Growing Ant Mutualists	PLOS ONE			English	Article							LEAF-CUTTING ANTS; ATTA-SEXDENS-RUBROPILOSA; ACTINOMYCETE BACTERIA; GARDENING ANT; HOST; FORMICIDAE; EVOLUTION; AGRICULTURE; HYMENOPTERA; COOPERATION	Mutualistic associations are shaped by the interplay of cooperation and conflict among the partners involved, and it is becoming increasingly clear that within many mutualisms multiple partners simultaneously engage in beneficial interactions. Consequently, a more complete understanding of the dynamics within multipartite mutualism communities is essential for understanding the origin, specificity, and stability of mutualisms. Fungus-growing ants cultivate fungi for food and maintain antibiotic-producing Pseudonocardia actinobacteria on their cuticle that help defend the cultivar fungus from specialized parasites. Within both ant-fungus and ant-bacterium mutualisms, mixing of genetically distinct strains can lead to antagonistic interactions (i.e., competitive conflict), which may prevent the ants from rearing multiple strains of either of the mutualistic symbionts within individual colonies. The success of different ant-cultivar-bacterium combinations could ultimately be governed by antagonistic interactions between the two mutualists, either as inhibition of the cultivar by Pseudonocardia or vice versa. Here we explore cultivar-Pseudonocardia antagonism by evaluating in vitro interactions between strains of the two mutualists, and find frequent antagonistic interactions both from cultivars towards Pseudonocardia and vice versa. To test whether such in vitro antagonistic interactions affect ant colonies in vivo, we performed sub-colony experiments using species of Acromyrmex leaf-cutting ants. We created novel ant-fungus-bacterium pairings in which there was antagonism from one, both, or neither of the ants' microbial mutualists, and evaluated the effect of directional antagonism on cultivar biomass and Pseudonocardia abundance on the cuticle of workers within subcolonies. Despite the presence of frequent in vitro growth suppression between cultivars and Pseudonocardia, antagonism from Pseudonocardia towards the cultivar did not reduce sub-colony fungus garden biomass, nor did cultivar antagonism towards Pseudonocardia reduce bacteria abundance on the cuticle of sub-colony workers. Our findings suggest that inter-mutualist antagonism does not limit what combinations of cultivar and Pseudonocardia strains Acromyrmex fungus-growing ants can maintain within nests.	[Poulsen, Michael; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Poulsen, M (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	Poulsen@bact.wisc.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	The Carlsberg Foundation; National Science Foundation [0747002]; Direct For Biological Sciences [0747002] Funding Source: National Science Foundation	The Carlsberg Foundation(Carlsberg Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by The Carlsberg Foundation to MP and National Science Foundation (CAREER 0747002) to CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS AS, 2009, COMMUNITY ANAL BACTE; Adams RMM, 2000, NATURWISSENSCHAFTEN, V87, P491, DOI 10.1007/s001140050765; BACCI M, 1995, BRAZ J MED BIOL RES, V28, P79; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Brandao CRF, 2001, SOCIOBIOLOGY, V38, P639; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; CAFARO MJ, CODIVERSIFICAT UNPUB; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; Carreiro SC, 1997, ANTON LEEUW INT J G, V71, P243, DOI 10.1023/A:1000182108648; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; Dekker KA, 1998, J ANTIBIOT, V51, P145, DOI 10.7164/antibiotics.51.145; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Fernandez-Marin H, 2004, BIOL J LINN SOC, V81, P39, DOI 10.1111/j.1095-8312.2004.00268.x; Frank SA, 1996, P ROY SOC B-BIOL SCI, V263, P339, DOI 10.1098/rspb.1996.0052; Frank SA, 2003, EVOLUTION, V57, P693; Gaume L, 1998, P ROY SOC B-BIOL SCI, V265, P569, DOI 10.1098/rspb.1998.0332; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; Haeder S, 2009, P NATL ACAD SCI USA, V106, P4742, DOI 10.1073/pnas.0812082106; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Ivens ABF, 2009, BEHAV ECOL, V20, P378, DOI 10.1093/beheco/arn150; Kiers ET, 2003, NATURE, V425, P78, DOI 10.1038/nature01931; Lee MY, 2006, J IND MICROBIOL BIOT, V33, P84, DOI 10.1007/s10295-005-0018-7; Little AEF, 2008, ECOLOGY, V89, P1216, DOI 10.1890/07-0815.1; Little AEF, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-124; Margulis L., 1993, SYMBIOSIS CELL EVOLU; Mehdiabadi NJ, 2006, BEHAV ECOL, V17, P291, DOI 10.1093/beheco/arj028; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Mueller UG, 2005, ANNU REV ECOL EVOL S, V36, P563, DOI 10.1146/annurev.ecolsys.36.102003.152626; Mueller UG, 2008, EVOLUTION, V62, P2894, DOI 10.1111/j.1558-5646.2008.00501.x; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Poulsen M, 2005, SCIENCE, V307, P741, DOI 10.1126/science.1106688; Poulsen M, 2005, MOL ECOL, V14, P3597, DOI 10.1111/j.1365-294X.2005.02695.x; Poulsen M, 2003, NATURWISSENSCHAFTEN, V90, P406, DOI 10.1007/s00114-003-0450-3; Poulsen M, 2003, FUNCT ECOL, V17, P260, DOI 10.1046/j.1365-2435.2003.00726.x; Poulsen M, 2002, INSECT SOC, V49, P15, DOI 10.1007/s00040-002-8271-5; POULSEN M, 2010, ENV MICRORE IN PRESS; Poulsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000960; Poulsen M, 2009, EVOLUTION, V63, P2235, DOI 10.1111/j.1558-5646.2009.00704.x; Reynolds HT, 2004, MYCOLOGIA, V96, P955, DOI 10.2307/3762079; Richard FJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1637, DOI 10.1007/s00265-007-0395-1; Rodrigues A, 2008, MICROB ECOL, V56, P604, DOI 10.1007/s00248-008-9380-0; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Santos AV, 2004, FEMS MICROBIOL LETT, V239, P319, DOI 10.1016/j.femsle.2004.09.005; *SAS STAT, 1994, SAS STAT US GUID, V1; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Seal JN, 2007, FUNCT ECOL, V21, P988, DOI 10.1111/j.1365-2435.2007.01294.x; Sen R, 2009, P NATL ACAD SCI USA, V106, P17805, DOI 10.1073/pnas.0904827106; Stachowicz JJ, 2005, ECOLOGY, V86, P2418, DOI 10.1890/04-0819; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Viana AMM, 2001, CHEMOECOLOGY, V11, P29, DOI 10.1007/PL00001829; von Ihering H., 1898, ZOOL ANZ, V21, P238; WAKSMAN SA, 1950, ACTINOMYCETES THEIR; WEBER NA, 1972, AM ZOOL, V12, P577; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466; Zhang MM, 2007, ISME J, V1, P313, DOI 10.1038/ismej.2007.41	73	29	29	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8748	10.1371/journal.pone.0008748	http://dx.doi.org/10.1371/journal.pone.0008748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090958	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900024
J	Imlach, WL; Finch, SC; Miller, JH; Meredith, AL; Dalziel, JE				Imlach, Wendy L.; Finch, Sarah C.; Miller, John H.; Meredith, Andrea L.; Dalziel, Julie E.			A Role for BK Channels in Heart Rate Regulation in Rodents	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNEL; CA2+-ACTIVATED K+ CHANNEL; LARGE-CONDUCTANCE; BETA-SUBUNIT; STRUCTURE ELUCIDATION; SMOOTH-MUSCLE; LOLITREM-B; TREMORGENIC MYCOTOXIN; GENE-EXPRESSION; MICE LACKING	The heart generates and propagates action potentials through synchronized activation of ion channels allowing inward Na+ and Ca2+ and outward K+ currents. There are a number of K+ channel types expressed in the heart that play key roles in regulating the cardiac cycle. Large conductance calcium-activated potassium (BK) ion channels are not thought to be directly involved in heart function. Here we present evidence that heart rate can be significantly reduced by inhibiting the activity of BK channels. Agents that specifically inhibit BK channel activity, including paxilline and lolitrem B, slowed heart rate in conscious wild-type mice by 30% and 42%, respectively. Heart rate of BK channel knock-out mice (Kcnma1(-/-)) was not affected by these BK channel inhibitors, suggesting that the changes to heart rate were specifically mediated through BK channels. The possibility that these effects were mediated through BK channels peripheral to the heart was ruled out with experiments using isolated, perfused rat hearts, which showed a significant reduction in heart rate when treated with the BK channel inhibitors paxilline (1 mu M), lolitrem B (1 mu M), and iberiotoxin (0.23 mu M), of 34%, 60%, and 42%, respectively. Furthermore, paxilline was shown to decrease heart rate in a dose-dependent manner. These results implicate BK channels located in the heart to be directly involved in the regulation of heart rate.	[Imlach, Wendy L.; Dalziel, Julie E.] AgResearch, Grasslands Res Ctr, Palmerston North, New Zealand; [Finch, Sarah C.] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand; [Miller, John H.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Meredith, Andrea L.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Imlach, Wendy L.] Univ Otago, Dept Pharmacol & Toxicol, Dunedin, New Zealand	AgResearch - New Zealand; AgResearch - New Zealand; Victoria University Wellington; University System of Maryland; University of Maryland Baltimore; University of Otago	Imlach, WL (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Med Ctr, New York, NY 10027 USA.	julie.dalziel@agresearch.co.nz	Imlach, Wendy/G-7609-2011; Finch, Sarah/L-5795-2013	Imlach, Wendy/0000-0002-7521-9969; Finch, Sarah/0000-0003-2765-5843; Dalziel, Julie/0000-0003-3629-2351; Meredith, Andrea/0000-0003-1061-2302	Marsden Fund; Royal Society of New Zealand [AGR302]; Neural Systems Research Theme, University of Otago, New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society of New Zealand(Royal Society of New Zealand); Neural Systems Research Theme, University of Otago, New Zealand	This work was supported by a Marsden Fund, Royal Society of New Zealand (http://marsden.rsnz.org/) grant AGR302 (J.D., S.F., A.M.) and a travel grant from the Neural Systems Research Theme, University of Otago, New Zealand (W.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bilmen JG, 2002, ARCH BIOCHEM BIOPHYS, V406, P55, DOI 10.1016/S0003-9861(02)00240-0; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CALLEWAERT G, 1986, PFLUG ARCH EUR J PHY, V406, P424, DOI 10.1007/BF00590947; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chen MY, 2009, J UROLOGY, V182, P374, DOI 10.1016/j.juro.2009.02.109; Dalziel JE, 2005, TOXICOL LETT, V155, P421, DOI 10.1016/j.toxlet.2004.11.011; DeFarias FP, 1996, EUR J PHARMACOL, V314, P123, DOI 10.1016/S0014-2999(96)00540-7; DWORETZKY SI, 1994, MOL BRAIN RES, V27, P189, DOI 10.1016/0169-328X(94)90203-8; Filosa JA, 2006, NAT NEUROSCI, V9, P1397, DOI 10.1038/nn1779; Franciolini F, 2001, PFLUG ARCH EUR J PHY, V441, P629, DOI 10.1007/s004240000471; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Gribkoff VK, 2001, NEUROSCIENTIST, V7, P166, DOI 10.1177/107385840100700211; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Imlach WL, 2008, J PHARMACOL EXP THER, V327, P657, DOI 10.1124/jpet.108.143933; Imlach WL, 2009, EUR J PHARMACOL, V605, P36, DOI 10.1016/j.ejphar.2008.12.031; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Longland CL, 2000, EUR J PHARMACOL, V408, P219, DOI 10.1016/S0014-2999(00)00775-5; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; Meredith AL, 2006, NAT NEUROSCI, V9, P1041, DOI 10.1038/nn1740; MILES CO, 1994, J AGR FOOD CHEM, V42, P1488, DOI 10.1021/jf00043a018; Munday-Finch SC, 1998, J AGR FOOD CHEM, V46, P590, DOI 10.1021/jf9706787; MundayFinch SC, 1996, J AGR FOOD CHEM, V44, P2782, DOI 10.1021/jf950396b; MUNDAYFINCH SC, 1995, J AGR FOOD CHEM, V43, P1283, DOI 10.1021/jf00053a029; MundayFinch SC, 1997, J AGR FOOD CHEM, V45, P199, DOI 10.1021/jf960396r; MundayFinch SC, 1996, PHYTOCHEMISTRY, V41, P327, DOI 10.1016/0031-9422(95)00515-3; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Oliveira NS, 2002, PHARMACOL RES, V46, P15, DOI 10.1016/S1043-6618(02)00074-9; PLUZNICK JL, 2005, AM J PHYSIOL-RENAL, V288, P57; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Ruttiger L, 2004, P NATL ACAD SCI USA, V101, P12922, DOI 10.1073/pnas.0402660101; Ryckwaert F, 2009, CRIT CARE MED, V37, P876, DOI 10.1097/CCM.0b013e31819b8199; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier M, 2006, J AM SOC NEPHROL, V17, P1275, DOI 10.1681/ASN.2005101111; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; SHEN KZ, 1994, PFLUG ARCH EUR J PHY, V426, P440, DOI 10.1007/BF00388308; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Sorensen MV, 2008, J PHYSIOL-LONDON, V586, P4251, DOI 10.1113/jphysiol.2008.156968; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thorneloe KS, 2005, AM J PHYSIOL-RENAL, V289, pF604, DOI 10.1152/ajprenal.00060.2005; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang L, 2003, RES VET SCI, V74, P93, DOI 10.1016/S0034-5288(02)00153-4; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; WILSON MF, 1980, ANN SURG, V191, P494, DOI 10.1097/00000658-198004000-00017; XIMOY SX, 1995, J PHYSIOL-LONDON, V486, P15, DOI 10.1113/jphysiol.1995.sp020787; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Zavala-Tecuapetla C, 2008, EUR J NEUROSCI, V27, P2871, DOI 10.1111/j.1460-9568.2008.06214.x	60	39	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8698	10.1371/journal.pone.0008698	http://dx.doi.org/10.1371/journal.pone.0008698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090847	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714600002
J	Farzaneh-Far, R; Lin, J; Epel, E; Lapham, K; Blackburn, E; Whooley, MA				Farzaneh-Far, Ramin; Lin, Jue; Epel, Elissa; Lapham, Kyle; Blackburn, Elizabeth; Whooley, Mary A.			Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study	PLOS ONE			English	Article							OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; DEPRESSIVE SYMPTOMS; OBESITY; BLOOD; RISK; ASSOCIATION; HEALTH; WOMEN	Background: Leukocyte telomere length, an emerging marker of biological age, has been shown to predict cardiovascular morbidity and mortality. However, the natural history of telomere length in patients with coronary artery disease has not been studied. We sought to investigate the longitudinal trajectory of telomere length, and to identify the independent predictors of telomere shortening, in persons with coronary artery disease. Methodology/Principal Findings: In a prospective cohort study of 608 individuals with stable coronary artery disease, we measured leukocyte telomere length at baseline, and again after five years of follow-up. We used multivariable linear and logistic regression models to identify the independent predictors of leukocyte telomere trajectory. Baseline and follow-up telomere lengths were normally distributed. Mean telomere length decreased by 42 base pairs per year (p < 0.001). Three distinct telomere trajectories were observed: shortening in 45%, maintenance in 32%, and lengthening in 23% of participants. The most powerful predictor of telomere shortening was baseline telomere length (OR per SD increase = 7.6; 95% CI 5.5, 10.6). Other independent predictors of telomere shortening were age (OR per 10 years = 1.6; 95% CI 1.3, 2.1), male sex (OR = 2.4; 95% CI 1.3, 4.7), and waist-to-hip ratio (OR per 0.1 increase = 1.4; 95% CI 1.0, 2.0). Conclusions/Significance: Leukocyte telomere length may increase as well as decrease in persons with coronary artery disease. Telomere length trajectory is powerfully influenced by baseline telomere length, possibly suggesting negative feedback regulation. Age, male sex, and abdominal obesity independently predict telomere shortening. The mechanisms and reversibility of telomeric aging in cardiovascular disease deserve further study.	[Farzaneh-Far, Ramin] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lin, Jue; Lapham, Kyle; Blackburn, Elizabeth] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Epel, Elissa] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Farzaneh-Far, R (corresponding author), San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu			American Heart Association [0875014N]; Department of Veterans Affairs; National Heart, Lung and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award (#0875014N). The Heart and Soul study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program); the National Heart, Lung and Blood Institute (R01 HL079235); the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program); the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program); the Ischemia Research and Education Foundation; and the Nancy Kirwan Heart Research Fund. Jue Lin and Kyle Lapham are supported by the Bernard and Barbro Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2006, AGING CELL, V5, P361, DOI 10.1111/j.1474-9726.2006.00222.x; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; den Buijs JO, 2004, MECH AGEING DEV, V125, P437, DOI 10.1016/j.mad.2004.03.007; EHRLENBACH S, 2009, INT J EPIDEMIOL; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Nordfjall K, 2008, SCAND J PUBLIC HEALT, V36, P744, DOI 10.1177/1403494808090634; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Ruo B, 2004, AM J CARDIOL, V94, P96, DOI 10.1016/j.amjcard.2004.03.035; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	33	169	173	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8612	10.1371/journal.pone.0008612	http://dx.doi.org/10.1371/journal.pone.0008612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072607	Green Published, gold			2022-12-27	WOS:000273414200008
J	Lam, YW; Yuan, Y; Isaac, J; Babu, CVS; Meller, J; Ho, SM				Lam, Ying Wai; Yuan, Yong; Isaac, Jared; Babu, C. V. Suresh; Meller, Jarek; Ho, Shuk-Mei			Comprehensive Identification and Modified-Site Mapping of S-Nitrosylated Targets in Prostate Epithelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; OXIDATIVE/NITROSATIVE STRESS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; REDOX STATE; NOBLE RAT; PROTEIN; CANCER; APOPTOSIS; CARCINOGENESIS	Background: Although overexpression of nitric oxide synthases (NOSs) has been found associated with prostate diseases, the underlying mechanisms for NOS-related prostatic diseases remain unclear. One proposed mechanism is related to the S-nitrosylation of key regulatory proteins in cell-signaling pathways due to elevated levels of NO in the prostate. Thus, our primary objective was to identify S-nitrosylated targets in an immortalized normal prostate epithelial cell line, NPrEC. Methodology/Principal Findings: We treated NPrEC with nitroso-cysteine and used the biotin switch technique followed by gel-based separation and mass spectrometry protein identification (using the LTQ-Orbitrap) to discover S-nitrosylated (SNO) proteins in the treated cells. In parallel, we adapted a peptide pull-down methodology to locate the site(s) of S-nitrosylation on the protein SNO targets identified by the first technique. This combined approach identified 116 SNO proteins and determined the sites of modification for 82 of them. Over 60% of these proteins belong to four functional groups: cell structure/cell motility/protein trafficking, protein folding/protein response/protein assembly, mRNA splicing/processing/transcriptional regulation, and metabolism. Western blot analysis validated a subset of targets related to disease development (proliferating cell nuclear antigen, maspin, integrin beta 4, alpha-catenin, karyopherin [importin] beta 1, and elongation factor 1A1). We analyzed the SNO sequences for their primary and secondary structures, solvent accessibility, and three-dimensional structural context. We found that about 80% of the SNO sites that can be mapped into resolved structures are buried, of which approximately half have charged amino acids in their three-dimensional neighborhood, and the other half residing within primarily hydrophobic pockets. Conclusions/Significance: We here identified 116 potential SNO targets and mapped their putative SNO sites in NPrEC. Elucidation of how this post-translational modification alters the function of these proteins should shed light on the role of NO in prostate pathologies. To our knowledge, this is the first report identifying SNO targets in prostate epithelial cells.	[Lam, Ying Wai; Yuan, Yong; Isaac, Jared; Babu, C. V. Suresh; Meller, Jarek; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Lam, Ying Wai; Meller, Jarek; Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH USA; [Ho, Shuk-Mei] Univ Cincinnati, Coll Med, Cincinnati Canc Consortium, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Lam, YW (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	shuk-mei.ho@uc.edu	Meller, Jaroslaw/A-1971-2011	Meller, Jaroslaw/0000-0002-1162-8253	National Institutes of Health [ES006096, CA015776, CA062269, CA112532, ES015584]; Department of Environmental Health; College of Medicine, of the University of Cincinnati; NATIONAL CANCER INSTITUTE [R01CA112532, R01CA015776, R01CA062269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096, R01ES015584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Environmental Health; College of Medicine, of the University of Cincinnati; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research supported in part with National Institutes of Health (www.nih.gov) grants ES006096, CA015776, CA062269, CA112532, and ES015584 (to SMH), and GM067823 (to JM), and internal funding support from the Department of Environmental Health, College of Medicine, of the University of Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltomaa SH, 2001, ANTICANCER RES, V21, P3101; Adamczak R, 2004, PROTEINS, V56, P753, DOI 10.1002/prot.20176; Arsova-Sarafinovska Z, 2009, CLIN BIOCHEM, V42, P1228, DOI 10.1016/j.clinbiochem.2009.05.009; Ascenzi P, 2000, BIOL CHEM, V381, P623, DOI 10.1515/BC.2000.081; AZAD N, 2009, AM J RESP C IN PRESS; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Baltaci S, 2001, BJU INT, V88, P100, DOI 10.1046/j.1464-410x.2001.02231.x; Benhar M, 2005, NAT CELL BIOL, V7, P645, DOI 10.1038/ncb0705-645; Camerini S, 2007, J PROTEOME RES, V6, P3224, DOI 10.1021/pr0701456; Chaiswing L, 2008, CANCER RES, V68, P5820, DOI 10.1158/0008-5472.CAN-08-0162; Chaiswing L, 2007, FREE RADICAL BIO MED, V43, P202, DOI 10.1016/j.freeradbiomed.2007.03.031; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Crowell JA, 2003, MOL CANCER THER, V2, P815; De Marzo AM, 2007, UROL ONCOL-SEMIN ORI, V25, P398, DOI 10.1016/j.urolonc.2007.05.007; Dua K, 2001, PROTEOMICS, V1, P1191, DOI 10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO;2-8; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; FIBBI B, 2009, INT J ANDRO IN PRESS; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Forrester MT, 2006, ACS CHEM BIOL, V1, P355, DOI 10.1021/cb600244c; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Gradini R, 1999, J PATHOL, V189, P224; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Han P, 2008, RAPID COMMUN MASS SP, V22, P1137, DOI 10.1002/rcm.3476; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; IGNARRO LJ, 1991, BIOCHEM PHARMACOL, V41, P485, DOI 10.1016/0006-2952(91)90618-F; Iyer AKV, 2008, NITRIC OXIDE-BIOL CH, V19, P146, DOI 10.1016/j.niox.2008.04.019; JAFFREY SR, 2001, SCI STKE, V86, pL1; Jaiswal M, 2001, CANCER RES, V61, P6388; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Kedia G, 2008, WORLD J UROL, V26, P603, DOI 10.1007/s00345-008-0303-y; Lam YW, 2008, PROTEOMICS, V8, P2750, DOI 10.1002/pmic.200700986; Lam YW, 2005, PROTEOMICS, V5, P2927, DOI 10.1002/pmic.200401165; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; LAVAL F, 1994, CARCINOGENESIS, V15, P443, DOI 10.1093/carcin/15.3.443; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lipton SA, 2007, INT REV NEUROBIOL, V82, P1, DOI 10.1016/S0074-7742(07)82001-0; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; LOWENSTEIN CJ, 1992, CELL, V70, P705, DOI 10.1016/0092-8674(92)90301-R; Mannick JB, 2008, METHOD ENZYMOL, V440, P231, DOI 10.1016/S0076-6879(07)00814-2; Margadant C, 2008, CURR OPIN CELL BIOL, V20, P589, DOI 10.1016/j.ceb.2008.05.001; Martinez-Ruiz Antonio, 2007, Methods Mol Biol, V357, P215; McKenzie S, 2008, ONCOGENE, V27, P7171, DOI 10.1038/onc.2008.321; Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Narayanan NK, 2009, PROSTATE, V69, P133, DOI 10.1002/pros.20862; Ng QS, 2007, LANCET ONCOL, V8, P111, DOI 10.1016/S1470-2045(07)70001-3; Olson SY, 2008, NITRIC OXIDE-BIOL CH, V19, P170, DOI 10.1016/j.niox.2008.04.005; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Polytarchou C, 2009, INT J CANCER, V124, P1785, DOI 10.1002/ijc.24084; Pontes-Junior Jose, 2009, J Carcinog, V8, P3; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tam NNC, 2007, AM J PATHOL, V171, P1334, DOI 10.2353/ajpath.2007.070199; Tam NNC, 2006, PROSTATE, V66, P57, DOI 10.1002/pros.20313; Uotila P, 2001, Urol Res, V29, P23; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146	64	72	72	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9075	10.1371/journal.pone.0009075	http://dx.doi.org/10.1371/journal.pone.0009075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140087	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442400013
J	Okpechi, IG; Rayner, BL; van der Merwe, L; Mayosi, BM; Adeyemo, A; Tiffin, N; Ramesar, R				Okpechi, Ikechi G.; Rayner, Brian L.; van der Merwe, Lize; Mayosi, Bongani M.; Adeyemo, Adebowale; Tiffin, Nicki; Ramesar, Rajkumar			Genetic Variation at Selected SNPs in the Leptin Gene and Association of Alleles with Markers of Kidney Disease in a Xhosa Population of South Africa	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; UNITED-STATES; BLOOD-PRESSURE; EXCESS RISK; OBESE GENE; POLYMORPHISM; HYPERTENSION	Background: Chronic kidney disease (CKD) is a significant public health problem that leads to end-stage renal disease (ESRD) with as many as 2 million people predicted to need therapy worldwide by 2010. Obesity is a risk factor for CKD and leptin, the obesity hormone, correlates with body fat mass and markers of renal function. A number of clinical and experimental studies have suggested a link between serum leptin and kidney disease. We hypothesised that variants in the leptin gene (LEP) may be associated with markers of CKD in indigenous black Africans. Methodology/Principal Findings: Black South Africans of Xhosa (distinct cultural Bantu-speaking population) descent were recruited for the study and four common polymorphisms of the LEP (rs7799039, rs791620, rs2167270 and STS-U43653 [ENSSNP5824596]) were analysed for genotype and haplotype association with urine albumin-to-creatinine ratio (UACR), estimated glomerular filtration rate (eGFR), Serum creatinine (Scr) and serum leptin level. In one of the four single nucleotide polymorphisms (SNPs) we examined, an association with the renal phenotypes was observed. Hypertensive subjects with the T allele (CT genotype) of the ENSSNP5824596 SNP had a significantly higher eGFR (p = 0.0141), and significantly lower Scr (p = 0.0137). This was confirmed by haplotype analysis. Also, the haplotype GAAC had a modest effect on urine albumin-to-creatinine ratio in normotensive subjects (p = 0.0482). Conclusions/Significance: These results suggest that genetic variations of the LEP may be associated with phenotypes that are markers of CKD in black Africans.	[Okpechi, Ikechi G.; Rayner, Brian L.; Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [van der Merwe, Lize] Univ Cape Town, Dept Stat, ZA-7925 Cape Town, South Africa; [Adeyemo, Adebowale] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Tiffin, Nicki; Ramesar, Rajkumar] Univ Cape Town, Div Human Genet, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Cape Town	Okpechi, IG (corresponding author), Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa.	ikokpechi@yahoo.com	Ramesar, Raj S/I-6941-2015; Rayner, Brian/AAA-3174-2021; Tiffin, Nicki/ABA-9391-2020; Tiffin, Nicki/A-5914-2013; van der Merwe, Lize/D-3148-2012	Ramesar, Raj S/0000-0001-5688-1634; Tiffin, Nicki/0000-0001-5083-2735; van der Merwe, Lize/0000-0001-9705-8126; Adeyemo, Adebowale/0000-0002-3105-3231; Rayner, Brian/0000-0002-0167-9591; Mayosi, Bongani/0000-0001-6641-8950	Wyeth Nephrology Funds	Wyeth Nephrology Funds	This study was supported by the Wyeth Nephrology Funds administered by the University of Cape Town. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballermann BJ, 1999, KIDNEY INT, V56, P1154, DOI 10.1046/j.1523-1755.1999.00650.x; Briley LP, 2006, SEMIN DIALYSIS, V19, P54, DOI 10.1111/j.1525-139X.2006.00119.x; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gaukrodger N, 2005, J MED GENET, V42, P474, DOI 10.1136/jmg.2004.027631; *HAPMAP, 2010, INT HAPMAP PROJ; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hinuy HM, 2006, MOL GENET METAB, V89, P374, DOI 10.1016/j.ymgme.2006.04.012; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Krop JS, 1999, ARCH INTERN MED, V159, P1777, DOI 10.1001/archinte.159.15.1777; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LEVEY A, 2001, J AM SOC NEPHROL, V11, P155; Lucantoni R, 2000, J CLIN ENDOCR METAB, V85, P3589, DOI 10.1210/jc.85.10.3589; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Okpechi Ikechi G, 2007, Diab Vasc Dis Res, V4, P365, DOI 10.3132/dvdr.2007.066; Porreca E, 2006, INT J OBESITY, V30, P209, DOI 10.1038/sj.ijo.0803150; Rudberg S, 1998, HORM RES, V50, P297, DOI 10.1159/000023294; Santopinto JJ, 2003, HEART, V89, P1003, DOI 10.1136/heart.89.9.1003; Seedat YK, 1999, J HUM HYPERTENS, V13, P747, DOI 10.1038/sj.jhh.1000911; Shintani M, 2002, J CLIN ENDOCR METAB, V87, P2909, DOI 10.1210/jc.87.6.2909; SINNWELL JP, 2010, HAPLO STATS VERSION; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI 10.1097/01.EDE.0000071413.55296.c4; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Xue JL, 2001, J AM SOC NEPHROL, V12, P2753, DOI 10.1681/ASN.V12122753; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9086	10.1371/journal.pone.0009086	http://dx.doi.org/10.1371/journal.pone.0009086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140086	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400022
J	Knoth, R; Singec, I; Ditter, M; Pantazis, G; Capetian, P; Meyer, RP; Horvat, V; Volk, B; Kempermann, G				Knoth, Rolf; Singec, Ilyas; Ditter, Margarethe; Pantazis, Georgios; Capetian, Philipp; Meyer, Ralf P.; Horvat, Volker; Volk, Benedikt; Kempermann, Gerd			Murine Features of Neurogenesis in the Human Hippocampus across the Lifespan from 0 to 100 Years	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; ADULT HUMAN HIPPOCAMPUS; TEMPORAL-LOBE EPILEPSY; DOUBLE CORTEX SYNDROME; MOUSE DENTATE GYRUS; NEURAL STEM-CELLS; PROGENITOR CELLS; HUMAN BRAIN; DOUBLECORTIN EXPRESSION; ALZHEIMERS-DISEASE	Background: Essentially all knowledge about adult hippocampal neurogenesis in humans still comes from one seminal study by Eriksson et al. in 1998, although several others have provided suggestive findings. But only little information has been available in how far the situation in animal models would reflect the conditions in the adult and aging human brain. We therefore here mapped numerous features associated with adult neurogenesis in rodents in samples from human hippocampus across the entire lifespan. Such data would not offer proof of adult neurogenesis in humans, because it is based on the assumption that humans and rodents share marker expression patterns in adult neurogenesis. Nevertheless, together the data provide valuable information at least about the presence of markers, for which a link to adult neurogenesis might more reasonably be assumed than for others, in the adult human brain and their change with increasing age. Methods and Findings: In rodents, doublecortin (DCX) is transiently expressed during adult neurogenesis and within the neurogenic niche of the dentate gyrus can serve as a valuable marker. We validated DCX as marker of granule cell development in fetal human tissue and used DCX expression as seed to examine the dentate gyrus for additional neurogenesis-associated features across the lifespan. We studied 54 individuals and detected DCX expression between birth and 100 years of age. Caveats for post-mortem analyses of human tissues apply but all samples were free of signs of ischemia and activated caspase-3. Fourteen markers related to adult hippocampal neurogenesis in rodents were assessed in DCX-positive cells. Total numbers of DCX expressing cells declined exponentially with increasing age, and co-expression of DCX with the other markers decreased. This argued against a non-specific re-appearance of immature markers in specimen from old brains. Early postnatally all 14 markers were co-expressed in DCX-positive cells. Until 30 to 40 years of age, for example, an overlap of DCX with Ki67, Mcm2, Sox2, Nestin, Prox1, PSA-NCAM, Calretinin, NeuN, and others was detected, and some key markers (Nestin, Sox2, Prox1) remained co-expressed into oldest age. Conclusions: Our data suggest that in the adult human hippocampus neurogenesis-associated features that have been identified in rodents show patterns, as well as qualitative and quantitative age-related changes, that are similar to the course of adult hippocampal neurogenesis in rodents. Consequently, although further validation as well as the application of independent methodology (e. g. electron microscopy and cell culture work) is desirable, our data will help to devise the framework for specific research on cellular plasticity in the aging human hippocampus.	[Knoth, Rolf; Singec, Ilyas; Ditter, Margarethe; Pantazis, Georgios; Capetian, Philipp; Meyer, Ralf P.; Volk, Benedikt] Univ Freiburg, Dept Neuropathol, Freiburg, Germany; [Singec, Ilyas] Burnham Inst Med Res, Stem Cell & Regenerat Program, La Jolla, CA USA; [Capetian, Philipp] Univ Freiburg, Lab Mol Neurosurg, Dept Stereotact & Funct Neurosurg, Freiburg, Germany; [Horvat, Volker; Kempermann, Gerd] CRTD Ctr Regenerat Therapies Dresden, Dresden, Germany	University of Freiburg; Sanford Burnham Prebys Medical Discovery Institute; University of Freiburg; Technische Universitat Dresden	Knoth, R (corresponding author), Univ Freiburg, Dept Neuropathol, Freiburg, Germany.	gerd.kempermann@crt-dresden.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061; SINGEC, ILYAS/0000-0003-3941-1838				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Amrein I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000455; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; BENABDALLAH N, 2008, NEUROBIOL AGING, P227, DOI DOI 10.1016/J.NEUROBIOLAGING.2008.1003.1002; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fahrner A, 2007, EXP NEUROL, V203, P320, DOI 10.1016/j.expneurol.2006.08.023; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukuda S, 2003, J NEUROSCI, V23, P9357; Garcia A, 2004, AGING CELL, V3, P363, DOI 10.1111/j.1474-9728.2004.00130.x; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Hermann A, 2006, J NEUROCHEM, V98, P629, DOI 10.1111/j.1471-4159.2006.03916.x; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; KLEMPIN F, 2007, EUR ARCH PSYCHIAT CL, P227; Komitova M, 2004, NEUROSCI LETT, V369, P24, DOI 10.1016/j.neulet.2004.07.035; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lee KY, 2008, MOL CELLS, V26, P5; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; Liu YWJ, 2008, EUR J NEUROSCI, V28, P2254, DOI 10.1111/j.1460-9568.2008.06518.x; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; Moe MC, 2005, BRAIN, V128, P2189, DOI 10.1093/brain/awh574; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montaron MF, 1999, EUR J NEUROSCI, V11, P1479, DOI 10.1046/j.1460-9568.1999.00579.x; Nacher J, 2003, NEUROBIOL AGING, V24, P273, DOI 10.1016/S0197-4580(02)00096-9; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Nagy Z, 2000, NEUROBIOL AGING, V21, P761, DOI 10.1016/S0197-4580(00)00223-2; Ni Dhuill CM, 1999, J NEUROSCI RES, V55, P99, DOI 10.1002/(SICI)1097-4547(19990101)55:1<99::AID-JNR11>3.0.CO;2-S; Osaki M, 2002, INT J MOL MED, V10, P161; Palmer TD, 2001, NATURE, V411, P42, DOI 10.1038/35075141; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x; Ratti A, 2006, J CELL SCI, V119, P1442, DOI 10.1242/jcs.02852; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Roy NS, 2000, NAT MED, V6, P271; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Singec I, 2003, J COMP NEUROL, V459, P278, DOI 10.1002/cne.10600; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; Verwer RWH, 2007, BRAIN, V130, P3321, DOI 10.1093/brain/awm264; Weber M, 2006, NEUROSCIENCE, V138, P1215, DOI 10.1016/j.neuroscience.2005.11.059; Weimer JM, 2006, NEURON, V49, P3, DOI 10.1016/j.neuron.2005.12.016; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167	75	447	452	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8809	10.1371/journal.pone.0008809	http://dx.doi.org/10.1371/journal.pone.0008809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126454	gold, Green Published, Green Submitted			2022-12-27	WOS:000274139100002
J	Evans, P; Sacan, A; Ungar, L; Tozeren, A				Evans, Perry; Sacan, Ahmet; Ungar, Lyle; Tozeren, Aydin			Sequence Alignment Reveals Possible MAPK Docking Motifs on HIV Proteins	PLOS ONE			English	Article							KINASE; IDENTIFICATION; SEARCH; SITES	Over the course of HIV infection, virus replication is facilitated by the phosphorylation of HIV proteins by human ERK1 and ERK2 mitogen-activated protein kinases (MAPKs). MAPKs are known to phosphorylate their substrates by first binding with them at a docking site. Docking site interactions could be viable drug targets because the sequences guiding them are more specific than phosphorylation consensus sites. In this study we use multiple bioinformatics tools to discover candidate MAPK docking site motifs on HIV proteins known to be phosphorylated by MAPKs, and we discuss the possibility of targeting docking sites with drugs. Using sequence alignments of HIV proteins of different subtypes, we show that MAPK docking patterns previously described for human proteins appear on the HIV matrix, Tat, and Vif proteins in a strain dependent manner, but are absent from HIV Rev and appear on all HIV Nef strains. We revise the regular expressions of previously annotated MAPK docking patterns in order to provide a subtype independent motif that annotates all HIV proteins. One revision is based on a documented human variant of one of the substrate docking motifs, and the other reduces the number of required basic amino acids in the standard docking motifs from two to one. The proposed patterns are shown to be consistent with in silico docking between ERK1 and the HIV matrix protein. The motif usage on HIV proteins is sufficiently different from human proteins in amino acid sequence similarity to allow for HIV specific targeting using small-molecule drugs.	[Evans, Perry; Ungar, Lyle] Univ Penn, Dept Comp & Informat Sci, Philadelphia, PA 19104 USA; [Sacan, Ahmet; Tozeren, Aydin] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Ctr Integrated Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Evans, P (corresponding author), Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA.	aydin.tozeren@drexel.edu			National Institutes of Health (NIH) [232240, T32 HG000046]; National Science Foundation (NSF) [235327]; Drexel University Calhoun Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Drexel University Calhoun Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was supported by the National Institutes of Health (NIH) grant #232240 and by the National Science Foundation (NSF) grant #235327. Additional support came from a Drexel University Calhoun Fellowship (WD) and from NIH training grant T32 HG000046 (PE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bardwell AJ, 2009, J BIOL CHEM, V284, P13165, DOI 10.1074/jbc.M900080200; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Barraud P, 2008, CURR HIV RES, V6, P91, DOI 10.2174/157016208783885056; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BUKRINSKAYA AG, 1996, PHOSPHORYLATION DEPE, P367; Burkhard K, 2009, CURR TOP MED CHEM, V9, P678, DOI 10.2174/156802609789044416; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dampier W, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-47; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Evans RJ, 2009, GER HIST, V27, P1, DOI 10.1093/gerhis/ghn073; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hancock CN, 2006, MED CHEM, V2, P213, DOI 10.2174/157340606776056151; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V377, P1123, DOI 10.1016/j.bbrc.2008.10.127; Lee TY, 2006, NUCLEIC ACIDS RES, V34, pD622, DOI 10.1093/nar/gkj083; Lin HY, 2003, BIOCHEMISTRY-US, V42, P7571, DOI 10.1021/bi0273967; LIU S, 2006, STRUCTURAL BASIS DOC; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; PAN C, 2009, MOL CELLULAR PROTEOM; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Sacan A, 2008, BIOINFORMATICS, V24, P2872, DOI 10.1093/bioinformatics/btn545; Schrager JA, 2002, J BIOL CHEM, V277, P6137, DOI 10.1074/jbc.M107322200; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; YANG X, 1999, AM SOC MICROBIOL, P3460; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; ZHANG Y, 2004, PROTEINS STRUCTURE F, V57	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8942	10.1371/journal.pone.0008942	http://dx.doi.org/10.1371/journal.pone.0008942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126615	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000019
J	Montemayor, C; Montemayor, OA; Ridgeway, A; Lin, F; Wheeler, DA; Pletcher, SD; Pereira, FA				Montemayor, Celina; Montemayor, Oscar A.; Ridgeway, Alex; Lin, Feng; Wheeler, David A.; Pletcher, Scott D.; Pereira, Fred A.			Genome-Wide Analysis of Binding Sites and Direct Target Genes of the Orphan Nuclear Receptor NR2F1/COUP-TFI	PLOS ONE			English	Article							PROMOTER-TRANSCRIPTION FACTOR; MOUSE INNER-EAR; RETINOIC ACID; RESPONSE ELEMENTS; HAIR CELL; COUP-TFI; PROTEIN GENE; HEARING-LOSS; FATTY-ACIDS; EXPRESSION	Background: Identification of bona fide direct nuclear receptor gene targets has been challenging but essential for understanding regulation of organismal physiological processes. Results: We describe a methodology to identify transcription factor binding sites and target genes in vivo by intersecting microarray data, computational binding site queries, and evolutionary conservation. We provide detailed experimental validation of each step and, as a proof of principle, utilize the methodology to identify novel direct targets of the orphan nuclear receptor NR2F1 (COUP-TFI). The first step involved validation of microarray gene expression profiles obtained from wild-type and COUP-TFI-/- inner ear tissues. Secondly, we developed a bioinformatic tool to search for COUP-TFI DNA binding sites in genomes, using a classification-type Hidden Markov Model trained with 49 published COUP-TF response elements. We next obtained a ranked list of candidate in vivo direct COUP-TFI targets by integrating the microarray and bioinformatics analyses according to the degree of binding site evolutionary conservation and microarray statistical significance. Lastly, as proof-of-concept, 5 specific genes were validated for direct regulation. For example, the fatty acid binding protein 7 (Fabp7) gene is a direct COUP-TFI target in vivo because: i) we identified 2 conserved COUP-TFI binding sites in the Fabp7 promoter; ii) Fapb7 transcript and protein levels are significantly reduced in COUP-TFI-/- tissues and in MEFs; iii) chromatin immunoprecipitation demonstrates that COUP-TFI is recruited to the Fabp7 promoter in vitro and in vivo and iv) it is associated with active chromatin having increased H3K9 acetylation and enrichment for CBP and SRC-1 binding in the newborn brain. Conclusion: We have developed and validated a methodology to identify in vivo direct nuclear receptor target genes. This bioinformatics tool can be modified to scan for response elements of transcription factors, cis-regulatory modules, or any flexible DNA pattern.	[Montemayor, Celina; Ridgeway, Alex; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Montemayor, Celina; Montemayor, Oscar A.; Lin, Feng; Pletcher, Scott D.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Pereira, Fred A.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Wheeler, David A.; Pletcher, Scott D.; Pereira, Fred A.] Baylor Coll Med, Program Cell & Mol Biol, Houston, TX 77030 USA; [Wheeler, David A.; Pletcher, Scott D.] Baylor Coll Med, Dept Human & Mol Genet, Houston, TX 77030 USA; [Wheeler, David A.] Baylor Coll Med, Ctr Human Genome, Houston, TX 77030 USA; [Pereira, Fred A.] Rice Univ, Dept Bioengn, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Rice University	Montemayor, C (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	fpereira@bcm.edu	Wheeler, David A/M-9740-2018	Wheeler, David A/0000-0002-9056-6299; Pereira, Fred/0000-0003-2100-0280; Ridgeway, Alex/0000-0001-6055-6375	National Institutes of Health [DC04585]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004585, R55DC004585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health DC04585 to FAP (http://www.nidcd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], IMAGEJ IMAGE PROCESS; Brown KK, 2009, AM J MED GENET A, V149A, P931, DOI 10.1002/ajmg.a.32764; Cabrero A, 2003, MOL PHARMACOL, V64, P764, DOI 10.1124/mol.64.3.764; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Deblois G, 2008, MOL ENDOCRINOL, V22, P1999, DOI 10.1210/me.2007-0546; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durbin R., 1998, BIOL SEQUENCE ANAL P; EDDY S, 1995, HMMER HIDDEN MARKOV; Faedo A, 2008, CEREB CORTEX, V18, P2117, DOI 10.1093/cercor/bhm238; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Keithley EM, 2005, HEARING RES, V209, P76, DOI 10.1016/j.heares.2005.06.009; Klockars T, 2003, JARO-J ASSOC RES OTO, V4, P24, DOI 10.1007/s10162-002-2058-2; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin F, 2002, J BIOL CHEM, V277, P21414, DOI 10.1074/jbc.M201885200; Moreno-Pelayo MA, 2003, J MED GENET, V40, P832, DOI 10.1136/jmg.40.11.832; Morris BJ, 2005, J HYPERTENS, V23, P1285, DOI 10.1097/01.hjh.0000173509.45363.dd; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Naka H, 2008, NAT NEUROSCI, V11, P1014, DOI 10.1038/nn.2168; NAPOLI JL, 1995, J STEROID BIOCHEM, V53, P497, DOI 10.1016/0960-0760(95)00096-I; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pereira FA, 2000, CELL MOL LIFE SCI, V57, P1388, DOI 10.1007/PL00000624; Pinto L, 2007, PROG NEUROBIOL, V83, P2, DOI 10.1016/j.pneurobio.2007.02.010; Pipaon C, 1999, MOL CELL BIOL, V19, P2734; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; *R PROJ, R PROJ STAT COMP; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Romand R, 2000, EUR J NEUROSCI, V12, P2793, DOI 10.1046/j.1460-9568.2000.00165.x; Romand R, 2003, CURR TOP DEV BIOL, V57, P261, DOI 10.1016/S0070-2153(03)57009-0; RONAN D, 2005, CHOLESTEROL MODULATE; ROTTMAN JN, 1993, J BIOL CHEM, V268, P11994; Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101; Schutz F, 2008, BIOINFORMATICS, V24, P1399, DOI 10.1093/bioinformatics/btn201; SLEPECKY NB, 1993, HEARING RES, V70, P73, DOI 10.1016/0378-5955(93)90053-4; Someya S, 2007, NEUROBIOL AGING, V28, P1613, DOI 10.1016/j.neurobiolaging.2006.06.024; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Varga G, 2007, BIODRUGS, V21, P117, DOI 10.2165/00063030-200721020-00006; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Wu J, 2008, J COMPUT BIOL, V15, P279, DOI 10.1089/cmb.2008.0024; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	58	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8910	10.1371/journal.pone.0008910	http://dx.doi.org/10.1371/journal.pone.0008910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111703	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800013
J	O'Shea, D; Cawood, TJ; O'Farrelly, C; Lynch, L				O'Shea, Donal; Cawood, Tom J.; O'Farrelly, Cliona; Lynch, Lydia			Natural Killer Cells in Obesity: Impaired Function and Increased Susceptibility to the Effects of Cigarette Smoke	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPONECTIN LEVELS; IMMUNE-RESPONSE; TOBACCO-SMOKE; CANCER; MICE; MORTALITY; LEPTIN; RISK; INFLAMMATION	Background: Obese individuals who smoke have a 14 year reduction in life expectancy. Both obesity and smoking are independantly associated with increased risk of malignancy. Natural killer cells (NK) are critical mediators of anti-tumour immunity and are compromised in obese patients and smokers. We examined whether NK cell function was differentially affected by cigarette smoke in obese and lean subjects. Methodology and Principal Findings: Clinical data and blood were collected from 40 severely obese subjects (BMI > 40 kg/m(2)) and 20 lean healthy subjects. NK cell levels and function were assessed using flow cytometry and cytotoxicity assays. The effect of cigarette smoke on NK cell ability to kill K562 tumour cells was assessed in the presence or absence of the adipokines leptin and adiponectin. NK cell levels were significantly decreased in obese subjects compared to lean controls (7.6 vs 16.6%, p = 0.0008). NK function was also significantly compromised in obese patients (30% +/- 13% vs 42% +/- 12%, p = 0.04). Cigarette smoke inhibited NK cell ability to kill tumour cell lines (p < 0.0001). NK cells from obese subjects were even more susceptible to the inhibitory effects of smoke compared to lean subjects (33% vs 28%, p = 0.01). Cigarette smoke prevented NK cell activation, as well as perforin and interferon-gamma secretion upon tumour challenge. Adiponectin but not leptin partially reversed the effects of smoke on NK cell function in both obese (p = 0.002) and lean controls (p = 0.01). Conclusions/Significance: Obese subjects have impaired NK cell activity that is more susceptible to the detrimental effects of cigarette smoke compared to lean subjects. This may play a role in the increase of cancer and infection seen in this population. Adiponectin is capable of restoring NK cell activity and may have therapeutic potential for immunity in obese subjects and smokers.	[O'Shea, Donal] St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland; [Cawood, Tom J.] Christchurch Hosp, Dept Endocrinol, Christchurch, New Zealand; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; [O'Farrelly, Cliona] Trinity Coll Dublin, Sch Med, Dublin, Ireland; [Lynch, Lydia] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Lynch, Lydia] St Vincents Univ Hosp, Educ & Res Ctr, Dublin 4, Ireland	University College Dublin; Saint Vincent's University Hospital; Christchurch Hospital New Zealand; Trinity College Dublin; Trinity College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University College Dublin; Saint Vincent's University Hospital	O'Shea, D (corresponding author), St Vincents Univ Hosp, Dept Endocrinol, Dublin 4, Ireland.	lydia.lynch@ucd.ie	Lynch, Lydia/ABD-5598-2021	Lynch, Lydia/0000-0002-4273-4681; O'Shea, Donal/0000-0002-1408-5274; O'Farrelly, Cliona/0000-0002-0616-2874	Health Research Board, Ireland; Diabetes Federation of Ireland	Health Research Board, Ireland; Diabetes Federation of Ireland	This work was supported by the Health Research Board, Ireland and the Diabetes Federation of Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Bernhard David, 2004, Journal of Pharmacological and Toxicological Methods, V50, P45, DOI 10.1016/j.vascn.2004.01.003; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Borrego F, 2005, MOL IMMUNOL, V42, P485, DOI 10.1016/j.molimm.2004.07.031; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Chalmers GW, 2001, CHEST, V120, P1917, DOI 10.1378/chest.120.6.1917; Dovio A, 2004, INT J OBESITY, V28, P894, DOI 10.1038/sj.ijo.0802639; Ezzati M, 2004, TOB CONTROL, V13, P388, DOI 10.1136/tc.2003.005215; FERSON M, 1979, INT J CANCER, V23, P603, DOI 10.1002/ijc.2910230504; Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022; Gil-Campos M, 2004, CLIN NUTR, V23, P963, DOI 10.1016/j.clnu.2004.04.010; GOTTSCHLICH MM, 1993, J AM DIET ASSOC, V93, P1261, DOI 10.1016/0002-8223(93)91952-M; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; HOLT PG, 1977, BACTERIOL REV, V41, P205, DOI 10.1128/MMBR.41.1.205-216.1977; Ishikawa M, 2007, CANCER SCI, V98, P1120, DOI 10.1111/j.1349-7006.2007.00486.x; KIESSLING R, 1975, EUR J IMMUNOL, V5, P117, DOI 10.1002/eji.1830050209; Kim KY, 2006, J IMMUNOL, V176, P5958, DOI 10.4049/jimmunol.176.10.5958; Kim S, 2000, P NATL ACAD SCI USA, V97, P2731, DOI 10.1073/pnas.050588297; Lamas O, 2004, J NUTR BIOCHEM, V15, P418, DOI 10.1016/j.jnutbio.2004.02.003; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lu JY, 2008, J BIOMED SCI, V15, P565, DOI 10.1007/s11373-008-9261-z; Lu LM, 2007, J IMMUNOL, V178, P936, DOI 10.4049/jimmunol.178.2.936; Lynch LA, 2009, OBESITY, V17, P601, DOI 10.1038/oby.2008.565; Mantzoros CS, 2007, EUR J CANCER, V43, P1430, DOI 10.1016/j.ejca.2007.03.026; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Mori A, 2006, INT J CANCER, V119, P2760, DOI 10.1002/ijc.22248; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Rakatzi I, 2004, DIABETOLOGIA, V47, P249, DOI 10.1007/s00125-003-1293-3; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; Roda JM, 2006, CANCER RES, V66, P517, DOI 10.1158/0008-5472.CAN-05-2429; SCOTT P, 1995, CURR OPIN IMMUNOL, V7, P34, DOI 10.1016/0952-7915(95)80026-3; Sennello JA, 2005, ENDOCRINOLOGY, V146, P2157, DOI 10.1210/en.2004-1572; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Takefuji S, 2007, PREV MED, V45, P471, DOI 10.1016/j.ypmed.2007.07.001; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797	43	102	103	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8660	10.1371/journal.pone.0008660	http://dx.doi.org/10.1371/journal.pone.0008660			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20107494	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300003
J	Baker, R; Kent, CV; Silbermann, RA; Hassell, JA; Young, LJT; Howe, LR				Baker, Rebecca; Kent, Claire V.; Silbermann, Rachel A.; Hassell, John A.; Young, Lawrence J. T.; Howe, Louise R.			Pea3 Transcription Factors and Wnt1-Induced Mouse Mammary Neoplasia	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EPIDERMAL-GROWTH-FACTOR; ETS GENE PEA3; MATRIX-METALLOPROTEINASE GENES; TUMOR PROGRESSION; STEM-CELLS; MOLECULAR CHARACTERIZATION; POLYOMAVIRUS ENHANCER; EXPRESSION PATTERNS; INTESTINAL TUMORS	The role of the PEA3 subfamily of Ets transcription factors in breast neoplasia is controversial. Although overexpression of PEA3 (E1AF/ETV4), and of the related factors ERM (ETV5) and ER81 (ETV1), have been observed in human and mouse breast tumors, PEA3 factors have also been ascribed a tumor suppressor function. Here, we utilized the MMTV/Wnt1 mouse strain to further interrogate the role of PEA3 transcription factors in mammary tumorigenesis based on our previous observation that Pea3 is highly expressed in MMTV/Wnt1 mammary tumors. Pea3 expression in mouse mammary tissues was visualized using a Pea3(NLSlacZ) reporter strain. In normal mammary glands, Pea3 expression is predominantly confined to myoepithelial cells. Wnt1 transgene expression induced marked amplification of this cell compartment in nontumorous mammary glands, accompanied by an apparent increase in Pea3 expression. The pattern of Pea3 expression in MMTV/Wnt1 mammary glands recapitulated the cellular profile of activated beta-catenin/TCF signaling, which was visualized using both beta-catenin immunohistochemistry and the beta-catenin/TCF-responsive reporter Axin2(NLSlacZ). To test the requirement for PEA3 factors in Wnt1-induced tumorigenesis, we employed a mammary-targeted dominant negative PEA3 transgene, Delta NPEA3En. Expression of Delta NPEA3En delayed early-onset tumor formation in MMTV/Wnt1 virgin females (P = 0.03), suggesting a requirement for PEA3 factor function for Wnt1-driven tumor formation. Consistent with this observation, expression of the Delta NPEA3En transgene was profoundly reduced in mammary tumors compared to nontumorous mammary glands from bigenic MMTV/Wnt1, MMTV/Delta NPEA3En mice (P = 0.01). Our data provide the first description of Wnt1-mediated expansion of the Pea3-expressing myoepithelial compartment in nontumorous mammary glands. Consistent with this observation, mammary myoepithelium was selectively responsive to Wnt1. Together these data suggest the MMTV/Wnt1 strain as a potential model of basal breast cancer. Furthermore, this study provides evidence for a protumorigenic role of PEA3 factors in breast neoplasia, and supports targeting the PEA3 transcription factor family in breast cancer.	[Baker, Rebecca; Kent, Claire V.; Silbermann, Rachel A.; Howe, Louise R.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Baker, Rebecca; Silbermann, Rachel A.; Howe, Louise R.] Rockefeller Univ, Strang Canc Res Lab, New York, NY 10021 USA; [Hassell, John A.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA	Cornell University; Rockefeller University; McMaster University; University of California System; University of California Davis	Baker, R (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.	lrhowe@med.cornell.edu		Howe, Louise/0000-0002-1468-7136	National Institutes of Health [R01 CA131219]; Irving Weinstein Foundation Inc.; NATIONAL CANCER INSTITUTE [R01CA131219] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irving Weinstein Foundation Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01 CA131219 (L. R. H.) and the Irving Weinstein Foundation Inc. (L. R. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2008, ONCOLOGY-NY, V22, P1233; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baert JL, 1997, INT J CANCER, V70, P590, DOI 10.1002/(SICI)1097-0215(19970304)70:5<590::AID-IJC17>3.0.CO;2-H; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrett JM, 2002, BREAST CANCER RES TR, V72, P227, DOI 10.1023/A:1014993006190; Benz CC, 1997, ONCOGENE, V15, P1513, DOI 10.1038/sj.onc.1201331; Bieche I, 2004, CARCINOGENESIS, V25, P405, DOI 10.1093/carcin/bgh024; Boedefeld WM, 2005, MOL CARCINOGEN, V43, P13, DOI 10.1002/mc.20093; Bojovic BB, 2008, DNA CELL BIOL, V27, P289, DOI 10.1089/dna.2007.0680; Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200; BUTTICE G, 1993, J BIOL CHEM, V268, P7196; Chen JH, 1996, ONCOGENE, V13, P1667; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Chotteau-Lelievre A, 2001, MECH DEVELOP, V108, P191, DOI 10.1016/S0925-4773(01)00480-4; Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9; ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Crawford HC, 1999, ONCOGENE, V18, P2883, DOI 10.1038/sj.onc.1202627; Crawford HC, 1996, ENZYME PROTEIN, V49, P20, DOI 10.1159/000468614; Crawford HC, 2001, MOL CELL BIOL, V21, P1370, DOI 10.1128/MCB.21.4.1370-1383.2001; Cui XS, 2000, ONCOGENE, V19, P5988, DOI 10.1038/sj.onc.1203993; D'Orazio D, 1997, GENE, V201, P179, DOI 10.1016/S0378-1119(97)00445-9; Dahl KDC, 2009, NEOPLASIA, V11, P1208, DOI 10.1593/neo.09942; Davidson B, 2003, CLIN CANCER RES, V9, P1412; deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605; Discenza MT, 2004, FEBS LETT, V560, P183, DOI 10.1016/S0014-5793(04)00104-8; El-Tanani M, 2004, J BIOL CHEM, V279, P20794, DOI 10.1074/jbc.M311131200; Firlej V, 2005, J BIOL CHEM, V280, P887, DOI 10.1074/jbc.M408017200; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Fleming FJ, 2004, J CLIN PATHOL, V57, P1069, DOI 10.1136/jcp.2004.016733; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hesselbrock DR, 2005, BREAST CANCER RES TR, V89, P289, DOI 10.1007/s10549-004-2622-z; Hida K, 1997, AM J PATHOL, V150, P2125; HIGASHINO F, 1993, NUCLEIC ACIDS RES, V21, P547, DOI 10.1093/nar/21.3.547; Hiroumi H, 2001, INT J CANCER, V93, P786, DOI 10.1002/ijc.1410; Horiuchi S, 2003, J PATHOL, V200, P568, DOI 10.1002/path.1387; Howe LR, 2005, CANCER RES, V65, P10113, DOI 10.1158/0008-5472.CAN-05-1524; Howe LR, 2002, CANCER RES, V62, P5405; Howe LR, 2003, CANCER RES, V63, P1906; Howe LR, 2001, J BIOL CHEM, V276, P20108, DOI 10.1074/jbc.M010692200; Iwasaki M, 2004, EXP CELL RES, V299, P525, DOI 10.1016/j.yexcr.2004.06.020; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang JH, 2007, BIOCHEM BIOPH RES CO, V358, P53, DOI 10.1016/j.bbrc.2007.04.043; Kaya M, 1996, ONCOGENE, V12, P221; Kinoshita J, 2002, SURGERY, V131, pS222, DOI 10.1067/msy.2002.119792; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; Ladle DR, 2002, PHYSIOL BEHAV, V77, P571, DOI 10.1016/S0031-9384(02)00907-1; Laing MA, 2000, MOL CELL BIOL, V20, P9337, DOI 10.1128/MCB.20.24.9337-9345.2000; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lynch CC, 2004, INT J ONCOL, V24, P1565; MARTIN ME, 1988, P NATL ACAD SCI USA, V85, P5839, DOI 10.1073/pnas.85.16.5839; Matsui K, 2006, ONCOL REP, V16, P153; Menendez JA, 2006, CURR PHARM BIOTECHNO, V7, P495, DOI 10.2174/138920106779116900; MONTE D, 1995, ONCOGENE, V11, P771; MONTE D, 1994, ONCOGENE, V9, P1397; Monte D, 1996, GENOMICS, V35, P236, DOI 10.1006/geno.1996.0345; Myers E, 2006, BRIT J CANCER, V95, P1404, DOI 10.1038/sj.bjc.6603427; Nishida T, 2007, BIOCHEM BIOPH RES CO, V360, P226, DOI 10.1016/j.bbrc.2007.06.037; Nosho K, 2005, CARCINOGENESIS, V26, P892, DOI 10.1093/carcin/bgi029; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Prestwich TC, 2007, CURR OPIN CELL BIOL, V19, P612, DOI 10.1016/j.ceb.2007.09.014; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; RORTH P, 1990, NUCLEIC ACIDS RES, V18, P5009, DOI 10.1093/nar/18.17.5009; Rosner A, 2002, AM J PATHOL, V161, P1087, DOI 10.1016/S0002-9440(10)64269-1; Scott GK, 2000, ONCOGENE, V19, P6490, DOI 10.1038/sj.onc.1204041; SCOTT GK, 1994, J BIOL CHEM, V269, P19848; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Shepherd TG, 2001, CURR BIOL, V11, P1739, DOI 10.1016/S0960-9822(01)00536-X; Span PN, 2003, BREAST CANCER RES TR, V79, P129, DOI 10.1023/A:1023338424677; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; TRIMBLE MS, 1993, ONCOGENE, V8, P3037; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Upadhyay S, 2006, CANCER RES, V66, P7870, DOI 10.1158/0008-5472.CAN-05-2902; Wang SC, 2001, SEMIN ONCOL, V28, P115, DOI 10.1016/S0093-7754(01)90289-1; Wang SC, 2000, DRUGS TODAY, V36, P835; WASYLYK C, 1989, EMBO J, V8, P3371, DOI 10.1002/j.1460-2075.1989.tb08500.x; Xia WY, 2006, BREAST CANCER RES TR, V98, P295, DOI 10.1007/s10549-006-9162-7; XIN JH, 1992, GENE DEV, V6, P481, DOI 10.1101/gad.6.3.481; Xing XM, 2000, NAT MED, V6, P189, DOI 10.1038/72294; Yamamoto H, 2004, CARCINOGENESIS, V25, P325, DOI 10.1093/carcin/bgh011; Yu ZM, 2006, MOL CARCINOGEN, V45, P667, DOI 10.1002/mc.20212	96	17	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8854	10.1371/journal.pone.0008854	http://dx.doi.org/10.1371/journal.pone.0008854			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107508	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896100018
J	Miao, L; Wang, M; Yin, WX; Yuan, Q; Chen, YX; Fleischmann, B; Hescheler, J; Ji, GJ				Miao, Lin; Wang, Min; Yin, Wen-Xuan; Yuan, Qi; Chen, Ying-Xiao; Fleischmann, Bernd; Hescheler, Juergen; Ji, Guangju			Atrial Natriuretic Peptide Regulates Ca2+ Channel in Early Developmental Cardiomyocytes	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-GMP; GUANYLATE-CYCLASE; ADENYLYL-CYCLASE; CALCIUM CURRENT; K+ CURRENT; IN-VITRO; RECEPTORS; CELLS; NO	Background: Cardiomyocytes derived from murine embryonic stem (ES) cells possess various membrane currents and signaling cascades link to that of embryonic hearts. The role of atrial natriuretic peptide (ANP) in regulation of membrane potentials and Ca2+ currents has not been investigated in developmental cardiomyocytes. Methodology/Principal Findings: We investigated the role of ANP in regulating L-type Ca2+ channel current (I-CaL) in different developmental stages of cardiomyocytes derived from ES cells. ANP decreased the frequency of action potentials (APs) in early developmental stage (EDS) cardiomyocytes, embryonic bodies (EB) as well as whole embryo hearts. ANP exerted an inhibitory effect on basal I-CaL in about 70% EDS cardiomyocytes tested but only in about 30% late developmental stage (LDS) cells. However, after stimulation of I-CaL by isoproterenol (ISO) in LDS cells, ANP inhibited the response in about 70% cells. The depression of I-CaL induced by ANP was not affected by either N omega, Nitro-L-Arginine methyl ester (L-NAME), a nitric oxide synthetase (NOS) inhibitor, or KT5823, a cGMP-dependent protein kinase (PKG) selective inhibitor, in either EDS and LDS cells; whereas depression of I-CaL by ANP was entirely abolished by erythro-9-(2-Hydroxy-3-nonyl) adenine (EHNA), a selective inhibitor of type 2 phosphodiesterase(PDE2) in most cells tested. Conclusion/Significances: Taken together, these results indicate that ANP induced depression of action potentials and I-CaL is due to activation of particulate guanylyl cyclase (GC), cGMP production and cGMP-activation of PDE2 mediated depression of adenosine 3', 5'-cyclic monophophate (cAMP)-cAMP-dependent protein kinase (PKA) in early cardiomyogenesis.	[Miao, Lin; Wang, Min; Yin, Wen-Xuan; Yuan, Qi; Chen, Ying-Xiao; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Fleischmann, Bernd] Univ Bonn, Inst Physiol, D-5300 Bonn, Germany; [Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Cologne, Germany	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Bonn; University of Cologne	Miao, L (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	J.Hescheler@uni-koeln.de; gj28@ibp.ac.cn	Yuan, Qi/M-9887-2018	Yuan, Qi/0000-0002-4028-8876; Ji, Guangju/0000-0001-8626-3490	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-R-50]; 973 Program [2007CB512100, 2009CB918701]; Foundation of Science and Technology [30670505]; 863 project [2006AA02A106]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); 973 Program(National Basic Research Program of China); Foundation of Science and Technology; 863 project(National High Technology Research and Development Program of China)	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No: KSCX2-YW-R-50), 973 Program (2007CB512100 and 2009CB918701), Foundation of Science and Technology (# 30670505), and 863 project (2006AA02A106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelalim EM, 2006, BIOCHEM BIOPH RES CO, V340, P689, DOI 10.1016/j.bbrc.2005.12.057; ANANDSRIVASTAVA MB, 1993, AM J HYPERTENS, V6, P538, DOI 10.1093/ajh/6.6.538; ANANDSRIVASTAVA MB, 1993, PHARMACOL REV, V45, P455; Baumgarten CM, 1995, AM J PHYSIOL-CELL PH, V269, pC1356, DOI 10.1152/ajpcell.1995.269.6.C1356; BKAILY G, 1993, J MOL CELL CARDIOL, V25, P1305, DOI 10.1006/jmcc.1993.1143; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CHINKERS M, 1989, NATURE, V338, P78, DOI 10.1038/338078a0; Clemo HF, 1996, J CARDIOVASC ELECTR, V7, P149, DOI 10.1111/j.1540-8167.1996.tb00510.x; CLEMO HF, 1992, J GEN PHYSIOL, V100, P89, DOI 10.1085/jgp.100.1.89; Doyle DD, 1997, CIRC RES, V81, P86, DOI 10.1161/01.RES.81.1.86; Favaretto AIV, 1997, PEPTIDES, V18, P1377, DOI 10.1016/S0196-9781(97)00209-X; Fischmeister R, 2005, COMP BIOCHEM PHYS A, V142, P136, DOI 10.1016/j.cbpb.2005.04.012; GAPOSCHKIN CG, 1990, AM J PHYSIOL, V258, pE543, DOI 10.1152/ajpendo.1990.258.3.E543; GISBERT MP, 1988, CIRC RES, V62, P660, DOI 10.1161/01.RES.62.4.660; HAN R, 1993, J PHYSIOL-LONDON, V461, P743; Hescheler J, 1997, CARDIOVASC RES, V36, P149, DOI 10.1016/S0008-6363(97)00193-4; HIWATARI M, 1986, CLIN EXP PHARMACOL P, V13, P163, DOI 10.1111/j.1440-1681.1986.tb00331.x; Ji GJ, 1999, FASEB J, V13, P313, DOI 10.1096/fasebj.13.2.313; KIRSTEIN M, 1995, J CLIN INVEST, V95, P794, DOI 10.1172/JCI117729; KOHYA T, 1989, JPN CIRC J, V53, P1399, DOI 10.1253/jcj.53.1399; Lainchbury JG, 2000, AM J PHYSIOL-HEART C, V278, pH33, DOI 10.1152/ajpheart.2000.278.1.H33; LEGRAND B, 1992, PFLUG ARCH EUR J PHY, V421, P486, DOI 10.1007/BF00370260; LEVI RC, 1989, PFLUG ARCH EUR J PHY, V413, P685, DOI 10.1007/BF00581823; LIN XB, 1995, CIRC RES, V77, P750, DOI 10.1161/01.RES.77.4.750; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; MCCALL D, 1990, J MOL CELL CARDIOL, V22, P201, DOI 10.1016/0022-2828(90)91116-O; MERY PF, 1993, J BIOL CHEM, V268, P26286; MERY PF, 1991, P NATL ACAD SCI USA, V88, P1197, DOI 10.1073/pnas.88.4.1197; NILIUS B, 1986, GEN PHYSIOL BIOPHYS, V5, P473; ONO K, 1991, J PHYSIOL-LONDON, V443, P387, DOI 10.1113/jphysiol.1991.sp018839; Pedram A, 2000, J BIOL CHEM, V275, P7365, DOI 10.1074/jbc.275.10.7365; RESINK TJ, 1988, EUR J BIOCHEM, V174, P531, DOI 10.1111/j.1432-1033.1988.tb14131.x; RUGG EL, 1989, BIOCHEM BIOPH RES CO, V162, P1339, DOI 10.1016/0006-291X(89)90820-6; SAVOIE P, 1995, FEBS LETT, V370, P6, DOI 10.1016/0014-5793(95)00780-D; SCHULZ S, 1989, CELL, V58, P1155, DOI 10.1016/0092-8674(89)90513-8; SEMIGRAN MJ, 1992, J AM COLL CARDIOL, V20, P98, DOI 10.1016/0735-1097(92)90144-C; SEMMEKROT B, 1991, BIOL NEONATE, V60, P341; SHEETS MF, 1991, SCIENCE, V252, P449, DOI 10.1126/science.1850170; Tajima M, 1998, CIRCULATION, V98, P2760, DOI 10.1161/01.CIR.98.24.2760; TOHSE N, 1995, BRIT J PHARMACOL, V114, P1076, DOI 10.1111/j.1476-5381.1995.tb13316.x; Yoshida T, 2008, INT J CARDIOL, V123, P147, DOI 10.1016/j.ijcard.2006.12.005; ZHOU ZF, 1992, J PHYSIOL-LONDON, V453, P503, DOI 10.1113/jphysiol.1992.sp019242; ZONGAZO MA, 1992, J PHYSIOL-PARIS, V86, P167, DOI 10.1016/0928-4257(92)90003-X	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8847	10.1371/journal.pone.0008847	http://dx.doi.org/10.1371/journal.pone.0008847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107504	gold, Green Published			2022-12-27	WOS:000273896100012
J	Gregersen, LH; Jacobsen, AB; Frankel, LB; Wen, JY; Krogh, A; Lund, AH				Gregersen, Lea H.; Jacobsen, Anders B.; Frankel, Lisa B.; Wen, Jiayu; Krogh, Anders; Lund, Anders H.			MicroRNA-145 Targets YES and STAT1 in Colon Cancer Cells	PLOS ONE			English	Article							SUPPRESSIVE MICRORNAS; COLORECTAL-CANCER; EXPRESSION; GROWTH; SIGNATURES; MECHANISM; MIR-143; IDENTIFICATION; DETERMINANTS; DEREGULATION	Background: MicroRNAs (miRNAs) have emerged as important gene regulators and are recognized as key players in tumorigenesis. miR-145 is reported to be down-regulated in several cancers, but knowledge of its targets in colon cancer remains limited. Methodology/Principal Findings: To investigate the role of miR-145 in colon cancer, we have employed a microarray based approach to identify miR-145 targets. Based on seed site enrichment analyses and unbiased word analyses, we found a significant enrichment of miRNA binding sites in the 3'-untranslated regions (UTRs) of transcripts down-regulated upon miRNA overexpression. Gene Ontology analysis showed an overrepresentation of genes involved in cell death, cellular growth and proliferation, cell cycle, gene expression and cancer. A number of the identified miRNA targets have previously been implicated in cancer, including YES, FSCN1, ADAM17, BIRC2, VANGL1 as well as the transcription factor STAT1. Both YES and STAT1 were verified as direct miR-145 targets. Conclusions/Significance: The study identifies and validates new cancer-relevant direct targets of miR-145 in colon cancer cells and hereby adds important mechanistic understanding of the tumor-suppressive functions of miR-145.	[Gregersen, Lea H.; Frankel, Lisa B.; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Gregersen, Lea H.; Frankel, Lisa B.; Krogh, Anders; Lund, Anders H.] Univ Copenhagen, Ctr Epigenet, Copenhagen, Denmark; [Gregersen, Lea H.; Jacobsen, Anders B.; Wen, Jiayu; Krogh, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Gregersen, LH (corresponding author), Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Berlin, Germany.	anders.lund@bric.ku.dk	Wen, Jiayu/R-1673-2017; Lund, Anders H./F-4786-2014; Skanderup, Anders Jacobsen/K-1081-2013; Gregersen, Lea H/AAI-2386-2021; Krogh, Anders/M-1541-2014	Wen, Jiayu/0000-0003-1249-6456; Lund, Anders H./0000-0002-7407-3398; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Gregersen, Lea H/0000-0002-1205-604X; Frankel, Lisa/0000-0001-7249-3607; Krogh, Anders/0000-0002-5147-6282	European Commission (EC) [201102]; The Novo Nordisk Foundation; The Lundbeck Foundation; The Danish National Research Foundation; The Danish Medical Research Council; The Danish Cancer Society; Danish National Advanced Technology Foundation	European Commission (EC)(European CommissionEuropean Commission Joint Research Centre); The Novo Nordisk Foundation(Novo Nordisk Foundation); The Lundbeck Foundation(Lundbeckfonden); The Danish National Research Foundation(Danmarks Grundforskningsfond); The Danish Medical Research Council(Danish Medical Research Council); The Danish Cancer Society(Danish Cancer Society); Danish National Advanced Technology Foundation	Work in the authors' laboratory is supported by European Commission (EC) FP7 funding (ONCOMIRS, grant agreement number 201102. This publication reflects only authors' views. The commission is not liable for any use that may be made of the information herein), The Novo Nordisk Foundation, The Lundbeck Foundation, The Danish National Research Foundation, The Danish Medical Research Council, The Danish Cancer Society and the Danish National Advanced Technology Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Akao Y, 2006, ONCOL REP, V16, P845; Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barraclough J, 2007, NEOPLASIA, V9, P745, DOI 10.1593/neo.07442; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bolstad B, 2005, BIOINFORMATICS COMPU; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen HC, 2009, BRIT J CANCER, V100, P1002, DOI 10.1038/sj.bjc.6604948; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; CHRISTOFFERSEN NR, 2009, CELL DEATH DIFFER; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gramantieri L, 2007, CANCER RES, V67, P6092, DOI 10.1158/0008-5472.CAN-06-4607; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Horvath CM, 2000, TRENDS BIOCHEM SCI, V25, P496, DOI 10.1016/S0968-0004(00)01624-8; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Ichimi T, 2009, INT J CANCER, V125, P345, DOI 10.1002/ijc.24390; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Jawhari AU, 2003, AM J PATHOL, V162, P69, DOI 10.1016/S0002-9440(10)63799-6; JOHNSON M, 2009, CELL SIGNAL; Kalabis J, 2006, J BIOL CHEM, V281, P6434, DOI 10.1074/jbc.M512905200; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Marstrand TT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001623; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nakagawa Y, 2007, BIOORGAN MED CHEM, V15, P5620, DOI 10.1016/j.bmc.2007.04.071; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Santoro MM, 2007, NAT GENET, V39, P1397, DOI 10.1038/ng.2007.8; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038	58	142	155	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8836	10.1371/journal.pone.0008836	http://dx.doi.org/10.1371/journal.pone.0008836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098684	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100027
J	Rule, NO; Ambady, N				Rule, Nicholas O.; Ambady, Nalini			Democrats and Republicans Can Be Differentiated from Their Faces	PLOS ONE			English	Article							CATEGORIZATION; APPEARANCE; ELECTIONS; ACCURACY	Background: Individuals' faces communicate a great deal of information about them. Although some of this information tends to be perceptually obvious (such as race and sex), much of it is perceptually ambiguous, without clear or obvious visual cues. Methodology/Principal Findings: Here we found that individuals' political affiliations could be accurately discerned from their faces. In Study 1, perceivers were able to accurately distinguish whether U. S. Senate candidates were either Democrats or Republicans based on photos of their faces. Study 2 showed that these effects extended to Democrat and Republican college students, based on their senior yearbook photos. Study 3 then showed that these judgments were related to differences in perceived traits among the Democrat and Republican faces. Republicans were perceived as more powerful than Democrats. Moreover, as individual targets were perceived to be more powerful, they were more likely to be perceived as Republicans by others. Similarly, as individual targets were perceived to be warmer, they were more likely to be perceived as Democrats. Conclusions/Significance: These data suggest that perceivers' beliefs about who is a Democrat and Republican may be based on perceptions of traits stereotypically associated with the two political parties and that, indeed, the guidance of these stereotypes may lead to categorizations of others' political affiliations at rates significantly more accurate than chance guessing.	[Rule, Nicholas O.; Ambady, Nalini] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Rule, NO (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	nicholas.rule@tufts.edu			National Science Foundation [BCS-0435547]	National Science Foundation(National Science Foundation (NSF))	This study was funded by National Science Foundation grant BCS-0435547 to Nalini Ambady and National Science Foundation Graduate Research Fellowship to Nicholas O. Rule. http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Antonakis J, 2009, SCIENCE, V323, P1183, DOI 10.1126/science.1167748; Ballew CC, 2007, P NATL ACAD SCI USA, V104, P17948, DOI 10.1073/pnas.0705435104; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; Chiao JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003666; COLLINS MA, 1995, J APPL SOC PSYCHOL, V25, P129, DOI 10.1111/j.1559-1816.1995.tb01588.x; Elms A. C., 1976, PERSONALITY POLITICS; Gelman Andrew, 2008, RED STATE BLUE STATE; Hayes D, 2005, AM J POLIT SCI, V49, P908, DOI 10.2307/3647705; HAYES D, 2009, FEMININE DEMOCRATS M; Livingston RW, 2009, PSYCHOL SCI, V20, P1229, DOI 10.1111/j.1467-9280.2009.02431.x; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Poutvaara P, 2009, J EXP SOC PSYCHOL, V45, P1132, DOI 10.1016/j.jesp.2009.06.007; QUANTY MB, 1975, J PERS SOC PSYCHOL, V32, P449, DOI 10.1037/h0077093; Rice DR, 2003, APPL COGNITIVE PSYCH, V17, P1129, DOI 10.1002/acp.990; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, SEX ROLES, V61, P644, DOI 10.1007/s11199-009-9658-9; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; RULE NO, 2010, J PERS SOC IN PRESS; Zebrowitz L. A., 1997, READING FACES WINDOW; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	25	91	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8733	10.1371/journal.pone.0008733	http://dx.doi.org/10.1371/journal.pone.0008733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545EJ	20090906	Green Submitted, Green Published, gold			2022-12-27	WOS:000273715000004
J	Zhou, ZM; Li, XM; Liu, B; Beutin, L; Xu, JG; Ren, Y; Feng, L; Lan, RT; Reeves, PR; Wang, L				Zhou, Zhemin; Li, Xiaomin; Liu, Bin; Beutin, Lothar; Xu, Jianguo; Ren, Yan; Feng, Lu; Lan, Ruiting; Reeves, Peter R.; Wang, Lei			Derivation of Escherichia coli O157:H7 from Its O55:H7 Precursor	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ENTEROCYTE EFFACEMENT; PATHOGENICITY ISLAND; INDEPENDENT ORIGINS; HEMORRHAGIC COLITIS; PROTEIN SECRETION; GENES; EVOLUTION; EXPRESSION; VIRULENCE	There are 29 E. coli genome sequences available, mostly related to studies of species diversity or mode of pathogenicity, including two genomes of the well-known O157:H7 clone. However, there have been no genome studies of closely related clones aimed at exposing the details of evolutionary change. Here we sequenced the genome of an O55:H7 strain, closely related to the major pathogenic O157:H7 clone, with published genome sequences, and undertook comparative genomic and proteomic analysis. We were able to allocate most differences between the genomes to individual mutations, recombination events, or lateral gene transfer events, in specific lineages. Major differences include a type II secretion system present only in the O55:H7 chromosome, fewer type III secretion system effectors in O55:H7, and 19 phage genomes or phagelike elements in O55:H7 compared to 23 in O157:H7, with only three common to both. Many other changes were found in both O55:H7 and O157:H7 lineages, but in general there has been more change in the O157:H7 lineages. For example, we found 50% more synonymous mutational substitutions in O157:H7 compared to O55:H7. The two strains also diverged at the proteomic level. Mutational synonymous SNPs were used to estimate a divergence time of 400 years using a new clock rate, in contrast to 14,000 to 70,000 years using the traditional clock rates. The same approaches were applied to three closely related extraintestinal pathogenic E. coli genomes, and similar levels of mutation and recombination were found. This study revealed for the first time the full range of events involved in the evolution of the O157:H7 clone from its O55:H7 ancestor, and suggested that O157:H7 arose quite recently. Our findings also suggest that E. coli has a much lower frequency of recombination relative to mutation than was observed in a comparable study of a Vibrio cholerae lineage.	[Zhou, Zhemin; Li, Xiaomin; Liu, Bin; Ren, Yan; Feng, Lu; Wang, Lei] Nankai Univ, Sch Biol Sci & Biotechnol, Tianjin Econ Tech Dev Area, Tianjin 300071, Peoples R China; [Zhou, Zhemin; Liu, Bin; Feng, Lu; Wang, Lei] Tianjin Res Ctr Funct Genom & Biochip, Tianjin, Peoples R China; [Beutin, Lothar] Fed Inst Risk Assessment, Natl Reference Lab Escherichia Coli, Berlin, Germany; [Xu, Jianguo] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Lan, Ruiting] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Reeves, Peter R.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Wang, Lei] Nankai Univ, Tianjin Key Lab Microbial Funct Gen, Tianjin 300071, Peoples R China	Nankai University; Federal Institute for Risk Assessment; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of New South Wales Sydney; University of Sydney; Nankai University	Zhou, ZM (corresponding author), Nankai Univ, Sch Biol Sci & Biotechnol, Tianjin Econ Tech Dev Area, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Liu, Bin/C-5083-2009; Zhou, Zhemin/AAX-5539-2020; Wang, Lei/C-5176-2009; Reeves, Peter R/A-6064-2008; feng, lu/M-5113-2015	Zhou, Zhemin/0000-0001-9783-0366; Wang, Lei/0000-0003-4427-0881; Reeves, Peter R/0000-0003-4479-7974; Lan, Ruiting/0000-0001-9834-5258	Tianjin Municipal Special Fund [05FZZDSH00800]; National Natural Science Foundation of China (NSFC) [30530010, 20536040]; Chinese National Science Fund [30788001]; NSFC [30670038, 30870070, 30870078, 30771175, 30900041]; National 863 Program of China [2006AA020703, 2006AA06Z409]; National 973 Program of China [2009CB522603]; National Key Programs for Infectious Diseases of China [2008ZX1004-002, 2008ZX1004-009, 2009ZX10004-108]	Tianjin Municipal Special Fund; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese National Science Fund(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); National 973 Program of China(National Basic Research Program of China); National Key Programs for Infectious Diseases of China	This work was supported by the Tianjin Municipal Special Fund for Science and Technology Innovation Grant 05FZZDSH00800; National Natural Science Foundation of China (NSFC) Key Programs Grants 30530010 and 20536040; the Chinese National Science Fund for Distinguished Young Scholars (30788001); NSFC General Program Grants 30670038, 30870070, 30870078, 30771175, and 30900041; National 863 Program of China Grants 2006AA020703 and 2006AA06Z409; National 973 Program of China Grant 2009CB522603; and National Key Programs for Infectious Diseases of China 2008ZX1004-002, 2008ZX1004-009, and 2009ZX10004-108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2002, INFECT IMMUN, V70, P3500, DOI 10.1128/IAI.70.7.3500-3509.2002; Afset JE, 2006, J CLIN MICROBIOL, V44, P3703, DOI 10.1128/JCM.00429-06; An HY, 1999, ADV EXP MED BIOL, V473, P179; Anthony KG, 1999, J BACTERIOL, V181, P5149, DOI 10.1128/JB.181.17.5149-5159.1999; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; Banatvala N, 2001, J INFECT DIS, V183, P1063, DOI 10.1086/319269; Beinke C, 1998, INFECT IMMUN, V66, P528, DOI 10.1128/IAI.66.2.528-539.1998; Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brunder W, 2006, INT J MED MICROBIOL, V296, P467, DOI 10.1016/j.ijmm.2006.05.005; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Creuzburg K, 2007, J CLIN MICROBIOL, V45, P2498, DOI 10.1128/JCM.00038-07; Darling Aaron E., 2007, V396, P135; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Drago-Serrano ME, 2006, FEMS MICROBIOL LETT, V265, P35, DOI 10.1111/j.1574-6968.2006.00463.x; Drake JW, 2007, CRIT REV BIOCHEM MOL, V42, P247, DOI 10.1080/10409230701495631; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; EMMERT DB, 1994, NUCLEIC ACIDS RES, V22, P3445, DOI 10.1093/nar/22.17.3445; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Feng P, 1998, J INFECT DIS, V177, P1750, DOI 10.1086/517438; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Frankel G, 2008, CELL MICROBIOL, V10, P549, DOI 10.1111/j.1462-5822.2007.01103.x; Fricke WF, 2008, J BACTERIOL, V190, P6779, DOI 10.1128/JB.00661-08; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gordon DM, 1999, MICROBIOL-SGM, V145, P2663, DOI 10.1099/00221287-145-10-2663; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; GUTTMAN DS, 1994, SCIENCE, V266, P1380, DOI 10.1126/science.7973728; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hill CW, 1999, RES MICROBIOL, V150, P665, DOI 10.1016/S0923-2508(99)00125-4; Ho TD, 2008, INFECT IMMUN, V76, P1858, DOI 10.1128/IAI.01688-07; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; Johnson TJ, 2007, J BACTERIOL, V189, P3228, DOI 10.1128/JB.01726-06; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; Kozub-Witkowski E, 2008, J APPL MICROBIOL, V104, P403, DOI 10.1111/j.1365-2672.2007.03545.x; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Leopold SR, 2009, P NATL ACAD SCI USA, V106, P8713, DOI 10.1073/pnas.0812949106; LINK CD, 1983, MOL GEN GENET, V189, P337, DOI 10.1007/BF00337827; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; McVean G, 2002, GENETICS, V160, P1231; Milkman R, 2003, GENETICS, V163, P475; Morabito S, 2003, INFECT IMMUN, V71, P3343, DOI 10.1128/IAI.71.6.3343-3348.2003; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Nie H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-173; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Oshima K, 2008, DNA RES, V15, P375, DOI 10.1093/dnares/dsn026; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Rosenshine I, 1996, INFECT IMMUN, V64, P966, DOI 10.1128/IAI.64.3.966-973.1996; Schmidt H.A., 2007, CURR PROTOC BIOINFOR, V17, p6.6.1, DOI [10.1002/0471250953.bi0606s17, DOI 10.1002/0471250953.BI0606S17]; Souza V, 1999, APPL ENVIRON MICROB, V65, P3373; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stein M, 1996, J BACTERIOL, V178, P6546, DOI 10.1128/jb.178.22.6546-6554.1996; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; TADDEI F, 1995, SCIENCE, V269, P288, DOI 10.1126/science.269.5222.288-b; Tarr PI, 2000, J BACTERIOL, V182, P6183, DOI 10.1128/JB.182.21.6183-6191.2000; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Trabulsi LR, 2002, EMERG INFECT DIS, V8, P508, DOI 10.3201/eid0805.010385; Wang L, 2002, J BACTERIOL, V184, P2620, DOI 10.1128/JB.184.10.2620-2625.2002; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; WHITTAM TS, 1993, INFECT IMMUN, V61, P1619, DOI 10.1128/IAI.61.5.1619-1629.1993; WHITTAM TS, 1996, ESCHERICHIA COLI SAL, P2708; Wick LM, 2005, J BACTERIOL, V187, P1783, DOI 10.1128/JB.187.5.1783-1791.2005; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706	80	83	95	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8700	10.1371/journal.pone.0008700	http://dx.doi.org/10.1371/journal.pone.0008700			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090843	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714600003
J	Hao, K; Chudin, E; Greenawalt, D; Schadt, EE				Hao, Ke; Chudin, Eugene; Greenawalt, Danielle; Schadt, Eric E.			Magnitude of Stratification in Human Populations and Impacts on Genome Wide Association Studies	PLOS ONE			English	Article							FOUNDER POPULATION; GENE-EXPRESSION; SUBSTRUCTURE; LOCI; ANCESTRY; PATTERNS; DISEASE	Genome-wide association studies (GWAS) may be biased by population stratification (PS). We conducted empirical quantification of the magnitude of PS among human populations and its impact on GWAS. Liver tissues were collected from 979, 59 and 49 Caucasian Americans (CA), African Americans (AA) and Hispanic Americans (HA), respectively, and genotyped using Illumina650Y (Ilmn650Y) arrays. RNA was also isolated and hybridized to Agilent whole-genome gene expression arrays. We propose a new method (i.e., hgdp-eigen) for detecting PS by projecting genotype vectors for each sample to the eigenvector space defined by the Human Genetic Diversity Panel (HGDP). Further, we conducted GWAS to map expression quantitative trait loci (eQTL) for the similar to 40,000 liver gene expression traits monitored by the Agilent arrays. HGDP-eigen performed similarly to the conventional self-eigen methods in capturing PS. However, leveraging the HGDP offered a significant advantage in revealing the origins, directions and magnitude of PS. Adjusting for eigenvectors had minor impacts on eQTL detection rates in CA. In contrast, for AA and HA, adjustment dramatically reduced association findings. At an FDR = 10%, we identified 65 eQTLs in AA with the unadjusted analysis, but only 18 eQTLs after the eigenvector adjustment. Strikingly, 55 out of the 65 unadjusted AA eQTLs were validated in CA, indicating that the adjustment procedure significantly reduced GWAS power. A number of the 55 AA eQTLs validated in CA overlapped with published disease associated SNPs. For example, rs646776 and rs10903129 have previously been associated with lipid levels and coronary heart disease risk, however, the rs10903129 eQTL was missed in the eigenvector adjusted analysis.	[Hao, Ke; Chudin, Eugene; Greenawalt, Danielle; Schadt, Eric E.] Rosetta Inpharmat, Dept Genet, Seattle, WA USA	Merck & Company	Hao, K (corresponding author), Rosetta Inpharmat, Dept Genet, Seattle, WA USA.	ke_hao@merck.com; eric.schadt@gmail.com			Merck Co, Inc	Merck Co, Inc(Merck & Company)	The study was funded by Merck & Co, Inc, which employed all authors responsible for study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Anderson CA, 2008, AM J HUM GENET, V83, P112, DOI 10.1016/j.ajhg.2008.06.008; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; Hao K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000109; Hindorff LA, 2009, CATALOG PUBLISHED GE; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	23	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8695	10.1371/journal.pone.0008695	http://dx.doi.org/10.1371/journal.pone.0008695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084173	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600041
J	Kodama, T; Gotoh, K; Hiyoshi, H; Morita, M; Izutsu, K; Akeda, Y; Park, KS; Cantarelli, VV; Dryselius, R; Iida, T; Honda, T				Kodama, Toshio; Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Morita, Mikiharu; Izutsu, Kaori; Akeda, Yukihiro; Park, Kwon-Sam; Cantarelli, Vlademir V.; Dryselius, Rikard; Iida, Tetsuya; Honda, Takeshi			Two Regulators of Vibrio parahaemolyticus Play Important Roles in Enterotoxicity by Controlling the Expression of Genes in the Vp-PAI Region	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; III SECRETION SYSTEM; PATHOGENICITY ISLAND; UNITED-STATES; CHOLERAE; IDENTIFICATION; PURIFICATION; PROTEIN; TOXIN; CELLS	Vibrio parahaemolyticus is an important pathogen causing food-borne disease worldwide. An 80-kb pathogenicity island (Vp-PAI), which contains two tdh (thermostable direct hemolysin) genes and a set of genes for the type III secretion system (T3SS2), is closely related to the pathogenicity of this bacterium. However, the regulatory mechanisms of Vp-PAI's gene expression are poorly understood. Here we report that two novel ToxR-like transcriptional regulatory proteins (VtrA and VtrB) regulate the expression of the genes encoded within the Vp-PAI region, including those for TDH and T3SS2-related proteins. Expression of vtrB was under control of the VtrA, as vector-expressed vtrB was able to recover a functional protein secretory capacity for T3SS2, independent of VtrA. Moreover, these regulatory proteins were essential for T3SS2-dependent biological activities, such as in vitro cytotoxicity and in vivo enterotoxicity. Enterotoxic activities of vtrA and/or vtrB deletion strains derived from the wild-type strain were almost absent, showing fluid accumulation similar to non-infected control. Whole genome transcriptional profiling of vtrA or vtrB deletion strains revealed that the expression levels of over 60 genes were downregulated significantly in these deletion mutant strains and that such genes were almost exclusively located in the Vp-PAI region. These results strongly suggest that VtrA and VtrB are master regulators for virulence gene expression in the Vp-PAI and play critical roles in the pathogenicity of this bacterium.	[Kodama, Toshio; Morita, Mikiharu; Akeda, Yukihiro; Park, Kwon-Sam; Cantarelli, Vlademir V.; Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan; [Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Izutsu, Kaori; Dryselius, Rikard; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Osaka, Japan; [Park, Kwon-Sam] Kunsan Natl Univ, Coll Ocean Sci & Technol, Dept Food Sci & Technol, Kusan, Jeollabuk Do, South Korea; [Cantarelli, Vlademir V.] Ctr Univ Feevale, Novo Hamburgo, RS, Brazil	Osaka University; Osaka University; Kunsan National University	Kodama, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan.	kodama@biken.osaka-u.ac.jp	Cantarelli, Vlademir/E-1970-2016	Hiyoshi, Hirotaka/0000-0003-3709-2386; Kodama, Toshio/0000-0002-6511-7301	Ministry of Education, Culture, Sports, Science and Technology of Japan [21790419, 17019058, 18073003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (21790419, http://kaken.nii.ac.jp/ja/p/21790419) and Scientific Research on Priority Areas Applied Genomics (17019058, http://kaken.nii.ac.jp/ja/p/17019058), and Matrix of Infection Phenomena from the Ministry of Education (18073003, http://kaken.nii.ac.jp/ja/p/18073003), Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; GOSHIMA K, 1977, J MOL CELL CARDIOL, V9, P191, DOI 10.1016/0022-2828(77)90029-3; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; HONDA T, 1976, INFECT IMMUN, V13, P163, DOI 10.1128/IAI.13.1.163-171.1976; HONDA T, 1990, CAN J MICROBIOL, V36, P395, DOI 10.1139/m90-069; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HONDA T, 1976, J JPN ASS INFECT DIS, V50, P216; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kodama T, 2008, INFECT IMMUN, V76, P4282, DOI 10.1128/IAI.01738-07; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Meador CE, 2007, J CLIN MICROBIOL, V45, P1133, DOI 10.1128/JCM.00042-07; Miller J.H., 1972, EXPT MOL GENETICS; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; MIYAMOTO Y, 1969, J BACTERIOL, V100, P1147, DOI 10.1128/JB.100.2.1147-1149.1969; MIYAMOTO Y, 1980, INFECT IMMUN, V28, P567; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nakano M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-155; NIIKAWA T, 1972, JPN J MED SCI BIOL, V25, P197; NISHIBUCHI M, 1992, INFECT IMMUN, V60, P3539, DOI 10.1128/IAI.60.9.3539-3545.1992; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Nomura T, 2000, MICROB PATHOGENESIS, V28, P25, DOI 10.1006/mpat.1999.0321; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Park KS, 2004, MICROBIOL IMMUNOL, V48, P313, DOI 10.1111/j.1348-0421.2004.tb03512.x; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; SAKURAI J, 1973, INFECT IMMUN, V8, P775, DOI 10.1128/IAI.8.5.775-780.1973; SAKURAI J, 1976, INFECT IMMUN, V13, P876, DOI 10.1128/IAI.13.3.876-883.1976; Skorupski K, 1997, MOL MICROBIOL, V25, P1003, DOI 10.1046/j.1365-2958.1997.5481909.x; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Takahashi A, 2001, J MED MICROBIOL, V50, P870, DOI 10.1099/0022-1317-50-10-870; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; TANG GQ, 1995, FEMS MICROBIOL LETT, V134, P233, DOI 10.1016/0378-1097(95)00411-3; Tang GQ, 1997, FEMS MICROBIOL LETT, V150, P289, DOI 10.1016/S0378-1097(97)00133-X; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; ZENYOJI H, 1971, J INFECT DIS, V123, P665, DOI 10.1093/infdis/123.6.665	47	48	57	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8678	10.1371/journal.pone.0008678	http://dx.doi.org/10.1371/journal.pone.0008678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084267	Green Submitted, gold, Green Published			2022-12-27	WOS:000273554600029
J	Brumfield, KM; Moroney, JV; Moore, TS; Simms, TA; Donze, D				Brumfield, Kristy M.; Moroney, James V.; Moore, Thomas S.; Simms, Tiffany A.; Donze, David			Functional Characterization of the Chlamydomonas reinhardtii ERG3 Ortholog, a Gene Involved in the Biosynthesis of Ergosterol	PLOS ONE			English	Article							MEMBRANE-LIPID BIOSYNTHESIS; CONSERVED DOMAIN DATABASE; C-5 STEROL DESATURASE; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; DRUG-RESISTANCE; YEAST; MUTANTS; PHYTOSTEROLS; EXPRESSION	Background: The predominant sterol in the membranes of the alga Chlamydomonas reinhardtii is ergosterol, which is commonly found in the membranes of fungi, but is rarely found in higher plants. Higher plants and fungi synthesize sterols by different pathways, with plants producing cycloartenol as a precursor to end-product sterols, while non-photosynthesizing organisms like yeast and humans produce lanosterol as a precursor. Analysis of the C. reinhardtii genome sequence reveals that this algae is also likely to synthesize sterols using a pathway resembling the higher plant pathway, indicating that its sterols are synthesized somewhat differently than in fungi. The work presented here seeks to establish experimental evidence to support the annotated molecular function of one of the sterol biosynthetic genes in the Chlamydomonas genome. Methodology/Principal Findings: A gene with homology to the yeast sterol C-5 desaturase, ERG3, is present in the Chlamydomonas genome. To test whether the ERG3 ortholog of C. reinhardtii encodes a sterol C-5 desaturase, Saccharomyces cerevisiae ERG3 knockout strains were created and complemented with a plasmid expressing the Chlamydomonas ERG3. Expression of C. reinhardtii ERG3 cDNA in erg3 null yeast was able to restore ergosterol biosynthesis and reverse phenotypes associated with lack of ERG3 function. Conclusions/Significance: Complementation of the yeast erg3 null phenotypes strongly suggests that the gene annotated as ERG3 in C. reinhardtii functions as a sterol C-5 desaturase.	[Brumfield, Kristy M.] Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA; [Moroney, James V.; Moore, Thomas S.; Simms, Tiffany A.; Donze, David] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Xavier University of Louisiana; Louisiana State University System; Louisiana State University	Brumfield, KM (corresponding author), Xavier Univ Louisiana, Dept Biol, New Orleans, LA USA.	ddonze@lsu.edu		Donze, David/0000-0002-7473-5902	National Science Foundation [MCB-0817823, IOS-0816957]; Div Of Molecular and Cellular Bioscience [0817823] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation (Grants to MCB-0817823 to D.D. and IOS-0816957 to J.V.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Methods Enzymol, V194, P1; ARTHINGTON BA, 1991, GENE, V102, P39, DOI 10.1016/0378-1119(91)90535-J; ArthingtonSkaggs BA, 1996, FEBS LETT, V392, P161, DOI 10.1016/0014-5793(96)00807-1; BAKER BJ, 1993, MARINE NATURAL PRODU, P1; BARD M, 1978, J BACTERIOL, V135, P1146, DOI 10.1128/JB.135.3.1146-1148.1978; BARD M, 1978, LIPIDS, V13, P533, DOI 10.1007/BF02533592; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Broach JR, 1991, MOL CELLULAR BIOL YE; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Darnet S, 2001, FEBS LETT, V508, P39, DOI 10.1016/S0014-5793(01)03002-2; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dudley AM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100004; Fernandes P, 2007, BIORESOURCE TECHNOL, V98, P2335, DOI 10.1016/j.biortech.2006.10.006; Gachotte D, 1996, PLANT J, V9, P391, DOI 10.1046/j.1365-313X.1996.09030391.x; GEALT MA, 1981, LIPIDS, V16, P133, DOI 10.1007/BF02535687; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GINER JL, 1993, CHEM REV, V93, P1735, DOI 10.1021/cr00021a004; Griffiths KM, 2003, PHYTOCHEMISTRY, V62, P147, DOI 10.1016/S0031-9422(02)00505-8; HEMMI K, 1995, BIOSCI BIOTECH BIOCH, V59, P482, DOI 10.1271/bbb.59.482; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; JAYASIMHA PBC, 2006, RECENT ADV PHYTOCHEM, V40; KLEINHANS FW, 1979, CHEM PHYS LIPIDS, V23, P143, DOI 10.1016/0009-3084(79)90042-2; LAMPEN JO, 1966, S SOC GENMICR; LEES N D, 1989, Steroids, V53, P567, DOI 10.1016/0039-128X(89)90032-9; LEES ND, 1979, BIOCHIM BIOPHYS ACTA, V553, P469, DOI 10.1016/0005-2736(79)90302-X; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; LUDWIG DL, 1993, GENE, V132, P33, DOI 10.1016/0378-1119(93)90511-Z; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miyazaki Y, 1999, GENE, V236, P43, DOI 10.1016/S0378-1119(99)00263-2; Moghadasian MH, 1999, AM J MED, V107, P588, DOI 10.1016/S0002-9343(99)00285-5; NES WD, 1990, P NATL ACAD SCI USA, V87, P7565, DOI 10.1073/pnas.87.19.7565; NES WR, 1988, J BIOL CHEM, V263, P11844; NORTON RA, 1991, LIPIDS, V26, P247, DOI 10.1007/BF02543980; OSUMI T, 1979, J BIOCHEM-TOKYO, V85, P819; OSUMI T, 1978, J BIOCHEM-TOKYO, V83, P681, DOI 10.1093/oxfordjournals.jbchem.a131961; PARKS LW, 1995, ANNU REV MICROBIOL, V49, P95, DOI 10.1146/annurev.mi.49.100195.000523; PARKS LW, 1982, LIPIDS, V17, P187, DOI 10.1007/BF02535102; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Salimova E, 1999, PLANT PHYSIOL BIOCH, V37, P241, DOI 10.1016/S0981-9428(99)80022-9; Schrick K, 2000, GENE DEV, V14, P1471; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Song ZH, 2007, LIPIDS, V42, P15, DOI 10.1007/s11745-006-3017-1; Souter M, 2002, PLANT CELL, V14, P1017, DOI 10.1105/tpc.001248; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Tapiero H, 2003, BIOMED PHARMACOTHER, V57, P321, DOI 10.1016/S0753-3322(03)00104-5; Taton M, 2000, BIOCHEMISTRY-US, V39, P701, DOI 10.1021/bi991467t; WACH A, 1994, YEAST, V10, P1808; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Yang WY, 2004, ARCH BIOCHEM BIOPHYS, V430, P198, DOI 10.1016/j.abb.2004.07.016; Yang WY, 2004, BIOCHEM J, V382, P51, DOI 10.1042/BJ20040254	56	26	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8659	10.1371/journal.pone.0008659	http://dx.doi.org/10.1371/journal.pone.0008659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20084111	Green Published, Green Submitted, gold			2022-12-27	WOS:000273456300009
J	Miller, JE; Hilliard, AT; White, SA				Miller, Julie E.; Hilliard, Austin T.; White, Stephanie A.			Song Practice Promotes Acute Vocal Variability at a Key Stage of Sensorimotor Learning	PLOS ONE			English	Article							SINGING-RELATED ACTIVITY; BASAL GANGLIA; FOXP2 EXPRESSION; GENE-EXPRESSION; SPEECH; NEURONS; LANGUAGE; BIRDSONG; NUCLEUS; CIRCUIT	Background: Trial by trial variability during motor learning is a feature encoded by the basal ganglia of both humans and songbirds, and is important for reinforcement of optimal motor patterns, including those that produce speech and birdsong. Given the many parallels between these behaviors, songbirds provide a useful model to investigate neural mechanisms underlying vocal learning. In juvenile and adult male zebra finches, endogenous levels of FoxP2, a molecule critical for language, decrease two hours after morning song onset within area X, part of the basal ganglia-forebrain pathway dedicated to song. In juveniles, experimental 'knockdown' of area X FoxP2 results in abnormally variable song in adulthood. These findings motivated our hypothesis that low FoxP2 levels increase vocal variability, enabling vocal motor exploration in normal birds. Methodology/Principal Findings: After two hours in either singing or non-singing conditions (previously shown to produce differential area X FoxP2 levels), phonological and sequential features of the subsequent songs were compared across conditions in the same bird. In line with our prediction, analysis of songs sung by 75 day (75d) birds revealed that syllable structure was more variable and sequence stereotypy was reduced following two hours of continuous practice compared to these features following two hours of non-singing. Similar trends in song were observed in these birds at 65d, despite higher overall within-condition variability at this age. Conclusions/Significance: Together with previous work, these findings point to the importance of behaviorally-driven acute periods during song learning that allow for both refinement and reinforcement of motor patterns. Future work is aimed at testing the observation that not only does vocal practice influence expression of molecular networks, but that these networks then influence subsequent variability in these skills.	[Miller, Julie E.; Hilliard, Austin T.; White, Stephanie A.] Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA; [Hilliard, Austin T.; White, Stephanie A.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Miller, JE (corresponding author), Univ Calif Los Angeles, Dept Physiol Sci, Los Angeles, CA 90095 USA.	sawhite@ucla.edu	Hilliard, Austin/AAT-7316-2020; Hilliard, Austin/AAM-1752-2020; White, Stephanie Ann/AAE-7683-2019	Hilliard, Austin/0000-0002-1289-4377; White, Stephanie Ann/0000-0002-3490-2294; Miller, Julie/0000-0003-0371-0342	University of California Los Angeles Mental Retardation Research Center [T32 HD0007032, RO1 MH070712]; ATH [2T32 MH019384-11A2, 1F31 MH082533-01A1]; Tennenbaum Family Creativity Initiative [1RO1 MH070712]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070712, T32MH019384, F31MH082533] Funding Source: NIH RePORTER	University of California Los Angeles Mental Retardation Research Center; ATH; Tennenbaum Family Creativity Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JEM was supported by University of California Los Angeles Mental Retardation Research Center T32 HD0007032 and RO1 MH070712 to SAW. ATH was supported by 2T32 MH019384-11A2 and 1F31 MH082533-01A1. SAW was funded by the Tennenbaum Family Creativity Initiative and 1RO1 MH070712. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Barnes TD, 2005, NATURE, V437, P1158, DOI 10.1038/nature04053; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brenowitz EA, 2005, TRENDS NEUROSCI, V28, P127, DOI 10.1016/j.tins.2005.01.004; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Castelino CB, 2005, EUR J NEUROSCI, V21, P1962, DOI 10.1111/j.1460-9568.2005.04028.x; Day NF, 2008, J NEUROPHYSIOL, V100, P2956, DOI 10.1152/jn.90501.2008; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dunn AM, 1996, ETHOLOGY, V102, P529; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Farries MA, 2005, J COMP NEUROL, V484, P93, DOI 10.1002/cne.20464; Farries MA, 2002, J NEUROSCI, V22, P3776; Gale SD, 2005, J NEUROPHYSIOL, V93, P1871, DOI 10.1152/jn.01053.2004; GALE SD, 2009, J CHEM NEUROANATOMY; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HILLIARD AH, 2009, SOC NEUR ABS; HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jarvis ED, 2005, NAT REV NEUROSCI, V6, P151, DOI 10.1038/nrn1606; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Johnson F, 2002, BEHAV BRAIN RES, V131, P57, DOI 10.1016/S0166-4328(01)00374-6; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Kojima S, 2009, J NEUROSCI, V29, P4782, DOI 10.1523/JNEUROSCI.4903-08.2009; Kozhevnikov AA, 2007, J NEUROPHYSIOL, V97, P4271, DOI 10.1152/jn.00952.2006; Kubikova L, 2007, EUR J NEUROSCI, V25, P2145, DOI 10.1111/j.1460-9568.2007.05368.x; Kuhl PK, 2007, DEVELOPMENTAL SCI, V10, P110, DOI 10.1111/j.1467-7687.2007.00572.x; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Luo MM, 1999, J NEUROSCI, V19, P6700; Luo MM, 2002, J NEUROPHYSIOL, V88, P1903, DOI 10.1152/jn.2002.88.4.1903; Luo MM, 1999, J COMP NEUROL, V403, P68; Markov A., 1971, EXTENSION LIMIT THEO, VVolume 1; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; Miller JE, 2008, J NEUROPHYSIOL, V100, P2015, DOI 10.1152/jn.90415.2008; NOWICKI S, 1991, CONDOR, V93, P1, DOI 10.2307/1368599; Overduin SA, 2006, J NEUROSCI, V26, P11888, DOI 10.1523/JNEUROSCI.1320-06.2006; PANAITOF SC, 2008, SOC NEUR ABS; Poopatanapong A, 2006, J NEUROBIOL, V66, P1613, DOI 10.1002/neu.20329; Rochefort C, 2007, DEV NEUROBIOL, V67, P809, DOI 10.1002/dneu.20393; Sakata JT, 2008, J NEUROPHYSIOL, V99, P1700, DOI 10.1152/jn.01296.2007; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Sasaki A, 2006, J NEUROSCI, V26, P9010, DOI 10.1523/JNEUROSCI.1335-06.2006; Scharff C, 2004, ANN NY ACAD SCI, V1016, P325, DOI 10.1196/annals.1298.032; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Soha JA, 2001, J COMP PSYCHOL, V115, P172, DOI 10.1037//0735-7036.115.2.172; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Vargha-Khadem F, 2005, NAT REV NEUROSCI, V6, P131, DOI 10.1038/nrn1605; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Vernes SC, 2007, AM J HUM GENET, V81, P1232, DOI 10.1086/522238; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Whitney O, 2005, J NEUROBIOL, V65, P251, DOI 10.1002/neu.20187; WOOLLEY SC, 2009, SOC NEUR ABS; Yanagihara S, 2006, EUR J NEUROSCI, V24, P3619, DOI 10.1111/j.1460-9568.2006.05228.x; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	72	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8592	10.1371/journal.pone.0008592	http://dx.doi.org/10.1371/journal.pone.0008592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066039	Green Published, gold			2022-12-27	WOS:000273338600015
J	Chung, JH; Kubota, H; Ozaki, Y; Uda, S; Kuroda, S				Chung, Jaehoon; Kubota, Hiroyuki; Ozaki, Yu-ichi; Uda, Shinsuke; Kuroda, Shinya			Timing-Dependent Actions of NGF Required for Cell Differentiation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR RECEPTOR; PC12 PHEOCHROMOCYTOMA CELLS; 2 DISTINCT PHASES; NEURONAL DIFFERENTIATION; NEURITE OUTGROWTH; PHOSPHATIDYLINOSITOL-3 KINASE; SIGNAL-TRANSDUCTION; ERK ACTIVATION; EXPRESSION	Background: Continuous NGF stimulation induces PC12 cell differentiation. However, why continuous NGF stimulation is required for differentiation is unclear. In this study, we investigated the underlying mechanisms of the timing-dependent requirement of NGF action for cell differentiation. Methodology/Principal Findings: To address the timing-dependency of the NGF action, we performed a discontinuous stimulation assay consisting of a first transient stimulation followed by an interval and then a second sustained stimulation and quantified the neurite extension level. Consequently, we observed a timing-dependent action of NGF on cell differentiation, and discontinuous NGF stimulation similarly induced differentiation. The first stimulation did not induce neurite extension, whereas the second stimulation induced fast neurite extension; therefore, the first stimulation is likely required as a prerequisite condition. These observations indicate that the action of NGF can be divided into two processes: an initial stimulation-driven latent process and a second stimulation-driven extension process. The latent process appears to require the activities of ERK and transcription, but not PI3K, whereas the extension-process requires the activities of ERK and PI3K, but not transcription. We also found that during the first stimulation, the activity of NGF can be replaced by PACAP, but not by insulin, EGF, bFGF or forskolin; during the second stimulation, however, the activity of NGF cannot be replaced by any of these stimulants. These findings allowed us to identify potential genes specifically involved in the latent process, rather than in other processes, using a microarray. Conclusions/Significance: These results demonstrate that NGF induces the differentiation of PC12 cells via mechanically distinct processes: an ERK-driven and transcription-dependent latent process, and an ERK- and PI3K-driven and transcription-independent extension process.	[Chung, Jaehoon; Kubota, Hiroyuki; Ozaki, Yu-ichi; Uda, Shinsuke; Kuroda, Shinya] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, CREST,Japan Sci & Technol Agcy, Tokyo 113, Japan	Japan Science & Technology Agency (JST); University of Tokyo	Chung, JH (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, CREST,Japan Sci & Technol Agcy, Tokyo 113, Japan.	skuroda@bi.s.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17017005, 18200021]; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by a grant in-aid for scientific research on priority areas "Systems Genomics'' (17017005), and Scientific Research (A) (18200021) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and by a grant in-aid from Uehara Memorial Foundation. J.C. was supported by a scholarship from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; BURSTEIN DE, 1978, P NATL ACAD SCI USA, V75, P6059, DOI 10.1073/pnas.75.12.6059; BURSTEIN DE, 1982, BRAIN RES, V247, P115, DOI 10.1016/0006-8993(82)91033-2; Cazillis M, 2004, EUR J NEUROSCI, V19, P798, DOI 10.1111/j.0953-816X.2004.03138.x; Chang JH, 2003, J BIOL CHEM, V278, P42877, DOI 10.1074/jbc.M308155200; Chen L, 2008, MOL ENDOCRINOL, V22, P454, DOI 10.1210/me.2007-0384; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; DIJKMANS TF, 2008, J NEUROCHEM; Draghetti C, 2009, J BIOL CHEM, V284, P32053, DOI 10.1074/jbc.M109.009324; Farias-Eisner R, 2001, J NEUROSCI RES, V63, P341, DOI 10.1002/1097-4547(20010215)63:4<341::AID-JNR1028>3.0.CO;2-P; Farias-Eisner R, 2000, J NEUROSCI, V20, P230, DOI 10.1523/JNEUROSCI.20-01-00230.2000; GERDIN MJ, 2007, SCI STKE; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Ha H, 2009, NAT REV NEPHROL, V5, P203, DOI 10.1038/nrneph.2009.15; Harada T, 2001, NAT CELL BIOL, V3, P453, DOI 10.1038/35074516; HASHIMOTO S, 1988, J CELL BIOL, V107, P1531, DOI 10.1083/jcb.107.4.1531; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Jackson TR, 1996, J CELL SCI, V109, P289; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; Jones SM, 1999, CURR BIOL, V9, P512, DOI 10.1016/S0960-9822(99)80235-8; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; KLIMASCHEWSKI L, 1995, NEUROSCI LETT, V195, P133, DOI 10.1016/0304-3940(95)11799-3; Korhonen JM, 1999, J BIOL CHEM, V274, P37307, DOI 10.1074/jbc.274.52.37307; Leeman MF, 2002, CRIT REV BIOCHEM MOL, V37, P149, DOI 10.1080/10409230290771483; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Munitic I, 2005, J IMMUNOL, V174, P4010, DOI 10.4049/jimmunol.174.7.4010; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nusser N, 2002, J BIOL CHEM, V277, P35840, DOI 10.1074/jbc.M203617200; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Pool M, 2008, J NEUROSCI METH, V168, P134, DOI 10.1016/j.jneumeth.2007.08.029; Rattenholl A, 2002, J BIOL CHEM, V277, P26372, DOI 10.1074/jbc.M203247200; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schimmelpfeng J, 2004, J NEUROSCI METH, V139, P299, DOI 10.1016/j.jneumeth.2004.05.010; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Yamamoto T, 2006, CURR BIOL, V16, P1171, DOI 10.1016/j.cub.2006.04.044; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	51	37	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9011	10.1371/journal.pone.0009011	http://dx.doi.org/10.1371/journal.pone.0009011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126402	Green Published, Green Submitted, gold			2022-12-27	WOS:000274207200010
J	Hollenbach, PW; Nguyen, AN; Brady, H; Williams, M; Ning, YH; Richard, N; Krushel, L; Aukerman, SL; Heise, C; MacBeth, KJ				Hollenbach, Paul W.; Nguyen, Aaron N.; Brady, Helen; Williams, Michelle; Ning, Yuhong; Richard, Normand; Krushel, Leslie; Aukerman, Sharon L.; Heise, Carla; MacBeth, Kyle J.			A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							DNA METHYLTRANSFERASE INHIBITORS; MYELODYSPLASTIC SYNDROMES; MULTIPLE-MYELOMA; L1210 LEUKEMIA; PHASE-III; 5-AZACYTIDINE; CANCER; 5-AZA-2'-DEOXYCYTIDINE; METHYLATION; APOPTOSIS	Background: The cytidine nucleoside analogs azacitidine (AZA) and decitabine (DAC) are used for the treatment of patients with myelodysplastic syndromes and acute myeloid leukemia (AML). Few non-clinical studies have directly compared the mechanisms of action of these agents in a head-to-head fashion, and the agents are often viewed as mechanistically similar DNA hypomethylating agents. To better understand the similarities and differences in mechanisms of these drugs, we compared their in vitro effects on several end points in human AML cell lines. Methodology/Principal Findings: Both drugs effected DNA methyltransferase 1 depletion, DNA hypomethylation, and DNA damage induction, with DAC showing equivalent activity at concentrations 2- to 10-fold lower than AZA. At concentrations above 1 mu M, AZA had a greater effect than DAC on reducing cell viability. Both drugs increased the sub-G1 fraction and apoptosis markers, with AZA decreasing all cell cycle phases and DAC causing an increase in G2-M. Total protein synthesis was reduced only by AZA, and drug-modulated gene expression profiles were largely non-overlapping. Conclusions/Significance: These data demonstrate shared mechanisms of action of AZA and DAC on DNA-mediated markers of activity, but distinctly different effects in their actions on cell viability, protein synthesis, cell cycle, and gene expression. The differential effects of AZA may be mediated by RNA incorporation, as the distribution of AZA in nucleic acid of KG-1a cells was 65: 35, RNA: DNA.	[Hollenbach, Paul W.; Nguyen, Aaron N.; Brady, Helen; Ning, Yuhong; Richard, Normand; Aukerman, Sharon L.; Heise, Carla; MacBeth, Kyle J.] Celgene Corp, San Francisco, CA USA; [Williams, Michelle; Krushel, Leslie] Univ Colorado Denver, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA	Bristol-Myers Squibb; Celgene Corporation; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hollenbach, PW (corresponding author), Celgene Corp, San Francisco, CA USA.	kmacbeth@celgene.com			Celgene Corporation	Celgene Corporation(Bristol-Myers SquibbCelgene Corporation)	This study was funded by Celgene Corporation (www.celgene.com). The authors received editorial support from Excerpta Medica for copy editing this manuscript, funded by Celgene Corporation. The authors wrote the manuscript and are fully responsible for content and editorial decisions for this manuscript.	ADAMS RLP, 1982, BIOCHIM BIOPHYS ACTA, V697, P286, DOI 10.1016/0167-4781(82)90091-4; BENNETT J, 1978, BIOCHEM PHARMACOL, V27, P1555, DOI 10.1016/0006-2952(78)90485-9; Berg T, 2007, LEUKEMIA RES, V31, P497, DOI 10.1016/j.leukres.2006.08.008; Blum W, 2007, J CLIN ONCOL, V25, P3884, DOI 10.1200/JCO.2006.09.4169; Cashen AF, 2008, CANCER CHEMOTH PHARM, V61, P759, DOI 10.1007/s00280-007-0531-7; Cataldo VD, 2009, EXPERT REV ANTICANC, V9, P875, DOI 10.1586/ERA.09.61; CIHAK A, 1974, CANCER RES, V34, P3003; CIHAK A, 1974, ONCOLOGY-BASEL, V30, P405; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Flotho C, 2009, LEUKEMIA, V23, P1019, DOI 10.1038/leu.2008.397; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; GLOVER AB, 1987, CANCER TREAT REP, V71, P959; GORCZYCA W, 1993, CANCER RES, V53, P3186; Griffiths EA, 2008, LEUKEMIA LYMPHOMA, V49, P650, DOI 10.1080/10428190801947575; HERSHKO A, 1971, NATURE-NEW BIOL, V232, P206, DOI 10.1038/newbio232206a0; Jiemjit A, 2008, ONCOGENE, V27, P3615, DOI 10.1038/sj.onc.1211018; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Khong T, 2008, HAEMATOLOGICA, V93, P860, DOI 10.3324/haematol.12261; Kiziltepe T, 2007, MOL CANCER THER, V6, P1718, DOI 10.1158/1535-7163.MCT-07-0010; Lavelle D, 2003, LEUKEMIA RES, V27, P999, DOI 10.1016/S0145-2126(03)00068-7; LI LH, 1970, CANCER RES, V30, P2760; LU LJW, 1980, CANCER RES, V40, P2701; Marcucci G, 2005, J CLIN PHARMACOL, V45, P597, DOI 10.1177/0091270004271947; MOMPARLER RL, 1984, CANCER CHEMOTH PHARM, V13, P191, DOI 10.1007/BF00269027; MOMPARLER RL, 1984, LEUKEMIA RES, V8, P1043, DOI 10.1016/0145-2126(84)90059-6; MURAKAMI T, 1995, CANCER RES, V55, P3093; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Qin T, 2007, CLIN CANCER RES, V13, P4225, DOI 10.1158/1078-0432.CCR-06-2762; Qin TC, 2009, BLOOD, V113, P659, DOI 10.1182/blood-2008-02-140038; REICHMAN M, 1973, BIOCHIM BIOPHYS ACTA, V324, P282, DOI 10.1016/0005-2787(73)90145-7; Santos FPS, 2010, EXPERT REV ANTICANC, V10, P9, DOI [10.1586/ERA.09.164, 10.1586/era.09.164]; Schmelz K, 2005, INT J CANCER, V114, P683, DOI 10.1002/ijc.20797; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Stresemann C, 2008, MOL CANCER THER, V7, P2998, DOI 10.1158/1535-7163.MCT-08-0411; WIJERMANS P, 2008, BLOOD, V112; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930	37	274	281	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9001	10.1371/journal.pone.0009001	http://dx.doi.org/10.1371/journal.pone.0009001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126405	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200004
J	Baldridge, GD; Burkhardt, NY; Oliva, AS; Kurtti, TJ; Munderloh, UG				Baldridge, Gerald D.; Burkhardt, Nicole Y.; Oliva, Adela S.; Kurtti, Timothy J.; Munderloh, Ulrike G.			Rickettsial ompB Promoter Regulated Expression of GFP(uv) in Transformed Rickettsia montanensis	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; FEVER GROUP RICKETTSIAE; MOUNTAIN WOOD TICK; SPOTTED-FEVER; DERMACENTOR-ANDERSONI; IXODES-SCAPULARIS; TRANSPOSON MUTAGENESIS; WESTERN MONTANA; GENE-EXPRESSION; CAPE-COD	Background: Rickettsia spp. (Rickettsiales: Rickettsiaceae) are Gram-negative, obligate intracellular, alpha-proteobacteria that have historically been associated with blood-feeding arthropods. Certain species cause typhus and spotted fevers in humans, but others are of uncertain pathogenicity or may be strict arthropod endosymbionts. Genetic manipulation of rickettsiae should facilitate a better understanding of their interactions with hosts. Methodology/Principal Findings: We transformed a species never associated with human disease, Rickettsia montanensis, by electroporation with a TN5 transposon (pMOD700) containing green fluorescent protein (GFPuv) and chloramphenicol acetyltransferase (CAT) genes under regulation of promoters cloned from the Rickettsia rickettsii ompB gene, and isolated a Chloramphenicol-resistant GFP-fluorescent rickettsiae population (Rmontanensis700). The Rmontanensis700 rickettsiae contained a single transposon integrated near an acetyl-CoA acetyltransferase gene in the rickettsial chromosome. Northern blots showed that GFPuv and CAT mRNAs were both expressed as two transcripts of larger and smaller than predicted length. Western immunoblots showed that Rmontanensis700 and E. coli transformed with a plasmid containing the pMOD700 transposon both expressed GFPuv proteins of the predicted molecular weight. Conclusions/Significance: Long-standing barriers to transformation of rickettsiae have been overcome by development of transposon-based rickettsial transformation vectors. The ompB promoter may be the most problematic of the four promoters so far employed in those vectors.	[Baldridge, Gerald D.; Burkhardt, Nicole Y.; Oliva, Adela S.; Kurtti, Timothy J.; Munderloh, Ulrike G.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Baldridge, GD (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	baldr001@umn.edu		Oliva Chavez, Adela/0000-0003-2397-0846	NIH [RO1 AI49424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049424, R01AI081690] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: NIH grant RO1 AI49424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammerman NC, 2004, EMERG INFECT DIS, V10, P1478, DOI 10.3201/eid1008.030882; ANDERSON BE, 1990, INFECT IMMUN, V58, P2760, DOI 10.1128/IAI.58.9.2760-2769.1990; ANDERSON JF, 1986, AM J TROP MED HYG, V35, P187, DOI 10.4269/ajtmh.1986.35.187; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baldridge GD, 2004, APPL ENVIRON MICROB, V70, P6628, DOI 10.1128/AEM.70.11.6628-6636.2004; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Baldridge GD, 2008, APPL ENVIRON MICROB, V74, P645, DOI 10.1128/AEM.02262-07; Baldridge GD, 2007, APPL ENVIRON MICROB, V73, P4984, DOI 10.1128/AEM.00988-07; Baldridge GD, 2007, J INVERTEBR PATHOL, V94, P163, DOI 10.1016/j.jip.2006.10.003; BELL EJ, 1963, J IMMUNOL, V90, P770; Benson MJ, 2004, APPL ENVIRON MICROB, V70, P616, DOI 10.1128/AEM.70.1.616-620.2004; BREITSCHWERDT EB, 1988, AM J VET RES, V49, P70; BURGDORFER W, 1975, ANN NY ACAD SCI, V266, P61, DOI 10.1111/j.1749-6632.1975.tb35088.x; Burgdorfer W., 1981, RICKETTSIAE RICKETTS, P585; Ceraul SM, 2007, INFECT IMMUN, V75, P1973, DOI 10.1128/IAI.01815-06; Cohen J, 1999, SCAND J INFECT DIS, V31, P202, DOI 10.1080/003655499750006290; DASCH GA, 2003, AM SOC RICK 18 M CUM; Dergousoff SJ, 2009, APPL ENVIRON MICROB, V75, P1786, DOI 10.1128/AEM.02554-08; Donovan BJ, 2002, ANN PHARMACOTHER, V36, P1590, DOI 10.1345/aph.1C089; FENG WC, 1980, AM J TROP MED HYG, V29, P691, DOI 10.4269/ajtmh.1980.29.691; FENG WC, 1980, INFECT IMMUN, V28, P627; Frati F, 2006, J INVERTEBR PATHOL, V93, P150, DOI 10.1016/j.jip.2006.07.002; Kurtti TJ, 2005, J INVERTEBR PATHOL, V90, P177, DOI 10.1016/j.jip.2005.09.001; LACKMAN D B, 1965, Health Lab Sci, V2, P135; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; Macaluso KR, 2003, ANN NY ACAD SCI, V990, P568, DOI 10.1111/j.1749-6632.2003.tb07428.x; Macaluso KR, 2002, J MED ENTOMOL, V39, P809, DOI 10.1603/0022-2585-39.6.809; Mulenga A, 2003, INSECT MOL BIOL, V12, P185, DOI 10.1046/j.1365-2583.2003.00400.x; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Niebylski ML, 1997, INT J SYST BACTERIOL, V47, P446, DOI 10.1099/00207713-47-2-446; Noda H, 1997, APPL ENVIRON MICROB, V63, P3926, DOI 10.1128/AEM.63.10.3926-3932.1997; NORMENT BR, 1984, AM J VET RES, V45, P1706; Ogata H, 2005, PLOS BIOL, V3, P1391, DOI 10.1371/journal.pbio.0030248; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Perotti MA, 2006, FASEB J, V20, P2372, DOI 10.1096/fj.06-5870fje; PHILIP RN, 1981, AM J TROP MED HYG, V30, P230, DOI 10.4269/ajtmh.1981.30.230; PICKERING LK, 2000, 2000 RED BOOK REPORT, P491; POLICASTRO PF, 1994, MICROBIOL-SGM, V140, P2941, DOI 10.1099/13500872-140-11-2941; PRETZMAN C, 1990, ANN NY ACAD SCI, V590, P227, DOI 10.1111/j.1749-6632.1990.tb42224.x; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Simser JA, 2002, APPL ENVIRON MICROB, V68, P4559, DOI 10.1128/AEM.68.9.4559-4566.2002; Simser JA, 2001, APPL ENVIRON MICROB, V67, P546, DOI 10.1128/AEM.67.2.546-552.2001; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Tucker AM, 2005, ANN NY ACAD SCI, V1063, P35, DOI 10.1196/annals.1355.005; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Weller SJ, 1998, J CLIN MICROBIOL, V36, P1305, DOI 10.1128/JCM.36.5.1305-1317.1998; Wood DO, 2000, INFECT IMMUN, V68, P6091, DOI 10.1128/IAI.68.11.6091-6093.2000	52	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8965	10.1371/journal.pone.0008965	http://dx.doi.org/10.1371/journal.pone.0008965			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126457	gold, Green Published, Green Submitted			2022-12-27	WOS:000274139100013
J	Khallou-Laschet, J; Varthaman, A; Fornasa, G; Compain, C; Gaston, AT; Clement, M; Dussiot, M; Levillain, O; Graff-Dubois, S; Nicoletti, A; Caligiuri, G				Khallou-Laschet, Jamila; Varthaman, Aditi; Fornasa, Giulia; Compain, Caroline; Gaston, Anh-Thu; Clement, Marc; Dussiot, Michael; Levillain, Olivier; Graff-Dubois, Stephanie; Nicoletti, Antonino; Caligiuri, Giuseppina			Macrophage Plasticity in Experimental Atherosclerosis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; ALTERNATIVE ACTIVATION; PPAR-GAMMA; MONONUCLEAR PHAGOCYTES; ARGINASE BALANCE; MICE; INFLAMMATION; EXPRESSION; PHENOTYPE	As in human disease, macrophages (M empty set) are central players in the development and progression of experimental atherosclerosis. In this study we have evaluated the phenotype of Mempty set associated with progression of atherosclerosis in the apolipoprotein E (ApoE) knockout (KO) mouse model. We found that bone marrow-derived Mempty set submitted to M1 and M2 polarization specifically expressed arginase (Arg) II and Arg I, respectively. This distinct arginase expression was used to evaluate the frequency and distribution of M1 and M2 Mempty set in cross-sections of atherosclerotic plaques of ApoE KO mice. Early lesions were infiltrated by Arg I+ (M2) Mempty set. This type of M empty set favored the proliferation of smooth muscle cells, in vitro. Arg II+ (M1) Mempty set appeared and prevailed in lesions of aged ApoE KO mice and lesion progression was correlated with the dominance of M1 over the M2 Mempty set phenotype. In order to address whether the M2->M1 switch could be due to a phenotypic switch of the infiltrated cells, we performed in vitro repolarization experiments. We found that fully polarized Mempty set retained their plasticity since they could revert their phenotype. The analysis of the distribution of Arg I-and Arg II-expressing Mempty set also argued against a recent recruitment of M1 Mempty set in the lesion. The combined data therefore suggest that the M2->M1 switch observed in vivo is due to a conversion of cells already present in the lesion. Our study suggests that interventional tools able to revert the Mempty set infiltrate towards the M2 phenotype may exert an atheroprotective action.	[Khallou-Laschet, Jamila; Varthaman, Aditi; Fornasa, Giulia; Compain, Caroline; Gaston, Anh-Thu; Clement, Marc; Dussiot, Michael; Graff-Dubois, Stephanie; Nicoletti, Antonino; Caligiuri, Giuseppina] INSERM, UMRS698, Paris, France; [Khallou-Laschet, Jamila; Nicoletti, Antonino] Univ Paris 07, Paris, France; [Levillain, Olivier] Univ Lyon 1, UMR5123, F-69622 Villeurbanne, France; [Graff-Dubois, Stephanie] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Sorbonne Universite	Khallou-Laschet, J (corresponding author), INSERM, UMRS698, Paris, France.	giuseppina.caligiuri@inserm.fr	CLEMENT, Marc/GVS-8052-2022; Caligiuri, Giuseppina/G-4810-2015; Nicoletti, Antonino/A-9460-2015; Fornasa, Giulia/AAB-8912-2019; Graff-Dubois, Stephanie/GQA-4845-2022	CLEMENT, Marc/0000-0002-6479-8360; Caligiuri, Giuseppina/0000-0003-4973-2205; Nicoletti, Antonino/0000-0002-2623-0897; Fornasa, Giulia/0000-0002-2250-7983; Varthaman, Aditi/0000-0002-8703-5534; Laschet, Jamila/0000-0002-5090-4417; Graff-Dubois, Stephanie/0000-0001-7273-3930	Fondation de France [Engt 2008-002724]; Fondation pour la Recherche Medicale [DCV2007-0409268]; Agence Nationale de la Recherche; French Ministry of Foreign and European Affairs [Egide 636511F]	Fondation de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Foreign and European Affairs	This work was supported in part by grants from the Fondation de France (www.fdf.org, Engt 2008-002724), the Fondation pour la Recherche Medicale (www.frm.org, DCV2007-0409268) and the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr, ANR project RELATE and project BROSCI). G. F. is the recipient of a Eiffel excellence scholarship from the French Ministry of Foreign and European Affairs (www.egide.asso.fr/eiffel, l). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Dupasquier M, 2006, J LEUKOCYTE BIOL, V80, P838, DOI 10.1189/jlb.1005564; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Khallou-Laschet J, 2006, ARTERIOSCL THROM VAS, V26, P353, DOI 10.1161/01.ATV.0000198401.05221.13; Levillain O, 2005, PFLUG ARCH EUR J PHY, V449, P491, DOI 10.1007/s00424-004-1336-8; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; Loke P, 2007, J IMMUNOL, V179, P3926, DOI 10.4049/jimmunol.179.6.3926; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munder M, 1998, J IMMUNOL, V160, P5347; Nair MG, 2003, IMMUNOL LETT, V85, P173, DOI 10.1016/S0165-2478(02)00225-0; Nicoletti A, 1998, J CLIN INVEST, V102, P910, DOI 10.1172/JCI119892; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Shearer JD, 1997, AM J PHYSIOL-ENDOC M, V272, pE181, DOI 10.1152/ajpendo.1997.272.2.E181; SMITH JD, 1995, P NATL ACAD SCI USA, V92, P8264, DOI 10.1073/pnas.92.18.8264; Staels B, 2005, CURR MED RES OPIN, V21, pS13, DOI 10.1185/030079905X36440; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217; Tupin E, 2004, J EXP MED, V199, P417, DOI 10.1084/jem.20030997; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	32	380	405	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8852	10.1371/journal.pone.0008852	http://dx.doi.org/10.1371/journal.pone.0008852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111605	Green Published, gold			2022-12-27	WOS:000273896300006
J	Jing, LL; Gordon, LR; Shtibin, E; Granato, M				Jing, Lili; Gordon, Laura R.; Shtibin, Elena; Granato, Michael			Temporal and Spatial Requirements of unplugged/MuSK Function during Zebrafish Neuromuscular Development	PLOS ONE			English	Article							MOTOR AXON OUTGROWTH; SKELETAL-MUSCLE; IN-VIVO; JUNCTION; RECEPTOR; MUSK; KINASE; INNERVATION; SYNAPSE; AGRIN	One of the earliest events in neuromuscular junction (NMJ) development is the accumulation of acetylcholine receptor (AChR) at the center of muscle cells. The unplugged/MuSK (muscle specific tyrosine kinase) gene is essential to initiate AChR clustering but also to restrict approaching growth cones to the muscle center, thereby coordinating pre- and postsynaptic development. To determine how unplugged/MuSK signaling coordinates these two processes, we examined the temporal and spatial requirements of unplugged/MuSK in zebrafish embryos using heat-shock inducible transgenes. Here, we show that despite its expression in muscle cells from the time they differentiate, unplugged/MuSK activity is first required just prior to the appearance of AChR clusters to simultaneously induce AChR accumulation and to guide motor axons. Furthermore, we demonstrate that ectopic expression of unplugged/MuSK throughout the muscle membrane results in wildtype-like AChR prepattern and neuromuscular synapses in the central region of muscle cells. We propose that AChR prepatterning and axonal guidance are spatio-temporally coordinated through common unplugged/MuSK signals, and that additional factor(s) restrict unplugged/MuSK signaling to a central muscle zone critical for establishing mid-muscle synaptogenesis.	[Jing, Lili; Gordon, Laura R.; Shtibin, Elena; Granato, Michael] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Jing, Lili] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Jing, LL (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu			National Institutes of Health (NIH) [R01HD037975]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by a National Institutes of Health (NIH) grant (R01HD037975) to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9; Bowen DC, 1998, DEV BIOL, V199, P309, DOI 10.1006/dbio.1998.8936; Cortes F, 2003, DEV CELL, V5, P865, DOI 10.1016/S1534-5807(03)00362-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Devoto SH, 1996, DEVELOPMENT, V122, P3371; FLANAGANSTEET H, 2005, DEVELOPMENT; FRANK E, 1974, J PHYSIOL-LONDON, V240, pP24; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; Hung W, 2007, DEVELOPMENT, V134, P237, DOI 10.1242/dev.02725; Inoue A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000113; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kim HA, 2008, STRUCT MULTIDISCIP O, V36, P1, DOI 10.1007/s00158-008-0256-1; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schweitzer J, 2005, DEV DYNAM, V234, P550, DOI 10.1002/dvdy.20525; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	31	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8843	10.1371/journal.pone.0008843	http://dx.doi.org/10.1371/journal.pone.0008843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107509	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896100009
J	Hill, EW; Gu, JJ; Eivers, SS; Fonseca, RG; McGivney, BA; Govindarajan, P; Orr, N; Katz, LM; MacHugh, D				Hill, Emmeline W.; Gu, Jingjing; Eivers, Suzanne S.; Fonseca, Rita G.; McGivney, Beatrice A.; Govindarajan, Preethi; Orr, Nick; Katz, Lisa M.; MacHugh, David			A Sequence Polymorphism in MSTN Predicts Sprinting Ability and Racing Stamina in Thoroughbred Horses	PLOS ONE			English	Article							TOOL	Variants of the MSTN gene encoding myostatin are associated with muscle hypertrophy phenotypes in a range of mammalian species, most notably cattle, dogs, mice, and humans. Using a sample of registered Thoroughbred horses (n = 148), we have identified a novel MSTN sequence polymorphism that is strongly associated (g.66493737C>T, P = 4.85 x 10(-8)) with best race distance among elite racehorses (n = 79). This observation was independently validated (P = 1.91 x 10(-6)) in a resampled group of Thoroughbreds (n = 62) and in a cohort of Thoroughbreds (n = 37, P = 0.0047) produced by the same trainer. We observed that C/C horses are suited to fast, short-distance races; C/T horses compete favorably in middle-distance races; and T/T horses have greater stamina. Evaluation of retrospective racecourse performance (n = 142) and stallion progeny performance predict that C/C and C/T horses are more likely to be successful two-year-old racehorses than T/T animals. Here we describe for the first time the identification of a gene variant in Thoroughbred racehorses that is predictive of genetic potential for an athletic phenotype.	[Hill, Emmeline W.; Gu, Jingjing; Eivers, Suzanne S.; Fonseca, Rita G.; McGivney, Beatrice A.; Govindarajan, Preethi; Orr, Nick; Katz, Lisa M.; MacHugh, David] Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland; [MacHugh, David] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Hill, EW (corresponding author), Univ Coll Dublin, Sch Agr Food Sci & Vet Med, Anim Genom Lab, Dublin 2, Ireland.	emmeline.hill@ucd.ie		MacHugh, David/0000-0002-8112-4704; Katz, Lisa/0000-0001-5547-2089; Garcia da Fonseca, Rita/0000-0003-2249-1608; Hill, Emmeline/0000-0002-1805-2250	Science Foundation Ireland [04-YI1-B539]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work has been financed by a Science Foundation Ireland, President of Ireland Young Researcher Award (04-YI1-B539) to EWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Gunn HM, 1987, EQUINE EXERCISE PHYS, V2; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; PURCELL S, PLINK VERSION 1 05; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 2001, MOL CLONING LAB MANU; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; van Baren MJ, 2004, BIOINFORMATICS, V20, P591, DOI 10.1093/bioinformatics/btg473; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WEATHERBY S, 1791, INTRO GEN STUD BOOK	16	134	151	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8645	10.1371/journal.pone.0008645	http://dx.doi.org/10.1371/journal.pone.0008645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098749	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000004
J	Lu, CR; Ding, F; Ke, AL				Lu, Changrui; Ding, Fang; Ke, Ailong			Crystal Structure of the S. solfataricus Archaeal Exosome Reveals Conformational Flexibility in the RNA-Binding Ring	PLOS ONE			English	Article							MESSENGER-RNAS; YEAST EXOSOME; ENDONUCLEOLYTIC CLEAVAGE; NUCLEAR SURVEILLANCE; QUALITY-CONTROL; RIBOSOMAL-RNA; DEGRADATION; EXPRESSION; COMPLEXES; RECONSTITUTION	Background: The exosome complex is an essential RNA 3'-end processing and degradation machinery. In archaeal organisms, the exosome consists of a catalytic ring and an RNA-binding ring, both of which were previously reported to assume three-fold symmetry. Methodology/Principal Findings: Here we report an asymmetric 2.9 angstrom Sulfolobus solfataricus archaeal exosome structure in which the three-fold symmetry is broken due to combined rigid body and thermal motions mainly within the RNA-binding ring. Since increased conformational flexibility was also observed in the RNA-binding ring of the related bacterial PNPase, we speculate that this may reflect an evolutionarily conserved mechanism to accommodate diverse RNA substrates for degradation. Conclusion/Significance: This study clearly shows the dynamic structures within the RNA-binding domains, which provides additional insights on mechanism of asymmetric RNA binding and processing.	[Lu, Changrui; Ding, Fang; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lu, CR (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	ailong.ke@cornell.edu		Lu, Changrui/0000-0002-2171-9888	Cornell MBG	Cornell MBG	Funding: This study is supported by Cornell MBG department grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Allmang C, 2000, NUCLEIC ACIDS RES, V28, P1684, DOI 10.1093/nar/28.8.1684; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrios A, 2007, METHODS, V41, P271, DOI 10.1016/j.ymeth.2006.08.007; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2003, EMBO REP, V4, P889, DOI 10.1038/sj.embor.embor929; Gatfield D, 2004, NATURE, V429, P575, DOI 10.1038/nature02559; Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hilleren PJ, 2003, MOL CELL, V12, P1453, DOI 10.1016/S1097-2765(03)00488-X; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020; Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Lorentzen E, 2008, METHOD ENZYMOL, V447, P417, DOI 10.1016/S0076-6879(08)02220-9; Makarova KS, 2005, CURR OPIN MICROBIOL, V8, P586, DOI 10.1016/j.mib.2005.08.003; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Milligan L, 2005, MOL CELL BIOL, V25, P9996, DOI 10.1128/MCB.25.22.9996-10004.2005; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Navarro MVAS, 2008, J BIOL CHEM, V283, P14120, DOI 10.1074/jbc.M801005200; Orban TI, 2005, RNA, V11, P459, DOI 10.1261/rna.7231505; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Portnoy V, 2005, EMBO REP, V6, P1188, DOI 10.1038/sj.embor.7400571; Selleck W, 2008, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864.PS0521S52; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; van Hoof A, 2000, MOL CELL BIOL, V20, P8230, DOI 10.1128/MCB.20.21.8230-8243.2000; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; Walter P, 2006, MOL MICROBIOL, V62, P1076, DOI 10.1111/j.1365-2958.2006.05393.x	51	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8739	10.1371/journal.pone.0008739	http://dx.doi.org/10.1371/journal.pone.0008739			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090900	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714900019
J	Vandorpe, DH; Xu, C; Shmukler, BE; Otterbein, LE; Trudel, M; Sachs, F; Gottlieb, PA; Brugnara, C; Alper, SL				Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Otterbein, Leo E.; Trudel, Marie; Sachs, Frederick; Gottlieb, Philip A.; Brugnara, Carlo; Alper, Seth L.			Hypoxia Activates a Ca2+-Permeable Cation Conductance Sensitive to Carbon Monoxide and to GsMTx-4 in Human and Mouse Sickle Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; CA2+-ACTIVATED K+ TRANSPORT; CALCIUM-CHELATOR ESTERS; TRANSGENIC SAD MICE; GARDOS CHANNEL; DISEASE; DEHYDRATION; DEOXYGENATION; FLUXES; INHIBITION	Background: Deoxygenation of sickle erythrocytes activates a cation permeability of unknown molecular identity (Psickle), leading to elevated intracellular [Ca2+] ([Ca2+](i)) and subsequent activation of K-Ca 3.1. The resulting erythrocyte volume decrease elevates intracellular hemoglobin S (HbSS) concentration, accelerates deoxygenation-induced HbSS polymerization, and increases the likelihood of cell sickling. Deoxygenation-induced currents sharing some properties of Psickle have been recorded from sickle erythrocytes in whole cell configuration. Methodology/Principal Findings: We now show by cell-attached and nystatin-permeabilized patch clamp recording from sickle erythrocytes of mouse and human that deoxygenation reversibly activates a Ca2+- and cation-permeable conductance sensitive to inhibition by Grammastola spatulata mechanotoxin-4 (GsMTx-4; 1 mu M), dipyridamole (100 mu M), DIDS (100 mu M), and carbon monoxide (25 ppm pretreatment). Deoxygenation also elevates sickle erythrocyte [Ca2+](i), in a manner similarly inhibited by GsMTx-4 and by carbon monoxide. Normal human and mouse erythrocytes do not exhibit these responses to deoxygenation. Deoxygenation-induced elevation of [Ca2+](i) in mouse sickle erythrocytes did not require KCa3.1 activity. Conclusions/Significance: The electrophysiological and fluorimetric data provide compelling evidence in sickle erythrocytes of mouse and human for a deoxygenation-induced, reversible, Ca2+- permeable cation conductance blocked by inhibition of HbSS polymerization and by an inhibitor of strctch-activated cation channels. This cation permeability pathway is likely an important source of intracellular Ca2+ for pathologic activation of KCa3.1 in sickle erythrocytes. Blockade of this pathway represents a novel therapeutic approach for treatment of sickle disease.	[Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mol & Vasc Med Unit, Boston, MA 02215 USA; [Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Renal, Boston, MA 02215 USA; [Otterbein, Leo E.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA; [Brugnara, Carlo] Harvard Univ, Childrens Hosp Boston, Sch Med, Dept Lab Med, Boston, MA 02215 USA; [Vandorpe, David H.; Xu, Chang; Shmukler, Boris E.; Alper, Seth L.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Brugnara, Carlo] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Trudel, Marie] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Sachs, Frederick; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Vandorpe, DH (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Mol & Vasc Med Unit, Boston, MA 02215 USA.	salper@bidmc.harvard.edu	Brugnara, Carlo/A-8041-2010; Gottlieb, Philip/C-3113-2019	Brugnara, Carlo/0000-0001-8192-8713; Gottlieb, Philip/0000-0003-3764-9885; Xu, Chang/0000-0002-5524-4550; Trudel, Marie/0000-0003-0057-2669	NIH [HL077765, HL15157, HL071797]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054887, R01HL077765, R01HL071797, P60HL015157] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was funded by NIH grants HL077765, HL15157, and HL071797. Additional funding was provided by the Julie Henry Fund at the Transplant Institute of Beth Israel Deaconess Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akel A, 2007, AM J PHYSIOL-CELL PH, V292, pC1759, DOI 10.1152/ajpcell.00158.2006; Alcantara RE, 2007, P NATL ACAD SCI USA, V104, P18451, DOI 10.1073/pnas.0706026104; ALPER SL, 2008, BLOOD CELLS MOL DIS; Andrews DA, 2002, BLOOD, V100, P3392, DOI 10.1182/blood.V100.9.3392; Ataga KI, 2008, BLOOD, V111, P3991, DOI 10.1182/blood-2007-08-110098; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bennekou P, 2006, BLOOD CELL MOL DIS, V36, P10, DOI 10.1016/j.bcmd.2005.10.004; Bennekou P, 2003, J MEMBRANE BIOL, V195, P1, DOI 10.1007/s00232-003-2036-6; BOOKCHIN RM, 1984, J LAB CLIN MED, V104, P855; Bowman CL, 2007, TOXICON, V49, P249, DOI 10.1016/j.toxicon.2006.09.030; Browning JA, 2007, BLOOD, V109, P2622, DOI 10.1182/blood-2006-03-001404; Bruce LJ, 2005, NAT GENET, V37, P1258, DOI 10.1038/ng1656; BRUGNARA C, 1993, J BIOL CHEM, V268, P8760; Brugnara C, 1996, J CLIN INVEST, V97, P1227, DOI 10.1172/JCI118537; Brugnara C, 2001, DRUG NEWS PERSPECT, V14, P208, DOI 10.1358/dnp.2001.14.4.858404; Christoph GW, 2005, BIOPHYS J, V88, P1371, DOI 10.1529/biophysj.104.051250; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Duranton C, 2002, J PHYSIOL-LONDON, V539, P847, DOI 10.1113/jphysiol.2001.013040; Ellory JC, 2008, BLOOD CELL MOL DIS, V41, P44, DOI 10.1016/j.bcmd.2008.03.003; ETZION Z, 1993, J CLIN INVEST, V92, P2489, DOI 10.1172/JCI116857; Fang J, 2006, NEUROSCI LETT, V404, P213, DOI 10.1016/j.neulet.2006.05.059; FOLLER M, 2008, IUBMB LIFE; GARCIASANCHO J, 1985, BIOCHIM BIOPHYS ACTA, V813, P148, DOI 10.1016/0005-2736(85)90357-8; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; HALPERIN JA, 1989, AM J PHYSIOL, V257, pC986, DOI 10.1152/ajpcell.1989.257.5.C986; Hankins JS, 2008, BRIT J HAEMATOL, V140, P80, DOI 10.1111/j.1365-2141.2007.06884.x; Hill K, 2007, J BIOL CHEM, V282, P7145, DOI 10.1074/jbc.M609600200; Hsu K, 2009, BLOOD, V114, P1919, DOI 10.1182/blood-2008-12-195180; JOINER CH, 1993, AM J PHYSIOL, V264, pC251, DOI 10.1152/ajpcell.1993.264.2.C251; Joiner CH, 2001, BLOOD, V97, P3976, DOI 10.1182/blood.V97.12.3976; JOINER CH, 1995, AM J PHYSIOL-CELL PH, V269, pC403, DOI 10.1152/ajpcell.1995.269.2.C403; JOINER CH, 1990, BLOOD, V76, P212; JOINER CH, 1988, BLOOD CELLS, V13, P339; JOINER CH, 1993, AM J PHYSIOL, V264, pC734, DOI 10.1152/ajpcell.1993.264.3.C734; Joiner CH, 2008, BLOOD, V111, P3918, DOI 10.1182/blood-2008-01-135350; Kaestner L, 2004, THROMB HAEMOSTASIS, V92, P1269, DOI 10.1160/TH04-06-0338; Kiefmann R, 2008, BLOOD, V111, P5205, DOI 10.1182/blood-2007-09-113902; Lew VL, 2007, BLOOD, V110, P1334, DOI 10.1182/blood-2006-11-057232; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Lew VL, 1997, J CLIN INVEST, V99, P2727, DOI 10.1172/JCI119462; Lew VL, 2002, BLOOD, V99, P2578, DOI 10.1182/blood.V99.7.2578; MAHAUTSMITH MP, 1995, J PHYSIOL-LONDON, V484, P15, DOI 10.1113/jphysiol.1995.sp020644; MERYMAN HT, 1991, VOX SANG, V60, P88, DOI 10.1111/j.1423-0410.1991.tb00880.x; MERYMAN HT, 1991, VOX SANG, V60, P99, DOI 10.1111/j.1423-0410.1991.tb00881.x; MOZZARELLI A, 1987, SCIENCE, V237, P500, DOI 10.1126/science.3603036; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; Rivera A, 2007, AM J PHYSIOL-CELL PH, V293, pC960, DOI 10.1152/ajpcell.00530.2006; Romero JR, 1997, J MEMBRANE BIOL, V159, P187, DOI 10.1007/s002329900282; Romero PJ, 2003, CELL BIOL INT, V27, P903, DOI 10.1016/j.cellbi.2003.07.002; ROSSI JPFC, 1981, BIOCHIM BIOPHYS ACTA, V648, P145, DOI 10.1016/0005-2736(81)90029-8; Rust MB, 2007, J CLIN INVEST, V117, P1708, DOI 10.1172/JCI30630; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; Sluyter R, 2004, J BIOL CHEM, V279, P44749, DOI 10.1074/jbc.M405631200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Steinberg MH, 2006, TRENDS PHARMACOL SCI, V27, P204, DOI 10.1016/j.tips.2006.02.007; Steinberg MH, 2003, ANNU REV MED, V54, P89, DOI 10.1146/annurev.med.54.101601.152439; Suchyna TM, 2000, J GEN PHYSIOL, V115, P583, DOI 10.1085/jgp.115.5.583; TIFFERT T, 1984, BIOCHIM BIOPHYS ACTA, V773, P143, DOI 10.1016/0005-2736(84)90559-5; Tiffert T, 1997, J PHYSIOL-LONDON, V505, P403, DOI 10.1111/j.1469-7793.1997.403bb.x; Tiffert T, 2001, CELL CALCIUM, V30, P337, DOI 10.1054/ceca.2001.0241; Tiffert T, 2007, J GEN PHYSIOL, V129, P429, DOI 10.1085/jgp.200709766; TRUDEL M, 1994, BLOOD, V84, P3189; TRUDEL M, 1991, EMBO J, V10, P3157, DOI 10.1002/j.1460-2075.1991.tb04877.x; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Yang L, 2000, BLOOD, V95, P2420, DOI 10.1182/blood.V95.7.2420.007k12_2420_2425	67	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8732	10.1371/journal.pone.0008732	http://dx.doi.org/10.1371/journal.pone.0008732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090940	gold, Green Published, Green Submitted			2022-12-27	WOS:000273714900013
J	Aruna, M; Nagaraja, T; Andal, S; Tarakeswari, S; Sirisha, PVS; Reddy, AG; Thangaraj, K; Singh, L; Reddy, BM				Aruna, Meka; Nagaraja, Theeya; Andal, Sadaranga; Tarakeswari, Surapaneni; Sirisha, Pisapati V. S.; Reddy, Alla G.; Thangaraj, Kumarasamy; Singh, Lalji; Reddy, B. Mohan			Role of Progesterone Receptor Polymorphisms in the Recurrent Spontaneous Abortions: Indian Case	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; GENE POLYMORPHISM; IMPLANTATION FAILURE; UTERINE FIBROIDS; DYDROGESTERONE; PROGINS; ASSOCIATION; MISCARRIAGE; PREGNANCY; DEFECTS	Background: We attempt to ascertain if the 3 linked single nucleotide polymorphisms (SNPs) of the Progesterone Receptor (PR) gene (exon 1: G 1031 C; S344T, exon 4: G 1978 T; L660V and exon 5: C 2310 T; H770H) and the PROGINS insertion in the intron G, between exons 7 and 8, are associated with Recurrent Spontaneous Abortion (RSA) in the Indian population. Methodology/Principal Findings: A total of 143 women with RSA and 150 controls were sequenced for all the 8 exons looking for the above 3 linked SNPs of the PR gene earlier implicated in the RSA, as well as for any new SNPs that may be possibly found in the Indian population. PROGINS insertion was screened by electrophoresis. We did not find any new mutations, not observed earlier, in our population. Further, we did not find significant role of the *2 allele (representing the mutant allele at the three SNP loci) or the T2 allele (PROGINS insertion) in the manifestation of RSA. We also did not find an LD pattern between each of the 3 SNPs and the PROGINS insertion. Conclusions/Significance: The results suggest that the PR gene mutations may not play any exclusive role in the manifestation of RSA, and instead, given significantly higher frequency of the *2 allele among the normal women, we surmise if it does not really confer a protective role among the Indian populations, albeit further studies are required in the heterogeneous populations of this region before making any conclusive statement.	[Aruna, Meka; Nagaraja, Theeya; Sirisha, Pisapati V. S.; Reddy, B. Mohan] Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India; [Andal, Sadaranga] Lakshmi Fertil Clin & Res Ctr, Nellore, Andhra Pradesh, India; [Tarakeswari, Surapaneni] Fernandez Hosp, Hyderabad, Andhra Pradesh, India; [Reddy, Alla G.; Thangaraj, Kumarasamy; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India	Indian Statistical Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aruna, M (corresponding author), Indian Stat Inst, Biol Anthropol Unit, Mol Anthropol Grp, Hyderabad, Andhra Pradesh, India.	bmr@isical.ac.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	Indian Statistical Institute	Indian Statistical Institute	This project was funded by Indian Statistical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babalioglu R, 1996, J ASSIST REPROD GEN, V13, P306, DOI 10.1007/BF02070143; BARRETT JC, 2005, BIOINFORMATICS; Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Bouchard P, 1999, J REPROD MED, V44, P153; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Chakravarty BN, 2005, J STEROID BIOCHEM, V97, P416, DOI 10.1016/j.jsbmb.2005.08.012; CLARKE CL, 1990, ENDOCR REV, V11, P266, DOI 10.1210/edrv-11-2-266; Coulam CB, 2008, J ASSIST REPROD GEN, V25, P119, DOI 10.1007/s10815-008-9210-9; Cramer DW, 2003, AM J OBSTET GYNECOL, V189, P1085, DOI 10.1067/S0002-9378(03)00517-9; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; El-Zibdeh MY, 2005, J STEROID BIOCHEM, V97, P431, DOI 10.1016/j.jsbmb.2005.08.007; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fernandez-Valdivia R, 2005, SEMIN REPROD MED, V23, P22, DOI 10.1055/s-2005-864031; Govindan S., 2007, Cancer Biomarkers, V3, P73; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Gruber CJ, 2005, J STEROID BIOCHEM, V97, P426, DOI 10.1016/j.jsbmb.2005.08.009; Hickman TN, 2002, FERTIL STERIL, V77, P1001, DOI 10.1016/S0015-0282(02)02953-9; Kieback D. G., 1998, J SOC GYNECOL INVEST, V5, P40; Kurz C, 2001, J SOC GYNECOL INVEST, V8, P295, DOI 10.1016/S1071-5576(01)00123-X; Lanasa MC, 2000, SEMIN REPROD MED, V18, P97, DOI 10.1055/s-2000-13480; LIRA S, 2000, MED SCI MONITOR, V6, P759; Luo G, 2008, REPROD SCI, V15, P147, DOI 10.1177/1933719107310990; MISRAHI M, 1987, BIOCHEM BIOPH RES CO, V143, P740, DOI 10.1016/0006-291X(87)91416-1; MISRAHI M, 1993, BIOCHIM BIOPHYS ACTA, V1216, P289, DOI 10.1016/0167-4781(93)90156-8; Omar MH, 2005, J STEROID BIOCHEM, V97, P421, DOI 10.1016/j.jsbmb.2005.08.013; PEPE GJ, 1995, ENDOCR REV, V16, P608, DOI 10.1210/er.16.5.608; Pisarska MD, 2003, FERTIL STERIL, V80, P651, DOI 10.1016/S0015-0282(03)00755-6; Reddy BM, 2005, HUM BIOL, V77, P803, DOI 10.1353/hub.2006.0018; REISS HE, 1998, REPROD MED A Z; ROUSSEAUMERCK MF, 1987, HUM GENET, V77, P280, DOI 10.1007/BF00284486; Sambrook J., 2002, MOL CLONING LAB MANU; Schweikert A, 2004, EUR J OBSTET GYN R B, V113, P67, DOI 10.1016/j.ejogrb.2003.04.002; Szekeres-Bartho J, 2001, SEMIN IMMUNOL, V13, P229, DOI 10.1006/smim.2000.0318; Szekeres-Bartho J, 2008, HUM REPROD UPDATE, V14, P27, DOI 10.1093/humupd/dmm035; Tong D, 2001, INT J CANCER, V95, P394, DOI 10.1002/1097-0215(20011120)95:6&lt;394::AID-IJC1070&gt;3.0.CO;2-X; Gomes MTV, 2007, FERTIL STERIL, V87, P1116, DOI 10.1016/j.fertnstert.2006.08.099	36	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8712	10.1371/journal.pone.0008712	http://dx.doi.org/10.1371/journal.pone.0008712			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090851	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714600015
J	Nold-Petry, CA; Lehrnbecher, T; Jarisch, A; Schwabe, D; Pfeilschifter, JM; Muhl, H; Nold, MF				Nold-Petry, Claudia A.; Lehrnbecher, Thomas; Jarisch, Andrea; Schwabe, Dirk; Pfeilschifter, Josef M.; Muhl, Heiko; Nold, Marcel F.			Failure of Interferon gamma to Induce the Anti-Inflammatory Interleukin 18 Binding Protein in Familial Hemophagocytosis	PLOS ONE			English	Article							CD8(+) T-CELLS; PERFORIN EXPRESSION; CUTTING EDGE; IFN-GAMMA; LYMPHOHISTIOCYTOSIS; VIRUS; GENE; CYTOKINES; IL-18; TH1	Background: Familial hemophagocytosis (FHL) is a rare disease associated with defects in proteins involved in CD8(+) T-cell cytotoxicity. Hyperactivation of immune cells results in a perilous, Th1-driven cytokine storm. We set out to explore the regulation of cytokines in an FHL patient who was clinically stable on low-dose immunosuppressive therapy after bone marrow transplantation over a six-month period. During this period, chimerism analyses showed that the fraction of host cells was between 1 and 10%. Both parents of the patient as well as healthy volunteers were studied for comparison. Methods/Principal Findings: Using ELISA, quantitative real-time PCR, and clinical laboratory methods, we investigated constitutive and inducible cytokines, polymorphisms, and clinical parameters in whole blood and whole blood cultures. Although routine laboratory tests were within the normal range, the chemokines IP-10 and IL-8 as well as the cytokine IL-27p28 were increased up to 10-fold under constitutive and stimulated conditions compared to healthy controls. Moreover, high levels of IFN gamma and TNF alpha were produced upon stimulation. Unexpectedly, IFNc induction of IL-18 binding protein (IL-18BP) was markedly reduced (1.6-fold vs 5-fold in controls). The patient's mother featured intermediately increased cytokine levels, whereas levels in the father were similar to those in the controls. Conclusions/Significance: Since IL-18 plays a major role in perpetuating hemophagocytosis, the failure of IFNc to induce IL-18BP may constitute a fundamental pathogenetic mechanism. Furthermore, increased production of IL-8 and IL-27 appears to be associated with this disease. Such dysregulation of cytokines was also found in the heterozygous parents, providing a novel insight into genotype-phenotype correlation of FHL which may encourage future research of this rare disease.	[Nold-Petry, Claudia A.; Pfeilschifter, Josef M.; Muhl, Heiko; Nold, Marcel F.] Johann Wolfgang Goethe Univ Hosp, Pharmazentrum Frankfurt, Frankfurt, Germany; [Lehrnbecher, Thomas; Jarisch, Andrea; Schwabe, Dirk] Johann Wolfgang Goethe Univ Hosp, Dept Pediat, Frankfurt, Germany; [Nold-Petry, Claudia A.; Nold, Marcel F.] Univ Colorado Denver, Div Infect Dis, Aurora, CO USA	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Nold-Petry, CA (corresponding author), Johann Wolfgang Goethe Univ Hosp, Pharmazentrum Frankfurt, Frankfurt, Germany.	mfnold@hotmail.com		Nold, Marcel/0000-0001-9682-4618; Nold, Claudia/0000-0002-7439-3834	Deutsche Forschungsgemeinschaft [Mu1284/3-2, 747/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants Mu1284/3-2 (Deutsche Forschungsgemeinschaft) to Dr. Muhl and No747/1-1 to Dr. Nold. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN M, 2008, J CELL MOL MED; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Baz EMK, 2002, THER APHER, V6, P159, DOI 10.1046/j.1526-0968.2002.00362.x; Busiello R, 2004, BLOOD, V103, P4610, DOI 10.1182/blood-2003-10-3551; Caballes RL, 1997, PATHOLOGY, V29, P92, DOI 10.1080/00313029700169644; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; COTE M, 2009, J CLIN INVEST; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; HENTER JI, 1991, BLOOD, V78, P2918, DOI 10.1182/blood.V78.11.2918.2918; Henter JI, 1997, MED PEDIATR ONCOL, V28, P342, DOI 10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.3.CO;2-Y; Hsieh SM, 2006, J IMMUNOL, V176, P4530, DOI 10.4049/jimmunol.176.8.4530; Hurgin V, 2002, P NATL ACAD SCI USA, V99, P16957, DOI 10.1073/pnas.262663399; ISHII E, 1991, ACTA HAEMATOL-BASEL, V85, P93; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kaser A, 2002, CLIN EXP IMMUNOL, V129, P332, DOI 10.1046/j.1365-2249.2002.01911.x; Katano H, 2005, BRIT J HAEMATOL, V128, P739, DOI 10.1111/j.1365-2141.2004.05305.x; Kogawa K, 2002, BLOOD, V99, P61, DOI 10.1182/blood.V99.1.61; Kono T, 1997, J PERIODONTOL, V68, P1223, DOI 10.1902/jop.1997.68.12.1223; Lehrnbecher T, 2005, LEUKEMIA, V19, P1745, DOI 10.1038/sj.leu.2403922; Lehrnbecher Thomas, 2003, Methods Mol Biol, V215, P71; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Mazodier K, 2005, BLOOD, V106, P3483, DOI 10.1182/blood-2005-05-1980; Muralitharan S, 2007, AM J HEMATOL, V82, P1099, DOI 10.1002/ajh.21009; Novick D, 2009, J CLIN IMMUNOL, V29, P38, DOI 10.1007/s10875-008-9217-0; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; NOVICK D, 2009, J AUTOIMMUN; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Smith VP, 2000, J GEN VIROL, V81, P1223, DOI 10.1099/0022-1317-81-5-1223; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Sullivan KE, 1998, PEDIATR RES, V44, P465, DOI 10.1203/00006450-199810000-00001; Takada H, 1999, BRIT J HAEMATOL, V106, P182, DOI 10.1046/j.1365-2141.1999.01504.x; Takada H, 2001, LEUKEMIA LYMPHOMA, V42, P21, DOI 10.3109/10428190109097673; Takeda A, 2003, J IMMUNOL, V170, P4886, DOI 10.4049/jimmunol.170.10.4886; Tamura K, 2008, PEDIATR BLOOD CANCER, V51, P662, DOI 10.1002/pbc.21660	38	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8663	10.1371/journal.pone.0008663	http://dx.doi.org/10.1371/journal.pone.0008663			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072626	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600016
J	Fraser, HB; Schadt, EE				Fraser, Hunter B.; Schadt, Eric E.			The Quantitative Genetics of Phenotypic Robustness	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; ARABIDOPSIS-THALIANA; TRAIT LOCI; DEVELOPMENTAL STABILITY; DROSOPHILA-MELANOGASTER; FLUCTUATING ASYMMETRY; POPULATION-STRUCTURE; CANALIZATION; HSP90; EVOLVABILITY	Phenotypic robustness, or canalization, has been extensively investigated both experimentally and theoretically. However, it remains unknown to what extent robustness varies between individuals, and whether factors buffering environmental variation also buffer genetic variation. Here we introduce a quantitative genetic approach to these issues, and apply this approach to data from three species. In mice, we find suggestive evidence that for hundreds of gene expression traits, robustness is polymorphic and can be genetically mapped to discrete genomic loci. Moreover, we find that the polymorphisms buffering genetic variation are distinct from those buffering environmental variation. In fact, these two classes have quite distinct mechanistic bases: environmental buffers of gene expression are predominantly sex-specific and trans-acting, whereas genetic buffers are not sex-specific and often cis-acting. Data from studies of morphological and life-history traits in plants and yeast support the distinction between polymorphisms buffering genetic and environmental variation, and further suggest that loci buffering different types of environmental variation do overlap with one another. These preliminary results suggest that naturally occurring polymorphisms affecting phenotypic robustness could be abundant, and that these polymorphisms may generally buffer either genetic or environmental variation, but not both.	[Fraser, Hunter B.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Schadt, Eric E.] Pacific Biosci, Menlo Pk, CA USA; [Schadt, Eric E.] Univ Washington, Dept Med Genet, Seattle, WA 98195 USA	Stanford University; University of Washington; University of Washington Seattle	Fraser, HB (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	hbfraser@stanford.edu; eschadt@pacificbiosciences.com			Merck	Merck(Merck & Company)	The study was funded by Merck (http://www.merck.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Alonso-Blanco C, 1998, GENETICS, V149, P749; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Borevitz JO, 2002, GENETICS, V160, P683; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; Donnelly SM, 1999, AM J PHYS ANTHROPOL, V108, P507, DOI 10.1002/(SICI)1096-8644(199904)108:4<507::AID-AJPA8>3.0.CO;2-0; Dworkin I, 2005, EVOLUTION, V59, P1500; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gibson G, 2007, CURR BIOL, V17, pR929, DOI 10.1016/j.cub.2007.08.044; Hall MC, 2007, P NATL ACAD SCI USA, V104, P13717, DOI 10.1073/pnas.0701936104; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Houle D, 1998, GENETICA, V102-3, P241, DOI 10.1023/A:1017034925212; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Leamy LJ, 1998, HEREDITY, V80, P509, DOI 10.1046/j.1365-2540.1998.00320.x; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Li Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000105; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; MCKENZIE JA, 1988, GENETICS, V120, P213; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; STEARNS SC, 1995, J EVOLUTION BIOL, V8, P539, DOI 10.1046/j.1420-9101.1995.8050539.x; VanderSchaar W, 1997, HEREDITY, V79, P190, DOI 10.1038/sj.hdy.6881880; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540	33	50	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8635	10.1371/journal.pone.0008635	http://dx.doi.org/10.1371/journal.pone.0008635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072615	Green Submitted, gold, Green Published			2022-12-27	WOS:000273414200013
J	Mueller, M; Renzullo, S; Brooks, R; Ruggli, N; Hofmann, MA				Mueller, Matthias; Renzullo, Sandra; Brooks, Roxann; Ruggli, Nicolas; Hofmann, Martin A.			Antigenic Characterization of Recombinant Hemagglutinin Proteins Derived from Different Avian Influenza Virus Subtypes	PLOS ONE			English	Article							A VIRUS; MONOCLONAL-ANTIBODIES; INSECT CELLS; H5N1 VIRUS; H1; STRAINS; ELISA; H2	Since the advent of highly pathogenic variants of avian influenza virus (HPAIV), the main focus of avian influenza research has been the characterization and detection of HPAIV hemagglutinin (HA) from H5 and H7 subtypes. However, due to the high mutation and reassortation rate of influenza viruses, in theory any influenza strain may acquire increased pathogenicity irrespective of its subtype. A comprehensive antigenic characterization of influenza viruses encompassing all 16 HA and 9 neuraminidase subtypes will provide information useful for the design of differential diagnostic tools, and possibly, vaccines. We have expressed recombinant HA proteins from 3 different influenza virus HA subtypes in the baculovirus system. These proteins were used to generate polyclonal rabbit antisera, which were subsequently employed in epitope scanning analysis using peptide libraries spanning the entire HA. Here, we report the identification and characterization of linear, HA subtype-specific as well as inter subtype-conserved epitopes along the HA proteins. Selected subtype-specific epitopes were shown to be suitable for the differentiation of anti-HA antibodies in an ELISA.	[Mueller, Matthias; Renzullo, Sandra; Brooks, Roxann; Ruggli, Nicolas; Hofmann, Martin A.] IVI, Mittelhausern, Switzerland		Mueller, M (corresponding author), IVI, Mittelhausern, Switzerland.	matthias.mueller@ivi.admin.ch		Ruggli, Nicolas/0000-0002-7679-6290	Swiss Federal Veterinary Office [01.06.09/7111024]	Swiss Federal Veterinary Office	The study was funded by the Swiss Federal Veterinary Office (www.bvet.admin.ch), grant no. 01.06.09/7111024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; EKIERT DC, 2009, SCIENCE; Gerdon AE, 2005, BIOMACROMOLECULES, V6, P3419, DOI 10.1021/bm050475o; GREEN N, 1982, CELL, V28, P477, DOI 10.1016/0092-8674(82)90202-1; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hofmann MA, 2008, VIRUS GENES, V37, P407, DOI 10.1007/s11262-008-0285-2; Huang HL, 2007, MOL IMMUNOL, V44, P1052, DOI 10.1016/j.molimm.2005.07.031; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; KALTHOFF D, 2009, VET MICROBIOL; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kelly TR, 2008, J AVIAN MED SURG, V22, P1, DOI 10.1647/2006-036R.1; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; NAYAK DP, 1985, VACCINE, V3, P165, DOI 10.1016/0264-410X(85)90097-0; NESTOROWICZ A, 1985, MOL IMMUNOL, V22, P145, DOI 10.1016/S0161-5890(85)80008-0; OIE, 2008, MAN DIAGN TESTS VACC, V1; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Rao SS, 2009, POULTRY SCI, V88, P860, DOI 10.3382/ps.2008-00360; SCHULZEGAHMEN U, 1986, EUR J BIOCHEM, V159, P283, DOI 10.1111/j.1432-1033.1986.tb09865.x; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Smirnov YA, 1999, ACTA VIROL, V43, P237; Starick E, 2006, J VET MED B, V53, P370, DOI 10.1111/j.1439-0450.2006.01007.x; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; Vareckova E, 2002, J CLIN MICROBIOL, V40, P2220, DOI 10.1128/JCM.40.6.2220-2223.2002; VARECKOVA E, 2007, VIRUS RES; VELUMANI S, 2007, J VIROL METHODS; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; Zander H, 2007, J MOL RECOGNIT, V20, P185, DOI 10.1002/jmr.823; Zou SM, 1997, J CLIN MICROBIOL, V35, P2623, DOI 10.1128/JCM.35.10.2623-2627.1997	33	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9097	10.1371/journal.pone.0009097	http://dx.doi.org/10.1371/journal.pone.0009097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140098	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442400026
J	Thaller, MC; Migliore, L; Marquez, C; Tapia, W; Cedeno, V; Rossolini, GM; Gentile, G				Thaller, Maria Cristina; Migliore, Luciana; Marquez, Cruz; Tapia, Washington; Cedeno, Virna; Rossolini, Gian Maria; Gentile, Gabriele			Tracking Acquired Antibiotic Resistance in Commensal Bacteria of Galapagos Land Iguanas: No Man, No Resistance	PLOS ONE			English	Article							MECHANISMS; WILD	Background: Antibiotic resistance, evolving and spreading among bacterial pathogens, poses a serious threat to human health. Antibiotic use for clinical, veterinary and agricultural practices provides the major selective pressure for emergence and persistence of acquired resistance determinants. However, resistance has also been found in the absence of antibiotic exposure, such as in bacteria from wildlife, raising a question about the mechanisms of emergence and persistence of resistant strains under similar conditions, and the implications for resistance control strategies. Since previous studies yielded some contrasting results, possibly due to differences in the ecological landscapes of the studied wildlife, we further investigated this issue in wildlife from a remote setting of the Galapagos archipelago. Methodology/Principal Findings: Screening for acquired antibiotic resistance was carried out in commensal enterobacteria from Conolophus pallidus, the terrestrial iguana of Isla Santa Fe, where: i) the abiotic conditions ensure to microbes good survival possibilities in the environment; ii) the animal density and their habits favour microbial circulation between individuals; and iii) there is no history of antibiotic exposure and the impact of humans and introduced animal species is minimal except for restricted areas. Results revealed that acquired antibiotic resistance traits were exceedingly rare among bacteria, occurring only as non-dominant strains from an area of minor human impact. Conclusions/Significance: Where both the exposure to antibiotics and the anthropic pressure are minimal, acquired antibiotic resistance traits are not normally found in bacteria from wildlife, even if the ecological landscape is highly favourable to bacterial circulation among animals. Monitoring antibiotic resistance in wildlife from remote areas could also be a useful tool to evaluate the impact of anthropic pressure.	[Thaller, Maria Cristina; Migliore, Luciana; Gentile, Gabriele] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Marquez, Cruz; Tapia, Washington] Galapagos Natl Pk Serv, Puerto Ayora, Galapagos Isl, Ecuador; [Cedeno, Virna] Epidemiol & Pathol Lab F Valverde, Puerto Ayora, Galapagos Isl, Ecuador; [Cedeno, Virna] Concepto Azul, Guayaquil, Ecuador; [Rossolini, Gian Maria] Univ Siena, Dipartimento Biol Mol, Siena, Italy	University of Rome Tor Vergata; University of Siena	Thaller, MC (corresponding author), Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy.	thaller@uniroma2.it	Migliore, Luciana/AAB-4245-2020; Gentile, Gabriele/E-8945-2013	Migliore, Luciana/0000-0003-3554-3841; Gentile, Gabriele/0000-0002-1045-6816; Tapia, Washington/0000-0002-5222-1804; THALLER, MARIA CRISTINA/0000-0003-2788-3563; ROSSOLINI, Gian Maria/0000-0002-9386-0434	Italian Ministry of Education, University and Research; CITES [IT/IM/2004/MCE/00041]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR)); CITES	This work was supported by a grant of the Italian Ministry of Education, University and Research to G. Gentile and by the Tor Vergata University Grant "Ricerche di Ateneo'' 2006-2007 to M.C. Thaller. Samples were collected under CITES permit IT/IM/2004/MCE/00041 granted to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartoloni A, 2006, T ROY SOC TROP MED H, V100, P119, DOI 10.1016/j.trstmh.2005.06.027; Bonomo RA, 2008, EXPERT REV ANTI-INFE, V6, P549, DOI 10.1586/14787210.6.5.549; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB S S; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Gilliver MA, 1999, NATURE, V401, P233, DOI 10.1038/45724; IUCN, 2001, IUCN RED LIST CAT CR; Mascaretti O.A., 2003, BACTERIA VERSUS ANTI; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Pallecchi L, 2008, EXPERT REV ANTI-INFE, V6, P725, DOI 10.1586/14787210.6.5.725; Singer RS, 2006, NAT REV MICROBIOL, V4, P943, DOI 10.1038/nrmicro1553; Sjolund M, 2008, EMERG INFECT DIS, V14, P70, DOI 10.3201/eid1401.070704	15	68	74	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8989	10.1371/journal.pone.0008989	http://dx.doi.org/10.1371/journal.pone.0008989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126545	Green Published, gold, Green Submitted			2022-12-27	WOS:000274209700015
J	Martins, FS; Dalmasso, G; Arantes, RME; Doye, A; Lemichez, E; Lagadec, P; Imbert, V; Peyron, JF; Rampal, P; Nicoli, JR; Czerucka, D				Martins, Flaviano S.; Dalmasso, Guillaume; Arantes, Rosa M. E.; Doye, Anne; Lemichez, Emmanuel; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Rampal, Patrick; Nicoli, Jacques R.; Czerucka, Dorota			Interaction of Saccharomyces boulardii with Salmonella enterica Serovar Typhimurium Protects Mice and Modifies T84 Cell Response to the Infection	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE TOXIN; INTERFERES; ACTIVATION; PATHWAYS	Background: Salmonella pathogenesis engages host cells in two-way biochemical interactions: phagocytosis of bacteria by recruitment of cellular small GTP-binding proteins induced by the bacteria, and by triggering a pro-inflammatory response through activation of MAPKs and nuclear translocation of NF-kappa B. Worldwide interest in the use of functional foods containing probiotic bacteria for health promotion and disease prevention has increased significantly. Saccharomyces boulardii is a non-pathogenic yeast used as a probiotic in infectious diarrhea. Methodology/Principal Findings: In this study, we reported that S. boulardii (Sb) protected mice from Salmonella enterica serovar Typhimurium (ST)-induced death and prevented bacterial translocation to the liver. At a molecular level, using T84 human colorectal cancer cells, we demonstrate that incubation with Sb before infection totally abolished Salmonella invasion. This correlates with a decrease of activation of Rac1. Sb preserved T84 barrier function and decreased ST-induced IL-8 synthesis. This anti-inflammatory effect was correlated with an inhibitory effect of Sb on ST-induced activation of the MAPKs ERK1/2, p38 and JNK as well as on activation of NF-kappa B. Electron and confocal microscopy experiments showed an adhesion of bacteria to yeast cells, which could represent one of the mechanisms by which Sb exerts its protective effects. Conclusions: Sb shows modulating effects on permeability, inflammation, and signal transduction pathway in T84 cells infected by ST and an in vivo protective effect against ST infection. The present results also demonstrate that Sb modifies invasive properties of Salmonella.	[Martins, Flaviano S.; Dalmasso, Guillaume; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Czerucka, Dorota] Ctr Mediterraneen Med Mol, Team Inflammat Canc Canc Stem Cells 4, INSERM, U895,C3M, Nice, France; [Doye, Anne; Lemichez, Emmanuel] Ctr Mediterraneen Med Mol, Team Toxines Microbiennes Relat Hote Pathogenes 6, INSERM, U895,C3M, Nice, France; [Martins, Flaviano S.; Dalmasso, Guillaume; Doye, Anne; Lemichez, Emmanuel; Lagadec, Patricia; Imbert, Veronique; Peyron, Jean-Francois; Czerucka, Dorota] Univ Nice Sophia Antipolis, UFR Med, IFR50, Fac Med, Nice, France; [Peyron, Jean-Francois] Hop Archet, Serv Pediat, CHU Nice, Nice, France; [Peyron, Jean-Francois] Hop Archet, Serv Hematol Clin, CHU Nice, Nice, France; [Lemichez, Emmanuel] Hop Archet, Serv Bacteriol, CHU Nice, Nice, France; [Rampal, Patrick] Ctr Hosp Princesse Grace, Serv Hepatogastroenterol, Monaco, Monaco; [Martins, Flaviano S.; Nicoli, Jacques R.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Belo Horizonte, MG, Brazil; [Arantes, Rosa M. E.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Martins, Flaviano S.] Univ Fed Minas Gerais, Dept Pediat, Fac Med, Belo Horizonte, MG, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice; CHU Nice; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Martins, FS (corresponding author), Univ Alberta, Div Gastroenterol, Fac Med & Dent, Katz Grp Rexall Ctr, Edmonton, AB, Canada.	czerucka@unice.fr	LAGADEC, Patricia/P-4538-2016; Jean-Francois, Peyron/AAA-9496-2022; Imbert, Véronique/I-6093-2016; Arantes, Rosa ME/C-5749-2013; Nicoli, Jacques R/K-4807-2015; Lemichez, Emmanuel/G-3559-2013; Peyron, Jean-Francois/M-5682-2016; Dalmasso, Guillaume/N-2443-2018	LAGADEC, Patricia/0000-0002-5105-782X; Jean-Francois, Peyron/0000-0001-6113-916X; Imbert, Véronique/0000-0003-2103-6718; Arantes, Rosa ME/0000-0003-1428-9717; Nicoli, Jacques R/0000-0003-2390-2608; Lemichez, Emmanuel/0000-0001-9080-7761; Peyron, Jean-Francois/0000-0001-6113-916X; Dalmasso, Guillaume/0000-0002-3433-870X; Martins, Flaviano/0000-0003-0741-3062	BIOCODEX S.A. (Gentilly, France); Region Provence-Alpes Cote dAzur; Conseil General des Alpes Maritimes; Faculte de Medecine de l'Universite de Nice-Sophia Antipolis; Centre Hospitalier Regional de Nice; INSERM; CAPES, Brazil	BIOCODEX S.A. (Gentilly, France); Region Provence-Alpes Cote dAzur(Region Provence-Alpes-Cote d'Azur); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); Faculte de Medecine de l'Universite de Nice-Sophia Antipolis; Centre Hospitalier Regional de Nice; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by BIOCODEX S.A. (Gentilly, France), the Region Provence-Alpes Cote dAzur, the Conseil General des Alpes Maritimes, the Faculte de Medecine de l'Universite de Nice-Sophia Antipolis, and the Centre Hospitalier Regional de Nice. This work was financed in part by an institutional grant from INSERM. F. S. Martins is recipient of a doctoral fellowship from CAPES, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandao RL, 1998, APPL ENVIRON MICROB, V64, P564; Castagliuolo I, 1996, INFECT IMMUN, V64, P5225, DOI 10.1128/IAI.64.12.5225-5232.1996; Chen XH, 2006, J BIOL CHEM, V281, P24449, DOI 10.1074/jbc.M605200200; CZERUCKA D, 1994, GASTROENTEROLOGY, V106, P65, DOI 10.1016/S0016-5085(94)94403-2; Czerucka D, 2007, ALIMENT PHARM THER, V26, P767, DOI 10.1111/j.1365-2036.2007.03442.x; Czerucka D, 2002, MICROBES INFECT, V4, P733, DOI 10.1016/S1286-4579(02)01592-7; Czerucka D, 2000, INFECT IMMUN, V68, P5998, DOI 10.1128/IAI.68.10.5998-6004.2000; Dahan S, 2003, INFECT IMMUN, V71, P766, DOI 10.1128/IAI.71.2.766-773.2003; DOYE A, 2002, METHOD ENZYMOL, V406, P447; FAO/WHO, 2002, FOOD AGR ORG UN WHO; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gedek BR, 1999, MYCOSES, V42, P261, DOI 10.1046/j.1439-0507.1999.00449.x; GIANNELLA RA, 1979, INFECT IMMUN, V23, P140, DOI 10.1128/IAI.23.1.140-145.1979; Hobbie S, 1997, J IMMUNOL, V159, P5550; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hopkins KL, 2008, EMERG INFECT DIS, V14, P340, DOI 10.3201/eid1402.070573; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; JUNG HC, 1995, J BIOL INVESTIG, V95, P647; KORHONEN TK, 1981, INFECT IMMUN, V32, P796, DOI 10.1128/IAI.32.2.796-804.1981; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; MUKAIDA N, 1994, J LEUKOCYTE BIOL, V56, P554, DOI 10.1002/jlb.56.5.554; Mumy KL, 2008, AM J PHYSIOL-GASTR L, V294, pG599, DOI 10.1152/ajpgi.00391.2007; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; Rodrigues ACP, 1996, J APPL BACTERIOL, V81, P251, DOI 10.1111/j.1365-2672.1996.tb04325.x; Sougioultzis S, 2006, BIOCHEM BIOPH RES CO, V343, P69, DOI 10.1016/j.bbrc.2006.02.080; Van Nhieu GT, 2005, CURR OPIN MICROBIOL, V8, P16, DOI 10.1016/j.mib.2004.12.006; Wallis TS, 2000, MOL MICROBIOL, V36, P997, DOI 10.1046/j.1365-2958.2000.01892.x; Whichard JM, 2007, EMERG INFECT DIS, V13, P1681, DOI 10.3201/eid1311.061438	32	74	79	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8925	10.1371/journal.pone.0008925	http://dx.doi.org/10.1371/journal.pone.0008925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111723	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800026
J	Vasan, S; Schlesinger, SJ; Huang, YX; Hurley, A; Lombardo, A; Chen, ZW; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Schmidt, C; Song, Y; Seamons, L; Dally, L; Ho, M; Smith, C; Markowitz, M; Cox, J; Gill, DK; Gilmour, J; Keefer, MC; Fast, P; Ho, DD				Vasan, Sandhya; Schlesinger, Sarah J.; Huang, Yaoxing; Hurley, Arlene; Lombardo, Angela; Chen, Zhiwei; Than, Soe; Adesanya, Phumla; Bunce, Catherine; Boaz, Mark; Boyle, Rosanne; Sayeed, Eddy; Clark, Lorna; Dugin, Daniel; Schmidt, Claudia; Song, Yang; Seamons, Laura; Dally, Len; Ho, Martin; Smith, Carol; Markowitz, Martin; Cox, Josephine; Gill, Dilbinder K.; Gilmour, Jill; Keefer, Michael C.; Fast, Patricia; Ho, David D.			Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B ' HIV-1 Candidate Vaccine	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; IMMUNITY; PLASMID; PRIME; BOOST; IMMUNIZATION; RECOMBINANT; CHALLENGE; INFECTION	Background: We conducted a Phase I dose escalation trial of ADVAX, a DNA-based candidate HIV-1 vaccine expressing Clade C/B' env, gag, pol, nef, and tat genes. Sequences were derived from a prevalent circulating recombinant form in Yunnan, China, an area of high HIV-1 incidence. The objective was to evaluate the safety and immunogenicity of ADVAX in human volunteers. Methodology/Principal Findings: ADVAX or placebo was administered intramuscularly at months 0, 1 and 3 to 45 healthy volunteers not at high risk for HIV-1. Three dosage levels [0.2 mg (low), 1.0 mg (mid), and 4.0 mg (high)] were tested. Twelve volunteers in each dosage group were assigned to receive ADVAX and three to receive placebo in a double-blind design. Subjects were followed for local and systemic reactogenicity, adverse events, and clinical laboratory parameters. Study follow up was 18 months. Humoral immunogenicity was evaluated by anti-gp120 binding ELISA. Cellular immunogenicity was assessed by a validated IFN gamma ELISpot assay and intracellular cytokine staining. ADVAX was safe and well-tolerated, with no vaccine-related serious adverse events. Local and systemic reactogenicity events were reported by 64% and 42% of vaccine recipients, respectively. The majority of events were mild. The IFN gamma ELISpot response rates to any HIV antigen were 0/9 (0%) in the placebo group, 3/12 (25%) in the low-dosage group, 4/12 (33%) in the mid-dosage group, and 2/12 (17%) in the high-dosage group. Overall, responses were generally transient and occurred to each gene product, although volunteers responded to single antigens only. Binding antibodies to gp120 were not detected in any volunteers, and HIV seroconversion did not occur. Conclusions/Significance: ADVAX delivered intramuscularly is safe, well-tolerated, and elicits modest but transient cellular immune responses.	[Vasan, Sandhya; Schlesinger, Sarah J.; Huang, Yaoxing; Hurley, Arlene; Chen, Zhiwei; Dugin, Daniel; Song, Yang; Markowitz, Martin; Ho, David D.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Vasan, Sandhya; Schlesinger, Sarah J.; Huang, Yaoxing; Hurley, Arlene; Chen, Zhiwei; Markowitz, Martin; Ho, David D.] Rockefeller Univ, New York, NY 10021 USA; [Lombardo, Angela; Than, Soe; Adesanya, Phumla; Boaz, Mark; Boyle, Rosanne; Sayeed, Eddy; Schmidt, Claudia; Fast, Patricia] Int AIDS Vaccine Initiat, New York, NY USA; [Bunce, Catherine; Keefer, Michael C.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Clark, Lorna; Seamons, Laura; Cox, Josephine; Gill, Dilbinder K.; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Core Lab, London, England; [Dally, Len; Ho, Martin; Smith, Carol] EMMES Corp, Rockville, MD USA	Rockefeller University; International AIDS Vaccine Initiative; University of Rochester; Imperial College London; International AIDS Vaccine Initiative; Emmes Corporation	Vasan, S (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY USA.	svasan@adarc.org	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888; Ho, Martin/0000-0002-8970-5095; Cox, Josephine/0000-0003-1301-7373	International AIDS Vaccine Initiative (IAVI); United States for International Development (USAID); Rockefeller University; University of Rochester Clinical and Translational Science	International AIDS Vaccine Initiative (IAVI); United States for International Development (USAID)(United States Agency for International Development (USAID)); Rockefeller University; University of Rochester Clinical and Translational Science	Funding for this study was provided by the International AIDS Vaccine Initiative (IAVI) and its donors, including the generous support of the American people through the United States for International Development (USAID). IAVI played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript. Support was also provided by the Rockefeller University and University of Rochester Clinical and Translational Science Awards.	Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Boyer JD, 2007, P NATL ACAD SCI USA, V104, P18648, DOI 10.1073/pnas.0709198104; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Chen FP, 2008, INT J THEOR PHYS, V47, P421, DOI 10.1007/s10773-007-9463-6; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Huang TX, 2008, JAIDS-J ACQ IMM DEF, V47, P403, DOI 10.1097/QAI.0b013e3181651b9d; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Jones NG, 2009, VACCINE, V27, P1136, DOI 10.1016/j.vaccine.2008.11.071; Luxembourg A, 2007, EXPERT OPIN BIOL TH, V7, P1647, DOI 10.1517/14712598.7.11.1647; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678; RAMANATHAN VD, AIDS RES HU IN PRESS; Sadagopal S, 2005, J VIROL, V79, P3243, DOI 10.1128/JVI.79.6.3243-3253.2005; *UNAIDS, 2007, UNAIDS0727EJC1322E; Wei Liu, 2006, Subst Abus, V27, P53; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	25	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8617	10.1371/journal.pone.0008617	http://dx.doi.org/10.1371/journal.pone.0008617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111582	Green Submitted, gold, Green Published			2022-12-27	WOS:000273896300002
J	Ichijima, Y; Yoshioka, K; Yoshioka, Y; Shinohe, K; Fujimori, H; Unno, J; Takagi, M; Goto, H; Inagaki, M; Mizutani, S; Teraoka, H				Ichijima, Yosuke; Yoshioka, Ken-ichi; Yoshioka, Yoshiko; Shinohe, Keitaro; Fujimori, Hiroaki; Unno, Junya; Takagi, Masatoshi; Goto, Hidemasa; Inagaki, Masaki; Mizutani, Shuki; Teraoka, Hirobumi			DNA Lesions Induced by Replication Stress Trigger Mitotic Aberration and Tetraploidy Development	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; HUMAN-CELLS; HOMOLOGOUS RECOMBINATION; DAMAGE CHECKPOINT; TUMOR-SUPPRESSOR; CATASTROPHE; TUMORIGENESIS; CYTOKINESIS; ANEUPLOIDY; PHOSPHORYLATION	During tumorigenesis, cells acquire immortality in association with the development of genomic instability. However, it is still elusive how genomic instability spontaneously generates during the process of tumorigenesis. Here, we show that precancerous DNA lesions induced by oncogene acceleration, which induce situations identical to the initial stages of cancer development, trigger tetraploidy/aneuploidy generation in association with mitotic aberration. Although oncogene acceleration primarily induces DNA replication stress and the resulting lesions in the S phase, these lesions are carried over into the M phase and cause cytokinesis failure and genomic instability. Unlike directly induced DNA double-strand breaks, DNA replication stress-associated lesions are cryptogenic and pass through cell-cycle checkpoints due to limited and ineffective activation of checkpoint factors. Furthermore, since damaged M-phase cells still progress in mitotic steps, these cells result in chromosomal mis-segregation, cytokinesis failure and the resulting tetraploidy generation. Thus, our results reveal a process of genomic instability generation triggered by precancerous DNA replication stress.	[Ichijima, Yosuke; Yoshioka, Ken-ichi; Yoshioka, Yoshiko; Shinohe, Keitaro; Fujimori, Hiroaki; Teraoka, Hirobumi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan; [Yoshioka, Ken-ichi; Fujimori, Hiroaki] Natl Canc Ctr, Res Inst, Div Biochem, Tokyo 104, Japan; [Unno, Junya; Takagi, Masatoshi; Mizutani, Shuki] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Grad Sch, Tokyo, Japan; [Goto, Hidemasa; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 464, Japan	Tokyo Medical & Dental University (TMDU); National Cancer Center - Japan; Tokyo Medical & Dental University (TMDU); Aichi Cancer Center	Ichijima, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Biochem, Tokyo, Japan.	kyoshiok@ncc.go.jp	Inagaki, Masaki/B-9920-2016; Takagi, Masatoshi/F-3713-2011	Takagi, Masatoshi/0000-0002-7580-9184; Goto, Hidemasa/0000-0002-6796-4467	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20770136, 20659047]; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI (20770136, 20659047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Deckbar D, 2007, J CELL BIOL, V176, P749, DOI 10.1083/jcb.200612047; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Huang XX, 2005, P NATL ACAD SCI USA, V102, P1065, DOI 10.1073/pnas.0409130102; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McCollum D, 2004, CURR BIOL, V14, pR953, DOI 10.1016/j.cub.2004.10.040; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakada S, 2006, J CLIN INVEST, V116, P80, DOI 10.1172/JCI25716; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Nitta M, 2004, ONCOGENE, V23, P6548, DOI 10.1038/sj.onc.1207873; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Powell SN, 2003, ONCOGENE, V22, P5784, DOI 10.1038/sj.onc.1206678; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Roninson IB, 2001, DRUG RESIST UPDATE, V4, P303, DOI 10.1054/drup.2001.0213; Sasaki R, 2009, CARCINOGENESIS, V30, P423, DOI 10.1093/carcin/bgp007; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tripathi V, 2007, J CELL BIOL, V178, P9, DOI 10.1083/jcb.200610051; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023	34	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8821	10.1371/journal.pone.0008821	http://dx.doi.org/10.1371/journal.pone.0008821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098673	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100013
J	Schutte, A; Hedrich, J; Stocker, W; Becker-Pauly, C				Schuette, Andre; Hedrich, Jana; Stoecker, Walter; Becker-Pauly, Christoph			Let It Flow: Morpholino Knockdown in Zebrafish Embryos Reveals a Pro-Angiogenic Effect of the Metalloprotease Meprin alpha(2)	PLOS ONE			English	Article							BETA-SUBUNIT; DIFFERENTIAL EXPRESSION; MOUSE KIDNEY; ENDOPEPTIDASES; ACTIVATION; CANCER; CELLS	Background: Meprin metalloproteases are thought to be involved in basic physiological functions such as cell proliferation and tissue differentiation. However, the specific functions of these enzymes are still ambiguous, although a variety of growth factors and structural proteins have been identified as meprin substrates. The discovery of meprins alpha(1), alpha(2) and beta in teleost fish provided the basis for uncovering their physiological functions by gene silencing in vivo. Methodology/Principal Findings: A Morpholino knockdown in zebrafish embryos targeting meprin alpha(1) and beta mRNA caused defects in general tissue differentiation. But meprin alpha(2) morphants were affected more specifically and showed severe failures in the formation of the vascular system provoking the hypothesis of a pro-angiogenic effect. The blood circulation was largely diminished resulting in erythrocyte accumulation. These phenotypes mimic a previously described VEGF-A morphant, revealing a possible role of meprin alpha in VEGF-A activation. Indeed, human recombinant meprin alpha processed the vascular endothelial growth factor-A (VEGF-A) specifically, revealing the same cleavage products detectable for VEGF from zebrafish whole lysate. Conclusions/Significance: Our results demonstrate that meprin metalloproteases are important for cell differentiation and proliferation already during embryogenesis, predominantly by the activation of growth factors. Thus, we conclude that meprins play a significant role in VEGF-A processing, subsequently regulating angiogenesis. Therefore, meprin alpha might be a new therapeutic target in cardiovascular diseases or in tumor growth inhibition.	[Schuette, Andre; Hedrich, Jana; Stoecker, Walter; Becker-Pauly, Christoph] Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, Mainz, Germany	Johannes Gutenberg University of Mainz	Schutte, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool Cell & Matrix Biol, Mainz, Germany.	beckerpa@uni-mainz.de	Becker-Pauly, Christoph/B-7569-2011; Schütte, Andre/N-6761-2014; Stöcker, Walter/AAB-9704-2019; Schuette, Andre/GXH-6728-2022	Stöcker, Walter/0000-0002-1515-6994; Schutte, Andre/0000-0003-3209-0373	Deutsche Forschungsgemeinschaft [BE-4086/1-1]; EU; Johannes Gutenberg-University of Mainz, Germany	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Johannes Gutenberg-University of Mainz, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (BE-4086/1-1) to CB, the EU FP7 Health IBDase to CB and WS, a start-up grant to CB, and a PhD fellowship to AS from the Johannes Gutenberg-University of Mainz, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANERJEE S, 2009, MUCOSAL IMMUNOLOGY; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; BERGIN DA, 2008, J BIOL CHEM; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; BEYNON RJ, 1981, BIOCHEM J, V199, P591, DOI 10.1042/bj1990591; BOND JS, 1995, PROTEIN SCI, V4, P1247, DOI 10.1002/pro.5560040701; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Elias PM, 2008, AM J PATHOL, V173, P689, DOI 10.2353/ajpath.2008.080088; Fouquet B, 1997, DEV BIOL, V183, P37, DOI 10.1006/dbio.1996.8495; Habeck H, 2002, CURR BIOL, V12, P1405, DOI 10.1016/S0960-9822(02)01044-8; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Ishmael FT, 2001, J BIOL CHEM, V276, P23207, DOI 10.1074/jbc.M102654200; KANE DA, 1993, DEVELOPMENT, V119, P447; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOUNNAS MZ, 1991, J BIOL CHEM, V266, P17350; Lottaz D, 1999, EUR J BIOCHEM, V259, P496, DOI 10.1046/j.1432-1327.1999.00071.x; Lottaz D, 2007, BIOL CHEM, V388, P337, DOI 10.1515/BC.2007.038; Matters GL, 2005, CLIN EXP METASTAS, V22, P331, DOI 10.1007/s10585-005-0660-5; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nasevicius A, 2000, YEAST, V17, P294, DOI 10.1002/1097-0061(200012)17:4<294::AID-YEA54>3.0.CO;2-5; Oneda B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002278; Rosmann S, 2002, J BIOL CHEM, V277, P40650, DOI 10.1074/jbc.M206203200; Schutte A, 2007, BIOL CHEM, V388, P523, DOI 10.1515/BC.2007.060; STERCHI EE, 1982, CLIN SCI, V62, P557, DOI 10.1042/cs0620557; STOCKER W, 1995, PROTEIN SCI, V4, P823; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143	30	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8835	10.1371/journal.pone.0008835	http://dx.doi.org/10.1371/journal.pone.0008835			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098618	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100026
J	Scott-Algara, D; Mancini-Bourgine, M; Fontaine, H; Pol, S; Michel, ML				Scott-Algara, Daniel; Mancini-Bourgine, Maryline; Fontaine, Helene; Pol, Stanislas; Michel, Marie-Louise			Changes to the Natural Killer Cell Repertoire after Therapeutic Hepatitis B DNA Vaccination	PLOS ONE			English	Article							HUMAN NK CELLS; DENDRITIC CELLS; SURFACE-ANTIGEN; MEDIATED IMMUNIZATION; CPG MOTIFS; INDUCTION; INNATE; RESPONSES; IMMUNOGENICITY; MODULATION	Background: Improvements to the outcome of adaptive immune responses could be achieved by inducing specific natural killer (NK) cell subsets which can cooperate with dendritic cells to select efficient T cell responses. We previously reported the induction or reactivation of T cell responses in chronic hepatitis B patients vaccinated with a DNA encoding hepatitis B envelope proteins during a phase I clinical trial. Methodology/Principal Findings: In this study, we examined changes in the peripheral NK cell populations occurring during this vaccine trial using flow cytometry analysis. Despite a constant number of NK cells in the periphery, a significant increase in the CD56(bright) population was observed after each vaccination and during the follow up. Among the 13 different NK cell markers studied by flow cytometry analysis, the expression of CD244 and NKG2D increased significantly in the CD56(bright) NK population. The ex vivo CD107a expression by CD56(bright) NK cells progressively increased in the vaccinated patients to reach levels that were significantly higher compared to chronically HBV-infected controls. Furthermore, modifications to the percentage of the CD56(bright) NK cell population were correlated with HBV-specific T cell responses detected by the ELISPOT assay. Conclusions/Significance: These changes in the CD56(bright) population may suggest a NK helper effect on T cell adaptive responses. Activation of the innate and adaptive arms of the immune system by DNA immunization may be of particular importance to the efficacy of therapeutic interventions in a context of chronic infections.	[Scott-Algara, Daniel] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Mancini-Bourgine, Maryline; Michel, Marie-Louise] Inst Pasteur, Lab Pathogenese Virus Hepatite B, Paris, France; [Mancini-Bourgine, Maryline; Michel, Marie-Louise] INSERM, U845, Paris, France; [Fontaine, Helene; Pol, Stanislas] Univ Paris 05, Hop Cochin, AP HP, INSERM,U567, Paris, France; [Michel, Marie-Louise] Hop Cochin, AP HP, Serv Hepatol, F-75674 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Scott-Algara, D (corresponding author), Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France.	maloum@pasteur.fr	BOURGINE, Maryline/G-3940-2017; Scott, Daniel/AFK-5428-2022; Michel, Marie-Louise/N-4384-2017	BOURGINE, Maryline/0000-0002-8850-8073; Scott-Algara, Daniel/0000-0003-1851-503X	Institut Pasteur; Institut National de la Santeet de la Recherche Medicale (INSERM)	Institut Pasteur(European Commission); Institut National de la Santeet de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Financial support was provided by Institut Pasteur (www.pasteur.fr) and Institut National de la Santeet de la Recherche Medicale (INSERM) (www. inserm. fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar P, 2006, J HEART LUNG TRANSPL, V25, P200, DOI 10.1016/j.healun.2005.08.007; Akbari O, 1999, J EXP MED, V189, P169, DOI 10.1084/jem.189.1.169; Azzoni L, 1998, J IMMUNOL, V161, P3493; Ballas ZK, 1996, J IMMUNOL, V157, P1840; Burgess SJ, 2008, IMMUNOL RES, V40, P18, DOI 10.1007/s12026-007-0060-9; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chan CJ, 2008, EUR J IMMUNOL, V38, P2964, DOI 10.1002/eji.200838764; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; Chlewicki LK, 2008, J IMMUNOL, V180, P8159, DOI 10.4049/jimmunol.180.12.8159; Davis HL, 1996, P NATL ACAD SCI USA, V93, P7213, DOI 10.1073/pnas.93.14.7213; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Dunn C, 2007, J EXP MED, V204, P667, DOI 10.1084/jem.20061287; Dunn C, 2009, GASTROENTEROLOGY, V137, P1289, DOI 10.1053/j.gastro.2009.06.054; Fisicaro P, 2009, GUT, V58, P974, DOI 10.1136/gut.2008.163600; Guidotti LG, 2001, ANNU REV IMMUNOL, V19, P65, DOI 10.1146/annurev.immunol.19.1.65; Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927; Hokland M, 2005, MOL IMMUNOL, V42, P381, DOI 10.1016/j.molimm.2004.07.016; Jinushi M, 2004, J IMMUNOL, V173, P6072, DOI 10.4049/jimmunol.173.10.6072; Jinushi M, 2007, IMMUNOLOGY, V120, P73, DOI 10.1111/j.1365-2567.2006.02479.x; Krebs P, 2009, BLOOD, V113, P6593, DOI 10.1182/blood-2009-01-201467; Krieg AM, 2003, NAT MED, V9, P831, DOI 10.1038/nm0703-831; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Loirat D, 2000, J IMMUNOL, V165, P4748, DOI 10.4049/jimmunol.165.8.4748; Mancini M, 1996, P NATL ACAD SCI USA, V93, P12496, DOI 10.1073/pnas.93.22.12496; Mancini-Bourgine M, 2004, HEPATOLOGY, V40, P874, DOI 10.1002/hep.20408; Mancini-Bourgine M, 2006, VACCINE, V24, P4482, DOI 10.1016/j.vaccine.2005.08.013; MICHEL ML, 1995, P NATL ACAD SCI USA, V92, P5307, DOI 10.1073/pnas.92.12.5307; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Moretta A, 2002, NAT REV IMMUNOL, V2, P957, DOI 10.1038/nri956; Oliviero B, 2009, GASTROENTEROLOGY, V137, P1151, DOI 10.1053/j.gastro.2009.05.047; Orange JS, 2006, CLIN IMMUNOL, V118, P1, DOI 10.1016/j.clim.2005.10.011; Poggi A, 1998, EUR J IMMUNOL, V28, P1611, DOI 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6; Pol S, 2006, EXPERT REV VACCINES, V5, P707, DOI 10.1586/14760584.5.5.707; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rehermann B, 2007, J HEPATOL, V46, P508, DOI 10.1016/j.jhep.2007.01.002; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; Wieland S, 2004, P NATL ACAD SCI USA, V101, P6669, DOI 10.1073/pnas.0401771101; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005; Zhou H, 2006, BLOOD, V107, P3251, DOI 10.1182/blood-2005-10-4231; Zhou H, 2005, P NATL ACAD SCI USA, V102, P10846, DOI 10.1073/pnas.0502208102	43	29	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8761	10.1371/journal.pone.0008761	http://dx.doi.org/10.1371/journal.pone.0008761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090916	Green Published, Green Submitted, gold			2022-12-27	WOS:000273715000017
J	Shin, R; Cao, JR; Webb, SM; Ikemoto, S				Shin, Rick; Cao, Junran; Webb, Sierra M.; Ikemoto, Satoshi			Amphetamine Administration into the Ventral Striatum Facilitates Behavioral Interaction with Unconditioned Visual Signals in Rats	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS SHELL; FREELY-MOVING RATS; OLFACTORY TUBERCLE; LOCOMOTOR-ACTIVITY; PLACE PREFERENCE; TEGMENTAL AREA; CONDITIONED REINFORCEMENT; DOPAMINERGIC-NEURONS; INCENTIVE SALIENCE; DRUG SEEKING	Background: Administration of psychomotor stimulants like amphetamine facilitates behavior in the presence of incentive distal stimuli, which have acquired the motivational properties of primary rewards through associative learning. This facilitation appears to be mediated by the mesolimbic dopamine system, which may also be involved in facilitating behavior in the presence of distal stimuli that have not been previously paired with primary rewards. However, it is unclear whether psychomotor stimulants facilitate behavioral interaction with unconditioned distal stimuli. Principal Findings: We found that noncontingent administration of amphetamine into subregions of the rat ventral striatum, particularly in the vicinity of the medial olfactory tubercle, facilitates lever pressing followed by visual signals that had not been paired with primary rewards. Noncontingent administration of amphetamine failed to facilitate lever pressing when it was followed by either tones or delayed presentation or absence of visual signals, suggesting that visual signals are key for enhanced behavioral interaction. Systemic administration of amphetamine markedly increased locomotor activity, but did not necessarily increase lever pressing rewarded by visual signals, suggesting that lever pressing is not a byproduct of heightened locomotor activity. Lever pressing facilitated by amphetamine was reduced by co-administration of the dopamine receptor antagonists SCH 23390 (D1 selective) or sulpiride (D2 selective). Conclusions: Our results suggest that amphetamine administration into the ventral striatum, particularly in the vicinity of the medial olfactory tubercle, activates dopaminergic mechanisms that strongly enhance behavioral interaction with unconditioned visual stimuli.	[Shin, Rick; Cao, Junran; Webb, Sierra M.; Ikemoto, Satoshi] Natl Inst Drug Abuse, Behav Neurosci Res Branch, NIH, US Dept HHS, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Shin, R (corresponding author), Natl Inst Drug Abuse, Behav Neurosci Res Branch, NIH, US Dept HHS, Baltimore, MD USA.	Satoshi.Ikemoto@nih.gov	Cao, Junran/E-7354-2013	Ikemoto, Satoshi/0000-0002-0732-7386	Intramural Research Program of the National Institute on Drug Abuse; National Institutes of Health [DA000439-10]; NATIONAL INSTITUTE ON DRUG ABUSE [Z01DA000439, ZIADA000439, K02DA000439] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding: This research was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health (Project number: DA000439-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona BJ, 2009, EUR J NEUROSCI, V30, P1889, DOI 10.1111/j.1460-9568.2009.07027.x; BADIANI A, 1995, PSYCHOPHARMACOLOGY, V117, P443, DOI 10.1007/BF02246217; Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; BARDO MT, 1989, PHARMACOL BIOCHEM BE, V32, P683, DOI 10.1016/0091-3057(89)90018-X; BERLYNE DE, 1969, ANN NY ACAD SCI, V159, P1059, DOI 10.1111/j.1749-6632.1969.tb12997.x; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Besheer J, 1999, BEHAV BRAIN RES, V103, P35, DOI 10.1016/S0166-4328(99)00021-2; Cadoni C, 2000, EUR J PHARMACOL, V387, pR23, DOI 10.1016/S0014-2999(99)00843-2; Chaudhri N, 2006, PSYCHOPHARMACOLOGY, V184, P353, DOI 10.1007/s00213-005-0178-1; CLARKE PBS, 1985, BRAIN RES, V348, P355, DOI 10.1016/0006-8993(85)90456-1; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; Crombag HS, 1996, BRAIN RES, V722, P227, DOI 10.1016/0006-8993(96)00066-2; CROW TJ, 1973, PSYCHOL MED, V3, P66, DOI 10.1017/S0033291700046353; David V, 2006, NEUROPHARMACOLOGY, V50, P1030, DOI 10.1016/j.neuropharm.2006.02.003; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Donny EC, 2003, PSYCHOPHARMACOLOGY, V169, P68, DOI 10.1007/s00213-003-1473-3; FINK JS, 1979, J COMP PHYSIOL PSYCH, V93, P34, DOI 10.1037/h0077587; Gray JA, 1995, BEHAV BRAIN RES, V71, P19, DOI 10.1016/0166-4328(95)00154-9; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Heimer L, 1975, GOLGI CENTENNIAL S P, P177; Heimer L., 1978, LIMBIC MECHANISMS CO, P95; Hernandez PJ, 2002, NAT NEUROSCI, V5, P1327, DOI 10.1038/nn973; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; HUSTON JP, 1989, NEUROSCI BIOBEHAV R, V13, P171, DOI 10.1016/S0149-7634(89)80027-2; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Ikemoto S, 2005, J NEUROSCI, V25, P5061, DOI 10.1523/JNEUROSCI.0892-05.2005; Ikemoto S, 2005, SYNAPSE, V56, P57, DOI 10.1002/syn.20124; Ikemoto S, 2003, J NEUROSCI, V23, P9305; Ikemoto S, 2002, NEUROSCIENCE, V113, P939, DOI 10.1016/S0306-4522(02)00247-6; Ikemoto S, 2001, J NEUROSCI METH, V110, P135, DOI 10.1016/S0165-0270(01)00428-9; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; KAVANAU JL, 1967, SCIENCE, V155, P1623, DOI 10.1126/science.155.3770.1623; KELLEY AE, 1991, PSYCHOPHARMACOLOGY, V103, P187, DOI 10.1007/BF02244202; Kish G. B., 1966, OPERANT BEHAVIOR ARE, P109; KISH GB, 1955, J COMP PHYSIOL PSYCH, V48, P261, DOI 10.1037/h0040782; LANDAUER TK, 1969, PSYCHOL REV, V76, P82, DOI 10.1037/h0026746; MARX MH, 1955, J COMP PHYSIOL PSYCH, V48, P73, DOI 10.1037/h0045062; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; NICHOLLS B, 1992, J NEUROSCI METH, V43, P171, DOI 10.1016/0165-0270(92)90026-A; NISELL M, 1995, PHARMACOL TOXICOL, V76, P157, DOI 10.1111/j.1600-0773.1995.tb00123.x; NISELL M, 1994, SYNAPSE, V16, P36, DOI 10.1002/syn.890160105; Olsen CM, 2009, NEUROPSYCHOPHARMACOL, V34, P1685, DOI 10.1038/npp.2008.226; PIJNENBURG AJJ, 1975, PSYCHOPHARMACOLOGIA, V41, P87, DOI 10.1007/BF00421062; Rebec GV, 1997, BRAIN RES, V776, P61, DOI 10.1016/S0006-8993(97)01004-4; Rebec GV, 1997, NEUROSCIENCE, V76, P707, DOI 10.1016/S0306-4522(96)00382-X; ROBBINS T, 1973, PSYCHOPHARMACOLOGIA, V28, P155, DOI 10.1007/BF00421400; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; ROBBINS TW, 1982, INT REV NEUROBIOL, V23, P303, DOI 10.1016/S0074-7742(08)60628-5; ROBBINS TW, 1989, NEUROSCI BIOBEHAV R, V13, P155, DOI 10.1016/S0149-7634(89)80025-9; Robinson DL, 2004, J NEUROCHEM, V90, P894, DOI 10.1111/j.1471-4159.2004.02559.x; Robinson TE, 2008, PHILOS T R SOC B, V363, P3137, DOI 10.1098/rstb.2008.0093; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sellings LHL, 2006, NEUROSCIENCE, V141, P1457, DOI 10.1016/j.neuroscience.2006.04.040; Sellings LHL, 2008, EUR J NEUROSCI, V28, P342, DOI 10.1111/j.1460-9568.2008.06341.x; Shin R, 2008, PSYCHOPHARMACOLOGY, V198, P261, DOI 10.1007/s00213-008-1131-x; SKINNER BF, 1948, J EXP PSYCHOL, V38, P168, DOI 10.1037//0096-3445.121.3.273; Spina L, 2006, PSYCHOPHARMACOLOGY, V184, P447, DOI 10.1007/s00213-005-0211-4; Staddon JER., 1987, HDB OPERANT BEHAVIOR, P125; STEWART J, 1958, Q J EXP PSYCHOL, V10, P56, DOI 10.1080/17470215808416254; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; TAGHZOUTI K, 1985, BRAIN RES, V344, P9, DOI 10.1016/0006-8993(85)91184-9; TAYLOR JR, 1986, PSYCHOPHARMACOLOGY, V90, P390; TAYLOR JR, 1984, PSYCHOPHARMACOLOGY, V84, P405, DOI 10.1007/BF00555222; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wyvell CL, 2000, J NEUROSCI, V20, P8122; [No title captured]	69	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8741	10.1371/journal.pone.0008741	http://dx.doi.org/10.1371/journal.pone.0008741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090902	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714900021
J	Zhao, YO; Konen-Waisman, S; Taylor, GA; Martens, S; Howard, JC				Zhao, Yang O.; Koenen-Waisman, Stephanie; Taylor, Gregory A.; Martens, Sascha; Howard, Jonathan C.			Localisation and Mislocalisation of the Interferon-Inducible Immunity-Related GTPase, Irgm1 (LRG-47) in Mouse Cells	PLOS ONE			English	Article							P47 RESISTANCE GTPASES; HOST-RESISTANCE; GAMMA; DEFENSE; IIGP1; MYCOBACTERIA; TUBERCULOSIS; MACROPHAGES; MECHANISM; AUTOPHAGY	Irgm1 (LRG-47) is an interferon-inducible Golgi membrane associated GTPase of the mouse whose disruption causes susceptibility to many different intracellular pathogens. Irgm1 has been variously interpreted as a regulator of homologous effector GTPases of the IRG family, a regulator of phagosome maturation and as an initiator of autophagy in interferon-induced cells. We find that endogenous Irgm1 localises to late endosomal and lysosomal compartments in addition to the Golgi membranes. The targeting motif known to be required for Golgi localisation is surprisingly also required for endolysosomal localisation. However, unlike Golgi localisation, localisation to the endolysosomal system also requires the functional integrity of the nucleotide binding site, and thus probably reflects transient activation. Golgi localisation is lost when Irgm1 is tagged at either N- or C-termini with EGFP, while localisation to the endolysosomal system is relatively favoured. N-terminally tagged Irgm1 localises predominantly to early endosomes, while C-terminally tagged Irgm1 localises to late endosomes and lysosomes. Both these anomalous distributions are reversed by inactivation of the nucleotide binding site, and the tagged proteins both revert to Golgi membrane localisation. Irgm1 is the first IRG protein to be found associated with the endolysosomal membrane system in addition to either Golgi (Irgm1 and Irgm2) or ER (Irgm3) membranes, and we interpret the result to be in favour of a regulatory function of IRGM proteins at cellular membrane systems. In future analyses it should be borne in mind that tagging of Irgm1 leads to loss of Golgi localisation and enhanced localisation on endolysosomal membranes, probably as a result of constitutive activation.	[Zhao, Yang O.; Koenen-Waisman, Stephanie; Martens, Sascha; Howard, Jonathan C.] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Med, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] Duke Univ, Med Ctr, Dept Immunol, Div Geriatr, Durham, NC 27710 USA; [Taylor, Gregory A.] VA Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC USA	University of Cologne; Duke University; Duke University; Duke University; Geriatric Research Education & Clinical Center	Zhao, YO (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-5000 Cologne, Germany.	j.howard@uni-koeln.de	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199; Howard, Jonathan/0000-0003-2756-5143	Deusche Forschungsgemeinschaft [SFB635, SFB670, SFB680]; National Institutes of Health [AI57831]; Education Ministry of the Land-Nordrhein-Westfalen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057831] Funding Source: NIH RePORTER	Deusche Forschungsgemeinschaft; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Education Ministry of the Land-Nordrhein-Westfalen; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by special research area grants SFB635, 670 and 680 from the Deusche Forschungsgemeinschaft to JCH and National Institutes of Health Grant AI57831 to GAT. Sascha Martens and Yang O. Zhao were supported by stipends from graduate schools of the Institute for Genetics supported by the Deutsche Forschungsgemeinschaft and the Education Ministry of the Land-Nordrhein-Westfalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Bernstein-Hanley I, 2006, P NATL ACAD SCI USA, V103, P14092, DOI 10.1073/pnas.0603338103; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Ghosh A, 2004, MOL CELL, V15, P727, DOI 10.1016/j.molcel.2004.07.017; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Henry SC, 2009, J LEUKOCYTE BIOL, V85, P877, DOI 10.1189/jlb.1008599; HUNN JP, 2008, EMBO J; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tiwari S, 2009, NAT IMMUNOL, V10, P907, DOI 10.1038/ni.1759; Uthaiah RC, 2003, J BIOL CHEM, V278, P29336, DOI 10.1074/jbc.M211973200; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016	24	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8648	10.1371/journal.pone.0008648	http://dx.doi.org/10.1371/journal.pone.0008648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072621	Green Published, gold			2022-12-27	WOS:000273554600011
J	Ceballos, G; Davidson, A; List, R; Pacheco, J; Manzano-Fischer, P; Santos-Barrera, G; Cruzado, J				Ceballos, Gerardo; Davidson, Ana; List, Rurik; Pacheco, Jesus; Manzano-Fischer, Patricia; Santos-Barrera, Georgina; Cruzado, Juan			Rapid Decline of a Grassland System and Its Ecological and Conservation Implications	PLOS ONE			English	Article							PRAIRIE DOG; CYNOMYS-LUDOVICIANUS; CHIHUAHUAN DESERT; DESERTIFICATION; DIVERSITY; HETEROGENEITY; BIODIVERSITY; COMPLEX; RODENTS; DRIVEN	One of the most important conservation issues in ecology is the imperiled state of grassland ecosystems worldwide due to land conversion, desertification, and the loss of native populations and species. The Janos region of northwestern Mexico maintains one of the largest remaining black-tailed prairie dog (Cynomys ludovicianus) colony complexes in North America and supports a high diversity of threatened and endangered species. Yet, cattle grazing, agriculture, and drought have greatly impacted the region. We evaluated the impact of human activities on the Janos grasslands, comparing changes in the vertebrate community over the last two decades. Our results reveal profound, rapid changes in the Janos grassland community, demonstrating large declines in vertebrate abundance across all taxonomic groups. We also found that the 55,000 ha prairie dog colony complex has declined by 73% since 1988. The prairie dog complex has become increasingly fragmented, and their densities have shown a precipitous decline over the years, from an average density of 25 per ha in 1988 to 2 per ha in 2004. We demonstrated that prairie dogs strongly suppressed woody plant encroachment as well as created open grassland habitat by clearing woody vegetation, and found rapid invasion of shrubland once the prairie dogs disappeared from the grasslands. Comparison of grasslands and shrublands showed markedly different species compositions, with species richness being greatest when both habitats were considered together. Our data demonstrate the rapid decline of a grassland ecosystem, and documents the dramatic loss in biodiversity over a very short time period concomitant with anthropogenic grassland degradation and the decline of a keystone species.	[Ceballos, Gerardo; Davidson, Ana; List, Rurik; Pacheco, Jesus; Manzano-Fischer, Patricia; Cruzado, Juan] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Santos-Barrera, Georgina] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ceballos, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico.	gceballo@ecologia.unam.mx	Manzano-Fischer, Patricia/AAR-7091-2021	Manzano-Fischer, Patricia/0000-0003-3048-431X; Ceballos, Gerardo/0000-0001-8374-2656	J.M. Kaplan Fund; Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Teconologi-a (CONACyT); Whitley Fund for Nature; Comision Nacional para el Conocimiento y Uso de la Biodiversidad; Defenders of Wildlife; Dutch Embassy in Mexico; Nature Conservancy; Environmental Flying Services; Foundation for Deep Ecology; National Black-footed Ferret Recovery Foundation; National Fish and Wildlife Foundation; National Wildlife Federation; Naturalia A. C., People's Trust for Endangered Species; Phoenix Zoo; Research Ranch Foundation; U.S. Agency for International Development; Sky Island Alliance; British Council; Wildlands Project; Turner Foundation; Universidad Nacional Autonoma de Mexico; National Science Foundation [OISE-0653296]	J.M. Kaplan Fund; Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Teconologi-a (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Whitley Fund for Nature; Comision Nacional para el Conocimiento y Uso de la Biodiversidad; Defenders of Wildlife; Dutch Embassy in Mexico; Nature Conservancy; Environmental Flying Services; Foundation for Deep Ecology; National Black-footed Ferret Recovery Foundation; National Fish and Wildlife Foundation; National Wildlife Federation; Naturalia A. C., People's Trust for Endangered Species; Phoenix Zoo; Research Ranch Foundation; U.S. Agency for International Development(United States Agency for International Development (USAID)); Sky Island Alliance; British Council(The British Council in India); Wildlands Project; Turner Foundation; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Science Foundation(National Science Foundation (NSF))	This research was supported by the J.M. Kaplan Fund, Direccion General de Asuntos del Personal Academico - Universidad Nacional Autonoma de Mexico, Ecociencia S.C., Consejo Nacional de Ciencia y Teconologi-a (CONACyT), Whitley Fund for Nature, Comision Nacional para el Conocimiento y Uso de la Biodiversidad, Defenders of Wildlife, the Dutch Embassy in Mexico, The Nature Conservancy, Environmental Flying Services, Foundation for Deep Ecology, National Black-footed Ferret Recovery Foundation, National Fish and Wildlife Foundation, National Wildlife Federation, Naturalia A. C., People's Trust for Endangered Species, Phoenix Zoo, Research Ranch Foundation, U.S. Agency for International Development, Sky Island Alliance, British Council, Wildlands Project, and Turner Foundation. ADD was supported by a postdoctoral scholarship by the Universidad Nacional Autonoma de Mexico and the National Science Foundation Grant OISE-0653296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVILAFLORES R, 2009, THESIS U ALBERTA EDM, P1; BIGGINS DE, 2006, CONSERVATION BLACK T; BIGGINS DE, 1993, TECHNIQUE EVALUATING; BOCK CE, 1990, J HERPETOL, V24, P445, DOI 10.2307/1565072; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; CABLE M, 1973, J ARIZONA ACAD SCI, V8, P127; Ceballos G, 1999, J ARID ENVIRON, V41, P161, DOI 10.1006/jare.1998.0479; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; CEBALLOS G, 1993, BIOL CONSERV, V63, P105, DOI 10.1016/0006-3207(93)90497-O; Clark T. W., 1989, 3 WILDL PRES TRUST; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Curtin CG, 2000, ECOL LETT, V3, P309, DOI 10.1046/j.1461-0248.2000.00166.x; Curtin C, 2008, CONSERV BIOL, V22, P870, DOI 10.1111/j.1523-1739.2008.00945.x; Davidson AD, 2008, J ARID ENVIRON, V72, P1133, DOI 10.1016/j.jaridenv.2007.12.015; Davidson AD, 2007, ECOGRAPHY, V30, P515, DOI 10.1111/j.0906-7590.2007.05032.x; Davidson AD, 2006, ECOGRAPHY, V29, P755, DOI 10.1111/j.2006.0906-7590.04699.x; Degenhardt W.G., 1996, AMPHIBIANS REPTILES; Desmond MJ, 2000, J WILDLIFE MANAGE, V64, P1067, DOI 10.2307/3803217; Drewa PB, 2001, J ARID ENVIRON, V48, P429, DOI 10.1006/jare.2000.0769; *FAO, 2006, 38 FAO UN; Fredrickson E, 1998, J ARID ENVIRON, V39, P191, DOI 10.1006/jare.1998.0390; GARCI A, 1988, MODIFICACIONES SISTE; *GOOGL EARTH, 2005, SPOT DIG GLOB SATT I; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Heady H.F., 1977, TERRESTRIAL VEGETATI, P491; Henwood W. D., 1998, PARKS, V8, P3; Heyer W.R., 1994, MEASURING MONITORING; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; *INEGI, 1995, ESP NAC H12 6 AG AGS; Jones A, 2000, WEST N AM NATURALIST, V60, P155; Kerley GIH, 2000, AM MIDL NAT, V144, P78, DOI 10.1674/0003-0031(2000)144[0078:IOGADI]2.0.CO;2; KNOPF FL, 1994, AUK, V111, P504, DOI 10.2307/4088620; Kotliar Natasha B., 2006, P53; List R, 2003, J ZOOL, V259, P1, DOI 10.1017/S0952836902002959; List R., 1997, THESIS OXFORD U OXFO; List Rurik, 1998, Revista Mexicana de Mastozoologia, V3, P95; Lomolino MV, 2004, BIOL CONSERV, V115, P89, DOI 10.1016/S0006-3207(03)00097-1; Loreau M., 2002, BIODIVERSITY ECOSYST, P294; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Manzano-Fischer P, 1999, STUD AVIAN BIOL, P263; Manzano-Fischer P, 2006, BIODIVERS CONSERV, V15, P3801, DOI 10.1007/s10531-005-5408-7; McClaran M.P., 1995, DESERT GRASSLAND, p346 p.; MCCUNE B, 1999, PC ORD WIND 4 10; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGarigal K., 2000, MULTIVARIATE STAT WI; MERCE E, 2001, THESIS U NACL AUTONO; Millennium-Ecosystem-Assessment, 2005, EC HUM WELL BEING DE; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller BJ, 2007, J WILDLIFE MANAGE, V71, P2801, DOI 10.2193/2007-041; Okin GS, 2009, BIOSCIENCE, V59, P237, DOI 10.1525/bio.2009.59.3.8; Peters DPC, 2006, BIOSCIENCE, V56, P491, DOI 10.1641/0006-3568(2006)56[491:DCLNII]2.0.CO;2; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; SAMSON FB, 1998, GRASSLANDS; *SAS I, 1999, SAS STAT US GUID 8 2; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas L., 2006, DISTANCE 5 0; Weltzin JF, 1997, ECOLOGY, V78, P751, DOI 10.1890/0012-9658(1997)078[0751:SMROVS]2.0.CO;2; WHICKER AD, 1988, BIOSCIENCE, V38, P778, DOI 10.2307/1310787; White R. P., 2000, PILOT ANAL GLOBAL EO; Whitford WG, 1997, J ARID ENVIRON, V37, P709, DOI 10.1006/jare.1997.0313; ZAVALETA ES, 2004, REALISTIC SPECIES LO, V12, P1175; [No title captured]	66	105	115	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8562	10.1371/journal.pone.0008562	http://dx.doi.org/10.1371/journal.pone.0008562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066035	Green Published, gold			2022-12-27	WOS:000273338600009
J	Huber, SK; Owen, JP; Koop, JAH; King, MO; Grant, PR; Grant, BR; Clayton, DH				Huber, Sarah K.; Owen, Jeb P.; Koop, Jennifer A. H.; King, Marisa O.; Grant, Peter R.; Grant, B. Rosemary; Clayton, Dale H.			Ecoimmunity in Darwin's Finches: Invasive Parasites Trigger Acquired Immunity in the Medium Ground Finch (Geospiza fortis)	PLOS ONE			English	Article							PHILORNIS-DOWNSI; INTRODUCED PARASITE; EPIZOOTIOLOGY; CONSERVATION; ANTIBODY; THREATS; POX	Background: Invasive parasites are a major threat to island populations of animals. Darwin's finches of the Galapagos Islands are under attack by introduced pox virus (Poxvirus avium) and nest flies (Philornis downsi). We developed assays for parasite-specific antibody responses in Darwin's finches (Geospiza fortis), to test for relationships between adaptive immune responses to novel parasites and spatial-temporal variation in the occurrence of parasite pressure among G. fortis populations. Methodology/Principal Findings: We developed enzyme-linked immunosorbent assays (ELISAs) for the presence of antibodies in the serum of Darwin's finches specific to pox virus or Philornis proteins. We compared antibody levels between bird populations with and without evidence of pox infection (visible lesions), and among birds sampled before nesting (prior to nest-fly exposure) versus during nesting (with fly exposure). Birds from the Pox-positive population had higher levels of pox-binding antibodies. Philornis-binding antibody levels were higher in birds sampled during nesting. Female birds, which occupy the nest, had higher Philornis-binding antibody levels than males. The study was limited by an inability to confirm pox exposure independent of obvious lesions. However, the lasting effects of pox infection (e. g., scarring and lost digits) were expected to be reliable indicators of prior pox infection. Conclusions/Significance: This is the first demonstration, to our knowledge, of parasite-specific antibody responses to multiple classes of parasites in a wild population of birds. Darwin's finches initiated acquired immune responses to novel parasites. Our study has vital implications for invasion biology and ecological immunology. The adaptive immune response of Darwin's finches may help combat the negative effects of parasitism. Alternatively, the physiological cost of mounting such a response could outweigh any benefits, accelerating population decline. Tests of the fitness implications of parasite-specific immune responses in Darwin's finches are urgently needed.	[Huber, Sarah K.; Koop, Jennifer A. H.; Clayton, Dale H.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [King, Marisa O.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Grant, Peter R.; Grant, B. Rosemary] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA	Utah System of Higher Education; University of Utah; Washington State University; Washington State University; Princeton University	Huber, SK (corresponding author), Randolph Macon Coll, Dept Biol, Ashland, VA 23005 USA.	sarahhuber@rmc.edu	Grant, Peter/HIR-3733-2022	Koop, Jennifer/0000-0002-5332-3618; Owen, Jeb/0000-0002-2042-0526	NSF [DEB-0118794, DEB-0816877]; Society for the Study of Evolution; Direct For Biological Sciences [0816877] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Society for the Study of Evolution; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work was supported by NSF (DEB-0118794 and DEB-0816877) and the Society for the Study of Evolution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardia DR, 2008, AVIAN IMMUNOLOGY, P421, DOI 10.1016/B978-012370634-8.50025-1; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; CURRY RL, 1989, J ANIM ECOL, V58, P441, DOI 10.2307/4841; Davison F, 2008, AVIAN IMMUNOLOGY, P107, DOI 10.1016/B978-012370634-8.50009-3; Dudaniec RY, 2007, BIOL CONSERV, V139, P325, DOI 10.1016/j.biocon.2007.07.006; DUSBABEK F, 1989, FOLIA PARASIT, V36, P83; Fessl B, 2002, IBIS, V144, P445, DOI 10.1046/j.1474-919X.2002.00076.x; Fessl B, 2006, BIOL CONSERV, V127, P55, DOI 10.1016/j.biocon.2005.07.013; Fessl B, 2006, PARASITOLOGY, V133, P739, DOI 10.1017/S0031182006001089; Fessl B., 2001, STUDIA DIPTEROLOGICA, V8, P317; Grant B. R., 1989, EVOLUTIONARY DYNAMIC; Grant P. R., 1986, ECOLOGY EVOLUTION DA; Hansen P, 1998, J IMMUNOL METHODS, V215, P1, DOI 10.1016/S0022-1759(98)00050-7; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; Kleindorfer S, 2006, J AVIAN BIOL, V37, P69, DOI 10.1111/j.0908-8857.2006.03503.x; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; MURANO T, 1989, POULTRY SCI, V68, P842, DOI 10.3382/ps.0680842; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Owen JP, 2007, TRENDS ECOL EVOL, V22, P228, DOI 10.1016/j.tree.2007.02.003; Parker PG, 2006, AUK, V123, P625, DOI 10.1642/0004-8038(2006)123[625:CMOTGI]2.0.CO;2; SCHNITZLEIN WM, 1988, VIRUS RES, V10, P65, DOI 10.1016/0168-1702(88)90058-5; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VARGAS H, 1987, J FIELD ORNITHOL, V58, P101; Wikelski M, 2004, ECOL SOC, V9	26	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8605	10.1371/journal.pone.0008605	http://dx.doi.org/10.1371/journal.pone.0008605			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066052	gold, Green Published			2022-12-27	WOS:000273338600023
J	Indurkhya, S; Beal, J				Indurkhya, Sagar; Beal, Jacob			Reaction Factoring and Bipartite Update Graphs Accelerate the Gillespie Algorithm for Large-Scale Biochemical Systems	PLOS ONE			English	Article							STOCHASTIC SIMULATION	ODE simulations of chemical systems perform poorly when some of the species have extremely low concentrations. Stochastic simulation methods, which can handle this case, have been impractical for large systems due to computational complexity. We observe, however, that when modeling complex biological systems: (1) a small number of reactions tend to occur a disproportionately large percentage of the time, and (2) a small number of species tend to participate in a disproportionately large percentage of reactions. We exploit these properties in LOLCAT Method, a new implementation of the Gillespie Algorithm. First, factoring reaction propensities allows many propensities dependent on a single species to be updated in a single operation. Second, representing dependencies between reactions with a bipartite graph of reactions and species requires only O(n) storage for n reactions, rather than the O(n(2)) required for a graph that includes only reactions. Together, these improvements allow our implementation of LOLCAT Method to execute orders of magnitude faster than currently existing Gillespie Algorithm variants when simulating several yeast MAPK cascade models.	[Indurkhya, Sagar] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Beal, Jacob] BBN Technol, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Raytheon Technologies; Raytheon BBN Technologies	Indurkhya, S (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jakebeal@bbn.com		Beal, Jacob/0000-0002-1663-5102	NSF [6898853]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 6898853. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gillespie DT, 2003, J CHEM PHYS, V119, P8229, DOI 10.1063/1.1613254; INDURKHYA S, 2009, CODE LOLCAT METHOD; Li H, 2006, LOGARITHMIC DIRECT M, DOI 10.1.1.79.7703; McCollum JM, 2006, COMPUT BIOL CHEM, V30, P39, DOI 10.1016/j.compbiolchem.2005.10.007; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; SALI H, 2005, J CHEM PHYS, V122; Salwinski L, 2004, NAT BIOTECHNOL, V22, P1017, DOI 10.1038/nbt991; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; THOMSON T, 2008, THESIS MIT	12	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8125	10.1371/journal.pone.0008125	http://dx.doi.org/10.1371/journal.pone.0008125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066048	gold, Green Published, Green Submitted			2022-12-27	WOS:000273338600001
J	Storms, V; Claeys, M; Sanchez, A; De Moor, B; Verstuyf, A; Marchal, K				Storms, Valerie; Claeys, Marleen; Sanchez, Aminael; De Moor, Bart; Verstuyf, Annemieke; Marchal, Kathleen			The Effect of Orthology and Coregulation on Detecting Regulatory Motifs	PLOS ONE			English	Article							FUNCTIONAL ELEMENTS; GIBBS SAMPLER; CONSERVATION; GENES; IDENTIFICATION; DISCOVERY; EVOLUTION	Background: Computational de novo discovery of transcription factor binding sites is still a challenging problem. The growing number of sequenced genomes allows integrating orthology evidence with coregulation information when searching for motifs. Moreover, the more advanced motif detection algorithms explicitly model the phylogenetic relatedness between the orthologous input sequences and thus should be well adapted towards using orthologous information. In this study, we evaluated the conditions under which complementing coregulation with orthologous information improves motif detection for the class of probabilistic motif detection algorithms with an explicit evolutionary model. Methodology: We designed datasets (real and synthetic) covering different degrees of coregulation and orthologous information to test how well Phylogibbs and Phylogenetic sampler, as representatives of the motif detection algorithms with evolutionary model performed as compared to MEME, a more classical motif detection algorithm that treats orthologs independently. Results and Conclusions: Under certain conditions detecting motifs in the combined coregulation-orthology space is indeed more efficient than using each space separately, but this is not always the case. Moreover, the difference in success rate between the advanced algorithms and MEME is still marginal. The success rate of motif detection depends on the complex interplay between the added information and the specificities of the applied algorithms. Insights in this relation provide information useful to both developers and users. All benchmark datasets are available at http://homes.esat.kuleuven.be/,kmarchal/Supplementary_Storms_Valerie_PlosONE.	[Storms, Valerie; Claeys, Marleen; Sanchez, Aminael; Marchal, Kathleen] Katholieke Univ Leuven, CMPG, Dept Microbial & Mol Syst, Louvain, Belgium; [Sanchez, Aminael] Cent Univ Marta Abreu Las Villas UCLV, Inst Plant Biotechnol, Mol Biol Lab, Santa Clara, Cuba; [De Moor, Bart] Katholieke Univ Leuven, Dept Elect Engn, ESAT SCD, Louvain, Belgium; [Verstuyf, Annemieke] Katholieke Univ Leuven, Lab Expt Med & Endocrinol LEGENDO, Louvain, Belgium	KU Leuven; Universidad Central "Marta Abreu" de Las Villas; KU Leuven; KU Leuven	Storms, V (corresponding author), Katholieke Univ Leuven, CMPG, Dept Microbial & Mol Syst, Louvain, Belgium.	kathleen.marchal@biw.kuleuven.be	Marchal, Kathleen/O-7936-2017; Marchal, Kathleen/B-5001-2013	Marchal, Kathleen/0000-0002-2169-4588; Marchal, Kathleen/0000-0002-2169-4588; Verstuyf, Annemieke/0000-0003-3193-2698	Katholieke Universiteit Leuven [GOA/08/011, CoE EF/05/007, CREA/08/023]; Institute for the Promotion of Innovation by Science and Technology in Flanders [SBO-BioFrame]; Interuniversitaire attractiepolen [P6/25]; Fonds wetenschappelijk onderzoek [G. 031805, G. 032909]; Human frontier science program [RGY0079/207C]	Katholieke Universiteit Leuven(KU Leuven); Institute for the Promotion of Innovation by Science and Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Interuniversitaire attractiepolen; Fonds wetenschappelijk onderzoek(FWO); Human frontier science program(Human Frontier Science Program)	This work was supported by the 'Katholieke Universiteit Leuven' [GOA/08/011, CoE EF/05/007, CREA/08/023]; the Institute for the Promotion of Innovation by Science and Technology in Flanders [SBO-BioFrame]; the 'Interuniversitaire attractiepolen' [P6/25 (BioMaGNet)]; the 'Fonds wetenschappelijk onderzoek' [G. 031805; G. 032909]; and the Human frontier science program [RGY0079/207C]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cai XH, 2007, BIOINFORMATICS, V23, P2013, DOI 10.1093/bioinformatics/btm282; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Edwards RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-57; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Li XM, 2005, P NATL ACAD SCI USA, V102, P9481, DOI 10.1073/pnas.0501620102; Liu J. S., 2001, SPRINGER SERIES STAT; Liu YY, 2004, GENOME RES, V14, P451, DOI 10.1101/gr.1327604; Marchal K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r9; McGuire AM, 2000, GENOME RES, V10, P744, DOI 10.1101/gr.10.6.744; Monsieurs P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-160; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Moses AM, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P324; Newberg LA, 2007, BIOINFORMATICS, V23, P1718, DOI 10.1093/bioinformatics/btm241; Perez JC, 2009, CELL, V138, P233, DOI 10.1016/j.cell.2009.07.002; Prakash A, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P348; Ray P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000090; Reddy TE, 2007, PLOS COMPUT BIOL, V3, P844, DOI 10.1371/journal.pcbi.0030090; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thijs G, 2002, BIOINFORMATICS, V18, P331, DOI 10.1093/bioinformatics/18.2.331; Thompson WA, 2007, NUCLEIC ACIDS RES, V35, pW232, DOI 10.1093/nar/gkm265; Tompa M, 2001, GENOME RES, V11, P1143, DOI 10.1101/gr.197101; Van Hellemont R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r113; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329	34	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 3	2010	5	2							e8938	10.1371/journal.pone.0008938	http://dx.doi.org/10.1371/journal.pone.0008938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554ZA	20140085	Green Published, gold			2022-12-27	WOS:000274474200002
J	Tremblay, L; Nguyen, T				Tremblay, Luc; Nguyen, Thanh			Real-Time Decreased Sensitivity to an Audio-Visual Illusion during Goal-Directed Reaching	PLOS ONE			English	Article							TACTILE DETECTION; HUMANS; SENSES; SOUND	In humans, sensory afferences are combined and integrated by the central nervous system (Ernst MO, Bulthoff HH (2004) Trends Cogn. Sci. 8: 162-169) and appear to provide a holistic representation of the environment. Empirical studies have repeatedly shown that vision dominates the other senses, especially for tasks with spatial demands. In contrast, it has also been observed that sound can strongly alter the perception of visual events. For example, when presented with 2 flashes and 1 beep in a very brief period of time, humans often report seeing 1 flash (i.e. fusion illusion, Andersen TS, Tiippana K, Sams M (2004) Brain Res. Cogn. Brain Res. 21: 301-308). However, it is not known how an unfolding movement modulates the contribution of vision to perception. Here, we used the audio-visual illusion to demonstrate that goal-directed movements can alter visual information processing in real-time. Specifically, the fusion illusion was linearly reduced as a function of limb velocity. These results suggest that cue combination and integration can be modulated in real-time by goal-directed behaviors; perhaps through sensory gating (Chapman CE, Beauchamp E (2006) J. Neurophysiol. 96: 1664-1675) and/or altered sensory noise (Ernst MO, Bulthoff HH (2004) Trends Cogn. Sci. 8: 162-169) during limb movements.	[Tremblay, Luc; Nguyen, Thanh] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada	University of Toronto	Tremblay, L (corresponding author), Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON, Canada.	luc.tremblay@utoronto.ca		, Luc/0000-0002-1148-1722	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Ontario Research Fund (ORF)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Research Fund (ORF)	Funding: Supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), Canada Foundation for Innovation (CFI), and the Ontario Research Fund (ORF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen TS, 2004, COGNITIVE BRAIN RES, V21, P301, DOI 10.1016/j.cogbrainres.2004.06.004; Chapman CE, 2006, J NEUROPHYSIOL, V96, P1664, DOI 10.1152/jn.00214.2006; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Howard I. P., 1966, HUMAN SPATIAL ORIENT; JIANG W, 1991, EXP BRAIN RES, V84, P342; Liu Q, 2007, NEUROREPORT, V18, P1861, DOI 10.1097/WNR.0b013e3282f1ab1d; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; ROCK I, 1964, SCIENCE, V143, P594, DOI 10.1126/science.143.3606.594; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; Williams SR, 2002, J NEUROPHYSIOL, V88, P1968, DOI 10.1152/jn.2002.88.4.1968; Witten IB, 2005, NEURON, V48, P489, DOI 10.1016/j.neuron.2005.10.020	15	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8952	10.1371/journal.pone.0008952	http://dx.doi.org/10.1371/journal.pone.0008952			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126451	Green Published, gold			2022-12-27	WOS:000274139100004
J	Dyszel, JL; Soares, JA; Swearingen, MC; Lindsay, A; Smith, JN; Ahmer, BMM				Dyszel, Jessica L.; Soares, Jitesh A.; Swearingen, Matthew C.; Lindsay, Amber; Smith, Jenee N.; Ahmer, Brian M. M.			E. coli K-12 and EHEC Genes Regulated by SdiA	PLOS ONE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; GRAM-NEGATIVE BACTERIA; FISCHERI LUXR PROTEIN; SALMONELLA-ENTERICA; ACID RESISTANCE; EXPRESSION; VIRULENCE; PLASMIDS; HOMOLOG	Background: Escherichia and Salmonella encode SdiA, a transcription factor of the LuxR family that regulates genes in response to N-acyl homoserine lactones (AHLs) produced by other species of bacteria. E. coli genes that change expression in the presence of plasmid-encoded sdiA have been identified by several labs. However, many of these genes were identified by overexpressing sdiA on a plasmid and have not been tested for a response to sdiA produced from its natural position in the chromosome or for a response to AHL. Methodology/Principal Findings: We determined that two important loci reported to respond to plasmid-based sdiA, ftsQAZ and acrAB, do not respond to sdiA expressed from its natural position in the chromosome or to AHLs. To identify genes that are regulated by chromosomal sdiA and/or AHLs, we screened 10,000 random transposon-based luciferase fusions in E. coli K-12 and a further 10,000 in E. coli O157:H7 for a response to AHL and then tested these genes for sdiA-dependence. We found that genes encoding the glutamate-dependent acid resistance system are up-regulated, and fliE is down-regulated, by sdiA. Gene regulation by sdiA of E. coli is only partially dependent upon AHL. Conclusions/Significance: The genes of E. coli that respond to plasmid-based expression of sdiA are largely different than those that respond to chromosomal sdiA and/or AHL. This has significant implications for determining the true function of AHL detection by E. coli.	[Dyszel, Jessica L.; Soares, Jitesh A.; Swearingen, Matthew C.; Lindsay, Amber; Smith, Jenee N.; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Dyszel, JL (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edu	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322	Public Health Service [AI0500002, AI073971]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073971, R01AI050002] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants AI0500002 and AI073971. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 1998, J BACTERIOL, V180, P1185, DOI 10.1128/JB.180.5.1185-1193.1998; Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Ahmer BMM, 1999, MOL MICROBIOL, V31, P971, DOI 10.1046/j.1365-2958.1999.01244.x; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; DYSZEL JL, 2009, J BACTERIOLOGY; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Hastings JW, 1999, J BACTERIOL, V181, P2667, DOI 10.1128/JB.181.9.2667-2668.1999; Henke JM, 2004, TRENDS CELL BIOL, V14, P648, DOI 10.1016/j.tcb.2004.09.012; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; Kalogeraki VS, 1997, GENE, V188, P69, DOI 10.1016/S0378-1119(96)00778-0; Kanamaru K, 2000, MOL MICROBIOL, V38, P805, DOI 10.1046/j.1365-2958.2000.02171.x; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kim W, 2006, J BACTERIOL, V188, P431, DOI 10.1128/JB.188.2.431-440.2006; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Lin JS, 1996, APPL ENVIRON MICROB, V62, P3094, DOI 10.1128/AEM.62.9.3094-3100.1996; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; Meighen EA, 1999, LUMINESCENCE, V14, P3, DOI 10.1002/(SICI)1522-7243(199901/02)14:1<3::AID-BIO507>3.0.CO;2-4; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; MILLER JH, SHORT COURSE BACTERI; Milton DL, 2006, INT J MED MICROBIOL, V296, P61, DOI 10.1016/j.ijmm.2006.01.044; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Smith Debra, 2006, Science Progress, V89, P167, DOI 10.3184/003685006783238335; Smith JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002826; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Stevens AM, 1999, CELL-CELL SIGNALING IN BACTERIA, P231; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Swift S, 1999, CELL-CELL SIGNALING IN BACTERIA, P291; Van Houdt R, 2006, FEMS MICROBIOL LETT, V256, P83, DOI 10.1111/j.1574-6968.2006.00103.x; WANG XD, 1991, EMBO J, V10, P3363, DOI 10.1002/j.1460-2075.1991.tb04900.x; Wei Y, 2001, J BACTERIOL, V183, P2259, DOI 10.1128/JB.183.7.2259-2264.2001; Wei Y, 2001, J BACTERIOL, V183, P2265, DOI 10.1128/JB.183.7.2265-2272.2001; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P185, DOI 10.1111/j.1574-6968.1998.tb13044.x; Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x	52	56	61	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8946	10.1371/journal.pone.0008946	http://dx.doi.org/10.1371/journal.pone.0008946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126629	Green Published, Green Submitted, gold			2022-12-27	WOS:000274138000021
J	Hsieh, YH; Chen, KF; Gaydos, CA; Rothman, RE; Kelen, GD				Hsieh, Yu-Hsiang; Chen, Kuan-Fu; Gaydos, Charlotte A.; Rothman, Richard E.; Kelen, Gabor D.			Antiviral Prescriptions to US Ambulatory Care Visits with a Diagnosis of Influenza before and after High Level of Adamantane Resistance 2005-06 Season	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; ORDER-ENTRY; INFECTIONS; RECOMMENDATIONS; VIRUS; RATES	Background: Rapid emergence of influenza A viruses resistance to anti-influenza drugs has been observed in the past five years. Our objective was to compare antiviral prescription patterns of ambulatory care providers to patients with a diagnosis of influenza before and after the 2005-2006 influenza season, which was temporally concordant with the emergence of adamantane resistance. We also determined providers' adherence to Centers for Disease Control and Prevention (CDC) 2006 interim treatment guidelines for influenza after the dissemination of guidelines. Methodology/Principal Findings: We conducted a multi-year cross-sectional analysis using 2002-2006 data from the national representative ambulatory care surveys, National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Our main outcome measure was prescription of any anti-influenza pharmaceutical medication, including amantadine, rimantadine, oseltamivir, and zanamivir. Analyses were performed using procedures taking into account the multi-stage survey design and weighted sampling probabilities of the data source. Overall, there were 941 visits to U. S. ambulatory care providers for which the diagnosis of influenza was made, representing 12,140,727 visits nationally. Antiviral drugs were prescribed in 21.7% of visits. Even though prescription rates were not significantly different by influenza season (2001-02: 26.4%; 2002-03: 11.2%; 2003-04: 16.5%; 2004-05: 18.0%; 2005-06: 35.8%; 2006-07: 46.5%, p = 0.061), significantly higher prescription rates were observed in the high adamantane resistance period (18.7% versus 37.0%, p = 0.023), and after the announcement of the 2006 guidelines (18.5% versus 38.8%, p = 0.032). Use of adamantanes decreased over time, in that they were commonly used during influenza seasons 2001-03 (60.1%), but used much less frequently during seasons 2003-05 (31.9%), and used rarely after high adamantane resistance emerged (2.2%) (p<0.001). Adherence to 2006 guidelines was 97.7%. After March 2006, no prescriptions for adamantanes were given to patients with a diagnosis of influenza. Conclusions/Significance: In this nationally representative study of U. S. ambulatory care visits, we found a complete absence of the use of adamantanes in all ambulatory care settings after March 2006, closely corresponding to release of the 2006 CDC interim guidelines. Adherence to such practice is an essential element for control and prevention of influenza, especially during the era of emergence of resistance to anti-viral drugs.	[Hsieh, Yu-Hsiang; Chen, Kuan-Fu; Rothman, Richard E.; Kelen, Gabor D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA; [Gaydos, Charlotte A.; Rothman, Richard E.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Chen, Kuan-Fu] Chang Gung Mem Hosp, Dept Emergency Med, Taipei 10591, Taiwan	Johns Hopkins University; Johns Hopkins University; Chang Gung Memorial Hospital	Hsieh, YH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD 21218 USA.	yhsieh1@jhmi.edu	Gaydos, Charlotte A./E-9937-2010	Rothman, Richard/0000-0002-1017-9505; Kelen, Gabor/0000-0002-3236-8286; Chen, Kuan-Fu/0000-0001-7287-9497	United States Department of Homeland Security [N00014-D6-1-0991]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	United States Department of Homeland Security(United States Department of Homeland Security (DHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Hsieh, Dr. Gaydos, Dr. Rothman and Dr. Kelen are supported in part by a grant from the United States Department of Homeland Security (Grant Number N00014-D6-1-0991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaro PV, 2006, ACAD EMERG MED, V13, P452, DOI 10.1197/j.aem.2005.09.015; Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; *CDCP, 2008, INT REC US INFL ANT; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P44; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Grijalva CG, 2009, JAMA-J AM MED ASSOC, V302, P758, DOI 10.1001/jama.2009.1163; *HLTH AL NETW, 2006, CDC REC US AM RIM TR; Hsieh YH, 2008, AIDS, V22, P2127, DOI 10.1097/QAD.0b013e328310e066; Kane BG, 2004, ACAD EMERG MED, V11, P371, DOI 10.1197/j.aem.2003.11.016; Linder JA, 2005, PHARMACOEPIDEM DR S, V14, P531, DOI 10.1002/pds.1067; Magid DJ, 2003, SEX TRANSM DIS, V30, P30, DOI 10.1097/00007435-200301000-00007; MCCAIG L, 2006, ANAL DATA NAMCS NHAM; *NAT CTR HLTH STAT, 2007, NAT AMB MED CAR SURV; Ozdas A, 2006, J AM MED INFORM ASSN, V13, P188, DOI 10.1197/jamia.M1656; Tracy CR, 2009, WORLD J UROL, V27, P259, DOI 10.1007/s00345-008-0338-0; Vanderweil SG, 2007, ACAD EMERG MED, V14, P366, DOI 10.1197/j.aem.2006.10.096; WHO (World Health Organization), 2009, ANT US RISK DRUG RES	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8945	10.1371/journal.pone.0008945	http://dx.doi.org/10.1371/journal.pone.0008945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126611	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000020
J	Boivin, MJ; Bangirana, P; Smith, RC				Boivin, Michael J.; Bangirana, Paul; Smith, Rebecca C.			The Relationship between Visual-Spatial and Auditory-Verbal Working Memory Span in Senegalese and Ugandan Children	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CEREBRAL MALARIA	Background: Using the Kaufman Assessment Battery for Children (K-ABC) Conant et al. (1999) observed that visual and auditory working memory (WM) span were independent in both younger and older children from DR Congo, but related in older American children and in Lao children [1]. The present study evaluated whether visual and auditory WM span were independent in Ugandan and Senegalese children. Method: In a linear regression analysis we used visual ( Spatial Memory, Hand Movements) and auditory (Number Recall) WM along with education and physical development (weight/height) as predictors. The predicted variable in this analysis was Word Order, which is a verbal memory task that has both visual and auditory memory components. Results: Both the younger (< 8.5 yrs) and older (> 8.5 yrs) Ugandan children had auditory memory span ( Number Recall) that was strongly predictive of Word Order performance. For both the younger and older groups of Senegalese children, only visual WM span ( Spatial Memory) was strongly predictive of Word Order. Number Recall was not significantly predictive of Word Order in either age group. Conclusions: It is possible that greater literacy from more schooling for the Ugandan age groups mediated their greater degree of interdependence between auditory and verbal WM. Our findings support those of Conant et al., who observed in their cross-cultural comparisons that stronger education seemed to enhance the dominance of the phonological-auditory processing loop for WM.	[Boivin, Michael J.] Michigan State Univ, Int Psychiat & Epidemiol Program, E Lansing, MI 48824 USA; [Boivin, Michael J.] Univ Michigan, Dept Psychiat, Neuropsychol Sect, Ann Arbor, MI 48109 USA; [Bangirana, Paul] Makerere Univ, Sch Med, Dept Psychiat, Kampala, Uganda; [Smith, Rebecca C.] Chestnut Hills Profess Sch Psychol, Grad Psychol Program, Philadelphia, PA USA	Michigan State University; University of Michigan System; University of Michigan; Makerere University	Boivin, MJ (corresponding author), Michigan State Univ, Int Psychiat & Epidemiol Program, E Lansing, MI 48824 USA.	boivin@msu.edu		Bangirana, Paul/0000-0002-7136-0594	West African Research Association (WARA); Institut Pasteur, Paris, France; Fulbright African Regional Research; National Institutes of Health [TW06794-01]; FOGARTY INTERNATIONAL CENTER [R21TW006794] Funding Source: NIH RePORTER	West African Research Association (WARA); Institut Pasteur, Paris, France; Fulbright African Regional Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	The Senegal study was made possible through a West African Research Association (WARA) Summer Research Fellowship award to Michael J. Boivin. The Institut Pasteur, Paris, France, provided funding to Dr. Ngagne Mbaye for the rural medical outpost, vehicle, and weekly outpatient clinic services in Bandia, Senegal. The authors very much appreciated his support of their assessment efforts in Bandia. Likewise, the authors are grateful to the World Vision Program of Senegal for its support of their assessment efforts in Maka Saar, Senegal. The Ugandan study was supported by a Fulbright African Regional Research Award to Michael J. Boivin, Ph.D., MPH, and by a National Institutes of Health Fogarty R21 award ( Grant TW06794-01) to Principal Investigator Chandy C. John. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREDOLO LP, 1975, DEV PSYCHOL, V11, P495, DOI 10.1037/h0076667; APPEL LF, 1972, CHILD DEV, V43, P1365, DOI 10.2307/1127522; Baddeley AD, 2001, AM PSYCHOL, V56, P851, DOI 10.1037/0003-066X.56.11.851; Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2004-2699; Bangirana P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007898; Boivin MJ, 2007, PEDIATRICS, V119, pE360, DOI 10.1542/peds.2006-2027; Boivin MJ, 2002, J DEV BEHAV PEDIATR, V23, P353, DOI 10.1097/00004703-200210000-00010; Conant LL, 2003, J CLIN EXP NEUROPSYC, V25, P1102, DOI 10.1076/jcen.25.8.1102.16722; Conant LL, 1999, J CLIN EXP NEUROPSYC, V21, P375, DOI 10.1076/jcen.21.3.375.912; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; HITCH GJ, 1988, MEM COGNITION, V16, P120, DOI 10.3758/BF03213479; HITCH GJ, 1989, MEM COGNITION, V17, P175, DOI 10.3758/BF03197067; John CC, 2008, PEDIATRICS, V122, pE92, DOI 10.1542/peds.2007-3709; Kaufman AS., 1983, KAUFMAN ASSESSMENT B; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79, DOI DOI 10.2307/J.CTVJF9VZ4.11; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WELLMAN HM, 1975, DEV PSYCHOL, V11, P780, DOI 10.1037/0012-1649.11.6.780	19	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8914	10.1371/journal.pone.0008914	http://dx.doi.org/10.1371/journal.pone.0008914			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550FX	20111706	Green Published, Green Submitted, gold			2022-12-27	WOS:000274114800017
J	Becker, K; Schneider, G; Eder, M; Ranft, A; Kochs, EF; Zieglgansberger, W; Dodt, HU				Becker, Klaus; Schneider, Gerhard; Eder, Matthias; Ranft, Andreas; Kochs, Eberhard F.; Zieglgaensberger, Walter; Dodt, Hans-Ulrich			Anaesthesia Monitoring by Recurrence Quantification Analysis of EEG Data	PLOS ONE			English	Article							SURGICAL-PATIENTS; BISPECTRAL INDEX; WAKEFULNESS; AWARENESS; PLOTS; STATE	Appropriate monitoring of the depth of anaesthesia is crucial to prevent deleterious effects of insufficient anaesthesia on surgical patients. Since cardiovascular parameters and motor response testing may fail to display awareness during surgery, attempts are made to utilise alterations in brain activity as reliable markers of the anaesthetic state. Here we present a novel, promising approach for anaesthesia monitoring, basing on recurrence quantification analysis (RQA) of EEG recordings. This nonlinear time series analysis technique separates consciousness from unconsciousness during both remifentanil/sevoflurane and remifentanil/propofol anaesthesia with an overall prediction probability of more than 85%, when applied to spontaneous one-channel EEG activity in surgical patients.	[Becker, Klaus; Dodt, Hans-Ulrich] Vienna Univ Technol, A-1040 Vienna, Austria; [Schneider, Gerhard; Ranft, Andreas; Kochs, Eberhard F.] Tech Univ Munich, Klinikum Rechts Isar, Dept Anaesthesiol, D-80804 Munich, Germany; [Eder, Matthias; Zieglgaensberger, Walter] Max Planck Inst Psychiat, Neuronal Network Dynam, D-80804 Munich, Germany	Technische Universitat Wien; Technical University of Munich; Max Planck Society	Becker, K (corresponding author), Vienna Univ Technol, A-1040 Vienna, Austria.	klaus.becker@meduniwien.ac.at		Eder, Matthias/0000-0002-2579-2628; Becker, Klaus/0000-0002-2406-0476; Schneider, Gerhard/0000-0002-4903-0118	Hertie Foundation	Hertie Foundation	This study was supported by the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER K, 2006, MONITORING DEPTH ANA; DUTTON RC, 1995, J CLIN MONITOR, V11, P41, DOI 10.1007/BF01627419; ECKMANN J, 1987, EPL-EUROPHYS LETT, V5, P973; JONES DR, 1993, J OPTIMIZ THEORY APP, V79, P157, DOI 10.1007/BF00941892; Li XL, 2007, NEUROSCI LETT, V424, P47, DOI 10.1016/j.neulet.2007.07.041; MARSCH R, EVIDENCE CONSISTENT; Messner M, 2003, ANESTH ANALG, V97, P488, DOI 10.1213/01.ANE.0000072741.78244.C0; Pilge S, 2006, ANESTHESIOLOGY, V104, P488, DOI 10.1097/00000542-200603000-00016; PILGE S, 2006, SPECTRAL ENTROPY MAY; Schneider G, 2003, BRIT J ANAESTH, V91, P329, DOI 10.1093/bja/aeg188; Schneider G, 2004, ANESTHESIOLOGY, V101, P1105, DOI 10.1097/00000542-200411000-00009; Schneider G, 2005, ANESTHESIOLOGY, V103, P934, DOI 10.1097/00000542-200511000-00006; SCHNEIDER G, 2010, CONSCIOUSNESS AWAREN, P115; SMITH WD, 1996, STAT MED, V15, P1999; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; TUNSTALL ME, 1979, ANAESTHESIA, V34, P316, DOI 10.1111/j.1365-2044.1979.tb04928.x; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Zbilut J. P., 1991, Proceedings. Computers in Cardiology (Cat. No.90CH3011-4), P263, DOI 10.1109/CIC.1990.144211; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; ZWEIG MH, 1993, CLIN CHEM, V39, P561	20	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8876	10.1371/journal.pone.0008876	http://dx.doi.org/10.1371/journal.pone.0008876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126649	Green Published, gold			2022-12-27	WOS:000273896500005
J	Guo, T; Gong, LC; Sui, SF				Guo, Ting; Gong, Lin-Chen; Sui, Sen-Fang			An Electrostatically Preferred Lateral Orientation of SNARE Complex Suggests Novel Mechanisms for Driving Membrane Fusion	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; SYNAPTOTAGMIN; BINDING; MODEL; SEQUESTRATION; ASSOCIATION; HEMIFUSION; PIP2	Biological membrane fusion is a basic cellular process catalyzed by SNARE proteins and additional auxiliary factors. Yet, the critical mechanistic details of SNARE-catalyzed membrane fusion are poorly understood, especially during rapid synaptic transmission. Here, we systematically assessed the electrostatic forces between SNARE complex, auxiliary proteins and fusing membranes by the nonlinear Poisson-Boltzmann equation using explicit models of membranes and proteins. We found that a previously unrecognized, structurally preferred and energetically highly favorable lateral orientation exists for the SNARE complex between fusing membranes. This preferred orientation immediately suggests a novel and simple synaptotagmin-dependent mechanistic trigger of membrane fusion. Moreover, electrostatic interactions between membranes, SNARE complex, and auxiliary proteins appear to orchestrate a series of membrane curvature events that set the stage for rapid synaptic vesicle fusion. Together, our electrostatic analyses of SNAREs and their regulatory factors suggest unexpected and potentially novel mechanisms for eukaryotic membrane fusion proteins.	[Guo, Ting; Sui, Sen-Fang] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Gong, Lin-Chen] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China; [Gong, Lin-Chen] Tsinghua Univ, Ctr Adv Study, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Guo, T (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	suisf@mail.tsinghua.edu.cn			National Natural Science Foundation of China [30970591]; National Basic Research Program of China [2010CD833706]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work is supported by National Natural Science Foundation of China ( 30970591) and National Basic Research Program of China (2010CD833706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Bollinger JG, 2004, BIOCHEMISTRY-US, V43, P13293, DOI 10.1021/bi049390i; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chernomordik LV, 2006, J CELL BIOL, V175, P201, DOI 10.1083/jcb.200607083; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; CHERNOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541, DOI 10.1016/0959-440X(95)80041-7; Cohen FS, 2004, J MEMBRANE BIOL, V199, P1, DOI 10.1007/s00232-004-0669-8; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Diraviyam K, 2006, BIOCHEMISTRY-US, V45, P2584, DOI 10.1021/bi051901t; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Duman JG, 2003, AM J PHYSIOL-CELL PH, V285, pC237, DOI 10.1152/ajpcell.00091.2003; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harbury PAB, 1998, STRUCT FOLD DES, V6, P1487, DOI 10.1016/S0969-2126(98)00147-6; HELFRICH WZ, 1973, NATURFORSCH C, V28, P11; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Kozlovsky Y, 2002, BIOPHYS J, V82, P882, DOI 10.1016/S0006-3495(02)75450-7; Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0; Kuzmin PI, 2001, P NATL ACAD SCI USA, V98, P7235, DOI 10.1073/pnas.121191898; Liu JG, 2006, BIOCHEM BIOPH RES CO, V347, P413, DOI 10.1016/j.bbrc.2006.06.085; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Marz KE, 2002, TRENDS NEUROSCI, V25, P381, DOI 10.1016/S0166-2236(02)02207-5; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murray D, 2002, MOL CELL, V9, P145, DOI 10.1016/S1097-2765(01)00426-9; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2005, TRENDS NEUROSCI, V28, P453, DOI 10.1016/j.tins.2005.06.007; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang JY, 2004, BIOPHYS J, V86, P1969, DOI 10.1016/S0006-3495(04)74260-5; Zimmerberg J, 2006, NAT STRUCT MOL BIOL, V13, P301, DOI 10.1038/nsmb0406-301	49	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8900	10.1371/journal.pone.0008900	http://dx.doi.org/10.1371/journal.pone.0008900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126653	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896500020
J	Long, ET; Baker, S; Oliveira, V; Sawitzki, B; Wood, KJ				Long, Elaine T.; Baker, Stephanie; Oliveira, Vanessa; Sawitzki, Birgit; Wood, Kathryn J.			Alpha-1,2-Mannosidase and Hence N-Glycosylation Are Required for Regulatory T Cell Migration and Allograft Tolerance in Mice	PLOS ONE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; L-SELECTIN EXPRESSION; LYMPH-NODES; DIFFERENTIAL GLYCOSYLATION; TRANSPLANTATION TOLERANCE; MYCOPHENOLATE-MOFETIL; ENDOTHELIAL-CELLS; ALPHA-MANNOSIDASE; GRAFT-REJECTION; DENDRITIC CELLS	Background: Specific immunological unresponsiveness to alloantigens can be induced in vivo by treating mice with a donor alloantigen in combination with a non-depleting anti-CD4 antibody. This tolerance induction protocol enriches for alloantigen reactive regulatory T cells (Treg). We previously demonstrated that alpha-1,2-mannosidase, an enzyme involved in the synthesis and processing of N-linked glycoproteins, is highly expressed in tolerant mice, in both graft infiltrating leukocytes and peripheral blood lymphocytes. Principal Findings: In this study we have identified that alpha-1,2-mannosidase expression increases in CD25(+)CD4(+) Treg when they encounter alloantigen in vivo. When alpha-1,2-mannosidase enzyme activity was blocked, Treg retained their capacity to suppress T cell proliferation in vitro but were unable to bind to physiologically relevant ligands in vitro. Further in vivo analysis demonstrated that blocking alpha-1,2-mannosidase in Treg resulted in the migration of significantly lower numbers to the peripheral lymph nodes in skin grafted mice following adoptive transfer, where they were less able to inhibit the proliferation of naive T cells responding to donor alloantigen and hence unable prevent allograft rejection in vivo. Significance: Taken together, our results suggest that activation of alloantigen reactive Treg results in increased alpha-1,2-mannosidase expression and altered N-glycosylation of cell surface proteins. In our experimental system, altered N-glycosylation is not essential for intrinsic Treg suppressive capacity, but is essential in vivo as it facilitates Treg migration to sites where they can regulate immune priming. Migration of Treg is central to their role in regulating in vivo immune responses and may require specific changes in N-glycosylation upon antigen encounter.	[Long, Elaine T.; Baker, Stephanie; Oliveira, Vanessa; Sawitzki, Birgit; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplant Res Immunol Grp, Oxford OX3 9DU, England	University of Oxford	Long, ET (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Transplant Res Immunol Grp, Oxford OX3 9DU, England.	elaine.long@nds.ox.ac.uk	Sawitzki, Birgit S/S-2307-2016	Goncalves de Oliveira, Vanessa Alexandra/0000-0001-6884-2675; Sawitzki, Birgit/0000-0001-8166-8579	Wellcome Trust; European Union; British Heart Foundation; Garfield Weston Trust	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); British Heart Foundation(British Heart Foundation); Garfield Weston Trust	This work was supported by The Wellcome Trust, the European Union through the RISET Integrated Project, British Heart Foundation and the Garfield Weston Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; BERG EL, 1993, NATURE, V366, P695, DOI 10.1038/366695a0; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Betti M, 2006, ANN ONCOL, V17, P235; Blaheta RA, 1999, TRANSPLANT P, V31, P1250, DOI 10.1016/S0041-1345(98)01984-8; BRADLEY LM, 1994, J EXP MED, V180, P2401, DOI 10.1084/jem.180.6.2401; Bushell A, 2007, AM J TRANSPLANT, V7, P759, DOI 10.1111/j.1600-6143.2006.01716.x; Bushell A, 2003, TRANSPLANTATION, V76, P449, DOI 10.1097/01.TP.0000083043.84630.99; Carvalho-Gaspar M, 2008, J IMMUNOL, V180, P6640, DOI 10.4049/jimmunol.180.10.6640; CHEN HL, DEMETRIOU M T CELL R; Chen X, 2006, EUR J IMMUNOL, V36, P671, DOI 10.1002/eji.200535353; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Daniels MA, 2002, NAT IMMUNOL, V3, P903, DOI 10.1038/ni1002-903; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DENNIS JW, 1989, CANCER RES, V49, P945; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; Fieger C B, 2001, Biochim Biophys Acta, V1524, P75; Guarda G, 2007, NAT IMMUNOL, V8, P743, DOI 10.1038/ni1469; Hara M, 2001, J IMMUNOL, V166, P3789, DOI 10.4049/jimmunol.166.6.3789; Heemann U, 1996, Transpl Immunol, V4, P64, DOI 10.1016/S0966-3274(96)80039-6; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Jones ND, 2006, J IMMUNOL, V176, P2316, DOI 10.4049/jimmunol.176.4.2316; Kingsley CI, 2002, J IMMUNOL, V168, P1080, DOI 10.4049/jimmunol.168.3.1080; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kosuge T, 2000, BIOL PHARM BULL, V23, P1; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Ma BY, 2004, BIOCHEM BIOPH RES CO, V317, P60, DOI 10.1016/j.bbrc.2004.03.012; Masteller EL, 2006, SEMIN IMMUNOL, V18, P103, DOI 10.1016/j.smim.2006.01.004; Morgan R, 2004, J IMMUNOL, V173, P7200, DOI 10.4049/jimmunol.173.12.7200; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; OLIVEIRA V, 2008, ANTICD4 MEDIATED SEL; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; QIN SX, 1990, EUR J IMMUNOL, V20, P2737, DOI 10.1002/eji.1830201231; Qu L, 2006, CELL RES, V16, P622, DOI 10.1038/sj.cr.7310065; RENKONEN R, 1991, EUR J IMMUNOL, V21, P777, DOI 10.1002/eji.1830210334; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; ROSEN SD, 1985, SCIENCE, V228, P1005, DOI 10.1126/science.4001928; Saitovitch D, 1996, TRANSPLANTATION, V61, P1642, DOI 10.1097/00007890-199606150-00016; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Sawitzki B, 2007, AM J TRANSPLANT, V7, P1091, DOI 10.1111/j.1600-6143.2007.01768.x; Sawitzki B, 2005, J EXP MED, V201, P1925, DOI 10.1084/jem.20050419; Siewert C, 2007, EUR J IMMUNOL, V37, P978, DOI 10.1002/eji.200636575; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; SPONAAS AM, 1994, INT IMMUNOL, V6, P277, DOI 10.1093/intimm/6.2.277; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Tang MLK, 1998, J IMMUNOL, V160, P5113; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; TURUNEN JP, 1995, J EXP MED, V182, P1133, DOI 10.1084/jem.182.4.1133; van Maurik A, 2002, J IMMUNOL, V169, P5401; Venturi GM, 2007, J IMMUNOL, V178, P291, DOI 10.4049/jimmunol.178.1.291; Weng SA, 1996, ARCH BIOCHEM BIOPHYS, V325, P113, DOI 10.1006/abbi.1996.0014; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Yuan Q, 2007, J EXP MED, V204, P1327, DOI 10.1084/jem.20062076	59	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8894	10.1371/journal.pone.0008894	http://dx.doi.org/10.1371/journal.pone.0008894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126660	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500017
J	Kage-Nakadai, E; Kobuna, H; Kimura, M; Gengyo-Ando, K; Inoue, T; Arai, H; Mitani, S				Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Kimura, Masako; Gengyo-Ando, Keiko; Inoue, Takao; Arai, Hiroyuki; Mitani, Shohei			Two Very Long Chain Fatty Acid Acyl-CoA Synthetase Genes, acs-20 and acs-22, Have Roles in the Cuticle Surface Barrier in Caenorhabditis elegans	PLOS ONE			English	Article							TRANSPORT PROTEIN-4; WRINKLE-FREE; C-ELEGANS; CLONING; EXPRESSION; LACS2; MUTATIONS; FEATURES; FAMILY; MOUSE	In multicellular organisms, the surface barrier is essential for maintaining the internal environment. In mammals, the barrier is the stratum corneum. Fatty acid transport protein 4 (FATP4) is a key factor involved in forming the stratum corneum barrier. Mice lacking Fatp4 display early neonatal lethality with features such as tight, thick, and shiny skin, and a defective skin barrier. These symptoms are strikingly similar to those of a human skin disease called restrictive dermopathy. FATP4 is a member of the FATP family that possesses acyl-CoA synthetase activity for very long chain fatty acids. How Fatp4 contributes to skin barrier function, however, remains to be elucidated. In the present study, we characterized two Caenorhabditis elegans genes, acs-20 and acs-22, that are homologous to mammalian FATPs. Animals with mutant acs-20 exhibited defects in the cuticle barrier, which normally prevents the penetration of small molecules. acs-20 mutant animals also exhibited abnormalities in the cuticle structure, but not in epidermal cell fate or cell integrity. The acs-22 mutants rarely showed a barrier defect, whereas acs-20; acs-22 double mutants had severely disrupted barrier function. Moreover, the barrier defects of acs-20 and acs-20; acs-22 mutants were rescued by acs-20, acs-22, or human Fatp4 transgenes. We further demonstrated that the incorporation of exogenous very long chain fatty acids into sphingomyelin was reduced in acs-20 and acs-22 mutants. These findings indicate that C. elegans Fatp4 homologue(s) have a crucial role in the surface barrier function and this model might be useful for studying the fundamental molecular mechanisms underlying human skin barrier and relevant diseases.	[Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Gengyo-Ando, Keiko; Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Kimura, Masako; Inoue, Takao; Arai, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Kage-Nakadai, Eriko; Kobuna, Hiroyuki; Gengyo-Ando, Keiko; Inoue, Takao; Arai, Hiroyuki; Mitani, Shohei] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan	Tokyo Women's Medical University; University of Tokyo; Japan Science & Technology Agency (JST)	Kage-Nakadai, E (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo, Japan.	mitani1@research.twmu.ac.jp	Gengyo-Ando, Keiko/AAC-4504-2019; Gengyo-Ando, Keiko/B-2753-2012		Japan Society for the promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Agency (JST); Core Research for Evolutional Science and Technology (CREST); Kao Foundation for Arts and Sciences	Japan Society for the promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Kao Foundation for Arts and Sciences	This study was supported by Grants-in-Aid for Scientific Research from Japan Society for the promotion of Science (JSPS) (to E. K.-N. and S. M.) and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. The study was supported by Japan Science and Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST). The study was also supported by the Kao Foundation for Arts and Sciences (to E. K.-N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT GR, 1959, J BIOL CHEM, V234, P469; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRENNER S, 1974, GENETICS, V77, P71; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; Gengyo-Ando K, 2006, BIOCHEM BIOPH RES CO, V349, P1345, DOI 10.1016/j.bbrc.2006.08.183; Gerdt S, 1997, GLYCOBIOLOGY, V7, P265, DOI 10.1093/glycob/7.2.265; Gilleard JS, 1997, MOL CELL BIOL, V17, P2301, DOI 10.1128/MCB.17.4.2301; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Mack Judith A., 2005, Birth Defects Research, V75, P314, DOI 10.1002/bdrc.20055; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mihalik SJ, 2002, J BIOL CHEM, V277, P24771, DOI 10.1074/jbc.M203295200; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Min J, 2007, NAT CHEM BIOL, V3, P55, DOI 10.1038/nchembio833; Moribe H, 2004, J CELL SCI, V117, P5209, DOI 10.1242/jcs.01403; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; Page A.P., 2007, CUTICLE, P1; Partridge FA, 2008, DEV BIOL, V317, P549, DOI 10.1016/j.ydbio.2008.02.060; Pei ZT, 2004, J BIOL CHEM, V279, P54454, DOI 10.1074/jbc.M410091200; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011; SCHAFFER JE, 1994, CELL, V79, P427, DOI 10.1016/0092-8674(94)90252-6; Schnurr J, 2004, PLANT CELL, V16, P629, DOI 10.1105/tpc.017608; Stahl A, 2002, DEV CELL, V2, P477, DOI 10.1016/S1534-5807(02)00143-0; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Tang DZ, 2007, PLANT PHYSIOL, V144, P1093, DOI 10.1104/pp.106.094318; Uchiyama A, 1996, J BIOL CHEM, V271, P30360, DOI 10.1074/jbc.271.48.30360; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	38	46	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8857	10.1371/journal.pone.0008857	http://dx.doi.org/10.1371/journal.pone.0008857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111596	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896300009
J	Kiya, T; Kubo, T				Kiya, Taketoshi; Kubo, Takeo			Analysis of GABAergic and Non-GABAergic Neuron Activity in the Optic Lobes of the Forager and Re-Orienting Worker Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GABA-LIKE IMMUNOREACTIVITY; MUSHROOM BODY; FEEDBACK NEURONS; BRAIN; BODIES; BEE; CONNECTIONS; NAVIGATION; SEQUENCE	Background: European honeybee (Apis mellifera L.) foragers have a highly developed visual system that is used for navigation. To clarify the neural basis underlying the highly sophisticated visual ability of foragers, we investigated the neural activity pattern of the optic lobes (OLs) in pollen-foragers and re-orienting bees, using the immediate early gene kakusei as a neural activity marker. Methodology/Principal Findings: We performed double-in situ hybridization of kakusei and Amgad, the honeybee homolog of the GABA synthesizing enzyme GAD, to assess inhibitory neural activity. kakusei-related activity in GABAergic and non-GABAergic neurons was strongly upregulated in the OLs of the foragers and re-orienting bees, suggesting that both types of neurons are involved in visual information processing. GABAergic neuron activity was significantly higher than non-GABAergic neuron activity in a part of the OLs of only the forager, suggesting that unique information processing occurs in the OLs of foragers. In contrast, GABAergic neuron activity in the antennal lobe was significantly lower than that of GABAergic neurons in the OLs in the forager and re-orienting bees, suggesting that kakusei-related visual activity is dominant in the brains of these bees. Conclusions/Significance: The present study provides the first evidence that GABAergic neurons are highly active in the OL neurons of free-moving honeybees and essential clue to reveal neural basis of the sophisticated visual ability that is equipped in the small and simple brain.	[Kiya, Taketoshi; Kubo, Takeo] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan	University of Tokyo	Kiya, T (corresponding author), Kanazawa Univ, Biol Course, Inst Sci & Engn, Kanazawa, Ishikawa, Japan.	kiya@staff.kanazawa-u.ac.jp	Kiya, Taketoshi/J-9032-2015; KUBO, TAKEO/G-4951-2014; Kiya, Taketoshi/GVT-7846-2022; Kiya, Taketoshi/ABE-6519-2020	Kiya, Taketoshi/0000-0002-5709-8016; Kiya, Taketoshi/0000-0002-5709-8016; Kubo, Takeo/0000-0002-5914-5269	Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN)	Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN)	This research was supported by the Promotion of Basic Activities for Innovative Bioscience (PRO-BRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicker G, 1999, MICROSC RES TECHNIQ, V45, P174, DOI 10.1002/(SICI)1097-0029(19990501)45:3<174::AID-JEMT5>3.3.CO;2-L; Bicker G, 1999, MICROSC RES TECHNIQ, V44, P166, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<166::AID-JEMT8>3.0.CO;2-T; BICKER G, 1985, BRAIN RES, V360, P394, DOI 10.1016/0006-8993(85)91262-4; Bornhauser BC, 1997, CELL TISSUE RES, V287, P211, DOI 10.1007/s004410050747; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; Dyer FC, 2002, ANNU REV ENTOMOL, V47, P917, DOI 10.1146/annurev.ento.47.091201.145306; Esch HE, 2001, NATURE, V411, P581, DOI 10.1038/35079072; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Ganeshina O, 2001, J COMP NEUROL, V437, P335, DOI 10.1002/cne.1287; Giurfa M, 1997, CURR OPIN NEUROBIOL, V7, P505, DOI 10.1016/S0959-4388(97)80030-X; Grunewald B, 1999, J COMP NEUROL, V404, P114; Grunewald B, 1999, J COMP PHYSIOL A, V185, P565, DOI 10.1007/s003590050417; Homberg U., 1994, DISTRIBUTION NEUROTR; JACKSON FR, 1990, J NEUROCHEM, V54, P1068, DOI 10.1111/j.1471-4159.1990.tb02359.x; Kiya T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000371; Kiya T, 2008, INSECT MOL BIOL, V17, P531, DOI 10.1111/j.1365-2583.2008.00821.x; MARTIN AR, 2001, NEURON BRAIN; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Okada R, 2007, J NEUROSCI, V27, P11736, DOI 10.1523/JNEUROSCI.2216-07.2007; PHILLIPS AM, 1993, J NEUROCHEM, V61, P1291, DOI 10.1111/j.1471-4159.1993.tb13621.x; Reinhard J, 2004, NATURE, V427, P411, DOI 10.1038/427411a; Ribi W.A., 1975, Quarterly Review of Biology, V50, P1; RIBI WA, 1984, CELL TISSUE RES, V236, P577, DOI 10.1007/BF00217225; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Seeley T., 1995, WISDOM HIVE SOCIAL P; Srinivasan MV, 2000, SCIENCE, V287, P851, DOI 10.1126/science.287.5454.851; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; von Frisch K, 1969, DANCE LANGUAGE ORIEN; Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302; Yang EC, 1997, J INSECT PHYSIOL, V43, P329, DOI 10.1016/S0022-1910(96)00111-4; Yang EC, 2004, J INSECT PHYSIOL, V50, P913, DOI 10.1016/j.jinsphys.2004.06.010	34	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8833	10.1371/journal.pone.0008833	http://dx.doi.org/10.1371/journal.pone.0008833			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098617	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100024
J	Man, RY; Onodera, T; Komatsu, E; Tsubata, T				Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi			Augmented B Lymphocyte Response to Antigen in the Absence of Antigen-Induced B Lymphocyte Signaling in an IgG-Transgenic Mouse Line	PLOS ONE			English	Article							CELL FATE DECISION; MARGINAL-ZONE; SURFACE-IMMUNOGLOBULIN; CD22-DEFICIENT MICE; NEGATIVE REGULATOR; RECEPTOR; CD22; ANERGY; EXPRESSION; MEMORY	IgG-containing B cell antigen receptor (IgG-BCR), the BCR mostly expressed on memory B cells, contains a distinct signaling function from IgM-BCR or IgD-BCR expressed on naive B cells. Because naive B cells transgenic for IgG exhibit augmented response to antigens similar to memory B cells, the distinct signaling function of IgG-BCR appears to play a role in augmented antibody responses of memory B cells. However, how IgG-BCR signaling augments B cell responses is not yet well understood. Here we demonstrate that B cells from IgG-transgenic mice are anergic with defect in generation of BCR signaling upon BCR ligation. However, these IgG-transgenic B cells generate markedly augmented antibody response to a T cell-dependent antigen, probably due to hyper-responsiveness to a T cell-derived signal through CD40. Both BCR signaling defect and augmented response to CD40 ligation are partially restored in xid IgG-transgenic mice in which BCR signaling is down-modulated due to a loss-of-function mutation in the tyrosine kinase Btk crucial for BCR signaling. Thus, IgG-BCR induces augmented B cell responses in the absence of antigen-induced BCR signaling probably through high ligand-independent BCR signaling that may "idle" B cells to make them ready to respond to T cell help. This finding strongly suggests a crucial role of ligand-independent signaling in receptor function.	[Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi] Tokyo Med & Dent Univ, Immunol Lab, Grad Sch Biomed Sci, Tokyo, Japan; [Man, Rong-Yong; Onodera, Taishi; Komatsu, Emi; Tsubata, Takeshi] Tokyo Med & Dent Univ, Dept Immunol, Med Res Inst, Tokyo, Japan; [Tsubata, Takeshi] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Man, RY (corresponding author), Tokyo Med & Dent Univ, Immunol Lab, Grad Sch Biomed Sci, Tokyo, Japan.	tsubata.imm@mri.tmd.ac.jp	Tsubata, Takeshi/AAI-7489-2021	Tsubata, Takeshi/0000-0003-0760-1258	Japan Science and Technology Agency [15390158]	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	Funding was provided by the Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/en/index.html) and the Japan Society for the Promotion of Science (15390158) (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 1996, EUR J IMMUNOL, V26, P250, DOI 10.1002/eji.1830260139; Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; Borrero M, 2002, J IMMUNOL, V168, P13, DOI 10.4049/jimmunol.168.1.13; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; COFFMAN RL, 1977, J IMMUNOL, V118, P1806; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Desiderio S, 1997, CURR OPIN IMMUNOL, V9, P534, DOI 10.1016/S0952-7915(97)80107-0; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; Gauld SB, 2006, CURR OPIN IMMUNOL, V18, P292, DOI 10.1016/j.coi.2006.03.015; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hasbold J, 1998, EUR J IMMUNOL, V28, P1040, DOI 10.1002/(SICI)1521-4141(199803)28:03<1040::AID-IMMU1040>3.3.CO;2-0; Heltemes LM, 2002, J IMMUNOL, V169, P1283, DOI 10.4049/jimmunol.169.3.1283; Hokazono Y, 2003, J IMMUNOL, V171, P1835, DOI 10.4049/jimmunol.171.4.1835; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; KENNY JJ, 1995, J IMMUNOL, V154, P5694; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Li XL, 2001, J IMMUNOL, V166, P3122, DOI 10.4049/jimmunol.166.5.3122; Li YJ, 2002, J EXP MED, V195, P181, DOI 10.1084/jem.20011453; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Marino E, 2008, DIABETES, V57, P395, DOI 10.2337/db07-0589; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Monroe JG, 2004, CURR OPIN IMMUNOL, V16, P288, DOI 10.1016/j.coi.2004.03.010; NEUBERGER MS, 1983, EMBO J, V2, P1373, DOI 10.1002/j.1460-2075.1983.tb01594.x; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Nitschke L, 1997, CURR BIOL, V7, P133, DOI 10.1016/S0960-9822(06)00057-1; Noorchashm H, 1999, INT IMMUNOL, V11, P765, DOI 10.1093/intimm/11.5.765; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Oliver AM, 1999, J IMMUNOL, V162, P7198; Onodera T, 2008, J IMMUNOL, V180, P907, DOI 10.4049/jimmunol.180.2.907; Otipoby KL, 1996, NATURE, V384, P634, DOI 10.1038/384634a0; Pillai S, 2005, ANNU REV IMMUNOL, V23, P161, DOI 10.1146/annurev.immunol.23.021704.115728; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Poe JC, 2004, NAT IMMUNOL, V5, P1078, DOI 10.1038/ni1121; Poe JC, 2004, J IMMUNOL, V172, P2100, DOI 10.4049/jimmunol.172.4.2100; Pogue SL, 2000, J EXP MED, V191, P1031, DOI 10.1084/jem.191.6.1031; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; ROTH PE, 1993, J EXP MED, V178, P2007, DOI 10.1084/jem.178.6.2007; Sato M, 2007, J IMMUNOL, V178, P2901, DOI 10.4049/jimmunol.178.5.2901; Sato S, 1996, IMMUNITY, V5, P551, DOI 10.1016/S1074-7613(00)80270-8; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; YEFENOF E, 1986, J IMMUNOL, V137, P85; YUAN D, 1977, J EXP MED, V145, P1421, DOI 10.1084/jem.145.6.1421	55	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8815	10.1371/journal.pone.0008815	http://dx.doi.org/10.1371/journal.pone.0008815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098688	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100009
J	Manning, SD; Springman, AC; Million, AD; Milton, NR; McNamara, SE; Somsel, PA; Bartlett, P; Davies, HD				Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.; McNamara, Sara E.; Somsel, Patricia A.; Bartlett, Paul; Davies, H. Dele			Association of Group B Streptococcus Colonization and Bovine Exposure: A Prospective Cross-Sectional Cohort Study	PLOS ONE			English	Article							CLINICAL MASTITIS; FECAL CARRIAGE; DAIRY-COWS; AGALACTIAE; SEROTYPE; DIVERSITY; PREVALENCE; MILK; TRANSMISSION; STUDENTS	Background: While Group B Streptococcus (GBS) human colonization and infection has long been suspected as originating from cows, several investigators have suggested that ongoing interspecies GBS transmission is unlikely due to genotyping data demonstrating that human and bovine-derived GBS strains represent mostly distinct populations. The possibility of ongoing transmission between humans and their livestock has not been systematically examined. Methodology/Principal Findings: To examine ongoing interspecies transmission, we conducted a prospective cross-sectional cohort study of 68 families and their livestock. Stool specimens were collected from 154 people and 115 livestock; GBS was detected in 19 (12.3%) humans and 2 (1.7%) animals (bovine and sheep). Application of multilocus sequence typing (MLST) identified 8 sequence types (STs or clones), with STs 1 and 23 predominating. There were 11 families in which two members submitted stools and at least one had GBS colonization. In 3 of these families, both members (consisting of couples) were colonized, yielding a co-colonization rate of 27% (95% CI: 7%-61%). Two of these couples had strains with identical MLST, capsule (cps) genotype, susceptibility, and RAPD profiles. One couple co-colonized with ST-1 (cps5) strains also had a bovine colonized with the identical strain type. On multivariate analysis of questionnaire data, cattle exposure was a predictor of GBS colonization, with each unit increase in days of cattle exposure increasing the odds of colonization by 20% (P = 0.02). These results support interspecies transmission with additional evidence for transmission provided by the epidemiological association with cattle exposure. Conclusions/Significance: Although GBS uncommonly colonizes livestock stools, increased frequency of cattle exposure was significantly associated with human colonization and one couple shared the same GBS strains as their bovine suggesting intraspecies transmission. These results set the framework for GBS as a possible zoonotic infection, which has significant public health implications.	[Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.] Michigan State Univ, Microbial Evolut Lab, E Lansing, MI 48824 USA; [Manning, Shannon D.; Springman, A. Cody; Million, Amber D.; Milton, Nicole R.; Bartlett, Paul] Michigan State Univ, Natl Food Safety & Toxicol Ctr, E Lansing, MI 48824 USA; [Manning, Shannon D.; Springman, A. Cody; Milton, Nicole R.; Davies, H. Dele] Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA; [McNamara, Sara E.; Somsel, Patricia A.] Michigan Dept Community Hlth, Bur Labs, Lansing, MI USA	Michigan State University; Michigan State University; Michigan State University; MDHHS - Michigan Department of Health & Human Services	Manning, SD (corresponding author), Michigan State Univ, Microbial Evolut Lab, E Lansing, MI 48824 USA.	daviesde@msu.edu	Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660	National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases) [AI066081]; National Institutes of Health, Department of Health and Human Services [N01-AI-30058]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066081] Funding Source: NIH RePORTER	National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported in part by Public Health Service grant AI066081 from the National Institutes of Health (National Institutes of Immunology, Allergy and Infectious Diseases) and a contract from the National Institutes of Health, Department of Health and Human Services, under the Food and Waterborne Diseases Integrated Research Network (NIH Research Contract N01-AI-30058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bisharat N, 2004, J CLIN MICROBIOL, V42, P2161, DOI 10.1128/JCM.42.5.2161-2167.2004; Bliss SJ, 2002, CLIN INFECT DIS, V34, P184, DOI 10.1086/338258; Bohnsack JF, 2004, EMERG INFECT DIS, V10, P1412, DOI 10.3201/eid1008.030917; BRGLEZ I, 1986, ZBL BAKT MIK HYG B, V182, P401; Brochet M, 2008, P NATL ACAD SCI USA, V105, P15961, DOI 10.1073/pnas.0803654105; Brochet M, 2006, MICROBES INFECT, V8, P1227, DOI 10.1016/j.micinf.2005.11.010; BRUNER DW, 1953, CORNELL VET, V43, P574; Clinical and laboratory standards institute, 2007, PERF STAND ANT SUS S, V27; Duarte RS, 2004, J CLIN MICROBIOL, V42, P4214, DOI 10.1128/JCM.42.9.4214-4222.2004; EASMON CSF, 1983, BRIT J OBSTET GYNAEC, V90, P633, DOI 10.1111/j.1471-0528.1983.tb09280.x; Edwards MS, 2005, CLIN INFECT DIS, V40, P352, DOI 10.1086/426820; FINCH LA, 1984, J APPL BACTERIOL, V57, P273, DOI 10.1111/j.1365-2672.1984.tb01391.x; Foxman B, 2006, AM J EPIDEMIOL, V163, P544, DOI 10.1093/aje/kwj075; HAMMERSCHLAG MR, 1977, PEDIATRICS, V60, P473; Hansen SM, 2004, J CLIN MICROBIOL, V42, P83, DOI 10.1128/JCM.42.1.83-89.2004; ISLAM AKMS, 1980, J CLIN PATHOL, V33, P1006, DOI 10.1136/jcp.33.10.1006; Jensen NE, 1996, EPIDEMIOL INFECT, V117, P417, DOI 10.1017/S0950268800059069; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones N, 2006, CLIN INFECT DIS, V42, P915, DOI 10.1086/500324; Keefe GP, 1997, CAN VET J, V38, P429; KUBIN V, 1983, FOLIA MICROBIOL, V28, P496, DOI 10.1007/BF02879689; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning S D, 2001, Clin Infect Dis, V33, pE137, DOI 10.1086/324588; Manning SD, 2005, J CLIN MICROBIOL, V43, P6113, DOI 10.1128/JCM.43.12.6113-6116.2005; Manning SD, 2004, CLIN INFECT DIS, V39, P380, DOI 10.1086/422321; Manning SD, 2002, EPIDEMIOLOGY, V13, P533, DOI 10.1097/00001648-200209000-00008; Manning SD, 2008, CLIN INFECT DIS, V47, P388, DOI 10.1086/589864; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Martinez G, 2000, J CLIN MICROBIOL, V38, P71; Mosabi JM, 1997, EPIDEMIOL INFECT, V118, P215, DOI 10.1017/S0950268897007474; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Oliveira ICM, 2006, CLIN MICROBIOL INFEC, V12, P887, DOI 10.1111/j.1469-0691.2006.01508.x; PERSSON KMS, 1986, EUR J CLIN MICROBIOL, V5, P156, DOI 10.1007/BF02013972; Pitkala A, 2004, J DAIRY SCI, V87, P2433, DOI 10.3168/jds.S0022-0302(04)73366-4; Sargeant JM, 1998, CAN VET J, V39, P33; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sukhnanand S, 2005, J CLIN MICROBIOL, V43, P1177, DOI 10.1128/JCM.43.3.1177-1186.2005; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tenhagen BA, 2009, J DAIRY RES, V76, P179, DOI 10.1017/S0022029908003786; van der Mee-Marquet N, 2008, J CLIN MICROBIOL, V46, P2906, DOI 10.1128/JCM.00421-08	42	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8795	10.1371/journal.pone.0008795	http://dx.doi.org/10.1371/journal.pone.0008795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098699	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000022
J	Olivieri, C; Ermini, L; Rizzi, E; Corti, G; Bonnal, R; Luciani, S; Marota, I; De Bellis, G; Rollo, F				Olivieri, Cristina; Ermini, Luca; Rizzi, Ermanno; Corti, Giorgio; Bonnal, Raoul; Luciani, Stefania; Marota, Isolina; De Bellis, Gianluca; Rollo, Franco			Characterization of Nucleotide Misincorporation Patterns in the Iceman's Mitochondrial DNA	PLOS ONE			English	Article							ANCIENT DNA; MISCODING LESIONS; SEQUENCE-ANALYSIS; GENETIC ANALYSES; DAMAGE; RETRIEVAL; REMAINS; DECAY	Background: The degradation of DNA represents one of the main issues in the genetic analysis of archeological specimens. In the recent years, a particular kind of post-mortem DNA modification giving rise to nucleotide misincorporation ("miscoding lesions") has been the object of extensive investigations. Methodology/Principal Findings: To improve our knowledge regarding the nature and incidence of ancient DNA nucleotide misincorporations, we have utilized 6,859 (629,975 bp) mitochondrial (mt) DNA sequences obtained from the 5,350-5,100-years-old, freeze-desiccated human mummy popularly known as the Tyrolean Iceman or Otzi. To generate the sequences, we have applied a mixed PCR/pyrosequencing procedure allowing one to obtain a particularly high sequence coverage. As a control, we have produced further 8,982 (805,155 bp) mtDNA sequences from a contemporary specimen using the same system and starting from the same template copy number of the ancient sample. From the analysis of the nucleotide misincorporation rate in ancient, modern, and putative contaminant sequences, we observed that the rate of misincorporation is significantly lower in modern and putative contaminant sequence datasets than in ancient sequences. In contrast, type 2 transitions represent the vast majority (85%) of the observed nucleotide misincorporations in ancient sequences. Conclusions/Significance: This study provides a further contribution to the knowledge of nucleotide misincorporation patterns in DNA sequences obtained from freeze-preserved archeological specimens. In the Iceman system, ancient sequences can be clearly distinguished from contaminants on the basis of nucleotide misincorporation rates. This observation confirms a previous identification of the ancient mummy sequences made on a purely phylogenetical basis. The present investigation provides further indication that the majority of ancient DNA damage is reflected by type 2 (cytosine -> thymine/guanine -> adenine) transitions and that type 1 transitions are essentially PCR artifacts.	[Olivieri, Cristina; Luciani, Stefania; Marota, Isolina; Rollo, Franco] Univ Camerino, Lab Archeoantropol Mol DNA Antico, Dipartimento Biol Mol Cellulare & Anim, I-62032 Camerino, Italy; [Ermini, Luca] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Rizzi, Ermanno; Corti, Giorgio; Bonnal, Raoul; De Bellis, Gianluca] CNR, Ist Tecnol Biomed, I-20133 Milan, Italy	University of Camerino; Newcastle University - UK; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Olivieri, C (corresponding author), Univ Camerino, Lab Archeoantropol Mol DNA Antico, Dipartimento Biol Mol Cellulare & Anim, I-62032 Camerino, Italy.	francougo.rollo@unicam.it	De Bellis, Gianluca/H-9725-2013; Rizzi, Ermanno/J-7448-2012; rizzi, ermanno/Q-3399-2016; Ermini, Luca/O-4813-2016	De Bellis, Gianluca/0000-0002-1622-4477; rizzi, ermanno/0000-0002-9898-2326; Ermini, Luca/0000-0001-8109-6021; Bonnal, Raoul/0000-0002-2123-6536; Olivieri, Cristina/0000-0002-2957-5452; Corti, Giorgio/0000-0001-6379-4117	Eli Lilly donation	Eli Lilly donation(Eli Lilly)	This research was supported by an Eli Lilly donation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Banerjee M, 2004, J ARCHAEOL SCI, V31, P59, DOI 10.1016/S0305-4403(03)00099-2; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; BROWN TA, 1992, ANTIQUITY, V66, P10, DOI 10.1017/S0003598X0008100X; Cooper A, 2000, SCIENCE, V289, P1139; Di Bernardo G, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e16; ECKERT KA, 1990, PCR PRACTICAL APPROA, P225; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Frey JE, 2004, HEREDITAS, V140, P92, DOI 10.1111/j.1601-5223.2004.01748.x; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gilbert MTP, 2007, NUCLEIC ACIDS RES, V35, P1, DOI 10.1093/nar/gkl483; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2005, AM J PHYS ANTHROPOL, V128, P110, DOI 10.1002/ajpa.20045; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; GILBERT MTP, 2005, MOL MARKERS PCR BIOI; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handt O, 1996, AM J HUM GENET, V59, P368; HANDT O, 1994, SCIENCE, V264, P1775, DOI 10.1126/science.8209259; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Helgason A, 2007, J MOL EVOL, V65, P92, DOI 10.1007/s00239-006-0259-8; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Lamers R, 2009, J MOL EVOL, V68, P40, DOI 10.1007/s00239-008-9184-3; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marota I, 2002, AM J PHYS ANTHROPOL, V117, P310, DOI 10.1002/ajpa.10045; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Sampietro ML, 2006, MOL BIOL EVOL, V23, P1801, DOI 10.1093/molbev/msl047; Spindler K, 1994, MAN ICE; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012	41	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8629	10.1371/journal.pone.0008629	http://dx.doi.org/10.1371/journal.pone.0008629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	541KO	20072618	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200002
J	Sureka, K; Hossain, T; Mukherjee, P; Chatterjee, P; Datta, P; Kundu, M; Basu, J				Sureka, Kamakshi; Hossain, Tofajjen; Mukherjee, Partha; Chatterjee, Paramita; Datta, Pratik; Kundu, Manikuntala; Basu, Joyoti			RETRACTED: Novel Role of Phosphorylation-Dependent Interaction between FtsZ and FipA in Mycobacterial Cell Division (Retracted article. See vol. 17, 2022)	PLOS ONE			English	Article; Retracted Publication							SER/THR PROTEIN-KINASES; FHA DOMAIN; SERINE/THREONINE KINASE; DNA-REPAIR; TUBERCULOSIS; PKNB; IDENTIFICATION; MIDCELL; LOCALIZATION; MUTAGENESIS	The bacterial divisome is a multiprotein complex. Specific protein-protein interactions specify whether cell division occurs optimally, or whether division is arrested. Little is known about these protein-protein interactions and their regulation in mycobacteria. We have investigated the interrelationship between the products of the Mycobacterium tuberculosis gene cluster Rv0014c-Rv0019c, namely PknA (encoded by Rv0014c) and FtsZ-interacting protein A, FipA (encoded by Rv0019c) and the products of the division cell wall (dcw) cluster, namely FtsZ and FtsQ. M. smegmatis strains depleted in components of the two gene clusters have been complemented with orthologs of the respective genes of M. tuberculosis. Here we identify FipA as an interacting partner of FtsZ and FtsQ and establish that PknA-dependent phosphorylation of FipA on T77 and FtsZ on T343 is required for cell division under oxidative stress. A fipA knockout strain of M. smegmatis is less capable of withstanding oxidative stress than the wild type and showed elongation of cells due to a defect in septum formation. Localization of FtsQ, FtsZ and FipA at mid-cell was also compromised. Growth and survival defects under oxidative stress could be functionally complemented by fipA of M. tuberculosis but not its T77A mutant. Merodiploid strains of M. smegmatis expressing the FtsZ(T343A) showed inhibition of FtsZ-FipA interaction and Z ring formation under oxidative stress. Knockdown of FipA led to elongation of M. tuberculosis cells grown in macrophages and reduced intramacrophage growth. These data reveal a novel role of phosphorylation-dependent protein-protein interactions involving FipA, in the sustenance of mycobacterial cell division under oxidative stress.	[Sureka, Kamakshi; Hossain, Tofajjen; Mukherjee, Partha; Chatterjee, Paramita; Datta, Pratik; Kundu, Manikuntala; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata, India	Department of Science & Technology (India); Bose Institute	Sureka, K (corresponding author), Bose Inst, Dept Chem, Kolkata, India.	joyoti@vsnl.com	Datta, Pratik/O-4400-2016; Sureka, Kamakshi/ABE-4125-2021	Datta, Pratik/0000-0001-6713-9961; Sureka, Kamakshi/0000-0003-3093-5299; Hossain, Sk Tofajjen/0000-0002-1448-1015	Council of Industrial Research, Government of India	Council of Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Council of Industrial Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BRAMHILL D, 1994, P NATL ACAD SCI USA, V91, P5813, DOI 10.1073/pnas.91.13.5813; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; DARI R, 1983, J BACTERIOL, V156, P243, DOI 10.1128/JB.156.1.243-250.1983; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; Daugelat S, 2003, MICROBES INFECT, V5, P1082, DOI 10.1016/S1286-4579(03)00205-3; Davis EO, 2002, J BACTERIOL, V184, P3287, DOI 10.1128/JB.184.12.3287-3295.2002; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; England P, 2009, FEBS LETT, V583, P301, DOI 10.1016/j.febslet.2008.12.036; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goehring NW, 2005, GENE DEV, V19, P127, DOI 10.1101/gad.1253805; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; Gupta M, 2009, J BIOL CHEM, V284, P34723, DOI 10.1074/jbc.M109.058834; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Katis VL, 2000, J BACTERIOL, V182, P3607, DOI 10.1128/JB.182.12.3607-3611.2000; Mahenthiralingam E, 1998, INFECT IMMUN, V66, P3626, DOI 10.1128/IAI.66.8.3626-3634.1998; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; O'Sullivan DM, 2008, J ANTIMICROB CHEMOTH, V62, P1199, DOI 10.1093/jac/dkn387; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Roy S, 2004, RES MICROBIOL, V155, P817, DOI 10.1016/j.resmic.2004.06.004; Schultz C, 2009, MOL MICROBIOL, V74, P724, DOI 10.1111/j.1365-2958.2009.06897.x; Singh A, 2006, TUBERCULOSIS, V86, P28, DOI 10.1016/j.tube.2005.04.002; Strong M, 2003, NUCLEIC ACIDS RES, V31, P7099, DOI 10.1093/nar/gkg924; Sureka K, 2007, MOL MICROBIOL, V65, P261, DOI 10.1111/j.1365-2958.2007.05814.x; Thakur M, 2008, BIOCHEM J, V415, P27, DOI 10.1042/BJ20080234; Thakur M, 2006, J BIOL CHEM, V281, P40107, DOI 10.1074/jbc.M607216200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vicente M, 1996, MOL MICROBIOL, V20, P1, DOI 10.1111/j.1365-2958.1996.tb02482.x; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walker GC., 1996, ESCHERICHIA COLI SAL, P1400; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976	48	61	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8590	10.1371/journal.pone.0008590	http://dx.doi.org/10.1371/journal.pone.0008590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066037	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600013
J	Brookes, SM; Nunez, A; Choudhury, B; Matrosovich, M; Essen, SC; Clifford, D; Slomka, MJ; Kuntz-Simon, G; Garcon, F; Nash, B; Hanna, A; Heegaard, PMH; Queguiner, S; Chiapponi, C; Bublot, M; Garcia, JM; Gardner, R; Foni, E; Loeffen, W; Larsen, L; Van Reeth, K; Banks, J; Irvine, RM; Brown, IH				Brookes, Sharon M.; Nunez, Alejandro; Choudhury, Bhudipa; Matrosovich, Mikhail; Essen, Stephen C.; Clifford, Derek; Slomka, Marek J.; Kuntz-Simon, Gaelle; Garcon, Fanny; Nash, Bethany; Hanna, Amanda; Heegaard, Peter M. H.; Queguiner, Stephane; Chiapponi, Chiara; Bublot, Michel; Maldonado Garcia, Jaime; Gardner, Rebecca; Foni, Emanuela; Loeffen, Willie; Larsen, Lars; Van Reeth, Kristien; Banks, Jill; Irvine, Richard M.; Brown, Ian H.			Replication, Pathogenesis and Transmission of Pandemic (H1N1) 2009 Virus in Non-Immune Pigs	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; ACUTE-PHASE PROTEIN; RECEPTOR-BINDING PROPERTIES; C-REACTIVE PROTEIN; INTERSPECIES TRANSMISSION; EXPERIMENTAL-INFECTION; MDCK CELLS; HEMAGGLUTININ; STRAINS; FERRETS	The declaration of the human influenza A pandemic (H1N1) 2009 (H1N1/09) raised important questions, including origin and host range [1,2]. Two of the three pandemics in the last century resulted in the spread of virus to pigs (H1N1, 1918; H3N2, 1968) with subsequent independent establishment and evolution within swine worldwide [3]. A key public and veterinary health consideration in the context of the evolving pandemic is whether the H1N1/09 virus could become established in pig populations [4]. We performed an infection and transmission study in pigs with A/California/07/09. In combination, clinical, pathological, modified influenza A matrix gene real time RT-PCR and viral genomic analyses have shown that infection results in the induction of clinical signs, viral pathogenesis restricted to the respiratory tract, infection dynamics consistent with endemic strains of influenza A in pigs, virus transmissibility between pigs and virus-host adaptation events. Our results demonstrate that extant H1N1/09 is fully capable of becoming established in global pig populations. We also show the roles of viral receptor specificity in both transmission and tissue tropism. Remarkably, following direct inoculation of pigs with virus quasispecies differing by amino acid substitutions in the haemagglutinin receptor-binding site, only virus with aspartic acid at position 225 (225D) was detected in nasal secretions of contact infected pigs. In contrast, in lower respiratory tract samples from directly inoculated pigs, with clearly demonstrable pulmonary pathology, there was apparent selection of a virus variant with glycine (225G). These findings provide potential clues to the existence and biological significance of viral receptor-binding variants with 225D and 225G during the 1918 pandemic [5].	[Brookes, Sharon M.; Nunez, Alejandro; Choudhury, Bhudipa; Essen, Stephen C.; Clifford, Derek; Slomka, Marek J.; Garcon, Fanny; Nash, Bethany; Hanna, Amanda; Gardner, Rebecca; Banks, Jill; Irvine, Richard M.; Brown, Ian H.] Vet Labs Agcy Weybridge, EU, OIE, FAO Reference Lab Avian Influenza & Newcastle Dis, Addlestone, Surrey, England; [Van Reeth, Kristien] Univ Ghent, Merelbeke, Belgium; [Kuntz-Simon, Gaelle; Queguiner, Stephane] Agence Francaise Securite Sanitaire Aliments, LERAPP, Unite Virol Immunol Porcines, Zoopole Les Croix, Ploufragan, France; [Loeffen, Willie] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Chiapponi, Chiara; Foni, Emanuela] Ist Zooprofilatt Sperimentale Lombardia Emilia Ro, Sez Parma, Parma, Italy; [Heegaard, Peter M. H.; Larsen, Lars] Tech Univ Denmark, Natl Vet Inst, Copenhagen, Denmark; [Matrosovich, Mikhail] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [Bublot, Michel] R&D, SAS, Lyon, France; [Maldonado Garcia, Jaime] Labs HIPRA, Amer Girona, Spain; [Choudhury, Bhudipa] World Org Anim Hlth, OFFLU, Paris, France	Food & Agriculture Organization of the United Nations (FAO); Veterinary Laboratories Agency; Ghent University; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Wageningen University & Research; IZS Lombardia e Emilia; Technical University of Denmark; Philipps University Marburg; HIPRA	Brookes, SM (corresponding author), Vet Labs Agcy Weybridge, EU, OIE, FAO Reference Lab Avian Influenza & Newcastle Dis, Addlestone, Surrey, England.	i.h.brown@vla.defra.gsi.gov.uk	Simon, Gaelle/ABI-1479-2020; Hanna, Amanda/D-8522-2011; Brookes, Sharon M/C-8016-2011; Choudhury, Bhudipa/D-3863-2011; Irvine, Richard M/E-2556-2011; Clifford, Derek/D-3034-2011; Nash, Bethany J/C-8160-2011; Castel, Alejandro Núñez/C-2560-2011; Loeffen, Willie/M-5344-2015; Garcon, Fanny/D-8001-2011; Brookes, Sharon M/W-2128-2019; Slomka, Marek J/D-8012-2011; Brown, Ian H/E-1119-2011; Banks, Jill/D-8848-2011; Essen, Stephen/E-9721-2011; Larsen, Lars E/G-3827-2015; Heegaard, Peter/E-9794-2015	Simon, Gaelle/0000-0003-1099-5075; Hanna, Amanda/0000-0001-9045-3553; Brookes, Sharon M/0000-0001-9207-6659; Choudhury, Bhudipa/0000-0002-1392-6414; Irvine, Richard M/0000-0002-1584-4076; Loeffen, Willie/0000-0003-4732-4590; Brookes, Sharon M/0000-0001-9207-6659; Larsen, Lars E/0000-0003-0730-5555; Nunez, Alejandro/0000-0001-5926-7541; Chiapponi, Chiara/0000-0001-8808-4680; Matrosovich, Mikhail/0000-0003-1618-2083; Heegaard, Peter/0000-0003-4506-4932	European Commission; Department of Environment, Food and Rural Affairs (United Kingdom)	European Commission(European CommissionEuropean Commission Joint Research Centre); Department of Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	The study was financially supported by the European Commission (DG SANCO, Unit D1 Animal Health) and the Department of Environment, Food and Rural Affairs (United Kingdom). Two authors (Bublot and Maldonado Garcia) are employed by commercial companies. The authors contributed intellectually to study design and result analyses, but no funds were provided by their employers directly to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown Ian H., 2008, V27, P88; BROWN IH, 1993, VET REC, V132, P598, DOI 10.1136/vr.132.24.598; COATES DM, 1986, J GEN VIROL, V67, P419, DOI 10.1099/0022-1317-67-3-419; Gambaryan AS, 2005, VIRUS RES, V114, P15, DOI 10.1016/j.virusres.2005.05.005; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Heegaard PMH, 2009, J IMMUNOL METHODS, V343, P112, DOI 10.1016/j.jim.2009.02.002; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Lipatov AS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000102; Londt B, 2008, AVIAN PATHOL, V37, P619, DOI 10.1080/03079450802499126; MA W, 2009, ZOONOSES PUBLIC HLTH; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich Mikhail N., 2008, V27, P134; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Mochalova L, 2003, VIROLOGY, V313, P473, DOI 10.1016/S0042-6822(03)00377-5; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; *OIE, 2009, ANIMAL HLTH INFORM, V22; *OIE, 2009, OIE DIS NOT PIGS CAN; *OIE, 2009, OIE DIS NOT PIGS ARG; *OIE WORLD ORG AN, 2008, SWIN INFL MAN DIAGN; Olsen C.W., DIS SWINE, P469; Ottolini MG, 2005, J GEN VIROL, V86, P2823, DOI 10.1099/vir.0.81145-0; Park AW, 2004, P ROY SOC B-BIOL SCI, V271, P1547, DOI 10.1098/rspb.2004.2766; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Slomka MJ, 2009, INFLUENZA OTHER RESP, V3, P151, DOI 10.1111/j.1750-2659.2009.00083.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorensen NS, 2006, VET IMMUNOL IMMUNOP, V113, P157, DOI 10.1016/j.vetimm.2006.04.008; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; STRETA D, 2009, VIROL J, V25, P34; TOMS GL, 1977, LANCET, V1, P68; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Weingartl HM, 2009, J VIROL, V83, P4287, DOI 10.1128/JVI.02399-08	35	126	128	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9068	10.1371/journal.pone.0009068	http://dx.doi.org/10.1371/journal.pone.0009068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140096	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400008
J	Nencioni, A; Cea, M; Garuti, A; Passalacqua, M; Raffaghello, L; Soncini, D; Moran, E; Zoppoli, G; Pistoia, V; Patrone, F; Ballestrero, A				Nencioni, Alessio; Cea, Michele; Garuti, Anna; Passalacqua, Mario; Raffaghello, Lizzia; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Pistoia, Vito; Patrone, Franco; Ballestrero, Alberto			Grb7 Upregulation Is a Molecular Adaptation to HER2 Signaling Inhibition Due to Removal of Akt-Mediated Gene Repression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HER2-POSITIVE BREAST-CANCER; TRANSCRIPTION FACTOR FKHR; FOCAL ADHESION KINASE; CELL-MIGRATION; SH2 DOMAIN; ADJUVANT CHEMOTHERAPY; TYROSINE KINASES; TRASTUZUMAB; EXPRESSION	The efficacy of anti-HER2 therapeutics, such as lapatinib and trastuzumab, is limited by primary and acquired resistance. Cellular adaptations that allow breast cancer cell to survive prolonged HER2 inhibition include de-repression of the transcription factor FOXO3A with consequent estrogen receptor activation, and/or increased HER3 signaling. Here, we used low-density arrays, quantitative PCR, and western blotting to determine how HER2 signaling inhibition with lapatinib or PI3K inhibitors affects the expression of genes involved in breast cancer metastatic spread and overall prognosis. Retroviral transgenesis was used to express constitutively active forms of Akt in the HER2(+) breast cancer cell line SKBR3, and Grb7 in MCF7 cells. Specific gene silencing was obtained by siRNAs transfection. A murine BT474 xenograft cancer model was used to assess the effect of lapatinib on gene expression in vivo. We found that lapatinib induces upregulation of Grb7, an adaptor protein involved in receptor tyrosine kinase signaling and promoting cell survival and cell migration. Grb7 upregulation induced by lapatinib was found to occur in cancer cells in vitro and in vivo. We demonstrate that Grb7 upregulation is recreated by PI3K inhibitors while being prevented by constitutively active Akt. Thus, Grb7 is repressed by PI3K signaling and lapatinib-mediated Akt inhibition is responsible for Grb7 de-repression. Finally, we show that Grb7 removal by RNA-interference reduces breast cancer cell viability and increases the activity of lapatinib. In conclusion, Grb7 upregulation is a potentially adverse consequence of HER2 signaling inhibition. Preventing Grb7 accumulation and/or its interaction with receptor tyrosine kinases may increase the benefit of HER2-targeting drugs.	[Nencioni, Alessio; Cea, Michele; Garuti, Anna; Soncini, Debora; Moran, Eva; Zoppoli, Gabriele; Patrone, Franco; Ballestrero, Alberto] Univ Genoa, Dept Internal Med, Ctr Excellence Biomed Res, I-16126 Genoa, Italy; [Passalacqua, Mario] Univ Genoa, Dept Expt Med, Biochem Sect, Ctr Excellence Biomed Res, I-16126 Genoa, Italy; [Passalacqua, Mario] INBB, Rome, Italy; [Raffaghello, Lizzia; Pistoia, Vito] G Gaslini Inst Children, Lab Oncol, Dept Expt & Lab Med, Genoa, Italy	University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Ctr Excellence Biomed Res, I-16126 Genoa, Italy.	A.Nencioni@gmx.net	Zoppoli, Gabriele/B-6935-2016; Zoppoli, Gabriele/A-9540-2010; Passalacqua, Mario/W-1973-2019; Ballestrero, Alberto/K-7546-2016; Nencioni, Alessio/K-3692-2018; Soncini, Debora/AAB-2230-2019; cea, Michele/K-3863-2018; Zoppoli, Gabriele/B-6935-2016	Zoppoli, Gabriele/0000-0003-3890-5588; Passalacqua, Mario/0000-0003-2779-6259; Ballestrero, Alberto/0000-0002-2601-7711; Soncini, Debora/0000-0001-5156-498X; cea, Michele/0000-0002-1530-6729; Zoppoli, Gabriele/0000-0002-1619-1708; Raffaghello, Lizzia/0000-0003-2357-0607; NENCIONI, ALESSIO/0000-0001-5068-8884	Associazione Italiana per la Ricerca sul Cancro; Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria; University of Genoa; Fondazione Italiana per la Lotta al Neuroblastoma	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria(Fondazione AIRC per la ricerca sul cancro); University of Genoa; Fondazione Italiana per la Lotta al Neuroblastoma	This study was supported by the Associazione Italiana per la Ricerca sul Cancro (START-UP grant to A.N., MFAG to L. R.), the Associazione Italiana per la Lotta a Leucemie-Linfomi e Mieloma (AIL) Sezione Liguria (F. P., A. B., A. G.), and the University of Genoa. L. R. is a recipient of a fellowship from the Fondazione Italiana per la Lotta al Neuroblastoma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrechek ER, 2003, CANCER RES, V63, P4920; Bai T, 2008, CARCINOGENESIS, V29, P473, DOI 10.1093/carcin/bgm221; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Chen FL, 2008, CLIN CANCER RES, V14, P6730, DOI 10.1158/1078-0432.CCR-08-0581; CHU PY, 2009, J BIOL CHEM; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Girault I, 2003, CLIN CANCER RES, V9, P1259; Han DC, 2000, J BIOL CHEM, V275, P28911, DOI 10.1074/jbc.M001997200; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hodgson JG, 2005, CANCER RES, V65, P9695, DOI 10.1158/0008-5472.CAN-05-0755; Hussain MHA, 2007, J CLIN ONCOL, V25, P2218, DOI 10.1200/JCO.2006.08.0994; Jimeno A, 2005, CANCER RES, V65, P3003, DOI 10.1158/0008-5472.CAN-04-3586; Kao J, 2006, GENE CHROMOSOME CANC, V45, P761, DOI 10.1002/gcc.20339; Kauraniemi P, 2001, CANCER RES, V61, P8235; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MARGOLIS B, 1992, P NATL ACAD SCI USA, V89, P8894, DOI 10.1073/pnas.89.19.8894; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pero SC, 2002, J BIOL CHEM, V277, P11918, DOI 10.1074/jbc.M111816200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Porter CJ, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-58; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Ravaud A, 2008, J CLIN ONCOL, V26, P2285, DOI 10.1200/JCO.2007.14.5029; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2005, J CLIN ONCOL, V23, P2502, DOI 10.1200/JCO.2005.12.157; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Tanaka S, 2006, JNCI-J NATL CANCER I, V98, P491, DOI 10.1093/jnci/djj105; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; van Agthoven T, 2009, J CLIN ONCOL, V27, P542, DOI 10.1200/JCO.2008.17.1462; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Yokote K, 1996, J BIOL CHEM, V271, P30942, DOI 10.1074/jbc.271.48.30942; Zheng Y, 2007, J IMMUNOL, V178, P2163, DOI 10.4049/jimmunol.178.4.2163	43	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9024	10.1371/journal.pone.0009024	http://dx.doi.org/10.1371/journal.pone.0009024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126311	gold, Green Published, Green Submitted			2022-12-27	WOS:000274207200019
J	Abraira, VE; Satoh, T; Fekete, DM; Goodrich, LV				Abraira, Victoria E.; Satoh, Takunori; Fekete, Donna M.; Goodrich, Lisa V.			Vertebrate Lrig3-ErbB Interactions Occur In Vitro but Are Unlikely to Play a Role in Lrig3-Dependent Inner Ear Morphogenesis	PLOS ONE			English	Article							SEMICIRCULAR CANAL FORMATION; GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; CARDIAC DEVELOPMENT; NEGATIVE REGULATOR; NEUREGULIN RECEPTOR; BREAST-CANCER; NETRIN 1; EXPRESSION; LRIG1	Background: The Lrig genes encode a family of transmembrane proteins that have been implicated in tumorigenesis, psoriasis, neural crest development, and complex tissue morphogenesis. Whether these diverse phenotypes reflect a single underlying cellular mechanism is not known. However, Lrig proteins contain evolutionarily conserved ectodomains harboring both leucine-rich repeats and immunoglobulin domains, suggesting an ability to bind to common partners. Previous studies revealed that Lrig1 binds to and inhibits members of the ErbB family of receptor tyrosine kinases by inducing receptor internalization and degradation. In addition, other receptor tyrosine kinase binding partners have been identified for both Lrig1 and Lrig3, leaving open the question of whether defective ErbB signaling is responsible for the observed mouse phenotypes. Methodology/Principal Findings: Here, we report that Lrig3, like Lrig1, is able to interact with ErbB receptors in vitro. We examined the in vivo significance of these interactions in the inner ear, where Lrig3 controls semicircular canal formation by determining the timing and extent of Netrin1 expression in the otic vesicle epithelium. We find that ErbB2 and ErbB3 are present in the early otic epithelium, and that Lrig3 acts cell-autonomously here, as would be predicted if Lrig3 regulates ErbB2/B3 activity. However, inhibition of ErbB activation in the chick otic vesicle has no detectable effect on Netrin gene expression or canal morphogenesis. Conclusions/Significance: Our results suggest that although both Lrig1 and Lrig3 can interact with ErbB receptors in vitro, modulation of Neuregulin signaling is unlikely to contribute to Lrig3-dependent processes of inner ear morphogenesis. These results highlight the similar binding properties of Lrig1 and Lrig3 and underscore the need to determine how these two family members bind to and regulate different receptors to affect diverse aspects of cell behavior in vivo.	[Abraira, Victoria E.; Goodrich, Lisa V.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Abraira, Victoria E.; Goodrich, Lisa V.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Satoh, Takunori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Aichi, Japan; [Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Nagoya University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Abraira, VE (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	Lisa_Goodrich@hms.harvard.edu	Fekete, Donna M/B-9170-2009	Fekete, Donna M/0000-0003-0662-0246	National Institute on Deafness [R01 DC007195, R01 DC002756, F31 DC008450]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007195, R01DC002756, F31DC008450] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the following grants from the National Institute on Deafness and other Communication Disorders (www.nidcd.nih.gov): R01 DC007195 (L.V.G.), R01 DC002756 (D.M.F.), and F31 DC008450 (V.E.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraira VE, 2008, DEVELOPMENT, V135, P4091, DOI 10.1242/dev.029330; Alavizadeh A, 2001, DEV BIOL, V234, P244, DOI 10.1006/dbio.2001.0241; Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Carraway KL, 1997, J MAMMARY GLAND BIOL, V2, P187, DOI 10.1023/A:1026360032602; Carraway KL, 2005, J CELL BIOCHEM, V96, P914, DOI 10.1002/jcb.20612; Chang W, 2004, DEVELOPMENT, V131, P4201, DOI 10.1242/dev.01292; Chang WI, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000050; Dammann CEL, 2003, AM J RESP CRIT CARE, V167, P1711, DOI 10.1164/rccm.200205-468OC; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Erickson SL, 1997, DEVELOPMENT, V124, P4999; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Ghiglione C, 2003, DEVELOPMENT, V130, P4483, DOI 10.1242/dev.00617; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Gilmore JL, 2008, BREAST CANCER RES TR, V110, P493, DOI 10.1007/s10549-007-9748-8; Golding JP, 2004, DEV BIOL, V266, P361, DOI 10.1016/j.ydbio.2003.11.003; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Guo DS, 2006, ACTA NEUROPATHOL, V111, P238, DOI 10.1007/s00401-006-0032-5; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Hume CR, 2003, JARO-J ASSOC RES OTO, V4, P422, DOI 10.1007/s10162-002-3008-8; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; KENNEDY TE, 1994, CELL, V78, P435; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; LeBras S, 1998, DIABETOLOGIA, V41, P1474, DOI 10.1007/s001250051094; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; LINDSTROM AK, 2007, INT J GYNECOL CANC; LJUSLINDER I, 2007, ACTA ONCOL, P1; Loftus SK, 2001, DNA RES, V8, P221, DOI 10.1093/dnares/8.5.221; MARTIN P, 1993, DEV BIOL, V159, P549, DOI 10.1006/dbio.1993.1263; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Miyazaki Y, 2004, DEV DYNAM, V230, P591, DOI 10.1002/dvdy.20078; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2004, DEV BIOL, V273, P350, DOI 10.1016/j.ydbio.2004.06.010; Qu SM, 2006, GENESIS, V44, P477, DOI 10.1002/dvg.20243; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3; Sakakibara A, 2006, J CELL SCI, V119, P3583, DOI 10.1242/jcs.03080; Salminen M, 2000, DEVELOPMENT, V127, P13; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stankovic K, 2004, J NEUROSCI, V24, P8651, DOI 10.1523/JNEUROSCI.0733-04.2004; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wong RWC, 2003, CELL MOL LIFE SCI, V60, P113, DOI 10.1007/s000180300007; Xiong Zongqiang, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P86; Yang WM, 2006, BJU INT, V98, P898, DOI 10.1111/j.1464-410X.2006.06405.x; Zhang M, 2002, HEARING RES, V169, P56, DOI 10.1016/S0378-5955(02)00339-8; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	65	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8981	10.1371/journal.pone.0008981	http://dx.doi.org/10.1371/journal.pone.0008981			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126551	Green Published, Green Submitted, gold			2022-12-27	WOS:000274209700010
J	Toyohara, J; Ishiwata, K; Sakata, M; Wu, J; Nishiyama, S; Tsukada, H; Hashimoto, K				Toyohara, Jun; Ishiwata, Kiichi; Sakata, Muneyuki; Wu, Jin; Nishiyama, Shingo; Tsukada, Hideo; Hashimoto, Kenji			In Vivo Evaluation of alpha 7 Nicotinic Acetylcholine Receptor Agonists [C-11]A-582941 and [C-11]A-844606 in Mice and Conscious Monkeys	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; BINDING-SITES; HUMAN BRAIN; DOPAMINE TRANSPORTERS; RADIOLIGAND BINDING; POSTMORTEM BRAIN; MESSENGER-RNA; PET; LOCALIZATION	Background: The alpha 7 nicotinic acetylcholine receptors (nAChRs) play an important role in the pathophysiology of neuropsychiatric diseases such as schizophrenia and Alzheimer's disease. The goal of this study was to evaluate the two carbon-11-labeled alpha 7 nAChR agonists [C-11]A-582941 and [C-11]A-844606 for their potential as novel positron emission tomography (PET) tracers. Methodology/Principal Findings: The two tracers were synthesized by methylation of the corresponding desmethyl precursors using [C-11] methyl triflate. Effects of receptor blockade in mice were determined by coinjection of either tracer along with a carrier or an excess amount of a selective alpha 7 nAChR agonist (SSR180711). Metabolic stability was investigated using radio-HPLC. Dynamic PET scans were performed in conscious monkeys with/without SSR180711-treatment. [C-11]A-582941 and [C-11]A-844606 showed high uptake in the mouse brain. Most radioactive compounds in the brain were detected as an unchanged form. However, regional selectivity and selective receptor blockade were not clearly observed for either compound in the mouse brain. On the other hand, the total distribution volume of [C-11]A-582941 and [C-11]A-844606 was high in the hippocampus and thalamus but low in the cerebellum in the conscious monkey brain, and reduced by pretreatment with SSR180711. Conclusions/Significance: A nonhuman primate study suggests that [C-11]A-582941 and [C-11]A-844606 would be potential PET ligands for imaging alpha 7 nAChRs in the human brain.	[Toyohara, Jun; Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Toyohara, Jun; Ishiwata, Kiichi; Sakata, Muneyuki] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan; [Nishiyama, Shingo; Tsukada, Hideo] Hamamatsu Photon KK, Cent Res Lab, Shizuoka, Japan	Chiba University; Tokyo Metropolitan Institute of Gerontology; Hamamatsu Photonics	Toyohara, J (corresponding author), Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Toyohara, Jun/C-4461-2011; Hashimoto, Kenji/I-5800-2015	Toyohara, Jun/0000-0003-4721-405X; Hashimoto, Kenji/0000-0002-8892-0439	National Institute of Biomedical Innovation of Japan [06-46]	National Institute of Biomedical Innovation of Japan(National Institute of Biomedical Innovation)	This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation of Japan (Grant ID: 06-46, to K. H.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2008, J PHARMACOL EXP THER, V324, P179, DOI 10.1124/jpet.107.130062; Basha A., 2005, US Patent, Patent No. [2005/0101602Al, 20050101602]; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Biton B, 2007, NEUROPSYCHOPHARMACOL, V32, P1, DOI 10.1038/sj.npp.1301189; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Briggs CA, 2008, BRIT J PHARMACOL, V153, P1054, DOI 10.1038/sj.bjp.0707649; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Bunnelle WH, 2009, J MED CHEM, V52, P4126, DOI 10.1021/jm900249k; Burghaus L, 2000, MOL BRAIN RES, V76, P385; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; CIMINO M, 1992, NEUROSCIENCE, V51, P77, DOI 10.1016/0306-4522(92)90472-E; Court J, 2001, BIOL PSYCHIAT, V49, P175, DOI 10.1016/S0006-3223(00)01116-1; Court JA, 2000, J CHEM NEUROANAT, V20, P281, DOI 10.1016/S0891-0618(00)00110-1; D'Andrea MR, 2006, CURR PHARM DESIGN, V12, P677, DOI 10.2174/138161206775474224; Davies ARL, 1999, NEUROPHARMACOLOGY, V38, P679, DOI 10.1016/S0028-3908(98)00221-4; Ding YS, 2005, J NEUROCHEM, V94, P337, DOI 10.1111/j.1471-4159.2005.03202.x; Falk L, 2003, DEV BRAIN RES, V142, P151, DOI 10.1016/S0165-3806(03)00063-4; FREEDMAN R, 1994, HARVARD REV PSYCHIAT, V2, P179, DOI 10.3109/10673229409017136; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Fujio M, 2002, NUCL MED BIOL, V29, P657, DOI 10.1016/S0969-8051(02)00305-0; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Han ZY, 2003, J COMP NEUROL, V461, P49, DOI 10.1002/cne.10659; Hashimoto K, 2004, NEUROPSYCHOPHARMACOL, V29, P2018, DOI 10.1038/sj.npp.1300512; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto Kenji, 2005, Current Medicinal Chemistry - Central Nervous System Agents, V5, P171, DOI 10.2174/1568015054863828; Hashimoto K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003231; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Ishiwata K, 2004, NUCL MED BIOL, V31, P493, DOI 10.1016/j.nucmedbio.2003.11.005; Ishiwata K, 2001, NUCL MED BIOL, V28, P281, DOI 10.1016/S0969-8051(00)00170-0; Ishiwata K, 1998, NUCL MED BIOL, V25, P195, DOI 10.1016/S0969-8051(97)00170-4; Kawamura K, 2004, ANN NUCL MED, V18, P165, DOI 10.1007/BF02985109; Kulak JM, 2004, BRAIN RES, V999, P193, DOI 10.1016/j.brainres.2003.10.062; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; LUKAS RJ, 1997, PHARMACOL REV, V51, P397; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; Nomikos GG, 2000, BEHAV BRAIN RES, V113, P97, DOI 10.1016/S0166-4328(00)00204-7; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; ONOE H, 1994, BRAIN RES, V663, P191, DOI 10.1016/0006-8993(94)91263-7; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Quik M, 2000, J COMP NEUROL, V425, P58, DOI 10.1002/1096-9861(20000911)425:1<58::AID-CNE6>3.0.CO;2-X; Romanelli MN, 2007, CHEMMEDCHEM, V2, P746, DOI 10.1002/cmdc.200600207; SCHRIMPF MR, 2005, Patent No. 20050234031; Sullivan JP, 1996, NEUROPHARMACOLOGY, V35, P725, DOI 10.1016/0028-3908(96)84644-2; TAKECHI H, 1994, NEUROSCI LETT, V182, P279, DOI 10.1016/0304-3940(94)90816-8; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Tietje KR, 2008, CNS NEUROSCI THER, V14, P65, DOI 10.1111/j.1527-3458.2008.00037.x; TOYOHARA J, 2010, OPEN MED CH IN PRESS; Toyohara J, 2009, ANN NUCL MED, V23, P301, DOI 10.1007/s12149-009-0240-x; Watanabe M, 1997, IEEE T NUCL SCI, V44, P1277, DOI 10.1109/23.597001; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x	52	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8961	10.1371/journal.pone.0008961	http://dx.doi.org/10.1371/journal.pone.0008961			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126539	Green Submitted, Green Published, gold			2022-12-27	WOS:000274209700005
J	Espinosa, MC; Rehman, MA; Chisamore-Robert, P; Jeffery, D; Yankulov, K				Espinosa, Maria Claudia; Rehman, Muhammad Attiq; Chisamore-Robert, Patricia; Jeffery, Daniel; Yankulov, Krassimir			GCN5 Is a Positive Regulator of Origins of DNA Replication in Saccharomyces cerevisiae	PLOS ONE			English	Article							HISTONE ACETYLATION; MYST FAMILY; ROLES; HBO1; INITIATION; PROTEIN; SAGA; ACETYLTRANSFERASES; PHOSPHORYLATION; MAINTENANCE	GCN5 encodes one of the non-essential Histone Acetyl Transferases in Saccharomyces cerevisiae. Extensive evidence has indicated that GCN5 is a key regulator of gene expression and could also be involved in transcriptional elongation, DNA repair and centromere maintenance. Here we show that the deletion of GCN5 decreases the stability of mini-chromosomes; that the tethering of Gcn5p to a crippled origin of replication stimulates its activity; that high dosage of GCN5 suppresses conditional phenotypes caused by mutant alleles of bona fide replication factors, orc2-1, orc5-1 and mcm5-461. Furthermore, Gcn5p physically associates with origins of DNA replication, while its deletion leads to localized condensation of chromatin at origins. Finally, Dgcn5 cells display a deficiency in the assembly of pre-replicative complexes. We propose that GCN5 acts as a positive regulator of DNA replication by counteracting the inhibitory effect of Histone Deacetylases.	[Espinosa, Maria Claudia; Rehman, Muhammad Attiq; Chisamore-Robert, Patricia; Jeffery, Daniel; Yankulov, Krassimir] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Espinosa, MC (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	yankulov@uoguelph.ca	Jeffery, Daniel/GVS-0791-2022; Rehman, Muhammad/L-1283-2019	Rehman, Muhammad/0000-0002-2062-1969; Yankulov, Krassimir/0000-0001-9440-9234	Natural Sciences and Engineering Research Council (NSERC) [043230]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding: This study was supported by a grant from Natural Sciences and Engineering Research Council (NSERC) (043230) to KY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Avvakumov N, 2007, ONCOGENE, V26, P5395, DOI 10.1038/sj.onc.1210608; Baker SP, 2007, ONCOGENE, V26, P5329, DOI 10.1038/sj.onc.1210603; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carrozza MJ, 2003, TRENDS GENET, V19, P321, DOI 10.1016/S0168-9525(03)00115-X; Clarke AS, 2006, MOL BIOL CELL, V17, P1744, DOI 10.1091/mbc.E05-07-0613; Crampton A, 2008, MOL CELL, V30, P156, DOI 10.1016/j.molcel.2008.02.019; Dillin A, 1997, GENETICS, V147, P1053; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dziak R, 2003, J BIOL CHEM, V278, P27372, DOI 10.1074/jbc.M301110200; EHRENHOFERMURRAY AE, 1995, SCIENCE, V270, P1671, DOI 10.1126/science.270.5242.1671; Gauthier L, 2002, GENETICS, V162, P1117; Gregory PD, 1999, METH MOL B, V119, P417; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; HARPER JW, 1993, CELL, V75, P805; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r46; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Iizuka M, 2008, MOL CELL BIOL, V28, P140, DOI 10.1128/MCB.00662-07; Irlbacher H, 2005, GENE DEV, V19, P1811, DOI 10.1101/gad.334805; Jacobson S, 2004, MOL CELL BIOL, V24, P6029, DOI 10.1128/MCB.24.13.6029-6039.2004; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Knott SRV, 2009, EPIGENETICS-US, V4, P262; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Kramer DJH, 2002, BIOTECHNIQUES, V32, P1036; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Li R, 1998, MOL CELL BIOL, V18, P1296, DOI 10.1128/MCB.18.3.1296; MAINE GT, 1984, GENETICS, V106, P365; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Paolinelli R, 2009, NAT STRUCT MOL BIOL, V16, P412, DOI 10.1038/nsmb.1583; Pappas DL, 2004, GENE DEV, V18, P769, DOI 10.1101/gad.1173204; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rehman MA, 2006, GENETICS, V174, P1801, DOI 10.1534/genetics.106.063446; Rehman MA, 2009, MOL BIOL CELL, V20, P631, DOI 10.1091/mbc.E08-01-0099; Reid JL, 2004, MOL CELL BIOL, V24, P757, DOI 10.1128/MCB.24.2.757-764.2004; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Suter B, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-38; Tye BK, 1999, METHODS, V18, P329, DOI 10.1006/meth.1999.0793; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; Vernarecci S, 2008, MOL CELL BIOL, V28, P988, DOI 10.1128/MCB.01366-07; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Wu ZQ, 2008, P NATL ACAD SCI USA, V105, P1919, DOI 10.1073/pnas.0712063105; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zou YF, 2008, NUCLEIC ACIDS RES, V36, P5189, DOI 10.1093/nar/gkn465	53	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8964	10.1371/journal.pone.0008964	http://dx.doi.org/10.1371/journal.pone.0008964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126453	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100012
J	Medina-Navarro, R; Duran-Reyes, G; Diaz-Flores, M; Vilar-Rojas, C				Medina-Navarro, Rafael; Duran-Reyes, Genoveva; Diaz-Flores, Margarita; Vilar-Rojas, Cecilia			Protein Antioxidant Response to the Stress and the Relationship between Molecular Structure and Antioxidant Function	PLOS ONE			English	Article							HUMAN-SERUM-ALBUMIN; HUMAN-BLOOD PLASMA; METHIONINE RESIDUES; OXIDATIVE STRESS; SULFENIC ACIDS; LUNG-CANCER; CAPACITY; SYSTEMS; PEROXIDATION; BILIRUBIN	Background: Proteins have long been considered a principal target for oxidants as a result of their abundance in biological systems. However, there is increasing evidence about the significant antioxidant activity in proteins such as albumin. It is leading to new concepts that even consider albumin not only as an antioxidant but as the major antioxidant in plasma known to be exposed to continuous oxidative stress. Evidence presented here establishes a previously unrecognized relationship between proteins' antioxidant capacity and structural stress. Methodology/Principal Findings: A chemiluminiscence based antioxidant assay was achieved to quantify the antioxidant capacity of albumin and other proteins. The capabilities of proteins as antioxidants were presented, but in addition a new and powerful component of the protein antioxidant capacity was discovered. The intrinsic component, designated as Response Surplus (RS), represents a silent reserve of antioxidant power that awakens when proteins face a structural perturbation (stressor) such as temperature, short wave UV light, the same reactive oxygen species, and more extreme changes like glucose or aldehyde-mediated structural modifications. The work also highlights the importance of structural changes in protein antioxidant properties and the participation of sulfhydryl groups (SHs) in the RS antioxidant component. Based on recent evidence about the SH group chemistry, a possible model for explaining RS is proposed. Conclusions/Significance: The data presented show the significant antioxidant behavior of proteins and demonstrate the existence of a previously unrecognized antioxidant response to the stress. Several implications, including changes in elementary concepts about antioxidants and protein function, should emerge from here.	[Medina-Navarro, Rafael] Ctr Biomed Res Michoacan CIBIMI IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico; [Duran-Reyes, Genoveva; Diaz-Flores, Margarita; Vilar-Rojas, Cecilia] IMSS, Biochem Med Res Unit, Natl Med Ctr, Mexico City, DF, Mexico	Instituto Mexicano del Seguro Social	Medina-Navarro, R (corresponding author), Ctr Biomed Res Michoacan CIBIMI IMSS, Dept Expt Metab, Morelia, Michoacan, Mexico.	rafael.medina@imss.gob.mx		DIAZ-FLORES, MARGARITA/0000-0001-9764-2701; Medina-Navarro, Rafael/0000-0002-7183-6126	RMN; Fundacion Mexicana para la Salud	RMN; Fundacion Mexicana para la Salud	Funding: The work was financially supported partially by the funds derived from a prize won by RMN; Fundacion Mexicana para la Salud (FUNSALUD PRIZE MEXICO 1999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aejmelaeus RT, 1997, FREE RADICAL BIO MED, V23, P69, DOI 10.1016/S0891-5849(96)00591-6; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Bourdon E, 1999, FASEB J, V13, P233, DOI 10.1096/fasebj.13.2.233; Bourdon E, 2005, FREE RADICAL RES, V39, P15, DOI 10.1080/10715760400024935; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREMS DN, 1991, J BIOL CHEM, V266, P1611; Carballal S, 2003, BIOCHEMISTRY-US, V42, P9906, DOI 10.1021/bi027434m; Ceriello A, 1997, DIABETES CARE, V20, P194, DOI 10.2337/diacare.20.2.194; ENGELHARD M, 1995, PROTEIN SCI, V4, P1553, DOI 10.1002/pro.5560040813; Erhola M, 1996, FREE RADICAL BIO MED, V21, P383, DOI 10.1016/0891-5849(96)00041-X; Erhola M, 1998, J EXP CLIN CANC RES, V17, P325; Faure P, 2005, DIABETES METAB, V31, P169, DOI 10.1016/S1262-3636(07)70183-0; Faure P, 2008, CLIN SCI, V114, P251, DOI 10.1042/CS20070276; GUTTERIDGE JMC, 1986, BIOCHIM BIOPHYS ACTA, V869, P119, DOI 10.1016/0167-4838(86)90286-4; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; HALLIWELL B, 1995, FREE RADICAL BIO MED, V18, P125, DOI 10.1016/0891-5849(95)91457-3; HALLIWELL B, 2003, FREE RADICAL BIO MED, P166; Halliwell B., 2007, FREE RADICALS BIOL M; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; JACOBSEN C, 1978, BIOCHEM J, V171, P453, DOI 10.1042/bj1710453; JOCELYN PC, 1987, METHOD ENZYMOL, V143, P44; KALYANARAMAN B, 1985, J BIOL CHEM, V260, P4003; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Medina-Navarro R, 2007, CHEM RES TOXICOL, V20, P1477, DOI 10.1021/tx7001355; MORENO SNJ, 1988, ARCH BIOCHEM BIOPHYS, V265, P267, DOI 10.1016/0003-9861(88)90127-0; NEUZIL J, 1994, J BIOL CHEM, V269, P16712; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Rezaei-Tavirani M, 2006, J BIOCHEM MOL BIOL, V39, P530, DOI 10.5483/BMBRep.2006.39.5.530; Satoh K, 1997, ANTICANCER RES, V17, P4377; SORIANI M, 1994, ARCH BIOCHEM BIOPHYS, V312, P180, DOI 10.1006/abbi.1994.1297; THOMAS JA, 1995, ARCH BIOCHEM BIOPHYS, V319, P1, DOI 10.1006/abbi.1995.1261; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Vaidya V, 2009, ANGEW CHEM INT EDIT, V48, P157, DOI 10.1002/anie.200804560; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; WETZEL R, 1980, EUR J BIOCHEM, V104, P469, DOI 10.1111/j.1432-1033.1980.tb04449.x; WHITEHEAD TP, 1992, ANAL CHIM ACTA, V266, P265, DOI 10.1016/0003-2670(92)85052-8	41	30	31	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8971	10.1371/journal.pone.0008971	http://dx.doi.org/10.1371/journal.pone.0008971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126468	Green Submitted, Green Published, gold			2022-12-27	WOS:000274139100019
J	Mouro-Chanteloup, I; Cochet, S; Chami, M; Genetet, S; Zidi-Yahiaoui, N; Engel, A; Colin, Y; Bertrand, O; Ripoche, P				Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Chami, Mohamed; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Engel, Andreas; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre			Functional Reconstitution into Liposomes of Purified Human RhCG Ammonia Channel	PLOS ONE			English	Article							RED-BLOOD-CELLS; NITROSOMONAS-EUROPAEA; TRANSPORT; PROTEINS; GLYCOPROTEIN; EXPRESSION; MEMBRANE; KIDNEY; WATER; RHBG	Background: Rh glycoproteins (RhAG, RhBG, RhCG) are members of the Amt/Mep/Rh family which facilitate movement of ammonium across plasma membranes. Changes in ammonium transport activity following expression of Rh glycoproteins have been described in different heterologous systems such as yeasts, oocytes and eukaryotic cell lines. However, in these complex systems, a potential contribution of endogenous proteins to this function cannot be excluded. To demonstrate that Rh glycoproteins by themselves transport NH(3), human RhCG was purified to homogeneity and reconstituted into liposomes, giving new insights into its channel functional properties. Methodology/Principal Findings: An HA-tag introduced in the second extracellular loop of RhCG was used to purify to homogeneity the HA-tagged RhCG glycoprotein from detergent-solubilized recombinant HEK293E cells. Electron microscopy analysis of negatively stained purified RhCG-HA revealed, after image processing, homogeneous particles of 9 nm diameter with a trimeric protein structure. Reconstitution was performed with sphingomyelin, phosphatidylcholine and phosphatidic acid lipids in the presence of the C(12)E(8) detergent which was subsequently removed by Biobeads. Control of protein incorporation was carried out by freeze-fracture electron microscopy. Particle density in liposomes was a function of the Lipid/Protein ratio. When compared to empty liposomes, ammonium permeability was increased two and three fold in RhCG-proteoliposomes, depending on the Lipid/Protein ratio (1/300 and 1/150, respectively). This strong NH(3) transport was reversibly inhibited by mercuric and copper salts and exhibited a low Arrhenius activation energy. Conclusions/Significance: This study allowed the determination of ammonia permeability per RhCG monomer, showing that the apparent Punit(NH3) (around 1 x 10(-3) mu m(3).s(-1)) is close to the permeability measured in HEK293E cells expressing a recombinant human RhCG (1.60 x 10(-3) mu m(3).s(-1)), and in human red blood cells endogenously expressing RhAG (2.18 x 10(-3) mu m(3).s(-1)). The major finding of this study is that RhCG protein is active as an NH(3) channel and that this function does not require any protein partner.	[Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] INSERM, UMR S 665, Paris, France; [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Univ Paris Diderot Paris 7, Paris, France; [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Chami, Mohamed; Engel, Andreas] Univ Basel, Biozentrum, E Muller Inst Struct Biol, Ctr Imaging & Nanoanalyt,C CINA, Basel, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Basel	Mouro-Chanteloup, I (corresponding author), INSERM, UMR S 665, Paris, France.	isabelle.mouro-chanteloup@inserm.fr	colin, yves/O-1910-2017; Isabelle, Mouro-Chanteloup/M-9750-2018	colin, yves/0000-0001-5196-4254; Isabelle, Mouro-Chanteloup/0000-0002-6368-9904; GENETET, Sandrine/0000-0001-8497-0087	Institut National de la Transfusion Sanguine, Paris; INSERM, Paris; Societe Francaise d'Hematologie; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale	Institut National de la Transfusion Sanguine, Paris; INSERM, Paris(Institut National de la Sante et de la Recherche Medicale (Inserm)); Societe Francaise d'Hematologie; Societe Francaise de Nephrologie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Transfusion Sanguine, Paris and INSERM, Paris. N.Z.-Y. acknowledges the financial support of the Societe Francaise d'Hematologie, of the Societe Francaise de Nephrologie and of the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200; Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y; Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518; Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P143; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D; Han KH, 2009, AM J PHYSIOL-LUNG C, V297, pL153, DOI 10.1152/ajplung.90524.2008; HODAK M, 2009, P NATL ACAD SCI US; Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102; Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369; Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002; Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55; Rigaud JL, 2003, METHOD ENZYMOL, V372, P65; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Stewart GS, 2006, AM J PHYSIOL-RENAL, V290, pF1437, DOI 10.1152/ajprenal.00449.2005; VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707; VERKMAN AS, 1989, AM J PHYSIOL, V257, pC837, DOI 10.1152/ajpcell.1989.257.5.C837; Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002; Weidinger K, 2007, FEMS MICROBIOL LETT, V273, P260, DOI 10.1111/j.1574-6968.2007.00805.x; Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215; Weiner ID, 2006, TRANSFUS CLIN BIOL, V13, P159, DOI 10.1016/j.tracli.2006.02.002; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101; Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657; ZIDIYAHIAOUI N, 2009, AM J PHYSL CELL PHYS	43	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8921	10.1371/journal.pone.0008921	http://dx.doi.org/10.1371/journal.pone.0008921			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126667	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000004
J	Tasseff, R; Nayak, S; Salim, S; Kaushik, P; Rizvi, N; Varner, JD				Tasseff, Ryan; Nayak, Satyaprakash; Salim, Saniya; Kaushik, Poorvi; Rizvi, Noreen; Varner, Jeffrey D.			Analysis of the Molecular Networks in Androgen Dependent and Independent Prostate Cancer Revealed Fragile and Robust Subsystems	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-TYROSINE-PHOSPHATASE; ACID-PHOSPHATASE; FACTOR RECEPTOR; MAP KINASE; SENSITIVITY-ANALYSIS; CELL-PROLIFERATION; SIGNALING PATHWAYS; SYSTEMS BIOLOGY; PHASE-II	Androgen ablation therapy is currently the primary treatment for metastatic prostate cancer. Unfortunately, in nearly all cases, androgen ablation fails to permanently arrest cancer progression. As androgens like testosterone are withdrawn, prostate cancer cells lose their androgen sensitivity and begin to proliferate without hormone growth factors. In this study, we constructed and analyzed a mathematical model of the integration between hormone growth factor signaling, androgen receptor activation, and the expression of cyclin D and Prostate-Specific Antigen in human LNCaP prostate adenocarcinoma cells. The objective of the study was to investigate which signaling systems were important in the loss of androgen dependence. The model was formulated as a set of ordinary differential equations which described 212 species and 384 interactions, including both the mRNA and protein levels for key species. An ensemble approach was chosen to constrain model parameters and to estimate the impact of parametric uncertainty on model predictions. Model parameters were identified using 14 steady-state and dynamic LNCaP data sets taken from literature sources. Alterations in the rate of Prostatic Acid Phosphatase expression was sufficient to capture varying levels of androgen dependence. Analysis of the model provided insight into the importance of network components as a function of androgen dependence. The importance of androgen receptor availability and the MAPK/Akt signaling axes was independent of androgen status. Interestingly, androgen receptor availability was important even in androgen-independent LNCaP cells. Translation became progressively more important in androgen-independent LNCaP cells. Further analysis suggested a positive synergy between the MAPK and Akt signaling axes and the translation of key proliferative markers like cyclin D in androgen-independent cells. Taken together, the results support the targeting of both the Akt and MAPK pathways. Moreover, the analysis suggested that direct targeting of the translational machinery, specifically eIF4E, could be efficacious in androgen-independent prostate cancers.	[Tasseff, Ryan; Nayak, Satyaprakash; Kaushik, Poorvi; Rizvi, Noreen; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA; [Salim, Saniya] Cornell Univ, Sch Biomed Engn, Ithaca, NY USA	Cornell University; Cornell University	Tasseff, R (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	jdv27@cornell.edu			Office of Naval Research [N000140610293]; SN; National Science Foundation	Office of Naval Research(Office of Naval Research); SN; National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the generous financial support of the Office of Naval Research(#N000140610293) to JDV, the support of SN, and the gracious financial support of RT by a National Science Foundation IGERT Nonlinear Systems Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020; Asthagiri AR, 2001, BIOTECHNOL PROGR, V17, P227, DOI 10.1021/bp010009k; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bandara S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000558; Barnes-Ellerbe S, 2004, MOL PHARMACOL, V66, P502, DOI 10.1124/mol.104.000356; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Bianco R, 2003, ONCOGENE, V22, P2812, DOI 10.1038/sj.onc.1206388; Brown KS, 2004, PHYS BIOL, V1, P184, DOI 10.1088/1478-3967/1/3/006; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Canil CM, 2005, J CLIN ONCOL, V23, P455, DOI 10.1200/JCO.2005.02.129; Cardillo MR, 2003, ANTICANCER RES, V23, P3825; CARSONJURICA MA, 1990, ENDOCR REV, V11, P201, DOI 10.1210/edrv-11-2-201; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; CULIG Z, 1994, CANCER RES, V54, P5474; de Souza PL, 2009, CURR CANCER DRUG TAR, V9, P163, DOI 10.2174/156800909787581006; DICKINSON RP, 1976, J COMPUT PHYS, V21, P123, DOI 10.1016/0021-9991(76)90007-3; Eder IE, 2000, CANCER GENE THER, V7, P997, DOI 10.1038/sj.cgt.7700202; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Gadkar KG, 2005, SYSTEMS BIOL, V2, P17, DOI 10.1049/sb:20045029; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gelmann EP, 2002, J CLIN ONCOL, V20, P3001, DOI 10.1200/JCO.2002.10.018; Gennemark P, 2009, BIOINFORMATICS, V25, P780, DOI 10.1093/bioinformatics/btp050; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Helmy M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004661; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Hu YC, 2004, J BIOL CHEM, V279, P33438, DOI 10.1074/jbc.M401781200; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huggins C, 1941, CANCER RES, V1, P293; Igawa T, 2003, PROSTATE, V55, P247, DOI 10.1002/pros.10240; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kuepfer L, 2007, NAT BIOTECHNOL, V25, P1001, DOI 10.1038/nbt1330; KURIYAMA M, 1982, J NATL CANCER I, V68, P99; Lee MS, 2003, ONCOGENE, V22, P781, DOI 10.1038/sj.onc.1206066; Li H, 2009, CANCER-AM CANCER SOC, V115, P4246, DOI 10.1002/cncr.24485; LIN MF, 1988, MOL CELL BIOL, V8, P5477, DOI 10.1128/MCB.8.12.5477; Lin MF, 2000, CELL BIOL INT, V24, P681, DOI 10.1006/cbir.2000.0433; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Lukas J, 1996, MOL CELL BIOL, V16, P6917; Mayawala K, 2004, BIOPHYS J, V87, pL1, DOI 10.1529/biophysj.104.051888; MCCONNELL JD, 1955, BR J UROL, V76, P5; Meng TC, 2000, ONCOGENE, V19, P2664, DOI 10.1038/sj.onc.1203576; Meng TC, 1998, J BIOL CHEM, V273, P22096, DOI 10.1074/jbc.273.34.22096; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nayak S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002016; Nazareth LV, 1996, J BIOL CHEM, V271, P19900, DOI 10.1074/jbc.271.33.19900; Palmer TN, 2005, ANNU REV EARTH PL SC, V33, P163, DOI 10.1146/annurev.earth.33.092203.122552; PAPSIDERO LD, 1980, CANCER RES, V40, P2428; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RIEGMAN PHJ, 1991, MOL ENDOCRINOL, V5, P1921, DOI 10.1210/mend-5-12-1921; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; SAKAI H, 1991, PROSTATE, V19, P265, DOI 10.1002/pros.2990190307; Sampson ER, 2001, J BIOL REG HOMEOS AG, V15, P123; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Selvarajoo Kumar, 2009, Journal of Bioinformatics and Computational Biology, V7, P243, DOI 10.1142/S0219720009003947; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; SINHA AA, 1988, PROSTATE, V13, P1, DOI 10.1002/pros.2990130102; Song SO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006758; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Stites EC, 2007, SCIENCE, V318, P463, DOI 10.1126/science.1144642; Tam L, 2007, BRIT J CANCER, V97, P378, DOI 10.1038/sj.bjc.6603871; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Veeramani S, 2005, ENDOCR-RELAT CANCER, V12, P805, DOI 10.1677/erc.1.00950; VIHKO P, 1979, INVEST UROL, V16, P349; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wilkinson MG, 2000, FASEB J, V14, P2147, DOI 10.1096/fj.00-0102rev; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yeh SY, 1999, P NATL ACAD SCI USA, V96, P5458, DOI 10.1073/pnas.96.10.5458; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Ziada A, 2004, PROSTATE, V60, P332, DOI 10.1002/pros.20065; 2006, CLIN CANC RES, V12, P2730; NAT BIOTECHNOL, V20, P370; CANC RES, V66, P11389	85	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8864	10.1371/journal.pone.0008864	http://dx.doi.org/10.1371/journal.pone.0008864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126616	Green Submitted, gold, Green Published			2022-12-27	WOS:000274138000003
J	Samhouri, JF; Levin, PS; Ainsworth, CH				Samhouri, Jameal F.; Levin, Phillip S.; Ainsworth, Cameron H.			Identifying Thresholds for Ecosystem-Based Management	PLOS ONE			English	Article							FOOD-WEB MODELS; ECOLOGICAL INDICATORS; MARINE ECOSYSTEMS; REGIME SHIFTS; FISHERIES; RESILIENCE; STABILITY; BIODIVERSITY; COMPLEXITY; FRAMEWORK	Background: One of the greatest obstacles to moving ecosystem-based management (EBM) from concept to practice is the lack of a systematic approach to defining ecosystem-level decision criteria, or reference points that trigger management action. Methodology/Principal Findings: To assist resource managers and policymakers in developing EBM decision criteria, we introduce a quantitative, transferable method for identifying utility thresholds. A utility threshold is the level of human-induced pressure (e. g., pollution) at which small changes produce substantial improvements toward the EBM goal of protecting an ecosystem's structural (e. g., diversity) and functional (e. g., resilience) attributes. The analytical approach is based on the detection of nonlinearities in relationships between ecosystem attributes and pressures. We illustrate the method with a hypothetical case study of (1) fishing and (2) nearshore habitat pressure using an empirically-validated marine ecosystem model for British Columbia, Canada, and derive numerical threshold values in terms of the density of two empirically-tractable indicator groups, sablefish and jellyfish. We also describe how to incorporate uncertainty into the estimation of utility thresholds and highlight their value in the context of understanding EBM trade-offs. Conclusions/Significance: For any policy scenario, an understanding of utility thresholds provides insight into the amount and type of management intervention required to make significant progress toward improved ecosystem structure and function. The approach outlined in this paper can be applied in the context of single or multiple human-induced pressures, to any marine, freshwater, or terrestrial ecosystem, and should facilitate more effective management.	[Samhouri, Jameal F.] Pacific States Marine Fisheries Commiss, Portland, OR USA; [Levin, Phillip S.] Natl Ocean & Atmospher Adm, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA USA; [Ainsworth, Cameron H.] Marine Resources Assessment Grp Amer Inc, St Petersburg, FL USA	National Oceanic Atmospheric Admin (NOAA) - USA	Samhouri, JF (corresponding author), Pacific States Marine Fisheries Commiss, Portland, OR USA.	Jameal.Samhouri@noaa.gov	Ainsworth, Cameron/E-8507-2011		NOAA Fisheries (Northwest Fisheries Science Center)	NOAA Fisheries (Northwest Fisheries Science Center)(National Oceanic Atmospheric Admin (NOAA) - USA)	This research was supported by NOAA Fisheries (Northwest Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, ECOL MODEL, V216, P354, DOI 10.1016/j.ecolmodel.2008.05.005; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B. M., 2008, BBMLE TOOLS GEN MAXI; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carwardine J, 2009, CONSERV LETT, V2, P3, DOI 10.1111/j.1755-263X.2008.00042.x; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Christensen V., 2005, ECOPATH ECOSIM USERS; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; DeLuca WV, 2008, BIOL CONSERV, V141, P2669, DOI 10.1016/j.biocon.2008.07.023; Field JC, 2006, PROG OCEANOGR, V68, P238, DOI 10.1016/j.pocean.2006.02.010; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Framstad E, 1997, P ROY SOC B-BIOL SCI, V264, P31, DOI 10.1098/rspb.1997.0005; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2003, MAR ECOL PROG SER, V253, P1, DOI 10.3354/meps253001; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P573, DOI 10.1016/j.icesjms.2005.12.009; Groffman PM, 2006, ECOSYSTEMS, V9, P1289, DOI 10.1007/s10021-006-0177-z; GRUMBINE RE, 1994, CONSERV BIOL, V8, P27, DOI 10.1046/j.1523-1739.1994.08010027.x; HAIST V, 2001, CANADIAN STOCK ASSES, V135, P1; Hunter ML, 2009, CONSERV BIOL, V23, P1053, DOI 10.1111/j.1523-1739.2009.01205.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 2005, FISH FISH, V6, P212, DOI 10.1111/j.1467-2979.2005.00189.x; Leslie HM, 2007, FRONT ECOL ENVIRON, V5, P540, DOI 10.1890/060093; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Link JS, 2005, ICES J MAR SCI, V62, P569, DOI 10.1016/j.icesjms.2004.12.015; Link JS, 2002, CAN J FISH AQUAT SCI, V59, P1429, DOI 10.1139/F02-115; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Martin J, 2009, ECOL APPL, V19, P1079, DOI 10.1890/08-0255.1; McLeod K.L., 2005, SCI CONSENSUS STATEM; Methratta ET, 2006, ECOL INDIC, V6, P575, DOI 10.1016/j.ecolind.2005.08.022; Morissette L, 2009, PROG OCEANOGR, V81, P174, DOI 10.1016/j.pocean.2009.04.013; Morris W. F., 2002, QUANTITATIVE CONSERV; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pirrone N, 2005, REG ENVIRON CHANGE, V5, P111, DOI 10.1007/s10113-004-0092-9; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; R Core Team, 2020, R LANG ENV STAT COMP; Rice JC, 2005, ICES J MAR SCI, V62, P516, DOI 10.1016/j.icesjms.2005.01.003; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Samhouri JF, 2009, ECOSYSTEMS, V12, P1283, DOI 10.1007/s10021-009-9286-9; Samhouri JF, 2009, OECOLOGIA, V160, P257, DOI 10.1007/s00442-009-1307-z; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2000, ECOSYSTEMS, V3, P451, DOI 10.1007/s100210000040; SCHINDLER DW, 1974, SCIENCE, V184, P897, DOI 10.1126/science.184.4139.897; Shannon LJ, 2009, ECOL INDIC, V9, P1078, DOI 10.1016/j.ecolind.2008.12.007; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Suter II G.W., 2007, ECOLOGICAL RISK ASSE; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Vasconcellos M, 1997, ECOL MODEL, V100, P125, DOI 10.1016/S0304-3800(97)00150-6; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Walters C, 2001, CAN J FISH AQUAT SCI, V58, P39, DOI 10.1139/cjfas-58-1-39; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Weible C, 2004, POLICY STUD J, V32, P187, DOI 10.1111/j.1541-0072.2004.00060.x	63	123	125	0	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8907	10.1371/journal.pone.0008907	http://dx.doi.org/10.1371/journal.pone.0008907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126647	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896500025
J	Holland, JP; Caldas-Lopes, E; Divilov, V; Longo, VA; Taldone, T; Zatorska, D; Chiosis, G; Lewis, JS				Holland, Jason P.; Caldas-Lopes, Eloisi; Divilov, Vadim; Longo, Valerie A.; Taldone, Tony; Zatorska, Danuta; Chiosis, Gabriela; Lewis, Jason S.			Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using Zr-89-DFO-Trastuzumab	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EMITTING RADIOTHERAPEUTIC AGENT; BREAST-CANCER XENOGRAFTS; ZR-89 IMMUNO-PET; MONOCLONAL-ANTIBODIES; BIODISTRIBUTION; DOSIMETRY; PERFORMANCE; MICROPET; THERAPY	Background: The positron-emitting radionuclide Zr-89 (t(1/2) = 3.17 days) was used to prepare Zr-89-radiolabeled trastuzumab for use as a radiotracer for characterizing HER2/neu-positive breast tumors. In addition, pharmacodynamic studies on HER2/neu expression levels in response to therapeutic doses of PU-H71 (a specific inhibitor of heat-shock protein 90 [Hsp90]) were conducted. Methodology/Principal Findings: Trastuzumab was functionalized with desferrioxamine B (DFO) and radiolabeled with [Zr-89] Zr-oxalate at room temperature using modified literature methods. ImmunoPET and biodistribution experiments in female, athymic nu/nu mice bearing sub-cutaneous BT-474 (HER2/neu positive) and/or MDA-MB-468 (HER2/neu negative) tumor xenografts were conducted. The change in Zr-89-DFO-trastuzumab tissue uptake in response to high-and low-specific-activity formulations and co-administration of PU-H71 was evaluated by biodistribution studies, Western blot analysis and immunoPET. Zr-89-DFO-trastuzumab radiolabeling proceeded in high radiochemical yield and specific-activity 104.3+/-2.1 MBq/mg (2.82+/-0.05 mCi/mg of mAb). In vitro assays demonstrated >99% radiochemical purity with an immunoreactive fraction of 0.87+/-0.07. In vivo biodistribution experiments revealed high specific BT-474 uptake after 24, 48 and 72 h (64.68+/-13.06% ID/g; 71.71+/-10.35% ID/g and 85.18+/-11.10% ID/g, respectively) with retention of activity for over 120 h. Pre-treatment with PU-H71 was followed by biodistribution studies and immunoPET of Zr-89-DFO-trastuzumab. Expression levels of HER2/neu were modulated during the first 24 and 48 h post-administration (29.75+/-4.43% ID/g and 41.42+/-3.64% ID/g, respectively). By 72 h radiotracer uptake (73.64+/-12.17% ID/g) and Western blot analysis demonstrated that HER2/neu expression recovered to baseline levels. Conclusions/Significance: The results indicate that Zr-89-DFO-trastuzumab provides quantitative and highly-specific delineation of HER2/neu positive tumors, and has potential to be used to measure the efficacy of long-term treatment with Hsp90 inhibitors, like PU-H71, which display extended pharmacodynamic profiles.	[Holland, Jason P.; Divilov, Vadim; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY USA; [Caldas-Lopes, Eloisi; Taldone, Tony; Zatorska, Danuta; Chiosis, Gabriela; Lewis, Jason S.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Longo, Valerie A.] Mem Sloan Kettering Canc Ctr, Small Anim Imaging Core Facil, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiol, Radiochem Serv, New York, NY USA.	lewisj2@mskcc.org	Holland, Jason P./AAO-5718-2020	Holland, Jason P./0000-0002-0066-219X; Lewis, Jason/0000-0001-7065-4534	Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center; Office of Science (BER), U.S. Department of Energy [DE-SC0002456]; U.S. Department of Defense Breast Cancer Research Program [BC085588]; Susan G. Komen for the Cure [KG091313]; National Institutes of Health (NIH) [R24-CA83084, P50-CA086438, P30-CA08748]; NATIONAL CANCER INSTITUTE [P50CA086438, P30CA008748, R01CA172546, R24CA083084] Funding Source: NIH RePORTER	Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center; Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Defense Breast Cancer Research Program(United States Department of Defense); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Geoffrey Beene Cancer Research Center of Memorial Sloan-Kettering Cancer Center (JSL), the Office of Science (BER), U.S. Department of Energy (Award DE-SC0002456, JSL), the U.S. Department of Defense Breast Cancer Research Program (BC085588, GC) and the Susan G. Komen for the Cure (Postdoctoral Fellowship, KG091313, TT). Technical services provided by the MSKCC Small-Animal Imaging Core Facility were supported in part by National Institutes of Health (NIH) grants R24-CA83084, P50-CA086438 and P30-CA08748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2009, J NUCL MED, V50, P123, DOI 10.2967/jnumed.108.054312; ANDERSON CJ, 1995, J NUCL MED, V36, P850; ANDERSON CJ, 1992, J NUCL MED, V33, P1685; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; BAUGHMAN SA, Patent No. 6627196; Beliakoff J, 2004, ANTI-CANCER DRUG, V15, P651, DOI 10.1097/01.cad.0000136876.11928.be; Borjesson PKE, 2009, J NUCL MED, V50, P1828, DOI 10.2967/jnumed.109.065862; Borjesson PKE, 2006, CLIN CANCER RES, V12, P2133, DOI 10.1158/1078-0432.CCR-05-2137; Boswell CA, 2007, NUCL MED BIOL, V34, P757, DOI 10.1016/j.nucmedbio.2007.04.001; Brouwers A, 2004, CANCER BIOTHER RADIO, V19, P155, DOI 10.1089/108497804323071922; Caldas-Lopes E, 2009, P NATL ACAD SCI USA, V106, P8368, DOI 10.1073/pnas.0903392106; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Citri A, 2004, CELL CYCLE, V3, P51; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Costantini DL, 2008, J NUCL MED, V49, P1498, DOI 10.2967/jnumed.108.051771; Dijkers ECF, 2009, J NUCL MED, V50, P974, DOI 10.2967/jnumed.108.060392; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Garmestani K, 2002, NUCL MED BIOL, V29, P599, DOI 10.1016/S0969-8051(02)00322-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland JP, 2009, NUCL MED BIOL, V36, P729, DOI 10.1016/j.nucmedbio.2009.05.007; Hynes N., 2005, NAT REV CANCER, V5, P580; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Kim JS, 2007, J NUCL MED, V48, P1527, DOI 10.2967/jnumed.107.040550; Kramer-Marek G, 2009, J NUCL MED, V50, P1131, DOI 10.2967/jnumed.108.057695; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Meijs WE, 1996, NUCL MED BIOL, V23, P439, DOI 10.1016/0969-8051(96)00020-0; MEIJS WE, 1994, APPL RADIAT ISOTOPES, V45, P1143, DOI 10.1016/0969-8043(94)90029-9; MEIJS WE, 1992, APPL RADIAT ISOTOPES, V43, P1443, DOI 10.1016/0883-2889(92)90170-J; Meijs WE, 1997, J NUCL MED, V38, P112; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Nayak TK, 2009, BIOCONJUGATE CHEM, V20, P825, DOI 10.1021/bc800299f; Niu G., 2009, EUR J NUCL MED MOL I; Orlova A, 2009, J NUCL MED, V50, P417, DOI 10.2967/jnumed.108.057919; Palm S, 2003, J NUCL MED, V44, P1148; Perik PJ, 2006, J CLIN ONCOL, V24, P2276, DOI 10.1200/JCO.2005.03.8448; Perk LR, 2008, EUR J NUCL MED MOL I, V35, P1857, DOI 10.1007/s00259-008-0774-5; Perk LR, 2006, EUR J NUCL MED MOL I, V33, P1337, DOI 10.1007/s00259-006-0160-0; Perk LR, 2005, J NUCL MED, V46, P1898; PERK LR, 2008, NATURE PROTOCOLS; Reilly RM, 2006, J NUCL MED, V47, P1023; Smith-Jones PM, 2006, J NUCL MED, V47, P793; Smith-Jones PM, 2004, NAT BIOTECHNOL, V22, P701, DOI 10.1038/nbt968; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; Taldone T, 2009, BIOORGAN MED CHEM, V17, P2225, DOI 10.1016/j.bmc.2008.10.087; Tang Y, 2005, NUCL MED BIOL, V32, P51, DOI 10.1016/j.nucmedbio.2004.08.003; Verel I, 2005, J NUCL MED, V46, p164S; Verel I, 2004, EUR J NUCL MED MOL I, V31, P1645, DOI 10.1007/s00259-004-1632-8; Verel I, 2003, CANCER BIOTHER RADIO, V18, P655, DOI 10.1089/108497803322287745; Verel I, 2003, J NUCL MED, V44, P1663; Verel I, 2003, J NUCL MED, V44, P1271; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu AM, 2008, CANCER J, V14, P191, DOI 10.1097/PPO.0b013e31817b07ae; Wu AM, 2009, J NUCL MED, V50, P2, DOI 10.2967/jnumed.108.056887; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanzonico P, 2008, J NUCL MED, V49, P1114, DOI 10.2967/jnumed.107.050203	58	112	116	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8859	10.1371/journal.pone.0008859	http://dx.doi.org/10.1371/journal.pone.0008859			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111600	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896300011
J	Simunovic, F; Yi, M; Wang, YL; Stephens, R; Sonntag, KC				Simunovic, Filip; Yi, Ming; Wang, Yulei; Stephens, Robert; Sonntag, Kai C.			Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease	PLOS ONE			English	Article							GENE-EXPRESSION; BIOLOGICAL THEMES; AFRICAN-AMERICAN; ALPHA-SYNUCLEIN; PHENOTYPE; PROTEIN; GENOME; MECHANISMS; CANCER; ASSOCIATION	Background: Epidemiological data suggest that the male gender is one of the risks factors for the development of Parkinson Disease (PD). Also, differences in the clinical manifestation and the course of PD have been observed between males and females. However, little is known about the molecular aspects underlying gender-specificity in PD. To address this issue, we determined the gene expression profiles of male and female dopamine (DA) neurons in sporadic PD. Methodology/Principal Findings: We analyzed Affymetrix-based microarrays on laser microdissected DA neurons from postmortem brains of sporadic PD patients and age-matched controls across genders. Pathway enrichment demonstrated that major cellular pathways involved in PD pathogenesis showed different patterns of deregulation between males and females with more prominent downregulation of genes related to oxidative phosporylation, apoptosis, synaptic transmission and transmission of nerve impulse in the male population. In addition, we found upregulation of gene products for metabolic processes and mitochondrial energy consumption in the age-matched male control neurons. On the single cell level, selected data validation using quantitative Real-Time (qRT)-PCR was consistent with microarray raw data and supported some of the observations from data analysis. Conclusions/Significance: On the molecular level, our results provide evidence that the expression profiles of aged normal and PD midbrain DA neurons are gender-specific. The observed differences in the expression profiles suggest a disease bias of the male gender, which could be in concordance with clinical observations that the male gender represents a risk factor for sporadic PD. Validation of gene expression by qRT-PCR supported the microarray results, but also pointed to several caveats involved in data interpretation.	[Simunovic, Filip; Sonntag, Kai C.] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA; [Yi, Ming; Stephens, Robert] NCI, Bioinformat Support Grp, Adv Biomed Comp Ctr, Frederick, MD 21701 USA; [Wang, Yulei] Appl Biosyst Inc, Foster City, CA USA	Harvard University; McLean Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Thermo Fisher Scientific; Applied Biosystems	Simunovic, F (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat, Belmont, MA 02178 USA.	ksonntag@mclean.harvard.edu	Simunovic, Filip/ABE-8802-2021; Sonntag, Kai-Christian/AAU-6921-2021	Simunovic, Filip/0000-0003-1755-5734; Yi, Ming/0000-0001-9098-1364; Sonntag, Kai-Christian/0000-0001-7979-8171; Wang, Yulei/0000-0002-9057-9786	Massachusetts' Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center	Massachusetts' Alzheimer's Disease Research Center; Harvard NeuroDiscovery Center	This research was in part supported by a grant from the Massachusetts' Alzheimer's Disease Research Center and the Harvard NeuroDiscovery Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Berg D, 2006, NEUROTOX RES, V9, P1, DOI 10.1007/BF03033302; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Boll MC, 2008, NEUROCHEM RES, V33, P1717, DOI 10.1007/s11064-008-9610-3; Braak H, 2008, NEUROLOGY, V70, P1916, DOI 10.1212/01.wnl.0000312279.49272.9f; Burke RE, 2008, J NEUROCHEM, V104, P875, DOI 10.1111/j.1471-4159.2007.05106.x; Burn DJ, 2007, J NEUROL NEUROSUR PS, V78, P787, DOI 10.1136/jnnp.2006.109991; Cai ZL, 2009, NEUROREPORT, V20, P569, DOI 10.1097/WNR.0b013e32832986c4; Cantuti-Castelvetri I, 2007, NEUROBIOL DIS, V26, P606, DOI 10.1016/j.nbd.2007.02.009; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Fatima N, 2008, CANCER EPIDEM BIOMAR, V17, P3051, DOI 10.1158/1055-9965.EPI-08-0261; Foglieni B, 2007, CLIN CHEM LAB MED, V45, P1450, DOI 10.1515/CCLM.2007.307; Francis PT, 2007, MOVEMENT DISORD, V22, pS351, DOI 10.1002/mds.21683; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Goldman JG, 2004, ARCH NEUROL-CHICAGO, V61, P1280, DOI 10.1001/archneur.61.8.1280; Haaxma CA, 2007, J NEUROL NEUROSUR PS, V78, P819, DOI 10.1136/jnnp.2006.103788; Jiang HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002484; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Lyons KE, 1998, CLIN NEUROPHARMACOL, V21, P118; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; Mellick GD, 2006, J NEURAL TRANSM-SUPP, P159; Michel PP, 2007, J NEUROCHEM, V101, P289, DOI 10.1111/j.1471-4159.2006.04424.x; Miksys S, 2006, J NEURAL TRANSM-SUPP, P177; Miller TM, 2008, ARCH NEUROL-CHICAGO, V65, P447, DOI 10.1001/archneur.65.4.nnr70007; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Moran LB, 2007, ACTA NEUROPATHOL, V113, P253, DOI 10.1007/s00401-006-0181-6; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nyswaner KM, 2008, GENETICS, V178, P197, DOI 10.1534/genetics.107.082602; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Patel S, 2006, BRAIN RES, V1081, P9, DOI 10.1016/j.brainres.2006.01.060; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Quik M, 2007, BIOCHEM PHARMACOL, V74, P1224, DOI 10.1016/j.bcp.2007.06.015; Sato K, 2006, MOVEMENT DISORD, V21, P1384, DOI 10.1002/mds.20993; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001; Simunovic F, 2009, BRAIN, V132, P1795, DOI 10.1093/brain/awn323; Srinivasan BS, 2009, HUM MUTAT, V30, P228, DOI 10.1002/humu.20840; Surmeier DJ, 2007, LANCET NEUROL, V6, P933, DOI 10.1016/S1474-4422(07)70246-6; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Tan JMM, 2009, ANTIOXID REDOX SIGN, V11, P2119, DOI 10.1089/ARS.2009.2490; Taylor KSM, 2007, J NEUROL NEUROSUR PS, V78, P905, DOI 10.1136/jnnp.2006.104695; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Twelves D, 2003, MOVEMENT DISORD, V18, P19, DOI 10.1002/mds.10305; Uitti RJ, 2005, PARKINSONISM RELAT D, V11, P139, DOI 10.1016/j.parkreldis.2004.10.007; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Viaggi C, 2006, J NEURAL TRANSM-SUPP, P173; Wallace TA, 2008, CANCER RES, V68, P927, DOI 10.1158/0008-5472.CAN-07-2608; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang Y, 2008, MED HYPOTHESES, V71, P546, DOI 10.1016/j.mehy.2008.05.021; Wooten GF, 2004, J NEUROL NEUROSUR PS, V75, P637, DOI 10.1136/jnnp.2003.020982; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617; Yang YX, 2009, NEUROREPORT, V20, P150, DOI 10.1097/WNR.0b013e32831c50df; Yi M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-200; Yi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003288	66	91	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8856	10.1371/journal.pone.0008856	http://dx.doi.org/10.1371/journal.pone.0008856			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111594	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896300008
J	Cadieu, N; Fruchard, S; Cadieu, JC				Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude			Innovative Individuals Are Not Always the Best Demonstrators: Feeding Innovation and Social Transmission in Serinus canaria	PLOS ONE			English	Article							TAENIOPYGIA-GUTTATA; ZEBRA FINCHES; COMMON MARMOSETS; TOOL-USE; FOOD; CHIMPANZEES; BEHAVIOR; PREFERENCES; HENS	Background: Feeding innovation occurs when individuals choose a novel, unknown type of food and/or acquire new feeding skills. Here we studied feeding innovation and social transmission of the new feeding habit in canaries. Adult canaries eat a wide variety of seeds but avoid larger ones such as those of sunflowers. We determined whether adults of both sexes are equally prone to innovate when confronted with sunflower seeds and whether free-interactions facilitate transmission of the new feeding habit in a sex-dependent manner. Methodology/Principal Findings: First we determined which sex was more innovative, i.e., was more successful at husking and eating the novel seeds. Males were clearly more innovative than females. Due to this, experienced males served as model for either male or female observers in three different conditions (free interaction with a demonstrator, visual interaction with a demonstrator placed behind a transparent wall and access to seeds in the presence of a non-demonstrating bird). During free interactions, the new feeding habit was only transmitted to females. In contrast, transmission of seed handling to male observers only occurred if demonstrator and observer were separated by the transparent wall. Indeed, aggressive behaviors between males prevented social transmission during free interactions. Finally, we studied the influence of the less innovative females in feeding-habit transmission. First, we obtained female demonstrators by making them freely interact with male demonstrators. Once they acquired innovative responses to sunflower seeds we studied feeding-habit transmission towards male and female observers. Observers of both sexes learned during free interactions with female demonstrators. No aggressive behavior occurred. Males were also able to learn after visual interactions with the female demonstrator. Conclusions/Significance: Our results show that the most innovative individuals (males) are not always the best demonstrators, and that social relationship and sex are crucial factors for the spread of a new feeding habit among canaries. These factors determine the kind of interaction between individuals and the time spent together, thus affecting the transmission of novel habits within the population.	[Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude] Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France; [Cadieu, Nicole; Fruchard, Stephane; Cadieu, Jean-Claude] Ctr Rech Cognit Anim, CNRS, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cadieu, N (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France.	cadieu@cict.fr			French Research Council (CNRS); University Paul Sabatier (Toulouse III)	French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier (Toulouse III)	This study was supported by the French Research Council (CNRS) and the University Paul Sabatier (Toulouse III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISNER R, 1992, ANIM BEHAV, V44, P327, DOI 10.1016/0003-3472(92)90038-B; [Anonymous], 1963, ANIMAL SPECIES EVOLU; BEAUCHAMP G, 1991, ANIM BEHAV, V41, P247, DOI 10.1016/S0003-3472(05)80476-2; Benskin CMWH, 2002, ANIM BEHAV, V64, P823, DOI 10.1006/anbe.2002.2005; Biro D, 2003, ANIM COGN, V6, P213, DOI 10.1007/s10071-003-0183-x; CADIEU JC, 1995, ANIM BEHAV, V50, P793, DOI 10.1016/0003-3472(95)80139-1; Cadieu N, 2008, BEHAV ECOL SOCIOBIOL, V62, P795, DOI 10.1007/s00265-007-0505-0; Cadieu N, 2004, ANIM BEHAV, V67, P1051, DOI 10.1016/j.anbehav.2003.10.004; Caldwell CA, 2003, ANIM BEHAV, V65, P1085, DOI 10.1006/anbe.2003.2145; COLEMAN SL, 1994, ANIM BEHAV, V48, P903, DOI 10.1006/anbe.1994.1315; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; DAGNELIE GB, 1975, THEORIES METHODES ST, P241; Drent PJ, 2003, P ROY SOC B-BIOL SCI, V270, P45, DOI 10.1098/rspb.2002.2168; FISHER J., 1949, BRITISH BIRDS, V42, P347; Fragaszy Dorothy M., 1996, P65, DOI 10.1016/B978-012273965-1/50005-4; Fritz J, 1999, ANIM BEHAV, V57, P785, DOI 10.1006/anbe.1998.1035; Gajdon GK, 2006, ANIM COGN, V9, P173, DOI 10.1007/s10071-006-0018-7; Galef B.G. Jr, 1988, P3; Gandolfi G., 1973, Bollettino Zool, V40, P69; GIRALDEAU LA, 1987, ANIM BEHAV, V35, P387, DOI 10.1016/S0003-3472(87)80262-2; GOODALL J, 1973, PRECULTURAL PRIMATE, P144; Greenberg Russell, 2003, P175; Hirata S, 2003, ANIM COGN, V6, P235, DOI 10.1007/s10071-003-0187-6; Katz M, 2003, ANIM COGN, V6, P11, DOI 10.1007/s10071-003-0158-y; KEAR JANET, 1962, PROC ZOOL SOC LONDON, V138, P163; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; Kwai M., 1965, PRIMATES, V6, P1, DOI DOI 10.1007/BF01794457; Leitner S, 2003, GEN COMP ENDOCR, V130, P102, DOI 10.1016/S0016-6480(02)00574-9; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Nicol CJ, 1999, ANIM BEHAV, V57, P163, DOI 10.1006/anbe.1998.0920; Ramsey G, 2007, BEHAV BRAIN SCI, V30, P393, DOI 10.1017/S0140525X07002373; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Reader S. M., 2003, ANIMAL INNOVATION, P3, DOI DOI 10.1093/ACPROF:OSO/9780198526223.001.0001; SCHWARTZ D, 1968, METHODES STAT USAGE; Sherwin CM, 2002, ANIM BEHAV, V63, P933, DOI 10.1006/anbe.2002.2000; Thorpe, 1963, LEARNING INSTINCT AN; Voigt C., 1998, Boletim do Museu Municipal do Funchal, P117; Voigt C, 2003, J ORNITHOL, V144, P86, DOI 10.1007/BF02465520; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; [No title captured]	42	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8841	10.1371/journal.pone.0008841	http://dx.doi.org/10.1371/journal.pone.0008841			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20111590	Green Published, gold			2022-12-27	WOS:000273896100007
J	Berthelot, G; Tafflet, M; El Helou, N; Len, S; Escolano, S; Guillaume, M; Nassif, H; Tolaini, J; Thibault, V; Desgorces, FD; Hermine, O; Toussaint, JF				Berthelot, Geoffroy; Tafflet, Muriel; El Helou, Nour; Len, Stephane; Escolano, Sylvie; Guillaume, Marion; Nassif, Hala; Tolaini, Julien; Thibault, Valerie; Desgorces, Francois Denis; Hermine, Olivier; Toussaint, Jean-Francois			Athlete Atypicity on the Edge of Human Achievement: Performances Stagnate after the Last Peak, in 1988	PLOS ONE			English	Article							ERYTHROPOIETIN ABUSE; PROGRESSION; RECORDS; LIMITS	The growth law for the development of top athletes performances remains unknown in quantifiable sport events. Here we present a growth model for 41351 best performers from 70 track and field (T&F) and swimming events and detail their characteristics over the modern Olympic era. We show that 64% of T&F events no longer improved since 1993, while 47% of swimming events stagnated after 1990, prior to a second progression step starting in 2000. Since then, 100% of swimming events continued to progress. We also provide a measurement of the atypicity for the 3919 best performances (BP) of each year in every event. The secular evolution of this parameter for T& F reveals four peaks; the most recent (1988) followed by a major stagnation. This last peak may correspond to the most recent successful attempt to push forward human physiological limits. No atypicity trend is detected in swimming. The upcoming rarefaction of new records in sport may be delayed by technological innovations, themselves depending upon economical constraints.	[Berthelot, Geoffroy; Tafflet, Muriel; El Helou, Nour; Len, Stephane; Escolano, Sylvie; Guillaume, Marion; Nassif, Hala; Tolaini, Julien; Thibault, Valerie; Desgorces, Francois Denis; Toussaint, Jean-Francois] Insep, IRMES, Paris, France; [Tafflet, Muriel; Escolano, Sylvie] INSERM, U970, Paris, France; [El Helou, Nour; Nassif, Hala; Desgorces, Francois Denis; Toussaint, Jean-Francois] Paris Descartes Univ, Fac Sci, Paris, France; [Hermine, Olivier] Hop Necker Enfants Malad, Serv Hematol, Paris, France; [Hermine, Olivier] CNRS, UMR 8147, Paris, France; [Toussaint, Jean-Francois] Hop Hotel Dieu, AP HP, CIMS, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Berthelot, G (corresponding author), Insep, IRMES, Paris, France.	geoffroy.berthelot@insep.fr	Helou, Nour El/AAH-6490-2021; Hermine, Olivier/Q-7072-2018	Helou, Nour El/0000-0002-6012-0042; Berthelot, Geoffroy/0000-0003-4036-6114; Hermine, Olivier/0000-0003-2574-3874; escolano, sylvie/0000-0003-0864-4321	Centre National de Developpement du Sport; Ministry of Health and Sport	Centre National de Developpement du Sport; Ministry of Health and Sport	The authors thank the Centre National de Developpement du Sport and the Ministry of Health and Sport for financial contributions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashenden MJ, 2001, J SPORT SCI, V19, P831, DOI 10.1080/026404101753113778; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; Cardenas A, 2004, J LIGHTWAVE TECHNOL, V22, P2460, DOI 10.1109/JLT.2004.834495; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; Diamanti-Kandarakis E, 2005, SPORTS MED, V35, P831, DOI 10.2165/00007256-200535100-00001; Dilger A, 2007, CONTEMP ECON POLICY, V25, P604, DOI 10.1111/j.1465-7287.2007.00076.x; DONALD BA, 2008, NATURE, V454, P692; Einmahl JHJ, 2008, J AM STAT ASSOC, V103, P1382, DOI 10.1198/016214508000000698; El Helou N, 2009, FUND CLIN PHARMACOL, V23, P85; FOGEL R, 2003, ESCAPE PREMATURE DEA; Franke WW, 1997, CLIN CHEM, V43, P1262; Guillaume M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007573; HOLMER I, 1974, EUR J APPL PHYSIOL O, V33, P95, DOI 10.1007/BF00449511; Hood M, 2005, IEEE SPECTRUM, V42, P13, DOI 10.1109/MSPEC.2005.1436991; JARNE G, 2005, ELECT J EVOLUTIONARY, V1048, P1; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kolmogorov SV, 1997, J APPL BIOMECH, V13, P88, DOI 10.1123/jab.13.1.88; LEN S, 2008, BEIJING HUMAN PERFOR, P258; Lu A, 2008, SCIENCE, V321, P626, DOI 10.1126/science.321.5889.626a; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Michalakelis C, 2008, TELECOMMUN POLICY, V32, P234, DOI 10.1016/j.telpol.2008.01.004; Miodownik M, 2007, MATER TODAY, V10, P6, DOI 10.1016/S1369-7021(07)70262-6; Nevill AM, 2007, INT J SPORTS MED, V28, P1012, DOI 10.1055/s-2007-965088; Nevill AM, 2005, MED SCI SPORT EXER, V37, P1785, DOI 10.1249/01.mss.0000181676.62054.79; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; RABINOVICH M, 2008, TRACK FIELD STAT; RIORDAN J, 1993, J SPORT HIST, V20, P49; RIORDAN J, 1999, IMPACT COMMUNISM SPO; Rossi Sergio, 2003, Dendrochronologia, V21, P33, DOI 10.1078/1125-7865-00034; Schumacher YO, 2009, INT J SPORT PHYSIOL, V4, P129, DOI 10.1123/ijspp.4.1.129; SILBER M, 1998, PHARM SPORT SPORT PH; Thibault V, 2009, FUND CLIN PHARMACOL, V23, P88; Toussaint Huub M, 2002, Sports Biomech, V1, P1, DOI 10.1080/14763140208522783; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; Wood J, 2008, MATER TODAY, V11, P1, DOI 10.1016/S1369-7021(08)70101-9; SWIMNEWS	36	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8800	10.1371/journal.pone.0008800	http://dx.doi.org/10.1371/journal.pone.0008800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098706	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000027
J	Perry, S; de Jong, BC; Solnick, JV; Sanchez, MD; Yang, SF; Lin, PL; Hansen, LM; Talat, N; Hill, PC; Hussain, R; Adegbola, RA; Flynn, J; Canfield, D; Parsonnet, J				Perry, Sharon; de Jong, Bouke C.; Solnick, Jay V.; Sanchez, Maria de la Luz; Yang, Shufang; Lin, Philana Ling; Hansen, Lori M.; Talat, Najeeha; Hill, Philip C.; Hussain, Rabia; Adegbola, Richard A.; Flynn, JoAnne; Canfield, Don; Parsonnet, Julie			Infection with Helicobacter pylori Is Associated with Protection against Tuberculosis	PLOS ONE			English	Article							HEALTHY-YOUNG ADULTS; CYNOMOLGUS MACAQUES; ELISPOT; DISEASE; GAMBIA; ASTHMA; RISK; ACQUISITION; IMMUNOLOGY; STRATEGIES	Background: Helicobacter pylori, a lifelong and typically asymptomatic infection of the stomach, profoundly alters gastric immune responses, and may benefit the host in protection against other pathogens. We explored the hypothesis that H. pylori contributes to the control of infection with Mycobacterium tuberculosis. Methodology/Principal Findings: We first examined M. tuberculosis-specific IFN-gamma and H. pylori antibody responses in 339 healthy Northern Californians undergoing routine tuberculin skin testing. Of 97 subjects (29%) meeting criteria for latent tuberculosis (TB) infection (LTBI), 45 (46%) were H. pylori seropositive. Subjects with LTBI who were H. pylori-seropositive had 1.5-fold higher TB antigen-induced IFN-gamma responses (p = 0.04, ANOVA), and a more Th-1 like cytokine profile in peripheral blood mononuclear cells, compared to those who were H. pylori seronegative. To explore an association between H. pylori infection and clinical outcome of TB exposure, we evaluated H. pylori seroprevalence in baseline samples from two high risk TB case-contact cohorts, and from cynomolgus macaques experimentally challenged with M. tuberculosis. Compared to 513 household contacts who did not progress to active disease during a median 24 months follow-up, 120 prevalent TB cases were significantly less likely to be H. pylori infected (AOR: 0.55, 95% CI 0.0.36-0.83, p = 0.005), though seroprevalence was not significantly different from non-progressors in 37 incident TB cases (AOR: 1.35 [95% CI 0.63-2.9] p = 0.44). Cynomolgus macaques with natural H. pylori infection were significantly less likely to progress to TB 6 to 8 months after M. tuberculosis challenge (RR: 0.31 [95% CI 0.12-0.80], p = 0.04). Conclusions/Significance: H. pylori infection may induce bystander effects that modify the risk of active TB in humans and non-human primates. That immunity to TB may be enhanced by exposure to other microbial agents may have important implications for vaccine development and disease control.	[Perry, Sharon; Sanchez, Maria de la Luz; Yang, Shufang; Parsonnet, Julie] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA; [de Jong, Bouke C.; Hill, Philip C.; Adegbola, Richard A.] MRC Labs, Fajara, Gambia; [Flynn, JoAnne] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Flynn, JoAnne] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA; [Solnick, Jay V.; Hansen, Lori M.; Canfield, Don] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Med, Davis, CA 95616 USA; [Solnick, Jay V.; Hansen, Lori M.; Canfield, Don] Univ Calif Davis, Sch Med, Ctr Comparat Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Lin, Philana Ling] Univ Pittsburgh, Childrens Hosp, Sch Med, Dept Pediat, Pittsburgh, PA 15260 USA; [Talat, Najeeha; Hussain, Rabia] Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan	Stanford University; MRC Laboratory Molecular Biology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Aga Khan University	Perry, S (corresponding author), Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA.	shnperry@stanford.edu	Flynn, JoAnne/ABC-7371-2020; Hussain, Rabia/E-9982-2015; de Jong, Bouke/A-3636-2013	de Jong, Bouke/0000-0002-1017-4675; Solnick, Jay/0000-0002-7435-8393; Parsonnet, Julie/0000-0001-7342-5366	National Institutes of Health (NIH) [K23-AI054443, R01-AI42801, R01-AI42081, HL075845]; Thrasher Fund; Bill & Melinda Gates Foundation; MRC [MC_U190071468] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054443, R01AI042081, R01AI042801] Funding Source: NIH RePORTER; Medical Research Council [MC_U190071468] Funding Source: researchfish	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thrasher Fund; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by National Institutes of Health (NIH) K23-AI054443 (S.P.), NIH R01-AI42801 (J.P.), NIH R01-AI42081 (J.S.), NIH HL075845 (J.L.F), the Thrasher Fund, and the Bill & Melinda Gates Foundation. The funders had no role in the study design, data collection, analysis, decision to publish or preparation of the manuscript.	AFFIFI AA, 1990, PRINCIPAL COMPONENTS, P371; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Blaser MJ, 2008, GUT, V57, P561, DOI 10.1136/gut.2007.133462; Capuano SV, 2003, INFECT IMMUN, V71, P5831, DOI 10.1128/IAI.71.10.5831-5844.2003; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Hanekom WA, 2008, PLOS MED, V5, P1033, DOI 10.1371/journal.pmed.0050145; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; LIN PL, 2009, INFECT IMMUNOL; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; McShane H, 2005, MICROBES INFECT, V7, P962, DOI 10.1016/j.micinf.2005.03.009; MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Parsonnet J, 1997, J INFECT DIS, V175, P1240, DOI 10.1086/593680; PerezPerez GI, 1997, INT J CANCER, V72, P453, DOI 10.1002/(SICI)1097-0215(19970729)72:3<453::AID-IJC13>3.0.CO;2-D; Perry S, 2004, J INFECT DIS, V190, P303, DOI 10.1086/421705; Perry S, 2008, CLIN VACCINE IMMUNOL, V15, P425, DOI 10.1128/CVI.00398-07; REPLOGLE ML, 1995, AM J EPIDEMIOL, V142, P856, DOI 10.1093/oxfordjournals.aje.a117725; Romero-Gallo J, 2002, CLIN DIAGN LAB IMMUN, V9, P1313, DOI 10.1128/CDLI.9.6.1313-1317.2002; Roussos A, 2006, RESPIRATION, V73, P708, DOI 10.1159/000093816; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Solnick JV, 1999, LAB ANIM SCI, V49, P197; Torres MA, 2003, EPIDEMIOL INFECT, V130, P87, DOI 10.1017/S0950268802007653; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; *WHO, 2008, GLOB TB CONTR SURV P; Wills-Karp M, 2001, NAT REV IMMUNOL, V1, P69, DOI 10.1038/35095579; Winthrop KL, 2006, NAT CLIN PRACT RHEUM, V2, P602, DOI 10.1038/ncprheum0336	40	108	114	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8804	10.1371/journal.pone.0008804	http://dx.doi.org/10.1371/journal.pone.0008804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098711	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000273779000030
J	Golemba, MD; Di Lello, FA; Bessone, F; Fay, F; Benetti, S; Jones, LR; Campos, RH				Golemba, Marcelo D.; Di Lello, Federico A.; Bessone, Fernando; Fay, Fabian; Benetti, Silvina; Jones, Leandro R.; Campos, Rodolfo H.			High Prevalence of Hepatitis C Virus Genotype 1b Infection in a Small Town of Argentina. Phylogenetic and Bayesian Coalescent Analysis	PLOS ONE			English	Article							MUTATION-RATE; NON-A; SEQUENCE; HCV; EPIDEMIOLOGY; NOMENCLATURE; PROPOSALS; COMMUNITY; OUTBREAK; GENOME	Previous studies in Argentina have documented a general prevalence of Hepatitis C Virus (HCV) infection close to 2%. In addition, a high prevalence of HCV has been recently reported in different Argentinean small rural communities. In this work, we performed a study aimed at analyzing the origins and diversification patterns of an HCV outbreak in Wheelwright, a small rural town located in Santa Fe province (Argentina). A total of 89 out of 1814 blood samples collected from people living in Wheelwright, were positive for HCV infection. The highest prevalence (4.9%) was observed in people older than 50 years, with the highest level for the group aged between 70-79 years (22%). The RFLP analyses showed that 91% of the positive samples belonged to the HCV-1b genotype. The E1/E2 and NS5B genes were sequenced, and their phylogenetic analysis showed that the HCV-1b sequences from Wheelwright were monophyletic. Bayesian coalescent-based methods were used to estimate substitution rates and time of the most recent common ancestor (tMRCA). The mean estimated substitution rates and the tMRCA for E1/E2 with and without HVR1 and NS5B were 7.41E-03 s/s/y and 61 years, 5.05E-03 s/s/y and 58 years and 3.24E-03 s/s/y and 53 years, respectively. In summary, the tMRCA values, the demographic model with constant population size, and the fact that the highest prevalence of infection was observed in elder people support the hypothesis that the HCV-1b introduction in Wheelwright initially occurred at least five decades ago and that the early epidemic was characterized by a fast rate of virus transmission. The epidemic seems to have been controlled later on down to the standard transmission rates observed elsewhere.	[Golemba, Marcelo D.; Di Lello, Federico A.; Campos, Rodolfo H.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina; [Bessone, Fernando] Univ Nacl Rosario, Serv Gastroenterol & Hepatol, Hosp Prov Centenario, RA-2000 Rosario, Santa Fe, Argentina; [Jones, Leandro R.] Estac Fotobiol Playa Union, Div Mol Biol, RA-9103 Rawson, Chubut, Argentina; [Fay, Fabian; Benetti, Silvina] Lab Cib Rosario, Rosario, Santa Fe, Argentina	University of Buenos Aires; National University of Rosario	Golemba, MD (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Virol, RA-1113 Buenos Aires, DF, Argentina.	rcampos@ffyb.uba.ar		Di Lello, Federico Alejandro/0000-0001-9771-9705; Jones, Leandro/0000-0002-5877-4194	Universidad de Buenos Aires [B037]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [01169]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [25355]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Universidad de Buenos Aires (SECyT-UBA 2008, B037, www.ffyb.uba.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET; PIP2009, 01169, www.conicet.gov.ar), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT; PICT2004, 25355, www.agencia.mincyt.gov.ar). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1992, J GEN VIROL, V73, P2725, DOI 10.1099/0022-1317-73-10-2725; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2014, TRACER V1 6; BESSONE F, 2005, ACTA GASTROENTEROL L, V35; Bracho MA, 2005, J CLIN MICROBIOL, V43, P2750, DOI 10.1128/JCM.43.6.2750-2755.2005; Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1; Coppola RC, 2000, J VIRAL HEPATITIS, V7, P130; Davidson F, 1999, METH MOLEC MED, V19, P175; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P564; Ferraro D, 2008, J MED VIROL, V80, P1723, DOI 10.1002/jmv.21276; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; Golovko AI, 2007, NEUROCHEM J+, V1, P1, DOI 10.1134/S1819712407010011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halfon P, 2002, J CLIN MICROBIOL, V40, P1541, DOI 10.1128/JCM.40.4.1541-1545.2002; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Idrees M, 2008, J DIGEST DIS, V9, P95, DOI 10.1111/j.1751-2980.2008.00329.x; Kato N, 2001, ACTA MED OKAYAMA, V55, P133; KATO N, 1990, P NATL ACAD SCI USA, V87, P9524, DOI 10.1073/pnas.87.24.9524; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; MENGARELLI S, 2006, ACTA GASTROENTEROL L, V36; Mizokami M, 2004, CANCER CHEMOTH PHARM, V54, pS83, DOI 10.1007/s00280-004-0892-0; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Picchio GR, 2006, LIVER INT, V26, P660, DOI 10.1111/j.1478-3231.2006.01290.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; RAMADAN A, 2006, ACTA GASTROENTEROL L, V36; Rispeter K, 2000, VIRUS GENES, V21, P179, DOI 10.1023/A:1008135413215; Robertson B, 1998, ARCH VIROL, V143, P2493, DOI 10.1007/s007050050479; Salemi M, 2002, J MOL EVOL, V54, P62, DOI 10.1007/s00239-001-0018-9; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Simmonds P, 2004, J GEN VIROL, V85, P3173, DOI 10.1099/vir.0.80401-0; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506	42	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8751	10.1371/journal.pone.0008751	http://dx.doi.org/10.1371/journal.pone.0008751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090919	gold, Green Submitted, Green Published			2022-12-27	WOS:000273715000010
J	Cheng, I; Witte, JS; Jacobsen, SJ; Haque, R; Quinn, VP; Quesenberry, CP; Caan, BJ; Van Den Eeden, SK				Cheng, Iona; Witte, John S.; Jacobsen, Steven J.; Haque, Reina; Quinn, Virginia P.; Quesenberry, Charles P.; Caan, Bette J.; Van Den Eeden, Stephen K.			Prostatitis, Sexually Transmitted Diseases, and Prostate Cancer: The California Men's Health Study	PLOS ONE			English	Article							RISK-FACTORS; COHORT; INFLAMMATION; METAANALYSIS; SYMPTOMS; BEHAVIOR; HISTORY	Background: Prostatitis and sexually transmitted diseases (STDs) have been positively associated with prostate cancer in previous case-control studies. However, results from recent prospective studies have been inconclusive. Methodogy/Principal Findings: We investigated the association between prostatitis, STDs, and prostate cancer among African American, Asian American, Latino, and White participants of the California Men's Health Study. Our analysis included 68,675 men, who completed a detailed baseline questionnaire in 2002-2003. We identified 1,658 incident prostate cancer cases during the follow-up period to June 30, 2006. Cox proportional hazards models were used to estimate relative risks and 95% confidence intervals. Overall, men having a history of prostatitis had an increased risk of prostate cancer than men with no history (RR = 1.30; 95% CI: 1.10-1.54). Longer duration of prostatitis symptoms was also associated with an increased risk of prostate cancer (P trend = 0.003). In addition, among men screened for prostate cancer (1 or 2 PSA tests), a nonsignificant positive association was observed between prostatitis and prostate cancer (RR = 1.10; 95% CI: 0.75-1.63). STDs were not associated with overall prostate cancer risk. In racial/ethnic stratified analysis, Latinos reporting any STDs had an increased risk of disease than those with no STDs (RR = 1.43; 95% CI: 1.07-1.91). Interestingly, foreign-born Latinos displayed a larger risk associated with STDs (RR = 1.87; 95% CI: 1.16-3.02) than U. S. born Latinos (RR = 1.15; 95% CI: 0.76-3.02). Conclusion: In summary, results from this prospective study suggest that prostatitis and STDs may be involved in prostate cancer susceptibility. While we cannot rule out the possible influence of incidental detection, future studies are warranted to further investigate the role of infectious agents related to prostatitis and STDs in prostate cancer development.	[Cheng, Iona] Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96822 USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Witte, John S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Jacobsen, Steven J.; Haque, Reina; Quinn, Virginia P.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Quesenberry, Charles P.; Caan, Bette J.; Van Den Eeden, Stephen K.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA	Cancer Research Center of Hawaii; University of Hawaii System; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Kaiser Permanente	Cheng, I (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96822 USA.	icheng@crch.hawaii.edu		Caan, Bette/0000-0002-5803-310X; Jacobsen, Steven/0000-0002-8174-8533	Community Benefits Program of Kaiser Permanente; National Institute of Health [CA 112355-01A1]; NATIONAL CANCER INSTITUTE [R25CA112355] Funding Source: NIH RePORTER	Community Benefits Program of Kaiser Permanente; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This study was funded in part by the California Cancer Research Program and the Community Benefits Program of Kaiser Permanente. IC was supported for this work by National Institute of Health R25T training grant (CA 112355-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2008, CANC FACTS FIG; *CDCP NAT SURV DAT, 2006, TRENDS REP SEX TRANS; Clemens JQ, 2006, J UROLOGY, V176, P593, DOI 10.1016/j.juro.2006.03.089; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dennis LK, 2002, EPIDEMIOLOGY, V13, P72, DOI 10.1097/00001648-200201000-00012; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Enger SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-172; Fernandez L, 2005, INT J EPIDEMIOL, V34, P193, DOI 10.1093/ije/dyh332; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P66, DOI 10.1007/BF01830728; Huang WY, 2008, CANCER EPIDEM BIOMAR, V17, P2374, DOI 10.1158/1055-9965.EPI-08-0173; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2008, INT J ANTIMICROB AG, V31, pS85, DOI 10.1016/j.ijantimicag.2007.08.028; Lightfoot N, 2004, ANN EPIDEMIOL, V14, P655, DOI 10.1016/j.annepidem.2003.11.006; Patel DA, 2005, CANCER CAUSE CONTROL, V16, P263, DOI 10.1007/s10552-004-3486-6; Roberts RO, 2004, EPIDEMIOLOGY, V15, P93, DOI 10.1097/01.ede.0000101022.38330.7c; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; Schaeffer AJ, 2002, J UROLOGY, V168, P1048, DOI 10.1016/S0022-5347(05)64572-7; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P2160, DOI 10.1158/1055-9965.EPI-05-0913; Taylor ML, 2005, FAM MED, V37, P506; True LD, 1999, J UROLOGY, V162, P2014, DOI 10.1016/S0022-5347(05)68090-1	22	97	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8736	10.1371/journal.pone.0008736	http://dx.doi.org/10.1371/journal.pone.0008736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090948	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900016
J	Blehaut, H; Mircher, C; Ravel, A; Conte, M; de Portzamparc, V; Poret, G; de Kermadec, FH; Rethore, MO; Sturtz, FG				Blehaut, Henri; Mircher, Clotilde; Ravel, Aime; Conte, Martine; de Portzamparc, Veronique; Poret, Gwendael; de Kermadec, Francoise Huon; Rethore, Marie-Odile; Sturtz, Franck G.			Effect of Leucovorin (Folinic Acid) on the Developmental Quotient of Children with Down's Syndrome (Trisomy 21) and Influence of Thyroid Status	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; INDUCED OXIDATIVE STRESS; METHYLENETETRAHYDROFOLATE REDUCTASE; METHOTREXATE TOXICITY; PLASMA HOMOCYSTEINE; CONTROLLED-TRIAL; FOLATE; SUPPLEMENTATION; HYPOTHYROIDISM; DEMENTIA	Background: Seven genes involved in folate metabolism are located on chromosome 21. Previous studies have shown that folate deficiency may contribute to mental retardation in Down's syndrome (DS). Methodology: We investigated the effect of oral folate supplementation (daily dose of 1.0+/-0.3 mg/kg) on cognitive functions in DS children, aged from 3 to 30 months. They received 1 mg/kg leucovorin or placebo daily, for 12 months, in a single-centre, randomised, double-blind study. Folinic acid (leucovorin, LV) was preferred to folic acid as its bioavailability is higher. The developmental age (DA) of the patients was assessed on the Brunet-Lezine scale, from baseline to the end of treatment. Results: The intent-to-treat analysis (113 patients) did not show a positive effect of leucovorin treatment. However, it identified important factors influencing treatment effect, such as age, sex, and concomitant treatments, including thyroid treatment in particular. A per protocol analysis was carried out on patients evaluated by the same examiner at the beginning and end of the treatment period. This analysis of 87 patients (43 LV-treated vs. 44 patients on placebo) revealed a positive effect of leucovorin on developmental age (DA). DA was 53.1% the normal value with leucovorin and only 44.1% with placebo (p < 0.05). This positive effect of leucovorin was particularly strong in patients receiving concomitant thyroxin treatment (59.5% vs. 41.8%, p < 0.05). No adverse event related to leucovorin was observed. Conclusion: These results suggest that leucovorin improves the psychomotor development of children with Down's syndrome, at least in some subgroups of the DS population, particularly those on thyroxin treatment.	[Blehaut, Henri; Mircher, Clotilde; Ravel, Aime; Conte, Martine; de Portzamparc, Veronique; Poret, Gwendael; Rethore, Marie-Odile; Sturtz, Franck G.] Inst Jerome Lejeune, Paris, France; [de Kermadec, Francoise Huon] Lab Appl Math, Rennes, France; [Rethore, Marie-Odile] Natl Acad Med, Paris, France; [Sturtz, Franck G.] Univ Limoges, Dept Biochem & Mol Genet, Limoges, France	Universite de Limoges	Blehaut, H (corresponding author), Inst Jerome Lejeune, Paris, France.	franck.sturtz@unilim.fr	Sturtz, Franck G./AAU-3975-2021	Sturtz, Franck G./0000-0001-6428-5162	Jerome Lejeune Foundation	Jerome Lejeune Foundation	Funding was received from the Jerome Lejeune Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Ayav A, 2005, AMINO ACIDS, V28, P37, DOI 10.1007/s00726-004-0151-z; BENNETT FC, 1983, PEDIATRICS, V72, P707; BIDDER RT, 1989, DEV MED CHILD NEUROL, V31, P532; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; BOTEZ MI, 1976, CAN MED ASSOC J, V115, P217; BOTEZ MI, 1979, FOLIC ACID NEUROLOGY, P435; BROCKER P, 1990, REV GERIATRIE, V15, P365; Catargi B, 1999, THYROID, V9, P1163, DOI 10.1089/thy.1999.9.1163; CHADEFAUX B, 1988, LANCET, V2, P741; Chapman R S, 2001, Downs Syndr Res Pract, V7, P1, DOI 10.3104/reviews.108; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Coste J, 2005, QUAL LIFE RES, V14, P641, DOI 10.1007/s11136-004-1260-6; Dauphinot L, 2005, HUM MOL GENET, V14, P373, DOI 10.1093/hmg/ddi033; David O, 1996, PEDIATR HEMAT ONCOL, V13, P271, DOI 10.3109/08880019609030827; Diekman MJM, 2001, CLIN ENDOCRINOL, V54, P197, DOI 10.1046/j.1365-2265.2001.01170.x; Durga J, 2006, NEUROBIOL AGING, V27, P334, DOI 10.1016/j.neurobiolaging.2005.01.003; Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Ellis JM, 2008, BMJ-BRIT MED J, V336, P594, DOI 10.1136/bmj.39465.544028.AE; ENK C, 1980, SCAND J HAEMATOL, V25, P63; Epstein C.J., 1995, METABOLIC MOL BASES, P749; Erdamar H, 2008, CLIN CHEM LAB MED, V46, P1004, DOI 10.1515/CCLM.2008.183; Fernandez V, 2006, COMP BIOCHEM PHYS C, V142, P231, DOI 10.1016/j.cbpc.2005.10.007; FORT P, 1984, J PEDIATR-US, V104, P545, DOI 10.1016/S0022-3476(84)80544-2; Francois Laurence Lion, 2004, Rev Prat, V54, P1991; Gueant JL, 2006, AM J CLIN NUTR, V83, P171; Gueant JL, 2005, J NEUROL NEUROSUR PS, V76, P706, DOI 10.1136/jnnp.2004.039875; Hussein WI, 1999, ANN INTERN MED, V131, P348, DOI 10.7326/0003-4819-131-5-199909070-00005; Hustad S, 2004, AM J CLIN NUTR, V80, P1050, DOI 10.1093/ajcn/80.4.1050; JOSSE D, 1997, BRUNET LEZINE REVISE, P308; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; LEJEUNE J, 1992, ANN GENET-PARIS, V35, P8; LEJEUNE J, 1990, AM J MED GENET, P20; LEJEUNE J, 1989, THERAPIE, V44, P115; LEJEUNE J, 1991, CANCER CHEMOTH PHARM, V27, P331, DOI 10.1007/BF00685122; LEZINE I, 1950, Ann Med Psychol (Paris), V108, P499; MALOUF M, 2003, COCHRANE DB SYST REV; Nedrebo BG, 1998, METABOLISM, V47, P89, DOI 10.1016/S0026-0495(98)90198-6; PEETERS MA, 1995, BRIT J HAEMATOL, V89, P678, DOI 10.1111/j.1365-2141.1995.tb08390.x; PEETERS MA, 1986, LANCET, V2, P1279; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; Prasher V P, 1999, Downs Syndr Res Pract, V6, P25, DOI 10.3104/reviews.95; Quadri P, 2005, CLIN CHEM LAB MED, V43, P1096, DOI 10.1515/CCLM.2005.191; Quadri P, 2004, AM J CLIN NUTR, V80, P114; Ramos MI, 2004, AM J CLIN NUTR, V80, P1024, DOI 10.1093/ajcn/80.4.1024; Ramos MI, 2005, AM J CLIN NUTR, V82, P1346, DOI 10.1093/ajcn/82.6.1346; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; SMITH GF, 1984, J PEDIATR-US, V105, P228, DOI 10.1016/S0022-3476(84)80118-3; Soldin S.J., 1999, PEDIAT REFERENCE RAN; SPECTOR R, 1979, FOLIC ACID NEUROLOGY, P187; Taub JW, 2005, PEDIATR BLOOD CANCER, V44, P33, DOI 10.1002/pbc.20092; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; YANGFENG TL, 1995, BIOCHEM BIOPH RES CO, V210, P874, DOI 10.1006/bbrc.1995.1739	55	33	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8394	10.1371/journal.pone.0008394	http://dx.doi.org/10.1371/journal.pone.0008394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20084109	Green Published, gold			2022-12-27	WOS:000273456300002
J	Varghese, K; Molnar, P; Das, M; Bhargava, N; Lambert, S; Kindy, MS; Hickman, JJ				Varghese, Kucku; Molnar, Peter; Das, Mainak; Bhargava, Neelima; Lambert, Stephen; Kindy, Mark S.; Hickman, James J.			A New Target for Amyloid Beta Toxicity Validated by Standard and High-Throughput Electrophysiology	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; MICROELECTRODE ARRAYS; NEURONAL NETWORKS; MULTIELECTRODE ARRAYS; HIPPOCAMPAL-NEURONS; SYNAPTIC ACTIVITY; DEFINED SYSTEM; OLIGOMERS; MECHANISMS	Background: Soluble oligomers of amyloid beta (A beta) are considered to be one of the major contributing factors to the development of Alzheimer's disease. Most therapeutic development studies have focused on toxicity directly at the synapse. Methodology/Principal Findings: Patch clamp studies detailed here have demonstrated that soluble A beta can also cause functional toxicity, namely it inhibits spontaneous firing of hippocampal neurons without significant cell death at low concentrations. This toxicity will eventually lead to the loss of the synapse as well, but may precede this loss by a considerable amount of time. In a key technological advance we have reproduced these results utilizing a fast and simple method based on extracellular electrophysiological recording of the temporal electrical activity of cultured hippocampal neurons using multielectrode arrays (MEAs) at low concentrations of A beta (1-42). We have also shown that this functional deficit can be reversed through use of curcumin, an inhibitor of A beta oligomerization, using both analysis methods. Conclusions/Significance: The MEA recording method utilized here is non-invasive, thus long term chronic measurements are possible and it does not require precise positioning of electrodes, thus it is ideal for functional screens. Even more significantly, we believe we have now identified a new target for drug development for AD based on functional toxicity of hippocampal neurons that could treat neurodegenerative diseases prior to the development of mild cognitive impairment.	[Varghese, Kucku; Molnar, Peter; Das, Mainak; Bhargava, Neelima; Lambert, Stephen; Hickman, James J.] Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA; [Varghese, Kucku; Kindy, Mark S.; Hickman, James J.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Lambert, Stephen] Univ Cent Florida, Coll Med, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; Medical University of South Carolina; State University System of Florida; University of Central Florida	Varghese, K (corresponding author), Univ Cent Florida, NanoSci Technol Ctr, Orlando, FL 32816 USA.	jhickman@mail.ucf.edu	Molnar, Peter/I-5980-2017	Molnar, Peter/0000-0002-1504-3092	Department of Energy [DE-FG-02-04ER46171]; National Institutes of Health [5R01EB005459]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005459] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the Department of Energy grant number DE-FG-02-04ER46171 and National Institutes of Health grant number 5R01EB005459 for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja TK, 2007, DRUG DEVELOP RES, V68, P84, DOI 10.1002/ddr.20170; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X; Chen QS, 2000, J NEUROSCI RES, V60, P65, DOI 10.1002/(SICI)1097-4547(20000401)60:1<65::AID-JNR7>3.0.CO;2-Q; Das M, 2003, BIOTECHNOL PROGR, V19, P1756, DOI 10.1021/bp034076l; Egert U, 1998, BRAIN RES PROTOC, V2, P229, DOI 10.1016/S1385-299X(98)00013-0; Francis PT, 2008, NEURODEGENER DIS, V5, P241, DOI 10.1159/000113713; Golan H, 2000, NEURAL PLAST, V7, P31, DOI 10.1155/NP.2000.31; Gramowski A, 2006, EUR J NEUROSCI, V24, P455, DOI 10.1111/j.1460-9568.2006.04892.x; Gross GW, 1997, EUR J CELL BIOL, V74, P36; GROSS GW, 1995, BIOSENS BIOELECTRON, V10, P553, DOI 10.1016/0956-5663(95)96931-N; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Hamaguchi T, 2006, CELL MOL LIFE SCI, V63, P1538, DOI 10.1007/s00018-005-5599-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hofmann F, 2006, J PHYSIOL-PARIS, V99, P125, DOI 10.1016/j.jphysparis.2005.12.005; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; Jhamandas JH, 2001, J NEUROPHYSIOL, V86, P1312, DOI 10.1152/jn.2001.86.3.1312; Jung DR, 1998, J VAC SCI TECHNOL A, V16, P1183, DOI 10.1116/1.581256; Keefer EW, 2001, NEUROTOXICOLOGY, V22, P3, DOI 10.1016/S0161-813X(00)00014-0; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Koike T, 2008, NEUROCHEM INT, V52, P751, DOI 10.1016/j.neuint.2007.09.007; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lacor PN, 2007, CURR GENOMICS, V8, P486, DOI 10.2174/138920207783769530; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; MATTSON MP, 1992, J NEUROSCI, V12, P376, DOI 10.1523/jneurosci.12-02-00376.1992; Meyer T, 2004, DRUG SAFETY, V27, P763, DOI 10.2165/00002018-200427110-00002; Nam Y, 2006, J NEUROSCI METH, V155, P296, DOI 10.1016/j.jneumeth.2006.01.014; Natarajan A, 2006, TOXICOL IN VITRO, V20, P375, DOI 10.1016/j.tiv.2005.08.014; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Offenhausser A, 1997, BIOSENS BIOELECTRON, V12, P819, DOI 10.1016/S0956-5663(97)00047-X; Parviz M, 2007, NEUROTOXICOLOGY, V28, P520, DOI 10.1016/j.neuro.2006.11.006; Schaffner AE, 1995, J NEUROSCI METH, V62, P111, DOI 10.1016/0165-0270(95)00063-1; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; THOMAS CA, 1972, EXP CELL RES, V74, P61, DOI 10.1016/0014-4827(72)90481-8; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; Waataja JJ, 2008, J NEUROCHEM, V104, P364, DOI 10.1111/j.1471-4159.2007.04973.x; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; ZHAO BL, 1989, CELL BIOPHYS, V14, P175, DOI 10.1007/BF02797132	45	44	57	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8643	10.1371/journal.pone.0008643	http://dx.doi.org/10.1371/journal.pone.0008643			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20062810	Green Published, Green Submitted, gold			2022-12-27	WOS:000273414200020
J	Fernandez-Ayala, DJM; Chen, SJ; Kemppainen, E; O'Dell, KMC; Jacobs, HT				Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; O'Dell, Kevin M. C.; Jacobs, Howard T.			Gene Expression in a Drosophila Model of Mitochondrial Disease	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-SYNTHASE KINASE-3; CONTROLLED CLINICAL-TRIAL; MALE COURTSHIP BEHAVIOR; FAT-BODY; ETHYLMALONIC ENCEPHALOPATHY; OXIDATIVE-PHOSPHORYLATION; DNA PHOSPHODIESTERASE; SEX-DETERMINATION; FEEDING-BEHAVIOR	Background: A point mutation in the Drosophila gene technical knockout (tko), encoding mitoribosomal protein S12, was previously shown to cause a phenotype of respiratory chain deficiency, developmental delay, and neurological abnormalities similar to those presented in many human mitochondrial disorders, as well as defective courtship behavior. Methodology/Principal Findings: Here, we describe a transcriptome-wide analysis of gene expression in tko 25t mutant flies that revealed systematic and compensatory changes in the expression of genes connected with metabolism, including upregulation of lactate dehydrogenase and of many genes involved in the catabolism of fats and proteins, and various anaplerotic pathways. Gut-specific enzymes involved in the primary mobilization of dietary fats and proteins, as well as a number of transport functions, were also strongly up-regulated, consistent with the idea that oxidative phosphorylation OXPHOS dysfunction is perceived physiologically as a starvation for particular biomolecules. In addition, many stress-response genes were induced. Other changes may reflect a signature of developmental delay, notably a down-regulation of genes connected with reproduction, including gametogenesis, as well as courtship behavior in males; logically this represents a programmed response to a mitochondrially generated starvation signal. The underlying signalling pathway, if conserved, could influence many physiological processes in response to nutritional stress, although any such pathway involved remains unidentified. Conclusions/Significance: These studies indicate that general and organ-specific metabolism is transformed in response to mitochondrial dysfunction, including digestive and absorptive functions, and give important clues as to how novel therapeutic strategies for mitochondrial disorders might be developed.	[Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; Jacobs, Howard T.] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; [Fernandez-Ayala, Daniel J. M.; Chen, Shanjun; Kemppainen, Esko; Jacobs, Howard T.] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [O'Dell, Kevin M. C.; Jacobs, Howard T.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland	Tampere University; Tampere University; Tampere University Hospital; University of Glasgow	Fernandez-Ayala, DJM (corresponding author), Univ Pablo Olavide, Ctr Andaluz Biol Desarrollo, Seville, Spain.	howard.t.jacobs@uta.fi	Kemppainen, Esko/AAF-7618-2019; Jacobs, Howard T/G-2434-2011	Jacobs, Howard/0000-0003-1895-6003; Fernandez-Ayala, Daniel Jose Moreno/0000-0001-8176-1431	Academy of Finland [118654, 116056, 119553]; Sigrid Juselius Foundation; Tampere University Hospital Medical Research [9F021]; European Union [LSHM-CT-2004-503116]; European Research Council [232738]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tampere University Hospital Medical Research; European Union(European Commission); European Research Council(European Research Council (ERC)European Commission)	This work was funded by Academy of Finland 118654, 116056, and 119553; Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund 9F021; European Union LSHM-CT-2004-503116; and European Research Council 232738. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; BENES H, 1990, DEV BIOL, V142, P138, DOI 10.1016/0012-1606(90)90157-E; Bennett D, 2003, GENETICS, V164, P235; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Boltz KA, 2007, DEV DYNAM, V236, P544, DOI 10.1002/dvdy.21032; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Burmester T, 1999, EUR J BIOCHEM, V262, P49, DOI 10.1046/j.1432-1327.1999.00315.x; CARLSON JR, 1985, DEV BIOL, V108, P341, DOI 10.1016/0012-1606(85)90038-7; CLARK AG, 1983, HEREDITAS, V99, P165, DOI 10.1111/j.1601-5223.1983.tb00888.x; Copeland WC, 2008, ANNU REV MED, V59, P131, DOI 10.1146/annurev.med.59.053006.104646; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; DEUTSCH J, 1989, DEV GENET, V10, P220, DOI 10.1002/dvg.1020100311; Didelot G, 2006, SCIENCE, V313, P851, DOI 10.1126/science.1127215; Dunlop J, 2004, CURR BIOL, V14, P2039, DOI 10.1016/j.cub.2004.10.048; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Fergestad Tim, 2006, Genetics, V173, P1357, DOI 10.1534/genetics.106.057463; Fujii S, 2002, EMBO J, V21, P5353, DOI 10.1093/emboj/cdf556; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Goto SG, 2001, GENE, V270, P259, DOI 10.1016/S0378-1119(01)00465-6; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Hakonen AH, 2007, EUR J HUM GENET, V15, P779, DOI 10.1038/sj.ejhg.5201831; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; Jacobs HT, 2004, BBA-BIOENERGETICS, V1659, P190, DOI 10.1016/j.bbabio.2004.07.004; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kanuka H, 2005, EMBO J, V24, P3793, DOI 10.1038/sj.emboj.7600822; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Kaufmann P, 2006, NEUROLOGY, V66, P324, DOI 10.1212/01.wnl.0000196641.05913.27; Kemppainen E, 2009, MITOCHONDRION, V9, P353, DOI 10.1016/j.mito.2009.07.002; Kirino Yohei, 2005, RNA Biol, V2, P41, DOI 10.4161/rna.2.2.1610; Kurapati R, 2000, J GERONTOL A-BIOL, V55, pB552, DOI 10.1093/gerona/55.11.B552; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; LEHNINGER A, 2004, PRINCIPLES BIOCH; LEVASHINA EA, 1995, EUR J BIOCHEM, V233, P694, DOI 10.1111/j.1432-1033.1995.694_2.x; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; LORENZ LJ, 1989, DEVELOPMENT, V107, P869; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Molinari F, 2002, SCIENCE, V298, P1779, DOI 10.1126/science.1076521; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; O'Brien T, 2003, IUBMB LIFE, V55, P505, DOI 10.1080/15216540310001626610; Okabe M, 1997, DEVELOPMENT, V124, P1045; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Prigione A, 2007, AGING CELL, V6, P619, DOI 10.1111/j.1474-9726.2007.00323.x; Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200; Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421; Rhoads DM, 2007, MITOCHONDRION, V7, P177, DOI 10.1016/j.mito.2007.01.002; Roof DJ, 1997, J CELL BIOL, V138, P575, DOI 10.1083/jcb.138.3.575; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saada A, 2007, J MED GENET, V44, P784, DOI 10.1136/jmg.2007.053116; Santra S, 2004, ANN NEUROL, V56, P662, DOI 10.1002/ana.20240; Sardiello M, 2003, NUCLEIC ACIDS RES, V31, P322, DOI 10.1093/nar/gkg123; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Scanga SE, 2000, ONCOGENE, V19, P3971, DOI 10.1038/sj.onc.1203739; Schon EA, 2000, TRENDS BIOCHEM SCI, V25, P555, DOI 10.1016/S0968-0004(00)01688-1; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Shah ZH, 1997, GENE, V204, P55, DOI 10.1016/S0378-1119(97)00521-0; Shaw M, 1997, FEBS LETT, V416, P307, DOI 10.1016/S0014-5793(97)01235-0; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink JAM, 2003, J INHERIT METAB DIS, V26, P199, DOI 10.1023/A:1024489218004; Spradling AC, 1999, GENETICS, V153, P135; Stacpoole PW, 1998, DRUG METAB REV, V30, P499, DOI 10.3109/03602539808996323; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; Szakmary A, 2005, CURR BIOL, V15, P171, DOI 10.1016/j.cub.2005.01.005; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tao Y, 2007, SEMIN CELL DEV BIOL, V18, P3, DOI 10.1016/j.semcdb.2006.12.001; TEAGUE BD, 1986, J EXP ZOOL, V240, P95, DOI 10.1002/jez.1402400112; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Todres E, 2000, INSECT MOL BIOL, V9, P581, DOI 10.1046/j.1365-2583.2000.00222.x; Toivonen JM, 2003, MITOCHONDRION, V3, P83, DOI 10.1016/S1567-7249(03)00077-1; Toivonen JM, 1999, MOL MICROBIOL, V31, P1735, DOI 10.1046/j.1365-2958.1999.01307.x; Toivonen JM, 2001, GENETICS, V159, P241; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Triepels RH, 2001, AM J MED GENET, V106, P37, DOI 10.1002/ajmg.1397; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Uttenweiler-Joseph S, 1998, P NATL ACAD SCI USA, V95, P11342, DOI 10.1073/pnas.95.19.11342; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wang SJ, 1999, MOL BIOL EVOL, V16, P1117, DOI 10.1093/oxfordjournals.molbev.a026202; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wolf FW, 2007, P NATL ACAD SCI USA, V104, P4653, DOI 10.1073/pnas.0700493104; Wolfner MF, 2003, CURR BIOL, V13, pR101, DOI 10.1016/S0960-9822(03)00038-1; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; YASUI A, 1994, EMBO J, V13, P6143, DOI 10.1002/j.1460-2075.1994.tb06961.x; Zarkovic J, 2005, PLANT MOL BIOL, V57, P871, DOI 10.1007/s11103-005-3249-0; Zhang YQ, 1999, GENETICS, V153, P891; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	114	52	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8549	10.1371/journal.pone.0008549	http://dx.doi.org/10.1371/journal.pone.0008549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066047	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000273338600008
J	Henn, MR; Sullivan, MB; Stange-Thomann, N; Osburne, MS; Berlin, AM; Kelly, L; Yandava, C; Kodira, C; Zeng, QD; Weiand, M; Sparrow, T; Saif, S; Giannoukos, G; Young, SK; Nusbaum, C; Birren, BW; Chisholm, SW				Henn, Matthew R.; Sullivan, Matthew B.; Stange-Thomann, Nicole; Osburne, Marcia S.; Berlin, Aaron M.; Kelly, Libusha; Yandava, Chandri; Kodira, Chinnappa; Zeng, Qiandong; Weiand, Michael; Sparrow, Todd; Saif, Sakina; Giannoukos, Georgia; Young, Sarah K.; Nusbaum, Chad; Birren, Bruce W.; Chisholm, Sallie W.			Analysis of High-Throughput Sequencing and Annotation Strategies for Phage Genomes	PLOS ONE			English	Article							MARINE SYNECHOCOCCUS STRAINS; PHOTOSYNTHESIS GENES; MICROBIAL GENOMES; PROTEIN FAMILIES; RNA GENES; VIRUSES; PROCHLOROCOCCUS; IDENTIFICATION; BACTERIOPHAGE; DATABASE	Background: Bacterial viruses (phages) play a critical role in shaping microbial populations as they influence both host mortality and horizontal gene transfer. As such, they have a significant impact on local and global ecosystem function and human health. Despite their importance, little is known about the genomic diversity harbored in phages, as methods to capture complete phage genomes have been hampered by the lack of knowledge about the target genomes, and difficulties in generating sufficient quantities of genomic DNA for sequencing. Of the approximately 550 phage genomes currently available in the public domain, fewer than 5% are marine phage. Methodology/Principal Findings: To advance the study of phage biology through comparative genomic approaches we used marine cyanophage as a model system. We compared DNA preparation methodologies (DNA extraction directly from either phage lysates or CsCl purified phage particles), and sequencing strategies that utilize either Sanger sequencing of a linker amplification shotgun library (LASL) or of a whole genome shotgun library (WGSL), or 454 pyrosequencing methods. We demonstrate that genomic DNA sample preparation directly from a phage lysate, combined with 454 pyrosequencing, is best suited for phage genome sequencing at scale, as this method is capable of capturing complete continuous genomes with high accuracy. In addition, we describe an automated annotation informatics pipeline that delivers high-quality annotation and yields few false positives and negatives in ORF calling. Conclusions/Significance: These DNA preparation, sequencing and annotation strategies enable a high-throughput approach to the burgeoning field of phage genomics.	[Henn, Matthew R.; Stange-Thomann, Nicole; Berlin, Aaron M.; Yandava, Chandri; Kodira, Chinnappa; Zeng, Qiandong; Weiand, Michael; Sparrow, Todd; Saif, Sakina; Giannoukos, Georgia; Young, Sarah K.; Nusbaum, Chad; Birren, Bruce W.] MIT & Harvard, Broad Inst, Cambridge, MA 02139 USA; [Sullivan, Matthew B.; Osburne, Marcia S.; Kelly, Libusha; Chisholm, Sallie W.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Henn, MR (corresponding author), MIT & Harvard, Broad Inst, Cambridge, MA 02139 USA.	mhenn@broadinstitute.org	Berlin, Aaron M/AFY-6549-2022; Zeng, Qiandong/AAF-3305-2019; Sullivan, Matthew B/H-3256-2011	Berlin, Aaron M/0000-0002-0714-2808; Sullivan, Matthew B/0000-0003-4040-9831; Chisholm, Sallie/0000-0003-1480-2445	Gordon and Betty Moore Foundation; NSF; DOE	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE))	This project is funded in large part by the Gordon and Betty Moore Foundation (through grants to MRH and to SWC), and in part by grants to SWC from NSF and DOE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Batzoglou S, 2002, GENOME RES, V12, P177, DOI 10.1101/gr.208902; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2007, OCEANOGRAPHY, V20, P135, DOI 10.5670/oceanog.2007.58; Champion MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000459; Chen F, 2002, APPL ENVIRON MICROB, V68, P2589, DOI 10.1128/AEM.68.5.2589-2594.2002; Clokie MRJ, 2006, ENVIRON MICROBIOL, V8, P827, DOI 10.1111/j.1462-2920.2005.00969.x; Culley AI, 2006, SCIENCE, V312, P1795, DOI 10.1126/science.1127404; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Heineman RH, 2009, MOL BIOL EVOL, V26, P1289, DOI 10.1093/molbev/msp037; Ireland DC, 1998, CLIN EXP IMMUNOL, V112, P255; Krause L, 2007, NUCLEIC ACIDS RES, V35, P540, DOI 10.1093/nar/gkl1083; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Millard AD, 2009, ENVIRON MICROBIOL, V11, P2370, DOI 10.1111/j.1462-2920.2009.01966.x; Mills SD, 2004, ANTIMICROB AGENTS CH, V48, P2524, DOI 10.1128/AAC.48.7.2524-2530.2004; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Oakey HJ, 2002, J APPL MICROBIOL, V93, P1089, DOI 10.1046/j.1365-2672.2002.01776.x; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Rohwer F, 2001, BIOTECHNIQUES, V31, P108, DOI 10.2144/01311rr02; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Stingl U, 2007, ISME J, V1, P361, DOI 10.1038/ismej.2007.49; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Wang YL, 2000, CELL MOL NEUROBIOL, V20, P509, DOI 10.1023/A:1007027232412; Weigele PR, 2007, ENVIRON MICROBIOL, V9, P1675, DOI 10.1111/j.1462-2920.2007.01285.x; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; 2002, NUCL ACIDS RES, V30, P2478; 2002, J BACTERIOL, V184, P6592	54	63	66	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9083	10.1371/journal.pone.0009083	http://dx.doi.org/10.1371/journal.pone.0009083			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140207	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400019
J	Ray, TS				Ray, Thomas S.			Psychedelics and the Human Receptorome	PLOS ONE			English	Article							PHARMACOLOGICAL CHARACTERIZATION; SEROTONIN RECEPTORS; IN-VITRO; CLASSICAL HALLUCINOGENS; CANNABINOID RECEPTOR; BINDING-SITES; AGONIST; AGENTS; MECHANISM; CLASSIFICATION	We currently understand the mental effects of psychedelics to be caused by agonism or partial agonism of 5-HT(2A) (and possibly 5-HT(2C)) receptors, and we understand that psychedelic drugs, especially phenylalkylamines, are fairly selective for these two receptors. This manuscript is a reference work on the receptor affinity pharmacology of psychedelic drugs. New data is presented on the affinity of twenty-five psychedelic drugs at fifty-one receptors, transporters, and ion channels, assayed by the National Institute of Mental Health-Psychoactive Drug Screening Program (NIMH-PDSP). In addition, comparable data gathered from the literature on ten additional drugs is also presented (mostly assayed by the NIMH-PDSP). A new method is introduced for normalizing affinity (K(i)) data that factors out potency so that the multi-receptor affinity profiles of different drugs can be directly compared and contrasted. The method is then used to compare the thirty-five drugs in graphical and tabular form. It is shown that psychedelic drugs, especially phenylalkylamines, are not as selective as generally believed, interacting with forty-two of forty-nine broadly assayed sites. The thirty-five drugs of the study have very diverse patterns of interaction with different classes of receptors, emphasizing eighteen different receptors. This diversity of receptor interaction may underlie the qualitative diversity of these drugs. It should be possible to use this diverse set of drugs as probes into the roles played by the various receptor systems in the human mind.	Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Ray, TS (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.	tray@ou.edu			NIMH-PDSP; National Institute on Drug Abuse Drug Supply Program	NIMH-PDSP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse Drug Supply Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work resulted from a large set of receptor affinity assays performed by the NIMH-PDSP (http://pdsp.med.unc.edu/). Although the project was specifically approved for the author by the NIMH and the NIMH-PDSP, it did not result in a grant in the sense of funds that flow through the author's institution. The funding went directly to the NIMH-PDSP which was at Case Western Reserve University at the time. Also, the National Institute on Drug Abuse Drug Supply Program (http://www.nida.nih.gov/) provided many of the drugs, but they also went directly to the NIMH-PDSP at Case Western. There was no other funding for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This statement is true except that the NIMH-PDSP actually produced the affinity data for twenty-five drugs, and provided it exclusively to the author.	Blair JB, 2000, J MED CHEM, V43, P4701, DOI 10.1021/jm000339w; CASTANAS E, 1985, J NEUROCHEM, V45, P677, DOI 10.1111/j.1471-4159.1985.tb04046.x; CLARK JA, 1988, MOL PHARMACOL, V34, P308; DARMANI NA, 1992, PHARMACOL BIOCHEM BE, V43, P765, DOI 10.1016/0091-3057(92)90406-6; DARMANI NA, 1994, PHARMACOL BIOCHEM BE, V48, P383, DOI 10.1016/0091-3057(94)90542-8; DE VJ, 2004, J PHARMACOL EXP THER, V310, P620; Gharagozlou Parham, 2003, BMC Pharmacol, V3, P1, DOI 10.1186/1471-2210-3-1; GLENNON RA, 1986, PSYCHOPHARMACOL BULL, V22, P953; Glennon RA, 2000, J MED CHEM, V43, P1011, DOI 10.1021/jm990550b; GLENNON RA, 1991, PHARMACOL BIOCHEM BE, V40, P1009, DOI 10.1016/0091-3057(91)90121-H; GLENNON RA, 1983, EUR J PHARMACOL, V91, P189, DOI 10.1016/0014-2999(83)90464-8; GLENNON RA, 1990, NEUROPSYCHOPHARMACOL, V3, P509; GLENNON RA, 1984, LIFE SCI, V35, P2505, DOI 10.1016/0024-3205(84)90436-3; GLENNON RA, 1991, LIFE SCI, V48, P2493, DOI 10.1016/0024-3205(91)90603-9; GLENNON RA, 1996, HANDB EXP PHARM, V118, P343; Griffin G, 2000, J PHARMACOL EXP THER, V292, P886; Iwamura H, 2001, J PHARMACOL EXP THER, V296, P420; LARGENT BL, 1984, P NATL ACAD SCI-BIOL, V81, P4983, DOI 10.1073/pnas.81.15.4983; Mauler F, 2002, J PHARMACOL EXP THER, V302, P359, DOI 10.1124/jpet.302.1.359; Neubig RR, 2003, PHARMACOL REV, V55, P597, DOI 10.1124/pr.55.4.4; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Nichols DE, 2002, J MED CHEM, V45, P4344, DOI 10.1021/jm020153s; NICHOLS DE, 1986, J PSYCHOACTIVE DRUGS, V18, P305, DOI 10.1080/02791072.1986.10472362; Roth BL, 2002, P NATL ACAD SCI USA, V99, P11934, DOI 10.1073/pnas.182234399; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Spetea M, 2003, EUR J NEUROSCI, V18, P290, DOI 10.1046/j.1460-9568.2003.02744.x; STANDIFER KM, 1994, J PHARMACOL EXP THER, V270, P1246; Valenzano KJ, 2004, J PHARMACOL EXP THER, V310, P783, DOI 10.1124/jpet.103.063313; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; Zhao GM, 2003, J PHARMACOL EXP THER, V307, P947, DOI 10.1124/jpet.103.054775	31	132	137	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9019	10.1371/journal.pone.0009019	http://dx.doi.org/10.1371/journal.pone.0009019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126400	Green Submitted, gold, Green Published			2022-12-27	WOS:000274207200014
J	Rohlfing, AK; Miteva, Y; Hannenhalli, S; Lamitina, T				Rohlfing, Anne-Katrin; Miteva, Yana; Hannenhalli, Sridhar; Lamitina, Todd			Genetic and Physiological Activation of Osmosensitive Gene Expression Mimics Transcriptional Signatures of Pathogen Infection in C. elegans	PLOS ONE			English	Article							PORE-FORMING TOXINS; CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; INNATE IMMUNITY; OSMOTIC-STRESS; BACTERIAL PATHOGENESIS; FUNGAL PATHOGENS; FACTOR SKN-1; GATA-FACTOR; PROTEIN	The soil-dwelling nematode C. elegans is a powerful system for comparative molecular analyses of environmental stress response mechanisms. Infection of worms with bacterial and fungal pathogens causes the activation of well-characterized innate immune transcriptional programs in pathogen-exposed hypodermal and intestinal tissues. However, the pathophysiological events that drive such transcriptional responses are not understood. Here, we show that infection-activated transcriptional responses are, in large part, recapitulated by either physiological or genetic activation of the osmotic stress response. Microarray profiling of wild type worms exposed to non-lethal hypertonicity identified a suite of genes that were also regulated by infection. Expression profiles of five different osmotic stress resistant (osr) mutants under isotonic conditions reiterated the wild type transcriptional response to osmotic stress and also showed substantial similarity to infection-induced gene expression under isotonic conditions. Computational, transgenic, and functional approaches revealed that two GATA transcription factors previously implicated in infection-induced transcriptional responses, elt-2 and elt-3, are also essential for coordinated tissue-specific activation of osmosensitive gene expression and promote survival under osmotically stressful conditions. Together, our data suggest infection and osmotic adaptation share previously unappreciated transcriptional similarities which might be controlled via regulation of tissue-specific GATA transcription factors.	[Rohlfing, Anne-Katrin; Miteva, Yana; Lamitina, Todd] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Hannenhalli, Sridhar] Univ Penn, Dept Genet, Penn Ctr Bioinformat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Rohlfing, AK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	lamitina@mail.med.upenn.edu			University of Pennsylvania Center of Excellence in Environmental Toxicology [1R01AA017580, R01GM085226, P30 ES013508]; National Institutes of Health (NIH); National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017580] Funding Source: NIH RePORTER	University of Pennsylvania Center of Excellence in Environmental Toxicology; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	1R01AA017580 to T. L. R01GM085226 to S. H. P30 ES013508 to the University of Pennsylvania Center of Excellence in Environmental Toxicology (T. L. member). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health (NIH) National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Choe KP, 2009, MOL CELL BIOL, V29, P2704, DOI 10.1128/MCB.01811-08; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2005, CURR OPIN IMMUNOL, V17, P4, DOI 10.1016/j.coi.2004.11.007; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Komatsu T, 2008, CATAL SURV ASIA, V12, P6, DOI 10.1007/s10563-007-9031-3; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Mello C, 1995, METHOD CELL BIOL, V48, P451; Miyakawa H, 1999, P NATL ACAD SCI USA, V96, P2538, DOI 10.1073/pnas.96.5.2538; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Moraes TF, 2008, CURR OPIN STRUC BIOL, V18, P258, DOI 10.1016/j.sbi.2007.12.011; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Powell Jennifer R., 2008, V415, P403, DOI 10.1007/978-1-59745-570-1_24; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Romney SJ, 2008, J BIOL CHEM, V283, P716, DOI 10.1074/jbc.M707043200; Senger K, 2006, P NATL ACAD SCI USA, V103, P15957, DOI 10.1073/pnas.0607608103; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen C, 2005, J BIOL CHEM, V280, P20580, DOI 10.1074/jbc.M501894200; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	51	53	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9010	10.1371/journal.pone.0009010	http://dx.doi.org/10.1371/journal.pone.0009010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126308	Green Published, gold, Green Submitted			2022-12-27	WOS:000274207200009
J	Orbach, DN; Veselka, N; Dzal, Y; Lazure, L; Fenton, MB				Orbach, Dara N.; Veselka, Nina; Dzal, Yvonne; Lazure, Louis; Fenton, M. Brock			Drinking and Flying: Does Alcohol Consumption Affect the Flight and Echolocation Performance of Phyllostomid Bats?	PLOS ONE			English	Article							FRUIT-EATING BATS; CAROLLIA-PERSPICILLATA; FORAGING BEHAVIOR; ETHANOL; FOOD; OLFACTION; DIET; CUES; APPETITE; ECOLOGY	levels of ethanol that could induce inebriation. To understand if consumption of ethanol by bats alters their access to food and general survival requires examination of behavioural responses to its ingestion, as well as assessment of interspecific variation in those responses. We predicted that bats fed ethanol would show impaired flight and echolocation behaviour compared to bats fed control sugar water, and that there would be behavioural differences among species. Methodology/Principal Findings: We fed wild caught Artibeus jamaicensis, A. lituratus, A. phaeotis, Carollia sowelli, Glossophaga soricina, and Sturnira lilium (Chiroptera, Phyllostomidae) sugar water (44 g of table sugar in 500 ml of water) or sugar water with ethanol before challenging them to fly through an obstacle course while we simultaneously recorded their echolocation calls. We used bat saliva, a non-invasive proxy, to measure blood ethanol concentrations ranging from 0 to .0.3% immediately before flight trials. Flight performance and echolocation behaviour were not significantly affected by consumption of ethanol, but species differed in their blood alcohol concentrations after consuming it. Conclusions/Significance: The bats we studied display a tolerance for ethanol that could have ramifications for the adaptive radiation of frugivorous and nectarivorous bats by allowing them to use ephemeral food resources over a wide span of time. By sampling across phyllostomid genera, we show that patterns of apparent ethanol tolerance in New World bats are broad, and thus may have been an important early step in the evolution of frugivory and nectarivory in these animals.	[Orbach, Dara N.; Veselka, Nina; Lazure, Louis; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON, Canada; [Dzal, Yvonne] Univ Regina, Dept Biol, Regina, SK S4S 0A2, Canada	Western University (University of Western Ontario); University of Regina	Orbach, DN (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	bfenton@uwo.ca	Dzal, Yvonne/AAA-3220-2022	Dzal, Yvonne/0000-0002-4391-0712	University of Western Ontario; Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada [R3516A03]	University of Western Ontario; Kenneth M Molson Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This project was supported by a grant from the University of Western Ontario (Graduate Thesis Research Award) to DN Orbach, and grants from the Kenneth M Molson Foundation and the Natural Sciences and Engineering Research Council of Canada (Discovery Grant R3516A03) to MB Fenton. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson CI, 2005, ALCOHOL, V36, P187, DOI 10.1016/j.alcohol.2005.09.001; Acharya KK, 1998, BEHAV PROCESS, V44, P59, DOI 10.1016/S0376-6357(98)00028-X; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; ALDRIDGE HDJN, 1988, J MAMMAL, V69, P379, DOI 10.2307/1381393; Banack SA, 1998, ECOLOGY, V79, P1949, DOI 10.1890/0012-9658(1998)079[1949:DSARUB]2.0.CO;2; Barnett CA, 2007, BEHAV ECOL, V18, P645, DOI 10.1093/beheco/arm027; BATTCOCK M, 1998, FAO AGR SERVICE B, V134; BONACCORSO FJ, 1987, J ANIM ECOL, V56, P907, DOI 10.2307/4956; BOSRON WF, 1984, ALCOHOL CLIN EXP RES, V8, P196, DOI 10.1111/j.1530-0277.1984.tb05837.x; Caton SJ, 2004, PHYSIOL BEHAV, V81, P51, DOI 10.1016/j.physbeh.2003.12.017; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; Crabbe JC, 2002, ANNU REV PSYCHOL, V53, P435, DOI 10.1146/annurev.psych.53.100901.135142; DEBUSSCHE M, 1987, OIKOS, V49, P244, DOI 10.2307/3565758; DENNIS J. V., 1987, BIRDERS WORLD, V1, P15; DiBattista D, 1998, ALCOHOL, V15, P55, DOI 10.1016/S0741-8329(97)00098-0; Dominy NJ, 2004, INTEGR COMP BIOL, V44, P295, DOI 10.1093/icb/44.4.295; Dubowski KM, 2002, FORENSIC SCI MED, P77; DUBOWSKI KM, 1975, Z RECHTSMED, V76, P93; Dudley R, 2004, INTEGR COMP BIOL, V44, P315, DOI 10.1093/icb/44.4.315; Dudley R, 2002, ADDICTION, V97, P381, DOI 10.1046/j.1360-0443.2002.00002.x; Dudley R, 2000, Q REV BIOL, V75, P3, DOI 10.1086/393255; Dumont ER, 2003, BAT ECOLOGY, P398; Fenton MB, 1999, ACTA CHIROPTEROL, V1, P127; Fenton MB, 2001, J TROP ECOL, V17, P511, DOI 10.1017/S0266467401001389; FITZGERALD SD, 1990, AVIAN DIS, V34, P488, DOI 10.2307/1591442; FUNAKOSHI K, 1993, J ZOOL, V230, P221, DOI 10.1111/j.1469-7998.1993.tb02684.x; GARRIOT JC, 2003, MED LEGAL ASPECTS AL; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Hetherington MM, 2001, PHYSIOL BEHAV, V74, P283, DOI 10.1016/S0031-9384(01)00598-4; HOFFMANN AA, 1984, BIOL J LINN SOC, V22, P43, DOI 10.1111/j.1095-8312.1984.tb00798.x; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Jones G, 1999, J EXP BIOL, V202, P3359; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kalko EKV, 1998, FUNCT ECOL, V12, P364, DOI 10.1046/j.1365-2435.1998.00198.x; Korine C, 2005, BEHAV ECOL SOCIOBIOL, V59, P12, DOI 10.1007/s00265-005-0003-1; Korine C, 1999, BIOL CONSERV, V88, P301, DOI 10.1016/S0006-3207(98)00126-8; KRULL KR, 1993, ALCOHOL CLIN EXP RES, V17, P771, DOI 10.1111/j.1530-0277.1993.tb00839.x; LASKA M, 1990, J COMP PHYSIOL A, V166, P395; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; Lutz Fritz-Ulrich, 1993, Blutalkohol, V30, P240; Mazeh S, 2008, BEHAV PROCESS, V77, P369, DOI 10.1016/j.beproc.2007.10.003; Middaugh LD, 1999, ALCOHOL, V17, P175, DOI 10.1016/S0741-8329(98)00055-X; Morris S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P363, DOI 10.1086/499983; Nelson Suzanne L., 2000, Pacific Science, V54, P301; NEWLAND MC, 1992, J STUD ALCOHOL, V53, P80, DOI 10.15288/jsa.1992.53.80; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; ORBACH DO, 2008, 38 ANN N AM S BAT RE; Prinzinger R, 1996, J ORNITHOL, V137, P319, DOI 10.1007/BF01651072; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; REID FA, 1998, FIELD GUIDE MAMMALS, P71; RIEGER JF, 1988, BIOTROPICA, V20, P161, DOI 10.2307/2388189; Sanchez F, 2004, INTEGR COMP BIOL, V44, P290, DOI 10.1093/icb/44.4.290; Sanchez F, 2008, J EXP BIOL, V211, P1475, DOI 10.1242/jeb.013268; Sanchez F, 2008, NATURWISSENSCHAFTEN, V95, P561, DOI 10.1007/s00114-008-0359-y; Sanchez F, 2006, J CHEM ECOL, V32, P1289, DOI 10.1007/s10886-006-9085-0; SCHWARTZ RH, 1989, ANN EMERG MED, V18, P1001, DOI 10.1016/S0196-0644(89)80470-6; SEDMAN AJ, 1976, J STUD ALCOHOL, V37, P1197, DOI 10.15288/jsa.1976.37.1197; Siegel R. K., 1989, INTOXICATION LIFE PU; Smolle KH, 1999, INTENS CARE MED, V25, P492, DOI 10.1007/s001340050886; Stephen L. J., 2000, Blue Jay, V58, P33; SUTTON D, 1970, PHYSIOL BEHAV, V5, P889, DOI 10.1016/0031-9384(70)90177-0; Thies W, 1998, BEHAV ECOL SOCIOBIOL, V42, P397, DOI 10.1007/s002650050454; WEINS F, 2008, P NATL ACAD SCI USA, V105, P10426; WILSON DE, 1973, SYST ZOOL, V22, P14, DOI 10.2307/2412374; Yeomans MR, 2004, BRIT J NUTR, V92, pS31, DOI 10.1079/BJN20041139	66	11	11	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8993	10.1371/journal.pone.0008993	http://dx.doi.org/10.1371/journal.pone.0008993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126552	gold, Green Published			2022-12-27	WOS:000274209700019
J	Lermen, D; Gorjup, E; Dyce, PW; von Briesen, H; Muller, P				Lermen, Dominik; Gorjup, Erwin; Dyce, Paul W.; von Briesen, Hagen; Mueller, Paul			Neuro-Muscular Differentiation of Adult Porcine Skin Derived Stem Cell-Like Cells	PLOS ONE			English	Article							HUMAN BONE-MARROW; SIDE POPULATION CELLS; PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO; NESTIN EXPRESSION; STROMAL CELLS; GENE-EXPRESSION; PRECURSOR CELLS; GROWTH-FACTOR	Background: Due to the genetic relationship to humans, porcine stem cells are a very important model system to investigate cell differentiation, associated cell signaling pathways, and cell fate. Porcine skin derived stem cells have been isolated from mid-gestation porcine fetus recently. To our knowledge, stem cells from the skin of the adult porcine organism have not been isolated until now. Hence, to our knowledge, we here describe the isolation, expansion, characterization and differentiation of multipotent porcine skin derived stem cell-like cells (pSSCs) from the adult porcine organism for the first time. Methodology/Principal Findings: pSSCs had a spindle shaped morphology similar to mesenchymal stem cells (MSCs). They could be maintained proliferatively active in vitro for more than 120 days and were able to form colonies from single cells. pSSCs expressed Sox2 and Oct3/4, both transcription factors essential to the pluripotent and self-renewing phenotypes of embryonic stem cells, which recently gained attention due to their function in inducing pluripotent stem cells. Furthermore, the expression of the progenitor marker nestin, the somatic stem cell markers Bcrp1/ABCG2, Bmi1, and Stat3 was detected by reverse transcriptase-polymerase chain reaction (RT-PCR) in undifferentiated pSSCs. Flow cytometry revealed the expression of the MSC related proteins CD9, CD29, CD44 and CD105, but not CD90. After neuronal differentiation cells with a characteristic morphology of neuronal and smooth muscle-like cells were present in the cultures. Subsequent immunochemistry and flow cytometry revealed the down-regulation of nestin and the up-regulation of the neuron specific protein beta-III-tubulin and the astrocyte marker GFAP. Also, alpha-SMA expressing cells increased during differentiation suggesting the neuro-muscular differentiation of these skin derived cells. pSSCs could also be induced to differentiate into adipocyte-like cells when cultured under specific conditions. Conclusions/Significance: Adult porcine skin harbors a population of stem cell-like cells (pSSCs) that can be isolated via enzymatic digestion. These pSSCs show characteristic features of MSCs originated in other tissues and express the embryonic stem cell marker Oct3/4, Sox2, and Stat3. Furthermore, pSSCs have the potential to differentiate into cells from two different germ lines, the ectoderm (neurons, astrocytes) and the mesoderm (smooth muscle cells, adipocytes).	[Lermen, Dominik; Mueller, Paul] Univ Trier, Dept Biogeog, Trier, Germany; [Gorjup, Erwin; von Briesen, Hagen] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, St Ingbert, Germany; [Dyce, Paul W.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	Universitat Trier; Fraunhofer Gesellschaft; University of Guelph	Lermen, D (corresponding author), Univ Trier, Dept Biogeog, Trier, Germany.	lermen@uni-trier.de		Dyce, Paul/0000-0002-4574-3321	DFG; German Research Foundation	DFG(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG))	Funding: This work was supported by the DFG, the German Research Foundation (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2005, EXP CELL RES, V310, P383, DOI 10.1016/j.yexcr.2005.08.015; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; Cotsarelis G, 1999, EXP DERMATOL, V8, P80, DOI 10.1111/j.1600-0625.1999.tb00351.x; Danner S, 2007, MOL HUM REPROD, V13, P11, DOI 10.1093/molehr/gal096; DICK IP, 1992, J PHARM PHARMACOL, V44, P640, DOI 10.1111/j.2042-7158.1992.tb05485.x; DiGirolamo CM, 1999, BRIT J HAEMATOL, V107, P275, DOI 10.1046/j.1365-2141.1999.01715.x; Draberova E, 2008, J NEUROPATH EXP NEUR, V67, P341, DOI 10.1097/NEN.0b013e31816a686d; Dunnwald M, 2001, EXP DERMATOL, V10, P45, DOI 10.1034/j.1600-0625.2001.100106.x; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Go MJ, 2008, EXP CELL RES, V314, P1147, DOI 10.1016/j.yexcr.2007.11.021; Gorjup E, 2009, EUR J CELL BIOL, V88, P409, DOI 10.1016/j.ejcb.2009.02.187; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Holt WV, 2004, REPRODUCTION, V127, P317, DOI 10.1530/rep.1.00074; Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49; Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobi U, 2007, SKIN RES TECHNOL, V13, P19, DOI 10.1111/j.1600-0846.2006.00179.x; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kajahn J, 2008, EUR J CELL BIOL, V87, P39, DOI 10.1016/j.ejcb.2007.07.004; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim M, 2002, CLIN CANCER RES, V8, P22; Kim MK, 2007, CLONING STEM CELLS, V9, P130, DOI 10.1089/clo.2006.0034; Kruse C, 2004, APPL PHYS A-MATER, V79, P1617, DOI 10.1007/s00339-004-2816-6; Kruse C, 2006, EXP DERMATOL, V15, P794, DOI 10.1111/j.1600-0625.2006.00471.x; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Leon-Quinto T, 2009, ANIM REPROD SCI, V112, P347, DOI 10.1016/j.anireprosci.2008.05.070; Lermen D, 2009, MOL ECOL, V18, P1030, DOI 10.1111/j.1365-294X.2008.04062.x; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liang LC, 2002, STEM CELLS, V20, P21, DOI 10.1634/stemcells.20-1-21; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LOO DT, 1994, NEUROREPORT, V5, P1585, DOI 10.1097/00001756-199408150-00011; MALCOLM RA, 2003, J PATHOL, V200, P547; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; MISKO TP, 1987, J EXP BIOL, V132, P177; Moreels M, 2008, NEUROPATH APPL NEURO, V34, P532, DOI 10.1111/j.1365-2990.2007.00910.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramsay TG, 1998, J ANIM SCI, V76, P484; REYNOLDS AJ, 1991, J CELL SCI, V99, P373; Ringe J, 2002, CELL TISSUE RES, V307, P321, DOI 10.1007/s00441-002-0525-z; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schwartz PH, 2005, STEM CELLS, V23, P1286, DOI 10.1634/stemcells.2004-0306; Shi CM, 2004, MED HYPOTHESES, V62, P683, DOI 10.1016/j.mehy.2003.12.022; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Shim H, 1997, BIOL REPROD, V57, P1089, DOI 10.1095/biolreprod57.5.1089; Simon GA, 2000, SKIN PHARMACOL APPL, V13, P229, DOI 10.1159/000029928; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; Tai MH, 2005, CARCINOGENESIS, V26, P495, DOI 10.1093/carcin/bgh321; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149; Xiang Ying, 2007, Journal of Zhejiang University-Science B, V8, P136, DOI 10.1631/jzus.2007.B0136; Zeng LP, 2006, STEM CELLS, V24, P2355, DOI 10.1634/stemcells.2005-0551; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	92	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8968	10.1371/journal.pone.0008968	http://dx.doi.org/10.1371/journal.pone.0008968			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126464	Green Published, gold, Green Submitted			2022-12-27	WOS:000274139100016
J	Rico, A; Bennett, MH; Forcat, S; Huang, WE; Preston, GM				Rico, Arantza; Bennett, Mark H.; Forcat, Silvia; Huang, Wei E.; Preston, Gail M.			Agroinfiltration Reduces ABA Levels and Suppresses Pseudomonas syringae-Elicited Salicylic Acid Production in Nicotiana tabacum	PLOS ONE			English	Article							PV. TOMATO DC3000; SYSTEMIC ACQUIRED-RESISTANCE; HYPERSENSITIVE CELL-DEATH; ACINETOBACTER SP ADP1; AGROBACTERIUM-TUMEFACIENS; INNATE IMMUNITY; DISEASE RESISTANCE; GENE-EXPRESSION; TOBACCO-LEAVES; CROWN-GALL	Background: Agrobacterium tumefaciens strain GV3101 (pMP90) is widely used in transient gene expression assays, including assays to study pathogen effectors and plant disease resistance mechanisms. However, inoculation of A. tumefaciens GV3101 into Nicotiana tabacum (tobacco) leaves prior to infiltration with pathogenic and non-host strains of Pseudomonas syringae results in suppression of macroscopic symptoms when compared with leaves pre-treated with a buffer control. Methodology/Findings: To gain further insight into the mechanistic basis of symptom suppression by A. tumefaciens we examined the effect of pre-treatment with A. tumefaciens on the growth of P. syringae, the production of the plant signalling molecules salicylic acid (SA) and abscisic acid (ABA), and the presence of callose deposits. Pre-treatment with A. tumefaciens reduced ABA levels, P. syringae multiplication and P. syringae-elicited SA and ABA production, but promoted increased callose deposition. However, pre-treatment with A. tumefaciens did not suppress necrosis or SA production in leaves inoculated with the elicitor HrpZ. Conclusions/Significance: Collectively, these results show that inoculation of N. tabacum leaves with A. tumefaciens alters plant hormone levels and plant defence responses to P. syringae, and demonstrate that researchers should consider the impact of A. tumefaciens on plant signal transduction when using A. tumefaciens-mediated transient expression assays to investigate ABA-regulated processes or pathogenicity and plant defence mechanisms.	[Rico, Arantza; Preston, Gail M.] Univ Oxford, Dept Plant Sci, Oxford, England; [Bennett, Mark H.; Forcat, Silvia] Univ London Imperial Coll Sci Technol & Med, Div Biol, London, England; [Huang, Wei E.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England	University of Oxford; Imperial College London; University of Sheffield	Rico, A (corresponding author), Univ Oxford, Dept Plant Sci, Oxford, England.	gail.preston@plants.ox.ac.uk	Huang, Wei/N-6880-2019; Rico, Arantza/Z-2414-2019	Huang, Wei/0000-0003-1302-6528; Rico, Arantza/0000-0002-4008-5569; Preston, Gail/0000-0003-3882-4438	Basque Government (Beca para la Formacion de Investigadores_DK); Biotechnology and Biological Sciences Research Council [BB/E007872/1]; Royal Society University; BBSRC [BB/E007872/1] Funding Source: UKRI	Basque Government (Beca para la Formacion de Investigadores_DK)(Basque Government); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society University(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: A. Rico was supported by a fellowship from the Basque Government (Beca para la Formacion de Investigadores_DK) and by Biotechnology and Biological Sciences Research Council Grant BB/E007872/1. G. M. Preston is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 2000, PLANT MOL BIOL, V44, P429, DOI 10.1023/A:1026561029533; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/j.1364-3703.2007.00437.x, 10.1111/J.1364-3703.2007.00437.X]; Bozso Z, 2005, J PHYTOPATHOL, V153, P596, DOI 10.1111/j.1439-0434.2005.01026.x; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; CHILTON MD, 1977, CELL, V11, P263, DOI 10.1016/0092-8674(77)90043-5; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Conrath U, 2002, TRENDS PLANT SCI, V7, P210, DOI 10.1016/S1360-1385(02)02244-6; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; de Torres M, 2006, PLANT J, V47, P368, DOI 10.1111/j.1365-313X.2006.02798.x; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; De Vleesschauwer D, 2008, PLANT PHYSIOL, V148, P1996, DOI 10.1104/pp.108.127878; DETORRESZABALA M, 2009, PLANT J, V59, P375, DOI DOI 10.1111/J.1365-313X.2009.03875.X; Ditt RF, 2001, P NATL ACAD SCI USA, V98, P10954, DOI 10.1073/pnas.191383498; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Forcat S, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-16; GARFINKEL DJ, 1981, CELL, V27, P143, DOI 10.1016/0092-8674(81)90368-8; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Huang J, 2003, PLANTA, V217, P767, DOI 10.1007/s00425-003-1039-y; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Huang WE, 2006, PLANT J, V46, P1073, DOI 10.1111/j.1365-313X.2006.02758.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klement Z, 2003, PEST MANAG SCI, V59, P465, DOI 10.1002/ps.694; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Laurie-Berry N, 2006, MOL PLANT MICROBE IN, V19, P789, DOI 10.1094/MPMI-19-0789; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Li JF, 2009, PLANT METHODS, V5, DOI [10.1186/1746-4811-5-6, 10.1371/journal.pcbi.1000450]; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Oh HS, 2005, PLANT J, V44, P348, DOI 10.1111/j.1365-313X.2005.02529.x; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruss GJ, 2008, MOL PLANT MICROBE IN, V21, P1528, DOI 10.1094/MPMI-21-12-1528; RICO A, 2008, PSEUDOMONAS SYRINGAE, P97; Rico A, 2008, MOL PLANT MICROBE IN, V21, P269, DOI 10.1094/MPMI-21-2-0269; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; ROBINETTE D, 1990, J BACTERIOL, V172, P5742, DOI 10.1128/jb.172.10.5742-5749.1990; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel MA, 2005, PLANT J, V42, P406, DOI 10.1111/j.1365-313X.2005.02382.x; Sawers RJH, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-15; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; STACHEL SE, 1986, EMBO J, V5, P1445, DOI 10.1002/j.1460-2075.1986.tb04381.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Uppalapati SR, 2007, MOL PLANT MICROBE IN, V20, P955, DOI 10.1094/MPMI-20-8-0955; VAN LAREBEKE N, 1974, NATURE, V252, P169, DOI 10.1038/252169a0; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vlot AC, 2008, CURR OPIN PLANT BIOL, V11, P436, DOI 10.1016/j.pbi.2008.05.003; WATSON B, 1975, J BACTERIOL, V123, P255, DOI 10.1128/JB.123.1.255-264.1975; Wroblewski T, 2005, PLANT BIOTECHNOL J, V3, P259, DOI 10.1111/j.1467-7652.2005.00123.x; Zhao YF, 2003, PLANT J, V36, P485, DOI 10.1046/j.1365-313X.2003.01895.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	64	32	33	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8977	10.1371/journal.pone.0008977	http://dx.doi.org/10.1371/journal.pone.0008977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126459	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000274139100023
J	Sacco, JJ; Botten, J; Macbeth, F; Bagust, A; Clark, P				Sacco, Joseph J.; Botten, Joanne; Macbeth, Fergus; Bagust, Adrian; Clark, Peter			The Average Body Surface Area of Adult Cancer Patients in the UK: A Multicentre Retrospective Study	PLOS ONE			English	Article							ANTICANCER DRUGS; DOSE CALCULATION; CHEMOTHERAPY; PHARMACOKINETICS; FORMULA; WEIGHT; HEIGHT; AGENTS	The majority of chemotherapy drugs are dosed based on body surface area (BSA). No standard BSA values for patients being treated in the United Kingdom are available on which to base dose and cost calculations. We therefore retrospectively assessed the BSA of patients receiving chemotherapy treatment at three oncology centres in the UK between 1(st) January 2005 and 31(st) December 2005. A total of 3613 patients receiving chemotherapy for head and neck, ovarian, lung, upper GI/pancreas, breast or colorectal cancers were included. The overall mean BSA was 1.79 m(2) (95% CI 1.78-1.80) with a mean BSA for men of 1.91 m(2) (1.90-1.92) and 1.71 m(2) (1.70-1.72) for women. Results were consistent across the three centres. No significant differences were noted between treatment in the adjuvant or palliative setting in patients with breast or colorectal cancer. However, statistically significant, albeit small, differences were detected between some tumour groups. In view of the consistency of results between three geographically distinct UK cancer centres, we believe the results of this study may be generalised and used in future costings and budgeting for new chemotherapy agents in the UK.	[Sacco, Joseph J.; Clark, Peter] Clatterbridge Ctr Oncol, Dept Med Oncol, Clatterbridge, Merseyside, England; [Botten, Joanne; Macbeth, Fergus] Velindre Canc Ctr, Dept Clin Oncol, Cardiff, S Glam, Wales; [Bagust, Adrian] Univ Liverpool, Liverpool Reviews & Implementat Grp, Liverpool L69 3BX, Merseyside, England	Clatterbridge Cancer Centre; Velindre Cancer Centre; University of Liverpool	Sacco, JJ (corresponding author), Clatterbridge Ctr Oncol, Dept Med Oncol, Clatterbridge, Merseyside, England.	joseph.sacco@nhs.net			National Institute for Health Research [08/88/01, 08/40/01, 08/207/01, 09/59/01]	National Institute for Health Research(National Institute for Health Research (NIHR))	The Liverpool Reviews and Implementation Group, including AB, was funded by the National Institute for Health Research Health Technology Assessment Programme to undertake reviews of submitted evidence in support of NICE technology appraisals, including the STAs mentioned in Appendix C (project numbers 08/88/01, 08/40/01, 08/207/01, 09/59/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views and opinions expressed here are those of the authors and do not necessarily reflect those of the National Institute of Health and Clinical Excellence or the Department of Health.	ASHCROFT D, 2007, NICE TECHNOLOGY APPR, V118; BAGUST A, 2006, PEMETREXED TREATMENT; BAGUST A, 2006, ERLOTINIB TREATMENT; Baker SD, 2002, JNCI-J NATL CANCER I, V94, P1883, DOI 10.1093/jnci/94.24.1883; BARNETT D, 2007, HEAD NECK CANC CETUX; Boyd E, 1935, GROWTH SURFACE AREA; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; Colleoni M, 2005, LANCET, V366, P1108, DOI 10.1016/S0140-6736(05)67110-3; Dooley MJ, 2004, SUPPORT CARE CANCER, V12, P653, DOI 10.1007/s00520-004-0606-5; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Felici A, 2002, EUR J CANCER, V38, P1677, DOI 10.1016/S0959-8049(02)00151-X; GEHAN EA, 1970, CANCER CHEMOTH REP 1, V54, P225; Gurney H, 1996, J CLIN ONCOL, V14, P2590, DOI 10.1200/JCO.1996.14.9.2590; Kaestner SA, 2007, CLIN ONCOL-UK, V19, P23, DOI 10.1016/j.clon.2006.10.010; Littlejohns P, 2003, LANCET ONCOL, V4, P242, DOI 10.1016/S1470-2045(03)01036-2; MACLEAN F, 2003, PHARM J, V270, P691; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; POWIS G, 1987, CANCER CHEMOTH PHARM, V20, P219, DOI 10.1007/BF00570489; Ratain MJ, 1998, J CLIN ONCOL, V16, P2297, DOI 10.1200/JCO.1998.16.7.2297; RATAIN MJ, 1991, J CLIN ONCOL, V9, P1480, DOI 10.1200/JCO.1991.9.8.1480; RODVOLD KA, 1988, J CLIN ONCOL, V6, P1321, DOI 10.1200/JCO.1988.6.8.1321; Rosner GL, 1996, J CLIN ONCOL, V14, P3000, DOI 10.1200/JCO.1996.14.11.3000; Sawyer M, 2001, INVEST NEW DRUG, V19, P171, DOI 10.1023/A:1010639201787; Sparreboom A, 2007, J CLIN ONCOL, V25, P4707, DOI 10.1200/JCO.2007.11.2938; Undevia SD, 2005, NAT REV CANCER, V5, P447, DOI 10.1038/nrc1629	25	128	141	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8933	10.1371/journal.pone.0008933	http://dx.doi.org/10.1371/journal.pone.0008933			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126669	Green Submitted, gold, Green Published			2022-12-27	WOS:000274138000011
J	Craft, JA; Gilbert, JA; Temperton, B; Dempsey, KE; Ashelford, K; Tiwari, B; Hutchinson, TH; Chipman, JK				Craft, John A.; Gilbert, Jack A.; Temperton, Ben; Dempsey, Kate E.; Ashelford, Kevin; Tiwari, Bela; Hutchinson, Tom H.; Chipman, J. Kevin			Pyrosequencing of Mytilus galloprovincialis cDNAs: Tissue-Specific Expression Patterns	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; FLOUNDER PLATICHTHYS-FLESUS; DEPENDENT SEX-RATIO; MITOCHONDRIAL-DNA; GENE-EXPRESSION; M-TROSSULUS; SMALL RNAS; EDULIS; MUSSELS; SEQUENCES	Background: Mytilus species are important in marine ecology and in environmental quality assessment, yet their molecular biology is poorly understood. Molecular aspects of their reproduction, hybridisation between species, mitochondrial inheritance, skewed sex ratios of offspring and adaptation to climatic and pollution factors are priority areas. Methodology/Principal Findings: To start to address this situation, expressed genetic transcripts from M. galloprovincialis were pyrosequenced. Transcripts were isolated from the digestive gland, foot, gill and mantle of both male and female mussels. In total, 175,547 sequences were obtained and for foot and mantle, 90% of the sequences could be assembled into contiguous fragments but this reduced to 75% for the digestive gland and gill. Transcripts relating to protein metabolism and respiration dominated including ribosomal proteins, cytochrome oxidases and NADH dehydrogenase subunits. Tissue specific variation was identified in transcripts associated with mitochondrial energy metabolism, with the digestive gland and gill having the greatest transcript abundance. Using fragment recruitment it was also possible to identify sites of potential small RNAs involved in mitochondrial transcriptional regulation. Sex ratios based on Vitelline Envelop Receptor for Lysin and Vitelline Coat Lysin transcript abundances, indicated that an equal sex distribution was maintained. Taxonomic profiling of the M. galloprovincialis tissues highlighted an abundant microbial flora associated with the digestive gland. Profiling of the tissues for genes involved in intermediary metabolism demonstrated that the gill and digestive gland were more similar to each other than to the other two tissues, and specifically the foot transcriptome was most dissimilar. Conclusions: Pyrosequencing has provided extensive genomic information for M. galloprovincialis and generated novel observations on expression of different tissues, mitochondria and associated microorganisms. It will also facilitate the much needed production of an oligonucleotide microarray for the organism.	[Craft, John A.; Dempsey, Kate E.] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Gilbert, Jack A.; Temperton, Ben; Hutchinson, Tom H.] Univ Liverpool, Plymouth Marine Lab, Liverpool L69 3BX, Merseyside, England; [Ashelford, Kevin] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Tiwari, Bela] Ctr Ecol & Hydrol, Nat Environm Res Council Environm Bioinformat Ctr, Wallingford, Oxon, England; [Chipman, J. Kevin] Univ Birmingham, Sch Biol Sci, Birmingham B15 2TT, W Midlands, England	Glasgow Caledonian University; Plymouth Marine Laboratory; University of Liverpool; University of Liverpool; UK Centre for Ecology & Hydrology (UKCEH); University of Birmingham	Craft, JA (corresponding author), Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland.	j.a.craft@gcal.ac.uk	Gilbert, Jack/AAF-3270-2019; Temperton, Ben/AAE-2785-2021	Hutchinson, Tom/0000-0001-8823-5442; Temperton, Ben/0000-0002-3667-8302; Ashelford, Kevin/0000-0003-3217-2811	Natural Environment Research Council (NERC); NERC [NBAF010002, pml010004] Funding Source: UKRI; Natural Environment Research Council [NBAF010002, CEH010021, pml010004] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) (www.nerc.ac.uk) by making available staff and pyrosequencing facilities at the NERC Biomolecular Analysis Facility at the University of Liverpool. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierne N, 2003, MOL ECOL, V12, P447, DOI 10.1046/j.1365-294X.2003.01730.x; Blunt RE, 2007, ENVIRON SCI POLLUT R, V14, P293, DOI 10.1065/espr2007.06.431; Brown M, 2006, MAR ENVIRON RES, V62, pS128, DOI 10.1016/j.marenvres.2006.04.057; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Diz AP, 2009, MOL CELL PROTEOMICS, V8, P132, DOI 10.1074/mcp.M800237-MCP200; Dondero F, 2006, GENE, V376, P24, DOI 10.1016/j.gene.2006.02.015; Falciani F, 2008, AQUAT TOXICOL, V90, P92, DOI 10.1016/j.aquatox.2008.07.020; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Goldberg ED, 2000, SCI TOTAL ENVIRON, V247, P165, DOI 10.1016/S0048-9697(99)00488-X; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; Hilbish TJ, 2002, MAR BIOL, V140, P137, DOI 10.1007/s002270100631; Hines A, 2007, ANAL BIOCHEM, V369, P175, DOI 10.1016/j.ab.2007.06.008; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Kenchington E, 2002, GENETICS, V161, P1579; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; Mitchelmore CL, 1998, MUTAT RES-FUND MOL M, V399, P135, DOI 10.1016/S0027-5107(97)00252-2; Mizi A, 2005, MOL BIOL EVOL, V22, P952, DOI 10.1093/molbev/msi079; Murata-Kamiya N, 2000, Nucleic Acids Symp Ser, P3; Nakamura T, 2009, PHARMACOL RES, V60, P515, DOI 10.1016/j.phrs.2009.05.002; PENNEC GL, 2003, AQUAT TOXICOL, V64, P131; Saavedra C, 1997, GENETICS, V145, P1073; SEDIK W, 2009, MARINE BIOL IN PRESS; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; SKIBINSKI DOF, 1983, BIOL J LINN SOC, V19, P137, DOI 10.1111/j.1095-8312.1983.tb00782.x; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Tanguy A, 2008, GENE, V408, P27, DOI 10.1016/j.gene.2007.10.021; Toro JE, 2002, MAR BIOL, V141, P897, DOI 10.1007/s00227-002-0897-3; Torrado M, 1998, CELL TISSUE RES, V294, P537, DOI 10.1007/s004410051204; Vander Jagt David L., 2008, Drug Metabolism and Drug Interactions, V23, P93; Venier P, 2003, GENE, V314, P29, DOI 10.1016/S0378-1119(03)00708-X; Venier P, 2006, MUTAT RES-FUND MOL M, V602, P121, DOI 10.1016/j.mrfmmm.2006.08.007; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Widdows J, 2002, MAR ENVIRON RES, V53, P327, DOI 10.1016/S0141-1136(01)00120-9; Williams TD, 2007, TOXICOL LETT, V168, P236, DOI 10.1016/j.toxlet.2006.10.020; Williams TD, 2006, ENVIRON SCI TECHNOL, V40, P6479, DOI 10.1021/es061142h; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0	43	103	106	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8875	10.1371/journal.pone.0008875	http://dx.doi.org/10.1371/journal.pone.0008875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111607	Green Published, gold, Green Accepted			2022-12-27	WOS:000273896300024
J	Puente, N; Elezgarai, I; Lafourcade, M; Reguero, L; Marsicano, G; Georges, F; Manzoni, OJ; Grandes, P				Puente, Nagore; Elezgarai, Izaskun; Lafourcade, Mathieu; Reguero, Leire; Marsicano, Giovanni; Georges, Francois; Manzoni, Olivier J.; Grandes, Pedro			Localization and Function of the Cannabinoid CB1 Receptor in the Anterolateral Bed Nucleus of the Stria Terminalis	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; VENTRAL TEGMENTAL AREA; STRESS-INDUCED RELAPSE; ADULT-RAT BRAIN; ENDOCANNABINOID SYSTEM; GLUTAMATERGIC SYNAPSES; ANANDAMIDE HYDROLYSIS; OPIATE WITHDRAWAL; EXTENDED AMYGDALA; COCAINE-SEEKING	Background: The bed nucleus of the stria terminalis (BNST) is involved in behaviors related to natural reward, drug addiction and stress. In spite of the emerging role of the endogenous cannabinoid (eCB) system in these behaviors, little is known about the anatomy and function of this system in the anterolateral BNST (alBNST). The aim of this study was to provide a detailed morphological characterization of the localization of the cannabinoid 1 (CB1) receptor a necessary step toward a better understanding of the physiological roles of the eCB system in this region of the brain. Methodology/Principal Findings: We have combined anatomical approaches at the confocal and electron microscopy level to ex-vivo electrophysiological techniques. Here, we report that CB1 is localized on presynaptic membranes of about 55% of immunopositive synaptic terminals for the vesicular glutamate transporter 1 (vGluT1), which contain abundant spherical, clear synaptic vesicles and make asymmetrical synapses with alBNST neurons. About 64% of vGluT1 immunonegative synaptic terminals show CB1 immunolabeling. Furthermore, 30% and 35% of presynaptic boutons localize CB1 in alBNST of conditional mutant mice lacking CB1 mainly from GABAergic neurons (GABA-CB1-KO mice) and mainly from cortical glutamatergic neurons (Glu-CB1-KO mice), respectively. Extracellular field recordings and whole cell patch clamp in the alBNST rat brain slice preparation revealed that activation of CB1 strongly inhibits excitatory and inhibitory synaptic transmission. Conclusions/Significance: This study supports the anterolateral BNST as a potential neuronal substrate of the effects of cannabinoids on stress-related behaviors.	[Puente, Nagore; Elezgarai, Izaskun; Reguero, Leire; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Bilbao, Spain; [Lafourcade, Mathieu; Georges, Francois; Manzoni, Olivier J.] INSERM, Equipe Physiopathol Transmiss & Plast Synapt, U862, Bordeaux, France; [Marsicano, Giovanni] Univ Bordeaux 2, INSERM, U862, NeuroCtr Magendie, F-33076 Bordeaux, France	University of Basque Country; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Puente, N (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Neurosci, Bilbao, Spain.	olivier.manzoni@inserm.fr; pedro.grandes@ehu.es	Puente, Nagore/H-7054-2015; Grandes, Pedro/H-7494-2015; Lafourcade, Mathieu/GQZ-7267-2022; Grandes, Pedro/AAA-1627-2019; Elezgarai, Izaskun/H-7076-2015; Marsicano, Giovanni/I-9603-2016; Manzoni, Olivier/M-7899-2016; Reguero, Leire/H-6865-2015	Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Elezgarai, Izaskun/0000-0003-0880-8058; Manzoni, Olivier/0000-0002-5579-6208; Reguero, Leire/0000-0002-0267-5568; Lafourcade, Mathieu/0000-0001-6117-1194; GEORGES, Francois/0000-0002-2628-2638; Marsicano, Giovanni/0000-0003-3804-1951	The Basque Country Government [GIC07/70-IT-432-07]; Red de Trastornos Adictivos (RETICS); Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion (MICINN) [RD07/0001/2001, SAF2009-07065]; Basque Country University; Basque Country Government; INSERM; ANR [ANR-06-NEURO-043-01]; Region Aquitaine; AVENIR/INSERM; European Foundation for the Study of Diabetes (EFSD); EU [HEALTH-F2-2008-223713]; European Commission [LSHM-CT-2005-19063]	The Basque Country Government; Red de Trastornos Adictivos (RETICS); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Country University; Basque Country Government(Basque Government); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR(French National Research Agency (ANR)); Region Aquitaine(Region Nouvelle-Aquitaine); AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); European Foundation for the Study of Diabetes (EFSD); EU(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Red de Trastornos Adictivos (RETICS), Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion (MICINN), grant RD07/0001/2001 and MICINN grant SAF2009-07065. Nagore Puente is supported by a Basque Country University grant for PhD Researcher's Specialization. Leire Reguero is in receipt of a predoctoral fellowship from the Basque Country Government. Dr. Olivier J. Manzoni's laboratory is supported by INSERM, ANR Neurosciences "Neurologie et Psychiatrie ANR-06-NEURO-043-01" and Region Aquitaine. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo C, 2001, PHARMACOL BIOCHEM BE, V70, P123, DOI 10.1016/S0091-3057(01)00578-0; Aston-Jones G, 1999, ANN NY ACAD SCI, V877, P486, DOI 10.1111/j.1749-6632.1999.tb09284.x; Bangasser DA, 2008, J NEUROSCI, V28, P6383, DOI 10.1523/JNEUROSCI.0831-08.2008; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clapper JR, 2009, NEUROPHARMACOLOGY, V56, P235, DOI 10.1016/j.neuropharm.2008.07.018; Delfs JM, 2000, NATURE, V403, P430, DOI 10.1038/35000212; Dong HW, 2001, BRAIN RES REV, V38, P192, DOI 10.1016/S0165-0173(01)00079-0; Dong HW, 2004, J COMP NEUROL, V468, P277, DOI 10.1002/cne.10949; Dong HW, 2001, J COMP NEUROL, V436, P430, DOI 10.1002/cne.1079; Dumont EC, 2005, NAT NEUROSCI, V8, P413, DOI 10.1038/nn1414; Egli RE, 2005, NEUROPSYCHOPHARMACOL, V30, P657, DOI 10.1038/sj.npp.1300639; Erb S, 1996, PSYCHOPHARMACOLOGY, V128, P408, DOI 10.1007/s002130050150; Fortin DA, 2007, CEREB CORTEX, V17, P163, DOI 10.1093/cercor/bhj133; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Georges F, 2002, J NEUROSCI, V22, P5173, DOI 10.1523/JNEUROSCI.22-12-05173.2002; Gobbi G, 2005, P NATL ACAD SCI USA, V102, P18620, DOI 10.1073/pnas.0509591102; Grueter BA, 2006, J NEUROSCI, V26, P3210, DOI 10.1523/JNEUROSCI.0170-06.2006; Grueter BA, 2005, NEUROPSYCHOPHARMACOL, V30, P1302, DOI 10.1038/sj.npp.1300672; Haller J, 2002, EUR J NEUROSCI, V16, P1395, DOI 10.1046/j.1460-9568.2002.02192.x; Harris GC, 2007, BEHAV BRAIN RES, V176, P251, DOI 10.1016/j.bbr.2006.10.012; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hill MN, 2005, EUR NEUROPSYCHOPHARM, V15, P593, DOI 10.1016/j.euroneuro.2005.03.003; Hoffman AF, 2003, EUR J NEUROSCI, V18, P524, DOI 10.1046/j.1460-9568.2003.02773.x; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Katona I, 2001, J NEUROSCI, V21, P9506, DOI 10.1523/JNEUROSCI.21-23-09506.2001; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; Larriva-Sahd J, 2006, J COMP NEUROL, V497, P772, DOI 10.1002/cne.21011; Lovinger David M., 2008, V184, P435; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Mackie K, 2007, PLOS BIOL, V5, P2106, DOI 10.1371/journal.pbio.0050280; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Martin JR, 2002, PHARMACOL BIOCHEM BE, V71, P615, DOI 10.1016/S0091-3057(01)00713-4; Massi L, 2008, J NEUROSCI, V28, P10496, DOI 10.1523/JNEUROSCI.2291-08.2008; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Matyas F, 2008, NEUROPHARMACOLOGY, V54, P95, DOI 10.1016/j.neuropharm.2007.05.028; McDonald AJ, 1999, ANN NY ACAD SCI, V877, P309, DOI 10.1111/j.1749-6632.1999.tb09275.x; McElligott ZA, 2009, PROG NEURO-PSYCHOPH, V33, P1329, DOI 10.1016/j.pnpbp.2009.05.022; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory K, 2007, PLOS BIOL, V5, P2354, DOI 10.1371/journal.pbio.0050269; Navarro M, 1997, NEUROREPORT, V8, P491, DOI 10.1097/00001756-199701200-00023; Nyiri G, 2005, NEUROSCIENCE, V136, P811, DOI 10.1016/j.neuroscience.2005.01.026; Olsen CM, 2008, PHYSIOL GENOMICS, V32, P283, DOI 10.1152/physiolgenomics.00224.2006; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; PUENTE, 2009, 4 EUR WORKSH CANN RE; RINALDICARMONA M, 1994, FEBS LETT, V350, P240, DOI 10.1016/0014-5793(94)00773-X; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Robbe D, 2001, J NEUROSCI, V21, P109, DOI 10.1523/JNEUROSCI.21-01-00109.2001; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Stewart J, 2000, J PSYCHIATR NEUROSCI, V25, P125; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Yoshida T, 2006, J NEUROSCI, V26, P4740, DOI 10.1523/JNEUROSCI.0054-06.2006	56	40	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8869	10.1371/journal.pone.0008869	http://dx.doi.org/10.1371/journal.pone.0008869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111610	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896300018
J	Ha, TY; Chang, KA; Kim, JA; Kim, HS; Kim, S; Chong, YH; Suh, YH				Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Chong, Young Hae; Suh, Yoo-Hun			S100a9 Knockdown Decreases the Memory Impairment and the Neuropathology in Tg2576 Mice, AD Animal Model	PLOS ONE			English	Article							ALZHEIMER AMYLOID PRECURSOR; MACROPHAGES MICROGLIA; MOUSE MODEL; BETA; PROTEIN; DISEASE; BRAIN; ACTIVATION; EXPRESSION; CALCIUM	Inflammation, insoluble protein deposition and neuronal cell loss are important features in the Alzheimer's disease (AD) brain. To investigate the regulatory genes responsible for the neuropathology in AD, we performed microarray analysis with APP(V717I)-CT100 transgenic mice, an animal model of AD, and isolated the S100a9 gene, which encodes an Winflammation-associated calcium binding protein. In another AD animal model, Tg2576 mouse brain, and in human AD brain, induction of S100a9 was confirmed. The endogenous expression of S100a9 was induced by treatment with A beta or CT peptides in a microglia cell line, BV2 cells. In these cells, silencing study of S100a9 showed that the induction of S100a9 increased the intracellular calcium level and up-regulated the inflammatory cytokines (IL-1 beta and TNF alpha) and iNOS. S100a9 lentiviral short hairpin RNA (sh-S100a9) was injected into the hippocampus region of the brains of 13-month-old Tg2576 mice. At two months after injection, we found that knockdown of S100a9 expression had improved the cognition decline of Tg2576 mice in the water maze task, and had reduced amyloid plaque burden. These results suggest that S100a9 induced by A beta or CT contributes to cause inflammation, which then affects the neuropathology including amyloid plaques burden and impairs cognitive function. Thus, the inhibition of S100a9 is a possible target for AD therapy.	[Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Dept Pharmacol, Natl Creat Res Initiat Ctr Alzheimers Dementia, Seoul, South Korea; [Ha, Tae-Young; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Kim, Seonghan; Suh, Yoo-Hun] Seoul Natl Univ, MRC, Neurosci Res Inst, Seoul, South Korea; [Chong, Young Hae] Ewha Womans Univ, Dept Microbiol, Sch Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University	Ha, TY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Natl Creat Res Initiat Ctr Alzheimers Dementia, Seoul, South Korea.	yhsuh@snu.ac.kr	Kim, Hye Sun/J-2752-2012; Suh, Yoo-Hun/J-2761-2012		Korea Ministry of Education, Science and Technology; National Research Foundation of Korea, Korea government [2009-0086201]; ministry of education, Science and Technology [R33-10167]; National Research Foundation of Korea, Ministry of Education, Science and Technology [2009-0082268]	Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Korea government(National Research Foundation of KoreaKorean Government); ministry of education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea, Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was financially supported by National Creative Research Initiative Grant (2006-2009) from Korea Ministry of Education, Science and Technology, in part by the National Research Foundation of Korea grant funded by the Korea government (2009-0086201), in part by WCU program (R33-10167) of the ministry of education, Science and Technology, and in part by the Conversing Research Center Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2009-0082268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1999, J NEUROL, V246, P358, DOI 10.1007/s004150050363; Bararia D, 2008, LEUKEMIA, V22, P800, DOI 10.1038/sj.leu.2405101; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chang KA, 2005, J PHARMACOL SCI, V97, P461, DOI 10.1254/jphs.CR0050014; Chang KA, 2006, MOL CELL BIOL, V26, P4327, DOI 10.1128/MCB.02393-05; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Farber K, 2006, GLIA, V54, P656, DOI 10.1002/glia.20412; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hermani A, 2005, EXP CELL RES, V312, P184, DOI 10.1016/j.yexcr.2005.10.013; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; KAMMESHEIDT A, 1992, P NATL ACAD SCI USA, V89, P10857, DOI 10.1073/pnas.89.22.10857; Kar S, 2004, J PSYCHIATR NEUROSCI, V29, P427; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kerkhoff C, 2002, J BIOL CHEM, V277, P41879, DOI 10.1074/jbc.M207990200; Kim CM, 2003, VECTOR-BORNE ZOONOT, V3, P17, DOI 10.1089/153036603765627424; Kuruto-Niwa R, 1998, CELL STRUCT FUNCT, V23, P109, DOI 10.1247/csf.23.109; Lambourne SL, 2005, MOL CELL BIOL, V25, P278, DOI 10.1128/MCB.25.1.278-293.2005; Lue LF, 1996, J NEUROPATH EXP NEUR, V55, P1083, DOI 10.1097/00005072-199655100-00008; MARIGGIO MA, 1994, NEUROSCIENCE, V60, P29, DOI 10.1016/0306-4522(94)90201-1; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Postler E, 1997, GLIA, V19, P27, DOI 10.1002/(SICI)1098-1136(199701)19:1<27::AID-GLIA3>3.0.CO;2-7; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shepherd CE, 2006, NEUROBIOL AGING, V27, P1554, DOI 10.1016/j.neurobiolaging.2005.09.033; Suh YH, 2002, PHARMACOL REV, V54, P469, DOI 10.1124/pr.54.3.469; Tong LQ, 2001, J BIOL CHEM, V276, P17301, DOI 10.1074/jbc.M010450200; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620	35	66	68	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8840	10.1371/journal.pone.0008840	http://dx.doi.org/10.1371/journal.pone.0008840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098622	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779100031
J	Karpushev, AV; Ilatovskaya, DV; Pavlov, TS; Negulyaev, YA; Staruschenko, A				Karpushev, Alexey V.; Ilatovskaya, Daria V.; Pavlov, Tengis S.; Negulyaev, Yuri A.; Staruschenko, Alexander			Intact Cytoskeleton Is Required for Small G Protein Dependent Activation of the Epithelial Na+ Channel	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-OH KINASE; PLANAR LIPID-BILAYERS; COLLECTING DUCT; ACTIN-FILAMENTS; SODIUM-CHANNEL; EXPRESSION SYSTEM; ARACHIDONIC-ACID; SMALL GTPASES; ION CHANNELS; CELL-LINE	Background: The Epithelial Na+ Channel (ENaC) plays a central role in control of epithelial surface hydration and vascular volume. Similar to other ion channels, ENaC activity is regulated, in part, by cortical cytoskeleton. Besides, the cytoskeleton is an established target for small G proteins signaling. Here we studied whether ENaC activity is modulated by changes in the state of the cytoskeleton and whether cytoskeletal elements are involved in small G protein mediated increase of ENaC activity. Methods and Findings: First, the functional importance of the cytoskeleton was established with whole-cell patch clamp experiments recording ENaC reconstituted in CHO cells. Pretreatment with Cytochalasin D (CytD; 10 mu g/ml; 1-2 h) or colchicine (500 mu M; 1-3 h) to disassembly F-actin and destroy microtubules, respectively, significantly decreased amiloride sensitive current. However, acute application of CytD induced rapid increase in macroscopic current. Single channel measurements under cell-attached conditions revealed similar observations. CytD rapidly increased ENaC activity in freshly isolated rat collecting duct, polarized epithelial mouse mpkCCD(c14) cells and HEK293 cells transiently transfected with ENaC subunits. In contrast, colchicine did not have an acute effect on ENaC activity. Small G proteins RhoA, Rac1 and Rab11a markedly increase ENaC activity. 1-2 h treatment with colchicine or CytD abolished effects of these GTPases. Interestingly, when cells were coexpressed with ENaC and RhoA, short-term treatment with CytD decreased ENaC activity. Conclusions: We conclude that cytoskeleton is involved in regulation of ENaC and is necessary for small G protein mediated increase of ENaC activity.	[Karpushev, Alexey V.; Ilatovskaya, Daria V.; Pavlov, Tengis S.; Staruschenko, Alexander] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Staruschenko, Alexander] Med Coll Wisconsin, Kidney Dis Ctr, Milwaukee, WI 53226 USA; [Ilatovskaya, Daria V.; Negulyaev, Yuri A.] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	Medical College of Wisconsin; Medical College of Wisconsin; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Karpushev, AV (corresponding author), Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	Staruschenko@mcw.edu	Negulyaev, Yuri/N-6531-2015; Karpushev, Alexey/K-5371-2014	Negulyaev, Yuri/0000-0002-1773-9798; Ilatovskaya, Daria/0000-0003-4832-4170; Karpushev, Alexey/0000-0001-8437-6424; Staruschenko, Alexander/0000-0002-5190-8356	American Heart Association [0730111N]; American Society of Nephrology Carl W. Gottschalk Research Scholar Grant [RFBR-08-04-00574, RFBR-10-04-00995]; Russian Academy of Sciences	American Heart Association(American Heart Association); American Society of Nephrology Carl W. Gottschalk Research Scholar Grant; Russian Academy of Sciences(Russian Academy of Sciences)	This research was supported by the American Heart Association grant 0730111N and the American Society of Nephrology Carl W. Gottschalk Research Scholar Grant (to A. Staruschenko), RFBR-08-04-00574 (to D. Ilatovskaya), RFBR-10-04-00995 and Molecular and Cell Biology Program of Russian Academy of Sciences (to Y. Negulyaev). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bens M, 1999, J AM SOC NEPHROL, V10, P923; Berdiev BK, 2001, BIOPHYS J, V80, P2176, DOI 10.1016/S0006-3495(01)76190-5; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; CANTIELLO HF, 1991, AM J PHYSIOL, V261, pC882, DOI 10.1152/ajpcell.1991.261.5.C882; Copeland SJ, 2001, AM J PHYSIOL-CELL PH, V281, pC231, DOI 10.1152/ajpcell.2001.281.1.C231; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; ELS WJ, 1993, J PHYSIOL-LONDON, V462, P447, DOI 10.1113/jphysiol.1993.sp019563; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Hayashi K, 2006, J PHARMACOL SCI, V100, P29, DOI 10.1254/jphs.FMJ05003X6; Jovov B, 1999, J BIOL CHEM, V274, P37845, DOI 10.1074/jbc.274.53.37845; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mastroberardino L, 1998, MOL BIOL CELL, V9, P3417, DOI 10.1091/mbc.9.12.3417; Mazzochi C, 2006, AM J PHYSIOL-RENAL, V291, pF1113, DOI 10.1152/ajprenal.00195.2006; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; Morimoto T, 2006, AM J PHYSIOL-RENAL, V291, pF663, DOI 10.1152/ajprenal.00514.2005; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; PEARL M, 1983, AM J PHYSIOL, V245, pC28, DOI 10.1152/ajpcell.1983.245.1.C28; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2007, J BIOL CHEM, V282, P14576, DOI 10.1074/jbc.M701348200; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; PRAT AG, 1993, AM J PHYSIOL, V265, pC224, DOI 10.1152/ajpcell.1993.265.1.C224; Saxena SK, 2006, BIOCHEM BIOPH RES CO, V351, P582, DOI 10.1016/j.bbrc.2006.10.087; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sharpe CC, 2003, J AM SOC NEPHROL, V14, P261, DOI 10.1097/01.ASN.0000048223.05219.E4; Staruschenko A, 2005, BBA-BIOMEMBRANES, V1669, P108, DOI 10.1016/j.bbamem.2005.01.005; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Staruschenko A, 2004, J BIOL CHEM, V279, P37771, DOI 10.1074/jbc.M402176200; Staruschenko A, 2007, J AM SOC NEPHROL, V18, P1652, DOI 10.1681/ASN.2007010020; Staruschenko Alexander, 2006, V337, P3; Sun P, 2006, AM J PHYSIOL-RENAL, V291, pF1192, DOI 10.1152/ajprenal.00112.2006; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; WANG WH, 1994, AM J PHYSIOL-RENAL, V267, pF592, DOI 10.1152/ajprenal.1994.267.4.F592; Wei Y, 2006, AM J PHYSIOL-RENAL, V290, pF1163, DOI 10.1152/ajprenal.00301.2005; Wei Y, 2002, AM J PHYSIOL-RENAL, V282, pF680, DOI 10.1152/ajprenal.00229.2001	37	33	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8827	10.1371/journal.pone.0008827	http://dx.doi.org/10.1371/journal.pone.0008827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098689	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779100019
J	Wooten, EC; Iyer, LK; Montefusco, M; Hedgepeth, AK; Payne, DD; Kapur, NK; Housman, DE; Mendelsohn, ME; Huggins, GS				Wooten, Eric C.; Iyer, Lakshmanan K.; Montefusco, Maria Claudia; Hedgepeth, Alyson Kelley; Payne, Douglas D.; Kapur, Navin K.; Housman, David E.; Mendelsohn, Michael E.; Huggins, Gordon S.			Application of Gene Network Analysis Techniques Identifies AXIN1/PDIA2 and Endoglin Haplotypes Associated with Bicuspid Aortic Valve	PLOS ONE			English	Article							NEURAL CREST; EXPRESSION; MUTATIONS; LINKAGE; NOTCH1; POWER; DISEASE; HEART	Bicuspid Aortic Valve (BAV) is a highly heritable congenital heart defect. The low frequency of BAV (1% of general population) limits our ability to perform genome-wide association studies. We present the application of four a priori SNP selection techniques, reducing the multiple-testing penalty by restricting analysis to SNPs relevant to BAV in a genome-wide SNP dataset from a cohort of 68 BAV probands and 830 control subjects. Two knowledge-based approaches, CANDID and STRING, were used to systematically identify BAV genes, and their SNPs, from the published literature, microarray expression studies and a genome scan. We additionally tested Functionally Interpolating SNPs (fitSNPs) present on the array; the fourth consisted of SNPs selected by Random Forests, a machine learning approach. These approaches reduced the multiple testing penalty by lowering the fraction of the genome probed to 0.19% of the total, while increasing the likelihood of studying SNPs within relevant BAV genes and pathways. Three loci were identified by CANDID, STRING, and fitSNPS. A haplotype within the AXIN1-PDIA2 locus (p-value of 2.926x10(-06)) and a haplotype within the Endoglin gene (p-value of 5.881x10(-04)) were found to be strongly associated with BAV. The Random Forests approach identified a SNP on chromosome 3 in association with BAV (p-value 5.061x10(-06)). The results presented here support an important role for genetic variants in BAV and provide support for additional studies in well-powered cohorts. Further, these studies demonstrate that leveraging existing expression and genomic data in the context of GWAS studies can identify biologically relevant genes and pathways associated with a congenital heart defect.	[Wooten, Eric C.; Iyer, Lakshmanan K.; Montefusco, Maria Claudia; Hedgepeth, Alyson Kelley; Kapur, Navin K.; Mendelsohn, Michael E.; Huggins, Gordon S.] MCRI Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA; [Payne, Douglas D.] Tufts Med Ctr, Div Cardiothorac Surg, Boston, MA USA; [Housman, David E.] MIT, Cambridge, MA 02139 USA	Tufts Medical Center; Massachusetts Institute of Technology (MIT)	Wooten, EC (corresponding author), MCRI Ctr Translat Genom, Mol Cardiol Res Inst, Boston, MA USA.	ghuggins@tuftsmedicalcenter.org		Iyer, Lakshmanan/0000-0001-9167-6396; Wooten, Eric/0000-0002-8403-8668	National Institutes of Health [HL077378]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023387] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077378, K08HL094909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This project was supported by the National Institutes of Health grants HL077378 (M. E. M.), and the American Heart Association (E. C. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; American Heart Association, 2009, HEART DIS STROK STAT; Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Biner S, 2009, J AM COLL CARDIOL, V53, P2288, DOI 10.1016/j.jacc.2009.03.027; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bureau A, 2005, GENET EPIDEMIOL, V28, P171, DOI 10.1002/gepi.20041; Chen R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r170; Cripe L, 2004, J AM COLL CARDIOL, V44, P138, DOI 10.1016/j.jacc.2004.03.050; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEANGELIS MM, 2007, OPHTHALMOLOGY; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ellison JW, 2007, J SURG RES, V142, P28, DOI 10.1016/j.jss.2006.04.040; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Hong F, RANKPROD RANK PRODUC; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Hutz JE, 2008, GENET EPIDEMIOL, V32, P779, DOI 10.1002/gepi.20346; *ILL, ILL ICONTROLDB; Jiang XB, 2000, DEVELOPMENT, V127, P1607; KAPPETEIN AP, 1991, J THORAC CARDIOV SUR, V102, P830, DOI 10.1016/S0022-5223(19)33931-5; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Loscalzo ML, 2007, AM J MED GENET A, V143A, P1960, DOI 10.1002/ajmg.a.31872; de la Pompa JL, 2009, PEDIATR CARDIOL, V30, P643, DOI 10.1007/s00246-008-9368-z; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Majumdar R, 2007, CARDIOVASC PATHOL, V16, P144, DOI 10.1016/j.carpath.2006.12.001; Mancini ML, 2007, DEV BIOL, V308, P520, DOI 10.1016/j.ydbio.2007.06.009; Martin LJ, 2007, HUM GENET, V121, P275, DOI 10.1007/s00439-006-0316-9; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Mohamed SA, 2006, BIOCHEM BIOPH RES CO, V345, P1460, DOI 10.1016/j.bbrc.2006.05.046; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qu R, 1998, CELL TISSUE RES, V292, P333, DOI 10.1007/s004410051064; R Development Core Team, R LANG ENV STAT COMP; Salahshor S, 2005, J CLIN PATHOL, V58, P225, DOI 10.1136/jcp.2003.009506; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SMYTH GK, 2004, STAT APPL GENETICS M, V3; TRANCHEVENT L, 2008, NUCLEIC ACIDS RES; TURRI M, 1990, EUR J CARDIO-THORAC, V4, P556, DOI 10.1016/1010-7940(90)90145-P; Valeria B, 2008, REPROD SCI, V15, P1018, DOI 10.1177/1933719108322429; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang JK, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-51; Wang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001050; RANDOM JUNGLE FAST I	52	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8830	10.1371/journal.pone.0008830	http://dx.doi.org/10.1371/journal.pone.0008830			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098615	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100021
J	Huang, ZG; Yang, JJ; Luo, GX; Gan, CJ; Cheng, WG; Yuan, SZ; Peng, X; Tan, JL; Wang, XJ; Hu, J; Yang, SW; Reisner, Y; Ge, LP; Wei, H; Cheng, P; Wu, J				Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Reisner, Yair; Ge, Liangpeng; Wei, Hong; Cheng, Ping; Wu, Jun			Embryonic Porcine Skin Precursors Can Successfully Develop into Integrated Skin without Teratoma Formation Posttransplantation in Nude Mouse Model	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; RAT BURN WOUNDS; TRANSPLANTATION; KERATINOCYTES; GENERATION; SURVIVAL; LIVER	How to improve the wound healing quality of severe burn patients is still a challenge due to lack of skin appendages and rete ridges, no matter how much progress has been made in the fields of either stem cell or tissue engineering. We thus systematically studied the growth potential and differentiation capacity of porcine embryonic skin precursors. Implantation of embryonic skin precursors (PESPs) of different gestational ages in nude mice can generate the integrity skin, including epidermis, dermis and skin appendages, such as sweat gland, hair follicle, sebaceous gland, etc.. PESPs of embryonic day 42 possess the maximal growth potential, while, the safe window time of PESPs transplantation for prevention of teratoma risk is E56 or later. In conclusion, PESPs can form the 3 dimensional structures of skin with all necessary skin appendages. Our data strongly indicate that porcine embryonic skin precursors harvested from E56 of minipig may provide new hope for high-quality healing of extensive burns and traumas.	[Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Huang, Zhenggen; Yang, Junjie; Luo, Gaoxing; Gan, Chengjun; Cheng, Wenguang; Yuan, Shunzong; Peng, Xu; Tan, Jianglin; Wang, Xiaojuan; Hu, Jie; Yang, Shiwei; Wu, Jun] Chongqing Key Lab Prote Dis, Chongqing, Peoples R China; [Reisner, Yair] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ge, Liangpeng; Wei, Hong] Third Mil Med Univ, Dept Zool, Chongqing, Peoples R China; [Cheng, Ping] Third Mil Med Univ, Dept Clin Lab Sci, Chongqing, Peoples R China	Army Medical University; Weizmann Institute of Science; Army Medical University; Army Medical University	Huang, ZG (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	junwupro1@yahoo.com.cn	Yuan, Shunzong/AAO-3551-2020; Gaoxing, LUO/AAE-4505-2020; Reisner, Yair/AAA-4772-2019	LUO, Gaoxing/0000-0003-4764-3209; Reisner, Yair/0000-0002-3354-6945	National High Technology Research and Development Project of China [2006AA02A121]; National Nature Science Foundation of China [30672174]; State Key Lab Funding [SKLZZ200808, SKLZZ200820]	National High Technology Research and Development Project of China(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Lab Funding	This work was supported by a grant from the National High Technology Research and Development Project of China ("863'' Project)(No. 2006AA02A121) and partly by National Nature Science Foundation of China (NSFC No. 30672174) and State Key Lab Funding (SKLZZ200808 to JW and SKLZZ200820 to GL). There are a total of 4 fundings involved in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Anderson GB, 1996, ANIM REPROD SCI, V45, P231, DOI 10.1016/S0378-4320(96)01581-3; Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099; Dekel B, 2003, NAT MED, V9, P53, DOI 10.1038/nm812; Eventov-Friedman S, 2005, P NATL ACAD SCI USA, V102, P2928, DOI 10.1073/pnas.0500177102; Eventov-Friedman S, 2006, PLOS MED, V3, P1165, DOI 10.1371/journal.pmed.0030215; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Hammerman Marc R, 2006, Clin Exp Nephrol, V10, P1, DOI 10.1007/s10157-005-0393-4; Hecht G, 2009, P NATL ACAD SCI USA, V106, P8659, DOI 10.1073/pnas.0812253106; Katchman H, 2008, STEM CELLS, V26, P1347, DOI 10.1634/stemcells.2007-0631; Luo GX, 2005, J TRAUMA, V59, P1209, DOI 10.1097/01.ta.0000189002.59950.dc; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Price RD, 2001, BRIT J PLAST SURG, V54, P687, DOI 10.1054/bjps.2001.3712; Qing Chun, 2004, Zhonghua Shao Shang Za Zhi, V20, P336; Roh C, 2006, PEDIATR RES, V59, p100R, DOI 10.1203/01.pdr.0000203572.51876.ba; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; TCHORSHYUTSIS D, 2009, DIABETES; Wang Y, 2008, J TRAUMA, V65, P154, DOI 10.1097/TA.0b013e31812f6f74	19	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8717	10.1371/journal.pone.0008717	http://dx.doi.org/10.1371/journal.pone.0008717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090918	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000002
J	Ali, MM; Janic, B; Babajani-Feremi, A; Varma, NRS; Iskander, ASM; Anagli, J; Arbab, AS				Ali, Meser M.; Janic, Branislava; Babajani-Feremi, Abbas; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Anagli, John; Arbab, Ali S.			Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; FACTOR-RECEPTOR; CONTRAST AGENT; BREAST-CANCER; TUMOR-GROWTH; IN-VIVO; GD-DTPA; EXPERIMENTAL-MODEL; MRI	Background: Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conjunction with chemotherapy and radiotherapy. However, changes in the tumor size, tumor vascular permeability, vascular density, expression of VEGFR2 and other angiogenic factors in response to PTK787 are not well documented. This study was to determine the changes in tumor size, vascular permeability, fractional plasma volume and expression of VEGFR2 in PTK787 treated U-251 glioma rat model by in vivo magnetic resonance imaging (MRI) and single photon emission computed tomography (SPECT). The findings were validated with histochemical and western blot studies. Methodologies and Principal Findings: Seven days after implantation of U251 glioma cells, animals were treated with either PTK787 or vehicle-only for two weeks, and then tumor size, tumor vascular permeability transfer constant (K-trans), fractional plasma volume (fPV) and expression of VEGFR2 and other relevant angiogenic factors were assessed by in vivo MRI and SPECT (Tc-99-HYNIC-VEGF), and by immunohistochemistry and western blot analysis. Dynamic contrast-enhanced MRI (DCE-MRI) using a high molecular weight contrast agent albumin-(GdDTPA) showed significantly increased K-trans at the rim of the treated tumors compared to that of the central part of the treated as well as the untreated (vehicle treated) tumors. Size of the tumors was also increased in the treated group. Expression of VEGFR2 detected by Tc-99m-HYNIC-VEGF SPECT also showed significantly increased activity in the treated tumors. In PTK787-treated tumors, histological staining revealed increase in microvessel density in the close proximity to the tumor border. Western blot analysis indicated increased expression of VEGF, SDF-1, HIF-1 alpha, VEGFR2, VEGFR3 and EGFR at the peripheral part of the treated tumors compared to that of central part of the treated tumors. Similar expression patters were not observed in vehicle treated tumors. Conclusion: These findings indicate that PTK787 treatment induced over expression of VEGF as well as the Flk-1/VEGFR2 receptor tyrosine kinase, especially at the rim of the tumor, as proven by DCE-MRI, SPECT imaging, immunohistochemistry and western blot.	[Ali, Meser M.; Janic, Branislava; Babajani-Feremi, Abbas; Varma, Nadimpalli R. S.; Iskander, A. S. M.; Anagli, John; Arbab, Ali S.] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Ali, MM (corresponding author), Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 USA.	saali@rad.hfh.edu	Arbab, Ali/AAS-1933-2020		National Institutes of Health [R01CA122031, 1R21CA129801, 1R21NS066143]; NATIONAL CANCER INSTITUTE [R01CA122031, R21CA129801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066143] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: The work is supported by National Institutes of Health grants R01CA122031 and 1R21CA129801, 1R21NS066143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MJ, 1990, J NUCL MED, V31, P2022; Arbab AS, 2008, FASEB J, V22, P3234, DOI 10.1096/fj.07-105676; Backer MV, 2007, NAT MED, V13, P504, DOI 10.1038/nm1522; Barboriak DP, 2008, J MAGN RESON IMAGING, V27, P1388, DOI 10.1002/jmri.21344; Barboriak DP, 2005, J DIGIT IMAGING, V18, P91, DOI 10.1007/s10278-004-1879-4; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bhujwalla ZM, 2003, CLIN CANCER RES, V9, P355; BICKNELL R, 1997, ROLE VASCULAR ENDOTH, P185; Blankenberg FG, 2006, EUR J NUCL MED MOL I, V33, P841, DOI 10.1007/s00259-006-0099-1; Cheng HLM, 2007, J MAGN RESON IMAGING, V25, P137, DOI 10.1002/jmri.20787; Daldrup H, 1998, AM J ROENTGENOL, V171, P941, DOI 10.2214/ajr.171.4.9762973; Dhermain F, 2005, B CANCER, V92, P333; Dietrich J, 2008, CURR OPIN NEUROL, V21, P736, DOI 10.1097/WCO.0b013e3283131370; Drevs J, 2002, CANCER RES, V62, P4015; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ewing JR, 2006, J CEREBR BLOOD F MET, V26, P310, DOI 10.1038/sj.jcbfm.9600189; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Fong TAT, 1999, CANCER RES, V59, P99; Gianfelice D, 2003, RADIOLOGY, V227, P849, DOI 10.1148/radiol.2281012163; Goldbrunner RH, 2004, NEUROSURGERY, V55, P426, DOI 10.1227/01.NEU.0000129551.64651.74; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; Lamszus K, 2005, CLIN CANCER RES, V11, P4934, DOI 10.1158/1078-0432.CCR-04-2270; Lee I, 2007, IN VIVO, V21, P721; Lee L, 2006, CANCER CHEMOTH PHARM, V57, P761, DOI 10.1007/s00280-005-0120-6; LEVASHOVA Z, 2009, BIOCONJUG CHEM; Levashova Z, 2008, BIOCONJUGATE CHEM, V19, P1049, DOI 10.1021/bc7004818; Lin PN, 1998, CELL GROWTH DIFFER, V9, P49; Los M, 2007, ONCOLOGIST, V12, P443, DOI 10.1634/theoncologist.12-4-443; Marzola P, 2005, CLIN CANCER RES, V11, P5827, DOI 10.1158/1078-0432.CCR-04-2655; Marzola P, 2003, INT J CANCER, V104, P462, DOI 10.1002/ijc.10953; Mussurakis S, 1997, BRIT J RADIOL, V70, P446, DOI 10.1259/bjr.70.833.9227224; Norden AD, 2008, NEUROLOGY, V70, P779, DOI 10.1212/01.wnl.0000304121.57857.38; Norden AD, 2008, CURR OPIN ONCOL, V20, P652, DOI 10.1097/CCO.0b013e32831186ba; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; OGAN MD, 1987, INVEST RADIOL, V22, P665, DOI 10.1097/00004424-198708000-00008; Pham CD, 1998, CANCER INVEST, V16, P225, DOI 10.3109/07357909809039771; Preda A, 2004, J MAGN RESON IMAGING, V20, P865, DOI 10.1002/jmri.20184; Raatschen HJ, 2008, RADIOLOGY, V247, P391, DOI 10.1148/radiol.2472070363; Remer Sandra, 2004, Clin J Oncol Nurs, V8, P368, DOI 10.1188/04.CJON.368-376; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; Semple SIK, 2006, ANN ONCOL, V17, P1393, DOI 10.1093/annonc/mdl136; SHAMES DM, 1993, MAGNET RESON MED, V29, P616, DOI 10.1002/mrm.1910290506; Silverman MD, 2007, ARTHRITIS RHEUM-US, V56, P1817, DOI 10.1002/art.22706; Taylor JS, 1999, J MAGN RESON IMAGING, V10, P903, DOI 10.1002/(SICI)1522-2586(199912)10:6<903::AID-JMRI1>3.0.CO;2-A; Turetschek K, 2003, EUR J NUCL MED MOL I, V30, P448, DOI 10.1007/s00259-002-1000-5; vanDijke CF, 1996, RADIOLOGY, V198, P813, DOI 10.1148/radiology.198.3.8628876; Wang ZH, 2001, MAGN RESON IMAGING, V19, P1063, DOI 10.1016/S0730-725X(01)00431-3; Wood JM, 2000, CANCER RES, V60, P2178	51	46	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8727	10.1371/journal.pone.0008727	http://dx.doi.org/10.1371/journal.pone.0008727			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090952	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900008
J	Priyadarshini, D; Gadia, RR; Tripathy, A; Gurukumar, KR; Bhagat, A; Patwardhan, S; Mokashi, N; Vaidya, D; Shah, PS; Cecilia, D				Priyadarshini, D.; Gadia, Rajesh R.; Tripathy, Anuradha; Gurukumar, K. R.; Bhagat, Asha; Patwardhan, Sampada; Mokashi, Nitin; Vaidya, Dhananjay; Shah, Paresh S.; Cecilia, D.			Clinical Findings and Pro-Inflammatory Cytokines in Dengue Patients in Western India: A Facility-Based Study	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; HEMORRHAGIC-FEVER; VIRUS-INFECTION; TNF-ALPHA; IMMUNE ACTIVATION; INTERFERON-GAMMA; RISK-FACTORS; CHILDREN; SEVERITY	Background: Descriptions of dengue immunopathogenesis have largely relied on data from South-east Asia and America, while India is poorly represented. This study characterizes dengue cases from Pune, Western India, with respect to clinical profile and pro-inflammatory cytokines. Methodology/Principal Findings: In 2005, 372 clinically suspected dengue cases were tested by MAC-ELISA and RT-PCR for dengue virus (DENV) aetiology. The clinical profile was recorded at the hospital. Circulating levels of IFN-gamma, TNF-alpha, IL-6, and IL-8 were assessed by ELISA and secondary infections were defined by IgM to IgG ratio. Statistical analysis was carried out using the SPSS 11.0 version. Of the 372 individuals, 221 were confirmed to be dengue cases. Three serotypes, DENV-1, 2 and 3 were co-circulating and one case of dual infection was identified. Of 221 cases, 159 presented with Dengue fever (DF) and 62 with Dengue hemorrhagic fever (DHF) of which six had severe DHF and one died of shock. There was a strong association of rash, abdominal pain and conjunctival congestion with DHF. Levels of IFN-gamma were higher in DF whereas IL-6 and IL-8 were higher in DHF cases (p<0.05). The mean levels of the three cytokines were higher in secondary compared to primary infections. Levels of IFN-gamma and IL-8 were higher in early samples collected 2-5 days after onset than late samples collected 6-15 days after onset. IFN-gamma showed significant decreasing time trend (p = 0.005) and IL-8 levels showed increasing trend towards significance in DHF cases (interaction p = 0.059). There was a significant association of IL-8 levels with thrombocytopenia and both IFN-gamma and IL-8 were positively associated with alanine transaminase levels. Conclusions/Significance: Rash, abdominal pain and conjunctival congestion could be prognostic symptoms for DHF. High levels of IL-6 and IL-8 were shown to associate with DHF. The time trend of IFN-gamma and IL-8 levels had greater significance than absolute values in DHF pathogenesis.	[Priyadarshini, D.; Tripathy, Anuradha; Gurukumar, K. R.; Bhagat, Asha; Shah, Paresh S.; Cecilia, D.] Natl Inst Virol, Pune, Maharashtra, India; [Gadia, Rajesh R.] King Edward Mem Hosp Women, Dept Gen Med, Pune, Maharashtra, India; [Patwardhan, Sampada] Deenanath Mangeshkar Hosp, Dept Microbiol, Pune, Maharashtra, India; [Mokashi, Nitin] Yashwant Rao Chauhan Mem Hosp, Dept Microbiol, Pune, Maharashtra, India; [Vaidya, Dhananjay] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV); Johns Hopkins University; Johns Hopkins Medicine	Priyadarshini, D (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	cdayaraj@niv.co.in	Vaidya, Dhananjay/AAL-5684-2020	Vaidya, Dhananjay/0000-0002-7164-1601	Indian Council of Medical Research; Indian Council of Medical Research (ICMR); Council of Scientific and Industrial Research (CSIR), Government of India	Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	Indian Council of Medical Research: www.icmr.org.in. Fellowship grants provided to D. Priyadarshini by Indian Council of Medical Research (ICMR) and to K. R. Gurukumar by Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avirutnan P, 1998, J IMMUNOL, V161, P6338; Balmaseda A, 2005, AM J TROP MED HYG, V73, P1059, DOI 10.4269/ajtmh.2005.73.1059; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chakravarti A, 2006, INDIAN J MED RES, V123, P25; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chaturvedi UC, 2006, FEMS IMMUNOL MED MIC, V47, P155, DOI 10.1111/j.1574-695X.2006.00058.x; Chen RF, 2005, FEMS IMMUNOL MED MIC, V44, P43, DOI 10.1016/j.femsim.2004.11.012; CONCEICAO TM, 2009, J INFECT        1015; Dar L, 1999, EMERG INFECT DIS, V5, P589, DOI 10.3201/eid0504.990427; Araujo FMD, 2006, MEM I OSWALDO CRUZ, V101, P925, DOI 10.1590/S0074-02762006000800017; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Gomber S, 2001, Indian Pediatr, V38, P477; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Gupta R, 2009, IMMUNOL INVEST, V38, P240, DOI 10.1080/08820130902766563; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350; HALSTEAD SB, 1980, AM J TROP MED HYG, V29, P638, DOI 10.4269/ajtmh.1980.29.638; Halstead Scott B., 2008, V5, P285; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Huang YH, 2000, AM J TROP MED HYG, V63, P71, DOI 10.4269/ajtmh.2000.63.71; Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Iyngkaran N., 1995, Singapore Medical Journal, V36, P218; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Juffrie M, 2000, INFECT IMMUN, V68, P702, DOI 10.1128/IAI.68.2.702-707.2000; Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; La Braga E, 2001, MEM I OSWALDO CRUZ, V96, P229, DOI 10.1590/S0074-02762001000200015; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; Malavige GN, 2006, QJM-INT J MED, V99, P299, DOI 10.1093/qjmed/hcl039; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; SABIN AB, 1952, AM J TROP MED HYG, V1, P363; SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932; Sathish N, 2002, INDIAN J MED RES, V115, P31; Saxena P, 2006, DENGUE B, V30, P283; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Suwandono A, 2006, T ROY SOC TROP MED H, V100, P855, DOI 10.1016/j.trstmh.2005.11.010; Talavera D, 2004, J GEN VIROL, V85, P1801, DOI 10.1099/vir.0.19652-0; Wali J P, 1999, J Assoc Physicians India, V47, P203; Watts DM, 1999, LANCET, V354, P1431, DOI 10.1016/S0140-6736(99)04015-5; WHO.,, 2012, DENGUE DENGUE HEMORR; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821; World Health Organization, 1999, WHO LAB MAN EX HUM S, P11	50	99	102	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8709	10.1371/journal.pone.0008709	http://dx.doi.org/10.1371/journal.pone.0008709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090849	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714600012
J	Putheti, P; Awasthi, A; Popoola, J; Gao, WD; Strom, TB				Putheti, Prabhakar; Awasthi, Amit; Popoola, Joyce; Gao, Wenda; Strom, Terry B.			Human CD4(+) Memory T Cells Can Become CD4(+)IL-9(+) T Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IL-9 EXPRESSION; TGF-BETA; TRANSCRIPTION FACTOR; HELPER-CELLS; MAST-CELLS; DIFFERENTIATION; INDUCTION; PHENOTYPE; CYTOKINES	Background: IL-9 is a growth factor for T- and mast-cells that is secreted by human Th2 cells. We recently reported that IL-(4+) TGF-beta directs mouse CD4(+)CD25(-)CD62L(+) T cells to commit to inflammatory IL-9 producing CD4(+) T cells. Methodology/Principal Findings: Here we show that human inducible regulatory T cells (iTregs) also express IL-9. IL-4+TGF-beta induced higher levels of IL-9 expression in plate bound-anti-CD3 mAb (pbCD3)/soluble-anti-CD28 mAb (sCD28) activated human resting memory CD4(+)CD25(-)CD45RO(+) T cells as compared to naive CD4(+)CD25(-)CD45RA(+) T cells. In addition, as compared to pbCD3/sCD28 plus TGF-beta stimulation, IL-4(+)TGF-beta stimulated memory CD4(+)D25(-)CD45RO(+) T cells expressed reduced FOXP3 protein. As analyzed by pre-amplification boosted single-cell real-time PCR, human CD4(+)IL-9(+)T cells expressed GATA3 and RORC, but not IL-10, IL-13, IFN gamma or IL-17A/F. Attempts to optimize IL-9 production by pbCD3/sCD28 and IL-4+TGF-beta stimulated resting memory CD4(+) T cells demonstrated that the addition of IL-1 beta, IL-12, and IL-21 further enhance IL-9 production. Conclusions/Significance: Taken together these data show both the differences and similarities between mouse and human CD4(+)IL9(+) T cells and reaffirm the powerful influence of inflammatory cytokines to shape the response of activated CD4(+) T cells to antigen.	[Putheti, Prabhakar; Popoola, Joyce; Gao, Wenda; Strom, Terry B.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA; [Awasthi, Amit] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Putheti, P (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med,Transplant Inst, Boston, MA 02215 USA.	tstrom@bidmc.harvard.edu	Strom, Terry B./E-9268-2010; Popoola, Joyce/AAP-8481-2020	Strom, Terry B./0000-0002-7570-0736; Popoola, Joyce/0000-0002-3114-3501	Juvenile Diabetes Research Foundation [7-2005-1329]; National Institute of Health [5P01 A1041521-1]; Medical Research Council [G0600698B] Funding Source: researchfish	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the grants to Terry B. Strom from the Juvenile Diabetes Research Foundation grant 7-2005-1329 and National Institute of Health grant 5P01 A1041521-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Gounni AS, 2000, J ALLERGY CLIN IMMUN, V106, P460, DOI 10.1067/mai.2000.109172; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; HOUSSIAU FA, 1995, J IMMUNOL, V154, P2624; Hultner L, 2000, J IMMUNOL, V164, P5556, DOI 10.4049/jimmunol.164.11.5556; Jarnicki AG, 2003, CURR OPIN PHARMACOL, V3, P449, DOI 10.1016/S1471-4892(03)00077-8; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; SCHMITT E, 1994, J IMMUNOL, V153, P3989; SCHMITT E, 1991, J IMMUNOL, V147, P3848; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; VANSNICK J, 1989, J EXP MED, V169, P363, DOI 10.1084/jem.169.1.363; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Voo K., 2009, P NATL ACAD SCI US; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	21	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8706	10.1371/journal.pone.0008706	http://dx.doi.org/10.1371/journal.pone.0008706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090929	Green Accepted, Green Published, gold			2022-12-27	WOS:000273714600009
J	Kolliker, M; Ridenhour, BJ; Gaba, S				Koelliker, Mathias; Ridenhour, Benjamin J.; Gaba, Sabrina			Antagonistic Parent-Offspring Co-Adaptation	PLOS ONE			English	Article							BEGGING INTENSITY; MATERNAL-CARE; CONFLICT; SELECTION; SOLICITATION; EVOLUTION; MODELS; NEED	Background: In species across taxa, offspring have means to influence parental investment (PI). PI thus evolves as an interacting phenotype and indirect genetic effects may strongly affect the co-evolutionary dynamics of offspring and parental behaviors. Evolutionary theory focused on explaining how exaggerated offspring solicitation can be understood as resolution of parent-offspring conflict, but the evolutionary origin and diversification of different forms of family interactions remains unclear. Methodology/Principal Findings: In contrast to previous theory that largely uses a static approach to predict how "offspring individuals'' and "parental individuals'' should interact given conflict over PI, we present a dynamic theoretical framework of antagonistic selection on the PI individuals obtain/take as offspring and the PI they provide as parents to maximize individual lifetime reproductive success; we analyze a deterministic and a stochastic version of this dynamic framework. We show that a zone for equivalent co-adaptation outcomes exists in which stable levels of PI can evolve and be maintained despite fast strategy transitions and ongoing co-evolutionary dynamics. Under antagonistic co-adaptation, cost-free solicitation can evolve as an adaptation to emerging preferences in parents. Conclusions/Significance: We show that antagonistic selection across the offspring and parental life-stage of individuals favors co-adapted offspring and parental behavior within a zone of equivalent outcomes. This antagonistic parent-offspring co-adaptation does not require solicitation to be costly, allows for rapid divergence and evolutionary novelty and potentially explains the origin and diversification of the observed provisioning forms in family life.	[Koelliker, Mathias] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Ridenhour, Benjamin J.] Univ Idaho, Dept Biol, Moscow, ID 83843 USA; [Gaba, Sabrina] INRA, Biol & Gest Adventices UMR1210, F-21034 Dijon, France	University of Basel; Idaho; University of Idaho; INRAE	Kolliker, M (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	mathias.koelliker@unibas.ch	Gaba, Sabrina/H-5240-2018; Gaba, Sabrina/N-8428-2013	Gaba, Sabrina/0000-0002-7145-6713; Gaba, Sabrina/0000-0002-7145-6713; Ridenhour, Benjamin/0000-0001-8271-4629	Swiss National Science Foundation [PP00A-119190]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was financially supported by the Swiss National Science Foundation (grant no. PP00A-119190 to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; BATESON P, 1994, TRENDS ECOL EVOL, V9, P399, DOI 10.1016/0169-5347(94)90066-3; Cheverud James M., 1994, P67; CHEVERUD JM, 1984, EVOLUTION, V38, P766, DOI 10.1111/j.1558-5646.1984.tb00349.x; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Dobler R, 2009, ANIM BEHAV, V77, P1427, DOI 10.1016/j.anbehav.2009.02.013; Dor R, 2009, EVOLUTION, V63, P738, DOI 10.1111/j.1558-5646.2008.00598.x; FELDMAN MW, 1982, AM NAT, V119, P285, DOI 10.1086/283909; Godfray HCJ, 2000, PHILOS T ROY SOC B, V355, P1581, DOI 10.1098/rstb.2000.0719; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Grodzinski U, 2007, P R SOC B, V274, P2449, DOI 10.1098/rspb.2007.0658; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Horn AG, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P127, DOI 10.1007/0-306-47660-6_7; HOULE D, 1992, GENETICS, V130, P195; Karasov WH, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P199, DOI 10.1007/0-306-47660-6_11; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Kolliker M, 2006, P ROY SOC B-BIOL SCI, V273, P1523, DOI 10.1098/rspb.2006.3475; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Linksvayer TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000994; LYNCH M, 1987, P NATL ACAD SCI USA, V84, P8507, DOI 10.1073/pnas.84.23.8507; Lynch M., 1998, GENETICS ANAL QUANTI; Mas F, 2008, ANIM BEHAV, V76, P1121, DOI 10.1016/j.anbehav.2008.06.011; Mas F, 2009, P R SOC B, V276, P2847, DOI 10.1098/rspb.2009.0498; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; Mock D. W., 1997, EVOLUTION SIBLING RI; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Parker GA, 2002, ECOL LETT, V5, P206, DOI 10.1046/j.1461-0248.2002.00301.x; PARKER GA, 1978, ANIM BEHAV, V26, P97, DOI 10.1016/0003-3472(78)90009-X; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Payne RJH, 1998, J THEOR BIOL, V195, P273, DOI 10.1006/jtbi.1998.0798; Price K, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P21, DOI 10.1007/0-306-47660-6_2; Qvarnstrom A, 2007, P R SOC B, V274, P1003, DOI 10.1098/rspb.2006.0255; Rodriguez-Girones MA, 1998, P NATL ACAD SCI USA, V95, P4453, DOI 10.1073/pnas.95.8.4453; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; Taylor PD, 2004, P ROY SOC B-BIOL SCI, V271, P669, DOI 10.1098/rspb.2003.2636; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wade MJ, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P5; Wagner A., 2005, ROBUSTNESS EVOLVABIL; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Wilson AJ, 2005, EVOLUTION, V59, P451; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Wolf JB, 1998, EVOLUTION, V52, P299, DOI [10.1111/j.1558-5646.1998.tb01632.x, 10.2307/2411068]; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Wolfram S, 1999, MATHEMATICA; [No title captured]	52	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8606	10.1371/journal.pone.0008606	http://dx.doi.org/10.1371/journal.pone.0008606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066041	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000273338600024
J	Cremasco, V; Benasciutti, E; Cella, M; Kisseleva, M; Croke, M; Faccio, R				Cremasco, Viviana; Benasciutti, Elisa; Cella, Marina; Kisseleva, Marina; Croke, Monica; Faccio, Roberta			Phospholipase C Gamma 2 Is Critical for Development of a Murine Model of Inflammatory Arthritis by Affecting Actin Dynamics in Dendritic Cells	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; ANTIGEN PRESENTATION; IN-VIVO; B-CELL; ACTIVATION; PODOSOMES; MIGRATION; C-GAMMA-2; PLC-GAMMA-2; REQUIREMENT	Background: Dendritic cells (DCs) are highly specialized cells, which capture antigen in peripheral tissues and migrate to lymph nodes, where they dynamically interact with and activate T cells. Both migration and formation of DC-T cell contacts depend on cytoskeleton plasticity. However, the molecular bases governing these events have not been completely defined. Methodology/Principal Findings: Utilizing a T cell-dependent model of arthritis, we find that PLC gamma 2-/- mice are protected from local inflammation and bone erosion. PLC gamma 2 controls actin remodeling in dendritic cells, thereby affecting their capacity to prime T cells. DCs from PLC gamma 2-/- mice mature normally, however they lack podosomes, typical actin structures of motile cells. Absence of PLC gamma 2 impacts both DC trafficking to the lymph nodes and migration towards CCL21. The interaction with T cells is also affected by PLC gamma 2 deficiency. Mechanistically, PLC gamma 2 is activated by CCL21 and modulates Rac activation. Rac1/2-/- DCs also lack podosomes and do not respond to CCL21. Finally, antigen pulsed PLC gamma 2-/- DCs fail to promote T cell activation and induce inflammation in vivo when injected into WT mice. Conversely, injection of WT DCs into PLC gamma 2-/- mice rescues the inflammatory response but not focal osteolysis, confirming the importance of PLC gamma 2 both in immune and bone systems. Conclusions/Significance: This study demonstrates a critical role for PLC gamma 2 in eliciting inflammatory responses by regulating actin dynamics in DCs and positions the PLC gamma 2 pathway as a common orchestrator of bone and immune cell functions during arthritis.	[Cremasco, Viviana; Benasciutti, Elisa; Faccio, Roberta] Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63130 USA; [Cremasco, Viviana; Faccio, Roberta] Univ Bari, Dept Human Anat & Histol, Bari, Italy; [Benasciutti, Elisa] Ist Sci San Raffaele, Dept Mol Genet, I-20132 Milan, Italy; [Cella, Marina; Croke, Monica] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Kisseleva, Marina] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Washington University (WUSTL); Washington University (WUSTL)	Cremasco, V (corresponding author), Washington Univ, Sch Med, Dept Orthopaed, St Louis, MO 63130 USA.	faccior@wustl.edu	Cella, Marina/G-8850-2011; Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313	Arthritis Foundation; NIH [R01 AR52921]; ARRA [63181]; Children Discovery Institute [42826]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	Arthritis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research funding from: the Arthritis Foundation to R. F., NIH to R. F. (R01 AR52921), ARRA to R. F.(63181), and CDI from the Children Discovery Institute to R. F. (42826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Benvenuti F, 2004, SCIENCE, V305, P1150, DOI 10.1126/science.1099159; Boes M, 2004, TRENDS CELL BIOL, V14, P175, DOI 10.1016/j.tcb.2004.02.004; Bouma G, 2007, BLOOD, V110, P4278, DOI 10.1182/blood-2007-06-096875; BOUSSO P, 2008, T CELL ACTIVATION DE; Calle Y, 2006, J CELL SCI, V119, P2375, DOI 10.1242/jcs.02939; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Chou HC, 2006, CURR BIOL, V16, P2337, DOI 10.1016/j.cub.2006.10.037; COGGESHALL KM, 1992, P NATL ACAD SCI USA, V89, P5660, DOI 10.1073/pnas.89.12.5660; Cope AP, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2412; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Cresswell P, 2005, IMMUNOL REV, V207, P5, DOI 10.1111/j.0105-2896.2005.00320.x; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; GOLDFIEN RD, 1991, J IMMUNOL, V146, P3703; Gotoh K, 2008, BLOOD, V111, P2973, DOI 10.1182/blood-2007-09-112169; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Leung BP, 2002, J IMMUNOL, V169, P7071, DOI 10.4049/jimmunol.169.12.7071; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Lutzky V, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2200; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Minobe S, 2009, NEUROSCI RES, V63, P294, DOI 10.1016/j.neures.2009.01.006; Ochando JC, 2006, NAT IMMUNOL, V7, P652, DOI 10.1038/ni1333; PANAYI GS, 1992, CLIN EXP RHEUMATOL, V10, P305; Sarkar S, 2005, FRONT BIOSCI-LANDMRK, V10, P656, DOI 10.2741/1560; Snapper SB, 2005, J LEUKOCYTE BIOL, V77, P993, DOI 10.1189/jlb.0804444; Tassi I, 2009, EUR J IMMUNOL, V39, P1369, DOI 10.1002/eji.200839313; van Golen KL, 2008, J CELL BIOCHEM, V104, P1587, DOI 10.1002/jcb.21652; Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walsh NC, 2005, IMMUNOL REV, V208, P228, DOI 10.1111/j.0105-2896.2005.00338.x; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang YQ, 2008, J BONE MINER RES, V23, P260, DOI 10.1359/JBMR.071013; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; XU S, 2009, J BIOL CHEM; XU S, 2009, J BIOL CHEM; Zhang ZY, 2004, MOL BIOL CELL, V15, P4234, DOI 10.1091/mbc.E04-03-0264	42	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8909	10.1371/journal.pone.0008909	http://dx.doi.org/10.1371/journal.pone.0008909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111715	gold, Green Published			2022-12-27	WOS:000274114800012
J	Yang, H; Liu, C; Zhong, YW; Luo, SQ; Monteiro, MJ; Fang, SY				Yang, Hui; Liu, Chao; Zhong, Yongwang; Luo, Shouqing; Monteiro, Mervyn J.; Fang, Shengyun			Huntingtin Interacts with the Cue Domain of gp78 and Inhibits gp78 Binding to Ubiquitin and p97/VCP	PLOS ONE			English	Article							RETICULUM-ASSOCIATED DEGRADATION; TERMINAL MUTANT HUNTINGTIN; ENDOPLASMIC-RETICULUM; ER STRESS; MISFOLDED PROTEINS; AAA ATPASE; NEURODEGENERATIVE DISEASES; POLYUBIQUITIN CHAINS; RETRO-TRANSLOCATION; CONJUGATING ENZYME	Huntington's disease (HD) is caused by polyglutamine expansion in huntingtin (htt) protein, but the exact mechanism of HD pathogenesis remains uncertain. Recent evidence suggests that htt proteins with expanded polyglutamine tracts induce endoplasmic reticulum (ER) stress, probably by interfering with ER-associated degradation (ERAD). Here we report that mutant htt interacts and interferes with the function of gp78, an ER membrane-anchored ubiquitin ligase (E3) involved in ERAD. Mapping studies showed that the HEAT repeats 2&3 of htt interact with the cue domain of gp78. The interaction competitively reduces polyubiquitinated protein binding to gp78 and also sterically blocks gp78 interaction of p97/VCP, a molecular chaperone that is essential for ERAD. These effects of htt negatively regulate the function of gp78 in ERAD and are aggravated by polyglutamine expansion. Paradoxically, gp78 is still able to ubiquitinate and facilitate degradation of htt proteins with expanded polyglutamine. The impairment of ERAD by mutant htt proteins is associated with induction of ER stress. Our studies provide a novel molecular mechanism that supports the involvement of ER stress in HD pathogenesis.	[Yang, Hui; Liu, Chao; Zhong, Yongwang; Monteiro, Mervyn J.; Fang, Shengyun] Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Luo, Shouqing] Cambridge Inst Med Res, Dept Med Genet, Cambridge, England	University System of Maryland; University of Maryland Baltimore; University of Cambridge	Yang, H (corresponding author), Univ Maryland, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.	fangs@umbi.umd.edu	Fang, Shengyun/H-3802-2011; Zhong, Yongwang/A-2527-2012; Monteiro, Mervyn J/H-3813-2011	Fang, Shengyun/0000-0001-7280-5463	NIH [5R01GM069967, 5R01GM066287]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066287, R01GM069967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by NIH grants 5R01GM069967 (SF) and 5R01GM066287 (MJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Ballar P, 2006, J BIOL CHEM, V281, P35359, DOI 10.1074/jbc.M603355200; Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen LZ, 2002, NEUROCHEM RES, V27, P891, DOI 10.1023/A:1020387414086; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; Homma K, 2009, EXPERT OPIN THER TAR, V13, P653, DOI 10.1517/14728220902980249; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Kazantsev AG, 2007, PROG NEUROBIOL, V83, P249, DOI 10.1016/j.pneurobio.2007.02.005; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Li XJ, 2010, BBA-MOL BASIS DIS, V1802, P62, DOI 10.1016/j.bbadis.2009.06.008; Li XY, 2009, MOL CELL BIOL, V29, P6106, DOI 10.1128/MCB.00420-09; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Luo SQ, 2008, HUM MOL GENET, V17, P895, DOI 10.1093/hmg/ddm362; Mitra S, 2008, THESCIENTIFICWORLDJO, V8, P421, DOI 10.1100/tsw.2008.60; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noh JY, 2009, J BIOL CHEM, V284, P11318, DOI 10.1074/jbc.M807620200; Orr AL, 2008, J NEUROSCI, V28, P2783, DOI 10.1523/JNEUROSCI.0106-08.2008; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Ponting CP, 2000, BIOCHEM J, V351, P527, DOI 10.1042/0264-6021:3510527; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Reijonen S, 2008, EXP CELL RES, V314, P950, DOI 10.1016/j.yexcr.2007.12.025; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roze E, 2008, CURR OPIN NEUROL, V21, P497, DOI 10.1097/WCO.0b013e328304b692; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang HM, 2009, HUM MOL GENET, V18, P737, DOI 10.1093/hmg/ddn404; Yang H, 2007, EXP CELL RES, V313, P538, DOI 10.1016/j.yexcr.2006.10.031; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Ying Z, 2009, HUM MOL GENET, V18, P4268, DOI 10.1093/hmg/ddp380; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	67	140	146	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8905	10.1371/journal.pone.0008905	http://dx.doi.org/10.1371/journal.pone.0008905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126661	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500024
J	Ulici, V; James, CG; Hoenselaar, KD; Beier, F				Ulici, Veronica; James, Claudine G.; Hoenselaar, Katie D.; Beier, Frank			Regulation of Gene Expression by PI3K in Mouse Growth Plate Chondrocytes	PLOS ONE			English	Article							TRANSGLUTAMINASE FACTOR XIIIA; ENDOCHONDRAL BONE-GROWTH; PROTEIN-KINASE B/AKT; SET ENRICHMENT; UP-REGULATION; II COLLAGEN; CARTILAGE; DIFFERENTIATION; TRANSCRIPTION; HYPERTROPHY	Background: Endochondral ossification, the process through which long bones are formed, involves chondrocyte proliferation and hypertrophic differentiation in the cartilage growth plate. In a previous publication we showed that pharmacological inhibition of the PI3K signaling pathway results in reduced endochondral bone growth, and in particular, shortening of the hypertrophic zone in a tibia organ culture system. In this current study we aimed to investigate targets of the PI3K signaling pathway in hypertrophic chondrocytes. Methodology/Principal Findings: Through the intersection of two different microarray analyses methods (classical single gene analysis and GSEA) and two different chondrocyte differentiation systems (primary chondrocytes treated with a pharmacological inhibitor of PI3K and microdissected growth plates), we were able to identify a high number of genes grouped in GSEA functional categories regulated by the PI3K signaling pathway. Genes such as Phlda2 and F13a1 were down-regulated upon PI3K inhibition and showed increased expression in the hypertrophic zone compared to the proliferative/resting zone of the growth plate. In contrast, other genes including Nr4a1 and Adamts5 were up-regulated upon PI3K inhibition and showed reduced expression in the hypertrophic zone. Regulation of these genes by PI3K signaling was confirmed by quantitative RT-PCR. We focused on F13a1 as an interesting target because of its known role in chondrocyte hypertrophy and osteoarthritis. Mouse E15.5 tibiae cultured with LY294002 (PI3K inhibitor) for 6 days showed decreased expression of factor XIIIa in the hypertrophic zone compared to control cultures. Conclusions/Significance: Discovering targets of signaling pathways in hypertrophic chondrocytes could lead to targeted therapy in osteoarthritis and a better understanding of the cartilage environment for tissue engineering.	[Ulici, Veronica; James, Claudine G.; Hoenselaar, Katie D.; Beier, Frank] Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON, Canada	Western University (University of Western Ontario)	Ulici, V (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodeling, London, ON, Canada.	fbeier@uwo.ca	Beier, Frank/T-4734-2019; Beier, Frank/G-4595-2013	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537	Canadian Arthritis Network; Natural Sciences and Engineering Research Council; Canada Research Chair Award; Canadian Institutes of Health Research [MOP 43899]	Canadian Arthritis Network; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	VU was the recipient of a graduate scholarship from the Canadian Arthritis Network (http://www.arthritisnetwork.ca/). KH was the recipient of summer studentships from the Natural Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/). FB is the recipient of a Canada Research Chair Award. Work in the lab of FB was supported by a grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html): MOP 43899. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-18; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Apostolidou S, 2007, J MOL MED, V85, P379, DOI 10.1007/s00109-006-0131-8; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BUCKWALTER JA, 1986, J BONE JOINT SURG AM, V68A, P243, DOI 10.2106/00004623-198668020-00010; Cancedda R, 2000, INT J DEV BIOL, V44, P707; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Chung UI, 2004, ENDOCR J, V51, P19, DOI 10.1507/endocrj.51.19; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Han YH, 2006, ONCOGENE, V25, P2974, DOI 10.1038/sj.onc.1209358; HUNZIKER EB, 1987, J BONE JOINT SURG AM, V69A, P162, DOI 10.2106/00004623-198769020-00002; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Johnson K, 2001, AM J PATHOL, V159, P149, DOI 10.1016/S0002-9440(10)61682-3; Jung YD, 1999, CANCER RES, V59, P4804; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kuhn I, 2001, PHYSIOL GENOMICS, V7, P105, DOI 10.1152/physiolgenomics.00052.2001; Liao JF, 1998, J BIOL CHEM, V273, P27320, DOI 10.1074/jbc.273.42.27320; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakano Y, 2007, J HISTOCHEM CYTOCHEM, V55, P675, DOI 10.1369/jhc.6A7091.2007; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Nurminskaya MV, 2002, DEV DYNAM, V223, P24, DOI 10.1002/dvdy.1230; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Saxena A, 2002, J BIOL CHEM, V277, P49935, DOI 10.1074/jbc.M206497200; Silverman JS, 1996, BLOOD, V88, P4072, DOI 10.1182/blood.V88.10.4072b.bloodjournal88104072b; Solomon Lauren A., 2008, Birth Defects Research, V84, P123, DOI 10.1002/bdrc.20124; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tchetina EV, 2007, MATRIX BIOL, V26, P247, DOI 10.1016/j.matbio.2007.01.006; Tchetina EV, 2005, J RHEUMATOL, V32, P876; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200; WOODS A, 2009, J CELL MOL MED	43	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8866	10.1371/journal.pone.0008866	http://dx.doi.org/10.1371/journal.pone.0008866			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111593	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896300015
J	Govind, G; Mittapalli, O; Griebel, T; Allmann, S; Bocker, S; Baldwin, IT				Govind, Geetha; Mittapalli, Omprakash; Griebel, Thasso; Allmann, Silke; Boecker, Sebastian; Baldwin, Ian Thomas			Unbiased Transcriptional Comparisons of Generalist and Specialist Herbivores Feeding on Progressively Defenseless Nicotiana attenuata Plants	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; TRYPSIN PROTEINASE-INHIBITOR; SUGAR-TRANSPORT PROTEINS; COLORADO POTATO BEETLES; LARGE-SCALE CHANGES; MOLECULAR-INTERACTIONS; TOBACCO HORNWORM; JASMONIC ACID; MICROARRAY ANALYSIS; MEDIATED DEFENSES	Background: Herbivore feeding elicits dramatic increases in defenses, most of which require jasmonate (JA) signaling, and against which specialist herbivores are thought to be better adapted than generalist herbivores. Unbiased transcriptional analyses of how neonate larvae cope with these induced plant defenses are lacking. Methodology/Principal Findings: We created cDNA microarrays for Manduca sexta and Heliothis virescens separately, by spotting normalized midgut-specific cDNA libraries created from larvae that fed for 24 hours on MeJA-elicited wild-type (WT) Nicotiana attenuata plants. These microarrays were hybridized with labeled probes from neonates that fed for 24 hours on WT and isogenic plants progressively silenced in JA-mediated defenses (N: nicotine; N/PI: N and trypsin protease inhibitors; JA: all JA-mediated defenses). H. virescens neonates regulated 16 times more genes than did M. sexta neonates when they fed on plants silenced in JA-mediated defenses, and for both species, the greater the number of defenses silenced in the host plant (JA. N/PI. N), the greater were the number of transcripts regulated in the larvae. M. sexta larvae tended to down-regulate while H. virescens larvae up-and down-regulated transcripts from the same functional categories of genes. M. sexta larvae regulated transcripts in a diet-specific manner, while H. virescens larvae regulated a similar suite of transcripts across all diet types. Conclusions/Significance: The observations are consistent with the expectation that specialists are better adapted than generalist herbivores to the defense responses elicited in their host plants by their feeding. While M. sexta larvae appear to be better adapted to N. attenuata's defenses, some of the elicited responses remain effective defenses against both herbivore species. The regulated genes provide novel insights into larval adaptations to N. attenuata's induced defenses, and represent potential targets for plant-mediated RNAi to falsify hypotheses about the process of adaptation.	[Govind, Geetha; Mittapalli, Omprakash; Allmann, Silke; Baldwin, Ian Thomas] Max Planck Inst Chem Ecol, Jena, Germany; [Griebel, Thasso; Boecker, Sebastian] Univ Jena, Fac Math & Comp Sci, Jena, Germany	Max Planck Society; Friedrich Schiller University of Jena	Govind, G (corresponding author), Max Planck Inst Chem Ecol, Jena, Germany.	baldwin@ice.mpg.de	Govind, Geetha/AAB-3203-2021; Baldwin, Ian T/K-1809-2013; Allmann, Silke/Q-6522-2017	Govind, Geetha/0000-0003-0450-0814; Allmann, Silke/0000-0001-6300-3741; Baldwin, Ian/0000-0001-5371-2974; Bocker, Sebastian/0000-0002-9304-8091	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funding: This work was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JE, 2004, INSECT MOL BIOL, V13, P649, DOI 10.1111/j.0962-1075.2004.00523.x; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; APPEL HM, 1992, ECOLOGY, V73, P216, DOI 10.2307/1938733; BALDWIN IT, 1994, J CHEM ECOL, V20, P2345, DOI 10.1007/BF02033207; Becerra JX, 2003, P NATL ACAD SCI USA, V100, P12804, DOI 10.1073/pnas.2133013100; Berenbaum MR, 1998, P NATL ACAD SCI USA, V95, P13743, DOI 10.1073/pnas.95.23.13743; Berenbaum MR, 2001, ANN MO BOT GARD, V88, P45, DOI 10.2307/2666131; Bezzerides A, 2004, P NATL ACAD SCI USA, V101, P9029, DOI 10.1073/pnas.0402480101; BIRK Y, 2003, PLANT PROTEASE INHIB, P170; BROADWAY RM, 1995, J INSECT PHYSIOL, V41, P107, DOI 10.1016/0022-1910(94)00101-L; Broadway RM, 1996, ARCH INSECT BIOCHEM, V32, P39, DOI 10.1002/(SICI)1520-6327(1996)32:1&lt;39::AID-ARCH3&gt;3.0.CO;2-S; Brunelle F, 2004, ARCH INSECT BIOCHEM, V55, P103, DOI 10.1002/arch.10135; Chen H, 2005, P NATL ACAD SCI USA, V102, P19237, DOI 10.1073/pnas.0509026102; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; COHEN MB, 1992, P NATL ACAD SCI USA, V89, P10920, DOI 10.1073/pnas.89.22.10920; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Darwish SA, 2008, PLANT MOL BIOL REP, V26, P12, DOI 10.1007/s11105-008-0019-6; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Eisner T, 2000, P NATL ACAD SCI USA, V97, P1634, DOI 10.1073/pnas.030532797; EISNER T, 1995, P NATL ACAD SCI US, V92; Engler HS, 2000, NATURE, V406, P144, DOI 10.1038/35018159; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ferry N, 2004, CURR OPIN BIOTECH, V15, P155, DOI 10.1016/j.copbio.2004.01.008; Frey M, 2000, P NATL ACAD SCI USA, V97, P14801, DOI 10.1073/pnas.260499897; Gaquerel E, 2009, PLANT PHYSIOL, V149, P1408, DOI 10.1104/pp.108.130799; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Giri AP, 1998, PLANT PHYSIOL, V116, P393, DOI 10.1104/pp.116.1.393; Glendinning JI, 2002, ENTOMOL EXP APPL, V104, P15, DOI 10.1023/A:1021271717409; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2004, PLANT J, V40, P35, DOI 10.1111/j.1365-313X.2004.02185.x; Halitschke R, 2003, PLANT J, V36, P794, DOI 10.1046/j.1365-313X.2003.01921.x; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Hayashi K, 2002, APPL ENVIRON MICROB, V68, P4996, DOI 10.1128/AEM.68.10.4996-5004.2002; HEILING S, 2010, PLANT CELL IN PRESS; HENDERSON PJF, 1990, PHILOS T ROY SOC B, V326, P391, DOI 10.1098/rstb.1990.0020; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hui DQ, 2003, PLANT PHYSIOL, V131, P1877, DOI 10.1104/pp.102.018176; Jansen JJ, 2009, METABOLOMICS, V5, P150, DOI 10.1007/s11306-008-0124-4; Jassbi AR, 2008, PLANT PHYSIOL, V146, P974, DOI 10.1104/pp.107.108811; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Karban R, 2002, ANNU REV ECOL SYST, V33, P641, DOI 10.1146/annurev.ecolsys.33.010802.150443; Keinanen M, 2001, J AGR FOOD CHEM, V49, P3553, DOI 10.1021/jf010200+; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kliebenstein D, 2002, GENETICS, V161, P325; Koo YD, 2008, INSECT MOL BIOL, V17, P235, DOI 10.1111/j.1365-2583.2008.00799.x; KRIEGER RI, 1971, SCIENCE, V172, P579, DOI 10.1126/science.172.3983.579; Li XC, 2002, NATURE, V419, P712, DOI 10.1038/nature01003; Liu YL, 2004, INSECT BIOCHEM MOLEC, V34, P1069, DOI 10.1016/j.ibmb.2004.06.010; MA RL, 1994, ARCH BIOCHEM BIOPHYS, V310, P332, DOI 10.1006/abbi.1994.1175; MADDRELL SHP, 1976, J EXP BIOL, V64, P267; MAIDEN MCJ, 1987, NATURE, V325, P641, DOI 10.1038/325641a0; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mechaber WL, 2000, ANN ENTOMOL SOC AM, V93, P447, DOI 10.1603/0013-8746(2000)093[0447:NNSHRF]2.0.CO;2; Mitra S, 2008, PLANT PHYSIOL, V148, P1128, DOI 10.1104/pp.108.124354; MORRIS CE, 1984, J EXP ZOOL, V229, P361, DOI 10.1002/jez.1402290304; Mozoruk J, 2006, PLANT SCI, V170, P1068, DOI 10.1016/j.plantsci.2006.01.014; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; Nosil P, 2002, NATURE, V417, P440, DOI 10.1038/417440a; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; PARR JC, 1972, ANN ENTOMOL SOC AM, V65, P1185, DOI 10.1093/aesa/65.5.1185; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pohnert G, 1999, TETRAHEDRON, V55, P11275, DOI 10.1016/S0040-4020(99)00639-0; Rasmann S, 2009, CURR OPIN PLANT BIOL, V12, P473, DOI 10.1016/j.pbi.2009.05.005; Ratzka A, 2002, P NATL ACAD SCI USA, V99, P11223, DOI 10.1073/pnas.172112899; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Rivard D, 2004, ARCH INSECT BIOCHEM, V55, P114, DOI 10.1002/arch.10136; ROSE RL, 1991, COMP BIOCHEM PHYS B, V99, P535, DOI 10.1016/0305-0491(91)90334-A; ROSENTHAL GA, 1982, SCIENCE, V217, P353, DOI 10.1126/science.217.4557.353; ROSENTHAL GA, 1978, SCIENCE, V202, P528, DOI 10.1126/science.202.4367.528; Sasabe M, 2004, GENE, V338, P163, DOI 10.1016/j.gene.2004.04.028; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; SELF LS, 1964, J INSECT PHYSIOL, V10, P907, DOI 10.1016/0022-1910(64)90081-2; Simpson S.J., 1995, P251; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Skibbe M, 2008, PLANT CELL, V20, P1984, DOI 10.1105/tpc.108.058594; SNYDER MJ, 1993, J CHEM ECOL, V19, P2903, DOI 10.1007/BF00980591; Snyder MJ, 1996, J COMP PHYSIOL A, V179, P255, DOI 10.1007/BF00222792; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Steppuhn A, 2008, MOL ECOL, V17, P3717, DOI 10.1111/j.1365-294X.2008.03862.x; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Stevens JL, 2000, INSECT BIOCHEM MOLEC, V30, P559, DOI 10.1016/S0965-1748(00)00024-2; van Dam NM, 2008, PLANT SIGNAL BEHAV, V3, P91, DOI 10.4161/psb.3.2.5220; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Voelckel C, 2001, CHEMOECOLOGY, V11, P121, DOI 10.1007/PL00001841; Vogel H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001081; WALDVOGEL M, 1990, EVOLUTION, V44, P1326, DOI 10.2307/2409292; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Wang L, 2008, PLANT PHYSIOL, V146, P904, DOI 10.1104/pp.107.109264; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Winterer J, 2001, MOL ECOL, V10, P1069, DOI 10.1046/j.1365-294X.2001.01239.x; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Zavala JA, 2004, PLANT PHYSIOL, V134, P1181, DOI 10.1104/pp.103.035634; Zavala JA, 2004, P NATL ACAD SCI USA, V101, P1607, DOI 10.1073/pnas.0305096101; Zhu-Salzman K, 2003, INSECT MOL BIOL, V12, P135, DOI 10.1046/j.1365-2583.2003.00395.x	107	77	80	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8735	10.1371/journal.pone.0008735	http://dx.doi.org/10.1371/journal.pone.0008735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090945	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900015
J	Zeiner, GM; Norman, KL; Thomson, JM; Hammond, SM; Boothroyd, JC				Zeiner, Gusti M.; Norman, Kara L.; Thomson, J. Michael; Hammond, Scott M.; Boothroyd, John C.			Toxoplasma gondii Infection Specifically Increases the Levels of Key Host MicroRNAs	PLOS ONE			English	Article							CELL-CYCLE ARREST; MIR-17-92 CLUSTER; EXPRESSION; MODULATION; ACTIVATION; APOPTOSIS; DISEASE; GROWTH; ROLES	Background: The apicomplexan parasite Toxoplasma gondii can infect and replicate in virtually any nucleated cell in many species of warm-blooded animals; thus, it has evolved the ability to exploit well-conserved biological processes common to its diverse hosts. Here we have investigated whether Toxoplasma modulates the levels of host microRNAs ( miRNAs) during infection. Methodology/Principal Findings: Using microarray profiling and a combination of conventional molecular approaches we report that Toxoplasma specifically modulates the expression of important host microRNAs during infection. We show that both the primary transcripts for miR-17 similar to 92 and miR-106b similar to 25 and the pivotal miRNAs that are derived from miR-17 similar to 92 display increased abundance in Toxoplasma-infected primary human cells; a Toxoplasma-dependent up-regulation of the miR-17 similar to 92 promoter is at least partly responsible for this increase. The abundance of mature miR-17 family members, which are derived from these two miRNA clusters, remains unchanged in host cells infected with the closely related apicomplexan Neospora caninum; thus, the Toxoplasma-induced increase in their abundance is a highly directed process rather than a general host response to infection. Conclusions/Significance: Altered levels of miR-17 similar to 92 and miR-106b similar to 25 are known to play crucial roles in mammalian cell regulation and have been implicated in numerous hyperproliferative diseases although the mechanisms driving their altered expression are unknown. Hence, in addition to the implications of these findings on the host-pathogen interaction, Toxoplasma may represent a powerful probe for understanding the normal mechanisms that regulate the levels of key host miRNAs.	[Zeiner, Gusti M.; Norman, Kara L.; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Thomson, J. Michael; Hammond, Scott M.] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Hammond, Scott M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zeiner, GM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Zeiner, Gusti/0000-0001-7815-5588; Boothroyd, John C./0000-0001-9719-745X	NIH [5F32AI066538, 5R01GM070674, AI21423, A173756]; Alberta Heritage Foundation; American Cancer Society [PF-05-152-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021423, R01AI073756, R01AI021423, F32AI066538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070674] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: G. M. Z. was supported by the NIH (5F32AI066538). K. L. N was supported by the Alberta Heritage Foundation for Medical Research postdoctoral fellowship. J.M.T. was supported by the American Cancer Society (PF-05-152-01). S. M. H. was supported by the NIH (5R01GM070674). J.C.B. was supported by the NIH (AI21423 and A173756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Brunet J, 2008, CELL MICROBIOL, V10, P908, DOI 10.1111/j.1462-5822.2007.01093.x; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; DVORAK JA, 1981, SCIENCE, V214, P1034, DOI 10.1126/science.7029713; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Lavine MD, 2009, MOL BIOCHEM PARASIT, V164, P95, DOI 10.1016/j.molbiopara.2008.11.014; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Lu Y, 2007, DEV BIOL, V310, P442, DOI 10.1016/j.ydbio.2007.08.007; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Molestina RE, 2008, CELL MICROBIOL, V10, P1153, DOI 10.1111/j.1462-5822.2008.01117.x; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Phelps ED, 2008, INFECT IMMUN, V76, P4703, DOI 10.1128/IAI.01447-07; PULVERTAFT RJV, 1964, LANCET, V1, P238; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473; Sundermann CA, 1999, INT J PARASITOL, V29, P1725, DOI 10.1016/S0020-7519(99)00114-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027	41	72	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8742	10.1371/journal.pone.0008742	http://dx.doi.org/10.1371/journal.pone.0008742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090903	gold, Green Published			2022-12-27	WOS:000273714900022
J	Liao, W; Zhang, ZQ; Pan, ZY; Mantini, D; Ding, JR; Duan, XJ; Luo, C; Lu, GM; Chen, HF				Liao, Wei; Zhang, Zhiqiang; Pan, Zhengyong; Mantini, Dante; Ding, Jurong; Duan, Xujun; Luo, Cheng; Lu, Guangming; Chen, Huafu			Altered Functional Connectivity and Small-World in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							DEFAULT-MODE; RESTING-STATE; HUMAN BRAIN; CINGULATE CORTEX; NEURAL NETWORKS; LOW-FREQUENCY; FMRI; EEG; ATTENTION; MRI	Background: The functional architecture of the human brain has been extensively described in terms of functional connectivity networks, detected from the low-frequency coherent neuronal fluctuations that can be observed in a resting state condition. Little is known, so far, about the changes in functional connectivity and in the topological properties of functional networks, associated with different brain diseases. Methodology/Principal Findings: In this study, we investigated alterations related to mesial temporal lobe epilepsy (mTLE), using resting state functional magnetic resonance imaging on 18 mTLE patients and 27 healthy controls. Functional connectivity among 90 cortical and subcortical regions was measured by temporal correlation. The related values were analyzed to construct a set of undirected graphs. Compared to controls, mTLE patients showed significantly increased connectivity within the medial temporal lobes, but also significantly decreased connectivity within the frontal and parietal lobes, and between frontal and parietal lobes. Our findings demonstrated that a large number of areas in the default-mode network of mTLE patients showed a significantly decreased number of connections to other regions. Furthermore, we observed altered small-world properties in patients, along with smaller degree of connectivity, increased n-to-1 connectivity, smaller absolute clustering coefficients and shorter absolute path length. Conclusions/Significance: We suggest that the mTLE alterations observed in functional connectivity and topological properties may be used to define tentative disease markers.	[Liao, Wei; Pan, Zhengyong; Ding, Jurong; Duan, Xujun; Luo, Cheng; Chen, Huafu] Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China; [Zhang, Zhiqiang; Lu, Guangming] Nanjing Univ, Dept Med Imaging, Nanjing Jinling Hosp, Sch Clin,Med Coll, Nanjing 210008, Peoples R China; [Mantini, Dante] Univ G dAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Mantini, Dante] Univ G DAnnunzio, Dept Clin Sci & Bioimaging, Chieti, Italy; [Mantini, Dante] Katholieke Univ Leuven, Sch Med, Lab Neuropsychophysiol, Louvain, Belgium	University of Electronic Science & Technology of China; Nanjing University; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; KU Leuven	Liao, W (corresponding author), Univ Elect Sci & Technol China, Key Lab NeuroInformat, Minist Educ, Sch Life Sci & Technol, Chengdu 610054, Peoples R China.	cjr.luguangming@vip.163.com; chenhf@uestc.edu.cn	Mantini, Dante/D-6989-2014; Luo, Cheng/A-4647-2015; Mantini, Dante/H-3061-2011	Mantini, Dante/0000-0001-6485-5559; Luo, Cheng/0000-0003-0524-5886; 	Natural Science Foundation of China [90820006, 30770590, 30470510, 30800264]; New Century Excellent Talents in University; MOE [107097]; 863 Program [2008AA02Z408]; Flanders Research Foundation (F.W.O.)	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); MOE(Ministry of Higher Education & Scientific Research (MHESR)); 863 Program(National High Technology Research and Development Program of China); Flanders Research Foundation (F.W.O.)(FWO)	WL, HC, ZP, JD and CL were supported by the Natural Science Foundation of China, Grant Nos. 90820006 and 30770590, by the New Century Excellent Talents in University, by the Key research project of science and technology of MOE (107097) and by the 863 Program No: 2008AA02Z408. ZZ and GL were supported by the Natural Science Foundation of China, Grant No. 30470510 and 30800264. DM was supported by the Flanders Research Foundation (F.W.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 2001, CLIN NEUROPHYSIOL, V112, P1746, DOI 10.1016/S1388-2457(01)00591-0; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Benar CG, 2002, NEUROIMAGE, V17, P1182, DOI 10.1006/nimg.2002.1164; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bettus G, 2008, EPILEPSY RES, V81, P58, DOI 10.1016/j.eplepsyres.2008.04.020; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Blumenfeld H, 2009, BRAIN, V132, P999, DOI 10.1093/brain/awp028; Blumenfeld H, 2004, CEREB CORTEX, V14, P892, DOI 10.1093/cercor/bhh048; Bragin A, 1999, HIPPOCAMPUS, V9, P137; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gotman J, 2006, J MAGN RESON IMAGING, V23, P906, DOI 10.1002/jmri.20577; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Guye M, 2006, BRAIN, V129, P1917, DOI 10.1093/brain/awl151; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jiang TZ, 2004, HUM BRAIN MAPP, V22, P63, DOI 10.1002/hbm.20012; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kobayashi E, 2006, EPILEPSIA, V47, P343, DOI 10.1111/j.1528-1167.2006.00427.x; Laufs H, 2007, HUM BRAIN MAPP, V28, P1023, DOI 10.1002/hbm.20323; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Liu YH, 2008, J NEUROL SCI, V268, P117, DOI 10.1016/j.jns.2007.11.019; Lopez L, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036107; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lui S, 2008, J MAGN RESON IMAGING, V27, P1214, DOI 10.1002/jmri.21370; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Perlbarg V, 2007, MAGN RESON IMAGING, V25, P35, DOI 10.1016/j.mri.2006.09.042; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Schevon CA, 2007, NEUROIMAGE, V35, P140, DOI 10.1016/j.neuroimage.2006.11.009; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam Cornelis J, 2007, Nonlinear Biomed Phys, V1, P3, DOI 10.1186/1753-4631-1-3; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendling F, 2003, BRAIN, V126, P1449, DOI 10.1093/brain/awg144; WU J, 1998, CHIN J RADIOL, P224; WU JW, 1998, CHIN J RADIOL, V32, P220; Zhang ZQ, 2009, J NEUROL, V256, P1705, DOI 10.1007/s00415-009-5187-2; Zhang ZQ, 2009, NEUROSCI LETT, V458, P97, DOI 10.1016/j.neulet.2009.04.040	66	376	387	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8525	10.1371/journal.pone.0008525	http://dx.doi.org/10.1371/journal.pone.0008525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072616	Green Submitted, Green Published, gold			2022-12-27	WOS:000273414200005
J	Kawabata, D; Venkatesh, J; Ramanujam, M; Davidson, A; Grimaldi, CM; Diamond, B				Kawabata, Daisuke; Venkatesh, Jeganathan; Ramanujam, Meera; Davidson, Anne; Grimaldi, Christine M.; Diamond, Betty			Enhanced Selection of High Affinity DNA-Reactive B Cells Following Cyclophosphamide Treatment in Mice	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CUTTING EDGE; BAFF; TOLERANCE; AUTOANTIBODY; INDUCTION; DEPLETION; SURVIVAL; SLE; LYMPHOCYTES	A major goal for the treatment of patients with systemic lupus erythematosus with cytotoxic therapies is the induction of long-term remission. There is, however, a paucity of information concerning the effects of these therapies on the reconstituting B cell repertoire. Since there is recent evidence suggesting that B cell lymphopenia might attenuate negative selection of autoreactive B cells, we elected to investigate the effects of cyclophosphamide on the selection of the re-emerging B cell repertoire in wild type mice and transgenic mice that express the H chain of an anti-DNA antibody. The reconstituting B cell repertoire in wild type mice contained an increased frequency of DNA-reactive B cells; in heavy chain transgenic mice, the reconstituting repertoire was characterized by an increased frequency of mature, high affinity DNA-reactive B cells and the mice expressed increased levels of serum anti-DNA antibodies. This coincided with a significant increase in serum levels of BAFF. Treatment of transgene-expressing mice with a BAFF blocking agent or with DNase to reduce exposure to autoantigen limited the expansion of high affinity DNA-reactive B cells during B cell reconstitution. These studies suggest that during B cell reconstitution, not only is negative selection of high affinity DNA-reactive B cells impaired by increased BAFF, but also that B cells escaping negative selection are positively selected by autoantigen. There are significant implications for therapy.	[Kawabata, Daisuke; Venkatesh, Jeganathan; Ramanujam, Meera; Davidson, Anne; Grimaldi, Christine M.; Diamond, Betty] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA	Northwell Health	Kawabata, D (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	bdiamond@nshs.edu		Davidson, Anne/0000-0002-4081-6464	NIAID; NIAMS; Arthritis Foundation (Daisuke Kawabata); SLE Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049938] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation (Daisuke Kawabata); SLE Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from NIAID (Anne Davidson) NIAMS (Christine M Grimaldi and Betty Diamond), a fellowship from the Arthritis Foundation (Daisuke Kawabata) and Career Development Awards from the SLE Foundation (Jeganathan Venkatesh and Meera Ramanujam). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja A, 2007, J IMMUNOL, V179, P3351, DOI 10.4049/jimmunol.179.5.3351; Ait-Azzouzene D, 2006, EUR J IMMUNOL, V36, P985, DOI 10.1002/eji.200535581; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Austin HA, 1997, J RHEUMATOL, V24, P61; BAKER D, 1987, INT J IMMUNOPHARMACO, V9, P175; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; BOUMPAS DT, 1995, ANN INTERN MED, V122, P940, DOI 10.7326/0003-4819-122-12-199506150-00009; Bynoe MS, 2000, P NATL ACAD SCI USA, V97, P2703, DOI 10.1073/pnas.040577497; Cambridge G, 2008, ANN RHEUM DIS, V67, P1011, DOI 10.1136/ard.2007.079418; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Davidson A, 2001, NEW ENGL J MED, V345, P340, DOI 10.1056/NEJM200108023450506; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Eisenberg R, 2006, NAT CLIN PRACT RHEUM, V2, P20, DOI 10.1038/ncprheum0042; Grimaldi CM, 2006, J IMMUNOL, V176, P2703, DOI 10.4049/jimmunol.176.5.2703; Hemendinger RA, 1996, IMMUNOPHARMACOLOGY, V35, P71, DOI 10.1016/0162-3109(96)00124-5; Hondowicz BD, 2007, INT IMMUNOL, V19, P465, DOI 10.1093/intimm/dxm011; Leandro MJ, 2005, RHEUMATOLOGY, V44, P1542, DOI 10.1093/rheumatology/kei080; Looney R. John, 2005, V8, P193; Lutsiak MEC, 2005, BLOOD, V105, P2862, DOI 10.1182/blood-2004-06-2410; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; OFFEN D, 1992, P NATL ACAD SCI USA, V89, P8332, DOI 10.1073/pnas.89.17.8332; Pelanda R, 1997, IMMUNITY, V7, P765, DOI 10.1016/S1074-7613(00)80395-7; Ramanujam M, 2006, J CLIN INVEST, V116, P724, DOI 10.1172/JCI26385; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Rolink AG, 2002, CURR OPIN IMMUNOL, V14, P266, DOI 10.1016/S0952-7915(02)00332-1; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Seror R, 2007, ANN RHEUM DIS, V66, P351, DOI 10.1136/ard.2006.057919; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Venkatesh J, 2006, J IMMUNOL, V176, P3311, DOI 10.4049/jimmunol.176.6.3311; Verthelyi D, 1998, LUPUS, V7, P223, DOI 10.1191/096120398678920037; Vlachoyiannopoulos PG, 2008, J RHEUMATOL, V35, P1768; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	33	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8418	10.1371/journal.pone.0008418	http://dx.doi.org/10.1371/journal.pone.0008418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066044	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600002
J	Greatorex, JS; Page, RF; Curran, MD; Digard, P; Enstone, JE; Wreghitt, T; Powell, PP; Sexton, DW; Vivancos, R; Nguyen-Van-Tam, JS				Greatorex, Jane S.; Page, Rosanna F.; Curran, Martin D.; Digard, Paul; Enstone, Joanne E.; Wreghitt, Tim; Powell, Penny P.; Sexton, Darren W.; Vivancos, Roberto; Nguyen-Van-Tam, Jonathan S.			Effectiveness of Common Household Cleaning Agents in Reducing the Viability of Human Influenza A/H1N1	PLOS ONE			English	Article							TIME RT-PCR; A VIRUS; INACTIVATION; ENVIRONMENTS	Background: In the event of an influenza pandemic, the majority of people infected will be nursed at home. It is therefore important to determine simple methods for limiting the spread of the virus within the home. The purpose of this work was to test a representative range of common household cleaning agents for their effectiveness at killing or reducing the viability of influenza A virus. Methodology/Principal Findings: Plaque assays provided a robust and reproducible method for determining virus viability after disinfection, while a National Standard influenza virus RT-PCR assay (VSOP 25, www.hpa-standardmethods.org.uk) was adapted to detect viral genome, and a British Standard (BS:EN 14476: 2005) was modified to determine virus killing. Conclusions/Significance: Active ingredients in a number of the cleaning agents, wipes, and tissues tested were able to rapidly render influenza virus nonviable, as determined by plaque assay. Commercially available wipes with a claimed antiviral or antibacterial effect killed or reduced virus infectivity, while nonmicrobiocidal wipes and those containing only low concentrations (<5%) of surfactants showed lower anti-influenza activity. Importantly, however, our findings indicate that it is possible to use common, low-technology agents such as 1% bleach, 10% malt vinegar, or 0.01% washing-up liquid to rapidly and completely inactivate influenza virus. Thus, in the context of the ongoing pandemic, and especially in low-resource settings, the public does not need to source specialized cleaning products, but can rapidly disinfect potentially contaminated surfaces with agents readily available in most homes.	[Greatorex, Jane S.; Curran, Martin D.; Wreghitt, Tim] Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England; [Page, Rosanna F.; Digard, Paul] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Enstone, Joanne E.; Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Nottingham NG7 2RD, England; [Powell, Penny P.; Sexton, Darren W.; Vivancos, Roberto] Univ E Anglia, Biomed Res Ctr, Norwich NR4 7TJ, Norfolk, England; [Nguyen-Van-Tam, Jonathan S.] Hlth Protect Agcy, Nottingham, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Health Protection Agency; University of Cambridge; University of Cambridge; University of Nottingham; University of East Anglia; Health Protection Agency	Greatorex, JS (corresponding author), Addenbrookes Hosp, Hlth Protect Agcy, Cambridge, England.	jvt@nottingham.ac.uk	Sexton, Darren/AAF-3171-2020; Nguyen-Van-Tam, Jonathan/I-2162-2019; Digard, Paul/B-7717-2008	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Digard, Paul/0000-0002-0872-9440; Sexton, Darren/0000-0003-3344-3150; Vivancos, Roberto/0000-0002-8203-8867; Powell, Penny/0000-0002-5347-0490	United Kingdom Health Protection Agency	United Kingdom Health Protection Agency	Funded by the United Kingdom Health Protection Agency. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. However, the manuscript was cleared for submission under the funder's manuscript approval standard operating procedures.	Abe M, 2007, JPN J INFECT DIS, V60, P342; *AUSVETPLAN, 2000, AUSTR VET EM PLAN OP; De Benedictis P, 2007, ZOONOSES PUBLIC HLTH, V54, P51, DOI 10.1111/j.1863-2378.2007.01029.x; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Healing T., 2006, COLL PRES SHIPP SPEC; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Lombardi ME, 2008, AVIAN DIS, V52, P118, DOI 10.1637/8055-070907-Reg; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; MUHAMMAD K, 2001, INT J AGR BIOL, V3, P416; Rennie P, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-38; Rice EW, 2007, EMERG INFECT DIS, V13, P1568, DOI 10.3201/eid1310.070323; Rolfe KJ, 2007, J CLIN VIROL, V39, P318, DOI 10.1016/j.jcv.2007.05.005; SATO SB, 1983, P NATL ACAD SCI-BIOL, V80, P3153, DOI 10.1073/pnas.80.11.3153; Suarez DL, 2003, AVIAN DIS, V47, P1091, DOI 10.1637/0005-2086-47.s3.1091; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; BSEN144762005	18	31	31	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8987	10.1371/journal.pone.0008987	http://dx.doi.org/10.1371/journal.pone.0008987			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126543	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000274209700013
J	Schwarz, J; Burguet, J; Rampin, O; Fromentin, G; Andrey, P; Tome, D; Maurin, Y; Darcel, N				Schwarz, Jessica; Burguet, Jasmine; Rampin, Olivier; Fromentin, Gilles; Andrey, Philippe; Tome, Daniel; Maurin, Yves; Darcel, Nicolas			Three-Dimensional Macronutrient-Associated Fos Expression Patterns in the Mouse Brainstem	PLOS ONE			English	Article							FOOD-INTAKE; 5-HT3 RECEPTORS; CHOLECYSTOKININ; PROTEIN; RAT; INFUSIONS; SATIETY; SYSTEM; FORMS	Background: The caudal brainstem plays an important role in short-term satiation and in the control of meal termination. Meal-related stimuli sensed by the gastrointestinal (GI) tract are transmitted to the area postrema (AP) via the bloodstream, or to the nucleus tractus solitarii (NTS) via the vagus nerve. Little is known about the encoding of macronutrient-specific signals in the caudal brainstem. We hypothesized that sucrose and casein peptone activate spatially distinct sub-populations of NTS neurons and thus characterized the latter using statistical three-dimensional modeling. Methodology/Principal Findings: Using immunolabeling of the proto-oncogene Fos as a marker of neuronal activity, in combination with a statistical three-dimensional modeling approach, we have shown that NTS neurons activated by sucrose or peptone gavage occupy distinct, although partially overlapping, positions. Specifically, when compared to their homologues in peptone-treated mice, three-dimensional models calculated from neuronal density maps following sucrose gavage showed that Fos-positive neurons occupy a more lateral position at the rostral end of the NTS, and a more dorsal position at the caudal end. Conclusion/Significance: To our knowledge, this is the first time that subpopulations of NTS neurons have be distinguished according to the spatial organization of their functional response. Such neuronal activity patterns may be of particular relevance to understanding the mechanisms that support the central encoding of signals related to the presence of macronutrients in the GI tract during digestion. Finally, this finding also illustrates the usefulness of statistical three-dimensional modeling to functional neuroanatomical studies.	[Schwarz, Jessica; Fromentin, Gilles; Tome, Daniel; Darcel, Nicolas] AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Schwarz, Jessica; Fromentin, Gilles; Tome, Daniel; Darcel, Nicolas] INRA, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] INRA, UMR Neurobiol Olfact & Prise Alimentaire 1197, Jouy En Josas, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] Univ Paris 11, UMR 1197, Orsay, France; [Burguet, Jasmine; Rampin, Olivier; Andrey, Philippe; Maurin, Yves] IFR 144 Neuro Sud Paris, Paris, France; [Andrey, Philippe] Univ Paris 06, Paris, France	AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Schwarz, J (corresponding author), AgroParisTech, CRNH IdF, Nutr Physiol & Ingest Behav UMR914, Paris, France.	nicolas.darcel@agroparistech.fr	Schwarz, Jessica/J-3374-2012; Andrey, Philippe/AAS-7228-2021	Schwarz, Jessica/0000-0002-2594-2200	European Commission's Sixth Framework Programme (FP6) [MEST-CT-20058-020494]	European Commission's Sixth Framework Programme (FP6)	The research that led to these results received funding from the European Commission's Sixth Framework Programme (FP6) under NuSISCO Contract No. MEST-CT-20058-020494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; ANDREY P, 2008, 5 IEEE INT S BIOM IM, P1183; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Bowen J, 2006, J CLIN ENDOCR METAB, V91, P1477, DOI 10.1210/jc.2005-1856; Burguet J, 2009, J COMP NEUROL, V513, P483, DOI 10.1002/cne.21954; Freeman SL, 2006, AM J PHYSIOL-GASTR L, V291, pG439, DOI 10.1152/ajpgi.00079.2006; Hayes MR, 2004, PHYSIOL BEHAV, V82, P663, DOI 10.1016/j.physbeh.2004.06.001; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; LIDDLE RA, 1985, J CLIN INVEST, V75, P1144, DOI 10.1172/JCI111809; LUO F, 2009, 3 DIMENSIONAL TONOTO; Malmierca MS, 2008, J NEUROSCI, V28, P4767, DOI 10.1523/JNEUROSCI.0238-08.2008; Maolood N, 2009, J CHEM NEUROANAT, V37, P182, DOI 10.1016/j.jchemneu.2008.12.007; Maschino E, 2006, COMPUT VIS IMAGE UND, V101, P16, DOI 10.1016/j.cviu.2005.06.004; Moran TH, 2004, AM J PHYSIOL-GASTR L, V286, pG183, DOI 10.1152/ajpgi.00434.2003; Morens C, 2000, J NUTR, V130, P2312, DOI 10.1093/jn/130.9.2312; NORGREN R, 1988, J COMP NEUROL, V273, P207, DOI 10.1002/cne.902730206; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Petersen CCH, 2003, PFLUG ARCH EUR J PHY, V447, P126, DOI 10.1007/s00424-003-1167-z; Phifer CB, 1998, AM J PHYSIOL-REG I, V274, pR1725, DOI 10.1152/ajpregu.1998.274.6.R1725; Raybould HE, 2003, AM J PHYSIOL-GASTR L, V284, pG367, DOI 10.1152/ajpgi.00292.2001; Raybould HE, 1999, AM J PHYSIOL-GASTR L, V277, pG751, DOI 10.1152/ajpgi.1999.277.4.G751; Raybould HE, 2006, AUTON NEUROSCI-BASIC, V125, P28, DOI 10.1016/j.autneu.2006.01.016; Schwartz GJ, 2006, PHILOS T R SOC B, V361, P1275, DOI 10.1098/rstb.2006.1862; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Silverman B.W., 1986, DENSITY ESTIMATION S; TEAM RDC, 2009, R A LANGUAGE ENV STA; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; WEI Y, 1995, FEBS LETT, V358, P219, DOI 10.1016/0014-5793(94)01430-9; Yamamoto T, 2000, BRAIN RES, V866, P144, DOI 10.1016/S0006-8993(00)02242-3; ZITTEL TT, 1994, BRAIN RES, V663, P266, DOI 10.1016/0006-8993(94)91272-6	31	23	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8974	10.1371/journal.pone.0008974	http://dx.doi.org/10.1371/journal.pone.0008974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126542	gold, Green Published, Green Submitted			2022-12-27	WOS:000274209700006
J	Okumu, FO; Killeen, GF; Ogoma, S; Biswaro, L; Smallegange, RC; Mbeyela, E; Titus, E; Munk, C; Ngonyani, H; Takken, W; Mshinda, H; Mukabana, WR; Moore, SJ				Okumu, Fredros O.; Killeen, Gerry F.; Ogoma, Sheila; Biswaro, Lubandwa; Smallegange, Renate C.; Mbeyela, Edgar; Titus, Emmanuel; Munk, Cristina; Ngonyani, Hassan; Takken, Willem; Mshinda, Hassan; Mukabana, Wolfgang R.; Moore, Sarah J.			Development and Field Evaluation of a Synthetic Mosquito Lure That Is More Attractive than Humans	PLOS ONE			English	Article							L-LACTIC ACID; ANOPHELES-GAMBIAE; MALARIA MOSQUITO; AEDES-AEGYPTI; CARBON-DIOXIDE; HUMAN SWEAT; IDENTIFICATION; BEHAVIOR; DIPTERA; ENVIRONMENT	Background: Disease transmitting mosquitoes locate humans and other blood hosts by identifying their characteristic odor profiles. Using their olfactory organs, the mosquitoes detect compounds present in human breath, sweat and skins, and use these as cues to locate and obtain blood from the humans. These odor compounds can be synthesized in vitro, then formulated to mimic humans. While some synthetic mosquito lures already exist, evidence supporting their utility is limited to laboratory settings, where long-range stimuli cannot be investigated. Methodology and Principal Findings: Here we report the development and field evaluation of an odor blend consisting of known mosquito attractants namely carbon dioxide, ammonia and carboxylic acids, which was optimized at distances comparable with attractive ranges of humans to mosquitoes. Binary choice assays were conducted inside a large-cage semi-field enclosure using attractant-baited traps placed 20 m apart. This enabled high-throughput optimization of concentrations at which the individual candidate attractants needed to be added so as to obtain a blend maximally attractive to laboratory-reared An. gambiae. To determine whether wild mosquitoes would also be attracted to this synthetic odor blend and to compare it with whole humans under epidemiologically relevant conditions, field experiments were conducted inside experimental huts, where the blend was compared with 10 different adult male volunteers (20-34 years old). The blend attracted 3 to 5 times more mosquitoes than humans when the two baits were in different experimental huts (10-100 metres apart), but was equally or less attractive than humans when compared side by side within same huts. Conclusion and Significance: This highly attractive substitute for human baits might enable development of technologies for trapping diseases.	[Okumu, Fredros O.; Killeen, Gerry F.; Ogoma, Sheila; Biswaro, Lubandwa; Mbeyela, Edgar; Titus, Emmanuel; Ngonyani, Hassan; Mshinda, Hassan; Moore, Sarah J.] Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania; [Okumu, Fredros O.; Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Okumu, Fredros O.; Ogoma, Sheila; Moore, Sarah J.] London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, London WC1, England; [Killeen, Gerry F.; Moore, Sarah J.] Univ Durham, Sch Biol Sci, Durham, England; [Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Munk, Cristina] Cornell Univ, Coll Agr & Life Sci, Ithaca, NY 14853 USA; [Smallegange, Renate C.; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, Wageningen, Netherlands	Ifakara Health Institute; University of Nairobi; University of London; London School of Hygiene & Tropical Medicine; Durham University; Liverpool School of Tropical Medicine; University of Liverpool; Cornell University; Wageningen University & Research	Okumu, FO (corresponding author), Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania.	fredros@ihi.or.tz	Smallegange, Renate C./L-1566-2019; Moore, Sarah J/HGE-7143-2022	Smallegange, Renate C./0000-0002-6946-9777; Moore, Sarah J/0000-0002-0938-6654	National Institutes of Health through the Grand Challenges in Global Health Initiative [121]; Wellcome Trust [076806]; USAID [621-A-00-08-0007-00];  [RCA-3125]	National Institutes of Health through the Grand Challenges in Global Health Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); USAID(United States Agency for International Development (USAID)); 	This work was funded by a grant from the Foundations for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH No. 121). Additional support included a PhD Studentship (RCA-3125) at London School of Hygiene and Tropical Medicine awarded to FOO and a Wellcome Trust Research Career Development Fellowship (Award number 076806) to GFK. The experimental huts construction was funded in part by an operational research grant from the Presidents Malaria Initiative (USAID award number 621-A-00-08-0007-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; [Anonymous], 1987, SUPPLEMENT ANOPHELIN; Bernier UR, 2007, J AM MOSQUITO CONTR, V23, P288, DOI 10.2987/8756-971X(2007)23[288:LCOAAA]2.0.CO;2; Bernier UR, 2003, J MED ENTOMOL, V40, P653, DOI 10.1603/0022-2585-40.5.653; Braks MAH, 2001, PHYSIOL ENTOMOL, V26, P142, DOI 10.1046/j.1365-3032.2001.00227.x; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cork A, 1996, MED VET ENTOMOL, V10, P269, DOI 10.1111/j.1365-2915.1996.tb00742.x; Ferguson HM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-158; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Khan ZR, 2000, PEST MANAG SCI, V56, P957, DOI 10.1002/1526-4998(200011)56:11<957::AID-PS236>3.0.CO;2-T; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; KILLEEN GFE, 2007, BMC INFECT DIS, P7; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; MUKABANA WR, 2002, MALARIA J, P1; NJIRU BN, 2006, MALARIA J, P5; OKUMU FO, J MED ENTOMOL; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; QIU YT, 2007, J MED ENTOMOL, P44; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Silva IM, 2005, J AM MOSQUITO CONTR, V21, P229, DOI 10.2987/8756-971X(2005)21[229:LEOMTB]2.0.CO;2; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; SMALLEGANGE R, 2009, J CHEM ECOL, P1; Smallegange RC, 2005, CHEM SENSES, V30, P145, DOI 10.1093/chemse/bji010; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	31	134	136	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8951	10.1371/journal.pone.0008951	http://dx.doi.org/10.1371/journal.pone.0008951			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126628	gold, Green Accepted, Green Published			2022-12-27	WOS:000274138000026
J	Rodelsperger, C; Dieterich, C				Roedelsperger, Christian; Dieterich, Christoph			CYNTENATOR: Progressive Gene Order Alignment of 17 Vertebrate Genomes	PLOS ONE			English	Article							CHROMOSOMAL HOMOLOGY; SYNTENY; ARABIDOPSIS; CONSTRAINT; CLUSTERS; REGIONS; P300	Whole genome gene order evolution in higher eukaryotes was initially considered as a random process. Gene order conservation or conserved synteny was seen as a feature of common descent and did not imply the existence of functional constraints. This view had to be revised in the light of results from sequencing dozens of vertebrate genomes. It became apparent that other factors exist that constrain gene order in some genomic regions over long evolutionary time periods. Outside of these regions, genomes diverge more rapidly in terms of gene content and order. We have developed CYNTENATOR, a progressive gene order alignment software, to identify genomic regions of conserved synteny over a large set of diverging species. CYNTENATOR does not depend on nucleotide-level alignments and a priori homology assignment. Our software implements an improved scoring function that utilizes the underlying phylogeny. In this manuscript, we report on our progressive gene order alignment approach, a and give a comparison to previous software and an analysis of 17 vertebrate genomes for conservation in gene order. CYNTENATOR has a runtime complexity of O(n(3)) and a space complexity of O(n(2)) with n being the gene number in a genome. CYNTENATOR performs as good as state-of-the-art software on simulated pairwise gene order comparisons, but is the only algorithm that works in practice for aligning dozens of vertebrate-sized gene orders. Lineage-specific characterization of gene order across 17 vertebrate genomes revealed mechanisms for maintaining conserved synteny such as enhancers and coregulation by bidirectional promoters. Genes outside conserved synteny blocks show enrichments for genes involved in responses to external stimuli, stimuli such as immunity and olfactory response in primate genome comparisons. We even see significant gene ontology term enrichments for breakpoint regions of ancestral nodes close to the root of the phylogeny. Additionally, our analysis of transposable elements has revealed a significant accumulation of LINE-1 elements in mammalian breakpoint regions. In summary, CYNTENATOR is a flexible and scalable tool for the identification of conserved gene orders across multiple species over long evolutionary distances.	[Roedelsperger, Christian] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Roedelsperger, Christian] Max Planck Inst Mol Genet, Berlin, Germany; [Dieterich, Christoph] Berlin Inst Med Syst Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Rodelsperger, C (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	christoph.dieterich@mdc-berlin.de	, roedelsberg/Q-3831-2019; Dieterich, Christoph/ABF-8459-2021	, roedelsberg/0000-0002-7905-9675; 	Max Planck Society; Helmholtz Society	Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Society(Helmholtz Association)	CR acknowledges funding by the Max Planck Society. CD acknowledges funding by the Helmholtz Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r38; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; Boyer F, 2005, BIOINFORMATICS, V21, P4209, DOI 10.1093/bioinformatics/bti711; Calabrese PP, 2003, BIOINFORMATICS, V19, pi74, DOI 10.1093/bioinformatics/btg1008; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Gregory T. R., 2011, EVOLUTION GENOME; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Hampson S, 2003, GENOME RES, V13, P999, DOI 10.1101/gr.814403; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Ling X, 2009, BIOINFORMATICS, V25, P571, DOI 10.1093/bioinformatics/btp027; Luc N, 2003, COMPUT BIOL CHEM, V27, P59, DOI 10.1016/S1476-9271(02)00097-X; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Ng MP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-192; OHNO S, 1973, NATURE, V244, P259, DOI 10.1038/244259a0; OSTLUND G, 2009, NUCL ACIDS RES; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rodelsperger C, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-14; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang XY, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-447; WATERMAN MS, 1987, J MOL BIOL, V197, P723, DOI 10.1016/0022-2836(87)90478-5; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yang MQ, 2007, PLOS COMPUT BIOL, V3, P733, DOI 10.1371/journal.pcbi.0030072; Yang MQ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S6-S9; Zeng X, 2008, P 11 INT C EXT DAT T	40	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8861	10.1371/journal.pone.0008861	http://dx.doi.org/10.1371/journal.pone.0008861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126624	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000274138000002
J	Semmens, BX; Auster, PJ; Paddack, MJ				Semmens, Brice X.; Auster, Peter J.; Paddack, Michelle J.			Using Ecological Null Models to Assess the Potential for Marine Protected Area Networks to Protect Biodiversity	PLOS ONE			English	Article							REEF FISH DIVERSITY; CORAL-REEFS; SPECIES COOCCURRENCE; HABITAT COMPLEXITY; TROPHIC CASCADES; ASSEMBLY RULES; NESTEDNESS; RESERVES; ABUNDANCE; COMMUNITIES	Marine protected area (MPA) networks have been proposed as a principal method for conserving biological diversity, yet patterns of diversity may ultimately complicate or compromise the development of such networks. We show how a series of ecological null models can be applied to assemblage data across sites in order to identify non-random biological patterns likely to influence the effectiveness of MPA network design. We use fish census data from Caribbean fore-reefs as a test system and demonstrate that: 1) site assemblages were nested, such that species found on sites with relatively few species were subsets of those found on sites with relatively many species, 2) species co-occurred across sites more than expected by chance once species-habitat associations were accounted for, and 3) guilds were most evenly represented at the richest sites and richness among all guilds was correlated (i.e., species and trophic diversity were closely linked). These results suggest that the emerging Caribbean marine protected area network will likely be successful at protecting regional diversity even if planning is largely constrained by insular, inventory-based design efforts. By recasting ecological null models as tests of assemblage patterns likely to influence management action, we demonstrate how these classic tools of ecological theory can be brought to bear in applied conservation problems.	[Semmens, Brice X.] NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Univ Connecticut, Natl Undersea Res Ctr, Groton, CT USA; [Paddack, Michelle J.] Santa Barbara City Coll, Dept Biol, Santa Barbara, CA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Connecticut; University of Connecticut	Semmens, BX (corresponding author), NOAA, Natl Marine Fisheries Serv, NW Fisheries Sci Ctr, Seattle, WA 98112 USA.	brice.semmens@noaa.gov	Auster, Peter/ABI-3568-2020		STAR EPA; National Research Council through the Northwest Fisheries Science Center, NOAA; Pew Marine Conservation; UK Natural Environment Resource Council [NE/C004442/1]; NERC [NE/C004442/1] Funding Source: UKRI; Natural Environment Research Council [NE/C004442/1] Funding Source: researchfish	STAR EPA; National Research Council through the Northwest Fisheries Science Center, NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Pew Marine Conservation; UK Natural Environment Resource Council; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a STAR EPA fellowship and a National Research Council post-doctoral fellowship through the Northwest Fisheries Science Center, NOAA, to BXS, a Pew Marine Conservation Fellowship to PJA, and a grant from the UK Natural Environment Resource Council NE/C004442/1 to MJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, ECOLOGY, V85, P2933, DOI 10.1890/03-3150; Almeida M, 2007, OIKOS, V116, P716, DOI 10.1111/j.2007.0030-1299.15803.x; Auster PJ, 2005, ENVIRON BIOL FISH, V74, P187, DOI 10.1007/s10641-005-8078-0; Ball IR, 2000, MARINE RESERVE DESIG; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; Bellwood DR, 2003, ECOL LETT, V6, P281, DOI 10.1046/j.1461-0248.2003.00432.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Boecklen WJ, 1997, OECOLOGIA, V112, P123, DOI 10.1007/s004420050292; Brune J. F., 2007, PLOS ONE         AUG, P1; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cowie-Haskell BD, 2003, MAR TECHNOL SOC J, V37, P68, DOI 10.4031/002533203787537447; Diamond J.M., 1975, P342; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; EHRLICH PR, 1973, AM NAT, V107, P157, DOI 10.1086/282823; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Feeley K, 2003, OECOLOGIA, V137, P104, DOI 10.1007/s00442-003-1321-5; Fischer J, 2002, OIKOS, V99, P193, DOI 10.1034/j.1600-0706.2002.990121.x; Fraschetti S, 2005, MAR ENVIRON RES, V59, P309, DOI 10.1016/j.marenvres.2004.05.007; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Heino J, 2009, FRESHWATER BIOL, V54, P1947, DOI 10.1111/j.1365-2427.2009.02250.x; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HOLM S, 1979, SCAND J STAT, V6, P65; HUSTON MA, 1985, ANNU REV ECOL SYST, V16, P149, DOI 10.1146/annurev.es.16.110185.001053; KELLEHER G, 1999, SERIES IUCN PROTECTE, V3; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Knight TM, 2005, NATURE, V437, P880, DOI 10.1038/nature03962; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; LUKOSCHEK V, 2000, P 9 INT COR REEF S B, V1, P23; Maiorano L, 2009, ICES J MAR SCI, V66, P137, DOI 10.1093/icesjms/fsn148; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marks K. W., 2007, ATLANTIC GULF RAPID; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Mora C, 2003, NATURE, V421, P933, DOI 10.1038/nature01393; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peres-Neto PR, 2001, OIKOS, V93, P110, DOI 10.1034/j.1600-0706.2001.930112.x; RANDALL JOHN E., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMI, V5, P665; Ripple WJ, 2008, BIOL CONSERV, V141, P1249, DOI 10.1016/j.biocon.2008.02.028; Roberts CM, 2003, ECOL APPL, V13, pS215; Roberts CM, 2003, ECOL APPL, V13, pS199; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; ROBERTSON DR, 1986, ECOLOGY, V67, P1372, DOI 10.2307/1938693; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; RUSS G, 1984, MAR ECOL PROG SER, V20, P23, DOI 10.3354/meps020023; Sala E, 2002, SCIENCE, V298, P1991, DOI 10.1126/science.1075284; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; Smith RJ, 2009, ICES J MAR SCI, V66, P188, DOI 10.1093/icesjms/fsn198; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stallings CD, 2008, ECOLOGY, V89, P2090, DOI 10.1890/07-1671.1; Stewart BD, 2001, MAR BIOL, V138, P383, DOI 10.1007/s002270000468; Stewart RR, 2003, MAR ECOL PROG SER, V253, P25, DOI 10.3354/meps253025; STONE L, 1992, OECOLOGIA, V91, P419, DOI 10.1007/BF00317632; STRAND S, 1988, COPEIA, P351, DOI 10.2307/1445875; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Ward TJ, 1999, ECOL APPL, V9, P691; Webster MS, 2002, ECOL LETT, V5, P549, DOI 10.1046/j.1461-0248.2002.00355.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Williams D. McB, 1991, ECOLOGY FISHES CORAL, P437; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; WILSON JB, 1989, OECOLOGIA, V80, P263, DOI 10.1007/BF00380161; *WORLD COMM PROT A, 2007, WORLD DAT PROT AR; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	75	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8895	10.1371/journal.pone.0008895	http://dx.doi.org/10.1371/journal.pone.0008895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111711	Green Published, Green Submitted, gold			2022-12-27	WOS:000274114800010
J	Hsieh, CC; Hernandez-Ledesma, B; Jeong, HJ; Park, JH; de Lumen, BO				Hsieh, Chia-Chien; Hernandez-Ledesma, Blanca; Jeong, Hyun Jin; Park, Jae Ho; de Lumen, Ben O.			Complementary Roles in Cancer Prevention: Protease Inhibitor Makes the Cancer Preventive Peptide Lunasin Bioavailable	PLOS ONE			English	Article							BOWMAN-BIRK INHIBITOR; CORE HISTONE ACETYLATION; MAMMALIAN-CELLS; SOY PROTEIN; HUMAN BREAST; FEMALE RATS; NUDE-MICE; IN-VITRO; GROWTH; CARCINOGENESIS	Background: The lower incidence of breast cancer among Asian women compared with Western countries has been partly attributed to soy in the Asian diet, leading to efforts to identify the bioactive components that are responsible. Soy Bowman Birk Inhibitor Concentrate (BBIC) is a known cancer preventive agent now in human clinical trials. Methodology/Principal Findings: The objectives of this work are to establish the presence and delineate the in vitro activity of lunasin and BBI found in BBIC, and study their bioavailability after oral administration to mice and rats. We report that lunasin and BBI are the two main bioactive ingredients of BBIC based on inhibition of foci formation, lunasin being more efficacious than BBI on an equimolar basis. BBI and soy Kunitz Trypsin Inhibitor protect lunasin from in vitro digestion with pancreatin. Oral administration of H-3-labeled lunasin with lunasin-enriched soy results in 30% of the peptide reaching target tissues in an intact and bioactive form. In a xenograft model of nude mice transplanted with human breast cancer MDA-MB-231 cells, intraperitoneal injections of lunasin, at 20 mg/kg and 4 mg/kg body weight, decrease tumor incidence by 49% and 33%, respectively, compared with the vehicle-treated group. In contrast, injection with BBI at 20 mg/kg body weight shows no effect on tumor incidence. Tumor generation is significantly reduced with the two doses of lunasin, while BBI is ineffective. Lunasin inhibits cell proliferation and induces cell death in the breast tumor sections. Conclusions/Significance: We conclude that lunasin is actually the bioactive cancer preventive agent in BBIC, and BBI simply protects lunasin from digestion when soybean and other seed foods are eaten by humans.	[Hsieh, Chia-Chien; Hernandez-Ledesma, Blanca; de Lumen, Ben O.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Jeong, Hyun Jin; Park, Jae Ho] Andong Natl Univ, Andong, South Korea	University of California System; University of California Berkeley; Andong National University	Hsieh, CC (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	nitto@berkeley.edu	Hernández-Ledesma, Blanca/M-8637-2013	Hernández-Ledesma, Blanca/0000-0001-7192-6044; de Lumen, Ben/0000-0001-9569-1921	American Institute for Cancer Research [05B087]; United States Department of Defense [W81XWH-04-1-0128]; European Commission [LUNAMICE 039241]; Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL	American Institute for Cancer Research; United States Department of Defense(United States Department of Defense); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL	Project number 05B087 awarded by the American Institute for Cancer Research (http://www.aicr.org/site/PageServer). Project number W81XWH-04-1-0128 awarded by the United States Department of Defense Congressionally Directed Medical Research Program (https://cdmrp.org). Project LUNAMICE 039241 awarded by the European Commission and the Spanish National Research Council for the Marie-Curie postdoctoral fellowship of BHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERCREUTZ CHT, 1995, J NUTR, V125, pS757, DOI 10.1093/jn/125.3_Suppl.757S; Banerjee S, 2008, CANCER LETT, V269, P226, DOI 10.1016/j.canlet.2008.03.052; BARNES S, 1990, PROG CLIN BIOL RES, V347, P239; Beliveau R, 2007, CAN FAM PHYSICIAN, V53, P1905; *BOARD TRUST, 1995, SIM GASTR FLUID SIM; Chen YW, 2005, CARCINOGENESIS, V26, P1296, DOI 10.1093/carcin/bgi062; Clemente A, 2005, J AGR FOOD CHEM, V53, P8979, DOI 10.1021/jf051528w; de Kok TM, 2008, EUR J NUTR, V47, P51, DOI 10.1007/s00394-008-2006-y; de Lumen BO, 2005, NUTR REV, V63, P16, DOI [10.1301/nr.2004.janr.16-21, 10.1111/j.1753-4887.2005.tb00106.x]; Dia VP, 2009, J AGR FOOD CHEM, V57, P1260, DOI 10.1021/jf803303k; Du XT, 2001, CANCER LETT, V164, P135, DOI 10.1016/S0304-3835(01)00381-0; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Hakkak R, 2000, CANCER EPIDEM BIOMAR, V9, P113; Hernandez-Ledesma B, 2009, FOOD CHEM, V115, P574, DOI 10.1016/j.foodchem.2008.12.054; Hsieh EA, 2004, J INVEST DERMATOL, V123, P530, DOI 10.1111/j.0022-202X.2004.23303.x; Jeong HJ, 2002, J AGR FOOD CHEM, V50, P5903, DOI 10.1021/jf0256945; Jeong HJ, 2007, CANCER LETT, V255, P42, DOI 10.1016/j.canlet.2007.03.022; Jeong HJ, 2007, J AGR FOOD CHEM, V55, P632, DOI 10.1021/jf062405u; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Johnson WD, 2006, INT J TOXICOL, V25, P219, DOI 10.1080/10915810600683366; Kennedy AR, 1998, PHARMACOL THERAPEUT, V78, P167, DOI 10.1016/S0163-7258(98)00010-2; Kennedy AR, 1996, CANCER RES, V56, P679; Kennedy AR, 2003, PHARM RES, V20, P1908, DOI 10.1023/B:PHAM.0000008035.02046.cb; KENNEDY AR, 1993, NUTR CANCER, V19, P281, DOI 10.1080/01635589309514259; KENNEDY AR, 1993, NUTR CANCER, V19, P191, DOI 10.1080/01635589309514249; Lam Y, 2003, NUTR CANCER, V47, P88, DOI 10.1207/s15327914nc4701_11; LAMBERT JD, 2008, CABI BOT MED CLIN PR, P328; Losso JN, 2008, CRIT REV FOOD SCI, V48, P94, DOI 10.1080/10408390601177589; Mai ZM, 2007, CARCINOGENESIS, V28, P1217, DOI 10.1093/carcin/bgm004; Mukhopadhyay S, 2006, MOL CELL BIOCHEM, V290, P169, DOI 10.1007/s11010-006-9184-9; Park JH, 2007, J AGR FOOD CHEM, V55, P10703, DOI 10.1021/jf072107c; Power KA, 2006, INT J CANCER, V118, P1316, DOI 10.1002/ijc.21464; Prasain JK, 2007, MOL PHARMACEUT, V4, P846, DOI 10.1021/mp700116u; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; TROLL W, 1980, CARCINOGENESIS, V1, P469, DOI 10.1093/carcin/1.6.469; Vantyghem SA, 2005, CANCER RES, V65, P3396, DOI 10.1158/0008-5472.CAN-04-4109; Wan XS, 1999, PROSTATE, V41, P243; Zhang LL, 1999, NUTR CANCER, V33, P165, DOI 10.1207/S15327914NC330208	41	87	89	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8890	10.1371/journal.pone.0008890	http://dx.doi.org/10.1371/journal.pone.0008890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126654	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500013
J	Watts, SM; Uhl, MM; Maurano, SP; Nuccio, EE				Watts, Sean M.; Uhl, Melissa M.; Maurano, Stephen P.; Nuccio, Erin E.			Using Small-Scale Studies to Prioritize Threats and Guide Recovery of a Rare Hemiparasitic Plant: Cordylanthus rigidus ssp littoralis	PLOS ONE			English	Article							CHAPARRAL SHRUB; UNITED-STATES; FIRE; CONSERVATION; GERMINATION; GRASSLAND; IMPACTS	Background: Recovering endangered species would benefit from identifying and ranking of the factors that threaten them. Simply managing for multiple positive influences will often aid in recovery; however, the relative impacts of multiple threats and/or interactions among them are not always predictable. We used a series of experiments and quantitative observational studies to examine the importance of five potential limiting factors to the abundance of a state-listed endangered hemiparasitic annual forb, Cordylanthus rigidus ssp. littoralis (C.r.l., California, USA): host availability, mammalian herbivores, insect seed predators, fire suppression, and exotic species. While this initial assessment is certainly not a complete list, these factors stem from direct observation and can inform provisional recommendations for management and further research. Methodology and Principal Findings: Studies were conducted at five sites and included assessments of the influence of host availability, exotic species, exclusion of mammalian herbivores and insect seed predators on C.r.l. productivity, and simulated effects of fire on seed germination. C.r.l. was limited by multiple threats: individuals with access to host species produced up to three times more inflorescences than those lacking hosts, mammalian herbivory reduced C.r.l. size and fecundity by more than 50% and moth larvae reduced seed production by up to 40%. Litter deposition and competition from exotic plant species also appears to work in conjunction with other factors to limit C.r.l. throughout its life cycle. Conclusions and Significance: The work reported here highlights the contribution that a series of small-scale studies can make to conservation and restoration. Taken as a whole, the results can be used immediately to inform current management and species recovery strategies. Recovery of C.r.l. will require management that addresses competition with exotic plant species, herbivore pressure, and availability of preferred host species.	[Watts, Sean M.; Uhl, Melissa M.; Maurano, Stephen P.] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Nuccio, Erin E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	Santa Clara University; University of California System; University of California Berkeley	Watts, SM (corresponding author), Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA.	SWatts@scu.edu		Nuccio, Erin/0000-0003-0189-183X	Santa Clara University [14007, 14009, 14015]	Santa Clara University	This work was funded by internal grants from Santa Clara University (http://www.scu.edu/; fund numbers: 14007, 14009 and 14015 to SMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt RJF, 2001, CONSERV BIOL, V15, P1274, DOI 10.1046/j.1523-1739.2001.00430.x; BARTHOLOMEW B, 1970, SCIENCE, V170, P1210, DOI 10.1126/science.170.3963.1210; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; BOYD RS, 1992, AM J BOT, V79, P1264, DOI 10.2307/2445054; *CA DFG, 2000, STAT RAR THREAT END, P131; *CA DFG, 2009, STAT FED END THREAT; CHUANG TI, 1971, AM J BOT, V58, P218, DOI 10.2307/2441157; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Deveny AJ, 2006, OECOLOGIA, V150, P69, DOI 10.1007/s00442-006-0503-3; Dyer AR, 1997, ECOL APPL, V7, P484, DOI 10.1890/1051-0761(1997)007[0484:IADCTR]2.0.CO;2; Gordon B. L., 1996, MONTEREY BAY AREA NA; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; Keeley JE, 2006, CONSERV BIOL, V20, P375, DOI 10.1111/J.1523-1739.2006.00339.X; KEELEY JE, 1985, J ECOL, V73, P445, DOI 10.2307/2260486; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; Lepetz V, 2009, BIODIVERS CONSERV, V18, P3185, DOI 10.1007/s10531-009-9636-0; LOUDA SM, 1995, ECOLOGY, V76, P229, DOI 10.2307/1940645; Marvier MA, 1997, CONSERV BIOL, V11, P839, DOI 10.1046/j.1523-1739.1997.96223.x; RABINOWITZ D, 1981, BIOL ASPECTS RARE PL; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Synge H, 1981, BIOL ASPECTS RARE PL; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	24	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8892	10.1371/journal.pone.0008892	http://dx.doi.org/10.1371/journal.pone.0008892			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126657	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500015
J	Willis, CG; Ruhfel, BR; Primack, RB; Miller-Rushing, AJ; Losos, JB; Davis, CC				Willis, Charles G.; Ruhfel, Brad R.; Primack, Richard B.; Miller-Rushing, Abraham J.; Losos, Jonathan B.; Davis, Charles C.			Favorable Climate Change Response Explains Non-Native Species' Success in Thoreau's Woods	PLOS ONE			English	Article							FLOWERING TIMES; PLANT; PHENOLOGY; TRAITS	Invasive species have tremendous detrimental ecological and economic impacts. Climate change may exacerbate species invasions across communities if non-native species are better able to respond to climate changes than native species. Recent evidence indicates that species that respond to climate change by adjusting their phenology (i.e., the timing of seasonal activities, such as flowering) have historically increased in abundance. The extent to which non-native species success is similarly linked to a favorable climate change response, however, remains untested. We analyzed a dataset initiated by the conservationist Henry David Thoreau that documents the long-term phenological response of native and non-native plant species over the last 150 years from Concord, Massachusetts (USA). Our results demonstrate that non-native species, and invasive species in particular, have been far better able to respond to recent climate change by adjusting their flowering time. This demonstrates that climate change has likely played, and may continue to play, an important role in facilitating non-native species naturalization and invasion at the community level.	[Willis, Charles G.; Ruhfel, Brad R.; Davis, Charles C.] Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Willis, Charles G.] Duke Univ, Dept Biol, Durham, NC USA; [Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Miller-Rushing, Abraham J.] USA Natl Phenol Network, Tucson, AZ USA; [Miller-Rushing, Abraham J.] Wildlife Soc, Bethesda, MD USA; [Losos, Jonathan B.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Duke University; Boston University; Harvard University	Willis, CG (corresponding author), Harvard Univ Hebaria, Dept Organism & Evolutionary Biol, 22 Divin Ave, Cambridge, MA 02138 USA.	cdavis@oeb.harvard.edu	Miller-Rushing, Abraham/D-5102-2009	Miller-Rushing, Abraham/0000-0003-3203-0143; Ruhfel, Brad/0000-0002-0230-4185; Willis, Charles/0000-0003-2543-246X	National Science Foundation [EF 04-31242]; Division of Environmental Biology (DEB) [0413458/0842749]	National Science Foundation(National Science Foundation (NSF)); Division of Environmental Biology (DEB)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	C. C. D. and R. B. P. were supported by National Science Foundation Grants Assembling the Tree of Life (AToL) EF 04-31242 and Division of Environmental Biology (DEB) 0413458/0842749, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; BIERZYCHUDEK P, 1981, AM NAT, V117, P838, DOI 10.1086/283773; BOLKER B, 2007, APE ANAL PHYLOGENETI; Cadotte MW, 2009, DIVERS DISTRIB, V15, P481, DOI 10.1111/j.1472-4642.2009.00560.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; CLEMENTS S, 2006, WILDFLOWERS FIELD FO; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Faegri K., 1978, PRINCIPLES POLLINATI; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; FLYNN S, 2006, ROYAL BOT GARDENS; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Knight KS, 2007, BIOL INVASIONS, V9, P925, DOI 10.1007/s10530-007-9091-3; Mack RN, 2002, ANN MO BOT GARD, V89, P176, DOI 10.2307/3298562; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mehrhoff L.J., 2003, IPANE INVASIVE PLANT; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Miller-Rushing AJ, 2008, J ECOL, V96, P1289, DOI 10.1111/j.1365-2745.2008.01436.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miller-Rushing AJ, 2006, AM J BOT, V93, P1667, DOI 10.3732/ajb.93.11.1667; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Primack RB, 2009, NEW PHYTOL, V182, P303, DOI 10.1111/j.1469-8137.2009.02800.x; Primack RB, 2009, BIOL CONSERV, V142, P500, DOI 10.1016/j.biocon.2008.10.038; Pysek Petr, 2007, V193, P97; Reich PB, 2007, ECOL APPL, V17, P1982, DOI 10.1890/06-1803.1; Simberloff D, 2000, SCI TOTAL ENVIRON, V262, P253, DOI 10.1016/S0048-9697(00)00527-1; Sola AJ, 2007, J ECOL, V95, P208, DOI 10.1111/j.1365-2745.2006.01191.x; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Thuiller Wilfried, 2007, V193, P197; United States Department of Agriculture (USDA), PLANTS DAT; VilO M., 2007, TERRESTRIAL ECOSYSTE, P93, DOI DOI 10.1007/978-3-540-32730-1_8; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; WEBB CO, 2008, PHYLOCOM SOFTWARE AN; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y	42	182	192	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8878	10.1371/journal.pone.0008878	http://dx.doi.org/10.1371/journal.pone.0008878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126652	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500007
J	Ganachari, M; Ruiz-Morales, JA; Pretell, JCGD; Dinh, J; Granados, J; Flores-Villanueva, PO				Ganachari, Malathesha; Ruiz-Morales, Jorge A.; de la Torre Pretell, Juan C. Gomez; Dinh, Jeffrey; Granados, Julio; Flores-Villanueva, Pedro O.			Joint Effect of MCP-1 Genotype GG and MMP-1 Genotype 2G/2G Increases the Likelihood of Developing Pulmonary Tuberculosis in BCG-Vaccinated Individuals	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; EXPRESSION; INFECTION; SUSCEPTIBILITY; POLYMORPHISMS; GRANULOMAS; REACTIVITY	We previously reported that the - 2518 MCP-1 genotype GG increases the likelihood of developing tuberculosis (TB) in non-BCG-vaccinated Mexicans and Koreans. Here, we tested the hypothesis that this genotype, alone or together with the 1607 MMP-1 functional polymorphism, increases the likelihood of developing TB in BCG-vaccinated individuals. We conducted population-based case-control studies of BCG-vaccinated individuals in Mexico and Peru that included 193 TB cases and 243 healthy tuberculin-positive controls from Mexico and 701 TB cases and 796 controls from Peru. We also performed immunohistochemistry (IHC) analysis of lymph nodes from carriers of relevant two-locus genotypes and in vitro studies to determine how these variants may operate to increase the risk of developing active disease. We report that a joint effect between the - 2518 MCP-1 genotype GG and the - 1607 MMP-1 genotype 2G/2G consistently increases the odds of developing TB 3.59-fold in Mexicans and 3.9-fold in Peruvians. IHC analysis of lymph nodes indicated that carriers of the two-locus genotype MCP-1 GG MMP-1 2G/2G express the highest levels of both MCP-1 and MMP-1. Carriers of these susceptibility genotypes might be at increased risk of developing TB because they produce high levels of MCP-1, which enhances the induction of MMP-1 production by M. tuberculosis-sonicate antigens to higher levels than in carriers of the other two-locus MCP-1 MMP-1 genotypes studied. This notion was supported by in vitro experiments and luciferase based promoter activity assay. MMP-1 may destabilize granuloma formation and promote tissue damage and disease progression early in the infection. Our findings may foster the development of new and personalized therapeutic approaches targeting MCP-1 and/or MMP-1.	[Ganachari, Malathesha; Ruiz-Morales, Jorge A.; Dinh, Jeffrey; Flores-Villanueva, Pedro O.] Methodist Hosp, Methodist Hosp Res Inst, Houston, TX 77030 USA; [de la Torre Pretell, Juan C. Gomez] Nongovt Org VIMASI, Lima, Peru; [Granados, Julio] Mexican Natl Inst Med & Nutr Salvador Zubiran, Dept Transplantat Immunol, Div Immunogenet, Mexico City, DF, Mexico	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Ganachari, M (corresponding author), Methodist Hosp, Methodist Hosp Res Inst, 6535 Fannin, Houston, TX 77030 USA.	poflores-villanueva@tmhs.org	Ganachari, malathesha/B-3015-2011	GOMEZ DE LA TORRE, JUAN CARLOS/0000-0003-4566-2027; Flores-Villanueva, Pedro/0000-0002-6184-4616	National Institutes of Health [R01 HL084347]; Methodist Hospital Research Institute (TMHRI), Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Methodist Hospital Research Institute (TMHRI), Houston, Texas; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grant R01 HL084347 and by recruitment funds from the Methodist Hospital Research Institute (TMHRI), Houston, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; BAILEY BE, 1995, B WORLD HEALTH ORGAN, V73, P673; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Behr MA, 1999, VACCINE, V17, P915, DOI 10.1016/S0264-410X(98)00277-1; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Castillo-Rodal AI, 2006, INFECT IMMUN, V74, P1718, DOI 10.1128/IAI.74.3.1718-1724.2006; CAWSTON TE, 1986, FEBS LETT, V209, P9, DOI 10.1016/0014-5793(86)81074-2; Cerda-Flores RM, 2002, AM J HUM BIOL, V14, P257, DOI 10.1002/ajhb.10020; CERVANTES J, 2002, B I FR ETUDES ANDINE, V2, P213; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; COLOTTA F, 1992, J IMMUNOL, V148, P760; Coraux Christelle, 2008, Proc Am Thorac Soc, V5, P689, DOI 10.1513/pats.200801-010AW; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Barros R. P., MEASURING INEQUALITY; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Diel R, 2009, CHEST, V135, P1010, DOI 10.1378/chest.08-2048; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; DUPONT WD, 2002, STAT MODELING BIOMED, P207; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; FITZGERALD D, 2005, MANDELL DOUGLAS BENN, P2852; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gueders MM, 2006, EUR J PHARMACOL, V533, P133, DOI 10.1016/j.ejphar.2005.12.082; HARTL DL, 1997, PRINCIPLES POPULATIO, P140; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Jamieson SE, 2004, GENES IMMUN, V5, P46, DOI 10.1038/sj.gene.6364029; Johnson MM, 2008, CURR OPIN PULM MED, V14, P203, DOI 10.1097/MCP.0b013e3282f9e650; Kaarteenaho-Wiik R, 2007, HUM PATHOL, V38, P147, DOI 10.1016/j.humpath.2006.07.001; Li HT, 2006, INT J TUBERC LUNG D, V10, P3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Luna JA, 2004, TUBERCULOSIS GUIDE S; LYNCH M, 1998, GENETICS ANAL QUANTI, P54; MOLINAGAMBOA JD, 1994, CLIN INFECT DIS, V19, P784, DOI 10.1093/clinids/19.4.784; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Oettinger T., 1999, Tubercle and Lung Disease, V79, P243, DOI 10.1054/tuld.1999.0206; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Rand L, 2009, J IMMUNOL, V182, P5865, DOI 10.4049/jimmunol.0801935; REICHENSTEIN W, 2001, J WEALTH MANAGEMENT, V4, P16; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Rutter JL, 1998, CANCER RES, V58, P5321; Santiago EM, 2003, PEDIATRICS, V112, pE298, DOI 10.1542/peds.112.4.e298; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Stein CM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004094; Suki B, 2005, J APPL PHYSIOL, V98, P1892, DOI 10.1152/japplphysiol.01087.2004; SZKLO M, 1999, EPIDEMIOLOGY BASICS, P211; Takiff HE, 2007, TUBERCULOSIS 2007 BA, P207; THOMAS DC, 2004, TESTING CANDIDATE GE, P253; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Viera AJ, 2005, FAM MED, V37, P360; Wang L, 2002, THORAX, V57, P804, DOI 10.1136/thorax.57.9.804; World Health Organization, 2008, GLOB TUB CONTR SURV; Wu B, 2007, INFECT IMMUN, V75, P3658, DOI 10.1128/IAI.00244-07; Xu Zhen-e, 2009, Zhonghua Er Ke Za Zhi, V47, P200; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88	61	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8881	10.1371/journal.pone.0008881	http://dx.doi.org/10.1371/journal.pone.0008881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111728	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896300025
J	Mashimo, T; Takizawa, A; Voigt, B; Yoshimi, K; Hiai, H; Kuramoto, T; Serikawa, T				Mashimo, Tomoji; Takizawa, Akiko; Voigt, Birger; Yoshimi, Kazuto; Hiai, Hiroshi; Kuramoto, Takashi; Serikawa, Tadao			Generation of Knockout Rats with X-Linked Severe Combined Immunodeficiency (X-SCID) Using Zinc-Finger Nucleases	PLOS ONE			English	Article							INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; EMBRYONIC STEM-CELLS; LYMPHOID DEVELOPMENT; NOG MICE; GENE; MODELS; MUTAGENESIS; MUTANT; BLASTOCYSTS; MUTATION	Background: Although the rat is extensively used as a laboratory model, the inability to utilize germ line-competent rat embryonic stem (ES) cells has been a major drawback for studies that aim to elucidate gene functions. Recently, zinc-finger nucleases (ZFNs) were successfully used to create genome-specific double-stranded breaks and thereby induce targeted gene mutations in a wide variety of organisms including plants, drosophila, zebrafish, etc. Methodology/Principal Findings: We report here on ZFN-induced gene targeting of the rat interleukin 2 receptor gamma (Il2rg) locus, where orthologous human and mouse mutations cause X-linked severe combined immune deficiency (X-SCID). Co-injection of mRNAs encoding custom-designed ZFNs into the pronucleus of fertilized oocytes yielded genetically modified offspring at rates greater than 20%, which possessed a wide variety of deletion/insertion mutations. ZFN-modified founders faithfully transmitted their genetic changes to the next generation along with the severe combined immune deficiency phenotype. Conclusions and Significance: The efficient and rapid generation of gene knockout rats shows that using ZFN technology is a new strategy for creating gene-targeted rat models of human diseases. In addition, the X-SCID rats that were established in this study will be valuable in vivo tools for evaluating drug treatment or gene therapy as well as model systems for examining the treatment of xenotransplanted malignancies.	[Mashimo, Tomoji; Takizawa, Akiko; Voigt, Birger; Yoshimi, Kazuto; Kuramoto, Takashi; Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan; [Hiai, Hiroshi] Shiga Med Ctr Adult Dis, Moriyama, Japan	Kyoto University	Mashimo, T (corresponding author), Kyoto Univ, Grad Sch Med, Inst Lab Anim, Kyoto, Japan.	tmashimo@anim.med.kyoto-u.ac.jp		Yoshimi, Kazuto/0000-0001-5110-1440	Ministry of Health, Labour, and Welfare	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a grant-in-aid for cancer research from the Ministry of Health, Labour, and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Dao MA, 1999, CURR OPIN MOL THER, V1, P553; DISANTO JP, 1995, P NATL ACAD SCI USA, V92, P377, DOI 10.1073/pnas.92.2.377; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Ito M, 2008, CURR TOP MICROBIOL, V324, P53; Kandavelou K, 2009, BIOCHEM BIOPH RES CO, V388, P56, DOI 10.1016/j.bbrc.2009.07.112; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Machida K, 2009, J TOXICOL SCI, V34, P123, DOI 10.2131/jts.34.123; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; Ohbo K, 1996, BLOOD, V87, P956, DOI 10.1182/blood.V87.3.956.bloodjournal873956; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ryu BY, 2005, P NATL ACAD SCI USA, V102, P14302, DOI 10.1073/pnas.0506970102; Santiago Y, 2008, P NATL ACAD SCI USA, V105, P5809, DOI 10.1073/pnas.0800940105; Shinohara T, 2006, P NATL ACAD SCI USA, V103, P13624, DOI 10.1073/pnas.0604205103; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Thomsen M, 2005, TISSUE ANTIGENS, V66, P73, DOI 10.1111/j.1399-0039.2005.00409.x; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Voigt B, 2009, DIS MODEL MECH, V2, P341, DOI 10.1242/dmm.002824; Wu J, 2007, CELL MOL LIFE SCI, V64, P2933, DOI 10.1007/s00018-007-7206-8; YOSHIMI K, 2009, CANC SCI; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	34	183	214	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8870	10.1371/journal.pone.0008870	http://dx.doi.org/10.1371/journal.pone.0008870			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111598	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896300019
J	Ellis, RD; Martin, LB; Shaffer, D; Long, CA; Miura, K; Fay, MP; Narum, DL; Zhu, DM; Mullen, GED; Mahanty, S; Miller, LH; Durbin, AP				Ellis, Ruth D.; Martin, Laura B.; Shaffer, Donna; Long, Carole A.; Miura, Kazutoyo; Fay, Michael P.; Narum, David L.; Zhu, Daming; Mullen, Gregory E. D.; Mahanty, Siddhartha; Miller, Louis H.; Durbin, Anna P.			Phase 1 Trial of the Plasmodium falciparum Blood Stage Vaccine MSP1(42)-C1/Alhydrogel with and without CPG 7909 in Malaria Naive Adults	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; APICAL MEMBRANE ANTIGEN-1; MONTANIDE ISA 720; ANTIBODY-RESPONSES; PROTECTION; SAFETY; IMMUNOGENICITY; ADJUVANT; CPG-7909; IMMUNITY	Background: Merozoite surface protein 1(42) (MSP1(42)) is a leading blood stage malaria vaccine candidate. In order to induce immune responses that cover the major antigenic polymorphisms, FVO and 3D7 recombinant proteins of MSP1(42) were mixed (MSP1(42)-C1). To improve the level of antibody response, MSP1(42)-C1 was formulated with Alhydrogel plus the novel adjuvant CPG 7909. Methods: A Phase 1 clinical trial was conducted in healthy malaria-naive adults at the Center for Immunization Research in Washington, D. C., to evaluate the safety and immunogenicity of MSP1(42)-C1/Alhydrogel +/- CPG 7909. Sixty volunteers were enrolled in dose escalating cohorts and randomized to receive three vaccinations of either 40 or 160 mu g protein adsorbed to Alhydrogel +/- 560 mu g CPG 7909 at 0, 1 and 2 months. Results: Vaccinations were well tolerated, with only one related adverse event graded as severe (Grade 3 injection site erythema) and all other vaccine related adverse events graded as either mild or moderate. Local adverse events were more frequent and severe in the groups receiving CPG. The addition of CPG enhanced anti-MSP1(42) antibody responses following vaccination by up to 49-fold two weeks after second immunization and 8-fold two weeks after the third immunization when compared to MSP1(42)-C1/Alhydrogel alone (p<0.0001). After the third immunization, functionality of the antibody was tested by an in vitro growth inhibition assay. Inhibition was a function of antibody titer, with an average of 3% (range -2 to 10%) in the non CPG groups versus 14% (3 to 32%) in the CPG groups. Conclusion/Significance: The favorable safety profile and high antibody responses induced with MSP1(42)-C1/Alhydrogel + CPG 7909 are encouraging. MSP1(42)-C1/Alhydrogel is being combined with other blood stage antigens and will be taken forward in a formulation adjuvanted with CPG 7909.	[Ellis, Ruth D.; Martin, Laura B.; Miura, Kazutoyo; Narum, David L.; Zhu, Daming; Mullen, Gregory E. D.; Mahanty, Siddhartha; Miller, Louis H.] NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD USA; [Shaffer, Donna; Durbin, Anna P.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Fay, Michael P.] NIAID, Biostat Res Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ellis, RD (corresponding author), NIAID, Malaria Vaccine Dev Branch, NIH, Rockville, MD USA.	ellisru@niaid.nih.gov	Fay, Michael P/A-2974-2008; Miura, Kazutoyo/AAY-9751-2020; Martin, Laura/N-1789-2013	Fay, Michael P/0000-0002-8643-9625; Miura, Kazutoyo/0000-0003-4455-2432; Martin, Laura/0000-0002-4431-4381; Mahanty, Siddhartha/0000-0003-1068-0524; Narum, David/0000-0003-3041-5402	National Institutes of Health, National Institute of Allergy and Infectious Disease; PATH Malaria Vaccine Initiative (MVI); United States Agency for International Development (USAID); Medical Research Council [G0600698B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000241, ZIAAI001020, ZIAAI001003, ZIAAI001056] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative (MVI); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural program of the National Institutes of Health, National Institute of Allergy and Infectious Disease. Support for this project was provided in part by the PATH Malaria Vaccine Initiative (MVI), which also supports the Growth Inhibition Assay (GIA) Reference Center, and by the United States Agency for International Development (USAID) Malaria Vaccine Development Program through a cooperative agreement between USAID and MVI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou WR, 2009, PARASITE IMMUNOL, V31, P492, DOI 10.1111/j.1365-3024.2009.01143.x; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Cooper CL, 2004, J CLIN IMMUNOL, V24, P693, DOI 10.1007/s10875-004-6244-3; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; DeFrancesco L, 2008, NAT BIOTECHNOL, V26, P470, DOI [10.1038/nbt0408-470a, 10.1038/nbt0508-484a]; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Doyle Mittie K, 2003, Expert Opin Drug Saf, V2, P401, DOI 10.1517/14740338.2.4.401; Ellis RD, 2009, VACCINE, V27, P4104, DOI 10.1016/j.vaccine.2009.04.077; HODGES JL, 1983, ENCY STAT, V3; Hu JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001952; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; Krieg AM, 2004, J IMMUNOTHER, V27, P460, DOI 10.1097/00002371-200411000-00006; Lyon JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002830; Malkin Elissa, 2007, PLoS Clin Trials, V2, pe12, DOI 10.1371/journal.pctr.0020012; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; Miura K, 2008, VACCINE, V26, P193, DOI 10.1016/j.vaccine.2007.10.064; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; MOORTHY VS, 2009, VACCINE, V25, P5719; Mullen GED, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002940; Murad YM, 2007, EXPERT OPIN BIOL TH, V7, P1257, DOI 10.1517/14712598.7.8.1257; Ockenhouse CF, 2006, VACCINE, V24, P3009, DOI 10.1016/j.vaccine.2005.11.028; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Roestenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003960; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sagara I, 2009, VACCINE, V27, P7292, DOI 10.1016/j.vaccine.2009.10.087; Sanderson F, 2008, AM J TROP MED HYG, V78, P878, DOI 10.4269/ajtmh.2008.78.878; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; *WHO, 2008, WORLD MAL REP 2008 W	35	65	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8787	10.1371/journal.pone.0008787	http://dx.doi.org/10.1371/journal.pone.0008787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107498	Green Submitted, Green Published, gold			2022-12-27	WOS:000273896100005
J	Lurkin, I; Stoehr, R; Hurst, CD; van Tilborg, AAG; Knowles, MA; Hartmann, A; Zwarthoff, EC				Lurkin, Irene; Stoehr, Robert; Hurst, Carolyn D.; van Tilborg, Angela A. G.; Knowles, Margaret A.; Hartmann, Arndt; Zwarthoff, Ellen C.			Two Multiplex Assays That Simultaneously Identify 22 Possible Mutation Sites in the KRAS, BRAF, NRAS and PIK3CA Genes	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; RECEPTOR INHIBITOR CETUXIMAB; BLADDER-CANCER; COLON-CANCER; PANITUMUMAB; EXPRESSION; CORRELATE; SURVIVAL	Recently a number of randomized trials have shown that patients with advanced colorectal cancer do not benefit from therapies targeting the epidermal growth factor receptor when their tumors harbor mutations in the KRAS, BRAF and PIK3CA genes. We developed two multiplex assays that simultaneously screen 22 nucleotides in the KRAS, NRAS, BRAF and PIK3CA genes for mutations. The assays were validated on 294 tumor DNA samples from patients with advanced colorectal cancer. In these samples 119 KRAS codon 12 and 13 mutations had been identified by sequence analysis, 126 tumors were wild-type for KRAS and the analysis failed in 49 of the 294 samples due to poor DNA quality. The two mutation assays detected 130 KRAS mutations, among which were 3 codon 61 mutations, and in addition 32 PIK3CA, 13 BRAF and 6 NRAS mutations. In 19 tumors a KRAS mutation was found together with a mutation in the PIK3CA gene. One tumor was mutant for both PIK3CA and BRAF. In summary, the mutations assays identified 161 tumors with a mutation, 120 were wild-type and the analysis failed in 13. The material cost of the 2 mutation assays was calculated to be 8-fold lower than the cost of sequencing required to obtain the same data. In addition, the mutation assays are less labor intensive. We conclude that the performance of the two multiplex mutation assays was superior to direct sequencing. In addition, these assays are cheaper and easier to interpret. The assays may also be of use for selection of patients with other tumor types.	[Lurkin, Irene; van Tilborg, Angela A. G.; Zwarthoff, Ellen C.] Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands; [Stoehr, Robert; Hartmann, Arndt] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany; [Hurst, Carolyn D.; Knowles, Margaret A.] St James Univ Hosp, Canc Res UK Clin Ctr, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	Erasmus University Rotterdam; Erasmus MC; University of Erlangen Nuremberg; Cancer Research UK; Saint James's University Hospital; University of Leeds	Lurkin, I (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl	Stoehr, Robert/D-7504-2011; van Tilborg, Angela/M-5704-2015	van Tilborg, Angela/0000-0003-3968-5345; Knowles, Margaret/0000-0002-9363-8657	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a research grant by the German Research Foundation (DFG) to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Burger M, 2008, EUR UROL, V54, P835, DOI 10.1016/j.eururo.2007.12.026; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Feng YZ, 2005, CLIN CANCER RES, V11, P6133, DOI 10.1158/1078-0432.CCR-04-2670; Hafner C, 2006, J CLIN INVEST, V116, P2201, DOI 10.1172/JCI28163; Hurst Carolyn D, 2009, BMC Res Notes, V2, P66, DOI 10.1186/1756-0500-2-66; HYNES NE, 2009, CURR OPIN CELL BIOL; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Junker K, 2008, NEOPLASIA, V10, P1, DOI 10.1593/neo.07178; Kompier LC, 2009, J PATHOL, V218, P104, DOI 10.1002/path.2507; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Raponi M, 2008, CURR OPIN PHARMACOL, V8, P413, DOI 10.1016/j.coph.2008.06.006; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; van Oers JMM, 2005, CLIN CANCER RES, V11, P7743, DOI 10.1158/1078-0432.CCR-05-1045; VANOERS JM, 2008, EUR UROL	23	73	77	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8802	10.1371/journal.pone.0008802	http://dx.doi.org/10.1371/journal.pone.0008802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098682	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779100003
J	Aziz-Zadeh, L; Sheng, T; Gheytanchi, A				Aziz-Zadeh, Lisa; Sheng, Tong; Gheytanchi, Anahita			Common Premotor Regions for the Perception and Production of Prosody and Correlations with Empathy and Prosodic Ability	PLOS ONE			English	Article							MIRROR-NEURON SYSTEM; EVENT-RELATED FMRI; SPEECH-PERCEPTION; FUNCTIONAL NEUROANATOMY; MOTOR FACILITATION; EMOTIONAL PROSODY; LATERALIZATION; SOUNDS; CORTEX; TMS	Background: Prosody, the melody and intonation of speech, involves the rhythm, rate, pitch and voice quality to relay linguistic and emotional information from one individual to another. A significant component of human social communication depends upon interpreting and responding to another person's prosodic tone as well as one's own ability to produce prosodic speech. However there has been little work on whether the perception and production of prosody share common neural processes, and if so, how these might correlate with individual differences in social ability. Methods: The aim of the present study was to determine the degree to which perception and production of prosody rely on shared neural systems. Using fMRI, neural activity during perception and production of a meaningless phrase in different prosodic intonations was measured. Regions of overlap for production and perception of prosody were found in premotor regions, in particular the left inferior frontal gyrus (IFG). Activity in these regions was further found to correlate with how high an individual scored on two different measures of affective empathy as well as a measure on prosodic production ability. Conclusions: These data indicate, for the first time, that areas that are important for prosody production may also be utilized for prosody perception, as well as other aspects of social communication and social understanding, such as aspects of empathy and prosodic ability.	[Aziz-Zadeh, Lisa; Sheng, Tong] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA; [Aziz-Zadeh, Lisa] Univ So Calif, Dept Occupat Sci, Los Angeles, CA USA; [Aziz-Zadeh, Lisa; Sheng, Tong] Univ So Calif, Grad Program Neurosci, Los Angeles, CA USA; [Gheytanchi, Anahita] Pacific Grad Sch Psychol, Palo Alto, CA USA	University of Southern California; University of Southern California; University of Southern California	Aziz-Zadeh, L (corresponding author), Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA.	lazizzad@usc.edu	Sheng, Tong/C-6306-2019	Sheng, Tong/0000-0003-1067-7608	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R03HD057594]; James H. Zumberge Individual Award; University of Southern California Brain and Creativity Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009975] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James H. Zumberge Individual Award; University of Southern California Brain and Creativity Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Award Number R03HD057594 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. This project was also generously funded by a James H. Zumberge Individual Award and the University of Southern California Brain and Creativity Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, EMOTION, V2, P23, DOI 10.1037/1528-3542.2.1.23; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Aziz-Zadeh L, 2004, EUR J NEUROSCI, V19, P2609, DOI 10.1111/j.0953-816X.2004.03348.x; Aziz-Zadeh L, 2002, EXP BRAIN RES, V144, P127, DOI 10.1007/s00221-002-1037-5; BEAUCOUSIN V, 2006, CEREB CORTEX; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Damasio A.R., 2000, FEELING WHAT HAPPENS; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; EHMAN RL, 1989, RADIOLOGY, V173, P255, DOI 10.1148/radiology.173.1.2781017; Ethofer T, 2006, HUM BRAIN MAPP, V27, P707, DOI 10.1002/hbm.20212; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Hare R.D., 2003, PSYCHOPATHY CHECKLIS, VON, P412; HARE RD, 1991, J ABNORM PSYCHOL, V100, P391, DOI 10.1037/0021-843X.100.3.391; Heilman KM, 2004, BRAIN LANG, V89, P411, DOI 10.1016/j.bandl.2004.01.006; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Lilienfield S. O., 2005, PSYCHOPATHIC PERSONA; Lotto AJ, 2009, TRENDS COGN SCI, V13, P110, DOI 10.1016/j.tics.2008.11.008; Mayer J., 2002, P INT C SPEECH PROS, P487; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Moelker A, 2003, HUM BRAIN MAPP, V20, P123, DOI 10.1002/hbm.10134; Moineau S, 2005, J SPEECH LANG HEAR R, V48, P884, DOI 10.1044/1092-4388(2005/061); Nebel K, 2005, HUM BRAIN MAPP, V24, P130, DOI 10.1002/hbm.20075; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2009, NAT REV NEUROSCI, V10, P295, DOI 10.1038/nrn2603; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; van Rijn S, 2005, EUR J NEUROSCI, V21, P3195, DOI 10.1111/j.1460-9568.2005.04130.x; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Wildgruber D, 2006, PROG BRAIN RES, V156, P249, DOI 10.1016/S0079-6123(06)56013-3; Wildgruber D, 2005, NEUROIMAGE, V24, P1233, DOI 10.1016/j.neuroimage.2004.10.034; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263	37	74	75	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8759	10.1371/journal.pone.0008759	http://dx.doi.org/10.1371/journal.pone.0008759			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546AI	20098696	Green Submitted, gold, Green Published			2022-12-27	WOS:000273779000008
J	Fenner, BJ; Scannell, M; Prehn, JHM				Fenner, Beau J.; Scannell, Michael; Prehn, Jochen H. M.			Expanding the Substantial Interactome of NEMO Using Protein Microarrays	PLOS ONE			English	Article							KAPPA-B ACTIVATION; GENOTOXIC STIMULI; KINASE COMPLEX; PATHWAY; ALPHA; UBIQUITINATION; DEGRADATION; RECEPTOR; BINDING; STRESS	Signal transduction by the NF-kappaB pathway is a key regulator of a host of cellular responses to extracellular and intracellular messages. The NEMO adaptor protein lies at the top of this pathway and serves as a molecular conduit, connecting signals transmitted from upstream sensors to the downstream NF-kappaB transcription factor and subsequent gene activation. The position of NEMO within this pathway makes it an attractive target from which to search for new proteins that link NF-kappaB signaling to additional pathways and upstream effectors. In this work, we have used protein microarrays to identify novel NEMO interactors. A total of 112 protein interactors were identified, with the most statistically significant hit being the canonical NEMO interactor IKKbeta, with IKKalpha also being identified. Of the novel interactors, more than 30% were kinases, while at least 25% were involved in signal transduction. Binding of NEMO to several interactors, including CALB1, CDK2, SAG, SENP2 and SYT1, was confirmed using GST pulldown assays and coimmunoprecipitation, validating the initial screening approach. Overexpression of CALB1, CDK2 and SAG was found to stimulate transcriptional activation by NF-kappaB, while SYT1 overexpression repressed TNFalpha-dependent NF-kappaB transcriptional activation in human embryonic kidney cells. Corresponding with this finding, RNA silencing of CDK2, SAG and SENP2 reduced NF-kappaB transcriptional activation, supporting a positive role for these proteins in the NF-kappaB pathway. The identification of a host of new NEMO interactors opens up new research opportunities to improve understanding of this essential cell signaling pathway.	[Fenner, Beau J.] Royal Coll Surgeons Ireland, Ctr Human Prote, Dublin 2, Ireland; Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Fenner, BJ (corresponding author), Royal Coll Surgeons Ireland, Ctr Human Prote, Dublin 2, Ireland.	prehn@rcsi.ie	Prehn, Jochen HM/A-3928-2010	Prehn, Jochen HM/0000-0003-3479-7794; Fenner, Beau/0000-0002-5356-7604	Science Foundation of Ireland [08/IN1/1949]; Higher Education Authority; European Union	Science Foundation of Ireland(Science Foundation Ireland); Higher Education Authority; European Union(European Commission)	This work was generously funded by the Science Foundation of Ireland (08/IN1/1949), the Higher Education Authority (PRTLI Cycle 4), and the European Union (FP6-Mobility, Marie Curie Transfer of Knowledge Fellowships; FP7-Health, APO-SYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU SW, 2009, ANTIOXID REDOX SIGNA; Berchtold CM, 2007, MOL CELL BIOL, V27, P497, DOI 10.1128/MCB.01772-06; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Carr CM, 2007, EMBO REP, V8, P834, DOI 10.1038/sj.embor.7401051; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chen EY, 1998, BIOCHEM BIOPH RES CO, V249, P728, DOI 10.1006/bbrc.1998.9224; Cheng JK, 2004, MOL CELL BIOL, V24, P6021, DOI 10.1128/MCB.24.13.6021-6028.2004; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Cordier F, 2009, J BIOL CHEM, V284, P2902, DOI 10.1074/jbc.M806655200; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; FENNER BJ, 2009, BIOCH BIOPHYS ACTA; Gu QY, 2007, J CELL BIOL, V178, P1009, DOI 10.1083/jcb.200612067; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Higashimoto T, 2008, J BIOL CHEM, V283, P35354, DOI 10.1074/jbc.M806258200; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Kim YS, 2003, J BIOL CHEM, V278, P28462, DOI 10.1074/jbc.M302584200; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kojetin DJ, 2006, NAT STRUCT MOL BIOL, V13, P641, DOI 10.1038/nsmb1112; Levy ED, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.260pe11; Li HX, 2006, J BIOL CHEM, V281, P13636, DOI 10.1074/jbc.M600620200; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Madziva MT, 2005, BRIT J PHARMACOL, V144, P761, DOI 10.1038/sj.bjp.0706035; Mankan AK, 2009, J CELL MOL MED, V13, P631, DOI 10.1111/j.1582-4934.2009.00632.x; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Moon KY, 2001, ANAL BIOCHEM, V292, P17, DOI 10.1006/abio.2001.5059; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Poyet JL, 2000, J BIOL CHEM, V275, P37966, DOI 10.1074/jbc.M006643200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Satoh J, 2009, NEUROPATH APPL NEURO, V35, P16, DOI 10.1111/j.1365-2990.2008.00947.x; Schwaller B, 2009, CELL MOL LIFE SCI, V66, P275, DOI 10.1007/s00018-008-8564-6; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Tan L., 2006, ACM T ARCHIT CODE OP, V3, P3, DOI DOI 10.1145/1132462.1132464; Tan M, 2008, ONCOGENE, V27, P1404, DOI 10.1038/sj.onc.1210780; Tian Y, 2007, J BIOL CHEM, V282, P16776, DOI 10.1074/jbc.M701913200; Tong Y, 2008, ONCOGENE, V27, P6385, DOI 10.1038/onc.2008.234; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang HJ, 2008, EUR J PHARMACOL, V595, P7, DOI 10.1016/j.ejphar.2008.07.044; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang GY, 2001, J CEREBR BLOOD F MET, V21, P722, DOI 10.1097/00004647-200106000-00010; Yoshihara M, 2004, NEUROSCIENTIST, V10, P566, DOI 10.1177/1073858404268770; Zhang H, 2002, MOL CELL BIOL, V22, P6498, DOI 10.1128/MCB.22.18.6498-6508.2002	50	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8799	10.1371/journal.pone.0008799	http://dx.doi.org/10.1371/journal.pone.0008799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098747	Green Submitted, Green Published, gold			2022-12-27	WOS:000273779000026
J	Hasegawa, T; Mikoda, N; Kitazawa, M; LaFerla, FM				Hasegawa, Tohru; Mikoda, Nobuyuki; Kitazawa, Masashi; LaFerla, Frank M.			Treatment of Alzheimer's Disease with Anti-Homocysteic Acid Antibody in 3xTg-AD Male Mice	PLOS ONE			English	Article							IMMATURE RATS; A-BETA; RECEPTOR; RELEASE; INHIBITION; METHIONINE; CULTURES; STRESS	Alzheimer's disease (AD) is an age-associated progressive neurodegenerative disorder with dementia, the exact pathogenic mechanisms of which remain unknown. We previously reported that homocysteic acid (HA) may be one of the pathological biomarkers in the brain with AD and that the increased levels of HA may induce the accumulation of intraneuronal amyloid-beta (A beta) peptides. In this study, we further investigated the pathological role of HA in a mouse model of AD. Four-monthold prepathological 3xTg-AD mice exhibited higher levels of HA in the hippocampus than did age-matched nontransgenic mice, suggesting that HA accumulation may precede both A beta and tau pathologies. We then fed 3-month-old 3xTg-AD mice with vitamin B6-deficient food for 3 weeks to increase the HA levels in the brain. Concomitantly, mice received either saline or anti-HA antibody intraventricularly via a guide cannula every 3 days during the course of the B6-deficient diet. We found that mice that received anti-HA antibody significantly resisted cognitive impairment induced by vitamin B6 deficiency and that AD-related pathological changes in their brains was attenuated compared with the saline-injected control group. A similar neuroprotective effect was observed in 12-month-old 3xTg-AD mice that received anti-HA antibody injections while receiving the regular diet. We conclude that increased brain HA triggers memory impairment and that this condition deteriorates with amyloid and leads to subsequent neurodegeneration in mouse models of AD.	[Hasegawa, Tohru] Saga Womens Jr Coll, Saga, Japan; [Mikoda, Nobuyuki] Kyudo Ltd, Tosu, Saga, Japan; [Kitazawa, Masashi; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of California System; University of California Irvine	Hasegawa, T (corresponding author), Saga Womens Jr Coll, Saga, Japan.	hasegawa@yumekobo-shizuka.com	Kitazawa, Masashi/AAI-1721-2021	Kitazawa, Masashi/0000-0003-2165-8197; MIKODA, NOBUYUKI/0000-0002-0708-4329	Arfresa Pharmcology	Arfresa Pharmcology	This experiment was supported by Arfresa Pharmcology (http://www.alfresa-pharma.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari Y, 2004, BIOCHEM BIOPH RES CO, V322, P1145, DOI 10.1016/j.bbrc.2004.07.136; ALSPECTOR E, RELATIONSHIP NEUROGE; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; DO KQ, 1988, J NEURAL TRANSM, V72, P185, DOI 10.1007/BF01243418; Do KQ, 1997, J NEUROCHEM, V68, P2386, DOI 10.1046/j.1471-4159.1997.68062386.x; Folbergrova J, 2007, EXP NEUROL, V204, P597, DOI 10.1016/j.expneurol.2006.12.010; Hasegawa T, 2005, J NEUROSCI RES, V80, P869, DOI 10.1002/jnr.20514; Hasegawa T, 2007, MED HYPOTHESES, V69, P1135, DOI 10.1016/j.mehy.2007.02.034; Kluska MM, 2005, NEUROSCIENCE, V135, P723, DOI 10.1016/j.neuroscience.2005.06.082; Langmeier M, 2003, EPILEPSIA, V44, P299, DOI 10.1046/j.1528-1157.2003.31702.x; LIEBERMA.M, 1965, BIOCHEM J, V97, P449, DOI 10.1042/bj0970449; Lockhart B, 2000, BRAIN RES, V855, P292, DOI 10.1016/S0006-8993(99)02372-0; McMahon JA, 2006, NEW ENGL J MED, V354, P2764, DOI 10.1056/NEJMoa054025; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; OHMORI S, 1975, H-S Z PHYSIOL CHEM, V356, P1369, DOI 10.1515/bchm2.1975.356.2.1369; Qu K, 2008, NEUROCHEM INT, V52, P155, DOI 10.1016/j.neuint.2007.05.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sommer S, 2004, J PROTEOME RES, V3, P572, DOI 10.1021/pr034115o	19	24	24	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8593	10.1371/journal.pone.0008593	http://dx.doi.org/10.1371/journal.pone.0008593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098691	gold, Green Published			2022-12-27	WOS:000273779000003
J	Beck, AH; Weng, ZM; Witten, DM; Zhu, S; Foley, JW; Lacroute, P; Smith, CL; Tibshirani, R; van de Rijn, M; Sidow, A; West, RB				Beck, Andrew H.; Weng, Ziming; Witten, Daniela M.; Zhu, Shirley; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; Tibshirani, Robert; van de Rijn, Matt; Sidow, Arend; West, Robert B.			3 '-End Sequencing for Expression Quantification (3SEQ) from Archival Tumor Samples	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUES; GENE-EXPRESSION; RNA-SEQ; BREAST-CANCER; MOLECULAR CLASSIFICATION; DNA MICROARRAYS; DESMOID TUMOR; GENOME; SIGNATURES; RELEVANT	Gene expression microarrays are the most widely used technique for genome-wide expression profiling. However, microarrays do not perform well on formalin fixed paraffin embedded tissue (FFPET). Consequently, microarrays cannot be effectively utilized to perform gene expression profiling on the vast majority of archival tumor samples. To address this limitation of gene expression microarrays, we designed a novel procedure (39-end sequencing for expression quantification (3SEQ)) for gene expression profiling from FFPET using next-generation sequencing. We performed gene expression profiling by 3SEQ and microarray on both frozen tissue and FFPET from two soft tissue tumors (desmoid type fibromatosis (DTF) and solitary fibrous tumor (SFT)) (total n = 23 samples, which were each profiled by at least one of the four platform-tissue preparation combinations). Analysis of 3SEQ data revealed many genes differentially expressed between the tumor types (FDR<0.01) on both the frozen tissue (similar to 9.6K genes) and FFPET (similar to 8.1K genes). Analysis of microarray data from frozen tissue revealed fewer differentially expressed genes (similar to 4.64K), and analysis of microarray data on FFPET revealed very few (69) differentially expressed genes. Functional gene set analysis of 3SEQ data from both frozen tissue and FFPET identified biological pathways known to be important in DTF and SFT pathogenesis and suggested several additional candidate oncogenic pathways in these tumors. These findings demonstrate that 3SEQ is an effective technique for gene expression profiling from archival tumor samples and may facilitate significant advances in translational cancer research.	[Beck, Andrew H.; Weng, Ziming; Zhu, Shirley; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; van de Rijn, Matt; Sidow, Arend; West, Robert B.] Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Weng, Ziming; Foley, Joseph W.; Lacroute, Phil; Smith, Cheryl L.; van de Rijn, Matt; Sidow, Arend] Stanford Univ, Med Ctr, Dept Genet, Stanford, CA 94305 USA; [Witten, Daniela M.; Tibshirani, Robert] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Tibshirani, Robert] Stanford Univ, Med Ctr, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [West, Robert B.] Palo Alto Vet Affairs Hlth Care Syst, Pathol & Lab Serv, Palo Alto, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Beck, AH (corresponding author), Stanford Univ, Med Ctr, Dept Pathol, Stanford, CA 94305 USA.	arend@stanford.edu; rbwest@stanford.edu		Foley, Joseph/0000-0002-1579-5286; West, Robert/0000-0002-8330-8283; Smith, Cheryl/0000-0003-4323-6382; van de Rijn, Matt/0000-0002-1909-9739	NIH [CA129927, CA112270]; Desmoid Tumor Research Foundation, Inc; Stanford Department of Pathology; NATIONAL CANCER INSTITUTE [R01CA129927, R01CA112270] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Desmoid Tumor Research Foundation, Inc; Stanford Department of Pathology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the NIH, CA129927 (RBW), CA112270 (MvdR), the Desmoid Tumor Research Foundation, Inc (MvdR), and the Stanford Department of Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alman BA, 1997, AM J PATHOL, V151, P329; Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Coudry RA, 2007, J MOL DIAGN, V9, P70, DOI 10.2353/jmoldx.2007.060004; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DeRisi J, 1996, NAT GENET, V14, P457; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Fu X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kotiligam D, 2008, HISTOL HISTOPATHOL, V23, P117, DOI 10.14670/HH-23.117; Lakhani SR, 2001, NAT REV CANCER, V1, P151, DOI 10.1038/35101087; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee CH, 2008, CLIN CANCER RES, V14, P1423, DOI 10.1158/1078-0432.CCR-07-1712; Li Y, 2007, J PATHOL, V211, P550, DOI 10.1002/path.2136; Liang P, 2003, NAT REV CANCER, V3, P869, DOI 10.1038/nrc1214; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mohr S, 2002, J CLIN ONCOL, V20, P3165, DOI 10.1200/JCO.2002.12.073; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Polakis P, 2000, GENE DEV, V14, P1837; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shendure Jay A, 2008, Curr Protoc Mol Biol, VChapter 7, DOI 10.1002/0471142727.mb0701s81; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Sotiriou C, 2007, NAT REV CANCER, V7, P545, DOI 10.1038/nrc2173; STEIGEN SE, 2009, MOD PATHOL; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WILHELM BT, 2009, METHODS; Yang JL, 2007, PATHOLOGY, V39, P319, DOI 10.1080/00313020701329823	67	94	96	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8768	10.1371/journal.pone.0008768	http://dx.doi.org/10.1371/journal.pone.0008768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098735	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900012
J	Guo, R; Ren, J				Guo, Rui; Ren, Jun			Alcohol Dehydrogenase Accentuates Ethanol-Induced Myocardial Dysfunction and Mitochondrial Damage in Mice: Role of Mitochondrial Death Pathway	PLOS ONE			English	Article							CONTRACTILE DYSFUNCTION; CARDIAC OVEREXPRESSION; INTRACELLULAR CA2+; OXIDATIVE STRESS; HEART-FAILURE; CELL-DEATH; APOPTOSIS; ACETALDEHYDE; CARDIOMYOPATHY; DISEASE	Objectives: Binge drinking and alcohol toxicity are often associated with myocardial dysfunction possibly due to accumulation of the ethanol metabolite acetaldehyde although the underlying mechanism is unknown. This study was designed to examine the impact of accelerated ethanol metabolism on myocardial contractility, mitochondrial function and apoptosis using a murine model of cardiac-specific overexpression of alcohol dehydrogenase (ADH). Methods: ADH and wild-type FVB mice were acutely challenged with ethanol (3 g/kg/d, i.p.) for 3 days. Myocardial contractility, mitochondrial damage and apoptosis (death receptor and mitochondrial pathways) were examined. Results: Ethanol led to reduced cardiac contractility, enlarged cardiomyocyte, mitochondrial damage and apoptosis, the effects of which were exaggerated by ADH transgene. In particular, ADH exacerbated mitochondrial dysfunction manifested as decreased mitochondrial membrane potential and accumulation of mitochondrial O-2(center dot-). Myocardium from ethanol-treated mice displayed enhanced Bax, Caspase-3 and decreased Bcl-2 expression, the effect of which with the exception of Caspase-3 was augmented by ADH. ADH accentuated ethanol-induced increase in the mitochondrial death domain components pro-caspase-9 and cytochrome C in the cytoplasm. Neither ethanol nor ADH affected the expression of ANP, total pro-caspase-9, cytosolic and total pro-caspase-8, TNF-alpha, Fas receptor, Fas L and cytosolic AIF. Conclusions: Taken together, these data suggest that enhanced acetaldehyde production through ADH overexpression following acute ethanol exposure exacerbated ethanol-induced myocardial contractile dysfunction, cardiomyocyte enlargement, mitochondrial damage and apoptosis, indicating a pivotal role of ADH in ethanol-induced cardiac dysfunction possibly through mitochondrial death pathway of apoptosis.	[Guo, Rui; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA	University of Wyoming	Guo, R (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022; Guo, Rui/ACH-5568-2022	Ren, Jun/0000-0002-0275-0783; 	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) [1R01 AA013412]; University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE) [5P20RR016474]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013412] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported in part by National Institutes of Health/National Institute on Alcohol Abuse and Alcoholism (NIH/NIAAA) 1R01 AA013412 and University of Wyoming Northern Rockies Regional IDeA Networks for Biomedical Excellence (INBRE) (5P20RR016474). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharinejad S, 2008, ANN THORAC SURG, V86, P109, DOI 10.1016/j.athoracsur.2008.03.057; Brown RA, 1999, CELL MOL BIOL, V45, P453; Cheng W, 1996, EXP CELL RES, V226, P316, DOI 10.1006/excr.1996.0232; DI LF, 1995, J PHYSL, V486, P1; Doser TA, 2009, CIRCULATION, V119, P1941, DOI 10.1161/CIRCULATIONAHA.108.823799; Duan JH, 2002, AM J PHYSIOL-HEART C, V282, pH1216, DOI 10.1152/ajpheart.00780.2001; Fadeel B, 2000, MED PRIN PRACT, V9, P151, DOI 10.1159/000054240; Gao HK, 2008, J CARDIOVASC PHARM, V52, P286, DOI 10.1097/FJC.0b013e318186a84d; Garlid KD, 2009, J MOL CELL CARDIOL, V46, P858, DOI 10.1016/j.yjmcc.2008.11.019; Gill C, 2002, FASEB J, V16, P135, DOI 10.1096/fj.01-0629com; GUERRI C, 1994, ADV EXP MED BIOL, V366, P291; Guo R, 2009, J MOL CELL CARDIOL, V47, P228, DOI 10.1016/j.yjmcc.2009.03.018; Hajnoczky G, 2005, ALCOHOL CLIN EXP RES, V29, P693, DOI 10.1097/01.ALC.0000163493.45344.7A; Haunstetter A, 1998, CIRC RES, V82, P1111, DOI 10.1161/01.RES.82.11.1111; Hintz KK, 2003, ALCOHOL CLIN EXP RES, V27, P1090, DOI 10.1097/01.ALC.0000075823.73536.DD; Katoh I, 2004, J BIOL CHEM, V279, P15515, DOI 10.1074/jbc.M311819200; LAPOSATA EA, 1986, SCIENCE, V231, P497, DOI 10.1126/science.3941913; Lee SD, 2008, MATURITAS, V61, P268, DOI 10.1016/j.maturitas.2008.07.004; Lee YJ, 2002, J PHARMACOL EXP THER, V301, P908, DOI 10.1124/jpet.301.3.908; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Li SY, 2008, J MOL CELL CARDIOL, V44, P992, DOI 10.1016/j.yjmcc.2008.02.276; Liang QR, 1999, J PHARMACOL EXP THER, V291, P766; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; Lu MC, 2007, OBESITY, V15, P2634, DOI 10.1038/oby.2007.315; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; Mallat Z, 1996, CIRCULATION, V94, P2493; McDonough Kathleen H., 1999, Frontiers in Bioscience, V4, pd601, DOI 10.2741/mcdonoug; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Parra V, 2008, CARDIOVASC RES, V77, P387, DOI 10.1093/cvr/cvm029; Patel VB, 1997, ADVERSE DRUG REACT T, V16, P15; Preedy Victor R., 1999, Frontiers in Bioscience, V4, pe58, DOI 10.2741/Preedy; Qin ZH, 2001, J BIOL CHEM, V276, P8079, DOI 10.1074/jbc.M007028200; Ren J, 1997, CELL MOL BIOL, V43, P825; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; Ren T, 2000, ALCOHOL ALCOHOLISM, V35, P554, DOI 10.1093/alcalc/35.6.554; Richardson PJ, 1998, NOVART FDN SYMP, V216, P35; Russo GL, 2003, NUTR METAB CARDIOVAS, V13, P291, DOI 10.1016/S0939-4753(03)80034-0; Saraste A, 1997, CIRCULATION, V95, P320; Song Ye, 2007, Rev Diabet Stud, V4, P159, DOI 10.1900/RDS.2007.4.159; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; White SJ, 2002, J CARDIAC SURG, V17, P549, DOI 10.1046/j.1540-8191.2002.01013.x; Zhang XC, 2004, ALCOHOL, V32, P175, DOI 10.1016/j.alcohol.2004.01.005	44	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8757	10.1371/journal.pone.0008757	http://dx.doi.org/10.1371/journal.pone.0008757			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090911	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000015
J	Rolli, CG; Seufferlein, T; Kemkemer, R; Spatz, JP				Rolli, Claudio G.; Seufferlein, Thomas; Kemkemer, Ralf; Spatz, Joachim P.			Impact of Tumor Cell Cytoskeleton Organization on Invasiveness and Migration: A Microchannel-Based Approach	PLOS ONE			English	Article							CANCER-CELLS; ADHESION	Cell migration is a fundamental feature of the interaction of cells with their surrounding. The cell's stiffness and ability to deform itself are two major characteristics that rule migration behavior especially in three-dimensional tissue. We simulate this situation making use of a micro-fabricated migration chip to test the active invasive behavior of pancreatic cancer cells (Panc-1) into narrow channels. At a channel width of 7 mm cell migration through the channels was significantly impeded due to size exclusion. A striking increase in cell invasiveness was observed once the cells were treated with the bioactive lipid sphingosylphosphorylcholine (SPC) that leads to a reorganization of the cell's keratin network, an enhancement of the cell's deformability, and also an increase in the cell's migration speed on flat surfaces. The migration speed of the highly deformed cells inside the channels was three times higher than of cells on flat substrates but was not affected upon SPC treatment. Cells inside the channels migrated predominantly by smooth sliding while maintaining constant cell length. In contrast, cells on adhesion mediating narrow lines moved in a stepwise way, characterized by fluctuations in cell length. Taken together, with our migration chip we demonstrate that the dimensionality of the environment strongly affects the migration phenotype and we suggest that the spatial cytoskeletal keratin organization correlates with the tumor cell's invasive potential.	[Rolli, Claudio G.; Spatz, Joachim P.] Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany; [Rolli, Claudio G.; Spatz, Joachim P.] Univ Heidelberg, Inst Phys Chem, Dept Biophys Chem, D-6900 Heidelberg, Germany; [Seufferlein, Thomas] Univ Klin & Poliklin Innere Med 1, Dept Innere Med, Halle, Saale, Germany; [Kemkemer, Ralf] Max Planck Inst Met Res, ZWE Biomat, D-70569 Stuttgart, Germany	Max Planck Society; Ruprecht Karls University Heidelberg; Max Planck Society	Rolli, CG (corresponding author), Max Planck Inst Met Res, Dept New Mat & Biosyst, D-70569 Stuttgart, Germany.	ralf.kemkemer@mf.mpg.de	Seufferlein, Thomas TW/P-7147-2018; Spatz, Joachim P/A-1107-2017	Spatz, Joachim P/0000-0003-3419-9807	National Institutes of Health [PN2 EY 016586]; University of Heidelberg; Max Planck Society; NATIONAL EYE INSTITUTE [PN2EY016586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Heidelberg; Max Planck Society(Max Planck Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This publication and the project described herein were partly supported by the National Institutes of Health, through the NIH Roadmap for Medical Research (PN2 EY 016586). The work was also supported by the Excellence Cluster "CellNetwork'' of the University of Heidelberg. The support of the Max Planck Society is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Greiner C, 2007, LANGMUIR, V23, P3495, DOI 10.1021/la0633987; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Irimia D, 2007, LAB CHIP, V7, P1783, DOI 10.1039/b710524j; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; Pouthas F, 2008, J CELL SCI, V121, P2406, DOI 10.1242/jcs.026849; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; SEUFFERLEIN T, 1995, J BIOL CHEM, V270, P24343, DOI 10.1074/jbc.270.41.24343; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; VEREYCKEN V, 1995, J PHYS III, V5, P1469, DOI 10.1051/jp3:1995204; Weibel DB, 2007, NAT REV MICROBIOL, V5, P209, DOI 10.1038/nrmicro1616; Weinberg RA, 2007, BIOL CANC; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002	22	117	121	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8726	10.1371/journal.pone.0008726	http://dx.doi.org/10.1371/journal.pone.0008726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090950	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900007
J	Cencioni, MT; Chiurchiu, V; Catanzaro, G; Borsellino, G; Bernardi, G; Battistini, L; Maccarrone, M				Cencioni, Maria Teresa; Chiurchiu, Valerio; Catanzaro, Giuseppina; Borsellino, Giovanna; Bernardi, Giorgio; Battistini, Luca; Maccarrone, Mauro			Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; CANNABINOID CB1; CELLS; PHARMACOLOGY; ENDOCANNABINOIDS; EXPRESSION; APOPTOSIS; SYSTEM	Background: Anandamide (AEA) is an endogenous lipid mediator that exerts several effects in the brain as well as in peripheral tissues. These effects are mediated mainly by two types of cannabinoid receptors, named CB1R and CB2R, making AEA a prominent member of the "endocannabinoid" family. Also immune cells express CB1 and CB2 receptors, and possess the whole machinery responsible for endocannabinoid metabolism. Not surprisingly, evidence has been accumulated showing manifold roles of endocannabinoids in the modulation of the immune system. However, details of such a modulation have not yet been disclosed in primary human 1-cells. Methodology/Significance: In this investigation we used flow cytometry and ELISA tests, in order to show that AEA suppresses proliferation and release of cytokines like IL-2, TNF-alpha and INF-gamma from activated human peripheral T-lymphocytes. However, AEA did not exert any cytotoxic effect on 1-cells. The immunosuppression induced by AEA was mainly dependent on CB2R, since it could be mimicked by the CB2R selective agonist JWH-015, and could be blocked by the specific CB2R antagonist SR144528. Instead the selective CB1R agonist ACEA, or the selective CB1R antagonist SR141716, were ineffective. Furthermore, we demonstrated an unprecedented immunosuppressive effect of AEA on IL-17 production, a typical cytokine that is released from the unique CD4+ T-cell subset T-helper 17. Conclusions/Significance: Overall, our study investigates for the first time the effects of the endocannabinoid AEA on primary human T-lymphocytes, demonstrating that it is a powerful modulator of immune cell functions. In particular, not only we clarify that CB2R mediates the immunosuppressive activity of AEA, but we are the first to describe such an immunosuppressive effect on the newly identified Th-17 cells. These findings might be of crucial importance for the rational design of new endocannabinoid-based immunotherapeutic approaches.	[Cencioni, Maria Teresa; Chiurchiu, Valerio; Catanzaro, Giuseppina; Borsellino, Giovanna; Bernardi, Giorgio; Battistini, Luca; Maccarrone, Mauro] Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy; [Catanzaro, Giuseppina; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy	IRCCS Santa Lucia; University of Teramo; University of Rome Tor Vergata	Battistini, L (corresponding author), Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy.	l.battistini@hsantalucia.it; mmaccarrone@unite.it	Borsellino, Giovanna/K-3074-2016; Maccarrone, Mauro/K-5398-2012; Battistini, luca/ABE-1882-2021; Cencioni, maria teresa/AAA-1849-2022; catanzaro, giuseppina/AGZ-8080-2022; Battistini, Luca/D-6920-2014; Chiurchiu, Valerio/G-6227-2011	Borsellino, Giovanna/0000-0002-4227-6481; Maccarrone, Mauro/0000-0002-3990-2963; Cencioni, maria teresa/0000-0002-2694-2392; catanzaro, giuseppina/0000-0001-8427-9691; Battistini, Luca/0000-0002-6488-4891; Chiurchiu, Valerio/0000-0002-0316-7311	Italian Ministry of Health (Progetto Finalizzato); Fondazione TERCAS [2009-2012]	Italian Ministry of Health (Progetto Finalizzato)(Ministry of Health, Italy); Fondazione TERCAS	We are grateful to Dr. Nicoletta Pasquariello (University of Teramo) for qRT-PCR analysis, and to Dr. Filomena Fezza (University of Rome "Tor Vergata") for [35S]GTP-gamma-S assays. This investigation was partly supported by Italian Ministry of Health (Progetto Finalizzato) to LB, and by Fondazione TERCAS (grants 2009-2012) to MM.	Bari M, 2006, J IMMUNOL, V177, P4971, DOI 10.4049/jimmunol.177.8.4971; Benito C, 2007, J NEUROSCI, V27, P2396, DOI 10.1523/JNEUROSCI.4814-06.2007; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Coffey RG, 1996, BIOCHEM PHARMACOL, V52, P743, DOI 10.1016/0006-2952(96)00356-5; Correa F, 2008, BIOCHEM J, V409, P761, DOI 10.1042/BJ20071329; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Do Y, 2004, J IMMUNOL, V173, P2373, DOI 10.4049/jimmunol.173.4.2373; Felder CC, 1996, FEBS LETT, V393, P231, DOI 10.1016/0014-5793(96)00891-5; FONSER IA, 2008, IMMUNOL REV, V226, P87; HILLARD CJ, 1989, J PHARMACOL EXP THER, V289, P1127; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; IBENEN K, 2008, EUR J PHARMACOL, V161, P207; Iwakura Y, 2008, IMMUNOL REV, V226, P57, DOI 10.1111/j.1600-065X.2008.00699.x; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P179, DOI 10.1038/sj.bjp.0707566; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 2001, ARCH BIOCHEM BIOPHYS, V393, P321, DOI 10.1006/abbi.2001.2500; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MARRION KS, 2008, CURR TOP MED CHEM, V3, P187; McAllister SD, 2002, PROSTAG LEUKOTR ESS, V66, P161, DOI 10.1054/plef.2001.0344; Nong L, 2002, J NEUROIMMUNOL, V127, P169, DOI 10.1016/S0165-5728(02)00113-3; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Puffenbarger RA, 2000, GLIA, V29, P58, DOI 10.1002/(SICI)1098-1136(20000101)29:1<58::AID-GLIA6>3.3.CO;2-N; RIMMERMAN X, 2008, BRIT J PHARMACOL, V133, P380; ROCKWELL GE, 2008, BIOCHEM PHARMACOL, V76, P531; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; TAKAAO F, 2007, LIFE SCI, V80, P1333; Wolf SA, 2008, CURR PHARM DESIGN, V14, P2266, DOI 10.2174/138161208785740090	30	172	175	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8688	10.1371/journal.pone.0008688	http://dx.doi.org/10.1371/journal.pone.0008688			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XE	20098669	gold, Green Published, Green Submitted			2022-12-27	WOS:000278099500001
J	Walmsley, GL; Arechavala-Gomeza, V; Fernandez-Fuente, M; Burke, MM; Nagel, N; Holder, A; Stanley, R; Chandler, K; Marks, SL; Muntoni, F; Shelton, GD; Piercy, RJ				Walmsley, Gemma L.; Arechavala-Gomeza, Virginia; Fernandez-Fuente, Marta; Burke, Margaret M.; Nagel, Nicole; Holder, Angela; Stanley, Rachael; Chandler, Kate; Marks, Stanley L.; Muntoni, Francesco; Shelton, G. Diane; Piercy, Richard J.			A Duchenne Muscular Dystrophy Gene Hot Spot Mutation in Dystrophin-Deficient Cavalier King Charles Spaniels Is Amenable to Exon 51 Skipping	PLOS ONE			English	Article							DMD GENE; SKELETAL-MUSCLE; CANINE MODEL; DELETION; EXPRESSION; MICE; DOG; CARDIOMYOPATHY; ORGANIZATION; THERAPY	Background: Duchenne muscular dystrophy (DMD), which afflicts 1 in 3500 boys, is one of the most common genetic disorders of children. This fatal degenerative condition is caused by an absence or deficiency of dystrophin in striated muscle. Most affected patients have inherited or spontaneous deletions in the dystrophin gene that disrupt the reading frame resulting in unstable truncated products. For these patients, restoration of the reading frame via antisense oligonucleotide-mediated exon skipping is a promising therapeutic approach. The major DMD deletion "hot spot" is found between exons 45 and 53, and skipping exon 51 in particular is predicted to ameliorate the dystrophic phenotype in the greatest number of patients. Currently the mdx mouse is the most widely used animal model of DMD, although its mild phenotype limits its suitability in clinical trials. The Golden Retriever muscular dystrophy (GRMD) model has a severe phenotype, but due to its large size, is expensive to use. Both these models have mutations in regions of the dystrophin gene distant from the commonly mutated DMD "hot spot". Methodology/Principal Findings: Here we describe the severe phenotype, histopathological findings, and molecular analysis of Cavalier King Charles Spaniels with dystrophin-deficient muscular dystrophy (CKCS-MD). The dogs harbour a missense mutation in the 59 donor splice site of exon 50 that results in deletion of exon 50 in mRNA transcripts and a predicted premature truncation of the translated protein. Antisense oligonucleotide-mediated skipping of exon 51 in cultured myoblasts from an affected dog restored the reading frame and protein expression. Conclusions/Significance: Given the small size of the breed, the amiable temperament and the nature of the mutation, we propose that CKCS-MD is a valuable new model for clinical trials of antisense oligonucleotide-induced exon skipping and other therapeutic approaches for DMD.	[Walmsley, Gemma L.; Fernandez-Fuente, Marta; Stanley, Rachael; Chandler, Kate; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Arechavala-Gomeza, Virginia; Fernandez-Fuente, Marta; Muntoni, Francesco; Piercy, Richard J.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Burke, Margaret M.] Harefield Hosp, Pathol Lab, Royal Brompton & Harefield NHS Fdn Trust, Harefield UB9 6JH, Middx, England; [Nagel, Nicole] Alphapet Vet Clin, Bognor Regis, West Sussex, England; [Marks, Stanley L.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Shelton, G. Diane] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA	University of London; University of London Royal Veterinary College; University of London; University College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; University of California System; University of California Davis; University of California System; University of California San Diego	Walmsley, GL (corresponding author), Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England.	rpiercy@rvc.ac.uk	Fernandez-Fuente, Marta/A-1761-2014; Arechavala-Gomeza, Virginia/C-1546-2008	Arechavala-Gomeza, Virginia/0000-0001-7703-3255	Muscular Dystrophy Association (USA); University College London Medical Research Council Neuromuscular translational research centre [G0502130]; Medical Research Council [G0502130, G0601943] Funding Source: researchfish; MRC [G0601943, G0502130] Funding Source: UKRI	Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); University College London Medical Research Council Neuromuscular translational research centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Muscular Dystrophy Association (USA) funds canine studies in the laboratory of one of the authors (GDS). Prof. Muntoni acknowledges the financial support from the Medical Research Coucil (Award G0502130) for antisense oligonucleotide studies and for funding the Biobank of the University College London Medical Research Council Neuromuscular translational research centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2004, AM J HUM GENET, V74, P83, DOI 10.1086/381039; Aartsma-Rus A, 2007, RNA, V13, P1609, DOI 10.1261/rna.653607; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Ambrosio CE, 2008, NEUROMUSCULAR DISORD, V18, P892, DOI 10.1016/j.nmd.2008.06.385; Arechavala-Gomeza V, 2007, HUM GENE THER, V18, P798, DOI 10.1089/hum.2006.061; Banks GB, 2008, CURR TOP DEV BIOL, V84, P431, DOI 10.1016/S0070-2153(08)00609-1; Bushby K., 2005, CURRENT PAEDIAT, V15, P292, DOI [DOI 10.1016/J.CUPE.2005.04.001, 10.1016/j.cupe.2005.04.001, 10.1016/j.cupe.2005.04.001.4D]; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Duan DS, 2006, HUM MOL GENET, V15, pR253, DOI 10.1093/hmg/ddl180; Dubowitz V, 2006, NEUROMUSCULAR DISORD, V16, P865, DOI 10.1016/j.nmd.2006.09.003; DUBOWITZ V, 2007, MUSCLE BIOPSY PRACTI, P11; FANIN M, 1995, MUSCLE NERVE, V18, P1115, DOI 10.1002/mus.880181007; Feron M, 2009, AM J PATHOL, V174, P1459, DOI 10.2353/ajpath.2009.080460; Gaschen F, 2001, ACTA NEUROPATHOL, V101, P591; GASCHEN FP, 1992, J NEUROL SCI, V110, P149, DOI 10.1016/0022-510X(92)90022-D; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Im WB, 1996, HUM MOL GENET, V5, P1149, DOI 10.1093/hmg/5.8.1149; KARPATI G, 1993, J NEUROPATH EXP NEUR, V52, P119, DOI 10.1097/00005072-199303000-00004; Kinali M, 2009, LANCET NEUROL, V8, P918, DOI 10.1016/S1474-4422(09)70211-X; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Nobile C, 1997, GENOMICS, V45, P421, DOI 10.1006/geno.1997.4911; OUDET C, 1992, HUM MOL GENET, V1, P599, DOI 10.1093/hmg/1.8.599; Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Schatzberg SJ, 1998, MUSCLE NERVE, V21, P991, DOI 10.1002/(SICI)1097-4598(199808)21:8<991::AID-MUS2>3.3.CO;2-S; Schatzberg SJ, 2004, VET CLIN N AM-SMALL, V34, P1497, DOI 10.1016/j.cvsm.2004.06.001; Schatzberg SJ, 1999, NEUROMUSCULAR DISORD, V9, P289, DOI 10.1016/S0960-8966(99)00011-5; SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J; Shelton GD, 2005, NEUROMUSCULAR DISORD, V15, P127, DOI 10.1016/j.nmd.2004.10.019; Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93; Shimatsu Yoshiki, 2005, Acta Myol, V24, P145; Sironi M, 2006, FASEB J, V20, P1910, DOI 10.1096/fj.05-5635fje; VALENTINE BA, 1989, AM J PATHOL, V135, P671; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; WINAND NJ, 1994, NEUROMUSCULAR DISORD, V4, P433, DOI 10.1016/0960-8966(94)90082-5; Yokota T, 2009, ANN NEUROL; Yokota T, 2006, J CELL SCI, V119, P2679, DOI 10.1242/jcs.03000; Yugeta Naoko, 2006, BMC Cardiovasc Disord, V6, P47, DOI 10.1186/1471-2261-6-47	48	85	89	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8647	10.1371/journal.pone.0008647	http://dx.doi.org/10.1371/journal.pone.0008647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20072625	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000273554600010
J	Wilson, AE; Kaul, RB; Sarnelle, O				Wilson, Alan E.; Kaul, RajReni B.; Sarnelle, Orlando			Growth Rate Consequences of Coloniality in a Harmful Phytoplankter	PLOS ONE			English	Article							CYANOBACTERIUM MICROCYSTIS-AERUGINOSA; EQUIVALENT SPHERICAL DIAMETER; ALLOMETRIC SCALING LAWS; KUTZ-EMEND-ELENKIN; CELL-SIZE; COLONY SIZE; MARINE-PHYTOPLANKTON; BODY-SIZE; PHAEOCYSTIS-POUCHETII; METABOLIC-RATE	Background: Allometric studies have shown that individual growth rate is inversely related to body size across a broad spectrum of organisms that vary greatly in size. Fewer studies have documented such patterns within species. No data exist directly documenting the influence of colony size on growth rate for microscopic, colonial organisms. Methodology/Principal Findings: To determine if similar negative relationships between growth rate and size hold for colonial organisms, we developed a technique for measuring the growth of individual colonies of a bloom-forming, toxic cyanobacterium, Microcystis aeruginosa using microscopy and digital image analysis. For five out of six genotypes of M. aeruginosa isolated from lakes in Michigan and Alabama, we found significant negative relationships between colony size and growth rate. We found large intraspecific variation in both the slope of these relationships and in the growth rate of colonies at a standard size. In addition, growth rate estimates for individual colonies were generally consistent with population growth rates measured using standard batch culture. Conclusions/Significance: Given that colony size varies widely within populations, our results imply that natural populations of colonial phytoplankton exist as a mosaic of individuals with widely varying ecological attributes (since size strongly affects growth rate, grazing mortality, and migration speed). Quantifying the influence of colony size on growth rate will permit development of more accurate, predictive models of ecological interactions (e. g., competition, herbivory) and their role in the proliferation of harmful algal blooms, in addition to increasing our understanding about why these interactions vary in strength within and across environments.	[Wilson, Alan E.; Kaul, RajReni B.] Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA; [Sarnelle, Orlando] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Auburn University System; Auburn University; Michigan State University	Wilson, AE (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Auburn, AL 36849 USA.	wilson@auburn.edu		Kaul, Rajreni/0000-0003-4820-5972; Wilson, Alan/0000-0003-1080-0354	National Science Foundation [0841864, 0841944]; Alabama Agricultural Experiment Station; United States Environmental Protection Agency [RD83170801]; Division Of Environmental Biology [0841864, 0841944] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Alabama Agricultural Experiment Station; United States Environmental Protection Agency(United States Environmental Protection Agency); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank the Cooperative Institute for Limnology and Ecosystems Research at the University of Michigan, the Great Lakes Environmental Research Laboratory, the Department of Fisheries and Wildlife at Michigan State University, and the Department of Fisheries and Allied Aquacultures at Auburn University for supporting this work. This research was funded by the National Science Foundation (grants 0841864 and 0841944), the Alabama Agricultural Experiment Station, and the United States Environmental Protection Agency's Science to Achieve Results (STAR) Program (grant RD83170801). Although the research described in this article has been funded in part by the United States Environmental Protection Agency through grant/cooperative agreement RD83170801 to O. Sarnelle, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS MA, 1991, CAN J FISH AQUAT SCI, V48, P1967, DOI 10.1139/f91-234; ARMBRUST EV, 1992, J PHYCOL, V28, P146, DOI 10.1111/j.0022-3646.1992.00146.x; BANSE K, 1976, J PHYCOL, V12, P135; Beardall J, 2009, NEW PHYTOL, V181, P295, DOI 10.1111/j.1469-8137.2008.02660.x; BRAND LE, 1981, EVOLUTION, V35, P1117, DOI 10.1111/j.1558-5646.1981.tb04981.x; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Caraco NF, 2006, LIMNOL OCEANOGR, V51, P664, DOI 10.4319/lo.2006.51.1_part_2.0664; Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781; Chan F, 2004, LIMNOL OCEANOGR, V49, P2171, DOI 10.4319/lo.2004.49.6.2171; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; COSTELLO J C, 1981, Journal of Plankton Research, V3, P415, DOI 10.1093/plankt/3.3.415; CRUMPTON WG, 1982, ECOLOGY, V63, P1729, DOI 10.2307/1940115; DALEY RJ, 1973, J PHYCOL, V9, P395, DOI 10.1111/j.0022-3646.1973.00395.x; DURBIN EG, 1977, J PHYCOL, V13, P150, DOI 10.1111/j.1529-8817.1977.tb02904.x; ELSER JJ, 1992, ECOLOGY, V72, P887; Finkel ZV, 2000, J THEOR BIOL, V204, P361, DOI 10.1006/jtbi.2000.2020; FURNAS M, 1978, J EXP MAR BIOL ECOL, V34, P97, DOI 10.1016/0022-0981(78)90034-5; Gao KS, 2004, J PHYCOL, V40, P523, DOI 10.1111/j.1529-8817.2004.03155.x; GEIDER RJ, 1986, MAR ECOL PROG SER, V30, P93, DOI 10.3354/meps030093; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Irwin AJ, 2006, J PLANKTON RES, V28, P459, DOI 10.1093/plankt/fbi148; Jacobsen A, 2007, AQUAT MICROB ECOL, V48, P105, DOI 10.3354/ame048105; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; JENNINGS BR, 1988, P ROY SOC LOND A MAT, V419, P137, DOI 10.1098/rspa.1988.0100; Joung SH, 2006, J MICROBIOL, V44, P562; Kim K, 1998, FUNCT ECOL, V12, P646, DOI 10.1046/j.1365-2435.1998.00228.x; LEHMAN JT, 1985, LIMNOL OCEANOGR, V30, P34, DOI 10.4319/lo.1985.30.1.0034; LEWIS WM, 1976, SCIENCE, V192, P885, DOI 10.1126/science.192.4242.885; Li YG, 2004, EUR J PHYCOL, V39, P9, DOI 10.1080/0967026032000157147; Lurling M, 2000, OIKOS, V88, P111, DOI 10.1034/j.1600-0706.2000.880113.x; Maranon E, 2007, LIMNOL OCEANOGR, V52, P2190, DOI 10.4319/lo.2007.52.5.2190; Nakaya F, 2005, P ROY SOC B-BIOL SCI, V272, P1963, DOI 10.1098/rspb.2005.3143; Nielsen SL, 2006, J PLANKTON RES, V28, P489, DOI 10.1093/plankt/fbi134; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; NUSCH E. A., 1980, ARCH HYDROBIOL BEIH, V14, P14; Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; PAERL HW, 1988, LIMNOL OCEANOGR, V33, P823, DOI 10.4319/lo.1988.33.4_part_2.0823; PORTER KG, 1977, AM SCI, V65, P159; Pratt MC, 2005, MAR ECOL PROG SER, V303, P153, DOI 10.3354/meps303153; Prescott G. W., 1962, ALGAE W GREAT LAKES; Reich PB, 2001, TRENDS ECOL EVOL, V16, P674, DOI 10.1016/S0169-5347(01)02306-0; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Reynolds CS, 2007, HYDROBIOLOGIA, V578, P37, DOI 10.1007/s10750-006-0431-6; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; REYNOLDS CS, 1975, BIOL REV, V50, P437, DOI 10.1111/j.1469-185X.1975.tb01060.x; REYNOLDS CS, 1973, PROC R SOC SER B-BIO, V184, P29, DOI 10.1098/rspb.1973.0029; REYNOLDS CS, 1978, BRIT PHYCOL J, V13, P269, DOI 10.1080/00071617800650331; Saker ML, 2005, J APPL MICROBIOL, V99, P749, DOI 10.1111/j.1365-2672.2005.02687.x; Sand-Jensen K, 2009, LIMNOL OCEANOGR, V54, P1282, DOI 10.4319/lo.2009.54.4.1282; Sarnelle O, 2005, LIMNOL OCEANOGR, V50, P896, DOI 10.4319/lo.2005.50.3.0896; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; STEMBERGER RS, 1981, CAN J FISH AQUAT SCI, V38, P721, DOI 10.1139/f81-095; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; TANG EPY, 1995, J PLANKTON RES, V17, P1325, DOI 10.1093/plankt/17.6.1325; Thessen AE, 2009, HARMFUL ALGAE, V8, P792, DOI 10.1016/j.hal.2009.01.003; Thomassen S, 1995, MAR ECOL PROG SER, V128, P239, DOI 10.3354/meps128239; Verity PG, 2007, J PLANKTON RES, V29, P359, DOI 10.1093/plankt/fbm021; Visser PM, 1997, HYDROBIOLOGIA, V349, P99, DOI 10.1023/A:1003001713560; Vuorio K, 2009, LIMNOL OCEANOGR, V54, P925, DOI 10.4319/lo.2009.54.3.0925; WATANABE M, 1996, TOXIC MICROCYSTIS, P13; Watanabe M.F., 1996, TOXIC MICROCYSTIS; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILLIAMS RICHARD B., 1964, ECOLOGY, V45, P877, DOI 10.2307/1934940; Wilson AE, 2005, APPL ENVIRON MICROB, V71, P6126, DOI 10.1128/AEM.71.10.6126-6133.2005; Wilson AE, 2007, LIMNOL OCEANOGR, V52, P1467, DOI 10.4319/lo.2007.52.4.1467; Wilson AE, 2006, APPL ENVIRON MICROB, V72, P7386, DOI 10.1128/AEM.00834-06; Wilson AE, 2006, LIMNOL OCEANOGR, V51, P1915, DOI 10.4319/lo.2006.51.4.1915; Yang RJ, 2006, J EXP MAR BIOL ECOL, V331, P33, DOI 10.1016/j.jembe.2005.09.015	73	26	28	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8679	10.1371/journal.pone.0008679	http://dx.doi.org/10.1371/journal.pone.0008679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084114	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600030
J	Simes, J; Voysey, M; O'Connell, R; Glasziou, P; Best, JD; Scott, R; Pardy, C; Byth, K; Sullivan, DR; Ehnholm, C; Keech, A				Simes, John; Voysey, Merryn; O'Connell, Rachel; Glasziou, Paul; Best, James D.; Scott, Russell; Pardy, Christopher; Byth, Karen; Sullivan, David R.; Ehnholm, Christian; Keech, Anthony		FIELD Study Investigators	A Novel Method to Adjust Efficacy Estimates for Uptake of Other Active Treatments in Long-Term Clinical Trials	PLOS ONE			English	Article							BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; NONCOMPLIANCE; OUTCOMES; THERAPY; MODELS; STROKE	Background: When rates of uptake of other drugs differ between treatment arms in long-term trials, the true benefit or harm of the treatment may be underestimated. Methods to allow for such contamination have often been limited by failing to preserve the randomization comparisons. In the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study, patients were randomized to fenofibrate or placebo, but during the trial many started additional drugs, particularly statins, more so in the placebo group. The effects of fenofibrate estimated by intention-to-treat were likely to have been attenuated. We aimed to quantify this effect and to develop a method for use in other long-term trials. Methodology/Principal Findings: We applied efficacies of statins and other cardiovascular drugs from meta-analyses of randomized trials to adjust the effect of fenofibrate in a penalized Cox model. We assumed that future cardiovascular disease events were reduced by an average of 24% by statins, and 20% by a first other major cardiovascular drug. We applied these estimates to each patient who took these drugs for the period they were on them. We also adjusted the analysis by the rate of discontinuing fenofibrate. Among 4,900 placebo patients, average statin use was 16% over five years. Among 4,895 assigned fenofibrate, statin use was 8% and nonuse of fenofibrate was 10%. In placebo patients, use of cardiovascular drugs was 1% to 3% higher. Before adjustment, fenofibrate was associated with an 11% reduction in coronary events (coronary heart disease death or myocardial infarction) (P = 0.16) and an 11% reduction in cardiovascular disease events (P = 0.04). After adjustment, the effects of fenofibrate on coronary events and cardiovascular disease events were 16% (P = 0.06) and 15% (P = 0.008), respectively. Conclusions/Significance: This novel application of a penalized Cox model for adjustment of a trial estimate of treatment efficacy incorporates evidence-based estimates for other therapies, preserves comparisons between the randomized groups, and is applicable to other long-term trials. In the FIELD study example, the effects of fenofibrate on the risks of coronary heart disease and cardiovascular disease events were underestimated by up to one-third in the original analysis.	[Simes, John; Voysey, Merryn; O'Connell, Rachel; Pardy, Christopher; Byth, Karen; Keech, Anthony] Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia; [Glasziou, Paul] Univ Oxford, Ctr Evidence Based Med, Oxford, England; [Best, James D.] Univ Melbourne, Fac Med, Melbourne, Vic, Australia; [Scott, Russell] Christchurch Hosp, Lipid & Diabet Res Grp, Christchurch, New Zealand; [Sullivan, David R.] Royal Prince Alfred Hosp, Dept Clin Biochem, Sydney, NSW, Australia; [Ehnholm, Christian] Natl Publ Hlth Inst, Biomedicum Helsinki, Helsinki, Finland	University of Sydney; University of Oxford; University of Melbourne; Christchurch Hospital New Zealand; University of Sydney; Finland National Institute for Health & Welfare; University of Helsinki	Simes, J (corresponding author), Univ Sydney, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW 2006, Australia.	john@ctc.usyd.edu.au	Scott, Russell/ABC-8328-2020; Glasziou, Paul/A-7832-2008; Simes, Robert John/P-1497-2014	Scott, Russell/0000-0002-2107-6480; Glasziou, Paul/0000-0001-7564-073X; Voysey, Merryn/0000-0001-6324-6559; Byth Wilson, Karen/0000-0002-1253-6393; Best, James/0000-0002-5239-9274	Laboratoires Fournier SA, Dijon, France; National Health and Medical Research Council, Australia	Laboratoires Fournier SA, Dijon, France; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	Fenofibrate Intervention and Event Lowering in Diabetes was supported by grants from Laboratoires Fournier SA, Dijon, France (now part of Solvay Pharmaceuticals), and the National Health and Medical Research Council, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2004, CARDIOVASC DIABETOL, V3, DOI 10.1186/1475-2840-3-9; Bond SJ, 2007, STAT MED, V26, P1473, DOI 10.1002/sim.2644; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Capewell S, 2008, HEART, V94, P8, DOI 10.1136/hrt.2007.123125; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COX DR, 1972, J R STAT SOC B, V34, P187; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; Frangakis CE, 1999, BIOMETRIKA, V86, P365, DOI 10.1093/biomet/86.2.365; GLASZIOU PP, 1992, J CLIN EPIDEMIOL, V45, P1251, DOI 10.1016/0895-4356(92)90166-K; Heritier SR, 2003, MED J AUSTRALIA, V179, P438, DOI 10.5694/j.1326-5377.2003.tb05627.x; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lee E, 2013, STAT METHODS SURVIVA; Lithell H, 2004, J HYPERTENS, V22, P1605, DOI 10.1097/01.hjh.0000133730.47372.4c; Little RJ, 2009, BIOMETRICS, V65, P640, DOI 10.1111/j.1541-0420.2008.01066.x; MARCUS SM, 2001, HLTH SERVICES OUTCOM, V2, P247, DOI DOI 10.1023/A:1020319328212; Mochizuki S, 2007, LANCET, V369, P1431, DOI 10.1016/S0140-6736(07)60669-2; Nagelkerke N, 2000, STAT MED, V19, P1849, DOI 10.1002/1097-0258(20000730)19:14<1849::AID-SIM506>3.0.CO;2-1; Neal B, 2000, LANCET, V356, P1955; NEWCOMBE RG, 1988, STAT MED, V7, P1179, DOI 10.1002/sim.4780071111; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; ROBINS JM, 1994, J AM STAT ASSOC, V89, P737, DOI 10.1080/01621459.1994.10476807; Rosenblum M, 2009, J R STAT SOC A STAT, V172, P443, DOI 10.1111/j.1467-985X.2009.00585.x; Scott R, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-13; SHEINER LB, 1995, CLIN PHARMACOL THER, V57, P6, DOI 10.1016/0009-9236(95)90260-0; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; White IR, 2005, STAT METHODS MED RES, V14, P327, DOI 10.1191/0962280205sm406oa; Yamaguchi T, 2004, STAT MED, V23, P1991, DOI 10.1002/sim.1816; YUSUF S, 1988, JAMA-J AM MED ASSOC, V260, P2088, DOI 10.1001/jama.260.14.2088; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; Yusuf S, 2001, NEW ENGL J MED, V345, P494	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8580	10.1371/journal.pone.0008580	http://dx.doi.org/10.1371/journal.pone.0008580			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072614	Green Published, gold			2022-12-27	WOS:000273414200007
J	Furtak, V; Mulky, A; Rawlings, SA; Kozhaya, L; Lee, K; KewalRamani, VN; Unutmaz, D				Furtak, Vyacheslav; Mulky, Alok; Rawlings, Stephen A.; Kozhaya, Lina; Lee, KyeongEun; KewalRamani, Vineet N.; Unutmaz, Derya			Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity	PLOS ONE			English	Article							VIRUS TYPE-1 RNA; STRESS GRANULES; PROTEIN; BODIES; REPLICATION; FAMILY; OVEREXPRESSION; IDENTIFICATION; ASSOCIATION; COMPLEXES	Exogenous retroviruses are obligate cellular parasites that co-opt a number of host proteins and functions to enable their replication and spread. Several host factors that restrict HIV and other retroviral infections have also recently been described. Here we demonstrate that Mov10, a protein associated with P-bodies that has a putative RNA-helicase domain, when overexpressed in cells can inhibit the production of infectious retroviruses. Interestingly, reducing the endogenous Mov10 levels in virus-producing cells through siRNA treatment also modestly suppresses HIV infectivity. The actions of Mov10 are not limited to HIV, however, as ectopic expression of Mov10 restricts the production of other lentiviruses as well as the gammaretrovirus, murine leukemia virus. We found that HIV produced in the presence of high levels of Mov10 is restricted at the pre-reverse transcription stage in target cells. Finally, we show that either helicase mutation or truncation of the C-terminal half of Mov10, where a putative RNA-helicase domain is located, maintained most of its HIV inhibition; whereas removing the N-terminal half of Mov10 completely abolished its activity on HIV. Together these results suggest that Mov10 could be required during the lentiviral lifecycle and that its perturbation disrupts generation of infectious viral particles. Because Mov10 is implicated as part of the P-body complex, these findings point to the potential role of cytoplasmic RNA processing machinery in infectious retroviral production.	[Furtak, Vyacheslav; Rawlings, Stephen A.; Kozhaya, Lina; Unutmaz, Derya] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Unutmaz, Derya] NYU, Sch Med, Dept Pathol, New York, NY USA; [Mulky, Alok; Lee, KyeongEun; KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA	New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Furtak, V (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	vineet@mac.com; derya@mac.com	Rawlings, Stephen/ABA-6797-2020; KewalRamani, Vineet/V-5084-2019	Rawlings, Stephen/0000-0003-3637-1447; 	National Institutes of Health [R21 AI078839]; National Cancer Institute's intramural Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute's intramural Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21 AI078839 to D. U. and in part by the National Cancer Institute's intramural Center for Cancer Research, which supports the HIV Drug Resistance Program of V.N.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askjaer P, 2000, J BIOL CHEM, V275, P11561, DOI 10.1074/jbc.275.16.11561; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Beliakova-Bethell N, 2006, RNA, V12, P94, DOI 10.1261/rna.2264806; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; CHECKLEY MA, MOL CELL BIOL, V30, P382; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Oswald-Richter K, 2007, PLOS PATHOG, V3, P553, DOI 10.1371/journal.ppat.0030058; Ott DE, 2008, REV MED VIROL, V18, P159, DOI 10.1002/rmv.570; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; SCHNIEKE A, 1983, J VIROL, V45, P505, DOI 10.1128/JVI.45.2.505-513.1983; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Southey R., 1837, STORY 3 BEARS; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Zhou YD, 2008, VIROLOGY, V372, P97, DOI 10.1016/j.virol.2007.10.027	33	92	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9081	10.1371/journal.pone.0009081	http://dx.doi.org/10.1371/journal.pone.0009081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140200	Green Submitted, Green Published, gold			2022-12-27	WOS:000274442400017
J	Sweiss, NJ; Salloum, R; Ghandi, S; Alegre, ML; Sawaqed, R; Badaracco, M; Pursell, K; Pitrak, D; Baughman, RP; Moller, DR; Garcia, JGN; Niewold, TB				Sweiss, Nadera J.; Salloum, Rafah; Ghandi, Seema; Alegre, Maria-Luisa; Sawaqed, Ray; Badaracco, Maria; Pursell, Kenneth; Pitrak, David; Baughman, Robert P.; Moller, David R.; Garcia, Joe G. N.; Niewold, Timothy B.			Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations	PLOS ONE			English	Article								Background: Sarcoidosis is a poorly understood chronic inflammatory condition. Infiltration of affected organs by lymphocytes is characteristic of sarcoidosis, however previous reports suggest that circulating lymphocyte counts are low in some patients with the disease. The goal of this study was to evaluate lymphocyte subsets in peripheral blood in a cohort of sarcoidosis patients to determine the prevalence, severity, and clinical features associated with lymphopenia in major lymphocyte subsets. Methodology/Principal Findings: Lymphocyte subsets in 28 sarcoid patients were analyzed using flow cytometry to determine the percentage of CD4, CD8, and CD19 positive cells. Greater than 50% of patients had abnormally low CD4, CD8, or CD19 counts (p<4x10(-10)). Lymphopenia was profound in some cases, and five of the patients had absolute CD4 counts below 200. CD4, CD8, and CD19 lymphocyte subset counts were significantly correlated (Spearman's rho 0.57, p = 0.0017), and 10 patients had low counts in all three subsets. Patients with severe organ system involvement including neurologic, cardiac, ocular, and advanced pulmonary disease had lower lymphocyte subset counts as a group than those patients with less severe manifestations (CD4 p = 0.0043, CD8 p = 0.026, CD19 p = 0.033). No significant relationships were observed between various medical therapies and lymphocyte counts, and lymphopenia was present in patients who were not receiving any medical therapy. Conclusions/Significance: Significant lymphopenia involving CD4, CD8, and CD19 positive cells was common in sarcoidosis patients and correlated with disease severity. Our findings suggest that lymphopenia relates more to disease pathology than medical treatment.	[Sweiss, Nadera J.] Univ Chicago, Rheumatol Sect, Sarcoidosis & Scleroderma Clin, Chicago, IL 60637 USA; [Ghandi, Seema] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sawaqed, Ray] Methodist Hosp, Merrillville, IN USA; [Pursell, Kenneth; Pitrak, David] Univ Chicago, Sect Infect Dis & Global Hlth, Chicago, IL 60637 USA; [Baughman, Robert P.] Univ Cincinnati, Med Ctr, Div Pulm & Crit Care, Cincinnati, OH 45267 USA; [Moller, David R.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Garcia, Joe G. N.] Univ Chicago, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University System of Ohio; University of Cincinnati; Johns Hopkins University; University of Chicago	Sweiss, NJ (corresponding author), Univ Chicago, Rheumatol Sect, Sarcoidosis & Scleroderma Clin, Chicago, IL 60637 USA.	nsweiss@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010; Niewold, Timothy/D-2669-2018	Niewold, Timothy/0000-0003-3532-6660; Gandhi, Seema/0000-0002-2363-2655; Sweiss, Nadera/0000-0003-2215-0221	NIH [K08 AI083790]; NIAID [AI071651]; Arthritis National Research Foundation Eng Tan Scholar Award; Lupus Research Institute; University of Chicago CTSA; Collaborative University of Chicago/Northshore University Health System [UL1 RR024999]; Abbott, Genentech; BMS; Foundation for Sarcoidosis Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI083790] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Arthritis National Research Foundation Eng Tan Scholar Award(National Research Foundation of Korea); Lupus Research Institute; University of Chicago CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Collaborative University of Chicago/Northshore University Health System; Abbott, Genentech(Abbott LaboratoriesRoche HoldingGenentech); BMS(Bristol-Myers Squibb); Foundation for Sarcoidosis Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Grant Support and Disclosures: TB Niewold: NIH K08 AI083790, NIAID Clinical Research Loan Repayment AI071651, Arthritis National Research Foundation Eng Tan Scholar Award, Lupus Research Institute, University of Chicago CTSA Core Subsidy Grant and Collaborative University of Chicago/Northshore University Health System Translational Research Pilot Grant from UL1 RR024999. NJ Sweiss: Investigator initiated grant support from Abbott, Genentech and BMS for sarcoidosis research, Young investigator award, Foundation for Sarcoidosis Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUGHMAN RP, 1985, CLIN EXP IMMUNOL, V61, P535; Gerke AK, 2008, CLIN CHEST MED, V29, P379, DOI 10.1016/j.ccm.2008.03.014; HEDFORS E, 1974, CLIN EXP IMMUNOL, V17, P219; KATARIA YP, 1976, ANN NY ACAD SCI, V278, P69, DOI 10.1111/j.1749-6632.1976.tb47017.x; Lower E E, 1988, Sarcoidosis, V5, P51; Noor A, 2007, CLIN DERMATOL, V25, P250, DOI 10.1016/j.clindermatol.2007.03.002; SELROOS O, 1979, ACTA MED SCAND, V206, P259; SLADE JD, 1983, J LAB CLIN MED, V101, P479; Zissel G, 2007, SEMIN RESP CRIT CARE, V28, P3, DOI 10.1055/s-2007-970329	9	79	81	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9088	10.1371/journal.pone.0009088	http://dx.doi.org/10.1371/journal.pone.0009088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140091	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442400024
J	Carneiro, I; Roca-Feltrer, A; Griffin, JT; Smith, L; Tanner, M; Schellenberg, JA; Greenwood, B; Schellenberg, D				Carneiro, Ilona; Roca-Feltrer, Arantxa; Griffin, Jamie T.; Smith, Lucy; Tanner, Marcel; Schellenberg, Joanna Armstrong; Greenwood, Brian; Schellenberg, David			Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis	PLOS ONE			English	Review							PLASMODIUM-FALCIPARUM MALARIA; INTERMITTENT PREVENTIVE TREATMENT; SEVERE CHILDHOOD MALARIA; TREATED BED NETS; CLINICAL PRESENTATION; NORTHERN GHANA; ENDEMIC AREAS; DOUBLE-BLIND; WEST-AFRICA; DESCRIPTIVE EPIDEMIOLOGY	Background: There is evidence that the age-pattern of Plasmodium falciparum malaria varies with transmission intensity. A better understanding of how this varies with the severity of outcome and across a range of transmission settings could enable locally appropriate targeting of interventions to those most at risk. We have, therefore, undertaken a pooled analysis of existing data from multiple sites to enable a comprehensive overview of the age-patterns of malaria outcomes under different epidemiological conditions in sub-Saharan Africa. Methodology/Principal Findings: A systematic review using PubMed and CAB Abstracts (1980-2005), contacts with experts and searching bibliographies identified epidemiological studies with data on the age distribution of children with P. falciparum clinical malaria, hospital admissions with malaria and malaria-diagnosed mortality. Studies were allocated to a 362 matrix of intensity and seasonality of malaria transmission. Maximum likelihood methods were used to fit five continuous probability distributions to the percentage of each outcome by age for each of the six transmission scenarios. The best-fitting distributions are presented graphically, together with the estimated median age for each outcome. Clinical malaria incidence was relatively evenly distributed across the first 10 years of life for all transmission scenarios. Hospital admissions with malaria were more concentrated in younger children, with this effect being even more pronounced for malaria-diagnosed deaths. For all outcomes, the burden of malaria shifted towards younger ages with increasing transmission intensity, although marked seasonality moderated this effect. Conclusions: The most severe consequences of P. falciparum malaria were concentrated in the youngest age groups across all settings. Despite recently observed declines in malaria transmission in several countries, which will shift the burden of malaria cases towards older children, it is still appropriate to target strategies for preventing malaria mortality and severe morbidity at very young children who will continue to bear the brunt of malaria deaths in Sub-Saharan Africa.	[Carneiro, Ilona; Roca-Feltrer, Arantxa; Smith, Lucy; Schellenberg, Joanna Armstrong; Greenwood, Brian; Schellenberg, David] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1, England; [Griffin, Jamie T.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, London, England; [Tanner, Marcel] Swiss Trop Inst, CH-4002 Basel, Switzerland	University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Basel; Swiss Tropical & Public Health Institute	Carneiro, I (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Dis Control & Vector Biol Unit, London WC1, England.	ilona.carneiro@lshtm.ac.uk	Roca-Feltrer, Arantxa/AAW-6986-2020	Schellenberg, David/0000-0001-8222-0186; Schellenberg, Joanna/0000-0002-0708-3676	Bill and Melinda Gates Foundation [33679]; Department for International Development, United Kingdom [HD205]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department for International Development, United Kingdom	This project was funded by The Bill and Melinda Gates Foundation (Grant ID 33679; www.gatesfoundation.org) through the Intermittent Preventive Treatment in Infants (IPTi) consortium. I. C. is also funded by the Department for International Development, United Kingdom (www.dfid.gov.uk) through the TARGETS Communicable Disease Consortium (Grant ID HD205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah S, 2007, AM J TROP MED HYG, V77, P99; Allen SJ, 1996, QJM-INT J MED, V89, P779, DOI 10.1093/qjmed/89.10.779; ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; ANDERSON RM, 1992, INDIRECTLY TRANSMITT, P379; [Anonymous], 2002, MODEL SELECTION MULT; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Bassat Q, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-37; Becher H, 2008, AM J TROP MED HYG, V78, P106, DOI 10.4269/ajtmh.2008.78.106; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bonnet S, 2002, TROP MED INT HEALTH, V7, P249, DOI 10.1046/j.1365-3156.2002.00861.x; BOYD M, 1949, EPIDEMIOLOGY MALARIA; Camara B, 2003, MED MALADIES INFECT, V33, P45, DOI 10.1016/S0399-077X(02)00014-8; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; DALESSANDRO U, 1995, LANCET, V345, P479, DOI 10.1016/S0140-6736(95)90582-0; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; DEFO BK, 1995, INT J EPIDEMIOL, V24, P204, DOI 10.1093/ije/24.1.204; DELACOLLETTE C, 1993, B SOC PATHOL EXOT, V86, P373; Diallo S, 2000, Sante, V10, P221; Diallo S, 1998, B SOC PATHOL EXOT, V91, P208; Dicko A, 2007, AM J TROP MED HYG, V77, P1028, DOI 10.4269/ajtmh.2007.77.1028; Etard JF, 2004, INT J EPIDEMIOL, V33, P1286, DOI 10.1093/ije/dyh259; Giha HA, 2005, T ROY SOC TROP MED H, V99, P243, DOI 10.1016/j.trstmh.2004.04.002; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; GUIGUEMDE TR, 1991, B SOC PATHOL EXOT, V84, P338; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Hay SI, 2000, T ROY SOC TROP MED H, V94, P113, DOI 10.1016/S0035-9203(00)90246-3; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Henry MC, 2003, TROP MED INT HEALTH, V8, P449, DOI 10.1046/j.1365-3156.2003.01053.x; Idro R, 2006, TROP MED INT HEALTH, V11, P115, DOI 10.1111/j.1365-3156.2005.01518.x; Imbert P, 2002, T ROY SOC TROP MED H, V96, P278, DOI 10.1016/S0035-9203(02)90099-4; Imbert P, 1997, T ROY SOC TROP MED H, V91, P22, DOI 10.1016/S0035-9203(97)90380-1; *IOM IOM, 2008, ASS ROL INT PREV TRE; Jaffar S, 1997, TROP MED INT HEALTH, V2, P28, DOI 10.1046/j.1365-3156.1997.d01-131.x; JALLOW M, MALARIAGEN PROJECT; Kazembe LN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-93; Kitua AY, 1996, TROP MED INT HEALTH, V1, P475, DOI 10.1046/j.1365-3156.1996.d01-89.x; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Koko J., 1999, Medecine d'Afrique Noire, V46, P10; Lusingu JPA, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-26; Maitland K, 2003, QJM-INT J MED, V96, P427, DOI 10.1093/qjmed/hcg077; *MAPP MAL RISK AFR, 2008, DUR MAL TRANSM SEAS; MARSH K, 1992, PARASITOLOGY, V104, pS53, DOI 10.1017/S0031182000075247; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; McGuinness D, 1998, T ROY SOC TROP MED H, V92, P527, DOI 10.1016/S0035-9203(98)90902-6; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; Modiano D, 1998, AM J TROP MED HYG, V59, P539, DOI 10.4269/ajtmh.1998.59.539; Molineaux L, 2020, GARKI PROJECT RES EP, V8; MULUMBA MP, CONGO MED J UNPUB; Murphy SC, 2001, AM J TROP MED HYG, V64, P57, DOI 10.4269/ajtmh.2001.64.57; Murray C., 1996, GLOBAL BURDEN DIS IN, V2; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; Okiro EA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-4; Olanrewaju W I, 2001, East Afr Med J, V78, P131; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Premji Z, 1997, ACTA TROP, V63, P101, DOI 10.1016/S0001-706X(96)00605-5; Reyburn H, 2005, JAMA-J AM MED ASSOC, V293, P1461, DOI 10.1001/jama.293.12.1461; Roca-Feltrer A, 2008, TROP MED INT HEALTH, V13, P771, DOI 10.1111/j.1365-3156.2008.02076.x; Roca-Feltrer A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-276; ROCAFELTRER A, 2008, ESTIMATING BURDEN AG, P423; Rodrigues A, 2008, TROP MED INT HEALTH, V13, P410, DOI 10.1111/j.1365-3156.2008.02016.x; ROGIER C, 1993, T ROY SOC TROP MED H, V87, P245, DOI 10.1016/0035-9203(93)90110-C; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; ROSS DA, 1993, LANCET, V342, P7, DOI 10.1016/0140-6736(93)91879-Q; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Saute F, 2003, T ROY SOC TROP MED H, V97, P655, DOI 10.1016/S0035-9203(03)80097-4; SCHAPIRA A, 1993, T ROY SOC TROP MED H, V87, P299, DOI 10.1016/0035-9203(93)90136-E; Schellenberg D, 2004, TROP MED INT HEALTH, V9, P68, DOI 10.1046/j.1365-3156.2003.01161.x; SCHELLENBERG D, 2003, T R SOC TROP MED HYG, V97; Schumacher R, 2002, MORTALITY STUDY GUIN; Slutsker L, 1996, AM J TROP MED HYG, V55, P77, DOI 10.4269/ajtmh.1996.55.77; SLUTSKER L, 1994, T ROY SOC TROP MED H, V88, P548, DOI 10.1016/0035-9203(94)90157-0; Smith T, 2004, AM J TROP MED HYG, V71, P80, DOI 10.4269/ajtmh.2004.71.80; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Smith TA, 2001, TRENDS PARASITOL, V17, P145, DOI 10.1016/S1471-4922(00)01814-6; Snow Robert W., 1994, Afr J Health Sci, V1, P71; SNOW RW, 1994, ACTA TROP, V57, P289, DOI 10.1016/0001-706X(94)90074-4; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SNOW RW, 2002, ESSENTIAL MALARIOLOG, P97; Tanner M, 2008, B WORLD HEALTH ORGAN, V86, P82, DOI 10.2471/BLT.07.050633; Taylor T, 2006, T ROY SOC TROP MED H, V100, P615, DOI 10.1016/j.trstmh.2005.09.021; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; THUMA PE, MALARIA ADMISSIONS M; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Trape JF, 1996, PARASITOL TODAY, V12, P236, DOI 10.1016/0169-4758(96)10015-6; Varandas L, 2001, ANN TROP PAEDIATR, V21, P211, DOI 10.1080/02724930120077781; VELEMA JP, 1991, T ROY SOC TROP MED H, V85, P430, DOI 10.1016/0035-9203(91)90206-E; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; Ye Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-46	103	176	176	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8988	10.1371/journal.pone.0008988	http://dx.doi.org/10.1371/journal.pone.0008988			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126547	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000274209700014
J	Roux, O; Billen, J; Orivel, J; Dejean, A				Roux, Olivier; Billen, Johan; Orivel, Jerome; Dejean, Alain			An Overlooked Mandibular-Rubbing Behavior Used during Recruitment by the African Weaver Ant, Oecophylla longinoda	PLOS ONE			English	Article							FRUIT-FLIES DIPTERA; LATREILLE HYMENOPTERA; PREDATORY BEHAVIOR; FORMICIDAE; TEPHRITIDAE; PHEROMONES	In Oecophylla, an ant genus comprising two territorially dominant arboreal species, workers are known to (1) use anal spots to mark their territories, (2) drag their gaster along the substrate to deposit short-range recruitment trails, and (3) drag the extruded rectal gland along the substrate to deposit the trails used in long-range recruitment. Here we study an overlooked but important marking behavior in which O. longinoda workers first rub the underside of their mandibles onto the substrate, and then-in a surprising posture-tilt their head and also rub the upper side of their mandibles. We demonstrate that this behavior is used to recruit nestmates. Its frequency varies with the rate at which a new territory, a sugary food source, a prey item, or an alien ant are discovered. Microscopy analyses showed that both the upper side and the underside of the mandibles possess pores linked to secretory glands. So, by rubbing their mandibles onto the substrate, the workers probably spread a secretion from these glands that is involved in nestmate recruitment.	[Roux, Olivier; Dejean, Alain] CNRS, UMR, Kourou, France; [Billen, Johan] Univ Leuven, Inst Zool, Entomol Lab, Leuven, Belgium; [Orivel, Jerome] CNRS, UMR, Lab Evolut & Diversite Biol, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); KU Leuven; Centre National de la Recherche Scientifique (CNRS)	Roux, O (corresponding author), CNRS, UMR, Kourou, France.	oroux@cict.fr	Orivel, Jerome/C-4034-2011; Roux, Olivier/A-1181-2011; Roux, Olivier/I-5675-2016	Orivel, Jerome/0000-0002-5636-3228; Dejean, Alain/0000-0002-3561-2248; Roux, Olivier/0000-0001-5440-0219; Billen, Johan/0000-0002-2392-7293	French Centre National de la Recherche Scientifique [2ID]	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Support for this study was provided by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUGNON G, 1992, INSECT SOC, V39, P341, DOI 10.1007/BF01323954; Bluthgen N, 2007, AUSTRAL ECOL, V32, P93, DOI 10.1111/j.1442-9993.2007.01744.x; BRADSHAW JWS, 1975, NATURE, V258, P230, DOI 10.1038/258230a0; BRADSHAW JWS, 1978, PHYSIOL ENTOMOL, P15; DEJEAN A, 1991, ETHOLOGY, V88, P89; Dejean A, 1996, OECOLOGIA, V106, P57, DOI 10.1007/BF00334407; DEJEAN A, 1990, WESTV STUD, P472; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; Dejean A, 2007, CR BIOL, V330, P701, DOI 10.1016/j.crvi.2007.06.005; HOLLDOBLER B, 1977, P NATL ACAD SCI USA, V74, P2072, DOI 10.1073/pnas.74.5.2072; HOLLDOBLER B, 1983, BIOTROPICA, V15, P241, DOI 10.2307/2387648; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P163, DOI 10.1007/BF00354978; HOLLDOBLER B, 1978, BEHAV ECOL SOCIOBIOL, V3, P19, DOI 10.1007/BF00300045; Holldobler B., 1990, pi; Kenne M, 2000, ENTOMOL EXP APPL, V94, P31, DOI 10.1023/A:1003900925341; Madi Y., 2006, ENTOMOTROPICA, V21, P117; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Offenberg J, 2007, INSECT SOC, V54, P248, DOI 10.1007/s00040-007-0938-5; Offenberg J, 2006, FUNCT ECOL, V20, P52, DOI 10.1111/j.1365-2435.2005.01059.x; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Peacor SD, 2001, P NATL ACAD SCI USA, V98, P3904, DOI 10.1073/pnas.071061998; Richard FJ, 2001, J INSECT BEHAV, V14, P271, DOI 10.1023/A:1007845929801; SCHOETERS E, 1994, ZOOMORPHOLOGY, V114, P125, DOI 10.1007/BF00396645; Van Mele P, 2008, AGR FOREST ENTOMOL, V10, P13, DOI 10.1111/j.1461-9563.2007.00350.x; Van Mele P, 2007, J ECON ENTOMOL, V100, P695, DOI 10.1603/0022-0493(2007)100[695:EOAAWA]2.0.CO;2; Van Mele P, 2009, PHYSIOL ENTOMOL, V34, P256, DOI 10.1111/j.1365-3032.2009.00685.x	26	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8957	10.1371/journal.pone.0008957	http://dx.doi.org/10.1371/journal.pone.0008957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126536	Green Submitted, Green Published, gold			2022-12-27	WOS:000274209700003
J	Langer, CCH; Ejsmont, RK; Schonbauer, C; Schnorrer, F; Tomancak, P				Langer, Christoph C. H.; Ejsmont, Radoslaw K.; Schoenbauer, Cornelia; Schnorrer, Frank; Tomancak, Pavel			In Vivo RNAi Rescue in Drosophila melanogaster with Genomic Transgenes from Drosophila pseudoobscura	PLOS ONE			English	Article							GENE; EXPRESSION; PROTEINS; ELEMENTS; DATABASE	Backgroud: Systematic, large-scale RNA interference (RNAi) approaches are very valuable to systematically investigate biological processes in cell culture or in tissues of organisms such as Drosophila. A notorious pitfall of all RNAi technologies are potential false positives caused by unspecific knock-down of genes other than the intended target gene. The ultimate proof for RNAi specificity is a rescue by a construct immune to RNAi, typically originating from a related species. Methodology/Principal Findings: We show that primary sequence divergence in areas targeted by Drosophila melanogaster RNAi hairpins in five non-melanogaster species is sufficient to identify orthologs for 81% of the genes that are predicted to be RNAi refractory. We use clones from a genomic fosmid library of Drosophila pseudoobscura to demonstrate the rescue of RNAi phenotypes in Drosophila melanogaster muscles. Four out of five fosmid clones we tested harbour cross-species functionality for the gene assayed, and three out of the four rescue a RNAi phenotype in Drosophila melanogaster. Conclusions/Significance: The Drosophila pseudoobscura fosmid library is designed for seamless cross-species transgenesis and can be readily used to demonstrate specificity of RNAi phenotypes in a systematic manner.	[Langer, Christoph C. H.; Schoenbauer, Cornelia; Schnorrer, Frank] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Ejsmont, Radoslaw K.; Tomancak, Pavel] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society; Max Planck Society	Langer, CCH (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	schnorrer@biochem.mpg.de; tomancak@mpi-cbg.de	Schnorrer, Frank/AIE-3578-2022; Tomancak, Pavel/C-2109-2009	Schnorrer, Frank/0000-0002-9518-7263; Tomancak, Pavel/0000-0002-2222-9370; Ejsmont, Radoslaw/0000-0001-7176-7848; Langer, Christoph C. H./0000-0001-8751-1564	Max-Planck Society; Human Frontier Science Program	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Program(Human Frontier Science Program)	This work was supported by the Max-Planck Society and the Human Frontier Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2008, MOL BIOL CELL, V19, P4287, DOI 10.1091/mbc.E08-02-0182; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Bird AW, 2008, J CELL BIOL, V182, P289, DOI 10.1083/jcb.200802005; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619; Burkart C, 2007, J MOL BIOL, V367, P953, DOI 10.1016/j.jmb.2007.01.059; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; EJSMONT RK, 2009, NAT METHODS; FESSLER LI, 1994, METHOD ENZYMOL, V245, P271; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; KONDO S, 2009, CROSS SPECIES RNAI R; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; MONTANEZ E, 2009, EMBO J; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perrimon N, 2007, FLY, V1, P1; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; SAIDE JD, 1989, J CELL BIOL, V109, P2157, DOI 10.1083/jcb.109.5.2157; Sarov M, 2005, TRENDS BIOTECHNOL, V23, P446, DOI 10.1016/j.tibtech.2005.06.007; Sarov M, 2006, NAT METHODS, V3, P839, DOI 10.1038/nmeth933; Schmid Andreas, 2008, V420, P239, DOI 10.1007/978-1-59745-583-1_14; SCHNORRER F, 2010, SYSTEMATIC GENETIC A; Schnorrer F, 2007, DEV CELL, V12, P751, DOI 10.1016/j.devcel.2007.02.017; Schulz JG, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp450; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483	45	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8928	10.1371/journal.pone.0008928	http://dx.doi.org/10.1371/journal.pone.0008928			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126626	Green Published, gold			2022-12-27	WOS:000274138000007
J	Dong, J; Gao, YP; Liu, Y; Shi, JX; Feng, JN; Li, ZG; Pan, HP; Xue, YN; Liu, CA; Shen, BF; Shao, NS; Yang, G				Dong, Jie; Gao, Yaping; Liu, Yu; Shi, Jinxia; Feng, Jiannan; Li, Zhanguo; Pan, Heping; Xue, Yanning; Liu, Chuan; Shen, Beifen; Shao, Ningsheng; Yang, Guang			The Protective Antibodies Induced by a Novel Epitope of Human TNF-alpha Could Suppress the Development of Collagen-Induced Arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; HUMAN-DISEASES; ANTAGONIST; ADALIMUMAB; INHIBITOR; BLOCKADE; EFFICACY; THERAPY; SAFETY	Tumor necrosis factor alpha (TNF-alpha) is a major inflammatory mediator that exhibits actions leading to tissue destruction and hampering recovery from damage. At present, two antibodies against human TNF-alpha (hTNF-alpha) are available, which are widely used for the clinic treatment of certain inflammatory diseases. This work was undertaken to identify a novel functional epitope of hTNF-alpha. We performed screening peptide library against anti-hTNF-alpha antibodies, ELISA and competitive ELISA to obtain the epitope of hTNF-alpha. The key residues of the epitope were identified by means of combinatorial alanine scanning and site-specific mutagenesis. The N terminus (80-91 aa) of hTNF-alpha proved to be a novel epitope (YG1). The two amino acids of YG1, proline and valine, were identified as the key residues, which were important for hTNF-alpha biological function. Furthermore, the function of the epitope was addressed on an animal model of collagen-induced arthritis (CIA). CIA could be suppressed in an animal model by prevaccination with the derivative peptides of YG1. The antibodies of YG1 could also inhibit the cytotoxicity of hTNF-alpha. These results demonstrate that YG1 is a novel epitope associated with the biological function of hTNF-alpha and the antibodies against YG1 can inhibit the development of CIA in animal model, so it would be a potential target of new therapeutic antibodies.	[Dong, Jie; Gao, Yaping; Liu, Yu; Feng, Jiannan; Pan, Heping; Xue, Yanning; Liu, Chuan; Shen, Beifen; Shao, Ningsheng; Yang, Guang] Beijing Inst Basic Med Sci, Beijing, Peoples R China; [Shi, Jinxia; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Academy of Military Medical Sciences - China; Peking University	Dong, J (corresponding author), Beijing Inst Basic Med Sci, Beijing, Peoples R China.	shaons@hotmail.com; yanggg@hotmail.com			Chinese National Key Program on Basic Research [2010CB529100]; National Natural Science Foundation of China [30700007, 30870093]; National High-Tech Research and Development Program [2006AA02Z132, 2006AA02Z323, 2006AA02A253]	Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program(National High Technology Research and Development Program of China)	This work was supported by grants from the Chinese National Key Program on Basic Research (2010CB529100, http://www.973.gov.cn/English/Index.aspx), the National Natural Science Foundation of China (30700007, 30870093, http://www.nsfc.gov.cn/nsfc2009/index.htm) and the National High-Tech Research and Development Program (2006AA02Z132, 2006AA02Z323, 2006AA02A253, http://www.863.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; Bombardieri S, 2007, RHEUMATOLOGY, V46, P1191, DOI 10.1093/rheumatology/kem091; CHIARA B, 2009, AUTOIMMUN REV, V8, P260; Daniel T., 2008, PHARMACOL THERAPEUT, V117, P244; DIGIOVINE FS, 1988, ANN RHEUM DIS, V47, P768, DOI 10.1136/ard.47.9.768; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362; FIRESTEIN GS, 1990, J IMMUNOL, V144, P3347; Fisher MC, 2009, NAT REV RHEUMATOL, V5, P288, DOI 10.1038/nrrheum.2009.51; Gibbons LJ, 2009, BIODRUGS, V23, P111, DOI 10.2165/00063030-200923020-00004; LARS K, 2009, LANCET, V373, P659; Lin J, 2008, CLIN IMMUNOL, V126, P13, DOI 10.1016/j.clim.2007.08.012; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Nanki T, 2004, J IMMUNOL, V173, P7010, DOI 10.4049/jimmunol.173.11.7010; Nishikawa M, 2003, ARTHRITIS RHEUM-US, V48, P2670, DOI 10.1002/art.11227; Reed C, 1997, PROTEIN ENG, V10, P1101, DOI 10.1093/protein/10.10.1101; ROBERTO C, 2009, AUTOIMMUN REV, V8, P274; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; Schiff MH, 2006, ANN RHEUM DIS, V65, P889, DOI 10.1136/ard.2005.043166; Setoguchi S, 2006, ARTHRITIS RHEUM-US, V54, P2757, DOI 10.1002/art.22056; Shibata H, 2008, J BIOL CHEM, V283, P998, DOI 10.1074/jbc.M707933200; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Waksman Y, 1996, CLIN EXP IMMUNOL, V103, P376; Wong M, 2008, CLIN IMMUNOL, V126, P121, DOI 10.1016/j.clim.2007.08.013	24	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8920	10.1371/journal.pone.0008920	http://dx.doi.org/10.1371/journal.pone.0008920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111721	Green Published, Green Submitted, gold			2022-12-27	WOS:000274114800022
J	Guerra, L; Albihn, A; Tronnersjo, S; Yan, QZ; Guidi, R; Stenerlow, B; Sterzenbach, T; Josenhans, C; Fox, JG; Schauer, DB; Thelestam, M; Larsson, LG; Henriksson, M; Frisan, T				Guerra, Lina; Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Guidi, Riccardo; Stenerlow, Bo; Sterzenbach, Torsten; Josenhans, Christine; Fox, James G.; Schauer, David B.; Thelestam, Monica; Larsson, Lars-Gunnar; Henriksson, Marie; Frisan, Teresa			Myc Is Required for Activation of the ATM-Dependent Checkpoints in Response to DNA Damage	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; C-MYC; INDUCED APOPTOSIS; TRANSCRIPTIONAL CONTROL; CANCER-CELLS; P53; ARREST; ALTERS; BAX; ONCOGENES	Background: The MYC protein controls cellular functions such as differentiation, proliferation, and apoptosis. In response to genotoxic agents, cells overexpressing MYC undergo apoptosis. However, the MYC-regulated effectors acting upstream of the mitochondrial apoptotic pathway are still unknown. Principal Findings: In this study, we demonstrate that expression of Myc is required to activate the Ataxia telangiectasia mutated (ATM)-dependent DNA damage checkpoint responses in rat cell lines exposed to ionizing radiation (IR) or the bacterial cytolethal distending toxin (CDT). Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc. Knock down of the endogenous levels of MYC by siRNA in the human cell line HCT116 resulted in decreased ATM and CHK2 phosphorylation in response to irradiation. Conversely, cell death induced by UV irradiation, known to activate the ATR-dependent checkpoint, was similar in all the cell lines, independently of the myc status. Conclusion: These data demonstrate that MYC contributes to the activation of the ATM-dependent checkpoint responses, leading to cell death in response to specific genotoxic stimuli.	[Guerra, Lina; Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Guidi, Riccardo; Thelestam, Monica; Larsson, Lars-Gunnar; Henriksson, Marie; Frisan, Teresa] Karolinska Inst, Dept Cell Biol, Stockholm, Sweden; [Guerra, Lina; Guidi, Riccardo; Thelestam, Monica; Frisan, Teresa] Karolinska Inst, Dept Mol Biol, Stockholm, Sweden; [Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Larsson, Lars-Gunnar; Henriksson, Marie] Karolinska Inst, Dept Microbiol, Stockholm, Sweden; [Albihn, Ami; Tronnersjo, Susanna; Yan, Qinzi; Larsson, Lars-Gunnar; Henriksson, Marie] Karolinska Inst, Dept Tumor Biol, S-10401 Stockholm, Sweden; [Stenerlow, Bo] Uppsala Univ, Rudbeck Lab, Div Biomed Radiat Sci, Uppsala, Sweden; [Sterzenbach, Torsten; Josenhans, Christine] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-3000 Hannover, Germany; [Fox, James G.; Schauer, David B.] MIT, Div Comparat Med, Dept Biol Engn, Cambridge, MA 02139 USA; [Larsson, Lars-Gunnar] Swedish Univ Agr Sci, Dept Plant Biol & Forest Genet, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Uppsala University; Hannover Medical School; Massachusetts Institute of Technology (MIT); Swedish University of Agricultural Sciences	Guerra, L (corresponding author), Karolinska Inst, Dept Cell Biol, Stockholm, Sweden.	Teresa.Frisan@ki.se	Henriksson, Marie Arsenian/F-5010-2015; Larsson, Lars-Gunnar/D-9747-2012; Frisan, Teresa/H-8444-2019	Frisan, Teresa/0000-0002-1209-0942; Arsenian Henriksson, Marie/0000-0001-6376-7792; Guidi, Riccardo/0000-0002-1033-0252	Swedish Research Council; Swedish Cancer Society; Ake Wiberg Foundation; Karolinska Institutet; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Ake Wiberg Foundation; Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work has been supported by the Swedish Research Council, the Swedish Cancer Society, the Ake Wiberg Foundation, and the Karolinska Institutet to TF, and by the Swedish Cancer Society and the Karolinska Institutet to MH and LGL. TF and MH are supported by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2001, MOL CELL BIOL, V21, P4929, DOI 10.1128/MCB.21.15.4929-4937.2001; Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Afanasyeva EA, 2007, INT J CANCER, V121, P2615, DOI 10.1002/ijc.22974; Albihn A, 2007, INT J CANCER, V121, P1821, DOI 10.1002/ijc.22866; Albihn A, 2006, J CELL BIOCHEM, V98, P1597, DOI 10.1002/jcb.20816; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bush A, 1998, GENE DEV, V12, P3797, DOI 10.1101/gad.12.24.3797; Chiang YC, 2003, J BIOL CHEM, V278, P19286, DOI 10.1074/jbc.M212043200; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Juin P, 2002, MOL CELL BIOL, V22, P6158, DOI 10.1128/MCB.22.17.6158-6169.2002; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lax AJ, 2005, NAT REV MICROBIOL, V3, P343, DOI 10.1038/nrmicro1130; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Maclean KH, 2007, MOL CANCER RES, V5, P705, DOI 10.1158/1541-7786.MCR-07-0058; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Radford IR, 1999, INT J RADIAT BIOL, V75, P521, DOI 10.1080/095530099140168; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Reimann M, 2007, BLOOD, V110, P2996, DOI 10.1182/blood-2007-02-075614; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sheen JH, 2003, BRIT J CANCER, V89, P1479, DOI 10.1038/sj.bjc.6601307; Sheen JH, 2002, MOL CELL BIOL, V22, P1819, DOI 10.1128/MCB.22.6.1819-1833.2002; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Soucie EL, 2001, MOL CELL BIOL, V21, P4725, DOI 10.1128/MCB.21.14.4725-4736.2001; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Thelestam M, 2005, REV PHYSIOL BIOCH P, V152, P111, DOI 10.1007/s10254-004-0030-8; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015	44	53	54	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8924	10.1371/journal.pone.0008924	http://dx.doi.org/10.1371/journal.pone.0008924			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111719	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800025
J	Lei, K; Cushing, BS; Musatov, S; Ogawa, S; Kramer, KM				Lei, Kelly; Cushing, Bruce S.; Musatov, Sergei; Ogawa, Sonoko; Kramer, Kristin M.			Estrogen Receptor-alpha in the Bed Nucleus of the Stria Terminalis Regulates Social Affiliation in Male Prairie Voles (Microtus ochrogaster)	PLOS ONE			English	Article							PATERNAL BEHAVIOR; VENTROMEDIAL NUCLEUS; NEONATAL CASTRATION; NEURAL ACTIVATION; FOS EXPRESSION; VASOPRESSIN; FEMALE; AGGRESSION; AMYGDALA; TESTOSTERONE	Estrogen receptor alpha (ER alpha) typically masculinizes male behavior, while low levels of ER alpha in the medial amygdala (MeA) and the bed nucleus of the stria terminalis (BST) are associated with high levels of male prosocial behavior. In the males of the highly social prairie vole (Microtus ochrogaster), increasing ER alpha in the MeA inhibited the expression of spontaneous alloparental behavior and produced a preference for novel females. To test for the effects of increased ER alpha in the BST, a viral vector was used to enhance ER alpha expression in the BST of adult male prairie voles. Following treatment, adult males were tested for alloparental behavior with 1-3-day- old pups, and for heterosexual social preference and affiliation. Treatment did not affect alloparental behavior as 73% of ER alpha-BST males and 62.5% of control males were alloparental. Increasing ER alpha in the BST affected heterosexual affiliation, with ER alpha-BST males spending significantly less total time in side-by-side contact with females relative to time spent with control males. ER alpha-BST males did not show a preference for either the familiar or novel female. These findings differed significantly from those reported in ER alpha-MeA enhanced males, where ER alpha inhibited alloparental behavior and produced a preference for a novel female. The findings from this study suggest two things: first, that increased ER alpha in the BST decreases social affiliation and second, that altering ER alpha in different regions of the social neural circuit differentially impacts the expression of social behavior.	[Lei, Kelly; Kramer, Kristin M.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA; [Cushing, Bruce S.] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Cushing, Bruce S.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Musatov, Sergei] Rockefeller Univ, Neurobiol & Behav Lab, Neurologix Inc, New York, NY 10021 USA; [Ogawa, Sonoko] Univ Tsukuba, Kansei Behav & Brain Sci Grad Sch Comprehens Huma, Tsukuba, Ibaraki, Japan	University of Memphis; University System of Ohio; University of Akron; University System of Ohio; University of Akron; Rockefeller University; University of Tsukuba	Lei, K (corresponding author), Florida State Univ, Dept Psychol, Program Neurosci, Tallahassee, FL 32306 USA.	cbruce@uakron.edu			University of Memphis; National Institute of Mental Health [MH-01992]; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH001992] Funding Source: NIH RePORTER	University of Memphis; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by funds provided by the University of Memphis (KMK) and a grant from the National Institute of Mental Health MH-01992 (BSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bester-Meredith JK, 2001, HORM BEHAV, V40, P51, DOI 10.1006/hbeh.2001.1666; Bester-Meredith JK, 1999, HORM BEHAV, V36, P25, DOI 10.1006/hbeh.1999.1522; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; Cooke BM, 2003, HORM BEHAV, V43, P336, DOI 10.1016/S0018-506X(02)00047-8; Curtis JT, 2003, PHYSIOL BEHAV, V80, P95, DOI 10.1016/S0031-9384(03)00226-9; Cushing BS, 2008, J NEUROSCI, V28, P10399, DOI 10.1523/JNEUROSCI.1928-08.2008; Cushing BS, 2006, J COMP NEUROL, V494, P595, DOI 10.1002/cne.20826; Cushing BS, 2005, NEUROSCI BIOBEHAV R, V29, P1089, DOI 10.1016/j.neubiorev.2005.04.001; Cushing BS, 2004, BRAIN RES, V1016, P247, DOI 10.1016/j.brainres.2004.05.010; Cushing BS, 2003, J NEUROENDOCRINOL, V15, P1021, DOI 10.1046/j.1365-2826.2003.01097.x; Cushing BS, 2003, BRAIN RES, V965, P203, DOI 10.1016/S0006-8993(02)04199-9; DeVries AC, 1996, P NATL ACAD SCI USA, V93, P11980, DOI 10.1073/pnas.93.21.11980; DeVries GJ, 1997, ANN NY ACAD SCI, V807, P273; EHERT G, 1993, NEUROREPORT, V11, P1247; Ferguson JN, 2001, J NEUROSCI, V21, P8278; Frazier CRM, 2006, HORM BEHAV, V50, P699, DOI 10.1016/j.yhbeh.2006.06.035; Gobrogge KL, 2007, J COMP NEUROL, V502, P1109, DOI 10.1002/cne.21364; HNATCZUK OC, 1994, J NEUROENDOCRINOL, V6, P89, DOI 10.1111/j.1365-2826.1994.tb00558.x; Keverne EB, 2004, CURR OPIN NEUROBIOL, V14, P777, DOI 10.1016/j.conb.2004.10.006; KIRKPATRICK B, 1994, BEHAV NEUROSCI, V108, P501, DOI 10.1037/0735-7044.108.3.501; KIRKPATRICK B, 1994, BRAIN RES, V658, P112, DOI 10.1016/S0006-8993(09)90016-6; Liu Y, 2001, BEHAV NEUROSCI, V115, P910, DOI 10.1037//0735-7044.115.4.910; Lonstein JS, 2002, HORM BEHAV, V41, P80, DOI 10.1006/hbeh.2001.1740; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Patisaul HB, 2008, HORM BEHAV, V53, P580, DOI 10.1016/j.yhbeh.2008.01.008; Patisaul HB, 2009, BEHAV BRAIN RES, V196, P317, DOI 10.1016/j.bbr.2008.09.026; Pfaus JG, 1997, BRAIN RES BULL, V44, P397, DOI 10.1016/S0361-9230(97)00219-0; Rasia-Filho AA, 2000, J PSYCHIATR NEUROSCI, V25, P14; Rissman EF, 1999, BRAIN RES, V835, P80, DOI 10.1016/S0006-8993(99)01452-3; Roberts RL, 1998, ANIM BEHAV, V55, P1131, DOI 10.1006/anbe.1997.0659; Schultz KN, 2009, J NEUROSCI, V29, P1897, DOI 10.1523/JNEUROSCI.4647-08.2009; Trezza V, 2009, J NEUROSCI, V29, P1, DOI 10.1523/JNEUROSCI.5193-08.2009; WANG ZX, 1993, BRAIN RES, V631, P156, DOI 10.1016/0006-8993(93)91203-5; Wang ZX, 1997, BRAIN RES, V767, P321, DOI 10.1016/S0006-8993(97)00617-3; Wersinger SR, 1997, HORM BEHAV, V32, P176, DOI 10.1006/hbeh.1997.1419; YAHR P, 1994, PSYCHONEUROENDOCRINO, V19, P463, DOI 10.1016/0306-4530(94)90033-7; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327	40	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8931	10.1371/journal.pone.0008931	http://dx.doi.org/10.1371/journal.pone.0008931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111713	Green Published, gold, Green Submitted			2022-12-27	WOS:000274114800027
J	Groves, B; Abrahamsen, H; Clingan, H; Frantz, M; Mavor, L; Bailey, J; Ma, D				Groves, Benjamin; Abrahamsen, Hilde; Clingan, Heather; Frantz, Michael; Mavor, Lauren; Bailey, Jeffrey; Ma, Dzwokai			An Inhibitory Role of the G-Protein Regulator AGS3 in mTOR-Dependent Macroautophagy	PLOS ONE			English	Article							ALPHA-INTERACTING PROTEIN; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA-SUBUNITS; TETRATRICOPEPTIDE REPEAT; AUTOPHAGOSOME FORMATION; MEDIATED INDUCTION; MAMMALIAN HOMOLOG; GOLGI MEMBRANES; HT-29 CELLS; GPR MOTIFS	Macroautophagy is a cellular process whereby the cell sequesters and recycles cytosolic constituents in a lysosome-dependent manner. It has also been implicated in a number of disorders, including cancer and neurodegeneration. Although a previous report that AGS3 over-expression promotes macroautophagy suggests a stimulatory role of AGS3 in this process, we have found that knock-down of AGS3, unexpectedly, also induces macroautophagy, indicating an inhibitory function of endogenous AGS3 in macroautophagy. Interestingly, AGS3 phosphorylation is decreased upon induction of mammalian target of rapamycin (mTOR)-dependent macroautophagy. Moreover, unlike wild-type AGS3, over-expression of an AGS3 mutant lacking this modification fails to enhance macroautophagic activity. These observations imply that AGS3 phosphorylation may participate in the modulation of macroautophagy.	[Groves, Benjamin; Clingan, Heather; Frantz, Michael; Mavor, Lauren; Bailey, Jeffrey; Ma, Dzwokai] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Groves, Benjamin; Bailey, Jeffrey; Ma, Dzwokai] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Abrahamsen, Hilde] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Abrahamsen, Hilde] Univ Oslo, Fac Med, Ctr Canc Biomed, Oslo, Norway	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Oslo; University of Oslo	Groves, B (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	ma@lifesci.ucsb.edu	Abrahamsen, Hilde/E-5323-2010	/0000-0002-6129-2938	American Heart Association (AHA) [07651554]; National Alliance for Research on Schizophrenia and Depression (NARSAD)	American Heart Association (AHA)(American Heart Association); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD)	This work was supported in part by the American Heart Association (AHA) award (#07651554) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) 2008 Young Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; BARR FA, 1991, FEBS LETT, V294, P239, DOI 10.1016/0014-5793(91)81438-E; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DEALMEIDA JB, 1994, J CELL SCI, V107, P507; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kochl R, 2006, TRAFFIC, V7, P129, DOI 10.1111/j.1600-0854.2005.00368.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Lanier SM, 2004, BIOL CELL, V96, P369, DOI 10.1016/j.biolcel.2004.03.012; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; OGIERDENIS E, 1995, J BIOL CHEM, V270, P13, DOI 10.1074/jbc.270.1.13; Pattingre S, 2004, METHOD ENZYMOL, V390, P17; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; Petiot A, 1999, BIOCHEM J, V337, P289, DOI 10.1042/0264-6021:3370289; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Rani MRS, 2002, J BIOL CHEM, V277, P38456, DOI 10.1074/jbc.M203204200; Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Smith DF, 2004, CELL STRESS CHAPERON, V9, P109, DOI 10.1379/CSC-31.1; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172	60	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8877	10.1371/journal.pone.0008877	http://dx.doi.org/10.1371/journal.pone.0008877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126274	gold, Green Published, Green Submitted			2022-12-27	WOS:000273896500006
J	Parmakelis, A; Moustaka, M; Poulakakis, N; Louis, C; Slotman, MA; Marshall, JC; Awono-Ambene, PH; Antonio-Nkondjio, C; Simard, F; Caccone, A; Powell, JR				Parmakelis, Aristeidis; Moustaka, Marina; Poulakakis, Nikolaos; Louis, Christos; Slotman, Michel A.; Marshall, Jonathon C.; Awono-Ambene, Parfait H.; Antonio-Nkondjio, Christophe; Simard, Frederic; Caccone, Adalgisa; Powell, Jeffrey R.			Anopheles Immune Genes and Amino Acid Sites Evolving Under the Effect of Positive Selection	PLOS ONE			English	Article							CODON-SUBSTITUTION MODELS; GAMBIAE SPECIES COMPLEX; QUANTITATIVE TRAIT LOCI; PLASMODIUM-FALCIPARUM; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; MALARIA INFECTION; INDIVIDUAL SITES; RECOMBINATION; SYSTEM	Background: It has long been the goal of vector biology to generate genetic knowledge that can be used to "manipulate'' natural populations of vectors to eliminate or lessen disease burden. While long in coming, progress towards reaching this goal has been made. Aiming to increase our understanding regarding the interactions between Plasmodium and the Anopheles immune genes, we investigated the patterns of genetic diversity of four anti-Plasmodium genes in the Anopheles gambiae complex of species. Methodology/Principal Findings: Within a comparative phylogenetic and population genetics framework, the evolutionary history of four innate immunity genes within the An. gambiae complex (including the two most important human malaria vectors, An. gambiae and An. arabiensis) is reconstructed. The effect of natural selection in shaping the genes' diversity is examined. Introgression and retention of ancestral polymorphisms are relatively rare at all loci. Despite the potential confounding effects of these processes, we could identify sites that exhibited dN/dS ratios greater than 1. Conclusions/Significance: In two of the studied genes, CLIPB14 and FBN8, several sites indicated evolution under positive selection, with CLIPB14 exhibiting the most consistent evidence. Considering only the sites that were consistently identified by all methods, two sites in CLIPB14 are adaptively driven. However, the analysis inferring the lineage-specific evolution of each gene was not in favor of any of the Anopheles lineages evolving under the constraints imposed by positive selection. Nevertheless, the loci and the specific amino acids that were identified as evolving under strong evolutionary pressure merit further investigation for their involvement in the Anopheles defense against microbes in general.	[Parmakelis, Aristeidis; Moustaka, Marina] Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece; [Parmakelis, Aristeidis; Poulakakis, Nikolaos; Louis, Christos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Parmakelis, Aristeidis; Poulakakis, Nikolaos; Marshall, Jonathon C.; Caccone, Adalgisa; Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA; [Louis, Christos] Fdn Res & Technol Heraklion, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Slotman, Michel A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Marshall, Jonathon C.] Weber State Univ, Dept Zool, Ogden, UT 84408 USA; [Awono-Ambene, Parfait H.; Antonio-Nkondjio, Christophe; Simard, Frederic] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Simard, Frederic] IRD, Bobo Dioulasso, Burkina Faso	National & Kapodistrian University of Athens; University of Crete; Yale University; Texas A&M University System; Texas A&M University College Station; Utah System of Higher Education; Weber State University; Institut de Recherche pour le Developpement (IRD)	Parmakelis, A (corresponding author), Univ Athens, Fac Biol, Dept Ecol & Taxon, Athens 11528, Greece.	aparmakel@biol.uoa.gr	SIMARD, Frederic/J-9489-2016; Poulakakis, Nikos/E-7848-2011; Caccone, Adalgisa/AAE-4238-2021; Louis, Christos/F-2527-2012; Parmakelis, Aristeidis/AAD-1162-2020; Marshall, Jonathon C./AGG-8101-2022; Frederic, SIMARD/AFV-5001-2022	SIMARD, Frederic/0000-0002-2871-5329; Caccone, Adalgisa/0000-0002-8949-9260; Parmakelis, Aristeidis/0000-0003-3092-4194; Frederic, SIMARD/0000-0002-2871-5329; Marshall, Jonathon/0000-0003-0955-4889; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [RO1 A1 046018]; Marie Curie [MOIF-CT-2006-021357]; University of Athens	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie(European Commission); University of Athens	This research was supported by the National Institutes of Health grant RO1 A1 046018 to J.R.P. and A. C. A. P. was supported by a Marie Curie Outgoing International Fellowship ( Contract No. MOIF-CT-2006-021357) and a "Kapodistrias'' Research Grant from the Research Secretariat of the University of Athens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anisimova M, 2003, GENETICS, V164, P1229; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; BESANSKY NJ, 2008, WHITE PAPER GENOME A; Capurro MD, 2000, AM J TROP MED HYG, V62, P427, DOI 10.4269/ajtmh.2000.62.427; Christophides GK, 2004, IMMUNOL REV, V198, P127, DOI 10.1111/j.0105-2896.2004.0127.x; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Donnelly MJ, 2004, HEREDITY, V92, P61, DOI 10.1038/sj.hdy.6800377; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; FELDMANN AM, 1986, TROP GEOGR MED, V38, P317; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; KALENDAR R, 2007, FASTPCR PCR PRIMER P; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lehmann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004549; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean GAT, 2001, HEREDITY, V87, P613, DOI 10.1046/j.1365-2540.2001.00965.x; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2001, HEREDITY, V86, P641, DOI 10.1046/j.1365-2540.2001.00895.x; Obbard DJ, 2007, MOL ECOL, V16, P3497, DOI 10.1111/j.1365-294X.2007.03395.x; Obbard DJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-117; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Parmakelis A, 2008, AM J TROP MED HYG, V78, P176, DOI 10.4269/ajtmh.2008.78.176; Parmakelis A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-79; Pond SK, 2005, MOL BIOL EVOL, V22, P2375, DOI 10.1093/molbev/msi232; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffler K, 2006, BIOINFORMATICS, V22, P2493, DOI 10.1093/bioinformatics/btl427; Simard F, 2007, INFECT GENET EVOL, V7, P285, DOI 10.1016/j.meegid.2006.11.004; Slotman MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000793; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; VERNICK KD, 1989, AM J TROP MED HYG, V40, P593, DOI 10.4269/ajtmh.1989.40.593; VERNICK KD, 1989, AM J TROP MED HYG, V40, P585, DOI 10.4269/ajtmh.1989.40.585; Volz J, 2005, J BIOL CHEM, V280, P40161, DOI 10.1074/jbc.M506191200; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8885	10.1371/journal.pone.0008885	http://dx.doi.org/10.1371/journal.pone.0008885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126662	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500009
J	Gomez-Varela, D; Kohl, T; Schmidt, M; Rubio, ME; Kawabe, H; Nehring, RB; Schafer, S; Stuhmer, W; Pardo, LA				Gomez-Varela, David; Kohl, Tobias; Schmidt, Manuela; Rubio, Maria E.; Kawabe, Hiroshi; Nehring, Ralf B.; Schaefer, Stephan; Stuehmer, Walter; Pardo, Luis A.			Characterization of Eag1 Channel Lateral Mobility in Rat Hippocampal Cultures by Single-Particle-Tracking with Quantum Dots	PLOS ONE			English	Article							SURFACE TRAFFICKING; AMPA RECEPTORS; ACTIN; CYTOSKELETON; ACTIVATION; DIFFUSION; DYNAMICS; EXPRESSION; FORM	Voltage-gated ion channels are main players involved in fast synaptic events. However, only slow intracellular mechanisms have so far been described for controlling their localization as real-time visualization of endogenous voltage-gated channels at high temporal and spatial resolution has not been achieved yet. Using a specific extracellular antibody and quantum dots we reveal and characterize lateral mobility as a faster mechanism to dynamically control the number of endogenous ether-a-go-go (Eag)1 ion channels inside synapses. We visualize Eag1 entering and leaving synapses by lateral diffusion in the plasma membrane of rat hippocampal neurons. Mathematical analysis of their trajectories revealed how the motion of Eag1 gets restricted when the channels diffuse into the synapse, suggesting molecular interactions between Eag1 and synaptic components. In contrast, Eag1 channels switch to Brownian movement when they exit synapses and diffuse into extrasynaptic membranes. Furthermore, we demonstrate that the mobility of Eag1 channels is specifically regulated inside synapses by actin filaments, microtubules and electrical activity. In summary, using single-particle-tracking techniques with quantum dots nanocrystals, our study shows for the first time the lateral diffusion of an endogenous voltage-gated ion channel in neurons. The location-dependent constraints imposed by cytoskeletal elements together with the regulatory role of electrical activity strongly suggest a pivotal role for the mobility of voltage-gated ion channels in synaptic activity.	[Gomez-Varela, David; Kohl, Tobias; Rubio, Maria E.; Stuehmer, Walter; Pardo, Luis A.] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Schmidt, Manuela] European Neurosci Inst, Gottingen, Germany; [Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Nehring, Ralf B.] Univ Texas Houston, Dept Neurosci, Houston, TX USA; [Nehring, Ralf B.] Univ Texas Houston, Dept Mol & Human Genet, Houston, TX USA; [Schaefer, Stephan] BIOTEC, Inst Biophys, Dresden, Germany; [Schmidt, Manuela; Stuehmer, Walter] Deutsch Forsch Gemeinschaft Res Ctr Mol Physiol B, Gottingen, Germany	Max Planck Society; Max Planck Society; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Technische Universitat Dresden	Gomez-Varela, D (corresponding author), Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, Hermann Rein Str 3, D-37075 Gottingen, Germany.	dgomezvarela@ucsd.edu	Kawabe, Hiroshi/U-7325-2018; Stuehmer, Walter/A-2176-2009; Pardo, Luis/C-5066-2013	Stuehmer, Walter/0000-0002-0642-7764; Pardo, Luis/0000-0003-1375-4349; Schmidt, Manuela/0000-0003-1972-3519	Max-Planck-Society; Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB); Japan Society for the Promotion of Science; Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core [HD024064]; EFRE-Fonds; Alexander-von-Humboldt-Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core; EFRE-Fonds; Alexander-von-Humboldt-Foundation(Alexander von Humboldt Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Max-Planck-Society (D. G. V., T. K., L. A. P. and W. S.), the Deutsche Forschungsgemeinschaft (DFG) Research Center for Molecular Physiology of the Brain (CMPB) (M. S. and W. S.), the Japan Society for the Promotion of Science (to H. K.), the Mental Retardation and Developmental Disabilities Research Center (MRDDRC) Mouse Physiology Core HD024064 (to R.B.N.), the EFRE-Fonds (to S. S.) and the Alexander-von-Humboldt-Foundation (to M. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bernstein BW, 1998, MOL BRAIN RES, V53, P236, DOI 10.1016/S0169-328X(97)00319-7; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Camacho J, 2000, PFLUG ARCH EUR J PHY, V441, P167, DOI 10.1007/s004240000420; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Clancy SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006330; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Jaskolski F, 2009, NEUROSCIENCE, V158, P19, DOI 10.1016/j.neuroscience.2008.01.075; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Mikasova L, 2008, P NATL ACAD SCI USA, V105, P18596, DOI 10.1073/pnas.0805959105; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; O'Malley D, 2005, FASEB J, V19, P1917, DOI 10.1096/fj.05-4166fje; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	41	35	37	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8858	10.1371/journal.pone.0008858	http://dx.doi.org/10.1371/journal.pone.0008858			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111597	Green Published, gold			2022-12-27	WOS:000273896300010
J	Baer, CF; Denver, DR				Baer, Charles F.; Denver, Dee R.			Spontaneous Mutations Decrease Sensitivity of Gene Expression to Random Environmental Variation in Caenorhabditis elegans	PLOS ONE			English	Article							SELECTION; EVOLUTION; CANALIZATION; PLASTICITY	Background: Biological phenotypes are described as "canalized'' if they are robust to minor variation of environment and/or genetic background. The existence of a robust phenotype logically implies that some underlying mechanism must be variable, in the sense of "able to vary'', in order to compensate for variation in the environment and/or genetic effects. Several lines of evidence lead to the conclusion that deleterious mutations predictably render morphological, developmental, and life-history traits more sensitive to small random environmental perturbations - that is, mutations de-canalize the phenotype. Methodology/Principal Findings: Using conventional dye-swap microarray methodology, we compared transcript abundance in a sample of >7,000 genes between four mutation accumulation (MA) lines of the nematode Caenorhabditis elegans and the common (unmutated) ancestor. There was significantly less environmental variance in the MA lines than in the ancestor, both among replicates of the same gene and among genes. Conclusions/Significance: Deleterious mutations consistently decrease the within-line component of variance in transcript abundance, which is straightforwardly interpreted as reducing the sensitivity of gene expression to small random variation in the environment. This finding is consistent with the idea that underlying variability in gene expression might be mechanistically responsible for phenotypic robustness.	[Baer, Charles F.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Baer, Charles F.] Univ Florida, Genet Inst, Gainesville, FL USA; [Denver, Dee R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Denver, Dee R.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Oregon State University; Oregon State University	Baer, CF (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.	cbaer@ufl.edu			NIH/NIGMS [1 R01GM072639-01A2]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072639] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH/NIGMS (http://www.nigms.nih.gov/) grant # 1 R01GM072639-01A2 to CFB (PI) and DRD (sub-contract). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer CF, 2008, AM NAT, V172, P272, DOI 10.1086/589455; Braendle C, 2008, DEV CELL, V15, P714, DOI 10.1016/j.devcel.2008.09.011; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; DUN RB, 1958, NATURE, V181, P1018, DOI 10.1038/1811018a0; Falconer D. S., 1989, QUANTITATIVE GENETIC, V3rd; Hill WG, 2004, GENET RES, V83, P121, DOI 10.1017/S0016672304006640; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; LYNCH M, 1998, SINAUER, V16, P980; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; MUKAI T, 1972, GENETICS, V72, P335; Ostrow D, 2007, GENETICS, V176, P1653, DOI 10.1534/genetics.107.074666; Proulx SR, 2005, AM NAT, V165, P147, DOI 10.1086/426873; Proulx SR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000911; RENDEL JM, 1959, EVOLUTION, V13, P425, DOI 10.1111/j.1558-5646.1959.tb03033.x; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Vassilieva LL, 1999, GENETICS, V151, P119; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 1997, EVOLUTION, V51, P329, DOI [10.2307/2411105, 10.1111/j.1558-5646.1997.tb02420.x]; Zhang XS, 2005, EVOLUTION, V59, P1237	24	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8750	10.1371/journal.pone.0008750	http://dx.doi.org/10.1371/journal.pone.0008750			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090917	Green Published, Green Submitted, gold			2022-12-27	WOS:000273715000009
J	Daubeuf, S; Aucher, A; Bordier, C; Salles, A; Serre, L; Gaibelet, G; Faye, JC; Favre, G; Joly, E; Hudrisier, D				Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Faye, Jean-Charles; Favre, Gilles; Joly, Etienne; Hudrisier, Denis			Preferential Transfer of Certain Plasma Membrane Proteins onto T and B Cells by Trogocytosis	PLOS ONE			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; ANTIGEN-PRESENTING CELLS; INTERCELLULAR TRANSFER; CUTTING EDGE; SURFACE MOLECULES; PROTEOMIC ANALYSIS; IMMUNE SYNAPSE; TARGET-CELLS; MHC; COMPLEXES	T and B cells capture antigens via membrane fragments of antigen presenting cells (APC) in a process termed trogocytosis. Whether (and how) a preferential transfer of some APC components occurs during trogocytosis is still largely unknown. We analyzed the transfer onto murine T and B cells of a large panel of fluorescent proteins with different intra-cellular localizations in the APC or various types of anchors in the plasma membrane (PM). Only the latter were transferred by trogocytosis, albeit with different efficiencies. Unexpectedly, proteins anchored to the PM's cytoplasmic face, or recruited to it via interaction with phosphinositides, were more efficiently transferred than those facing the outside of the cell. For proteins spanning the PM's whole width, transfer efficiency was found to vary quite substantially, with tetraspanins, CD4 and FcR gamma found among the most efficiently transferred proteins. We exploited our findings to set immunodiagnostic assays based on the capture of preferentially transferred components onto T or B cells. The preferential transfer documented here should prove useful in deciphering the cellular structures involved in trogocytosis.	[Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Joly, Etienne; Hudrisier, Denis] CNRS, IPBS, Toulouse, France; [Daubeuf, Sandrine; Aucher, Anne; Bordier, Christine; Salles, Audrey; Serre, Laurent; Gaibelet, Gerald; Joly, Etienne; Hudrisier, Denis] Univ Toulouse, UPS, IPBS, Toulouse, France; [Salles, Audrey] Ctr Immunol, Marseille Luminy, France; [Gaibelet, Gerald] Hop Purpan, INSERM, U563, Toulouse, France; [Faye, Jean-Charles; Favre, Gilles] Inst Claudius Regaud, INSERM, U563, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UDICE-French Research Universities; Aix-Marseille Universite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Claudius Regaud; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Daubeuf, S (corresponding author), CNRS, IPBS, Toulouse, France.	atn@cict.fr; denis.hudrisier@ipbs.fr	Joly, Etienne/A-5644-2009; FAVRE, Gilles/K-9189-2014	Joly, Etienne/0000-0002-7264-2681; FAVRE, Gilles/0000-0002-2344-1883; Hudrisier, Denis/0000-0002-3631-9561; Salles, Audrey/0000-0002-1890-6957	Agence Nationale pour la Recherche, ANR RIB; Region Midi-Pyrenes, Agro-Bio-Sante; CNRS	Agence Nationale pour la Recherche, ANR RIB(French National Research Agency (ANR)); Region Midi-Pyrenes, Agro-Bio-Sante; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funds from the Agence Nationale pour la Recherche, ANR RIB program (http://www.agence-nationale-recherche.fr/), Region Midi-Pyrenes, Agro-Bio-Sante program (http://www.midipyrenees.fr/) and CNRS (http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold PY, 1999, EUR J IMMUNOL, V29, P1363, DOI 10.1002/(SICI)1521-4141(199904)29:04<1363::AID-IMMU1363>3.0.CO;2-0; Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Barraud-Lange V, 2007, FASEB J, V21, P3446, DOI 10.1096/fj.06-8035hyp; Beadling C, 2006, NAT MED, V12, P1208, DOI 10.1038/nm1413; Beum PV, 2006, J IMMUNOL, V176, P2600, DOI 10.4049/jimmunol.176.4.2600; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; Busch A, 2008, J IMMUNOL, V181, P3965, DOI 10.4049/jimmunol.181.6.3965; Buschow SI, 2009, TRAFFIC, V10, P1528, DOI 10.1111/j.1600-0854.2009.00963.x; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DAUBEUF S, 2008, CYTOM PART A, V75, P380; Daubeuf Sandrine, 2007, Immunol Invest, V36, P687, DOI 10.1080/08820130701674596; Daubeuf S, 2006, NAT PROTOC, V1, P2536, DOI 10.1038/nprot.2006.400; Davis DM, 2008, NAT REV MOL CELL BIO, V9, P431, DOI 10.1038/nrm2399; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Delaguillaumie A, 2002, J CELL SCI, V115, P433; Fayolle C, 1999, J IMMUNOL, V162, P4157; Funakoshi T, 2003, ONCOGENE, V22, P674, DOI 10.1038/sj.onc.1206106; Gaibelet G, 2006, J BIOL CHEM, V281, P37921, DOI 10.1074/jbc.M607103200; Harshyne LA, 2003, J IMMUNOL, V170, P2302, DOI 10.4049/jimmunol.170.5.2302; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188; Hudrisier D, 2005, EUR J IMMUNOL, V35, P2284, DOI 10.1002/eji.200526266; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hudrisier D, 2002, FASEB J, V16, P477, DOI 10.1096/fj.01-0933rev; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Hudrisier D, 2009, J IMMUNOL, V183, P6102, DOI 10.4049/jimmunol.0900821; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Hwang I, 2001, J IMMUNOL, V166, P5099, DOI 10.4049/jimmunol.166.8.5099; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Joliot A, 2004, NAT CELL BIOL, V6, P189, DOI 10.1038/ncb0304-189; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; JOLY E, 2007, NAT PRECEDINGS; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Machlenkin A, 2008, CANCER RES, V68, P2006, DOI 10.1158/0008-5472.CAN-07-3119; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; McCabe JB, 1999, MOL BIOL CELL, V10, P3771, DOI 10.1091/mbc.10.11.3771; Miguet L, 2006, PROTEOMICS, V6, P153, DOI 10.1002/pmic.200500133; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Pardigon N, 2006, J IMMUNOL, V177, P1590, DOI 10.4049/jimmunol.177.3.1590; Patel DM, 2001, CELL IMMUNOL, V214, P21, DOI 10.1006/cimm.2002.1887; Patel DM, 1999, J IMMUNOL, V163, P5201; Patel DM, 2001, CELL IMMUNOL, V214, P165, DOI 10.1006/cimm.2001.1897; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Puaux AL, 2006, EUR J IMMUNOL, V36, P779, DOI 10.1002/eji.200535407; Quah BJC, 2008, P NATL ACAD SCI USA, V105, P4259, DOI 10.1073/pnas.0800259105; Rechavi O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001204; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Smyth LA, 2007, AM J TRANSPLANT, V7, P1442, DOI 10.1111/j.1600-6143.2007.01816.x; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; SPRENT J, 2005, SCI STKE, V273, P1; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tomaru U, 2003, NAT MED, V9, P469, DOI 10.1038/nm845; Toomre D, 1999, J CELL SCI, V112, P21; Vanherberghen B, 2004, P NATL ACAD SCI USA, V101, P16873, DOI 10.1073/pnas.0406240101; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wetzel SA, 2006, CRIT REV IMMUNOL, V26, P1; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Yu YYL, 2002, J IMMUNOL, V168, P3145, DOI 10.4049/jimmunol.168.7.3145	71	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8716	10.1371/journal.pone.0008716	http://dx.doi.org/10.1371/journal.pone.0008716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090930	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714600017
J	Lopez-Fontal, R; Zeini, M; Traves, PG; Gomez-Ferreria, M; Aranda, A; Saez, GT; Cerda, C; Martin-Sanz, P; Hortelano, S; Bosca, L				Lopez-Fontal, Raquel; Zeini, Miriam; Traves, Paqui G.; Gomez-Ferreria, Mariana; Aranda, Ana; Saez, Guillermo T.; Cerda, Concha; Martin-Sanz, Paloma; Hortelano, Sonsoles; Bosca, Lisardo			Mice Lacking Thyroid Hormone Receptor beta Show Enhanced Apoptosis and Delayed Liver Commitment for Proliferation after Partial Hepatectomy	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; RAT-LIVER; SYMMETRIC DIMETHYLARGININE; HEPATOCYTE PROLIFERATION; REGENERATING MOUSE; SURVIVAL FACTOR; REGULATORY ROLE; NITRIC-OXIDE; IN-VITRO; EXPRESSION	Background: The role of thyroid hormones and their receptors (TR) during liver regeneration after partial hepatectomy (PH) was studied using genetic and pharmacologic approaches. Roles in liver regeneration have been suggested for T3, but there is no clear evidence distinguishing the contribution of increased amounts of T3 from the modulation by unoccupied TRs. Methodology/Principal Findings: Mice lacking TR alpha 1/TR beta or TR beta alone fully regenerated liver mass after PH, but showed delayed commitment to the initial round of hepatocyte proliferation and transient but intense apoptosis at 48h post-PH, affecting similar to 30% of the remaining hepatocytes. Pharmacologically induced hypothyroidism yielded similar results. Loss of TR activity was associated with enhanced nitrosative stress in the liver remnant, due to an increase in the activity of the nitric oxide synthase (NOS) 2 and 3, caused by a transient decrease in the concentration of asymmetric dimethylarginine (ADMA), a potent NOS inhibitor. This decrease in the ADMA levels was due to the presence of a higher activity of dimethylarginineaminohydrolase-1 (DDAH-1) in the regenerating liver of animals lacking TR alpha 1/TR beta or TR beta. DDAH-1 expression and activity was paralleled by the activity of FXR, a transcription factor involved in liver regeneration and up-regulated in the absence of TR. Conclusions/Significance: We report that TRs are not required for liver regeneration; however, hypothyroid mice and TR beta-or TR alpha 1/TR beta-deficient mice exhibit a delay in the restoration of liver mass, suggesting a specific role for TRb in liver regeneration. Altered regenerative responses are related with a delay in the expression of cyclins D1 and E, and the occurrence of liver apoptosis in the absence of activated TRb that can be prevented by administration of NOS inhibitors. Taken together, these results indicate that TRb contributes significantly to the rapid initial round of hepatocyte proliferation following PH, and improves the survival of the regenerating liver at later times.	[Lopez-Fontal, Raquel; Zeini, Miriam; Hortelano, Sonsoles] CNIC, Madrid, Spain; [Traves, Paqui G.; Gomez-Ferreria, Mariana; Aranda, Ana; Martin-Sanz, Paloma; Bosca, Lisardo] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Saez, Guillermo T.; Cerda, Concha] Hosp Gen Univ, Dept Bioquim & Biol Mol, Serv Anal Clin, Valencia, Spain; [Martin-Sanz, Paloma; Bosca, Lisardo] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Clinic Universitari de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Lopez-Fontal, R (corresponding author), CNIC, Madrid, Spain.	shortelano@cnic.es; lbosca@iib.uam.es	G. Traves, Paqui/L-5693-2014; Bosca, Lisardo/A-2059-2008; Hortelano, Sonsoles/A-7954-2010; Martín-Sanz, Paloma/K-1303-2014; Aranda, Ana/ABG-8820-2020	G. Traves, Paqui/0000-0001-5749-8426; Bosca, Lisardo/0000-0002-0253-5469; Hortelano, Sonsoles/0000-0003-2528-0072; Aranda, Ana/0000-0002-8338-9589; Saez, Guillermo/0000-0002-8164-4048	MICINN [BFU2008-02161, BFU2007-62402, SAF2007-60511, SAF2007-60551]; Comunidad de Madrid [S-BIO-0283/2006]; FIS-RECAVA [RD06/0014/0025, PI05.0050, PI080070]; Fundacion Mutua Madrilea; Instituto de Salud Carlos III; Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation	MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); FIS-RECAVA; Fundacion Mutua Madrilea; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation	This work was supported by grants BFU2008-02161, BFU2007-62402, SAF2007-60511, and SAF2007-60551 from MICINN; S-BIO-0283/2006 from Comunidad de Madrid and FIS-RECAVA RD06/0014/0025 to L. B.; and PI05.0050, PI080070, and the Fundacion Mutua Madrilea to S. H. RECAVA and Ciberehd are funded by the Instituto de Salud Carlos III. R.L-F. is supported by a fellowship from Instituto de Salud Carlos III. The CNIC is supported by the Spanish Ministry of Science and Innovation and the Pro-CNIC Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisi A, 2005, CELL PHYSIOL BIOCHEM, V15, P69, DOI 10.1159/000083639; Callejas NA, 2000, GASTROENTEROLOGY, V119, P493, DOI 10.1053/gast.2000.9374; Chobanyan K, 2007, J CHROMATOGR B, V858, P32, DOI 10.1016/j.jchromb.2007.08.002; Dong H, 2007, ENDOCRINOLOGY, V148, P3932, DOI 10.1210/en.2007-0452; FALZACAPPA CV, 2006, J CELL PHYSIOL, V206, P309, DOI [10.1002/jcp.20460, DOI 10.1002/jcp.20460, DOI 10.1002/JCP.20460]; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Frey D, 2006, STRUCTURE, V14, P901, DOI 10.1016/j.str.2006.03.006; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Grant N, 2007, MED HYPOTHESES, V68, P641, DOI 10.1016/j.mehy.2006.07.045; Hoeke MO, 2009, HEPATOLOGY, V49, P151, DOI 10.1002/hep.22661; HORTELANO S, 1995, HEPATOLOGY, V21, P776; Hu TH, 2006, J BIOL CHEM, V281, P39831, DOI 10.1074/jbc.M606779200; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Jones SA, 2003, MOL CELL ENDOCRINOL, V199, P49, DOI 10.1016/S0303-7207(02)00296-4; Kariv R, 2003, LIVER INT, V23, P187, DOI 10.1034/j.1600-0676.2003.00827.x; Kester MHA, 2009, ENDOCRINOLOGY, V150, P540, DOI 10.1210/en.2008-0344; Kucharova Silvia, 2002, Endocr Regul, V36, P37; Kumar A, 2007, J HEPATOL, V46, P888, DOI 10.1016/j.jhep.2006.12.015; Laleman W, 2005, HEPATOLOGY, V42, P1382, DOI 10.1002/hep.20968; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Leiper J, 2007, NAT MED, V13, P198, DOI 10.1038/nm1543; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; Messarah M, 2007, CR BIOL, V330, P107, DOI 10.1016/j.crvi.2006.11.004; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mojena M, 2001, FASEB J, V15, P583; Nijveldt RJ, 2004, LIVER INT, V24, P510, DOI 10.1111/j.1478-3231.2004.0948.x; Nijveldt RJ, 2004, JPEN-PARENTER ENTER, V28, P382, DOI 10.1177/0148607104028006382; Palm F, 2007, AM J PHYSIOL-HEART C, V293, pH3227, DOI 10.1152/ajpheart.00998.2007; Pibiri M, 2001, FASEB J, V15, P1006, DOI 10.1096/fj.00-0416com; Pope AJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1679, DOI 10.1152/ajpcell.00224.2007; RODD C, 1992, ENDOCRINOLOGY, V131, P2559, DOI 10.1210/en.131.6.2559; Saelim N, 2007, APOPTOSIS, V12, P1781, DOI 10.1007/s10495-007-0109-1; SCHWARTZ HL, 1992, J BIOL CHEM, V267, P11794; Siroen MPC, 2005, HEPATOLOGY, V41, P559, DOI 10.1002/hep.20579; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; Sun YW, 2007, PROTEOMICS, V7, P4398, DOI 10.1002/pmic.200600913; Tien ES, 2007, J PHARMACOL EXP THER, V320, P307, DOI 10.1124/jpet.106.112706; Venditti P, 2006, CELL MOL LIFE SCI, V63, P414, DOI 10.1007/s00018-005-5457-9; Vizzutti F, 2007, EUR J CLIN INVEST, V37, P509, DOI 10.1111/j.1365-2362.2007.01814.x; Wang D, 2007, CIRC RES, V101, P627, DOI 10.1161/CIRCRESAHA.107.158915; Weiss RE, 1998, ENDOCRINOLOGY, V139, P4945, DOI 10.1210/en.139.12.4945; Wilcken DEL, 2007, MOL GENET METAB, V91, P309, DOI 10.1016/j.ymgme.2007.04.017; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Zeini M, 2005, FASEB J, V19, P995, DOI 10.1096/fj.04-3233fje	46	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8710	10.1371/journal.pone.0008710	http://dx.doi.org/10.1371/journal.pone.0008710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090848	Green Published, gold			2022-12-27	WOS:000273714600013
J	James, CG; Stanton, LA; Agoston, H; Ulici, V; Underhill, TM; Beier, F				James, Claudine G.; Stanton, Lee-Anne; Agoston, Hanga; Ulici, Veronica; Underhill, T. Michael; Beier, Frank			Genome-Wide Analyses of Gene Expression during Mouse Endochondral Ossification	PLOS ONE			English	Article							GROWTH-PLATE CHONDROCYTES; QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; SKELETAL DEVELOPMENT; CONNECTIVE TISSUES; MESSENGER-RNA; LINKAGE SCAN; LONG BONES; IN-VITRO; CARTILAGE	Background: Endochondral ossification is a complex process involving a series of events that are initiated by the establishment of a chondrogenic template and culminate in its replacement through the coordinated activity of osteoblasts, osteoclasts and endothelial cells. Comprehensive analyses of in vivo gene expression profiles during these processes are essential to obtain a complete understanding of the regulatory mechanisms involved. Methodology/Principal Findings: To address these issues, we completed a microarray screen of three zones derived from manually segmented embryonic mouse tibiae. Classification of genes differentially expressed between each respective zone, functional categorization as well as characterization of gene expression patterns, cytogenetic loci, signaling pathways and functional motifs both confirmed reported data and provided novel insights into endochondral ossification. Parallel comparisons of the microdissected tibiae data set with our previously completed micromass culture screen further corroborated the suitability of micromass cultures for modeling gene expression in chondrocyte development. The micromass culture system demonstrated striking similarities to the in vivo microdissected tibiae screen; however, the micromass system was unable to accurately distinguish gene expression differences in the hypertrophic and mineralized zones of the tibia. Conclusions/Significance: These studies allow us to better understand gene expression patterns in the growth plate and endochondral bones and provide an important technical resource for comparison of gene expression in diseased or experimentally-manipulated cartilages. Ultimately, this work will help to define the genomic context in which genes are expressed in long bones and to understand physiological and pathological ossification.	[James, Claudine G.; Stanton, Lee-Anne; Agoston, Hanga; Ulici, Veronica; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodelling, London, ON, Canada; [Underhill, T. Michael] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Western University (University of Western Ontario); University of British Columbia	James, CG (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, CIHR Grp Skeletal Dev & Remodelling, London, ON, Canada.	vulici@uwo.ca; fbeier@uwo.ca	Beier, Frank/G-4595-2013; Beier, Frank/T-4734-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537	Canadian Institutes of Health [MOP 43899]; Ontario Graduate Studentship in Science and Technology; Canadian Arthritis Network; Canada Research Chair Award	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Studentship in Science and Technology; Canadian Arthritis Network; Canada Research Chair Award(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	CGJ received a doctoral scholarship from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) and an Ontario Graduate Studentship in Science and Technology (http://osap.gov.on.ca/eng/Not_Secure/Plan_Grants_full_sepapp_OGS_12345.htm). VU was the recipient of a graduate scholarship from the Canadian Arthritis Network (http://www.arthritisnetwork.ca). HA received Ontario Graduate Studentship awards. FB is the recipient of a Canada Research Chair Award. Work on this project was supported by grants from the Canadian Institutes of Health Research (MOP 43899). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854; Bluteau G, 2007, BONE, V40, P568, DOI 10.1016/j.bone.2006.09.024; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOOTHANDFORD RP, 2009, CELL TISSUE RES; Brandal P, 2005, CANCER GENET CYTOGEN, V160, P15, DOI 10.1016/j.cancergencyto.2004.11.016; Cavalier L, 2000, EUR J HUM GENET, V8, P527, DOI 10.1038/sj.ejhg.5200476; CHEN JK, 1992, J BONE MINER RES, V7, P987; Cohen MM, 2006, AM J MED GENET A, V140A, P2646, DOI 10.1002/ajmg.a.31368; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; Dreier R, 2008, MATRIX BIOL, V27, P319, DOI 10.1016/j.matbio.2008.01.006; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x; Halbert AR, 1998, CANCER GENET CYTOGEN, V104, P52, DOI 10.1016/S0165-4608(97)00450-0; Hayman AR, 2000, J ANAT, V196, P433, DOI 10.1046/j.1469-7580.2000.19630433.x; Hayman DM, 2006, TISSUE ENG, V12, P2573, DOI 10.1089/ten.2006.12.2573; HECHT JT, 1993, GENOMICS, V18, P661, DOI 10.1016/S0888-7543(05)80370-2; Hecht JT, 2001, MATRIX BIOL, V20, P251, DOI 10.1016/S0945-053X(01)00136-6; HOFSTETTER W, 1995, BONE, V17, P145, DOI 10.1016/S8756-3282(95)00163-8; Horner A, 2002, DEV DYNAM, V225, P35, DOI 10.1002/dvdy.10132; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Incisivo V, 2003, Minerva Stomatol, V52, P457; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; James CG, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-30; James CG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-205; Kim JO, 2003, J CELL BIOCHEM, V90, P998, DOI 10.1002/jcb.10680; Lee GM, 1997, OSTEOARTHR CARTILAGE, V5, P261, DOI 10.1016/S1063-4584(97)80022-2; Lefebvre V, 1998, MATRIX BIOL, V16, P529; Lo IFM, 1998, AM J MED GENET, V78, P55, DOI 10.1002/(SICI)1096-8628(19980616)78:1<55::AID-AJMG11>3.3.CO;2-R; LOCHNER K, 2006, BIOGERONTOLOGY, V6; Lukic IK, 2005, CLIN EXP IMMUNOL, V139, P236, DOI 10.1111/j.1365-2249.2005.02680.x; MacLean HE, 2004, J CLIN INVEST, V113, P1334, DOI 10.1172/JCI200421252; Makihira S, 2003, ENDOCRINOLOGY, V144, P2480, DOI 10.1210/en.2002-220746; Mariani FV, 2003, NATURE, V423, P319, DOI 10.1038/nature01655; Mikic B, 2004, J ORTHOPAED RES, V22, P552, DOI 10.1016/j.orthres.2003.09.002; Milo M, 2003, BIOCHEM SOC T, V31, P1510; MITROVIC D, 1979, J RHEUMATOL, V6, P124; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; OKEEFE RJ, 1994, J BONE MINER RES, V9, P1713; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ortega N, 2003, ANN NY ACAD SCI, V995, P109, DOI 10.1111/j.1749-6632.2003.tb03214.x; Rajpar MH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000691; Ralston SH, 2005, HUM MOL GENET, V14, P943, DOI 10.1093/hmg/ddi088; Rantakokko J, 1999, J BONE MINER RES, V14, P1934, DOI 10.1359/jbmr.1999.14.11.1934; Riminucci M, 1997, AM J PATHOL, V151, P1587; Robinson P, 2002, INFECT IMMUN, V70, P4534, DOI 10.1128/IAI.70.8.4534-4538.2002; Rosado E, 2002, BBA-MOL CELL RES, V1590, P1, DOI 10.1016/S0167-4889(02)00194-5; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Shears DJ, 2004, AM J MED GENET A, V128A, P6, DOI 10.1002/ajmg.a.20640; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SKERRY TM, 1994, EUR J CLIN NUTR, V48, pS190; Stickens D, 2000, DEV DYNAM, V218, P452, DOI 10.1002/1097-0177(200007)218:3<452::AID-DVDY1000>3.0.CO;2-P; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Streeten EA, 2006, J BONE MINER RES, V21, P1433, DOI 10.1359/JBMR.060602; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugars RV, 2006, BBA-MOL CELL RES, V1763, P1031, DOI 10.1016/j.bbamcr.2006.08.027; Sugimoto M, 1998, CELL TISSUE RES, V292, P325, DOI 10.1007/s004410051063; Suter A, 2001, DEVELOPMENT, V128, P4899; Takahara M, 2004, J ORTHOPAED RES, V22, P1050, DOI 10.1016/j.orthres.2004.01.011; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; Toyosawa S, 2004, BONE, V35, P553, DOI 10.1016/j.bone.2004.03.030; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Wakui M, 2001, BIOCHEM BIOPH RES CO, V282, P200, DOI 10.1006/bbrc.2001.4550; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Wang Y, 2006, J HISTOCHEM CYTOCHEM, V54, P1327, DOI 10.1369/jhc.6A6923.2006; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Weizmann S, 2005, MATRIX BIOL, V24, P520, DOI 10.1016/j.matbio.2005.07.003; Whittock NV, 2004, AM J HUM GENET, V74, P1249, DOI 10.1086/421053; Williams CS, 2001, NEOPLASIA, V3, P428, DOI 10.1038/sj.neo.7900177; Wynne F, 2003, CALCIFIED TISSUE INT, V72, P651, DOI 10.1007/s00223-002-2086-2; Yan W, 2004, BONE, V35, P1273, DOI 10.1016/j.bone.2004.09.009; Yu H, 2007, CALCIFIED TISSUE INT, V80, P103, DOI 10.1007/s00223-006-0187-z; Zelzer E, 2004, DEVELOPMENT, V131, P2161, DOI 10.1242/dev.01053; Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zori RT, 1998, AM J MED GENET, V78, P450, DOI 10.1002/(SICI)1096-8628(19980806)78:5<450::AID-AJMG10>3.0.CO;2-E	83	31	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8693	10.1371/journal.pone.0008693	http://dx.doi.org/10.1371/journal.pone.0008693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084171	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600040
J	Paauw, A; Leverstein-van Hall, MA; Verhoef, J; Fluit, AC				Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.			Evolution in Quantum Leaps: Multiple Combinatorial Transfers of HPI and Other Genetic Modules in Enterobacteriaceae	PLOS ONE			English	Article							HIGH-PATHOGENICITY ISLAND; ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA; NONRIBOSOMAL PEPTIDE; DNA POLYMORPHISM; LIVER-ABSCESS; IRP2 GENE; CLOACAE; BACTERIA; IDENTIFICATION	Horizontal gene transfer is a key step in the evolution of Enterobacteriaceae. By acquiring virulence determinants of foreign origin, commensals can evolve into pathogens. In Enterobacteriaceae, horizontal transfer of these virulence determinants is largely dependent on transfer by plasmids, phages, genomic islands (GIs) and genomic modules (GMs). The High Pathogenicity Island (HPI) is a GI encoding virulence genes that can be transferred between different Enterobacteriaceae. We investigated the HPI because it was present in an Enterobacter hormaechei outbreak strain (EHOS). Genome sequence analysis showed that the EHOS contained an integration site for mobile elements and harbored two GIs and three putative GMs, including a new variant of the HPI (HPI-ICEEh1). We demonstrate, for the first time, that combinatorial transfers of GIs and GMs between Enterobacter cloacae complex isolates must have occurred. Furthermore, the excision and circularization of several combinations of the GIs and GMs was demonstrated. Because of its flexibility, the multiple integration site of mobile DNA can be considered an integration hotspot (IHS) that increases the genomic plasticity of the bacterium. Multiple combinatorial transfers of diverse combinations of the HPI and other genomic elements among Enterobacteriaceae may accelerate the generation of new pathogenic strains.	[Paauw, Armand; Leverstein-van Hall, Maurine A.; Verhoef, Jan; Fluit, Ad C.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Paauw, A (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	apaauw@umcutrecht.nl			Microbiology Department of the UMCU	Microbiology Department of the UMCU	The study was funded by the Microbiology Department of the UMCU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baquero F, 2004, NAT REV MICROBIOL, V2, P510, DOI 10.1038/nrmicro909; Bearden SW, 1997, INFECT IMMUN, V65, P1659, DOI 10.1128/IAI.65.5.1659-1668.1997; Brem D, 2001, MICROBIOL-SGM, V147, P1115, DOI 10.1099/00221287-147-5-1115; CARNIEL E, 1989, INFECT IMMUN, V57, P540, DOI 10.1128/IAI.57.2.540-545.1989; CARNIEL E, 1992, MOL MICROBIOL, V6, P379, DOI 10.1111/j.1365-2958.1992.tb01481.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; DEALMEIDA AMP, 1993, MICROB PATHOGENESIS, V14, P9, DOI 10.1006/mpat.1993.1002; Delmas J, 2006, DIAGN MICR INFEC DIS, V55, P263, DOI 10.1016/j.diagmicrobio.2006.02.003; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; Fluit AC, 2001, EUR J CLIN MICROBIOL, V20, P617; Fu YX, 1997, GENETICS, V147, P915; Groisman EA, 1996, CELL, V87, P791, DOI 10.1016/S0092-8674(00)81985-6; GUILVOUT I, 1993, J BACTERIOL, V175, P5488, DOI 10.1128/JB.175.17.5488-5504.1993; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Henderson JP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000305; Hoffmann H, 2003, APPL ENVIRON MICROB, V69, P5306, DOI 10.1128/AEM.69.9.5306-5318.2003; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Hu J, 2005, WORLD J GASTROENTERO, V11, P5816, DOI 10.3748/wjg.v11.i37.5816; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jores J, 2004, INT J MED MICROBIOL, V294, P103, DOI 10.1016/j.ijmm.2004.06.024; Kampfer P, 2008, INT J HYG ENVIR HEAL, V211, P374, DOI 10.1016/j.ijheh.2007.07.021; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leavis HL, 2006, CURR OPIN MICROBIOL, V9, P454, DOI 10.1016/j.mib.2006.07.001; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Leverstein-van Hall MA, 2006, J CLIN MICROBIOL, V44, P518, DOI 10.1128/JCM.44.2.518-524.2006; Lin TL, 2008, J BACTERIOL, V190, P515, DOI 10.1128/JB.01219-07; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Mokracka J, 2004, FEMS IMMUNOL MED MIC, V40, P51, DOI 10.1016/S0928-8244(03)00276-1; Paauw A, 2006, EMERG INFECT DIS, V12, P807; PAAUW A, 2009, MICROBIOL, V155, P1558; Paauw A, 2007, J CLIN MICROBIOL, V45, P1420, DOI 10.1128/JCM.02242-06; Paauw A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008240; Paauw A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003018; Pelludat C, 1998, J BACTERIOL, V180, P538, DOI 10.1128/JB.180.3.538-546.1998; Pfeifer BA, 2003, APPL ENVIRON MICROB, V69, P6698, DOI 10.1128/AEM.69.11.6698-6702.2003; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Rakin A, 1999, INFECT IMMUN, V67, P5265, DOI 10.1128/IAI.67.10.5265-5274.1999; Rooney AP, 2009, FEMS MICROBIOL LETT, V295, P82, DOI 10.1111/j.1574-6968.2009.01581.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Schubert S, 2002, INFECT IMMUN, V70, P5335, DOI 10.1128/IAI.70.9.5335-5337.2002; Schubert S, 1998, INFECT IMMUN, V66, P480, DOI 10.1128/IAI.66.2.480-485.1998; Schubert S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000257; Siddique T, 2007, J ENVIRON QUAL, V36, P621, DOI 10.2134/jeq2006.0357; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; TAJIMA F, 1989, GENETICS, V123, P585; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Valdebenito M, 2006, INT J MED MICROBIOL, V296, P513, DOI 10.1016/j.ijmm.2006.06.003; Gomis-Ruth FX, 2006, CURR OPIN STRUC BIOL, V16, P744, DOI 10.1016/j.sbi.2006.10.004	53	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8662	10.1371/journal.pone.0008662	http://dx.doi.org/10.1371/journal.pone.0008662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084283	gold, Green Published, Green Submitted			2022-12-27	WOS:000273554600015
J	Taylor-Blake, B; Zylka, MJ				Taylor-Blake, Bonnie; Zylka, Mark J.			Prostatic Acid Phosphatase Is Expressed in Peptidergic and Nonpeptidergic Nociceptive Neurons of Mice and Rats	PLOS ONE			English	Article							PRIMARY SENSORY NEURONS; GENE-RELATED PEPTIDE; SPINAL-CORD; DORSAL-HORN; PKC-GAMMA; PAIN; RECEPTOR; ECTONUCLEOTIDASE; COEXISTENCE; CAPSAICIN	Thiamine monophosphatase (TMPase, also known as Fluoride-resistant acid phosphatase or FRAP) is a classic histochemical marker of small-to medium-diameter dorsal root ganglia (DRG) neurons and has primarily been studied in the rat. Previously, we found that TMPase was molecularly identical to Prostatic acid phosphatase (PAP) using mice. In addition, PAP was expressed in a majority of nonpeptidergic, isolectin B4-binding (IB4(+)) nociceptive neurons and a subset of peptidergic, calcitonin gene-related peptide-containing (CGRP(+)) nociceptive neurons. At the time, we were unable to determine if PAP was present in rat DRG neurons because the antibody we used did not cross-react with PAP in rat tissues. In our present study, we generated a chicken polyclonal antibody against the secretory isoform of mouse PAP. This antibody detects mouse, rat and human PAP protein on western blots. Additionally, this antibody detects PAP in mouse and rat small-to medium-diameter DRG neurons and axon terminals in lamina II of spinal cord. In the rat, 92.5% of all PAP(+) cells bind the nonpeptidergic marker IB4 and 31.8% of all PAP(+) cells contain the peptidergic marker CGRP. Although PAP is found in peptidergic and nonpeptidergic neurons of mice and rats, the percentage of PAP+ neurons that express these markers differs between species. Moreover, PAP(+) axon terminals in the rat partially overlap with Protein kinase C gamma (PKC gamma(+)) interneurons in dorsal spinal cord whereas PAP(+) axon terminals in the mouse terminate dorsal to PKC gamma(+) interneurons. Collectively, our studies highlight similarities and differences in PAP localization within nociceptive neurons of mice and rats.	[Taylor-Blake, Bonnie; Zylka, Mark J.] Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Taylor-Blake, B (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	zylka@med.unc.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022		Rita Allen Foundation; National Institute of Neurological Disorders and Stroke (NINDS) [R01NS060725]; National Institute of Child Health and Human Development (NICHD) [P30NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060725, P30NS045892] Funding Source: NIH RePORTER	Rita Allen Foundation; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to MJZ from The Searle Scholars Program, Rita Allen Foundation and National Institute of Neurological Disorders and Stroke (NINDS) (R01NS060725). Confocal imaging was performed at the University of North Carolina Chapel Hill (UNC-CH) Confocal Imaging Facility, which is co-funded by NINDS and National Institute of Child Health and Human Development (NICHD) (P30NS045892). MJZ is a Rita Allen Foundation Milton E. Cassel Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The chicken antibody described in this paper will be made commercially available via Aves Labs. The authors received no funding from Aves Labs, nor will they be financially compensated by Aves Labs when this antibody is sold.	Campagnola L, 2008, J NEUROSCI METH, V169, P27, DOI 10.1016/j.jneumeth.2007.11.012; CARR PA, 1990, NEUROSCIENCE, V36, P751, DOI 10.1016/0306-4522(90)90017-X; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; COLMANT H J, 1959, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V199, P60, DOI 10.1007/BF00361100; COOPER JF, 1976, UROL RES, V4, P111; DALSGAARD CJ, 1984, NEUROSCI LETT, V51, P139, DOI 10.1016/0304-3940(84)90275-1; DODD J, 1983, COLD SPRING HARB SYM, V48, P685, DOI 10.1101/SQB.1983.048.01.072; GAMSE R, 1985, EUR J PHARMACOL, V114, P61, DOI 10.1016/0014-2999(85)90520-5; Gutman AB, 1938, J CLIN INVEST, V17, P473, DOI 10.1172/JCI100974; HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Kaija H, 2006, DYNAMICS BONE CARTIL, P165; KNYIHAR E, 1970, B ASSOC ANAT, V149, P768; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; Mogil JS, 2005, P NATL ACAD SCI USA, V102, P12938, DOI 10.1073/pnas.0503264102; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; OSTROWSKI WS, 1994, CLIN CHIM ACTA, V226, P121, DOI 10.1016/0009-8981(94)90209-7; Polgar E, 1999, BRAIN RES, V833, P71, DOI 10.1016/S0006-8993(99)01500-0; Quintero IB, 2007, CANCER RES, V67, P6549, DOI 10.1158/0008-5472.CAN-07-1651; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; ROIKO K, 1990, GENE, V89, P223, DOI 10.1016/0378-1119(90)90009-G; SANYAL S, 1974, BRAIN RES, V76, P161, DOI 10.1016/0006-8993(74)90523-X; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P219, DOI 10.3109/07367228809144628; Sowa NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004248; Taira AL, 2007, ONCOLOGY-NY, V21, P1003; VIHKO P, 1982, J UROLOGY, V128, P202, DOI 10.1016/S0022-5347(17)52818-9; WANG H, 1994, NEUROSCIENCE, V62, P539, DOI 10.1016/0306-4522(94)90387-5; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002; Zylka MJ, 2008, NEURON, V60, P111, DOI 10.1016/j.neuron.2008.08.024; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	38	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8674	10.1371/journal.pone.0008674	http://dx.doi.org/10.1371/journal.pone.0008674			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084276	Green Published, Green Submitted, gold			2022-12-27	WOS:000273554600026
J	Carrel, MA; Emch, M; Jobe, RT; Moody, A; Wan, XF				Carrel, Margaret A.; Emch, Michael; Jobe, R. Todd; Moody, Aaron; Wan, Xiu-Feng			Spatiotemporal Structure of Molecular Evolution of H5N1 Highly Pathogenic Avian Influenza Viruses in Vietnam	PLOS ONE			English	Article							DIVERSITY; ORIGIN; CHINA	Background: Vietnam is one of the countries most affected by outbreaks of H5N1 highly pathogenic avian influenza viruses. First identified in Vietnam in poultry in 2001 and in humans in 2004, the virus has since caused 111 cases and 56 deaths in humans. In 2003/2004 H5N1 outbreaks, nearly the entire poultry population of Vietnam was culled. Our earlier study (Wan et al., 2008, PLoS ONE, 3(10): e3462) demonstrated that there have been at least six independent H5N1 introductions into Vietnam and there were nine newly emerged reassortants from 2001 to 2007 in Vietnam. H5N1 viruses in Vietnam cluster distinctly around Hanoi and Ho Chi Minh City. However, the nature of the relationship between genetic divergence and geographic patterns is still unclear. Methodology/Principal Findings: In this study, we hypothesized that genetic distances between H5N1 viruses in Vietnam are correlated with geographic distances, as the result of distinct population and environment patterns along Vietnam's long north to south longitudinal extent. Based on this hypothesis, we combined spatial statistical methods with genetic analytic techniques and explicitly used geographic space to explore genetic evolution of H5N1 highly pathogenic avian influenza viruses at the sub-national scale in Vietnam. Our dataset consisted of 125 influenza viruses (with whole genome sets) isolated in Vietnam from 2003 to 2007. Our results document the significant effect of space and time on genetic evolution and the rise of two regional centers of genetic mixing by 2007. These findings give insight into processes underlying viral evolution and suggest that genetic differentiation is associated with the distance between concentrations of human and poultry populations around Hanoi and Ho Chi Minh City. Conclusions/Significance: The results show that genetic evolution of H5N1 viruses in Vietnamese domestic poultry is highly correlated with the location and spread of those viruses in geographic space. This correlation varies by scale, time, and gene, though a classic isolation by distance pattern is observed. This study is the first to characterize the geographic structure of influenza viral evolution at the sub-national scale in Vietnam and can shed light on how H5N1 HPAIVs evolve in certain geographic settings.	[Carrel, Margaret A.; Emch, Michael; Jobe, R. Todd; Moody, Aaron] Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA; [Wan, Xiu-Feng] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	University of North Carolina; University of North Carolina Chapel Hill; Mississippi State University	Carrel, MA (corresponding author), Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA.	emch@unc.edu; wan@cvm.msstate.edu			National Science Foundation (NSF) [BCS-0717688]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Science Foundation (NSF) Award BCS-0717688 to ME, XFW, and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Donis R. O., 2008, Emerging Infectious Diseases, V14, pe1; Duan L, 2008, VIROLOGY, V380, P243, DOI 10.1016/j.virol.2008.07.038; Duan L, 2007, J VIROL, V81, P7529, DOI 10.1128/JVI.00327-07; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; R Core Team, 2018, R LANG ENV STAT COMP; Salzberg SL, 2007, EMERG INFECT DIS, V13, P713, DOI 10.3201/eid1305.070013; Small M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.188702; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Wallace RG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001697; Wan XF, 2007, BIOINFORMATICS, V23, P2368, DOI 10.1093/bioinformatics/btm354; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; WEBSTER RG, 2005, ARCH VIROL         S, V19, P117, DOI DOI 10.1007/3-211-29981-5_; WHO, 2008, AV INFL SIT PAK UPD; *WHO, 2009, CUM NUMB CONF HUM CA; Wright S, 1940, AM NAT, V74, P232, DOI 10.1086/280891; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhao ZM, 2008, J GEN VIROL, V89, P2182, DOI 10.1099/vir.0.2008/001875-0	25	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 8	2010	5	1							e8631	10.1371/journal.pone.0008631	http://dx.doi.org/10.1371/journal.pone.0008631			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541KO	20072619	gold, Green Published, Green Submitted			2022-12-27	WOS:000273414200003
J	Lim, J; Tan, JC; Parimal, S; Dinges, DF; Chee, MWL				Lim, Julian; Tan, Jiat Chow; Parimal, Sarayu; Dinges, David F.; Chee, Michael W. L.			Sleep Deprivation Impairs Object-Selective Attention: A View from the Ventral Visual Cortex	PLOS ONE			English	Article							TOP-DOWN; MEMORY; PERFORMANCE; NIGHT; FMRI; MODULATION; ACTIVATION; MECHANISMS	Background: Most prior studies on selective attention in the setting of total sleep deprivation (SD) have focused on behavior or activation within fronto-parietal cognitive control areas. Here, we evaluated the effects of SD on the top-down biasing of activation of ventral visual cortex and on functional connectivity between cognitive control and other brain regions. Methodology/Principal Findings: Twenty-three healthy young adult volunteers underwent fMRI after a normal night of sleep (RW) and after sleep deprivation in a counterbalanced manner while performing a selective attention task. During this task, pictures of houses or faces were randomly interleaved among scrambled images. Across different blocks, volunteers responded to house but not face pictures, face but not house pictures, or passively viewed pictures without responding. The appearance of task-relevant pictures was unpredictable in this paradigm. SD resulted in less accurate detection of target pictures without affecting the mean false alarm rate or response time. In addition to a reduction of fronto-parietal activation, attending to houses strongly modulated parahippocampal place area (PPA) activation during RW, but this attention-driven biasing of PPA activation was abolished following SD. Additionally, SD resulted in a significant decrement in functional connectivity between the PPA and two cognitive control areas, the left intraparietal sulcus and the left inferior frontal lobe. Conclusions/Significance: SD impairs selective attention as evidenced by reduced selectivity in PPA activation. Further, reduction in fronto-parietal and ventral visual task-related activation suggests that it also affects sustained attention. Reductions in functional connectivity may be an important additional imaging parameter to consider in characterizing the effects of sleep deprivation on cognition.	[Lim, Julian; Tan, Jiat Chow; Parimal, Sarayu; Chee, Michael W. L.] Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore; [Lim, Julian; Dinges, David F.] Univ Penn, Sch Med, Dept Psychiat, Div Sleep & Chronobiol, Philadelphia, PA 19104 USA	National University of Singapore; University of Pennsylvania	Lim, J (corresponding author), Duke NUS Grad Med Sch, Neurosci & Behav Disorders Program, Singapore, Singapore.	julianzl@psych.upenn.edu; michael.chee@duke-nus.edu.sg	Lim, Julian/K-7447-2016; Dinges, David/P-7183-2019; Lim, Julian/E-6844-2011	Lim, Julian/0000-0002-1214-6758; Lim, Julian/0000-0002-1214-6758; Chee, Michael/0000-0002-6087-0548	Defense Science and Technology Agency, Singapore [POD0713897]; STaR [0004/2008]; NASA [NCC 9-58]; AFOSR [FA9550-05-1-0293]	Defense Science and Technology Agency, Singapore; STaR; NASA(National Aeronautics & Space Administration (NASA)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was conducted in Singapore and was supported by the Defense Science and Technology Agency, Singapore (POD0713897; MC) and a STaR award (0004/2008; MC). DFD was supported by the National Space Biomedical Research Institute through NASA NCC 9-58 and in part by AFOSR Grant FA9550-05-1-0293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chee MWL, 2008, J NEUROSCI, V28, P5519, DOI 10.1523/JNEUROSCI.0733-08.2008; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Chee MWL, 2010, NEUROIMAGE, V49, P1903, DOI 10.1016/j.neuroimage.2009.08.067; Chuah LYM, 2008, J NEUROSCI, V28, P11369, DOI 10.1523/JNEUROSCI.4045-08.2008; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dinges DF, 1995, J SLEEP RES, V4, P4, DOI 10.1111/j.1365-2869.1995.tb00220.x; Drummond SPA, 2004, SLEEP, V27, P445; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Frey DJ, 2004, J SLEEP RES, V13, P305, DOI 10.1111/j.1365-2869.2004.00429.x; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gazzaley A, 2005, NAT NEUROSCI, V8, P1298, DOI 10.1038/nn1543; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Horowitz TS, 2003, PSYCHOL SCI, V14, P549, DOI 10.1046/j.0956-7976.2003.psci_1464.x; Jennings JR, 2003, PSYCHOL SCI, V14, P473, DOI 10.1111/1467-9280.02456; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2007, SLEEP, V30, P61, DOI 10.1093/sleep/30.1.61; Mander BA, 2008, BRAIN RES, V1217, P148, DOI 10.1016/j.brainres.2008.04.030; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Portas CM, 1998, J NEUROSCI, V18, P8979; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Santhi N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001233; Saxe R, 2006, NEUROIMAGE, V30, P1088, DOI 10.1016/j.neuroimage.2005.12.062; Serences JT, 2004, CEREB CORTEX, V14, P1346, DOI 10.1093/cercor/bhh095; Slagter HA, 2007, BRAIN RES, V1177, P90, DOI 10.1016/j.brainres.2007.07.097; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomasi D, 2009, CEREB CORTEX, V19, P233, DOI 10.1093/cercor/bhn073; Van Dongen HPA, 2004, SLEEP, V27, P423; Versace F, 2006, BIOL PSYCHOL, V71, P248, DOI 10.1016/j.biopsycho.2005.04.003; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005	38	45	47	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9087	10.1371/journal.pone.0009087	http://dx.doi.org/10.1371/journal.pone.0009087			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NT	20140099	Green Published, gold, Green Submitted			2022-12-27	WOS:000274442400023
J	Kruger, C; Kappen, C				Kruger, Claudia; Kappen, Claudia			Expression of Cartilage Developmental Genes in Hoxc8-and Hoxd4-Transgenic Mice	PLOS ONE			English	Article							INDIAN-HEDGEHOG; NITRIC-OXIDE; CHONDROCYTE PROLIFERATION; TISSUE INHIBITOR; BONE-FORMATION; GROWTH; CHONDROGENESIS; DIFFERENTIATION; LIMB; OSTEOGENESIS	Hox genes encode transcription factors, which regulate skeletal patterning and chondrocyte differentiation during the development of cartilage, the precursor to mature bone. Overexpression of the homeobox transcription factors Hoxc8 and Hoxd4 causes severe cartilage defects due to delay in cartilage maturation. Matrix metalloproteinases (MMPs), bone morphogenetic proteins (BMPs) and fibroblastic growth factors (FGFs) are known to play important roles in skeletal development and endochondral bone formation and remodeling. In order to investigate whether these molecules are aberrantly expressed in Hoxc8- and/or Hoxd4-transgenic cartilage, we performed quantitative RT-PCR on chondrocytes from Hox-transgenic mice. Gene expression levels of Bmp4, Fgf8, Fgf10, Mmp9, Mmp13, Nos3, Timp3, Wnt3a and Wnt5a were altered in Hoxc8-transgenic chondrocytes, and Fgfr3, Ihh, Mmp8, and Wnt3a expression levels were altered in Hoxd4-transgenic chondrocytes, respectively. Notably, Wnt3a expression was elevated in Hoxc8- and reduced in Hoxd4-transgenic cartilage. These results suggest that both transcription factors affect cartilage maturation through different molecular mechanisms, and provide the basis for future studies into the role of these genes and possible interactions in pathogenesis of cartilage defects in Hoxc8- and Hoxd4-transgenic mice.	[Kruger, Claudia; Kappen, Claudia] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Kappen, Claudia] Univ Nebraska Med Ctr, Ctr Human Mol Genet, Munroe Meyer Inst Genet & Rehabil, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Kruger, C (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Dept Maternal Biol, Baton Rouge, LA 70803 USA.	Claudia.Kappen@pbrc.edu			University of Nebraska Medical Center [R21 DE14523]; Phillip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC014523] Funding Source: NIH RePORTER	University of Nebraska Medical Center; Phillip Morris External Research Program; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded in part by R21 DE14523 (to Claudia Kappen), a Dean's indirect cost award from the University of Nebraska Medical Center, and a grant from the Phillip Morris External Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE SS, 1994, DEV DYNAM, V200, P177, DOI 10.1002/aja.1002000302; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Burke D, 1998, TRENDS BIOCHEM SCI, V23, P59, DOI 10.1016/S0968-0004(97)01170-5; Chen L, 1999, J CLIN INVEST, V104, P1517, DOI 10.1172/JCI6690; Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706; Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Cormier Stephania A, 2003, BMC Dev Biol, V3, P4, DOI 10.1186/1471-213X-3-4; Daumer KM, 2004, J CELL BIOCHEM, V93, P526, DOI 10.1002/jcb.20190; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Eames B. Frank, 2003, Birth Defects Research, V69, P93, DOI 10.1002/bdrc.10016; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Evans DM, 1996, J BONE MINER RES, V11, P300; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gregg AR, 1998, AM J PHYSIOL-HEART C, V275, pH2319, DOI 10.1152/ajpheart.1998.275.6.H2319; GREGG AR, 1995, MAMM GENOME, V6, P152, DOI 10.1007/BF00303267; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Hartenstein B, 2006, J INVEST DERMATOL, V126, P486, DOI 10.1038/sj.jid.5700084; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Joronen K, 2000, HISTOCHEM CELL BIOL, V114, P157; Kappen C, 2004, GENESIS, V39, P155, DOI 10.1002/gene.20036; KAPPEN C, 2000, GENETIC MANIPULATION, P69; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kawakami Y, 1999, DEV GROWTH DIFFER, V41, P29; Kruger C, 2006, BIRTH DEFECTS RES A, V76, P216, DOI 10.1002/bdra.20245; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Lotz M, 1999, RHEUM DIS CLIN N AM, V25, P269, DOI 10.1016/S0889-857X(05)70067-3; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Mak KK, 2008, DEVELOPMENT, V135, P1947, DOI 10.1242/dev.018044; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Ornitz DM, 2001, GENOME BIOL, V2; Ortega N, 2004, TRENDS CELL BIOL, V14, P86, DOI 10.1016/j.tcb.2003.12.003; Rundle CH, 1998, BBA-GENE STRUCT EXPR, V1398, P164, DOI 10.1016/S0167-4781(98)00046-3; Rundle CH, 1999, J EXP ZOOL, V283, P612, DOI 10.1002/(SICI)1097-010X(19990501)283:6<612::AID-JEZ14>3.3.CO;2-O; Sasano Y, 2002, J HISTOCHEM CYTOCHEM, V50, P325, DOI 10.1177/002215540205000304; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Teixeira CC, 2005, BONE, V37, P37, DOI 10.1016/j.bone.2005.03.010; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Turner CH, 1997, BONE, V21, P487, DOI 10.1016/S8756-3282(97)00202-0; Vincenti MP, 2000, METH MOL B, V151, P121, DOI 10.1385/1-59259-046-2:121; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yueh YG, 1998, P NATL ACAD SCI USA, V95, P9956, DOI 10.1073/pnas.95.17.9956; Zhou J, 2007, BIOCHEM BIOPH RES CO, V363, P513, DOI 10.1016/j.bbrc.2007.08.198	58	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e8978	10.1371/journal.pone.0008978	http://dx.doi.org/10.1371/journal.pone.0008978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	20126390	Green Submitted, Green Published, gold			2022-12-27	WOS:000274207200002
J	Kim, SY; Dunn, IF; Firestein, R; Gupta, P; Wardwell, L; Repich, K; Schinzel, AC; Wittner, B; Silver, SJ; Root, DE; Boehm, JS; Ramaswamy, S; Lander, ES; Hahn, WC				Kim, So Young; Dunn, Ian F.; Firestein, Ron; Gupta, Piyush; Wardwell, Leslie; Repich, Kara; Schinzel, Anna C.; Wittner, Ben; Silver, Serena J.; Root, David E.; Boehm, Jesse S.; Ramaswamy, Sridhar; Lander, Eric S.; Hahn, William C.			CK1 epsilon Is Required for Breast Cancers Dependent on beta-Catenin Activity	PLOS ONE			English	Article							COLON-CANCER; WNT; EXPRESSION; ACTIVATION; GENE; INHIBITOR; PATHWAY; CELLS; IC261; CKI	Background: Aberrant beta-catenin signaling plays a key role in several cancer types, notably colon, liver and breast cancer. However approaches to modulate beta-catenin activity for therapeutic purposes have proven elusive to date. Methodology: To uncover genetic dependencies in breast cancer cells that harbor active beta-catenin signaling, we performed RNAi-based loss-of-function screens in breast cancer cell lines in which we had characterized beta-catenin activity. Here we identify CSNK1E, the gene encoding casein kinase 1 epsilon (CK1 epsilon) as required specifically for the proliferation of breast cancer cells with activated beta-catenin and confirm its role as a positive regulator of beta-catenin-driven transcription. Furthermore, we demonstrate that breast cancer cells that harbor activated beta-catenin activity exhibit enhanced sensitivity to pharmacological blockade of Wnt/beta-catenin signaling. We also find that expression of CK1e is able to promote oncogenic transformation of human cells in a beta-catenin-dependent manner. Conclusions/Significance: These studies identify CK1 epsilon as a critical contributor to activated beta-catenin signaling in cancer and suggest it may provide a potential therapeutic target for cancers that harbor active beta-catenin. More generally, these observations delineate an approach that can be used to identify druggable synthetic lethal interactions with signaling pathways that are frequently activated in cancer but are difficult to target with the currently available small molecule inhibitors.	[Kim, So Young; Dunn, Ian F.; Firestein, Ron; Wardwell, Leslie; Repich, Kara; Schinzel, Anna C.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wittner, Ben; Ramaswamy, Sridhar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Firestein, Ron] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, So Young; Schinzel, Anna C.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kim, So Young; Firestein, Ron; Schinzel, Anna C.; Boehm, Jesse S.; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Kim, So Young; Dunn, Ian F.; Firestein, Ron; Gupta, Piyush; Repich, Kara; Schinzel, Anna C.; Silver, Serena J.; Root, David E.; Boehm, Jesse S.; Ramaswamy, Sridhar; Lander, Eric S.; Hahn, William C.] Broad Inst, Cambridge, MA USA; [Wittner, Ben; Ramaswamy, Sridhar] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Ramaswamy, Sridhar] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University	Kim, SY (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	William_Hahn@dfci.harvard.edu		Boehm, Jesse/0000-0002-6795-6336	Department of Defense postdoctoral fellowship; National Institutes of Health (NIH) [K08 CA134836-01]; Mentored Clinical Scientist Award [P50 CA127003]; GI SPORE Career Development [R33 CA128625, R01 CA130988]; Department of Defense Idea Award [W81XWH-07-1-0408]; Dana-Farber Harvard Cancer Center SPORE in Breast Cancer [P50 CA89393]; NATIONAL CANCER INSTITUTE [P50CA127003, K08CA134836, K08CA100339, R33CA128625, R01CA130988, P50CA089393] Funding Source: NIH RePORTER	Department of Defense postdoctoral fellowship(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Clinical Scientist Award; GI SPORE Career Development; Department of Defense Idea Award(United States Department of Defense); Dana-Farber Harvard Cancer Center SPORE in Breast Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Department of Defense postdoctoral fellowship (S.Y.K.), the Brain Science Foundation and Warren-Whitman-Richardson Foundation (I. D.), K08 CA134836-01 from National Institutes of Health (NIH): Mentored Clinical Scientist Award and P50 CA127003: GI SPORE Career Development Grant (R.F.), R33 CA128625 (W.C.H.), R01 CA130988 (W.C.H.), Department of Defense Idea Award W81XWH-07-1-0408 (W.C.H.), Dana-Farber Harvard Cancer Center SPORE in Breast Cancer P50 CA89393 (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Badura L, 2007, J PHARMACOL EXP THER, V322, P730, DOI 10.1124/jpet.107.122846; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Behrend L, 2000, ONCOGENE, V19, P5303, DOI 10.1038/sj.onc.1203939; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Brockschmidt C, 2008, GUT, V57, P799, DOI 10.1136/gut.2007.123695; Cowling VH, 2007, MOL CELL BIOL, V27, P5135, DOI 10.1128/MCB.02282-06; Damalas A, 1999, EMBO J, V18, P3054, DOI 10.1093/emboj/18.11.3054; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Klippel A, 1996, MOL CELL BIOL, V16, P4117; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liefeld T, 2005, BIOINFORMATICS, V21, P3681, DOI 10.1093/bioinformatics/bti587; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Liu XH, 1996, CANCER RES, V56, P5125; Lo PK, 2006, CANCER BIOL THER, V5, P281, DOI 10.4161/cbt.5.3.2384; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mashhoon N, 2000, J BIOL CHEM, V275, P20052, DOI 10.1074/jbc.M001713200; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; Veeck J, 2008, CARCINOGENESIS, V29, P991, DOI 10.1093/carcin/bgn076; Yang WS, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r92	38	62	67	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8979	10.1371/journal.pone.0008979	http://dx.doi.org/10.1371/journal.pone.0008979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126544	gold, Green Published, Green Submitted			2022-12-27	WOS:000274209700008
J	Loser, K; Brzoska, T; Oji, V; Auriemma, M; Voskort, M; Kupas, V; Klenner, L; Mensing, C; Hauschild, A; Beissert, S; Luger, TA				Loser, Karin; Brzoska, Thomas; Oji, Vinzenz; Auriemma, Matteo; Voskort, Maik; Kupas, Verena; Klenner, Lars; Mensing, Cornelius; Hauschild, Axel; Beissert, Stefan; Luger, Thomas A.			The Neuropeptide Alpha-Melanocyte-Stimulating Hormone Is Critically Involved in the Development of Cytotoxic CD8(+) T Cells in Mice and Humans	PLOS ONE			English	Article							HUMAN MELANOCORTIN-1 RECEPTOR; NF-KAPPA-B; CUTANEOUS MALIGNANT-MELANOMA; IN-VITRO; RED HAIR; SKIN-CANCER; INFLAMMATORY AGENTS; FUNCTION MUTATIONS; DENDRITIC CELLS; GENE VARIANTS	Background: The neuropeptide alpha-melanocyte-stimulating hormone is well known as a mediator of skin pigmentation. More recently, it has been shown that alpha-melanocyte-stimulating hormone also plays pivotal roles in energy homeostasis, sexual function, and inflammation or immunomodulation. Alpha-melanocyte-stimulating hormone exerts its antiinflammatory and immunomodulatory effects by binding to the melanocortin-1 receptor, and since T cells are important effectors during immune responses, we investigated the effects of alpha-melanocyte-stimulating hormone on T cell function. Methodology/Principal Findings: T cells were treated with alpha-melanocyte-stimulating hormone, and subsequently, their phenotype and function was analyzed in a contact allergy as well as a melanoma model. Furthermore, the relevance of alpha-melanocyte-stimulating hormone-mediated signaling for the induction of cytotoxicity was assessed in CD8(+) T cells from melanoma patients with functional and nonfunctional melanocortin-1 receptors. Here we demonstrate that the melanocortin-1 receptor is expressed by murine as well as human CD8(+) T cells, and we furthermore show that alpha-melanocyte-stimulating hormone/melanocortin-1 receptor-mediated signaling is critical for the induction of cytotoxicity in human and murine CD8(+) T cells. Upon adoptive transfer, alpha-melanocyte-stimulating hormone-treated murine CD8(+) T cells significantly reduced contact allergy responses in recipient mice. Additionally, the presented data indicate that alpha-melanocyte-stimulating hormone via signaling through a functional melanocortin-1 receptor augmented antitumoral immunity by up-regulating the expression of cytotoxic genes and enhancing the cytolytic activity in tumor-specific CD8(+) T cells. Conclusions/Significance: Together, these results point to an important role of alpha-melanocyte-stimulating hormone in MHC class I-restricted cytotoxicity. Therefore, treatment of contact allergies or skin cancer with alpha-melanocyte-stimulating hormone or other more stable agonists of melanocortin-1 receptor might ameliorate disease or improve antitumoral immune responses.	[Loser, Karin; Brzoska, Thomas; Oji, Vinzenz; Auriemma, Matteo; Voskort, Maik; Kupas, Verena; Klenner, Lars; Beissert, Stefan; Luger, Thomas A.] Univ Munster, Dept Dermatol, D-4400 Munster, Germany; [Loser, Karin; Oji, Vinzenz; Beissert, Stefan] Univ Munster, Interdisciplinary Ctr Clin Res, D-4400 Munster, Germany; [Mensing, Cornelius; Hauschild, Axel] Univ Kiel, Dept Dermatol, D-2300 Kiel, Germany	University of Munster; University of Munster; University of Kiel	Loser, K (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-4400 Munster, Germany.	loserk@uni-muenster.de	Hauschild, Axel/B-3185-2010	Oji, Vinzenz/0000-0003-1380-4828	Interdisciplinary Center of Clinical Research [Lo2/017/07]; German Cancer Society [107891]; German Research Association [Lo817/2-1]	Interdisciplinary Center of Clinical Research; German Cancer Society; German Research Association(German Research Foundation (DFG))	This study was supported by Interdisciplinary Center of Clinical Research grant Lo2/017/07 to KL and SB, German Cancer Society grant 107891 to KL and SB, and German Research Association grant Lo817/2-1 to KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mallek ZA, 2008, PHOTOCHEM PHOTOBIOL, V84, P501, DOI 10.1111/j.1751-1097.2008.00294.x; Adachi S, 1999, J IMMUNOL, V163, P3363; Andersen GN, 2001, CLIN EXP IMMUNOL, V126, P441, DOI 10.1046/j.1365-2249.2001.01604.x; Balkow S, 2009, EXP DERMATOL, V18, P78, DOI 10.1111/j.1600-0625.2008.00800.x; Barnetson R S, 1997, Australas J Dermatol, V38 Suppl 1, pS63; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Becher E, 1999, ANN NY ACAD SCI, V885, P188; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Bhardwaj R, 1997, J IMMUNOL, V158, P3378; Botchkarev VA, 1999, ANN NY ACAD SCI, V885, P433; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Brzoska T, 2008, ENDOCR REV, V29, P581, DOI 10.1210/er.2007-0027; Catania A, 1996, PEPTIDES, V17, P675, DOI 10.1016/0196-9781(96)00037-X; Cavani Andrea, 2008, V94, P93, DOI 10.1159/000154934; CHHAJLANI V, 1992, FEBS LETT, V309, P417, DOI 10.1016/0014-5793(92)80820-7; Cooper A, 2005, J IMMUNOL, V175, P4806, DOI 10.4049/jimmunol.175.7.4806; Cutuli M, 2000, J LEUKOCYTE BIOL, V67, P233, DOI 10.1002/jlb.67.2.233; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Elliott RJ, 2004, J INVEST DERMATOL, V122, P1010, DOI 10.1111/j.0022-202X.2004.22404.x; Eves P, 2003, BRIT J CANCER, V89, P2004, DOI 10.1038/sj.bjc.6601349; Fargnoli Maria Concetta, 2003, Hum Mutat, V21, P655, DOI 10.1002/humu.9150; GEHLSEN KR, 1992, PIGM CELL RES, V5, P219, DOI 10.1111/j.1600-0749.1992.tb00540.x; Grabbe S, 1996, J IMMUNOL, V156, P473; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; Han D, 2007, GENE THER, V14, P383, DOI 10.1038/sj.gt.3302862; Hedley SJ, 2000, MELANOMA RES, V10, P323, DOI 10.1097/00008390-200008000-00003; High WA, 2005, J AM ACAD DERMATOL, V53, P89, DOI 10.1016/j.jaad.2005.03.006; Ichiyama T, 1999, J NEUROIMMUNOL, V99, P211, DOI 10.1016/S0165-5728(99)00122-8; Kalden DH, 1999, ANN NY ACAD SCI, V885, P254; KAMEYAMA K, 1990, INT J CANCER, V45, P1151, DOI 10.1002/ijc.2910450627; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin J, 2008, BRIT J DERMATOL, V159, P286, DOI 10.1111/j.1365-2133.2008.08682.x; Lipton JM, 1999, ANN NY ACAD SCI, V885, P173; Lipton JM, 1997, IMMUNOL TODAY, V18, P140, DOI 10.1016/S0167-5699(97)01009-8; LIPTON JM, 1994, ANN NY ACAD SCI, V741, P137, DOI 10.1111/j.1749-6632.1994.tb39654.x; Loser K, 2005, GENE THER, V12, P1294, DOI 10.1038/sj.gt.3302567; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; Luger TA, 2003, ANN NY ACAD SCI, V994, P133, DOI 10.1111/j.1749-6632.2003.tb03172.x; Luger TA, 2000, ANN NY ACAD SCI, V917, P232; Luger TA, 1996, J DERMATOL SCI, V13, P5, DOI 10.1016/0923-1811(95)00485-8; LUNEC J, 1992, MELANOMA RES, V2, P5, DOI 10.1097/00008390-199205000-00002; Maaser C, 2006, GUT, V55, P1415, DOI 10.1136/gut.2005.083634; Maaser C, 2006, ANN NY ACAD SCI, V1072, P123, DOI 10.1196/annals.1326.016; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; Manna SK, 1998, J IMMUNOL, V161, P2873; Melief C J, 1991, Semin Cancer Biol, V2, P347; Mossner R, 2007, ARCH DERMATOL RES, V298, P371, DOI 10.1007/s00403-006-0708-7; Morandini R, 1998, J CELL PHYSIOL, V175, P276, DOI 10.1002/(SICI)1097-4652(199806)175:3<276::AID-JCP5>3.0.CO;2-L; MORTON DL, 1971, PROG EXP TUMOR RES, V14, P25; MOUNTJOY KG, 1994, MOL CELL ENDOCRINOL, V102, pR7, DOI 10.1016/0303-7207(94)90113-9; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; NEUMANNANDERSEN G, 2005, SCAND J IMMUNOL, V61, P279; Nishida T, 2004, INT IMMUNOPHARMACOL, V4, P1059, DOI 10.1016/j.intimp.2004.04.011; Raap U, 2003, J IMMUNOL, V171, P353, DOI 10.4049/jimmunol.171.1.353; Rajora N, 1997, PEPTIDES, V18, P381, DOI 10.1016/S0196-9781(96)00345-2; Rees JL, 2000, PIGM CELL RES, V13, P135, DOI 10.1034/j.1600-0749.2000.130303.x; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Ringholm A, 2004, J INVEST DERMATOL, V123, P917, DOI 10.1111/j.0022-202X.2004.23444.x; Sanchez-Laorden BL, 2007, J BIOL CHEM, V282, P3241, DOI 10.1074/jbc.M606865200; Schioth HB, 1997, EUR J PHARMACOL, V319, P369, DOI 10.1016/S0014-2999(96)00959-4; Schioth HB, 1999, BIOCHEM BIOPH RES CO, V260, P488, DOI 10.1006/bbrc.1999.0935; Scott MC, 2002, J CELL SCI, V115, P2349; STAR RA, 1995, P NATL ACAD SCI USA, V92, P8016, DOI 10.1073/pnas.92.17.8016; Straten PT, 1999, CANCER IMMUNOL IMMUN, V48, P386, DOI 10.1007/s002620050591; Sturm RA, 2002, MELANOMA RES, V12, P405, DOI 10.1097/00008390-200209000-00001; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Tenaud I, 2007, EXP DERMATOL, V16, P500, DOI 10.1111/j.1600-0625.2007.00552.x; Wikberg JES, 2000, PHARMACOL RES, V42, P393, DOI 10.1006/phrs.2000.0725; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021; Yoon SW, 2003, J BIOL CHEM, V278, P32914, DOI 10.1074/jbc.M302444200	73	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8958	10.1371/journal.pone.0008958	http://dx.doi.org/10.1371/journal.pone.0008958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126537	Green Published, gold, Green Submitted			2022-12-27	WOS:000274209700004
J	Cushion, MT; Linke, MJ; Ashbaugh, A; Sesterhenn, T; Collins, MS; Lynch, K; Brubaker, R; Walzer, PD				Cushion, Melanie T.; Linke, Michael J.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Brubaker, Ronald; Walzer, Peter D.			Echinocandin Treatment of Pneumocystis Pneumonia in Rodent Models Depletes Cysts Leaving Trophic Burdens That Cannot Transmit the Infection	PLOS ONE			English	Article							CARINII-PNEUMONIA; JIROVECI PNEUMONIA; INFLAMMATORY RESPONSES; ASPERGILLUS-FUMIGATUS; CASPOFUNGIN; EFFICACY; THERAPY; MICE; TRIMETHOPRIM; MECHANISMS	Fungi in the genus Pneumocystis cause pneumonia (PCP) in hosts with debilitated immune systems and are emerging as comorbidity factors associated with chronic diseases such as COPD. Limited therapeutic choices and poor understanding of the life cycle are a result of the inability of these fungi to grow outside the mammalian lung. Within the alveolar lumen, Pneumocystis spp., appear to have a bi-phasic life cycle consisting of an asexual phase characterized by binary fission of trophic forms and a sexual cycle resulting in formation of cysts, but the life cycle stage that transmits the infection is not known. The cysts, but not the trophic forms, express beta -1,3-D-glucan synthetase and contain abundant beta -1,3-D-glucan. Here we show that therapeutic and prophylactic treatment of PCP with echinocandins, compounds which inhibit the synthesis of beta -1,3-D-glucan, depleted cysts in rodent models of PCP, while sparing the trophic forms which remained in significant numbers. Survival was enhanced in the echincandin treated mice, likely due to the decreased beta -1,3-D-glucan content in the lungs of treated mice and rats which coincided with reductions of cyst numbers, and dramatic remodeling of organism morphology. Strong evidence for the cyst as the agent of transmission was provided by the failure of anidulafungin-treated mice to transmit the infection. We show for the first time that withdrawal of anidulafungin treatment with continued immunosuppression permitted the repopulation of cyst forms. Treatment of PCP with an echinocandin alone will not likely result in eradication of infection and cessation of echinocandin treatment while the patient remains immunosuppressed could result in relapse. Importantly, the echinocandins provide novel and powerful chemical tools to probe the still poorly understood bi-phasic life cycle of this genus of fungal pathogens.	[Cushion, Melanie T.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Walzer, Peter D.] Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA; [Cushion, Melanie T.; Linke, Michael J.; Ashbaugh, Alan; Sesterhenn, Tom; Collins, Margaret S.; Lynch, Keeley; Walzer, Peter D.] Vet Adm Med Ctr, Cincinnati, OH 45220 USA; [Brubaker, Ronald] Christ Hosp, Dept Pathol, Cincinnati, OH 45219 USA	University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Christ Hospital - Ohio	Cushion, MT (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45221 USA.	melanie.cushion@uc.edu		Cushion, Melanie T./0000-0001-6621-2784	National Institutes of Allergy and Infectious Diseases [NO1 AI75319]; Public Health Service Grant [R01 AI076104]; Medical Research Service, Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076104, N01AI075319] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Medical Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by Public Health Service Contract NO1 AI75319 from the National Institutes of Allergy and Infectious Diseases (to M. T. C. and P. D. W.); Public Health Service Grant R01 AI076104 (M. T. C.); Medical Research Service, Department of Veterans Affairs (M. T. C. and P. D. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JM, 2009, EUKARYOT CELL, V8, P446, DOI 10.1128/EC.00309-08; Beltz K, 2006, KLIN PADIATR, V218, P177, DOI 10.1055/s-2006-933433; Carmona EM, 2006, J IMMUNOL, V177, P459, DOI 10.4049/jimmunol.177.1.459; Collins MS, 2001, J EUKARYOT MICROBIOL, p178S; Cushion MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000423; Cushion MT, 2006, ANTIMICROB AGENTS CH, V50, P2337, DOI 10.1128/AAC.00126-06; Cushion MT, 2009, CURR MED CHEM, V16, P2514, DOI 10.2174/092986709788682038; Cushion MT, 2009, EUKARYOT CELL, V8, P197, DOI 10.1128/EC.00202-08; Evans SE, 2005, AM J RESP CELL MOL, V32, P490, DOI 10.1165/rcmb.2004-0300OC; Fisk DT, 2003, CLIN INFECT DIS, V36, P70, DOI 10.1086/344951; Hahn PY, 2003, J BIOL CHEM, V278, P2043, DOI 10.1074/jbc.M209715200; HEE SQ, 2003, BIOL MONITORING INTR, P78; Hof H, 2008, MYCOSES, V51, P1, DOI 10.1111/j.1439-0507.2008.01522.x; Hohl TM, 2008, J INFECT DIS, V198, P176, DOI 10.1086/589304; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Icenhour CR, 2002, EUKARYOT CELL, V1, P414, DOI 10.1128/EC.1.3.414-419.2002; Ito M, 2000, ANTIMICROB AGENTS CH, V44, P2259, DOI 10.1128/AAC.44.9.2259-2262.2000; Kamboj M, 2006, CLIN INFECT DIS, V43, pE92, DOI 10.1086/508282; Kanaani H, 2007, J AEROSOL SCI, V38, P83, DOI 10.1016/j.jaerosci.2006.10.003; Kauffman CA, 2008, SEMIN RESP CRIT CARE, V29, P211, DOI 10.1055/s-2008-1063859; Kaur N, 2007, DIGEST DIS SCI, V52, P1481, DOI 10.1007/s10620-006-9250-x; Komano Y, 2009, ARTHRIT RHEUM-ARTHR, V61, P305, DOI 10.1002/art.24283; KURTZ MB, 1994, ANTIMICROB AGENTS CH, V38, P1480, DOI 10.1128/AAC.38.7.1480; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Limper AH, 2003, J EUKARYOT MICROBIOL, V50, P646, DOI 10.1111/j.1550-7408.2003.tb00667.x; Linke M, 2005, MICROBES INFECT, V7, P748, DOI 10.1016/j.micinf.2005.01.011; Linke MJ, 2003, EMERG INFECT DIS, V9, P1613, DOI 10.3201/eid0912.030270; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Morris A, 2008, COPD, V5, P43, DOI 10.1080/15412550701817656; Morris A, 2008, CLIN INFECT DIS, V46, P634, DOI 10.1086/526779; Patel Naimish, 2004, Treat Respir Med, V3, P381, DOI 10.2165/00151829-200403060-00005; Powles MA, 1998, ANTIMICROB AGENTS CH, V42, P1985, DOI 10.1128/AAC.42.8.1985; Qureshi MH, 2001, J IMMUNOL, V166, P5704, DOI 10.4049/jimmunol.166.9.5704; Radhi S, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-118; Ruan SB, 2002, INFECT IMMUN, V70, P6107, DOI 10.1128/IAI.70.11.6107-6113.2002; Russian DA, 1998, DRUG RESIST UPDATE, V1, P16, DOI 10.1016/S1368-7646(98)80210-0; SCHMATZ DM, 1991, J PROTOZOOL, V38, pS151; Steele C, 2003, J EXP MED, V198, P1677, DOI 10.1084/jem.20030932; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; Thompson MF, 2009, SCAND J INFECT DIS, P1; Utili R, 2007, TRANSPLANTATION, V84, P685, DOI 10.1097/01.tp.0000280546.91617.6c; Vassallo R, 2000, J IMMUNOL, V164, P3755, DOI 10.4049/jimmunol.164.7.3755; Vohra PK, 2004, BIOCHEM BIOPH RES CO, V319, P193, DOI 10.1016/j.bbrc.2004.04.154; WALZER PD, 1992, ANTIMICROB AGENTS CH, V36, P1935, DOI 10.1128/AAC.36.9.1935; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Waters L, 2007, EXPERT OPIN INV DRUG, V16, P899, DOI 10.1517/13543784.16.6.899; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227	48	100	112	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2010	5	1							e8524	10.1371/journal.pone.0008524	http://dx.doi.org/10.1371/journal.pone.0008524			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550PA	20126455	gold, Green Published, Green Submitted			2022-12-27	WOS:000274139100001
J	Abuya, TO; Fegan, G; Amin, AA; Akhwale, WS; Noor, AM; Snow, RW; Marsh, V				Abuya, Timothy O.; Fegan, Greg; Amin, Abdinasir A.; Akhwale, Willis S.; Noor, Abdisalan M.; Snow, Robert W.; Marsh, Vicki			Evaluating Different Dimensions of Programme Effectiveness for Private Medicine Retailer Malaria Control Interventions in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; HOME TREATMENT; PUBLIC-HEALTH; RURAL KENYA; DRUG; MANAGEMENT; DISTRICTS; KNOWLEDGE; SERVICES	Background: Private medicine retailers (PMRs) are key partners in the home management of fevers in many settings. Current evidence on effectiveness for PMR interventions at scale is limited. This study presents evaluation findings of two different programs implemented at moderate scale targeting PMRs for malaria control in the Kisii and Kwale districts of Kenya. Key components of this evaluation were measurement of program performance, including coverage, PMR knowledge, practices, and utilization based on spatial analysis. Methodology/Principal Findings: The study utilized mixed quantitative methods including retail audits and surrogate client surveys based on post-intervention cross-sectional surveys in intervention and control areas and mapping of intervention outlets. There was a large and significant impact on PMR knowledge and practices of the program in Kisii, with 60.5% of trained PMRs selling amodiaquine medicines in adequate doses compared to 2.8% of untrained ones (OR; 53.5: 95% CI 6.7, 428.3), a program coverage of 69.7% targeted outlets, and a potential utilization of about 30,000 children under five. The evaluation in Kwale also indicates a significant impact with 18.8% and 2.3% intervention and control PMRs selling amodiaquine with correct advice, respectively (OR; 9.4: 95% CI 1.1, 83.7), a program coverage of 25.3% targeted outlets, and a potential utilization of about 48,000 children under five. A provisional benchmark of 7.5 km was a reasonable threshold distance for households to access PMR services. Conclusions/Significance: This evaluation show that PMR interventions operationalized in the district level settings are likely to impact PMR knowledge and practices and lead to increased coverage of appropriate treatment to target populations. There is value of evaluating different dimensions of public health programs, including quality, spatial access, and implementation practice. This approach strengthens the potential contribution of pragmatic study designs to evaluating public health programs in the real world.	[Abuya, Timothy O.; Fegan, Greg; Marsh, Vicki] Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya; [Fegan, Greg] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Amin, Abdinasir A.] Populat Serv Int, Malaria Control & Child Survival Dept, Nairobi, Kenya; [Akhwale, Willis S.] Minist Hlth, Div Vector Borne Dis, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Kenya Med Res Inst, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.; Marsh, Vicki] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; Kenya Medical Research Institute; University of Oxford	Abuya, TO (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res, Kilifi, Kenya.	tabuya@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018; Abuya, Timothy/AAH-5479-2020; Snow, Robert William/AFR-1436-2022	Fegan, Greg W/0000-0002-2663-2765; Snow, Robert William/0000-0003-3725-6088; Marsh, Vicki/0000-0002-5178-4250; Huicho, Luis/0000-0002-5272-5885	Kenya Medical Research Institute (KEMRI); Wellcome Trust [084538, 079080, 081829]; World Health Organization Kenya Country Office	Kenya Medical Research Institute (KEMRI); Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization Kenya Country Office	Funding support for the surveys was provided by the Kenya Medical Research Institute (KEMRI), the Wellcome Trust, and the World Health Organization Kenya Country Office. T.O.A. is supported by the Wellcome Trust Strategic Award (#084538). R. W. S. is supported by the Wellcome Trust as Principal Research Fellow (#079080). A.M.N. is supported by the Wellcome Trust as a Research Training Fellow (#081829). This paper is published with the permission of the Director of KEMRI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2009, AM J TROP MED HYG, V80, P905, DOI 10.4269/ajtmh.2009.80.905; Abuya TO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-57; *AFF MED FAC MAL, 2007, TECHN PROP INCR ACC; Amin AA, 2003, TROP MED INT HEALTH, V8, P1143, DOI 10.1046/j.1360-2276.2003.01140.x; AMIN AA, 2005, RANGE QUALITY COSTS; Black N, 1996, BRIT MED J, V312, P1215; *COGME, 1998, 10 COGME US DEP HHS; Gitonga CW, 2008, TROP MED INT HEALTH, V13, P487, DOI 10.1111/j.1365-3156.2008.02026.x; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Greer G, 2004, IMPROVING MANAGEMENT; Guagliardo MF, 2004, HEALTH PLACE, V10, P273, DOI 10.1016/j.healthplace.2003.01.001; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; Madden JM, 1997, SOC SCI MED, V45, P1465, DOI 10.1016/S0277-9536(97)00076-2; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; Marsh VM, 1999, TROP MED INT HEALTH, V4, P383, DOI 10.1046/j.1365-3156.1999.00403.x; McCombie SC, 2002, HEALTH POLICY PLANN, V17, P333, DOI 10.1093/heapol/17.4.333; *MERLIN ICIPE JOIN, MERL MAL CONTR W KEN; *MIN HLTH, 2006, DISTR LED MED RET TR; *MOH, 2001, NAT MAL STRAT 2001 2; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Ross L, 2005, J PUBLIC HEALTH, V27, P331, DOI 10.1093/pubmed/fdi058; SABOT O, 2008, DISTRIBUTION ARTEMIS, P27; SNOW R, MODELLING ANTIMALARI; Tawfik Y, 2006, TROP MED INT HEALTH, V11, P967, DOI 10.1111/j.1365-3156.2006.01622.x; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; WHO, 2004, SCAL HOM BAS MAN MAL; Williams HA, 2004, SOC SCI MED, V59, P501, DOI 10.1016/j.socscimed.2003.11.010; World Health Organization, 2005, WHOHTMMAL20051101	30	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8937	10.1371/journal.pone.0008937	http://dx.doi.org/10.1371/journal.pone.0008937			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	550OR	20126620	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000274138000015
J	Matsumura, K; Opiekun, M; Oka, H; Vachani, A; Albelda, SM; Yamazaki, K; Beauchamp, GK				Matsumura, Koichi; Opiekun, Maryanne; Oka, Hiroaki; Vachani, Anil; Albelda, Steven M.; Yamazaki, Kunio; Beauchamp, Gary K.			Urinary Volatile Compounds as Biomarkers for Lung Cancer: A Proof of Principle Study Using Odor Signatures in Mouse Models of Lung Cancer	PLOS ONE			English	Article							ELECTRONIC NOSE; ORGANIC-COMPOUNDS; IN-VITRO; IDENTIFICATION; MICE; DISCRIMINATION; DIAGNOSIS; VECTOR; STAGE	A potential strategy for diagnosing lung cancer, the leading cause of cancer-related death, is to identify metabolic signatures (biomarkers) of the disease. Although data supports the hypothesis that volatile compounds can be detected in the breath of lung cancer patients by the sense of smell or through bioanalytical techniques, analysis of breath samples is cumbersome and technically challenging, thus limiting its applicability. The hypothesis explored here is that variations in small molecular weight volatile organic compounds ("odorants'') in urine could be used as biomarkers for lung cancer. To demonstrate the presence and chemical structures of volatile biomarkers, we studied mouse olfactory-guided behavior and metabolomics of volatile constituents of urine. Sensor mice could be trained to discriminate between odors of mice with and without experimental tumors demonstrating that volatile odorants are sufficient to identify tumor-bearing mice. Consistent with this result, chemical analyses of urinary volatiles demonstrated that the amounts of several compounds were dramatically different between tumor and control mice. Using principal component analysis and supervised machine-learning, we accurately discriminated between tumor and control groups, a result that was cross validated with novel test groups. Although there were shared differences between experimental and control animals in the two tumor models, we also found chemical differences between these models, demonstrating tumor-based specificity. The success of these studies provides a novel proof-of-principle demonstration of lung tumor diagnosis through urinary volatile odorants. This work should provide an impetus for similar searches for volatile diagnostic biomarkers in the urine of human lung cancer patients.	[Matsumura, Koichi; Opiekun, Maryanne; Yamazaki, Kunio; Beauchamp, Gary K.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Oka, Hiroaki] Panasonic Corp, Kyoto, Japan; [Vachani, Anil; Albelda, Steven M.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Panasonic; University of Pennsylvania	Matsumura, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba, Japan.	beauchamp@monell.org			Panasonic Corporation	Panasonic Corporation	This study was supported by Panasonic Corporation. As indicated under the competing interest section, an employee of Panasonic, Dr. H. Oka, helped conceive the original idea and reviewed the manuscript. No other role in this research was played by Dr. Oka and Panasonic.	Bach PB, 2007, JAMA-J AM MED ASSOC, V297, P953, DOI 10.1001/jama.297.9.953; Belda-Iniesta C, 2007, CLIN TRANSL ONCOL, V9, P354; Bernabei M, 2008, SENSOR ACTUAT B-CHEM, V131, P1, DOI 10.1016/j.snb.2007.12.030; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Chen X, 2007, CANCER-AM CANCER SOC, V110, P835, DOI 10.1002/cncr.22844; Di Natale C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003139; Dragonieri S, 2009, LUNG CANCER, V64, P166, DOI 10.1016/j.lungcan.2008.08.008; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Gordon RT, 2008, J ALTERN COMPLEM MED, V14, P61, DOI 10.1089/acm.2006.6408; Gramolini AO, 2008, CLIN PHARMACOL THER, V83, P758, DOI 10.1038/clpt.2008.18; Greenberg AK, 2007, CURR OPIN PULM MED, V13, P249, DOI 10.1097/MCP.0b013e32819f8f06; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kodogiannis VS, 2008, IEEE T INF TECHNOL B, V12, P707, DOI 10.1109/TITB.2008.917928; Kwak J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003591; Lechner M, 2007, CURR MED CHEM, V14, P987, DOI 10.2174/092986707780362916; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; McCulloch M, 2006, INTEGR CANCER THER, V5, P30, DOI 10.1177/1534735405285096; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Monahan E, 1993, LAB ANIMALS      JUN, P38; Montag S, 2001, P NATL ACAD SCI USA, V98, P9249, DOI 10.1073/pnas.161266398; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PERBELLINI L, 1986, ARCH TOXICOL, V58, P229, DOI 10.1007/BF00297111; Radhika V, 2007, NAT CHEM BIOL, V3, P325, DOI 10.1038/nchembio882; Ravenel JG, 2008, RADIOLOGY, V247, P400, DOI 10.1148/radiol.2472070868; Ravenel JG, 2008, AM J ROENTGENOL, V190, P755, DOI 10.2214/AJR.07.2899; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; SONG G, 2009, LUNG CANC AOP WHAT I; Sponring A, 2009, ANTICANCER RES, V29, P419; Turner APF, 2004, NAT REV MICROBIOL, V2, P161, DOI 10.1038/nrmicro823; Weissleder R, 2008, NATURE, V452, P580, DOI 10.1038/nature06917; Wilderman MJ, 2005, CANCER RES, V65, P8379, DOI 10.1158/0008-5472.CAN-05-0920; Willis CM, 2004, BMJ-BRIT MED J, V329, P712, DOI 10.1136/bmj.329.7468.712; Willse A, 2005, ANAL CHEM, V77, P2348, DOI 10.1021/ac048711t; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; Yamazaki K, 2002, P NATL ACAD SCI USA, V99, P5612, DOI 10.1073/pnas.082093099; ZLATKIS A, 1981, CLIN CHEM, V27, P789	40	87	91	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8819	10.1371/journal.pone.0008819	http://dx.doi.org/10.1371/journal.pone.0008819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111698	Green Published, Green Submitted, gold			2022-12-27	WOS:000274114800005
J	Rosvall, M; Bergstrom, CT				Rosvall, Martin; Bergstrom, Carl T.			Mapping Change in Large Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; COMMUNITY STRUCTURE	Change is a fundamental ingredient of interaction patterns in biology, technology, the economy, and science itself: Interactions within and between organisms change; transportation patterns by air, land, and sea all change; the global financial flow changes; and the frontiers of scientific research change. Networks and clustering methods have become important tools to comprehend instances of these large-scale structures, but without methods to distinguish between real trends and noisy data, these approaches are not useful for studying how networks change. Only if we can assign significance to the partitioning of single networks can we distinguish meaningful structural changes from random fluctuations. Here we show that bootstrap resampling accompanied by significance clustering provides a solution to this problem. To connect changing structures with the changing function of networks, we highlight and summarize the significant structural changes with alluvial diagrams and realize de Solla Price's vision of mapping change in science: studying the citation pattern between about 7000 scientific journals over the past decade, we find that neuroscience has transformed from an interdisciplinary specialty to a mature and stand-alone discipline.	[Rosvall, Martin; Bergstrom, Carl T.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bergstrom, Carl T.] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Washington; University of Washington Seattle; The Santa Fe Institute	Rosvall, M (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	rosvall@u.washington.edu	Bergstrom, Carl T./H-2299-2011; Rosvall, Martin/ABD-6411-2020; Rosvall, Martin/A-9488-2015	Bergstrom, Carl T./0000-0002-2070-385X; Rosvall, Martin/0000-0002-7181-9940	National Institute of General Medical Sciences Models [5U01GM07649]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences Models(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences Models of Infectious Disease Agent Study program cooperative agreement 5U01GM07649. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 2009, ARXIV09060612; Costenbader E, 2003, SOC NETWORKS, V25, P283, DOI 10.1016/S0378-8733(03)00012-1; Cowan WM, 2000, ANNU REV NEUROSCI, V23, P343, DOI 10.1146/annurev.neuro.23.1.343; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hunter DR, 2008, J AM STAT ASSOC, V103, P248, DOI 10.1198/016214507000000446; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Penrose D., 1993, OCCUPATIONAL THERAPY, DOI [10.1007/978-1-4899-3085-9, DOI 10.1007/978-1-4899-3085-9, DOI 10.1007/978-1-4899-4541-9]; PRICE DJD, 1965, SCIENCE, V149, P510; ROSVALL M, 2009, ARXIV09061405; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; THOMPSON SK, 2002, SAMPLING	21	341	356	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8694	10.1371/journal.pone.0008694	http://dx.doi.org/10.1371/journal.pone.0008694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111700	Green Submitted, Green Published, gold			2022-12-27	WOS:000274114800002
J	Benard, A; Mercie, P; Alioum, A; Bonnet, F; Lazaro, E; Dupon, M; Neau, D; Dabis, F; Chene, G				Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Lazaro, Estibaliz; Dupon, Michel; Neau, Didier; Dabis, Francois; Chene, Genevieve		GECSA	Bacterial Pneumonia among HIV-Infected Patients: Decreased Risk After Tobacco Smoking Cessation. ANRS CO3 Aquitaine Cohort, 2000-2007	PLOS ONE			English	Article							CIGARETTE-SMOKING; ANTIRETROVIRAL THERAPY; PNEUMOCOCCAL VACCINATION; CARDIOVASCULAR-DISEASE; IMPACT; IMMUNODEFICIENCY; PROGRESSION; MORBIDITY; MORTALITY; LEVEL	Background: Bacterial pneumonia is still a substantial cause of morbidity and mortality in HIV-infected patients in the era of combination Antiretroviral Therapy. The benefit of tobacco withdrawal on the risk of bacterial pneumonia has not been quantified in such populations, exposed to other important risk factors such as HIV-related immunodeficiency. Our objective was to estimate the effect of tobacco smoking withdrawal on the risk of bacterial pneumonia among HIV-infected individuals. Methodology/Principal Findings: Patients of the ANRS CO3 Aquitaine Cohort with >= two visits during 2000-2007 and without bacterial pneumonia at the first visit were included. Former smokers were patients who stopped smoking since >= one year. We used Cox proportional hazards models adjusted on CD4+ lymphocytes (CD4), gender, age, HIV transmission category, antiretroviral therapy, cotrimoxazole prophylaxis, statin treatment, viral load and previous AIDS diagnosis. 135 cases of bacterial pneumonia were reported in 3336 patients, yielding an incidence of 12 parts per thousand patient-years. The adjusted hazard of bacterial pneumonia was lower in former smokers (Hazard Ratio (HR): 0.48; P = 0.02) and never smokers (HR: 0.50; P = 0.01) compared to current smokers. It was higher in patients with,200 CD4 cells/mu L and in those with 200 to 349 CD4 cells/mL (HR: 2.98 and 1.98, respectively; both P, 0.01), but not in those with 350 to 499 CD4 cells/mu L (HR: 0.93; P = 0.79), compared to those with >= 500 CD4 cells/mu L. The interaction between CD4 cell count and tobacco smoking status was not statistically significant. Conclusions/Significance: Smoking cessation dramatically reduces the risk of bacterial pneumonia, whatever the level of immunodeficiency. Smoking cessation interventions should become a key element of the clinical management of HIV-infected individuals.	[Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Neau, Didier; Dabis, Francois; Chene, Genevieve] INSERM, U897, CIC EC7, Bordeaux, France; [Benard, Antoine; Mercie, Patrick; Alioum, Ahmadou; Bonnet, Fabrice; Neau, Didier; Dabis, Francois; Chene, Genevieve] Univ Victor Segalen Bordeaux 2, ISPED, Bordeaux, France; [Benard, Antoine; Mercie, Patrick; Bonnet, Fabrice; Lazaro, Estibaliz; Dupon, Michel; Neau, Didier; Dabis, Francois; Chene, Genevieve] CHU Bordeaux, COREVIH Aquitaine, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Benard, A (corresponding author), INSERM, U897, CIC EC7, Bordeaux, France.	antoine.benard@isped.u-bordeaux2.fr	chene, genevieve/H-8665-2014; Alioum, Ahmadou/U-3789-2019; Bonnet, Fabrice/T-3254-2019; Benard, Antoine/N-4738-2015; DABIS, FRANCOIS/S-9298-2019	chene, genevieve/0000-0002-8368-6460; Benard, Antoine/0000-0003-2289-8096; DABIS, FRANCOIS/0000-0002-1614-8857; BREILH, Dominique/0000-0002-3783-2797	Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France); Conseil Regional d'Aquitaine	Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France)(ANRS); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	The Groupe d'Epidimiologie Clinique du SIDA en Aquitaine (GECSA) is supported by the Agence Nationale de recherches sur le sida et les hepatites virales (ANRS, France) through the Coordinated Action N7 and by the Conseil Regional d'Aquitaine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Beck James M., 2001, American Journal of Respiratory and Critical Care Medicine, V164, P2120; Benard A, 2006, INT J TUBERC LUNG D, V10, P378; Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Bonnet F, 2007, HIV MED, V8, P547, DOI 10.1111/j.1468-1293.2007.00508.x; Bouhnik AD, 2002, JAIDS-J ACQ IMM DEF, V31, pS149, DOI 10.1097/00126334-200212153-00013; Bruyand M, 2009, CLIN INFECT DIS, V49, P1109, DOI 10.1086/605594; Burns DN, 1996, J ACQ IMMUN DEF SYND, V13, P374, DOI 10.1097/00042560-199612010-00012; CLARKE JR, 1995, THORAX, V50, P567, DOI 10.1136/thx.50.5.567; Crothers K, 2005, J GEN INTERN MED, V20, P1142, DOI 10.1111/j.1525-1497.2005.0255.x; Dray-Spira R, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000255082.31728.52; Duval X, 2008, ANTIVIR THER, V13, P389; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gordin FM, 2008, AM J RESP CRIT CARE, V178, P630, DOI 10.1164/rccm.200804-617OC; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; Joy R, 2008, JAIDS-J ACQ IMM DEF, V47, P500, DOI 10.1097/QAI.0b013e3181648dfd; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Le Moing V, 2006, HIV MED, V7, P261, DOI 10.1111/j.1468-1293.2006.00370.x; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; Lewden C, 2008, JAIDS-J ACQ IMM DEF, V48, P590, DOI 10.1097/QAI.0b013e31817efb54; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; PITTET LA, 2009, AM J RESP CELL MOL B; Rodriguez-Barradas MC, 2008, CLIN INFECT DIS, V46, P1093, DOI 10.1086/529201; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sullivan JH, 2000, AM J RESP CRIT CARE, V162, P64, DOI 10.1164/ajrccm.162.1.9904101; Tetrault JM, 2007, ARCH INTERN MED, V167, P221, DOI 10.1001/archinte.167.3.221; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Twigg HL, 1996, CELL IMMUNOL, V170, P127, DOI 10.1006/cimm.1996.0142; van de Garde EMW, 2006, THORAX, V61, P957, DOI 10.1136/thx.2006.062885; Wewers MD, 1998, AM J RESP CRIT CARE, V158, P1543, DOI 10.1164/ajrccm.158.5.9802035	32	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8896	10.1371/journal.pone.0008896	http://dx.doi.org/10.1371/journal.pone.0008896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126646	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896500018
J	Vallur, AC; Maizels, N				Vallur, Aarthy C.; Maizels, Nancy			Distinct Activities of Exonuclease 1 and Flap Endonuclease 1 at Telomeric G4 DNA	PLOS ONE			English	Article							WERNER-SYNDROME PROTEIN; REPEAT-CONTAINING RNA; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MAMMALIAN TELOMERES; SECONDARY STRUCTURE; GENOMIC STABILITY; REPLICATION FORK; MISMATCH REPAIR	Background: Exonuclease 1 (EXO1) and Flap endonuclease 1 (FEN1) are members of the RAD2 family of structure-specific nucleases. Genetic analysis has identified roles for EXO1 and FEN1 in replication, recombination, DNA repair and maintenance of telomeres. Telomeres are composed of G-rich repeats that readily form G4 DNA. We recently showed that human EXO1 and FEN1 exhibit distinct activities on G4 DNA substrates representative of intermediates in immunoglobulin class switch recombination. Methodology/Principal Findings: We have now compared activities of these enzymes on telomeric substrates bearing G4 DNA, identifying non-overlapping functions that provide mechanistic insight into the distinct telomeric phenotypes caused by their deficiencies. We show that hFEN1 but not hEXO1 cleaves substrates bearing telomeric G4 DNA 5'-flaps, consistent with the requirement for FEN1 in telomeric lagging strand replication. Both hEXO1 and hFEN1 are active on substrates bearing telomeric G4 DNA tails, resembling uncapped telomeres. Notably, hEXO1 but not hFEN1 is active on transcribed telomeric G-loops. Conclusion/Significance: Our results suggest that EXO1 may act at transcription-induced telomeric structures to promote telomere recombination while FEN1 has a dominant role in lagging strand replication at telomeres. Both enzymes can create ssDNA at uncapped telomere ends thereby contributing to recombination.	[Vallur, Aarthy C.; Maizels, Nancy] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maizels, Nancy] Univ Washington, Dept Biochem, Sch Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Vallur, AC (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	maizels@u.washington.edu			NIH [R01 GM65988, PO1 CA77852]; NATIONAL CANCER INSTITUTE [P01CA077852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 GM65988 and PO1 CA77852 to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Barnes CJ, 1996, J BIOL CHEM, V271, P29624, DOI 10.1074/jbc.271.47.29624; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Brosh RM, 2001, EMBO J, V20, P5791; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Duquette ML, 2007, CANCER RES, V67, P2586, DOI 10.1158/0008-5472.CAN-06-2419; Duquette ML, 2004, GENE DEV, V18, P1618, DOI 10.1101/gad.1200804; Eddy J, 2008, NUCLEIC ACIDS RES, V36, P1321, DOI 10.1093/nar/gkm1138; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Frank G, 2001, J BIOL CHEM, V276, P36295, DOI 10.1074/jbc.M103397200; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Fry M, 1999, J BIOL CHEM, V274, P12797, DOI 10.1074/jbc.274.18.12797; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; HARRINGTON JJ, 1994, GENE DEV, V8, P1344, DOI 10.1101/gad.8.11.1344; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Huang PH, 2001, CURR BIOL, V11, P125, DOI 10.1016/S0960-9822(01)00021-5; Huber MD, 2002, NUCLEIC ACIDS RES, V30, P3954, DOI 10.1093/nar/gkf530; Huber MD, 2006, J MOL BIOL, V358, P1071, DOI 10.1016/j.jmb.2006.01.077; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kruisselbrink E, 2008, CURR BIOL, V18, P900, DOI 10.1016/j.cub.2008.05.013; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Maizels N, 2005, ANNU REV GENET, V39, P23, DOI 10.1146/annurev.genet.39.073003.110544; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Maleki S, 2002, CURR GENET, V41, P333, DOI 10.1007/s00294-002-0307-x; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Ng LJ, 2009, NUCLEIC ACIDS RES, V37, P1152, DOI 10.1093/nar/gkn1030; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Parenteau J, 2002, GENETICS, V162, P1583; Parenteau J, 1999, MOL CELL BIOL, V19, P4143; Perlot T, 2008, P NATL ACAD SCI USA, V105, P3843, DOI 10.1073/pnas.0712291105; Phan AT, 2006, CURR OPIN STRUC BIOL, V16, P288, DOI 10.1016/j.sbi.2006.05.011; Saharia A, 2009, ONCOGENE, V28, P1162, DOI 10.1038/onc.2008.458; Saharia A, 2008, CURR BIOL, V18, P496, DOI 10.1016/j.cub.2008.02.071; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Sharma S, 2003, J BIOL CHEM, V278, P23487, DOI 10.1074/jbc.M212798200; Sharma S, 2004, MOL BIOL CELL, V15, P734, DOI 10.1091/mbc.E03-08-0567; Sharma S, 2004, J BIOL CHEM, V279, P9847, DOI 10.1074/jbc.M309898200; Sun H, 1998, J BIOL CHEM, V273, P27587, DOI 10.1074/jbc.273.42.27587; Sun H, 1999, NUCLEIC ACIDS RES, V27, P1978, DOI 10.1093/nar/27.9.1978; Sun XM, 2003, DNA REPAIR, V2, P925, DOI 10.1016/S1568-7864(03)00093-4; Tishkoff DX, 1998, CANCER RES, V58, P5027; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsolou A, 2007, DNA REPAIR, V6, P1607, DOI 10.1016/j.dnarep.2007.05.010; Vallur AC, 2008, P NATL ACAD SCI USA, V105, P16508, DOI 10.1073/pnas.0805327105; Wang WS, 2005, J BIOL CHEM, V280, P5391, DOI 10.1074/jbc.M412359200; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Wilson DM, 1998, NUCLEIC ACIDS RES, V26, P3762, DOI 10.1093/nar/26.16.3762; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	65	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8908	10.1371/journal.pone.0008908	http://dx.doi.org/10.1371/journal.pone.0008908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126648	gold, Green Submitted, Green Published			2022-12-27	WOS:000273896500026
J	Gargiulo, F; Ternes, S; Huet, S; Deffuant, G				Gargiulo, Floriana; Ternes, Sonia; Huet, Sylvie; Deffuant, Guillaume			An Iterative Approach for Generating Statistically Realistic Populations of Households	PLOS ONE			English	Article							SPATIAL MICROSIMULATION; INFLUENZA; OUTBREAKS; MODEL	Background: Many different simulation frameworks, in different topics, need to treat realistic datasets to initialize and calibrate the system. A precise reproduction of initial states is extremely important to obtain reliable forecast from the model. Methodology/Principal Findings: This paper proposes an algorithm to create an artificial population where individuals are described by their age, and are gathered in households respecting a variety of statistical constraints (distribution of household types, sizes, age of household head, difference of age between partners and among parents and children). Such a population is often the initial state of microsimulation or (agent) individual-based models. To get a realistic distribution of households is often very important, because this distribution has an impact on the demographic evolution. Usual techniques from microsimulation approach cross different sources of aggregated data for generating individuals. In our case the number of combinations of different households (types, sizes, age of participants) makes it computationally difficult to use directly such methods. Hence we developed a specific algorithm to make the problem more easily tractable. Conclusions/Significance: We generate the populations of two pilot municipalities in Auvergne region (France) to illustrate the approach. The generated populations show a good agreement with the available statistical datasets (not used for the generation) and are obtained in a reasonable computational time.	[Gargiulo, Floriana; Ternes, Sonia; Huet, Sylvie; Deffuant, Guillaume] LISC, Clermont Ferrand, France; [Ternes, Sonia] EMBRAPA, Dept Agr Informat, Sao Paulo, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Gargiulo, F (corresponding author), LISC, Clermont Ferrand, France.	floriana.gargiulo@gmail.com	Huet, Sylvie/AAV-5505-2020; Gargiulo, Floriana/GYJ-8061-2022	Huet, Sylvie/0000-0003-2973-7738; 	EU [ENV 2007-1, 212345]	EU(European Commission)	This publication has been funded under the PRIMA (Prototypical policy impacts on multifunctional activities in rural municipalities) collaborative project, EU 7th Framework Programme (ENV 2007-1), contract no. 212345. https://prima.cemagref.fr/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Ballas D, 2006, J RURAL STUD, V22, P367, DOI 10.1016/j.jrurstud.2006.01.002; Ballas D, 2005, POPUL SPACE PLACE, V11, P157, DOI 10.1002/psp.359; Ballas D, 2007, ENVIRON PLANN A, V39, P2482, DOI 10.1068/a38441; Ballas D, 2007, GEOGR ANAL, V39, P44, DOI 10.1111/j.1538-4632.2006.00695.x; BIRKIN M, 2006, SYNTHETIC DEMOGRAPHI; Colizza V, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-34; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; degli Atti MLC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001790; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; *EUR, 1999, DEM FEC DAT 1999; Gotts NM, 2003, CYBERNET SYST, V34, P663, DOI 10.1080/01969720390241566; HOLM E, 2004, MICROSIMULATION MODE; *INSEE, 1990, ENQ ET HIST FAM 1999; *INSEE, 1990, FRENCH POP CENS 1990; King A, 1999, DYNAMOD 2 OVERVIEW; NAGEL K, 1999, TRANSIMS TRANSPORTAT; Norman P, 1999, PUTTING ITERATIVE PR; Smith DM, 2009, ENVIRON PLANN A, V41, P1251, DOI 10.1068/a4147; Williamson P, 1998, ENVIRON PLANN A, V30, P785, DOI 10.1068/a300785	20	53	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8828	10.1371/journal.pone.0008828	http://dx.doi.org/10.1371/journal.pone.0008828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	547NK	20107505	Green Published, Green Submitted, gold			2022-12-27	WOS:000273896100006
J	Frei, R; Steinle, J; Birchler, T; Loeliger, S; Roduit, C; Steinhoff, D; Seibl, R; Buchner, K; Seger, R; Reith, W; Lauener, RP				Frei, Remo; Steinle, Johanna; Birchler, Thomas; Loeliger, Susanne; Roduit, Caroline; Steinhoff, Dirk; Seibl, Reinhart; Buechner, Katja; Seger, Reinhard; Reith, Walter; Lauener, Roger P.			MHC Class II Molecules Enhance Toll-Like Receptor Mediated Innate Immune Responses	PLOS ONE			English	Article							LIPID RAFTS; EPITHELIAL-CELLS; MATURATION	Background: Major histocompatibility complex (MHC) class II molecules play crucial roles in immune activation by presenting foreign peptides to antigen-specific T helper cells and thereby inducing adaptive immune responses. Although adaptive immunity is a highly effective defense system, it takes several days to become fully operational and needs to be triggered by danger-signals generated during the preceding innate immune response. Here we show that MHC class II molecules synergize with Toll-like receptor (TLR) 2 and TLR4 in inducing an innate immune response. Methodology/Principal Findings: We found that co-expression of MHC class II molecules and TLR2 or TLR4 in human embryonic kidney (HEK) cells 293 leads to enhanced production of the anti-microbial peptide human-beta-defensin (hBD) 2 after treatment with TLR2 stimulus bacterial lipoprotein (BLP) or TLR4 ligand lipopolysaccharide (LPS), respectively. Furthermore, we found that peritoneal macrophages of MHC class II knock-out mice show a decreased responsiveness to TLR2 and TLR4 stimuli compared to macrophages of wild-type mice. Finally, we show that MHC class II molecules are physically and functionally associated with TLR2 in lipid raft domains of the cell membrane. Conclusions/Significance: These results demonstrate that MHC class II molecules are, in addition to their central role in adaptive immunity, also implicated in generating optimal innate immune responses.	[Frei, Remo; Steinle, Johanna; Loeliger, Susanne; Roduit, Caroline; Steinhoff, Dirk; Seibl, Reinhart; Buechner, Katja; Seger, Reinhard; Lauener, Roger P.] Univ Zurich, Childrens Hosp, Div Immunol Allergol, Zurich, Switzerland; [Birchler, Thomas] Univ Zurich Hosp, Clin Immunol Sect, CH-8091 Zurich, Switzerland; [Reith, Walter] Univ Geneva, Sch Med, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland	University Children's Hospital Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Geneva	Frei, R (corresponding author), Univ Zurich, Childrens Hosp, Div Immunol Allergol, Zurich, Switzerland.	remo.frei@kispi.uzh.ch; roger.lauener@hgk.ch	Frei, Remo/AAI-9180-2020; Roduit, Caroline/S-4928-2017; Lauener, Roger P/O-8612-2016	Lauener, Roger P/0000-0002-8412-606X; Roduit, Caroline/0000-0002-5988-0570	Swiss National Science Foundation [3200-100324]; Kuehne Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kuehne Foundation	This work was supported by grants from the Swiss National Science Foundation (Nr. 3200-100324; http://www.snf.ch) and by the Kuehne Foundation (http://www.kuehne-stiftung.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Anderson HA, 2000, NAT IMMUNOL, V1, P156, DOI 10.1038/77842; Birchler T, 2001, EUR J IMMUNOL, V31, P3131, DOI 10.1002/1521-4141(200111)31:11<3131::AID-IMMU3131>3.0.CO;2-G; Bouillon M, 2003, J BIOL CHEM, V278, P7099, DOI 10.1074/jbc.M211566200; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Hertz CJ, 2001, J IMMUNOL, V166, P2444, DOI 10.4049/jimmunol.166.4.2444; Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Michelsen KS, 2001, J BIOL CHEM, V276, P25680, DOI 10.1074/jbc.M011615200; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	18	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8808	10.1371/journal.pone.0008808	http://dx.doi.org/10.1371/journal.pone.0008808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098705	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000273779000034
J	Merrill, JC; Melhuish, TA; Kagey, MH; Yang, SH; Sharrocks, AD; Wotton, D				Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Yang, Shen-Hsi; Sharrocks, Andrew D.; Wotton, David			A Role for Non-Covalent SUMO Interaction Motifs in Pc2/CBX4 E3 Activity	PLOS ONE			English	Article							NUCLEAR-BODY FORMATION; PROTEIN MODIFICATION; UBIQUITIN LIGASE; POLYCOMB PROTEIN; BINDING MOTIF; SUMOYLATION; MODIFIER; PML; CONJUGATION; UBC9	Background: Modification of proteins by the small ubiquitin like modifier (SUMO) is an essential process in mammalian cells. SUMO is covalently attached to lysines in target proteins via an enzymatic cascade which consists of E1 and E2, SUMO activating and conjugating enzymes. There is also a variable requirement for non-enzymatic E3 adapter like proteins, which can increase the efficiency and specificity of the sumoylation process. In addition to covalent attachment of SUMO to target proteins, specific non-covalent SUMO interaction motifs (SIMs) that are generally short hydrophobic peptide motifs have been identified. Methodology/Principal Findings: Intriguingly, consensus SIMs are present in most SUMO E3s, including the polycomb protein, Pc2/Cbx4. However, a role for SIMs in SUMO E3 activity remains to be shown. We show that Pc2 contains two functional SIMs, both of which contribute to full E3 activity in mammalian cells, and are also required for sumoylation of Pc2 itself. Pc2 forms distinct sub-nuclear foci, termed polycomb bodies, and can recruit partner proteins, such as the corepressor CtBP. We demonstrate that mutation of the SIMs in Pc2 prevents Pc2-dependent CtBP sumoylation, and decreases enrichment of SUMO1 and SUMO2 at polycomb foci. Furthermore, mutational analysis of both SUMO1 and SUMO2 reveals that the SIM-interacting residues of both SUMO isoforms are required for Pc2-mediated sumoylation and localization to polycomb foci. Conclusions/Significance: This work provides the first clear evidence for a role for SIMs in SUMO E3 activity.	[Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Merrill, Jacqueline C.; Melhuish, Tiffany A.; Kagey, Michael H.; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Yang, Shen-Hsi; Sharrocks, Andrew D.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Virginia; University of Virginia; University of Manchester	Merrill, JC (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu	Sharrocks, Andrew/J-6756-2013	Wotton, David/0000-0002-4652-5350	National Institutes of Health [HD39926]; Wellcome Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant, HD39926, to D.W. S.-H.Y. and A.D.S. were funded by a grant from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Guo DH, 2004, NAT GENET, V36, P837, DOI 10.1038/ng1391; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2001, TRENDS BIOCHEM SCI, V26, P332, DOI 10.1016/S0968-0004(01)01849-7; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hochstrasser M, 2001, CELL, V107, P5, DOI 10.1016/S0092-8674(01)00519-0; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506; Kagey MH, 2003, CELL, V113, P127, DOI 10.1016/S0092-8674(03)00159-4; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; LI B, 2007, BIOCH J; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; MACPHERSON MJ, 2008, MOL CELL BIOL; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Schwartz DC, 2003, TRENDS BIOCHEM SCI, V28, P321, DOI 10.1016/S0968-0004(03)00113-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	47	53	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8794	10.1371/journal.pone.0008794	http://dx.doi.org/10.1371/journal.pone.0008794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098713	gold, Green Published, Green Submitted			2022-12-27	WOS:000273779000021
J	Zhang, HG; Chen, YF; Ding, M; Jin, L; Case, DT; Jiao, YP; Wang, XP; Bai, CX; Jin, G; Yang, JM; Wang, H; Yuan, JB; Huang, W; Wang, ZG; Chen, RB				Zhang, Hai-Guo; Chen, Yao-Fong; Ding, Ming; Jin, Li; Case, D. Troy; Jiao, Yun-Ping; Wang, Xian-Ping; Bai, Chong-Xian; Jin, Gang; Yang, Jiang-Ming; Wang, Han; Yuan, Jian-Bing; Huang, Wei; Wang, Zhu-Gang; Chen, Ren-Biao			Dermatoglyphics from All Chinese Ethnic Groups Reveal Geographic Patterning	PLOS ONE			English	Article							ABORIGINAL POPULATION	Completion of a survey of dermatoglyphic variables for all ethnic groups in an ethnically diverse country like China is a huge research project, and an achievement that anthropological and dermatoglyphic scholars in the country could once only dream of. However, through the endeavors of scientists in China over the last 30 years, the dream has become reality. This paper reports the results of a comprehensive analysis of dermatoglyphics from all ethnic groups in China. Using cluster analysis and principal component analysis of dermatoglyphics, it has been found that Chinese populations can be generally divided into a southern group and a northern group. Furthermore, there has been considerable debate about the origins of many Chinese populations and about proper assignment of these peoples to larger ethnic groups. In this paper, we suggest that dermatoglyphic data can inform these debates by helping to classify a Chinese population as a northern or southern group, using selected reference populations and quantitative methods. This study is the first to assemble and investigate dermatoglyphics from all 56 Chinese ethnic groups. It is fortunate that data on population dermatoglyphics, a field of physical anthropology, have now been collected for all 56 Chinese ethnic groups, because intermarriage between individuals from different Chinese ethnic groups occurs more frequently in recent times, making population dermatoglyphic research an ever more challenging field of inquiry.	[Zhang, Hai-Guo; Wang, Zhu-Gang; Chen, Ren-Biao] Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200030, Peoples R China; [Chen, Yao-Fong] Tzu Chi Univ, Inst Human Dev, Hualien, Taiwan; [Ding, Ming; Jiao, Yun-Ping] Yunnan Res Inst Family Planning, Kunming, Peoples R China; [Jin, Li] Fudan Univ, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Case, D. Troy] N Carolina State Univ, Dept Sociol & Anthropol, Raleigh, NC 27695 USA; [Wang, Xian-Ping] Peoples Hosp Tibet Autonomous Reg, Lhasa, Tibet Autonomou, Peoples R China; [Bai, Chong-Xian] Hlth Training Sch Cadres, Yunnan, Honghe Pref, Peoples R China; [Jin, Gang] Peoples Hosp Xinjiang Uygur Autonomous Reg, Urumqi, Xinjiang Uygur, Peoples R China; [Yang, Jiang-Ming; Wang, Han] Qinghai Hosp Tradit Chinese Med, Xining, Qinghai, Peoples R China; [Yuan, Jian-Bing] Wulumuqi Epidem Prevent Stn, Urumqi, Xinjiang Uygur, Peoples R China; [Huang, Wei] Chinese Natl Human Genome Ctr Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Tzu Chi University; Fudan University; University of North Carolina; North Carolina State University	Zhang, HG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Med Genet, Shanghai 200030, Peoples R China.	zhanghaiguo2002@yahoo.com.cn	Jin, Li/M-5063-2019; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	Chinese National Human Genome Center at Shanghai	Chinese National Human Genome Center at Shanghai	HGZ thanks the Chinese National Human Genome Center at Shanghai for their grant support.	CHAI CK, 1971, AM J PHYS ANTHROPOL, V34, P369, DOI 10.1002/ajpa.1330340306; Chen Huan-qin, 2007, Zhongguo Xinyao yu Linchuang Zazhi, V26, P276; Chen Yao-feng, 2007, Jiepou Xuebao, V38, P606; Chen YF, 2008, SCI CHINA SER C, V51, P80, DOI 10.1007/s11427-008-0010-3; Chen YF, 2007, SCI CHINA SER C, V50, P135, DOI 10.1007/s11427-007-0005-5; CUMMINS H, 1943, FINGER PRINTS PALMS; DING M, 2001, DERMATOGLYPHICS PARA, P66; DU RF, 2004, POPULATION GENETICS, P41; GRACE HJ, 1973, HUM HERED, V23, P53, DOI 10.1159/000152553; GRACE HJ, 1974, HUM HERED, V24, P167, DOI 10.1159/000152649; HUA ZH, 1993, ACTA ANTHR SINICA, V12, P366; HUA ZH, 1995, ACTA ANTHR SINICA, V14, P233; Li H, 2006, COMPUT-AIDED CIV INF, V21, P306, DOI 10.1111/j.1467-8667.2006.00437.x; LI H, 2000, ANTHR J, V19, P244; LI H, 1999, J FUDAN U NATURAL SC, V38, P517; [林凌 Lin Ling], 2002, [人类学学报, Acta Anthropologica Sinica], V21, P293; LIU SM, 1985, TIANJIN MED J, V13, P342; LONG ZG, 1987, J YOUJIANG MED COLL, V9, P26; LU SH, 1995, ACTA ANTHR SINICA, V14, P240; PENROSE LS, 1963, NATURE, V197, P933, DOI 10.1038/197933a0; Reed T, 2006, AM J MED GENET A, V140A, P263, DOI 10.1002/ajmg.a.31086; RUAN JC, 1992, J SHANGHAI TEACHERS, V21, P86; SCHAUMANN B, 1976, DERMATOGLYPHICS MED; [王平 Wang Ping], 2003, [解剖学报, Acta Anatomica Sinica], V34, P208; WU LF, 1991, DERMATOGLYPHICS NATL, P168; [徐双进 Xu Shuangjin], 2004, [解剖学报, Acta Anatomica Sinica], V35, P660; [杨江民 Yang Jiangmin], 2002, [人类学学报, Acta Anthropologica Sinica], V21, P315; [袁疆斌 Yuan Jiangbin], 2003, [解剖学杂志, Chinese Journal of Anatomy], V26, P178; ZHANG HG, 2002, NATL DERMATOGLYPHICS, P11; ZHANG HG, 2006, HUMAN DERMATOGLYPHIC; [张子波 Zhang Zibo], 2004, [人类学学报, Acta Anthropologica Sinica], V23, P164	31	26	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8783	10.1371/journal.pone.0008783	http://dx.doi.org/10.1371/journal.pone.0008783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098698	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779000012
J	Chan, RWY; Yuen, KM; Yu, WCL; Ho, CCC; Nicholls, JM; Peiris, JSM; Chan, MCW				Chan, Renee W. Y.; Yuen, Kit M.; Yu, Wendy C. L.; Ho, Carol C. C.; Nicholls, John M.; Peiris, J. S. Malik; Chan, Michael C. W.			Influenza H5N1 and H1N1 Virus Replication and Innate Immune Responses in Bronchial Epithelial Cells Are Influenced by the State of Differentiation	PLOS ONE			English	Article							HUMAN AIRWAY EPITHELIUM; CYTOKINE RESPONSES; HUMAN ALVEOLAR; IN-VITRO; INFECTION; MECHANISM; RECEPTOR; MUCIN; PATHOGENESIS; CORONAVIRUS	Influenza H5N1 virus continues to be enzootic in poultry and transmits zoonotically to humans. Although a swine-origin H1N1 virus has emerged to become pandemic, its virulence for humans remains modest in comparison to that seen in zoonotic H5N1 disease. As human respiratory epithelium is the primary target cells for influenza viruses, elucidating the viral tropism and host innate immune responses of influenza H5N1 virus in human bronchial epithelium may help to understand the pathogenesis. Here we established primary culture of undifferentiated and well differentiated normal human bronchial epithelial (NHBE) cells and infected with highly pathogenic influenza H5N1 virus (A/Vietnam/3046/2004) and a seasonal influenza H1N1 virus (A/Hong Kong/54/1998), the viral replication kinetics and cytokine and chemokine responses were compared by qPCR and ELISA. We found that the in vitro culture of the well differentiated NHBE cells acquired the physiological properties of normal human bronchi tissue which express high level of alpha 2-6-linked sialic acid receptors and human airway trypsin-like (HAT) protease, in contrast to the low expression in the non-differentiated NHBE cells. When compared to H1N1 virus, the H5N1 virus replicated more efficiently and induced a stronger type I interferon response in the undifferentiated NHBE cells. In contrast, in well differentiated cultures, H5N1 virus replication was less efficient and elicited a lower interferon-beta response in comparison with H1N1 virus. Our data suggest that the differentiation of bronchial epithelial cells has a major influence in cells' permissiveness to human H1N1 and avian H5N1 viruses and the host innate immune responses. The reduced virus replication efficiency partially accounts for the lower interferon-beta responses in influenza H5N1 virus infected well differentiated NHBE cells. Since influenza infection in the bronchial epithelium will lead to tissue damage and associate with the epithelium regeneration, the data generated from the undifferentiated NHBE cultures may also be relevant to disease pathogenesis.	[Chan, Renee W. Y.; Yuen, Kit M.; Yu, Wendy C. L.; Ho, Carol C. C.; Peiris, J. S. Malik; Chan, Michael C. W.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Yuen, Kit M.; Nicholls, John M.] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Pokfulam, Hong Kong, Peoples R China; [Peiris, J. S. Malik] HKU Pasteur Res Ctr, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, RWY (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China.	mchan@hkucc.hku.hk	Chan, Renee/D-4799-2012; Chan, Michael Chi Wai/C-4212-2009; Chan, Renee Wan Yi/AAA-6598-2020; Nicholls, John Malcolm/C-4375-2009	Chan, Michael Chi Wai/0000-0001-8174-8405; Chan, Renee Wan Yi/0000-0001-6485-0926; Nicholls, John Malcolm/0000-0001-7217-7444	Research Fund for Control of Infectious Disease; Hong Kong SAR Government; General Research Fund [HKU 7612/08M]; Research Grants Council, Hong Kong SAR Government; AoE Funding [AoE/M-12/06]; University Grants Committee	Research Fund for Control of Infectious Disease; Hong Kong SAR Government; General Research Fund; Research Grants Council, Hong Kong SAR Government(Hong Kong Research Grants Council); AoE Funding; University Grants Committee	Funding: This work was supported by Research Fund for Control of Infectious Disease Grant (RFCID grants, reference no: 03040712 and 06060552) from the Research Fund for Control of Infectious Disease, Health, Welfare and Food Bureau, Hong Kong SAR Government and the General Research Fund (HKU 7612/08M), Research Grants Council, Hong Kong SAR Government (to M. C. W. C); and AoE Funding (AoE/M-12/06) from the Area of Excellence Scheme of the University Grants Committee, Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1997, INT ARCH ALLERGY IMM, V113, P307, DOI 10.1159/000237584; Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; BAUM LG, 1990, ACTA HISTOCHEM, P35; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chan MCW, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-102; CHAN RWY, 2009, DAS181 INHIBITS H5N1, P389; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Danahay H, 2006, AM J PHYSIOL-LUNG C, V290, pL558, DOI 10.1152/ajplung.00351.2005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; LeSimple P, 2007, AM J RESP CELL MOL, V36, P296, DOI 10.1165/rcmb.2006-0270OC; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Matsukura S, 1996, J ALLERGY CLIN IMMUN, V98, P1080, DOI 10.1016/S0091-6749(96)80195-3; NELSON J, 1993, VIRUS RES, V29, P155, DOI 10.1016/0168-1702(93)90056-S; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Park JA, 2005, AM J PATHOL, V167, P651, DOI 10.1016/S0002-9440(10)62040-8; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; PEREZPADILLA R, 2009, N ENGL J MED; SHUCHIH, 2008, J PHARM SCI, V9999; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Sims AC, 2008, VIRUS RES, V133, P33, DOI 10.1016/j.virusres.2007.03.013; Suzuki Y, 2005, BIOL PHARM BULL, V28, P399, DOI 10.1248/bpb.28.399; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; *WHO, 2009, CUM NUMB CONF HUM CA; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC	31	72	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8713	10.1371/journal.pone.0008713	http://dx.doi.org/10.1371/journal.pone.0008713			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090947	Green Submitted, Green Published, gold			2022-12-27	WOS:000273714900002
J	Yoder-Himes, DR; Konstantinidis, KT; Tiedje, JM				Yoder-Himes, Deborah R.; Konstantinidis, Konstantinos T.; Tiedje, James M.			Identification of Potential Therapeutic Targets for Burkholderia cenocepacia by Comparative Transcriptomics	PLOS ONE			English	Article							SIGNAL PEPTIDES; EXOPOLYSACCHARIDE PRODUCTION; CAENORHABDITIS-ELEGANS; PROTECTIVE ANTIGEN; ESCHERICHIA-COLI; GENE-EXPRESSION; CABLE PILI; CEPACIA; PROTEIN; PREDICTION	Background: Burkholderia cenocepacia is an endemic soil dweller and emerging opportunistic pathogen in patients with cystic fibrosis (CF). The identification of virulence factors and potential therapeutic targets has been hampered by the genomic diversity within the species as many factors are not shared among the pathogenic members of the species. Methodology/Principal Findings: In this study, global identification of putative virulence factors was performed by analyzing the transcriptome of two related strains of B. cenocepacia (one clinical, one environmental) under conditions mimicking cystic fibrosis sputum versus soil. Soil is a natural reservoir for this species; hence, genes induced under CF conditions relative to soil may represent adaptations that have occurred in clinical strains. Under CF conditions, several genes encoding proteins thought to be involved in virulence were induced and many new ones were identified. Our analysis, in combination with previous studies, reveals 458 strain-specific genes, 126 clinical-isolate-specific, and at least four species-specific genes that are induced under CF conditions. The chromosomal distribution of the induced genes was disproportionate to the size of the chromosome as genes expressed under soil conditions by both strains were more frequent on the second chromosome and those differentially regulated between strains were more frequent on the third chromosome. Conservation of these induced genes was established using the 11 available Bcc genome sequences to indicate whether potential therapeutic targets would be species-wide. Conclusions/Significance: Comparative transcriptomics is a useful way to identify new potential virulence factors and therapeutic targets for pathogenic bacteria. We identified eight genes induced under CF conditions that were also conserved in the Bcc and may constitute particularly attractive therapeutic targets due to their signal sequence, predicted cellular location, and homology to known therapeutic targets.	[Yoder-Himes, Deborah R.; Tiedje, James M.] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA	Michigan State University; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Yoder-Himes, DR (corresponding author), Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA.	tiedjej@msu.edu	Konstantinidis, Kostas/ABE-7113-2020	Konstantinidis, Kostas/0000-0002-0954-4755; Yoder-Himes, Deborah/0000-0001-9576-3833	Cystic Fibrosis Foundation; National Science Foundation [056252]; National Institutes of Health [R21HL087833]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087833] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by the Cystic Fibrosis Foundation Therapeutics with contributions on the role of expression in speciation by National Science Foundation Grant 056252 and on screening for virulence determinants by National Institutes of Health Grant R21HL087833. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldwin A, 2004, INFECT IMMUN, V72, P1537, DOI 10.1128/IAI.72.3.1537-1547.2004; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BIEMANS RKP, 2006, VACCINE COMPOSITIONS; Chain PSG, 2006, P NATL ACAD SCI USA, V103, P15280, DOI 10.1073/pnas.0606924103; Chiu HC, 2007, HELICOBACTER, V12, P74; Chung JW, 2003, INFECT IMMUN, V71, P904, DOI 10.1128/IAI.71.2.904-909.2003; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141; Dave JA, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-30; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Genevrois S, 2003, EMBO J, V22, P1780, DOI 10.1093/emboj/cdg174; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Gingues S, 2005, J BACTERIOL, V187, P8247, DOI 10.1128/JB.187.24.8247-8255.2005; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Hutchison ML, 1999, MICROBES INFECT, V1, P1005, DOI 10.1016/S1286-4579(99)80518-8; Hutchison ML, 1998, INFECT IMMUN, V66, P2033, DOI 10.1128/IAI.66.5.2033-2039.1998; KILMER VJ, 1982, HDB SOILS CLIMATE AG, P190; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kothe M, 2003, CELL MICROBIOL, V5, P343, DOI 10.1046/j.1462-5822.2003.00280.x; Law RJ, 2008, J BACTERIOL, V190, P7209, DOI 10.1128/JB.00481-08; Leiske DL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-72; Lipski SL, 2007, INFECT IMMUN, V75, P314, DOI 10.1128/IAI.01330-06; LiPuma J J, 2001, Transpl Infect Dis, V3, P149, DOI 10.1034/j.1399-3062.2001.003003149.x; LiPuma JJ, 2002, LANCET, V359, P2002, DOI 10.1016/S0140-6736(02)08836-0; Loosmore SM, 1997, INFECT IMMUN, V65, P3701, DOI 10.1128/IAI.65.9.3701-3707.1997; Mahenthiralingam E, 1997, J CLIN MICROBIOL, V35, P808, DOI 10.1128/JCM.35.4.808-816.1997; Meinke A, 2004, CURR OPIN MICROBIOL, V7, P314, DOI 10.1016/j.mib.2004.04.008; Mohr CD, 2001, MICROBES INFECT, V3, P425, DOI 10.1016/S1286-4579(01)01389-2; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielubowicz GR, 2008, INFECT IMMUN, V76, P4222, DOI 10.1128/IAI.00533-08; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; PARKE JL, 2000, BURKHOLDERIA CEPACIA; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; Redford P, 2006, INFECT IMMUN, V74, P4030, DOI 10.1128/IAI.01984-05; Sajjan U, 2002, MICROBIOL-SGM, V148, P3477, DOI 10.1099/00221287-148-11-3477; Sajjan U, 2002, CELL MICROBIOL, V4, P73, DOI 10.1046/j.1462-5822.2002.00171.x; SAJJAN US, 1995, J BACTERIOL, V177, P1030, DOI 10.1128/jb.177.4.1030-1038.1995; Schweizer Herbert P, 2003, Genet Mol Res, V2, P48; Slater SC, 2009, J BACTERIOL, V191, P2501, DOI 10.1128/JB.01779-08; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; Sokol PA, 2007, FUTURE MICROBIOL, V2, P555, DOI 10.2217/17460913.2.5.555; Tashiro Y, 2008, J BACTERIOL, V190, P3969, DOI 10.1128/JB.02004-07; THOMAS WR, 1990, INFECT IMMUN, V58, P1909, DOI 10.1128/IAI.58.6.1909-1913.1990; Tomich M, 2003, FEMS MICROBIOL LETT, V228, P287, DOI 10.1016/S0378-1097(03)00785-7; Tomich M, 2004, J BACTERIOL, V186, P3826, DOI 10.1128/JB.186.12.3826-3836.2004; Tomich M, 2003, INFECT IMMUN, V71, P1405, DOI 10.1128/IAI.71.3.1405-1415.2003; Tomich M, 2004, J BACTERIOL, V186, P1009, DOI 10.1128/JB.186.4.1009-1020.2004; Tomich M, 2002, INFECT IMMUN, V70, P1799, DOI 10.1128/IAI.70.4.1799-1806.2002; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Visser MB, 2004, INFECT IMMUN, V72, P2850, DOI 10.1128/IAI.72.5.2850-2857.2004; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Zlosnik JEA, 2008, J CLIN MICROBIOL, V46, P1470, DOI 10.1128/JCM.02273-07; ON LINE RESOURCE TGD	61	30	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8724	10.1371/journal.pone.0008724	http://dx.doi.org/10.1371/journal.pone.0008724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090946	Green Published, Green Submitted, gold			2022-12-27	WOS:000273714900005
J	Russello, MA; Poulakakis, N; Gibbs, JP; Tapia, W; Benavides, E; Powell, JR; Caccone, A				Russello, Michael A.; Poulakakis, Nikos; Gibbs, James P.; Tapia, Washington; Benavides, Edgar; Powell, Jeffrey R.; Caccone, Adalgisa			DNA from the Past Informs Ex Situ Conservation for the Future: An "Extinct'' Species of Galapagos Tortoise Identified in Captivity	PLOS ONE			English	Article							GIANT TORTOISES; POPULATION-STRUCTURE; GENETIC-DIVERGENCE; PHYLOGEOGRAPHY; RELATEDNESS; MANAGEMENT; HISTORY	Background: Although not unusual to find captive relicts of species lost in the wild, rarely are presumed extinct species rediscovered outside of their native range. A recent study detected living descendents of an extinct Galapagos tortoise species (Chelonoidis elephantopus) once endemic to Floreana Island on the neighboring island of Isabela. This finding adds to the growing cryptic diversity detected among these species in the wild. There also exists a large number of Galapagos tortoises in captivity of ambiguous origin. The recently accumulated population-level haplotypic and genotypic data now available for C. elephantopus add a critical reference population to the existing database of 11 extant species for investigating the origin of captive individuals of unknown ancestry. Methodology/Findings: We reanalyzed mitochondrial DNA control region haplotypes and microsatellite genotypes of 156 captive individuals using an expanded reference database that included all extant Galapagos tortoise species as well as the extinct species from Floreana. Nine individuals (six females and three males) exhibited strong signatures of Floreana ancestry and a high probability of assignment to C. elephantopus as detected by Bayesian assignment and clustering analyses of empirical and simulated data. One male with high assignment probability to C. elephantopus based on microsatellite genotypic data also possessed a "Floreana-like'' mitochondrial DNA haplotype. Significance: Historical DNA analysis of museum specimens has provided critical spatial and temporal components to ecological, evolutionary, taxonomic and conservation-related research, but rarely has it informed ex situ species recovery efforts. Here, the availability of population-level genotypic data from the extinct C. elephantopus enabled the identification of nine Galapagos tortoise individuals of substantial conservation value that were previously misassigned to extant species of varying conservation status. As all captive individuals of C. elephantopus ancestry currently reside at a centralized breeding facility on Santa Cruz, these findings permit breeding efforts to commence in support of the reestablishment of this extinct species to its native range.	[Russello, Michael A.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Poulakakis, Nikos] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Poulakakis, Nikos] Univ Crete, Nat Hist Museum Crete, Iraklion, Crete, Greece; [Gibbs, James P.] SUNY Syracuse, Coll Environm Sci & Forestry, Syracuse, NY 13210 USA; [Tapia, Washington] Galapagos Natl Pk Serv, Puerto Ayora, Galapagos, Ecuador; [Benavides, Edgar; Powell, Jeffrey R.; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	University of British Columbia; University of British Columbia Okanagan; University of Crete; University of Crete; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Yale University	Russello, MA (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	michael.russello@ubc.ca	Poulakakis, Nikos/E-7848-2011; Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Tapia, Washington/0000-0002-5222-1804	Paul and Bay Foundation; Turtle Conservation Fund; National Geographic Society; Yale Institute for Biospheric Studies (YIBS)	Paul and Bay Foundation; Turtle Conservation Fund; National Geographic Society(National Geographic Society); Yale Institute for Biospheric Studies (YIBS)	Funding was provided by the Paul and Bay Foundation, Turtle Conservation Fund, National Geographic Society, and Yale Institute for Biospheric Studies (YIBS) Ecosave funds to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beheregaray LB, 2004, P NATL ACAD SCI USA, V101, P6514, DOI 10.1073/pnas.0400393101; Beheregaray LB, 2003, CONSERV GENET, V4, P31, DOI 10.1023/A:1021864214375; Burns CE, 2003, ANIM CONSERV, V6, P329, DOI 10.1017/S1367943003003408; Caccone A, 2002, EVOLUTION, V56, P2052; Ciofi C, 2006, GENETICS, V172, P1727, DOI 10.1534/genetics.105.047860; Ciofi C, 2002, MOL ECOL, V11, P2265, DOI 10.1046/j.1365-294X.2002.01617.x; Ciofi Claudio, 2009, V17, P269; Collins, 1994, CAPTIVE MANAGEMENT C, P297; Cornuet JM, 1999, GENETICS, V153, P1989; Driscoll CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004125; Ernst CH., 1989, TURTLES WORLD; FRITTS TH, 1984, BIOL J LINN SOC, V21, P165, DOI 10.1111/j.1095-8312.1984.tb02059.x; Gaimard J. P., 1824, VOYAGE AUTOUR MONDE, P174; Hedrick PW, 2009, J HERED, V100, P411, DOI 10.1093/jhered/esp024; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2014, IUCN RED LIST THREAT; Iyengar A, 2007, MOL ECOL, V16, P2436, DOI 10.1111/j.1365-294X.2007.03291.x; Lancaster ML, 2006, MOL ECOL, V15, P3681, DOI 10.1111/j.1365-294X.2006.03041.x; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; Lynch M, 1999, GENETICS, V152, P1753; Milinkovitch MC, 2004, P ROY SOC B-BIOL SCI, V271, P341, DOI 10.1098/rspb.2003.2607; Milinkovitch Michel C., 2007, BMC Ecology, V7, P2, DOI 10.1186/1472-6785-7-2; Nicholls H, 2006, LONESOME GEORGE LIFE; Poulakakis N, 2008, P NATL ACAD SCI USA, V105, P15464, DOI 10.1073/pnas.0805340105; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard Peter C.H., 1996, Chelonian Research Monographs, V1, P1; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Russello M., 2009, IREL V1 0 ONLINE TOO; Russello MA, 2007, ANIM CONSERV, V10, P304, DOI 10.1111/j.1469-1795.2007.00113.x; Russello MA, 2005, BIOL LETT-UK, V1, P287, DOI 10.1098/rsbl.2005.0317; Russello MA, 2004, MOL ECOL, V13, P2829, DOI 10.1111/j.1365-294X.2004.02266.x; Russello MA, 2007, MOL ECOL, V16, P2405, DOI 10.1111/j.1365-294X.2007.03376.x; Russello MA, 2007, CURR BIOL, V17, pR317, DOI 10.1016/j.cub.2007.03.002; Steeves TE, 2010, BIOL LETTERS, V6, P94, DOI 10.1098/rsbl.2009.0478; Van Denburgh J., 1914, Proceedings of the California Academy of Science (4th Series), V2; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WHARTON DC, 1990, BACKCROSSING SPECIES	39	30	31	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8683	10.1371/journal.pone.0008683	http://dx.doi.org/10.1371/journal.pone.0008683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084268	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600033
J	Wisniewska, M; Karlberg, T; Lehtio, L; Johansson, I; Kotenyova, T; Moche, M; Schuler, H				Wisniewska, Magdalena; Karlberg, Tobias; Lehtio, Lari; Johansson, Ida; Kotenyova, Tetyana; Moche, Martin; Schuler, Herwig			Crystal Structures of the ATPase Domains of Four Human Hsp70 Isoforms: HSPA1L/Hsp70-hom, HSPA2/Hsp70-2, HSPA6/Hsp70B ', and HSPA5/BiP/GRP78	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE EXCHANGE; HEAT-SHOCK-PROTEIN-70 FAMILY; GENETIC POLYMORPHISMS; SUBSTRATE-BINDING; EXPRESSION; CHAPERONES; DNAK; SITE	The 70-kDa heat shock proteins (Hsp70) are chaperones with central roles in processes that involve polypeptide remodeling events. Hsp70 proteins consist of two major functional domains: an N-terminal nucleotide binding domain (NBD) with ATPase activity, and a C-terminal substrate binding domain (SBD). We present the first crystal structures of four human Hsp70 isoforms, those of the NBDs of HSPA1L, HSPA2, HSPA5 and HSPA6. As previously with Hsp70 family members, all four proteins crystallized in a closed cleft conformation, although a slight cleft opening through rotation of subdomain IIB was observed for the HSPA5-ADP complex. The structures presented here support the view that the NBDs of human Hsp70 function by conserved mechanisms and contribute little to isoform specificity, which instead is brought about by the SBDs and by accessory proteins.	[Wisniewska, Magdalena; Karlberg, Tobias; Lehtio, Lari; Johansson, Ida; Kotenyova, Tetyana; Moche, Martin; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden	Karolinska Institutet	Wisniewska, M (corresponding author), Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501; Lehtio, Lari/0000-0001-7250-832X; Moche, Martin/0000-0002-4834-7076	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Brewer JW, 2005, NAT IMMUNOL, V6, P23, DOI 10.1038/ni1149; Brocchieri L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-19; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Dudek J, 2009, CELL MOL LIFE SCI, V66, P1556, DOI 10.1007/s00018-009-8745-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feng HL, 2001, FERTIL STERIL, V76, P1136, DOI 10.1016/S0015-0282(01)02892-8; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; GAUT JR, 1993, J BIOL CHEM, V268, P12691; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govin J, 2006, J BIOL CHEM, V281, P37888, DOI 10.1074/jbc.M608147200; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; HENDERSHOT LM, 1994, GENOMICS, V20, P281, DOI 10.1006/geno.1994.1166; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; ISHIHARA M, 1995, TISSUE ANTIGENS, V46, P59, DOI 10.1111/j.1399-0039.1995.tb02477.x; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; LEUNG TKC, 1990, BIOCHEM J, V267, P125, DOI 10.1042/bj2670125; LEUNG TKC, 1992, GENOMICS, V12, P74, DOI 10.1016/0888-7543(92)90409-L; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; MCCARTY JS, 1991, P NATL ACAD SCI USA, V88, P9513, DOI 10.1073/pnas.88.21.9513; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MILNER CM, 1990, IMMUNOGENETICS, V32, P242; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noonan EJ, 2007, CELL STRESS CHAPERON, V12, P219, DOI 10.1379/CSC-278.1; Osipiuk J, 1999, ACTA CRYSTALLOGR D, V55, P1105, DOI 10.1107/S0907444999002103; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; SARGENT CA, 1989, P NATL ACAD SCI USA, V86, P1968, DOI 10.1073/pnas.86.6.1968; Sasaki T, 2008, J CELL BIOL, V182, P449, DOI 10.1083/jcb.200802113; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Son WY, 1999, MOL HUM REPROD, V5, P1122, DOI 10.1093/molehr/5.12.1122; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Spagnolo P, 2007, INVEST OPHTH VIS SCI, V48, P3019, DOI 10.1167/iovs.06-1485; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; TING J, 1988, DNA-J MOLEC CELL BIO, V7, P275, DOI 10.1089/dna.1988.7.275; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; WEI JY, 1995, J BIOL CHEM, V270, P26670, DOI 10.1074/jbc.270.44.26670; Wu XJ, 2004, BIOCHEM J, V378, P793, DOI 10.1042/BJ20031680; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P1309, DOI 10.1038/nsmb.1518; Zhu DH, 1997, DEVELOPMENT, V124, P3007; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	51	105	114	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8625	10.1371/journal.pone.0008625	http://dx.doi.org/10.1371/journal.pone.0008625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20072699	gold, Green Published			2022-12-27	WOS:000273456300005
J	Ringkamp, M; Johanek, LM; Borzan, J; Hartke, TV; Wu, G; Pogatzki-Zahn, EM; Campbell, JN; Shim, B; Schepers, RJ; Meyer, RA				Ringkamp, Matthias; Johanek, Lisa M.; Borzan, Jasenka; Hartke, Timothy V.; Wu, Gang; Pogatzki-Zahn, Esther M.; Campbell, James N.; Shim, Beom; Schepers, Raf J.; Meyer, Richard A.			Conduction Properties Distinguish Unmyelinated Sympathetic Efferent Fibers and Unmyelinated Primary Afferent Fibers in the Monkey	PLOS ONE			English	Article							VELOCITY RECOVERY CYCLES; INNERVATING HUMAN SKIN; C-FIBERS; RAT; SODIUM; NOCICEPTORS; NERVE; INACTIVATION; HYPERALGESIA; MODALITY	Background: Different classes of unmyelinated nerve fibers appear to exhibit distinct conductive properties. We sought a criterion based on conduction properties for distinguishing sympathetic efferents and unmyelinated, primary afferents in peripheral nerves. Methodology/Principal Findings: In anesthetized monkey, centrifugal or centripetal recordings were made from single unmyelinated nerve fibers in the peroneal or sural nerve, and electrical stimuli were applied to either the sciatic nerve or the cutaneous nerve endings, respectively. In centrifugal recordings, electrical stimulation at the sympathetic chain and dorsal root was used to determine the fiber's origin. In centrifugal recordings, sympathetic fibers exhibited absolute speeding of conduction to a single pair of electrical stimuli separated by 50 ms; the second action potential was conducted faster (0.61 for all 0.16%) than the first unconditioned action potential. This was never observed in primary afferents. Following 2 Hz stimulation (3 min), activity-dependent slowing of conduction in the sympathetics (8.6 for all 0.5%) was greater than in one afferent group (6.7 for all 0.5%) but substantially less than in a second afferent group (29.4 for all 1.9%). In centripetal recordings, most mechanically-insensitive fibers also exhibited absolute speeding to twin pulse stimulation. The subset that did not show this absolute speeding was responsive to chemical stimuli (histamine, capsaicin) and likely consists of mechanically-insensitive afferents. During repetitive twin pulse stimulation, mechanosensitive afferents developed speeding, and speeding in sympathetic fibers increased. Conclusions/Significance: The presence of absolute speeding provides a criterion by which sympathetic efferents can be differentiated from primary afferents. The differences in conduction properties between sympathetics and afferents likely reflect differential expression of voltage-sensitive ion channels.	[Ringkamp, Matthias; Johanek, Lisa M.; Hartke, Timothy V.; Wu, Gang; Pogatzki-Zahn, Esther M.; Campbell, James N.; Shim, Beom; Schepers, Raf J.; Meyer, Richard A.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Borzan, Jasenka] Johns Hopkins Univ, Dept Anesthesiol, Sch Med, Baltimore, MD USA; [Meyer, Richard A.] Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Ringkamp, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA.	platelet@jhmi.edu		Shim, Beom/0000-0003-1318-7778	National Institutes of Health [NS-14447, NS-047399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047399, R01NS014447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (NS-14447 and NS-047399). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMETT CJ, 1963, J PHYSIOL-LONDON, V165, P130, DOI 10.1113/jphysiol.1963.sp007047; BARRETT EF, 1982, J PHYSIOL-LONDON, V323, P117, DOI 10.1113/jphysiol.1982.sp014064; Bostock H, 2003, J PHYSIOL-LONDON, V553, P649, DOI 10.1113/jphysiol.2003.046342; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98, DOI 10.1152/jn.1983.49.1.98; Campero M, 2004, ACTA PHYSIOL SCAND, V182, P305, DOI 10.1111/j.1365-201X.2004.01357.x; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; DARIANSMITH I, 1979, J NEUROPHYSIOL, V42, P1297, DOI 10.1152/jn.1979.42.5.1297; De Col R, 2008, J PHYSIOL-LONDON, V586, P1089, DOI 10.1113/jphysiol.2007.145383; Gee MD, 1996, NEUROSCIENCE, V73, P667, DOI 10.1016/0306-4522(96)00070-X; George A, 2007, J PHYSIOL-LONDON, V578, P213, DOI 10.1113/jphysiol.2006.116129; Leffler A, 2007, J PHARMACOL EXP THER, V320, P354, DOI 10.1124/jpet.106.109025; Martinez-Pinna J, 2000, J PHYSIOL-LONDON, V527, P249, DOI 10.1111/j.1469-7793.2000.00249.x; MEYER RA, 1991, BRAIN RES, V561, P252, DOI 10.1016/0006-8993(91)91601-V; NAMER B, 2008, J NEUROPHYSIOL; Peng YB, 1999, J NEUROPHYSIOL, V82, P1164, DOI 10.1152/jn.1999.82.3.1164; RAYMOND SA, 1990, BRAIN RES, V526, P318, DOI 10.1016/0006-8993(90)91239-D; Ringkamp M, 1999, PAIN, V79, P143, DOI 10.1016/S0304-3959(98)00186-9; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; Schmelz M, 1997, J NEUROSCI, V17, P8003; Scroggs RS, 2008, J PHYSIOL-LONDON, V586, P923, DOI 10.1113/jphysiol.2008.150821; Serra J, 2004, J NEUROPHYSIOL, V91, P2770, DOI 10.1152/jn.00565.2003; Serra J, 1999, J PHYSIOL-LONDON, V515, P799, DOI 10.1111/j.1469-7793.1999.799ab.x; THALHAMMER JG, 1994, SOMATOSENS MOT RES, V11, P243, DOI 10.3109/08990229409051392; Weidner C, 1999, J NEUROSCI, V19, P10184; Weidner C, 2000, J PHYSIOL-LONDON, V527, P185, DOI 10.1111/j.1469-7793.2000.00185.x; Weidner C, 2002, J NEUROSCI, V22, P6704; Wessberg J, 2003, J NEUROPHYSIOL, V89, P1567, DOI 10.1152/jn.00256.2002	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9076	10.1371/journal.pone.0009076	http://dx.doi.org/10.1371/journal.pone.0009076			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140089	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442400014
J	Kram, YA; Mantey, S; Corbo, JC				Kram, Yoseph A.; Mantey, Stephanie; Corbo, Joseph C.			Avian Cone Photoreceptors Tile the Retina as Five Independent, Self-Organizing Mosaics	PLOS ONE			English	Article							CELL-REARRANGEMENT MODEL; MINIMAL-SPACING RULE; OIL DROPLETS; ZEBRAFISH RETINA; VORONOI TESSELLATIONS; GANGLION-CELLS; COLOR-VISION; SPECTRAL SENSITIVITIES; PATTERN-FORMATION; MAMMALIAN RETINA	The avian retina possesses one of the most sophisticated cone photoreceptor systems among vertebrates. Birds have five types of cones including four single cones, which support tetrachromatic color vision and a double cone, which is thought to mediate achromatic motion perception. Despite this richness, very little is known about the spatial organization of avian cones and its adaptive significance. Here we show that the five cone types of the chicken independently tile the retina as highly ordered mosaics with a characteristic spacing between cones of the same type. Measures of topological order indicate that double cones are more highly ordered than single cones, possibly reflecting their posited role in motion detection. Although cones show spacing interactions that are cell type-specific, all cone types use the same density-dependent yardstick to measure intercone distance. We propose a simple developmental model that can account for these observations. We also show that a single parameter, the global regularity index, defines the regularity of all five cone mosaics. Lastly, we demonstrate similar cone distributions in three additional avian species, suggesting that these patterning principles are universal among birds. Since regular photoreceptor spacing is critical for uniform sampling of visual space, the cone mosaics of the avian retina represent an elegant example of the emergence of adaptive global patterning secondary to simple local interactions between individual photoreceptors. Our results indicate that the evolutionary pressures that gave rise to the avian retina's various adaptations for enhanced color discrimination also acted to fine-tune its spatial sampling of color and luminance.	[Kram, Yoseph A.; Mantey, Stephanie; Corbo, Joseph C.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Kram, YA (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	jcorbo@pathology.wustl.edu		Corbo, Joseph/0000-0002-9323-7140	National Eye Institute [R01EY018826]; Howard Hughes Medical Institute; Office of Undergraduate Research Hoopes Award; NATIONAL EYE INSTITUTE [R01EY018826] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Undergraduate Research Hoopes Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This project was funded by a grant from the National Eye Institute (R01EY018826). Additional financial support came from a Summer Undergraduate Research Fellowship from the Howard Hughes Medical Institute and the Office of Undergraduate Research Hoopes Award at Washington University and from an undergraduate summer research fellowship from the Honors Program at the University of Michigan Flint. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt Peter Kurt, 1996, Revista Brasileira de Biologia, V56, P199; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; [Anonymous], VERTEBRATE EYE ITS A, DOI 10.1097/00005053-194409000-00057; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Aste T., 2008, PURSUIT PERFECT PACK, V2nd; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; BOSSOMAIER TRJ, 1985, VISION RES, V25, P145, DOI 10.1016/0042-6989(85)90089-6; BOWMAKER JK, 1977, VISION RES, V17, P755, DOI 10.1016/0042-6989(77)90117-1; BRANCHEK T, 1984, J COMP NEUROL, V224, P107, DOI 10.1002/cne.902240109; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Cellerino A, 2000, EUR J NEUROSCI, V12, P613, DOI 10.1046/j.1460-9568.2000.00944.x; Collin SP, 2009, PHILOS T R SOC B, V364, P2925, DOI 10.1098/rstb.2009.0099; COOK JE, 1992, J COMP NEUROL, V318, P355, DOI 10.1002/cne.903180402; Cook JE, 1996, VISUAL NEUROSCI, V13, P15, DOI 10.1017/S0952523800007094; Cook JE, 2000, TRENDS NEUROSCI, V23, P26, DOI 10.1016/S0166-2236(99)01487-3; CURCIO CA, 1992, VISUAL NEUROSCI, V9, P169, DOI 10.1017/S0952523800009639; Daudet N, 2009, DEV BIOL, V326, P86, DOI 10.1016/j.ydbio.2008.10.033; DUNN RF, 1966, J ULTRA MOL STRUCT R, V16, P672, DOI 10.1016/S0022-5320(66)80013-8; Eglen SJ, 2008, VISUAL NEUROSCI, V25, P209, DOI 10.1017/S0952523808080176; Eglen SJ, 2006, MATH MED BIOL, V23, P79, DOI 10.1093/imammb/dql003; ENGSTROM KJELL, 1963, ACTA ZOOL, V44, P179; FRENCH AS, 1977, BIOL CYBERN, V27, P229, DOI 10.1007/BF00344144; Galli-Resta L, 1999, EUR J NEUROSCI, V11, P1461, DOI 10.1046/j.1460-9568.1999.00555.x; GERVOIS A, 1992, J PHYS A-MATH GEN, V25, P6169, DOI 10.1088/0305-4470/25/23/014; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GOLDSMITH TH, 1984, VISION RES, V24, P1661, DOI 10.1016/0042-6989(84)90324-9; GRANER F, 2001, PHYS REV E, V63; Hart NS, 2005, J COMP PHYSIOL A, V191, P381, DOI 10.1007/s00359-004-0595-3; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Jacobs GH, 1996, P NATL ACAD SCI USA, V93, P577, DOI 10.1073/pnas.93.2.577; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; LEMAITRE J, 1993, PHILOS MAG B, V67, P347, DOI 10.1080/13642819308220137; Lopez R, 2005, J NEUROSCI RES, V79, P401, DOI 10.1002/jnr.20360; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; MAIER EJ, 1993, J COMP PHYSIOL A, V172, P295, DOI 10.1007/BF00216611; Manning JR, 2009, VISUAL NEUROSCI, V26, P5, DOI 10.1017/S095252380808084X; MEYER DB, 1973, EXP EYE RES, V17, P347, DOI 10.1016/0014-4835(73)90244-3; Mochizuki A, 2002, J THEOR BIOL, V215, P345, DOI 10.1006/jtbi.2001.2508; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; Okabe A., 2000, SPATIAL TESSELLATION, P43, DOI 10.1002/9780470317013.ch2; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Quilliet C, 2008, PHIL MAG LETT, V88, P651, DOI 10.1080/09500830802334249; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Raven MA, 2003, J COMP NEUROL, V461, P123, DOI 10.1002/cne.10693; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Sadoc J. F., 1999, FOAMS EMULSIONS; Schliecker G, 2002, ADV PHYS, V51, P1319, DOI 10.1080/00018730210140814; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Shamim KM, 1997, VISUAL NEUROSCI, V14, P811, DOI 10.1017/S095252380001155X; SHAPIRO MB, 1985, J AM STAT ASSOC, V80, P803, DOI 10.2307/2288535; Stenkamp DL, 2007, INT REV CYTOL, V259, P173, DOI 10.1016/S0074-7696(06)59005-9; Stenkamp DL, 2001, J COMP NEUROL, V431, P363, DOI 10.1002/1096-9861(20010319)431:4<363::AID-CNE1076>3.0.CO;2-7; SZETO K, 2002, PHYS REV LETT, V88, P3; Teixeira PIC, 2002, EUR PHYS J E, V9, P161, DOI 10.1140/epje/i2002-10070-8; Tohya S, 1999, J THEOR BIOL, V200, P231, DOI 10.1006/jtbi.1999.0990; Tohya S, 2003, J THEOR BIOL, V221, P289, DOI 10.1006/jtbi.2003.3192; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2003, P ROY SOC B-BIOL SCI, V270, P1255, DOI 10.1098/rspb.2003.2381; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WASSLE H, 1978, PROC R SOC SER B-BIO, V200, P441, DOI 10.1098/rspb.1978.0026; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117; YELLOTT JI, 1982, VISION RES, V22, P1205, DOI 10.1016/0042-6989(82)90086-4; YELLOTT JI, 1983, SCIENCE, V221, P382, DOI 10.1126/science.6867716; YOUNG SR, 1984, VISION RES, V24, P129, DOI 10.1016/0042-6989(84)90098-1; Zhu HX, 2001, PHILOS MAG A, V81, P2765, DOI 10.1080/01418610010032364	73	111	113	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8992	10.1371/journal.pone.0008992	http://dx.doi.org/10.1371/journal.pone.0008992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126550	Green Published, Green Submitted, gold			2022-12-27	WOS:000274209700018
J	Bitton, DA; Smith, DL; Connolly, Y; Scutt, PJ; Miller, CJ				Bitton, Danny A.; Smith, Duncan L.; Connolly, Yvonne; Scutt, Paul J.; Miller, Crispin J.			An Integrated Mass-Spectrometry Pipeline Identifies Novel Protein Coding-Regions in the Human Genome	PLOS ONE			English	Article							FALSE DISCOVERY RATES; TILING ARRAYS; GENE; ANNOTATION; SEARCH; DATABASES; PEPTIDES; SEQUENCE; MODEL; PROTEOMICS	Background: Most protein mass spectrometry (MS) experiments rely on searches against a database of known or predicted proteins, limiting their ability as a gene discovery tool. Results: Using a search against an in silico translation of the entire human genome, combined with a series of annotation filters, we identified 346 putative novel peptides [False Discovery Rate (FDR), <5%] in a MS dataset derived from two human breast epithelial cell lines. A subset of these were then successfully validated by a different MS technique. Two of these correspond to novel isoforms of Heterogeneous Ribonuclear Proteins, while the rest correspond to novel loci. Conclusions: MS technology can be used for ab initio gene discovery in human data, which, since it is based on different underlying assumptions, identifies protein-coding genes not found by other techniques. As MS technology continues to evolve, such approaches will become increasingly powerful.	[Bitton, Danny A.; Scutt, Paul J.; Miller, Crispin J.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England; [Smith, Duncan L.; Connolly, Yvonne] Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Biol Mass Spectrometry Facil, Manchester, Lancs, England	Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester; Cancer Research UK; Paterson Institute for Cancer Research; University of Manchester	Bitton, DA (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK, Appl Computat Biol & Bioinformat Grp, Manchester, Lancs, England.	cmiller@picr.man.ac.uk		Miller, Crispin/0000-0003-4341-1283	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This project was funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carr S, 2004, MOL CELL PROTEOMICS, V3, P531, DOI 10.1074/mcp.T400006-MCP200; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Choudhary JS, 2001, PROTEOMICS, V1, P651, DOI 10.1002/1615-9861(200104)1:5<651::AID-PROT651>3.0.CO;2-N; Choudhary JS, 2001, TRENDS BIOTECHNOL, V19, pS17, DOI 10.1016/S0167-7799(01)01795-4; Claverie JM, 2001, SCIENCE, V291, P1255, DOI 10.1126/science.1058969; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; DeLano WL, 2002, PYMOL USERS MANUAL; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fermin D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r35; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guigo R, 2003, P NATL ACAD SCI USA, V100, P1140, DOI 10.1073/pnas.0337561100; Guigo R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s2; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Halasz G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r59; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; JIRI P, 2008, PROTEOMICS, V8, P1744; Jones AR, 2009, PROTEOMICS, V9, P1220, DOI 10.1002/pmic.200800473; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kerlavage A, 2002, NUCLEIC ACIDS RES, V30, P129, DOI 10.1093/nar/30.1.129; Kuster B, 2001, PROTEOMICS, V1, P641; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Liang F, 2000, NAT GENET, V25, P239, DOI 10.1038/76126; Menon R, 2009, CANCER RES, V69, P300, DOI 10.1158/0008-5472.CAN-08-2145; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Okoniewski MJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r79; Okoniewski MJ, 2007, BIOTECHNIQUES, V42, P181, DOI 10.2144/000112315; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RYO Y, 2006, GENOME INFORM, V17, P88; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Tanner S, 2007, GENOME RES, V17, P231, DOI 10.1101/gr.5646507; Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Yates JR, 1997, J PROTEIN CHEM, V16, P495	58	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8949	10.1371/journal.pone.0008949	http://dx.doi.org/10.1371/journal.pone.0008949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126623	gold, Green Published, Green Submitted			2022-12-27	WOS:000274138000024
J	Laird, RM; Hayes, SM				Laird, Renee M.; Hayes, Sandra M.			Roles of the Src Tyrosine Kinases Lck and Fyn in Regulating gamma delta TCR Signal Strength	PLOS ONE			English	Article							T-CELL-RECEPTOR; ALPHA-BETA; INTERLEUKIN-7 RECEPTOR; FAMILY KINASES; DEFICIENT MICE; LYMPHOCYTE DEVELOPMENT; ENRICHED MICRODOMAINS; THYMOCYTE DEVELOPMENT; ANTIGEN RECEPTOR; INTERFERON-GAMMA	Lck and Fyn, members of the Src family of tyrosine kinases, are key components of the alpha beta TCR-coupled signaling pathway. While it is generally accepted that both Lck and Fyn positively regulate signal transduction by the alpha beta TCR, recent studies have shown that Lck and Fyn have distinct functions in this signaling pathway, with Lck being a positive regulator and Fyn being a negative regulator of alpha beta TCR signal transduction. To determine whether Lck and Fyn also differentially regulate gamma delta TCR signal transduction, we analyzed gamma delta T cell development and function in mice with reduced Lck or Fyn expression levels. We found that reducing Lck or Fyn levels altered the strength of the gamma delta TCR signaling response, with low levels of Lck weakening gamma delta TCR signal strength and low levels of Fyn augmenting gamma delta TCR signal strength. These alterations in gamma delta TCR signal strength had profound effects not only on alpha beta/gamma delta lineage choice, but also on gamma delta thymocyte maturation and gamma delta T cell effector function. These results indicate that the cellular levels of Lck and Fyn play a role in regulating the strength of the gamma delta TCR signaling response at different stages in the life of the gamma delta T cell.	[Laird, Renee M.; Hayes, Sandra M.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Laird, RM (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY USA.	HayesSa@upstate.edu			Hendricks Fund	Hendricks Fund	This work was supported in part by the Hendricks Fund for Medical Research awarded to S. M. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; BRDICKA T, J EXP MED, V191, P1591; BRUNO S, 1992, CELL PROLIFERAT, V25, P31, DOI 10.1111/j.1365-2184.1992.tb01435.x; Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Denny MF, 2000, MOL CELL BIOL, V20, P1426, DOI 10.1128/MCB.20.4.1426-1435.2000; Filby A, 2007, J IMMUNOL, V179, P4635, DOI 10.4049/jimmunol.179.7.4635; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldrath AW, 2000, J EXP MED, V192, P557, DOI 10.1084/jem.192.4.557; Groves T, 1996, IMMUNITY, V5, P417, DOI 10.1016/S1074-7613(00)80498-7; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hayes SM, 2002, IMMUNITY, V16, P827, DOI 10.1016/S1074-7613(02)00320-5; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; KAWAI K, 1995, J EXP MED, V181, P345, DOI 10.1084/jem.181.1.345; Kim K, 1998, J IMMUNOL, V160, P5735; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Laird RM, 2009, MOL IMMUNOL, V46, P2429, DOI 10.1016/j.molimm.2009.03.029; Legname G, 2000, IMMUNITY, V12, P537, DOI 10.1016/S1074-7613(00)80205-8; LEY SC, 1994, J CELL BIOL, V125, P639, DOI 10.1083/jcb.125.3.639; Lovatt M, 2006, MOL CELL BIOL, V26, P8655, DOI 10.1128/MCB.00168-06; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Murali-Krishna K, 2000, J IMMUNOL, V165, P1733, DOI 10.4049/jimmunol.165.4.1733; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Page ST, 1997, EUR J IMMUNOL, V27, P554, DOI 10.1002/eji.1830270229; PAGE TH, 1995, EUR J IMMUNOL, V25, P2956, DOI 10.1002/eji.1830251036; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; PENNINGER J, 1993, SCIENCE, V260, P358, DOI 10.1126/science.8469988; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PETRIE HT, 1992, EUR J IMMUNOL, V22, P2185, DOI 10.1002/eji.1830220836; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Schweighoer E, 1996, J EXP MED, V183, P2033, DOI 10.1084/jem.183.5.2033; Seddon B, 2000, SCIENCE, V290, P127, DOI 10.1126/science.290.5489.127; SIM GK, 1995, J IMMUNOL, V154, P5821; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Trobridge PA, 2001, EUR J IMMUNOL, V31, P3567, DOI 10.1002/1521-4141(200112)31:12<3567::AID-IMMU3567>3.0.CO;2-M; Utting O, 1998, J IMMUNOL, V160, P5410; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; VENKITARAMAN AR, 1992, P NATL ACAD SCI USA, V89, P12083, DOI 10.1073/pnas.89.24.12083; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Yasuda K, 2002, J IMMUNOL, V169, P2813, DOI 10.4049/jimmunol.169.6.2813; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	56	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2010	5	1							e8899	10.1371/journal.pone.0008899	http://dx.doi.org/10.1371/journal.pone.0008899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NO	20126650	Green Published, gold, Green Submitted			2022-12-27	WOS:000273896500019
J	Gokara, M; Sudhamalla, B; Amooru, DG; Subramanyam, R				Gokara, Mahesh; Sudhamalla, Babu; Amooru, Damu G.; Subramanyam, Rajagopal			Molecular Interaction Studies of Trimethoxy Flavone with Human Serum Albumin	PLOS ONE			English	Article							RADICAL SCAVENGING ACTIVITY; CRYSTAL-STRUCTURE; POLYPHENOLIC COMPOUNDS; GENETIC ALGORITHM; RETINOIC ACID; BINDING-SITES; FATTY-ACIDS; DOCKING; FLUORESCENCE; INHIBITION	Background: Human serum albumin (HSA) is the most abundant protein in blood plasma, having high affinity binding sites for several endogenous and exogenous compounds. Trimethoxy flavone (TMF) is a naturally occurring flavone isolated from Andrographis viscosula and used in the treatment of dyspepsia, influenza, malaria, respiratory functions and as an astringent and antidote for poisonous stings of some insects. Methodology/Principal Findings: The main aim of the experiment was to examine the interaction between TMF and HSA at physiological conditions. Upon addition of TMF to HSA, the fluorescence emission was quenched and the binding constant of TMF with HSA was found to be K(TMF) = 1.0 +/- 0.01x10(3) M(-1), which corresponds to -5.4 kcal M(-1) of free energy. Micro-TOF Q mass spectrometry results showed a mass increase of from 66,513 Da (free HSA) to 66,823 Da (HAS + Drug), indicating the strong binding of TMF with HSA resulting in decrease of fluorescence. The HSA conformation was altered upon binding of TMF to HSA with decrease in alpha-helix and an increase in beta-sheets and random coils suggesting partial unfolding of protein secondary structure. Molecular docking experiments found that TMF binds strongly with HSA at IIIA domain of hydrophobic pocket with hydrogen bond and hydrophobic interactions. Among which two hydrogen bonds are formed between O (19) of TMF to Arg 410, Tyr 411 and another one from O (7) of TMF to Asn 391, with bond distance of 2.1 angstrom, 3.6 angstrom and 2.6 angstrom, respectively. Conclusions/Significance: In view of the evidence presented, it is imperative to assign a greater role of HSA's as a carrier molecule for many drugs to understand the interactions of HSA with TMF will be pivotal in the design of new TMF-inspired drugs.	[Gokara, Mahesh; Sudhamalla, Babu; Subramanyam, Rajagopal] Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India; [Amooru, Damu G.] Yogi Vemana Univ, Dept Chem, Kadapa, India	University of Hyderabad; Yogi Vemana University	Gokara, M (corresponding author), Univ Hyderabad, Dept Biochem, Sch Life Sci, Hyderabad 500134, Andhra Pradesh, India.	srgsl@uohyd.ernet.in	Gokara, Mahesh/G-1061-2011	Gokara, Mahesh/0000-0001-7095-887X	University of Hyderabad	University of Hyderabad(University of Hyderabad)	The University of Hyderabad provided partial funding of this work (maintenance grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanas'ev IB, 2001, BIOCHEM PHARMACOL, V61, P677, DOI 10.1016/S0006-2952(01)00526-3; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Amic D, 2003, CROAT CHEM ACTA, V76, P55; Beauchemin R, 2007, BIOMACROMOLECULES, V8, P3177, DOI 10.1021/bm700697a; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Bian Q., 2004, INT J BIOL MACROMOL, V34, P275, DOI DOI 10.1016/J.IJBIOMAC.2004.09.005; Boege F, 1996, J BIOL CHEM, V271, P2262, DOI 10.1074/jbc.271.4.2262; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Charbonneau D, 2009, J PHYS CHEM B, V113, P1777, DOI 10.1021/jp8092012; Chopra RN, 1980, GLOSSARY INDIAN MED; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Diniz A, 2008, ANAL BIOANAL CHEM, V391, P625, DOI 10.1007/s00216-008-2046-4; Dufour C, 2005, BBA-GEN SUBJECTS, V1721, P164, DOI 10.1016/j.bbagen.2004.10.013; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; HANSEN UK, 1990, DANISH MED B, V37, P57; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; He Y, 2008, J FLUORESC, V18, P433, DOI 10.1007/s10895-007-0283-0; HUSAIN SR, 1987, PHYTOCHEMISTRY, V26, P2489, DOI 10.1016/s0031-9422(00)83860-1; Jagetia GC, 2003, MUTAGENESIS, V18, P337, DOI 10.1093/mutage/geg001; Jiang YL, 2008, BIOORGAN MED CHEM, V16, P6406, DOI 10.1016/j.bmc.2008.05.002; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kanakis CD, 2006, J MOL STRUCT, V798, P69, DOI 10.1016/j.molstruc.2006.03.051; Kandagal PB, 2008, J PHARMACEUT BIOMED, V47, P260, DOI 10.1016/j.jpba.2008.01.027; Karnaukhova E, 2007, BIOCHEM PHARMACOL, V73, P901, DOI 10.1016/j.bcp.2006.11.023; Kirtikar K.R., 1975, INDIAN MED PLANTS, V3, P1884; Kosa T, 1998, PHARMACEUT RES, V15, P449, DOI 10.1023/A:1011932516717; LAING L, 2007, BIOMACROMOLECULES, V9, P50; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Maiti TK, 2008, J PHOTOCH PHOTOBIO A, V194, P297, DOI 10.1016/j.jphotochem.2007.08.028; Middleton E, 2000, PHARMACOL REV, V52, P673; MULLER WE, 1979, PHARMACOLOGY, V19, P59, DOI 10.1159/000137289; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; Obach RS, 2000, J PHARMACOL EXP THER, V294, P88; Peters T., 1996, ALL ALBUMIN BIOCH GE; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Petitpas I, 2001, J MOL BIOL, V314, P955, DOI 10.1006/jmbi.2000.5208; Rao YK, 2003, CHEM PHARM BULL, V51, P1374, DOI 10.1248/cpb.51.1374; Ren WY, 2003, MED RES REV, V23, P519, DOI 10.1002/med.10033; Sengupta B, 2002, BIOCHEM BIOPH RES CO, V299, P400, DOI 10.1016/S0006-291X(02)02667-0; SHAHPER NK, 2008, J PROTEOMICS BIOIN S, V1, pS20; Sinha SS, 2008, J PHYS CHEM B, V112, P4884, DOI 10.1021/jp709809b; SRIVASTAVA AK, 1985, BIOCHEM BIOPH RES CO, V131, P1, DOI 10.1016/0006-291X(85)91761-9; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V95, P81, DOI 10.1016/j.jphotobiol.2009.01.002; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Yang CS, 2001, ANNU REV NUTR, V21, P381, DOI 10.1146/annurev.nutr.21.1.381; Yi P, 2008, EUR J MED CHEM, V43, P604, DOI 10.1016/j.ejmech.2007.04.020; Yue YY, 2009, J PHARMACEUT BIOMED, V49, P753, DOI 10.1016/j.jpba.2008.12.017; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6; 2009, BIOPOLYMERS, V91, P108	57	94	96	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 21	2010	5	1							e8834	10.1371/journal.pone.0008834	http://dx.doi.org/10.1371/journal.pone.0008834			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AJ	20098677	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779100025
J	Stimson, RH; Lobley, GE; Maraki, I; Morton, NM; Andrew, R; Walker, BR				Stimson, Roland H.; Lobley, Gerald E.; Maraki, Ioanna; Morton, Nicholas M.; Andrew, Ruth; Walker, Brian R.			Effects of Proportions of Dietary Macronutrients on Glucocorticoid Metabolism in Diet-Induced Obesity in Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; BODY-FAT DISTRIBUTION; HUMAN ADIPOSE-TISSUE; WEIGHT-LOSS; CORTISOL METABOLISM; INSULIN SENSITIZATION; BLOOD-PRESSURE; ZUCKER RATS; EXPRESSION; MEN	Tissue glucocorticoid levels in the liver and adipose tissue are regulated by regeneration of inactive glucocorticoid by 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and inactivation by 5 alpha- and 5 beta-reductases. A low carbohydrate diet increases hepatic 11 beta-HSD1 and reduces glucocorticoid metabolism during weight loss in obese humans. We hypothesized that similar variations in macronutrient proportions regulate glucocorticoid metabolism in obese rats. Male Lister Hooded rats were fed an obesity-inducing ad libitum 'Western' diet (37% fat, n = 36) for 22 weeks, then randomised to continue this diet (n = 12) or to switch to either a low carbohydrate (n = 12) or a moderate carbohydrate (n = 12) diet for the final 8 weeks. A parallel lean control group were fed an ad libitum control diet (10% fat, n = 12) throughout. The low and moderate carbohydrate diets decreased hepatic 11 beta-HSD1 mRNA compared with the Western diet (both 0.7+/-0.0 vs 0.9+/-0.1 AU; p<0.01), but did not alter 11 beta-HSD1 in adipose tissue. 5 alpha-Reductase mRNA was increased on the low carbohydrate compared with the moderate carbohydrate diet. Compared with lean controls, the Western diet decreased 11 beta-HSD1 activity (1.6+/-0.1 vs 2.8+/-0.1 nmol/mcg protein/hr; p<0.001) and increased 5 alpha-reductase and 5 beta-reductase mRNAs (1.9+/-0.3 vs 1.0+/-0.2 and 1.6+/-0.1 vs 1.0+/-0.1 AU respectively; p<0.01) in the liver, and reduced 11 beta-HSD1 mRNA and activity (both p<0.01) in adipose tissue. Although an obesity-inducing high fat diet in rats recapitulates the abnormal glucocorticoid metabolism associated with human obesity in liver (but not in adipose tissue), a low carbohydrate diet does not increase hepatic 11 beta-HSD1 in obese rats as occurs in humans.	[Stimson, Roland H.; Maraki, Ioanna; Morton, Nicholas M.; Andrew, Ruth; Walker, Brian R.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Lobley, Gerald E.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Div Obes & Metab Hlth, Aberdeen, Scotland	University of Edinburgh; University of Aberdeen	Stimson, RH (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	roland.stimson@ed.ac.uk	Morton, NICHOLAS/ABF-3774-2020; Andrew, Ruth/C-2727-2008	Andrew, Ruth/0000-0002-6916-2994	Scottish Government and the British Heart Foundation	Scottish Government and the British Heart Foundation	This work was funded by the core grant to the Rowett Institute of Nutrition and Health from the Rural and Environment Research Analysis Directorate of the Scottish Government and the British Heart Foundation. The funders had no role in study design, data collection and analysis decision to publish or preparation of the manuscript.	Andrew R, 1998, J CLIN ENDOCR METAB, V83, P1806, DOI 10.1210/jc.83.5.1806; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Benedict C, 2005, J CLIN ENDOCR METAB, V90, P1692, DOI 10.1210/jc.2004-1792; Berger J, 2001, J BIOL CHEM, V276, P12629, DOI 10.1074/jbc.M003592200; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; EICHELER W, 1995, EXP CLIN ENDOCR DIAB, V103, P105, DOI 10.1055/s-0029-1211337; Engeli S, 2004, OBES RES, V12, P9, DOI 10.1038/oby.2004.3; Goedecke JH, 2006, CLIN ENDOCRINOL, V65, P81, DOI 10.1111/j.1365-2265.2006.02552.x; Hermanowski-Vosatka A, 2000, BIOCHEM BIOPH RES CO, V279, P330, DOI 10.1006/bbrc.2000.3966; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Jang C, 2007, J CLIN ENDOCR METAB, V92, P3314, DOI 10.1210/jc.2006-2729; Johnstone AM, 2004, EUR J ENDOCRINOL, V150, P185, DOI 10.1530/eje.0.1500185; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Liu YJ, 2006, ENDOCRINOLOGY, V147, P5061, DOI 10.1210/en.2006-0243; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; Livingstone DEW, 2005, OBES RES, V13, P1523, DOI 10.1038/oby.2005.186; Lobley GE, 2007, BRIT J NUTR, V97, P1099, DOI 10.1017/S0007114507691934; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; Paulsen SK, 2007, OBESITY, V15, P1954, DOI 10.1038/oby.2007.233; Purnell JQ, 2009, AM J PHYSIOL-ENDOC M, V296, pE351, DOI 10.1152/ajpendo.90769.2008; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Sandeep TC, 2005, DIABETES, V54, P872, DOI 10.2337/diabetes.54.3.872; Stewart PM, 1999, J CLIN ENDOCR METAB, V84, P1022, DOI 10.1210/jc.84.3.1022; Stimson RH, 2007, J CLIN ENDOCR METAB, V92, P4480, DOI 10.1210/jc.2007-0692; Stulnig TM, 2002, DIABETES, V51, P2426, DOI 10.2337/diabetes.51.8.2426; Tomlinson JW, 2008, DIABETES, V57, P1536, DOI 10.2337/db08-0094; Tomlinson JW, 2004, J CLIN ENDOCR METAB, V89, P2711, DOI 10.1210/jc.2003-031376; Tomlinson JW, 2002, J CLIN ENDOCR METAB, V87, P5630, DOI 10.1210/jc.2002-020687; Wake DJ, 2007, CLIN ENDOCRINOL, V66, P440, DOI 10.1111/j.1365-2265.2007.02755.x; Wake DJ, 2007, J CLIN ENDOCR METAB, V92, P1848, DOI 10.1210/jc.2006-2713; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Westerbacka J, 2003, J CLIN ENDOCR METAB, V88, P4924, DOI 10.1210/jc.2003-030596	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8779	10.1371/journal.pone.0008779	http://dx.doi.org/10.1371/journal.pone.0008779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20098742	Green Published, gold, Green Submitted			2022-12-27	WOS:000273778900021
J	Singaravelan, N; Pavlicek, T; Beharav, A; Wakamatsu, K; Ito, S; Nevo, E				Singaravelan, Natarajan; Pavlicek, Tomas; Beharav, Alex; Wakamatsu, Kazumasa; Ito, Shosuke; Nevo, Eviatar			Spiny Mice Modulate Eumelanin to Pheomelanin Ratio to Achieve Cryptic Coloration in "Evolution Canyon," Israel	PLOS ONE			English	Article							LOWER NAHAL OREN; PIGMENT TYPES; MOUNT-CARMEL; ADAPTIVE VARIATION; GENETIC-BASIS; PELAGE COLOR; MELANISM; MOUSE; DIVERSITY; MELANOGENESIS	Background: Coat coloration in mammals is an explicit adaptation through natural selection. Camouflaging with the environment is the foremost evolutionary drive in explaining overall coloration. Decades of enquiries on this topic have been limited to repetitive coat color measurements to correlate the morphs with background/habitat blending. This led to an overwhelming endorsement of concealing coloration as a local phenotypic adaptation in animals, primarily rodents to evade predators. However, most such studies overlooked how rodents actually achieve such cryptic coloration. Cryptic coloration could be attained only through optimization between the yellow- to brown-colored "pheomelanin" and gray to black-colored "eumelanin" in the hairs. However, no study has explored this conjecture yet. "Evolution Canyon" (EC) in Israel is a natural microscale laboratory where the relationship between organism and environment can be explored. EC is comprised of an "African" slope (AS), which exhibits a yellowbrownish background habitat, and a "European" slope (ES), exhibiting a dark grayish habitat; both slopes harbor spiny mice (Acomys cahirinus). Here, we examine how hair melanin content of spiny mice living in the opposing slopes of EC evolves toward blending with their respective background habitat. Methodology/Principal Findings: We measured hair-melanin (both eumelanin and pheomelanin) contents of 30 spiny mice from the EC using high-performance liquid chromatography (HPLC) that detects specific degradation products of eumelanin and pheomelanin. The melanin pattern of A. cahirinus approximates the background color of the slope on which they dwell. Pheomelanin is slightly (insignificantly) higher in individuals found on the AS to match the brownish background, whereas individuals of the ES had significantly greater eumelanin content to mimic the dark grayish background. This is further substantiated by a significantly higher eumelanin and pheomelanin ratio on the ES than on the AS. Conclusion/Significance: It appears that rodents adaptively modulate eumelanin and pheomelanin contents to achieve cryptic coloration in contrasting habitats even at a microscale.	[Singaravelan, Natarajan; Pavlicek, Tomas; Beharav, Alex; Nevo, Eviatar] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel; [Wakamatsu, Kazumasa; Ito, Shosuke] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Aichi, Japan	University of Haifa; Fujita Health University	Singaravelan, N (corresponding author), Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel.	yoursings@gmail.com	Pavlicek, Tomas/C-4768-2008; Wakamatsu, Kazumasa/AAZ-5877-2020	Wakamatsu, Kazumasa/0000-0003-1748-9001; Ito, Shosuke/0000-0001-9182-5144	University of Haifa; Council of Higher Education, Israel; Ancell Teicher Research Foundation; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS) [20591357]	University of Haifa; Council of Higher Education, Israel; Ancell Teicher Research Foundation; Israel Discount Bank Chair of Evolutionary Biology; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	NS acknowledges his postdoctoral fellowship support by University of Haifa and the Council of Higher Education, Israel. EN acknowledges the financial support of the Ancell Teicher Research Foundation for Genetics and Molecular Evolution, and the Israel Discount Bank Chair of Evolutionary Biology. KW and SI acknowledge the funding supported by the Japan Society for the Promotion of Science (JSPS) (No. 20591357). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIEV G, 1990, PIGM CELL RES, V3, P177, DOI 10.1111/j.1600-0749.1990.tb00286.x; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Belk MC, 1996, J MAMMAL, V77, P882, DOI 10.2307/1382694; BENSON SETH B., 1933, UNIV CALIFORNIA PUBL ZOOL, V40, P1; Blaustein L, 1996, ISRAEL J ZOOL, V42, P327; BRADBURY MW, 1988, J HERED, V79, P133, DOI 10.1093/oxfordjournals.jhered.a110471; Camargo CR, 2006, AN ACAD BRAS CIENC, V78, P77, DOI 10.1590/S0001-37652006000100009; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cecchi T, 2004, PIGM CELL RES, V17, P307, DOI 10.1111/j.1600-0749.2004.00139.x; CHAPPELL MA, 1984, P NATL ACAD SCI-BIOL, V81, P5484, DOI 10.1073/pnas.81.17.5484; Cott H.B., 1940, ADAPTIVE COLORATION; COWLES RB, 1967, SCIENCE, V158, P1340, DOI 10.1126/science.158.3806.1340; Darwin C., 1859, ORIGINS SPECIES MEAN; Dice L. R., 1938, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, Vno. 375, P1; Dice L. R., 1930, Occasional Papers of the Museum of Zoology University of Michigan Ann Arbor, V213, P1; Endler J.A., 1977, Monographs in Population Biology, pi; Endler J.A., 1986, Monographs in Population Biology, pviii; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; GAUSE G. F., 1947, TRANS CONNECTICUT ACAD ARTS AND SCI, V37, P17; Gloger, 1833, ABANDERN VOGEL DURCH; Hall E. R., 1942, J MAMMAL, V23, P51, DOI DOI 10.2307/1374855; HETH G, 1988, OECOLOGIA, V74, P617, DOI 10.1007/BF00380062; Hoekstra HE, 2003, MOL ECOL, V12, P1185, DOI 10.1046/j.1365-294X.2003.01788.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; ITO S, 1994, PIGM CELL RES, V7, P141, DOI 10.1111/j.1600-0749.1994.tb00041.x; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Ito S, 2001, PIGM CELL RES, V14, P180, DOI 10.1034/j.1600-0749.2001.140307.x; ITO S, 1984, J INVEST DERMATOL, V83, P12, DOI 10.1111/1523-1747.ep12261634; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; KETTLEWELL HBD, 1956, PROC R SOC SER B-BIO, V145, P297, DOI 10.1098/rspb.1956.0037; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Krupa JJ, 2000, J MAMMAL, V81, P86, DOI 10.1644/1545-1542(2000)081<0086:MTCOES>2.0.CO;2; Lai YC, 2008, J ZOOL, V274, P270, DOI 10.1111/j.1469-7998.2007.00382.x; Linnen CR, 2009, SCIENCE, V325, P1095, DOI 10.1126/science.1175826; Majerus M, 1998, MELANISM EVOLUTION A; Monks NJ, 1998, AFR J ECOL, V36, P102, DOI 10.1046/j.1365-2028.1998.108-89108.x; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Mundy NI, 2007, PLOS BIOL, V5, P1842, DOI 10.1371/journal.pbio.0050250; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E, 1998, ACTA THERIOL, P9; Nevo E, 1998, CATENA, V33, P241, DOI 10.1016/S0341-8162(98)00071-X; NEVO E, 2009, TRENDS EVOL BIOL, V1, P1; NEVO E, 1985, ACTA ZOOL FENN, V170, P131; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Schmalhausen II., 1949, FACTORS EVOLUTION TH, P327; SIRACUSA LD, 1994, TRENDS GENET, V10, P423, DOI 10.1016/0168-9525(94)90112-0; SPONENBERG DP, 1988, PIGM CELL RES, V1, P410, DOI 10.1111/j.1600-0749.1988.tb00144.x; SPONENBERG DP, 1988, PIGM CELL RES, V1, P414, DOI 10.1111/j.1600-0749.1988.tb00145.x; STEARNS SC, 1989, BIOSCIENCE, V39, P436, DOI 10.2307/1311135; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Tchernov E., 1968, SUCCESSION RODENT FA; Thayer GH, 1909, CONCEALING COLORATIO; ULMER FA, 1989, J MAMMAL, V22, P285; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x	65	14	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8708	10.1371/journal.pone.0008708	http://dx.doi.org/10.1371/journal.pone.0008708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090935	Green Published, gold, Green Submitted			2022-12-27	WOS:000273714600011
J	Andrews, J; Kennette, W; Pilon, J; Hodgson, A; Tuck, AB; Chambers, AF; Rodenhiser, DI				Andrews, Joseph; Kennette, Wendy; Pilon, Jenna; Hodgson, Alexandra; Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.			Multi-Platform Whole-Genome Microarray Analyses Refine the Epigenetic Signature of Breast Cancer Metastasis with Gene Expression and Copy Number	PLOS ONE			English	Article							CARCINOMA CELL-LINES; DNA METHYLATION; WIDE; THERAPY; MODEL; 14-3-3-SIGMA; VALIDATION; MDA-MB-468; REVEALS; VARIANT	Background: We have previously identified genome-wide DNA methylation changes in a cell line model of breast cancer metastasis. These complex epigenetic changes that we observed, along with concurrent karyotype analyses, have led us to hypothesize that complex genomic alterations in cancer cells (deletions, translocations and ploidy) are superimposed over promoter-specific methylation events that are responsible for gene-specific expression changes observed in breast cancer metastasis. Methodology/Principal Findings: We undertook simultaneous high-resolution, whole-genome analyses of MDA-MB-468GFP and MDA-MB-468GFP-LN human breast cancer cell lines (an isogenic, paired lymphatic metastasis cell line model) using Affymetrix gene expression (U133), promoter (1.0R), and SNP/CNV (SNP 6.0) microarray platforms to correlate data from gene expression, epigenetic (DNA methylation), and combination copy number variant/single nucleotide polymorphism microarrays. Using Partek Software and Ingenuity Pathway Analysis we integrated datasets from these three platforms and detected multiple hypomethylation and hypermethylation events. Many of these epigenetic alterations correlated with gene expression changes. In addition, gene dosage events correlated with the karyotypic differences observed between the cell lines and were reflected in specific promoter methylation patterns. Gene subsets were identified that correlated hyper (and hypo) methylation with the loss (or gain) of gene expression and in parallel, with gene dosage losses and gains, respectively. Individual gene targets from these subsets were also validated for their methylation, expression and copy number status, and susceptible gene pathways were identified that may indicate how selective advantage drives the processes of tumourigenesis and metastasis. Conclusions/Significance: Our approach allows more precisely profiling of functionally relevant epigenetic signatures that are associated with cancer progression and metastasis.	[Andrews, Joseph; Kennette, Wendy; Pilon, Jenna; Hodgson, Alexandra; Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.] London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada; [Pilon, Jenna; Hodgson, Alexandra; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.; Rodenhiser, David I.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Oncol, London, ON, Canada; [Rodenhiser, David I.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Paediat, London, ON, Canada; [Tuck, Alan B.; Chambers, Ann F.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol, London, ON, Canada; [Rodenhiser, David I.] Childrens Hlth Res Inst, EpiGenWestern Res Grp, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Andrews, J (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, London, ON, Canada.	drodenhi@uwo.ca	Chambers, Ann F/L-6285-2015	Chambers, Ann F/0000-0002-9509-5123	Canadian Breast Cancer Research Alliance [016506]; Canadian Breast Cancer Foundation; Cancer Research Society	Canadian Breast Cancer Research Alliance; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Cancer Research Society	Financial support gratefully acknowledged by grant #016506 from the Canadian Breast Cancer Research Alliance, with special funding support from the Canadian Breast Cancer Foundation and the Cancer Research Society. AFC is Canada Research Chair in Oncology, supported by the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, AFF NETTF TOOL; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; de Tayrac M, 2009, GENE CHROMOSOME CANC, V48, P55, DOI 10.1002/gcc.20618; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fadlelmola FM, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-2; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; FENG Y, 2006, BREAST CANC RES TREA; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Horie-Inoue K, 2006, SEMIN CANCER BIOL, V16, P235, DOI 10.1016/j.semcancer.2006.03.006; Johnson N, 2008, BREAST CANCER RES TR, V111, P55, DOI 10.1007/s10549-007-9758-6; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lodygin D, 2006, SEMIN CANCER BIOL, V16, P214, DOI 10.1016/j.semcancer.2006.03.008; MARGARETO J, 2009, CANC INVEST, P1; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Momparler RL, 2005, SEMIN ONCOL, V32, P443, DOI 10.1053/j.seminoncol.2005.07.008; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Pusztai L, 2006, CLIN CANCER RES, V12, P7209, DOI 10.1158/1078-0432.CCR-06-2649; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Rodenhiser DI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2121; RODENHISER DI, 2008, CLIN EXP METASTASIS; Sadikovic B, 2008, J BIOL CHEM, V283, P4051, DOI 10.1074/jbc.M707506200; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vantyghem SA, 2005, CLIN EXP METASTAS, V22, P351, DOI 10.1007/s10585-005-0745-1; Veeck J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2151; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weigelt B, 2005, CANCER RES, V65, P9155, DOI 10.1158/0008-5472.CAN-05-2553; Welch DR, 2004, BREAST CANCER RES, V6, P61, DOI 10.1186/bcr736; Woelfle U, 2003, CANCER RES, V63, P5679; Xu J, 2008, CANCER GENET CYTOGEN, V181, P1, DOI 10.1016/j.cancergencyto.2007.05.030; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; ZHANG RD, 1991, INVAS METAST, V11, P204; EXONPRIMER SOFTWARE; PRIMERQUEST SOFTWARE	47	40	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8665	10.1371/journal.pone.0008665	http://dx.doi.org/10.1371/journal.pone.0008665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084286	Green Submitted, gold, Green Published			2022-12-27	WOS:000273554600018
J	Viana, DS; Gordo, I; Sucena, E; Moita, MAP				Viana, Duarte S.; Gordo, Isabel; Sucena, Elio; Moita, Marta A. P.			Cognitive and Motivational Requirements for the Emergence of Cooperation in a Rat Social Game	PLOS ONE			English	Article							TIT-FOR-TAT; PRISONERS-DILEMMA; RECIPROCAL ALTRUISM; NEURAL BASIS; EVOLUTION; MUTUALISM; PIGEONS; FOOD	Background: Game theory and the Prisoner's Dilemma (PD) game in particular, which captures the paradox of cooperative interactions that lead to benefits but entail costs to the interacting individuals, have constituted a powerful tool in the study of the mechanisms of reciprocity. However, in non-human animals most tests of reciprocity in PD games have resulted in sustained defection strategies. As a consequence, it has been suggested that under such stringent conditions as the PD game humans alone have evolved the necessary cognitive abilities to engage in reciprocity, namely, numerical discrimination, memory and control of temporal discounting. Methodology/Principal Findings: We use an iterated PD game to test rats (Rattus norvegicus) for the presence of such cognitive abilities by manipulating the strategy of the opponent, Tit-for-Tat and Pseudo-Random, or the relative size of the temptation to defect. We found that rats shape their behaviour according to the opponent's strategy and the relative outcome resulting from cooperative or defective moves. Finally, we show that the behaviour of rats is contingent upon their motivational state (hungry versus sated). Conclusions/Significance: Here we show that rats understand the payoff matrix of the PD game and the strategy of the opponent. Importantly, our findings reveal that rats possess the necessary cognitive capacities for reciprocity-based cooperation to emerge in the context of a prisoner's dilemma. Finally, the validation of the rat as a model to study reciprocity-based cooperation during the PD game opens new avenues of research in experimental neuroscience.	[Viana, Duarte S.; Moita, Marta A. P.] Gulbenkian Inst Sci, Fundacao Champalimaud Neurosci Program, Oeiras, Portugal; [Sucena, Elio] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Sucena, Elio] Gulbenkian Inst Sci, Ctr Biol Desenvolvimento, Oeiras, Portugal	Fundacao Champalimaud; Universidade de Lisboa	Viana, DS (corresponding author), Gulbenkian Inst Sci, Fundacao Champalimaud Neurosci Program, Oeiras, Portugal.	moita@igc.gulbenkian.pt	Gordo, Isabel/D-6770-2013; Viana, Duarte/AAA-1482-2020; Sucena, Élio/M-1753-2015; Sucena, Élio/ABF-6684-2020	Gordo, Isabel/0000-0003-1622-5143; Viana, Duarte/0000-0002-7864-0871; Sucena, Élio/0000-0001-8810-870X; Sucena, Élio/0000-0001-8810-870X; Moita, Marta/0000-0002-5144-6905	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao para a Ciencia e a Tecnologia, Portugal [POCTI/0664/2004]	Fundacao Champalimaud; Instituto Gulbenkian de Ciencia; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao Champalimaud, Instituto Gulbenkian de Ciencia and Fundacao para a Ciencia e a Tecnologia, Portugal (POCTI/0664/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Baker F, 2002, PSYCHON B REV, V9, P482, DOI 10.3758/BF03196303; Camerer CF, 2006, SCIENCE, V311, P47, DOI 10.1126/science.1110600; CLEMENTS KC, 1995, ANIM BEHAV, V50, P527, DOI 10.1006/anbe.1995.0267; Dugatkin L.A., 1997, COOPERATION ANIMALS; Dugatkin LA, 2002, NATURWISSENSCHAFTEN, V89, P533, DOI 10.1007/s00114-002-0379-y; Dugatkin Lee Alan, 1998, P38; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; FLOOD M, 1983, BEHAV SCI, V28, P65, DOI 10.1002/bs.3830280108; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Hall SS, 2003, BEHAV PROCESS, V60, P199, DOI 10.1016/S0376-6357(02)00123-7; Harris AC, 2002, PSYCHOL REC, V52, P429, DOI 10.1007/BF03395196; HART BL, 1992, ANIM BEHAV, V44, P1073, DOI 10.1016/S0003-3472(05)80319-7; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Kefi S, 2007, ANIM BEHAV, V74, pE1, DOI 10.1016/j.anbehav.2006.11.025; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Krams I, 2008, BEHAV ECOL SOCIOBIOL, V62, P599, DOI 10.1007/s00265-007-0484-1; Lee D, 2008, NAT NEUROSCI, V11, P404, DOI 10.1038/nn2065; LOMBARDO MP, 1985, SCIENCE, V227, P1363, DOI 10.1126/science.227.4692.1363; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olendorf R, 2004, P ROY SOC B-BIOL SCI, V271, P177, DOI 10.1098/rspb.2003.2586; Pusey Anne E., 1997, P254; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rutte C, 2008, BEHAV ECOL SOCIOBIOL, V62, P499, DOI 10.1007/s00265-007-0474-3; Rutte C, 2007, PLOS BIOL, V5, P1421, DOI 10.1371/journal.pbio.0050196; Sheldon KM, 1999, J PERS SOC PSYCHOL, V77, P1245, DOI 10.1037/0022-3514.77.6.1245; Sokal Robert R., 1969, BIOMETRY; Stephens David W., 1998, P239; Stephens DW, 2006, BEHAV PROCESS, V71, P29, DOI 10.1016/j.beproc.2005.09.003; Stephens DW, 2002, SCIENCE, V298, P2216, DOI 10.1126/science.1078498; Stevens JR, 2004, TRENDS COGN SCI, V8, P60, DOI 10.1016/j.tics.2003.12.003; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Watson KK, 2008, PHILOS T R SOC B, V363, P3825, DOI 10.1098/rstb.2008.0159; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; WILKINSON GS, 1984, NATURE, V308, P181, DOI 10.1038/308181a0; WILLIAMS BA, 1994, ANIMAL LEARNING COGN, P81; Yi R, 2005, LEARN BEHAV, V33, P324, DOI 10.3758/BF03192861	43	44	44	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8483	10.1371/journal.pone.0008483	http://dx.doi.org/10.1371/journal.pone.0008483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	543EV	20084113	Green Submitted, Green Published, gold			2022-12-27	WOS:000273554600003
J	Walther, FJ; Waring, AJ; Hernandez-Juviel, JM; Gordon, LM; Wang, ZD; Jung, CL; Ruchala, P; Clark, AP; Smith, WM; Sharma, S; Notter, RH				Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.; Wang, Zhengdong; Jung, Chun-Ling; Ruchala, Piotr; Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu; Notter, Robert H.			Critical Structural and Functional Roles for the N-Terminal Insertion Sequence in Surfactant Protein B Analogs	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CAPTIVE BUBBLE METHOD; TRANSFORM INFRARED-SPECTROSCOPY; HELICAL PEPTOID ANALOGS; SAPOSIN-LIKE PROTEINS; PULMONARY SURFACTANT; LUNG-SURFACTANT; SECONDARY STRUCTURE; SP-C; SYNTHETIC SURFACTANT	Background: Surfactant protein B (SP-B; 79 residues) belongs to the saposin protein superfamily, and plays functional roles in lung surfactant. The disulfide cross-linked, N- and C-terminal domains of SP-B have been theoretically predicted to fold as charged, amphipathic helices, suggesting their participation in surfactant activities. Earlier structural studies with Mini-B, a disulfide-linked construct based on the N- and C-terminal regions of SP-B (i.e., similar to residues 8-25 and 63-78), confirmed that these neighboring domains are helical; moreover, Mini-B retains critical in vitro and in vivo surfactant functions of the native protein. Here, we perform similar analyses on a Super Mini-B construct that has native SP-B residues (1-7) attached to the N-terminus of Mini-B, to test whether the N-terminal sequence is also involved in surfactant activity. Methodology/Results: FTIR spectra of Mini-B and Super Mini-B in either lipids or lipid-mimics indicated that these peptides share similar conformations, with primary alpha-helix and secondary beta-sheet and loop-turns. Gel electrophoresis demonstrated that Super Mini-B was dimeric in SDS detergent-polyacrylamide, while Mini-B was monomeric. Surface plasmon resonance (SPR), predictive aggregation algorithms, and molecular dynamics (MD) and docking simulations further suggested a preliminary model for dimeric Super Mini-B, in which monomers self-associate to form a dimer peptide with a "saposin-like" fold. Similar to native SP-B, both Mini-B and Super Mini-B exhibit in vitro activity with spread films showing near-zero minimum surface tension during cycling using captive bubble surfactometry. In vivo, Super Mini-B demonstrates oxygenation and dynamic compliance that are greater than Mini-B and compare favorably to full-length SP-B. Conclusion: Super Mini-B shows enhanced surfactant activity, probably due to the self-assembly of monomer peptide into dimer Super Mini-B that mimics the functions and putative structure of native SP-B.	[Walther, Frans J.; Waring, Alan J.; Hernandez-Juviel, Jose M.; Gordon, Larry M.] Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA; [Walther, Frans J.] Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; [Waring, Alan J.; Jung, Chun-Ling; Ruchala, Piotr] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Wang, Zhengdong; Notter, Robert H.] Univ Rochester, Dept Pediat, Rochester, NY USA; [Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Dept Chem, Pomona, CA 91768 USA; [Clark, Andrew P.; Smith, Wesley M.; Sharma, Shantanu] Calif State Polytech Univ Pomona, Ctr Macromol Modeling & Mat Design, Pomona, CA 91768 USA; [Notter, Robert H.] Univ Rochester, Dept Environm Med, Rochester, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; University of Rochester; California State University System; California State Polytechnic University Pomona; California State University System; California State Polytechnic University Pomona; University of Rochester	Walther, FJ (corresponding author), Univ Calif Los Angeles, Med Ctr, Los Angeles Biomed Res Inst Harbor, Torrance, CA 90509 USA.	fwalther@lumc.nl		Walther, Frans/0000-0003-1931-159X; RUCHALA, PIOTR/0000-0002-5574-2779	National Institutes of Health [HL-092158, ES-015330, HL-080775, HL-094641]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094641, R44HL080775, R43HL080775, R01HL092158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors gratefully acknowledge the financial support of the National Institutes of Health through grants HL-092158, ES-015330, HL-080775, and HL-094641. NIH had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Aguilar MI, 2005, NEUROTOX RES, V7, P17, DOI 10.1007/BF03033773; Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Alattia JR, 2006, J MOL BIOL, V362, P943, DOI 10.1016/j.jmb.2006.08.009; ANDERSSON M, 1995, FEBS LETT, V362, P328, DOI 10.1016/0014-5793(95)00268-E; Audie J, 2009, BIOPHYS CHEM, V139, P84, DOI 10.1016/j.bpc.2008.10.007; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Biswas N, 2007, BBA-BIOMEMBRANES, V1768, P1070, DOI 10.1016/j.bbamem.2007.01.020; Booth V, 2004, BIOCHEMISTRY-US, V43, P15187, DOI 10.1021/bi0481895; Bourbigot S, 2009, BIOPOLYMERS, V91, P1, DOI 10.1002/bip.21071; Bridges JP, 2006, J CELL BIOL, V172, P395, DOI 10.1083/jcb.200508016; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; BRUNI R, 1991, P NATL ACAD SCI USA, V88, P7451, DOI 10.1073/pnas.88.16.7451; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cairo CW, 2002, BIOCHEMISTRY-US, V41, P8620, DOI 10.1021/bi0156254; Castillo V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000476; Chang YS, 2005, CHEM PHYS LIPIDS, V137, P77, DOI 10.1016/j.chemphyslip.2005.07.002; Chang YS, 2004, BIOORG MED CHEM LETT, V14, P5983, DOI 10.1016/j.bmcl.2004.10.001; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chen R, 2002, PROTEINS, V47, P281, DOI 10.1002/prot.10092; CHESS P, 2005, LUNG INJURY MECH PAT, P617; COCHRANE CG, 1991, SCIENCE, V254, P566, DOI 10.1126/science.1948032; Cockshutt AM, 1992, PULMONARY SURFACTANT, P339; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; CRUZ A, 1995, BBA-LIPID LIPID MET, V1255, P68, DOI 10.1016/0005-2760(94)00210-P; Curstedt T, 2006, BIOL NEONATE, V89, P336, DOI 10.1159/000092871; de Groot NS, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-18; de Groot NS, 2006, FEBS J, V273, P658, DOI 10.1111/j.1742-4658.2005.05102.x; Dluhy RA, 2003, BIOPHYS J, V85, P2417, DOI 10.1016/S0006-3495(03)74665-7; FAN BR, 1990, ANAL BIOCHEM, V186, P41, DOI 10.1016/0003-2697(90)90569-U; FAN BR, 1991, FEBS LETT, V282, P220, DOI 10.1016/0014-5793(91)80481-H; FIELDS C G, 1991, Peptide Research, V4, P95; Fioroni M, 2001, J PHYS CHEM B, V105, P10967, DOI 10.1021/jp012476q; Freites JA, 2003, BIOPHYS J, V84, P2169, DOI 10.1016/S0006-3495(03)75023-1; Gast K, 2001, EUR BIOPHYS J BIOPHY, V30, P273, DOI 10.1007/s002490100148; Gerig JT, 2004, BIOPHYS J, V86, P3166, DOI 10.1016/S0006-3495(04)74364-7; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Gordon LM, 2008, BBA-BIOMEMBRANES, V1778, P2127, DOI 10.1016/j.bbamem.2008.05.002; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gordon LM, 1996, PROTEIN SCI, V5, P1662, DOI 10.1002/pro.5560050820; Gray JJ, 2003, PROTEINS, V52, P118, DOI 10.1002/prot.10384; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hawgood S, 2004, BIOL NEONATE, V85, P285, DOI 10.1159/000078169; Hawkins CA, 2005, J MOL BIOL, V346, P1381, DOI 10.1016/j.jmb.2004.12.045; Hong DP, 1999, J AM CHEM SOC, V121, P8427, DOI 10.1021/ja990833t; IMAMURA T, 2006, ENCY SURFACE COLLOID, P5251; Ivanova MI, 2004, P NATL ACAD SCI USA, V101, P10584, DOI 10.1073/pnas.0403756101; JOHANSSON J, 1991, BIOCHEMISTRY-US, V30, P6917, DOI 10.1021/bi00242a015; JOHANSSON J, 1994, EUR RESPIR J, V7, P372, DOI 10.1183/09031936.94.07020372; JOHANSSON J, 1995, BIOCHEM J, V307, P535, DOI 10.1042/bj3070535; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAHN MC, 1995, AM J PHYSIOL-LUNG C, V269, pL567, DOI 10.1152/ajplung.1995.269.5.L567; Kandasamy SK, 2005, BIOPHYS J, V88, P1577, DOI 10.1529/biophysj.104.038430; Kang JH, 1996, BIOCHEM MOL BIOL INT, V40, P617; Kaznessis YN, 2002, J MOL BIOL, V322, P569, DOI 10.1016/S0022-2836(02)00774-X; Kim W, 2005, J BIOL CHEM, V280, P35069, DOI 10.1074/jbc.M505763200; Kurutz JW, 2002, BIOCHEMISTRY-US, V41, P9627, DOI 10.1021/bi016077x; Lee H, 2005, BIOPHYS J, V89, P3807, DOI 10.1529/biophysj.105.066241; Lee KYC, 1997, COLLOID SURFACE A, V128, P225, DOI 10.1016/S0927-7757(96)03919-2; Lee KYC, 2001, BIOPHYS J, V81, P572, DOI 10.1016/S0006-3495(01)75724-4; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lipp MM, 1996, SCIENCE, V273, P1196, DOI 10.1126/science.273.5279.1196; Lipp MM, 1998, PHYS REV LETT, V81, P1650, DOI 10.1103/PhysRevLett.81.1650; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; LUND S, 1989, J BIOL CHEM, V264, P4907; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; MALCOLM JD, 1980, CAN J CHEM ENG, V58, P151, DOI 10.1002/cjce.5450580203; MCDONNELL PA, 1993, J MAGN RESON SER B, V102, P120, DOI 10.1006/jmrb.1993.1073; Mingarro I, 2008, CURR MED CHEM, V15, P393, DOI 10.2174/092986708783497364; MUNFORD RS, 1995, J LIPID RES, V36, P1653; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; NOTTER RH, 2000, LUNG SURFACTANTS BAS; Notter RH, 2007, MINI-REV MED CHEM, V7, P932, DOI 10.2174/138955707781662627; PastranaRios B, 1995, BIOPHYS J, V69, P2531, DOI 10.1016/S0006-3495(95)80124-4; Perez-Gil J, 2002, BIOL NEONATE, V81, P6, DOI 10.1159/000056765; PEREZGIL J, 1991, BIOCHEM INT, V25, P715; POSSMAYER F, 1988, AM REV RESPIR DIS, V138, P990, DOI 10.1164/ajrccm/138.4.990; Power JHT, 1999, J EXP BIOL, V202, P2543; REVAK SD, 1991, PEDIATR RES, V29, P460, DOI 10.1203/00006450-199105010-00010; REYNOLDS JA, 1970, P NATL ACAD SCI USA, V66, P1002, DOI 10.1073/pnas.66.3.1002; Roccatano D, 2005, PROTEIN SCI, V14, P2582, DOI 10.1110/ps.051426605; Ryan MA, 2005, BIOCHEMISTRY-US, V44, P861, DOI 10.1021/bi0485575; Sammalkorpi M, 2007, J PHYS CHEM B, V111, P11722, DOI 10.1021/jp072587a; Sarker M, 2007, BIOCHEMISTRY-US, V46, P11047, DOI 10.1021/bi7011756; SCHOEL WM, 1994, BBA-GEN SUBJECTS, V1200, P281, DOI 10.1016/0304-4165(94)90169-4; SCHURCH S, 1989, J APPL PHYSIOL, V67, P2389, DOI 10.1152/jappl.1989.67.6.2389; SCHURCH S, 1992, BIOCHIM BIOPHYS ACTA, V1103, P127, DOI 10.1016/0005-2736(92)90066-U; Schurch S, 2001, COMP BIOCHEM PHYS A, V129, P195, DOI 10.1016/S1095-6433(01)00316-6; Serrano AG, 2006, BIOPHYS J, V90, P238, DOI 10.1529/biophysj.105.073403; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Seurynck SL, 2005, CHEM BIOL, V12, P77, DOI 10.1016/j.chembiol.2004.10.014; Seurynck-Servoss SL, 2006, BIOCHEMISTRY-US, V45, P11809, DOI 10.1021/bi060617e; Small D. M., 1986, PHYS CHEM LIPIDS ALK; Stenger PC, 2009, BBA-BIOMEMBRANES, V1788, P358, DOI 10.1016/j.bbamem.2008.11.021; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Tanford C., 1980, HYDROPHOBIC EFFECT F, V2; Trovato A, 2006, PLOS COMPUT BIOL, V2, P1608, DOI 10.1371/journal.pcbi.0020170; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; VANDENBUSSCHE G, 1992, BIOCHEMISTRY-US, V31, P9169, DOI 10.1021/bi00153a008; Walther FJ, 1998, PEDIATR RES, V43, P666, DOI 10.1203/00006450-199805000-00016; Walther FJ, 2005, EXP LUNG RES, V31, P563, DOI 10.1080/019021490951531; Walther FJ, 2002, EXP LUNG RES, V28, P623, DOI 10.1080/01902140260426733; Walther FJ, 2002, BIOL NEONATE, V82, P181, DOI 10.1159/000063607; Walther FJ, 2000, MOL GENET METAB, V71, P342, DOI 10.1006/mgme.2000.3053; Walther FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001039; Walther FJ, 2007, NEONATOLOGY, V91, P303, DOI 10.1159/000101346; Wang YD, 2003, BIOCHEMISTRY-US, V42, P4015, DOI 10.1021/bi027344h; WARING A, 1989, Peptide Research, V2, P308; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Waring AJ, 1996, PEPTIDE RES, V9, P28; WILLSON DF, 2005, PEDIAT CRITICAL CARE, P453; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Yount NY, 2009, P NATL ACAD SCI USA, V106, P14972, DOI 10.1073/pnas.0904465106; Zaltash S, 2000, BBA-BIOMEMBRANES, V1466, P179, DOI 10.1016/S0005-2736(00)00199-1; Zaltash S, 2001, BIOL CHEM, V382, P933, DOI 10.1515/BC.2001.116	117	37	40	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8672	10.1371/journal.pone.0008672	http://dx.doi.org/10.1371/journal.pone.0008672			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084172	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600024
J	Rapanelli, M; Lew, SE; Frick, LR; Zanutto, BS				Rapanelli, Maximiliano; Eduardo Lew, Sergio; Romina Frick, Luciana; Silvano Zanutto, Bonifacio			Plasticity in the Rat Prefrontal Cortex: Linking Gene Expression and an Operant Learning with a Computational Theory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC CONSOLIDATION; PROTEIN EXPRESSION; NEURONAL-ACTIVITY; MESSENGER-RNA; SYNAPSIN-I; DOPAMINE; BRAIN; STRIATUM	The plasticity in the medial Prefrontal Cortex (mPFC) of rodents or lateral prefrontal cortex in non human primates (IPFC), plays a key role neural circuits involved in learning and memory. Several genes, like brain-derived neurotrophic factor (BDNF), cAMP response element binding (CREB), Synapsin I, Calcium/calmodulin-dependent protein kinase II (CamKII), activity-regulated cytoskeleton-associated protein (Arc), c-jun and c-fos have been related to plasticity processes. We analysed differential expression of related plasticity genes and immediate early genes in the mPFC of rats during learning an operant conditioning task. Incompletely and completely trained animals were studied because of the distinct events predicted by our computational model at different learning stages. During learning an operant conditioning task, we measured changes in the mRNA levels by Real-Time RT-PCR during learning; expression of these markers associated to plasticity was incremented while learning and such increments began to decline when the task was learned. The plasticity changes in the IPFC during learning predicted by the model matched up with those of the representative gene BDNF. Herein, we showed for the first time that plasticity in the mPFC in rats during learning of an operant conditioning is higher while learning than when the task is learned, using an integrative approach of a computational model and gene expression.	[Rapanelli, Maximiliano; Romina Frick, Luciana; Silvano Zanutto, Bonifacio] Consejo Nacl Invest Cient & Tecn, IBYME, Lab Biol Comportamiento, RA-1033 Buenos Aires, DF, Argentina; [Eduardo Lew, Sergio; Silvano Zanutto, Bonifacio] Univ Buenos Aires, Inst Ingn Biomed, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires	Rapanelli, M (corresponding author), Consejo Nacl Invest Cient & Tecn, IBYME, Lab Biol Comportamiento, RA-1033 Buenos Aires, DF, Argentina.	rapanelli@dna.uba.ar	rapanelli, maximiliano/P-3141-2016; Lew, Sergio/AAE-7122-2022	rapanelli, maximiliano/0000-0001-7329-2364; Lew, Sergio/0000-0001-7700-6687	Agencia Nacional de Promocion Cientifica y Tecnotogica [PICT 2006 2485]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 5876]; Universidad de Buenos Aires (UBACyT); Sigma Xi [G200803150637]	Agencia Nacional de Promocion Cientifica y Tecnotogica; Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); Sigma Xi	This study was funded by Agencia Nacional de Promocion Cientifica y Tecnotogica (PICT 2006 2485), Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 5876), Universidad de Buenos Aires (UBACyT) and Sigma Xi (G200803150637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Alfonso J, 2006, BIOL PSYCHIAT, V59, P244, DOI 10.1016/j.biopsych.2005.06.036; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; de Wit S, 2009, J NEUROSCI, V29, P11330, DOI 10.1523/JNEUROSCI.1639-09.2009; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Gaiddon C, 1996, J NEUROCHEM, V66, P2279; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gomez-Pinilla F, 2001, BRAIN RES, V904, P13, DOI 10.1016/S0006-8993(01)02394-0; Gonon F, 1997, J NEUROSCI, V17, P5972; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; Kennerley SW, 2009, J NEUROSCI, V29, P3259, DOI 10.1523/JNEUROSCI.5353-08.2009; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Kwon B, 2008, BRAIN RES, V1207, P128, DOI 10.1016/j.brainres.2008.01.072; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Lew SE, 2008, NEUROCOMPUTING, V71, P2782, DOI 10.1016/j.neucom.2007.09.010; Lew SE, 2001, IEEE IJCNN, P331, DOI 10.1109/IJCNN.2001.939041; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Miyashita T, 2008, NEUROBIOL LEARN MEM, V89, P269, DOI 10.1016/j.nlm.2007.08.012; Montague PR, 2004, NATURE, V431, P760, DOI 10.1038/nature03015; Morimoto K, 1998, BRAIN RES, V783, P57, DOI 10.1016/S0006-8993(97)01154-2; Murray KD, 2003, NEUROSCIENCE, V122, P407, DOI 10.1016/j.neuroscience.2003.07.015; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Petrides M, 2000, J NEUROSCI, V20, P7496; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rapanelli M, 2009, NEUROSCIENCE, V163, P1031, DOI 10.1016/j.neuroscience.2009.07.037; Romanelli P, 2007, BEHAV BRAIN RES, V184, P91, DOI 10.1016/j.bbr.2007.06.021; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Soule J, 2006, BIOCHEM SOC T, V34, P600, DOI 10.1042/BST0340600; Svarnik OE, 2005, NEUROSCIENCE, V136, P33, DOI 10.1016/j.neuroscience.2005.07.038; Teather LA, 2005, NEUROBIOL LEARN MEM, V84, P75, DOI 10.1016/j.nlm.2005.03.006; Tseng KY, 2006, SYNAPSE, V59, P412, DOI 10.1002/syn.20255; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Wang J, 2001, CEREB CORTEX, V11, P452, DOI 10.1093/cercor/11.5.452; ZANUTTO BS, 2007, PLOS COMPUT BIOL, V3	46	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8656	10.1371/journal.pone.0008656	http://dx.doi.org/10.1371/journal.pone.0008656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	601XB	20111591	Green Submitted, Green Published, gold			2022-12-27	WOS:000278099200001
J	Erlwein, O; Kaye, S; McClure, MO; Weber, J; Wills, G; Collier, D; Wessely, S; Cleare, A				Erlwein, Otto; Kaye, Steve; McClure, Myra O.; Weber, Jonathan; Wills, Gillian; Collier, David; Wessely, Simon; Cleare, Anthony			Failure to Detect the Novel Retrovirus XMRV in Chronic Fatigue Syndrome	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; PROSTATE-CANCER PATIENTS; GAMMARETROVIRUS; TUMORS; SCALE	Background: In October 2009 it was reported that 68 of 101 patients with chronic fatigue syndrome (CFS) in the US were infected with a novel gamma retrovirus, xenotropic murine leukaemia virus-related virus (XMRV), a virus previously linked to prostate cancer. This finding, if confirmed, would have a profound effect on the understanding and treatment of an incapacitating disease affecting millions worldwide. We have investigated CFS sufferers in the UK to determine if they are carriers of XMRV. Methodology: Patients in our CFS cohort had undergone medical screening to exclude detectable organic illness and met the CDC criteria for CFS. DNA extracted from blood samples of 186 CFS patients were screened for XMRV provirus and for the closely related murine leukaemia virus by nested PCR using specific oligonucleotide primers. To control for the integrity of the DNA, the cellular beta-globin gene was amplified. Negative controls (water) and a positive control (XMRV infectious molecular clone DNA) were included. While the beta-globin gene was amplified in all 186 samples, neither XMRV nor MLV sequences were detected. Conclusion: XMRV or MLV sequences were not amplified from DNA originating from CFS patients in the UK. Although we found no evidence that XMRV is associated with CFS in the UK, this may be a result of population differences between North America and Europe regarding the general prevalence of XMRV infection, and might also explain the fact that two US groups found XMRV in prostate cancer tissue, while two European studies did not.	[Erlwein, Otto; Kaye, Steve; McClure, Myra O.; Weber, Jonathan; Wills, Gillian] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wright Fleming Inst, Jefferiss Res Trust Labs,Sect Infect Dis, London, England; [Collier, David] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Wessely, Simon; Cleare, Anthony] Kings Coll London, Inst Psychiat, Dept Psychol Med, London WC2R 2LS, England	Imperial College London; University of London; King's College London; University of London; King's College London	Erlwein, O (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Wright Fleming Inst, Jefferiss Res Trust Labs,Sect Infect Dis, St Marys Campus,Norfolk Pl, London, England.	m.mcclure@imperial.ac.uk	Cleare, Anthony/AAN-5418-2021; Wessely, Simon C/A-8713-2008; Collier, David A/D-1649-2011; Cleare, Anthony J/B-4506-2008	Collier, David A/0000-0003-4087-1559; Wessely, Simon Charles/0000-0002-6743-9929; McClure, Myra/0000-0002-5494-407X	NHS Foundation Trust/Institute of Psychiatry National Institute of Health Biomedical Resaerch Centre; NIHR Biomedical Research Centre; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	NHS Foundation Trust/Institute of Psychiatry National Institute of Health Biomedical Resaerch Centre; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	AC, DC and SW are partially funded by the South London and Maudsley NHS Foundation Trust/Institute of Psychiatry National Institute of Health Biomedical Resaerch Centre. The team from Imperial College is grateful for support from the NIHR Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; Deale A, 1997, AM J PSYCHIAT, V154, P408; DEFREITAS E, 1991, P NATL ACAD SCI USA, V88, P2922, DOI 10.1073/pnas.88.7.2922; Euba R, 1996, BRIT J PSYCHIAT, V168, P121, DOI 10.1192/bjp.168.1.121; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FOLKS TM, 1993, CIBA F SYMP, V173, P160; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; FURUTA RA, 2009, COLD SPRING HARB RET; GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439; GOW JW, 1992, J CLIN PATHOL, V45, P1058, DOI 10.1136/jcp.45.12.1058; HENEINE W, 1994, CLIN INFECT DIS, V18, pS121, DOI 10.1093/clinids/18.Supplement_1.S121; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; HONDA M, 1993, MICROBIOL IMMUNOL, V37, P779, DOI 10.1111/j.1348-0421.1993.tb01705.x; KHAN AS, 1993, ANN INTERN MED, V118, P241, DOI 10.7326/0003-4819-118-4-199302150-00001; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Quarmby L, 2007, BEHAV RES THER, V45, P1085, DOI 10.1016/j.brat.2006.08.019; ROBERTS AD, 2009, PSYCHOL MED IN PRESS; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Sharpe M, 1997, GEN HOSP PSYCHIAT, V19, P185, DOI 10.1016/S0163-8343(97)80315-5; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6; Wilson A, 2001, AUST NZ J PSYCHIAT, V35, P520, DOI 10.1046/j.1440-1614.2001.00888.x	26	173	178	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8519	10.1371/journal.pone.0008519	http://dx.doi.org/10.1371/journal.pone.0008519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066031	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338600004
J	Heikkila, JE; Vaha-Koskela, MJV; Ruotsalainen, JJ; Martikainen, MW; Stanford, MM; McCart, JA; Bell, JC; Hinkkanen, AE				Heikkila, Jari E.; Vaha-Koskela, Markus J. V.; Ruotsalainen, Janne J.; Martikainen, Miika W.; Stanford, Marianne M.; McCart, J. Andrea; Bell, John C.; Hinkkanen, Ari E.			Intravenously Administered Alphavirus Vector VA7 Eradicates Orthotopic Human Glioma Xenografts in Nude Mice	PLOS ONE			English	Article							SEMLIKI-FOREST-VIRUS; CANCER STEM-CELL; MALIGNANT GLIOMAS; GLIOBLASTOMA-MULTIFORME; ONCOLYTIC VIRUS; IMMUNODEFICIENT MICE; GENE-EXPRESSION; A7(74) STRAIN; TUMOR; THERAPY	Background: VA7 is a neurotropic alphavirus vector based on an attenuated strain of Semliki Forest virus. We have previously shown that VA7 exhibits oncolytic activity against human melanoma xenografts in immunodeficient mice. The purpose of this study was to determine if intravenously administered VA7 would be effective against human glioma. Methodology/Principal Findings: In vitro, U87, U251, and A172 human glioma cells were infected and killed by VA7-EGFP. In vivo, antiglioma activity of VA7 was tested in Balb/c nude mice using U87 cells stably expressing firefly luciferase in subcutaneous and orthotopic tumor models. Intravenously administered VA7-EGFP completely eradicated 100% of small and 50% of large subcutaneous U87Fluc tumors. A single intravenous injection of either VA7-EGFP or VA7 expressing Renilla luciferase (VA7-Rluc) into mice bearing orthotopic U87Fluc tumors caused a complete quenching of intracranial firefly bioluminescence and long-term survival in total 16 of 17 animals. In tumor-bearing mice injected with VA7-Rluc, transient intracranial and peripheral Renilla bioluminescence was observed. Virus was well tolerated and no damage to heart, liver, spleen, or brain was observed upon pathological assessment at three and ninety days post injection, despite detectable virus titers in these organs during the earlier time point. Conclusion: VA7 vector is apathogenic and can enter and destroy brain tumors in nude mice when administered systemically. This study warrants further elucidation of the mechanism of tumor destruction and attenuation of the VA7 virus.	[Heikkila, Jari E.; Vaha-Koskela, Markus J. V.; Hinkkanen, Ari E.] Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland; [Vaha-Koskela, Markus J. V.; Stanford, Marianne M.; Bell, John C.] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Ruotsalainen, Janne J.; Martikainen, Miika W.; Hinkkanen, Ari E.] Univ Kuopio, Dept Biotechnol & Mol Med, AI Virtanen Inst, FIN-70211 Kuopio, Finland; [McCart, J. Andrea] Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON, Canada	Abo Akademi University; University of Ottawa; Ottawa Hospital Research Institute; University of Eastern Finland; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Heikkila, JE (corresponding author), Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland.	jari.heikkila@abo.fi		Ruotsalainen, Janne/0000-0002-5312-5486; Stanford, Marianne/0000-0003-0432-3707; Vaha-Koskela, Markus/0000-0001-7764-7820	K. Albin Johanssons Stiftelse; Medicinska Understodsforeningen Liv och Halsa; Stiftelsens for Abo Akademi Forskningsinstitut; Finnish Cancer Organizations; Cancer Society of South-Western Finland; Canadian Institutes of Health Research; Terry Fox Foundation	K. Albin Johanssons Stiftelse; Medicinska Understodsforeningen Liv och Halsa; Stiftelsens for Abo Akademi Forskningsinstitut; Finnish Cancer Organizations; Cancer Society of South-Western Finland; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation	This study was funded by K. Albin Johanssons Stiftelse, Medicinska Understodsforeningen Liv och Halsa, Stiftelsens for Abo Akademi Forskningsinstitut, The Finnish Cancer Organizations, and The Cancer Society of South-Western Finland. JCB is supported by the Canadian Institutes of Health Research and Terry Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amor S, 1996, J GEN VIROL, V77, P281, DOI 10.1099/0022-1317-77-2-281; Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BRADISH CJ, 1971, J GEN VIROL, V12, P114, DOI 10.1099/0022-1317-12-2-141; Camphausen K, 2005, P NATL ACAD SCI USA, V102, P8287, DOI 10.1073/pnas.0502887102; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Currier MA, 2005, CANCER GENE THER, V12, P407, DOI 10.1038/sj.cgt.7700799; FAZAKERLEY JK, 1993, VIROLOGY, V195, P627, DOI 10.1006/viro.1993.1414; Fragkoudis R, 2007, J GEN VIROL, V88, P3373, DOI 10.1099/vir.0.83191-0; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Geoerger B, 2004, CANCER RES, V64, P5753, DOI 10.1158/0008-5472.CAN-04-0499; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gromeier M, 2000, P NATL ACAD SCI USA, V97, P6803, DOI 10.1073/pnas.97.12.6803; Grote D, 2001, BLOOD, V97, P3746, DOI 10.1182/blood.V97.12.3746; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Kambara H, 2005, CANCER RES, V65, P2832, DOI 10.1158/0008-5472.CAN-04-3227; KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8; KOLUJOHN EO, 1983, T R SOC TROP MED HYG, V77, P149; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Lun XQ, 2005, CANCER RES, V65, P9982, DOI 10.1158/0008-5472.CAN-05-1201; Lun XQ, 2009, CLIN CANCER RES, V15, P2777, DOI 10.1158/1078-0432.CCR-08-2342; Lun X, 2006, JNCI-J NATL CANCER I, V98, P1546, DOI 10.1093/jnci/djj413; Maatta AM, 2007, INT J CANCER, V121, P863, DOI 10.1002/ijc.22758; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; MATHIOT CC, 1990, AM J TROP MED HYG, V42, P386, DOI 10.4269/ajtmh.1990.42.386; MATSUKADO Y, 1961, J NEUROSURG, V18, P636, DOI 10.3171/jns.1961.18.5.0636; McCart JA, 2001, CANCER RES, V61, P8751; McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6; MINETA T, 1995, NAT MED, V1, P938, DOI 10.1038/nm0995-938; Otto-Duessel M, 2006, MOL IMAGING, V5, P57, DOI 10.2310/7290.2006.00006; Ozduman K, 2008, J NEUROSCI, V28, P1882, DOI 10.1523/JNEUROSCI.4905-07.2008; Pang BC, 2007, ANN ACAD MED SINGAP, V36, P358; Phuong LK, 2003, CANCER RES, V63, P2462; Rodriguez-Madoz JR, 2007, MOL THER, V15, P2164, DOI 10.1038/sj.mt.6300274; Shah AC, 2007, GENE THER, V14, P1045, DOI 10.1038/sj.gt.3302942; Singh SK, 2003, CANCER RES, V63, P5821; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tuittila MT, 2000, J VIROL, V74, P4579, DOI 10.1128/JVI.74.10.4579-4589.2000; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaha-Koskela MJV, 2006, CANCER RES, V66, P7185, DOI 10.1158/0008-5472.CAN-05-2214; Vaha-Koskela MJV, 2003, J NEUROVIROL, V9, P1, DOI 10.1080/13550280390173382; Wilcox ME, 2001, J NATL CANCER I, V93, P903, DOI 10.1093/jnci/93.12.903	46	40	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8603	10.1371/journal.pone.0008603	http://dx.doi.org/10.1371/journal.pone.0008603			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066051	Green Submitted, Green Published, gold			2022-12-27	WOS:000273338600021
J	Yi, HG; Xi, YL; Liu, J; Wang, JR; Wu, JY; Xu, T; Chen, W; Chen, BB; Lin, ML; Wang, H; Zhou, MM; Li, JS; Xu, ZY; Jin, SG; Bao, QY				Yi, Huiguang; Xi, Yali; Liu, Jing; Wang, Junrong; Wu, Jinyu; Xu, Teng; Chen, Wei; Chen, Biaobang; Lin, Meili; Wang, Huan; Zhou, Mingming; Li, Jinsong; Xu, Zuyuan; Jin, Shouguang; Bao, Qiyu			Sequence Analysis of pKF3-70 in Klebsiella pneumoniae: Probable Origin from R100-Like Plasmid of Escherichia coli	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; NUCLEOTIDE-SEQUENCE; COMPARATIVE GENOMICS; DNA-SEQUENCE; GENE; REPLICATION; R1; MOBILIZATION; BLA(CTX-M); RESISTANCE	Background: Klebsiella pneumoniae is a clinically significant species of bacterium which causes a variety of diseases. Clinical treatment of this bacterial infection is greatly hindered by the emergence of multidrug-resistant strains. The resistance is largely due to the acquisition of plasmids carrying drug-resistant as well as pathogenic genes, and its conjugal transfer facilitates the spread of resistant phenotypes. Methodology/Principal Findings: The 70,057 bp plasmid pKF3-70, commonly found in Klebsiella pneumoniae, is composed of five main functional modules, including regions involved in replication, partition, conjugation, transfer leading, and variable regions. This plasmid is more similar to several Escherichia coli plasmids than any previously reported K. pneumoniae plasmids and pKF3-70 like plasmids share a common and conserved backbone sequence. The replication system of the pKF3-70 is 100% identical to that of RepFII plasmid R100 from E. coli. A beta-lactamase gene ctx-m-14 with its surrounding insertion elements (ISEcp1, truncated IS903 and a 20 bp inverted repeat sequence) may compose an active transposon which is directly bordered by two putative target repeats "ATTAC.'' Conclusions/Significance: The K. pneumoniae plasmid pKF3-70 carries an extended-spectrum beta-lactamase gene, ctx-m14. The conjugative characteristic makes it a widespread plasmid among genetically relevant genera which poses significant threat to public health.	[Yi, Huiguang; Xi, Yali; Liu, Jing; Wang, Junrong; Wu, Jinyu; Xu, Teng; Chen, Wei; Chen, Biaobang; Lin, Meili; Wang, Huan; Zhou, Mingming; Li, Jinsong; Xu, Zuyuan; Bao, Qiyu] Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China; [Yi, Huiguang] Fudan Univ, T Life Res Ctr, Shanghai 200433, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Wenzhou Medical University; Fudan University; State University System of Florida; University of Florida	Yi, HG (corresponding author), Wenzhou Med Coll, Inst Biomed Informat, Zhejiang Prov Key Lab Med Genet, Wenzhou, Peoples R China.	baoqy@genomics.org.cn	Bao, Qiyu/AAH-6113-2020; Jin, Shouguang/N-5548-2016	Bao, Qiyu/0000-0001-6523-8763; li, Jinsong/0000-0003-0764-3706; Yi, Huiguang/0000-0002-9676-7438	Science and Technology Foundation of Zhejiang Province, China [2008C23074]; Science and Technology Foundation of Wenzhou City, China [Y2006B002]; Wenzhou Science and Technology Development Program [Y20080105]; Foundation of Wenzhou Medical College, China [XNK06006]	Science and Technology Foundation of Zhejiang Province, China; Science and Technology Foundation of Wenzhou City, China; Wenzhou Science and Technology Development Program; Foundation of Wenzhou Medical College, China	This work was supported by the Science and Technology Foundation of Zhejiang Province, China (2008C23074); Science and Technology Foundation of Wenzhou City, China (Y2006B002); Wenzhou Science and Technology Development Program (Y20080105); and Foundation of Wenzhou Medical College, China (XNK06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambe J P, 2007, Niger J Clin Pract, V10, P290; BARTHELEMY M, 1992, BIOCHIM BIOPHYS ACTA, V1122, P15, DOI 10.1016/0167-4838(92)90121-S; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bidet P, 2005, ANTIMICROB AGENTS CH, V49, P3562, DOI 10.1128/AAC.49.8.3562-3565.2005; Bistue AJCS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001800; BLOMBERG P, 1992, EMBO J, V11, P2675, DOI 10.1002/j.1460-2075.1992.tb05333.x; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bouet JY, 2007, MOL MICROBIOL, V65, P1405, DOI 10.1111/j.1365-2958.2007.05882.x; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Brilli M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-551; Camacho EM, 2005, INT MICROBIOL, V8, P279; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Chanawong A, 2002, ANTIMICROB AGENTS CH, V46, P630, DOI 10.1128/AAC.46.3.630-637.2002; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; Decousser JW, 2001, ANTIMICROB AGENTS CH, V45, P3595, DOI 10.1128/AAC.45.12.3595-3598.2001; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELICIELLO I, 1993, ANAL BIOCHEM, V212, P394, DOI 10.1006/abio.1993.1346; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; GERDES K, 1986, J MOL BIOL, V190, P269, DOI 10.1016/0022-2836(86)90001-X; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Jensen RB, 1997, J MOL BIOL, V269, P505, DOI 10.1006/jmbi.1997.1061; JENSEN RB, 1994, J MOL BIOL, V236, P1299, DOI 10.1016/0022-2836(94)90059-0; Johnson TJ, 2006, J BACTERIOL, V188, P5975, DOI 10.1128/JB.00204-06; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Jurczak A, 2007, Adv Med Sci, V52 Suppl 1, P30; Karami N, 2007, J ANTIMICROB CHEMOTH, V60, P1142, DOI 10.1093/jac/dkm327; Karim A, 2001, FEMS MICROBIOL LETT, V201, P237, DOI 10.1016/S0378-1097(01)00276-2; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Lawley T, 2004, PLASMID BIOLOGY, P203; Ma L, 2002, ANTIMICROB AGENTS CH, V46, P1985, DOI 10.1128/AAC.46.6.1985-1988.2002; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Manwaring NP, 1999, PLASMID, V41, P219, DOI 10.1006/plas.1999.1390; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Nordstrom K, 2006, PLASMID, V55, P1, DOI 10.1016/j.plasmid.2005.07.002; NORDSTROM M, 1985, PLASMID, V13, P81, DOI 10.1016/0147-619X(85)90060-5; Ohtsubo H, 1986, Adv Biophys, V21, P115, DOI 10.1016/0065-227X(86)90018-3; Poirel L, 2003, ANTIMICROB AGENTS CH, V47, P2938, DOI 10.1128/AAC.47.9.2938-2945.2003; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; TABUCHI A, 1988, J MOL BIOL, V202, P511, DOI 10.1016/0022-2836(88)90282-3; Taylor DE, 2004, PLASMID BIOLOGY, P473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Venkatesan MM, 2004, PLASMID BIOLOGY, P395; Xiong ZZ, 2002, DIAGN MICR INFEC DIS, V44, P195, DOI 10.1016/S0732-8893(02)00441-8; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	50	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 6	2010	5	1							e8601	10.1371/journal.pone.0008601	http://dx.doi.org/10.1371/journal.pone.0008601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540NF	20066042	Green Published, gold, Green Submitted			2022-12-27	WOS:000273338600019
J	Platek, SM; Singh, D				Platek, Steven M.; Singh, Devendra			Optimal Waist-to-Hip Ratios in Women Activate Neural Reward Centers in Men	PLOS ONE			English	Article							BODY-FAT DISTRIBUTION; NUCLEUS-ACCUMBENS; ORBITOFRONTAL CORTEX; SEXUAL-DIMORPHISM; BRAIN; FACES; ATTRACTIVENESS; PREFERENCES; BEAUTY; FMRI	Secondary sexual characteristics convey information about reproductive potential. In the same way that facial symmetry and masculinity, and shoulder-to-hip ratio convey information about reproductive/genetic quality in males, waist-to-hip-ratio (WHR) is a phenotypic cue to fertility, fecundity, neurodevelopmental resources in offspring, and overall health, and is indicative of "good genes'' in women. Here, using fMRI, we found that males show activation in brain reward centers in response to naked female bodies when surgically altered to express an optimal (similar to 0.7) WHR with redistributed body fat, but relatively unaffected body mass index (BMI). Relative to presurgical bodies, brain activation to postsurgical bodies was observed in bilateral orbital frontal cortex. While changes in BMI only revealed activation in visual brain substrates, changes in WHR revealed activation in the anterior cingulate cortex, an area associated with reward processing and decision-making. When regressing ratings of attractiveness on brain activation, we observed activation in forebrain substrates, notably the nucleus accumbens, a forebrain nucleus highly involved in reward processes. These findings suggest that an hourglass figure (i.e., an optimal WHR) activates brain centers that drive appetitive sociality/attention toward females that represent the highest-quality reproductive partners. This is the first description of a neural correlate implicating WHR as a putative honest biological signal of female reproductive viability and its effects on men's neurological processing.	[Platek, Steven M.] Georgia Gwinnett Coll, Dept Psychol, Lawrenceville, GA USA; [Singh, Devendra] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	University System of Georgia; Georgia Gwinnett College; University of Texas System; University of Texas Austin	Platek, SM (corresponding author), Georgia Gwinnett Coll, Dept Psychol, Lawrenceville, GA USA.	splatek@gmail.com	Singh, Devendra Narain/K-3055-2013	Singh, Devendra Narain/0000-0003-3832-1507	University of Liverpool; Pioneer Fund	University of Liverpool; Pioneer Fund	This work was supported by a faculty induction award from the University of Liverpool and a grant from the Pioneer Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bjork JM, 2008, ADDICTION, V103, P1308, DOI 10.1111/j.1360-0443.2008.02250.x; Bostwick JM, 2008, MAYO CLIN PROC, V83, P226, DOI 10.4065/83.2.226; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Chen NK, 2003, NEUROIMAGE, V19, P817, DOI 10.1016/S1053-8119(03)00091-0; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Dufour DL, 2002, AM J HUM BIOL, V14, P584, DOI 10.1002/ajhb.10071; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 2002, ANN REV SEX RES, V12, P145; He F, 2008, STEREOT FUNCT NEUROS, V86, P320, DOI 10.1159/000160155; Hedges VL, 2009, GENES BRAIN BEHAV, V8, P442, DOI 10.1111/j.1601-183X.2009.00491.x; Heinz A, 2004, AM J PSYCHIAT, V161, P1783, DOI 10.1176/appi.ajp.161.10.1783; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; LASSEK W, 2008, EVOL HUM BEHAV, V29, P28; Nelson TL, 1999, OBES RES, V7, P199, DOI 10.1002/j.1550-8528.1999.tb00702.x; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Penton-Voak IS, 2003, J COMP PSYCHOL, V117, P264, DOI 10.1037/0735-7036.117.3.264; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Platek SM, 2005, NEUROIMAGE, V25, P1336, DOI 10.1016/j.neuroimage.2004.12.037; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P289, DOI 10.1016/j.neuropsychologia.2008.07.018; REDING K, REWARD RESPONS UNPUB; Rupp HA, 2009, HORM BEHAV, V56, P66, DOI 10.1016/j.yhbeh.2009.03.005; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; SINGH D, 1994, INT J OBESITY, V18, P731; Singh D, 2007, PERS INDIV DIFFER, V43, P329, DOI 10.1016/j.paid.2006.12.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stein DJ, 2001, AM J PSYCHIAT, V158, P1590, DOI 10.1176/appi.ajp.158.10.1590; Stoeckel LE, 2009, BRAIN RES BULL, V79, P388, DOI 10.1016/j.brainresbull.2009.05.016; Swami V, 2008, PERS INDIV DIFFER, V44, P98, DOI 10.1016/j.paid.2007.07.017; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Thornhill R, 1999, EVOL HUM BEHAV, V20, P105, DOI 10.1016/S1090-5138(98)00044-0; Wetsman A, 1999, EVOL HUM BEHAV, V20, P219, DOI 10.1016/S1090-5138(99)00007-0; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Yu DW, 1998, NATURE, V396, P321, DOI 10.1038/24512; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	45	57	58	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9042	10.1371/journal.pone.0009042	http://dx.doi.org/10.1371/journal.pone.0009042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554NT	20140088	gold, Green Published, Green Submitted			2022-12-27	WOS:000274442400002
J	Rienstra, H; Katta, K; Celie, JWAM; van Goor, H; Navis, G; van den Born, J; Hillebrands, JL				Rienstra, Heleen; Katta, Kirankumar; Celie, Johanna W. A. M.; van Goor, Harry; Navis, Gerjan; van den Born, Jacob; Hillebrands, Jan-Luuk			Differential Expression of Proteoglycans in Tissue Remodeling and Lymphangiogenesis after Experimental Renal Transplantation in Rats	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; MUSCLE-CELL PROLIFERATION; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EPITHELIAL-MESENCHYMAL TRANSITION; GLOMERULAR EXTRACELLULAR-MATRIX; INTERTUBULAR CAPILLARY CHANGES; BASEMENT-MEMBRANE; L-SELECTIN; LYMPHATIC NEOANGIOGENESIS; DIABETIC-NEPHROPATHY	Background: Chronic transplant dysfunction explains the majority of late renal allograft loss and is accompanied by extensive tissue remodeling leading to transplant vasculopathy, glomerulosclerosis and interstitial fibrosis. Matrix proteoglycans mediate cell-cell and cell-matrix interactions and play key roles in tissue remodeling. The aim of this study was to characterize differential heparan sulfate proteoglycan and chondroitin sulfate proteoglycan expression in transplant vasculopathy, glomerulosclerosis and interstitial fibrosis in renal allografts with chronic transplant dysfunction. Methods: Renal allografts were transplanted in the Dark Agouti-to-Wistar Furth rat strain combination. Dark Agouti-to-Dark Agouti isografts and non-transplanted Dark Agouti kidneys served as controls. Allograft and isograft recipients were sacrificed 66 and 81 days (mean) after transplantation, respectively. Heparan sulfate proteoglycan (collXVIII, perlecan and agrin) and chondroitin sulfate proteoglycan (versican) expression, as well as CD31 and LYVE-1 (vascular and lymphatic endothelium, respectively) expression were (semi-) quantitatively analyzed using immunofluorescence. Findings: Arteries with transplant vasculopathy and sclerotic glomeruli in allografts displayed pronounced neo-expression of collXVIII and perlecan. In contrast, in interstitial fibrosis expression of the chondroitin sulfate proteoglycan versican dominated. In the cortical tubular basement membranes in both iso-and allografts, induction of collXVIII was detected. Allografts presented extensive lymphangiogenesis (p<0.01 compared to isografts and non-transplanted controls), which was associated with induced perlecan expression underneath the lymphatic endothelium (p<0.05 and p<0.01 compared to isografts and non-transplanted controls, respectively). Both the magnitude of lymphangiogenesis and perlecan expression correlated with severity of interstitial fibrosis and impaired graft function. Interpretation: Our results reveal that changes in the extent of expression and the type of proteoglycans being expressed are tightly associated with tissue remodeling after renal transplantation. Therefore, proteoglycans might be potential targets for clinical intervention in renal chronic transplant dysfunction.	[Rienstra, Heleen] Univ Groningen, Dept Cell Biol, Univ Med Ctr Groningen, Immunol Sect, Groningen, Netherlands; [Katta, Kirankumar; Navis, Gerjan; van den Born, Jacob] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Div Nephrol, Groningen, Netherlands; [Celie, Johanna W. A. M.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Div Pathol, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Groningen	Rienstra, H (corresponding author), Univ Groningen, Dept Cell Biol, Univ Med Ctr Groningen, Immunol Sect, Groningen, Netherlands.	j.l.hillebrands@path.umcg.nl	van+Goor, Harry/AAS-7712-2020	van Goor, Harry/0000-0002-6670-1577; Hillebrands, Jan-Luuk/0000-0003-3135-3274	Dutch Kidney Foundation [C03.6015]; University Medical Center Groningen	Dutch Kidney Foundation; University Medical Center Groningen	This study was supported by a Career Stimulation Program Grant from the Dutch Kidney Foundation (C03.6015, J.-L.H. and H. R.) and the University Medical Center Groningen (K. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2005, TRANSPLANTATION, V79, P672, DOI 10.1097/01.TP.0000155961.57664.DB; Aresu L, 2007, VIRCHOWS ARCH, V451, P937, DOI 10.1007/s00428-007-0482-8; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bellini MH, 2007, NEPHROLOGY, V12, P459, DOI 10.1111/j.1440-1797.2007.00850.x; Bingley JA, 1998, J VASC SURG, V28, P308, DOI 10.1016/S0741-5214(98)70167-3; Bjornson A, 2005, AM J PHYSIOL-RENAL, V288, pF748, DOI 10.1152/ajprenal.00202.2004; Granqvist ABR, 2006, AM J PHYSIOL-RENAL, V291, pF722, DOI 10.1152/ajprenal.00433.2005; Celie JWAM, 2008, AM J PHYSIOL-RENAL, V294, pF253, DOI 10.1152/ajprenal.00429.2007; Celie JWAM, 2007, AM J PATHOL, V170, P1865, DOI 10.2353/ajpath.2007.070061; Celie JWAM, 2009, FRONT BIOSCI-LANDMRK, V14, P4932, DOI 10.2741/3578; Celie JWAM, 2005, J BIOL CHEM, V280, P26965, DOI 10.1074/jbc.M502188200; Celie JWAM, 2005, J IMMUNOL METHODS, V298, P155, DOI 10.1016/j.jim.2005.01.009; Chapman JR, 2005, J AM SOC NEPHROL, V16, P3015, DOI 10.1681/ASN.2005050463; Colvin RB, 2004, J AM SOC NEPHROL, V15, P827, DOI 10.1097/01.ASN.0000117895.24143.87; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Farb A, 2004, CIRCULATION, V110, P940, DOI 10.1161/01.CIR.0000139337.56084.30; Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3; Hillebrands JL, 2003, ARTERIOSCL THROM VAS, V23, P380, DOI 10.1161/01.ATV.0000059337.60393.64; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jiang XN, 2003, J HISTOCHEM CYTOCHEM, V51, P1393, DOI 10.1177/002215540305101101; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kawashima H, 1999, INT IMMUNOL, V11, P393, DOI 10.1093/intimm/11.3.393; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kinsella MG, 2004, ATHEROSCLEROSIS, V175, P51, DOI 10.1016/j.atherosclerosis.2004.01.045; Kinsella MG, 2003, ARTERIOSCL THROM VAS, V23, P608, DOI 10.1161/01.ATV.0000063109.94810.EE; Kouwenhoven EA, 2000, TRANSPL INT, V13, P385; Kunter U, 2003, TRANSPLANTATION, V75, P3, DOI 10.1097/00007890-200301150-00002; Labropoulou VT, 2006, HISTOPATHOLOGY, V49, P582, DOI 10.1111/j.1365-2559.2006.02558.x; Lavin PJ, 2008, CURR OPIN NEPHROL HY, V17, P386, DOI 10.1097/MNH.0b013e32830464f4; Lin H, 1996, J HEART LUNG TRANSPL, V15, P1233; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Lortat-Jacob H, 2002, P NATL ACAD SCI USA, V99, P1229, DOI 10.1073/pnas.032497699; Maciel TT, 2008, J NEPHROL, V21, P753; Malek P, 1968, Lymphology, V1, P4; MAZZUCCO G, 1994, ULTRASTRUCT PATHOL, V18, P533, DOI 10.3109/01913129409021895; MONGA G, 1992, MODERN PATHOL, V5, P125; Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593; OToole JJ, 1996, P NATL ACAD SCI USA, V93, P7369, DOI 10.1073/pnas.93.14.7369; PAUL LC, 1984, KIDNEY INT, V25, P771, DOI 10.1038/ki.1984.89; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Rienstra H, 2009, AM J TRANSPLANT, V9, P463, DOI 10.1111/j.1600-6143.2008.02534.x; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Rutkowski JM, 2006, AM J PHYSIOL-HEART C, V291, pH1402, DOI 10.1152/ajpheart.00038.2006; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Sakko AJ, 2001, CANCER RES, V61, P926; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; Sephel GC, 1996, MATRIX BIOL, V15, P263, DOI 10.1016/S0945-053X(96)90117-1; Shimizu A, 2000, CLIN TRANSPLANT, V14, P6, DOI 10.1034/j.1399-0012.2000.0140s3006.x; Sinniah R, 1999, ULTRASTRUCT PATHOL, V23, P359, DOI 10.1080/019131299281329; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stoessel A, 2008, AM J PHYSIOL-RENAL, V295, pF717, DOI 10.1152/ajprenal.00071.2008; Stuht S, 2007, AM J TRANSPLANT, V7, P377, DOI 10.1111/j.1600-6143.2006.01638.x; Suzuki T, 2001, AM J PATHOL, V158, P75, DOI 10.1016/S0002-9440(10)63946-6; Talusan P, 2005, MOL CELL PROTEOMICS, V4, P1350, DOI 10.1074/mcp.M500088-MCP200; TAMSMA JT, 1994, DIABETOLOGIA, V37, P313, DOI 10.1007/BF00398060; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Tran PK, 2007, ATHEROSCLEROSIS, V190, P264, DOI 10.1016/j.atherosclerosis.2006.03.010; Tran PK, 2004, CIRC RES, V94, P550, DOI 10.1161/01.RES.0000117772.86853.34; van den Born J, 2006, J BIOL CHEM, V281, P29606, DOI 10.1074/jbc.M601552200; van Goor H, 2009, KIDNEY INT, V75, P767, DOI 10.1038/ki.2009.45; vandenBorn J, 1995, J BIOL CHEM, V270, P31303, DOI 10.1074/jbc.270.52.31303; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; vandenBorn J, 1996, J BIOL CHEM, V271, P22802, DOI 10.1074/jbc.271.37.22802; Waanders F, 2009, AM J PHYSIOL-RENAL, V296, pF1072, DOI 10.1152/ajprenal.90643.2008; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Yang YX, 2001, PEDIATR NEPHROL, V16, P429, DOI 10.1007/s004670100563	75	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 5	2010	5	2							e9095	10.1371/journal.pone.0009095	http://dx.doi.org/10.1371/journal.pone.0009095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554NT	20140097	Green Published, Green Submitted, gold			2022-12-27	WOS:000274442400025
J	Duncan, CDS; Weeks, KM				Duncan, Caia D. S.; Weeks, Kevin M.			The Mrs1 Splicing Factor Binds the bI3 Group I Intron at Each of Two Tetraloop-Receptor Motifs	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MITOCHONDRIAL INTRONS; TERTIARY INTERACTIONS; SHAPE CHEMISTRY; RNA; PROTEIN; RIBOZYME; DOMAIN; SITE; ARCHITECTURE	Most large ribozymes require protein cofactors in order to function efficiently. The yeast mitochondrial bI3 group I intron requires two proteins for efficient splicing, Mrs1 and the bI3 maturase. Mrs1 has evolved from DNA junction resolvases to function as an RNA cofactor for at least two group I introns; however, the RNA binding site and the mechanism by which Mrs1 facilitates splicing were unknown. Here we use high-throughput RNA structure analysis to show that Mrs1 binds a ubiquitous RNA tertiary structure motif, the GNRA tetraloop-receptor interaction, at two sites in the bI3 RNA. Mrs1 also interacts at similar tetraloop-receptor elements, as well as other structures, in the self-folding Azoarcus group I intron and in the RNase P enzyme. Thus, Mrs1 recognizes general features found in the tetraloop-receptor motif. Identification of the two Mrs1 binding sites now makes it possible to create a model of the complete six-component bI3 ribonucleoprotein. All protein cofactors bind at the periphery of the RNA such that every long-range RNA tertiary interaction is stabilized by protein binding, involving either Mrs1 or the bI3 maturase. This work emphasizes the strong evolutionary pressure to bolster RNA tertiary structure with RNA-binding interactions as seen in the ribosome, spliceosome, and other large RNA machines.	[Duncan, Caia D. S.; Weeks, Kevin M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Duncan, CDS (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA.	weeks@unc.edu		Duncan, Caia/0000-0001-8564-964X	National Institutes of Health (NIH) [GM056222, GM064803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056222, R01GM064803] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM056222 (bI3 ribonucleoprotein) and GM064803 (methods development) to K. M. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Caprara MG, 2007, RNA, V13, P211, DOI 10.1261/rna.307907; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Ding F, 2008, RNA, V14, P1164, DOI 10.1261/rna.894608; Duncan CDS, 2008, BIOCHEMISTRY-US, V47, P8504, DOI 10.1021/bi800207b; Gesteland R., 2006, RNA WORLD, V3rd edn. Cold Spring Harbor; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; JAEGER L, 1994, J MOL BIOL, V236, P1271, DOI 10.1016/0022-2836(94)90055-8; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; LATHAM JA, 1989, SCIENCE, V245, P276, DOI 10.1126/science.2501870; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Longo A, 2005, NAT STRUCT MOL BIOL, V12, P779, DOI 10.1038/nsmb976; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mitra S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn267; Mortimer SA, 2007, J AM CHEM SOC, V129, P4144, DOI 10.1021/ja0704028; Paukstelis PJ, 2008, NATURE, V451, P94, DOI 10.1038/nature06413; Paukstelis PJ, 2005, MOL CELL, V17, P417, DOI 10.1016/j.molcel.2004.12.026; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Shcherbakova I, 2008, NAT PROTOC, V3, P288, DOI 10.1038/nprot.2007.533; Tanner MA, 1996, RNA, V2, P74; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; Vasa SM, 2008, RNA, V14, P1979, DOI 10.1261/rna.1166808; Vicens Q, 2006, TRENDS BIOCHEM SCI, V31, P41, DOI 10.1016/j.tibs.2005.11.008; Vicens Q, 2008, RNA, V14, P2013, DOI 10.1261/rna.1027208; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; Webb AE, 2001, J MOL BIOL, V309, P1087, DOI 10.1006/jmbi.2001.4714; Weeks KM, 1997, CURR OPIN STRUC BIOL, V7, P336, DOI 10.1016/S0959-440X(97)80048-6; WEEKS KM, 1995, CELL, V82, P221, DOI 10.1016/0092-8674(95)90309-7; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; Zhang Xu-hong, 2008, Asian Journal of Ecotoxicology, V3, P9; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	44	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2010	5	2							e8983	10.1371/journal.pone.0008983	http://dx.doi.org/10.1371/journal.pone.0008983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551LF	20126554	Green Published, gold, Green Submitted			2022-12-27	WOS:000274209700011
J	Zani, BG; Indolfi, L; Edelman, ER				Zani, Brett G.; Indolfi, Laura; Edelman, Elazer R.			Tubular Bridges for Bronchial Epithelial Cell Migration and Communication	PLOS ONE			English	Article							DROSOPHILA TRACHEAL SYSTEM; HEPATOCYTE GROWTH-FACTOR; INTERCELLULAR BRIDGES; TUNNELING NANOTUBES; AIRWAY EPITHELIUM; OXIDATIVE STRESS; GENE-EXPRESSION; PROLIFERATION; CYTONEMES; LUNG	Background: Biological processes from embryogenesis to tumorigenesis rely on the coordinated coalescence of cells and synchronized cell-to-cell communication. Intercellular signaling enables cell masses to communicate through endocrine pathways at a distance or by direct contact over shorter dimensions. Cellular bridges, the longest direct connections between cells, facilitate transfer of cellular signals and components over hundreds of microns in vitro and in vivo. Methodology/Principal Findings: Using various cellular imaging techniques on human tissue cultures, we identified two types of tubular, bronchial epithelial (EP) connections, up to a millimeter in length, designated EP bridges. Structurally distinct from other cellular connections, the first type of EP bridge may mediate transport of cellular material between cells, while the second type of EP bridge is functionally distinct from all other cellular connections by mediating migration of epithelial cells between EP masses. Morphological and biochemical interactions with other cell types differentially regulated the nuclear factor-kappa B and cyclooxygenase inflammatory pathways, resulting in increased levels of inflammatory molecules that impeded EP bridge formation. Pharmacologic inhibition of these inflammatory pathways caused increased morphological and mobility changes stimulating the biogenesis of EP bridges, in part through the upregulation of reactive oxygen species pathways. Conclusions/Significance: EP bridge formation appears to be a normal response of EP physiology in vitro, which is differentially inhibited by inflammatory cellular pathways depending upon the morphological and biochemical interactions between EP cells and other cell types. These tubular EP conduits may represent an ultra long-range form of direct intercellular communication and a completely new mechanism of tissue-mediated cell migration.	[Zani, Brett G.; Indolfi, Laura; Edelman, Elazer R.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Indolfi, Laura] Univ Naples Federico 2, Italian Inst Technol, Interdisciplinary Res Ctr Biomat CRIB, Naples, Italy; [Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Istituto Italiano di Tecnologia - IIT; University of Naples Federico II; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zani, BG (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	zani@mit.edu		Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM 49039]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 GM 49039 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chen F, 2003, CANCER RES, V63, P7689; Chen F, 2006, J BIOL CHEM, V281, P37142, DOI 10.1074/jbc.M603631200; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Gupton Stephanie L, 2007, Sci STKE, V2007, pre5, DOI 10.1126/stke.4002007re5; Gurke S, 2008, HISTOCHEM CELL BIOL, V129, P539, DOI 10.1007/s00418-008-0412-0; Hartney JM, 2006, AM J PHYSIOL-LUNG C, V290, pL105, DOI 10.1152/ajplung.00221.2005; Hase K, 2009, NAT CELL BIOL, V11, P1427, DOI 10.1038/ncb1990; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Hsiung F, 2005, NATURE, V437, P560, DOI 10.1038/nature03951; Jaspers I, 2001, AM J RESP CELL MOL, V24, P769, DOI 10.1165/ajrcmb.24.6.4344; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lu YB, 2005, J IMMUNOL, V175, P5423, DOI 10.4049/jimmunol.175.8.5423; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Myerburg MM, 2007, AM J PHYSIOL-LUNG C, V292, pL1352, DOI 10.1152/ajplung.00328.2006; Newton R, 2007, J PHARMACOL EXP THER, V321, P734, DOI 10.1124/jpet.106.118125; ONFELT B, 2005, SCI STKE, pPE55; Pan TL, 2001, AM J RESP CELL MOL, V25, P353, DOI 10.1165/ajrcmb.25.3.4004; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Rustom A, 2009, ANN NY ACAD SCI, V1178, P129, DOI 10.1111/j.1749-6632.2009.04997.x; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2; SCHUGER L, 1990, DEVELOPMENT, V110, P1091; Schwarz MA, 2004, AM J RESP CELL MOL, V30, P784, DOI 10.1165/rcmb.2003-0145OC; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Sherer NM, 2007, NAT CELL BIOL, V9, P310, DOI 10.1038/ncb1544; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; WOLFF JR, 1972, ANGIOLOGICA, V9, P11; Woodruff RI, 1998, DEV BIOL, V200, P82, DOI 10.1006/dbio.1998.8948; Zahner G, 2006, FEBS LETT, V580, P2523, DOI 10.1016/j.febslet.2006.03.063	43	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 28	2010	5	1							e8930	10.1371/journal.pone.0008930	http://dx.doi.org/10.1371/journal.pone.0008930			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550OR	20126618	Green Published, gold, Green Submitted			2022-12-27	WOS:000274138000009
J	Peedicayil, A; Vierkant, RA; Hartmann, LC; Fridley, BL; Fredericksen, ZS; White, KL; Elliott, EA; Phelan, CM; Tsai, YY; Berchuck, A; Iversen, ES; Couch, FJ; Peethamabaran, P; Larson, MC; Kalli, KR; Kosel, ML; Shridhar, V; Rider, DN; Liebow, M; Cunningham, JM; Schildkraut, JM; Sellers, TA; Goode, EL				Peedicayil, Abraham; Vierkant, Robert A.; Hartmann, Lynn C.; Fridley, Brooke L.; Fredericksen, Zachary S.; White, Kristin L.; Elliott, Elaine A.; Phelan, Catherine M.; Tsai, Ya-Yu; Berchuck, Andrew; Iversen, Edwin S., Jr.; Couch, Fergus J.; Peethamabaran, Prema; Larson, Melissa C.; Kalli, Kimberly R.; Kosel, Matthew L.; Shridhar, Vijayalakshmi; Rider, David N.; Liebow, Mark; Cunningham, Julie M.; Schildkraut, Joellen M.; Sellers, Thomas A.; Goode, Ellen L.			Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SUSCEPTIBILITY; EXPRESSION; ACETYLATION; PERFORMANCE; SET; DNA	Background: We previously identified a panel of genes associated with outcome of ovarian cancer. The purpose of the current study was to assess whether variants in these genes correlated with ovarian cancer risk. Methods and Findings: Women with and without invasive ovarian cancer (749 cases, 1,041 controls) were genotyped at 136 single nucleotide polymorphisms (SNPs) within 13 candidate genes. Risk was estimated for each SNP and for overall variation within each gene. At the gene-level, variation within MSL1 (male-specific lethal-1 homolog) was associated with risk of serous cancer (p = 0.03); haplotypes within PRPF31 (PRP31 pre-mRNA processing factor 31 homolog) were associated with risk of invasive disease (p = 0.03). MSL1 rs7211770 was associated with decreased risk of serous disease (OR 0.81, 95% CI 0.66-0.98; p = 0.03). SNPs in MFSD7, BTN3A3, ZNF200, PTPRS, and CCND1A were inversely associated with risk (p < 0.05), and there was increased risk at HEXIM1 rs1053578 (p = 0.04, OR 1.40, 95% CI 1.02-1.91). Conclusions: Tumor studies can reveal novel genes worthy of follow-up for cancer susceptibility. Here, we found that inherited markers in the gene encoding MSL1, part of a complex that modifies the histone H4, may decrease risk of invasive serous ovarian cancer.	[Peedicayil, Abraham; Vierkant, Robert A.; Hartmann, Lynn C.; Fridley, Brooke L.; Fredericksen, Zachary S.; White, Kristin L.; Elliott, Elaine A.; Couch, Fergus J.; Peethamabaran, Prema; Larson, Melissa C.; Kalli, Kimberly R.; Kosel, Matthew L.; Shridhar, Vijayalakshmi; Rider, David N.; Liebow, Mark; Cunningham, Julie M.; Goode, Ellen L.] Mayo Clin, Coll Med, Rochester, MN 55905 USA; [Phelan, Catherine M.; Tsai, Ya-Yu; Sellers, Thomas A.] H Lee Moffitt Canc Res Inst, Tampa, FL USA; [Berchuck, Andrew; Iversen, Edwin S., Jr.; Schildkraut, Joellen M.] Duke Univ, Durham, NC USA	Mayo Clinic; H Lee Moffitt Cancer Center & Research Institute; Duke University	Peedicayil, A (corresponding author), Mayo Clin, Coll Med, Rochester, MN 55905 USA.	egoode@mayo.edu	Vierkant, Robert/AAP-4927-2020; Fridley, Brooke L/D-8315-2015	Vierkant, Robert/0000-0001-6242-5221; Fridley, Brooke L/0000-0001-7739-7956; Peedicayil, Abraham/0000-0002-9318-566X	National Cancer Institute [R01 CA122443, R01 CA88868]; Ovarian Cancer Research Fund; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE [R01CA122443, R01CA088868] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ovarian Cancer Research Fund; Fred C. and Katherine B. Andersen Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute [R01 CA122443, R01 CA88868], the Ovarian Cancer Research Fund, and the Fred C. and Katherine B. Andersen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cooper GM., 2007, CELL MOL APPROACH; Cunningham JM, 2008, CANCER EPIDEM BIOMAR, V17, P1781, DOI 10.1158/1055-9965.EPI-07-2849; De Smet F, 2005, CLIN CANCER RES, V11, P7958, DOI 10.1158/1078-0432.CCR-05-1216; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gayther SA, 2007, CANCER RES, V67, P3027, DOI 10.1158/0008-5472.CAN-06-3261; Hartmann LC, 2005, CLIN CANCER RES, V11, P2149, DOI 10.1158/1078-0432.CCR-04-1673; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; LI Y, 2006, AM J HUM GENET S, V79, P416; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lynch HT, 2009, MOL ONCOL, V3, P97, DOI 10.1016/j.molonc.2009.02.004; Morales V, 2004, EMBO J, V23, P2258, DOI 10.1038/sj.emboj.7600235; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pearce CL, 2008, BRIT J CANCER, V98, P282, DOI 10.1038/sj.bjc.6604170; Pharoah PDP, 2002, BEST PRACT RES CL OB, V16, P449, DOI 10.1053/beog.2002.0296; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Ramus SJ, 2008, INT J CANCER, V123, P380, DOI 10.1002/ijc.23448; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schildkraut JM, 2009, CANCER RES, V69, P2349, DOI 10.1158/0008-5472.CAN-08-2902; Sellers TA, 2005, CANCER EPIDEM BIOMAR, V14, P2536, DOI 10.1158/1055-9965.EPI-05-0142; Sellers TA, 2008, CANCER EPIDEM BIOMAR, V17, P397, DOI 10.1158/1055-9965.EPI-07-0565; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	33	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 27	2010	5	1							e8884	10.1371/journal.pone.0008884	http://dx.doi.org/10.1371/journal.pone.0008884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	550FX	20111712	Green Submitted, Green Published, gold			2022-12-27	WOS:000274114800009
J	Vasan, S; Schlesinger, SJ; Chen, ZW; Hurley, A; Lombardo, A; Than, S; Adesanya, P; Bunce, C; Boaz, M; Boyle, R; Sayeed, E; Clark, L; Dugin, D; Boente-Carrera, M; Schmidt, C; Fang, Q; LeiBa; Huang, YX; Zaharatos, GJ; Gardiner, DF; Caskey, M; Seamons, L; Ho, M; Dally, L; Smith, C; Cox, J; Gill, D; Gilmour, J; Keefer, MC; Fast, P; Ho, DD				Vasan, Sandhya; Schlesinger, Sarah J.; Chen, Zhiwei; Hurley, Arlene; Lombardo, Angela; Than, Soe; Adesanya, Phumla; Bunce, Catherine; Boaz, Mark; Boyle, Rosanne; Sayeed, Eddy; Clark, Lorna; Dugin, Daniel; Boente-Carrera, Mar; Schmidt, Claudia; Fang, Qing; LeiBa; Huang, Yaoxing; Zaharatos, Gerasimos J.; Gardiner, David F.; Caskey, Marina; Seamons, Laura; Ho, Martin; Dally, Len; Smith, Carol; Cox, Josephine; Gill, Dilbinder; Gilmour, Jill; Keefer, Michael C.; Fast, Patricia; Ho, David D.			Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B '/C Candidate Vaccine	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALLPOX VACCINATION; HIV-1 VACCINE; UNITED-STATES; T-CELLS; IMMUNITY; PRIME; BOOST; RESPONSES; REGIMEN	Background: We conducted a Phase I dose-escalation trial of ADMVA, a Clade-B'/C-based HIV-1 candidate vaccine expressing env, gag, pol, nef, and tat in a modified vaccinia Ankara viral vector. Sequences were derived from a prevalent circulating HIV-1 recombinant form in Yunnan, China, an area of high HIV incidence. The objective was to evaluate the safety and immunogenicity of ADMVA in human volunteers. Methodology/Principal Findings: ADMVA or placebo was administered intramuscularly at months 0, 1 and 6 to 50 healthy adult volunteers not at high risk for HIV-1. In each dosage group [1 x 10(7) (low), 5 x 10(7) (mid), or 2.5 x 10(8) pfu (high)] volunteers were randomized in a 3:1 ratio to receive ADMVA or placebo in a double-blinded design. Subjects were followed for local and systemic reactogenicity, adverse events including cardiac adverse events, and clinical laboratory parameters. Study follow up was 18 months. Humoral immunogenicity was evaluated by anti-gp120 binding ELISA, immunoflourescent staining, and HIV-1 neutralization. Cellular immunogenicity was assessed by a validated IFN gamma ELISpot assay and intracellular cytokine staining. Anti-vaccinia binding titers were measured by ELISA. ADMVA was generally well-tolerated, with no vaccine-related serious adverse events or cardiac adverse events. Local or systemic reactogenicity events were reported by 77% and 78% of volunteers, respectively. The majority of events were of mild intensity. The IFN gamma ELISpot response rate to any HIV antigen was 0/12 (0%) in the placebo group, 3/12 (25%) in the low dosage group, 6/12 (50%) in the mid dosage group, and 8/13 (62%) in the high dosage group. Responses were often multigenic and occasionally persisted up to one year post vaccination. Antibodies to gp120 were detected in 0/12 (0%), 8/13 (62%), 6/12 (50%) and 10/13 (77%) in the placebo, low, mid, and high dosage groups, respectively. Antibodies persisted up to 12 months after vaccination, with a trend toward agreement with the ability to neutralize HIV-1 SF162 in vitro. Two volunteers mounted antibodies that were able to neutralize clade-matched viruses. Conclusions/Significance: ADMVA was well-tolerated and elicited durable humoral and cellular immune responses.	[Vasan, Sandhya; Schlesinger, Sarah J.; Chen, Zhiwei; Hurley, Arlene; Dugin, Daniel; Boente-Carrera, Mar; Fang, Qing; LeiBa; Huang, Yaoxing; Zaharatos, Gerasimos J.; Gardiner, David F.; Ho, David D.] Aaron Diamond AIDS Res Ctr, New York, NY USA; [Vasan, Sandhya; Schlesinger, Sarah J.; Chen, Zhiwei; Hurley, Arlene; Huang, Yaoxing; Zaharatos, Gerasimos J.; Caskey, Marina; Ho, David D.] Rockefeller Univ, New York, NY 10021 USA; [Lombardo, Angela; Than, Soe; Adesanya, Phumla; Boaz, Mark; Boyle, Rosanne; Sayeed, Eddy; Schmidt, Claudia; Fast, Patricia] Int AIDS Vaccine Initiat, New York, NY USA; [Bunce, Catherine; Keefer, Michael C.] Univ Rochester, Med Ctr, Rochester, NY 14642 USA; [Gardiner, David F.] Weill Cornell Med Ctr, New York, NY USA; [Clark, Lorna; Cox, Josephine; Gill, Dilbinder; Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, Int AIDS Vaccine Initiat Core Lab, London, England; [Seamons, Laura; Ho, Martin; Dally, Len; Smith, Carol] EMMES Corp, Rockville, MD USA	Rockefeller University; International AIDS Vaccine Initiative; University of Rochester; Cornell University; Imperial College London; International AIDS Vaccine Initiative; Emmes Corporation	Vasan, S (corresponding author), Aaron Diamond AIDS Res Ctr, New York, NY USA.	svasan@adarc.org	Chen, Zhiwei/B-7793-2019	Chen, Zhiwei/0000-0002-4511-2888; Cox, Josephine/0000-0003-1301-7373; Ho, Martin/0000-0002-8970-5095; Caskey, Marina/0000-0003-1727-8693	International AIDS Vaccine Initiative (IAVI); United States for International Development (USAID); Rockefeller University; University of Rochester Clinical and Translational Science	International AIDS Vaccine Initiative (IAVI); United States for International Development (USAID)(United States Agency for International Development (USAID)); Rockefeller University; University of Rochester Clinical and Translational Science	Funding for this study was provided by the International AIDS Vaccine Initiative (IAVI) and its donors, including the generous support of the American people through the United States for International Development (USAID). IAVI played a direct role in study design, data collection and analysis, decision to publish, and preparation of this manuscript. Support was also provided by the Rockefeller University and University of Rochester Clinical and Translational Science Awards.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Amara RR, 2001, SCIENCE, V292, P69, DOI 10.1126/science.1058915; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Casey CG, 2005, JAMA-J AM MED ASSOC, V294, P2734, DOI 10.1001/jama.294.21.2734; Chen FP, 2008, INT J THEOR PHYS, V47, P421, DOI 10.1007/s10773-007-9463-6; Ellenberger D, 2006, VIROLOGY, V352, P216, DOI 10.1016/j.virol.2006.04.005; Goonetilleke N, 2006, J VIROL, V80, P4717, DOI 10.1128/JVI.80.10.4717-4728.2006; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Huang TX, 2008, JAIDS-J ACQ IMM DEF, V47, P403, DOI 10.1097/QAI.0b013e3181651b9d; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Mansfield K, 2008, J VIROL, V82, P4135, DOI 10.1128/JVI.00015-08; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Schweighardt B, 2007, JAIDS-J ACQ IMM DEF, V46, P1, DOI 10.1097/01.qai.0000286594.11191.91; *UNAIDS, 2007, UNAIDS0727EJC1322E; Wei Liu, 2006, Subst Abus, V27, P53; Wiser I, 2007, VACCINE, V25, P976, DOI 10.1016/j.vaccine.2006.09.046; Xiao Y, 2007, SOC SCI MED, V64, P665, DOI 10.1016/j.socscimed.2006.09.019; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004	25	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 25	2010	5	1							e8816	10.1371/journal.pone.0008816	http://dx.doi.org/10.1371/journal.pone.0008816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NM	20111599	gold, Green Submitted, Green Published			2022-12-27	WOS:000273896300005
J	Huang, V; Qin, Y; Wang, J; Wang, XL; Place, RF; Lin, GT; Lue, TF; Li, LC				Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Lin, Guiting; Lue, Tom F.; Li, Long-Cheng			RNAa Is Conserved in Mammalian Cells	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; NONHUMAN-PRIMATES; P53 RESTORATION; EXPRESSION; ACTIVATION; APOPTOSIS; DELIVERY; BINDING; DNA	Background: RNA activation (RNAa) is a newly discovered mechanism of gene activation triggered by small double-stranded RNAs termed 'small activating RNAs' (saRNAs). Thus far, RNAa has only been demonstrated in human cells and is unclear whether it is conserved in other mammals. Methodology/Principal Findings: In the present study, we evaluated RNAa in cells derived from four mammalian species including nonhuman primates (African green monkey and chimpanzee), mouse, and rat. Previously, we identified saRNAs leading to the activation of E-cadherin, p21, and VEGF in human cells. As the targeted sequences are highly conserved in primates, transfection of each human saRNA into African green monkey (COS1) and chimpanzee (WES) cells also resulted in induction of the intended gene. Additional saRNAs targeting clinically relevant genes including p53, PAR4, WT1, RB1, p27, NKX3-1, VDR, IL2, and pS2 were also designed and transfected into COS1 and WES cells. Of the nine genes, p53, PAR4, WT1, and NKX3-1 were induced by their corresponding saRNAs. We further extended our analysis of RNAa into rodent cell types. We identified two saRNAs that induced the expression of mouse Cyclin B1 in NIH/3T3 and TRAMP C1 cells, which led to increased phosphorylation of histone H3, a downstream marker for chromosome condensation and entry into mitosis. We also identified two saRNAs that activated the expression of CXCR4 in primary rat adipose-derived stem cells. Conclusions/Significance: This study demonstrates that RNAa exists in mammalian species other than human. Our findings also suggest that nonhuman primate disease models may have clinical applicability for validating RNAa-based drugs.	[Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Li, Long-Cheng] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Huang, Vera; Qin, Yi; Wang, Ji; Wang, Xiaoling; Place, Robert F.; Lin, Guiting; Lue, Tom F.; Li, Long-Cheng] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Huang, V (corresponding author), Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	lilc@urology.ucsf.edu	Wang, Ji/I-5795-2012; Li, Long-Cheng/D-8078-2017	Li, Long-Cheng/0000-0002-3971-6335; Huang, Vera/0000-0003-1882-9522	National Institutes of Health [1R21CA131774-02, 1R01GM090293-0109]; Department of Defense [W81XWH-08-1-0260]; NATIONAL CANCER INSTITUTE [R21CA131774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (1R21CA131774-02 and 1R01GM090293-0109) and Department of Defense (W81XWH-08-1-0260). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Blagbrough IS, 2009, PHARM RES-DORDR, V26, P1, DOI 10.1007/s11095-008-9646-8; DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729; ELDEIRY WS, 1994, CANCER RES, V54, P1169; Foster BA, 1997, CANCER RES, V57, P3325; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Juan G, 1998, CYTOMETRY, V32, P71, DOI 10.1002/(SICI)1097-0320(19980601)32:2<71::AID-CYTO1>3.0.CO;2-H; Kumari SR, 1998, CANCER RES, V58, P5075; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; LIN G, 2009, STEM C IN PRESS 0226; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Perez AL, 2009, MUSCLE NERVE, V40, P562, DOI 10.1002/mus.21317; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Querbes W, 2009, OLIGONUCLEOTIDES, V19, P23, DOI 10.1089/oli.2008.0165; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	26	139	167	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8848	10.1371/journal.pone.0008848	http://dx.doi.org/10.1371/journal.pone.0008848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107511	gold, Green Submitted, Green Published			2022-12-27	WOS:000273896100013
J	Fanarraga, ML; Bellido, J; Jaen, C; Villegas, JC; Zabala, JC				Lopez Fanarraga, Monica; Bellido, Javier; Jaen, Cristina; Carlos Villegas, Juan; Carlos Zabala, Juan			TBCD Links Centriologenesis, Spindle Microtubule Dynamics, and Midbody Abscission in Human Cells	PLOS ONE			English	Article							FOLDING COFACTOR D; GAMMA-TUBULIN; BETA-TUBULIN; FISSION YEAST; PROTEIN; CENTROSOME; CENTRIOLE; CILIOGENESIS; CYCLE; IDENTIFICATION	Microtubule-organizing centers recruit alpha- and beta-tubulin polypeptides for microtubule nucleation. Tubulin synthesis is complex, requiring five specific cofactors, designated tubulin cofactors (TBCs) A-E, which contribute to various aspects of microtubule dynamics in vivo. Here, we show that tubulin cofactor D (TBCD) is concentrated at the centrosome and midbody, where it participates in centriologenesis, spindle organization, and cell abscission. TBCD exhibits a cell-cycle-specific pattern, localizing on the daughter centriole at G1 and on procentrioles by S, and disappearing from older centrioles at telophase as the protein is recruited to the midbody. Our data show that TBCD overexpression results in microtubule release from the centrosome and G1 arrest, whereas its depletion produces mitotic aberrations and incomplete microtubule retraction at the midbody during cytokinesis. TBCD is recruited to the centriole replication site at the onset of the centrosome duplication cycle. A role in centriologenesis is further supported in differentiating ciliated cells, where TBCD is organized into "centriolar rosettes". These data suggest that TBCD participates in both canonical and de novo centriolar assembly pathways.	[Lopez Fanarraga, Monica; Bellido, Javier; Jaen, Cristina; Carlos Zabala, Juan] Univ Cantabria, Dept Biol Mol, Marques de Valdecilla Fac Med, Inst Formac & Invest, E-39005 Santander, Spain	Universidad de Cantabria	Fanarraga, ML (corresponding author), Univ Cantabria, Dept Biol Mol, Marques de Valdecilla Fac Med, Inst Formac & Invest, E-39005 Santander, Spain.	zabalajc@unican.es	Fanarraga, Monica/AAE-5804-2019; Zabala, Juan Carlos/K-5163-2014; Fanarraga, Mónica L./M-6177-2014	Fanarraga, Monica/0000-0003-4754-311X; Zabala, Juan Carlos/0000-0003-2679-5473; Fanarraga, Mónica L./0000-0003-4754-311X; VILLEGAS, JUAN CARLOS/0000-0003-3293-8653	Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D;  [BFU2007-64882]	Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D; 	This study was funded by BFU2007-64882 and Consolider-Ingenio Spanish Ministry of Education and Science Centrosome-3D (http://ciencia.micinn.fecyt.es/ciencia/jsp/plantilla.jsp?area=consolider&id=51) and the Instituto de Formacion e Investigacion Marques de Valdecilla (http://www.fmdv.org/index2.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzi KC, 2002, MOL CELL BIOL, V22, P138, DOI 10.1128/MCB.22.1.138-147.2002; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Archer JE, 1998, MOL CELL BIOL, V18, P1757, DOI 10.1128/MCB.18.3.1757; ARCHER JE, 1995, CELL, V82, P425, DOI 10.1016/0092-8674(95)90431-X; AVILA J, 2008, CURRENT PROTOCOLS CE; Bartolini F, 2005, J CELL SCI, V118, P1197, DOI 10.1242/jcs.01719; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Cunningham LA, 2008, J BIOL CHEM, V283, P7155, DOI 10.1074/jbc.M706753200; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Doxsey SJ, 2005, MOL CELL, V20, P170, DOI 10.1016/j.molcel.2005.10.010; Fanarraga ML, 1999, CELL MOTIL CYTOSKEL, V43, P243, DOI 10.1002/(SICI)1097-0169(1999)43:3<243::AID-CM7>3.0.CO;2-0; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Fedyanina OS, 2009, YEAST, V26, P235, DOI 10.1002/yea.1663; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Keller CE, 2005, TRENDS CELL BIOL, V15, P570; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kortazar D, 2007, EXP CELL RES, V313, P425, DOI 10.1016/j.yexcr.2006.09.002; Kortazar D, 2006, PROTEIN EXPRES PURIF, V49, P196, DOI 10.1016/j.pep.2006.03.005; LAJOIEMAZENC I, 1994, J CELL SCI, V107, P2825; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; SHU HB, 1995, J CELL SCI, V108, P2955; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Szymanski D, 2002, CURR BIOL, V12, pR767, DOI 10.1016/S0960-9822(02)01288-5; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; ZABALA JC, 1992, CELL MOTIL CYTOSKEL, V23, P222, DOI 10.1002/cm.970230306	45	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2010	5	1							e8846	10.1371/journal.pone.0008846	http://dx.doi.org/10.1371/journal.pone.0008846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	547NK	20107510	Green Published, gold			2022-12-27	WOS:000273896100011
J	Anaclet, C; Pedersen, NP; Fuller, PM; Lu, J				Anaclet, Christelle; Pedersen, Nigel P.; Fuller, Patrick M.; Lu, Jun			Brainstem Circuitry Regulating Phasic Activation of Trigeminal Motoneurons during REM Sleep	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; ORAL MOTOR NUCLEI; MUSCLE-ACTIVITY; ACTIVE SLEEP; HORSERADISH-PEROXIDASE; SOMATIC MOTONEURONS; RETICULAR-FORMATION; LUMBAR MOTONEURONS; PARADOXICAL SLEEP; WAKE STATES	Background: Rapid eye movement sleep (REMS) is characterized by activation of the cortical and hippocampal electroencephalogram (EEG) and atonia of non-respiratory muscles with superimposed phasic activity or twitching, particularly of cranial muscles such as those of the eye, tongue, face and jaw. While phasic activity is a characteristic feature of REMS, the neural substrates driving this activity remain unresolved. Here we investigated the neural circuits underlying masseter (jaw) phasic activity during REMS. The trigeminal motor nucleus (Mo5), which controls masseter motor function, receives glutamatergic inputs mainly from the parvocellular reticular formation (PCRt), but also from the adjacent paramedian reticular area (PMnR). On the other hand, the Mo5 and PCRt do not receive direct input from the sublaterodorsal (SLD) nucleus, a brainstem region critical for REMS atonia of postural muscles. We hypothesized that the PCRt-PMnR, but not the SLD, regulates masseter phasic activity during REMS. Methodology/Principal Findings: To test our hypothesis, we measured masseter electromyogram (EMG), neck muscle EMG, electrooculogram (EOG) and EEG in rats with cell-body specific lesions of the SLD, PMnR, and PCRt. Bilateral lesions of the PMnR and rostral PCRt (rPCRt), but not the caudal PCRt or SLD, reduced and eliminated REMS phasic activity of the masseter, respectively. Lesions of the PMnR and rPCRt did not, however, alter the neck EMG or EOG. To determine if rPCRt neurons use glutamate to control masseter phasic movements, we selectively blocked glutamate release by rPCRt neurons using a Crelox mouse system. Genetic disruption of glutamate neurotransmission by rPCRt neurons blocked masseter phasic activity during REMS. Conclusions/Significance: These results indicate that (1) premotor glutamatergic neurons in the medullary rPCRt and PMnR are involved in generating phasic activity in the masseter muscles, but not phasic eye movements, during REMS; and (2) separate brainstem neural circuits control postural and cranial muscle phasic activity during REMS.	[Anaclet, Christelle] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Anaclet, C (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Sleep Med, Boston, MA 02215 USA.	jlu@bidmc.harvard.edu		Anaclet, Christelle/0000-0002-0526-8132; Pedersen, Nigel/0000-0002-8494-0635	NIH [NS 051609, NS 062727, NS 061841]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061841, R01NS051609, R01NS062727] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH NS 051609, NS 062727 and NS 061841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Boeve BF, 2007, BRAIN, V130, P2770, DOI 10.1093/brain/awm056; Brooks PL, 2008, J NEUROSCI, V28, P3535, DOI 10.1523/JNEUROSCI.5023-07.2008; Burgess C, 2008, J NEUROSCI, V28, P4649, DOI 10.1523/JNEUROSCI.0334-08.2008; Chan E, 2006, AM J RESP CRIT CARE, V174, P1264, DOI 10.1164/rccm.200605-597OC; CHASE MH, 1989, J NEUROSCI, V9, P743; Elmquist JK, 1996, J COMP NEUROL, V374, P315, DOI 10.1002/(SICI)1096-9861(19961021)374:3<315::AID-CNE1>3.0.CO;2-4; Fay RA, 1997, BRAIN RES REV, V25, P255, DOI 10.1016/S0165-0173(97)00026-X; Fenik VB, 2008, NEUROSCIENCE, V157, P473, DOI 10.1016/j.neuroscience.2008.08.069; Fenik VB, 2005, AM J RESP CRIT CARE, V172, P1322, DOI 10.1164/rccm.200412-1750OC; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; GROSSER GS, 1971, PSYCHOL BULL, V75, P60, DOI 10.1037/h0030303; HENDRICKS JC, 1982, BRAIN RES, V239, P81, DOI 10.1016/0006-8993(82)90835-6; JOUVET M, 1959, CR SOC BIOL, V153, P422; JOUVET M., 1965, PROGR BRAIN RES, V18, P20; JOUVET M, 1959, CR SOC BIOL, V153, P1024; Kato T, 2007, NEUROSCI RES, V58, P265, DOI 10.1016/j.neures.2007.03.008; KODAMA T, 1990, NEUROSCI LETT, V114, P277, DOI 10.1016/0304-3940(90)90576-U; Lai YY, 2001, J NEUROSCI, V21, P7384, DOI 10.1523/JNEUROSCI.21-18-07384.2001; LAI YY, 1993, J COMP NEUROL, V336, P321, DOI 10.1002/cne.903360302; Lavigne GJ, 2001, J DENT RES, V80, P443, DOI 10.1177/00220345010800020801; Lazarus M, 2007, NAT NEUROSCI, V10, P1131, DOI 10.1038/nn1949; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Lu JW, 2005, RESP PHYSIOL NEUROBI, V147, P191, DOI 10.1016/j.resp.2005.05.007; Marciano C. R., 2001, Revista Brasileira de Ciencia do Solo, V25, P1, DOI 10.1590/S0100-06832001000100001; Neuzeret PC, 2009, J SLEEP RES, V18, P113, DOI 10.1111/j.1365-2869.2008.00708.x; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PEDROARENA C, 1994, BRAIN RES, V653, P31, DOI 10.1016/0006-8993(94)90368-9; SASTRE JP, 1979, PHYSIOL BEHAV, V22, P979; Scammell T, 1998, P NATL ACAD SCI USA, V95, P7754, DOI 10.1073/pnas.95.13.7754; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; SOJA PJ, 1991, J NEUROSCI, V11, P2804; Taepavarapruk N, 2008, J NEUROPHYSIOL, V100, P598, DOI 10.1152/jn.01231.2007; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; TRAVERS JB, 1983, J COMP NEUROL, V220, P280, DOI 10.1002/cne.902200303; Travers JB, 2005, J COMP NEUROL, V488, P28, DOI 10.1002/cne.20604; Vetrivelan R, 2009, J NEUROSCI, V29, P9361, DOI 10.1523/JNEUROSCI.0737-09.2009; Volgin DV, 2008, J APPL PHYSIOL, V105, P1576, DOI 10.1152/japplphysiol.90670.2008; Zhang X, 2009, SLEEP MED, V10, P143, DOI 10.1016/j.sleep.2007.12.002	42	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8788	10.1371/journal.pone.0008788	http://dx.doi.org/10.1371/journal.pone.0008788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098748	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000016
J	Benayoun, BA; Caburet, S; Dipietromaria, A; Georges, A; D'Haene, B; Pandaranayaka, PJE; L'Hote, D; Todeschini, AL; Krishnaswamy, S; Fellous, M; De Baere, E; Veitia, RA				Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; D'Haene, Barbara; Pandaranayaka, P. J. Eswari; L'Hote, David; Todeschini, Anne-Laure; Krishnaswamy, Sankaran; Fellous, Marc; De Baere, Elfride; Veitia, Reiner A.			Functional Exploration of the Adult Ovarian Granulosa Cell Tumor-Associated Somatic FOXL2 Mutation p.Cys134Trp (c.402C > G)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXL2; FORKHEAD DOMAIN; EXPRESSION; GENE; BLEPHAROPHIMOSIS; IDENTIFICATION; AGGREGATION; EVOLUTION; PITUITARY; RECEPTOR	Background: The somatic mutation in the FOXL2 gene c.402C>G (p.Cys134Trp) has recently been identified in the vast majority of adult ovarian granulosa cell tumors (OGCTs) studied. In addition, this mutation seems to be specific to adult OGCTs and is likely to be a driver of malignant transformation. However, its pathogenic mechanisms remain elusive. Methodology/Principal Findings: We have sequenced the FOXL2 open reading frame in a panel of tumor cell lines (NCI-60, colorectal carcinoma cell lines, JEG-3, and KGN cells). We found the FOXL2 c.402C>G mutation in the adult OGCT-derived KGN cell line. All other cell lines analyzed were negative for the mutation. In order to gain insights into the pathogenic mechanism of the p.Cys134Trp mutation, the subcellular localization and mobility of the mutant protein were studied and found to be no different from those of the wild type (WT). Furthermore, its transactivation ability was in most cases similar to that of the WT protein, including in conditions of oxidative stress. A notable exception was an artificial promoter known to be coregulated by FOXL2 and Smad3, suggesting a potential modification of their interaction. We generated a 3D structural model of the p.Cys134Trp variant and our analysis suggests that homodimer formation might also be disturbed by the mutation. Conclusions/Significance: Here, we confirm the specificity of the FOXL2 c.402C>G mutation in adult OGCTs and begin the exploration of its molecular significance. This is the first study demonstrating that the p.Cys134Trp mutant does not have a strong impact on FOXL2 localization, solubility, and transactivation abilities on a panel of proven target promoters, behaving neither as a dominant-negative nor as a loss-of-function mutation. Further studies are required to understand the specific molecular effects of this outstanding FOXL2 mutation.	[Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Inst Jacques Monod, Programme Pathol Mol & Cellulaire, F-75251 Paris, France; [Benayoun, Berenice A.; Caburet, Sandrine; Dipietromaria, Aurelie; Georges, Adrien; L'Hote, David; Todeschini, Anne-Laure; Veitia, Reiner A.] Univ Paris 07, Paris, France; [Georges, Adrien] Ecole Normale Super, F-75231 Paris, France; [D'Haene, Barbara; De Baere, Elfride] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Pandaranayaka, P. J. Eswari; Krishnaswamy, Sankaran] Kamaraj Univ, Sch Biotechnol, Madurai, Tamil Nadu, India; [Fellous, Marc] Inst Cochin, Dept Genet & Dev, Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Ghent University; Ghent University Hospital; Madurai Kamaraj University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Benayoun, BA (corresponding author), Inst Jacques Monod, Programme Pathol Mol & Cellulaire, 2 Pl Jussieu, F-75251 Paris, France.	veitia.reiner@ijm.univ-paris-diderot.fr	Benayoun, Bérénice A./K-7048-2012; Georges, Adrien/ABD-6348-2021; De Baere, Elfride/E-7405-2017; Caburet, Sandrine/AAH-3435-2019; LHOTE, David/AAD-5390-2020; L'Hote, David/L-2653-2017	Benayoun, Bérénice A./0000-0002-7401-4777; De Baere, Elfride/0000-0002-5609-6895; L'Hote, David/0000-0001-5658-5018; Caburet, Sandrine/0000-0002-7404-8213; Georges, Adrien/0000-0003-4208-2393; Pandaranayaka, Eswari/0000-0003-3021-853X; Krishnaswamy, Sankaran/0000-0002-6797-4614	AMN/University Paris Diderot-Paris 7; Fondation de la Recherche Medicale; Ecole Normale Superieure; Government of India; Centre National de la Recherche Scientifique; Institut Universitaire de France; Association pour la Recherche contre le Cancer [1140]; Ghent University [01SB1409]	AMN/University Paris Diderot-Paris 7; Fondation de la Recherche Medicale(Fondation pour la Recherche Medicale); Ecole Normale Superieure; Government of India; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ghent University(Ghent University)	B.A.B. is supported by an AMN/University Paris Diderot-Paris 7 fellowship. S.C., D.L., and A.L.T. are supported by University Paris Diderot-Paris 7. A.D. is supported by a Fondation de la Recherche Medicale fellowship. A. G. is supported by an Ecole Normale Superieure fellowship. P.J.E.P. is supported by a Government of India fellowship. E.D.B. is a senior clinical investigator from Research Foundation Flanders. R.A.V. is supported by University Paris Diderot-Paris 7, the Centre National de la Recherche Scientifique, the Institut Universitaire de France, and the Association pour la Recherche contre le Cancer. The Bioinformatics facilities at Madurai Kamaraj University are funded by the Department of Biotechnology, Government of India. This work was funded by a grant from the Association pour la Recherche contre le Cancer (1140) and by BOF-BILA grant 01SB1409 from Ghent University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Benayoun BA, 2010, BBA-REV CANCER, V1805, P1, DOI 10.1016/j.bbcan.2009.09.002; Benayoun BA, 2009, ADV EXP MED BIOL, V665, P207; Benayoun BA, 2009, HUM MOL GENET, V18, P632, DOI 10.1093/hmg/ddn389; Beysen D, 2005, AM J HUM GENET, V77, P205, DOI 10.1086/432083; Beysen D, 2008, HUM MOL GENET, V17, P2030, DOI 10.1093/hmg/ddn100; Beysen D, 2008, HUM MUTAT, V29, pE205, DOI 10.1002/humu.20819; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Caburet S, 2004, J MED GENET, V41, P932, DOI 10.1136/jmg.2004.024356; Cocquet J, 2003, CYTOGENET GENOME RES, V101, P206, DOI 10.1159/000074338; Cocquet J, 2002, J MED GENET, V39, P916, DOI 10.1136/jmg.39.12.916; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; D'haene B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000522; Dipietromaria A, 2009, HUM MOL GENET, V18, P3324, DOI 10.1093/hmg/ddp273; Ellsworth BS, 2003, MOL CELL ENDOCRINOL, V206, P93, DOI 10.1016/S0303-7207(03)00235-1; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; Grundker C, 2002, J CLIN ENDOCR METAB, V87, P1427, DOI 10.1210/jc.87.3.1427; Hamelin V, 2006, BLOOD, V107, P3106, DOI 10.1182/blood-2005-07-2953; Kalfa N, 2005, J PEDIATR ENDOCR MET, V18, P25; Kalfa N, 2007, FERTIL STERIL, V87, P896, DOI 10.1016/j.fertnstert.2006.11.016; Kawai S, 2005, BIOCHEM BIOPH RES CO, V328, P306, DOI 10.1016/j.bbrc.2004.12.173; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kim SG, 2005, MOL BIOL CELL, V16, P4672, DOI 10.1091/mbc.E05-01-0054; Laissue P, 2009, J MED GENET, V46, P455, DOI 10.1136/jmg.2008.065086; Litichever N, 2009, J MOL NEUROSCI, V39, P78, DOI 10.1007/s12031-009-9185-8; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Moumne L, 2008, MOL CELL ENDOCRINOL, V282, P2, DOI 10.1016/j.mce.2007.11.006; Moumne L, 2008, HUM MOL GENET, V17, P1010, DOI 10.1093/hmg/ddm373; Murdoch WJ, 2005, BIOL REPROD, V73, P586, DOI 10.1095/biolreprod.105.042622; Nallathambi Jeyabalan, 2008, Hum Mutat, V29, pE123, DOI 10.1002/humu.20809; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Obsil T, 2008, ONCOGENE, V27, P2263, DOI 10.1038/onc.2008.20; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Pectasides D, 2008, CANCER TREAT REV, V34, P1, DOI 10.1016/j.ctrv.2007.08.007; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; Qian XQ, 2004, MUTAT RES-FUND MOL M, V554, P19, DOI 10.1016/j.mrfmmm.2004.02.014; Rigourd V, 2009, J REPROD IMMUNOL, V82, P174, DOI 10.1016/j.jri.2009.05.001; Sambrook J., 2001, MOL CLONING LAB MANU; Schrader KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007988; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Treier M, 1998, GENE DEV, V12, P1691, DOI 10.1101/gad.12.11.1691; ZLOTOGORA J, 1983, AM J HUM GENET, V35, P1020	44	57	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8789	10.1371/journal.pone.0008789	http://dx.doi.org/10.1371/journal.pone.0008789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098707	Green Published, gold, Green Submitted			2022-12-27	WOS:000273779000017
J	Xu, ML; Su, ZC				Xu, Minli; Su, Zhengchang			A Novel Alignment-Free Method for Comparing Transcription Factor Binding Site Motifs	PLOS ONE			English	Article							POSITION FREQUENCY MATRICES; DNA-SEQUENCE DISSIMILARITY; OPEN-ACCESS DATABASE; PROTEIN SEQUENCES; IDENTIFICATION; SIMILARITY; PATTERNS; JASPAR; GENES	Background: Transcription factor binding site (TFBS) motifs can be accurately represented by position frequency matrices (PFM) or other equivalent forms. We often need to compare TFBS motifs using their PFMs in order to search for similar motifs in a motif database, or cluster motifs according to their binding preference. The majority of current methods for motif comparison involve a similarity metric for column-to-column comparison and a method to find the optimal position alignment between the two compared motifs. In some applications, alignment-free methods might be preferred; however, few such methods with high accuracy have been described. Methodology/Principal Findings: Here we describe a novel alignment-free method for quantifying the similarity of motifs using their PFMs by converting PFMs into k-mer vectors. The motifs could then be compared by measuring the similarity among their corresponding k-mer vectors. Conclusions/Significance: We demonstrate that our method in general achieves similar performance or outperforms the existing methods for clustering motifs according to their binding preference and identifying similar motifs of transcription factors of the same family.	[Xu, Minli; Su, Zhengchang] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Xu, ML (corresponding author), Univ Pittsburgh, Dept Computat Biol, Pittsburgh, PA 15260 USA.	zcsu@uncc.edu		Xu, Minli/0000-0002-0528-2946	University of North Carolina at Charlotte; Carolinas Medical Center University of North Carolina at Charlotte (CMC-UNCC); National Science Foundation [EF0849615]	University of North Carolina at Charlotte; Carolinas Medical Center University of North Carolina at Charlotte (CMC-UNCC); National Science Foundation(National Science Foundation (NSF))	This research was partially supported by a grant from the University of North Carolina at Charlotte, a grant from the Carolinas Medical Center University of North Carolina at Charlotte (CMC-UNCC) Collaborative Research Fund and a grant (EF0849615) from the National Science Foundation to Zhengchang Su. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2003, BIOINFORMATICS, V19, pII5, DOI 10.1093/bioinformatics/btg1052; BLAISDELL BE, 1986, P NATL ACAD SCI USA, V83, P5155, DOI 10.1073/pnas.83.14.5155; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; KARIN M, 1990, New Biologist, V2, P126; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Mahony S, 2005, BIOINFORMATICS, V21, pI283, DOI 10.1093/bioinformatics/bti1025; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mironov AA, 1999, NUCLEIC ACIDS RES, V27, P2981, DOI 10.1093/nar/27.14.2981; Narlikar L, 2006, BIOINFORMATICS, V22, P157, DOI 10.1093/bioinformatics/bti731; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; PETRILLI P, 1993, COMPUT APPL BIOSCI, V9, P205; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Strang G, 1988, LINEAR ALGEBRA ITS A; Stuart GW, 2002, BIOINFORMATICS, V18, P100, DOI 10.1093/bioinformatics/18.1.100; Stuart GW, 2002, MOL BIOL EVOL, V19, P554, DOI 10.1093/oxfordjournals.molbev.a004111; TORNEY DC, 1990, SFI S SCI C, V7, P109; VANHEEL M, 1991, J MOL BIOL, V220, P877, DOI 10.1016/0022-2836(91)90360-I; Vinga S, 2003, BIOINFORMATICS, V19, P513, DOI 10.1093/bioinformatics/btg005; Wang T, 2005, P NATL ACAD SCI USA, V102, P17400, DOI 10.1073/pnas.0505147102; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wu TJ, 1997, BIOMETRICS, V53, P1431, DOI 10.2307/2533509; Wu TJ, 2001, BIOMETRICS, V57, P441, DOI 10.1111/j.0006-341X.2001.00441.x; Zhang SQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp248	33	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2010	5	1							e8797	10.1371/journal.pone.0008797	http://dx.doi.org/10.1371/journal.pone.0008797			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AI	20098703	Green Published, Green Submitted, gold			2022-12-27	WOS:000273779000024
J	Sansom, SL; Prabhu, VS; Hutchinson, AB; An, Q; Hall, HI; Shrestha, RK; Lasry, A; Taylor, AW				Sansom, Stephanie L.; Prabhu, Vimalanand S.; Hutchinson, Angela B.; An, Qian; Hall, H. Irene; Shrestha, Ram K.; Lasry, Arielle; Taylor, Allan W.			Cost-Effectiveness of Newborn Circumcision in Reducing Lifetime HIV Risk among US Males	PLOS ONE			English	Article							NEONATAL CIRCUMCISION; YOUNG MEN; INFECTION; PREVENTION; HERPES; SEROCONVERSION; DISEASE; HEALTH; STATES; RAKAI	Background: HIV incidence was substantially lower among circumcised versus uncircumcised heterosexual African men in three clinical trials. Based on those findings, we modeled the potential effect of newborn male circumcision on a U. S. male's lifetime risk of HIV, including associated costs and quality-adjusted life-years saved. Methodology/Principal Findings: Given published estimates of U. S. males' lifetime HIV risk, we calculated the fraction of lifetime risk attributable to heterosexual behavior from 2005-2006 HIV surveillance data. We assumed 60% efficacy of circumcision in reducing heterosexually-acquired HIV over a lifetime, and varied efficacy in sensitivity analyses. We calculated differences in lifetime HIV risk, expected HIV treatment costs and quality-adjusted life years (QALYs) among circumcised versus uncircumcised males. The main outcome measure was cost per HIV-related QALY saved. Circumcision reduced the lifetime HIV risk among all males by 15.7% in the base case analysis, ranging from 7.9% for white males to 20.9% for black males. Newborn circumcision was a cost-saving HIV prevention intervention for all, black and Hispanic males. The net cost of newborn circumcision per QALY saved was $87,792 for white males. Results were most sensitive to the discount rate, and circumcision efficacy and cost. Conclusions/Significance: Newborn circumcision resulted in lower expected HIV-related treatment costs and a slight increase in QALYs. It reduced the 1.87% lifetime risk of HIV among all males by about 16%. The effect varied substantially by race and ethnicity. Racial and ethnic groups who could benefit the most from circumcision may have least access to it due to insurance coverage and state Medicaid policies, and these financial barriers should be addressed. More data on the long-term protective	[Sansom, Stephanie L.; Prabhu, Vimalanand S.; Hutchinson, Angela B.; An, Qian; Hall, H. Irene; Shrestha, Ram K.; Lasry, Arielle; Taylor, Allan W.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Sansom, SL (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	sos9@cdc.gov		Taylor, Allan/0000-0001-7496-8768				Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; [Anonymous], 2006, STAT HLTH NOT CIRC I; [Anonymous], 2007, HEIGHT NAT RESP HIV; [Anonymous], NATL VITAL STAT REPO; [Anonymous], WORLD FACTB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Buchbinder SP, 2005, JAIDS-J ACQ IMM DEF, V39, P82, DOI 10.1097/01.qai.0000134740.41585.f4; Centers for Disease Control and Prevention, 2006, HIV AIDS SURVEILLANC, V18; Christakis DA, 2000, PEDIATRICS, V105, P246; GANIATS TG, 1991, MED DECIS MAKING, V11, P282, DOI 10.1177/0272989X9101100406; Gold MR, 1996, COST EFFECTIVENESS H; Gray RH, 2007, AIDS, V21, P845, DOI 10.1097/QAD.0b013e3280187544; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000187; Grulich AE, 2001, AIDS, V15, P1188, DOI 10.1097/00002030-200106150-00020; Hall HI, 2008, JAIDS-J ACQ IMM DEF, V49, P294, DOI 10.1097/QAI.0b013e3181893f17; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; *HJ KAIS FAM FDN, 2007, KEY FACTS RAC ETHN M; Kahn JG, 2006, PLOS MED, V3, P2349, DOI 10.1371/journal.pmed.0030517; KRIESS JK, 1993, J INFECT DIS, V168, P1404, DOI 10.1093/infdis/168.6.1404; KUNG HC, 2007, DEATHS FINAL DATA 20; Lannon CM, 1999, PEDIATRICS, V103, P686; Lawler F H, 1991, Fam Med, V23, P587; Leibowitz AA, 2009, AM J PUBLIC HEALTH, V99, P138, DOI 10.2105/AJPH.2008.134403; MANSFIELD CJ, 1995, J FAM PRACTICE, V41, P370; Mattson CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002443; MILLETT GA, 2007, J ACQ IMMUN DEF SYND, V45, P643; Millett GA, 2008, JAMA-J AM MED ASSOC, V300, P1674, DOI 10.1001/jama.300.14.1674; Prejean J., 2008, Morbidity and Mortality Weekly Report, V57, P985; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Schoen EJ, 2006, J UROLOGY, V175, P1111, DOI 10.1016/S0022-5347(05)00399-X; Sobngwi-Tambekou J, 2009, J INFECT DIS, V199, P958, DOI 10.1086/597208; TELZAK EE, 1993, ANN INTERN MED, V119, P1181, DOI 10.7326/0003-4819-119-12-199312150-00005; Templeton DJ, 2009, AIDS, V23, P2347, DOI 10.1097/QAD.0b013e32833202b8; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Van Howe RS, 2004, MED DECIS MAKING, V24, P584, DOI 10.1177/0272989X04271039; Warner L, 2009, J INFECT DIS, V199, P59, DOI 10.1086/595569; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; *WHO, 2009, MAL CIRC HIV PREV; *WHO, 2009, CHOOSING INT AR COST; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; Xu F, 2007, SEX TRANSM DIS, V34, P479, DOI 10.1097/01.olq.0000253335.41841.04; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; 2005, MARKETSCAN DATABASE	50	54	56	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8723	10.1371/journal.pone.0008723	http://dx.doi.org/10.1371/journal.pone.0008723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20090910	Green Published, Green Submitted, gold			2022-12-27	WOS:000273715000003
J	Yoshikawa, T; Hill, TE; Yoshikawa, N; Popov, VL; Galindo, CL; Garner, HR; Peters, CJ; Tseng, CT				Yoshikawa, Tomoki; Hill, Terence E.; Yoshikawa, Naoko; Popov, Vsevolod L.; Galindo, Cristi L.; Garner, Harold R.; Peters, C. J.; Tseng, Chien-Te (Kent)			Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection	PLOS ONE			English	Article							INTERFERON-INDUCIBLE PROTEIN-10; DHORI-VIRUS ORTHOMYXOVIRIDAE; MOUSE HEPATITIS-VIRUS; HOST GENE-EXPRESSION; TRANSCRIPTION FACTORS; I INTERFERON; THOGOTOVIRUS INFECTION; POSITIVE FEEDBACK; IFN-ALPHA/BETA; INDUCTION	Human lung epithelial cells are likely among the first targets to encounter invading severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Not only can these cells support the growth of SARS-CoV infection, but they are also capable of secreting inflammatory cytokines to initiate and, eventually, aggravate host innate inflammatory responses, causing detrimental immune-mediated pathology within the lungs. Thus, a comprehensive evaluation of the complex epithelial signaling to SARS-CoV is crucial for paving the way to better understand SARS pathogenesis. Based on microarray-based functional genomics, we report here the global gene response of 2B4 cells, a cloned bronchial epithelial cell line derived from Calu-3 cells. Specifically, we found a temporal and spatial activation of nuclear factor (NF)kappa B, activator protein (AP)-1, and interferon regulatory factor (IRF)-3/7 in infected 2B4 cells at 12-, 24-, and 48-hrs post infection (p.i.), resulting in the activation of many antiviral genes, including interferon (IFN)-beta, -lambda s, inflammatory mediators, and many IFN-stimulated genes (ISGs). We also showed, for the first time, that IFN-beta and IFN-lambda s were capable of exerting previously unrecognized, non-redundant, and complementary abilities to limit SARS-CoV replication, even though their expression could not be detected in infected 2B4 bronchial epithelial cells until 48 hrs p.i. Collectively, our results highlight the mechanics of the sequential events of antiviral signaling pathway/s triggered by SARS-CoV in bronchial epithelial cells and identify novel cellular targets for future studies, aiming at advancing strategies against SARS.	[Yoshikawa, Tomoki; Hill, Terence E.; Yoshikawa, Naoko; Peters, C. J.; Tseng, Chien-Te (Kent)] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Popov, Vsevolod L.; Peters, C. J.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Popov, Vsevolod L.; Peters, C. J.; Tseng, Chien-Te (Kent)] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Galindo, Cristi L.; Garner, Harold R.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas	Yoshikawa, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA.	sktseng@utmb.edu		Yoshikawa, Tomoki/0000-0001-7601-4036	National Institutes of Health [R21AI072201]; Western Regional Center [U54 AI057156]; Viral Respiratory Pathogens Research Unit [NO1 AI3009]; US Based Collaboration in Emerging Viral and Prior Diseases [NO1 AI25489]; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025489, R21AI072201, U54AI057156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Western Regional Center; Viral Respiratory Pathogens Research Unit; US Based Collaboration in Emerging Viral and Prior Diseases; James W. McLaughlin Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by National Institutes of Health (http://www3.niaid.nih.gov/) Grant R21AI072201, a Career Development Grant award through the Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (U54 AI057156), as well as Subcontract awards on SARS from the Viral Respiratory Pathogens Research Unit (NO1 AI3009) (to CKT), and US Based Collaboration in Emerging Viral and Prior Diseases (NO1 AI25489). T. Y. was supported by the James W. McLaughlin Fellowship Fund (http://research.utmb.edu/intramural_funding/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Al-Shahrour F, 2008, NUCLEIC ACIDS RES, V36, pW341, DOI 10.1093/nar/gkn318; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; ANDERSON CR, 1973, INDIAN J MED RES, V61, P1416; Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275; BASBAUM CB, 1990, AM REV RESPIR DIS, V141, pS141, DOI 10.1164/ajrccm/141.3_Pt_2.S141; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen PCH, 2004, J PATHOL, V203, P729, DOI 10.1002/path.1575; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Cinatl J, 2004, CELL MOL LIFE SCI, V61, P2100, DOI 10.1007/s00018-004-4222-9; De Lang A, 2007, PLOS PATHOG, V3, P1129, DOI 10.1371/journal.ppat.0030112; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUTTA SK, 1983, CAN J COMP MED, V47, P64; FINKBEINER WE, 1993, AM J RESP CELL MOL, V9, P547, DOI 10.1165/ajrcmb/9.5.547; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Glass WG, 2004, J IMMUNOL, V173, P4030, DOI 10.4049/jimmunol.173.6.4030; Haagmans BL, 2004, NAT MED, V10, P290, DOI 10.1038/nm1001; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Hensley LE, 2004, EMERG INFECT DIS, V10, P317, DOI 10.3201/eid1002.030482; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huang KJ, 2005, J MED VIROL, V75, P185, DOI 10.1002/jmv.20255; Imai Y, 2008, EXP PHYSIOL, V93, P543, DOI 10.1113/expphysiol.2007.040048; Jia HP, 2005, J VIROL, V79, P14614, DOI 10.1128/JVI.79.23.14614-14621.2005; Jiang Y, 2005, AM J RESP CRIT CARE, V171, P850, DOI 10.1164/rccm.200407-857OC; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kopecky-Bromberg SA, 2006, J VIROL, V80, P785, DOI 10.1128/JVI.80.2.785-793.2006; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lang ZW, 2003, CHINESE MED J-PEKING, V116, P976; Langford M P, 1981, Methods Enzymol, V78, P339; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Li GY, 2008, AM J TROP MED HYG, V78, P675, DOI 10.4269/ajtmh.2008.78.675; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Martin LD, 1997, EUR RESPIR J, V10, P2139, DOI 10.1183/09031936.97.10092139; Mateo RI, 2007, AM J TROP MED HYG, V76, P785, DOI 10.4269/ajtmh.2007.76.785; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Morgenstern B, 2005, BIOCHEM BIOPH RES CO, V326, P905, DOI 10.1016/j.bbrc.2004.11.128; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Ng LF, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-34; Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Polito AJ, 1998, J ALLERGY CLIN IMMUN, V102, P714, DOI 10.1016/S0091-6749(98)70008-9; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Roth-Cross JK, 2007, J VIROL, V81, P7189, DOI 10.1128/JVI.00013-07; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Sims AC, 2005, J VIROL, V79, P15511, DOI 10.1128/JVI.79.24.15511-15524.2005; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Spiegel M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-17; Tang BSF, 2005, J VIROL, V79, P6180, DOI 10.1128/JVI.79.10.6180-6193.2005; Tang NLS, 2005, CLIN CHEM, V51, P2333, DOI 10.1373/clinchem.2005.054460; TAUB DD, 1995, J IMMUNOL, V155, P3877; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; To K, 2004, J PATHOL, V202, P157, DOI 10.1002/path.1510; Tseng CTK, 2007, J VIROL, V81, P1162, DOI 10.1128/JVI.01702-06; Tseng CTK, 2005, J VIROL, V79, P9470, DOI 10.1128/JVI.79.15.9470-9479.2005; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Yan KW, 2003, INT J SURG PATHOL, V11, P118, DOI 10.1177/106689690301100208; Yoshikawa N, 2009, J VIROL, V83, P5451, DOI 10.1128/JVI.02272-08; Yoshikawa T, 2009, J VIROL, V83, P3039, DOI 10.1128/JVI.01792-08; Zhang YC, 2004, INFECT IMMUN, V72, P4410, DOI 10.1128/IAI.72.8.4410-4415.2004; Zheng BJ, 2004, J INTERF CYTOK RES, V24, P388, DOI 10.1089/1079990041535610; Zhong B, 2006, VIROLOGY, V352, P14, DOI 10.1016/j.virol.2006.04.029; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	79	118	122	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 15	2010	5	1							e8729	10.1371/journal.pone.0008729	http://dx.doi.org/10.1371/journal.pone.0008729			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EI	20090954	gold, Green Published, Green Submitted			2022-12-27	WOS:000273714900010
J	Vogelgesang, A; May, VEL; Grunwald, U; Bakkeboe, M; Langner, S; Wallaschofski, H; Kessler, C; Broker, BM; Dressel, A				Vogelgesang, Antje; May, Verena E. L.; Grunwald, Uwe; Bakkeboe, Maren; Langner, Soenke; Wallaschofski, Henry; Kessler, Christof; Broeker, Barbara M.; Dressel, Alexander			Functional Status of Peripheral Blood T-Cells in Ischemic Stroke Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; INDUCED IMMUNODEPRESSION; PROTEIN HMGB1; INFECTION; ACTIVATION; RELEASE; BRAIN; EXPRESSION; MONOCYTES	Stroke is a major cause of disability and leading cause of death in the northern hemisphere. Only recently it became evident that cerebral ischemia not only leads to brain tissue damage and subsequent local inflammation but also to a dramatic loss of peripheral blood T-cells with subsequent infections. However, only scarce information is available on the activation status of surviving T cells. This study therefore addressed the functional consequences of immunological changes induced by stroke in humans. For this purpose peripheral blood T-cells were isolated from 93 stroke patients and the expression of activation makers was determined. In addition ex vivo stimulation assays were applied to asses the functionality of T cells derived from blood of stroke patients. Compared to healthy controls, stroke patients demonstrated an enhanced surface expression of HLA-DR (p<0.0001) and CD25 (p = 0.02) on T cells, revealing that stroke leads to T cell activation, while CTLA-4 remained undetectable. In vitro studies revealed that catecholamines inhibit CTLA-4 upregulation in activated T cells. Ex vivo, T cells of stroke patients proliferated unimpaired and released increased amounts of the proinflammatory cytokine TNF-alpha (p<0.01) and IL-6 (p<0.05). Also, in sera of stroke patients HMGB1 concentrations were increased (p = 0.0002). The data demonstrate that surviving T cells in stroke patients remain fully functional and are primed towards a TH1 response, in addition we provide evidence that catecholamine mediated inhibition of CTLA-4 expression and serum HMGB1 release are possible mediators in stroke induced activation of T cells.	[Vogelgesang, Antje; May, Verena E. L.; Bakkeboe, Maren; Kessler, Christof; Dressel, Alexander] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Grunwald, Uwe; Broeker, Barbara M.] Ernst Moritz Arndt Univ Greifswald, Inst Immunol & Transfus Med, Greifswald, Germany; [Langner, Soenke] Ernst Moritz Arndt Univ Greifswald, Dept Radiol, Greifswald, Germany; [Wallaschofski, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald	Vogelgesang, A (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany.	adressel@uni-greifswald.de	Vogelgesang, Antje/AAQ-1194-2021; Bröker, Barbara M/O-4850-2015; Langner, Soenke/ABB-6744-2021; Dressel, Alexander/F-9142-2015	Vogelgesang, Antje/0000-0003-2984-0831; Bröker, Barbara M/0000-0002-5020-8542; Langner, Soenke/0000-0001-7241-1173; Dressel, Alexander/0000-0002-9055-4327	German Federal Ministry for Education and Research [01-ZZ-0403]; German Research Foundation	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Federal Ministry for Education and Research (NBL3 program, reference 01-ZZ-0403) and the German Research Foundation, Research Training Group 840. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; PETERSEN CM, 1992, EXP CELL RES, V201, P160, DOI 10.1016/0014-4827(92)90360-K; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Urra X, 2009, STROKE, V40, P1262, DOI 10.1161/STROKEAHA.108.532085; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Zhang DP, 2009, EUR J NEUROL, V16, P498, DOI 10.1111/j.1468-1331.2008.02512.x; ZHENG Y, 2008, ACQUISITION SUPPRESS, P1683	26	70	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2010	5	1							e8718	10.1371/journal.pone.0008718	http://dx.doi.org/10.1371/journal.pone.0008718			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EF	20090932	gold, Green Submitted, Green Published			2022-12-27	WOS:000273714600018
J	Becker, D; Tetens, J; Brunner, A; Burstel, D; Ganter, M; Kijas, J; Drogemuller, C				Becker, Doreen; Tetens, Jens; Brunner, Adrian; Buerstel, Daniela; Ganter, Martin; Kijas, James; Droegemueller, Cord		Int Sheep Genomics Consortium	Microphthalmia in Texel Sheep Is Associated with a Missense Mutation in the Paired-Like Homeodomain 3 (PITX3) Gene	PLOS ONE			English	Article							HOMEOBOX GENE; RIEGER-SYNDROME; APHAKIA MICE; LINKAGE MAP; GENOME; ANOPHTHALMIA; CATARACTS; DEFECTS; LENS; MALFORMATIONS	Microphthalmia in sheep is an autosomal recessive inherited congenital anomaly found within the Texel breed. It is characterized by extremely small or absent eyes and affected lambs are absolutely blind. For the first time, we use a genome-wide ovine SNP array for positional cloning of a Mendelian trait in sheep. Genotyping 23 cases and 23 controls using Illumina's OvineSNP50 BeadChip allowed us to localize the causative mutation for microphthalmia to a 2.4 Mb interval on sheep chromosome 22 by association and homozygosity mapping. The PITX3 gene is located within this interval and encodes a homeodomain-containing transcription factor involved in vertebrate lens formation. An abnormal development of the lens vesicle was shown to be the primary event in ovine microphthalmia. Therefore, we considered PITX3 a positional and functional candidate gene. An ovine BAC clone was sequenced, and after full-length cDNA cloning the PITX3 gene was annotated. Here we show that the ovine microphthalmia phenotype is perfectly associated with a missense mutation (c.338G>C, p.R113P) in the evolutionary conserved homeodomain of PITX3. Selection against this candidate causative mutation can now be used to eliminate microphthalmia from Texel sheep in production systems. Furthermore, the identification of a naturally occurring PITX3 mutation offers the opportunity to use the Texel as a genetically characterized large animal model for human microphthalmia.	[Becker, Doreen; Brunner, Adrian; Droegemueller, Cord] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Tetens, Jens] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany; [Buerstel, Daniela; Ganter, Martin] Univ Vet Med Hannover, Clin Pigs & Small Ruminants, Forens Med & Ambulatory Serv Small Anim, Hannover, Germany; [Kijas, James] Commonwealth Sci & Ind Res Org Livestock Ind, Brisbane, Qld, Australia	University of Bern; University of Kiel; University of Veterinary Medicine Hannover, Foundation; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Becker, D (corresponding author), Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland.	Cord.Droegemueller@itz.unibe.ch	Becker, Doreen/AAF-9108-2020; Tetens, Jens/H-5344-2012; Simianer, Henner/A-6574-2015; Kijas, James W/A-4656-2011	Becker, Doreen/0000-0003-0425-6284; Simianer, Henner/0000-0002-7551-3797; Kijas, James W/0000-0002-1417-8278; Drogemuller, Cord/0000-0001-9773-522X; Tetens, Jens/0000-0001-5352-464X	Swiss National Science Foundation (SNSF), Berne, Switzerland [3100A0-116247]; H.W. Schaumann Stiftung, Hamburg, Germany	Swiss National Science Foundation (SNSF), Berne, Switzerland(Swiss National Science Foundation (SNSF)); H.W. Schaumann Stiftung, Hamburg, Germany	This study was financed by research grants of the Swiss National Science Foundation (SNSF), Berne, Switzerland (grant no. 3100A0-116247), and the H. W. Schaumann Stiftung, Hamburg, Germany, to CD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AR, 2009, GENOMICS, V94, P55, DOI 10.1016/j.ygeno.2009.04.001; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Andersson L, 2009, GENETICA, V136, P341, DOI 10.1007/s10709-008-9312-4; ASO S, 1995, LAB ANIM SCI, V45, P41; Beever JE, 2006, ANIM GENET, V37, P66, DOI 10.1111/j.1365-2052.2005.01398.x; Bidinost C, 2006, INVEST OPHTH VIS SCI, V47, P1274, DOI 10.1167/iovs.05-1095; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chow RL, 2001, ANNU REV CELL DEV BI, V17, P255, DOI 10.1146/annurev.cellbio.17.1.255; Cockett NE, 1999, MAMM GENOME, V10, P35, DOI 10.1007/s003359900938; Cockett NE, 2003, CYTOGENET GENOME RES, V102, P76, DOI 10.1159/000075728; Cook Cynthia S., 1995, Veterinary and Comparative Ophthalmology, V5, P109; CRAWFORD AM, 1995, GENETICS, V140, P703; Dalrymple BP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r152; DE GROOT T., 1957, Landbouwkundig Tijdschrift, V69, P819; Fantes J, 2003, NAT GENET, V33, P461, DOI 10.1038/ng1120; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Graw J, 2003, NAT REV GENET, V4, P876, DOI 10.1038/nrg1202; HANSET R., 1961, ANN MED VET, V105, P443; HARING F, 1970, Zuechtungskunde, V42, P385; JACKSON EKM, 1990, VET REC, V126, P650; Jolly RD, 2004, NEW ZEAL VET J, V52, P52, DOI 10.1080/00480169.2004.36405; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Maddox JF, 2001, GENOME RES, V11, P1275, DOI 10.1101/gr.GR-1350R; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; Murphy AM, 2007, MAMM GENOME, V18, P43, DOI 10.1007/s00335-006-0016-8; Nezamzadeh R, 2005, ANIM GENET, V36, P297, DOI 10.1111/j.1365-2052.2005.01301.x; PATTERSON DF, 1988, J AM VET MED ASSOC, V193, P1131; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Roe WD, 2003, NEW ZEAL VET J, V51, P194, DOI 10.1080/00480169.2003.36364; Sakazume S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-84; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi XH, 2005, MECH DEVELOP, V122, P513, DOI 10.1016/j.mod.2004.11.012; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Tetens J, 2007, TIERAERZTL PRAX G N, V35, P211; Tetens J, 2007, INVEST OPHTH VIS SCI, V48, P3506, DOI 10.1167/iovs.07-0041; Valleix S, 2006, AM J HUM GENET, V79, P358, DOI 10.1086/505654; van der Linde-Sipman JS, 2003, J COMP PATHOL, V128, P269, DOI 10.1053/jcpa.2002.0632; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47; Voronina VA, 2004, HUM MOL GENET, V13, P315, DOI 10.1093/hmg/ddh025; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; 2009, HOMEPAGE ILLUMINA; 2009, HOMEPAGE SPIDEY; 2009, HOMEPAGE POLYPHEN; 2009, HOMEPAGE PMUT; 2009, HOMEPAGE PFIZER ANIM; 2009, HOMEPAGE PLINK; 2009, HOMEPAGE PDB	54	43	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8689	10.1371/journal.pone.0008689	http://dx.doi.org/10.1371/journal.pone.0008689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084168	Green Published, gold, Green Submitted			2022-12-27	WOS:000273554600037
J	De Weer, A; Poppe, B; Vergult, S; Van Vlierberghe, P; Petrick, M; De Bock, R; Benoit, Y; Noens, L; De Paepe, A; Van Roy, N; Menten, B; Speleman, F				De Weer, An; Poppe, Bruce; Vergult, Sarah; Van Vlierberghe, Pieter; Petrick, Marjan; De Bock, Robrecht; Benoit, Yves; Noens, Lucien; De Paepe, Anne; Van Roy, Nadine; Menten, Bjorn; Speleman, Frank			Identification of Two Critically Deleted Regions within Chromosome Segment 7q35-q36 in EVI1 Deregulated Myeloid Leukemia Cell Lines	PLOS ONE			English	Article							GENE; ESTABLISHMENT; INACTIVATION; DELETIONS; COMMON; LOCUS	Chromosomal rearrangements involving the EVI1 proto-oncogene are a recurrent finding in myeloid leukemias and are indicative of a poor prognosis. Rearrangements of the EVI1 locus are often associated with monosomy 7 or cytogenetic detectable deletions of part of 7q. As EVI1 overexpression alone is not sufficient to induce leukemia, loss of a 7q tumour suppressor gene might be a required cooperating event. To test this hypothesis, we performed high-resolution array comparative genomic hybridization analysis of twelve EVI1 overexpressing patients and three EVI1 deregulated cell lines to search for 7q submicroscopic deletions. This analysis lead to the delineation of two critical regions, one of 0.39 Mb on 7q35 containing the CNTNAP2 gene and one of 1.33 Mb on chromosome bands 7q35-q36 comprising nine genes in EVI1 deregulated cell lines. These findings open the way to further studies aimed at identifying the culprit EVI1 implicated tumour suppressor genes on 7q.	[De Weer, An; Poppe, Bruce; Vergult, Sarah; Van Vlierberghe, Pieter; De Paepe, Anne; Van Roy, Nadine; Menten, Bjorn; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Petrick, Marjan] AZ Sint Lucas, Dept Radiotherapy Oncol & Hematol, Ghent, Belgium; [De Bock, Robrecht] ZNA Middelheim, Dept Hematol, Antwerp, Belgium; [Benoit, Yves] Ghent Univ Hosp, Dept Pediat Hematooncol, B-9000 Ghent, Belgium; [Noens, Lucien] Ghent Univ Hosp, Dept Hematol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; ZNA Middelheim Hospital; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital	De Weer, A (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	franki.speleman@ugent.be	speleman, frank/AAR-5184-2020; Menten, Björn/B-3072-2013; Van Vlierberghe, Pieter/G-8894-2013	speleman, frank/0000-0002-6628-8559; Van Vlierberghe, Pieter/0000-0001-9063-7205; Vergult, Sarah/0000-0002-0816-6262; Menten, Bjorn/0000-0001-8182-659X	BOF [01D28905]; FWO-Vlaanderen [G. 0106.05]; GOA-UGent [12051203]; IWT-Vlaanderen [060848]	BOF; FWO-Vlaanderen(FWO); GOA-UGent; IWT-Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	A. De Weer is the recipient of a BOF grant (Bijzonder Onderzoeksfonds UGent, grant no. 01D28905). B. Poppe is a senior clinical investigator of Fonds voor Wetenschappelijk Onderzoek (FWO) Vlaanderen, P. Van Vlierberghe is a post-doc of FWO-Vlaanderen and S. Vergult is an aspirant of FWO-Vlaanderen. This study was supported by the FWO-Vlaanderen, grant no. G. 0106.05, by GOA-UGent, grant no. 12051203 and by IWT-Vlaanderen SBO grant no. 060848. This text presents research results of the Belgian Program of Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy Programming. The scientific responsibility is assumed by the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASNAFI V, 2008, BLOOD; Asou H, 1996, JPN J CANCER RES, V87, P269, DOI 10.1111/j.1349-7006.1996.tb00216.x; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; Cardoso C, 2000, EUR J HUM GENET, V8, P174, DOI 10.1038/sj.ejhg.5200439; De Weer A, 2008, HAEMATOL-HEMATOL J, V93, P1903, DOI 10.3324/haematol.13192; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Giefing M, 2008, CANCER GENET CYTOGEN, V184, P38, DOI 10.1016/j.cancergencyto.2008.03.004; Hu ZB, 1996, LEUKEMIA, V10, P1025; Kolomietz E, 2001, BLOOD, V97, P3581, DOI 10.1182/blood.V97.11.3581; LeBeau MM, 1996, BLOOD, V88, P1930; Liu Y, 2006, MOL CELL BIOL, V26, P3114, DOI 10.1128/MCB.26.8.3114-3123.2006; Lopingco MC, 1996, CURR TOP MICROBIOL, V211, P211; LUGTHART S, 2008, BLOOD; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Nucifora G, 1997, LEUKEMIA, V11, P2022, DOI 10.1038/sj.leu.2400880; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Poppe B, 2006, GENE CHROMOSOME CANC, V45, P349, DOI 10.1002/gcc.20295; Suzuki E, 2004, P NATL ACAD SCI USA, V101, P14788, DOI 10.1073/pnas.0406536101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; WELTE K, 1985, P NATL ACAD SCI USA, V82, P1526, DOI 10.1073/pnas.82.5.1526; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1	26	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8676	10.1371/journal.pone.0008676	http://dx.doi.org/10.1371/journal.pone.0008676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543EV	20084277	Green Submitted, gold, Green Published			2022-12-27	WOS:000273554600028
J	Just, MA; Cherkassky, VL; Aryal, S; Mitchell, TM				Just, Marcel Adam; Cherkassky, Vladimir L.; Aryal, Sandesh; Mitchell, Tom M.			A Neurosemantic Theory of Concrete Noun Representation Based on the Underlying Brain Codes	PLOS ONE			English	Article							EVENT-RELATED FMRI; NEURAL REPRESENTATIONS; CORTEX; RECOGNITION; OBJECTS; TOOLS; HUMANS; STATES; LOBE; AREA	This article describes the discovery of a set of biologically-driven semantic dimensions underlying the neural representation of concrete nouns, and then demonstrates how a resulting theory of noun representation can be used to identify simple thoughts through their fMRI patterns. We use factor analysis of fMRI brain imaging data to reveal the biological representation of individual concrete nouns like apple, in the absence of any pictorial stimuli. From this analysis emerge three main semantic factors underpinning the neural representation of nouns naming physical objects, which we label manipulation, shelter, and eating. Each factor is neurally represented in 3-4 different brain locations that correspond to a cortical network that co-activates in non-linguistic tasks, such as tool use pantomime for the manipulation factor. Several converging methods, such as the use of behavioral ratings of word meaning and text corpus characteristics, provide independent evidence of the centrality of these factors to the representations. The factors are then used with machine learning classifier techniques to show that the fMRI-measured brain representation of an individual concrete noun like apple can be identified with good accuracy from among 60 candidate words, using only the fMRI activity in the 16 locations associated with these factors. To further demonstrate the generativity of the proposed account, a theory-based model is developed to predict the brain activation patterns for words to which the algorithm has not been previously exposed. The methods, findings, and theory constitute a new approach of using brain activity for understanding how object concepts are represented in the mind.	[Just, Marcel Adam; Cherkassky, Vladimir L.; Aryal, Sandesh] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Mitchell, Tom M.] Carnegie Mellon Univ, Sch Comp Sci, Machine Learning Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Just, MA (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	just@cmu.edu		Just, Marcel/0000-0003-1245-3050	W. M. Keck Foundation; National Science Foundation [IIS-0835797]; Direct For Computer & Info Scie & Enginr [0835797] Funding Source: National Science Foundation	W. M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was supported by the W. M. Keck Foundation and the National Science Foundation, Grant No. IIS-0835797. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Creem-Regehr SH, 2005, COGNITIVE BRAIN RES, V22, P457, DOI 10.1016/j.cogbrainres.2004.10.006; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; FILLENBAUM S, 1971, STRUCTURES SUBJECTIV; GORSUCH R, 1983, FACTOR ANAL, P239; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Hermsdorfer J, 2007, NEUROIMAGE, V36, pT109, DOI 10.1016/j.neuroimage.2007.03.037; Lacquaniti F, 1997, NEUROIMAGE, V5, P129, DOI 10.1006/nimg.1996.0254; Lewis JW, 2006, NEUROSCIENTIST, V12, P211, DOI 10.1177/1073858406288327; MILLER GA, 1987, LANGUAGE PERCEPTION; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; RIPS LJ, 1973, J VERB LEARN VERB BE, V12, P1, DOI 10.1016/S0022-5371(73)80056-8; ROMNEY AK, 1964, AM ANTHROPOL, V66, P146; SHEPARD RN, 1992, PSYCHOL SCI, V3, P97, DOI 10.1111/j.1467-9280.1992.tb00006.x; Shikata E, 2001, J NEUROPHYSIOL, V85, P1309, DOI 10.1152/jn.2001.85.3.1309; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Simon O, 2002, NEURON, V33, P475, DOI 10.1016/S0896-6273(02)00575-5; Sugiura M, 2005, J COGNITIVE NEUROSCI, V17, P183, DOI 10.1162/0898929053124956; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978	27	130	130	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 13	2010	5	1							e8622	10.1371/journal.pone.0008622	http://dx.doi.org/10.1371/journal.pone.0008622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	543EV	20084104	Green Published, gold			2022-12-27	WOS:000273554600006
J	Wu, H; Min, JR; Lunin, VV; Antoshenko, T; Dombrovski, L; Zeng, H; Allali-Hassani, A; Campagna-Slater, V; Vedadi, M; Arrowsmith, CH; Plotnikov, AN; Schapira, M				Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu			Structural Biology of Human H3K9 Methyltransferases	PLOS ONE			English	Article							HISTONE LYSINE METHYLTRANSFERASES; PRODUCT SPECIFICITY; PROTEIN METHYLTRANSFERASES; MOLECULAR REPLACEMENT; METHYLATION; DOMAIN; RECOGNITION; MECHANISM; CATALYSIS; CHROMATIN	SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.	[Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	alexander.plotnikov@mssm.edu; matthieu.schapira@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by the Structural Genomics Consortium (SGC), a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	206	217	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8570	10.1371/journal.pone.0008570	http://dx.doi.org/10.1371/journal.pone.0008570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20967253	gold, Green Published			2022-12-27	WOS:000273456300003
J	Prasanna, SJ; Gopalakrishnan, D; Shankar, SR; Vasandan, AB				Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu			Pro-Inflammatory Cytokines, IFN gamma and TNF alpha, Influence Immune Properties of Human Bone Marrow and Wharton Jelly Mesenchymal Stem Cells Differentially	PLOS ONE			English	Article							PROLIFERATION IN-VITRO; NECROSIS-FACTOR-ALPHA; STROMAL CELLS; LIFE-SPAN; IMMUNOGENICITY; FETAL; TRANSPLANTATION; REJECTION; RESPONSES; SUPPRESSION	Background: Wharton's jelly derived stem cells (WJMSCs) are gaining attention as a possible clinical alternative to bone marrow derived mesenchymal stem cells (BMMSCs) owing to better accessibility, higher expansion potential and low immunogenicity. Usage of allogenic mesenchymal stem cells (MSC) could be permissible in vivo only if they retain their immune properties in an inflammatory setting. Thus the focus of this study is to understand and compare the immune properties of BMMSCs and WJMSCs primed with key pro-inflammatory cytokines, Interferon-gamma (IFN gamma) and Tumor Necrosis Factor-alpha (TNF alpha). Methodology/Principal Findings: Initially the effect of priming on MSC mediated suppression of alloantigen and mitogen induced lymphoproliferation was evaluated in vitro. Treatment with IFN gamma or TNF alpha, did not ablate the immune-suppression caused by both the MSCs. Extent of immune-suppression was more with WJMSCs than BMMSCs in both the cases. Surprisingly, priming BMMSCs enhanced suppression of mitogen driven lymphoproliferation only; whereas IFN gamma primed WJMSCs were better suppressors of MLRs. Further, kinetic analysis of cytokine profiles in co-cultures of primed/unprimed MSCs and Phytohematoagglutinin (PHA) activated lymphocytes was evaluated. Results indicated a decrease in levels of pro-inflammatory cytokines. Interestingly, a change in kinetics and thresholds of Interleukin-2 (IL-2) secretion was observed only with BMMSCs. Analysis of activation markers on PHA-stimulated lymphocytes indicated different expression patterns in co-cultures of primed/unprimed WJMSCs and BMMSCs. Strikingly, co-culture with WJMSCs resulted in an early activation of a negative co-stimulatory molecule, CTLA4, which was not evident with BMMSCs. A screen for immune suppressive factors in primed/unprimed WJMSCs and BMMSCs indicated inherent differences in IFN gamma inducible Indoleamine 2, 3-dioxygenase (IDO) activity, Hepatocyte growth factor (HGF) and Prostaglandin E-2 (PGE2) levels which could possibly influence the mechanism of immune-modulation. Conclusion/Significance: This study demonstrates that inflammation affects the immune properties of MSCs distinctly. Importantly different tissue derived MSCs could utilize unique mechanisms of immune-modulation.	[Prasanna, S. Jyothi; Gopalakrishnan, Divya; Shankar, Shilpa Rani; Vasandan, Anoop Babu] Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Prasanna, SJ (corresponding author), Manipal Univ, Manipal Inst Regenerat Med, Constituent Inst, Bangalore, Karnataka, India.	jyothi.prasanna@manipal.edu			Department of Biotechnology, India [BT/PR7091/MED/14/941/2006]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grant BT/PR7091/MED/14/941/2006 obtained from Department of Biotechnology, India (dbtindia.nic.in). The funders have no role in the study design, data analysis and collection, decision to publish or preparation of the manuscript.	Agaugue S, 2006, J IMMUNOL, V177, P2061, DOI 10.4049/jimmunol.177.4.2061; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; CARTER A, 1990, BRIT J HAEMATOL, V74, P424, DOI 10.1111/j.1365-2141.1990.tb06330.x; Caruso A, 1997, CYTOMETRY, V27, P71, DOI 10.1002/(SICI)1097-0320(19970101)27:1<71::AID-CYTO9>3.0.CO;2-O; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chan WK, 2008, EXP HEMATOL, V36, P1545, DOI 10.1016/j.exphem.2008.06.008; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Fang LB, 2006, TRANSPLANTATION, V82, P1370, DOI 10.1097/01.tp.0000232450.62408.f9; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gotherstrom C, 2004, AM J OBSTET GYNECOL, V190, P239, DOI 10.1016/j.ajog.2003.07.022; Gotherstrom C, 2003, BONE MARROW TRANSPL, V32, P265, DOI 10.1038/sj.bmt.1704111; Gotherstrom C, 2005, HAEMATOLOGICA, V90, P1017; Hoogduijn MJ, 2007, STEM CELLS DEV, V16, P597, DOI 10.1089/scd.2006.0110; JOHANNISSON A, 1995, CYTOMETRY, V19, P343, DOI 10.1002/cyto.990190409; Jones BJ, 2008, EXP HEMATOL, V36, P733, DOI 10.1016/j.exphem.2008.03.006; Kadam SS, 2009, IN VITRO CELL DEV-AN, V45, P23, DOI 10.1007/s11626-008-9155-4; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Krampera M, 2007, STEM CELLS DEV, V16, P797, DOI 10.1089/scd.2007.0024; Krampera M, 2006, CURR OPIN PHARMACOL, V6, P435, DOI 10.1016/j.coph.2006.02.008; Le Blanc K, 2003, CYTOTHERAPY, V5, P485, DOI 10.1080/14653240310003611; Le Blanc K, 2005, BIOL BLOOD MARROW TR, V11, P321, DOI 10.1016/j.bbmt.2005.01.005; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Magatti M, 2008, STEM CELLS, V26, P182, DOI 10.1634/stemcells.2007-0491; Majumdar MK, 2003, J BIOMED SCI, V10, P228, DOI 10.1159/000068710; McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pierdomenico L, 2005, TRANSPLANTATION, V80, P836, DOI 10.1097/01.tp.0000173794.72151.88; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; ROTH MD, 1994, J EXP MED, V179, P857, DOI 10.1084/jem.179.3.857; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Sundin M, 2007, HAEMATOLOGICA, V92, P1208, DOI 10.3324/haematol.11446; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Xuan Min, 2006, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V22, P433; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; YOO KH, 2009, CELL IMMUNOL; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	63	399	423	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 2	2010	5	2							e9016	10.1371/journal.pone.0009016	http://dx.doi.org/10.1371/journal.pone.0009016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551KN	21152066	Green Submitted, gold, Green Published			2022-12-27	WOS:000274207200013
J	Cox, MJ; Allgaier, M; Taylor, B; Baek, MS; Huang, YJ; Daly, RA; Karaoz, U; Andersen, GL; Brown, R; Fujimura, KE; Wu, B; Tran, D; Koff, J; Kleinhenz, ME; Nielson, D; Brodie, EL; Lynch, SV				Cox, Michael J.; Allgaier, Martin; Taylor, Byron; Baek, Marshall S.; Huang, Yvonne J.; Daly, Rebecca A.; Karaoz, Ulas; Andersen, Gary L.; Brown, Ronald; Fujimura, Kei E.; Wu, Brian; Tran, Diem; Koff, Jonathan; Kleinhenz, Mary Ellen; Nielson, Dennis; Brodie, Eoin L.; Lynch, Susan V.			Airway Microbiota and Pathogen Abundance in Age-Stratified Cystic Fibrosis Patients	PLOS ONE			English	Article							POPULATION-DYNAMICS; BACTERIAL DIVERSITY; LUNG-INFECTIONS; SPUTUM; EXACERBATIONS; PRODUCTIVITY; COMMUNITIES; PHYLOGENIES; ACTIVATION; SUCCESSION	Bacterial communities in the airways of cystic fibrosis (CF) patients are, as in other ecological niches, influenced by autogenic and allogenic factors. However, our understanding of microbial colonization in younger versus older CF airways and the association with pulmonary function is rudimentary at best. Using a phylogenetic microarray, we examine the airway microbiota in age stratified CF patients ranging from neonates (9 months) to adults (72 years). From a cohort of clinically stable patients, we demonstrate that older CF patients who exhibit poorer pulmonary function possess more uneven, phylogenetically-clustered airway communities, compared to younger patients. Using longitudinal samples collected form a subset of these patients a pattern of initial bacterial community diversification was observed in younger patients compared with a progressive loss of diversity over time in older patients. We describe in detail the distinct bacterial community profiles associated with young and old CF patients with a particular focus on the differences between respective "early'' and "late'' colonizing organisms. Finally we assess the influence of Cystic Fibrosis Transmembrane Regulator (CFTR) mutation on bacterial abundance and identify genotype-specific communities involving members of the Pseudomonadaceae, Xanthomonadaceae, Moraxellaceae and Enterobacteriaceae amongst others. Data presented here provides insights into the CF airway microbiota, including initial diversification events in younger patients and establishment of specialized communities of pathogens associated with poor pulmonary function in older patient populations.	[Cox, Michael J.; Huang, Yvonne J.; Fujimura, Kei E.; Wu, Brian; Koff, Jonathan; Kleinhenz, Mary Ellen; Nielson, Dennis; Lynch, Susan V.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Allgaier, Martin; Taylor, Byron; Baek, Marshall S.; Brown, Ronald] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Daly, Rebecca A.; Karaoz, Ulas; Andersen, Gary L.; Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Ecol, Berkeley, CA 94720 USA; [Daly, Rebecca A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Huang, Yvonne J.; Koff, Jonathan; Kleinhenz, Mary Ellen] Univ Calif San Francisco, Adult Cyst Fibrosis Program, San Francisco, CA 94143 USA; [Wu, Brian; Tran, Diem; Nielson, Dennis] Univ Calif San Francisco, Pediat Cyst Fibrosis Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cox, MJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Lynch, Susan V/B-6272-2009; Karaoz, Ulas/J-7093-2014; Andersen, Gary/G-2792-2015; Cox, Michael/A-6959-2010; Brodie, Eoin L/A-7853-2008; Huang, Yvonne/A-7360-2015	Karaoz, Ulas/0000-0002-8238-6757; Andersen, Gary/0000-0002-1618-9827; Brodie, Eoin L/0000-0002-8453-8435; Cox, Michael/0000-0002-4002-1506; Nielson, Dennis/0000-0003-0275-8942; Huang, Yvonne/0000-0002-7497-6597; Daly, Rebecca/0000-0003-2223-7458	NIH/NIAID [AI075410]; CFRI; NIH/NHLBI [HL-073856]; STAR [FP-916933]; U.S. Environmental Protection Agency; US Department of Energy by the University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080074] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CFRI; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); STAR; U.S. Environmental Protection Agency(United States Environmental Protection Agency); US Department of Energy by the University of California, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVL, ELB, UK and GLA are supported by NIH/NIAID award AI075410 http://www.nih.gov/. MJC is supported by an Elizabeth Nash, CFRI research fellowship http://www.elizabethnashfoundation.org. DN is partly funded by NIH/NHLBI award HL-073856. RAD was supported under a STAR Research Assistance Agreement No. FP-916933 awarded by the U.S. Environmental Protection Agency. This publication has not been formally reviewed by the EPA http://www.epa.gov/. The views expressed in this publication are solely those of the group of authors and the EPA does not endorse any products or commercial services mentioned in this publication. Part of this work was performed under the auspices of the US Department of Energy by the University of California, Lawrence Berkeley National Laboratory, under Contract DE-AC02-05CH11231 http://www.lbl.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadori A, 2009, RESP MED, V103, P407, DOI 10.1016/j.rmed.2008.09.024; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Atkinson TP, 2008, FEMS MICROBIOL REV, V32, P956, DOI 10.1111/j.1574-6976.2008.00129.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bittar F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002908; Bowman C M, 2002, J Cyst Fibros, V1, P194, DOI 10.1016/S1569-1993(02)00003-6; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Bruzzese E, 2007, CLIN NUTR, V26, P322, DOI 10.1016/j.clnu.2007.01.004; Coenye T, 2002, J CLIN MICROBIOL, V40, P2062, DOI 10.1128/JCM.40.6.2062-2069.2002; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Gao-sheng Zhang, 2007, Journal of Zhejiang University-Science B, V8, P540, DOI 10.1631/jzus.2007.B0540; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HAHN DL, 2002, FRONT BIOSCI, V7, P66; HAMADY M, 2009, ISME J IN PRESS; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hogardt M, 2008, JPN J INFECT DIS, V61, P77; HOIBY N, 1988, CHEST, V94, pS97, DOI 10.1378/chest.94.2_Supplement.97S; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Jackson CR, 2003, OIKOS, V101, P444, DOI 10.1034/j.1600-0706.2003.12254.x; Jahn HU, 2000, J INFECT DIS, V182, P1678, DOI 10.1086/317608; KEMBEL SW, 2008, PICANTE TOOLS INTEGR; Kerem B, 1996, EUR J HUM GENET, V4, P65; Kolak M, 2003, INT J MED MICROBIOL, V293, P309, DOI 10.1078/1438-4221-00265; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LAWLEY TD, 2009, INFECT IMMUN; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEY R, 2006, NATURE, V444, P1023; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Marcante S, 2009, ANN BOT-LONDON, V103, P1129, DOI 10.1093/aob/mcp047; Martinez-Medina M, 2006, INFLAMM BOWEL DIS, V12, P1136, DOI 10.1097/01.mib.0000235828.09305.0c; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Meyer EH, 2006, P NATL ACAD SCI USA, V103, P2782, DOI 10.1073/pnas.0510282103; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pollard K.S., 2014, MULTTEST RESAMPLING; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; QIN J, NATURE, V464, P59; RAZVI S, 2009, CHEST; ROBERTS RC, 1983, INFECT IMMUN, V40, P553, DOI 10.1128/IAI.40.2.553-562.1983; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Saiman Lisa, 2004, Paediatr Respir Rev, V5 Suppl A, pS367, DOI 10.1016/S1526-0542(04)90065-6; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Shen Y E, 1991, J Hyg Epidemiol Microbiol Immunol, V35, P309; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Souza Helena A. P. H. M., 2006, J. Pediatr. (Rio J.), V82, P377, DOI [10.1590/S0021-75572006000600012, 10.2223/JPED.1527]; STECHER B, PLOS PATHOG, V6; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Team RDC, 2019, R LANG ENV STAT COMP; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wardle DA, 2003, SCIENCE, V300, P972, DOI 10.1126/science.1082709; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2006, ECOLOGY, V87, pS1, DOI 10.1890/0012-9658(2006)87[1:IPICE]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Widdicombe JH, 2001, PFLUG ARCH EUR J PHY, V443, pS8; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1	74	383	395	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11044	10.1371/journal.pone.0011044	http://dx.doi.org/10.1371/journal.pone.0011044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615KY	20585638	Green Published, Green Submitted, gold			2022-12-27	WOS:000279135400003
J	Sun, J; Wang, XT; Lau, A; Liao, TYA; Bucci, C; Hmama, Z				Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Bucci, Cecilia; Hmama, Zakaria			Mycobacterial Nucleoside Diphosphate Kinase Blocks Phagosome Maturation in Murine Raw 264.7 Macrophages	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TUBERCULOSIS PHAGOSOME; RAB7; TRANSPORT; RILP; VIRULENCE; DISTINCT; IDENTIFICATION; MANIPULATION	Background: Microorganisms capable of surviving within macrophages are rare, but represent very successful pathogens. One of them is Mycobacterium tuberculosis (Mtb) whose resistance to early mechanisms of macrophage killing and failure of its phagosomes to fuse with lysosomes causes tuberculosis (TB) disease in humans. Thus, defining the mechanisms of phagosome maturation arrest and identifying mycobacterial factors responsible for it are key to rational design of novel drugs for the treatment of TB. Previous studies have shown that Mtb and the related vaccine strain, M. bovis bacille Calmette-Guerin (BCG), disrupt the normal function of host Rab5 and Rab7, two small GTPases that are instrumental in the control of phagosome fusion with early endosomes and late endosomes/lysosomes respectively. Methodology/Principal Findings: Here we show that recombinant Mtb nucleoside diphosphate kinase (Ndk) exhibits GTPase activating protein (GAP) activity towards Rab5 and Rab7. Then, using a model of latex bead phagosomes, we demonstrated that Ndk inhibits phagosome maturation and fusion with lysosomes in murine RAW 264.7 macrophages. Maturation arrest of phagosomes containing Ndk-beads was associated with the inactivation of both Rab5 and Rab7 as evidenced by the lack of recruitment of their respective effectors EEA1 (early endosome antigen 1) and RILP (Rab7-interacting lysosomal protein). Consistent with these findings, macrophage infection with an Ndk knocked-down BCG strain resulted in increased fusion of its phagosome with lysosomes along with decreased survival of the mutant. Conclusion: Our findings provide evidence in support of the hypothesis that mycobacterial Ndk is a putative virulence factor that inhibits phagosome maturation and promotes survival of mycobacteria within the macrophage.	[Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy	University of British Columbia; Vancouver Coastal Health Research Institute; University of Salento	Sun, J (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	hmama@interchange.ubc.ca	Bucci, Cecilia/F-6699-2012	Bucci, Cecilia/0000-0002-6232-6183; Amdur, Richard/0000-0002-4900-653X; Sun, Jim/0000-0002-6873-6052	Canadian Institutes of Health Research [MOP-84557]; British Columbia Lung Association; Michael Smith Foundation for Health Research; TBVets Charitable Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); TBVets Charitable Foundation	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84557) and British Columbia Lung Association. Z. Hmama was supported by scholar awards from the Michael Smith Foundation for Health Research and the TBVets Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Astarie-Dequeker C, 2002, J CELL SCI, V115, P81; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Chopra P, 2004, FEBS LETT, V571, P212, DOI 10.1016/j.febslet.2004.06.073; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Chow Chung-Wai, 2004, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1507s22; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kimura N, 2003, J BIOENERG BIOMEMBR, V35, P41, DOI 10.1023/A:1023489722460; LEE BY, 1995, J CLIN INVEST, V96, P245, DOI 10.1172/JCI118028; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; PAWELRAMMINGEN U, 2000, MOL MICROBIOL, V36, P737; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Ramachandra L, 1999, CELL MICROBIOL, V1, P205, DOI 10.1046/j.1462-5822.1999.00026.x; Roberts RL, 1999, J CELL SCI, V112, P3667; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40	60	106	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8769	10.1371/journal.pone.0008769	http://dx.doi.org/10.1371/journal.pone.0008769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20613869	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900013
J	Cox, MJ; Huang, YJ; Fujimura, KE; Liu, JT; McKean, M; Boushey, HA; Segal, MR; Brodie, EL; Cabana, MD; Lynch, SV				Cox, Michael J.; Huang, Yvonne J.; Fujimura, Kei E.; Liu, Jane T.; McKean, Michelle; Boushey, Homer A.; Segal, Mark R.; Brodie, Eoin L.; Cabana, Michael D.; Lynch, Susan V.			Lactobacillus casei Abundance Is Associated with Profound Shifts in the Infant Gut Microbiome	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; IRRITABLE-BOWEL-SYNDROME; INTESTINAL MICROBIOTA; BACTERIAL DIVERSITY; PROBIOTIC BACTERIA; COMMUNITY ECOLOGY; ASTHMA PREVENTION; IMMUNE FUNCTION; ATOPIC DISEASE; CLONE LIBRARY	Colonization of the infant gut by microorganisms over the first year of life is crucial for development of a balanced immune response. Early alterations in the gastrointestinal microbiota of neonates has been linked with subsequent development of asthma and atopy in older children. Here we describe high-resolution culture-independent analysis of stool samples from 6-month old infants fed daily supplements of Lactobacillus casei subsp. Rhamnosus (LGG) or placebo in a double-blind, randomized Trial of Infant Probiotic Supplementation (TIPS). Bacterial community composition was examined using a high-density microarray, the 16S rRNA PhyloChip, and the microbial assemblages of infants with either high or low LGG abundance were compared. Communities with high abundance of LGG exhibited promotion of phylogenetically clustered taxa including a number of other known probiotic species, and were significantly more even in their distribution of community members. Ecologically, these aspects are characteristic of communities that are more resistant to perturbation and outgrowth of pathogens. PhyloChip analysis also permitted identification of taxa negatively correlated with LGG abundance that have previously been associated with atopy, as well as those positively correlated that may prove useful alternative targets for investigation as alternative probiotic species. From these findings we hypothesize that a key mechanism for the protective effect of LGG supplementation on subsequent development of allergic disease is through promotion of a stable, even, and functionally redundant infant gastrointestinal community.	[Cox, Michael J.; Fujimura, Kei E.; Lynch, Susan V.] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; [Huang, Yvonne J.; Liu, Jane T.; Boushey, Homer A.; Cabana, Michael D.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [McKean, Michelle; Cabana, Michael D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Segal, Mark R.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Brodie, Eoin L.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Dept Ecol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Cox, MJ (corresponding author), Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA.	susan.lynch@ucsf.edu	Lynch, Susan V/B-6272-2009; Karaoz, Ulas/J-7093-2014; Andersen, Gary/G-2792-2015; Cox, Michael/A-6959-2010; Brodie, Eoin L/A-7853-2008; Huang, Yvonne/A-7360-2015	Karaoz, Ulas/0000-0002-8238-6757; Andersen, Gary/0000-0002-1618-9827; Brodie, Eoin L/0000-0002-8453-8435; Cox, Michael/0000-0002-4002-1506; Nielson, Dennis/0000-0003-0275-8942; Huang, Yvonne/0000-0002-7497-6597; Daly, Rebecca/0000-0003-2223-7458	National Institutes of Health (NIH) [HL080074, HL074207]; Tobacco-Related Disease Research Program; National Institutes of Health/National Center for Research Resources (NIH/NCRR) [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080074] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program(University of California System); National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SVL is supported by an American Lung Association Award (http://www.lungusa.org/), MDC and and HAB are supported by a National Institutes of Health (NIH) award (http://www.nih.gov/), HL080074 to MDC and HL074207 to HAB and ELB, and YLH by a Tobacco-Related Disease Research Program award (http://www.trdrp.org/). Part of this work was performed at Lawrence Berkeley National Laboratory under the auspices of the University of California under contract number DOE DE-AC02-05CH11231. This study was also supported in part by National Institutes of Health/National Center for Research Resources (NIH/NCRR) University of California San Francisco Clinical and Translational Science (UCSF-CTSI) Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Baken KA, 2006, INT J FOOD MICROBIOL, V112, P8, DOI 10.1016/j.ijfoodmicro.2006.06.009; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barbara G, 2008, J CLIN GASTROENTEROL, V42, pS214, DOI 10.1097/MCG.0b013e31817da129; Barrett JS, 2008, WORLD J GASTROENTERO, V14, P5020, DOI 10.3748/wjg.14.5020; Bell SG, 2007, NEONATAL NETW, V26, P57, DOI 10.1891/0730-0832.26.1.57; Betsi GL, 2008, AM J CLIN DERMATOL, V9, P93, DOI 10.2165/00128071-200809020-00002; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brodie EL, 2006, APPL ENVIRON MICROB, V72, P6288, DOI 10.1128/AEM.00246-06; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Flanagan JL, 2007, J CLIN MICROBIOL, V45, P1954, DOI 10.1128/JCM.02187-06; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; Galdeano CM, 2007, CLIN VACCINE IMMUNOL, V14, P485, DOI 10.1128/CVI.00406-06; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Ghadimi D, 2008, IMMUNOBIOLOGY, V213, P677, DOI 10.1016/j.imbio.2008.02.001; Gill H, 2008, ADV EXP MED BIOL, V606, P423, DOI 10.1007/978-0-387-74087-4_17; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Kalliomaki M., 2002, Current Drug Targets - Infectious Disorders, V2, P193; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; KEMBEL SW, 2008, PICANTE TOOLS INTEGR; Kumar PS, 2006, J CLIN MICROBIOL, V44, P3665, DOI 10.1128/JCM.00317-06; KUVAEVA IB, 1984, NAHRUNG, V28, P689; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEY R, 2006, NATURE, V444, P1023; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu AH, 2007, PAEDIATR PERINAT EP, V21, P2, DOI 10.1111/j.1365-3016.2007.00878.x; Maassen CBM, 2000, VACCINE, V18, P2613, DOI 10.1016/S0264-410X(99)00378-3; Nova E, 2007, BRIT J NUTR, V98, pS90, DOI 10.1017/S0007114507832983; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Park CW, 2008, J MED FOOD, V11, P405, DOI 10.1089/jmf.2007.0144; Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pollard K.S., 2014, MULTTEST RESAMPLING; Prescott SL, 1998, J IMMUNOL, V160, P4730; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Sagaram US, 2009, APPL ENVIRON MICROB, V75, P1566, DOI 10.1128/AEM.02404-08; Sakamoto M, 2004, J MED MICROBIOL, V53, P563, DOI 10.1099/jmm.0.45576-0; Samanta M, 2009, J TROP PEDIATRICS, V55, P128, DOI 10.1093/tropej/fmn091; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sepp E, 1997, ACTA PAEDIATR, V86, P956, DOI 10.1111/j.1651-2227.1997.tb15178.x; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Staley JT, 2005, FEMS MICROBIOL LETT, V243, P9, DOI 10.1016/j.femsle.2004.11.034; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; SUNAGAWA S, 2009, ISME J; Team RDC, 2019, R LANG ENV STAT COMP; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; THOMSEN SF, 2009, AM J RESP CRIT CARE; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Verhulst SL, 2008, J ASTHMA, V45, P828, DOI 10.1080/02770900802339734; Versalovic J, 2007, HEPATOLOGY, V46, P618, DOI 10.1002/hep.21916; Webb CO, 2006, ECOLOGY, V87, pS1, DOI 10.1890/0012-9658(2006)87[1:IPICE]2.0.CO;2; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WILLIAMS E, 2008, ALIMENT PHARM THER; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yoo Jennifer, 2007, Proc Am Thorac Soc, V4, P277, DOI 10.1513/pats.200702-033AW	73	383	395	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 18	2010	5	1							e8745	10.1371/journal.pone.0008745	http://dx.doi.org/10.1371/journal.pone.0008745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545EJ	20585638	Green Published, gold, Green Submitted			2022-12-27	WOS:000273715000006
